"concept","cuis","rep_cuis","excluded_cuis","cc"
"fondaparinux no","C1098510","C1098510","",859
"baseline aspirin dose $nmbr$ mg","C0024671;C0026410;C0168634;C0439269;C1442488;C1960952;C2346927;C4321396;C4521761;C4696290","C0004057","",1366
"blood pressure lowering medication use","C0005823;C0240320;C0441994;C1271104;C1272641;C2003888",NULL,NULL,119
"all cause mortality at $nmbr$ year","C0015127;C0026565;C0026566;C0439234;C0439508;C0444868;C1524003;C3539085",NULL,NULL,1099
"baseline dmard use n","C0042153;C0168634;C0242708;C0457083;C1442488;C1947944",NULL,NULL,625
"egfr ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"high risk ri $nmbr$","C0035487;C0332167;C1826843;C3272283;C4050568;C4319571","C4319571","",837
"omega $nmbr$ fa","C1719844","C0015684","",1236
"anti ischaemia agents","C0022116;C0040616;C4321499",NULL,NULL,1668
"sfc $nmbr$ $nmbr$ mg twice daily n $nmbr$","C0024671;C0026410;C0439269;C0585361;C1960952;C2346927;C4321396;C4521536;C4521761",NULL,NULL,1283
"edema z","C0013604;C1717255",NULL,NULL,690
"benralizumab","C2982078",NULL,NULL,947
"$nmbr$ and no moderate or severe deformity n $nmbr$","C0000768;C0205081;C0205082;C0221430;C0302142;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335",NULL,NULL,321
"dbp during the follow up period mmhg","C0439475;C0439531;C0536221;C0589120;C1522577;C1704685;C1948053;C3274571;C3813197;C4281799",NULL,NULL,605
"renal biopsy class","C0194073;C0456387;C1518526;C1705943",NULL,NULL,452
"total daily dose of ics mean gc","C0444504;C0815320;C2347634;C2348070;C2348143;C3537453;C4281799;C4551720",NULL,NULL,37
"dizziness","C0012833;C0042571;C1963093;C4084788;C4085547;C4085548;C4085549;C4553830","","",-10
"lipid trial participants n","C0023779;C1997894;C2242969",NULL,NULL,278
"carotid bulb sites","C0007281;C0205145","C0007272","",1547
"spinal","C0521329",NULL,NULL,1551
"disease duration $nmbr$ to b $nmbr$ years n $nmbr$","C0439234;C0872146","C0449238","",1989
"statin at last follow up","C0360714;C0589120;C1522577;C1704685;C3274571","C0360714","",872
"known thrombophilic condition no","C0012634;C0205309;C0348080;C0398623;C1705253;C3864998",NULL,NULL,1710
"duration of type $nmbr$ diabetes categories n","C1320657;C1547660","C0011849;C1320657","",907
"a worldwide black and non black patients","C0005680;C0027567;C0085756;C0439541;C1829939","C0005680",";C1706779",188
"ics n","C0815320;C4551720","C3540778","",2182
"mineralocorticoid receptor antagonist","C1579268",NULL,NULL,185
"aminosalicylate","C0368663;C2825094","C0368663","",1691
"all cause mortality or hosp for worsening hf hs crp $nmbr$ $nmbr$ mg l","C0015127;C0018488;C0026565;C0026566;C0332271;C0439268;C0444868;C1313497;C1457868;C1524003;C1538440;C1546960;C3273279;C3539085;C3890735;C4048285","C0018801",";C0168634;C1524003",12
"walk for exercise","C0015259;C0080331;C1522704","C0015259","",1380
"left ventricular ejection fraction median iqr","C0428772;C0488728;C0549183;C0876920;C2347635;C2348144;C2939193","C0018801;C0428772","",1273
"coronary angiography","C0085532;C1548829",NULL,NULL,1724
"pg mg","C1627892",NULL,NULL,197
"czp mtx mtx","C0025677;C0054841;C1417487;C1861828;C1872109","C0025677;C1872109","",2217
"final timi flow grade post ppci","C0205088;C0441800;C0687676;C0919553;C1546485;C1704687;C3244287;C3272266;C3469826;C3853528",NULL,NULL,531
"total daily insulin dose units kgt","C0021641;C0439148;C1519795;C1533581;C1579433;C2348070;C3714501;C3853603",NULL,NULL,157
"pef at baseline l_ min","C0030771;C0168634;C0702093;C1442488;C1518922;C1524029;C1542834;C3813700",NULL,NULL,1475
"region united states","C0017446;C0041703;C0205147",NULL,NULL,1550
"laba non users","C1518422;C1706077",NULL,NULL,534
"$nmbr$ ml min $nmbr$ $nmbr$ ni","C0028075;C0439445;C2348274;C3869926;C3869927",NULL,NULL,153
"creatinine mg dl sd","C0010294;C0439269;C1561535;C2699239","C0600061;C0010294","",952
"mean hscrp mg l sd","C0439268;C0444504;C2347634;C2348143;C2699239","C0006560","",286
"body mass index waist to hip ratio","C0005893;C0205682;C0578022;C1305855","C0205682","",1409
"baseline bp mean sd","C0168634;C0488053;C1442488;C2699239",NULL,NULL,625
"nitrate oral or topical","C0028125;C0332237;C0442027;C0699857;C3848573;C4521986",NULL,NULL,2031
"$nmbr$ months number n","C0237753;C0439231;C0449788",NULL,NULL,1556
"oral diabetic agent","C0241863;C0442027;C0450442;C1254351;C1521826;C4521986","C0020616",";C0013227;C3244316;C4284232;C0450442;C1254351;C1515187;C1521826;C2826257",33
"age mean sd yrs","C0001779;C0444504;C2347634;C2348143;C2699239","C0001779","",480
"insulin glargine insulin lispro award $nmbr$ n $nmbr$","C0004446;C0293359;C0907402","C0907402",";C1998602;C0004446;C0005126;C2344255;C4050145;C0229089;C0439164;C1512019;C3273373;C3665488",69
"bdp ff g n $nmbr$","C0004906;C0439267;C1422585;C1538710;C4554348",NULL,NULL,1597
"feno ppb","C1415800",NULL,NULL,1737
"fev $nmbr$ fvc a","C3714541",NULL,NULL,1599
"primary cause of chf","C0015127;C0018802;C0205225;C0439612;C0439631;C1524003",NULL,NULL,2343
"daytime mean sbp abpm at week $nmbr$ mmhg","C0085805;C0332169;C0332174;C0439230;C0439475;C0444504;C2347634;C2348143",NULL,NULL,607
"corticosteroids and immunosuppressants","C0001617;C0021081;C3539185;C3540725;C3540726;C3540727",NULL,NULL,1650
"disease characteristics","C0599878",NULL,NULL,1652
"post hoc analysis","C0002778;C0687676;C0936012;C1524024;C1704687;C3469826",NULL,NULL,245
"mean sd periostin ng ml","C0219433;C0439275;C0444504;C1424662;C2347634;C2348143;C2699239;C3812270",NULL,NULL,37
"all cause mort hf hosp","C0015127;C0018488;C1313497;C1524003;C1538440;C3273279;C3815322","C0018801",";C0168634;C1524003",12
"$nmbr$ yr warfarin experience","C0043031;C0237607;C0439234;C0596545",NULL,NULL,1099
"$nmbr$ $nmbr$ o lt","C0023376;C0230426;C0483204;C3887647;C4521399",NULL,NULL,1678
"health care use rate peryear","C0814514;C0871208;C1521828",NULL,NULL,1103
"components of the first cid","C0205435;C0449432;C1279901;C1707433",NULL,NULL,806
"change from baseline in fevj mb","C0024853;C0168634;C0392747;C0443172;C1442488;C1705241;C4319952",NULL,NULL,767
"clinical features of hf","C0018488;C0683325;C1313497;C1538440;C3273279","C0018801",";C0168634;C1524003",12
"history of atrial fibrillation or flutter","C0016385;C0729790;C2242390",";C0004238","",1009
"nyha classes iii iv","C0278962","C0018802;C1882083","",453
"minutes from prehospital ecg to pci median iqr","C0439232;C0549183;C0700321;C0702093;C0876920;C1282918;C1623258;C2347166;C2347635;C2348144;C2939193;C4049621",NULL,NULL,635
"ulcerative colitis","C0009324",NULL,NULL,1026
"triglycerides mean","C0041004;C0444504;C2347634;C2348143","C0041004","",368
"undiagnosed diabetes n $nmbr$","C0011847;C0011849;C1408353","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"baseline pssi score mean sd","C0168634;C0444504;C0449820;C1442488;C2347634;C2348143;C2699239;C4050231",NULL,NULL,1287
"migraine without aura","C0338480","C0338480","",1941
"region n a","C0017446;C0205147","C0017446","",369
"severe fev $nmbr$ predicted","C0205082;C0681842;C1882327;C3714541;C4050465;C4050466",NULL,NULL,1599
"insulin pmol l t vital signs","C0021641;C0150404;C0439284;C0518766;C1533581;C1579433;C3714501",NULL,NULL,157
"r $nmbr$ mg","C0024671;C0026410;C0205090;C0439269;C0684010;C1960952;C2346927;C2603358;C4321396;C4521761",NULL,NULL,192
"mean sd egfr ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C0444504;C1739039;C2347634;C2348143;C2699239;C3811844;C3812682","C3811844;C0017654","",307
"pcs score","C0449820;C1864389;C1882368;C4050231",NULL,NULL,749
"severe or very severe copd","C0024117;C0205082;C1412502;C3641272;C3714496;C4050419;C4050465;C4050466","C0024117;C0205082",";C4050419;C1412502;C3714496;C0018026;C1304897;C4050465;C4050466",1836
"icd crt d n","C0021122",NULL,NULL,256
"history of chd at baseline no","C0019664;C0019665;C0168634;C0262512;C0262926;C0280604;C1442488;C1705255;C2004062;C3542407",NULL,NULL,970
"all canakinumab","C2718773","C2718773","",372
"median feno ppba","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"no regular consumption","C0009830;C0205272;C1947907",NULL,NULL,1711
"bb after randomisation","C0004739;C0034656;C0332297",NULL,NULL,714
"previous or current use of im and cs no","C0010182;C0205156;C0271160;C0521116;C1524063;C1552607;C1705970;C3540510;C4085345",NULL,NULL,136
"digitalis n","C0012252;C0304520","C0012265","",989
"smoking status at screening n","C0037369;C0220908;C0220909;C0421330;C0453996;C1519386;C1698960;C1710031;C1710032;C1710477;C1881674;C2348164",NULL,NULL,796
"thrombophilia no e","C0398623",NULL,NULL,623
"non white raceb","C0007457;C0043157;C0220938;C1518422","C0034510;C1518422;C0043157","",1401
"transfusions","C0005841;C0199960;C1879316","C0005841","",1241
"$nmbr$ y rate per $nmbr$ persons se n","C0027361;C0036919;C0871208;C1521828",NULL,NULL,567
"icd vs placebo","C0021122;C0032042;C1696465;C1706408","C0972395","",1360
"no oral antidiabetic medication","C0175795;C0442027;C0935929;C4521986",NULL,NULL,995
"other medical history no","C0262926;C1704706",NULL,NULL,832
"previous coronary artery bypass graft","C2144990","C2144990","",227
"disease site no","C0012634;C0205145;C1515974;C2825164",NULL,NULL,1193
"body mass index mean sd d","C0005893;C0444504;C0578022;C1305855;C2347634;C2348143;C2699239","C1305855","",1734
"absent","C0332197;C4285062",NULL,NULL,485
"canakinumab hscrp $nmbr$ $nmbr$ mg l at $nmbr$ months n $nmbr$","C0439231;C0439268;C2718773","C2718773","",372
"electrocardiogram","C0013798;C1547122;C1623258","C1623258","",1129
"race or ethnic group no t","C0015031;C0034510;C1706779;C1879937;C2603360;C3853635",";C0034510","",1107
"pr virgin islands n","C0042752;C0279759;C0279766;C1418864;C3538934;C3538935;C3889640;C4048189;C4082178;C4082184;C4085573;C4552913;C4552914",NULL,NULL,1518
"demography","C0011298",NULL,NULL,582
"final mean mg dl","C0205088;C0439269;C0444504;C1546485;C2347634;C2348143;C3853528",NULL,NULL,1680
"asia pacific","C0003980","C0003980","",1382
"no of previous biologic dmards no","C0205156;C1552607;C4055380",NULL,NULL,1045
"data are reported as percentage or mean standard deviation unless otherwise indicated ng normoglycemia igm impaired glucose metabolism ldl low density lipoprotein hdl high density lipoprotein fpg fasting plasma glucose a median interquartile range p $nmbr$ $nmbr$ vs ng p $nmbr$ $nmbr$ vs ng","C0015663;C0017725;C0017887;C0023820;C0023821;C0028074;C0178587;C0202042;C0205251;C0221099;C0439165;C0444504;C0455280;C0549183;C0580545;C0596620;C0684224;C0700287;C0871420;C0876920;C1154908;C1442989;C1444656;C1511726;C1549488;C1550472;C1561533;C1706005;C1711350;C1828170;C2347634;C2347635;C2348143;C2348144;C2828392;C2939193;C3245479;C3714741;C3890211;C4048187;C4319718;C4321351;C4522223",NULL,NULL,1482
"previous pci before index acs","C0205156;C0600653;C0742343;C0918012;C1552607;C1552854;C1637833;C2986546;C4049621;C4318612","C1532338","",1661
"at ldl c bq goal at baseline no","C0018017;C0168634;C0560038;C1442488;C1571704;C3541236",NULL,NULL,1688
"mean sd of predicted normal fevi","C0205307;C0231683;C0429706;C0439166;C0444504;C0681842;C0849974;C1561566;C1882327;C2347086;C2347634;C2348143;C2699239;C4528367;C4553972",NULL,NULL,37
"systolic bp mm hg","C0439475;C0871470","C0005823","",1469
"$nmbr$ to $nmbr$ ml min n $nmbr$ $nmbr$","C0439445","C3811844;C0017654","",307
"standard therapy n $nmbr$","C2936643",NULL,NULL,1646
"ind gly n $nmbr$","C0017890;C0523677;C4049864","C3814772;C1722260","",1509
"ratio to baseline in eosinophil count at week $nmbr$ geometric mean se on loge scale cells ll","C0007584;C0007634;C0036919;C0168634;C0175659;C0200638;C0332174;C0349674;C0439230;C0456603;C0750879;C1442488;C1547037;C1947916;C2697934;C2986759",NULL,NULL,1012
"region europe union","C0015179;C0017446;C0205147","C0017446","",369
"exenatide er","C0167117;C3810541;C3811131",NULL,NULL,759
"change from baseline median iqr","C0168634;C0392747;C0443172;C0549183;C0876920;C1442488;C1705241;C2347635;C2348144;C2939193;C4319952",NULL,NULL,635
"genotype","C0017431",NULL,NULL,602
"s e","C0565930;C2603362",NULL,NULL,1784
"asian or oriental","C0078988;C0699027","C0078988","",284
"creatinine clearance $nmbr$ ml min no weight $nmbr$ kg no","C0005910;C0022718;C0043100;C0439209;C0439445;C0812399;C1305866;C1705104;C4054209","C0812399",";C3889287;C0452249;C0522467;C1337213;C1576800;C3890003;C0005910;C0022718;C1305866;C1705104;C1705224;C3887665",79
"bmi mean sd kg m $nmbr$","C0444504;C0578022;C1532718;C2347634;C2348143;C2699239",";C1305855","",206
"n indacaterol $nmbr$ ug indacaterol $nmbr$ ug placebo","C0032042;C0369718;C0441922;C1319635;C1696465;C1706408;C1722260","C0032042","",28
"group difference","C0441833;C0687744;C1257890;C1519504;C1705241;C1705242;C1705428;C1705429",NULL,NULL,1466
"left sided colitis","C2887821",NULL,NULL,43
"cornell voltage duration product mm x ms","C0449238;C0598352;C1514468;C1704444;C2349943;C2926735;C3539704;C3713294;C4330985;C4554674",NULL,NULL,126
"immy without corticosteroid n","C0001617;C3536709",NULL,NULL,1650
"ethnicitya hispanic or latino","C0086409;C0086528","C0086528;C0086409;C0015031","",363
"history of chd at baseline","C0019664;C0019665;C0168634;C0262512;C0262926;C0280604;C1442488;C1705255;C2004062;C3542407",NULL,NULL,970
"hazard inleraction","C0598697",NULL,NULL,345
"renal subgroup","C0022646;C1079230;C1515021",NULL,NULL,1637
"das $nmbr$ esr mean sd","C0051767;C0057671;C0444504;C2347634;C2348143;C2699239;C3811131",NULL,NULL,1914
"total cholesterol mmo $nmbr$ $nmbr$","C0201950;C0543421","C0543421","",1504
"treatment before admission","C0039798;C0087111;C0184666;C0809949;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,470
"all cause","C0015127;C1524003",NULL,NULL,924
"europe israel or australia","C0004340;C0015176;C0022271","C0015176","",337
"bmi kg m $nmbr$ mean","C0444504;C0578022;C1532718;C2347634;C2348143",";C1305855","",206
"baseline short acting anticholinergics","C0079613;C0168634;C0242896;C1282927;C1442488;C1704930;C1806781;C1869853;C2350002;C3537307;C3540711;C3890007;C4048375",NULL,NULL,1704
"hbalc $nmbr$ mmol mol $nmbr$ $nmbr$ n $nmbr$ $nmbr$","C3829066","","",820
"$nmbr$ help needed still independent","C0027552;C0085862;C0686904;C1269765;C1290940;C1299583;C1552861",NULL,NULL,1202
"gaviscon da n $nmbr$","C0011318;C0061146;C3668815",NULL,NULL,1074
"ileum","C0020885","C0020885","",1341
"severe oab subgroup","C0205082;C1079230;C1515021;C4050465;C4050466",NULL,NULL,313
"mortality shock or congestive heart failure within $nmbr$ days","C0018802;C0026565;C0026566;C0036974;C0439228","C0018801",";C0168634;C1524003",12
"ascvd b no","C3665365",NULL,NULL,344
"aa g","C0282379;C0439267;C1235746;C1882141;C4554792",NULL,NULL,1754
"variables $nmbr$","C0439828",NULL,NULL,1018
"vasoprotectives","C0304533",NULL,NULL,2316
"total randomised n","C0439175;C0439810",NULL,NULL,508
"a $nmbr$ c n","C1272460",NULL,NULL,419
"abdominal aortic no","C0003484",NULL,NULL,1699
"present smokerc","C0150312;C0449450",NULL,NULL,287
"nontraumatic leg or foot amputation","C0023216;C0188605;C1140621",NULL,NULL,1613
"age $nmbr$ yr or $nmbr$ yr","C0001779;C0439234","C0001779","",480
"sacubitril valsartan","C4033631","C4033631","",2084
"$nmbr$ placebo","C0032042;C1696465;C1706408","C0032042","",28
"oral corticosteroid","C0001617;C0442027;C3536709;C4521986",NULL,NULL,1650
"weight kg mean s e","C0005910;C0043100;C0444504;C1275571;C1305866;C1705104;C2347634;C2348143","C0043100","",1915
"antidiabetic medications","C0935929",NULL,NULL,995
"change to week $nmbr$","C0332174;C0392747;C0439230;C0443172;C1705241;C4319952",NULL,NULL,767
"disease duration y mean sd","C0444504;C0872146;C2347634;C2348143;C2699239","C0449238;C0872146","",903
"digoxin n $nmbr$ $nmbr$","C0012265","C0012265","",989
"rivaroxaban plus","C1739768","C1739768","",1225
"other atherosclerotic cvd st depression on","C0007222;C0333482;C0520887","C0004153","",1698
"row n $nmbr$","C1552840;C1552846",NULL,NULL,852
"body mass index kg m $nmbr$","C0005893;C0578022;C1305855;C1532718","C1305855","",1734
"age year mean sd","C0001779;C0439234;C0439508;C0444504;C2347634;C2348143;C2699239","C0001779","",480
"pra median min max ng ml h","C0033727;C0369286;C0441932;C0549183;C0564385;C0633231;C0702093;C0876920;C1141951;C1419788;C1524029;C1533072;C2347635;C2348144;C2827900;C2939193;C3274822;C3669212;C3813700;C4050009;C4283900;C4528284",NULL,NULL,1475
"insulin therapy","C0021641;C0039798;C0087111;C1363945;C1533581;C1579433;C3714501",NULL,NULL,2347
"class ia","C0020980;C0456387;C0694634;C1518526;C1705943;C1947960",NULL,NULL,452
"body mass index kg m $nmbr$ sd","C0005893;C0578022;C1305855;C1532718;C2699239","C1305855","",1734
"age y median $nmbr$ th to $nmbr$ th percentiles","C0001779;C0039725;C0039738;C0549183;C0876920;C1264641;C1420718;C2347635;C2348144;C2939193;C4282123;C4285344","C0001779","",2234
"use of inhaled glucocorticoids at baseline","C0004048;C0017710;C0168634;C1442488;C1524063;C3540777;C3540778","C3540778","",2182
"characteristic outcome","C1274040;C1521970",NULL,NULL,1602
"dabigatran $nmbr$ mg bid vs warfarin","C0024671;C0026410;C0043031;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761",NULL,NULL,775
"lp a nmol l mean sd","C0065058;C0439282;C0444504;C1439335;C2347634;C2348143;C2699239;C4553379",NULL,NULL,37
"$nmbr$ year risk for chd","C0439234;C0439508;C1282512",NULL,NULL,1099
"all bleeding","C0019080",NULL,NULL,707
"immunosuppressant with or without corticosteroid","C0001617;C0021081;C3536709",NULL,NULL,1650
"fatigue range $nmbr$ $nmbr$","C0015672;C1514721;C2348147;C3463815;C3542016;C4050243;C4554645","C0015672",";C4050243;C3542016;C0424589;C0542479;C1442080;C4330907;C0444504;C4553152",10
"carotid","C0741968","C0007272","",1547
"chronic bronchitist","C0205191",NULL,NULL,1701
"hormonal status","C0449438;C0458083",NULL,NULL,543
"bmi indicates body mass index sbp systolic blood pressure dbp lipoprotein a ldl c was calculated with the friedewald formula hypertension and diabetes were based on physician diagnosis smoker includes current and past smokers","C0005893;C0011847;C0011849;C0011900;C0012164;C0020538;C0031831;C0065058;C0085805;C0125953;C0332257;C0337664;C0444686;C0488055;C0489829;C0521116;C0536221;C0578022;C0804815;C0871470;C1096202;C1305855;C1306620;C1439335;C1441506;C1444637;C1527178;C1552866;C1704338;C1704656;C1705501;C1705938;C1705970;C1963138;C2700399;C3813197;C4281799;C4284302",NULL,NULL,456
"normoalbuminuria no total no","C0439175;C0439810",NULL,NULL,508
"age $nmbr$ $nmbr$ yr elevated biomarkers and previous vascular","C0001779;C0005516;C0005847;C0205156;C0205250;C0439234;C1552607;C1558950;C1801960;C3163633","C0001779","",480
"active canakinumab n $nmbr$ $nmbr$","C0205177;C2718773;C3853793;C3888249",NULL,NULL,496
"crcl at randomization ml min","C0034656;C0439445;C1846718","C3811844;C0017654","",307
"placebo insulin n $nmbr$","C0021641;C0032042;C1533581;C1579433;C1696465;C1706408;C3714501",NULL,NULL,157
"aqlq score mean sd","C0444504;C0449820;C2347634;C2348143;C2699239;C4050231;C4055434",NULL,NULL,1287
"teaes reported by $nmbr$ patients in the overall brv group n","C0030705;C0155502;C0282416;C0441848;C1561607;C1709908",NULL,NULL,1743
"nyha class ii n $nmbr$","C1882085","C0018802;C1882083","",453
"with higher classes indicating greater limitations on physical activity owing to","C0015259;C0026606;C0205250;C0449295;C0456387;C1518526;C1704243;C1705943;C4019422","C0015259","",1380
"cvd death","C0007222;C0011065;C1306577;C4082313;C4552775",NULL,NULL,323
"who idf ifg","C1334085;C1708411",NULL,NULL,1259
"non drug eluting stent","C1322815;C1518422","C1322815","",365
"current smoker $nmbr$ cigarettes day no","C0332173;C0439228;C0439505;C0677453;C3173209;C3241966","C3241966","",1420
"potassium at admission mmol l $nmbr$","C0032821;C0184666;C0202194;C0304475;C0597277;C0809949;C1532563;C3714637","C0302353","",1959
"systolic pressure at ankle level mmhg mean sd","C0003086;C0003087;C0039155;C0439475;C0441889;C0444504;C0445074;C0456079;C0871470;C1547707;C2347634;C2348143;C2699239;C2946261",NULL,NULL,1287
"evenls per $nmbr$ $nmbr$ palienl years","C0439234",NULL,NULL,1099
"weight kg mean sd","C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209",NULL,NULL,2326
"xi $nmbr$ $nmbr$ p $nmbr$ $nmbr$","C1720296",NULL,NULL,520
"us n $nmbr$","C0369718;C0441922",NULL,NULL,1553
"rivaroxaban","C1739768","C1739768","",1225
"nonischemic cardiomyopathy no","C0878544",NULL,NULL,652
"lipid medication n","C0013227;C0023779;C3244316;C4284232",NULL,NULL,2265
"cabg","C0010055","C0010055","",389
"body mass index no i","C0005893;C0021966;C0221138;C0578022;C1305855","C1305855","",1734
"total resolution of dactylitisb","C0439175;C0439810;C1514893;C1706463;C2699488",NULL,NULL,508
"cvd","C0007222","C0007222","",1790
"at weeks $nmbr$ and $nmbr$","C0439230",NULL,NULL,1012
"amlodipine $nmbr$ mg v $nmbr$","C0024671;C0026410;C0051696;C0439269;C1960952;C2346927;C4321396;C4521761","","",78
"screening absolute reversibility fev $nmbr$ ml","C0205344;C0220908;C0220909;C0439526;C0449261;C1698960;C1705224;C1710031;C1710032;C1710477;C2348164;C3714541;C3887665","C0449261;C0231999","",1315
"total pack yrs","C0439175;C0439810;C1968515;C2825051;C2828395",NULL,NULL,139
"sjc $nmbr$ joints mean sd","C0022417;C0392905;C0444504;C2347634;C2348143;C2699239",";C0451521","",1140
"apob apoa $nmbr$ ratio","C0003592;C0003593;C0456603;C0523508;C1547037;C3252643;C4553344;C4553379","C0003592","",427
"prior acbi or arb use","C0042153;C0332152;C0457083;C1947944;C2826257;C3888198",NULL,NULL,44
"stage $nmbr$ a ckd cohort post hoc analysis excluding metformin users","C0025598;C0086027;C0205390;C0332196;C0687676;C1300072;C1306673;C1561643;C1704687;C1706077;C2828389;C3469826",NULL,NULL,541
"calima overall n $nmbr$","C0282416;C1561607",NULL,NULL,1743
"oil","C0028908;C0032085;C1517288;C3541397",NULL,NULL,1681
"cabg history","C0010055;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062","C0010055","",389
"difference in ls mean vs placebo $nmbr$ ci","C0008107;C0023668;C0032042;C0444504;C1696465;C1705241;C1705242;C1706408;C2347634;C2348143;C3259781",NULL,NULL,519
"p value for interaction age continuous","C0001779;C0549178;C1704675;C1709380","C0001779","",480
"steroids n","C0038317",NULL,NULL,1648
"documented coronary artery disease","C0010054;C0010068;C1301725;C1609436;C1956346","C0010068;C1956346",";C0026410;C1710701",226
"alcohol use $nmbr$ drink wk","C0001948;C0042153;C0332174;C0439230;C0452428;C0457083;C0556297;C1947944","C0001948","",875
"physical role","C0031809;C0035820;C0205485;C1509143;C1705810;C3871154",NULL,NULL,506
"all strokes n","C0038454;C0369718;C0441922;C4554100",NULL,NULL,1762
"myocardial infarction without st segment elevation no","C1536220",NULL,NULL,570
"previous angina pectoris","C0002962;C0205156;C1552607","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"subjects $nmbr$ years of age n","C0681850;C1510829;C1550501;C1706203;C2349001;C2697811","C1510829","",481
"number of patients with fractures","C0016658;C2360800",NULL,NULL,1811
"oral anticoagulants","C0354604","C0354604","",1747
"mean sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,1287
"non anterior","C0205094;C1518422","C0205094","",1243
"baseline crp","C0168634;C1442488;C3890735;C4048285",NULL,NULL,1545
"criterion","C0243161",NULL,NULL,783
"nonfatal stroke","C0038454;C4554100",NULL,NULL,507
"time since first luts years","C0040223;C0205435;C0439234;C0574785;C1279901;C3541383",NULL,NULL,757
"amlodipine vaisartan n $nmbr$","C0051696","","",78
"albiglutide n $nmbr$","C2607479","C2607479","",277
"cha $nmbr$ ds $nmbr$ vasc $nmbr$","C1420648;C3714751",NULL,NULL,968
"ldl c median iqr mg dl","C0439269;C0549183;C0876920;C2347635;C2348144;C2939193","C0023824","",1068
"heparin plus tirofiban n $nmbr$","C0019134;C0247025;C0332287;C0770546",NULL,NULL,804
"bmi mean kg m $nmbr$ sd","C0444504;C0578022;C1532718;C2347634;C2348143;C2699239",";C1305855","",206
"death from any cause","C0007465","C0007465","",1423
"management distribution medical treatment","C0001554;C0030677;C0199168;C0205476;C0376636;C0520511;C0679624;C1273870;C1704711;C3273539",NULL,NULL,488
"loop diuretic","C0354100;C3536704","C0354100","",991
"psoriatic arthritis pain","C0003872;C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4317006;C4553004;C4554132","","",2176
"yes n $nmbr$","C1549445;C1705108;C1710701",NULL,NULL,147
"death due to renal failure","C0011065;C0035078;C0678226;C1306577;C1963154;C4082313;C4552775","C0035078;C0011065","",939
"p value fo interactio","C1709380",NULL,NULL,7
"total time of fondaparinux treatment before","C0039798;C0040223;C0087111;C0439175;C0439810;C1098510;C1522326;C1533734;C1705169;C3538994;C3541383;C3887704","C1098510","",859
"sfc $nmbr$ $nmbr$ pg twice daily n $nmbr$","C0030827;C0072225;C0585361;C1266240;C4521536",NULL,NULL,208
"medical therapies","C0418981",NULL,NULL,640
"fpi mean sd pu mlt","C0018387;C0444504;C2347634;C2348143;C2699239;C4553833",NULL,NULL,2135
"p $nmbr$ vs usual care","C0369773;C1947933;C2603361;C3538928",NULL,NULL,391
"p","C0369773;C2603361",NULL,NULL,1823
"current smokers n medicai history n","C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C3173209;C3241966","C3241966","",1420
"sal n $nmbr$","C0036140;C0037494;C0206136",NULL,NULL,853
"control $nmbr$ months n $nmbr$","C0243148;C0439231;C1550141;C1882979;C2587213;C3274648;C4553389",NULL,NULL,675
"family history of venous thromboembolism","C0015576;C0042449;C0241889;C0348013;C0455533;C1704727;C1997614","C0241889","",1493
"estimated gfr ml min per $nmbr$ $nmbr$ m $nmbr$ mean sd","C0017654;C0369637;C0439445;C0441923;C0444504;C0750572;C1424601;C2347634;C2348143;C2699239","C3811844;C0017654","",592
"interaction pf","C1704675;C3815179",NULL,NULL,888
"seronegative rf ve and acpa ve subgroup","C0035448;C0042469;C0201660;C0521144;C0748398;C1079230;C1515021;C1525410;C1547111;C1706063;C3714652;C4321495",NULL,NULL,347
"micral test result","C0456984;C0587081",NULL,NULL,805
"czp $nmbr$ mg n lll","C0024671;C0026410;C0054841;C0439269;C1261077;C1861828;C1872109;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2274
"clopidogrel $nmbr$ mg loading doset","C0024671;C0026410;C0070166;C0439269;C1708715;C1960952;C2346927;C4321396;C4521761","C0070166",";C0369286;C0033727;C4049621",217
"change from baseline to week $nmbr$ in uas $nmbr$","C0168634;C0332174;C0392747;C0439230;C0443172;C1442488;C1705241;C4319952",NULL,NULL,625
"sbp $nmbr$ mm hg and dbp $nmbr$ mm hg $nmbr$ $nmbr$","C0085805;C0439475;C0536221;C3813197;C4281799",NULL,NULL,607
"major cv event","C0205082;C0205164;C0441471;C3538987;C4019010;C4048877;C4318503;C4318856;C4521762","C1320716;C0205082","",2077
"hepatic disorders","C0023895","C0023895","",1611
"sun $nmbr$ $nmbr$","C0038817;C0376223",NULL,NULL,1286
"ics only","C0205171;C0815320;C1720467;C4551720",NULL,NULL,137
"united states or canada","C0006823;C0041703",NULL,NULL,1550
"no of events totol no","C0441471;C3541888",NULL,NULL,412
"injectable anti hyperglycaemic n","C0432633;C1272883","C1321567","",361
"other antithrombotic medication for index event no","C0013227;C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C3244316;C4019010;C4284232",NULL,NULL,412
"cdai score mean s d","C0444504;C0449820;C0683448;C1413248;C2347634;C2348143;C3273706;C4050231",NULL,NULL,697
"any aes n","C1412268;C2699274","C0877248","",47
"lvef within $nmbr$ months","C0428772;C0439231;C0488728","C0018801;C0428772","",1273
"unknown missing","C0439673;C1551393;C1705492;C3272743;C3541433;C4050014","C1705492","",1144
"mod sev exacerbation rates","C0011860;C0439793;C0458216;C0871208;C1521828;C2983285;C4086268","C4086268;C1521828;C0439793","",1195
"postbronchodilator fev $nmbr$ l","C2599594;C3714541",NULL,NULL,1599
"cmh rr $nmbr$ ci","C0008107;C3259781;C4554402",NULL,NULL,1544
"ecg and imaging data","C0011923;C0079595;C1511726;C1623258;C3245479;C3714741",NULL,NULL,1427
"$nmbr$ antianginal drugs","C0013227;C1874267;C3537168;C3687832",NULL,NULL,367
"dipyridamole","C0012582","C0012582","",1228
"vildagliptin n $nmbr$","C1570906","C1570906","",2068
"cardiovascular hospitalization","C0007226;C0019993;C3887460",NULL,NULL,649
"total cholesterol mmol l sd","C0201950;C0543421;C1532563;C2699239","C0543421","",1504
"peripheral artery stenosis","C4025272",NULL,NULL,934
"change from baseline in acq $nmbr$ score","C0168634;C0392747;C0443172;C0449820;C1442488;C1705241;C2919686;C4050231;C4319952",NULL,NULL,767
"prior history of cardiovascular disease n","C0332152;C0455539;C2826257",NULL,NULL,1494
"without cerebrovascular disease","C0007820",NULL,NULL,728
"sotagliflozin","C3896939","C3896939","",2067
"aml hctz n $nmbr$","C0020261;C0023465;C0023467",NULL,NULL,1149
"msfc timed $nmbr$ foot walk test median seconds","C0016504;C0347981;C0392761;C0457385;C0549183;C0876920;C2346504;C2347635;C2348144;C2348613;C2348704;C2939193;C4277740",NULL,NULL,635
"stage $nmbr$ $nmbr$","C0205390;C1300072;C1306673",NULL,NULL,541
"established ascvd","C0443211;C1272684;C3665365","C0004153","",1698
"metformin use n","C0025598;C0042153;C0457083;C1947944","C0025598","",1345
"placebo ideglira","C0032042;C1696465;C1706408;C4308663",NULL,NULL,774
"cornell index pv","C0030840;C0032463;C0600653;C0918012;C1552854;C1637833;C2986546",NULL,NULL,734
"study treatment","C1521826",NULL,NULL,717
"unknown type","C0332307;C0439673;C1547052;C3541433;C4050014",NULL,NULL,93
"egfr mumin $nmbr$ $nmbr$ m $nmbr$","C0369637;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"large very large","C0442824;C0549177;C2984081","","",-10
"gusto severe moderate","C1299393",NULL,NULL,322
"blood eosinophil count geometric mean sd loge scale cells ll","C0007584;C0007634;C0014467;C0175659;C0349674;C0750480;C1705566;C1947916;C2697934;C2699239;C2986759","C0014467","",849
"rando in na","C0597484;C1272460;C1546968;C1879645;C4049872;C4552882",NULL,NULL,419
"high dose","C0444956","C0444956","",111
"blood leukocyte count $nmbr$ cells per l","C0023508;C0023516;C0347983;C0427512",NULL,NULL,659
"taking calcium supplements at baseline n","C0006675;C0006726;C0168634;C0242295;C1442488;C1515187;C1947943;C2348609;C2936886;C3540037;C3714611","C0006675;C2348609","",2187
"mean sd days since","C0439228;C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"any pulmonary medication","C0013227;C0024109;C2707265;C2709248;C3244316;C4284232;C4522268",NULL,NULL,572
"yes r $nmbr$ y","C0205090;C0684010;C1549445;C1705108;C1710701;C2603358",NULL,NULL,147
"history of more than $nmbr$ prior mi","C0019664;C0019665;C0262512;C0262926;C0332152;C1705255;C2004062;C2826257;C3810814",NULL,NULL,832
"duration of pci min median n iqr","C0449238;C0549183;C0702093;C0876920;C1524029;C2347635;C2348144;C2926735;C2939193;C3813700;C4049621",NULL,NULL,1895
"intensified baseline n $nmbr$","C0168634;C1442488",NULL,NULL,625
"rosuvastatin n $nmbr$ $nmbr$","C0965129","C0965129","",886
"class i or no symptoms","C0441885;C0683368;C1319793;C1457887;C2698967",NULL,NULL,613
"amlodipine valsartan $nmbr$ $nmbr$ mg n $nmbr$ i","C0021966;C0024671;C0026410;C0221138;C0369718;C0439269;C0441922;C1960952;C1962523;C2346927;C4321396;C4521761","","",78
"ertugliflozin $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C4079805;C4321396;C4521761","C4079805","",1180
"mean duration offollow up years","C0439234;C0444504;C0449238;C2347634;C2348143;C2926735",NULL,NULL,1099
"clinical history","C0019664;C0019665;C0205210;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"prior tnf inhibitor exposure","C0274281;C0332152;C0332157;C1448177;C1999216;C2826257",NULL,NULL,362
"tah n $nmbr$","C0404079","","",-10
"$nmbr$ $nmbr$ moderate","C0205081;C1881878;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"completed prior febuxostat studya","C0205197;C0249529;C0332152;C2826257;C3854010",NULL,NULL,26
"previous antihypertensive treatment no","C0003364;C0039798;C0087111;C0205156;C1522326;C1533734;C1552607;C1705169;C3538994;C3887704",";C0003364","",1579
"calcium antagonists n","C0006684","C0006684","",1884
"aged $nmbr$ y or older n","C0001779;C0001792;C0580836;C1999167","C0001779","",480
"eq $nmbr$ d visual analog score","C0205163;C0234621;C0243071;C0439185;C0449820;C4050231",NULL,NULL,1625
"heavy calcification","C0006660;C0006663;C0175895;C0439539;C1533591;C1879982;C2242558","C1533591","",264
"statin group","C0360714;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429",NULL,NULL,1526
"mean median mtx dose mg week","C0024671;C0026410;C0332174;C0366550;C0439230;C0439269;C0444504;C0549183;C0876920;C1960952;C2346927;C2347634;C2347635;C2348143;C2348144;C2939193;C4321396;C4521761",NULL,NULL,192
"coronary angiography during the index hospital stay","C0002978;C0085532;C0428776;C0600653;C0918012;C1548829;C1552854;C1637833;C2986546;C3489408",NULL,NULL,1724
"hispanic latino","C0086409;C0086528","C0086528;C0086409;C0015031","",363
"ptga $nmbr$ $nmbr$ cm vas","C0042815;C3536884;C3827561",NULL,NULL,1751
"pasi score $nmbr$ $nmbr$ t mean sd","C0444504;C0449820;C2347634;C2348143;C2699239;C4050231;C4528685",NULL,NULL,37
"any prerandomization failure of an antiarrhythmic drug no","C0003195;C0231174;C0301380;C0680095","C0003195","",379
"mean bp mmhg","C0037623;C0439475;C0444504;C1415692;C1708288;C2347634;C2348143;C4318478","C0005823","",1469
"obese","C0028754",NULL,NULL,710
"factor v leiden","C0380964;C0584960;C1414509;C3542419",NULL,NULL,2019
"core study to first infusion","C0205435;C0444669;C0557651;C0574032;C1167518;C1279901;C1706352;C1827465;C1882467;C2603343;C3274653",NULL,NULL,1242
"dose reduction at randomization no i","C0021966;C0034656;C0178602;C0221138;C0301630;C0392756;C0869039;C1114758;C1293152;C4551656",NULL,NULL,110
"psa n $nmbr$","C3810537;C3813209",NULL,NULL,125
"joint damage outcomes mitt population","C0010957;C0022417;C0032659;C0392905;C1257890;C1274040;C1706309;C1883709",NULL,NULL,900
"difference $nmbr$ years baseline","C0168634;C0439234;C1442488;C1705241;C1705242",NULL,NULL,625
"no","C1518422","C1518422","",10000
"nyha class when patient was last in stable condition before admission","C0030705;C0184666;C0677946;C0809949;C1517741;C1882083;C3538874",NULL,NULL,1035
"ls mean difference between treatment groups $nmbr$ ci","C0008107;C0023668;C0039798;C0087111;C0374505;C0444504;C1522326;C1533734;C1705169;C1705241;C1705242;C2347634;C2348143;C3259781;C3538994;C3887704",NULL,NULL,519
"baseline serum mg $nmbr$ $nmbr$ mmol l","C0024671;C0026410;C0168634;C0229671;C0439190;C0439268;C0439269;C1442488;C1532563;C1546774;C1550100;C1960952;C2346927;C4321396;C4521761","C0006560","",193
"use of cgm yes","C1524063;C1549445;C1705108;C1710701",NULL,NULL,147
"adjustedb c beta se","C0036919;C0330390;C0439096;C2004068",NULL,NULL,1429
"mitt population","C0032659;C1257890",NULL,NULL,900
"cv death mi stroke","C0011065;C0038454;C1306577;C3538987;C3810814;C4048877;C4082313;C4318503;C4552775;C4554100",NULL,NULL,323
"cv death myocardial infarction stroke","C0011065;C0027051;C0038454;C0428953;C1306577;C2926063;C3538987;C3810814;C4048877;C4082313;C4318503;C4552775;C4552959;C4554100",NULL,NULL,323
"diabetes durationa median","C0011847;C0011849;C0549183;C0876920;C2347635;C2348144;C2939193","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"anticholinergics","C0242896;C3537307;C3540711",NULL,NULL,1704
"stricturing","C1261287",NULL,NULL,1651
"bmi sd kg m $nmbr$","C0578022;C1532718;C2699239",";C1305855","",206
"prior hospitalization for hf","C0018488;C0019993;C0332152;C1313497;C1538440;C2826257;C3273279",NULL,NULL,2359
"race no i","C0021966;C0034510;C0221138;C1706779;C3853635",";C0034510","",1107
"no htn","C0020538","C0020538","",1365
"new onset atrial fibrillation","C0741281","C0004238","",90
"eosinophils $nmbr$ $nmbr$ x $nmbr$ $nmbr$ $nmbr$ n $nmbr$","C0014467;C0200638","C0014467","",849
"bsl baseline cl confidence interval esrd end stage renal disease hb hemoglobin hr hazard ratio k rate of events per $nmbr$ patient years of follow up yr year multivariate cox model with hemoglobin category and baseline urinary albumimcreatinine ratio serum albumin serum creatinine and hemoglobin as covariates","C0009667;C0019046;C0022661;C0030705;C0036773;C0042027;C0168634;C0201976;C0229671;C0439234;C0441471;C0456603;C0589120;C0596019;C0597277;C0600061;C0683312;C0728877;C0871208;C1442488;C1521828;C1522577;C1524119;C1546774;C1547037;C1549954;C1550100;C1565830;C1704685;C1708601;C2362049;C2985465;C3161035;C3274571;C3274659;C3541888;C3714583;C3853906;C3889287",NULL,NULL,1099
"all recurrent strokes","C1836785",NULL,NULL,1419
"surgical technique","C0683469",NULL,NULL,1128
"paracetamol","C0000970",NULL,NULL,502
"baseline pcsi $nmbr$ a","C0168634;C1442488",NULL,NULL,625
"absolute time spent on h day","C0033727;C0332173;C0369286;C0439228;C0439505;C0439546;C0441932;C0564385;C0680968;C4528284",NULL,NULL,1621
"no worsening in pga","C0016410;C0332271;C1457868;C1546960;C3541266;C4050369",NULL,NULL,1525
"antihyperglycemic","C0020616","C0020616",";C0013227;C3244316;C4284232;C0450442;C1254351;C1515187;C1521826;C2826257",33
"\bl sc n n","C0005918;C0006413;C0282380;C1552663;C2827109",NULL,NULL,655
"$nmbr$ h pmg mmol l","C2827804",NULL,NULL,671
"key secondary end points","C0027627;C0175668;C0205436;C2349179",NULL,NULL,1484
"with stent","C0038257",NULL,NULL,569
"peripheral arterial stenosis","C4025272",NULL,NULL,934
"metformin alone","C0025598;C0205171;C0439044;C0679994",NULL,NULL,926
"ics alone","C0205171;C0439044;C0679994;C0815320;C4551720",NULL,NULL,926
"missing data no total no","C0439175;C0439810;C4684714","C4684714","",1145
"normal uln n $nmbr$","C0205307;C0231683;C0439166;C1519815;C2347086;C4553972",NULL,NULL,1676
"othery ethnicity n","C0015031;C0243103",NULL,NULL,787
"lipid levels mg dlj total cholesterol","C0024671;C0026410;C0201950;C0428460;C0439269;C0543421;C1960952;C2346927;C4321396;C4521761","C0023779","",1967
"atenolol no $nmbr$","C0004147","C0004147","",1055
"gender male female number","C0043210;C0079399;C0086287;C0086582;C0237753;C0449788;C1522384;C1705497;C1705498;C1706180;C1706428;C1706429","C0086582","",1276
"mean arterial pressure difference","C0428886;C1705241;C1705242",NULL,NULL,1466
"elevated bnp $nmbr$ pg ml","C0054015;C0205250;C0439297;C1095989;C1417808;C2982014;C3163633",NULL,NULL,1635
"czp $nmbr$ mg q $nmbr$ w","C0024671;C0026410;C0054841;C0439269;C1861828;C1872109;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2274
"haq di improvement $nmbr$ $nmbr$","C2986411;C3826998;C4321476",NULL,NULL,1665
"antihypertensive treatments","C0003364;C0087111",";C0003364","",1579
"edoxaban dose adjusted at randomisation n","C0034656;C0178602;C0456081;C0869039;C1114758;C2975435",NULL,NULL,110
"early clopidogrel intended","C0070166;C1279919;C1283828;C1551357",NULL,NULL,1487
"af type no","C0332307;C0344434;C1547052;C4049859",NULL,NULL,603
"clinical and patient reported characteristics at baseline and randomization","C0034656;C0205210;C0588446;C4684572",NULL,NULL,793
"mean body mass indexj","C0444504;C0518010;C2347634;C2348143",NULL,NULL,146
"prior urate lowering therapies n","C0441994;C0729829;C0935936;C1514463;C2003888",NULL,NULL,1022
"sustained esrd death due to kidney failure or sustained decrease of $nmbr$ in egfr from baseline","C0011065;C0022661;C0035078;C0168634;C0392756;C0443318;C0547047;C0678226;C1306577;C1442488;C1739039;C2316810;C3811844;C3812682;C4082313;C4552775","C0035078","",342
"aortic","C0003483",NULL,NULL,1700
"initial heparin no","C0019134;C0205265;C0770546;C1279901;C1555582;C1705685",NULL,NULL,806
"dapagliflozin","C2353951","C2353951","",2066
"nob systolic blood pressure mm hg","C0439475;C0488055;C0871470;C1306620","C0005823","",1469
"$nmbr$ min","C0702093;C1524029;C3813700",NULL,NULL,1475
"reversibility in fev at","C0449261;C3714541","C0449261;C0231999","",1315
"severe copdc n z $nmbr$","C0205082;C4050465;C4050466",NULL,NULL,313
"past or current","C0521116;C1444637;C1705970;C4284302",NULL,NULL,456
"interaction","C1704675",NULL,NULL,888
"bmi mean sd","C0444504;C0578022;C2347634;C2348143;C2699239",NULL,NULL,2125
"pre bronchodilator fev i l","C0021966;C0221138;C2599602;C3714541",NULL,NULL,1021
"severe cord qvai $nmbr$ sfc","C0205082;C1550235;C1706500;C3489532;C4050465;C4050466;C4521536",NULL,NULL,1283
"all others eteed for $nmbr$ mg edoxaban dose at","C1955473;C2975435;C3539125;C4086581",NULL,NULL,741
"diet i pravastatin n $nmbr$","C0012155;C0012159;C0021966;C0085542;C0221138;C1519433;C2983588;C3668949","C0012155","",1199
"ltt other than statin","C0360714","C0360714","",872
"brv $nmbr$ mg day n","C0155502;C0439422","","",198
"with cerebrovascular disease","C0007820",NULL,NULL,728
"juvenile myoclonic epilepsy","C0270853",NULL,NULL,1607
"metformin no","C0025598","C0025598","",1345
"duration of t $nmbr$ d years","C0439234;C0449238;C2926735",NULL,NULL,1099
"phosphodiesterase type $nmbr$ inhibitors","C0031638;C0332307;C1547052;C1656262;C3539996",NULL,NULL,603
"$nmbr$ f $nmbr$ q","C0016327","","",-10
"hba $nmbr$ c month $nmbr$","C0019016;C0332177;C0439231;C1825777;C3538758",NULL,NULL,1476
"person years","C0027361;C0439234;C2347489",NULL,NULL,1099
"hemoglobin g dlf","C1319312","C0019046","",1177
"fasting plasma glucose mg dl $nmbr$","C0015663;C0202042;C0439269;C0455280","C0455280;C0015663",";C0168634",21
"normoglycaemic individuals n","C0027361;C0237401;C0580545",NULL,NULL,588
"baseline total ipss mean sd","C0168634;C0439175;C0439810;C0444504;C1019118;C1442488;C1998280;C2347634;C2348143;C2699239;C2827405;C3811063",NULL,NULL,2129
"glyeated haemoglobin","C0019046","","",1176
"liraglutide $nmbr$ $nmbr$ mg mean n","C0024671;C0026410;C0439269;C0444504;C1456408;C1960952;C2346927;C2347634;C2348143;C4321396;C4521761","C1456408","",1566
"complex partial ib","C0439855;C0728938;C1550516;C1704241;C2744579;C3890035;C4283819",NULL,NULL,1398
"increased waist circumference","C0205217;C0442805;C0455829","C0455829","",1413
"serum total ige iu ml","C0439458;C1441420",NULL,NULL,301
"hmgcoa rl","C0047420;C1419337;C3539667",NULL,NULL,657
"fgf $nmbr$ low $nmbr$ elevated biomarkers","C0005516;C0016026;C0205250;C0205251;C0919505;C1550472;C3163633;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"heart rate mean sd b p m","C0018810;C0369637;C0441923;C0444504;C2347634;C2348143;C2699239","C0018810","",1105
"clinical or lesion rf for st","C0035448;C0036056;C0201660;C0205210;C0221198;C0748398;C1546698;C1547111;C3272372",NULL,NULL,793
"indacaterol $nmbr$ gg qd","C0017454;C0018370;C0332173;C1722260",NULL,NULL,1457
"baseline bsa mean sd","C0168634;C0444504;C1442488;C2347634;C2348143;C2699239",NULL,NULL,1287
"type of hospital care","C0259945;C0332307;C1547052",NULL,NULL,603
"previous ml interaction p $nmbr$ $nmbr$","C0205156;C0439526;C1552607;C1704675;C1705224;C3887665",NULL,NULL,300
"pe","C0070939;C1880476;C4284304",NULL,NULL,1516
"interim analysis","C4684691",NULL,NULL,182
"insulin glargine oad bd prandial","C0005126;C0907402;C1998602;C2344255;C4050145;C4553624","C0907402",";C1998602;C0004446;C0005126;C2344255;C4050145;C0229089;C0439164;C1512019;C3273373;C3665488",69
"yes vs no","C1549445;C1705108;C1710701",NULL,NULL,147
"any acuity bleeding","C0333276","","",-10
"worsened","C1457868;C4084902","C0332271",";C1538440;C3273279;C1412502",282
"crp median range mg literl","C0024671;C0026410;C0439269;C0549183;C0876920;C1514721;C1960952;C2346927;C2347635;C2348144;C2348147;C2939193;C3542016;C3890735;C4048285;C4321396;C4521761","C0006560","",286
"$nmbr$ $nmbr$ $nmbr$ ci $nmbr$ $nmbr$ $nmbr$ $nmbr$ n $nmbr$","C0008107;C3259781",NULL,NULL,519
"$nmbr$ to $nmbr$ mg l n $nmbr$","C0439268","C0006560","",193
"lev exposed","C0023556;C0332157",NULL,NULL,1275
"no ascvd additional cv risk factors n","C0035648;C1524062;C1553898;C3538987;C3665365;C4048877;C4318503",NULL,NULL,1777
"admission for hf in previous year n","C0018488;C0184666;C0205156;C0439234;C0439508;C0809949;C1313497;C1538440;C1552607;C3273279","C0018801",";C0168634;C1524003",12
"mmrc grade n","C0441800;C0919553;C3244287;C3826977",NULL,NULL,683
"non lad","C1518422","","",343
"adalimumab","C1122087",NULL,NULL,942
"$nmbr$ step or incident vitrectomy or photocoagulation","C0023694;C0042903;C1261552;C1328010;C1551358;C1704379;C1705117;C2825408;C3814463",NULL,NULL,571
"age yr race no f","C0001779;C0016327;C0034510;C0439234;C1706779;C3853635","C0001779","",480
"$nmbr$ mg d peq","C0439422","","",198
"baseline pre bronchodilator fev $nmbr$ l","C0168634;C1442488;C2599602;C3714541",NULL,NULL,682
"infliximab combination therapy","C0009429;C0205195;C0556895;C0666743;C1947911;C3811910;C4076075","C0666743","",154
"apo apolipoprotein dm diabetes mellitus hdl c high density lipoprotein cholesterol ldl c low density lipoprotein cholesterol tc total cholesterol tg triglycerides includes agents acting on the renin angiotensin system beta blocking agents calcium channel blockers and diuretics median values standard deviation for medians calculated by q $nmbr$ q $nmbr$ $nmbr$ $nmbr$ includes cardiac glycosides antiarrhythmics class i and iii vasodilators used in cardiac diseases and other cardiac preparations expressed as g l","C0001645;C0003195;C0003591;C0003594;C0006684;C0008377;C0011849;C0012634;C0012798;C0017977;C0018787;C0023821;C0023824;C0035096;C0039411;C0040642;C0041004;C0041405;C0041698;C0042295;C0042402;C0079613;C0201950;C0202117;C0332257;C0428473;C0439070;C0439294;C0441885;C0444686;C0450442;C0456615;C0543421;C0549183;C0871420;C0876920;C1254351;C1273517;C1319793;C1441506;C1521826;C1521827;C1522601;C1552866;C1704930;C1705160;C1824670;C1869853;C2347635;C2348144;C2698967;C2700399;C2757014;C2939193;C2984247;C3272447;C3541930;C3715113;C3812761;C3890007;C4048375;C4522122",NULL,NULL,960
"vas $nmbr$ $nmbr$","C0042815;C3536884;C3827561",NULL,NULL,1751
"a $nmbr$ vs placebo","C0032042;C1696465;C1706408","C0032042","",28
"icsa plus laba n","C0332287",NULL,NULL,1650
"ratio $nmbr$ ci","C0008107;C0456603;C1547037;C3259781",NULL,NULL,519
"iv $nmbr$","C0022326;C4265176",NULL,NULL,1257
"tender joint count $nmbr$ $nmbr$ joints","C0451530","C0451530","",1139
"prevalent vertebral fracture","C0033105;C0080179;C0220900",NULL,NULL,2023
"copd severity","C0024117;C0439793;C0522510;C1412502;C3714496",NULL,NULL,1546
"history of diabetes mellitus","C0455488",NULL,NULL,1491
"no previous ischemic stroke tia n $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0007787;C0205156;C0917805;C0948008;C1054154;C1552607",NULL,NULL,1669
"intention to treat","C0040363;C0041260;C0087111;C0162425;C1283828;C1292734;C1522326;C1883351",NULL,NULL,1975
"any aes","C1412268;C2699274","C0877248","",47
"known duration of diabetes yr","C0011847;C0011849;C0205309;C0439234;C0449238;C2926735","C2926735;C0011849","",1988
"glycoprotein iib iiia inhibitor use before angiography","C0002978;C0016011;C0042153;C0457083;C1947944;C1999216",NULL,NULL,1723
"anticoagulant group n $nmbr$","C0003280;C0441848;C0848112;C3536711","C0003280","",450
"at end of follow up","C0444930;C0589120;C1522577;C1704685;C2746065;C3274571",NULL,NULL,1584
"des type","C0011702;C0332307;C1547052;C4551552",NULL,NULL,603
"previous congestive heart failure no","C0018802;C0205156;C1552607","C0018801",";C0168634;C1524003",12
"lira","C1555441",NULL,NULL,1270
"mean age sd years","C0444504;C1510829;C2347634;C2348143;C2699239","C1510829","",481
"rosuvastatin n rate $nmbr$","C0871208;C0965129;C1521828","C0965129","",886
"fenofibric acid $nmbr$ low dose statin","C0060179;C0360714;C0445550;C1708745","C0445550","",112
"serum creatinine mg dl","C0201976;C0439269;C0600061","C0600061;C0010294","",952
"gpiib iiia receptor inhibitor","C0016011;C0597357;C1999216",NULL,NULL,808
"coronary events $nmbr$","C0741923","C0948089",";C0026544",225
"dose mg week","C0024671;C0026410;C0178602;C0332174;C0439230;C0439269;C0869039;C1114758;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"body massindex mean sd a","C0242821;C0444504;C0460148;C1268086;C2347634;C2348143;C2699239;C4082212",NULL,NULL,1911
"completed previous febuxostat study","C0205156;C0249529;C1552607;C2348557",NULL,NULL,26
"peripheral arterial disease no","C0085096;C1704436","C0085096","",933
"fasting insulin pmol l","C0015663;C0021641;C0439284;C1533581;C1579433;C3714501",NULL,NULL,157
"median yr","C0439234;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"olmesartan along with ccb n $nmbr$","C0006684;C1098320",NULL,NULL,704
"aldosterone receptor antagonists","C1579268",NULL,NULL,185
"poor tried previous glucocorticoid laba","C0017710;C0032854;C0205156;C0542537;C1552607;C2700379","C3540778","",2182
"stent plus placebo","C0032042;C0038257;C0332287;C1696465;C1706408",NULL,NULL,569
"baseline median mg l","C0168634;C0439268;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193","C0006560","",193
"composite endpoint","C0205199;C1547335;C2349179;C2826544","C0205199","",1631
"severe teaes","C0205082;C4050465;C4050466",NULL,NULL,313
"b aza treatment ref","C0004482;C0039798;C0087111;C1425988;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,1881
"grip strength median","C0429271;C0549183;C0876920;C2347635;C2348144;C2598165;C2939193","C0429271","",578
"patient s global assessment of","C4054229",NULL,NULL,491
"graft pci percutaneous coronary intervention tia transient","C0007787;C0040704;C0181074;C0205374;C0332835;C0917805;C1054154;C1532338;C1961139","C1532338","",1661
"st depression or elevation","C0439775;C0520887;C0702240","C0520887",";C0011570;C0011581;C0344315;C4049644;C0702240;C4085311;C4084909",1856
"$nmbr$ fevi $nmbr$ $nmbr$ pred","C0032952;C0044955;C0849974;C1561566;C4528367",NULL,NULL,1601
"doxazosin group","C0114873;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429","C0114873","",1219
"acuity minor","C0026193;C0205165;C0750509",NULL,NULL,1474
"insulin lispro mix $nmbr$ lispro mix $nmbr$ insulin glargine insulin lispro","C0205430;C0293359;C0907402;C1421951;C1720722;C4553942",NULL,NULL,985
"rheumatic heart disease","C0035439",NULL,NULL,97
"amlodipine valsartan $nmbr$ $nmbr$ mg v $nmbr$","C0024671;C0026410;C0439269;C1960952;C1962523;C2346927;C4321396;C4521761","","",78
"other nsaids","C0003211",NULL,NULL,2121
"baseline lipids mean sd mmol l","C0023779;C0168634;C0444504;C1442488;C1532563;C2347634;C2348143;C2699239",NULL,NULL,670
"moderate ipss $nmbr$ n $nmbr$","C0205081;C1019118;C1881878;C1998280;C2827405;C3811063;C4049705;C4049706;C4085643;C4321335","C1998280",";C1019118;C3811063;C4050465;C4050466;C4049706;C0168634;C1705273;C1880519;C3853603",124
"any dose reduction","C0178602;C0301630;C0392756;C0869039;C1114758;C1293152;C4551656",NULL,NULL,110
"rankin scale $nmbr$","C0451405",NULL,NULL,1003
"valsartan n $nmbr$","C0216784","C0216784","",1206
"dietary epa dha intake mg day","C0142831;C0439422;C1286104;C2348308","","",198
"dbp mmhg mean sd","C0439475;C0444504;C0536221;C2347634;C2348143;C2699239;C3813197;C4281799",NULL,NULL,605
"intensive n $nmbr$","C0162425;C0522510;C1283828;C1550453",NULL,NULL,561
"esr mm hour git config global user name your name","C0027365;C0205246;C0439227;C0564385;C1418224;C1547383;C1548600;C1706077;C2348867;C2827597;C3811131;C4330985;C4522128;C4554674","C1619634","",298
"hot climate subset","C0178683;C1515021",NULL,NULL,1657
"k m n","C0369637;C0441923;C0597277;C1708601",NULL,NULL,923
"baseline normoglycaemia fpg $nmbr$ $nmbr$ mmol l n","C0168634;C0580545;C1442488;C1532563",NULL,NULL,670
"clopidogrel no of patients","C0030705;C0070166","C0070166",";C0369286;C0033727;C4049621",217
"lev naive","C0023556",NULL,NULL,1275
"sbp dbp mean","C0085805;C0444504;C0536221;C2347634;C2348143;C3813197;C4281799",NULL,NULL,605
"$nmbr$ baseline mean","C0168634;C0444504;C1442488;C2347634;C2348143",NULL,NULL,625
"statin medication","C0013227;C0360714;C3244316;C4284232","C0360714","",872
"baseline systolic blood pressure mm hg","C0439475;C4274438","C0005823","",1469
"diabetics n $nmbr$","C0241863",NULL,NULL,996
"age of onset","C0206132;C3175530",NULL,NULL,736
"region no total","C0017446;C0205147;C0439175;C0439810",NULL,NULL,1060
"normal responders n $nmbr$","C0205307;C0231683;C0439166;C2347086;C4553972",NULL,NULL,687
"heat failure","C0018837;C0231174;C0680095","","",-10
"randomized treatment n","C0034656;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3815594;C3887704",NULL,NULL,236
"ls mean difference se","C0023668;C0036919;C0444504;C1705241;C1705242;C2347634;C2348143",NULL,NULL,567
"$nmbr$ beats min","C0702093;C1524029;C3813700",NULL,NULL,1475
"glipizide n $nmbr$","C0017642",NULL,NULL,2046
"adjusted for all baseline variables $nmbr$","C0168634;C0439828;C0456081;C1442488",NULL,NULL,1018
"gene","C0017337","C0017337","",1084
"mean of jsw mm","C0444504;C2347634;C2348143;C4330985;C4554674",NULL,NULL,297
"interaction j $nmbr$ valuet","C1704675",NULL,NULL,1010
"tofacitinib $nmbr$ mg bid","C0024671;C0026410;C0439269;C1960952;C2346927;C2930696;C4321396;C4521761","C2930696","",857
"coronary artery stenosis $nmbr$","C0242231","C0205042","",228
"prior mi","C0332152;C2826257;C3810814",NULL,NULL,516
"procedures in the hospital no","C0019994;C0025664;C0184661;C1510665;C2700391;C3538935",NULL,NULL,290
"reason for enrollment in active a no","C0150312;C0205177;C0332285;C0392360;C1516879;C1696073;C1707101;C3853793;C3888021;C3888249",NULL,NULL,496
"ciass i","C0021966;C0221138",NULL,NULL,455
"alteplase","C0032143",NULL,NULL,1594
"age y","C0001779","C0001779","",480
"bosentan use","C0042153;C0252643;C0457083;C1947944","C0252643","",1328
"mean predicted value prebronchodilation","C0444504;C0681842;C1522609;C1882327;C2347634;C2348143",NULL,NULL,37
"randomized to aspirin use","C0004057;C0034656;C0042153;C0457083;C1947944;C3815594",NULL,NULL,692
"or for cana vs pbo $nmbr$ ci","C0008107;C0031962;C1418845;C3259781",NULL,NULL,1302
"greater than or equal to $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$","C0205163;C0369637;C0439093;C0439445;C0441923","C3811844;C0017654","",307
"total cholesterol $nmbr$ $nmbr$ mmol lt","C0023376;C0201950;C0230426;C0439190;C0543421;C3887647;C4521399","C0543421","",1504
"difference vs placebo $nmbr$ cl p","C0032042;C0596019;C1696465;C1705241;C1705242;C1706408","C0032042","",28
"om $nmbr$ mg aml $nmbr$ mg hctz $nmbr$ mg n $nmbr$","C0020261;C0023465;C0023467;C0028971;C1319635;C1705272",NULL,NULL,186
"dm present","C0011816;C0150312;C0449450;C3250443","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"smoking pack years","C0037369;C0453996;C1277691;C1881674","C0037369","",420
"patients with enthesitis at week $nmbr$ radiographic progression change from baseline to week $nmbr$ in psa modified total shs score","C0030705;C0168634;C0242656;C0332174;C0392747;C0439175;C0439230;C0439810;C0443172;C0444708;C0449258;C0449820;C1282952;C1442488;C1705241;C3810537;C3813209;C3889737;C4050231;C4319952",NULL,NULL,767
"permanent users","C0205355;C1706077",NULL,NULL,718
"missing ed duration y","C0449238;C1551393;C1705492;C2926735;C3272743;C3538926",NULL,NULL,411
"patients full analysis sety n","C0002778;C0030705;C0443225;C0936012;C1524024",NULL,NULL,183
"current cigarette smoking no","C0239059;C0521116;C0700219;C1705970",NULL,NULL,797
"$nmbr$ $nmbr$ $nmbr$ mmol mol","C3829066",NULL,NULL,668
"early use intended","C0042153;C0457083;C1279919;C1283828;C1551357;C1947944",NULL,NULL,1487
"procedure","C0184661;C2700391;C3274430;C3539779",NULL,NULL,290
"severity of heartburnb","C0439793;C0522510",NULL,NULL,561
"age y mean s d","C0001779;C0444504;C2347634;C2348143","C0001779","",480
"tibia fracture","C0040185","C0040185","",1113
"closure","C0185003;C1521802","C1521802","",2212
"czp combined arms n $nmbr$","C0054841;C0205195;C0206655;C0446516;C1861828;C1872109;C2681631;C3715044;C4553528","C1872109","",1406
"women taking estrogen","C0014939;C0043210;C1515187;C2936882;C4542544","C0014939","",340
"nyha iv","C0022326;C1275491;C4265176",NULL,NULL,151
"$nmbr$ and or $nmbr$ moderate or severe deformity or both n $nmbr$","C0000768;C0205081;C0205082;C0221430;C0302142;C0369718;C0441922;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335",NULL,NULL,1428
"hbalc in median iqr","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,1897
"sokolow lyon mm","C4330985;C4554674",NULL,NULL,297
"$nmbr$ to $nmbr$ iiil iiim $nmbr$ $nmbr$ m $nmbr$","C0369637;C0441923",NULL,NULL,923
"age yrs median $nmbr$ th $nmbr$ th","C0001779;C0039725;C0039738;C0549183;C0876920;C1420718;C2347635;C2348144;C2939193;C4282123;C4285344",NULL,NULL,148
"non smokers receiving lipid lowering drugs $nmbr$ blockers and either an ace inhibitor or angiotension receptor blocker","C0003015;C0086440;C0337672;C0597357;C1514756;C3844638;C4541021;C4554605","C0086440","",1773
"baseline measurements","C0168634;C0242485;C1442488",NULL,NULL,625
"myocardial ischaemia","C0010054;C0151744","C0010054;C0151744","",1361
"past cardiovascular history no","C0007226;C0332119;C1444637;C1880008;C3887460;C4284302",NULL,NULL,456
"apob g l","C0003593;C0439294;C0456615;C3252643","C0003593","",426
"no antidiabetic drug","C0935929",NULL,NULL,995
"kilip class","C0456387;C1518526;C1705943",NULL,NULL,452
"cdai score mean sda","C0276477;C0444504;C0449820;C0683448;C1413248;C1428349;C1553165;C2347634;C2348143;C3273706;C4050231",NULL,NULL,697
"risk factors for stroke","C0035648;C0038454;C1553898;C4554100",NULL,NULL,175
"mean sd years daily ocs use n","C0042153;C0332173;C0369718;C0439234;C0441922;C0444504;C0457083;C1947944;C2347634;C2348143;C2699239",NULL,NULL,37
"pulse in beats minute mean sd","C0232117;C0391850;C0439385;C0444504;C1947910;C2347634;C2348143;C2699239",NULL,NULL,37
"age yrs $nmbr$","C0001779",NULL,NULL,148
"suit quartile $nmbr$ b $nmbr$ $nmbr$ nmol mmol n $nmbr$","C1532564;C1533073;C2828255",NULL,NULL,1016
"time from index acs event to randomisation days","C0034656;C0040223;C0439228;C0441471;C0600653;C0742343;C0918012;C1552854;C1637833;C2986546;C3541383;C4019010;C4318612",NULL,NULL,1621
"$nmbr$ mono","C1551432;C1551969",NULL,NULL,1474
"ibdq score","C0449820;C4050231",NULL,NULL,748
"moderate severe reduction in egfr","C0205081;C0205082;C0301630;C0392756;C1293152;C1739039;C1881878;C3811844;C3812682;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335;C4551656","C3811844;C0017654","",592
"colonoscopy","C0009378;C1548837",NULL,NULL,1728
"anatomic extent of qualifying event n x","C0220784;C0439792;C0441471;C1514624;C4019010",NULL,NULL,412
"mean hba $nmbr$ c mmol mol","C0019016;C0444504;C1825777;C2347634;C2348143;C3538758;C3829066",NULL,NULL,668
"baseline das $nmbr$ mean s e","C0051767;C0057671;C0168634;C0444504;C1442488;C2347634;C2348143",NULL,NULL,625
"duration of ra mean sd years","C0439234;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735;C3538806;C4048756","C0003873;C0449238","",1997
"current smokers","C3173209;C3241966","C3241966","",1420
"blood pressure $nmbr$ mm hg","C0005823;C0439475;C1271104;C1272641","C0005823","",15
"no laba no ics tiotropium n $nmbr$ placebo n $nmbr$","C0032042;C0213771;C0815320;C1696465;C1706408;C4551720","C0032042","",28
"non ex drinker","C0457801",NULL,NULL,176
"total ige levelx iu ml median range","C0439175;C0439458;C0439810;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016",NULL,NULL,635
"strata modelb hr $nmbr$ ci p value","C0008107;C1709380;C3259781",NULL,NULL,7
"nyha functional class i","C0205245;C0542341;C1882084;C2700217",NULL,NULL,1531
"fibrin specilic","C0015982",NULL,NULL,802
"treated vessel","C0005847;C1522326",NULL,NULL,743
"relative risk reduction $nmbr$ cl","C0080103;C0205345;C0242492;C0301630;C0392756;C0596019;C1137094;C1293152;C1547039;C4551656",NULL,NULL,658
"cardiovascular and oral hypoglycemic drugs no","C0007226;C0359086;C3887460",NULL,NULL,649
"selected key secondary efficacy endpoints","C1280519;C1707391;C1707887;C4528314",NULL,NULL,1483
"item","C1551338;C4554251",NULL,NULL,988
"all dulaglutide $nmbr$ $nmbr$ mg insulin lispro insulin glargine n $nmbr$","C0024671;C0026410;C0293359;C0439269;C0907402;C1960952;C2346927;C3179549;C4321396;C4521761",NULL,NULL,2268
"hr $nmbr$ cl","C0596019",NULL,NULL,1542
"at home systolic pressure $nmbr$ mm hg","C0439475;C0871470;C4534363","C0005823","",1469
"extent of index event","C0439792;C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010",NULL,NULL,734
"old stroke","C1536121","C4554100","",336
"characteristics of pulmonary embolism at inclusion","C0007637;C0034065;C1512693;C1521970","C1521970","",1110
"systolic blood pressure mm hq","C0488055;C0871470;C1306620;C4330985;C4554674","C0871470","",615
"hospitalization for acs","C0019993;C0742343;C4318612",NULL,NULL,2147
"haq score $nmbr$ $nmbr$ scale","C0102923;C0175659;C0349674;C0449820;C0451208;C1947916;C4050231",NULL,NULL,1667
"white mtx n","C0007457;C0025677;C0043157;C0220938;C1417487","C0043157","",1402
"no hypertension","C0020538;C1963138","C0020538","",1364
"specific syndromes","C0039082;C0205369;C1552740;C1558916",NULL,NULL,617
"semuloparin n $nmbr$","C2700104","C2700104","",1934
"drug eluting stent implanted at least one","C0021102;C0205447;C1322815;C2828363","C1322815","",365
"age y $nmbr$","C0001779","C0001779","",480
"united states canada","C0006823;C0041703","C0006823;C0041703","",1301
"previous","C0205156;C1552607",NULL,NULL,1044
"acm","C0001143;C1549040",NULL,NULL,695
"$nmbr$ mo","C0026544;C0332177",NULL,NULL,1476
"coexisting conditions no","C0012634;C0348080;C1705253;C3864998",NULL,NULL,1710
"waist circumference s $nmbr$ men or $nmbr$ cm women","C0025266;C0043210;C0455829","C0455829","",1413
"ci confidence interval esrd end stage renal disease n n number of patients who had an event total number of patients aadjusted with terms including treatment losartan or placebo geographic region genotype and the treatment genotype interaction bp value for treatment genotype interaction i e comparison of the losartan treatment effect between the $nmbr$ genotype groups","C0008107;C0009667;C0017431;C0017446;C0022661;C0030705;C0032042;C0037623;C0039798;C0087111;C0126174;C0205147;C0233324;C0332257;C0441471;C0441833;C0683454;C0687744;C1257890;C1280500;C1415692;C1515273;C1517526;C1518681;C1519504;C1522326;C1522609;C1533734;C1552839;C1696465;C1704675;C1705169;C1705313;C1705428;C1705429;C1706408;C1707455;C1708288;C2348382;C2360800;C2826302;C3259781;C3538994;C3887704;C4019010;C4288115;C4318478",NULL,NULL,1633
"stroke m $nmbr$","C0038454;C0369637;C0441923;C4554100",NULL,NULL,1762
"$nmbr$ high risk","C0332167;C3272283;C4050568;C4319571","C4319571","",837
"placebo dexlansoprazole","C0032042;C1696465;C1706408;C2348248","C0032042","",28
"baseline hb $nmbr$ g $nmbr$ $nmbr$ n $nmbr$","C0062408;C0168634;C0439267;C1442488",NULL,NULL,2188
"antihypertensive therapy","C0585941",";C0003364","",1579
"nitrates","C0028125;C0699857;C3848573",NULL,NULL,537
"mh crpnorr","C0026514;C2930980",NULL,NULL,302
"o $nmbr$ i i","C0021966;C0221138;C0483204","","",-10
"elevated bnp","C0054015;C0205250;C1095989;C1417808;C2982014;C3163633",NULL,NULL,1635
"hdlc concentration","C0086045;C1446561;C1704429;C3827302",NULL,NULL,676
"hdl c mmol l mean","C0444504;C1532563;C2347634;C2348143;C3715113","C0023822","",821
"diastolic total","C0012000;C0439175;C0439810","C0012000","",844
"medications at enrolment","C0013227;C0802604;C1516879;C1696073;C2598133;C3888021;C4284232",NULL,NULL,339
"cs","C0010182;C0271160;C3540510;C4085345",NULL,NULL,136
"with corticosteroid treatment $nmbr$","C0001617;C0039798;C0087111;C1522326;C1533734;C1705169;C3536709;C3538994;C3887704","C0017710","",1348
"adjusted mean se $nmbr$ ci","C0008107;C0036919;C0444504;C0456081;C2347634;C2348143;C3259781",NULL,NULL,519
"baseline diastolic blood pressure mean sd mm hg","C0439475;C0444504;C2347634;C2348143;C2699239;C4274392","C0005823","",1469
"duration of treatment in the healing study n","C0043240;C0205249;C0444921;C0557651;C2603343",NULL,NULL,1730
"tanezumab $nmbr$ $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346819;C2346927;C4321396;C4521761",NULL,NULL,2309
"enalapril","C0014025",NULL,NULL,164
"d $nmbr$ vs warfarin","C0043031;C0073187;C0332173;C4484261","C0043031","",858
"geometric mean blood eosinophil count on loge scale cells ljj","C0175659;C0200638;C0349674;C1947916;C2697934;C2986759","C0014467","",849
"body mass index $nmbr$ no f","C0005893;C0016327;C0578022;C1305855","C1305855","",1734
"nadroparin vs control","C0206232;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389","C0206232","",860
"history of fistulising disease n","C0683519;C0730226;C0850708;C0944983",NULL,NULL,105
"body weight change from baseline","C0005911;C0168634;C0392747;C0443172;C1303013;C1442488;C1705241;C4319952",NULL,NULL,767
"peripheral","C0205100",NULL,NULL,932
"noninsulin therapy","C0039798;C0087111;C1363945",NULL,NULL,236
"crp mean mg dl sd","C0439269;C0444504;C2347634;C2348143;C2699239;C3890735;C4048285","C0006560","",286
"hypokalaemia","C0020621;C4553966","C4553966;C0020621",";C0032821;C0202194;C0304475;C0597277;C1532563;C3714637",32
"median interquartile range yr","C0439234;C0549183;C0876920;C1711350;C2347635;C2348144;C2939193",NULL,NULL,1099
"at qualifying event","C0441471;C1514624;C4019010",NULL,NULL,412
"documented hypoglycaemiac","C1301725;C1609436","C0020615","",35
"febuxostat $nmbr$ mg daily n $nmbr$ n","C0024671;C0026410;C0249529;C0332173;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2282
"adjusted mean se change from baseline","C0036919;C0168634;C0392747;C0443172;C0444504;C0456081;C1442488;C1705241;C2347634;C2348143;C4319952",NULL,NULL,37
"patients with event patients analyzed","C0030705;C0441471;C0936012;C4019010",NULL,NULL,1035
"median q $nmbr$ q $nmbr$ lp a mg dl","C0065058;C0439269;C0549183;C0876920;C1439335;C2347635;C2348144;C2939193;C4553379",NULL,NULL,635
"outcome variant","C0205419;C1274040",NULL,NULL,1602
"at entry","C1705654",NULL,NULL,1588
"positive for hla b $nmbr$ n","C0019737;C0439178;C0550853;C1415561;C1446409;C1514241;C2825490;C3812269",NULL,NULL,1803
"creatinine mg dl","C0010294;C0439269;C1561535","C0600061;C0010294","",952
"systolic blood pressure $nmbr$ mm hg no","C0439475;C0488055;C0871470;C1306620","C0005823","",1469
"all of the colon","C0009368;C3888384","C0009368","",1971
"europe i","C0015176;C0021966;C0221138","C0015176","",337
"pci revascularization","C0581603;C4049621",NULL,NULL,1736
"boost intensify premix i global patient population","C0021966;C0030705;C0032659;C0205246;C0221138;C1257890;C1511253;C1874596;C2348867",NULL,NULL,904
"asui score mean","C0444504;C0449820;C2347634;C2348143;C4050231",NULL,NULL,37
"dm or diabetic complications","C0011816;C0342257;C3250443",NULL,NULL,955
"pci procedure","C0184661;C2700391;C3274430;C3539779;C4049621","C1532338","",1661
"hdl c $nmbr$ mg dl n","C0439269;C3715113","C0023822","",1962
"g","C0439267",NULL,NULL,1485
"pah ssc","C0030123;C3203102;C3897657;C4284467",NULL,NULL,1663
"$nmbr$ $nmbr$ months n","C0439231",NULL,NULL,1530
"estimated glomerular filtration rate $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ i","C0021966;C0023806;C0221138;C0369637;C0439445;C0441923;C0702093;C1524029;C3811844;C3813700",NULL,NULL,923
"$nmbr$ $nmbr$ fn t score","C0449820;C1570610;C4050231",NULL,NULL,748
"cv death or hf hosp","C0011065;C0018488;C1306577;C1313497;C1538440;C3273279;C3538987;C4048877;C4082313;C4318503;C4552775",NULL,NULL,323
"action tested is between the continuous variable and treatment","C0039798;C0087111;C0392366;C0439828;C0441472;C0549178;C1522326;C1533734;C1705169;C3266814;C3538994;C3887704;C4553760",NULL,NULL,1018
"hispanic ethnic group no t","C0015031;C0086409;C1879937;C2603360","C0086409","",865
"time sample drawn h","C0033727;C0040223;C0369286;C0370003;C0441932;C0564385;C2347026;C3541383;C4528284",NULL,NULL,308
"general health vas $nmbr$ $nmbr$ mm","C0042815;C0424575;C3536884;C3827561;C4018875;C4330985;C4554674",NULL,NULL,1751
"history of asthma related intubation no","C0021925;C0439849;C0445223;C0455544",NULL,NULL,319
"number of events event per $nmbr$ person years","C0027361;C0439234;C2347489;C4330837","C4330837","",1810
"minutes from pre pci angiography to post pci angiography median iqr","C0002978;C0332152;C0439232;C0549183;C0687676;C0700321;C0702093;C0740175;C0876920;C1282918;C1704687;C2257086;C2347166;C2347635;C2348144;C2939193;C3469826;C3669034;C4049621",NULL,NULL,635
"$nmbr$ $nmbr$ ml min $nmbr$","C0439445","C3811844;C0017654","",307
"prior heart failure n $nmbr$ $nmbr$","C0018801;C0018802;C0332152;C2826257;C4554158","C0018801",";C0168634;C1524003",12
"left ventricular ejection fraction within previous $nmbr$ mo no total no $nmbr$","C0026544;C0205156;C0332177;C0428772;C0439175;C0439810;C0488728;C1552607",NULL,NULL,1476
"insulin glargine oad","C0907402","C0907402",";C1998602;C0004446;C0005126;C2344255;C4050145;C0229089;C0439164;C1512019;C3273373;C3665488",69
"patients without chronic","C0030705;C0205191",NULL,NULL,1701
"cv death or first hhf","C0011065;C0205435;C1279901;C1306577;C3538987;C4048877;C4082313;C4318503;C4552775",NULL,NULL,839
"mssbp $nmbr$ mmhg","C0439475",NULL,NULL,1471
"with previous surgery","C0038894;C0038895;C0205156;C0543467;C1274039;C1552607",NULL,NULL,598
"non haemorrhagic stroke no","C0038454;C0333275;C1518422;C4554100",NULL,NULL,581
"vi $nmbr$ $nmbr$ $nmbr$","C0205999",NULL,NULL,515
"baseline ldlc level n $nmbr$ $nmbr$ s $nmbr$ $nmbr$ mg dl","C0168634;C0439269;C0441889;C0456079;C1416822;C1442488;C1547707;C2946261","C0023824;C1442488","",1964
"post menopausal without hormone replacement","C0019930","C0019930","",281
"angiotensin il receptor blocker","C0003018;C0020898;C0021764;C0022271;C0034787;C1149183;C1622222;C4521302","C0521942","",779
"median iqr age years","C0549183;C0876920;C1510829;C2347635;C2348144;C2939193",NULL,NULL,635
"nos $nmbr$ glu $nmbr$ asp g t n","C0125690;C0326287;C0439267;C1518425;C2986835",NULL,NULL,131
"$nmbr$ ml min $nmbr$","C0439445","C3811844;C0017654","",307
"rr $nmbr$ aci p value","C0814206;C1510682;C1709380;C2346870;C4050575;C4554402",NULL,NULL,7
"significant worsening in kccq clinical","C0205210;C0237881;C0332271;C0750502;C1457868;C1546944;C1546960;C3476798",NULL,NULL,788
"all cardiovascular","C0007226;C3887460",NULL,NULL,649
"ibs $nmbr$ $nmbr$","C0022104;C0432306",NULL,NULL,137
"hscrp post baseline baseline ratio ls mean se","C0023668;C0036919;C0168634;C0444504;C0456603;C0687676;C1442488;C1547037;C1704687;C2347634;C2348143;C3469826",NULL,NULL,973
"age at entry years","C1510829;C1705654","C1510829","",481
"early","C1279919",NULL,NULL,1487
"$nmbr$ $nmbr$ o $nmbr$ s o $nmbr$","C0483204","","",-10
"$nmbr$ and $nmbr$ $nmbr$ and $nmbr$ mmol mol","C3829066",NULL,NULL,668
"cardiac risk","C0018787;C0035647;C1522601;C4552904","C0035647","",173
"estrogen supplementation","C0014939;C0242297;C2936882;C4542544","C0014939","",340
"tender joint count of $nmbr$ joints","C0451530","C0451530","",1139
"ff $nmbr$ ig n $nmbr$","C0021027;C0305052;C0360506;C4554348",NULL,NULL,1260
"value $nmbr$","C1522609",NULL,NULL,9
"bmi kg m $nmbr$ mean $nmbr$ sd","C0444504;C0578022;C1532718;C2347634;C2348143;C2699239",";C1305855","",206
"basdai $nmbr$","C1998004","C1998004","",1354
"hospitalized for asthma n","C0004096;C0701159;C2984299",NULL,NULL,694
"copd severity gold $nmbr$","C0018026;C0024117;C0439793;C0522510;C1304897;C1412502;C3714496",NULL,NULL,1546
"elevation of troponin levels no total no","C0041199;C0439175;C0439775;C0439810;C0441889;C0702240",NULL,NULL,508
"heart rate b p m mean sd","C0018810;C0369637;C0441923;C0444504;C2347634;C2348143;C2699239","C0018810","",1105
"high tt $nmbr$ $nmbr$ n $nmbr$","C0205250;C1299351;C1452561;C2700149;C3887512;C3889660;C4321237;C4522209;C4554543",NULL,NULL,834
"risk factor predefined for falling at screening n","C0000921;C0035648;C0085639;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164",NULL,NULL,798
"symptom onset to arrival in catheterization laboratory","C0007430;C0022877;C1555577;C1706079;C3244292;C4086878;C4283904",NULL,NULL,978
"controlled","C2587213;C2911690",NULL,NULL,675
"bmi kg m mean sd","C0444504;C0578022;C1532718;C2347634;C2348143;C2699239",NULL,NULL,1735
"colon","C0009368;C3888384","C0009368","",1971
"r r $nmbr$ ci","C0008107;C0205090;C0684010;C2603358;C3259781",NULL,NULL,519
"only cerebrovascular disease","C0007820;C0205171;C1720467",NULL,NULL,728
"psoriasis n","C0033860","C0033860","",1358
"freqency of events","C0441471;C3541888",NULL,NULL,412
"normal function or mild impairment","C0221099;C0684336;C2945599;C4296962",NULL,NULL,329
"placebo","C0032042;C1696465;C1706408","C0032042","",28
"t $nmbr$ d","C2603360","","",-10
"age yij","C0001779","C0001779","",480
"thiazides","C0541746","","",993
"patient assessment of pain $nmbr$ $nmbr$ mm mean sd","C0030193;C0030198;C0030705;C0444504;C0518090;C0679830;C1962977;C2347634;C2348143;C2699239;C2984058;C4085210;C4085211;C4085212;C4330985;C4553004;C4554132;C4554674","C0030193","",1338
"estimate $nmbr$ ci","C0008107;C0750572;C3259781",NULL,NULL,519
"eligibility risk factorsa","C0013893;C0035647;C1548635;C4552904","C0013893;C0035648","",1317
"p sitosterol total c imol mmol","C0037215;C0220914;C0369773;C0439175;C0439190;C0439810;C2603361",NULL,NULL,1503
"exacerbations in the past $nmbr$ months n","C4086268;C4331910","C4086268","",889
"diagnosis of hefh n","C0011900;C1704338;C1704656",NULL,NULL,841
"pre bronchodilation fev $nmbr$","C0439566;C3714541",NULL,NULL,1599
"creatinine pmol l","C0010294;C0439284;C1561535","C0600061;C0010294","",952
"ics non users qvai $nmbr$ sfc","C0815320;C1518422;C1706077;C4521536;C4551720",NULL,NULL,1283
"anterior or non anterior ml","C0205094;C0439526;C1518422;C1705224;C3887665",NULL,NULL,1244
"high density lipoprotein cholesterol mg l","C0023822;C0439268","C0023822","",821
"age in years","C1510829","C1510829","",481
"pancreatic cancer","C0235974;C0346647;C2984259","C0235974;C0346647","",1865
"chronic obstructive pulmonary disease n","C0024117",NULL,NULL,1726
"lipids","C0023779","C0023779","",1772
"glyburide","C0017628","C0017628","",1350
"catheter access site","C0085590;C0444454;C0449652;C0589360;C1554204",NULL,NULL,493
"su","C0038642;C1705534",NULL,NULL,1286
"sbp at baseline","C0085805;C0168634;C1442488",NULL,NULL,606
"enrollment to randomization","C0034656;C1516879;C1696073;C3888021",NULL,NULL,339
"blood pressure","C0005823;C1271104;C1272641","C0005823","",15
"any bp lowering agents","C0037623;C0441994;C0450442;C1254351;C1415692;C1521826;C1708288;C2003888;C4318478",NULL,NULL,608
"dbp sd mm hg","C0439475;C0536221;C2699239;C3813197;C4281799",NULL,NULL,605
"$nmbr$ $nmbr$ referent","C1706462",NULL,NULL,1464
"gene chr snp","C0017337;C0043459;C0752046;C1527094;C1861559;C3890034;C4050175","C0017337","",1084
"$nmbr$ years or older","C0439234;C0580836",NULL,NULL,1099
"plasma lipids mg dl $nmbr$ total cholesterol mean","C0023779;C0439269;C0444504;C0858034;C2347634;C2348143",NULL,NULL,192
"total cholesterol mmol le","C0023190;C0201950;C0439090;C0439190;C0543421;C1423767;C2697858","C0543421","",1504
"enoxaparin $nmbr$ mg n $nmbr$ $nmbr$","C0024671;C0026410;C0206460;C0439269;C1960952;C2346927;C4321396;C4521761","C0206460","",862
"eacit e total score","C2964552",NULL,NULL,540
"right ventricular dysfunction no total no","C0242707;C0439175;C0439810;C1556315","C0242707","",1882
"first co primary outcome","C0205225;C0205435;C0439612;C0439631;C1274040;C1279901;C3245499",NULL,NULL,2339
"no of treated lesions","C0221198;C1522326",NULL,NULL,552
"apo b apo a i ratio","C0003593;C0085201;C0456603;C1547037;C1677784;C3252643","C0003593","",426
"race n white","C0007457;C0034510;C0043157;C0220938;C1706779;C3853635",";C0034510","",1107
"cangrelor n n","C1121991","C1121991","",1247
"conventional treatment","C2945704",NULL,NULL,725
"primary outcomes","C0205225;C0439612;C0439631;C1274040",NULL,NULL,2339
"prior nsaid use","C0003211;C0042153;C0332152;C0457083;C1947944;C2826257;C3536840",NULL,NULL,2121
"intermediate","C0205103;C1550465;C2827755;C3889971","C0205103",";C0015663;C1550465;C2827755;C3889971;C0079613;C1704930;C1869853;C3890007;C4048375",1096
"time from onset of pain to randomization hr","C0030193;C0034656;C0449244;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132","C0030193;C0449244;C0034656","",2169
"diabetic participants","C0241863;C0679646",NULL,NULL,996
"day $nmbr$ oral glucocorticoid use no","C0017710;C0042153;C0332173;C0439228;C0439505;C0442027;C0457083;C1947944;C4521986",NULL,NULL,1621
"new or worsentna neohrodathv","C0205314",NULL,NULL,1718
"females $nmbr$","C0086287","C0086287","",1277
"tnf naivea","C1448177",NULL,NULL,362
"apob $nmbr$","C0003593;C3252643","C0003593","",426
"end point sd","C2349179;C2699239;C2826544","C2349179","",1136
"baseline cha $nmbr$ ds $nmbr$ vascb c","C0168634;C1420648;C1442488;C3714751",NULL,NULL,968
"$nmbr$ s $nmbr$ s $nmbr$","C0565930;C2603362",NULL,NULL,1784
"nyha class","C1882083","C0018802;C1882083","",453
"ctd population subgroup","C0032659;C1079230;C1257890;C1335071;C1442905;C1515021",NULL,NULL,904
"medications at randomization","C0013227;C0034656;C0802604;C2598133;C4284232",NULL,NULL,2263
"$nmbr$ point mace","C0349381;C0949745;C1445339;C1552961;C2347617;C3714763","C1320716","",414
"least squares mean difference $nmbr$ cl","C0023189;C0444504;C0596019;C1705241;C1705242;C2347634;C2348143",NULL,NULL,658
"bmi kg m $nmbr$ cholesterol mg dl","C0008377;C0439269;C0578022;C1532718",";C1305855","",206
"white n $nmbr$ $nmbr$","C0007457;C0043157;C0220938","C0043157","",1402
"qol due to urinary symptoms","C0426359;C0518214;C0678226","C0034380","",1116
"vte vte related deathsa n n","C0439849;C0445223;C0630906","C1861172","",318
"initial aspirin no","C0004057;C0205265;C1279901;C1555582;C1705685","C0004057","",1366
"sotagliflozin n $nmbr$","C3896939","C3896939","",2067
"homa ir score","C0022065;C0022071;C0449820;C1448132;C4050231","","",1397
"criteria for subcortical vad by mri","C0024485;C0077973;C0243161;C0815275;C1824234;C3890166",NULL,NULL,517
"previous cd related surgery ref a","C0007928;C0034283;C0038894;C0038895;C0205156;C0439849;C0445223;C0543467;C1274039;C1425988;C1552607;C4552032",NULL,NULL,1795
"degree of stenosis of diameter","C1301886;C4034225","C4034225","",2082
"event rate vr","C0441471;C0871208;C1521828;C3476815;C4019010",NULL,NULL,2007
"use of other medications no","C0240320",NULL,NULL,1061
"patients with measurement","C0030705;C0242485",NULL,NULL,490
"peak fev $nmbr$ $nmbr$ $nmbr$ h response","C0033727;C0369286;C0441932;C0444505;C0564385;C0871261;C1704632;C1706817;C2911692;C3714541;C4528284",NULL,NULL,726
"rf and acpa negative $nmbr$","C0035448;C0201660;C0205160;C0748398;C1513916;C1525410;C1547111;C1706063;C2825415;C2825491;C3853545",NULL,NULL,1569
"characteristic age yr","C0001779;C0439234;C1521970",NULL,NULL,2015
"race white","C0007457;C0034510;C0043157;C0220938;C1706779;C3853635",";C0034510","",1107
"renal functiona","C0022646","C0232804","",1532
"midas score","C0449820;C1309950;C1423498;C4049617;C4050231",NULL,NULL,748
"lipid measure","C0023779;C0079809;C0242485",NULL,NULL,2
"number of treated vessels per patient","C0005847;C0030705;C0237753;C0449788;C1522326",NULL,NULL,743
"pm n","C0030266;C4049155",NULL,NULL,954
"qrs interval $nmbr$ msec no","C0439223;C0520880",NULL,NULL,141
"events no","C0441471;C3541888",NULL,NULL,412
"updrs part ii adl","C0001288;C0449719;C1420005;C1709471;C1710602;C3639721;C4082587",NULL,NULL,521
"arterial area mm $nmbr$","C0003842;C0017446;C0205146;C0221464;C4330985;C4554674",NULL,NULL,297
"postbronchodilator fevj predicted","C0681842;C1882327;C2599594","C0024119","",288
"gad positive no","C0270549;C0439178;C1414925;C1446409;C1514241;C2825490;C3812269",NULL,NULL,2061
"hdl mg dl","C0439269;C3715113","C0023822","",1962
"baseline hdl c","C0168634;C1442488;C3715113","C0023822","",821
"change from baseline ls means se","C0023668;C0036919;C0168634;C0392747;C0443172;C1442488;C1704970;C1705241;C4319952",NULL,NULL,567
"ppbc score mean sd","C0444504;C0449820;C2347634;C2348143;C2699239;C4050231",NULL,NULL,1287
"$nmbr$ year framingham chd risk $nmbr$ mean sd","C0439234;C0439508;C0444504;C1282512;C2347634;C2348143;C2699239;C3166866",NULL,NULL,1099
"caucasian simva","C0007457;C0043157",NULL,NULL,586
"hba $nmbr$ c $nmbr$ level","C0019016;C0441889;C0456079;C1547707;C1825777;C2946261;C3538758","","",820
"crp mg l n","C0439268;C3890735;C4048285","C0006560","",286
"by gfr stratum for all participants ml min per $nmbr$ $nmbr$ m","C0017654;C0369637;C0439445;C0441923;C0679646;C1424601","C3811844;C0017654","",592
"any ulcerative colitis medication","C0009324;C0013227;C3244316;C4284232",NULL,NULL,1026
"p j $nmbr$ trend","C1518835;C1521798;C4554533",NULL,NULL,550
"subcutaneous unfractionated heparin","C0353681",NULL,NULL,1662
"male eze simva n $nmbr$","C0086582;C1706180;C1706428;C1706429",NULL,NULL,586
"$nmbr$ incidence in any treatment group in the overall safety population","C0021149;C0032659;C0036043;C0220856;C0282416;C0374505;C1257890;C1561607;C1705187",NULL,NULL,904
"postprandial indices","C0376674;C4033634",NULL,NULL,593
"prior mi n $nmbr$ $nmbr$","C0332152;C2826257;C3810814",NULL,NULL,516
"rr $nmbr$ cl value","C0596019;C1522609;C4554402",NULL,NULL,1542
"rf positive $nmbr$ iu ml","C0035448;C0201660;C0439178;C0439458;C0748398;C1446409;C1514241;C1547111;C2825490;C3812269","C0035448","",1435
"isehemie heart disease","C0018799","C0010054;C0151744","",1361
"death q wave mi or ischemia driven revasc","C0011065;C0022116;C0378365;C0861151;C1306577;C4082313;C4321499;C4552775;C4683688","C1305738","",385
"imm","C0205470",NULL,NULL,1261
"timi bleeding major minor","C0019080;C4441842",NULL,NULL,530
"mean preoperative abpi of the index","C0444504;C0445204;C0600653;C0918012;C1552854;C1637833;C2347634;C2348143;C2986546",NULL,NULL,734
"no prior cancer","C0006826;C0332152;C0998265;C1306459;C2826257","C0006826","",1819
"mean sd post bronchodilator fev $nmbr$ percentage predicted","C0439165;C0444504;C0681842;C1549488;C1561533;C1882327;C2347634;C2348143;C2599594;C2699239;C3714541",NULL,NULL,1599
"previous medication for respiratory disease no","C0012634;C0013227;C0035204;C0035242;C0205156;C0418986;C1552607;C3244316;C4284232",NULL,NULL,976
"at six weeks","C0205452;C0439230",NULL,NULL,1012
"blood pressure mm hg mean sd","C0428886;C0439475;C2699239","C0005823","",1469
"$nmbr$ drug related aes","C0013227;C0439849;C0445223;C1254351;C1412268;C2699274",NULL,NULL,367
"$nmbr$ aminosalicylic compounds no","C0205198;C1706082","C0368663","",1691
"aicd","C0972395;C2611803;C3537205;C3546309","C0972395","",1360
"nyha functional class $nmbr$","C0205245;C0542341;C1882083;C2700217",NULL,NULL,1531
"treatment arm zoledronate","C0392938;C1522541",NULL,NULL,950
"vedolizumab","C2742797",NULL,NULL,943
"time since diagnosis of ciu csuf y","C0011900;C0040223;C0578870;C1704338;C1704656;C3541383",NULL,NULL,841
"sensitivity analyses","C0002778;C0020517;C0036667;C0312418;C0427965;C0936012;C1511883;C1522640;C1524024;C2346484;C2349185",NULL,NULL,183
"conventional treatment n $nmbr$","C2945704",NULL,NULL,725
"concomitant antiplatelet","C0521115",NULL,NULL,447
"history of amputation","C0002688;C0019664;C0019665;C0262512;C0262926;C0332840;C1546539;C1705255;C2004062",NULL,NULL,832
"glycated hemoglobin n","C0062408;C3666909","","",1176
"responders of three item end point at $nmbr$ weeks","C0205449;C0439230;C1551338;C2349179;C2826544;C4554251",NULL,NULL,1012
"tiotropium $nmbr$ mg respimat n z $nmbr$","C0024671;C0026410;C0213771;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2300
"oral contraceptives","C0009905","C0304289;C0009905","",1921
"$nmbr$ g n $nmbr$","C0439267",NULL,NULL,1486
"empagiiflozin $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2277
"thoracic cage fractures","C0016658;C0222762",NULL,NULL,2028
"anti ccp antibody positive n","C0432633;C0741132;C1525410;C1704514","C4318437","",360
"protein in urine $nmbr$","C0033687","C0033687","",285
"race $nmbr$","C0034510;C1706779;C3853635",";C0034510","",1107
"non asian n $nmbr$ $nmbr$","C0078988;C1518422","C0078988","",1369
"cholesterol mean sd n","C0008377;C0444504;C2347634;C2348143;C2699239","C0008377","",1501
"congestive heart failure definite","C0018802;C0439544;C1704787","C0018801",";C0168634;C1524003",12
"total basdai score mean sd","C0439175;C0439810;C0444504;C0449820;C1998004;C2347634;C2348143;C2699239;C4050231",NULL,NULL,37
"edoxaban n $nmbr$","C2975435","C2975435","",1220
"b mace","C0349381;C0949745;C1445339","C1320716","",414
"diagnosis yr","C0011900;C0439234;C1704338;C1704656",NULL,NULL,1099
"prior treatment no","C1514463",NULL,NULL,574
"medications at baseline n","C0013227;C0168634;C0802604;C1442488;C2598133;C4284232",NULL,NULL,2263
"$nmbr$ $nmbr$ drinks day if male female","C0043210;C0086287;C0086582;C0332173;C0439228;C0439505;C0452428;C1705497;C1705498;C1706180;C1706428;C1706429",NULL,NULL,178
"current smoking","C0037369;C0453996;C0521116;C1705970;C1881674","C0037369;C0521116","",2224
"recurrent ischemia urgent revascularization","C0022116;C0439609;C0581603;C1455761;C2945760;C3272275;C4321499",NULL,NULL,1668
"advanced","C0205179","C0205179","",190
"time to first oral or systemic corticosteroid","C0040223;C0205435;C0442027;C1279901;C3541383;C4053960;C4521986",NULL,NULL,1649
"vldl cholesterol","C0023826;C0523560","C0023824;C0023826","",1066
"saxagliptin $nmbr$ $nmbr$ mg n z $nmbr$","C0024671;C0026410;C0439269;C1611934;C1960952;C2346927;C4321396;C4521761","C1611934","",2069
"baseline hbalc $nmbr$ to $nmbr$","C0168634;C1442488","","",1176
"p $nmbr$ interaction","C0369773;C1704675;C2603361",NULL,NULL,888
"hdl c level mean sd mg dl","C0439269;C0441889;C0444504;C0456079;C1547707;C2347634;C2348143;C2699239;C2946261;C3715113","C0023822","",1962
"new or worsenina neohrodathv","C0205314",NULL,NULL,1718
"cholesterol mmol l","C0008377;C1532563","C0008377","",1501
"total stent length","C0038257;C0439175;C0439810;C1444754;C1706316","C0038257;C1444754","",1748
"recent cardioversion within $nmbr$ days before randomization","C0013778;C0034656;C0332185;C0439228",NULL,NULL,1621
"versus tiotropium $nmbr$ pg","C0030827;C0072225;C0213771;C1266240","C0213771","",1372
"pooled eze simva","C1709595;C2349200;C4522255","C0074554","",1840
"asia pacific and africa","C0001737;C0003980",NULL,NULL,48
"non compliance","C0376405;C0457432",NULL,NULL,1690
"patients with remission","C1277626",NULL,NULL,878
"methotrexate treatment","C0746573","C0025677","",716
"hba $nmbr$ c $nmbr$ $nmbr$ to $nmbr$ $nmbr$ $nmbr$ $nmbr$ mmol mol","C0019016;C1825777;C3538758;C3829066","","",820
"crp mean mg l sd","C0439268;C0444504;C2347634;C2348143;C2699239;C3890735;C4048285","C0006560","",286
"$nmbr$ ci","C0008107;C3259781",NULL,NULL,519
"cha $nmbr$ ds $nmbr$ vasc score median iqr","C0449820;C0549183;C0876920;C1420648;C2347635;C2348144;C2939193;C3714751;C4050231",NULL,NULL,968
"standard treatment n $nmbr$","C4684780",NULL,NULL,717
"post bronchodilator fev $nmbr$ reversibility percentage of baseline value","C0168634;C0439165;C0449261;C1442488;C1522609;C1549488;C1561533;C2599594;C3714541",";C0037981","",1197
"p value for interaction $nmbr$","C1704675;C1709380",NULL,NULL,7
"coronary artery bypass surgery","C0010055","C0010055","",389
"data are expr","C1511726;C3245479;C3714741",NULL,NULL,1427
"no of patients with atrial tachyarrhythmia","C0018792;C0030705;C0080203","C0080203","",381
"no of patients with psa","C0030705;C3810537;C3813209",NULL,NULL,125
"other mixed n $nmbr$","C0205430;C3160715",NULL,NULL,985
"hazard ratio $nmbr$ cl nateglinide vs placebo","C0032042;C0596019;C0903898;C1696465;C1706408;C2985465","C2985465","",975
"n t","C0369718;C0441922",NULL,NULL,1553
"intermittent claudication","C0021775","C0021775","",263
"amlodipine and valsartan","C0051696;C0216784","C0216784;C0051696","",2085
"gold $nmbr$ $nmbr$ $nmbr$","C0018026;C1304897","C0024117;C0521117","",213
"$nmbr$ failure","C0231174;C0680095",NULL,NULL,1969
"fev $nmbr$ litres post salbutamol mean sd","C0001927;C0444504;C0475211;C0687676;C1704687;C2347634;C2348143;C2699239;C3469826;C3714541",NULL,NULL,584
"ischaemic cardiomyopathy","C0349782",NULL,NULL,652
"$nmbr$ hr prandial glucose","C0017725;C1998602;C4553624",NULL,NULL,827
"fev $nmbr$ litres pre ipratropium mean sd","C0027235;C0332152;C0444504;C0475211;C0740175;C2257086;C2347634;C2348143;C2699239;C3669034;C3714541",NULL,NULL,1599
"one at baseline","C0168634;C0205447;C1442488",NULL,NULL,625
"experimental intervention group n $nmbr$","C0184661;C0441848;C0886296;C1273869;C1517586",NULL,NULL,290
"black af rican american","C0085756;C0344434;C4049859",NULL,NULL,1794
"canagliflozin dose","C0178602;C0869039;C1114758;C2974540","C2974540","",1181
"previous deep vein thrombosis or pulmonary embolism","C0034065;C0149871;C0205156;C1552607",NULL,NULL,630
"lev status","C0023556;C0449438",NULL,NULL,543
"grouped region","C0017446;C0205147;C0439745;C4319846","C0017446","",369
"indication for stent","C0038257;C0392360;C3146298",NULL,NULL,1713
"asia pacific region and south africa","C0003980;C0017446;C0037712;C0205147","C0003980","",1382
"subjects","C0681850;C1550501;C1706203;C2349001;C2697811",NULL,NULL,1655
"elevated non hdl cholesterol","C0205250;C0729627;C1535899;C3163633","C0023822","",821
"mean sf $nmbr$ score $nmbr$ ci","C0008107;C0037712;C3259781;C3533236",NULL,NULL,519
"pasi c median min max","C0549183;C0702093;C0876920;C1524029;C2347635;C2348144;C2939193;C3813700;C4528685",NULL,NULL,1475
"maintenance use no","C0024501;C0042153;C0457083;C1947944",NULL,NULL,118
"prior mi stroke","C0038454;C0332152;C2826257;C3810814;C4554100",NULL,NULL,294
"ineffective therapy","C0039798;C0087111;C1363945;C3242229",NULL,NULL,236
"antihypertensive agents n","C0003364",";C0003364","",1579
"statin therapy","C1278454",NULL,NULL,1646
"baseline systolic blood pressure","C4274438","C0005823","",1469
"no dysglycaemia or mets pbo n $nmbr$ vs evomab n $nmbr$","C0031962;C0812270;C1705694;C1960636;C2939420",NULL,NULL,921
"previous use of systemic steroids for ciu csu","C0205156;C0205373;C0281991;C0578870;C1552607",NULL,NULL,2396
"prespecified subgroup analyses","C2986480",NULL,NULL,1636
"east asia","C0015631","C0003980","",1382
"hospitalisation for chf within $nmbr$ years of randomisation","C0018802;C0019993;C0034656;C0439234",NULL,NULL,2359
"history of major macrovascular disease n","C0205082;C0205164;C0683519;C0730226;C0850708;C0944983;C4318856;C4521762","C0004153","",1698
"group c n $nmbr$","C0441848",NULL,NULL,1638
"baseline eosinophil $nmbr$ cells pl","C0168634;C0682547;C1442488;C3897966;C4049765","C0014467;C0007584","",1806
"no alcohol consumption on average","C0001948;C1510992;C2825518","C0001948","",875
"waisvhip median","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"blood pressure mean sd mm hg systolic","C0039155;C0428886;C0439475;C2699239","C0005823","",1469
"no aspirin or ppi","C0004057;C0358591;C0871125;C3811894","C0004057","",1366
"sia","C1225105;C1551538",NULL,NULL,1400
"pneumonia events n","C0032285;C0441471;C3541888",NULL,NULL,412
"randomization to arrival in catheterization laboratory","C0007430;C0022877;C0034656;C1555577;C1706079;C3244292;C4283904",NULL,NULL,978
"history of thyroid disease n","C0040132;C0683519;C0730226;C0850708;C0944983;C3540038",NULL,NULL,105
"ls mean $nmbr$ ci treatment difference vs placebo","C0008107;C0023668;C0032042;C0039798;C0087111;C0444504;C1522326;C1533734;C1696465;C1705169;C1705241;C1705242;C1706408;C2347634;C2348143;C3259781;C3538994;C3887704","C0032042","",28
"p value cangrelor versus clopidogrel in women","C0043210;C0070166;C1121991;C1709380","C1121991;C0070166;C1709380","",2097
"canakinumab il $nmbr$ lowest tertile","C0020898;C0021764;C0022271;C1708760;C2718773","C2718773","",372
"lipid disorder","C0154251","C0086440","",1773
"diff_measure","C0079809;C0242485",NULL,NULL,2
"regional anaesthesia","C0002911",NULL,NULL,53
"cabg during index hospitalization","C0010055;C0019993;C0600653;C0918012;C1552854;C1637833;C2986546","C0010055","",389
"alpha blocker other vasodilator","C0001641;C0042402;C3537240","C0001641","",961
"statistics","C0038215;C0600673",NULL,NULL,181
"cerebral ischemia","C0007785;C0917798",NULL,NULL,929
"change from baseline to week $nmbr$ in dlqi scorez","C0168634;C0332174;C0392747;C0439230;C0443172;C1442488;C1705241;C3899393;C4319952",NULL,NULL,1012
"heart failure hf","C0018488;C0018801;C0018802;C1313497;C1538440;C3273279;C4554158","C0018801",";C0168634;C1524003",12
"km event at $nmbr$ y","C0441471;C3887676;C4019010",NULL,NULL,412
"czp $nmbr$ mg","C0024671;C0026410;C0054841;C0439269;C1861828;C1872109;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2274
"a primary composite outcome","C0205199;C0205225;C0439612;C0439631;C1274040;C1547335",NULL,NULL,2339
"metformin other oral anti dm drugs","C0011816;C0025598;C0029167;C0175795;C0304289;C3250443","C0025598","",1345
"mets n","C0812270;C1705694;C2939420",NULL,NULL,921
"$nmbr$ days composite of death new mi urgent revascularization and definite st","C0011065;C0036056;C0205199;C0439544;C0439609;C0581603;C1306577;C1547335;C1704787;C3272275;C3272372;C3810814;C4082313;C4552775;C4689466",NULL,NULL,246
"ideglira","C4308663",NULL,NULL,774
"$nmbr$ h n","C0033727;C0369286;C0441932;C0564385;C4528284",NULL,NULL,308
"systolic blood pressure $nmbr$ mm hg and diastolic","C0012000;C0439475;C0488055;C0871470;C1306620","C0005823","",1469
"$nmbr$ mm hg","C0439475",NULL,NULL,1888
"acei or arb","C3888198",NULL,NULL,44
"dm absent","C0011816;C0332197;C3250443;C4285062",NULL,NULL,485
"composite of death mi urg ent revasc","C0011065;C0205199;C0378365;C0919420;C1306577;C1367721;C1547335;C1705448;C3810814;C3889152;C4082313;C4552775",NULL,NULL,323
"level no","C0441889;C0456079;C1547707;C2946261",NULL,NULL,744
"large vessel atherosclerosis","C0003850;C0004153;C0225990","C0004153","",1698
"serum cholesterol mmol liter","C0439190;C0475211;C0587184","C0008377","",1501
"former smokers","C0337671","C0037369","",420
"aldosterone blocker","C0002006",NULL,NULL,963
"anorexigen use","C0042153;C0457083;C1947944",NULL,NULL,118
"tender joint count range $nmbr$ $nmbr$ joints","C0451530;C1514721;C2348147;C3542016","C0451530","",1139
"iii","C0439070;C1705160",NULL,NULL,524
"race nonwhite","C0034510;C1706779;C3853635","C0034510;C1518422;C0043157","",1401
"bp $nmbr$ $nmbr$ n","C0037623;C1415692;C1708288;C4318478",NULL,NULL,608
"met se","C0036919;C0428210;C1550543;C4317104",NULL,NULL,39
"prior cardiovascular disease","C0007222;C0332152;C2826257","C0007222","",1790
"type $nmbr$ diabetes n","C1320657","C0011849;C1320657","",907
"atrial fibrillation onset","C0004238;C0206132;C0332162;C0344434;C1963067",";C0004238","",1009
"treatment duration before randomization days","C0034656;C0439228;C0444921;C3259042",NULL,NULL,1621
"categories of urinary acr g mg","C0042027;C0683312;C1300563;C1412134;C1515941;C1524119",NULL,NULL,52
"triglyceride mg dl d","C0041004;C0439422;C3642216","C0041004","",368
"serum haemoglobin a $nmbr$ c concentration mean sd","C0019020;C0444504;C0683149;C2347634;C2348143;C2699239;C3889898","","",1176
"ics use","C0042153;C0457083;C0815320;C1947944;C4551720","C3540778","",2182
"baseline ptga","C0168634;C1442488",NULL,NULL,625
"late load","C0205087;C1550025;C1704782;C1708715",NULL,NULL,1056
"gastrooesophageal reflux disease","C0017168;C4553201","C0017168","",99
"p valueb","C0369773;C2603361",NULL,NULL,1872
"enact $nmbr$ trial","C0008976",NULL,NULL,1020
"history of microalbuminuria no","C3532606","C0033687","",376
"risk reduction $nmbr$ ci","C0008107;C1137094;C3259781",NULL,NULL,171
"no aspirin at baseline","C0004057;C0168634;C1442488",NULL,NULL,625
"baseline upgr $nmbr$ gm gm $nmbr$ mg mmole","C0017480;C0168634;C0567349;C1442488;C2348885;C3854019",NULL,NULL,625
"oral corticosteroid use n","C0001617;C0239126;C0442027;C1527415;C3536709;C4521986",NULL,NULL,1650
"patients n n a","C0030705",NULL,NULL,1035
"qualifying type of atherosclerosis no","C0003850;C0004153;C0332307;C1514624;C1547052","C0004153","",1698
"antiplatelets agents","C0085826","","",1191
"anticholinergic","C0242896;C3537004",NULL,NULL,1704
"atorvastatin n","C0286651","C0286651","",885
"estimated glomerular filtration rate no","C3811844","C3811844;C0017654","",592
"medication at randomization","C0013227;C0034656;C3244316;C4284232",NULL,NULL,2263
"hemoglobin a $nmbr$ c mean sd","C0019020;C0444504;C2347634;C2348143;C2699239;C3889898",NULL,NULL,37
"nfs $nmbr$ $nmbr$ high","C0205250;C1299351;C1555018;C2700149;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"bolus administered no","C1186706;C1511237;C1521801;C1705509;C3812160",NULL,NULL,632
"yes $nmbr$ $nmbr$ y","C1549445;C1705108;C1710701",NULL,NULL,147
"continued use of gpa","C0549178;C1524063;C3495801;C4553145",NULL,NULL,25
"pancreas","C0030274","C0030274","",2229
"history of major microvascular disease no","C0205082;C0205164;C0443258;C0683519;C0730226;C0850708;C0944983;C4318856;C4521762",NULL,NULL,105
"irregular or ulcerated ica p laque","C0041582;C0201519;C0205271;C3887532",NULL,NULL,2245
"baseline diabetes","C0011847;C0011849;C0168634;C1442488","C0011849;C1442488","",2191
"stent plus abciximab","C0038257;C0288672;C0332287",NULL,NULL,569
"endoscopy subscore","C0014245",NULL,NULL,1728
"tg mg dl mean sd","C0337445;C0439269;C0444504;C2347634;C2348143;C2699239","C0041004","",368
"other antiplatelet agents","C0085826","","",1191
"cox $nmbr$ selective nsaid use","C0003211;C0036576;C0042153;C0457083;C1565830;C1707391;C1947944;C3536840",NULL,NULL,2123
"simple partial ia","C0020980;C0205352;C0694634;C0728938;C1550516;C1947960",NULL,NULL,1399
"etd $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ ci p $nmbr$ $nmbr$","C0008107;C1180255;C3259781",NULL,NULL,519
"apo a $nmbr$ mg dl mean sd","C0003592;C0439269;C0444504;C0523508;C2347634;C2348143;C2699239;C4553344;C4553379",NULL,NULL,1909
"median iqr admission data","C0184666;C0549183;C0809949;C0876920;C1511726;C2347635;C2348144;C2939193;C3245479;C3714741",NULL,NULL,635
"history of fistullzing disease n","C0683519;C0730226;C0850708;C0944983",NULL,NULL,105
"need for urgent coronary artery bypass grafting","C0010055;C0027552;C0439609;C0686904;C3272275",NULL,NULL,2032
"labd alone","C0205171;C0396059;C0439044;C0679994","C0060657;C0073992","",1508
"lv systolic dysfunction n","C0023128;C0731033;C0749225;C1881413",NULL,NULL,2107
"high dose statin n $nmbr$ $nmbr$","C0360714;C0444956","C0444956","",111
"draining fistulae n","C0544791",NULL,NULL,1596
"unadjusted hr $nmbr$ ci for $nmbr$ sd increment","C0008107;C1439367;C1705117;C2699239;C3259781",NULL,NULL,1581
"rhinitis","C0035455",";C0035455","",272
"fasting insulin tiu ml","C0015663;C0021641;C0439526;C1533581;C1579433;C1705224;C3714501;C3887665",NULL,NULL,157
"asthma control status at randomization no","C0004096;C0034656;C0243148;C0449438;C1550141;C1882979;C2587213;C2984299;C3274648;C4553389",NULL,NULL,675
"severe n b","C0205082;C4050465;C4050466",NULL,NULL,313
"weight kg duration of pah n","C0005910;C0022718;C0030123;C0043100;C0439209;C0449238;C1305866;C1705104;C2926735;C3203102;C4054209;C4284467","C0005910","",1250
"lipid concentrations total cholesterol mmol l","C0023779;C0086045;C0201950;C0543421;C1532563","C0023779","",1772
"p int","C0369773;C2603361;C3272375",NULL,NULL,1264
"nasopharyngitis","C0027441","C0031350","",273
"acetylsalicylic acid","C0004057","C0004057","",1366
"multiple $nmbr$ chd risk factors that confer a $nmbr$ year risk of chd $nmbr$","C0035648;C0280604;C0439064;C0439234;C0439508;C1282512;C1553898;C3542407",NULL,NULL,175
"diastolic bp mmhg sd","C0428883;C0439475;C2699239","C0428883","",842
"balloon angioplasty plus abciximab","C0002996;C0002997;C0288672;C0332287","C0002996","",1721
"past or nonsmoker","C0337672;C0425293;C1444637;C4284302;C4554605","C0037369","",420
"postbronchodilator fev $nmbr$ reversibility","C0449261;C2599594;C3714541","C0449261;C0231999","",1315
"d dimer ng ml","C0060323;C0439275",NULL,NULL,986
"ef domain","C1880389;C1883221;C3541951",NULL,NULL,998
"$nmbr$ or $nmbr$ high cardiovascular risk categories","C0007226;C0332167;C0683312;C3272283;C3887460;C4050568;C4319571","C4319571","",837
"study","C0557651;C2603343",NULL,NULL,1730
"$nmbr$ standard n $nmbr$","C1442989;C2828392",NULL,NULL,1482
"rheumatoid factor or acpa positive or both","C0035448;C0201660;C0439178;C1446409;C1514241;C1525410;C1706063;C2825490;C3812269",NULL,NULL,2059
"younger patients aged $nmbr$ years","C0001779;C0001792;C0030705;C0332239;C0439234;C1999167",NULL,NULL,148
"$nmbr$ $nmbr$ drinks","C0452428",NULL,NULL,178
"percent of patients","C0030705;C0439165",NULL,NULL,1035
"normal $nmbr$ ml min","C0205307;C0231683;C0439166;C0439445;C2347086;C4553972",NULL,NULL,687
"time from onset of symptoms to presentation hr","C0449450;C1320528",NULL,NULL,287
"time since diagnosis of diabetes no","C0011847;C0011849;C0011900;C0040223;C1704338;C1704656;C3541383","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"atherosclerotic vascular disease no","C0004153","C0004153","",1698
"hdl choleslerol","C3715113","C0023822","",821
"tnfi ir","C0022065;C0022071;C1448132","","",1397
"patients without dm n $nmbr$","C0011816;C0030705;C3250443",NULL,NULL,955
"b postbronchodilator fevl predicted","C0681842;C1882327;C2599594","C0024119","",288
"ni","C0028075;C2348274;C3869926;C3869927",NULL,NULL,153
"mean sd age years","C0444504;C1510829;C2347634;C2348143;C2699239",NULL,NULL,37
"data are number of patients or hazard ratio $nmbr$ cl p values are forthe test of heterogeneity cad coronary artery disease bmi body mass index which is weight in kg divided by the square of height in metres ldl low density lipoprotein hdl high density lipoprotein there is a deficit of clinical data in some patients with the events","C0005910;C0018787;C0019409;C0022718;C0022885;C0023820;C0023821;C0030705;C0039593;C0042295;C0043100;C0162429;C0178587;C0205120;C0205251;C0242960;C0332849;C0392366;C0439209;C0441471;C0456984;C0475209;C0489786;C0596019;C0852949;C1305855;C1305866;C1504769;C1511726;C1515976;C1516606;C1550472;C1552595;C1705104;C2239547;C2360800;C2985465;C2987487;C3245479;C3541888;C3714741;C3813548;C3831328;C3890211;C4048187;C4054209;C4284121;C4318744;C4321351;C4522223","","",-10
"reteplase","C0256103",NULL,NULL,1876
"mean systolic blood pressure sd mm hg","C0039155;C0428886;C0439475;C0444504;C0488053;C0488055;C0871470;C1306620;C2347634;C2348143;C2699239","C0005823","",1469
"osteoarthritis","C0029408","C0029408","",1356
"years modified hoehn and yahr stage n","C0205390;C0392747;C0439234;C1300072;C1306673;C3889737",NULL,NULL,541
"digit symbol substitution","C0582802;C0679214;C1555721;C1698987;C1706204;C3241971",NULL,NULL,1005
"diabetes duration subgroups","C0011847;C0011849;C0449238;C1079230;C2926735","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"vomiting","C0042963;C1963281;C3898969;C4084766;C4084767;C4084768;C4084769","C0042963","",1023
"type of atrial fibrillation","C0004238;C0332307;C0344434;C1547052;C1963067",";C0004238","",1009
"mean sd fev $nmbr$ fvc","C0444504;C2347634;C2348143;C2699239;C3714541",NULL,NULL,2142
"age at onset y","C0206132;C3870509",NULL,NULL,736
"below knee popliteal","C0022742;C0022745;C0442037;C0542339;C1552829;C1963703","C0442037","",1979
"losartan n $nmbr$","C0126174","C0126174","",1207
"ezetimibe simvastatin double dose statin rosuvastatin","C0178602;C0205173;C0360714;C0869039;C0965129;C1114758;C1532737;C1705764;C1705765","C0074554","",1840
"female gender n","C0086287","C0086287","",1277
"cardiac death","C0376297",NULL,NULL,645
"coronary artery bypass graft n","C0010055;C1260596","C0010055","",389
"unknown","C0439673;C3541433;C4050014",NULL,NULL,93
"hemoglobin a $nmbr$ c mean sd b","C0062248;C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"mrf subjects","C0312443;C0681850;C1412879;C1550501;C1706203;C2349001;C2697811",NULL,NULL,1655
"coronary artery disease history","C0010054;C0010068;C0019664;C0019665;C0262512;C0262926;C1705255;C1956346;C2004062","C0010068;C1956346",";C0026410;C1710701",226
"calcium channel inhibitor","C0006685;C1999216","C0006684","",1884
"at index event no","C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010",NULL,NULL,412
"hba $nmbr$ c categories n","C0019016;C0683312;C1825777;C3538758","","",820
"cabg or angioplasty","C0010055;C0162577;C1548817","C0162577","",1722
"mean of mean cimt mean sd mm","C0444504;C2347634;C2348143;C2699239;C4330985;C4554674",NULL,NULL,297
"kg","C0022718;C0439209;C4054209",NULL,NULL,205
"baseline ics","C0168634;C0815320;C1442488;C4551720","C3540778","",2182
"medications in use at baseline n","C0013227;C0042153;C0150312;C0168634;C0332285;C0457083;C0802604;C1442488;C1707101;C1947944;C2598133;C4284232",NULL,NULL,2263
"updrs iii motor","C0439070;C1513492;C1705160;C1705994;C3639721",NULL,NULL,1473
"edema","C0013604;C1717255",NULL,NULL,690
"men no","C0025266",NULL,NULL,1842
"dabigatran $nmbr$ mg $nmbr$ mg per yr","C0439234;C1319635;C2348066",NULL,NULL,775
"very severe","C3641272;C4050419","C3641272",";C0018026;C1304897;C1412502;C4050419;C4050465;C4050466",913
"other medical history no total no","C0262926;C0439175;C0439810;C1704706",NULL,NULL,832
"entire evaluable cohort","C0009247;C0439751;C0444667;C0599755;C1516986","C0599755","",2208
"abdominal obesity","C0311277","C0311277","",1313
"enrollment in lmwh","C0019139;C1516879;C1696073;C3536766;C3888021",NULL,NULL,339
"elevated vs normalb","C0205250;C3163633",NULL,NULL,415
"nonaspirin antiplatelet agent","C0085826;C0722138","","",1191
"left main artery","C0003842;C0205091;C0205225;C0226004;C0443246;C1542147;C1552822",NULL,NULL,42
"baseline albuminuria","C0001925;C0168634;C1442488",NULL,NULL,625
"physician global assessment $nmbr$ $nmbr$ mm vas","C0042815;C3536884;C3827561;C4050369;C4330985;C4554674",NULL,NULL,1751
"sexa male","C0086582;C1706180;C1706428;C1706429","C0086582","",1276
"female n","C0043210;C0086287;C1705497;C1705498","C0086287","",1277
"reported hypertension","C0020538;C0684224;C0700287;C1963138;C4319718","C0020538","",1364
"outcome measure","C0086749",NULL,NULL,3
"glimepiride","C0061323","C0061323","",1155
"a glucosidase inhibitors","C1512211",NULL,NULL,814
"no longer met study criteria","C0205166;C0243161;C0428210;C0557651;C1550543;C1706317;C2603343;C4317104",NULL,NULL,39
"prior medication use n","C0240320;C0332152;C2826257",NULL,NULL,294
"$nmbr$ to $nmbr$ years n","C0439234",NULL,NULL,1099
"no chd simva n $nmbr$","C0280604;C3542407",NULL,NULL,970
"ecg","C1623258","C1623258","",1129
"lipid trial participantsk","C0008976;C0023779",NULL,NULL,1020
"proximal gl tract n","C0018229;C0205107;C1185740;C1423073;C1427674;C4489236",NULL,NULL,1804
"psoriasis duration years","C0033860;C0439234;C0449238;C2926735",NULL,NULL,1099
"gm","C0017480;C3854019",NULL,NULL,956
"mean s d hbalc","C0444504;C2347634;C2348143","","",820
"metabolic syndrome n","C0524620",NULL,NULL,617
"lv diastolic dysfunction n","C0023128;C0520863;C0731033;C1881413",NULL,NULL,2108
"polyarticular arthritis no rheumatoid nodules","C0035450;C0162323","","",-10
"basal insulin analogue dose coefficient","C0178602;C0205112;C0243071;C0366513;C0650607;C0869039;C1114758;C1707429;C2825028","C0650607","",354
"before pci","C4049621",NULL,NULL,1736
"previous stroke ortia $nmbr$ $nmbr$","C0038454;C0205156;C1552607;C4554100",NULL,NULL,1762
"napsi score $nmbr$ $nmbr$ of target fingernail","C0222001;C0449820;C1521840;C2986546;C4050231",NULL,NULL,748
"mean s d bmi kg m $nmbr$","C0444504;C0578022;C1532718;C2347634;C2348143",NULL,NULL,1735
"dyslipidemia $nmbr$","C0242339","C0242339","",1770
"oral agent","C0442027;C0450442;C1254351;C1521826;C4521986",NULL,NULL,484
"education $nmbr$ years","C0013621;C0013622;C0013658;C0039401;C0439234","C0013658","",1990
"left side n","C0205091",NULL,NULL,42
"white cell count x $nmbr$ _ $nmbr$ liter","C0023508;C0427512;C0475211",NULL,NULL,659
"apo b mg dl mean sd","C0003593;C0439269;C0444504;C2347634;C2348143;C2699239;C3252643",NULL,NULL,1910
"ics use no","C0042153;C0457083;C0815320;C1947944;C4551720","C3540778","",2182
"overweight","C0497406","C0497406","",1248
"japanese subgroup n $nmbr$","C0376247;C1079230;C1515021;C1556094","C0022341","",1815
"difference in change","C0392747;C0443172;C1705241;C1705242;C4319952",NULL,NULL,1466
"albuminuria and previous maerovaseular disease plus established renal disease egfr $nmbr$ $nmbr$ ml min l $nmbr$ in with an uacr $nmbr$ mg g or egfr $nmbr$ $nmbr$ ml inin l $nmbr$ in with any uacr mg g","C0001925;C0012634;C0022658;C0205156;C0332287;C0443211;C0702093;C1272684;C1300563;C1524029;C1552607;C1635169;C1739039;C3811844;C3812682;C3813700",NULL,NULL,2112
"nstemi","C3537184;C4255010",NULL,NULL,529
"$nmbr$ i ii $nmbr$","C0021966;C0221138;C1710602;C4082587",NULL,NULL,523
"nyha iii or iv","C0022326;C0439070;C1275491;C1705160;C4265176",NULL,NULL,151
"insulin plus oral","C0021641;C0442027;C1533581;C1579433;C3714501;C4521986",NULL,NULL,157
"patients with ascvd but no prior ml hr $nmbr$ cl","C0030705;C0332152;C0439526;C0596019;C1705224;C2826257;C3665365;C3887665",NULL,NULL,1542
"l dopa carbidopa l dopa carbidopa entacapone","C0165921;C0353697",NULL,NULL,1231
"high dosage ics plus laba with baseline blood eosinophils a $nmbr$ cells per pl n $nmbr$","C0005773;C0007584;C0007634;C0014467;C0168634;C0178602;C0200638;C0205250;C0815320;C1299351;C1442488;C2700149;C2986497;C3887512;C3889660;C3897966;C4049765;C4321237;C4522209;C4551720",NULL,NULL,834
"leeds dactylitis index basic mean sd","C0239161;C0444504;C0600653;C0918012;C1527178;C1552854;C1637833;C2347634;C2348143;C2699239;C2986546",NULL,NULL,37
"disabling or fatal stroke","C0038454;C1302234;C1705232;C4554100",NULL,NULL,1682
"rr cl","C0596019;C4554402",NULL,NULL,1542
"baseline bmi $nmbr$ to $nmbr$ kg m $nmbr$ n $nmbr$ $nmbr$ change from baseline to $nmbr$ weeks","C0168634;C0392747;C0439230;C0443172;C0578022;C1442488;C1532718;C1705241;C4319952",";C1305855","",206
"selena sledai mean score sd","C0451528;C2699239;C3533236","C0451528","",2175
"recent cardioversion within $nmbr$ days before randomization no","C0013778;C0034656;C0332185;C0439228",NULL,NULL,1621
"cns systemic embolism","C0013922;C0205373;C1704212;C3714787",NULL,NULL,631
"blood eosinophil count $nmbr$ cells per l","C0200638","C0750879","",848
"for combined hemoglobin groups","C0019046;C0205195;C0441833;C0687744;C1257890;C1519504;C1552839;C1705428;C1705429",NULL,NULL,1526
"serum creatinine gmol","C0201976;C0600061","C0600061;C0010294","",952
"d non vertebral fragility fractures fas","C0016658;C0073187;C0302113;C0332173;C0549207;C1518422;C4484261",NULL,NULL,2026
"patients with specific disease characteristics","C0030705;C0205369;C0599878;C1552740",NULL,NULL,1652
"and after pci median iqr d","C0549183;C0876920;C2347635;C2348144;C2939193;C4049621",NULL,NULL,1736
"angiographic features","C0002978;C1521970;C1706388;C2346469;C2348519",NULL,NULL,2018
"$nmbr$ beds","C0004916","C0004916","",1791
"other race n","C0034510;C1706779;C3853635",";C0034510","",1107
"descent","C0205386;C0680043",NULL,NULL,1203
"bmi mean sd kg m","C0444504;C0578022;C1532718;C2347634;C2348143;C2699239",";C1305855","",206
"osmotic diuresis related aes","C0232823;C0439849;C0445223;C1412268;C2699274","C0877248","",47
"tiotropium $nmbr$ g n $nmbr$","C0213771;C0439267","C0213771","",1372
"diuretic thiazide","C0012802","","",993
"$nmbr$ erosion n","C0333307;C1880549;C1959609;C3887524",NULL,NULL,1046
"african american","C0085756","C0005680",";C1706779",188
"other treatment assignment","C0039798;C0087111;C1516050;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,236
"$nmbr$ exacerbations","C4086268","C4086268","",889
"denosumab n $nmbr$ n","C1690432",NULL,NULL,943
"hazard ratio $nmbr$ ci j","C0008107;C2985465;C3259781","C2985465","",975
"rest angina","C0002965;C0152172","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"vitamin d","C0014695;C0042866;C2936842;C3537249;C3714503","C0042866","",866
"fpg mean sd mg dl mmol l","C0439269;C0444504;C1532563;C2347634;C2348143;C2699239","C0015663;C0202042","",1960
"hazard ratio with","C2985465","C2985465","",975
"$nmbr$ o $nmbr$ o $nmbr$","C0483204","","",-10
"age mean yr sd","C0001779;C0439234;C0444504;C2347634;C2348143;C2699239","C0001779","",480
"shoulder pain","C0037011","C0037011","",2173
"absolute l","C0205344",NULL,NULL,1578
"$ $nmbr$ and $nmbr$ years","C0439234",NULL,NULL,1099
"tio $nmbr$ ig n $nmbr$","C0021027;C0305052;C0360506",NULL,NULL,1260
"ustekinumab $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1608841;C1960952;C2346927;C4321396;C4521761","C1608841","",371
"most common aes","C0205214;C0205393;C1412268;C1522138;C2699274;C3245511","C0877248","",47
"selected baseline medications","C0013227;C0168634;C0802604;C1442488;C1707391;C2598133;C4284232",NULL,NULL,625
"median q $nmbr$ q $nmbr$ tgs","C0549183;C0876920;C1156212;C1537574;C2347635;C2348144;C2939193",NULL,NULL,635
"facial psoriasis n","C1276112","C0033860","",1358
"mean serum creatinine mg dl","C0201976;C0439269;C0444504;C0600061;C2347634;C2348143","C0600061;C0010294","",952
"mean of maximum cimt mean sd mm","C0444504;C0806909;C1552615;C2347634;C2348143;C2699239;C2826546;C4330985;C4554674","","",1262
"timi major or minor bleeding","C0019080;C0026193;C0205082;C0205164;C0205165;C4318856;C4521762",NULL,NULL,1474
"prediabetes","C0362046","C0362046",";C0168634;C1334085;C1708411",910
"patients with supplemental vitamin d dose of $nmbr$ iu day starting at screeningc n","C0030705;C0178602;C0420176;C0439465;C0439659;C0869039;C1114758;C3541352",NULL,NULL,110
"indication","C0392360;C3146298",NULL,NULL,1713
"l c","C0439394;C1706495;C3642217","","",-10
"time from longest event to randomisation","C0034656;C0040223;C0441471;C1522425;C3541383;C4019010",NULL,NULL,692
"reversible to albuterolc d n","C0205343",NULL,NULL,733
"apo a l g l","C0628062","C0085201","",1852
"number of treated lesions per patient","C0030705;C0449791;C1522326",NULL,NULL,1870
"mean sd anthropometry","C0003188;C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"$nmbr$ days","C0439228",NULL,NULL,1621
"anthropometric characteristics","C0003188;C1521970","C1521970","",1110
"major bleeding events","C0019080;C0205082;C0205164;C0441471;C3541888;C4318856;C4521762","C0019080;C0205082","",2076
"symptom duration","C0449238;C1457887;C2926735;C3854129",NULL,NULL,901
"nausea and or vomiting adverse events","C0027497;C0042963;C0877248;C1705413;C1963179;C1963281;C2984057;C3829611;C3898969;C4084766;C4084767;C4084768;C4084769;C4084796;C4085222;C4085661;C4085862;C4255480;C4552888;C4552889;C4553767","C0042963","",1023
"cardiac diseasec","C0018787;C1522601",NULL,NULL,1481
"$nmbr$ ml min $nmbr$ $nmbr$","C0439445","C3811844;C0017654","",307
"body mass index mean sd","C0005893;C0444504;C0578022;C1305855;C2347634;C2348143;C2699239","C1305855","",1734
"fev predicted","C0681842;C1882327;C3714541",NULL,NULL,1599
"mean sd predicted normal fev $nmbr$","C0205307;C0231683;C0439166;C0444504;C0681842;C1882327;C2347086;C2347634;C2348143;C2699239;C3714541;C4553972",NULL,NULL,1599
"major","C0205082;C0205164;C4318856;C4521762",NULL,NULL,1472
"fatal chd nonfatal ml","C0280604;C0439526;C1302234;C1705224;C1705232;C3542407;C3887665",NULL,NULL,300
"cardiac parameters","C0018787;C0449381;C1522601",NULL,NULL,1481
"method of identification ofstenosis","C1301921",NULL,NULL,922
"corticosteroid use at baseline no","C0168634;C0239126;C1442488","C0239126",";C0168634;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1425988;C1947944",120
"normal $nmbr$ $nmbr$","C0205307;C0231683;C0439166;C2347086;C4553972",NULL,NULL,687
"angiotensin converting enzyme inhibitor or angiotensin","C0003015;C0003018;C2757044;C3536837;C4521302;C4541021","C0003015","",811
"first primary change in updrs score wk wk $nmbr$ $nmbr$","C0205225;C0205435;C0332174;C0392747;C0439230;C0439612;C0439631;C0443172;C0449820;C1279901;C1705241;C3639721;C4050231;C4319952",NULL,NULL,748
"imaging data mean sd","C0011923;C0079595;C0444504;C1511726;C2347634;C2348143;C2699239;C3245479;C3714741",NULL,NULL,37
"$nmbr$ to $nmbr$ cells mm","C0007584;C0007634;C4330985;C4554674","","",-10
"rivaroxaban alone n $nmbr$","C0205171;C0439044;C0679994;C1739768",NULL,NULL,926
"gastrointestinal disorders","C0017178",NULL,NULL,1610
"absolute risk reduction $nmbr$ ci y","C0008107;C3179139;C3259781",NULL,NULL,171
"ertugliflozin $nmbr$ mg vs placebo glirneplride","C0024671;C0026410;C0032042;C0439269;C1696465;C1706408;C1960952;C2346927;C4079805;C4321396;C4521761","C4079805","",1180
"moderate n $nmbr$ $nmbr$","C0205081;C1881878;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"biack hispanic","C0086409","C0086409","",865
"years duration oa","C0029408;C0439234;C0449238;C2926735;C3887876",NULL,NULL,1099
"proportion of patients with trough fevi $nmbr$ ml above baseline n","C0030705;C0168634;C0429706;C0439526;C0444506;C0849974;C1442488;C1561566;C1705224;C1709707;C3887665;C4528367",NULL,NULL,1601
"ipss unit","C0439148;C0439453;C1019118;C1509845;C1519795;C1704753;C1880519;C1998280;C2827405;C3811063;C3853603","C1998280",";C1019118;C3811063;C4050465;C4050466;C4049706;C0168634;C1705273;C1880519;C3853603",124
"ace","C1452534;C4284014",NULL,NULL,46
"ntpro cnp ng ml","C0439275;C3889729",NULL,NULL,204
"aspirin and ppi","C0004057;C0358591;C0871125;C3811894","C0004057","",1366
"glucose mmol l","C0017725;C1532563",NULL,NULL,670
"st","C0036056;C3272372",NULL,NULL,246
"less than $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439092;C0439445;C0441923","C0439092","",1749
"asia pacific and south africa","C0003980;C0037712","C0003980","",1382
"asthma population n $nmbr$","C0004096;C0032659;C1257890;C2984299",NULL,NULL,694
"non high density lipoprotein mg dl baseline median n $nmbr$ $nmbr$","C0168634;C0439269;C0549183;C0876920;C1442488;C1535899;C2347635;C2348144;C2939193",NULL,NULL,635
"p value between groups","C0441833;C0441849;C0687744;C1257890;C1519504;C1522609;C1552839;C1705428;C1705429;C1709380",NULL,NULL,1526
"killip class $nmbr$ no","C1881332","C1881332","",846
"ics use yes no","C0042153;C0457083;C0815320;C1512698;C1947944;C4551720",NULL,NULL,464
"caffeine","C0006644;C0236734","C0006644",";C1710701",1816
"fibrinolytic therapy no","C0040044",NULL,NULL,1703
"gusto severe","C0205082;C4050465;C4050466",NULL,NULL,313
"respiratory medication","C0418986",NULL,NULL,976
"stroke see or cv death","C0011065;C0038454;C0042789;C1306577;C1947903;C3538987;C4048877;C4082313;C4318503;C4552775;C4554100","C4554100","",336
"stroke se","C0036919;C0038454;C4554100",NULL,NULL,1762
"fastest third","C0015663;C0205437;C0456962;C2985769",NULL,NULL,358
"prior coronary artery bypass graft","C0010055;C0332152;C1260596;C2826257","C0010055","",389
"mean body mass index kg m $nmbr$ sd","C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239","C1305855","",1734
"hazard ratio $nmbr$ cl valsartan vs placebo","C0032042;C0216784;C0596019;C1696465;C1706408;C2985465","C0216784","",1206
"basdai ls mean change from baseline se","C0023668;C0036919;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C1998004;C2347634;C2348143;C4319952",NULL,NULL,567
"serum uric acid mg dl","C0439269;C0455272;C0700634",NULL,NULL,2308
"baseline abi affected limb","C0015385;C0168634;C0392760;C1314939;C1328319;C1442488;C3888326","C1328319","",1233
"pooled empagliflozin n $nmbr$","C1709595;C2349200;C3490348;C4522255",NULL,NULL,2332
"previous cancer no","C0006826;C0205156;C0998265;C1306459;C1552607","C0006826","",1819
"urgent revascularization because of unstable angina","C0002965;C0439609;C0581603;C3272275",NULL,NULL,1002
"female simva n $nmbr$","C0043210;C0086287;C1705497;C1705498",NULL,NULL,586
"prior analgesic products n","C0002771;C0332152;C2826257",NULL,NULL,58
"history of pci","C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C4049621","C1532338","",1661
"systolic blood pressure $nmbr$ mm hg","C0439475;C0488055;C0871470;C1306620","C0005823","",1469
"beta blocker use at randomization","C0001645;C0034656;C0042153;C0457083;C1947944","C0001645","",959
"mmol mol","C3829066",NULL,NULL,668
"egfr $nmbr$ ml min n","C0439445;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"sjc mean sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,1589
"stroke fatal and nonfatal","C0038454;C1302234;C1705232;C4554100",NULL,NULL,507
"postmenopausal current hormone","C0019932;C0232970;C0521116;C1705970;C4521914","C0232970;C0279025","",2225
"infarct related artery location","C0003842;C0021308;C0226004;C0439849;C0445223;C0450429;C1515974;C4284930;C4284931","C1515974;C0021308","",1948
"mmse mini mental state examination adas cog alzhei","C0451306;C3539026","C0451306","",305
"alirocumab $nmbr$ $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C3491162;C4321396;C4521761",NULL,NULL,948
"insulin glargine n $nmbr$ ll","C0907402",NULL,NULL,663
"age $nmbr$ yrs","C0001779",NULL,NULL,148
"angiotensin receptive blocker","C0003018;C0544683;C4521302","C0521942","",779
"metabolic syndrome $nmbr$","C0524620",NULL,NULL,617
"albuminuria progression","C0001925;C0242656;C0449258","C0001925","",375
"function subscale","C0031843;C0542341;C0700205;C1705273",NULL,NULL,1531
"eosinophil count","C0200638;C0750879","C0750879","",848
"aml $nmbr$ mg hctz $nmbr$ mg","C0020261;C0023465;C0023467;C1319635",NULL,NULL,1149
"cana $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1418845;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"dronedarone n $nmbr$","C0766326","C0766326","",1923
"wml load at follow up mri stratified by baseline severity of wml load","C0024485;C0168634;C0205363;C0439793;C0522510;C0589120;C1442488;C1522577;C1550025;C1704685;C1704782;C1708715;C1824234;C3274571;C3890166",NULL,NULL,1056
"$nmbr$ $nmbr$ $nmbr$ $nmbr$ mmol l","C1532563",NULL,NULL,670
"physician","C0031831;C0804815",NULL,NULL,1520
"hdl cholesterol $nmbr$ $nmbr$ mmol l","C0023822;C0392885;C1532563","C0023822","",821
"ifg","C1334085;C1708411",NULL,NULL,1259
"duration of ra mean min max yrs","C0444504;C0449238;C0702093;C1524029;C2347634;C2348143;C2926735;C3538806;C3813700;C4048756",NULL,NULL,138
"ace inhibitor or angiotensin ii receptor blocker","C0003015;C0521942;C3536793;C4541021","C0003015","",811
"statin er niacin n $nmbr$","C0027996;C0360714;C1142562;C3810541;C3811131","C0360714","",872
"standardized mean difference","C0444504;C1705241;C1705242;C2347634;C2348143",NULL,NULL,37
"niacin n $nmbr$","C0027996;C1142562","C0027996","",871
"tanezumab all doses combined","C0178602;C0205195;C2346819",NULL,NULL,110
"question $nmbr$ morning stiffness since arising","C0332284;C0457086;C1522634;C4019053;C4318616",NULL,NULL,754
"mean age y range","C0001779;C0444504;C1514721;C2347634;C2348143;C2348147;C3542016","C0001779","",480
"severe n z $nmbr$","C0205082;C4050465;C4050466",NULL,NULL,313
"median age years iqr","C0549183;C0876920;C1510829;C2347635;C2348144;C2939193","C1510829","",481
"drug eluting stent","C1322815","C1322815","",365
"saphenous vein graft","C0729538",NULL,NULL,462
"per $nmbr$ participant years composite of first occurrence death all cause nonfatal ml or nonfatal stroke cardiovascular death excluding those classified as unable to determine","C0007226;C0008902;C0011065;C0015127;C0038454;C0040363;C0041260;C0205199;C0205435;C0243132;C0332196;C0439234;C0439526;C0566415;C0679646;C1279901;C1299582;C1306577;C1524003;C1547335;C1554210;C1705224;C1883351;C2698741;C2745955;C2828389;C3887460;C3887665;C4048706;C4082313;C4321405;C4552775;C4554048;C4554100",NULL,NULL,649
"user","C1548600;C1706077",NULL,NULL,534
"region ofthe world","C0017446;C0205147;C2700280","C0017446","",369
"male no","C0086582;C1706180;C1706428;C1706429","C0086582","",1276
"arrhythmia","C0003811","C0003811","",380
"placebo tiotropium n $nmbr$ non tiotropium n $nmbr$","C0032042;C0213771;C1518422;C1696465;C1706408","C0032042","",28
"scr gmol l","C1539487;C4050416",NULL,NULL,187
"mild dysfunction crcl $nmbr$ $nmbr$ ml min n $nmbr$ $nmbr$ $nmbr$","C0439445;C1846718;C3274775","C3811844;C0017654","",307
"hba $nmbr$ c mmol mold","C0019016;C0369241;C0439190;C1825777;C3538758","","",820
"pci delay due to low risk","C0205421;C0678226;C3272281;C3538919;C4049621",NULL,NULL,174
"ics laba nz $nmbr$","C0027978;C0815320;C4551720",NULL,NULL,2193
"inhaled j $nmbr$ agonist","C0004048;C2987634",NULL,NULL,167
"liver disorder","C0023895","C0023895","",1611
"brv $nmbr$ mg day n $nmbr$","C0155502;C0439422","","",198
"primary endpoint death mi idr st","C0011065;C0036056;C1306577;C2986535;C3272372;C3810814;C4082313;C4552775","C2986535","",230
"chads $nmbr$ scoref","C0007928;C1413373","","",2128
"glucocorticoids at baseline","C0017710;C0168634;C1442488;C3540777;C3540778","C0017710","",1348
"previous pci n","C0205156;C1552607;C4049621","C1532338","",1661
"interaction p value $nmbr$ $nmbr$","C1704675;C1709380",NULL,NULL,7
"weight kg median iqr","C0005910;C0022718;C0043100;C0439209;C0549183;C0876920;C1305866;C1705104;C2347635;C2348144;C2939193;C4054209","C0005910","",1250
"ast increased","C0205217;C0442805;C1415181;C3891303",NULL,NULL,459
"$nmbr$ $nmbr$ n","C0369718;C0441922",NULL,NULL,1553
"tofacitinib $nmbr$ mg twice daily n $nmbr$","C0024671;C0026410;C0439269;C0585361;C1960952;C2346927;C2930696;C4321396;C4521761",NULL,NULL,2302
"ldl hdl ratio","C0428621","C0023824","",1068
"eze simva gender","C0079399;C1522384","C0079399","",1083
"fasting glucose mg dl mean sd","C0015663;C0017725;C0439269;C0444504;C2347634;C2348143;C2699239","C0017725;C0015663","",2280
"furosemide","C0016860","C0016860","",1162
"number of events annualised rate","C0871208;C1521828;C4330837","C4330837","",1810
"acarbose no","C0050393",NULL,NULL,442
"caucasians","C0007457;C0043157","C0043157","",1329
"hospitalization for heart failure","C3898876","C0018801",";C0168634;C1524003",12
"any cardiovascular disease","C0007222","C0007222","",1790
"ivabradine","C0257190","C0257190",";C0687744;C1257890;C1519504;C1705428;C1705429;C0441848",68
"hypertension n $nmbr$","C0020538;C1963138","C0020538","",1364
"no hypertension n $nmbr$","C0020538;C1963138","C0020538","",1364
"t $nmbr$ d duration years","C0439234;C0449238;C2603360;C2926735",NULL,NULL,1099
"alcohol consumption once weekly","C0001948;C0558293","C0001948","",875
"fasting c peptide nmol l c","C0006558;C0015663;C0439282","C0006558","",1154
"tobacco use","C0040335;C0543414;C0841002;C3853727",NULL,NULL,23
"current cigarette smoker","C0337667;C0521116;C0677453;C1704760;C1705970;C3173209;C3241966;C3890423","C3241966","",1420
"females itt n $nmbr$","C0086287","C0086287","",1277
"median cardiac troponin t iqr pg ml","C0439297;C0549183;C0876920;C2347635;C2348144;C2939193;C3538889",NULL,NULL,1903
"prior peripheral arterial disease","C0085096;C0332152;C1704436;C2826257","C0085096","",933
"exacerbation within $nmbr$ mo","C0026544;C0332177;C4086268",NULL,NULL,1476
"history of upper gi events perforations ulcers and bleeding n","C0019080;C0019664;C0019665;C0041582;C0203057;C0262512;C0262926;C0441471;C0549099;C1705255;C2004062;C3541888",NULL,NULL,832
"randomization to","C0034656",NULL,NULL,1709
"left circumflex","C0205091;C0443246;C1552822;C1880089","C0226037","",1414
"lv ejection fraction","C0023128;C0489482;C0731033;C1881413;C2700378",NULL,NULL,2106
"i $nmbr$ i","C0021966;C0221138",NULL,NULL,1021
"death from cv causes major coronary event or nonfatal stroke","C0011065;C0015127;C0038454;C0205082;C0205164;C0741923;C1306577;C1314792;C1524003;C3538987;C4048877;C4082313;C4318503;C4318856;C4521762;C4552775;C4554100",NULL,NULL,507
"ics labd","C0396059;C0815320;C4551720",NULL,NULL,1650
"no ef data","C1511726;C3245479;C3714741",NULL,NULL,1427
"patients with chronic","C0030705;C0205191",NULL,NULL,1701
"female patients n","C0150905","C0086287","",1970
"laa ostium","C0444567",NULL,NULL,1307
"aspirin dose mg d","C0439422;C4696290","C0004057","",1366
"active vs placebo","C0032042;C0205177;C1696465;C1706408;C3853793;C3888249","C0032042","",28
"subgroup based on","C1079230;C1515021;C1527178;C1705938",NULL,NULL,1637
"ed therapy","C0039798;C0087111;C1363945;C3538926",NULL,NULL,411
"median time to first exacerbation months $nmbr$ ci","C0008107;C0205435;C0549183;C0556969;C0876920;C1279901;C2347635;C2348144;C2939193;C3259781;C4086268",NULL,NULL,519
"clopidogrel n n","C0070166","C0070166",";C0369286;C0033727;C4049621",217
"change from baseline","C0168634;C0392747;C0443172;C1442488;C1705241;C4319952",NULL,NULL,625
"body mass index category no l","C0005893;C0439394;C0578022;C0683312;C1305855;C1706495;C3642217;C3889287","C1305855","",1734
"previous percutaneous coronary intervention","C0205156;C1532338;C1552607","C1532338","",1661
"infarct on brain imaging","C0011923;C0079595;C0751955",NULL,NULL,1742
"atrial fibrillation flutter n","C0155709",";C0004238","",1009
"previous diabetes","C0011847;C0011849;C0205156;C1552607","C0205156;C0011849","",2389
"total no $nmbr$","C0439175;C0439810",NULL,NULL,509
"mean","C0444504;C2347634;C2348143",NULL,NULL,37
"impaired renal function","C1565489","C1565489","",937
"with des","C0011702;C4551552",NULL,NULL,465
"cardiac medications at discharge","C0018787;C0806915;C1522601","C0007220","",897
"osteoprotegerin decreased","C0205216;C0392756;C0442797;C0538161;C1308614;C1336645",NULL,NULL,730
"baseline albumin creatinine ratio in $nmbr$ classes","C0168634;C0456387;C0486293;C1318293;C1442488;C1518526;C1705943;C4019422","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"angiography during index hospitalization","C0002978;C0019993;C0600653;C0918012;C1552854;C1637833;C2986546",NULL,NULL,734
"european","C0239307;C1535514","C0239307","",504
"lo lo lo","C0206579;C1232424",NULL,NULL,1057
"concomitant medication no ace inhibitor","C0003015;C0013227;C0521115;C3244316;C4284232;C4541021","C0013227;C0521115","",1916
"number of implanted stents n mean sd","C0237753;C0444504;C0449788;C0522776;C2347634;C2348143;C2699239",NULL,NULL,37
"p value for east asian versus non east asian","C0078988;C1518422;C1707877;C1709380","C0078988","",1369
"n stented lesions","C0038257;C0221198;C0369718;C0441922",NULL,NULL,472
"adjusted mean se trough fevi ml","C0036919;C0429706;C0439526;C0444504;C0444506;C0456081;C0849974;C1561566;C1705224;C2347634;C2348143;C3887665;C4528367",NULL,NULL,1601
"previous ptca","C0205156;C1552607;C2936173","C1532338","",1661
"single vessel coronary artery diseasea","C0005847;C0265903",NULL,NULL,743
"ezetimibe tc triglycerides hdl c lg dl l $nmbr$ $nmbr$ mmol l to qualify as having","C0023128;C0039411;C0040363;C0040642;C0041260;C0041405;C0041698;C0062152;C0439190;C0694651;C1142985;C1824670;C1883351;C3272447;C3642216;C4522122","","",-10
"total cholesterol hdl c ratio","C0439175;C0439810;C0523558","C0543421","",1504
"warfarin n $nmbr$","C0043031","C0043031","",858
"tiotropium olodaterol $nmbr$ $nmbr$","C4032878",NULL,NULL,1510
"improving anemia bsl hb $nmbr$ g i $nmbr$ yr $nmbr$ $nmbr$ g i $nmbr$","C0002871;C0019046;C0021966;C0221138;C0439234;C1000483;C1272745;C1319635;C1549954;C4554633",NULL,NULL,152
"serum creatinine","C0201976;C0600061","C0600061;C0010294","",952
"other statin","C0360714","C0360714","",872
"transient st elevation","C0040704;C0205374;C0520886",NULL,NULL,722
"mg dl mean sd","C0439269;C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"secondary nonresponse","C0027627;C0175668;C0205436",NULL,NULL,1484
"moderate trs $nmbr$ $nmbr$ n $nmbr$ $nmbr$","C0205081;C0266427;C0968917;C1150746;C1881878;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"primary outcome plus revascularization or nonfatal hf","C0018488;C0205225;C0332287;C0439612;C0439631;C0581603;C1274040;C1313497;C1538440;C3273279",NULL,NULL,2339
"tanezumab $nmbr$ $nmbr$ mg nsaid","C0003211;C0024671;C0026410;C0439269;C1960952;C2346819;C2346927;C3536840;C4321396;C4521761",NULL,NULL,2309
"race or ethnic group n","C0015031;C0034510;C0441848;C0680174;C1706779;C3853635",NULL,NULL,787
"volumetric bmd by qct","C0412669;C0445383",NULL,NULL,709
"cardiovascular risk factors and history","C0019664;C0019665;C0262512;C0262926;C0850624;C1705255;C2004062",NULL,NULL,651
"at discharge","C0012621;C0030685;C2926602",NULL,NULL,390
"severe $nmbr$","C0205082;C4050465;C4050466",NULL,NULL,313
"mean sd kg m $nmbr$","C0444504;C1532718;C2347634;C2348143;C2699239",NULL,NULL,1287
"without metabolic syndrome","C0524620",NULL,NULL,617
"drug naive","C0013227;C1254351",NULL,NULL,1008
"hypokalemia potassium $nmbr$ $nmbr$ mmol l","C0020621;C0032821;C0202194;C0304475;C0597277;C1532563;C3714637;C4553966","C4553966;C0020621",";C0032821;C0202194;C0304475;C0597277;C1532563;C3714637",32
"diabetes treatment","C0011847;C0011849;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"olodaterol","C2934193",NULL,NULL,1510
"use of rescue albuterol puffs day","C0001927;C0332173;C0439228;C0439505;C1524063;C1533107",NULL,NULL,1621
"moderate or severe renal disease n","C0022646;C0022658;C0205081;C0205082;C1836348;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335","C1565489","",937
"medications on admission","C0013227;C0457453;C0802604;C2598133;C4284232",NULL,NULL,2263
"incidence rate per $nmbr$ person yr","C0027361;C0439234;C1708485;C2347489","C1708485","",1106
"renal failure","C0035078;C1963154","C1565489","",937
"glucocorticoids","C0017710;C3540777;C3540778","C0017710","",1348
"cardiovascular death nonfatal myocardial infarction or nonfatal stroke","C0007226;C0011065;C0027051;C0038454;C0428953;C1306577;C2926063;C3810814;C3887460;C4082313;C4552775;C4552959;C4554100",NULL,NULL,323
"ed $nmbr$ yr no","C0439234;C3538926",NULL,NULL,1099
"gi bleed","C0019080;C1708130;C3539617;C4050121",NULL,NULL,525
"prior oma use n $nmbr$","C0042153;C0332152;C0457083;C1947944;C2826257",NULL,NULL,294
"haq di","C3826998;C4321476",NULL,NULL,1665
"intensive control n $nmbr$ no of patients percent","C0030705;C0162425;C0243148;C0439165;C0522510;C1283828;C1550141;C1550453;C1882979;C2587213;C3274648;C4553389",NULL,NULL,1035
"testosterone level nmol l","C0428412;C0439282;C0523912",NULL,NULL,669
"serum creatinine mean sd n","C0201976;C0444504;C0600061;C2347634;C2348143;C2699239","C0600061;C0010294","",952
"number of vessels treated index pci","C0005847;C0237753;C0449788;C0600653;C0918012;C1522326;C1552854;C1637833;C2986546;C4049621",NULL,NULL,743
"$nmbr$ m b m in","C1709500",NULL,NULL,1132
"limited","C0439801;C2674459;C3542948;C4050251",NULL,NULL,278
"geographical region","C0017446","C0017446","",369
"serum bone specific alkaline","C0205369;C0229671;C0262950;C1546774;C1550100;C1552740;C1979842",NULL,NULL,951
"second primary composite outcome","C0205199;C0205225;C0205436;C0439612;C0439631;C0457385;C0565930;C1274040;C1547335;C1561503;C1705190",NULL,NULL,2342
"any established coronary artery disease","C0010054;C0010068;C0443211;C1272684;C1956346","C0010068;C1956346",";C0026410;C1710701",226
"cat $nmbr$","C0007450;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282",NULL,NULL,255
"at or above the median","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"history of coronary","C0018787;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"age years mean range","C0444504;C1510829;C1514721;C2347634;C2348143;C2348147;C3542016","C1510829","",481
"cardiac rhythm disorders","C0264886",NULL,NULL,1674
"umec vi $nmbr$ $nmbr$ $nmbr$ n $nmbr$ $nmbr$","C0205999",NULL,NULL,515
"rhabdomyolysis myopathy or myalgia with ck elevation $nmbr$ x uln","C0009212;C0010287;C0026848;C0035410;C0231528;C0439775;C0702240;C1519815;C1872855;C4552646;C4552660",NULL,NULL,815
"mean sd age yr","C0001779;C0439234;C0444504;C2347634;C2348143;C2699239","C0001779","",480
"acr response","C0871261;C1412134;C1515941;C1704632;C1706817;C2911692",NULL,NULL,52
"tc","C0039411;C0040642;C0041405;C0041698;C1824670;C3272447;C4522122","C0041004","",368
"aspirin alone n $nmbr$","C0004057;C0205171;C0439044;C0679994","C0004057","",1366
"received first loading dose","C0205435;C1279901;C1514756;C3714444",NULL,NULL,806
"mostly satisfied","C0205393;C0242428;C0750554;C4049977;C4084799","C0242428","",243
"age y mean sd","C0001779;C0444504;C2347634;C2348143;C2699239","C0001779","",480
"baseline symptom days perweek","C0168634;C0439228;C1442488;C1457887;C3854129",NULL,NULL,613
"predicted normal","C0205307;C0231683;C0439166;C0681842;C1882327;C2347086;C4553972","C0024119","",288
"hazard interaction","C0598697;C1704675",NULL,NULL,345
"baseline high sensitivity crp","C0168634;C1441604;C1442488;C3890735;C4048285",NULL,NULL,1545
"concomitant medication $nmbr$","C0013227;C0521115;C3244316;C4284232","C0013227;C0521115","",1916
"nontrial ppi","C0358591;C0871125;C3811894",NULL,NULL,1738
"angiotensin ll receptor antagonist no","C0003018;C4521302;C4543207","C0521942","",779
"pathologic q waves no","C0429090",NULL,NULL,1606
"dyspnoea mmrc grade n","C0013404;C0441800;C0919553;C1963100;C3244287;C3826977",NULL,NULL,683
"baseline post bronchodilator predicted fev $nmbr$ and no concurrent tiotropium","C0168634;C0205420;C0213771;C0681842;C1442488;C1882327;C2599594;C3714541",NULL,NULL,1599
"$nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ to $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ to $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0040363;C0041260;C1883351",NULL,NULL,431
"prior oad","C0332152;C2826257",NULL,NULL,294
"mu l $ mmol l b","C0439190;C0439342",NULL,NULL,671
"golimumab combined n $nmbr$","C0205195;C2353893",NULL,NULL,941
"region of enrollment n","C0017446;C0205147;C1516879;C1696073;C3888021","C0017446","",369
"smoking status current","C0521116;C1519386;C1705970","C0037369;C0521116","",2224
"$nmbr$ aes leading to discontinuation","C0332152;C0457454;C1412268;C1444662;C1522538;C2699274;C4552847",NULL,NULL,1063
"lama","C0999593;C1416775",NULL,NULL,1300
"baseline ed severity","C0168634;C0439793;C0522510;C1442488;C3538926",NULL,NULL,561
"toast classification of qualifying stroke no","C0038454;C1514624;C1710306;C4521230;C4554100",NULL,NULL,1762
"antithrombotic coagulant","C0009117",NULL,NULL,1705
"serum cholesterol mg dld","C0024671;C0026410;C0439269;C0587184;C1414063;C1960952;C2346927;C2826331;C4321396;C4521761",NULL,NULL,2303
"history of ml","C0019664;C0019665;C0262512;C0262926;C0439526;C1705224;C1705255;C2004062;C3887665",NULL,NULL,300
"elevated hscrp $nmbr$ mg l n","C0205250;C0439268;C3163633",NULL,NULL,833
"modified has bled $ $nmbr$","C0019080;C0392747;C3889737",NULL,NULL,767
"adjusted or $nmbr$ ci c","C0008107;C0456081;C3259781",NULL,NULL,519
"concomitant mao b inhibitor use","C0042153;C0457083;C0521115;C0595265;C1947944;C2917433",NULL,NULL,118
"europe","C0015176","C0015176","",337
"cvd without mi or stroke n $nmbr$","C0007222;C0038454;C3810814;C4554100",NULL,NULL,1762
"p value","C1709380",NULL,NULL,7
"emotional role","C0013987;C0035820;C0849912;C1705810;C3871154",NULL,NULL,506
"severe or very severe smoking status","C0205082;C1519386;C3641272;C4050419;C4050465;C4050466","C3641272",";C0018026;C1304897;C1412502;C4050419;C4050465;C4050466",913
"$nmbr$ $nmbr$ to $nmbr$ $nmbr$ mg mmol","C0567349;C2348885",NULL,NULL,200
"lowest activated clotting","C0005778;C1328723;C1708760;C1879547",NULL,NULL,1344
"clinic research experience n","C0008972;C0237607;C0596545",NULL,NULL,1460
"female sex n of patients","C0009253;C0030705;C0036864;C0043210;C0079399;C0086287;C0150831;C0150905;C0804628;C1314687;C1522384;C1705497;C1705498","C0086287","",1970
"elevated cholesterol","C0020443","","",1390
"mean bmd sd g cm $nmbr$","C0439267;C0444504;C2347634;C2348143;C2699239",NULL,NULL,701
"history of diabetes mellitus n $nmbr$","C0455488",NULL,NULL,1491
"anti ccp positive $nmbr$ u ml n","C0432633;C0439178;C0439340;C1446409;C1514241;C1525410;C1704514;C1880521;C2825490;C2945590;C3812269","C4318437","",360
"d","C0073187;C0332173;C4484261",NULL,NULL,1833
"ldl c mg dl","C0439269","C0023824","",1963
"cancer n","C0006826;C0998265;C1306459","C0006826","",1819
"difference vs pbof mean s e t","C0444504;C1705241;C1705242;C2347634;C2348143",NULL,NULL,1466
"eligibility risk factors no t","C0013893;C0035648;C1548635;C1553898;C2603360","C0013893;C0035648","",1317
"metformin su tzd","C0025598;C0038642;C1705534","C0038766;C0025598","",2253
"no chd simva","C0280604;C3542407",NULL,NULL,970
"dose adjustment n","C2826232",NULL,NULL,113
"stable angina n","C0340288",NULL,NULL,1003
"hormone replacement therapy","C0282402",NULL,NULL,549
"serum creatinine level mean sd mg dl","C0439269;C0444504;C0600061;C2347634;C2348143;C2699239",NULL,NULL,2304
"psa pain vas","C0042815;C3810537;C3813209",NULL,NULL,125
"ldl cholesterol $nmbr$ $nmbr$ mmol l","C0023824;C0202117;C1532563","C0023824","",1068
"or taking antihypertensive medication","C0003364;C1290952",";C0003364","",1579
"mestizos","C0682082",NULL,NULL,922
"severity of copd n gold $nmbr$ moderate","C0018026;C0024117;C0205081;C0439793;C0522510;C1304897;C1412502;C1881878;C3714496;C4049705;C4049706;C4085643;C4321335","C0024117;C0521117","",213
"previous vka use","C0042153;C0205156;C0457083;C1552607;C1947944",NULL,NULL,1352
"female n lll $nmbr$","C0043210;C0086287;C1261077;C1705497;C1705498","C0086287","",1277
"patients with prevalent kidney disease at baseline","C0022646;C0030705;C0168634;C0227665;C0683921;C1442488",NULL,NULL,1035
"annual exacerbation rate","C0332181;C0871208;C1521828;C4086268",NULL,NULL,2005
"$nmbr$ year","C0439234;C0439508",NULL,NULL,1099
"dihydropyridine ccbs","C0006684;C0012315;C0220821",NULL,NULL,704
"history of chf","C0018802;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"histamine $nmbr$ receptor antagonist","C0019590;C4521896","C0019590","",870
"timi risk score interaction p $nmbr$ $nmbr$","C0035647;C0449820;C1704675;C4050231;C4552904",NULL,NULL,2052
"prior coronary revascularization pci or cabg","C0010055;C0332152;C0877341;C2826257;C4049621","C0877341",";C4049621;C1552607",223
"adamantane derivatives","C3653470","C3653470","",1171
"cardiac catheterization","C0018795","C0018795",";C4049621",267
"aspirin dose at randomization","C0034656;C4696290","C0004057","",1366
"lipid trial participants","C0023779;C1997894;C2242969",NULL,NULL,278
"lvh by ecg or echocardiographyd","C0232306","C0232306","",406
"post bronchodilator fev $nmbr$ l a","C2599594;C3714541",NULL,NULL,680
"baseline sjc mean s e","C0168634;C0444504;C1442488;C2347634;C2348143",NULL,NULL,1589
"lower tertile b $nmbr$ $nmbr$","C0441994;C1548802;C2003888",NULL,NULL,1612
"patients with $nmbr$ exacerbations resulting in emergency department visit","C0030705;C0332294;C0545082;C0553618;C0562508;C1512346;C1704729;C2826704;C4086268","C4086268","",889
"nt pro bnp pmol literf","C0439192;C0669479;C0754710",NULL,NULL,1511
"baseline sitosterol","C0037215;C0168634;C0220914;C1442488",NULL,NULL,625
"most frequent non infectious teaesb","C0205393;C0239998;C1518422",NULL,NULL,2352
"hx cabg","C0010055;C0262926;C3814444",NULL,NULL,832
"$nmbr$ initial heparin treatment duration","C0019134;C0205265;C0444921;C0770546;C1279901;C1555582;C1705685;C3259042","C0019134","",863
"no of moderate or severe exacerbations in previous","C0205081;C0205082;C0205156;C1552607;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4086268;C4321335",NULL,NULL,313
"anthropometrics mean sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,1908
"intent to use glycoprotein iib iiia inhibitor","C0016011;C0040363;C0041260;C0042153;C0162425;C0457083;C1283828;C1550453;C1883351;C1947944;C1999216",NULL,NULL,431
"mean ml min $nmbr$ $nmbr$ m","C0369637;C0439445;C0441923;C0444504;C2347634;C2348143",NULL,NULL,37
"normal study termination","C0205307;C0231683;C0439166;C0557651;C1549081;C1692758;C2347086;C2603343;C4553972",NULL,NULL,687
"fev $nmbr$ fvc","C3714541",NULL,NULL,1599
"sulphonamides urea derivatives","C0038760;C0041942;C0243072","C0038760","",2065
"anterior myocardial infarction no total no","C0340293;C0439175;C0439810",NULL,NULL,647
"o os","C2673162",NULL,NULL,130
"medical therapy alone","C0205171;C0418981;C0439044;C0679994",NULL,NULL,640
"a v n $nmbr$","C1272460",NULL,NULL,419
"parental history of myocardial infarction before $nmbr$ yr of age","C0001779;C0030551;C0439234;C1275835",NULL,NULL,641
"copd medication at study entry","C0013175;C0024117;C1412502;C1705654;C3714496",NULL,NULL,1726
"vitamin k antagonist experiencedk n $nmbr$ $nmbr$","C1096489;C2267235",";C0043031","",868
"q $nmbr$ $nmbr$ $nmbr$ number n","C0237753;C0449788",NULL,NULL,1556
"high uln and $nmbr$ xuln n $nmbr$","C0205250;C1299351;C1519815;C2700149;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"das $nmbr$ $nmbr$ esr $nmbr$","C0051767;C0057671;C3811131","C1619634","",298
"phgada mm","C4330985;C4554674",NULL,NULL,297
"pbo statin $nmbr$","C0031962;C0360714",NULL,NULL,435
"dabigatran n $nmbr$","C2348066",NULL,NULL,775
"pah sle","C0024141;C0030123;C3203102;C4284467",NULL,NULL,1663
"yes weight kg interaction p $nmbr$ $nmbr$","C0005910;C0022718;C0043100;C0439209;C1305866;C1549445;C1704675;C1705104;C1705108;C1710701;C4054209","C0005910","",1250
"gold grade $nmbr$","C0018026;C0441800;C0919553;C1304897;C3244287",NULL,NULL,683
"patient s global assessment","C4054229",NULL,NULL,491
"baseline ste mm","C0168634;C1420459;C1442488;C3811127;C4330985;C4554674",NULL,NULL,297
"fev $nmbr$ fvc post albuterol","C0001927;C0687676;C1704687;C3469826;C3714541",NULL,NULL,680
"combined golimumab groups","C0205195;C0441833;C0687744;C1257890;C1519504;C1552839;C1705428;C1705429;C2353893",NULL,NULL,941
"mmrc grade","C0441800;C0919553;C3244287;C3826977",NULL,NULL,683
"median crcl ml min","C0439445;C0549183;C0876920;C1846718;C2347635;C2348144;C2939193","C3811844;C0017654","",307
"history of impaired renal function no","C0019664;C0019665;C0262512;C0262926;C1565489;C1705255;C2004062","C1565489","",937
"valproate","C0080356",NULL,NULL,1574
"nyha ii n","C1275491;C1710602;C4082587",NULL,NULL,151
"im and cs use no","C0010182;C0042153;C0271160;C0457083;C1947944;C3540510;C4085345",NULL,NULL,136
"past or nonsmoker n $nmbr$","C0337672;C0425293;C1444637;C4284302;C4554605","C0037369","",420
"baseline msdbp mmhg mean sd","C0168634;C0439475;C0444504;C1442488;C2347634;C2348143;C2699239",NULL,NULL,1471
"age years s d","C1510829","C1510829","",481
"body mass indext","C0518010","C1305855","",1734
"early crohn s disease","C0010346;C1279919",NULL,NULL,1487
"mean mg dl level no","C0439269;C0441889;C0444504;C0456079;C1547707;C2347634;C2348143;C2946261",NULL,NULL,192
"antihypertensive randomization no a","C0003364;C0034656",";C0003364","",1579
"patients with enthesitis n","C0030705;C1282952","C1282952","",271
"time since pd diagnosis mean sd","C0011900;C0040223;C0444504;C1704338;C1704656;C2347634;C2348143;C2699239;C3541383;C4553228;C4553229",NULL,NULL,37
"persistent n","C0205322;C0332996",NULL,NULL,719
"estimate","C0750572",NULL,NULL,536
"post fev $nmbr$ pred","C0032952;C0044955;C0687676;C1704687;C3469826;C3714541","C3714541","",296
"obese bmi $nmbr$","C0028754;C0578022",NULL,NULL,1735
"etanercept","C0717758",NULL,NULL,1587
"lymphocytes $nmbr$ il","C0020898;C0021764;C0022271;C0024264;C4018897",NULL,NULL,672
"qrs $nmbr$ msec","C0439223",NULL,NULL,141
"previous ics only","C0205156;C0205171;C0815320;C1552607;C1720467;C4551720",NULL,NULL,137
"aspirin but no ppi","C0004057;C0358591;C0871125;C3811894","C0004057","",1366
"p value ancova treatment difference a","C0039798;C0087111;C0814908;C1522326;C1533734;C1705169;C1705241;C1705242;C1709380;C3538994;C3887704",NULL,NULL,7
"creatinine $nmbr$ $nmbr$ mg dl","C0010294;C0439269;C1561535","C0600061;C0010294","",952
"$nmbr$ years eze simva $nmbr$","C0439234",NULL,NULL,1099
"$nmbr$ yr no","C0439234",NULL,NULL,86
"dental procedure","C0011331",NULL,NULL,349
"cardiovascular death mi or stroke","C0007226;C0011065;C0038454;C1306577;C3810814;C3887460;C4082313;C4552775;C4554100",NULL,NULL,323
"p value aged $nmbr$ vs $nmbr$ years","C0001779;C0001792;C0439234;C1709380;C1999167",NULL,NULL,1099
"pt","C0032743;C0699718",NULL,NULL,1513
"bl h y unilateral","C0005918;C0006413;C0033727;C0205092;C0369286;C0441932;C0564385;C1552663;C2827109;C4528284",NULL,NULL,655
"f plasma glucose mmol l","C0016327;C0202042;C0455280;C1532563","C0015663;C0202042","",1960
"primary cause of heart failure","C0015127;C0018801;C0018802;C0205225;C0439612;C0439631;C1524003;C4554158",NULL,NULL,2343
"right coronary artery n","C1261316","C1261316","",224
"dupilumab $nmbr$","C3660996",NULL,NULL,942
"ne ne","C0027608;C0028219;C3538705","","",-10
"score on modified rankin scale median iqr","C0449820;C0549183;C0876920;C2347635;C2348144;C2939193;C2984908;C3854213;C4050231",NULL,NULL,635
"pbo adjusted ls mean change se","C0023668;C0031962;C0036919;C0392747;C0443172;C0444504;C0456081;C1705241;C2347634;C2348143;C4319952",NULL,NULL,435
"$nmbr$ $nmbr$ $nmbr$ cl $nmbr$ $nmbr$ to $nmbr$ $nmbr$ p $nmbr$ $nmbr$","C0596019",NULL,NULL,432
"is domain luts severity","C0439793;C0522510;C0574785;C1880389;C1883221;C3541951",NULL,NULL,1658
"$nmbr$ events $nmbr$ $nmbr$","C0441471;C3541888",NULL,NULL,412
"type of myocardial infarction no","C0027051;C0332307;C0428953;C1547052;C2926063;C3810814;C4552959",NULL,NULL,646
"glycopyrrolate glycopyrrolate eflow cs $nmbr$ meg eflow cs $nmbr$ meg n $nmbr$ n $nmbr$","C0010182;C0017970;C0024489;C0025175;C0072225;C0271160;C3540510;C4085345",NULL,NULL,136
"immunosuppressive use n","C0021081;C0042153;C0457083;C1947944","C0021081","",1424
"imt mm","C0334121;C1704614;C4318736;C4330985;C4554674","","",1262
"europe lsrael","C0015176","C0015176","",337
"sf $nmbr$ v $nmbr$ domain scores mean sd","C0037712;C0444504;C0449820;C1880389;C1883221;C2347634;C2348143;C2699239;C3541951;C4050231",NULL,NULL,1287
"total scores total score range $nmbr$ $nmbr$","C1514721;C2348147;C2964552;C3542016",NULL,NULL,479
"$nmbr$ mg day","C0439422","","",198
"previous disease no f","C0012634;C0016327;C0205156;C1552607",NULL,NULL,2120
"high risk $nmbr$ $nmbr$","C0332167;C3272283;C4050568;C4319571","C4319571","",837
"mean ham d score $nmbr$ ci","C0008107;C1570167;C3259781;C3533236;C3853311",NULL,NULL,519
"storage subscore","C0337174;C1698986;C1753314",NULL,NULL,539
"brain volume cm $nmbr$","C1113695",NULL,NULL,1739
"all stroke","C0038454;C4554100",NULL,NULL,1762
"age median","C0001779;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,1890
"number ol patients $nmbr$ years","C0030705;C0237753;C0439234;C0449788",NULL,NULL,1099
"$nmbr$ $nmbr$ day","C0332173;C0439228;C0439505",NULL,NULL,1621
"lipids mg dl","C0023779;C0439269","C0023779","",1772
"male sex no","C0086582","C0086582","",1276
"ccv history condition at baseline","C0168634;C0683519;C1442488",NULL,NULL,262
"ss $nmbr$ n $nmbr$ vs $nmbr$","C2699257;C3891295;C4551874",NULL,NULL,117
"nyha functional class at screening","C0205245;C0220908;C0220909;C0542341;C1698960;C1710031;C1710032;C1710477;C1882083;C2348164;C2700217",NULL,NULL,1531
"$nmbr$ mg dl eze simva n $nmbr$","C0439269",NULL,NULL,192
"period ii","C0439531;C1710602;C1948053;C4082587",NULL,NULL,521
"concomitant oral glucose lowering agents zz","C0017725;C0441994;C0442027;C2003888;C2347310;C2347852;C4521986",NULL,NULL,1746
"treatment comparison","C0039798;C0087111;C1522326;C1533734;C1705169;C1707455;C3538994;C3887704",NULL,NULL,1633
"reversibility $nmbr$ itt n $nmbr$","C0449261","C0449261","",2160
"p subgroup","C0369773;C1079230;C1515021;C2603361",NULL,NULL,1637
"$nmbr$ h ppg mmol l","C1418888;C2827804",NULL,NULL,671
"combined major macrovascular events","C0205082;C0205164;C0205195;C0441471;C3541888;C4318856;C4521762","C1320716;C0205082","",2077
"body mass indexj","C0518010","C1305855","",1734
"prior ptca or cabg","C0010055;C0332152;C2826257;C2936173","C2936173;C0010055","",1524
"smokers qva $nmbr$ $nmbr$ fc","C0337664;C2983605","C0037369","",420
"laboratory measures","C0022877;C0079809;C0242485;C1879489;C3244292;C4283904",NULL,NULL,978
"dm or ckd","C0011816;C1561643;C3250443",NULL,NULL,955
"b major cardiovascular events","C0205082;C0205164;C1320716;C4318856;C4521762","C1320716;C0205082","",2077
"age y median q $nmbr$ q $nmbr$","C0001779;C0549183;C0876920;C2347635;C2348144;C2939193","C0001779","",480
"bmi kg m $nmbr$","C0578022;C1532718",NULL,NULL,1735
"adjusted or $nmbr$ ci b","C0008107;C0456081;C3259781",NULL,NULL,519
"age yrs $nmbr$ $nmbr$","C0001779",NULL,NULL,148
"worsening angina","C0002965","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"laba ics use at screening n","C0042153;C0220908;C0220909;C0457083;C0815320;C1698960;C1710031;C1710032;C1710477;C1947944;C2348164;C4551720",NULL,NULL,2193
"pasi score $nmbr$ $nmbr$ mean sd","C0444504;C0449820;C2347634;C2348143;C2699239;C4050231;C4528685",NULL,NULL,37
"p value inter","C0205103;C1548610;C1709380","C1709380","",1986
"coronary artery disease no total no","C0010054;C0010068;C0439175;C0439810;C1956346","C0010068;C1956346",";C0026410;C1710701",226
"st segment depression or t wave inversion on ecg","C0021943;C0021945;C0429104;C0520887;C0520888;C1623258;C1705687;C2349984","C0520887","",1091
"continuous","C0549178",NULL,NULL,1561
"african descent","C0027567;C0205386;C0680043","C0027567","",2083
"statin and or other lipid lowering agent therapy","C0039798;C0086440;C0087111;C0360714;C0450442;C0585943;C1254351;C1363945;C1521826","C0585943;C0086440","",1774
"arb or ace inhibitor n","C0003015;C3888198;C4541021",NULL,NULL,44
"beta blocker no total no","C0001645;C0439175;C0439810","C0001645","",959
"treatment stratum","C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,552
"baseline hba $nmbr$ c mean s e","C0019016;C0168634;C0444504;C1442488;C1825777;C2347634;C2348143;C3538758","","",820
"other ischaemic heart disease non infarction","C0010054;C0021308;C0151744;C1518422",NULL,NULL,1616
"glycated hemoglobin","C0017853","","",1176
"triglycerides tx difference vs pbo ls mean change from baseline se","C0023668;C0031962;C0036919;C0041004;C0041403;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C1705242;C2347634;C2348143;C4319952",NULL,NULL,567
"creatinine ratio","C0010294;C0456603;C1547037;C1561535","C0600061;C0010294","",952
"neuraxial alonee","C3714787",NULL,NULL,927
"cv risk factors and history","C0019664;C0019665;C0035648;C0262512;C0262926;C1553898;C1705255;C2004062;C3538987;C4048877;C4318503",NULL,NULL,1777
"statins n","C0360714","C0360714","",872
"gdf $nmbr$ ng ml","C0439275;C1418244",NULL,NULL,204
"fibrinolysis n $nmbr$","C0016017;C1305868","C0016017","",1143
"medical history of hypertension","C0020538;C0199168;C0205476;C0262926;C0455527;C1963138","C0020538","",1364
"without n $nmbr$ $nmbr$","C0369718;C0441922",NULL,NULL,880
"add on to met $nmbr$","C0428210;C1550543;C1883712;C4317104",NULL,NULL,39
"all trials","C0008976",NULL,NULL,1020
"egfr $nmbr$ to $nmbr$ ml min n","C0439445;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"$nmbr$ ng l","C0439297",NULL,NULL,202
"with haq di decrease $nmbr$ $nmbr$","C0392756;C0547047;C3826998;C4321476",NULL,NULL,1665
"mean disease duration y sd","C0444504;C0872146;C2347634;C2348143;C2699239","C0449238;C0872146","",903
"celecoxib n $nmbr$","C0538927",NULL,NULL,2033
"no p blocker intake at randomisation n $nmbr$","C0034656;C0369773;C1512806;C2603361",NULL,NULL,1585
"pre fvc","C0332152;C0740175;C2257086;C3669034;C3714541",NULL,NULL,294
"post acute ischemic stroke","C0205178;C0475224;C0687676;C0751956;C0948008;C1704687;C3469826",NULL,NULL,1669
"women","C0043210","C0043210",";C3541888;C1720467",1323
"individuals with normoglycaemia","C0027361;C0237401;C0580545",NULL,NULL,588
"crcl ml min at randomization","C0034656;C0439445;C1846718","C3811844;C0017654","",307
"has bledo","C1019275","","",-10
"qualifying event","C0441471;C1514624;C4019010",NULL,NULL,412
"er visit","C0545082;C1512346;C2826704;C3810541;C3811131",NULL,NULL,276
"p value nt","C0332126;C1449832;C1709380;C3889152;C4050156;C4283901;C4284038",NULL,NULL,91
"$nmbr$ $nmbr$ mm hg","C0439475",NULL,NULL,1888
"duration of dementia symptoms months","C0011265;C0436359;C0439231;C0497327",NULL,NULL,1530
"nyha class ii n $nmbr$ l $nmbr$","C1882085","C0018802;C1882083","",453
"female participants who are $nmbr$ years postmenopausal","C0043210;C0086287;C0232970;C0439234;C0679646;C1705497;C1705498","C0232970","",1041
"esr mean sd mg dl","C0439269;C0444504;C2347634;C2348143;C2699239;C3811131","C1619634","",298
"priorother predefined medical conditions","C0012634;C0199168;C0205476;C0348080;C1705253;C3864998",NULL,NULL,1710
"coronary heart disease death","C0010054;C0010068;C0011065;C1306577;C1956346;C4082313;C4552775","C0010068;C1956346",";C0026410;C1710701",226
"corticosteroid without imm n","C0001617;C0205470;C3536709",NULL,NULL,1650
"continued thienopyridine n","C0549178;C1120149",NULL,NULL,1561
"atv $nmbr$ mg","C0024671;C0026410;C0210243;C0439269;C0674679;C1145759;C1334862;C1960952;C2346927;C4321396;C4521761",NULL,NULL,1411
"infections","C3714514","C3714514","",1093
"prednisone use","C0032952;C0042153;C0457083;C1947944","C0032952","",2384
"comorbidities other than diabetes","C0009488;C0011847;C0011849",NULL,NULL,765
"bmi at baseline kg m $nmbr$","C0168634;C0578022;C1442488;C1532718",";C1305855","",206
"oral hypoglycemic agents","C0359086","C0359086","",1744
"min per $nmbr$ $nmbr$ m $nmbr$","C0369637;C0441923;C0702093;C1524029;C3813700",NULL,NULL,1475
"extent of index pe n of pe patients","C0030705;C0070939;C0439792;C0600653;C0918012;C1552854;C1637833;C1880476;C2986546;C4284304",NULL,NULL,1516
"mean se bii ls mean se","C0023668;C0036919;C0444504;C1413059;C2347634;C2348143",NULL,NULL,567
"n events n subjects","C0369718;C0441471;C0441922;C0681850;C1550501;C1706203;C2349001;C2697811;C3541888",NULL,NULL,1655
"psoriasis","C0033860","C0033860","",1358
"dbp mm hg sd","C0439475;C0536221;C2699239;C3813197;C4281799",NULL,NULL,605
"no diabetes p $nmbr$","C0011847;C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"urinary albumin to creatinine ratio no","C0455271;C1318330","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"eq $nmbr$ d $nmbr$ l no pain or discomfortf","C0030193;C0205163;C0439185;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132","C0030193","",1338
"combination treatment ifx aza","C0004482;C0020823;C0039798;C0087111;C0205195;C1522326;C1533734;C1705169;C1947911;C3538994;C3811910;C3887704","","",2099
"baseline fev $nmbr$ median range l","C0168634;C0549183;C0876920;C1442488;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016;C3714541",NULL,NULL,1599
"albuterol use","C0001927;C0042153;C0457083;C1947944",NULL,NULL,118
"diastolic blood pressure subgroups","C0428883;C1079230;C1305849","C0428883","",842
"timi non cabg major","C0010055;C0205082;C0205164;C1518422;C4318856;C4521762",NULL,NULL,2079
"non ex tobacco user","C1518422;C3853727",NULL,NULL,23
"renal functionc n","C0022646","C0232804","",1532
"europe $nmbr$ n $nmbr$ $nmbr$","C0015176","C0015176","",337
"renal function egfr ml min $nmbr$ $nmbr$ m $nmbr$ according to mdrd n","C0232804;C0369637;C0439445;C0441923;C0680240;C1739039;C3811844;C3812682;C3839656","C3811844;C0017654","",592
"$nmbr$ day s initial heparin treatment duration","C0019134;C0205265;C0332173;C0439228;C0439505;C0444921;C0770546;C1279901;C1555582;C1705685;C3259042","C0019134","",863
"heart rate at rest in the supine position beats min","C0018810;C0035253;C0038846;C0702093;C1524029;C1622890;C3813700","C0018810","",1105
"hf hospitalization or cardiovascular death","C0007226;C0011065;C0018488;C0019993;C1306577;C1313497;C1538440;C3273279;C3887460;C4082313;C4552775",NULL,NULL,323
"gusto moderate severe bleeding","C0019080;C0205081;C0205082;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335",NULL,NULL,313
"region of residence p $nmbr$ $nmbr$","C0017446;C0205147;C0237096","C0017446","",369
"serum urea nitrogen mg dl","C0028158;C0229671;C0439269;C0600137;C0856666;C1291218;C1546774;C1550100;C1550581;C3683557","C0005845","",2271
"metformin n $nmbr$","C0025598","C0025598","",1345
"no stroke n $nmbr$ $nmbr$","C0038454;C4554100",NULL,NULL,1762
"europe zone $nmbr$","C0015176;C1710706","C0015176","",337
"placebo carisbamate $nmbr$ mg carisbamate $nmbr$ mg","C0032042;C1319635;C1696465;C1706408;C1871983","C0032042","",28
"gfr mdrd ml min $nmbr$ $nmbr$ m $nmbr$","C0017654;C0369637;C0439445;C0441923;C1424601;C3839656","C3811844;C0017654","",592
"haq di scoreff","C3826998;C4321476",NULL,NULL,1665
"bilag a b or c domain score n","C0449820;C1440044;C1880389;C1883221;C3541951;C3845933;C4050231",NULL,NULL,998
"laba ics n $nmbr$","C0815320;C4551720",NULL,NULL,1305
"eligibility stratum","C0013893;C1548635","C0013893","",2161
"cardiac disorders soc","C0018799","C0018799","",1278
"difference $nmbr$ ci p value","C0008107;C1705241;C1705242;C1709380;C3259781",NULL,NULL,519
"black race and ss $nmbr$ n $nmbr$ vs $nmbr$","C0005680;C2699257;C3891295;C4551874",NULL,NULL,966
"exacerbations in the year before study","C0439234;C0439508;C0557651;C2603343;C4086268","C4086268","",1991
"hla b $nmbr$ positive n","C0439178;C1426226;C1446409;C1514241;C2825490;C3812269",NULL,NULL,1163
"other missing","C1551393;C1705492;C3272743","C1705492","",1144
"abatacept monotherapy n $nmbr$","C1619966","C1619966","",1190
"tiotropium $nmbr$ mg respimat n $nmbr$","C0024671;C0026410;C0213771;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2300
"activities of daily living updrs subscore baseline mean sd","C0001288;C0168634;C0444504;C1442488;C2347634;C2348143;C2699239;C3639721;C4050548",NULL,NULL,625
"$nmbr$ $nmbr$ l ot","C0439394;C1318464;C1418208;C1705587;C1706495;C3642217","","",-10
"bloodpressure mean sd m m hg","C0025424;C0428257;C0428886;C1709500;C2347108;C2347109;C2348272;C2699239","C0871470","",615
"mean total ipss sd","C0439175;C0439810;C0444504;C1019118;C1998280;C2347634;C2348143;C2699239;C2827405;C3811063",NULL,NULL,1287
"age mean $nmbr$ sd years","C0444504;C1510829;C2347634;C2348143;C2699239",NULL,NULL,1907
"multivessel disease","C0012634",NULL,NULL,1867
"nyha class $nmbr$ $nmbr$ no n llll","C0369718;C0441922;C1882083","C0018802;C1882083","",453
"any bleeding","C0019080",NULL,NULL,707
"total asthma symptom score mean sdz","C0004096;C0444504;C2347634;C2348143;C2984299;C3533163",NULL,NULL,694
"sample size n","C0242618","C0242618","",1194
"nonwhite race","C0034510;C1706779;C3853635","C0034510;C1518422;C0043157","",1401
"p net difference","C0369773;C1456447;C1705241;C1705242;C2603361;C3853572;C3887809;C3890893",NULL,NULL,1081
"received an oral aha within $nmbr$ weeks prior to screening","C0050451;C0220908;C0220909;C0439230;C0442027;C0772110;C1514756;C1698960;C1710031;C1710032;C1710477;C2348164;C4521986",NULL,NULL,1012
"fatal","C1302234;C1705232",NULL,NULL,1682
"with any stent","C0038257",NULL,NULL,569
"copd population n $nmbr$","C0024117;C0032659;C1257890;C1412502;C3714496",NULL,NULL,1726
"extensive n","C0205231","C0205231","",1167
"anyantianginal agent","C0450442;C1254351;C1521826",NULL,NULL,484
"patients with $nmbr$ bsa psoriasis skin involvement n","C0030705;C0033860;C0444099;C1123023;C1314939;C4520765","C0005902;C0033860","",2177
"duration of hypertension months","C0020538;C0439231;C0449238;C1963138;C2926735","C0020538","",1364
"fpci vs ppci in men","C0025266",NULL,NULL,1822
"history of postmenopausal fracture","C0232970;C1272071",NULL,NULL,1494
"median range treatment duration d","C0444921;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3259042;C3542016",NULL,NULL,479
"fp","C0016704;C1419068;C1419906;C3541238;C3541412",NULL,NULL,1820
"never used lev","C0023556;C1273517;C2003901",NULL,NULL,1275
"efficacy end points","C1280519;C1707887;C2349179","C1707887;C2349179","",1122
"ebria","C1917247",NULL,NULL,409
"tendonitis","C0039503","","",-10
"disease duration mean sd years","C0439234;C0444504;C0872146;C2347634;C2348143;C2699239","C0449238;C0872146","",903
"rate is number of events per $nmbr$ patient years of follow up fthe p value for number of patients from log rank for total number of hospitalizations from permutation test by treatment comparing the","C0022885;C0030705;C0039593;C0039798;C0087111;C0392366;C0439175;C0439234;C0439810;C0456984;C0589120;C0667477;C0699794;C0871208;C1515976;C1521828;C1522326;C1522577;C1533734;C1704685;C1705169;C1707455;C1708728;C1709380;C1882348;C2360800;C2986775;C3274571;C3538994;C3831328;C3887704;C4086639;C4318744;C4330837",NULL,NULL,1103
"scarring on renal biopsy","C0005558;C0008767;C0194073;C0220797;C1700247;C2004491","C1700247","",1943
"mean sd reversibility fev $nmbr$ at","C0444504;C0449261;C2347634;C2348143;C2699239;C3714541","C0449261;C0231999","",1315
"long acting bronchodilator use at screening","C0006280;C0042153;C0079613;C0205166;C0220908;C0220909;C0457083;C1698960;C1704930;C1706317;C1710031;C1710032;C1710477;C1869853;C1947944;C2348164;C3890007;C4048375",NULL,NULL,499
"difference $nmbr$ cl","C0596019;C1705241;C1705242",NULL,NULL,658
"stroke n","C0038454;C4554100",NULL,NULL,1762
"hba $nmbr$ c in patients with baseline hba $nmbr$ c $nmbr$ $nmbr$ mmol mol mmol mol la n baseline sd adjusted mean change $nmbr$ ci placebo subtracted change se","C0008107;C0019016;C0023031;C0023749;C0027960;C0030705;C0032042;C0036919;C0168634;C0230347;C0324740;C0392747;C0439189;C0443172;C0444504;C0456081;C1442488;C1456781;C1696465;C1705241;C1706408;C1719767;C1824986;C1825777;C1960955;C2346906;C2347634;C2348143;C2348589;C2699239;C3259781;C3538758;C3665593;C4319952;C4553351",NULL,NULL,2139
"unadjusted hr","C1439367",NULL,NULL,1581
"days between acs and rand","C0439228;C0742343;C1555436;C4318612",NULL,NULL,2148
"heart failure or lvef $nmbr$ associated with index acs event","C0018801;C0018802;C0332281;C0428772;C0441471;C0488728;C0600653;C0742343;C0918012;C1552854;C1637833;C2986546;C4019010;C4318612;C4554158","C0018801;C0428772","",1273
"ideglira ideg lira","C1555441;C4308663",NULL,NULL,774
"less severe $nmbr$","C0205082;C0439092;C0547044;C4050465;C4050466",NULL,NULL,313
"rivaroxaban n $nmbr$","C1739768","C1739768","",1225
"calcium supplements","C0006675;C0006726;C0242295;C1947943;C2348609;C2936886;C3540037;C3714611","C0006675;C2348609","",2187
"previous infliximab therapy no of patients","C0030705;C0205156;C1552607;C4076075",NULL,NULL,2387
"diagnosis of allergic rhinitis","C0011900;C1334103;C1704338;C1704656;C2607914;C4552864",NULL,NULL,841
"age $ $nmbr$ yrs","C0001779","C0001779","",480
"change median baseline crp $nmbr$ mg l","C0168634;C0392747;C0439268;C0443172;C0549183;C0876920;C1442488;C1705241;C2347635;C2348144;C2939193;C3890735;C4048285;C4319952","C0006560","",286
"third heart sound","C0232237;C0232278",NULL,NULL,1644
"$nmbr$ $nmbr$ to $nmbr$ $nmbr$ $nmbr$ to $nmbr$ mmol mol","C0040363;C0041260;C1883351;C3829066",NULL,NULL,431
"b digit symbol substitution insulin glargine vs standard care","C0291665;C0582802;C0679214;C0907402;C1442989;C1555721;C1698987;C1706204;C1947933;C2828392;C3241971",NULL,NULL,1005
"lansoprazole $nmbr$ mg qd","C0024671;C0026410;C0050940;C0332173;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2288
"jvp $ $nmbr$ cm h $nmbr$ o","C0455483",NULL,NULL,1778
"sprint acr $nmbr$ $nmbr$","C1412134;C1515941",NULL,NULL,52
"cerebrovascular or peripheral arterial disease n","C0085096;C1704436;C1880018","C0085096","",933
"cv death n","C0011065;C1306577;C3538987;C4048877;C4082313;C4318503;C4552775",NULL,NULL,323
"diabetes duration y","C0011847;C0011849;C0449238;C2926735","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"advanced n","C0205179","C0205179","",190
"ap value from an ancova with corresponding baseline lipid value as the covariate and with a effect for treatment group","C0002680;C0023779;C0039798;C0087111;C0168634;C0441833;C0687744;C0814908;C1257890;C1280500;C1442488;C1518681;C1519504;C1522326;C1522609;C1533734;C1705169;C1705428;C1705429;C2348382;C3538994;C3887704;C3887950",NULL,NULL,1807
"prior use of systemic","C0205373;C0332152;C1524063;C2826257",NULL,NULL,294
"decreased appetite","C0232462","","",-10
"ind gly $nmbr$ $nmbr$ pg o d n $nmbr$","C0017890;C0523677;C2827928;C4049864","C3814772;C1722260","",1509
"years with gouty arthritis","C0003868;C0439234",NULL,NULL,1099
"sedbp mmhg mean_ sd a","C0439475;C0444504;C2347634;C2348143;C2699239",NULL,NULL,2127
"higher risk n $nmbr$","C0332167;C3272283;C4050568;C4319571","C4319571","",837
"testing order","C0039593;C0392366;C1705175;C1705176;C1705177;C1705178;C1882348;C3889825;C4284072",NULL,NULL,1614
"device group n $nmbr$","C0025080;C0441848;C0699733",NULL,NULL,732
"hla b $nmbr$","C0019737;C0550853;C1415561",NULL,NULL,1803
"mean percentage change from baseline to final visit","C0168634;C0205088;C0392747;C0439165;C0443172;C0444504;C0545082;C1442488;C1512346;C1546485;C1549488;C1561533;C1705241;C2347634;C2348143;C2826704;C3853528;C4319952",NULL,NULL,1680
"cardiac mediations","C0018787;C0680727;C1522601",NULL,NULL,1481
"hba $nmbr$ c n b","C0019016;C1825777;C3538758","","",820
"$nmbr$ day mortality","C0026565;C0026566;C0332173;C0439228;C0439505",NULL,NULL,1621
"median $nmbr$ ci time to weekly iss mid response up to week $nmbr$ wk f","C0008107;C0016327;C0034746;C0332174;C0439230;C0549183;C0876920;C1740819;C1845118;C2347635;C2348144;C2939193;C3259781",NULL,NULL,1013
"baseline heart rate beats min","C0018810;C0168634;C0702093;C1442488;C1524029;C3813700","C0018810","",1105
"no patients with","C0030705",NULL,NULL,1035
"baseline statin intensity","C0168634;C0360714;C0522510;C1442488",NULL,NULL,561
"involved gastrointestinal","C0521362;C1314939",NULL,NULL,312
"diabetes and untreated hypertension","C0011847;C0011849;C0745134","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"black or african heritage","C0005680;C0027567;C0085756;C0439541;C2986513","C0005680",";C1706779",188
"no pretreatment","C1550147;C2709094;C3539075;C3539076",NULL,NULL,715
"olmesartan medoxomil $nmbr$ mg n $nmbr$","C0024671;C0026410;C0386393;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2293
"fp n $nmbr$ $nmbr$","C0016704;C1419068;C1419906;C3541238;C3541412",NULL,NULL,1820
"non detectable unknown n","C0439673;C1518422;C3541433;C3830527;C4050014",NULL,NULL,93
"participants at baseline n","C0168634;C0679646;C1442488",NULL,NULL,1033
"nyha class n ii","C1882085","C0018802;C1882083","",453
"united states n $nmbr$ $nmbr$","C0041703",NULL,NULL,1550
"egfr in ml min $nmbr$ $nmbr$ m median iqr","C0369637;C0439445;C0441923;C0549183;C0876920;C1739039;C2347635;C2348144;C2939193;C3811844;C3812682","C3811844;C0017654","",592
"diabetesh yes","C1549445;C1705108;C1710701",NULL,NULL,147
"initial treatment randomization","C0034656;C0039798;C0087111;C0205265;C1279901;C1522326;C1533734;C1555582;C1705169;C1705685;C3538994;C3887704",NULL,NULL,236
"leukotriene receptor antagonists","C0595726;C2757015;C3542962",NULL,NULL,185
"pl $nmbr$ $nmbr$","C3897966;C4049765","","",-10
"alcohol consumption $nmbr$ drink dav","C0001948;C0009830;C0452428;C0556297;C1947907","C0001948","",875
"hs crp mg l median","C0439268;C0549183;C0876920;C2347635;C2348144;C2939193;C3890735;C4048285",NULL,NULL,1545
"prior stemi","C0332152;C1536220;C2826257;C3538872",NULL,NULL,570
"bmi mean sd kg m $nmbr$ c","C0444504;C0578022;C1532718;C2347634;C2348143;C2699239",";C1305855","",206
"ics use at screeningg n","C0042153;C0457083;C0815320;C1947944;C4551720","C3540778","",2182
"enrolled in russia or georgia","C0017452;C0017454;C0035970;C4684790","C0035970;C0017452","",123
"amlodipine lisinopril $nmbr$","C0051696;C0065374","","",78
"swollen joint count $nmbr$ joints","C0451521",";C0451521","",1140
"moderate s $nmbr$ $nmbr$","C0205081;C1881878;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"heart failure $nmbr$ month before admission","C0018801;C0018802;C0184666;C0332177;C0439231;C0809949;C4554158","C0018801",";C0168634;C1524003",12
"dutasteride","C0754659",NULL,NULL,1647
"treatment with any bp lowering drugs","C0037623;C0441994;C1415692;C1708288;C2003888;C3469597;C4318478",NULL,NULL,608
"multiple tnfi","C0439064",NULL,NULL,330
"aspirin erdp clopidogrel no of patients total no","C0004057;C0030705;C0070166;C0439175;C0439810","C0004057","",1366
"bail out use of glycoprotein iib iiia inhibitors","C0016011;C0175673;C0243077;C1524063",NULL,NULL,808
"itca $nmbr$ $nmbr$ mg day n $nmbr$","C0165330;C0439422","","",198
"race black or african american n","C0005680;C0027567;C0034510;C0085756;C0439541;C1706779;C3853635","C0005680",";C1706779",188
"indian","C1524069",NULL,NULL,637
"crohn s disease duration","C0010346;C0449238;C2926735",NULL,NULL,901
"st segment depression $nmbr$ mm","C0520887;C4330985;C4554674","C0520887",";C0011570;C0011581;C0344315;C4049644;C0702240;C4085311;C4084909",1856
"serum albumin g l","C0036773;C0439294;C0456615;C0728877",NULL,NULL,953
"fev $nmbr$ pre bronchodilator","C2599602;C3714541",NULL,NULL,682
"tobacco user","C3853727",NULL,NULL,23
"lipid lowering agents","C0086440","C0086440","",1773
"sirukumab $nmbr$ mg q $nmbr$ w","C0024671;C0026410;C0439269;C1960952;C2346927;C3254570;C4321396;C4521761",NULL,NULL,2311
"history of pci n","C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C4049621","C1532338","",1661
"mean sd years","C0439234;C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"other atherosclerotic","C0333482","C0004153","",1698
"mean acq $nmbr$ scores","C0444504;C0449820;C2347634;C2348143;C2919686;C4050231",NULL,NULL,37
"prior copd medication","C0013227;C0024117;C0332152;C1412502;C2826257;C3244316;C3714496;C4284232",NULL,NULL,1726
"immobilization","C0020944;C4048292",NULL,NULL,1707
"exenatide no of events total no","C0167117;C0439175;C0439810;C0441471;C3541888",NULL,NULL,759
"cardiac valvular disease","C0018824","C0018824","",103
"number of prior aeds","C0180309;C0237753;C0332152;C0449788;C2826257",NULL,NULL,1556
"st depression only","C0205171;C0520887;C1720467",NULL,NULL,925
"median $nmbr$ $nmbr$","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"canagliflozin $nmbr$ mg vs sitagliptin $nmbr$ mg","C0024671;C0026410;C0439269;C1565750;C1960952;C2346927;C2974540;C4321396;C4521761","C1565750","",1184
"endpoint baseline","C0168634;C1442488;C2349179;C2826544",NULL,NULL,627
"prior stroke before index event","C0332152;C0441471;C0456712;C2826257;C4019010","C0038454;C0332152","",2380
"cabg performed during index hospitalization","C0010055;C0019993;C0600653;C0884358;C0918012;C1552854;C1637833;C2986546","C0010055","",389
"stent type","C0038257;C0332307;C1547052",NULL,NULL,603
"ast $nmbr$ x uln on two consecutive visits","C0205448;C0545082;C1415181;C1512346;C1519815;C1707491;C3891303",NULL,NULL,1676
"diet pravastatin n $nmbr$","C0012155;C0012159;C0085542;C1519433;C2983588;C3668949","C0012155","",1199
"fatal or nonfatal stroke","C0038454;C1302234;C1705232;C4554100",NULL,NULL,507
"vorapaxar $nmbr$ y","C2974521","C2974521","",1448
"hder","C3898895",NULL,NULL,1614
"relative wall thickness","C0080103;C0205345;C0677535;C1280412;C1547039",NULL,NULL,760
"baseline fpg","C0168634;C1442488",NULL,NULL,1821
"pifr l min","C0702093;C1524029;C3813700",NULL,NULL,1475
"nx","C0445085",NULL,NULL,89
"vildagliptin metformin vldm","C0025598;C1570906","C1570906;C0025598","",2251
"physician global assessment of disease activity vas $nmbr$ $nmbr$ mm","C0042815;C3536884;C3827561;C4050369;C4330985;C4554674",NULL,NULL,1751
"baseline sgrq total score","C0168634;C1442488;C2964552",NULL,NULL,540
"in the spironolactone group and $nmbr$ patients in the placebo group","C0030705;C0032042;C0037982;C0441833;C0687744;C1257890;C1519504;C1696465;C1705428;C1705429;C1706408","C0037982","",1405
"patients with improvement $ $nmbr$ $nmbr$","C0030705;C2986411",NULL,NULL,1035
"baseline gfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n","C0017654;C0168634;C0369637;C0439445;C0441923;C1424601;C1442488","C3811844;C0017654","",592
"number of exacerbations in last $nmbr$ months","C0237753;C0449788;C4086268;C4331910","C4086268","",889
"vein graft stented","C0038257;C0042449;C0181074;C0332835;C1961139",NULL,NULL,569
"previous stroke ortransient ischaemic attack","C0038454;C0205156;C0745413;C1552607;C4554100",NULL,NULL,1762
"presence of tophi n","C0150312;C0221248;C0392148;C3854307",NULL,NULL,2369
"simvastatin n","C0074554","C0074554","",1840
"daytime mean dbp abpm at week $nmbr$ mmhg","C0332169;C0332174;C0439230;C0439475;C0444504;C0536221;C2347634;C2348143;C3813197;C4281799","C0005823","",1469
"lipid difference mg dl","C0023779;C0439269;C1705241;C1705242","C0023779","",1967
"other antihypertensive medications","C0003364",";C0003364","",1579
"versus olodaterol $nmbr$ pg","C0030827;C0072225;C1266240;C2934193",NULL,NULL,1510
"subarachnoid hemorrhage","C0038525",NULL,NULL,581
"diabetic $nmbr$","C0241863",NULL,NULL,996
"fpg mean sd mg dlt","C0024671;C0026410;C0439269;C0444504;C1413248;C1960952;C2346927;C2347634;C2348143;C2699239;C3273706;C4321396;C4521761",NULL,NULL,192
"ct or mr scan of the brain","C0007673;C0024485;C0034606;C0441633;C0596217;C0881827;C1417249;C2347167;C2826292;C3254418;C3540513;C3813556;C3888140;C4050513",NULL,NULL,2357
"high n $nmbr$","C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"previous stroke or transient ischemic attack no total no","C0007787;C0038454;C0205156;C0439175;C0439810;C0917805;C1552607;C4554100",NULL,NULL,1762
"egfr mdrd n","C1739039;C3811844;C3812682;C3839656","C3811844;C0017654","",592
"laba alone","C0205171;C0439044;C0679994","C0060657;C0073992","",1508
"key fc fasting glucose bp this category did not include ar have $nmbr$ of the indicated charac","C0015663;C0017725;C0037623;C0332257;C0683312;C1415692;C1436327;C1444656;C1518422;C1552866;C1708288;C2700399;C2983605;C2986463;C3884535;C3889287;C4318478;C4521369",NULL,NULL,562
"primary endpoint at $nmbr$ months","C0439231;C2986535","C2986535","",230
"beta blocker use at baseline","C0001645;C0042153;C0168634;C0457083;C1442488;C1947944","C0001645","",959
"medications for crohn s disease taken at baseline no","C0010346;C0013227;C0168634;C0802604;C1442488;C1883727;C2598133;C4284232",NULL,NULL,366
"diabetes mellitus no total no","C0011849;C0439175;C0439810","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"proteinuria $nmbr$ g $nmbr$ h","C0033687;C0560020;C1962972;C4554346","C0033687","",285
"age of asthma onset years","C0004096;C0206132;C0439234;C2984299;C3175530",NULL,NULL,736
"demographics age years mean sd","C0011298;C0444504;C1510829;C1704791;C2347634;C2348143;C2699239",NULL,NULL,582
"medical history","C0262926;C1704706",NULL,NULL,832
"composite of death mi stro ke urgent revasc definit e acute stent thrombosis","C0011065;C0022558;C0155626;C0205199;C0378365;C0439609;C1306577;C1547335;C3272275;C3897493;C4082313;C4552775",NULL,NULL,622
"mycophenolate mofetil cyclophosphamide","C0010583;C0209368","C0209368","",304
"cvd mi stroke","C0007222;C0038454;C3810814;C4554100",NULL,NULL,1762
"diabetics","C0241863",NULL,NULL,996
"long term antiplatelet therapy","C0443252;C1096021","","",1191
"ethnic background","C0015031",NULL,NULL,787
"sulphonylurea","C0038766;C3536898","C0038766","",752
"prior non cns se","C0036919;C0332152;C1518422;C2826257;C3714787",NULL,NULL,294
"gold n","C0018026;C1304897","C0024117;C0521117","",213
"teaes in a $nmbr$ of individuals","C0027361;C0237401",NULL,NULL,588
"total asthma symptom score","C0004096;C2984299;C3533163",NULL,NULL,694
"median tg iqr","C0337445;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"any peripheral revascularization","C0205100;C0581603","C0581603","",1213
"a $nmbr$ c median","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"gastroduodenum","C0391900","C0450199","",341
"steroid use","C0281991","C0239126",";C0168634;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1425988;C1947944",120
"weight of $nmbr$ kg n","C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209","C0005910","",1250
"stroke see","C0038454;C0042789;C1947903;C4554100","C4554100","",336
"concomitant dvt n","C0149871;C0521115;C2926618;C3899446","C0149871","",252
"coronary artery disease no c","C0010054;C0010068;C1956346","C0010068;C1956346",";C0026410;C1710701",226
"uae p g min","C0560021;C1519789",NULL,NULL,1552
"calcium mmol l","C0006675;C0006726;C1532563;C2936886;C3540037;C3714611","C0006675","",1373
"qualifying risk factor n","C0035648;C1514624",NULL,NULL,175
"plus minus values are means sd percentages may not total $nmbr$ because of rounding the body mass index is the weight in kilograms divided by the square of the height in meters to convert the values for creatinine to micromoles per liter multiply by $nmbr$ $nmbr$ ace denotes angiotensin converting enzyme cabg coronary artery bypass grafting nt probnp n terminal pro b type natriuretic peptide nyha new york heart association and pci percutaneous coro nary intervention race was reported by the investigators one patient in nyha class i was mistakenly included in the placebo group this category includes any angina like symptoms at any time in the past with no confirmation of diagnosis of coro nary heart disease required possible scores range from $nmbr$ to $nmbr$ with lower scores indicating a better quality of life anemia was defined by world health organization criteria as a hemoglobin level of less than $nmbr$ g per deciliter in men and less than $nmbr$ g per deciliter in women nt probnp levels are influenced by a variety of factors including age sex body mass index and renal function no clinically useful normal range has been established some patients were taking both loop and thiazide diuretics","C0001779;C0002871;C0004083;C0005893;C0005910;C0009253;C0010055;C0010294;C0012802;C0018787;C0022709;C0025266;C0027976;C0030705;C0032042;C0034510;C0035173;C0036864;C0040223;C0040363;C0041260;C0042295;C0043100;C0043210;C0043237;C0079399;C0086715;C0184661;C0205088;C0205120;C0205447;C0232804;C0243161;C0332126;C0332149;C0332257;C0332272;C0332288;C0332306;C0332307;C0332490;C0332849;C0376558;C0439092;C0439165;C0439175;C0439194;C0439209;C0439241;C0439267;C0439810;C0439849;C0441074;C0441833;C0441889;C0441994;C0443211;C0445022;C0449820;C0475211;C0489786;C0521091;C0522523;C0578022;C0596306;C0596672;C0683312;C0687744;C0699792;C0804628;C0814287;C0858277;C0886296;C1000483;C1144709;C1257890;C1272684;C1273869;C1275491;C1281911;C1292769;C1305855;C1305866;C1314687;C1317554;C1444637;C1449832;C1452534;C1514721;C1514873;C1515187;C1518422;C1519504;C1522384;C1547052;C1548802;C1549488;C1552595;C1552866;C1561533;C1561535;C1696465;C1704788;C1704970;C1705104;C1705314;C1705315;C1705428;C1705429;C1705910;C1706408;C1706779;C1709908;C1719797;C1882084;C1883351;C1883525;C2003888;C2346866;C2348147;C2362652;C2699239;C2700399;C2709270;C2825907;C2911648;C3537020;C3539106;C3541383;C3542016;C3827682;C3853635;C3889152;C3889287;C4049621;C4050156;C4283901;C4284014;C4284038;C4284302;C4522046;C4554633",NULL,NULL,1835
"persistent af n","C0205322;C0332996;C0344434;C4049859",NULL,NULL,719
"exact b","C2828393;C4050514",NULL,NULL,1291
"trait","C0599883","","",-10
"hba $nmbr$ c mean sd b","C0019016;C0444504;C1825777;C2347634;C2348143;C2699239;C3538758","","",820
"adjusted for all baseline variables and interaction between acei and baseline upb","C0168634;C0439828;C0456081;C1442488;C1704675",NULL,NULL,1018
"insulin glargine vs standard care least squares mean $nmbr$ cl","C0023189;C0444504;C0596019;C0907402;C1442989;C1947933;C2347634;C2348143;C2828392",NULL,NULL,37
"ukpds $nmbr$ year risk score $nmbr$","C0035647;C0439234;C0439508;C0449820;C4050231;C4552904",NULL,NULL,1099
"heterogeneity p value","C0019409;C0242960;C1709380",NULL,NULL,7
"laba or lama","C0999593;C1416775",NULL,NULL,1300
"total updrs score range $nmbr$ $nmbr$ y","C0439175;C0439810;C0449820;C1514721;C2348147;C3542016;C3639721;C4050231",NULL,NULL,479
"baseline ezetimibe usec","C0168634;C0439224;C1142985;C1442488",NULL,NULL,625
"corticosteroid with or without immunosuppressants","C0001617;C0021081;C3536709",NULL,NULL,1650
"history of peripheral vascular disease","C1881056",NULL,NULL,932
"mean weight kg mean sd","C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209",NULL,NULL,37
"npi","C1412208;C1549728;C3539727",NULL,NULL,153
"pe and dvt","C0070939;C0149871;C1880476;C2926618;C3899446;C4284304",NULL,NULL,1516
"aspirin at baseline","C0004057;C0168634;C1442488","C0004057","",1366
"pred","C0032952;C0044955","C3714541","",296
"status spmsq $nmbr$","C0449438",NULL,NULL,543
"low medium microalbuminuria n $nmbr$","C0009458;C0205251;C0439536;C0730345;C1550472;C1705217;C3244283;C3890211;C4048187;C4085196;C4321351;C4522223;C4522282;C4522283","C0730345","",2204
"epa group no of events","C0441471;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C3541888",NULL,NULL,408
"time since diagnosis of t $nmbr$ dm","C0011816;C0011900;C0040223;C1704338;C1704656;C3250443;C3541383",NULL,NULL,841
"gold stage","C0018026;C0205390;C1300072;C1304897;C1306673",NULL,NULL,541
"smoking pack yearsa","C0037369;C0453996;C1881674;C1968515;C2825051;C2828395","C0037369","",420
"week $nmbr$ n $nmbr$","C0332174;C0439230",NULL,NULL,1012
"ho","C0019905;C1832110;C3889614",NULL,NULL,443
"daily activities social functioning","C0037395;C0871707",NULL,NULL,1653
"aes leading to","C0332152;C1412268;C1522538;C2699274","C0877248","",47
"total intravenous loop diuretics mg","C0024671;C0026410;C0348016;C0354100;C0439175;C0439269;C0439810;C1960952;C2346927;C4321396;C4521761","C0354100","",991
"naive yes","C1549445;C1705108;C1710701",NULL,NULL,147
"cross damp time l llhrs min n $nmbr$","C0040223;C0205381;C0702093;C1524029;C2828360;C3541383;C3813700;C3891560",NULL,NULL,1475
"ustekinumab n $nmbr$","C1608841","C1608841","",371
"annanginal drugs $nmbr$ l s $nmbr$","C0013227;C3687832",NULL,NULL,367
"subgroup","C1079230;C1515021",NULL,NULL,1637
"peripheral artery disease details","C1522508;C1561567;C1704436;C4025272",NULL,NULL,934
"biologics user","C0005515;C0005522;C1548600;C1706077;C4553887",NULL,NULL,534
"neohrodathv and all cause mortalitv","C0015127;C1524003",NULL,NULL,924
"randomised patients with spondylitis at baseline n","C0030705;C0038012;C0168634;C1442488","C0038012","",269
"trough fvc response l","C0444506;C0871261;C1704632;C1706817;C2911692;C3714541",NULL,NULL,726
"p regional difference","C0369773;C0682132;C2603361",NULL,NULL,1823
"$nmbr$ $nmbr$ days","C0439228",NULL,NULL,1621
"use of ics","C0815320;C1524063;C4551720","C3540778","",2182
"mra spironolactone or eplerenone","C0037982;C0243032;C0961485;C1609165;C3891069","C0037982","",1405
"$nmbr$ years old","C0439234;C0580836",NULL,NULL,1099
"itt patients n","C0030705",NULL,NULL,1035
"pancolitis","C0868908","C0868908","",270
"af","C0344434;C4049859",NULL,NULL,1794
"postbronchodilator lung function at screening","C0035245;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C2599594",NULL,NULL,680
"renal function severe","C0205082;C0232804;C4050465;C4050466",NULL,NULL,313
"clinical history no","C0019664;C0019665;C0205210;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"concomitant cardiovascular therapy no","C0007226;C0521115;C0587038;C1707479;C3887460",NULL,NULL,648
"unstable angina $nmbr$ mo ago","C0002965;C0026544;C0332177",NULL,NULL,1002
"data missing","C1511726;C1551393;C1705492;C3245479;C3272743;C3714741","C1705492","",1144
"p value lnteraction","C1709380",NULL,NULL,7
"major bleed","C0019080;C0205082;C0205164;C4318856;C4521762","C0019080;C0205082","",2076
"frequency of events","C0376249;C0439603;C0441471;C0871396;C1561548;C1705502;C3541888;C3898838;C4321352",NULL,NULL,412
"non black n $nmbr$","C0005680;C0027567;C0085756;C0439541;C1518422","C0005680",";C1706779",188
"haq pain score","C0102923;C0451208;C0582148",NULL,NULL,1667
"premature cad among family members","C0086282;C0151526;C0205252;C1504769;C2239547;C3813548;C4018905;C4284121",NULL,NULL,698
"at increased fall risk n $nmbr$","C0085639;C0205217;C0238715;C0442805;C1268740;C4553726;C4699158","C1268740","",1850
"not japan","C0022341;C1518422","C0022341","",1815
"outcome_subgroup","C1079230;C1274040;C1515021",NULL,NULL,1637
"rhabdomyolysis myopathy or elevated creatine phosphokinase $nmbr$ x upper limit of normal n $nmbr$","C0010286;C0026848;C0035410;C0205250;C1427255;C1519815;C3163633;C4552660",NULL,NULL,815
"americas n $nmbr$","C0002454;C0596070","C0002454","",392
"cystitis","C0010692;C0600041;C1963088","","",-10
"waist circumference cm sd","C0455829;C2699239","C0455829","",1413
"apolipoprotein b mg dl","C0003593;C0439269","C0003591","",1028
"lacunar infarction n","C0333559","C0333559;C0241970","",1216
"transient","C0040704;C0205374",NULL,NULL,722
"energy fatigue","C0015672;C0424589;C0542479;C1442080;C3463815;C4050243;C4330907;C4554645","C0015672",";C4050243;C3542016;C0424589;C0542479;C1442080;C4330907;C0444504;C4553152",10
"time since rheumatoid arthritis diagnosis years","C0003873;C0011900;C0040223;C0439234;C1704338;C1704656;C3541383",NULL,NULL,1099
"black n $nmbr$","C0005680;C0027567;C0085756;C0439541",NULL,NULL,966
"post fvc","C0687676;C1704687;C3469826;C3714541",NULL,NULL,680
"normoglycemic","C0580545",NULL,NULL,34
"nitrate oral or intravenous","C0028125;C0348016;C0442027;C0699857;C3848573;C4521986",NULL,NULL,537
"arterial access site","C3272298",NULL,NULL,493
"acute medication intake days month","C0013227;C0205178;C0556971;C1512806;C3244316;C4284232",NULL,NULL,366
"daily off time mean sd h dayf","C0033727;C0040223;C0332173;C0369286;C0441932;C0444504;C0564385;C2347634;C2348143;C2699239;C3541383;C4528284",NULL,NULL,37
"mean sd bmi kg m $nmbr$","C0444504;C0578022;C1532718;C2347634;C2348143;C2699239",NULL,NULL,2141
"hospitalization for heart failure within $nmbr$ mo","C0026544;C0332177;C3898876","C0018801",";C0168634;C1524003",12
"months from qualifying stroke","C0038454;C0439231;C1514624;C4554100",NULL,NULL,1762
"non cns embolism","C0013922;C1518422;C1704212;C3714787",NULL,NULL,631
"total cigarette pack years mean sd","C0439175;C0439810;C0444504;C1303175;C2347634;C2348143;C2699239",NULL,NULL,37
"diet group","C0012155;C0012159;C0441833;C0687744;C1257890;C1519433;C1519504;C1705428;C1705429;C2983588;C3668949","C0012155","",1199
"age a $nmbr$","C0001779","C0001779","",480
"acid","C0001128;C0202406",NULL,NULL,346
"open label population","C0032659;C1257890;C1709323",NULL,NULL,904
"baseline variable","C0168634;C0439828;C1442488;C4553760",NULL,NULL,1018
"modified rankin scale at screening $nmbr$ $nmbr$","C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C2984908;C3854213",NULL,NULL,798
"current smoker n n","C3173209;C3241966","C3241966","",1420
"hscrp mg l","C0439268","C0006560","",286
"non c","C1518422",NULL,NULL,85
"minimum stent diameter","C0038257;C4054490",NULL,NULL,569
"major amputationsb","C0205082;C0205164;C4318856;C4521762",NULL,NULL,1472
"disease site no of patients","C0012634;C0030705;C0205145;C1515974;C2825164",NULL,NULL,1193
"s wave in v $nmbr$ mm","C0456681;C4301968",NULL,NULL,386
"death from coronary heart disease","C0010054;C0010068;C0011065;C1306577;C1956346;C4082313;C4552775","C0010068;C1956346",";C0026410;C1710701",226
"about $nmbr$ mg l or more","C0205172;C0439268","C0006560","",193
"study eye characteristics","C0015392;C0700042;C1568011",NULL,NULL,597
"gold group a","C0018026;C0441835;C1304897;C4522145",NULL,NULL,1640
"mayo $ $nmbr$ n","C0454788;C1077578",NULL,NULL,425
"numbers do not always sum to group totals due to missing information for some variables fbody mass index was calculated as weight in kilograms divided by the square of height in meters hypertension was defined as a self reported systolic blood pressure $nmbr$ mm hg a diastolic blood pressure $nmbr$ mm hg or physician diagnosed hypertension hyperlipidemia was defined as a self reported total cholesterol $nmbr$ mg dl $nmbr$ $nmbr$ mmol l or physician diagnosed high cholesterol diabetes was defined by self report","C0005910;C0011847;C0011849;C0011900;C0020443;C0020473;C0020538;C0025424;C0031831;C0043100;C0201950;C0205120;C0237753;C0332849;C0428257;C0428465;C0428883;C0439175;C0439209;C0439269;C0439475;C0439810;C0439828;C0441074;C0441833;C0444686;C0449788;C0488055;C0489786;C0543421;C0577559;C0577573;C0600653;C0678226;C0681906;C0687744;C0804815;C0871470;C0918012;C1096155;C1257890;C1305849;C1305866;C1306372;C1306620;C1441506;C1515051;C1518422;C1519504;C1522133;C1532563;C1552595;C1552854;C1637833;C1704788;C1705104;C1705428;C1705429;C1963138;C2003902;C2347108;C2347109;C2348272;C2700446;C2986546;C3146286;C3152252;C3539106;C3539882;C3812891;C4283905;C4330985;C4524803;C4554674;C4555212","C0005823","",1469
"pulsed blood pressure","C0232108","C0005823","",1469
"number of participants with an event","C0237753;C0441471;C0449788;C0679646;C4019010",NULL,NULL,1556
"no renal dysfunction","C1565489;C3279454","C1565489","",937
"placebo no of events total no","C0032042;C0439175;C0439810;C0441471;C1696465;C1706408;C3541888","C0032042","",28
"standard allocation","C1442989;C1706778;C2828392",NULL,NULL,1482
"end of trial","C0008976;C0444930;C2746065",NULL,NULL,1020
"nonfatai myocardiai infarction","C0021308",NULL,NULL,2144
"prevalence of each metabolic syndrome criterion","C0033105;C0220900;C0243161;C0524620",NULL,NULL,783
"placebo n $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0032042;C1696465;C1706408","C0032042","",28
"estimated means and treatment differences","C0039798;C0087111;C0750572;C1522326;C1533734;C1704970;C1705169;C1705241;C1705242;C3538994;C3887704",NULL,NULL,1466
"rf mg dl per unit","C0024671;C0026410;C0035448;C0201660;C0439148;C0439269;C0439453;C0748398;C1509845;C1519795;C1532632;C1547111;C1638407;C1704753;C1880519;C1960952;C2346927;C3642216;C3853603;C4321396;C4521761","C0035448","",1435
"pre bronchodilator screening fev $nmbr$ ml","C0220908;C0220909;C0439526;C1698960;C1705224;C1710031;C1710032;C1710477;C2348164;C2599602;C3714541;C3887665",NULL,NULL,682
"egfr using cg mdrd formulae of patients","C0012164;C0030705;C0043444;C0489829;C1524063;C1567075;C1705501;C1739039;C3540479;C3811844;C3812682;C3839656","C3811844;C0017654","",592
"center location","C0205099",NULL,NULL,677
"concomitant therapy","C1707479",NULL,NULL,446
"baseline diastolic blood pressure mm hg","C0439475;C4274392","C0005823","",1469
"age at diagnosis $nmbr$ years","C0439234;C1828181;C3173302","C1828181","",483
"north america plus america and new zealand","C0027978;C0028405;C0324547;C0332287","C0028405","",1463
"v hctz","C0020261",NULL,NULL,1149
"atorvastatin pravastatin","C0085542;C0286651","C0286651","",885
"mean score on das $nmbr$ $nmbr$ crp","C0051767;C0057671;C3533236;C3890735;C4048285",NULL,NULL,143
"su monotherapy","C0038642;C1705534","C0038766","",752
"radiate","C0332301",NULL,NULL,1622
"history of hf","C0018488;C0019664;C0019665;C0262512;C0262926;C1313497;C1538440;C1705255;C2004062;C3273279",NULL,NULL,832
"randomization to placebo or telmisartan","C0032042;C0034656;C0248719;C1696465;C1706408","C0248719","",1205
"other individual and exploratory end points","C0027361;C0237401;C2349179",NULL,NULL,588
"d dimer levelsatinclusion","C0060323",NULL,NULL,986
"hba $nmbr$ c in median q $nmbr$ q $nmbr$ n","C0019016;C0549183;C0876920;C1825777;C2347635;C2348144;C2939193;C3538758",NULL,NULL,1897
"mssbp mm hga","C4330985;C4554674",NULL,NULL,297
"trough fevi l","C0429706;C0444506;C0849974;C1561566;C4528367",NULL,NULL,1601
"hrg","C1437978;C1705020",NULL,NULL,560
"ldl particle numbers week $nmbr$","C0237753;C0332174;C0439230;C0449788;C2612459","C0023824","",1068
"all causa mortality","C0026565;C0026566;C3903827","C0026565","",1312
"hdl cholesterol mmol","C0023822;C0392885;C0439190","C0023822","",821
"less than $nmbr$","C0439092","C0439092","",1749
"median weight kg iqr","C0005910;C0022718;C0043100;C0439209;C0549183;C0876920;C1305866;C1705104;C2347635;C2348144;C2939193;C4054209",NULL,NULL,2326
"black race n $nmbr$ vs $nmbr$","C0005680",NULL,NULL,966
"age $nmbr$ years or more","C0205172;C1510829","C1510829","",481
"glomerular","C0022663;C0268731","","",-10
"i lisinopril n $nmbr$","C0021966;C0065374;C0221138","C0065374","",847
"partial mayo score mean sd","C0444504;C0449820;C0454788;C0728938;C1077578;C1550516;C2347634;C2348143;C2699239;C4050231",NULL,NULL,425
"greater than or equal to $nmbr$","C0205163;C0439093",NULL,NULL,1617
"highest tg tertile","C0337445;C1522410","C0041004","",209
"history of elms n","C0019664;C0019665;C0262512;C0262926;C0330531;C1705255;C2004062;C2980688",NULL,NULL,1787
"wap $nmbr$ c ng ml","C0439275",NULL,NULL,204
"\ge category","C0683312;C1292300;C3538705;C3889287",NULL,NULL,562
"egfr $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n $nmbr$ $nmbr$","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"aclidinium $nmbr$ pg","C0030827;C0072225;C1266240;C2699757",NULL,NULL,2329
"coenzyme q $nmbr$ p g ml","C0041536;C1300565",NULL,NULL,1395
"caffeine user n","C3532939","C0006644",";C1710701",1816
"mae","C0286540;C4085238","C1320716","",414
"thrombus aspiration done per lesion","C0087086;C0220787;C0221198;C0302148;C0349707;C0700198;C1272695;C1546698;C2712334;C2827071;C3146237",NULL,NULL,1641
"elevated baseline crp","C0168634;C0742906;C1442488","C0006560","",286
"baseline total cholesterol","C0168634;C0201950;C0543421;C1442488","C0543421","",1504
"albuminuria $nmbr$ gram gram cr","C0001925;C0201975;C1319635;C3539604;C3711669;C4084730;C4553336;C4553337",NULL,NULL,700
"$nmbr$ $nmbr$ mmol l n $nmbr$","C1532563",NULL,NULL,670
"ri $nmbr$","C0035487;C1826843",NULL,NULL,1440
"psoriasis duration years mean sd","C0033860;C0439234;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735",NULL,NULL,1099
"total sgrq mean total score sd","C0439175;C0439810;C0444504;C2347634;C2348143;C2699239;C2964552;C3533236",NULL,NULL,540
"mean a sd mg dl mmol $nmbr$","C0439190;C0439269;C0444504;C0567349;C2347634;C2348143;C2348885;C2699239;C3642216",NULL,NULL,200
"primary cv endpoint","C2986535;C3538987;C4048877;C4318503","C2986535","",230
"baseline $nmbr$ $nmbr$ meq l eos $nmbr$ $nmbr$ or $nmbr$ $nmbr$ meq l","C0168634;C0439375;C1442488;C1623465;C1861303",NULL,NULL,1626
"sex interaction p $nmbr$ $nmbr$","C0009253;C0036864;C0079399;C0804628;C1314687;C1522384;C1704675",NULL,NULL,568
"duration of disease yr mean","C0439234;C0444504;C0872146;C2347634;C2348143","C0449238;C0872146","",903
"nap","C0870935;C1423800;C4283878","","",-10
"cardiovascular disease n $nmbr$","C0007222","C0007222","",1790
"crcb ml min mean s e","C0439390;C0439445;C0444504;C0702093;C1524029;C2347634;C2348143;C3813700",NULL,NULL,37
"triglycerides mg dl median q $nmbr$ q $nmbr$","C0041004;C0439269;C0549183;C0876920;C2347635;C2348144;C2939193","C0041004","",368
"pre bronchodilation fvc","C0439566;C3714541",NULL,NULL,1599
"symptom duration months","C0439231;C0449238;C1457887;C2926735;C3854129",NULL,NULL,901
"laboratory values in patients with history of diabetes","C0011847;C0011849;C0019664;C0019665;C0022877;C0030705;C0042295;C0262512;C0262926;C1705255;C2004062;C3244292;C4283904","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"mean s d apob mg dl","C0003593;C0439269;C0444504;C2347634;C2348143;C3252643",NULL,NULL,192
"general anaesthesia","C0002915;C2930406",NULL,NULL,53
"sulfonylurea derivatives","C0038766","C0038766","",752
"history of mi or stroke","C0019664;C0019665;C0038454;C0262512;C0262926;C1705255;C2004062;C3810814;C4554100",NULL,NULL,832
"placebo allocation","C0032042;C1696465;C1706408;C1706778","C0032042","",28
"local eosinophil count cells per pl t","C0007584;C0007634;C0200638;C0205276;C0750879;C3897966;C4049765","C0014467;C0007584","",1806
"vildagliptin $nmbr$ mg qd n $nmbr$","C0024671;C0026410;C0332173;C0439269;C1570906;C1960952;C2346927;C4321396;C4521761","C1570906","",2068
"chd risk factors","C0035648;C0280604;C1553898;C3542407",NULL,NULL,175
"cardiac therapy n d","C3654025",NULL,NULL,644
"asthma related health","C0004096;C0018684;C0439849;C0445223;C2984299",NULL,NULL,319
"moderate n z $nmbr$","C0205081;C1881878;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"intensive therapy n $nmbr$","C0039798;C0087111;C0162425;C0522510;C1283828;C1363945;C1550453",NULL,NULL,561
"temporary risk factor","C0035648;C0205374;C1548539;C3245481",NULL,NULL,175
"peripheral angioplasty","C0162577;C0205100;C1548817","C0162577","",1722
"copd exacerbation history n","C0019664;C0019665;C0262512;C0262926;C0740304;C1705255;C2004062",NULL,NULL,832
"arr $nmbr$ ci","C0008107;C2170357;C3259781;C4084934",NULL,NULL,51
"no prior ms therapies","C1514463;C2349943;C3539704;C3713294",NULL,NULL,574
"demographic factors","C0011292;C0011298",NULL,NULL,582
"daily","C0332173",NULL,NULL,1488
"nocturnal back pain $nmbr$ $nmbr$ mm vas mean sd","C0042815;C0444504;C1970122;C2347634;C2348143;C2699239;C3536884;C3827561;C4330985;C4554674",NULL,NULL,297
"hba c mmol mol","C0019016;C1825777;C3538758;C3829066","","",820
"vascular accidents n","C0000924;C0005847;C1558950;C1801960",NULL,NULL,743
"atrial fibrillation n","C0004238;C0344434;C1963067",";C0004238","",1009
"total no","C0439175;C0439810",NULL,NULL,508
"ex drinker","C0337679",NULL,NULL,176
"prior immunosuppressive exposure n","C0021081;C0274281;C0332152;C0332157;C2826257",NULL,NULL,294
"antiplatelet at randomization","C0034656","","",1191
"current smoker ex smoker","C3173209;C3241966","C3241966","",1420
"losartan","C0126174","C0126174","",1207
"mild decrease $nmbr$ $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$","C0369637;C0392756;C0439445;C0441923;C0547047;C2945599","C3811844;C0017654","",307
"percent of predicted value before bronchodilation","C1371299;C1882327;C3537072",NULL,NULL,6
"nyha grade iii or iv","C0022326;C0205617;C0450094;C0475271;C0687697;C1275491;C3889290;C4050000;C4265176;C4283820;C4283821;C4283822",NULL,NULL,151
"flex fn f score $nmbr$ $nmbr$","C0016327;C0449820;C1570610;C4050231",NULL,NULL,748
"mean sd change in pre bronchodilator fev $nmbr$ l","C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C2599602;C2699239;C3714541;C4319952",NULL,NULL,767
"previous anti inflammatory antirheumatic products n","C0003191;C0205156;C0333348;C0432633;C1514468;C1552607",NULL,NULL,156
"any coronary revascularization","C0877341","C0877341",";C4049621;C1552607",223
"high risk clinical features","C0332167;C0683325;C3272283;C4050568;C4319571","C4319571","",837
"duration of psoriasis years mean sd","C0033860;C0439234;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735","C0033860;C2926735","",1996
"observation","C0302523;C0700325;C1964257;C3889687",NULL,NULL,984
"mean sd post bronchodilator","C0444504;C2347634;C2348143;C2599594;C2699239",NULL,NULL,2142
"postbronchodilator fev $nmbr$ predicted","C0681842;C1882327;C2599594;C3714541",NULL,NULL,680
"persistent or paroxysmal","C0205311;C0205322;C0332996",NULL,NULL,719
"treatment satisfaction","C3476649","C0025677","",716
"ls means difference $nmbr$ ci $nmbr$","C0008107;C0023668;C1704970;C1705241;C1705242;C3259781",NULL,NULL,519
"n","C0369718;C0441922",NULL,NULL,1553
"other lipid parameters","C0023779;C0449381",NULL,NULL,1187
"age year mean sda","C0001779;C0276477;C0439234;C0439508;C0444504;C1428349;C1553165;C2347634;C2348143","C0001779","",480
"eduglinozin $nmbr$ mg vs placebo glimepiride","C0024671;C0026410;C0032042;C0061323;C0439269;C1696465;C1706408;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2045
"duration of oral antidiabetic treatment y mean sd","C0442027;C0444504;C0444921;C0935929;C2347634;C2348143;C2699239;C4521986",NULL,NULL,995
"air insulin air insulin insulin glargine","C0001861;C0907402;C3536832",NULL,NULL,61
"low molecular weight heparin or intravenous unfractionated heparin","C0019139;C0354566;C3536766","C3536766","",1343
"st t wave n","C0036056;C0429103;C3272372",NULL,NULL,2356
"body mass index $nmbr$ kg m $nmbr$ n","C0005893;C0578022;C1305855;C1532718",";C1305855","",206
"ultra","C0728475",NULL,NULL,1270
"oral blood glucose lowering drug $nmbr$ $nmbr$ $nmbr$","C0005802;C0013227;C0017725;C0018938;C0441994;C0442027;C1254351;C2003888;C4521986",NULL,NULL,1746
"components of primary composite end point secondary end points","C0205199;C1547335;C1882460;C4528314","C0205199","",1631
"absolute time spent on with troublesome dyskinesia h day","C0013384;C0033727;C0332173;C0369286;C0439228;C0439505;C0439546;C0441932;C0564385;C0680968;C4528284","C0013384","",1131
"aspirin or other antiplatelet agents","C0004057;C0085826","","",1191
"premixed insulin with oads","C0021641;C1533581;C1579433;C3714501",NULL,NULL,157
"nonfatal ml","C0439526;C1705224;C3887665",NULL,NULL,300
"aml $nmbr$ mg hctz $nmbr$ mg n $nmbr$","C0020261;C0023465;C0023467;C1319635",NULL,NULL,1149
"white blood cell count cellsx $nmbr$","C0023508;C0427512",NULL,NULL,659
"age $nmbr$ yr elevated biomarkers and st segment changes","C0001779;C0005516;C0205250;C0232326;C0439234;C3163633","C0001779","",480
"small vessel","C0225988",NULL,NULL,746
"$nmbr$ io $nmbr$","C1046794;C3146236",NULL,NULL,444
"time from onset of qualifying stroke to randomization","C0034656;C0038454;C0449244;C1514624;C4554100",NULL,NULL,1762
"biguanide metformin","C0005382;C0025598;C3537187;C4317165","C0005382","",685
"physician s ga $nmbr$ $nmbr$ mmvas","C0016993;C0031831;C0804815",NULL,NULL,1750
"hospitalizations","C0019993",NULL,NULL,2358
"pbo adjusted ls mean change","C0023668;C0031962;C0392747;C0443172;C0444504;C0456081;C1705241;C2347634;C2348143;C4319952",NULL,NULL,435
"non stenotic vessels n","C0679403;C1518422",NULL,NULL,745
"rivastigmine","C0649350","C0649350","",1937
"social functioning","C0037395",NULL,NULL,1533
"secondary endpoints","C4528314",NULL,NULL,1483
"esr mm h median min max","C0033727;C0369286;C0441932;C0456680;C0549183;C0564385;C0702093;C0876920;C1524029;C2347635;C2348144;C2939193;C3642211;C3811131;C3813700;C4528284",NULL,NULL,1475
"oral aminosalicylates","C0368663;C0442027;C4521986","C0368663","",1691
"cha $nmbr$ ds $nmbr$ vasc score","C0449820;C1420648;C3714751;C4050231",NULL,NULL,968
"presence of enthesitis","C0150312;C0392148;C1282952;C3854307",NULL,NULL,2367
"hip $nmbr$ vertebral fractures","C0019552;C0019557;C0022122;C0080179;C0549207;C1505163;C3538851;C4284725",NULL,NULL,830
"diabetes at baseline","C0011847;C0011849;C0168634;C1442488",NULL,NULL,625
"ace inhibitor use","C0003015;C0042153;C0457083;C1947944;C4541021","C0003015","",811
"lvh by echo or ecg","C0058928;C0149721;C1623258;C1655045","C0232306","",406
"ace inhibitor arb or both","C0003015;C3888198;C4541021",NULL,NULL,44
"bleeding","C0019080",NULL,NULL,707
"time since bph diagnosis years","C0005001;C0011900;C0040223;C0439234;C1704272;C1704338;C1704656;C3541383",NULL,NULL,1099
"increased risk for thrombotic cardiovascular","C0007226;C0087086;C3887460;C4699158",NULL,NULL,1641
"risk factors bmi kg m $nmbr$ mean sd","C0035648;C0444504;C0578022;C1532718;C1553898;C2347634;C2348143;C2699239",NULL,NULL,1735
"aspirin thienopyridine","C0004057;C1120149","C1120149",";C0039798;C0087111;C1363945;C1709561;C1947944",73
"phase $nmbr$ dose finding trial","C0008976;C0037088;C0178602;C0205390;C0243095;C0869039;C1114758;C1710475;C2825141",NULL,NULL,110
"causes of dvt or pe no","C0015127;C0070939;C0149871;C1314792;C1880476;C2926618;C3899446;C4284304",NULL,NULL,1516
"difference from baselinea","C1705241;C1705242",NULL,NULL,1466
"serum creatinine limo $nmbr$ $nmbr$","C0201976;C0600061","C0600061;C0010294","",952
"$nmbr$ mg dl eze simva $nmbr$ $nmbr$","C0439269",NULL,NULL,192
"egfr ml min $nmbr$ $nmbr$ m $nmbr$ mdrd mean sd","C0369637;C0439445;C0441923;C0444504;C1739039;C2347634;C2348143;C2699239;C3811844;C3812682;C3839656","C3811844;C0017654","",592
"pad","C0182158;C0332568;C3540603;C3669270;C3814046;C4319657",NULL,NULL,1752
"failure","C0231174;C0680095",NULL,NULL,1969
"standard","C1442989;C2828392",NULL,NULL,1482
"glycated hemoglobin mean sd","C0017853;C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"rank based on treatment placebo","C0032042;C0667477;C0699794;C1527178;C1696465;C1705938;C1706408;C4684449","C0025677","",716
"no of events sample size i i","C0021966;C0221138;C0370003;C0441471;C0456389;C2347026;C3541888",NULL,NULL,1004
"non hdl c mg dl mean sd","C0439269;C0444504;C1518422;C2347634;C2348143;C2699239;C3715113",NULL,NULL,37
"hypovolaemia","C0546884","","",-10
"duration of study drug administration hr","C0013175;C2348354",NULL,NULL,1731
"relative decrease $nmbr$","C0080103;C0205345;C0392756;C0547047;C1547039",NULL,NULL,760
"estimated gfr renal function stage","C0017654;C0205390;C0232804;C0750572;C1300072;C1306673;C1424601",NULL,NULL,541
"antibodies to infliximab n","C3533054",NULL,NULL,434
"oac experienced bn","C0005005;C0034700;C0237607;C0596545;C1706574;C4551963",NULL,NULL,1460
"open triple n $nmbr$","C0175566;C0205174",NULL,NULL,1322
"mean s d diastolic blood pressure mm hg","C0012000;C0428883;C0428886;C0439475;C0444504;C0488053;C1305849;C2347634;C2348143","C0005823","",1469
"active cancer no","C0006826;C0205177;C0998265;C1306459;C3853793;C3888249","C0006826","",1819
"rolofylline n $nmbr$","C0166128","C0166128",";C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1114758;C1425688;C1521941;C2709207",67
"alcohol users n","C0556297",";C0001962","",1053
"no prior dm","C0011816;C0332152;C2826257;C3250443",NULL,NULL,955
"rituximab","C0393022",NULL,NULL,946
"am_ delta","C0439097;C1705241;C3146239;C3538806;C3540585;C3815527",NULL,NULL,38
"stroke transient ischemic attack","C0007787;C0038454;C0917805;C4554100",NULL,NULL,1762
"number insulin glargine","C0237753;C0449788;C0907402",NULL,NULL,1556
"baseline lipid profile mg dl mean sd","C0023779;C0168634;C0439269;C0444504;C1442488;C1979963;C2003903;C2347634;C2348143;C2699239","C0023779","",1772
"pack years smoked","C0037366;C0439994;C1277691;C1881674","C1277691","",1297
"obese patients n","C0028754;C0030705",NULL,NULL,1035
"mean age yr range","C0001779;C0439234;C0444504;C1514721;C2347634;C2348143;C2348147;C3542016","C0001779","",480
"death mi idr st or gusto moderate severe bleeding","C0011065;C0019080;C0036056;C0205081;C0205082;C1306577;C1881878;C3272372;C3810814;C4049705;C4049706;C4050465;C4050466;C4082313;C4085643;C4321335;C4552775",NULL,NULL,321
"predose fev at randomization","C0034656;C0439565;C3714541;C3812758","C3714541;C0439565","",295
"physical activity","C0015259;C0026606","C0015259","",1380
"patients with mild pain womac pain score $nmbr$ $nmbr$","C0030705;C0278138;C0449820;C0582148;C2945599;C4050231;C4522280",NULL,NULL,748
"enthesitis","C1282952","C1282952","",271
"peri operative cabg participants","C0010055;C0347985;C0679646;C1882154",NULL,NULL,1033
"native american","C0282204;C1515945","C0282204","",2254
"$nmbr$ serious aes","C0205404;C1412268;C2699274",NULL,NULL,916
"left anterior descending artery","C0226032","C0226032","",2098
"atrial fibrillation alone","C0004238;C0205171;C0344434;C0439044;C0679994;C1963067",";C0004238","",1009
"data presented as mean sd unless otherwise specified acopd severity is based on the gold $nmbr$ criteria $nmbr$ gold $nmbr$ $nmbr$ bon a scale of $nmbr$ $nmbr$ with higher scores indicating worse health status the mcid is a change of $nmbr$ units on a scale of $nmbr$ $nmbr$ with higher scores indicating more severe dyspnea on a scale of $nmbr$ $nmbr$ with higher scores indicating worse health status","C0018026;C0018759;C0175659;C0205172;C0205250;C0205369;C0243161;C0332271;C0349674;C0392747;C0439148;C0439793;C0443172;C0444504;C0449450;C0449820;C0522510;C1279889;C1304897;C1457868;C1511726;C1519795;C1527178;C1552041;C1705241;C1705938;C1947916;C2080700;C2347634;C2348143;C2699239;C2986536;C3245479;C3714741;C3853603;C4319952",NULL,NULL,561
"fev $nmbr$ of predicted value","C0681842;C1522609;C1882327;C3714541",";C0037981","",1197
"fasting serum glucose mean sd mg dl","C0015663;C0202041;C0439269;C0444504;C2347634;C2348143;C2699239;C3534430","C0017725;C0015663","",2280
"in trial nonfatal or fatal stroke n $nmbr$ $nmbr$","C0008976;C0038454;C0150312;C0332285;C1302234;C1705232;C1707101;C4554100",NULL,NULL,507
"non cvd mortality","C0007222;C0026565;C0026566;C1518422","C0026565","",1312
"previous stroke or tia n $nmbr$","C0007787;C0038454;C0205156;C0917805;C1054154;C1552607;C4554100",NULL,NULL,1592
"community hospital","C0020003",NULL,NULL,2361
"white race no i","C0007457;C0021966;C0034510;C0043157;C0220938;C0221138;C1706779;C3853635","C0043157","",1402
"target vessel revascularization","C0449618;C0581603",NULL,NULL,747
"glucose mg dl mean","C0017725;C0439269;C0444504;C2347634;C2348143",NULL,NULL,2283
"ppi","C0358591;C0871125;C3811894",NULL,NULL,1738
"fev $nmbr$ reversibility sd","C0449261;C2699239;C3714541","C0449261;C0231999","",1315
"early eptifibatide","C0253563;C1279919",NULL,NULL,1487
"asthma exacerbations","C0349790","C0349790","",890
"st t wavett","C0036056;C3272372",NULL,NULL,2356
"either ocs use nasal polyps pre bd fvc $nmbr$ of predicted or age at diagnosis sl $nmbr$ years","C0005126;C0027430;C0042153;C0332152;C0439234;C0457083;C0681842;C0740175;C1828181;C1882327;C1947944;C2257086;C2344255;C3173302;C3669034;C3714541;C3844638;C4050145","C0027430","",353
"maintenance ocs use n","C0024501;C0042153;C0369718;C0441922;C0457083;C1947944",NULL,NULL,24
"chads $nmbr$ scoret","C0007928;C1413373","","",2128
"exercise category","C3669314","","",-10
"q $nmbr$ $nmbr$ $nmbr$ kg n $nmbr$ vs $nmbr$","C0022718;C0439209;C4054209",NULL,NULL,205
"restenotic vessel","C0005847;C0333186",NULL,NULL,743
"cardiovascular disease risk category","C0683312;C1113685;C3889287",NULL,NULL,562
"time to end of study ivus median iqr days","C0439548;C0444930;C0549183;C0557651;C0876920;C1456025;C2347635;C2348144;C2603343;C2746065;C2939193",NULL,NULL,635
"men without ed n $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0025266;C3538926",NULL,NULL,1842
"white n n","C0007457;C0043157;C0220938","C0043157","",1402
"chest discomfort","C0235710","","",-10
"treatment by subgroup interaction","C0039798;C0087111;C1079230;C1515021;C1522326;C1533734;C1704675;C1705169;C3538994;C3887704",NULL,NULL,236
"azl m hctz n $nmbr$","C0020261;C0369637;C0441923",NULL,NULL,923
"lower limb angioplasty or bypass surgery","C0745788;C1536078",NULL,NULL,2040
"ezetimibe n","C1142985","C1142985","",1165
"omalizumab lsm","C0966225","C0966225","",940
"chronic kidney disease no t","C1561643;C2603360;C4553188","C1561643","",967
"severe very severe","C0205082;C0442824;C2984081;C4050465;C4050466",NULL,NULL,313
"experienced","C0237607;C0596545",NULL,NULL,1460
"haq di score $nmbr$ $nmbr$","C0449820;C3826998;C4050231;C4321476",NULL,NULL,1665
"baseline sitosterol lathosterol","C0037215;C0064673;C0168634;C0220914;C1442488",NULL,NULL,625
"event patients in group incidence $nmbr$ person year","C0021149;C0027361;C0030705;C0220856;C0439234;C0439508;C0441471;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C2347489;C4019010","C0021149","",1467
"white black other","C0005680;C0007457;C0027567;C0043157;C0085756;C0220938;C0439541","C0043157","",1402
"dipeptidyl peptidase $nmbr$ inhibitors","C0003015",NULL,NULL,1854
"mtx only","C0025677;C0205171;C1417487;C1720467","C0025677","",1408
"b concomitant respiratory medications n","C0418986;C0521115",NULL,NULL,976
"ipah fpah drug and toxin","C0013227;C0040549;C0152171;C1254351;C1419079;C4522020",NULL,NULL,484
"fpg mmol l mg dl","C3642216;C3898312",NULL,NULL,1977
"carotid artery disease","C0007273","C0007273","",2195
"verapamil sr n $nmbr$","C1527129","C0042523","",1450
"women n $nmbr$ vs $nmbr$","C0043210","C0086287","",1970
"infarct localization n","C0021308;C0475264;C1744691","C0021308;C0475264","",899
"dual ii","C0205173;C1554184;C1710602;C4082587",NULL,NULL,521
"j $nmbr$ coefficient","C1707429",NULL,NULL,720
"albumin to creatinine ratio i","C0021966;C0221138;C0486293;C1318293",NULL,NULL,1021
"weight kg","C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209","C0005910","",1250
"female perimenopausal or $nmbr$ years postmenopausal","C0043210;C0086287;C0232970;C0439234;C0849668;C1705497;C1705498;C3839366","C0232970","",1041
"egfr ml min $nmbr$ $nmbr$ m $nmbr$ mean sd","C0369637;C0439445;C0441923;C0444504;C1739039;C2347634;C2348143;C2699239;C3811844;C3812682","C3811844;C0017654","",592
"myocardial infarction within the previous $nmbr$ yr","C0027051;C0205156;C0428953;C0439234;C1552607;C2926063;C3810814;C4552959",NULL,NULL,646
"hypersensitivity n","C0020517;C0520946","C0332324","",1164
"duration of dm years","C0011816;C0439234;C0449238;C2926735;C3250443",NULL,NULL,901
"catheterization performed for qualifying event","C0007430;C0441471;C0884358;C1514624;C4019010",NULL,NULL,412
"$nmbr$ mg empagliflozin","C0024671;C0026410;C0439269;C1960952;C2346927;C3490348;C4321396;C4521761","C3490348","",1182
"tg mmol l mg dl median","C0337445;C0549183;C0876920;C2347635;C2348144;C2939193;C3642216;C3898312",NULL,NULL,635
"ppi or h $nmbr$ receptor antagonist n","C0033727;C0358591;C0369286;C0441932;C0564385;C0871125;C3811894;C4528284;C4543207",NULL,NULL,185
"frequent or continuous","C0332183;C0549178",NULL,NULL,404
"mean sd age in years","C0444504;C1510829;C2347634;C2348143;C2699239",NULL,NULL,37
"syndesmophyte present n","C0150312;C0221690;C0449450",NULL,NULL,287
"diastolic blood pressure mmhg","C0428883;C0439475;C1305849","C0005823","",1469
"hazard ratio for cardiovascular death stroke or myocardial infarction $nmbr$ ci","C0008107;C0011065;C0027051;C0428953;C1306577;C2926063;C2985465;C3259781;C3810814;C4082313;C4552775;C4552959",NULL,NULL,519
"syndecan $nmbr$ ng ml","C0075691;C0439275;C1419891",NULL,NULL,204
"lumbar spine bmd t","C0024091;C3887615",NULL,NULL,1551
"apob apoal ratio","C0003593;C0456603;C1547037;C3252643","C0003593","",426
"angiotensin converting enzyme inhibitors angiotensin receptor blockers","C0003015;C0597357;C2757044",NULL,NULL,962
"primary composite outcome","C0205199;C0205225;C0439612;C0439631;C1274040;C1547335",NULL,NULL,2339
"baseline mg dl mmol l","C0168634;C0439269;C1442488;C1532563",NULL,NULL,192
"placebo secukinumab $nmbr$ mg","C0024671;C0026410;C0032042;C0439269;C1696465;C1706408;C1960952;C2346927;C3179547;C4321396;C4521761",NULL,NULL,944
"lesion s","C0221198;C1546698",NULL,NULL,472
"total ldl c","C0439175;C0439810",NULL,NULL,1685
"rerandomization to placebo n $nmbr$ f","C0016327;C0032042;C1696465;C1706408","C0032042","",28
"recent surgery or trauma","C0038894;C0038895;C0043251;C0332185;C0543467;C1274039;C1510467;C3263723;C3714660;C4049136",NULL,NULL,598
"terrible","C3827840",NULL,NULL,674
"thrombophilia","C0398623",NULL,NULL,623
"eq $nmbr$ d $nmbr$ l no pain or discomfortc","C0030193;C0205163;C0439185;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132","C0030193","",1338
"immunomodulatory drugs","C0013227;C3687832",NULL,NULL,367
"moderate renal impairment n","C0205081;C1565489;C1881878;C4049705;C4049706;C4085643;C4321335","C1565489","",937
"alogliptin n $nmbr$","C1958126","C1958126","",1183
"time from onset of symptoms to start of fibrinolytic therapy hr","C0040044;C0040363;C0041260;C0439659;C1320528;C1883351",NULL,NULL,1703
"surgical technique post randomisation characteristic","C0034656;C0683469;C0687676;C1521970;C1704687;C3469826",NULL,NULL,2017
"hab $nmbr$ c mean sem","C0444504;C2347634;C2348143",NULL,NULL,36
"$nmbr$ drinks wk","C0332174;C0439230;C0452428",NULL,NULL,178
"baseline insulin daily dose kg","C0021641;C0022718;C0168634;C0332173;C0366513;C0439209;C1442488;C1533581;C1579433;C2348070;C3714501;C4054209",NULL,NULL,1488
"index inclusion acute coronary syndrome","C0007637;C0600653;C0918012;C0948089;C1512693;C1552854;C1637833;C2986546",NULL,NULL,734
"history of atrial fibrillation and or flutter","C0016385;C0729790;C2242390",";C0004238","",1009
"high sensitivityc reactive protein mg l","C0033684;C0205250;C0205332;C0439268;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209","C0006560","",286
"efficacy variable","C0439828;C1280519;C1707887;C4553760","C1707887;C2349179","",1122
"duration of diabetes mean sd y","C0011847;C0011849;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"subpopulation","C1257890",NULL,NULL,904
"drug eluting stent n","C1322815","C1322815","",365
"left ventricular ejection fraction","C0428772;C0488728","C0018801;C0428772","",1273
"intermediate $nmbr$ $nmbr$","C0205103;C1550465;C2827755;C3889971","C0205103",";C0015663;C1550465;C2827755;C3889971;C0079613;C1704930;C1869853;C3890007;C4048375",1096
"medical therapy before randomization no total no","C0034656;C0418981;C0439175;C0439810",NULL,NULL,508
"hscrp mg l c","C0439268","C0006560","",286
"baseline cardiovascular medication c n","C0007220;C0168634;C1442488","C0007220","",897
"heart failure","C0018801;C0018802;C4554158","C0018801",";C0168634;C1524003",12
"average daily dose of target","C1510992;C1521840;C2348070;C2825518;C2986546",NULL,NULL,735
"glomerular filtration rate","C0017654;C1561549","C3811844;C0017654","",592
"other atherosclerotic cvd","C0007222;C0333482","C0004153","",1698
"alcohol consumption","C0001948","C0001948","",875
"change from baseline to week $nmbr$ in weekly no of hives score","C0042109;C0168634;C0332174;C0392747;C0439230;C0443172;C0449820;C1442488;C1705241;C4050231;C4319952",NULL,NULL,748
"not at goal","C0018017;C1518422;C1571704",NULL,NULL,1688
"baseline normoglycemia","C0168634;C0580545;C1442488",NULL,NULL,34
"high nafld fibrosis score nfs $nmbr$ $nmbr$","C0205250;C0400966;C1299351;C1555018;C1954436;C1954437;C2700149;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"past smoker n","C0337664;C1444637;C4284302","C0037369","",420
"cardiac arrhythmia","C0003811;C0264886;C1560249","C0003811","",380
"asymmetric peripheral arthritis","C0238694;C0332514","C0003864","",274
"estonia","C0014908","","",-10
"l vs c","C0439394;C1706495;C3642217","","",-10
"$nmbr$ des type","C0011702;C0332307;C1547052;C4551552",NULL,NULL,603
"history of major macrovascular disease no","C0205082;C0205164;C0683519;C0730226;C0850708;C0944983;C4318856;C4521762","C0004153","",1698
"hispanic or latino ethnic groupf","C0015031;C0086409;C0086528;C0680174","C0086528;C0086409;C0015031","",363
"current smoker n $nmbr$ $nmbr$","C3173209;C3241966","C3241966","",1420
"treatment with any blood pressure","C0005823;C0033095;C0039798;C0087111;C0460139;C0596197;C1271104;C1272641;C1306345;C1522326;C1533734;C1705169;C3538994;C3887704;C4284008","C0005823","",15
"never took alendronate","C0102118;C1515187;C2003901",NULL,NULL,513
"baseline serum calcium level n","C0036785;C0168634;C0728876;C1442488",NULL,NULL,625
"severe life threatening","C0205082;C1546953;C2826244;C3537125;C4050465;C4050466",NULL,NULL,313
"dose reduced at randomization","C0034656;C0178602;C0392756;C0869039;C1114758",NULL,NULL,110
"n $nmbr$ yrs","C0369718;C0441922",NULL,NULL,1553
"education yrs mean sd","C0013621;C0013622;C0013658;C0039401;C0444504;C2347634;C2348143;C2699239","C0013658","",902
"anti cholinergics short acting a","C0079613;C0242896;C1282927;C1704930;C1806781;C1869853;C2350002;C3890007;C4048375",NULL,NULL,499
"$nmbr$ $nmbr$ lung fields","C0225759",NULL,NULL,476
"metabolic syndrome $nmbr$ baseline lipids mg dl","C0023779;C0168634;C0439269;C0524620;C1442488","C0023779","",1772
"control group","C0009932",NULL,NULL,1639
"eosinophils $nmbr$ itt n $nmbr$","C0014467;C0200638","C0014467","",849
"mean se trough l","C0036919;C0444504;C0444506;C2347634;C2348143",NULL,NULL,567
"with baseline vertebral fracture","C0080179;C0168634;C1442488",NULL,NULL,625
"treatment with anti platelet drugs","C0039798;C0087111;C1522326;C1533734;C1705169;C2963157;C3538994;C3887704",NULL,NULL,236
"total n","C0439175;C0439810",NULL,NULL,508
"nephropathy","C0022658","C0022658","",320
"baseline tobacco use","C0040335;C0168634;C0543414;C0841002;C1442488;C3853727",NULL,NULL,23
"subgroup p value","C1079230;C1515021;C1709380",NULL,NULL,7
"moderate impairment egfr $nmbr$ $nmbr$","C0205081;C0221099;C0684336;C1739039;C1881878;C3811844;C3812682;C4049705;C4049706;C4085643;C4321335","C3811844;C0017654","",592
"fibrinogen g l","C0016006;C0439294;C0456615;C1167394;C2587184;C3540039","C0016006","",1142
"left atrial diameter","C0225860;C0225861;C1301886","C0225860","",1196
"anti gad negative","C0205160;C0270549;C1414925;C1513916;C2825415;C2825491;C3853545",NULL,NULL,1569
"hemoglobin g dl","C0019046;C0439267;C1319312;C3642216",NULL,NULL,1486
"dietary calcium intake mean sd mg d","C0439422;C0444504;C0489458;C2347634;C2348143;C2699239",NULL,NULL,2134
"vldl","C0523560","C0023824;C0023826","",1066
"fp versus other ics","C0016704;C0815320;C1419068;C1419906;C3541238;C3541412;C4551720",NULL,NULL,1359
"baseline metformin","C0025598;C0168634;C1442488","C0025598","",1345
"weight kg cardiovascular history no","C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C1880008;C4054209","C0005910","",1250
"tamsulosin $nmbr$ $nmbr$ mg vs placebo","C0024671;C0026410;C0032042;C0257343;C0439269;C1696465;C1706408;C1960952;C2346927;C4321396;C4521761","C0257343","",1346
"$nmbr$ $nmbr$ f $nmbr$ $nmbr$ $nmbr$ $nmbr$ h","C0016327;C0033727;C0369286;C0441932;C0564385;C4528284",NULL,NULL,308
"amputation no","C0002688;C0332840;C1546539","C0002688","",1973
"north ameriea","C1709269",NULL,NULL,579
"female n race n","C0034510;C0043210;C0086287;C1705497;C1705498;C1706779;C3853635",NULL,NULL,2014
"phosphatase mean sd ng mlf","C0017887;C0028074;C0031678;C0066495;C0444504;C1149880;C2347634;C2348143;C2699239;C4522024",NULL,NULL,37
"d population","C0032659;C0073187;C0332173;C1257890;C4484261",NULL,NULL,904
"sss score","C0037052;C0449820;C0723181;C4050231",NULL,NULL,748
"smoking in the past year","C0037369;C0453996;C1881674;C4086728","C0037369","",420
"crcl at baseline ml min","C0168634;C0439445;C1442488;C1846718","C3811844;C0017654","",307
"bmi $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0578022",NULL,NULL,1735
"tnf antagonist failure population n $nmbr$","C0032659;C0231174;C0231491;C0680095;C1257890;C1448177",NULL,NULL,11
"participants without hf at baseline","C0018488;C0168634;C0679646;C1313497;C1442488;C1538440;C3273279",NULL,NULL,1033
"basdai responses at week $nmbr$","C0332174;C0439230;C0871261;C1998004","C1998004","",1354
"smoker a","C0337664","C0037369","",420
"apo b mean sd mg dl","C0003593;C0439269;C0444504;C2347634;C2348143;C2699239;C3252643","C0003593","",426
"sf $nmbr$ score","C0037712;C0449820;C4050231",NULL,NULL,1782
"fenofibric acid $nmbr$ $nmbr$","C0060179",NULL,NULL,1696
"gp iib iiia inhibitor before pci no","C0016011;C1999216;C4049621",NULL,NULL,808
"ustekinumab combined","C0205195;C1608841","C1608841","",371
"unfractionated only","C0205171;C1720467",NULL,NULL,925
"ff vi $nmbr$ mg $nmbr$ mg n $nmbr$","C0205999;C1319635;C4554348",NULL,NULL,515
"rosiglitazone $nmbr$ mg daik","C0024671;C0026410;C0289313;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2298
"$nmbr$ symptom days per week","C0677547;C1457887;C3854129",NULL,NULL,613
"previously taken methotrexate","C0025677;C1883727","C0025677","",716
"primary pci","C0205225;C0439612;C0439631;C4049621",NULL,NULL,2340
"dulaglutide $nmbr$ $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C3179549;C4321396;C4521761",NULL,NULL,2276
"randomized to active yitamin e","C0034656;C0205177;C3815594;C3853793;C3888249",NULL,NULL,496
"intracerebral","C0442111",NULL,NULL,929
"concomitant aedsb n","C0521115",NULL,NULL,448
"component for all instruments higher scores indicate more severe disease ara denotes american rheumatism association now called","C0004083;C0009326;C0035435;C0205172;C0205250;C0325983;C0439849;C0449432;C0449820;C0596070;C0596306;C0679006;C0699792;C1705248;C1836348;C1947967;C1948052;C2316832;C3890184;C4282437;C4321455;C4551823","","",-10
"blood pressure mmhg systolic","C0005823;C0039155;C0439475;C1271104;C1272641","C0005823","",15
"distal one third of radius","C0034627;C0205437;C0205447;C0450168;C0588207;C1306504",NULL,NULL,1644
"neuraxial anaesthesia","C0002903;C0002912;C0002930;C3714787;C4049933",NULL,NULL,927
"ace i or arb","C0021966;C0221138;C1452534;C3888198;C4284014",NULL,NULL,46
"baseline hba $nmbr$ c","C0019016;C0168634;C1442488;C1825777;C3538758","","",820
"overall n n loopy","C0181687;C0282416;C0445022;C1561607",NULL,NULL,1727
"simvastatin $nmbr$ mg n $nmbr$","C0024671;C0026410;C0074554;C0439269;C1960952;C2346927;C4321396;C4521761","C0074554","",1840
"homa_ir median q $nmbr$ q $nmbr$ $nmbr$","C0022065;C0022071;C0549183;C0876920;C1448132;C2347635;C2348144;C2939193",NULL,NULL,635
"hscrp mg dl","C0439269","C0006560","",286
"time mean sd min procedure","C0040223;C0184661;C0444504;C0702093;C1524029;C2347634;C2348143;C2699239;C2700391;C3274430;C3539779;C3541383;C3813700",NULL,NULL,290
"change from baseline in predicted fev $nmbr$","C0168634;C0392747;C0443172;C0681842;C1442488;C1705241;C1882327;C3714541;C4319952",NULL,NULL,1599
"participant reported hypertension no","C0020538;C0679646;C0684224;C0700287;C1963138;C2698741;C4319718;C4554048","C0020538","",1364
"losartan n $nmbr$ $nmbr$","C0126174","C0126174","",1207
"present $nmbr$ mg dl","C0150312;C0439269;C0449450",NULL,NULL,287
"point difference $nmbr$ ci c","C0008107;C1552961;C1705241;C1705242;C2347617;C3259781;C3714763",NULL,NULL,1466
"high risk criterion","C0243161;C0332167;C3272283;C4050568;C4319571","C4319571","",837
"magnetic resonance angiography","C0243032",NULL,NULL,2350
"symptomatic infarct swelling","C0013604;C0021308;C0038999;C0231220",NULL,NULL,1764
"event","C0441471;C4019010",NULL,NULL,412
"use of ticagrelor","C1524063;C1999375",NULL,NULL,25
"patients without draining fistulae at baseline n $nmbr$","C0030705;C0168634;C0544791;C1442488",NULL,NULL,1596
"fxs","C0016667","","",-10
"aspirin any dose","C0004057;C0178602;C0869039;C1114758","C0004057","",1366
"digital clubbing n","C0009080;C0149651",NULL,NULL,990
"medications no","C0013227;C0802604;C2598133;C4284232",NULL,NULL,2263
"cardiogenic shock","C0036980",NULL,NULL,653
"hypertension no total no","C0020538;C0439175;C0439810;C1963138","C0020538","",1364
"statin with niacin","C0027996;C0360714;C1142562","C0360714","",872
"randomised treatment","C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,236
"pooled","C1709595;C2349200;C4522255","C1709595;C1524024","",211
"calcium antagonist strategy n $nmbr$ $nmbr$","C0006684;C0679199","C0006684","",1884
"incidence rate n","C1708485","C1708485","",1106
"ticagrelor pre hosp n $nmbr$","C0332152;C0740175;C1999375;C2257086;C3669034",NULL,NULL,2379
"propafenone","C0033429",NULL,NULL,1047
"treatment at randomization no","C0034656;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,692
"liraglutide $nmbr$ $nmbr$ mg oad","C0024671;C0026410;C0439269;C1456408;C1960952;C2346927;C4321396;C4521761","C1456408","",1566
"non reversible","C0205343;C1518422",NULL,NULL,733
"hazard ratio and $nmbr$ ci","C0008107;C2985465;C3259781","C2985465","",975
"lowest tertile range $nmbr$ $nmbr$ $nmbr$ $nmbr$ mg dl mean sd $nmbr$ $nmbr$ $nmbr$ $nmbr$ mg dl","C0024671;C0026410;C0439269;C0444504;C1514721;C1708760;C1960952;C2346927;C2347634;C2348143;C2348147;C2699239;C3539687;C3542016;C4321396;C4521761",NULL,NULL,37
"postmenopausal hormone use","C0019932;C0042153;C0232970;C0457083;C1947944;C4521914","C0232970","",1041
"mean_delta","C0439097;C0444504;C1705241;C2347634;C2348143;C3146239;C3538806;C3540585;C3815527",NULL,NULL,38
"lesion location","C0221198;C0450429;C1515974;C1546698;C4284930;C4284931",NULL,NULL,906
"other diuretic","C0012798",NULL,NULL,992
"established atherosclerotic cardiovascular disease","C0004153;C0443211;C1272684","C0004153","",1698
"previous coronary revascularisation","C0205156;C0877341;C1552607","C0877341",";C4049621;C1552607",223
"any statin","C0360714","C0360714","",872
"respiratory related","C0439849;C0445223;C0521346;C1546767",NULL,NULL,319
"duration of study drug infusion","C0392877;C0449238;C0557651;C2603343;C2926735",NULL,NULL,901
"high risk of diabetes","C0011847;C0011849;C0332167","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"high risk without atherosclerotic vascular disease","C0004153;C0332167;C3272283;C4050568;C4319571","C4319571","",837
"mean bmi kg m $nmbr$ sd","C0444504;C0578022;C1532718;C2347634;C2348143;C2699239",";C1305855","",206
"mean bm $nmbr$ s d kg m $nmbr$","C0006416;C0444504;C1532718;C2347634;C2348143",NULL,NULL,37
"baseline treatments n a","C0087111;C0168634;C1442488",NULL,NULL,625
"no of panents total no $nmbr$","C0439175;C0439810",NULL,NULL,508
"ocs at baseline","C0168634;C1442488",NULL,NULL,625
"cat $nmbr$ n $nmbr$ $nmbr$","C0007450;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282",NULL,NULL,255
"normalized womac score","C0449820;C1882115;C4050231",NULL,NULL,748
"baseline","C0168634;C1442488",NULL,NULL,625
"non hdl choleslerol","C1518422;C3715113","C0023822","",821
"placebo vonoprazan $nmbr$","C0032042;C1696465;C1706408;C4080009","C0032042","",28
"patients treated with atenoloi n $nmbr$","C0030705;C0332293",NULL,NULL,1035
"european trial","C0008976;C0239307;C1535514","C0239307","",504
"post salbutamol fev $nmbr$ l b mean sd","C0001927;C0444504;C0687676;C1704687;C2347634;C2348143;C2699239;C3469826;C3714541",NULL,NULL,584
"aspirin dose at baseline mg","C0004057;C0024671;C0026410;C0168634;C0439269;C1442488;C1960952;C2346927;C4086581;C4321396;C4521761;C4696290","C0004057","",1366
"dabigatran $nmbr$ mg versus warfarin","C0024671;C0026410;C0043031;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761",NULL,NULL,775
"fibrous","C0016059;C0439709",NULL,NULL,1733
"$nmbr$ $nmbr$ $nmbr$ o $nmbr$ o","C0483204","","",-10
"mi previous pci and chronic obstructive pulmonary disease","C0024117;C0205156;C1552607;C3810814;C4049621",NULL,NULL,516
"previous coronary procedure of group","C0018787;C0018821;C0205156;C0441833;C0687744;C1257890;C1279986;C1519504;C1552607;C1705428;C1705429;C2986530",NULL,NULL,1526
"concomitant use of corticosteroids","C0001617;C0521115;C1524063;C3539185;C3540725;C3540726;C3540727",NULL,NULL,1650
"network","C0150775;C1513822;C1705739;C1882071",NULL,NULL,514
"pfo with mild to moderate shunt and atrial septal aneurysm","C0232180;C0521533;C0542331;C1299392;C1442858",NULL,NULL,322
"weight kg mean s d","C0005910;C0043100;C0444504;C1275571;C1305866;C1705104;C2347634;C2348143","C0043100","",1915
"gender","C0079399;C1522384","C0079399","",1083
"history of heart failure n","C0455531","C0018801",";C0168634;C1524003",12
"laboratory values at randomization median and iqr","C0022877;C0034656;C0042295;C0549183;C0876920;C2347635;C2348144;C2939193;C3244292;C4283904",NULL,NULL,635
"apo a $nmbr$ g l","C0003592;C0439294;C0456615;C0523508;C4553344;C4553379","C0003592","",427
"snp","C0752046;C1527094",NULL,NULL,1586
"i $nmbr$ i i $nmbr$ $nmbr$","C0021966;C0221138",NULL,NULL,1021
"edoxaban lower dose vs warfarin","C0043031;C0445550;C1708745;C2975435","C0445550","",112
"activity range $nmbr$ $nmbr$ mean sd","C0205177;C0439167;C0441655;C0444504;C1514721;C1561536;C2347634;C2348143;C2348147;C2699239;C3542016;C3668946;C4049938;C4049939",NULL,NULL,494
"baseline nihss score","C0168634;C0449820;C1442488;C1697238;C4050231",NULL,NULL,748
"mean baseline ei score","C0022067;C0168634;C0444504;C0449820;C1414370;C1442488;C2347634;C2348143;C2348481;C4050231",NULL,NULL,625
"baseline steroids","C0038317;C0168634;C1442488",NULL,NULL,625
"n pyr","C0369718;C0441922",NULL,NULL,1518
"intent to use direct thrombin","C0040018;C0040363;C0041260;C0042153;C0162425;C0439851;C0457083;C1283828;C1550453;C1883351;C1947931;C1947944",NULL,NULL,431
"duration of disease mo","C0026544;C0332177;C0872146",NULL,NULL,1476
"pulse pressure median $nmbr$ $nmbr$","C0549183;C0876920;C0949236;C2347635;C2348144;C2939193",NULL,NULL,635
"serum pepsinogen i iit","C0077923;C0229671;C0523816;C1546774;C1550100",NULL,NULL,951
"bmi no","C0578022",NULL,NULL,1735
"$nmbr$ $nmbr$ with cv disease n $nmbr$","C0007222","C0007222","",1790
"leeds enthesitis index score $nmbr$ no","C0449820;C0451148;C4050231",NULL,NULL,748
"hf signs and symptoms","C0018488;C0220912;C0220913;C0311392;C0683368;C1313497;C1457887;C1538440;C3273279","C0018801",";C0168634;C1524003",12
"pre enrollment antihyperglycemic therapy","C0020616;C1516879;C1696073;C1882440;C3888021",NULL,NULL,339
"age mean sd y","C0001779;C0444504;C2347634;C2348143;C2699239","C0001779","",480
"documented asymptomatic cardiac ischemiac","C0018787;C0231221;C1301725;C1522601;C1609436",NULL,NULL,1481
"valvular heart disease","C0018824;C1963123","C0018824","",103
"nihss score","C0449820;C1697238;C4050231",NULL,NULL,748
"atherosclerotic vascular disease history no","C0004153;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062","C0004153","",1698
"baseline mssbp msdbp mm hg","C0168634;C0439475;C1442488","C0005823","",1469
"aetiology of pah","C0015127;C0030123;C1314792;C1524003;C3203102;C4284467",NULL,NULL,924
"nonblack race no j","C0034510;C1706779;C3853635",";C0034510","",1107
"egfr $nmbr$ ml min","C0439445;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"neurologicai events","C0441471;C3541888",NULL,NULL,412
"infliiimab i","C0021966;C0221138",NULL,NULL,1021
"dactylitis score $nmbr$ $nmbr$ scale","C0175659;C0239161;C0349674;C0449820;C1947916;C4050231","C0239161","",492
"without hypertension at baseline to hypertension","C0020538;C0168634;C1442488;C1963138",NULL,NULL,625
"age mean sd","C0001779;C0444504;C2347634;C2348143;C2699239",NULL,NULL,1907
"assigned to topiramate","C0040363;C0041260;C0076829;C1516050;C1552601;C1883351",NULL,NULL,755
"$nmbr$ glucose lowering medication no","C0013227;C0017725;C0441994;C2003888;C3244316;C4284232",NULL,NULL,366
"no ckd n","C1561643","C1561643","",967
"combination therapy n $nmbr$","C0009429;C0556895",NULL,NULL,2363
"hispanic ethnic group no i","C0015031;C0021966;C0086409;C0221138;C1879937","C0086409","",865
"prior non haemorrhagic stroke","C0332152;C0553692;C1518422;C2826257",NULL,NULL,581
"did not enrol into osler","C1518422",NULL,NULL,85
"patients with ra as or psa n $nmbr$","C0030705;C3538806;C3810537;C3813209;C4048756",NULL,NULL,1755
"baseline lipids mg dl","C0023779;C0168634;C0439269;C1442488","C0023779","",1772
"baseline pulmonary medication","C0013227;C0024109;C0168634;C1442488;C2707265;C2709248;C3244316;C4284232;C4522268",NULL,NULL,572
"atm locus","C1708726;C3711796",NULL,NULL,695
"diabetes and currently on an oral hypoglycaemic agent orinsulin","C0011847;C0011849;C0359086;C0521116","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"cause of heart failure","C0015127;C0018801;C0018802;C1524003;C4554158","C0018801",";C0168634;C1524003",12
"pre diabetes mellitus n $nmbr$","C0362046","C0362046",";C0168634;C1334085;C1708411",910
"severe very severea","C0205082;C0442824;C2984081;C4050465;C4050466",NULL,NULL,313
"no nonsevere hypoglycemia","C0020615;C4553659","C0020615","",35
"tia","C0007787;C0917805;C1054154",NULL,NULL,1592
"and vfx status","C0449438",NULL,NULL,309
"prior admb","C0332152;C2826257",NULL,NULL,294
"history of stroke or transient ischemic attack","C0007787;C0019664;C0019665;C0038454;C0262512;C0262926;C0917805;C1705255;C2004062;C4554100",NULL,NULL,832
"hospitalization in previous year with management of heart failure as major component no","C0001554;C0018801;C0018802;C0019993;C0205082;C0205156;C0205164;C0376636;C0439234;C0439508;C0449432;C1273870;C1552607;C1705248;C3273539;C4318856;C4521762;C4554158",NULL,NULL,1472
"a overall and subgroups bv statin potency","C0085166;C0282416;C0360714;C1079230;C1511278;C1561607;C3245505","C0360714","",872
"lipoprotein a median qi q $nmbr$ nmol l","C0065058;C0125953;C0376586;C0439282;C0549183;C0876920;C1096202;C1439335;C2347635;C2348144;C2939193","C0065058","",1769
"unstable angina requiring hospitalization","C0002965;C0019993",NULL,NULL,1002
"multi vessel or left main","C0005847;C0205091;C0205225;C0439064;C0443246;C1542147;C1552822;C3266262",NULL,NULL,743
"hdl mean sd mg dl","C0439269;C0444504;C2347634;C2348143;C2699239;C3715113",NULL,NULL,37
"necrosis n a","C0027540;C1334928",NULL,NULL,1549
"belgium","C0004950","C0004950","",1375
"hbaic mean s d","C0444504;C2347634;C2348143","","",820
"ncep atp iii risk factors","C0035648;C0439070;C1553898;C1705160;C2744579;C4552600",NULL,NULL,524
"digoxin scd no y","C0012265","C0012265","",989
"heterogeneity test","C0019409;C0022885;C0039593;C0242960;C0392366;C0456984;C1515976;C3831328;C4318744",NULL,NULL,242
"formoterol $nmbr$ pg vs placebo","C0030827;C0032042;C0060657;C0072225;C1266240;C1696465;C1706408",NULL,NULL,2330
"blood pressure mm","C0005823;C1271104;C1272641;C4330985;C4554674","C0005823","",15
"bmi mean sd kg m $nmbr$","C0444504;C0578022;C1532718;C2347634;C2348143;C2699239",NULL,NULL,2125
"low dose aspirin use","C0042153;C0457083;C1947944;C2608320",NULL,NULL,2183
"baseline geometric mean cv","C0168634;C1442488;C2986759;C3538987;C4048877;C4318503",NULL,NULL,1777
"sacral and or lumbar","C0024090;C0036037",NULL,NULL,1558
"inspiratory capacity l","C0021610;C0802663",NULL,NULL,977
"muscle twitching","C0015644;C0231530","C0037763","",1150
"prior cv history","C0019664;C0019665;C0262512;C0262926;C0332152;C1705255;C2004062;C2826257;C3538987;C4048877;C4318503",NULL,NULL,1777
"no of signs or symptoms of chff","C0220912;C0220913;C0311392;C0683368;C1457887",NULL,NULL,613
"age y sex no","C0001779;C0009253;C0036864;C0079399;C0804628;C1314687;C1522384","C0001779","",480
"tnf antagonist","C0231491;C1448177",NULL,NULL,184
"bare metal stent","C2825200","C2825200","",348
"unclassified","C0205426;C1546437;C2347854;C4085229",NULL,NULL,95
"aclidinium formoterol $nmbr$ $nmbr$ pg twice daily","C0030827;C0060657;C0072225;C0585361;C1266240;C2699757",NULL,NULL,2329
"normal bmi $nmbr$","C4229017",NULL,NULL,1735
"s $nmbr$ kg m $nmbr$","C0565930;C1532718;C2603362",";C1305855","",206
"total hip bmi t score","C0019552;C0022122;C0578022;C1505163;C2964552;C3538851;C4284725",NULL,NULL,830
"patients with event patients analysed","C0030705;C0441471;C4019010",NULL,NULL,1035
"paclitaxel eluting","C0144576",NULL,NULL,500
"companion $nmbr$ $nmbr$ hours","C0031268;C0335343;C0439227;C0682323",NULL,NULL,1000
"high risk $nmbr$","C0332167;C3272283;C4050568;C4319571","C4319571","",837
"therapy asa $nmbr$ placebo $nmbr$","C0004057;C0032042;C0039798;C0087111;C1363945;C1696465;C1706408;C3853627","C0032042","",28
"baseline post bronchodilator predicted fev $nmbr$ and concurrent tiotropium use","C0042153;C0168634;C0205420;C0213771;C0457083;C0681842;C1442488;C1882327;C1947944;C2599594;C3714541",NULL,NULL,1599
"caleium ehannel bloekers ccb","C0006684","C0006684","",1884
"management distribution","C0001554;C0376636;C0520511;C1273870;C1704711;C3273539",NULL,NULL,488
"nyha class n","C1882083","C0018802;C1882083","",453
"patients with uncomplicated events p o $nmbr$","C0030705;C0441471;C0443334;C3541888",NULL,NULL,1035
"baseline bnp concentration pg ml","C0054015;C0086045;C0168634;C0439297;C1095989;C1417808;C1442488;C1446561;C2982014;C3827302",NULL,NULL,625
"gt","C1435727;C1704693;C2697657",NULL,NULL,250
"age group $nmbr$","C0027362;C2348001",NULL,NULL,45
"reported in ecrf","C0684224;C0700287;C4319718;C4551412",NULL,NULL,1335
"oral agent and or insulin therapy","C0021641;C0039798;C0087111;C0442027;C0450442;C1254351;C1363945;C1521826;C1533581;C1579433;C3714501;C4521986",NULL,NULL,484
"qrs duration $nmbr$ ms n","C0429025;C0488377;C2349943;C3539704;C3713294",NULL,NULL,126
"incl uncertain","C0087130;C0268281;C1418854;C4085655",NULL,NULL,1092
"age at diagnosis s $nmbr$ years","C0439234;C1828181;C3173302","C1828181","",483
"non calcium antagonist strategy ncas events n","C0006684;C0441471;C0679199;C1413309;C1518422;C3541888;C3813543","C1518422;C0679199;C0006684","",1374
"das $nmbr$ hscrp","C0051767;C0057671",NULL,NULL,143
"heart failure history","C0018801;C0018802;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C4554158","C0018801",";C0168634;C1524003",12
"km rates e s","C0871208;C1521828;C3887676",NULL,NULL,2008
"high normal n $nmbr$","C0205250;C0205307;C0231683;C0439166;C1299351;C2347086;C2700149;C3887512;C3889660;C4321237;C4522209;C4553972",NULL,NULL,687
"dbp mean sd mm hg","C0439475;C0444504;C0536221;C2347634;C2348143;C2699239;C3813197;C4281799",NULL,NULL,605
"prebronchodilator fev $nmbr$","C2599602;C3714541",NULL,NULL,1599
"heart rate beats per min","C0018810;C0439385","C0018810","",1105
"open no","C0175566",NULL,NULL,1322
"moderate or severe copd exacerbations","C0205081;C0205082;C0740304;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335",NULL,NULL,321
"chads $nmbr$ components n","C0007928;C0449432;C1413373","","",2128
"duration of diabetes mellitus y","C0011849;C0449238;C2926735","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"cabg surgery","C0010055;C0038894;C0038895;C0543467;C1274039","C0010055","",389
"selected clinical characteristics n","C0683325;C1707391",NULL,NULL,789
"diabetesduration mean sd y","C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"kl $nmbr$","C1366480;C1416656;C1704887",NULL,NULL,657
"sbp mm hg","C0085805;C0439475",NULL,NULL,607
"history of heart failure","C0455531","C0018801",";C0168634;C1524003",12
"$nmbr$ kg m $nmbr$ n $nmbr$","C1532718",";C1305855","",206
"ipss mean sd","C0444504;C1019118;C1998280;C2347634;C2348143;C2699239;C2827405;C3811063",NULL,NULL,1287
"venous","C0042449;C0348013",NULL,NULL,917
"$nmbr$ $nmbr$ vr no","C3476815",NULL,NULL,86
"net ep $nmbr$","C1456447;C1880476;C3853572;C3887809;C3890893;C4321526",NULL,NULL,1081
"sinusitis","C0037199;C4553555",NULL,NULL,1838
"$nmbr$ polnt mace","C0349381;C0949745;C1445339","C1320716","",414
"hazard ratio with high $nmbr$ cl","C0205250;C0596019;C1299351;C2700149;C2985465;C3887512;C3889660;C4321237;C4522209","C2985465","",975
"getgoal l asia","C0003980",NULL,NULL,1686
"modified acc or aha lesion class b $nmbr$ or c","C0050451;C0175754;C0221198;C0282160;C0392747;C0456387;C0772110;C1518526;C1546698;C1705943;C3541413;C3889737",NULL,NULL,452
"tg $nmbr$ hdl $nmbr$ n $nmbr$","C0337445;C3715113","C0041004","",209
"simvastatin monotherapy n $nmbr$ $nmbr$","C0074554","C0074554","",1840
"patients receiving statin","C0030705;C0360714;C1514756","C0360714","",872
"atorvastatin $nmbr$ mg n $nmbr$","C0024671;C0026410;C0286651;C0439269;C1960952;C2346927;C4321396;C4521761","C0286651","",885
"previous htn n","C0020538;C0205156;C1552607",NULL,NULL,1044
"egfr $nmbr$ $nmbr$","C1739039;C3811844;C3812682","C3811844;C0017654","",592
"pre bd fvc $nmbr$ of predicted","C0005126;C0332152;C0681842;C0740175;C1882327;C2257086;C2344255;C3669034;C3714541;C4050145",NULL,NULL,294
"total c","C0439175;C0439810",NULL,NULL,508
"ischemic hf etiology","C0015127;C0018488;C0475224;C1313497;C1314792;C1524003;C1538440;C3273279","C0018801",";C0168634;C1524003",12
"number randomized","C0034656;C0237753;C0449788;C3815594",NULL,NULL,692
"patients events n","C0030705;C0441471;C3541888",NULL,NULL,1035
"nt probnp $nmbr$ ng ml n","C0439275;C1317554;C2825907;C4284038",NULL,NULL,204
"mean score","C3533236",NULL,NULL,37
"etoricoxib","C0972314","C0972314","",1130
"fev $nmbr$ pred post albuterol","C0001927;C0032952;C0044955;C0687676;C1704687;C3469826;C3714541",NULL,NULL,1599
"previous myocardial infarction","C0027051;C0205156;C0428953;C1552607;C2926063;C3810814;C4552959",NULL,NULL,646
"before a change to the enrollment form was implemented in august $nmbr$ bnp","C0054015;C0348078;C0376315;C0392747;C0443172;C1095989;C1417808;C1516879;C1522492;C1696073;C1705241;C2982014;C3831448;C3888021;C4255237;C4319952;C4520547",NULL,NULL,767
"previous cardiovascular event no","C0205156;C1320716;C1552607","C1320716","",414
"time to first morbidity mortality event up to the end of the treatment periodd","C0026538;C0026565;C0026566;C0039798;C0040223;C0087111;C0205435;C0220880;C0441471;C0444930;C0547043;C1279901;C1522326;C1533734;C1705169;C2746065;C3538994;C3541383;C3887704;C4019010",NULL,NULL,757
"estimated gfr ml min $nmbr$ $nmbr$ m $nmbr$","C0017654;C0369637;C0439445;C0441923;C0750572;C1424601","C3811844;C0017654","",592
"age $nmbr$ yr no","C0001779;C0439234",NULL,NULL,86
"inguinal hernia repair","C0021446","","",-10
"acr $nmbr$ week $nmbr$ responders n $nmbr$","C0332174;C0439230;C1412134;C1515941",NULL,NULL,1012
"any blood transfusion","C0005841;C0281867","C0005841","",1241
"p interaction rx arm sex","C0009253;C0036864;C0079399;C0369773;C0446516;C0804628;C1314687;C1425688;C1521941;C1522384;C1704675;C2603361;C2709207;C3715044;C4553528",NULL,NULL,568
"reversibility of fev $nmbr$","C0449261;C3714541","C0449261;C0231999","",1315
"levetiracetam","C0377265;C3693636",NULL,NULL,777
"western europe and other","C0043129","","",599
"mean s d calculated ldl cholesterol","C0023824;C0202117;C0444504;C0444686;C1441506;C2347634;C2348143","C0023824","",1068
"measures","C0079809;C1879489",NULL,NULL,2
"iu","C0049272;C0439453;C0694756",NULL,NULL,1253
"sbp office measurement mmhg","C0085805;C0242485;C0439475;C0442603",NULL,NULL,607
"femoral neck","C0015815",NULL,NULL,511
"prior ml before index acs","C0332152;C0439526;C0600653;C0742343;C0918012;C1552854;C1637833;C1705224;C2826257;C2986546;C3887665;C4318612",NULL,NULL,2150
"amputation","C0002688;C0332840;C1546539","C0002688","",895
"statin intensity per acc ahac","C0175754;C0282160;C0360714;C0522510;C3541413","C0360714","",872
"distribution of metformin dose at randomization n","C0025598;C0034656;C0178602;C0520511;C0869039;C1114758;C1704711",NULL,NULL,892
"no asa","C0004057;C3853627",NULL,NULL,60
"no laba no ics n","C0815320;C4551720",NULL,NULL,1359
"verapamil n","C0042523","C0042523","",1450
"coiticosieroids at baseline","C0168634;C1442488",NULL,NULL,625
"glucose non fasting or random nmol l","C0015663;C0017725;C0034656;C0439282;C0439605;C1518422","C0017725;C0015663","",1846
"immunomodulators","C0001551;C0005525;C1527392","C1527392","",1425
"drug related saes","C0013227;C0439849;C0445223;C1254351;C1519255;C1622657;C4553214","C1519255","",1282
"antihypertensive medication use n","C0003364;C0042153;C0457083;C1947944",";C0003364","",1579
"history of upper gl events perforations ulcers bleeding n","C0018229;C0019080;C0019664;C0019665;C0041582;C0262512;C0262926;C0369718;C0441471;C0441922;C0549099;C1282910;C1423073;C1427674;C1705255;C2004062;C3541888",NULL,NULL,739
"ss at baseline","C0168634;C1442488;C2699257;C3891295;C4551874",NULL,NULL,117
"ll n","C0369718;C0441922",NULL,NULL,1553
"safety population n","C0032659;C0036043;C1257890;C1705187",NULL,NULL,904
"estimated gfr $nmbr$ ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$ n a","C0017654;C0369637;C0439445;C0441923;C0750572;C1424601","C3811844;C0017654","",592
"calcitonin","C0006668;C0770558;C1704385;C2825090;C4520796","","",-10
"patients characteristics age years mean sd","C0444504;C0815172;C1510829;C2347634;C2348143;C2699239","C1510829","",481
"o $nmbr$ ii","C0483204;C1710602;C4082587",NULL,NULL,521
"$nmbr$ y ears","C0013443;C0521421",NULL,NULL,149
"smokers","C0337664","C0037369","",420
"never smoked n","C0037366;C0439994;C1881674;C2003901","C0037369","",420
"imm corticosteroid n","C0001617;C0205470;C3536709",NULL,NULL,1650
"shfm annual mortality","C0026565;C0026566;C0332181","C0026565","",1312
"tender joint count $nmbr$ joints","C0451530","C0451530","",1139
"$nmbr$ to $nmbr$ m um in","C0369637;C0441923",NULL,NULL,923
"inadequate response or intolerance to $nmbr$ anti tnfdrug","C0205412;C0231199;C0439856;C0871261;C1704632;C1706817;C1744706;C2355652;C2911692","C1744706;C0666743","",1094
"number of exacerbations in previous year mean sd","C0205156;C0237753;C0439234;C0439508;C0444504;C0449788;C1552607;C2347634;C2348143;C2699239;C4086268",NULL,NULL,37
"dual ii end of trial hba $nmbr$ c","C0008976;C0019016;C0205173;C0444930;C0444967;C1554184;C1825777;C2746065;C3538758",NULL,NULL,1020
"none or seldom","C0522498",NULL,NULL,547
"no of events total","C0439175;C0439810;C0441471;C3541888",NULL,NULL,1059
"antiplatelet onl group n $nmbr$","C0441848","","",1191
"dactylitis score $nmbr$ $nmbr$ mean sd","C0239161;C0444504;C0449820;C2347634;C2348143;C2699239;C4050231","C0239161","",492
"drug related teaes $nmbr$","C0013227;C0439849;C0445223;C1254351","C0877248","",47
"exacerbations in the previous year","C0205156;C0439234;C0439508;C1552607;C4086268",NULL,NULL,2393
"rescue use mean no of inhalations d","C0004048;C0042153;C0354922;C0444504;C0457083;C1947944;C2347634;C2348143",NULL,NULL,37
"mean asui scored","C0444504;C0449820;C2347634;C2348143",NULL,NULL,37
"tertile $nmbr$ $nmbr$ $nmbr$ pg ml n $nmbr$","C0439297",NULL,NULL,674
"extent of disease no total no","C0439175;C0439810;C0449279;C4553144","C0449279","",1809
"olodaterol $nmbr$ m g","C0456715;C2934193",NULL,NULL,1510
"heart rate group at baseline","C0018810;C0168634;C0441833;C0687744;C1257890;C1442488;C1519504;C1705428;C1705429",NULL,NULL,625
"heart failure treated hospitalized fatal","C0018801;C0018802;C0701159;C1302234;C1522326;C1705232;C4554158","C0018801",";C0168634;C1524003",12
"concomitant medications after randomization","C0013227;C0034656;C0521115;C0802604;C2598133;C4284232","C0013227;C0521115","",1916
"mean yr","C0439234;C0444504;C2347634;C2348143",NULL,NULL,1099
"previous myocardial infarction no","C0027051;C0205156;C0428953;C1552607;C2926063;C3810814;C4552959",NULL,NULL,646
"etn mtx n $nmbr$","C0014758;C0025677;C0717758;C1417487","C0025677","",1408
"other combination","C0205195;C1947911;C3811910",NULL,NULL,997
"no chd","C0280604;C3542407",NULL,NULL,970
"adverse events any grade","C0441800;C0877248;C0919553;C1705413;C3244287","C0877248","",47
"nonfatal ischemic stroke","C0948008",NULL,NULL,1669
"infarct location","C0021308;C0450429;C1515974;C4284930;C4284931","C1515974;C0021308","",1948
"b lack","C0332268",NULL,NULL,1296
"median $nmbr$ th $nmbr$ th percentile","C0039725;C0039738;C0549183;C0876920;C1264641;C1420718;C2347635;C2348144;C2939193;C4282123;C4285344",NULL,NULL,1433
"high risk for diabetes","C0011847;C0011849;C0205250;C0332167;C1171304;C1299351;C2700149;C3272283;C3887512;C3889660;C4050568;C4319571;C4321237;C4522209","C4319571","",837
"tiotropium $nmbr$ pg","C0030827;C0072225;C0213771;C1266240","C0213771","",1372
"normotensive n $nmbr$","C2712122","C2712122","",1168
"paci n $nmbr$","C1165245",NULL,NULL,2094
"pde $nmbr$ inhibitors","C0031638",NULL,NULL,814
"current medication no","C0746467","C0746467","",1416
"antithrombotic drug use at time of event","C0013227;C0040223;C0441471;C1254351;C1524063;C3541383;C4019010",NULL,NULL,412
"international prostate symptom score","C1998280","C1998280",";C1019118;C3811063;C4050465;C4050466;C4049706;C0168634;C1705273;C1880519;C3853603",124
"south or central american","C0238914;C1710133",NULL,NULL,1559
"p for heterogeneity of treatment effect between tertiles $nmbr$ $nmbr$","C0019409;C0242960;C0369773;C1518681;C2603361",NULL,NULL,1873
"baseline corticosteroid use mg","C0024671;C0026410;C0168634;C0239126;C0439269;C1442488;C1960952;C2346927;C4321396;C4521761","C0239126",";C0168634;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1425988;C1947944",120
"prior arrhythmias n","C0003811;C0332152;C2826257","C0003811","",380
"$nmbr$ $nmbr$ to $nmbr$ ml min","C0439445","C3811844;C0017654","",307
"czp $nmbr$ mg n $nmbr$","C0024671;C0026410;C0054841;C0439269;C1861828;C1872109;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2274
"duration of last qualifying episode of atrial fibrillation $nmbr$ days","C0004238;C0332189;C0344434;C0439228;C0449238;C1514624;C1963067;C2926735",";C0004238","",1009
"age $nmbr$ yr and st segment changes","C0001779;C0232326;C0439234","C0001779","",480
"post bronchodilator fev $nmbr$ predicted normal a","C0205307;C0231683;C0439166;C0681842;C1882327;C2347086;C2599594;C3714541;C4553972",NULL,NULL,680
"race ethnicity no","C0015031;C0034510;C0243103;C1706779;C3853635",NULL,NULL,787
"fa $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"sgrq c total scoreb","C0439175;C0439810;C3826872",NULL,NULL,508
"patient global assessment $nmbr$ $nmbr$ mm vas","C0042815;C3536884;C3827561;C4054229;C4330985;C4554674",NULL,NULL,1751
"predicted pre bronchodilator fev $nmbr$","C0681842;C1882327;C2599602;C3714541",NULL,NULL,682
"primary target vessel","C0205225;C0439612;C0439631;C0449618",NULL,NULL,229
"inclusion diagnosis","C0007637;C0011900;C1512693;C1704338;C1704656",NULL,NULL,841
"timi risk score no total no f","C0016327;C0035647;C0439175;C0439810;C0449820;C4050231;C4552904",NULL,NULL,2052
"i without mets n $nmbr$","C0021966;C0221138;C0812270;C1705694;C2939420",NULL,NULL,921
"combination facilitated pci","C0205195;C1947911;C3811910;C4049621",NULL,NULL,997
"$nmbr$ mg g n","C1300563",NULL,NULL,196
"long acting","C0079613;C0205166;C1704930;C1706317;C1869853;C3890007;C4048375",NULL,NULL,499
"ertugliflozin $nmbr$ mg vs placebo glinepiride","C0024671;C0026410;C0032042;C0439269;C1696465;C1706408;C1960952;C2346927;C4079805;C4321396;C4521761","C4079805","",1180
"cardiovascular death","C0007226;C0011065;C1306577;C3887460;C4082313;C4552775",NULL,NULL,323
"psa modified mases score $nmbr$ $nmbr$ scale","C0175659;C0349674;C0392747;C0449820;C1947916;C3810537;C3813209;C3889737;C4050231",NULL,NULL,125
"cigarette smoking","C0239059;C0700219",NULL,NULL,797
"with ckd intensive n $nmbr$","C0162425;C0522510;C1283828;C1550453;C1561643","C1561643","",967
"unknown none of the above","C0439673;C1282910;C1552828;C3541433;C4050014",NULL,NULL,93
"p $nmbr$ min twice week","C0332174;C0369773;C0439230;C0702093;C1524029;C1720725;C1948050;C2603361;C3813700",NULL,NULL,1012
"duration of pre randomization anticoagulant therapy","C0034656;C0332152;C0740175;C2257086;C2711563;C3669034",NULL,NULL,294
"s $nmbr$ years","C0439234;C0565930;C2603362",NULL,NULL,1099
"dual iv","C0022326;C0205173;C1554184;C4265176",NULL,NULL,1257
"any new anti hyperglycemic rx","C0205314;C1425688;C1521941;C2709207","C0020616",";C0013227;C3244316;C4284232;C0450442;C1254351;C1515187;C1521826;C2826257",33
"smoking consumption pack years","C0425291;C1277691","C1277691","",1297
"nsaid use no total no","C0003211;C0042153;C0439175;C0439810;C0457083;C1947944;C3536840",NULL,NULL,508
"dexlansoprazole mr $nmbr$ mg qd","C0024485;C0024671;C0026410;C0332173;C0439269;C1417249;C1960952;C2346927;C2347167;C2348248;C3254418;C4050513;C4321396;C4521761",NULL,NULL,1506
"baricitinib $nmbr$ mg qd n $nmbr$","C0024671;C0026410;C0332173;C0439269;C1960952;C2346927;C4044947;C4321396;C4521761","C4044947","",1956
"$nmbr$ mg day placebo","C0032042;C0439422;C1696465;C1706408","C0032042","",28
"cv risk factor","C0035648;C3538987;C4048877;C4318503",NULL,NULL,1777
"prior hf hospitalization n $nmbr$","C0018488;C0019993;C0332152;C1313497;C1538440;C2826257;C3273279",NULL,NULL,2359
"psa duration years","C0439234;C0449238;C2926735;C3810537;C3813209",NULL,NULL,1099
"cv death ml ischemic stroke hosp for hf cor revasc ua","C0011065;C0018488;C0018787;C0041580;C0042014;C0056331;C0378365;C0439526;C0948008;C1306577;C1313497;C1538440;C1705224;C3273279;C3538987;C3887665;C4048877;C4082313;C4318503;C4552775",NULL,NULL,1669
"number of clinically significant asthma exacerbations in last year prior to baseline","C0168634;C0237753;C0237881;C0332152;C0349790;C0439234;C0439508;C0449788;C0750502;C1442488;C1517741;C1546944",NULL,NULL,1099
"alert","C0239110;C2004580;C3665546;C3669039;C4084853;C4553014",NULL,NULL,41
"nonblack n $nmbr$ adjusted hazard ratio","C0456081;C2985465",NULL,NULL,1689
"medical and lifestyle history","C0019664;C0019665;C0023676;C0199168;C0205476;C0262512;C0262926;C1705255;C2004062",NULL,NULL,1490
"north america n $nmbr$","C0028405","C0028405","",1463
"age b $nmbr$ y n $nmbr$","C0001779","C0001779","",480
"number of patients with exacerbations in the previous $nmbr$ months n","C0205156;C0439231;C1552607;C2360800;C4086268","C4086268","",889
"serum creatinine mg dl mean sd","C0201976;C0439269;C0444504;C0600061;C2347634;C2348143;C2699239","C0600061;C0010294","",952
"cmann whitney u test wilcoxon sum rank test","C0439148;C0667477;C0683443;C0699794;C1515051",NULL,NULL,1740
"$nmbr$ y kaplan meier rate $nmbr$ ci","C0008107;C0871208;C1521828;C3259781",NULL,NULL,2008
"lav ml","C0019682;C0439526;C1705224;C3887665",NULL,NULL,300
"previous ml before index acs","C0205156;C0439526;C0600653;C0742343;C0918012;C1552607;C1552854;C1637833;C1705224;C2986546;C3887665;C4318612",NULL,NULL,300
"ckd egfr $nmbr$ b","C1561643;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"o","C0483204","","",-10
"death or ich","C0011065;C0019191;C1306577;C3272597;C3281105;C4082313;C4552775",NULL,NULL,323
"ace inhibitor treatment","C0003015;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704;C4541021","C0003015","",811
"week $nmbr$ et","C0040028;C0332174;C0439230",NULL,NULL,1012
"nstemi n $nmbr$ $nmbr$","C3537184;C4255010",NULL,NULL,529
"tnfi exposed","C0332157","C0332157",";C0274281;C0231491;C1420817;C4521367;C4521846;C1552607",27
"oral antidiabetes monotherapya n","C0442027;C4521986",NULL,NULL,1746
"has bled $nmbr$ $nmbr$","C0019080",NULL,NULL,707
"st change $nmbr$ mm","C0036056;C0392747;C0443172;C1705241;C3272372;C4319952;C4330985;C4554674",NULL,NULL,2356
"lesion length mean sd mm","C0221198;C0444504;C1444754;C1546698;C1706316;C2347634;C2348143;C2699239;C4330985;C4554674",NULL,NULL,472
"mmf n $nmbr$","C0083765;C0209368;C3848524","C0209368","",304
"any other lipid lowering therapy n","C0585943","C0585943;C0086440","",1774
"hospitalized for an exacerbation","C0701159;C4086268","C4086268","",889
"haemodynamics and lv function","C0019010;C0023128;C0031843;C0542341;C0700205;C0731033;C1705273;C1881413;C4281788",NULL,NULL,1531
"hdl $nmbr$","C3715113","C0023822","",821
"alc at week $nmbr$","C0332174;C0439230;C1424945;C3811058",NULL,NULL,395
"total cohort","C0009247;C0439175;C0439810;C0599755","C0599755","",2208
"vascular territory $nmbr$","C0005847;C1301808;C1558950;C1801960;C2983136",NULL,NULL,743
"psoriasis affecting $nmbr$ of body surface","C0033860;C0392760;C0489451;C1314939","C0005902;C0033860","",2177
"physical component","C0031809;C0205485;C0449432;C1509143;C1705248",NULL,NULL,1519
"lipid trial participants no","C0023779;C1997894;C2242969",NULL,NULL,278
"ipah hpah hiv drug or toxin induced","C0013227;C0019682;C0019699;C0040549;C0152171;C0205263;C0340543;C0637939;C1150929;C1254351;C4522020",NULL,NULL,1664
"investigator reported aes","C0035173;C0684224;C0700287;C1412268;C2699274;C4319718","C0877248","",47
"digoxin or digitalis glycoside","C0012253;C0012265","C0012265","",989
"squamous cell carcinoma","C0007137;C1302853",NULL,NULL,661
"vascular disordersb","C0005847;C1558950;C1801960",NULL,NULL,743
"caucasian eze simva n $nmbr$","C0007457;C0043157","C0043157","",1329
"rest angina past $nmbr$ h","C0002965;C0033727;C0152172;C0369286;C0441932;C0564385;C1444637;C4284302;C4528284","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"empagliflozin","C3490348","C3490348","",1182
"two lesions","C0205448;C0221198",NULL,NULL,429
"flex baseline bmd mean sd g cm $nmbr$","C0168634;C0439267;C0444504;C1442488;C2347634;C2348143;C2699239",NULL,NULL,701
"age $nmbr$","C0001779","C0001779","",480
"ls mean difference $nmbr$ ci","C0008107;C0023668;C0444504;C1705241;C1705242;C2347634;C2348143;C3259781",NULL,NULL,519
"current drinker","C0556297","C0001948","",875
"total randomized n","C0034656;C0439175;C0439810;C3815594",NULL,NULL,508
"no psa n $nmbr$","C3810537;C3813209",NULL,NULL,125
"select lipids and lipoproteins","C0023779;C0023820;C1707391","C0023779","",1772
"or raloxifene","C0244404",NULL,NULL,1538
"drinking n lipid values mmol l","C0001948;C0023779;C0042295;C0684271;C1532563","C0023779","",1772
"screening fev $nmbr$ predicted","C0220908;C0220909;C0681842;C1698960;C1710031;C1710032;C1710477;C1882327;C2348164;C3714541",NULL,NULL,1599
"prior brachytherapy","C0006098;C0332152;C2826257",NULL,NULL,294
"lesions","C0221198",NULL,NULL,472
"vorapaxar no $nmbr$ y km","C2974521;C3887676","C2974521","",1448
"elevated bun $nmbr$ $nmbr$ meq l","C0151539;C0439375",NULL,NULL,1626
"time since prior alendronate use n","C0040223;C0042153;C0102118;C0332152;C0457083;C1947944;C2826257;C3541383",NULL,NULL,1573
"race or ethnic group f","C0015031;C0016327;C0034510;C0441840;C0680174;C1706779;C1879937;C3853635",NULL,NULL,787
"positive cu index test z n","C0022885;C0039593;C0392366;C0439178;C0456984;C0600653;C0918012;C1177210;C1446409;C1514241;C1515976;C1552854;C1637833;C2347872;C2825490;C2986546;C3812269;C3831328;C4318744",NULL,NULL,242
"ace inhibitor or arb at enrollment","C0003015;C1516879;C1696073;C3888021;C3888198;C4541021",NULL,NULL,44
"rrr $nmbr$ cl","C0596019",NULL,NULL,1542
"$nmbr$ ml additional angiography","C0002978;C0439526;C1524062;C1705224;C3887665",NULL,NULL,1723
"laba use patients","C0030705;C0042153;C0457083;C1947944",NULL,NULL,1035
"current xanthine derivative use","C0042153;C0043314;C0043318;C0457083;C0521116;C1527240;C1705970;C1947944","C0043318","",359
"kheeatne index dvt","C0149871;C0600653;C0918012;C1552854;C1637833;C2926618;C2986546;C3899446","C0149871","",252
"months log transformed","C0439231;C1510411;C1708728;C2986775",NULL,NULL,1530
"standard care allocation","C1442989;C1706778;C1947933;C2828392",NULL,NULL,1482
"indomethacin","C0021246",NULL,NULL,636
"class iii","C0441887;C2698969",NULL,NULL,845
"risk factors and medical history","C0035648;C0262926;C1553898;C1704706",NULL,NULL,832
"rhabdomyolysis","C0035410;C4552660",NULL,NULL,815
"classification of index venous thromboembolism no","C0008902;C0008903;C0600653;C0678229;C0918012;C1552854;C1637833;C1997614;C2986546",NULL,NULL,734
"previous or current im use no","C0042153;C0205156;C0457083;C0521116;C1552607;C1705970;C1947944",NULL,NULL,118
"elevated troponin $nmbr$ $nmbr$ pg l","C0041199;C0205250;C0439278;C3163633",NULL,NULL,1605
"age years interaction p $nmbr$ $nmbr$","C1510829;C1704675","C1510829","",481
"percentages","C0439165;C1549488;C1561533",NULL,NULL,291
"history of crohn s disease surgery n","C0010346;C0455610",NULL,NULL,105
"left circumflex artery n","C0226037","C0226037","",1414
"crp concentration $nmbr$ $nmbr$ mg dl $nmbr$ mg l n","C0086045;C1446561;C2827881;C3642216;C3827302;C3890735;C4048285",NULL,NULL,676
"other oral hypoglycemic drug s","C0359086","C0359086","",1744
"bnp","C0054015;C1095989;C1417808;C2982014",NULL,NULL,1635
"n $nmbr$ $nmbr$","C0369718;C0441922",NULL,NULL,1553
"antihypertensive therapy n","C0585941",";C0003364","",1579
"alvesv per ml","C0439526;C1705224;C3887665",NULL,NULL,300
"vascular disease of group","C0042373;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429",NULL,NULL,1526
"cvd mi stroke urgent coronary revascularization","C0007222;C0038454;C0439609;C0877341;C3272275;C3810814;C4554100","C0877341;C3272275","",1212
"negative $nmbr$ $nmbr$ n","C0205160;C1513916;C2825415;C2825491;C3853545",NULL,NULL,1569
"fev $nmbr$ fvc ratio sd","C0456603;C1547037;C2699239;C3714541",NULL,NULL,1599
"clopidogrel or ticlopidine","C0040207;C0070166","C0070166","",216
"bursitis","C0006444","","",-10
"social function","C0037395",NULL,NULL,1533
"min max age","C0001779;C0702093;C1524029;C3813700","C0001779","",480
"baseline inflammation markers","C0005516;C0021368;C0168634;C1442488",NULL,NULL,155
"hawaiian pacific islander","C0242191;C0337920","C0337920;C0242191","",1331
"ratio to baseline in total ige at week $nmbr$ geometric mean se on loge scale u ml","C0036919;C0168634;C0175659;C0332174;C0349674;C0439230;C0439340;C0456603;C0806481;C1442488;C1547037;C1880521;C1947916;C2697934;C2945590;C2986759","","",241
"net clinical benefit cv death mi stroke gusto moderate severe bleeding","C0011065;C0019080;C0038454;C0205081;C0205082;C1306577;C1456447;C1881878;C3538987;C3810814;C3853572;C3887809;C3890893;C4048877;C4049705;C4049706;C4050465;C4050466;C4082313;C4085643;C4318503;C4321335;C4552775;C4554100;C4684590",NULL,NULL,323
"mra regimen n $nmbr$","C0040808;C0243032;C1609165;C2945654;C3891069","","",239
"meglitinide","C0065880",";C0065880","",1156
"prior lower gi clinical event","C0205210;C0332152;C0441471;C0441994;C1548802;C1708130;C2003888;C2826257;C3539617;C4019010;C4050121",NULL,NULL,294
"antidiabetic medication","C0935929",NULL,NULL,995
"non european trial","C0008976;C0239307;C1518422;C1535514","C0239307","",504
"ggt increased","C0205217;C0442805;C1415053",NULL,NULL,2262
"enoxaparin","C0206460","C0206460","",862
"clopidogrel","C0070166","C0070166",";C0369286;C0033727;C4049621",217
"cardiovascular disease","C0007222","C0007222","",1790
"$nmbr$ egfr ml min $nmbr$ $nmbr$ m $nmbr$ a","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"no peripheral revascularization n $nmbr$ $nmbr$","C0205100;C0581603",NULL,NULL,932
"study period fatal pe","C0070939;C0439531;C0557651;C1302234;C1705232;C1880476;C1948053;C2603343;C4284304",NULL,NULL,575
"background lipid lowering therapy","C0585943;C1706907","C0585943;C0086440","",1774
"ref","C1425988","","",-10
"xi l $nmbr$ p $nmbr$ $nmbr$","C1720296",NULL,NULL,520
"copd exacerbations during the previous year","C0205156;C0439234;C0439508;C0740304;C1552607","C0740304","",1987
"previous analgesic products n","C0002771;C0205156;C1552607",NULL,NULL,1044
"statin usage","C0360714;C0457083","C0360714","",872
"copd n $nmbr$","C0024117;C1412502;C3714496",NULL,NULL,1726
"mean baseline ldl c mmol l","C0168634;C0444504;C1442488;C1532563;C2347634;C2348143",NULL,NULL,625
"history of cad","C0019664;C0019665;C0262512;C0262926;C1504769;C1705255;C2004062;C2239547;C3813548;C4284121",NULL,NULL,832
"more than $nmbr$ lesions per vessel","C0005847;C0205172;C0221198;C1546698",NULL,NULL,472
"pentraxin $nmbr$ ng ml","C0439275",NULL,NULL,204
"low body weight $nmbr$ kg","C0022718;C0041667;C0439209;C4054209",NULL,NULL,2326
"median triglyceride mg dl","C0041004;C0439269;C0549183;C0876920;C2347635;C2348144;C2939193","C0041004","",368
"primary composite end points","C0205199;C0205225;C0439612;C0439631;C1547335;C2349179",NULL,NULL,2339
"esr mm hour per unit","C0456685;C3811131;C4330985;C4554674","C1619634","",298
"atherosclerotic cardiovascular disease","C0004153","C0004153","",1698
"previous therapies n","C0087111;C0205156;C1552607",NULL,NULL,1044
"non hdl c mmol l","C1518422;C1532563;C3715113","C0023822","",821
"baseline hbalc $nmbr$ $nmbr$ $nmbr$ mmol mol $nmbr$","C0168634;C1442488;C3829066",NULL,NULL,2188
"smoker or ex smoker n","C0337664;C0337671;C4555205","C0037369","",420
"fatal nonfatal ccvd","C1302234;C1705232",NULL,NULL,1682
"crcl sd ml min","C0439445;C1846718;C2699239","C3811844;C0017654","",307
"sitting systolic blood pressure mm hg","C0277814;C0439475;C0488055;C0871470;C1306620;C2584297;C4050224","C0005823","",1469
"seropositivity status n","C0449438;C0521143","C0521143","",1318
"rec ischemia due worsening angina","C0002965;C0022116;C0678226;C1424025;C2606415;C3146286;C4321499","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"acr $nmbr$ mg g","C1300563;C1412134;C1515941",NULL,NULL,2315
"baseline spga mean sd","C0168634;C0444504;C1442488;C2347634;C2348143;C2699239",NULL,NULL,1766
"atypical absence","C0595948","","",-10
"general allergic events","C0205246;C0441471;C0700624;C3541888;C3812897;C3891294;C4521767",NULL,NULL,1085
"hba $nmbr$ c $nmbr$ $nmbr$","C0019016;C1825777;C3538758","","",820
"microalbuminuria no","C0730345","C0033687","",376
"ileum only","C0020885;C0205171;C1720467","C0020885","",1341
"trough fev response l","C0444506;C0871261;C1704632;C1706817;C2911692;C3714541",NULL,NULL,726
"chads $nmbr$ score","C0007928;C0449820;C1413373;C4050231","","",2128
"dmab n $nmbr$","C0012411",NULL,NULL,1753
"abdominal or perianal fistula at baseline n","C0000726;C0168634;C0267561;C1442488",NULL,NULL,625
"gold grade $nmbr$ and ics non users at screening","C0018026;C0220908;C0220909;C0441800;C0815320;C0919553;C1304897;C1518422;C1698960;C1706077;C1710031;C1710032;C1710477;C2348164;C3244287;C4551720",NULL,NULL,1359
"$nmbr$ $nmbr$ tng cll","C0023434",NULL,NULL,660
"lsm difference","C1705241;C1705242",NULL,NULL,1466
"never nsaid","C0003211;C2003901;C3536840",NULL,NULL,2122
"baricitinib $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4044947;C4321396;C4521761","C4044947","",1956
"estimated odds ratio","C0028873;C0750572","C0028873","",1078
"men n","C0025266",NULL,NULL,1842
"endpoint week $nmbr$","C0332174;C0439230;C2349179;C2826544",NULL,NULL,1012
"mean lixi dose sd lg day","C0023128;C0178602;C0332173;C0439228;C0439505;C0444504;C0694651;C0869039;C1114758;C2347634;C2348143;C2699239",NULL,NULL,1030
"table $nmbr$ selected baseline characteristics of the study patients","C0030705;C0039224;C0168634;C0557651;C1442488;C1568011;C1706074;C1707391;C2603343;C4684572",NULL,NULL,627
"female sex no race no f","C0016327;C0034510;C0086287;C1706779;C3853635",NULL,NULL,2014
"bb","C0004739;C0332297",NULL,NULL,714
"any coronary artery disease","C0010054;C0010068;C1956346","C0010068;C1956346",";C0026410;C1710701",226
"empty","C1880497",NULL,NULL,999
"no cardiovascular disorder $nmbr$","C0007222","C0007222","",1790
"table $nmbr$ characteristics of the patients at baseline","C0039224;C0168634;C0815172;C1442488;C1706074",NULL,NULL,1652
"other llt use","C0042153;C0457083;C1947944;C2347090",NULL,NULL,1265
"sdai $nmbr$ t","C3871128","C3871128","",1355
"creatinine $nmbr$ x baseline","C0010294;C0168634;C1442488;C1561535",NULL,NULL,625
"incidence rate no $nmbr$ person years","C0027361;C0439234;C1708485;C2347489","C0021149","",1998
"$nmbr$ per pl in $nmbr$ months before screening","C0220908;C0220909;C0439231;C1698960;C1710031;C1710032;C1710477;C2348164;C3897966;C4049765",NULL,NULL,798
"on with troublesome dyskinesia","C0013384","C0013384","",1131
"infarct related vessel","C0005847;C0021308;C0439849;C0445223",NULL,NULL,319
"tiotropium n $nmbr$ non tiotropium n $nmbr$ $nmbr$","C0213771;C1518422","C0213771","",1372
"mean no agents sd other medications","C0013227;C0444504;C0450442;C0802604;C1254351;C1521826;C2347634;C2348143;C2598133;C2699239;C4284232",NULL,NULL,366
"mineralocorticoid receptor antagonists","C1373021;C1579268",NULL,NULL,185
"before amendment","C0680532;C2346732",NULL,NULL,489
"patients with macroalbuminuria at baseline","C0030705;C0168634;C1442488","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"metoprolol n $nmbr$ $nmbr$","C0025859",NULL,NULL,679
"no total","C0439175;C0439810",NULL,NULL,508
"cardiovascular risk factors and history no","C0019664;C0019665;C0262512;C0262926;C0850624;C1705255;C2004062",NULL,NULL,651
"duration mean sd years","C0439234;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735",NULL,NULL,37
"mean change in radiographic end points","C0392747;C0443172;C0444504;C0444708;C1705241;C2347634;C2348143;C2349179;C4319952","C2349179","",1136
"leisure","C0086542",NULL,NULL,3
"leflunomide mean dose $nmbr$ $nmbr$ mg day","C0063041;C0178602;C0439422;C0444504;C0869039;C1114758;C2347634;C2348143",NULL,NULL,2319
"death n","C0011065;C1306577;C4082313;C4552775",NULL,NULL,1855
"group b","C4522078",NULL,NULL,1640
"baseline ecrcl","C0168634;C1442488",NULL,NULL,625
"retinopathy stage $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0035309;C0205390;C1300072;C1306673;C1962966",NULL,NULL,541
"australia","C0004340",NULL,NULL,54
"om $nmbr$ aml $nmbr$ hctz $nmbr$ mg","C0020261;C0023465;C0023467;C0024671;C0026410;C0028971;C0439269;C1705272;C1960952;C2346927;C4321396;C4521761",NULL,NULL,1149
"stratum i","C0021966;C0221138",NULL,NULL,1021
"neither pbo statin eze statin","C0031962;C0360714",NULL,NULL,435
"$nmbr$ $ $nmbr$ ml min","C0439445","C3811844;C0017654","",307
"leading to death","C0011065;C0332152;C1306577;C1522538;C4082313;C4552775",NULL,NULL,323
"fistula at baseline n","C0016169;C0168634;C1442488",NULL,NULL,1595
"major coronary event","C0205082;C0205164;C0741923;C4318856;C4521762","C1320716;C0205082","",2077
"serious adverse events","C1519255",";C1519255","",1851
"wafarin event incidence n","C0021149;C0220856;C0441471;C4019010","C0043031","",858
"tg mmol l","C0337445;C1532563","C0041004","",209
"microvascular complications n","C0009566;C0443258;C1171258","C0443258;C0009566","",1214
"fasting plasma insulin mu liter","C0015663;C0028971;C0347978;C0475211;C0857690;C3714918",NULL,NULL,157
"other anti platelet agents","C0005821;C0040616","","",1191
"placebo pts n","C0032042;C1419129;C1696465;C1706408;C2698747",NULL,NULL,1512
"semaglutide","C3885068",NULL,NULL,1567
"rheumatoid factor and acpa positive","C0035448;C0201660;C0439178;C1446409;C1514241;C1525410;C1706063;C2825490;C3812269",NULL,NULL,2059
"patients with $nmbr$ exacerbations resulting in ed visit","C0030705;C0332294;C0545082;C1512346;C2826704;C3538926;C4086268","C4086268","",889
"ranolazine n $nmbr$ $nmbr$","C0073633",NULL,NULL,71
"non elderly $nmbr$ years","C0001792;C0439234;C1518422;C1999167",NULL,NULL,1489
"mean sitting diastolic blood pressure","C0444504;C1319894;C2347634;C2348143",NULL,NULL,37
"id genotype","C0009450;C0017431;C0600091;C1441613",NULL,NULL,1255
"any glycoprotein iib iiia inhibitor use","C0016011;C0042153;C0457083;C1947944;C1999216",NULL,NULL,118
"renal impairment crcl $nmbr$ ml min","C0439445;C1565489;C1846718","C3811844;C0017654","",592
"atherosclerotic vascular disease n","C0004153","C0004153","",1698
"hazard ratio or difference $nmbr$ $nmbr$ cl p value","C0596019;C1705241;C1705242;C1709380;C2985465",NULL,NULL,658
"cdai mean sd","C0444504;C0683448;C1413248;C2347634;C2348143;C2699239;C3273706",NULL,NULL,697
"change to week $nmbr$","C0332174;C0392747;C0439230;C0443172;C1705241;C4319952",NULL,NULL,1012
"age year median","C0001779;C0439234;C0439508;C0549183;C0876920;C2347635;C2348144;C2939193","C0001779","",480
"timi $nmbr$ and spoke and time $nmbr$ h","C0033727;C0040223;C0369286;C0441932;C0564385;C3541383;C4528284",NULL,NULL,757
"renal","C0022646","C0022646","",1951
"positive for rheumatoid factor anti cyclic citrullinated peptide antibodies or both ff","C0003241;C0035448;C0201660;C0439178;C0439596;C0741132;C1320283;C1446409;C1511572;C1514241;C2825490;C3812269;C4505301;C4554348",NULL,NULL,2062
"fpg mg dl mmol l","C0439269;C1532563","C0015663;C0202042","",1960
"pm pef sd l min","C0030266;C0030771;C0702093;C1518922;C1524029;C1542834;C2699239;C3813700;C4049155",NULL,NULL,566
"dose mg","C0024671;C0026410;C0178602;C0439269;C0869039;C1114758;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"insulin glargine allocation","C0907402;C1706778","C0907402",";C1998602;C0004446;C0005126;C2344255;C4050145;C0229089;C0439164;C1512019;C3273373;C3665488",69
"ra","C3538806;C4048756",NULL,NULL,1755
"olmesartan medoxomil $nmbr$ mg hctz $nmbr$ $nmbr$ mg n $nmbr$","C0020261;C0386393;C1319635",NULL,NULL,1149
"budesonide","C0054201","C0054201","",1160
"revascularization history","C0019664;C0019665;C0262512;C0262926;C0581603;C1705255;C2004062",NULL,NULL,832
"body mass index kg m $nmbr$","C0005893;C0578022;C1305855;C1532718",";C1305855","",206
"previous labd alone","C0205156;C0205171;C0396059;C0439044;C0679994;C1552607","C0060657;C0073992","",1508
"body weight kg mean s d","C0005910;C0444504;C1275571;C1305866;C2347634;C2348143","C0005910","",1250
"cad and or crvd","C1504769;C2239547;C3813548;C4284121",NULL,NULL,698
"natalizumab n $nmbr$ f","C0016327;C1172734",NULL,NULL,1825
"claudication only","C0021775;C0205171;C0311395;C1456822;C1720467","C0021775","",263
"no active cancer","C0006826;C0205177;C0998265;C1306459;C3853793;C3888249","C0006826","",1819
"age $nmbr$ $nmbr$ years itt n $nmbr$","C1510829","C1510829","",481
"l eft anterior descending","C0205094;C0205386;C0439394;C0451214;C1547177;C1706495;C3642217","C0226032","",2098
"duration of diabetes years mean sd","C0011847;C0011849;C0439234;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735","C2926735;C0011849","",1988
"first primary composite outcome","C0205199;C0205225;C0205435;C0439612;C0439631;C1274040;C1279901;C1547335",NULL,NULL,2339
"white european","C0007457;C0043157;C0220938;C0239307;C1535514","C0239307","",504
"peak creatine kinase mb u l","C0010290;C0439339;C0444505;C0523584",NULL,NULL,460
"insulin use n","C0240016",NULL,NULL,122
"ind gly","C0017890;C0523677;C4049864","C3814772;C1722260","",1509
"m $nmbr$ s","C0439493;C1513009",NULL,NULL,1634
"antiplatelet drugs","C0085826;C2963157","","",1191
"any timi bleeding","C0019080",NULL,NULL,707
"overall $nmbr$","C0282416;C1561607",NULL,NULL,1743
"score on st george s respiratory questionnaire","C3472502",NULL,NULL,751
"diabetes duration years","C0011847;C0011849;C0439234;C0449238;C2926735","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"serum cholesterol mean sd mg dl","C0439269;C0444504;C0587184;C2347634;C2348143;C2699239",NULL,NULL,2303
"egfr $nmbr$ ml min $nmbr$ $nmbr$ m","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"neoplasia n","C0027651;C1882062",NULL,NULL,418
"baseline cardiovascular assessment","C0007226;C0168634;C0846600;C1442488;C3887460;C4684571",NULL,NULL,625
"time from fibrinolytic therapy to study drug administration no total no","C0013175;C0013216;C0040044;C0040223;C0040227;C0150270;C0206209;C0439175;C0439810;C0557651;C1611232;C2349982;C2603343;C3469597;C3541383;C3665478",NULL,NULL,1703
"acs type","C0332307;C0742343;C1547052;C4318612",NULL,NULL,603
"hypertrophy per ecg n $nmbr$ $nmbr$","C0020564;C1623258","C0149721","",1496
"post menopausal with hormone replacement","C0019930","C0019930","",281
"forearm fracture","C1305215","C0016536","",1211
"b pooled new and worsened vertebral fractures mfas","C0080179;C0205314;C1457868;C1549796;C1549980;C1709595;C2349200;C4084902;C4522255","C0080179","",1038
"hctz n $nmbr$","C0020261",NULL,NULL,1149
"chd simva $nmbr$ $nmbr$","C0280604;C3542407",NULL,NULL,970
"creatinine clearance category ml min","C0439445;C0683312;C0812399;C3889287","C0812399",";C3889287;C0452249;C0522467;C1337213;C1576800;C3890003;C0005910;C0022718;C1305866;C1705104;C1705224;C3887665",79
"systolic blood pressure change from baseline","C0392747;C0443172;C1705241;C4274438;C4319952","C0005823","",1469
"revascularization during index hospitalization","C0019993;C0581603;C0600653;C0918012;C1552854;C1637833;C2986546","C0581603","",1213
"alirocumab","C3491162",NULL,NULL,948
"bnp pg ml i","C0021966;C0023806;C0030827;C0054015;C0072225;C0221138;C0439297;C1095989;C1266240;C1417808;C2982014",NULL,NULL,1635
"pacemaker or icd","C0021122;C0030163;C0810633;C1546728;C3275122;C3853703","C0972395","",1360
"$nmbr$ $nmbr$ mmol liter apob apoa l ratio","C0003592;C0003593;C0456603;C0475211;C0523508;C1532563;C1547037;C3252643;C4553344;C4553379","C0003592","",427
"unfractionated heparin or enoxaparin plus glycoprotein iib iiia inhibitors n $nmbr$","C0016011;C0019134;C0206460;C0243077;C0332287;C2825026","C0206460","",862
"treatment glargine","C0039798;C0087111;C0907402;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,236
"neurocognitive disorders","C0029227;C4041080",NULL,NULL,1610
"drug therapy","C0013216;C0013217",NULL,NULL,554
"distance to ldl c goal","C0012751;C0018017;C1571704",NULL,NULL,1688
"male n z $nmbr$","C0086582;C1706180;C1706428;C1706429","C0086582","",1276
"baseline sitting dbp mm hg","C0168634;C0277814;C0439475;C0536221;C1442488;C2584297;C3813197;C4050224;C4281799",NULL,NULL,605
"body mass indexc","C0518010","C1305855","",1734
"treatment group on treatment il $nmbr$ threshold","C0020898;C0021764;C0022271;C0039798;C0087111;C0441833;C0449864;C0687744;C1257890;C1519504;C1522326;C1533734;C1705169;C1705428;C1705429;C3538994;C3887704",NULL,NULL,1526
"nyha class when patient was last in stable condition","C0030705;C0677946;C1517741;C1882083;C3538874",NULL,NULL,1035
"bmi $nmbr$ kg m $nmbr$","C0578022;C1532718",NULL,NULL,1735
"previous pde $nmbr$ inhibitors","C0031638;C0205156;C1552607",NULL,NULL,1044
"dates of recruitment","C0011008;C2348077;C2949735",NULL,NULL,1863
"$nmbr$ years vs $nmbr$ years","C0439234",NULL,NULL,1099
"russia","C0035970","C0035970;C0017452","",123
"cluster $nmbr$ not reversible no diuretic n $nmbr$","C0012798;C0205343;C1518422;C1555715;C1704332",NULL,NULL,733
"indication for index procedure","C0600653;C0918012;C1552854;C1637833;C2315323;C2986546",NULL,NULL,734
"positive troponin i or t no","C0077401;C0439178;C1446409;C1514241;C2603360;C2825490;C3812269",NULL,NULL,1163
"corticosteroid use at baseline","C0168634;C0239126;C1442488","C0239126",";C0168634;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1425988;C1947944",120
"caucasian n $nmbr$ $nmbr$","C0007457;C0043157","C0043157","",1329
"no aspirin","C0004057","C0004057","",1366
"diabetes n $nmbr$","C0011847;C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"das $nmbr$ mean sd","C0051767;C0057671;C0444504;C2347634;C2348143;C2699239",NULL,NULL,1914
"no cv event n $nmbr$ $nmbr$","C0441471;C3538987;C4019010;C4048877;C4318503",NULL,NULL,1777
"overall a phase population","C0032659;C0205390;C0282416;C1257890;C1561607;C1710475",NULL,NULL,1743
"psoriasis covering $nmbr$ bsa n","C0033860;C0180153;C0439844","C0033860","",1358
"prior ms treatment with ifn beta or","C0015980;C1514463;C2349943;C3539704;C3713294",NULL,NULL,574
"ctn l ng ml","C0439275;C0917591",NULL,NULL,204
"$nmbr$ ml niin l $nmbr$ ni","C0028075;C1635169;C2348274;C3869926;C3869927",NULL,NULL,153
"systolic blood pressure mmhg","C0439475;C0488055;C0871470;C1306620","C0005823","",1469
"acuity bleeding major minor","C0019080;C0750509;C4441842",NULL,NULL,1474
"vldl c","C0523560","C0023824;C0023826","",1066
"hba $nmbr$ c baseline mean hba $nmbr$ c sd","C0019016;C0168634;C0444504;C1442488;C1825777;C2347634;C2348143;C2699239;C3538758","","",820
"systemic glucocorticoid use at randomization n","C0017710;C0034656;C0042153;C0205373;C0457083;C1947944","C0017710","",1348
"$nmbr$ st $nmbr$ $nmbr$","C0036056;C3272372",NULL,NULL,246
"st elevation myocardial infarction","C1536220;C3538872",NULL,NULL,570
"lta max response to $nmbr$ pm adp defined hpr patients","C0030266;C0030705;C0523452;C1337105;C1704788;C2611142;C3539106;C4049155",NULL,NULL,1200
"arb at enrollment","C1516879;C1696073;C3888021;C3888198",NULL,NULL,44
"rivaroxaban alone n $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0205171;C0439044;C0679994;C1739768",NULL,NULL,926
"any adverse event ae","C0877248;C3887670","C0877248","",47
"ldl c in mmol l baseline mean sd n wk $nmbr$ and change mean se n","C0036919;C0168634;C0332174;C0392747;C0439230;C0443172;C0444504;C1442488;C1532563;C1705241;C2347634;C2348143;C2699239;C4319952",NULL,NULL,625
"chronic renal insufficiency","C0403447;C1561643","C1561643","",967
"mean fvc sd","C0444504;C2347634;C2348143;C2699239;C3714541",NULL,NULL,1599
"history of macrovascular disease","C0683519;C0730226;C0850708;C0944983","C0004153","",1698
"persistent anemia bsl hb $nmbr$ g i $nmbr$ yr $nmbr$ $nmbr$ g i $nmbr$","C0019046;C0021966;C0221138;C0439234;C0741008;C1319635;C1549954",NULL,NULL,1099
"parameters at baseline","C0168634;C0449381;C1442488",NULL,NULL,1187
"fibrinolytic agents before or after entry","C0016018;C1705654",NULL,NULL,1619
"medication in use at the baseline","C0013227;C0042153;C0150312;C0168634;C0332285;C0457083;C1442488;C1707101;C1947944;C3244316;C4284232",NULL,NULL,625
"randomized patients","C0030705;C0034656;C3815594",NULL,NULL,692
"carotid infarct","C0021308;C0741968","C0007272","",1547
"egfr crcl $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C1739039;C1846718;C3811844;C3812682","C3811844;C0017654","",592
"bsl hb gl $nmbr$","C0018229;C0019046;C1423073;C1427674;C1549954",NULL,NULL,1804
"metformin open label","C0025598;C1709323","C0025598","",1345
"eligibility risk factors t ascvo","C0013893;C0035648;C1548635;C1553898","C0013893;C0035648","",1317
"saxagliptin $nmbr$ $nmbr$ mg n $nmbr$ $nmbr$","C0024671;C0026410;C0439269;C1611934;C1960952;C2346927;C4321396;C4521761","C1611934","",2069
"visit $nmbr$ ldl cholesterol strata","C0023824;C0202117;C0545082;C1512346;C2826704","C0023824","",1068
"charlson comorbidity index","C4546361",NULL,NULL,766
"functional outcome mrs $nmbr$ $nmbr$","C0205245;C0542341;C1274040;C1522706;C2349188;C2700217;C3714939;C3854213",NULL,NULL,1531
"prior bisphosphonate usage","C0012544;C0332152;C0457083;C2267018;C2826257",NULL,NULL,294
"asian or pacific islander","C0078988;C0242191",NULL,NULL,1609
"high sensitivity c reactive protein mg l","C0006560;C0439268;C1413716;C1441604;C4048285","C0006560","",286
"native hawaiian other","C0337920","C0337920;C0242191","",1331
"concomitant cardiovascular therapies no","C0007226;C0521115;C0587038;C1707479;C3887460",NULL,NULL,648
"years since last gout flare","C0018099;C0439234;C1517205;C1517741;C3540542","C0018099;C1517741;C1517205","",1268
"intended durat sm of antccagubficn","C0036154;C1283828;C1551357;C4553627",NULL,NULL,587
"non east asianf","C1518422;C1707877","C0078988","",1369
"radiographic characteristics at baseline and randomization","C0034656;C0444708;C4684572",NULL,NULL,692
"family history of premature heart disease","C0018787;C0151526;C0205252;C0850707;C4018905",NULL,NULL,1481
"hba $nmbr$ c change from baseline","C0019016;C0168634;C0392747;C0443172;C1442488;C1705241;C1825777;C3538758;C4319952","","",820
"rs $nmbr$ rs $nmbr$","C0035970;C3714753;C3813325","","",-10
"systolic blood pressure mm hg $nmbr$","C0439475;C0488055;C0871470;C1306620","C0005823","",1469
"anti dsdna $nmbr$ iu ml","C0439458;C0741099",NULL,NULL,301
"bmi categories n","C0578022;C0683312",NULL,NULL,1735
"ses cd mean sd","C0007928;C0034283;C0444504;C2347634;C2348143;C2699239;C4552032",NULL,NULL,37
"bmi $nmbr$ kg m $nmbr$","C0578022;C1532718",";C1305855","",206
"prior disease modifying drugs resulting in inadequate response mean no patient","C0012634;C0013227;C0030705;C0205412;C0332152;C0332294;C0392747;C0439856;C0444504;C0871261;C1704632;C1706817;C2347634;C2348143;C2826257;C2911692;C3687832",NULL,NULL,2120
"hr with edoxaban $nmbr$ ci","C0008107;C2975435;C3259781","C2975435","",1220
"baseline concomitant therapies","C0168634;C1442488;C1707479",NULL,NULL,446
"dabigatran group","C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C2348066",NULL,NULL,1526
"glycohemoglobin mean sd","C0202054;C0444504;C0696092;C2347634;C2348143;C2699239","","",1176
"no cases","C0868928;C1533148",NULL,NULL,114
"bmi median iqr kg m $nmbr$","C0549183;C0578022;C0876920;C1532718;C2347635;C2348144;C2939193",NULL,NULL,1735
"number of pack years","C0237753;C0449788;C1277691","C1277691","",1297
"urine albumin to creatinine ratio","C0455271;C1318330","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"etanercept n $nmbr$","C0717758",NULL,NULL,1587
"serum biochemistry potassium mmol l","C0005477;C0302353;C0543465;C1532563","C0032821","",1371
"miami k antagonist received","C0231491;C0597277;C1514756;C1551421;C1708601",NULL,NULL,184
"rest ofworld","C0035253;C1622890","C2700280","",247
"previous mi and t $nmbr$ dm","C0011816;C0205156;C1552607;C2603360;C3250443;C3810814",NULL,NULL,955
"acute stent thrombosis definite or probable","C0033204;C0205178;C0332148;C0439544;C1704787;C3897493",NULL,NULL,622
"logistic regression","C0206031",NULL,NULL,1563
"csf a $nmbr$ pm","C0030266;C3540512;C3889436;C4049155",NULL,NULL,954
"risk factors","C0035648;C1553898",NULL,NULL,175
"first procedure","C0184661;C0205435;C1279901;C2700391;C3274430;C3539779",NULL,NULL,290
"trigl yeerides m mol l","C0027960;C0324740;C0347982;C0369637;C0439189;C0441923;C0456616;C1456781;C1824986;C3665593",NULL,NULL,667
"ptca $nmbr$ h","C0033727;C0369286;C0441932;C0564385;C2936173;C4528284",NULL,NULL,308
"fibrinolytic","C0040044",NULL,NULL,1703
"alcohol intake a","C0001948","C0001948","",875
"stroke ortia","C0038454;C4554100",NULL,NULL,1762
"potassium meql mean sd available for $nmbr$ patients","C0030705;C0032821;C0202194;C0304475;C0444504;C0470187;C0597277;C2347634;C2348143;C2699239;C3714637","C0032821","",1371
"median q $nmbr$ q $nmbr$ total daily insulin dose $nmbr$","C0021641;C0549183;C0876920;C1533581;C1579433;C2347635;C2348070;C2348144;C2939193;C3714501",NULL,NULL,635
"mean postbronchodilatora fev $nmbr$ predicted sd","C0444504;C0681842;C1882327;C2347634;C2348143;C2699239;C3714541",NULL,NULL,1599
"microalbuminuria uacr $nmbr$ $nmbr$","C0730345","C0033687","",376
"n $nmbr$ pufa events patients","C0030705;C0032615;C0369718;C0441471;C0441922;C3541888",NULL,NULL,1553
"haemorrhagic stroke","C0553692",NULL,NULL,581
"event number","C0237753;C0441471;C0449788;C4019010",NULL,NULL,412
"mean slicc damage index score sd","C0010957;C0600653;C0918012;C1552854;C1637833;C1883709;C2699239;C2986546;C3533236",NULL,NULL,734
"left ventricular hypertrophy on echo","C0058928;C0149721;C1655045;C3484363","C0149721","",1496
"high eosinophil subgroup $nmbr$ ml n $nmbr$","C0014457;C0439526;C1079230;C1515021;C1705224;C3887665",NULL,NULL,300
"total stent length mm","C0038257;C0439175;C0439810;C1444754;C1706316;C4330985;C4554674","C0038257;C1444754","",1748
"total hip bmd g cm $nmbr$","C0019552;C0022122;C0439175;C0439267;C0439810;C1505163;C3538851;C4284725",NULL,NULL,508
"nondiabetic participants","C0679646",NULL,NULL,449
"chronic heart failure","C0018802;C0264716","C0018801",";C0168634;C1524003",12
"co morbidities","C0009488",NULL,NULL,765
"primary management strategy","C0001554;C0205225;C0376636;C0439612;C0439631;C0679199;C1273870;C3273539",NULL,NULL,488
"warfarin at last follow up","C0043031;C0589120;C1522577;C1704685;C3274571","C0043031","",858
"prior treatment history $nmbr$","C0019664;C0019665;C0262512;C0262926;C1514463;C1705255;C2004062",NULL,NULL,832
"anti ccp antibody positive","C0741132;C4318437","C4318437","",360
"secukinumab pooled n $nmbr$","C1709595;C2349200;C3179547;C4522255",NULL,NULL,2333
"femoral neck bmd t score","C0015815;C0449820;C4050231",NULL,NULL,748
"non study ppi use","C0042153;C0358591;C0457083;C0557651;C0871125;C1518422;C1947944;C2603343;C3811894",NULL,NULL,1738
"overall n $nmbr$ $nmbr$","C0282416;C1561607",NULL,NULL,1743
"apixaban $nmbr$ $nmbr$ mg bid","C0024671;C0026410;C0439269;C1831808;C1960952;C2346927;C4321396;C4521761","C1831808","",1224
"cardiac disease","C0018799","C0018799","",1278
"iii or iv","C0022326;C0439070;C1705160;C4265176",NULL,NULL,1257
"ms mean sd","C0444504;C2347634;C2348143;C2349943;C2699239;C3539704;C3713294",NULL,NULL,126
"baseline ifg fpg $nmbr$ $nmbr$ $nmbr$ $nmbr$ mmol l n","C0168634;C1334085;C1442488;C1532563;C1708411",NULL,NULL,1259
"cardioembolic infarction n","C0021308",NULL,NULL,647
"pi","C0122626;C0429863;C3537219;C3539772",NULL,NULL,1738
"esrd or $nmbr$ decline in gfr","C0017654;C0022661;C0035078;C1424601;C2316810","C0035078",";C1424601",1828
"prior angiography showing stenosis $nmbr$ n $nmbr$ $nmbr$ a","C0002978;C0332152;C0678234;C1261287;C1547282;C2632116;C2826257",NULL,NULL,1651
"diuretic any","C0012798",NULL,NULL,992
"cardiac disorder","C0018799","C0018799","",1278
"median $nmbr$","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"gusto moderate bleeding ich","C0019080;C0019191;C0205081;C1881878;C3272597;C3281105;C4049705;C4049706;C4085643;C4321335",NULL,NULL,1363
"history of vte","C0019664;C0019665;C0262512;C0262926;C0630906;C1705255;C2004062",NULL,NULL,832
"cells per pl t","C0007584;C0007634;C3897966;C4049765","C0014467;C0007584","",1806
"lvh by ecg echo","C0058928;C0232306;C1655045","C0232306","",406
"yes insulin treated","C0021641;C1522326;C1533581;C1549445;C1579433;C1705108;C1710701;C3714501",NULL,NULL,157
"all women","C0043210","C0043210",";C3541888;C1720467",1323
"parameters","C0449381",NULL,NULL,1187
"no prior heart failure","C0018801;C0018802;C0332152;C2826257;C4554158","C0018801",";C0168634;C1524003",12
"median duration of study drug administration iqr days","C0013175;C0439228;C0549183;C0876920;C2347635;C2348144;C2348354;C2939193",NULL,NULL,1621
"formal education years","C0439234;C0681344",NULL,NULL,1099
"aspirin or other antiplatelet drug","C0004057;C0085826","","",1191
"p $nmbr$ z $nmbr$ n $nmbr$","C0369773;C2603361",NULL,NULL,1823
"microalbuminuria mg g cr","C0201975;C0730345;C1300563;C3539604;C3711669;C4084730;C4553336;C4553337",NULL,NULL,2315
"high periostin subgroup $nmbr$ ng ml n $nmbr$","C0205250;C0219433;C0439275;C1079230;C1299351;C1424662;C1515021;C2700149;C3812270;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"pbo czp $nmbr$ mg q $nmbr$ w week $nmbr$ n $nmbr$","C0024671;C0026410;C0031962;C0054841;C0332174;C0439230;C0439269;C1861828;C1872109;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"primary prevention cohort","C0009247;C0033144;C0599755","C0033144;C0599755","",2209
"womac score","C0449820;C4050231",NULL,NULL,748
"ibdq score mean sd","C0444504;C0449820;C2347634;C2348143;C2699239;C4050231",NULL,NULL,748
"prior use of osteoporosis medications","C0013227;C0029456;C0332152;C0802604;C1524063;C2598133;C2826257;C4284232;C4554622",NULL,NULL,2264
"p blocker before admission","C0184666;C0369773;C0809949;C2603361",NULL,NULL,1823
"dm","C0011816;C3250443",NULL,NULL,955
"mayo $nmbr$ n","C0454788;C1077578",NULL,NULL,425
"omega $nmbr$ fatty acid","C0015684;C1719844","C0015684","",1236
"unfractionated heparin no","C0019134;C2825026","C0019134","",864
"glucose lowering medications","C0013227;C0017725;C0441994;C0802604;C2003888;C2598133;C4284232","C0020616",";C0013227;C3244316;C4284232;C0450442;C1254351;C1515187;C1521826;C2826257",33
"smoking current smoker","C0037369;C0453996;C1881674;C3173209;C3241966","C3241966","",1420
"south n","C1710133",NULL,NULL,1559
"change in femoral neck bmd from fit baseline to flex baseline","C0015815;C0036572;C0168634;C0392747;C0443172;C1442488;C1705241;C2349186;C4048158;C4319952;C4553125",NULL,NULL,625
"ticagrelor in hosp n $nmbr$","C1999375","C1999375;C1510665","",1246
"on without troublesome dyskinesia","C0013384","C0013384","",1131
"renal insufficiency no","C0035078;C1565489","C1565489","",937
"parental history of mii","C0019664;C0019665;C0030551;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"other diagnostic procedure","C0430022;C1546908",";C0430022","",2240
"ex current smoker","C0337671;C0521116;C1704625;C1705970;C3173209;C3241966;C4555205","C3241966","",1420
"haemoglobin g dl mean sd available for $nmbr$ patients","C0019046;C0030705;C0439267;C0444504;C0470187;C1319312;C2347634;C2348143;C2699239;C3642216",NULL,NULL,37
"no previous dmard therapy","C0039798;C0087111;C0205156;C0242708;C1363945;C1552607",NULL,NULL,1044
"ticagrelor $nmbr$ mg $nmbr$ yr km","C0024671;C0026410;C0439234;C0439269;C1960952;C1999375;C2346927;C3887676;C4321396;C4521761",NULL,NULL,1099
"gissi prevention $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0199176;C1706420;C2700409",NULL,NULL,1715
"not available","C0686905",NULL,NULL,92
"on pump time l $nmbr$ hrs min n $nmbr$","C0040223;C0702093;C1524029;C1568891;C3541383;C3813700;C3842462",NULL,NULL,1475
"currently","C0521116",NULL,NULL,1417
"diabetic no","C0241863",NULL,NULL,996
"difference vs ff $nmbr$ pg $nmbr$ ci","C0008107;C0030827;C0072225;C1266240;C1705241;C1705242;C3259781;C4554348",NULL,NULL,208
"$nmbr$ $nmbr$ mo n","C0026544;C0332177",NULL,NULL,1476
"vildagliptin $nmbr$ mg daily","C0024671;C0026410;C0332173;C0439269;C1570906;C1960952;C2346927;C4321396;C4521761","C1570906","",2068
"non european","C0239307;C1518422;C1535514","C0239307","",504
"fev $nmbr$ pre bronchodilator predicted normal mean sd c d","C0012358;C0205307;C0231683;C0439166;C0444504;C0681842;C1882327;C2347086;C2347634;C2348143;C2599602;C2699239;C3714541;C4553972",NULL,NULL,682
"nonsmoker n","C0337672;C0425293;C4554605","C0037369","",420
"aspirin clopidogrel n $nmbr$ $nmbr$ $nmbr$","C0004057;C0070166","C0070166",";C0369286;C0033727;C4049621",217
"australia new zealand south africa","C0037712;C4289954",NULL,NULL,55
"partial evolving to secondarily generalized ic","C0020750;C0205246;C0332253;C0728938;C1550516;C4554818",NULL,NULL,1593
"visit $nmbr$ blood pressures","C0545082;C1272641;C1512346;C2826704","C0005823","",15
"inflix no","C0666743","C0666743","",154
"qrs duration ms","C0429025;C0488377;C2349943;C3539704;C3713294",NULL,NULL,126
"varespladib","C2713485","C2713485","",1449
"nocturia episodes $nmbr$ h","C0028734;C0033727;C0332189;C0369286;C0441932;C0564385;C4528284",NULL,NULL,308
"csf $nmbr$ s hydroxy","C0700307;C3540512;C3889436",NULL,NULL,1497
"no of events total no $nmbr$","C0439175;C0439810;C0441471;C3541888",NULL,NULL,1059
"a ngina $nmbr$ day s previously","C0332173;C0439228;C0439505",NULL,NULL,1621
"and physical examination","C0031809;C1744699",NULL,NULL,1519
"rs totala","C0035970;C3714753;C3813325","","",-10
"empagliflozin $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C3490348;C4321396;C4521761","C3490348","",1182
"mean age years sd","C0444504;C1510829;C2347634;C2348143;C2699239","C1510829","",481
"ldl c calculated mg dl mean sd","C0439269;C0444504;C0444686;C1441506;C2347634;C2348143;C2699239","C0023824","",1963
"medical history of cv disease or heart failure n","C0007222;C0018801;C0018802;C0262926;C4554158","C0018801",";C0168634;C1524003",12
"systemic corticosteroids no","C4053960",NULL,NULL,1649
"ckd stage $nmbr$","C0205390;C1300072;C1306673;C1561643",NULL,NULL,541
"mg day","C0439422","","",198
"high density lipoprotein cholesterol median $nmbr$ th $nmbr$ th percentiles mg dl","C0023822;C0039725;C0039738;C0439269;C0549183;C0876920;C1264641;C1420718;C2347635;C2348144;C2939193;C4282123;C4285344","C0023822","",821
"ra duration months","C0439231;C0449238;C2926735;C3538806;C4048756",NULL,NULL,901
"rituximab $nmbr$ x $nmbr$ mg mtx n $nmbr$","C0024671;C0025677;C0026410;C0393022;C0439269;C1417487;C1960952;C2346927;C4321396;C4521761",NULL,NULL,946
"high density lipoprotein cholesterol mean mg dl sd","C0023822;C0439269;C0444504;C2347634;C2348143;C2699239","C0023822","",821
"gastrointestinal area involved n total n","C0017446;C0205146;C0369718;C0439175;C0439810;C0441922;C0521362;C1314939",NULL,NULL,312
"$nmbr$ $nmbr$ ng ml n $nmbr$","C0439275",NULL,NULL,204
"hbaie mean sd","C0444504;C2347634;C2348143;C2699239","","",820
"glargine allocation","C0907402;C1706778","C0907402",";C1998602;C0004446;C0005126;C2344255;C4050145;C0229089;C0439164;C1512019;C3273373;C3665488",69
"age years $nmbr$","C1510829","C1510829","",481
"overall population n $nmbr$ $nmbr$ non cana n $nmbr$ cana $nmbr$ mg n $nmbr$ cana $nmbr$ mg n $nmbr$","C0032659;C0282416;C1257890;C1319635;C1418845;C1518422;C1561607",NULL,NULL,1302
"mtss at baseline observed case","C0168634;C0868928;C1441672;C1442488;C1706255;C1706256",NULL,NULL,114
"plasma lipoproteins mmol l","C0023820;C0032105;C1532563;C1550098;C4521445","C0023820","",1221
"new om","C0028971;C0205314;C1705272",NULL,NULL,957
"previous ischemic stroke n","C0205156;C0948008;C1552607",NULL,NULL,1669
"persistent faol n $nmbr$","C0205322;C0332996",NULL,NULL,719
"b age subgroups","C0001779;C1304659","C0001779","",480
"bl bm $nmbr$ $nmbr$ kg m","C0005918;C0006413;C0006416;C1532718;C1552663;C2827109",";C1305855","",206
"waist circumference","C0455829","C0455829","",1413
"age at disease onset years","C0012634;C0206132;C0439234;C3870509",NULL,NULL,736
"median $nmbr$ number n","C0237753;C0449788;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"placebo $nmbr$ yr km","C0032042;C0439234;C1696465;C1706408;C3887676","C0032042","",28
"$nmbr$ $nmbr$ $nmbr$ $nmbr$ ti","C0039247;C0040302;C1553045;C1704756",NULL,NULL,1430
"la diameter","C0023031;C0023749;C0230347;C1301886;C2346906;C4553351",NULL,NULL,1269
"or $nmbr$ cl","C0596019",NULL,NULL,658
"prednisone or equivalent dose mg day","C0032952;C0178602;C0205163;C0439185;C0439422;C0869039;C1114758",NULL,NULL,110
"previous af","C0205156;C0344434;C1552607;C4049859",NULL,NULL,1794
"smoking pack year years","C0037369;C0439234;C0439508;C0453996;C1277691;C1881674","C0037369","",420
"severity of copd gold $nmbr$","C0018026;C0024117;C0439793;C0522510;C1304897;C1412502;C3714496",NULL,NULL,1546
"evolocumab n $nmbr$","C3529352",NULL,NULL,948
"h","C0033727;C0369286;C0441932;C0564385;C4528284",NULL,NULL,308
"cana $nmbr$ mg n $nmbr$ $nmbr$","C0024671;C0026410;C0439269;C1418845;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"other steroids","C0038317",NULL,NULL,1648
"$nmbr$ mg $nmbr$ wk n $nmbr$","C1881833",NULL,NULL,194
"azl m $nmbr$ mg cld $nmbr$ mg","C0369637;C0441923;C1319635",NULL,NULL,923
"exacerbation historyh n","C4086268","C4086268","",889
"previous stroke or tia","C0007787;C0038454;C0205156;C0917805;C1054154;C1552607;C4554100",NULL,NULL,1592
"duration of diabetes mellitus median iqr y","C0011849;C0449238;C0549183;C0876920;C2347635;C2348144;C2926735;C2939193","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"exacerbation in previous year","C0205156;C0439234;C0439508;C1552607;C4086268","C4086268","",1991
"b blockers at baseline","C0168634;C1442488",NULL,NULL,1152
"tk","C0041405;C0220928;C4050092",NULL,NULL,1434
"n $nmbr$ pufa n $nmbr$","C0032615;C0369718;C0441922",NULL,NULL,1553
"or $nmbr$ $nmbr$ $nmbr$ cl $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0596019",NULL,NULL,658
"p val $nmbr$","C0042285;C0369773;C0523975;C2603361",NULL,NULL,1872
"previous ami n","C0205156;C1552607;C4319936",NULL,NULL,1044
"psoriasis bsa $nmbr$ n","C0033860","C0005902;C0033860","",2177
"ppg mmol l","C1418888;C1532563",NULL,NULL,671
"selexipag patients events n","C0030705;C0441471;C2000145;C3541888",NULL,NULL,799
"nyha class iii iv","C0278962","C0018802;C1882083","",453
"medical therapy","C0418981",NULL,NULL,640
"t $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ ng ml","C0439275;C2603360",NULL,NULL,204
"alt or ast $nmbr$ x uln $nmbr$","C1266129;C1415181;C1519815;C3891303;C4553172",NULL,NULL,1676
"hospitalization for heart failure within previous $nmbr$ mo no","C0026544;C0205156;C0332177;C1552607;C3898876",NULL,NULL,824
"left circumflex artery","C0226037","C0226037","",1414
"angiotensin receptor blocker and or ace","C0034787;C1452534;C1622222;C4284014",NULL,NULL,963
"mean wall thickness cm","C0677535;C4054557",NULL,NULL,703
"esr mm h mean sd","C0444504;C0456680;C2347634;C2348143;C2699239;C3811131","C1619634","",298
"aborted cardiac arrest","C0018790;C1550015;C1609614;C4085625;C4318470;C4553105",NULL,NULL,643
"migraine occurrence days month","C0149931;C0243132;C0556971;C1554210;C2745955",NULL,NULL,684
"odds ratio versus placebo $nmbr$ ci","C0008107;C0028873;C0032042;C1696465;C1706408;C3259781",NULL,NULL,519
"age median $nmbr$ th $nmbr$ th percentiles y","C0001779;C0039725;C0039738;C0549183;C0876920;C1264641;C1420718;C2347635;C2348144;C2939193;C4282123;C4285344","C0001779","",2234
"diagnosed y","C0011900",NULL,NULL,841
"non cardiovascular mortality","C0007226;C0026565;C0026566;C1518422;C3887460","C0026565","",1312
"sertraline","C0074393;C0524265",NULL,NULL,594
"exacerbation within previous $nmbr$ mo no","C0026544;C0205156;C0332177;C1552607;C4086268",NULL,NULL,1476
"upper limbs","C1140618",NULL,NULL,1554
"xi $nmbr$ $nmbr$","C1720296",NULL,NULL,520
"number of patients or mean sd","C0444504;C2347634;C2348143;C2360800;C2699239",NULL,NULL,1811
"doubling of baseline serum creatinine or esrd rr ci","C0008107;C0022661;C0035078;C0168634;C0201976;C0205173;C0600061;C1442488;C1705764;C2316810;C3259781;C4554402",NULL,NULL,1544
"antiplatelet use","C0042153;C0457083;C1947944","","",1191
"past smoker","C0337664;C1444637;C4284302","C0037369","",420
"education no","C0013621;C0013622;C0013658;C0039401","C0013658","",902
"tg median sdy rng cjl","C0337445;C0549183;C0876920;C1424906;C2347635;C2348144;C2939193",NULL,NULL,635
"cv death mi stroke recurrent ischemia","C0011065;C0022116;C0038454;C1306577;C1455761;C2945760;C3538987;C3810814;C4048877;C4082313;C4318503;C4321499;C4552775;C4554100",NULL,NULL,323
"disease duration b $nmbr$ years n $nmbr$","C0439234;C0872146","C0449238;C0872146","",903
"diastolic treated at baseline","C0012000;C0168634;C1442488;C1522326","C0012000","",844
"left ventricular hypertrophy","C0149721;C3484363","C0149721","",1496
"p value for interaction $nmbr$ $nmbr$","C1704675;C1709380",NULL,NULL,7
"angiotensin converting enzyme inhibitor or angiotensin receptor blocker","C0003015;C0034787;C1622222;C2757044;C3536837;C4541021",NULL,NULL,963
"consistency of effect","C0332529;C1280500;C1518681;C1547017;C2348382",NULL,NULL,402
"bosentan n $nmbr$","C0252643","C0252643","",1328
"stroke or systemic","C0038454;C0205373;C4554100",NULL,NULL,1762
"hf total","C0018488;C0439175;C0439810;C1313497;C1538440;C3273279","C0018801",";C0168634;C1524003",12
"baseline egfr","C0168634;C1442488;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"overall analysis","C0002778;C0282416;C0936012;C1524024;C1561607",NULL,NULL,183
"mtx n $nmbr$","C0025677;C1417487","C0025677","",1408
"hospitalization n","C0019993",NULL,NULL,2358
"triglyceride","C0041004","C0041004","",368
"moderate dysfunction","C3274776",NULL,NULL,1535
"not present at screening but within previous year","C0150312;C0205156;C0220908;C0220909;C0439234;C0439508;C0449450;C1518422;C1552607;C1698960;C1710031;C1710032;C1710477;C2348164",NULL,NULL,287
"mean copd duration y sd","C0024117;C0444504;C0449238;C1412502;C2347634;C2348143;C2699239;C2926735;C3714496",NULL,NULL,1726
"panel b","C0441833;C1706365;C1999270",NULL,NULL,1527
"baseline ecrcl $nmbr$ $nmbr$ ml min","C0168634;C0439445;C1442488",NULL,NULL,625
"nyha chf class","C0018802;C1882083","C0018802;C1882083","",453
"hospitalization for unstable angina","C0002965;C0019993",NULL,NULL,1002
"baseline sbp mean sd mm hg","C0085805;C0168634;C0439475;C0444504;C1442488;C2347634;C2348143;C2699239",NULL,NULL,607
"percutaneous intervention","C0184661;C0522523;C0886296;C1273869","C1532338","",1661
"body weight kg sd","C0005910;C0022718;C0439209;C1305866;C2699239;C4054209",NULL,NULL,2326
"current or prior smoking","C0037369;C0332152;C0453996;C0521116;C1705970;C1881674;C2826257","C0037369;C0521116","",2224
"previous medications n","C0013227;C0205156;C0802604;C1552607;C2598133;C4284232",NULL,NULL,366
"age years mean sd","C0444504;C1510829;C2347634;C2348143;C2699239","C1510829","",481
"ethnic origin white","C0007457;C0015031;C0043157;C0220938",NULL,NULL,787
"prior ml","C0332152;C0439526;C1705224;C2826257;C3887665",NULL,NULL,300
"sf $nmbr$ v $nmbr$ mcs mean sd","C0037712;C0444504;C2347634;C2348143;C2699239",NULL,NULL,1782
"after amendment","C0680532;C2346732",NULL,NULL,489
"bsa affected","C0392760;C1314939",NULL,NULL,311
"previous cabg surgery","C0010055;C0038894;C0038895;C0205156;C0543467;C1274039;C1552607","C0010055","",389
"insulin type n","C0457592",NULL,NULL,162
"esrd on losartan","C0022661;C0035078;C0126174;C2316810","C0035078","",342
"apoal mg dl","C0439269",NULL,NULL,2269
"clavicle fracture","C0159658",NULL,NULL,2024
"women n","C0043210","C0043210",";C3541888;C1720467",1323
"edoxaban n $nmbr$ n n","C2975435","C2975435","",1220
"sex","C0009253;C0036864;C0079399;C0804628;C1314687;C1522384",NULL,NULL,568
"waist circumference women $nmbr$ in $nmbr$ cm men $nmbr$ in $nmbr$ cm tc $nmbr$ c $nmbr$ mg dl","C0025266;C0039411;C0040642;C0041405;C0041698;C0043210;C0439269;C0455829;C1824670;C3272447;C4522122","C0455829","",1413
"atopic at baseline yes","C0168634;C0392707;C1442488;C1549445;C1705108;C1710701","C0392707","",1412
"men with ed n $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0025266;C3538926",NULL,NULL,1842
"catheterization laboratory in","C0007430;C0022877;C3244292;C4283904",NULL,NULL,978
"estimated glomerular filtration rate ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C3811844",NULL,NULL,923
"glipizide","C0017642",NULL,NULL,2046
"acr mg g mean sd","C0444504;C1300563;C1412134;C1515941;C2347634;C2348143;C2699239",NULL,NULL,2315
"tpm naive","C0076829",NULL,NULL,755
"chd men","C0025266;C0280604;C3542407",NULL,NULL,1842
"ldl c median","C0549183;C0876920;C2347635;C2348144;C2939193","C0023824","",1068
"planned thienopyridine at baseline","C0168634;C1120149;C1301732;C1442488",NULL,NULL,625
"event patients $nmbr$ pt y","C0030705;C0032743;C0441471;C0699718;C4019010",NULL,NULL,1513
"first year","C0205435;C0439234;C0439508;C1279901",NULL,NULL,1099
"rest ofthe world","C0035253;C1622890;C2700280","C2700280","",247
"placebo controlled period","C0439531;C1706408;C1948053",NULL,NULL,575
"u s non black patients","C0005680;C0027567;C0041703;C0085756;C0439541;C1829939","C0005680",";C1706779",188
"teaes leading to discontinuation of study drug","C0013175;C0332152;C0457454;C1444662;C1522538;C4552847",NULL,NULL,1731
"insulinogenic index dinsulino_ $nmbr$ o min dglucoseo $nmbr$ o min","C0600653;C0702093;C0918012;C1524029;C1552854;C1637833;C2986546;C3813700",NULL,NULL,734
"treatment groups n","C0039798;C0087111;C0441848;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,236
"elevated at wk $nmbr$ no","C0205250;C0332174;C0439230;C3163633",NULL,NULL,415
"cigarette smoking n","C0239059;C0700219",NULL,NULL,797
"mean change from baseline in the number of","C0168634;C0237753;C0392747;C0443172;C0444504;C0449788;C1442488;C1705241;C2347634;C2348143;C4319952",NULL,NULL,767
"rec ischemia leading to hosp","C0022116;C0332152;C1424025;C1522538;C2606415;C4321499",NULL,NULL,1668
"alcohol usef n","C0001962;C0001975",";C0001962","",1053
"digoxin at last follow up","C0012265;C0589120;C1522577;C1704685;C3274571","C0012265","",989
"or $nmbr$ _value","C1522609",NULL,NULL,9
"hr b p m","C0369637;C0441923",NULL,NULL,827
"insulin median q $nmbr$ q $nmbr$ pmol l","C0021641;C0439284;C0549183;C0876920;C1533581;C1579433;C2347635;C2348144;C2939193;C3714501",NULL,NULL,1899
"total mayo score $","C0454788;C1077578;C2964552",NULL,NULL,425
"mineralcorticoid receptor antagonist","C4543207",NULL,NULL,185
"atenolol $nmbr$ $nmbr$","C0004147","C0004147","",1055
"sbp indicates systolic blood pressure dbp diastolic blood pressure aa arachidonic acid epa eicosapentaenoic acid values for age bmi total cholesterol ldl cholesterol hdl cholesterol sbp dbp aa epa and epa aa ratio represent the mean values represent the median interquartile range p values are for the differences between the no epa and epa groups","C0000545;C0003695;C0042295;C0085805;C0282379;C0428883;C0439175;C0439632;C0439810;C0441833;C0444504;C0456603;C0488055;C0536221;C0549183;C0578022;C0687744;C0871470;C0876920;C1235746;C1257890;C1306620;C1519504;C1547037;C1552839;C1705241;C1705242;C1705428;C1705429;C1709380;C1711350;C1882141;C1882932;C2316832;C2347634;C2347635;C2348143;C2348144;C2699193;C2939193;C3813197;C4281799;C4554792",NULL,NULL,635
"glycemia mg dl","C0005802;C0439269",NULL,NULL,2283
"viidagliptin $nmbr$ mg daily glimepiride","C0024671;C0026410;C0061323;C0332173;C0439269;C1960952;C2346927;C4321396;C4521761","C1570906","",2068
"receiving concomitant corticosteroids","C0001617;C0521115;C1514756;C3539185;C3540725;C3540726;C3540727",NULL,NULL,1650
"renal insufficiency failure","C0035078;C0231174;C0231179;C0680095;C1565489;C1963154","C1565489","",937
"enalapril aliskiren n $nmbr$","C0014025;C1120110",NULL,NULL,164
"cana $nmbr$ mg","C0024671;C0026410;C0439269;C1418845;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"change $nmbr$ ci","C0008107;C0392747;C0443172;C1705241;C3259781;C4319952",NULL,NULL,519
"prior pci","C0332152;C2826257;C4049621","C1532338","",1661
"$nmbr$ mg kgf n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"proportion of individuals a alirocumab placebo","C0027361;C0032042;C0237401;C1696465;C1706408;C1709707;C3491162","C0032042","",28
"hispanic black","C0005680;C0027567;C0085756;C0086409;C0439541","C0005680",";C1706779",188
"physical examination","C0031809;C1744699",NULL,NULL,1519
"diff_measure dm added this as table had multiple headings","C0011816;C0039224;C0079809;C0242485;C0439064;C1524062;C1706074;C3250443",NULL,NULL,955
"region of the world","C0017446;C0205147;C2700280","C0017446","",369
"apo b","C0003593;C3252643","C0003593","",426
"mg daily","C0024671;C0026410;C0332173;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"spirometry","C0037981",";C0037981","",1197
"no of events total no","C0439175;C0439810;C0441471;C3541888",NULL,NULL,1059
"ii $nmbr$ amlodipine lisinopril chlorthalidone chlorthalidone","C0008294;C0051696;C0065374;C1710602;C4082587",NULL,NULL,521
"no cs and is","C0010182;C0271160;C3540510;C4085345",NULL,NULL,136
"lack of efficacy with $nmbr$ anti interleukin $nmbr$","C0021764;C0235828;C1527200",NULL,NULL,2151
"former smoker no","C0337671","C0037369","",420
"score on the minnesota living with heart failure scaled","C0018801;C0018802;C0026183;C0175659;C0349674;C0449820;C0595998;C1947916;C4050231;C4520849;C4551704;C4554158","C0018801",";C0168634;C1524003",12
"$nmbr$ $nmbr$ t $nmbr$ c u","C0439148;C2603360","","",-10
"basdai question $nmbr$ score $nmbr$ $nmbr$ mean sd","C0444504;C0449820;C1522634;C1998004;C2347634;C2348143;C2699239;C4050231",NULL,NULL,37
"history of claudication","C2315493",NULL,NULL,1492
"females n $nmbr$","C0086287","C0086287","",1277
"$nmbr$ abciximab n $nmbr$","C0288672","C0288672","",374
"bifurcation lesion with side branch $ $nmbr$ $nmbr$ mm stented","C0038257;C0184906;C0205384;C0221198;C0441987;C1253959;C1546698;C1881507;C2700383;C2826234;C3146289;C4330985;C4554674",NULL,NULL,893
"on oac at time of randomisation n","C0034656;C0040223;C3541383",NULL,NULL,692
"$nmbr$ to $nmbr$ mg dl","C0439269",NULL,NULL,192
"crp mg l mean sd","C0439268;C0444504;C2347634;C2348143;C2699239;C3890735;C4048285","C0006560","",286
"insulin glargine","C0907402","C0907402",";C1998602;C0004446;C0005126;C2344255;C4050145;C0229089;C0439164;C1512019;C3273373;C3665488",69
"reported by physicians data are median iqr all data are mean sd or number unless otherwise indicated","C0031831;C0237753;C0444504;C0449788;C0549183;C0876920;C1444656;C1511726;C1709908;C2347634;C2347635;C2348143;C2348144;C2699239;C2939193;C3245479;C3714741",NULL,NULL,37
"transient ischaemic attack no","C0007787;C0917805",NULL,NULL,1592
"risk difference","C0035647;C1705241;C1705242;C4552904",NULL,NULL,1466
"topiramate","C0076829",NULL,NULL,755
"estimated gfr","C0017654;C0750572;C1424601",NULL,NULL,536
"class ic","C0020750;C0456387;C1518526;C1705943;C4554818",NULL,NULL,452
"in hospital","C0019994;C1510665","C0019994",";C4049621",261
"thrombolytic therapy","C0040044",NULL,NULL,1703
"mean hba $nmbr$ c s d","C0019016;C0444504;C1825777;C2347634;C2348143;C3538758","","",820
"azl ma","C0024443;C3887485",NULL,NULL,1753
"dbp mmhg","C0439475;C0536221;C3813197;C4281799",NULL,NULL,605
"prior cabg surgery","C0010055;C0455610","C0010055","",219
"history of a transient ischaemic attack","C0455536","C0455536","",1295
"prior bp use","C0037623;C0042153;C0332152;C0457083;C1415692;C1708288;C1947944;C2826257;C4318478",NULL,NULL,294
"history of symptomatic","C0019664;C0019665;C0231220;C0262512;C0262926;C1705255;C2004062",NULL,NULL,611
"homa ir mean sd mu l $ mmol l b","C0022065;C0022071;C0439190;C0439342;C0444504;C1448132;C2347634;C2348143;C2699239","","",1397
"tocilizumab n $nmbr$","C1609165",NULL,NULL,2295
"hba median","C0019016;C0549183;C0876920;C1825777;C2347635;C2348144;C2939193;C3538758",NULL,NULL,635
"electrophysiological study no weight ibj","C0005910;C0043100;C0850293;C1305866;C1705104",NULL,NULL,1925
"previous pci or cabg","C0010055;C0205156;C1552607;C4049621","C1532338","",1661
"mets w o t $nmbr$ dm","C0011816;C0812270;C1705694;C2939420;C3250443",NULL,NULL,955
"treated vessel native coronary","C0005847;C0018787;C0302891;C1522326",NULL,NULL,1481
"ldl c $nmbr$ mg dl no","C0439269","C0023824","",1963
"rosuva $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761","C0965129","",886
"timing of clopidogrel loading dose","C0070166;C0449243;C1704250;C3714444","C0070166",";C0369286;C0033727;C4049621",217
"brv overall","C0155502;C0282416;C1561607",NULL,NULL,1743
"patients characteristics","C0815172",NULL,NULL,1652
"nos $nmbr$ $nmbr$ a g n","C0326287;C0439267;C1518425",NULL,NULL,131
"moderate to severe copd exacerbation","C0740304;C1299393",NULL,NULL,322
"lebrikizumab $nmbr$ $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C2981360;C4321396;C4521761",NULL,NULL,2287
"hospitalization for heart failure n","C3898876","C0018801",";C0168634;C1524003",12
"crp mg l $nmbr$","C0439268;C3890735;C4048285","C0006560","",286
"on non metformin aha","C0025598;C0050451;C0772110;C1518422",NULL,NULL,85
"no beta blocker use","C0001645;C0042153;C0457083;C1947944","C0001645","",959
"mild","C2945599",NULL,NULL,329
"ischaemic dilated cardiomyopathy","C1960867",NULL,NULL,816
"sulfasalazine use at randomization n","C0034656;C0036078;C0042153;C0457083;C1947944",NULL,NULL,2184
"mean iglar dose sd u day","C0178602;C0444504;C0456683;C0869039;C1114758;C2347634;C2348143;C2699239",NULL,NULL,37
"prior cv event","C0332152;C0441471;C2826257;C3538987;C4019010;C4048877;C4318503",NULL,NULL,1777
"patients with enthesitis at baseline no","C0030705;C0168634;C1282952;C1442488","C1282952","",271
"western europe and lebanon","C0023190;C0043129","","",599
"russia and georgia","C0017452;C0017454;C0035970","C0035970;C0017452","",123
"new stroke","C0038454;C0205314;C4554100",NULL,NULL,1762
"theophylline compound","C0039771;C0205198;C1706082","C0039771","",66
"white hispanic n","C1533020;C1533021","C1533021","",1309
"r wave in avl mm","C0429091;C0449216;C4330985;C4554674",NULL,NULL,297
"experience","C0237607;C0596545",NULL,NULL,1460
"current smoker at baseline n","C0168634;C1442488;C3173209;C3241966","C3241966","",1420
"extended duration enoxaparin n $nmbr$","C0206460;C0231448;C0231449;C0439792;C0449238;C2926735",NULL,NULL,901
"continued thienopyridine n $nmbr$","C0549178;C1120149",NULL,NULL,1561
"prior implantable cardiodefibrillator n","C0021102;C0332152;C2826257",NULL,NULL,294
"hba $nmbr$ c median q $nmbr$ q $nmbr$","C0019016;C0549183;C0876920;C1825777;C2347635;C2348144;C2939193;C3538758",NULL,NULL,1897
"mean age y mean sd","C0001779;C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"prior mi within $nmbr$ y no","C0332152;C2826257;C3810814",NULL,NULL,516
"crcl of $nmbr$ $nmbr$ ml min n","C0439445;C1846718","C3811844;C0017654","",307
"hctz hydrochlorothiazide based on a _ $nmbr$ test t data were missing for some patients","C0020261;C0022885;C0030705;C0039593;C0242356;C0392366;C0456984;C0993637;C1515976;C1551393;C1705492;C3272743;C3831328;C4318744",NULL,NULL,1149
"$ $nmbr$ years","C0439234",NULL,NULL,1099
"statins","C0360714","C0360714","",872
"resection performed","C0015252;C0728940;C0884358",NULL,NULL,576
"metformin pioglitazone","C1635037","C0025598","",1345
"baseline anti hyperglycemic medications n","C0013227;C0168634;C0432633;C0802604;C1442488;C2598133;C4284232","C0020616",";C0013227;C3244316;C4284232;C0450442;C1254351;C1515187;C1521826;C2826257",33
"primary end points","C0205225;C0439612;C0439631;C2349179",NULL,NULL,2339
"glucosamine n $nmbr$","C0017718","C0017718","",1161
"high density lipoprotein","C0023821",NULL,NULL,835
"fev $nmbr$ fvc post salbutamol","C0001927;C0687676;C1704687;C3469826;C3714541",NULL,NULL,1599
"pulmonary congestion cxr","C0006888;C0039985;C0242073",NULL,NULL,768
"severe hypoglycemia","C0020615;C0205082;C4050465;C4050466;C4553659",NULL,NULL,313
"mean predicted dlco sd","C0444504;C0681842;C1516251;C1882327;C2347634;C2348143;C2699239",NULL,NULL,37
"diastolic pressure mm hg","C0428883;C0439475","C0005823","",1469
"hyperlipidemia no","C0020473;C0428465;C4555212","C0020473;C4555212",";C0439810;C1710701",29
"$nmbr$ n $nmbr$ l $nmbr$","C0369718;C0441922",NULL,NULL,1553
"duration of disease before baseline","C0168634;C0872146;C1442488","C0449238;C0872146","",903
"baseline ldl c $nmbr$ $nmbr$ to $nmbr$ $nmbr$ mmol lc","C0168634;C0439190;C1442488","C0023824","",1068
"macroalbuminuria at baseline $nmbr$ of patients treated","C0030705;C0168634;C1442488;C1522326",NULL,NULL,625
"locf","C2825507",NULL,NULL,965
"diabetes duration mean sd","C0011847;C0011849;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"mean sd postbronchodilator fev $nmbr$ predicted","C0444504;C0681842;C1882327;C2347634;C2348143;C2599594;C2699239;C3714541",NULL,NULL,1599
"no prior mi","C0332152;C2826257;C3810814",NULL,NULL,516
"histor y of congestive heart failure no","C0018802","C0018801",";C0168634;C1524003",12
"alcohol with $nmbr$ drink d","C0001948;C0556297","C0001948","",875
"type $nmbr$ diabetes pbo n $nmbr$ vs evomab n $nmbr$","C0031962;C1320657",NULL,NULL,435
"anemia no total","C0002871;C0439175;C0439810;C1000483;C4554633",NULL,NULL,152
"creatinine mg dl mean sd","C0010294;C0439269;C0444504;C1561535;C2347634;C2348143;C2699239","C0600061;C0010294","",952
"beta carotene","C0053396;C0696105","C0053396","",2233
"previous therapy","C0039798;C0087111;C0205156;C1363945;C1552607",NULL,NULL,1044
"eq $nmbr$ da health index status score","C0011318;C0018759;C0205163;C0439185;C0449820;C0600653;C0918012;C1552854;C1637833;C2986546;C3668815;C4050231",NULL,NULL,1625
"biomarker status","C0449442",NULL,NULL,544
"smoking in past yr","C0037369;C0439234;C0453996;C1444637;C1881674;C4284302","C0037369","",420
"discontinued","C1444662",NULL,NULL,1562
"in hospital ticagrelor","C0019994;C1510665;C1999375","C1999375;C1510665","",1246
"intravenous heparin","C0354566","C0019134","",864
"corticosteroid dose prednisone","C0001617;C0032952;C0178602;C0869039;C1114758;C3536709",NULL,NULL,110
"ertugliflozin $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4079805;C4321396;C4521761","C4079805","",1180
"history of paroxysmal af","C0019664;C0019665;C0235480;C0262512;C0262926;C1705255;C2004062","C0235480","",1446
"lp a median q $nmbr$ q $nmbr$","C0065058;C0549183;C0876920;C1439335;C2347635;C2348144;C2939193;C4553379",NULL,NULL,635
"met su tzd","C0038642;C0428210;C1550543;C1705534;C4317104",NULL,NULL,1729
"previous oad","C0205156;C1552607",NULL,NULL,14
"antihypertensives","C0003364",";C0003364","",1579
"median duration of symptoms range yr","C0436359;C0439234;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016",NULL,NULL,1099
"das $nmbr$ esr mean sd das $nmbr$ esr remission","C0051767;C0057671;C0444504;C0544452;C0687702;C2347634;C2348143;C2699239;C3811131","C1619634","",298
"hf without known reduced ef","C0018488;C0205309;C0392756;C1313497;C1538440;C3273279","C0018801;C0428772","",1273
"teaes of special interest","C0205555;C0543488",NULL,NULL,1098
"diuretic drugs excluding antialdosterone","C0012798;C0013227;C0332196;C2828389;C3687832",NULL,NULL,992
"reslizumab","C1869620",NULL,NULL,947
"change median q $nmbr$ q $nmbr$","C0392747;C0443172;C0549183;C0876920;C1705241;C2347635;C2348144;C2939193;C4319952",NULL,NULL,635
"hospitalization for acute limb ischemia","C0019993;C0205178;C2945695",NULL,NULL,1577
"abbreviations teae treatment emergent adverse event gly glycopyrrolate inhalation solution bid twice daily","C0000723;C0017890;C0017970;C0523677;C0585361;C1154181;C4684800",NULL,NULL,724
"insulin oad","C0021641;C1533581;C1579433;C3714501",NULL,NULL,157
"weight median iqr kg","C0005910;C0022718;C0043100;C0439209;C0549183;C0876920;C1305866;C1705104;C2347635;C2348144;C2939193;C4054209","C0005910","",1250
"total feet score","C0016504;C0347981;C2964552",NULL,NULL,540
"mean bmi s d kg m","C0444504;C0578022;C1532718;C2347634;C2348143",";C1305855","",206
"sodium","C0037473;C0597484;C3541959;C3714642","C0037473","",1378
"pooled secukinumab","C1709595;C2349200;C3179547;C4522255",NULL,NULL,2333
"gg","C0017454;C0018370",NULL,NULL,201
"flex pbo","C0031962",NULL,NULL,435
"diagnosis y mean sd","C0011900;C0444504;C1704338;C1704656;C2347634;C2348143;C2699239",NULL,NULL,37
"death mi idr st or any timi bleeding","C0011065;C0019080;C0036056;C1306577;C3272372;C3810814;C4082313;C4552775",NULL,NULL,246
"europe n z $nmbr$","C0015176","C0015176","",337
"formoterol $nmbr$ g n $nmbr$","C0060657;C0439267","C0060657;C0073992","",1508
"mean mmrc grade units sd","C0439148;C0441800;C0444504;C0919553;C1519795;C2347634;C2348143;C2699239;C3244287;C3826977;C3853603",NULL,NULL,683
"statin intensity $nmbr$ $nmbr$","C0360714;C0522510","C0360714","",872
"total hip or knee replacement","C0019552;C0022122;C0086511;C0439175;C0439810;C1505163;C3538851;C4284725",NULL,NULL,830
"anti coagulants","C0848112","C0003280","",450
"medication adherence","C2364172","C2364172","",1465
"low n $nmbr$","C0205251;C1550472;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"comparison with placebo","C0032042;C1696465;C1706408;C1707455","C0032042","",28
"antithrombotic medications n","C0013227;C0802604;C2598133;C4284232",NULL,NULL,366
"potassium sparing at enrollment","C0032821;C0202194;C0304475;C0597277;C1516879;C1696073;C3714637;C3888021","C0032821","",1371
"procalcitonin ng ml","C0072027;C0439275",NULL,NULL,204
"selective vascular history","C0005847;C0019664;C0019665;C0036576;C0262512;C0262926;C1558950;C1705255;C1707391;C1801960;C2004062",NULL,NULL,832
"platelet count x $nmbr$ mm $nmbr$","C0032181;C1287267;C4330985;C4554674",NULL,NULL,2385
"or ulcerations n","C0041582","C0041582","",1451
"pde $nmbr$ inhibitor monotherapy","C0031638",NULL,NULL,814
"no prior ml","C0332152;C0439526;C1705224;C2826257;C3887665",NULL,NULL,300
"without concomitant ics","C0521115;C0815320;C4551720","C3540778","",2182
"gamma glutamyltransferase u l","C0017040;C0439339",NULL,NULL,460
"clinical dementia rating score","C4304227",NULL,NULL,791
"time since epilepsy diagnosis years","C0011900;C0014544;C0040223;C0439234;C1704338;C1704656;C3541383",NULL,NULL,1099
"insulin glargine n $nmbr$ py","C0030428;C0907402;C3538810",NULL,NULL,1517
"use of parenteral antithrombotic agents no","C0030547;C1524063;C1704311;C4522267",NULL,NULL,1705
"disease localization n","C0012634;C0475264;C1744691",NULL,NULL,2119
"antihypertensive therapy no","C0585941",";C0003364","",1579
"pain vas range $nmbr$ $nmbr$ mm mean sd","C0042815;C0444504;C1514721;C2347634;C2348143;C2348147;C2699239;C3542016;C4330985;C4554674",NULL,NULL,37
"systolic blood pressure mm hg sd","C0439475;C0488055;C0871470;C1306620;C2699239","C0005823","",1469
"all cause mortality n $nmbr$","C0015127;C0026565;C0026566;C0444868;C1524003;C3539085",NULL,NULL,924
"age median range years","C0549183;C0876920;C1510829;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016","C1510829","",481
"sd","C2699239",NULL,NULL,1287
"mean daily dose range mg i","C0021966;C0024671;C0026410;C0221138;C0439269;C0444504;C1514721;C1960952;C2346927;C2347634;C2348070;C2348143;C2348147;C3542016;C4321396;C4521761",NULL,NULL,192
"$nmbr$ $nmbr$ $nmbr$ ci $nmbr$ $nmbr$ to $nmbr$ $nmbr$","C0008107;C3259781",NULL,NULL,519
"coronar y artery bypass grafting","C0450140;C0741847","C0010055","",1843
"prior stroke or transient ischemic attack","C0007787;C0038454;C0332152;C0917805;C2826257;C4554100",NULL,NULL,1762
"obesity bm $nmbr$ $nmbr$ kg m $nmbr$","C0006416;C0028754;C1532718;C1963185",NULL,NULL,710
"apixaban $nmbr$ mg","C0024671;C0026410;C0439269;C1831808;C1960952;C2346927;C4321396;C4521761","C1831808","",1224
"p value for","C1709380",NULL,NULL,7
"any stroke","C0038454;C4554100",NULL,NULL,1762
"nicotine pack years","C0028040;C1277691","C1277691","",1297
"lvh on ecg","C0232306","C0232306","",406
"taking antihypertensive treatment at","C0003364;C0039798;C0087111;C1515187;C1522326;C1533734;C1705169;C3538994;C3887704",";C0003364","",1579
"non caucasian eze simva $nmbr$","C0007457;C0043157;C1518422","C0043157","",1329
"sf $nmbr$ mcs mean sd","C0037712;C0444504;C2347634;C2348143;C2699239",NULL,NULL,1782
"prior pacemaker n","C0030163;C0332152;C0810633;C1546728;C2826257;C3275122;C3853703",NULL,NULL,503
"number of visits mean sd","C0444504;C1549755;C2347634;C2348143;C2699239",NULL,NULL,37
"copd severity n a","C0024117;C0439793;C0522510;C1412502;C3714496",NULL,NULL,1546
"hazard ratio $nmbr$ cl","C0596019;C2985465","C2985465","",975
"mean time since asthma","C0004096;C0040223;C0444504;C2347634;C2348143;C2984299;C3541383",NULL,NULL,757
"high density lipoprotein cholesterol tx difference vs pbo ls mean change from baseline se","C0023668;C0023822;C0031962;C0036919;C0041403;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C1705242;C2347634;C2348143;C4319952",NULL,NULL,767
"subgroup p valuef","C1079230;C1515021",NULL,NULL,1637
"non st segment elevation myocardial infarction","C0441635;C1518422;C1536220;C1536221;C1536222;C3537184;C4255010",NULL,NULL,529
"unhappy","C1688635","","",-10
"all cause mortality or hf hospitalization","C0015127;C0018488;C0019993;C0026565;C0026566;C0444868;C1313497;C1524003;C1538440;C3273279;C3539085",NULL,NULL,924
"class i","C0441885;C1319793;C2698967",NULL,NULL,454
"$nmbr$ $nmbr$ mg liter antiplatelet agents","C0024671;C0026410;C0085826;C0439269;C0475211;C1960952;C2346927;C4321396;C4521761","","",1191
"variable demographic characteristics","C0439828;C0683970;C4553760",NULL,NULL,583
"age category n $nmbr$ years","C0683312;C1510829;C3889287",NULL,NULL,562
"heritable","C0439660",NULL,NULL,1001
"hoehn and yahr stage baseline mean sd","C0168634;C0205390;C0444504;C1300072;C1306673;C1442488;C2347634;C2348143;C2699239",NULL,NULL,541
"treatment diff vs tio $nmbr$ ci","C0008107;C0039798;C0087111;C1522326;C1533734;C1705169;C3259781;C3538994;C3887704",NULL,NULL,519
"diastolic mean sd","C0012000;C0444504;C2347634;C2348143;C2699239",NULL,NULL,2130
"pooled placebo","C0032042;C1696465;C1706408;C1709595;C2349200;C4522255","C0032042","",28
"jsn median min max","C0549183;C0702093;C0876920;C1524029;C2347635;C2348144;C2939193;C3813700",NULL,NULL,1475
"mild dysfunction or normal","C0205307;C0231683;C0439166;C2347086;C3274775;C4553972",NULL,NULL,687
"metabolic syndrome no $nmbr$","C0524620",NULL,NULL,617
"height cm mean sd a","C0444504;C0489786;C2347634;C2348143;C2699239","C0489786","",1249
"hc","C0020268;C0262499;C1413512",NULL,NULL,825
"apoa $nmbr$ g l","C0003592;C0439294;C0456615;C0523508;C4553344;C4553379","C0003592","",427
"laa closure n $nmbr$","C0185003;C1521802",NULL,NULL,1307
"$nmbr$ prolonged antithrombotic pretreatment n $nmbr$","C0439590;C1550147;C2709094;C3539075;C3539076",NULL,NULL,1705
"years of education","C0013621;C0013622;C0013658;C0039401;C0439234","C0013658","",902
"des","C0011702;C4551552",NULL,NULL,465
"metformin use","C0025598;C0042153;C0457083;C1947944","C0025598","",1345
"screening mean sd morning pef mean","C0030771;C0220908;C0220909;C0332170;C0444504;C1518922;C1542834;C1698960;C1710031;C1710032;C1710477;C2347634;C2348143;C2348164;C2699239",NULL,NULL,566
"previous treatment in the healing study n","C0043240;C0205156;C0205249;C1521826;C1552607;C3161471",NULL,NULL,717
"blood eosinophils mean range cells mlb","C0005773;C0007584;C0007634;C0014467;C0200638;C0444504;C1514721;C2347634;C2348143;C2348147;C3542016","C0014467","",849
"apremilast $nmbr$ mg bid n $nmbr$","C0024671;C0026410;C0439269;C1678805;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2270
"history of mi or stroke n","C0019664;C0019665;C0038454;C0262512;C0262926;C1705255;C2004062;C3810814;C4554100",NULL,NULL,832
"non hdl cholesterol j","C0729627;C1535899","C0023822","",821
"lower limb fractures","C0016658;C0023216",NULL,NULL,1613
"pci for index mi","C0600653;C0918012;C1552854;C1637833;C2986546;C3810814;C4049621","C1532338","",1661
"lor ii","C1416897;C1416899;C1710602;C2986770;C4082587",NULL,NULL,521
"sfc $nmbr$ mg $nmbr$ mg","C1319635;C4521536",NULL,NULL,1283
"chf on losartan","C0018802;C0126174",NULL,NULL,769
"use of compression stockings no","C0038348;C1524063",NULL,NULL,794
"baseline hbi mean sd","C0168634;C0444504;C1442488;C2347634;C2348143;C2699239",NULL,NULL,1287
"patients with eligible ses cd score","C0007928;C0030705;C0034283;C0449820;C1548635;C4050231;C4552032",NULL,NULL,699
"age subgroups","C0001779;C1079230","C0001779","",480
"high microalbuminuria to macroalbuminuria n $nmbr$","C0205250;C0730345;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"deaths","C0011065;C1306577",NULL,NULL,1855
"mtx naive or free","C0025677;C0332296;C1417487;C1880497;C1996904","C0025677","",1408
"gmi women","C0043210","C0043210",";C3541888;C1720467",1323
"weight at baseline","C1303013",NULL,NULL,626
"italy n $nmbr$","C0022277",NULL,NULL,1683
"tonic","C3543842",NULL,NULL,1702
"infected n a","C0439663","C3714514","",1093
"cv entry criteria","C0243161;C1705654;C3538987;C4048877;C4318503",NULL,NULL,783
"atopic","C0392707","C0392707","",1412
"p lace of randomization interaction p $nmbr$ $nmbr$","C0034656;C0280109;C0369773;C0453991;C1704675;C2603361",NULL,NULL,888
"only dvt","C0149871;C0205171;C1720467;C2926618;C3899446","C0149871","",252
"annual asthma exacerbation rates","C0332181;C0349790;C0871208;C1521828",NULL,NULL,2005
"pigr ng ml","C0439275;C1418569",NULL,NULL,204
"blood eosinophil count cells mm $nmbr$ no","C0005773;C0200638;C0750879;C4330985;C4554674","C0750879","",848
"median nt probnp iqr pg ml","C0439297;C0549183;C0669479;C0754710;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"factors dabigatran","C1521761;C2348066;C2827422",NULL,NULL,775
"mdrd egfr geometric mean cv a b ml","C0439526;C1705224;C1739039;C2986759;C3538987;C3811844;C3812682;C3839656;C3887665;C4048877;C4318503","C3811844;C0017654","",592
"history ot chd n","C0019664;C0019665;C0262512;C0262926;C0280604;C1318464;C1418208;C1705255;C1705587;C2004062;C3542407",NULL,NULL,970
"hr $nmbr$ cl","C0596019",NULL,NULL,658
"intention to treat with st segment elevation myocardial infarction","C0040363;C0041260;C0087111;C0162425;C1283828;C1292734;C1522326;C1536220;C1883351",NULL,NULL,431
"pulse beats min cholesterol mmol l","C0008377;C0232117;C0391850;C1947910;C2827896","C0232117","",1117
"time to all cause death up to end of the study","C0007465;C0015127;C0040223;C0444930;C0547043;C0557651;C1301931;C1524003;C2603343;C2746065;C3541383",NULL,NULL,410
"area of retinal hemorrhage within the grid mean sd dab","C0017446;C0035317;C0086162;C0205146;C0444504;C1081457;C1415284;C2347634;C2348143;C2348395;C2699239;C2825313;C4522144",NULL,NULL,370
"liraglutide $nmbr$ $nmbr$ mg ls means n","C0023668;C0024671;C0026410;C0439269;C1456408;C1704970;C1960952;C2346927;C4321396;C4521761","C1456408","",1566
"vorapaxar placebo $nmbr$ yr","C0032042;C0439234;C1696465;C1706408;C2974521",NULL,NULL,1099
"evidence or thombus n","C3887511","","",-10
"fvc","C3714541",NULL,NULL,1599
"gender n","C0079399;C1522384","C0079399","",1083
"hdl cholesterol mmol l women mean sd","C0023822;C0043210;C0392885;C0444504;C1532563;C2347634;C2348143;C2699239",NULL,NULL,37
"chlor","C0308648",NULL,NULL,969
"so","C0037640","","",-10
"placebo eze ezetimibe erol apo apolipoprotein metabolic syndrome patients were eans and percentage changes are","C0003591;C0030705;C0032042;C0392747;C0439165;C0443172;C0524620;C1142985;C1549488;C1561533;C1696465;C1706408","","",-10
"$nmbr$ flex fn f score","C0016327;C0449820;C1570610;C4050231",NULL,NULL,748
"$nmbr$ mwd decrease $nmbr$ m","C0369637;C0392756;C0441923;C0547047",NULL,NULL,923
"other pacific islander","C0242191",NULL,NULL,1609
"hscrp range mg l","C0439268;C1514721;C2348147;C3542016",NULL,NULL,479
"f emale","C0016327",NULL,NULL,1825
"chd","C0280604;C3542407",NULL,NULL,970
"warfarin n $nmbr$ n y","C0043031","C0043031","",858
"serum ua $nmbr$ mg dl by month $nmbr$","C0041580;C0042014;C0229671;C0332177;C0439231;C0439269;C1546774;C1550100",NULL,NULL,237
"dmard ir anti tnf ir","C0022065;C0022071;C0242708;C1448132;C1448177","","",1397
"major amputations at week $nmbr$","C0002688;C0205082;C0205164;C0332174;C0439230;C4318856;C4521762","C0002688","",895
"triglycerides week $nmbr$ a","C0041004;C0332174;C0439230","C0041004","",368
"$nmbr$ st and $nmbr$ nd quartile","C0036056;C2828255;C3272372",NULL,NULL,246
"characteristic age","C0001779;C1521970",NULL,NULL,2015
"key secondary end point st","C0036056;C3272372;C4528314",NULL,NULL,246
"weight mean $nmbr$ sd kg","C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209","C0043100","",1915
"hdl cholesterol mmol lt","C0023376;C0023822;C0230426;C0392885;C0439190;C3887647;C4521399",NULL,NULL,1678
"sex male","C0086582","C0086582","",1276
"budesonide mmx $nmbr$ mg n $nmbr$","C0024671;C0026410;C0054201;C0439269;C1960952;C2346927;C4321396;C4521761","C0054201","",1160
"v alsartan hctz n","C0020261",NULL,NULL,1149
"unadjusteda beta se","C0036919;C0330390;C0439096;C2004068",NULL,NULL,1429
"prior coronary artery disease yes","C0010054;C0010068;C0332152;C1549445;C1705108;C1710701;C1956346;C2826257","C0010068;C1956346",";C0026410;C1710701",226
"left anterior descending","C0205386;C0441998;C1547177","C0226032","",2098
"n ms","C0369718;C0441922;C2349943;C3539704;C3713294",NULL,NULL,126
"serum cholesterol mg l","C0439268;C0587184","C0008377","",1501
"multivitamin use yes","C0042153;C0301532;C0457083;C1549445;C1705108;C1710701;C1947944","C0301532",";C1710701;C1705970",1032
"laparoscopic cholecystectomy","C0162522","C0162522","",1393
"body weighta kg","C0022718;C0242821;C0439209;C0460148;C1268086;C4054209;C4082212","C0005910","",1250
"$nmbr$ ix","C0015491",NULL,NULL,1256
"no of individuals","C0027361;C0237401",NULL,NULL,588
"demographic data","C4684639",NULL,NULL,583
"rf positive no","C0035448;C0201660;C0439178;C0748398;C1446409;C1514241;C1547111;C2825490;C3812269","C0035448","",1435
"structural heart disease no f","C0016327;C1290384",NULL,NULL,585
"concomitant oral corticosteroids n","C0001617;C0442027;C0521115;C3539185;C3540725;C3540726;C3540727;C4521986",NULL,NULL,1650
"average of maximum far wall cimt mm","C0205108;C0677535;C0806909;C1510992;C1552615;C2825518;C2826546;C4330985;C4554674","","",1262
"aspirin dose","C4696290","C0004057","",1366
"ama s e","C0002461;C0279755;C2825862",NULL,NULL,1300
"esr mm h","C0456680;C3811131","C1619634","",298
"placebo no of events no","C0032042;C0441471;C1696465;C1706408;C3541888","C0032042","",28
"serious ae","C0205404;C3887670",NULL,NULL,916
"cause of heart failure no","C0015127;C0018801;C0018802;C1524003;C4554158","C0018801",";C0168634;C1524003",12
"sjc $nmbr$ $nmbr$ mean sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,1589
"remission at maintenance trial entry no","C0008976;C0024501;C0544452;C0687702;C1705654",NULL,NULL,1588
"mean duration of disease years","C0439234;C0444504;C0872146;C2347634;C2348143",NULL,NULL,1099
"hdl c at baseline","C0168634;C1442488;C3715113","C0023822","",821
"primary renal endpoint or death","C0011065;C0022646;C1306577;C2986535;C4082313;C4552775","C2986535;C0022646","",938
"concomitant conventional dmard use","C0042153;C0242708;C0439858;C0457083;C0521115;C1947944","C0242708",";C0026544",231
"homa b median ql q $nmbr$","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,634
"of group","C0441833;C0687744;C1257890;C1519504;C1705428;C1705429",NULL,NULL,1526
"albumin creatinine ratio","C0486293;C1318293","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"om $nmbr$ mg aml $nmbr$ mg hctz $nmbr$ mg","C0020261;C0023465;C0023467;C0028971;C1319635;C1705272",NULL,NULL,186
"normalized","C1882115",NULL,NULL,1692
"evening","C0587117",NULL,NULL,800
"education mean sd years","C0013621;C0013622;C0013658;C0039401;C0439234;C0444504;C2347634;C2348143;C2699239","C0013658","",1990
"ace inhibitors or angiotensin ii blockers","C0003009;C0003015;C1366631;C3714928","C0003015","",811
"jsn score $nmbr$ $nmbr$","C0449820;C4050231",NULL,NULL,2055
"previous use of biologic systemic therapy n","C0005515;C0005527;C0205156;C0205373;C0205460;C1515119;C1524063;C1552607",NULL,NULL,2391
"very high $nmbr$ xuln n $nmbr$","C0442804;C4321397",NULL,NULL,1478
"f $nmbr$ vs placebo","C0016327;C0032042;C1696465;C1706408","C0032042","",28
"de n $nmbr$","C0011198;C0017480;C3541240",NULL,NULL,1620
"ldlc","C1416822","C0023824","",1068
"lsm difference $nmbr$ cl","C0596019;C1705241;C1705242",NULL,NULL,658
"qualifying atherosclerosis","C0003850;C0004153;C1514624","C0004153","",1698
"claudication fontaine class $nmbr$","C0021775;C0311395;C0456387;C1456822;C1518526;C1705943","C0021775","",263
"classification of epilepsy type n","C0008902;C0008903;C0014544;C0332307;C0678229;C1547052",NULL,NULL,2362
"dlqi patients with $nmbr$ bsa psoriasis","C0030705;C0033860;C3899393","C0005902;C0033860","",2177
"pao $nmbr$ at rest mm hg","C0035253;C0232555;C0439475;C1423784;C1427155;C1622890;C4318615","","",-10
"risk factors only","C0035648;C0205171;C1553898;C1720467",NULL,NULL,175
"median age interquartile range yr","C0001779;C0439234;C0549183;C0876920;C1711350;C2347635;C2348144;C2939193","C0001779","",480
"total group n $nmbr$","C0439175;C0439810;C0441848",NULL,NULL,1638
"saxagliptin n $nmbr$ $nmbr$","C1611934","C1611934","",2069
"serum creatinine gmol l","C0201976;C0600061","C0600061;C0010294","",952
"s arm","C0446516;C0565930;C2603362;C3715044;C4553528",NULL,NULL,950
"stroke subtype","C0038454;C0449560;C4554100",NULL,NULL,1762
"whole cohort","C0009247;C0444667;C0599755","C0599755","",2208
"nominal p vs placebo","C0032042;C1696465;C1706408","C0032042","",28
"no statin vs statin alone vs any statin plus other llt","C0205171;C0360714;C0439044;C0679994;C2347090","C0360714","",872
"prebronchodilator fev $nmbr$ l","C2599602;C3714541",NULL,NULL,1599
"marital status married","C0024819;C0024841;C0555047;C1716536;C3172566",NULL,NULL,49
"no new jsn among patients with $nmbr$ uninvolved joint at baseline","C0022417;C0030705;C0168634;C0205314;C0205429;C0392905;C1442488;C1706309",NULL,NULL,625
"hispanic american","C0019576","C0019576","",2257
"bivalirudin only","C0168273;C0205171;C1720467",NULL,NULL,776
"canada or united states","C0006823;C0041703","C0006823;C0041703","",1301
"change from baseline adjusted mean $nmbr$ ci","C0008107;C0168634;C0392747;C0443172;C0444504;C0456081;C1442488;C1705241;C2347634;C2348143;C3259781;C4319952",NULL,NULL,625
"harzard ratio $nmbr$ ci","C0008107;C0456603;C1547037;C3259781",NULL,NULL,519
"chronic non steroidal antiinflammatory drugs","C0003211;C0205191",NULL,NULL,2122
"severe recurrent ischemia","C0022116;C0205082;C1455761;C2945760;C4050465;C4050466;C4321499",NULL,NULL,1668
"diabetes mellitus n $nmbr$ $nmbr$","C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"$nmbr$ fev $nmbr$ $nmbr$ pred","C0032952;C0044955;C3714541","C3714541","",296
"lipid values mmol l","C0023779;C0042295;C1532563","C0023779","",1772
"timi risk score no total no c","C0035647;C0439175;C0439810;C0449820;C4050231;C4552904",NULL,NULL,1954
"walking","C0080331;C4283795;C4321241;C4321242","C0080331","",1146
"crp mg l median","C0439268;C0549183;C0876920;C2347635;C2348144;C2939193;C3890735;C4048285","C0006560","",286
"non white race","C0007457;C0043157;C1518422","C0034510;C1518422;C0043157","",1401
"serum triglycerides mmol liter","C0439190;C0475211;C0542495","C0041004","",368
"year $nmbr$","C0439234;C0439508",NULL,NULL,1099
"other cardiac surgery n","C0018821;C0524727",NULL,NULL,2337
"aspirin n $nmbr$","C0004057","C0004057","",1366
"nt probnp median pg ml","C0439297;C0549183;C0669479;C0754710;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"no increased risk for falls","C0000921;C0035647;C0085639;C1849142;C4552904;C4699158","C0035647","",173
"ff vi $nmbr$ $nmbr$ g","C0205999;C0439267;C4554348",NULL,NULL,515
"lp a week $nmbr$","C0065058;C0332174;C0439230;C1439335;C4553379","C0065058","",1769
"varespladib n $nmbr$","C2713485","C2713485","",1449
"gusto bleeding severe moderate","C0019080;C1299393",NULL,NULL,707
"$nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n","C0369637;C0439445;C0441923",NULL,NULL,923
"$nmbr$ predicted","C0681842;C1882327","C0024119","",288
"monocytes $nmbr$ nl","C0026473;C0027778;C0560008;C3892223",NULL,NULL,1805
"transient monocular blindness","C0149793","C0149793","",1426
"lowest","C1708760",NULL,NULL,1344
"copd medication taken for at least $nmbr$ months before study entry","C0013227;C0024117;C0439231;C0557651;C1412502;C1705654;C1883727;C2603343;C3244316;C3714496;C4284232",NULL,NULL,1530
"mean sd pre bronchodilator","C0444504;C2347634;C2348143;C2599602;C2699239",NULL,NULL,2142
"sf $nmbr$ pcs","C0037712;C1864389;C1882368",NULL,NULL,1782
"baseline in check pifr l min","C0168634;C0702093;C1283174;C1442488;C1524029;C1555524;C3813700;C4321547",NULL,NULL,1475
"medical therapy before admission","C0184666;C0418981;C0809949",NULL,NULL,640
"id n $nmbr$","C0009450;C0600091;C1441613",NULL,NULL,1255
"second loading dose","C0205436;C0457385;C0565930;C1561503;C1705190;C3714444",NULL,NULL,1783
"stenosis as assessed by investigator","C0035173;C0678234;C1261287;C1516048;C2632116",NULL,NULL,1651
"symptomatic heart fail","C0018787;C0231175;C0231220",NULL,NULL,1481
"drug and insulint","C0013227;C1254351",NULL,NULL,484
"bsa mean sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,1287
"valvular disease mitral","C0746591;C3258293","C0018824","",103
"baseline basfi","C0168634;C1442488",NULL,NULL,625
"micro macro albuminuria ckd and or retinopathy","C0001925;C0035309;C0085672;C1553035;C1561643;C1962966;C2984010;C3811161;C4049106",NULL,NULL,1719
"mean age s d year","C0001779;C0439234;C0439508;C0444504;C2347634;C2348143","C0001779","",480
"$nmbr$ week to $nmbr$ month","C0332174;C0332177;C0439230;C0439231",NULL,NULL,1012
"rotigotine n $nmbr$","C1700683;C4318637","C0289313","",1761
"feno $nmbr$ mg eze $nmbr$ mg n $nmbr$","C1319635",NULL,NULL,1831
"male patients","C0150904",";C0150904","",1037
"coronary end point","C0018787;C2349179;C2826544",NULL,NULL,2039
"hospital admission for heart failure","C0018801;C0018802;C0184666;C4554158","C0018801",";C0168634;C1524003",12
"ldl c bq mg dl mean sd","C0439269;C0444504;C0560038;C2346983;C2347634;C2348143;C2699239;C3541236;C3642216","C0023824","",1963
"generalized","C0205246",NULL,NULL,1085
"patients with glycated hemoglobin $nmbr$ $nmbr$ and $nmbr$ episode of severe hypoglycemia","C0017853;C0020615;C0030705;C0205082;C0332189;C4050465;C4050466;C4553659",NULL,NULL,313
"d $nmbr$ n n","C0073187;C0332173;C4484261",NULL,NULL,1833
"use of supplemental oxygen n","C4067893;C4554557","C4534306","",1327
"seizure types reported during baseline n a","C0036572;C0168634;C0332307;C0684224;C0700287;C1442488;C1959629;C4319718;C4553401",NULL,NULL,625
"duration of rheumatoid arthritis yr","C0003873;C0439234;C0449238;C2926735","C0003873","",1848
"modified se adl scale","C0001288;C0036919;C0175659;C0349674;C0392747;C1420005;C1947916;C3889737",NULL,NULL,567
"sbp median n $nmbr$ o $nmbr$","C0085805;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"age $nmbr$ y n","C0001779","C0001779","",480
"no antianginal drug","C0013227;C1254351;C1874267;C3537168","C3537168","",382
"cholecystitis chronic","C0008325;C0205191;C1963083;C4553186",NULL,NULL,1701
"diabetes p o $nmbr$","C0011847;C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"nice classification of copd severity of obstruction n $nmbr$","C0008902;C0008903;C0024117;C0028778;C0439793;C0522510;C0678229;C1412502;C1882136;C3714496;C4087029",NULL,NULL,1546
"triglycerides mmol l mean sd","C0041004;C0444504;C1532563;C2347634;C2348143;C2699239","C0041004","",368
"baseline crp levels $nmbr$ mg l","C0168634;C0439268;C0441889;C1442488;C3890735;C4048285","C0006560","",286
"history of tia n","C0007787;C0019664;C0019665;C0262512;C0262926;C0917805;C1054154;C1705255;C2004062",NULL,NULL,832
"ischemic heart disease","C0010054;C0151744","C0010054;C0151744","",1361
"patients n","C0030705",NULL,NULL,1035
"hs crp mg l","C0439268;C3890735;C4048285",NULL,NULL,1545
"median delay h","C0033727;C0205421;C0369286;C0441932;C0549183;C0564385;C0876920;C2347635;C2348144;C2939193;C4528284",NULL,NULL,635
"days from acs to randomization","C0034656;C0439228;C0742343;C4318612",NULL,NULL,1709
"u s sites","C0041703;C0205145",NULL,NULL,1193
"austria","C0004348",NULL,NULL,55
"prior percutaneous coronary intervention no","C0332152;C1532338;C2826257","C1532338","",1661
"proximal gi tract","C0017189;C0205107;C4489236","C0205107;C0521362","",2242
"time since ipf diagnosisa mean years sd","C0034069;C0040223;C0439234;C0444504;C1800706;C2347634;C2348143;C2699239;C3541383",";C1800706","",1254
"baseline sesbp mean sd mm hg","C0168634;C0439475;C0444504;C1442488;C2347634;C2348143;C2699239",NULL,NULL,2127
"genetic subgroup","C0017296;C0314603;C1079230;C1515021",NULL,NULL,1637
"$nmbr$ yo n $nmbr$","C1413296",NULL,NULL,440
"hospitalization in the past $nmbr$ months prior to baseline","C0019993;C0168634;C1442488;C4331910",NULL,NULL,625
"all doses n $nmbr$","C0178602",NULL,NULL,110
"b includes both ex smokers and nonsmokers","C0332257;C0337671;C0337672;C1552866;C2700399;C4554605;C4555205","C0037369","",420
"cardiovascular events","C1320716","C1320716","",414
"values were calculated using t tests for continuous variables and chi square","C0042295;C0439828;C0444686;C0549178;C0871472;C1441506;C1524063;C1552646",NULL,NULL,1018
"isolated upper gastrointestinal disease behavior n","C0004927;C0205409;C0810300;C1548221;C2707008",NULL,NULL,1927
"primary end point","C2986535","C2986535","",230
"impaired fasting glucose","C1272092","C1272092","",20
"rate ratio vs placebo $nmbr$ ci","C0008107;C0032042;C0456603;C0871208;C1521828;C1547037;C1696465;C1706408;C3259781","C0032042","",28
"diabetes duration ycars","C0011847;C0011849;C0449238;C2926735","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"glp $nmbr$ receptor agonist other than study drug","C0013175;C0018301;C1422069;C1425391;C1539338;C2350813;C4543206","C0014361;C2987634",";C1422069;C1425391;C1539338",1153
"crp mean sd mg $nmbr$","C0024671;C0026410;C0439269;C0444504;C1960952;C2346927;C2347634;C2348143;C2699239;C3890735;C4048285;C4321396;C4521761","C0006560","",286
"weight $ $nmbr$ $nmbr$ kg $nmbr$ $nmbr$ kg n","C0005910;C0043100;C1305866;C1319635;C1705104","C0005910","",1250
"spironolactone n","C0037982","C0037982","",1405
"comparison with placebo mean","C0032042;C0444504;C1696465;C1706408;C1707455;C2347634;C2348143","C0032042","",28
"cardiac","C0018787;C1522601",NULL,NULL,1481
"hazard ratio $nmbr$ ci for adjudicated type $nmbr$ diabetes","C0008107;C1320657;C2985465;C3259781","C2985465","",975
"gusto severe or","C0205082;C4050465;C4050466",NULL,NULL,313
"body mass index kg m","C0005893;C0578022;C1305855;C1532718","C1305855","",1734
"cumulative nsaid score mean sd","C0003211;C0444504;C0449820;C1511559;C2347634;C2348143;C2699239;C3536840;C4050231",NULL,NULL,1287
"$nmbr$ participants","C0679646",NULL,NULL,1033
"baseline medications","C0013227;C0168634;C0802604;C1442488;C2598133;C4284232",NULL,NULL,625
"mean sd postbronchodilator fev $nmbr$ reversibility","C0444504;C0449261;C2347634;C2348143;C2599594;C2699239;C3714541","C0449261;C0231999","",1315
"warfarin n n rate","C0043031;C0871208;C1521828","C0043031","",858
"femoral neck t score","C0015815;C0449820;C4050231",NULL,NULL,748
"no pa","C0030428;C3541314",NULL,NULL,1517
"acr functional class n","C0205245;C0456387;C0542341;C1412134;C1515941;C1518526;C1705943;C2700217",NULL,NULL,52
"colorectal cancer","C0009402;C0346629;C1527249;C2984278;C3542412","C1527249","",1818
"early invasive $nmbr$","C0205281;C1279919;C1334278",NULL,NULL,762
"no prior angina n $nmbr$ $nmbr$","C0002962;C0332152;C2826257","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"group c","C0441837",NULL,NULL,1640
"tender joint count of $nmbr$","C0451530","C0451530","",1139
"high density lipoprotein cholesterol mean sd mmol l","C0023822;C0444504;C1532563;C2347634;C2348143;C2699239","C0023822","",821
"carotid artery diseaset","C0007272;C0162859","C0007272","",1547
"pitavastatin $nmbr$ mg","C0024671;C0026410;C0439269;C1101838;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2296
"receiving antihypertensive treatment n blood pressure mm hg mean sd","C0003364;C0039798;C0087111;C0428886;C0439475;C1514756;C1522326;C1533734;C1705169;C2699239;C3538994;C3887704","C0005823","",1469
"measures mmol l","C0079809;C0242485;C1532563;C1879489",NULL,NULL,2
"time since psa diagnosis years mean sd","C0011900;C0040223;C0439234;C0444504;C1704338;C1704656;C2347634;C2348143;C2699239;C3541383;C3810537;C3813209",NULL,NULL,1099
"systolic blood pressure median $nmbr$ $nmbr$","C0488055;C0549183;C0871470;C0876920;C1306620;C2347635;C2348144;C2939193","C0871470","",615
"toricoxib $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761","C0972314","",1130
"non stent thrombosis related mi","C0439849;C0445223;C1518422;C3810814;C3897493",NULL,NULL,622
"st segment elevation myocardial infarction","C1536220",NULL,NULL,570
"combined cvd","C0007222;C0205195",NULL,NULL,997
"mean sd of predicted normal eevi","C0205307;C0231683;C0439166;C0444504;C0681842;C1882327;C2347086;C2347634;C2348143;C2699239;C4553972","C0024119","",288
"killip class $nmbr$","C1881332","C1881332","",846
"serum sodium meq liter","C0439152;C0475211;C0523891","C0523891","",1379
"black non hispanic","C0005680;C0027567;C0085756;C0439541;C1518422;C1518424;C1533017;C1533018","C0005680",";C1706779",188
"duration of hypercholesterolaemia mean sd year","C0020443;C0439234;C0439508;C0444504;C0449238;C1522133;C2347634;C2348143;C2699239;C2926735","","",1390
"baseline lipid and lipoprotein values","C0023779;C0023820;C0042295;C0168634;C1442488",NULL,NULL,2190
"pah classification","C0008902;C0008903;C0030123;C0678229;C3203102;C4284467",NULL,NULL,265
"aspirin dipyridamole","C0732279","C0004057","",1366
"region pooled","C0017446;C0205147;C1709595;C2349200;C4522255","C0017446","",369
"active cancer at randomization","C0006826;C0034656;C0205177;C0998265;C1306459;C3853793;C3888249","C0006826","",1819
"pioglitazone pts n","C0071097;C1419129;C2698747",NULL,NULL,1760
"two or more antihypertensive medications","C0003364;C0205172;C0205448",";C0003364","",1579
"no regular aspirin use","C0004057;C0042153;C0205272;C0457083;C1947944",NULL,NULL,118
"creatinine ratio $nmbr$ $nmbr$","C0010294;C0456603;C1547037;C1561535","C0600061;C0010294","",952
"unstable angina","C0002965","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"previous disease and drug use","C0012634;C0205156;C0242510;C1552607",NULL,NULL,2120
"medications at study entry no total no","C0013175;C0439175;C0439810;C1705654",NULL,NULL,508
"p value on vs off omt","C1709380",NULL,NULL,254
"fibrofatty mm","C4330985;C4554674",NULL,NULL,1733
"conservative strategy n $nmbr$ $nmbr$","C0679199",NULL,NULL,981
"baseline ldl c $nmbr$ mg dl","C0168634;C0439269;C1442488","C0023824;C1442488","",1964
"bmi n","C0578022",NULL,NULL,1735
"fluvastatin n $nmbr$","C0082608","C0082608","",1222
"limb amputation","C0002689",NULL,NULL,1555
"fasting plasma glucose mmol l $nmbr$","C0015663;C0202042;C0455280;C1532563","C0015663;C0202042","",1960
"nonfatal mi fatal chdt","C1302234;C1705232;C3810814",NULL,NULL,1682
"ace inhibitors through hospital discharge or day $nmbr$","C0003015;C0332173;C0439228;C0439505;C0586003","C0003015","",811
"lumbar epidural","C0581283",NULL,NULL,1558
"st segment depression $nmbr$ $nmbr$ mv","C0520887;C1454484;C1705503;C4281602","C0520887","",1920
"baseline monthly pos seizure rate","C0036572;C0168634;C0332177;C0871208;C1262869;C1442488;C1521828;C1959629;C3496112;C3496399;C4553401",NULL,NULL,2012
"heparin alone n $nmbr$","C0019134;C0205171;C0439044;C0679994;C0770546",NULL,NULL,926
"inflammatory","C0333348",NULL,NULL,156
"estimated mean","C0444504;C0750572;C2347634;C2348143",NULL,NULL,37
"ischemic outcomes","C0475224;C1274040",NULL,NULL,1670
"stratum $nmbr$ inadequate response or intolerance to $nmbr$ bdmards of same moa or $nmbr$ of multiple moa","C0205412;C0231199;C0439064;C0439856;C0445247;C0871261;C1704632;C1706817;C1744706;C2355652;C2911692;C4551881",NULL,NULL,726
"health assessment questionnaire disability index","C4321476",NULL,NULL,1665
"digoxin or digitalis preparations","C0012265;C0304520","C0012265","",989
"fasting cholesterol mg dl","C0008377;C0015663;C0439269",NULL,NULL,2000
"icosapent ethyl events n","C0058978;C0441471;C3541888",NULL,NULL,412
"no pah specific therapy","C0030123;C0039798;C0087111;C0205369;C1363945;C1552740;C3203102;C4284467",NULL,NULL,236
"osteopontin ng ml","C0069676;C0439275;C1420369;C1505427;C4084879",NULL,NULL,204
"heart failure hospitalizations","C3898876","C0018801",";C0168634;C1524003",12
"peripheral neuropathy","C0031117",NULL,NULL,1718
"early n","C1279919",NULL,NULL,1487
"$nmbr$ moto $nmbr$ yr n","C0439234",NULL,NULL,1099
"currently smoker","C0337664;C0521116","C0037369","",420
"body weight at randomization","C0005910;C0034656;C0242821;C0460148;C1268086;C1305866;C2985844;C4082212","C0005910","",1250
"$nmbr$ $nmbr$ o $nmbr$ $nmbr$ oo","C0483204",NULL,NULL,434
"interaction p","C1704675",NULL,NULL,888
"definite acute stent thrombosis","C0205178;C0439544;C1704787;C3897493",NULL,NULL,622
"subject characteristics","C0681884;C1519021;C1706465",NULL,NULL,1652
"stented lesions","C0038257;C0221198",NULL,NULL,472
"v hctz n $nmbr$","C0020261",NULL,NULL,1149
"previous treatment","C0039798;C0087111;C0205156;C1522326;C1533734;C1552607;C1705169;C3538994;C3887704",NULL,NULL,236
"aspirin plus clopidogrel n $nmbr$","C0004057;C0070166;C0332287","C0070166",";C0369286;C0033727;C4049621",217
"ischemic etiology","C0015127;C0475224;C1314792;C1524003",NULL,NULL,924
"pvaluefor interaction $nmbr$ $nmbr$","C1704675",NULL,NULL,1010
"triglycerides median qi q $nmbr$ mmol l","C0041004;C0376586;C0549183;C0876920;C1532563;C2347635;C2348144;C2939193","C0041004","",368
"patients with pulmonary embolism","C0030705;C0034065",NULL,NULL,1035
"no polyvascular disease n $nmbr$ $nmbr$","C0012634",NULL,NULL,1868
"other or missing data","C4684714","C4684714","",1145
"symptoms and feelings","C0683368;C1457887;C1527305",NULL,NULL,613
"treated with insulin","C0021641;C0332293;C1533581;C1579433;C3714501",NULL,NULL,157
"$nmbr$ ci b","C0008107;C3259781",NULL,NULL,519
"history of parental myocardial","C0019664;C0019665;C0027061;C0030551;C0262512;C0262926;C1522564;C1705255;C2004062",NULL,NULL,832
"complex anatomy n $nmbr$ $nmbr$","C0002808;C0439855;C0700276;C1384516;C1704241",NULL,NULL,693
"high disease activity $nmbr$ $nmbr$ n","C0012634;C0205250;C1292728;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209;C4699623","C1292728",";C4050231;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209",101
"dermal","C0221928;C1522447",NULL,NULL,349
"benralizumab q $nmbr$ w n $nmbr$","C2982078",NULL,NULL,947
"antiplatelet therapy dual","C0205173;C1096021;C1554184","","",1191
"mean sd cdai","C0444504;C0683448;C1413248;C2347634;C2348143;C2699239;C3273706",NULL,NULL,697
"self reported disease severity $nmbr$ $nmbr$ scale","C0175659;C0349674;C0521117;C0681906;C1947916;C2700446",NULL,NULL,97
"priorother not predefined medical conditions","C0012634;C0199168;C0205476;C0348080;C1518422;C1705253;C3864998",NULL,NULL,1710
"multiple risk factors","C0035648;C0439064;C1553898",NULL,NULL,175
"rf","C0035448;C0201660;C0748398;C1547111","C0035448","",1435
"l ll","C0439394;C1706495;C3642217",NULL,NULL,663
"drug eluting stent implanted","C0021102;C1322815;C2828363","C1322815","",365
"deep vein thrombosis or pulmonary embolism no","C0034065;C0149871",NULL,NULL,630
"ezetimibe simvastatin n $nmbr$ $nmbr$","C1532737","C0074554","",1840
"who idf impaired fasting glucose","C1272092","C1272092","",20
"vadas score","C0449820;C4050231",NULL,NULL,748
"respiratory rate breaths min","C0231832;C0439386;C0489258","C0231832","",1102
"cardiovascular risk factors and medical history","C0262926;C0850624;C1704706",NULL,NULL,832
"any electrocardiographic abnormality no","C0522055","C0522055","",1314
"fvc predicted mean sd","C0444504;C0681842;C1882327;C2347634;C2348143;C2699239;C3714541",NULL,NULL,1599
"low c $nmbr$ c $nmbr$ and anti dsdna","C0012854;C0205251;C0311474;C1550472;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"score on modified mini mental state examination median iqr","C0549183;C0876920;C2347635;C2348144;C2939193;C4304091",NULL,NULL,635
"reduced hdl cholesterol","C0151691","C0023822","",821
"percent of predicted fev $nmbr$","C1882327;C3714541",NULL,NULL,1599
"moderate ckd at randomization","C0034656;C0205081;C1561643;C1881878;C4049705;C4049706;C4085643;C4321335","C1561643","",967
"definite stent thrombosis","C0439544;C1704787;C3897493",NULL,NULL,915
"no of events no of patients","C0030705;C0441471;C3541888",NULL,NULL,412
"serum creatinine $nmbr$ pmol l n","C0201976;C0439284;C0600061","C0600061;C0010294","",952
"change from baseline to week $nmbr$ in weekly size of largest hive score","C0042109;C0168634;C0221232;C0332174;C0392747;C0439230;C0443172;C0443228;C0449820;C0456389;C1442488;C1705241;C4050231;C4319952",NULL,NULL,1012
"three arm","C0205449;C0446516;C3715044;C4553528",NULL,NULL,950
"$nmbr$ yr since menopause","C0025320;C0439234;C0567312",NULL,NULL,1099
"lack of effectiveness","C0235828",NULL,NULL,2151
"cortteosterom relrsclory status","C0449438",NULL,NULL,543
"creatinine clearance $nmbr$ to $nmbr$ ml min no f","C0016327;C0151280","C0812399",";C3889287;C0452249;C0522467;C1337213;C1576800;C3890003;C0005910;C0022718;C1305866;C1705104;C1705224;C3887665",79
"drinking n","C0001948;C0684271","C0001948","",875
"crp mg l median range","C0439268;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016;C3890735;C4048285","C0006560","",286
"fevi predicted mean sd $nmbr$","C0444504;C0681842;C0849974;C1561566;C1882327;C2347634;C2348143;C2699239;C4528367",NULL,NULL,37
"undetermined","C0205258;C3536725;C4082977",NULL,NULL,1086
"change from baseline in aqlq s score","C0168634;C0392747;C0443172;C0449820;C1442488;C1705241;C4050231;C4055434;C4319952",NULL,NULL,748
"who functional class no c","C0205245;C0456387;C0542341;C1518526;C1705943;C2700217",NULL,NULL,452
"urinary acr mg mmol","C0042027;C0567349;C1412134;C1515941;C1524119;C2348885","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"estimated gfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$","C0017654;C0369637;C0439445;C0441923;C0750572;C1424601","C3811844;C0017654","",592
"female sex n","C0086287","C0086287","",1277
"postmenopausal no hrt","C0232970;C0282402",NULL,NULL,549
"model $nmbr$","C3161035;C3274659;C3714583;C3853906",NULL,NULL,1320
"medications through day $nmbr$","C0013227;C0332173;C0439228;C0439505;C0802604;C2598133;C4284232",NULL,NULL,2263
"post dose","C0439568",NULL,NULL,113
"first medical contact no","C0199168;C0205435;C0205476;C0332158;C0337611;C1279901;C1705415;C3812666",NULL,NULL,639
"fenofibrate n $nmbr$","C0033228","C0033228","",803
"prespecified subgroups","C1079230",NULL,NULL,1637
"statin or ezetimibe","C0360714;C1142985","C0360714;C1142985","",1862
"low $nmbr$ $nmbr$ n $nmbr$ $nmbr$ $nmbr$","C0205251;C1550472;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"number of people n","C0027361;C0237753;C0449788",NULL,NULL,1556
"nateglinide n n","C0903898",NULL,NULL,2047
"sd mg dl","C0439269;C2699239",NULL,NULL,192
"gold group c","C0018026;C0441837;C1304897",NULL,NULL,1640
"lacunar","C0241970;C1459585","C0333559;C0241970","",1216
"glucose lowering therapy n","C0017725;C0039798;C0087111;C0441994;C1363945;C2003888","C0020616",";C0013227;C3244316;C4284232;C0450442;C1254351;C1515187;C1521826;C2826257",33
"baseline crp mg dl","C0168634;C0439269;C1442488;C3890735;C4048285","C0006560","",286
"mean sd mssbp mm hg","C0439475;C0444504;C2347634;C2348143;C2699239","C0005823","",1469
"etoricoxib n $nmbr$ $nmbr$","C0972314","C0972314","",1130
"$nmbr$ bsa psoriasis no","C0033860","C0005902;C0033860","",2177
"urgent revascularizati on","C0439609;C3272275","C0877341;C3272275","",1212
"gly $nmbr$ g bid","C0017890;C0439267;C0523677","","",-10
"statin use at study entry n","C0360714;C0869040;C1705654",NULL,NULL,1588
"subdural epidural","C0038541;C0228134;C0812144",NULL,NULL,585
"atorvastatin $nmbr$ mg n $nmbr$ $nmbr$","C0024671;C0026410;C0286651;C0439269;C1960952;C2346927;C4321396;C4521761","C0286651","",885
"n patients with risk faetors for cv disease aged $nmbr$","C0001779;C0001792;C0007222;C0030705;C0035647;C0369718;C0441922;C1999167;C4552904","C0007222","",1790
"prior immunosuppressant failure","C0021081;C0231174;C0332152;C0680095;C2826257",NULL,NULL,294
"female eze simva $nmbr$","C0043210;C0086287;C1705497;C1705498","C0086287","",1277
"$nmbr$ responder rate n","C0871208;C1521828",NULL,NULL,1103
"cvd without ml troke","C0007222;C0439526;C1705224;C3887665","C0007222","",1790
"ard per $nmbr$ $nmbr$ patient years $nmbr$ ci","C0008107;C0030705;C0439234;C1817569;C1826411;C3259781",NULL,NULL,1099
"no active cancer center level inr percent time","C0040223;C0205177;C0439165;C0441889;C0456079;C0525032;C1513817;C1547707;C1704538;C2946261;C3541383;C3853793;C3888249",NULL,NULL,744
"primary safety end point severe life threatening","C0036043;C0205082;C1546953;C1705187;C2826244;C2986535;C3537125;C4050465;C4050466","C2986535","",230
"index acs","C0600653;C0742343;C0918012;C1552854;C1637833;C2986546;C4318612",NULL,NULL,2147
"baseline lp a mg dl","C0065058;C0168634;C0439269;C1439335;C1442488;C4553379",NULL,NULL,192
"ics nonusers n","C0815320;C4551720","C3540778","",2182
"combined $nmbr$ year cvd","C0007222;C0205195;C0439234;C0439508",NULL,NULL,997
"mucolytics","C0026698",NULL,NULL,1608
"time intervals h","C0033727;C0369286;C0441932;C0564385;C0872291;C4528284",NULL,NULL,756
"atherosclerotic vascular disease history n t","C0004153;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062","C0004153","",1698
"baseline uric acid","C0041980;C0168634;C1442488",NULL,NULL,625
"cigarette smoker no","C0337667","C0037369","",420
"mean sd feno ppb","C0444504;C1415800;C2347634;C2348143;C2699239",NULL,NULL,1737
"time in therapeutic range median iqr","C0040223;C0087111;C0302350;C0460097;C0549183;C0876920;C1554109;C2347635;C2348144;C2939193;C3541383",NULL,NULL,757
"difference in ls means $nmbr$ ci a","C0008107;C0023668;C1704970;C1705241;C1705242;C3259781",NULL,NULL,519
"continued thienopyridine n $nmbr$ $nmbr$","C0549178;C1120149",NULL,NULL,1561
"previous ischemic stroke tia n $nmbr$ $nmbr$ $nmbr$","C0007787;C0205156;C0917805;C0948008;C1054154;C1552607",NULL,NULL,1669
"alpha blocker","C0001641","C0001641","",961
"baseline alc $nmbr$ $nmbr$","C0168634;C1424945;C1442488;C3811058",NULL,NULL,395
"hospitalized angina","C0002962;C0701159","C0701159","",260
"any severity","C0439793;C0522510",NULL,NULL,561
"apob week $nmbr$","C0003593;C0332174;C0439230;C3252643",NULL,NULL,1012
"moderate n $nmbr$","C0205081;C1881878;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"ics users at screening","C0220908;C0220909;C0815320;C1698960;C1706077;C1710031;C1710032;C1710477;C2348164;C4551720","C3540778","",2182
"lung function mean","C0035245;C0444504;C2347634;C2348143",NULL,NULL,37
"race and ss at baseline","C0034510;C0168634;C1442488;C1706779;C2699257;C3853635;C3891295;C4551874",NULL,NULL,388
"oral corticosteroids","C0001617;C0442027;C3539185;C3540725;C3540726;C3540727;C4521986",NULL,NULL,1650
"cardiovascular history","C1880008",NULL,NULL,650
"current smoker at screening n","C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C3173209;C3241966","C3241966","",1420
"lived alone","C0205171;C0439044;C0679994;C1548795;C1634625;C2982691",NULL,NULL,926
"background aha therapy at screening a","C0039798;C0050451;C0087111;C0220908;C0220909;C0772110;C1363945;C1698960;C1706907;C1710031;C1710032;C1710477;C2348164",NULL,NULL,236
"disease duration yr mean sd","C0439234;C0444504;C0872146;C2347634;C2348143;C2699239","C0449238;C0872146","",903
"non ischaemic cardiomyopathy","C0349782;C1518422",NULL,NULL,652
"off pump","C0182537;C1518543",NULL,NULL,1582
"heart disease risk factors","C0741920","","",170
"second serum creatinine","C0201976;C0205436;C0457385;C0565930;C0600061;C1561503;C1705190","C0600061;C0010294","",952
"prior hf n $nmbr$ $nmbr$","C0018488;C0332152;C1313497;C1538440;C2826257;C3273279","C0018801",";C0168634;C1524003",12
"amann whitney u test wilcoxon sum rank test","C0439148;C0667477;C0683443;C0699794;C1515051",NULL,NULL,1740
"$nmbr$ min time","C0040223;C0702093;C1524029;C3541383;C3813700",NULL,NULL,1475
"highest killip classiciation pre pci","C0332152;C0740175;C1522410;C2257086;C3669034;C4049621",NULL,NULL,840
"ups score mean sd","C0334463;C0444504;C0449820;C2347634;C2348143;C2699239;C3542434;C4050231",NULL,NULL,37
"proportion of angioedema free days from week $nmbr$ to week $nmbr$ x","C0002994;C0332174;C0332296;C0439228;C0439230;C1709707;C1880497;C1996904",NULL,NULL,689
"non hispanic non latino","C0086528;C1518424","C0086409","",865
"c reactive protein mg literj","C0006560;C0024671;C0026410;C0439269;C1413716;C1960952;C2346927;C4048285;C4321396;C4521761","C0006560","",286
"change in sbp $nmbr$ months","C0085805;C0392747;C0439231;C0443172;C1705241;C4319952",NULL,NULL,1530
"data are expressed as median sd except","C0549183;C0876920;C1511726;C2347635;C2348144;C2699239;C2939193;C3245479;C3714741",NULL,NULL,1427
"wml load at baseline mri","C0024485;C0168634;C1442488;C1550025;C1704782;C1708715;C1824234;C3890166",NULL,NULL,1056
"orthostatic hypotension","C0020651","C0020649","",1048
"alt u l","C0439339;C1266129;C4553172",NULL,NULL,460
"rentrop score","C0449820;C4050231",NULL,NULL,748
"ck $nmbr$ x uln $nmbr$","C0009212;C0010287;C1519815;C1872855",NULL,NULL,1675
"baseline hs crp tertiles mg i","C0021966;C0024671;C0026410;C0168634;C0221138;C0439269;C1442488;C1960952;C2346927;C3890735;C4048285;C4321396;C4521761",NULL,NULL,1545
"low complement anti dsdna positive n $nmbr$","C0012854;C0311474;C0432633;C0439178;C1446409;C1514241;C2825490;C3812269;C3897137",NULL,NULL,1163
"non ischaemic dilated cardiomyopathy","C1518422;C1960867",NULL,NULL,816
"time since cessation of full dose warfarin therapy","C0039798;C0040223;C0087111;C0178602;C0366686;C0443225;C0869039;C1114758;C1363945;C1880019;C3541383;C4303340",NULL,NULL,236
"dbp $nmbr$ mmhg","C0439475;C0536221;C3813197;C4281799",NULL,NULL,605
"history of cabg","C0010055;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062","C0010055","",389
"mean stents per lesion sd","C0038257;C0221198;C0444504;C1546698;C2347634;C2348143;C2699239",NULL,NULL,472
"region latin american","C0017446;C0205147;C1553378",";C0023122","",1461
"aspirin orother antiplatelet drug","C0004057;C0013227;C0085826;C1254351","","",1191
"age y median iqr","C0001779;C0549183;C0876920;C2347635;C2348144;C2939193","C0001779","",480
"time to first exacerbation","C0040223;C0205435;C1279901;C3541383;C4086268",NULL,NULL,757
"prior hypertension","C0020538;C0332152;C1963138;C2826257","C0020538","",1365
"week o baseline mean sd","C0168634;C0332174;C0439230;C0444504;C1442488;C2347634;C2348143;C2699239",NULL,NULL,1287
"hba $nmbr$ c d","C0012358;C0019016;C1825777;C3538758","","",820
"post bronchodilator percent of predicted fev $nmbr$ sd","C1882327;C2599594;C2699239;C3714541",NULL,NULL,1599
"hit $nmbr$ score","C0272285;C0332159;C0449820;C1708373;C4050231",NULL,NULL,748
"placebo n $nmbr$ subjects","C0032042;C0681850;C1550501;C1696465;C1706203;C1706408;C2349001;C2697811","C0032042","",28
"hypoglycemia","C0020615;C4553659","C0020615","",35
"symptom onset to pci h","C0033727;C0369286;C0441932;C0564385;C4049621;C4086878;C4528284",NULL,NULL,308
"fbg mmol l","C1532563","C0015663;C0202042","",1960
"age $nmbr$ years itt n $nmbr$","C1510829","C1510829","",481
"fatal nonfatal hospitalized heart failure","C0018801;C0018802;C0701159;C1302234;C1705232;C4554158","C0018801",";C0168634;C1524003",12
"established atherosclerotic cardiovascular disease no","C0004153;C0443211;C1272684","C0004153","",1698
"eos count cells pl","C0007584;C0007634;C0750480;C1623465;C1705566;C1861303;C3897966;C4049765","C0014467;C0007584","",1806
"hypercholesterolemia $nmbr$ mg dl","C0020443;C0439269;C1522133","","",1390
"i blocker","C0021966;C0221138",NULL,NULL,963
"no stsd $nmbr$ mm on admission n $nmbr$ $nmbr$","C0184666;C0809949;C4330985;C4554674",NULL,NULL,297
"tg median min max","C0337445;C0549183;C0702093;C0876920;C1524029;C2347635;C2348144;C2939193;C3813700","C0041004","",209
"white non hispanic","C0007457;C0043157;C0220938;C1518422;C1518424;C1533020;C1533021","C0043157","",1402
"metreo modified intention to treat population","C0032659;C0087111;C0162425;C0392747;C1257890;C1283828;C1292734;C1522326;C3889737",NULL,NULL,1064
"canada","C0006823",NULL,NULL,2156
"bnp pg ml","C0054015;C0439297;C1095989;C1417808;C2982014",NULL,NULL,1635
"reason for enrollment in active a","C0150312;C0205177;C0332285;C0392360;C1516879;C1696073;C1707101;C3853793;C3888021;C3888249",NULL,NULL,496
"disease history","C0683519",NULL,NULL,105
"total daily insulin dose u day","C0021641;C0456683;C1533581;C1579433;C2348070;C3714501",NULL,NULL,157
"rate difference lebrikizumab placebo","C0032042;C0871208;C1521828;C1696465;C1705241;C1705242;C1706408;C2981360","C2981360","",373
"insulin and oral hypoglycemic drugs","C0021641;C0359086;C1533581;C1579433;C3714501","C0020616",";C0013227;C3244316;C4284232;C0450442;C1254351;C1515187;C1521826;C2826257",33
"pfor","C1151635",NULL,NULL,235
"$nmbr$ mo mean sd x","C0026544;C0332177;C0444504;C2347634;C2348143;C2699239",NULL,NULL,1476
"treatment with antiplatelet drugs","C3469597",NULL,NULL,2073
"history of impaired renal function","C0019664;C0019665;C0262512;C0262926;C1565489;C1705255;C2004062","C1565489","",937
"baseline lipid parameters mg dl mmol l or g l","C0023779;C0168634;C0439269;C0439294;C0449381;C0456615;C1442488;C1532563",NULL,NULL,670
"seated sbp at $nmbr$ weeks mmhg","C0085805;C0277814;C0439230;C0439475;C1283233",NULL,NULL,607
"any cvd history","C0007222;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"blood pressure mean sd mm hgt","C0428886;C2699239;C4330985;C4554674",NULL,NULL,297
"qualifying type of atherosclerosis n","C0003850;C0004153;C0332307;C1514624;C1547052","C0004153","",1698
"stomach","C0038351;C3714551",NULL,NULL,539
"inter","C0205103;C1548610","","",-10
"in remission at maintenance study baseline","C0024501;C0168634;C0544452;C0557651;C0687702;C1442488;C2603343",NULL,NULL,625
"percentage of patients with event","C0030705;C0439165;C0441471;C1549488;C1561533;C4019010",NULL,NULL,291
"fev $nmbr$ litres post ipratropium mean sd","C0027235;C0444504;C0475211;C0687676;C1704687;C2347634;C2348143;C2699239;C3469826;C3714541",NULL,NULL,1599
"serum creatinine xmol l","C0201976;C0600061","C0600061;C0010294","",952
"sama","C1075468",NULL,NULL,1300
"mean alc","C0444504;C1424945;C2347634;C2348143;C3811058",NULL,NULL,395
"baseline sbp mm","C0085805;C0168634;C1442488;C4330985;C4554674",NULL,NULL,297
"ff $nmbr$ $nmbr$ ci $nmbr$ $nmbr$","C0008107;C3259781;C4554348",NULL,NULL,1597
"dabigatran $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761",NULL,NULL,775
"crp level mean sd mg dl","C0439269;C0441889;C0444504;C0456079;C1547707;C2347634;C2348143;C2699239;C2946261;C3890735;C4048285","C0006560","",286
"surgery","C0038894;C0038895;C0543467;C1274039",NULL,NULL,598
"age $nmbr$ yrs n","C0001779",NULL,NULL,148
"crude model hr $nmbr$ ci","C0008107;C3161035;C3259781;C3274659;C3714583;C3853906","C1439367","",2162
"baseline antihyperglycemic medications n","C0013227;C0020616;C0168634;C0802604;C1442488;C2598133;C4284232",NULL,NULL,366
"$nmbr$ to s $nmbr$ yrs","C0040363;C0041260;C1883351",NULL,NULL,431
"points","C1552961;C2347617;C3714763",NULL,NULL,1135
"ldl c $nmbr$ mg dl","C0439269","C0023824","",1963
"vasodilator","C0042402;C3537240","C0042402","",817
"moderate impairment $nmbr$ to $nmbr$ ml min","C0205081;C0221099;C0439445;C0684336;C1881878;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"placebofigolimumab $nmbr$ mg $nmbr$ mgt","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"median time to event weeks","C0040223;C0439230;C0441471;C0549183;C0876920;C2347635;C2348144;C2939193;C3541383;C4019010",NULL,NULL,635
"neither cs nor imm","C0010182;C0205470;C0271160;C3540510;C4085345",NULL,NULL,136
"medical history and risk factors no total","C0035648;C0262926;C0439175;C0439810;C1553898;C1704706",NULL,NULL,832
"pre treatment n c","C1550147;C2709094;C3539075;C3539076",NULL,NULL,715
"discontinuations","C0457454",NULL,NULL,1562
"race no total no f","C0016327;C0034510;C0439175;C0439810;C1706779;C3853635",";C0034510","",1107
"statin n $nmbr$","C0360714","C0360714","",872
"right coronary artery","C1261316","C1261316","",224
"saxa dapa met n $nmbr$","C0369718;C0428210;C0441922;C1550543;C4317104",NULL,NULL,39
"aphasia","C0003537",NULL,NULL,1523
"jsn mean sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,1287
"sacubitril valsartan n $nmbr$","C4033631","C4033631","",2084
"grade $nmbr$","C0441800;C0919553;C3244287",NULL,NULL,683
"fluticasone alone n $nmbr$","C0082607;C0205171;C0439044;C0679994",NULL,NULL,926
"sbp mm hg median iqr","C0085805;C0439475;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"placebo mean","C0032042;C0444504;C1696465;C1706408;C2347634;C2348143","C0032042","",28
"vildagliptin","C1570906","C1570906","",2068
"lipid lowering","C0023779;C0441994;C2003888",NULL,NULL,1022
"a $nmbr$ n $nmbr$","C0369718;C0441922",NULL,NULL,1553
"oral glucocorticoid use at baseline no t","C0017710;C0168634;C1442488;C1527415;C2603360","C0017710","",1348
"increase in serum creatinine","C0201976;C0442805;C0600061","C0600061;C0010294","",952
"tnf alpha pg ml","C0439297;C1448177;C1456820;C1522669",NULL,NULL,202
"$nmbr$ servings wk n $nmbr$","C0332174;C0439230;C1519269",NULL,NULL,1012
"no baseline immunosuppressant use","C0021081;C0042153;C0168634;C0457083;C1442488;C1947944","C0021081","",1424
"$ $nmbr$ exacerbations","C4086268","C4086268","",889
"ldl cholesterol sd mg dl","C0023824;C0202117;C0439269;C2699239","C0023824","",1963
"prior cardiac resynchronization therapy n","C0332152;C1167956;C2826257",NULL,NULL,1885
"african latin american","C0085756","C0005680",";C1706779",188
"mean sd mg n $nmbr$ $nmbr$ $nmbr$","C0024671;C0026410;C0439269;C0444504;C1960952;C2346927;C2347634;C2348143;C2699239;C4321396;C4521761",NULL,NULL,37
"baseline luts severity n","C0168634;C0439793;C0522510;C0574785;C1442488",NULL,NULL,1658
"partial mayo score","C0449820;C0454788;C0728938;C1077578;C1550516;C4050231",NULL,NULL,425
"positive cu index test","C0022885;C0039593;C0392366;C0439178;C0456984;C0600653;C0918012;C1177210;C1446409;C1514241;C1515976;C1552854;C1637833;C2347872;C2825490;C2986546;C3812269;C3831328;C4318744",NULL,NULL,242
"family history of premature chdj","C0151526;C0205252;C0241889;C4018905","C0241889","",1493
"diabetic eye disease","C0342245","C0342245","",596
"hydralazine","C0020223",NULL,NULL,71
"caucasian race","C0007457","C0043157","",1329
"disease duration year mean sda","C0276477;C0439234;C0439508;C0444504;C0872146;C1428349;C1553165;C2347634;C2348143","C0449238;C0872146","",903
"nyha iii or iv n $nmbr$ $nmbr$","C0022326;C0439070;C1275491;C1705160;C4265176",NULL,NULL,151
"cardiovascular history no total no","C0439175;C0439810;C1880008",NULL,NULL,650
"beta blocker except sotalol","C0001645;C0037707","C0001645","",959
"patient s assessment of pain $nmbr$ $nmbr$ vas","C0042815;C0679830",NULL,NULL,491
"aceis arbs","C3888198",NULL,NULL,44
"$nmbr$ cells ul $nmbr$ $nmbr$","C0439378",NULL,NULL,662
"demographic and clinical characteristics","C0011298;C0683325",NULL,NULL,582
"taking statins n a","C0360714;C1515187","C0360714","",2167
"ischaemic heart disease or cerebrovascular disorder n","C0007820;C0010054;C0151744","C0010054;C0151744","",1361
"coronary bypass surgery","C0010055","C0010055","",389
"non fatal stroke","C0038454;C1302234;C1518422;C1705232;C4554100",NULL,NULL,507
"non caucasian eze simva n $nmbr$","C0007457;C0043157;C1518422","C0043157","",1329
"gusto moderate severe","C0205081;C0205082;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335",NULL,NULL,313
"mean sd pain vas","C0042815;C0444504;C2347634;C2348143;C2699239",NULL,NULL,1751
"se tf total c","C0036919;C0439175;C0439810;C4048299;C4048587",NULL,NULL,567
"semaglutide $nmbr$ $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C3885068;C4321396;C4521761",NULL,NULL,1567
"nationality","C0027473","C0027473","",2159
"dabigatran $nmbr$ vs warfarin p inter","C0043031;C0205103;C1548610;C2348066",NULL,NULL,775
"diastolic mmhg","C0012000;C0439475","C0005823","",1469
"multiple","C0439064",NULL,NULL,330
"cdai","C0683448;C1413248;C3273706",NULL,NULL,697
"non transient risk factors for recurrent vte n","C0035648;C0040704;C0205374;C0439597;C0630906;C1553898",NULL,NULL,175
"non united states","C0041703;C1518422",NULL,NULL,85
"framingham risk score arbitrary units","C0035647;C0439183;C0449820;C3166866;C4050231;C4552904","C3166866;C0035647","",1952
"randomization groups $nmbr$ and $nmbr$","C0034656;C0441833;C0687744;C1257890;C1519504;C1552839;C1705428;C1705429",NULL,NULL,1526
"$nmbr$ i $nmbr$ $nmbr$ $nmbr$ i $nmbr$ $nmbr$","C0021966;C0221138",NULL,NULL,1021
"vilanterol n $nmbr$","C2935023",NULL,NULL,930
"low subgroup","C0205251;C1079230;C1515021;C1550472;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"low hdl cholesterol","C0151691","C0023822","",821
"duplex ultrasonography","C3825392",NULL,NULL,1716
"sex male no","C0086582","C0086582","",1276
"american indian or","C0002460",NULL,NULL,637
"nateglinide n $nmbr$","C0903898",NULL,NULL,2047
"prior use of $ $nmbr$ systemic therapies","C0205373;C0332152;C1514463;C1515119;C1524063;C2826257",NULL,NULL,294
"chd cerebrovascular disease men $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0007820;C0025266;C0280604;C3542407",NULL,NULL,1842
"gout history mean sd years","C0018099;C0019664;C0019665;C0262512;C0262926;C0439234;C0444504;C1705255;C2004062;C2347634;C2348143;C2699239",NULL,NULL,2137
"pulse beats min","C0232117;C0391850;C0702093;C1524029;C1947910;C3813700","C0232117","",1117
"stent thrombosis arc definite probable","C0033204;C0332148;C0439544;C1704787;C3897493",NULL,NULL,915
"usual care n $nmbr$ la","C0023031;C0023749;C0230347;C1947933;C2346906;C3538928;C4553351",NULL,NULL,1849
"exposed","C0332157","C0332157",";C0274281;C0231491;C1420817;C4521367;C4521846;C1552607",27
"aldosterone antagonists e g spironolactone","C0002007;C0037982;C2757004","C0002007",";C0034678;C0525678;C1514727",1758
"prior cancer","C0006826;C0332152;C0998265;C1306459;C2826257","C0006826","",1819
"ex smokers n $nmbr$","C0337671;C4555205","C0037369","",420
"aspirin and other antiplatelet","C0004057","C0004057","",1366
"interval from randomization to angiography","C0002978;C0034656;C1272706;C1552654;C1552713",NULL,NULL,1723
"ld edoxaban vs warfarin","C0043031;C0694649;C2975435","C0043031","",858
"active smoker","C0205177;C0337664;C3853793;C3888249","C0037369","",420
"bp lowering treatments n","C0037623;C0087111;C0441994;C1415692;C1708288;C2003888;C4318478",NULL,NULL,608
"initial heparin treatment duration","C0019134;C0205265;C0444921;C0770546;C1279901;C1555582;C1705685;C3259042","C0019134","",863
"cardiac medications during index hospitalization no","C0013227;C0019993;C0428776;C0802604;C2598133;C4284232",NULL,NULL,2266
"stool frequency subscore","C0015733;C0183622;C0376249;C0439603;C0871396;C1561548;C1705502;C3898838;C4321352",NULL,NULL,1006
"colon only n","C0009368;C0205171;C1720467;C3888384","C0009368","",1971
"serum creatinine level","C0600061","C0600061;C0010294","",952
"estimated creatinine clearancet","C0010294;C0750572;C1561535","C0812399",";C3889287;C0452249;C0522467;C1337213;C1576800;C3890003;C0005910;C0022718;C1305866;C1705104;C1705224;C3887665",79
"cataract","C0086543;C4555209",";C0086543","",1290
"nebivolol n $nmbr$","C0068475",NULL,NULL,679
"percent atheroma volume at baseline","C0168634;C0264956;C1442488;C1690016;C3887614",NULL,NULL,625
"age range years","C1510829;C1514721;C2348147;C3542016","C1510829","",481
"non epa n $nmbr$","C1518422",NULL,NULL,85
"mmrc at baseline","C0168634;C1442488;C3826977",NULL,NULL,625
"delighted","C3830544",NULL,NULL,317
"no vka at randomization","C0034656",NULL,NULL,1352
"bifurcation per lesion","C0184906;C0221198;C1546698;C3146289",NULL,NULL,893
"$nmbr$ o i $nmbr$ mm hg","C0021966;C0221138;C0439475;C0483204",NULL,NULL,1888
"pci indication","C0392360;C3146298;C4049621",NULL,NULL,1713
"interaction p value $nmbr$","C1704675;C1709380",NULL,NULL,7
"prostate volume ml","C0439526;C1441416;C1705224;C3887665","C1441416","",1575
"age yr range","C0001779;C0439234;C1514721;C2348147;C3542016","C0001779","",480
"hazard ratio $nmbr$ ci","C0008107;C2985465;C3259781","C2985465","",975
"symptom free days in the past $nmbr$ weeks","C0332296;C0439228;C0677547;C1444637;C1457887;C1880497;C1996904;C2987125;C3854129;C4284302",NULL,NULL,613
"eular good response","C0205170;C0871261;C1704632;C1706817;C2911692",NULL,NULL,726
"tertile $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ pg ml n $nmbr$","C0439297",NULL,NULL,674
"rosuva $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761","C0965129","",886
"impaired glucose tolerance or impaired fasting glucose","C0271650;C1272092","C1272092","",20
"geometric mean","C2986759","","",241
"normalized volume measures","C0079809;C0242485;C0449468;C1690016;C1705102;C1879489;C1882115;C2700258",NULL,NULL,1119
"rosuvastatin n","C0965129","C0965129","",886
"positive troponin or ck mb","C0010290;C0041199;C0439178;C1446409;C1514241;C2825490;C3812269",NULL,NULL,1603
"ppi but no aspirin","C0004057;C0358591;C0871125;C3811894","C0004057","",1366
"other defined","C1704788;C3539106",NULL,NULL,1200
"de","C0011198;C0017480;C3541240",NULL,NULL,1620
"primary gusto moderate or severe bleeding","C0019080;C0205081;C0205082;C0205225;C0439612;C0439631;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335",NULL,NULL,707
"laa length","C1444754;C1706316",NULL,NULL,1922
"mean $nmbr$ ci change from $nmbr$ $nmbr$ to $nmbr$ $nmbr$ mg","C0008107;C0024671;C0026410;C0392747;C0439269;C0443172;C0444504;C1705241;C1960952;C2346927;C2347634;C2348143;C3259781;C4319952;C4321396;C4521761",NULL,NULL,519
"plasma glucose $nmbr$ hr after glucose load mmol liter","C0202042;C0439190;C0455280;C0475211;C1550025;C1704782;C1708715","C0202042","",1958
"inflammatory disease","C1290884","C0021390","",107
"metoprolol group n $nmbr$","C0025859;C0441848",NULL,NULL,679
"combined ischaemic heart disease and or cerebrovascular disorder","C0007820;C0010054;C0151744;C0205195","C0010054;C0151744","",1361
"carotid artery stenosis n","C0007282","C0007282","",2196
"mean mayo score sd","C0454788;C1077578;C2699239;C3533236",NULL,NULL,425
"rest of world","C0035253;C1622890;C2700280","C2700280","",247
"central south","C0205099;C1710133;C1879652",NULL,NULL,1559
"$nmbr$ $nmbr$ $nmbr$ ci $nmbr$ $nmbr$ $nmbr$ $nmbr$ n $nmbr$ p $nmbr$ $nmbr$","C0008107;C3259781",NULL,NULL,519
"post erior anterior spine","C0037949;C0205094;C0687676;C1704687;C2752558;C3469826",NULL,NULL,1133
"heart rate at rest beats min","C0018810;C0035253;C0702093;C1524029;C1622890;C3813700","C0018810","",1105
"cs and im","C0010182;C0271160;C3540510;C4085345",NULL,NULL,136
"overweight bmi $nmbr$ to $nmbr$","C0497406;C0578022","C0497406","",1248
"ii $nmbr$ ii $nmbr$","C1710602;C4082587",NULL,NULL,521
"microvascular disease history n","C0443258;C0683519",NULL,NULL,105
"fpg change mg dl","C0392747;C0439269;C0443172;C1705241;C4319952",NULL,NULL,192
"baseline procedure n","C0168634;C0184661;C1442488;C2700391;C3274430;C3539779",NULL,NULL,290
"leukopenia","C0023530;C0750394",NULL,NULL,505
"basdai score mean sd","C0444504;C0449820;C1998004;C2347634;C2348143;C2699239;C4050231",NULL,NULL,37
"history of macroalbuminuriat n","C0019664;C0019665;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"p blocker intake at randomisation n $nmbr$ o","C0034656;C0369773;C1512806;C2603361",NULL,NULL,1823
"previous cerebrovascular event","C0205156;C0441471;C1552607;C1880018;C4019010",NULL,NULL,412
"womac pain score","C0582148",";C0030198","",1340
"no cardiovascular disease n $nmbr$","C0007222","C0007222","",1790
"other ics","C0815320;C4551720","C3540778","",2182
"p value for trend across categories","C0683312;C1521798;C1709380;C4554533",NULL,NULL,7
"std n n loopy","C0181687;C0445022",NULL,NULL,1727
"$nmbr$ $nmbr$ $nmbr$ $nmbr$ mg l","C0439268","C0006560","",193
"patients treated set n","C0030705;C0036849;C1442518;C1522326;C1705195",NULL,NULL,552
"$nmbr$ clf","C3540486;C4553190",NULL,NULL,1679
"k rate","C0597277;C0871208;C1521828;C1708601",NULL,NULL,1103
"no previous treatment with infliximab","C0039798;C0087111;C0205156;C0666743;C1522326;C1533734;C1552607;C1705169;C3538994;C3887704","C0666743","",154
"su n","C0038642;C1705534",NULL,NULL,1286
"ldl c calculated mean sd","C0444504;C0444686;C1441506;C2347634;C2348143;C2699239",NULL,NULL,37
"age mean","C0001779;C0444504;C2347634;C2348143","C0001779","",480
"pah classification no","C0008902;C0008903;C0030123;C0678229;C3203102;C4284467",NULL,NULL,265
"body mass index $nmbr$ kg m $nmbr$","C0005893;C0578022;C1305855;C1532718",";C1305855","",206
"all cause death","C0011065;C0015127;C1306577;C1524003;C4082313;C4552775",NULL,NULL,1855
"without dyspnoea","C0013404;C1963100","C0013404","",1227
"aspirin use at baseline","C0004057;C0042153;C0168634;C0457083;C1442488;C1947944","C0004057","",1366
"diabetes mellitus status","C1317301",NULL,NULL,544
"joint swelling","C0152031","C0152031","",1138
"$nmbr$ days definite st","C0036056;C0439228;C0439544;C1704787;C3272372",NULL,NULL,246
"loop diuretic use","C0042153;C0354100;C0457083;C1947944;C3536704","C0354100","",991
"vertebral fracture and or t score s $nmbr$ $nmbr$","C0080179;C0449820;C0718146;C4050231",NULL,NULL,2023
"active or previous cancer","C0006826;C0205156;C0205177;C0998265;C1306459;C1552607;C3853793;C3888249","C0006826","",1819
"not hospitalized for heart failure in the year prior to study enrollment","C0018801;C0018802;C0332152;C0701159;C1516879;C1518422;C1696073;C3258203;C3888021;C4554158","C0018801",";C0168634;C1524003",12
"current tobacco smoker qualifying event","C0040329;C0086707;C0441471;C0521116;C0740009;C1514624;C1705970;C3173209;C3241966;C4019010;C4505217","C3241966","",1420
"hospitalisation related to exacerbation n","C0019993;C0439849;C0445223;C4086268",NULL,NULL,319
"systolic blood pressure mm hg median range","C0439475;C0488055;C0549183;C0871470;C0876920;C1306620;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016",NULL,NULL,635
"nyha class no","C1882083","C0018802;C1882083","",453
"abatacept $nmbr$ mg kg n $nmbr$","C0439272;C1619966","C1619966","",1190
"short term n $nmbr$","C0443303",NULL,NULL,949
"hypertrophic cardiomyopathy","C0007194;C4551472",NULL,NULL,816
"ecg lvh cornell","C0232306","C0232306","",406
"tc mg dl","C0039411;C0040642;C0041405;C0041698;C0439269;C1824670;C3272447;C4522122","C0041004","",368
"egfr ckd epi cystatinc ml min $nmbr$ $nmbr$ m $nmbr$ n","C0162734;C0369637;C0439445;C0441923;C1561643;C1739039;C3811844;C3812682;C4281721","C3811844;C0017654","",592
"no hospitalization in the past $nmbr$ months prior to baseline ref","C0019993;C0168634;C1425988;C1442488;C4331910",NULL,NULL,625
"timi risk score $nmbr$ n","C0035647;C0449820;C4050231;C4552904",NULL,NULL,1954
"smoking history current smoker","C1519384;C3173209;C3241966","C3241966","",1420
"has bled score","C0019080;C0449820;C4050231",NULL,NULL,707
"difference vs pbo","C0031962;C1705241;C1705242",NULL,NULL,435
"evolocumab $nmbr$ mg every $nmbr$ weeks n $nmbr$","C0024671;C0026410;C0439230;C0439269;C1960952;C2346927;C3529352;C4321396;C4521761",NULL,NULL,948
"rhabdomyolysis n $nmbr$","C0035410;C4552660",NULL,NULL,815
"ff $nmbr$ g","C0439267;C4554348",NULL,NULL,1597
"gait","C0016928",NULL,NULL,462
"$nmbr$ $nmbr$ mm hg diastolic blood pressure","C0428883;C0439475;C1305849",NULL,NULL,1888
"cyclosporine n $nmbr$","C0010592;C0010594","C0010594","",1384
"past or current angina pectoris","C0002962;C0521116;C1444637;C1705970;C4284302",NULL,NULL,456
"budesonide budesonide formoterol","C1276807","C1276807","",1159
"$nmbr$ mg day early start","C0439422;C0439659;C1279919",NULL,NULL,1487
"history coronary revascularization","C0019664;C0019665;C0262512;C0262926;C0877341;C1705255;C2004062",NULL,NULL,832
"post bronchodilator","C2599594",NULL,NULL,680
"inhaled anticholinergic","C0004048;C0242896;C3537004",NULL,NULL,167
"mean reversibility","C0444504;C0449261;C2347634;C2348143","C0449261;C0231999","",1315
"sbp dbp mmhg","C0085805;C0439475;C0536221;C3813197;C4281799",NULL,NULL,607
"prior stent","C0038257;C0332152;C2826257",NULL,NULL,569
"egfr $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"very severe copd","C0024117;C1412502;C3641272;C3714496;C4050419","C0024117;C0205082",";C4050419;C1412502;C3714496;C0018026;C1304897;C4050465;C4050466",1836
"coronary artery bypass graft","C0010055;C1260596","C0010055","",389
"glucocorticoids combined with immunosuppressive agents","C0017710;C0021081;C0205195;C3540777;C3540778","C0021081","",1424
"height cm mean sd","C0444504;C0489786;C2347634;C2348143;C2699239","C0489786","",1249
"final timi flow","C0205088;C1546485;C3272266;C3853528",NULL,NULL,531
"$nmbr$ nd and $nmbr$ rd quartile","C0694666;C2828255;C4553350",NULL,NULL,1436
"alt increased","C0205217;C0442805;C1266129;C4553172","C0002594;C0205217","",2227
"at c data","C1511726;C3245479;C3714741",NULL,NULL,1427
"statin with ezetimibe","C0360714;C1142985","C0360714;C1142985","",1862
"dulaglutide $nmbr$ $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C3179549;C4321396;C4521761",NULL,NULL,2276
"total antihypertensive use","C0003364;C0042153;C0439175;C0439810;C0457083;C1947944",NULL,NULL,508
"total n $nmbr$ n","C0439175;C0439810",NULL,NULL,508
"i $nmbr$ years of age","C0021966;C0221138;C1510829","C1510829","",481
"pga score range","C0016410;C0449820;C1514721;C2348147;C3541266;C3542016;C4050231;C4050369",NULL,NULL,1525
"baricitinib $nmbr$ mg daily n $nmbr$","C0024671;C0026410;C0332173;C0439269;C1960952;C2346927;C4044947;C4321396;C4521761","C4044947","",1956
"creatinine clearance no","C0812399","C0812399",";C3889287;C0452249;C0522467;C1337213;C1576800;C3890003;C0005910;C0022718;C1305866;C1705104;C1705224;C3887665",79
"antihypertensive use","C0003364;C0042153;C0457083;C1947944",";C0003364","",1579
"$nmbr$ $nmbr$ ref","C1425988","","",-10
"at end of follow up no total no","C0439175;C0439810;C0444930;C0589120;C1522577;C1704685;C2746065;C3274571",NULL,NULL,1584
"hba $nmbr$ c all countries","C0019016;C0454664;C1825777;C3538758",NULL,NULL,396
"mean age y sd","C0001779;C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"intensity of rest pain mmvas mean sd","C0035253;C0234253;C0444504;C0522510;C1320357;C1622890;C2347634;C2348143;C2699239;C4085211","C0030193","",1338
"current smoker no of patients","C0030705;C3173209;C3241966","C0037369","",420
"egfr via mdrd ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682;C3839656","C3811844;C0017654","",592
"nesiritide n $nmbr$","C0054015",NULL,NULL,1635
"alpha receptor antagonist","C0439095;C2003941;C2350010;C4543207","C0001641","",961
"week $nmbr$ mean sem","C0332174;C0439230;C0444504;C2347634;C2348143",NULL,NULL,36
"patients using concurrent tiotropium","C0030705;C0205420;C0213771;C1524063","C0213771","",1372
"multivessel stenting","C0038257;C2348535",NULL,NULL,569
"rosuvastatin $nmbr$ mg","C0024671;C0026410;C0439269;C0965129;C1960952;C2346927;C4321396;C4521761","C0965129","",886
"hba $nmbr$ c strata","C0019016;C1825777;C3538758","","",820
"change from baseline in mean $nmbr$ h dbp mmhg","C0033727;C0168634;C0369286;C0392747;C0439475;C0441932;C0443172;C0444504;C0536221;C0564385;C1442488;C1705241;C2347634;C2348143;C3813197;C4281799;C4319952;C4528284",NULL,NULL,605
"mean hbaic s d","C0444504;C2347634;C2348143","","",820
"uacr mg mmol interquartile range b","C0567349;C1711350;C2348885",NULL,NULL,187
"tiotropium n $nmbr$","C0213771","C0213771","",1372
"stenting plus medical therapy n $nmbr$","C0038257;C0418981;C2348535",NULL,NULL,640
"other medication usage","C0013227;C0457083;C3244316;C4284232",NULL,NULL,740
"fibrates","C1449704;C3540783",NULL,NULL,1733
"baseline concentration","C0086045;C0168634;C1442488;C1446561;C3827302",NULL,NULL,625
"new onset diabetes","C0011847;C0011849;C0746890","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"angiotensin converting enzyme inhibitor","C0003015;C2757044;C3536837;C4541021","C0003015","",811
"haq di improvement from baseline to week $nmbr$","C0168634;C0332174;C0439230;C1442488;C2986411;C3826998;C4321476",NULL,NULL,1665
"oral corticosteroid dose mg day","C0001617;C0178602;C0439422;C0442027;C0869039;C1114758;C3536709;C4521986",NULL,NULL,110
"baseline hematocrit median iqr","C0018935;C0168634;C0518014;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193","C0518014","",1292
"sedbp mmhg mean _sd d","C0439475;C0444504;C2347634;C2348143;C2699239",NULL,NULL,2127
"hdl c mmol l mg dl","C3642216;C3715113;C3898312",NULL,NULL,1977
"women $nmbr$ cm","C0043210",NULL,NULL,703
"vessel disease","C0042373",NULL,NULL,102
"current prescribed medications","C0521116;C1705970;C3166216;C3202967",NULL,NULL,1417
"duration of","C0449238;C2926735",NULL,NULL,901
"maximum cimt a med an","C0806909;C1552615;C2826546;C4321267","","",1262
"fev $nmbr$ at baseline","C0168634;C1442488;C3714541",NULL,NULL,1599
"patients without clinically evident vascular disease","C0030705;C0042373;C3887511","C0042373","",914
"hscrp mg liter","C0024671;C0026410;C0439269;C0475211;C1960952;C2346927;C4321396;C4521761","C0006560","",286
"not provided","C1518422;C1999230",NULL,NULL,85
"patients with change from baseline in psa modified total shs score $nmbr$","C0030705;C0168634;C0392747;C0439175;C0439810;C0443172;C0449820;C1442488;C1705241;C3810537;C3813209;C3889737;C4050231;C4319952",NULL,NULL,125
"prior vka use for $nmbr$ d","C0042153;C0332152;C0457083;C1947944;C2826257",NULL,NULL,294
"medication","C0013227;C3244316;C4284232",NULL,NULL,366
"jvd $ $nmbr$ cm h $nmbr$ o","C0425687;C0455483",NULL,NULL,1778
"copd exacerbation history in the previous year n","C0019664;C0019665;C0205156;C0262512;C0262926;C0439234;C0439508;C0740304;C1552607;C1705255;C2004062","C0740304","",1987
"cardiac surgery type","C0018821;C0332307;C0524727;C1547052",NULL,NULL,603
"disease hare no i","C0012634;C0021966;C0221138;C0242372;C1425660",NULL,NULL,1279
"prior medications","C0013227;C0332152;C0802604;C2598133;C2826257;C4284232",NULL,NULL,366
"mean number of combined visits hospitalizations","C0205195;C0444504;C0545082;C1512346;C2347634;C2348143;C4086639",NULL,NULL,37
"s $nmbr$ $nmbr$","C0565930;C2603362",NULL,NULL,1784
"symptomatic hypotension with sbp $nmbr$ mm hg","C0020649;C0085805;C0231220;C0439475;C3163620","C0020649","",1048
"angina with documented ischemia","C0002962;C0022116;C1301725;C1609436;C4321499","C0010054;C0151744","",1361
"non dihydropyridine ccbs","C0006684;C0012315;C0220821;C1518422",NULL,NULL,704
"anticoagulants","C0003280","C0003280","",450
"receiving antihypertensive","C0003364;C1514756",";C0003364","",1579
"ischemic heart disease n","C0010054;C0151744","C0010054;C0151744","",1361
"cv","C3538987;C4048877;C4318503",NULL,NULL,1777
"peripheral arterial revascularization","C0003842;C0205100;C0221464;C0581603","C0581603","",1213
"ertugliflozin $nmbr$ mg vs placebo glimepiride","C0024671;C0026410;C0032042;C0061323;C0439269;C1696465;C1706408;C1960952;C2346927;C4079805;C4321396;C4521761","C4079805","",1180
"previous cad n","C0205156;C1504769;C1552607;C2239547;C3813548;C4284121",NULL,NULL,698
"week $nmbr$ n or for cana vs pbo $nmbr$ ci","C0008107;C0031962;C0332174;C0439230;C1418845;C3259781",NULL,NULL,1302
"any other llts other than statin","C0360714;C2347090",NULL,NULL,1763
"age y $nmbr$ th $nmbr$ th percentiles","C0001779;C0039725;C0039738;C1264641;C1420718;C4282123;C4285344","C0001779","",2234
"ff blocker","C4554348",NULL,NULL,1597
"m","C0369637;C0441923",NULL,NULL,923
"pneumonia in past year","C0032285;C4086728",NULL,NULL,2346
"swollen","C0038999",NULL,NULL,1764
"p b int","C1539794;C3272375",NULL,NULL,1264
"any site","C0205145;C1515974;C2825164",NULL,NULL,1193
"race ethnicity white non hispanic","C0007457;C0015031;C0034510;C0043157;C0220938;C0243103;C1518422;C1518424;C1533020;C1533021;C1706779;C3853635",NULL,NULL,787
"i $nmbr$ i $nmbr$ $nmbr$ i $nmbr$","C0021966;C0221138",NULL,NULL,1021
"total phase $nmbr$ pooled n $nmbr$","C0205390;C0369718;C0439175;C0439810;C0441922;C1709595;C1710475;C2349200;C4522255",NULL,NULL,1553
"number resulting in ed visit","C0237753;C0332294;C0449788;C0545082;C1512346;C2826704;C3538926",NULL,NULL,1556
"pre bronchodilator fev $nmbr$ l","C2599602;C3714541",NULL,NULL,1599
"topical","C0332237",NULL,NULL,1125
"characteristic age mean sd yr","C0001779;C0439234;C0444504;C1521970;C2347634;C2348143;C2699239",NULL,NULL,1099
"end of follow up","C0444930;C0589120;C1522577;C1704685;C2746065;C3274571",NULL,NULL,1584
"golimumab $nmbr$ mg $nmbr$ mgt","C0024671;C0026410;C0439269;C1960952;C2346927;C2353893;C4321396;C4521761",NULL,NULL,941
"age at enrolment years","C1510829;C1516879;C1696073;C3888021","C1510829","",481
"ard $nmbr$ cl per $nmbr$ patient years","C0030705;C0439234;C0596019;C1817569;C1826411",NULL,NULL,1099
"age y sd","C0001779;C2699239","C0001779","",480
"enthesitis score mases $nmbr$ $nmbr$ mean sd","C0444504;C0449820;C1282952;C2347634;C2348143;C2699239;C4050231",NULL,NULL,37
"lisinopril chlorthalidone","C0008294;C0065374","C0008294","",70
"years since symptom onset","C0439234;C4086878",NULL,NULL,1099
"insulin oral antidiabetic medication s","C0021641;C0175795;C0442027;C0935929;C1533581;C1579433;C3714501;C4521986",NULL,NULL,995
"p value for trend","C1521798;C1709380;C4554533",NULL,NULL,7
"diagnosis years","C0011900;C0439234;C1704338;C1704656",NULL,NULL,1099
"average dose mg week","C0024671;C0026410;C0178602;C0332174;C0439230;C0439269;C0869039;C1114758;C1510992;C1960952;C2346927;C2825518;C4321396;C4521761",NULL,NULL,192
"ischemic heart disease indicator no n $nmbr$ l","C0010054;C0021212;C0151744;C0369718;C0441922;C1235732;C1522602","C0010054;C0151744","",1361
"intent of conservative strategy","C0162425;C0679199;C1283828;C1550453",NULL,NULL,981
"average age year","C0001779;C0439234;C0439508;C1510992;C2825518","C0001779","",480
"week $nmbr$ outcome","C0332174;C0439230;C1274040",NULL,NULL,1012
"valsartan hctz n n","C0020261;C0216784","C0216784","",1206
"hdl cholesterol mmol l median iqr","C0023822;C0392885;C0549183;C0876920;C1532563;C2347635;C2348144;C2939193","C0023822","",821
"not hispanie latino","C0086528;C1518422","C0086528;C0086409;C0015031","",363
"change meanlse","C0392747;C0443172;C1705241;C4319952",NULL,NULL,767
"all patients on maximally tolerated statin other llt","C0030705;C0360714;C2347090","C0360714","",872
"overall pea population","C0030738;C0032659;C0069964;C0070939;C0282416;C1257890;C1262903;C1561607;C3257529",NULL,NULL,904
"japan and south korea","C0022341;C0022773","C0022341","",1815
"mrf","C0312443;C1412879",NULL,NULL,1543
"revascularisation but no antiplatelets lipid lowering agents or p blockers","C0086440;C0369773;C0581603;C2603361","C0086440","",1773
"$nmbr$ to $nmbr$ ml min per $nmbr$ $nmbr$ m","C0369637;C0439445;C0441923","C3811844;C0017654","",307
"white race no $","C0007457;C0034510;C0043157;C0220938;C1706779;C3853635","C0043157","",1402
"distribution no","C0520511;C1704711",NULL,NULL,892
"$nmbr$ years bmi","C0439234;C0578022",NULL,NULL,1735
"duration of type $nmbr$ diabetes","C0449238;C1320657;C2926735","C0011849;C1320657","",907
"bmi kg m $nmbr$ mean sd a","C0444504;C0578022;C1532718;C2347634;C2348143;C2699239",NULL,NULL,2125
"calcium mmol $nmbr$ $nmbr$","C0006675;C0006726;C0439190;C2936886;C3540037;C3714611","C0006675","",1373
"ace lorarb","C1452534;C4284014",NULL,NULL,46
"left anterior descending coronary artery","C0226032","C0226032","",2098
"elective surgery","C0206058","C0747973","",1169
"other n","C0369718;C0441922",NULL,NULL,742
"$nmbr$ to $nmbr$ mm hg no","C0439475",NULL,NULL,1888
"family history of premature chd","C0151526;C0205252;C0241889;C0280604;C3542407;C4018905","C0241889","",1493
"stratification variables","C0439828;C1514983",NULL,NULL,1018
"diabetes therapy n","C3274787;C3539002",NULL,NULL,556
"intracranial hemorrhage n","C0151699;C4554169","C0151699","",384
"prior history of ml or ischemic stroke","C0019664;C0019665;C0262512;C0262926;C0332152;C0439526;C0948008;C1705224;C1705255;C2004062;C2826257;C3887665",NULL,NULL,300
"mean age years $nmbr$ ci","C0008107;C0444504;C1510829;C2347634;C2348143;C3259781","C1510829","",481
"class ll iv","C0022326;C0456387;C1518526;C1705943;C4265176",NULL,NULL,1257
"nyha ii","C1275491;C1710602;C4082587",NULL,NULL,151
"mean difference $nmbr$ cl","C0444504;C0596019;C1705241;C1705242;C2347634;C2348143",NULL,NULL,658
"one third radius","C0034627;C0205437;C0205447;C1306504",NULL,NULL,1644
"baseline cdr sb n $nmbr$ $nmbr$","C0038111;C0168634;C1442488;C3811240;C4521843",NULL,NULL,696
"baseline to year $nmbr$","C0168634;C0439234;C0439508;C1442488",NULL,NULL,1099
"ra symptom duration year","C0439234;C0439508;C0449238;C1457887;C2926735;C3538806;C3854129;C4048756",NULL,NULL,901
"baseline insulin dose u kg lsm se","C0036919;C0168634;C0366513;C1300561;C1442488",NULL,NULL,567
"pravastatin","C0085542","C0085542","",1841
"mean lipid difference mg dl hdl c","C0023779;C0439269;C0444504;C1705241;C1705242;C2347634;C2348143;C3715113",NULL,NULL,192
"median $nmbr$ $nmbr$ number n","C0237753;C0449788;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"black","C0005680;C0027567;C0085756;C0439541","C0005680",";C1706779",188
"mtx use at baseline","C0025677;C0042153;C0168634;C0457083;C1417487;C1442488;C1947944","C0025677","",1408
"$nmbr$ $nmbr$ ml s m $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n","C0369637;C0439445;C0441923",NULL,NULL,923
"hispanie latino","C0086528","C0086528;C0086409;C0015031","",363
"non frail","C0871754;C1518422",NULL,NULL,1741
"sitagliptin $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1565750;C1960952;C2346927;C4321396;C4521761","C1565750","",1184
"non hdl c mean sd","C0444504;C1518422;C2347634;C2348143;C2699239;C3715113","C0023822","",821
"lesions b $nmbr$ c","C0221198;C1546698",NULL,NULL,472
"liraglutide $nmbr$ $nmbr$ mg day n $nmbr$","C0439422;C1456408","C1456408","",1566
"labs at the index acs event","C0441471;C0587081;C0600653;C0742343;C0918012;C1552854;C1637833;C2986546;C4019010;C4318612",NULL,NULL,734
"benzodiazepine or bzra","C0005064;C3536850;C4048284",NULL,NULL,1538
"indacaterol group n $nmbr$","C0441848;C1722260","C1722260","",1875
"difference in ls mean $nmbr$ $nmbr$ cl","C0023668;C0444504;C0596019;C1705241;C1705242;C2347634;C2348143",NULL,NULL,658
"basal","C0205112","","",-10
"af on baseline ecg n","C0168634;C0344434;C1442488;C1623258;C4049859",";C0004238","",1009
"bmi body mass index bnp brain natriuretic peptide dbp diastolic blood pressure gfr glomerular filtration rate hr heart rate iqr interquartile range kccq kansas city cardiomyopathy questionnaire n number nt n terminal nyha new york heart association sbp systolic blood pressure","C0004083;C0005767;C0005768;C0005823;C0012000;C0017654;C0018787;C0018810;C0027976;C0033095;C0039155;C0054015;C0085805;C0205088;C0229664;C0237753;C0332126;C0439849;C0449788;C0460139;C0536221;C0596306;C0699792;C1095989;C1271104;C1272641;C1275491;C1305855;C1306345;C1417808;C1424601;C1449832;C1561549;C1705314;C1705315;C1711350;C2982014;C3476086;C3476798;C3813197;C3889152;C4050156;C4281799;C4283901;C4284008;C4284038",NULL,NULL,1015
"adjusted hr $nmbr$ ci compared with no diabetes at bl or at year $nmbr$","C0005918;C0006413;C0008107;C0011847;C0011849;C0439234;C0439508;C0456081;C1552663;C1707455;C2827109;C3259781",NULL,NULL,519
"acuity major or","C0205082;C0205164;C0750509;C4318856;C4521762",NULL,NULL,1472
"$nmbr$ cell function","C0007613",NULL,NULL,661
"peripheral artery occlusive disease","C1306889","C0085096","",933
"percutaneous coronary intervention done","C1532338","C1532338","",1661
"n unless otherwise specified","C0205369;C0369718;C0441922",NULL,NULL,1553
"flex baseline bmd t score at lumbar spine meanisd","C0024091;C0168634;C0449820;C1442488;C3887615;C4050231",NULL,NULL,1551
"in therapeutic range for warfarin subjects","C0043031;C0460097;C0681850;C1550501;C1706203;C2349001;C2697811",NULL,NULL,1655
"ankle brachial index","C1328319;C3888326","C1328319","",1233
"cangrelor","C1121991","C1121991","",1247
"patients with low $nmbr$ mg dl c $nmbr$","C0030705;C0205251;C0439269;C1550472;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"previous diabetes mellitus","C0011849;C0205156;C1552607","C0205156;C0011849","",2389
"unprotected left main stented","C0038257;C0205091;C0205225;C0443246;C1542147;C1552822",NULL,NULL,42
"o oi $nmbr$ $nmbr$ $nmbr$ to $nmbr$ $nmbr$","C0029118;C0029434;C0483204","","",-10
"regular aspirin use","C0004057;C0042153;C0205272;C0457083;C1947944",NULL,NULL,118
"total by treatment","C0039798;C0087111;C0439175;C0439810;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,236
"week $nmbr$ baseline","C0168634;C0332174;C0439230;C1442488",NULL,NULL,1012
"median total cholesterol mmol l","C0201950;C0543421;C0549183;C0876920;C1532563;C2347635;C2348144;C2939193","C0543421","",1504
"relative risk comparing icd therapy and placebo","C0021122;C0032042;C0039798;C0087111;C0242492;C1363945;C1696465;C1706408;C1707455","C0972395","",1360
"oral antidiabetes combination therapy without insulina n","C0009429;C0442027;C0556895;C4521986",NULL,NULL,159
"no of hospitalised patients","C0030705",NULL,NULL,1035
"carvedilol","C0054836","C0054836","",1972
"severe ipss $nmbr$ n $nmbr$","C0205082;C1019118;C1998280;C2827405;C3811063;C4050465;C4050466","C1998280",";C1019118;C3811063;C4050465;C4050466;C4049706;C0168634;C1705273;C1880519;C3853603",124
"median sd mg mmol","C0549183;C0567349;C0876920;C2347635;C2348144;C2348885;C2699239;C2939193",NULL,NULL,200
"number of patients","C2360800",NULL,NULL,1811
"death udmi idr","C0011065;C1306577;C4082313;C4552775","C0011065","",220
"intent to use gp iib iiia","C0016011;C0040363;C0041260;C0042153;C0162425;C0457083;C1283828;C1550453;C1883351;C1947944",NULL,NULL,431
"h $nmbr$ receptor antagonist","C0033727;C0369286;C0441932;C0564385;C4528284;C4543207",NULL,NULL,185
"low dose combination therapy","C0009429;C0445550;C0556895;C1708745","C0445550","",112
"flex aln","C0729594;C2681220",NULL,NULL,400
"scale obesity and prediabetes","C0028754;C0175659;C0349674;C0362046;C1947916;C1963185",NULL,NULL,710
"nonvertebral fractures","C0016658",NULL,NULL,2026
"left atrial dimension cm","C0018792;C0439534;C2950135",NULL,NULL,41
"systolic blood pressure $nmbr$ mm hg and diastolic blood pressure $nmbr$ mm hg","C0428883;C0439475;C0488055;C0871470;C1305849;C1306620","C0005823","",1469
"patients with radiographic erosion n n","C0030705;C0333307;C0444708;C1880549;C1959609;C3887524",NULL,NULL,1046
"extensive colitisy","C0205231","C0205231;C0009319","",2063
"p valuea","C0369773;C2603361",NULL,NULL,1872
"mean number of clinically significant asthma exacerbations","C0237753;C0237881;C0349790;C0444504;C0449788;C0750502;C1546944;C2347634;C2348143","C0349790","",890
"previous tnf antagonist use n","C0042153;C0205156;C0231491;C0457083;C1448177;C1552607;C1947944",NULL,NULL,2391
"systemic symptoms","C0205373;C0683368;C1457887",NULL,NULL,613
"due to ecg changes","C0392747;C0443172;C1623258;C1705241;C4319952",NULL,NULL,767
"baseline of induction n","C0168634;C0205263;C0857127;C1442488",NULL,NULL,625
"pre bronchodilator fev $nmbr$ l","C2599602;C3714541",NULL,NULL,682
"current smoker yes","C1549445;C1705108;C1710701;C3173209;C3241966",NULL,NULL,147
"insulin metformin","C0021641;C0025598;C1533581;C1579433;C3714501",NULL,NULL,157
"history of or current cardiac disorders","C0018799;C0019664;C0019665;C0262512;C0262926;C0521116;C1705255;C1705970;C2004062",NULL,NULL,832
"limb sd","C0015385;C2699239",NULL,NULL,1555
"index event n n","C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010",NULL,NULL,412
"rate difference events year","C0439234;C0439508;C0441471;C0871208;C1521828;C1705241;C1705242;C3541888",NULL,NULL,2009
"nt probnp pmol l","C0439284;C0669479;C0754710",NULL,NULL,1511
"aclidinium $nmbr$ g n $nmbr$ a","C0439267;C2699757",NULL,NULL,1485
"stent thrombosis","C3897493",NULL,NULL,622
"abciximab n $nmbr$","C0288672","C0288672","",374
"total n $nmbr$ $nmbr$","C0439175;C0439810",NULL,NULL,508
"mean sd hdl c mg dl","C0439269;C0444504;C2347634;C2348143;C2699239;C3715113",NULL,NULL,192
"use of hormone replacement therapy a","C0282402;C1524063",NULL,NULL,549
"duration of diabetes months","C0011847;C0011849;C0439231;C0449238;C2926735","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"bolus and corrections","C1186706;C1511237;C1705509;C1705565;C1947976;C3812160",NULL,NULL,632
"index stroke $nmbr$ days before randomization no","C0034656;C0439228;C0456712",NULL,NULL,1621
"ret abx facil pci","C0389252;C4049621",NULL,NULL,1736
"streptokinase","C0038418","","",-10
"group a n $nmbr$","C0441848",NULL,NULL,1638
"alc mmol mol","C1424945;C3811058;C3829066",NULL,NULL,668
"act total score $nmbr$ and or improvement from baseline $nmbr$","C0079613;C0168634;C1442488;C1704930;C1869853;C2964552;C2986411;C3890007;C4048375",NULL,NULL,499
"$nmbr$ $nmbr$ mu l mmol l","C0439190;C0439342",NULL,NULL,671
"months from mi median iqr","C0439231;C0549183;C0876920;C2347635;C2348144;C2939193;C3810814",NULL,NULL,635
"acc aha lesion class b $nmbr$ or c n","C0221198;C0456387;C1518526;C1546698;C1705943;C4072694",NULL,NULL,452
"risk model endpoint","C0035647;C2349179;C2826544;C3161035;C3274659;C3714583;C3853906;C4552904",NULL,NULL,1320
"age years mean _ sd sex n","C0009253;C0036864;C0079399;C0444504;C0804628;C1314687;C1510829;C1522384;C2347634;C2348143;C2699239","C1510829","",481
"outcome according to renal function level in ml min","C0022646;C0232804;C0439445;C0441889;C0456079;C0680240;C0935587;C1274040;C1547707;C2946261","C3811844;C0017654","",592
"$nmbr$ year risk of chd","C0439234;C0439508;C1282512",NULL,NULL,1099
"race white n $nmbr$ $nmbr$","C0007457;C0034510;C0043157;C0220938;C1706779;C3853635",";C0034510","",1107
"currently on aha therapy","C0039798;C0050451;C0087111;C0521116;C0772110;C1363945",NULL,NULL,236
"coefficient","C1707429",NULL,NULL,720
"baseline bmi","C0168634;C0578022;C1442488",NULL,NULL,1735
"atenolol strategy","C0004147;C0679199",NULL,NULL,981
"dpp $nmbr$ inhibitor therapy","C0039798;C0087111;C1363945;C1414174;C1999216",NULL,NULL,610
"prior use of synthetic dmards","C0242708;C0332152;C1524063;C1883254;C2826257",NULL,NULL,2377
"cholesterol ng ml","C0008377;C0439275",NULL,NULL,204
"bnp $nmbr$ pg ml n $nmbr$ $nmbr$","C0054015;C0439297;C1095989;C1417808;C2982014",NULL,NULL,1635
"bmi kg m $nmbr$ median range","C0549183;C0578022;C0876920;C1514721;C1532718;C2347635;C2348144;C2348147;C2939193;C3542016",";C1305855","",206
"number of patients with","C2360800",NULL,NULL,1811
"aa","C0282379;C1235746;C1882141;C4554792",NULL,NULL,1754
"mean duration of surgery sd min","C0038894;C0038895;C0444504;C0449238;C0543467;C0702093;C1274039;C1524029;C2347634;C2348143;C2699239;C2926735;C3813700",NULL,NULL,1475
"$nmbr$ months","C0439231",NULL,NULL,1530
"certolizumab group","C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1872109",NULL,NULL,1526
"total cholesterol mg dl","C0201950;C0439269;C0543421","C0543421","",1504
"time since first af diagnosis yrs","C0011900;C0040223;C0205435;C0344434;C1279901;C1704338;C1704656;C3541383;C4049859",NULL,NULL,140
"within $nmbr$ h after","C0033727;C0369286;C0441932;C0564385;C4528284",NULL,NULL,308
"pasi $nmbr$","C4528685",NULL,NULL,1522
"trough fev $nmbr$ response","C0444506;C0871261;C1704632;C1706817;C2911692;C3714541",NULL,NULL,726
"acr $nmbr$ response at week $nmbr$ n","C0332174;C0439230;C0871261;C1412134;C1515941;C1704632;C1706817;C2911692",NULL,NULL,52
"median albumin to creatinine ratio interquartile range","C0486293;C0549183;C0876920;C1318293;C1711350;C2347635;C2348144;C2939193","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"$nmbr$ $nmbr$ $nmbr$ overweight","C0497406","C0497406","",1248
"ff vi n $nmbr$","C0205999;C4554348",NULL,NULL,515
"use of high dose inhaled glucocorticoid no","C0004048;C0017710;C0444956;C1524063","C3540778","",2182
"class v only","C0205171;C0457166;C1720467;C1880098",NULL,NULL,925
"glycopyrronium $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C3814772;C4321396;C4521761",NULL,NULL,192
"weight kg mean $nmbr$ sd","C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209",NULL,NULL,2326
"estimated creatinine clearance $nmbr$ rmb mint","C0452249;C0522467;C0750572;C0812399;C1337213;C1576800;C3890003","C0812399",";C3889287;C0452249;C0522467;C1337213;C1576800;C3890003;C0005910;C0022718;C1305866;C1705104;C1705224;C3887665",79
"pacemaker","C0030163;C0810633;C1546728;C3275122;C3853703",NULL,NULL,503
"randomized $nmbr$ hr after presentation","C0034656;C0449450;C3815594",NULL,NULL,692
"fev $nmbr$ predicted sd","C0681842;C1882327;C2699239;C3714541",NULL,NULL,1599
"systolic blood pressure mmhg interaction p $nmbr$ $nmbr$","C0439475;C0488055;C0871470;C1306620;C1704675","C0005823","",1469
"patients with nail psoriasis mnapsi $nmbr$","C0030705;C0406322",NULL,NULL,1035
"mean sd esr mm h","C0444504;C0456680;C2347634;C2348143;C2699239;C3811131","C1619634","",298
"mra use","C0042153;C0243032;C0457083;C1609165;C1947944;C3891069","","",239
"meglitinides glinides","C0065880;C1579432;C3537178",";C0065880","",1156
"cortical only","C0001613;C0007776;C0022655;C0205171;C1720467",NULL,NULL,792
"difference mepo pbo $nmbr$ ci","C0008107;C0031962;C1705241;C1705242;C3259781",NULL,NULL,435
"low molecular weight heparin only","C0019139;C0205171;C1720467;C3536766","C3536766","",1343
"number of swollen joints $nmbr$ $nmbr$ mean sd","C0038999;C0444504;C0449813;C2347634;C2348143;C2699239",NULL,NULL,1764
"major or clinically relevant non major bleeding","C0019080;C0205082;C0205164;C1518422;C2347946;C4318856;C4521762",NULL,NULL,85
"western","C1705493",NULL,NULL,600
"pb","C1415801;C3819255",NULL,NULL,1737
"bnp $nmbr$ pg ml n $nmbr$","C0054015;C0439297;C1095989;C1417808;C2982014",NULL,NULL,1635
"c reactive proteinc","C0205332","C0006560","",286
"intense physical activity","C0015259;C0026606;C0522510",NULL,NULL,561
"liraglutide","C1456408","C1456408","",1566
"number resulting in emergency department visit","C0237753;C0332294;C0449788;C0545082;C0553618;C0562508;C1512346;C1704729;C2826704",NULL,NULL,1556
"non cabg or combined","C0010055;C0205195;C1518422",NULL,NULL,85
"all randomized all cause mortality or hospitalization for worsening hf","C0015127;C0018488;C0019993;C0026565;C0026566;C0034656;C0332271;C0444868;C1313497;C1457868;C1524003;C1538440;C1546960;C3273279;C3539085;C3815594",NULL,NULL,924
"$nmbr$ $nmbr$ fi $nmbr$","C4050619",NULL,NULL,1598
"physical function $nmbr$ $nmbr$ short form $nmbr$ subscale","C0031843;C0348078;C0376315;C0516981;C0542341;C0597240;C0700205;C0700329;C1282927;C1522492;C1705273;C1806781;C2350002;C2964478;C4049916;C4255237",NULL,NULL,1531
"females n","C0086287","C0086287","",1277
"non smoker","C0337672;C0425293;C4554605","C0037369","",420
"suspected myocardial infarction","C0027051;C0332147;C0428953;C0750491;C2926063;C3810814;C4552959",NULL,NULL,646
"intravenous anticoagulant during hospitalisation","C0003280;C0019993;C0348016;C0848112;C3536711","C0003280;C0019993;C0348016","",2070
"center level ttr","C0032923;C0205099;C0441889;C0456079;C1421224;C1547707;C2946261;C3810851",NULL,NULL,744
"previous a blocker","C0205156;C1552607",NULL,NULL,13
"weight kg median","C0005910;C0022718;C0043100;C0439209;C0549183;C0876920;C1305866;C1705104;C2347635;C2348144;C2939193;C4054209","C0005910","",1250
"racec n","C4287599",";C0034510","",1107
"remission by baseline duration of steroid","C0038317;C0168634;C0814126;C1442488",NULL,NULL,625
"$nmbr$ $nmbr$ $nmbr$ $nmbr$ c $nmbr$ r","C0722969","","",-10
"previous systemic treatment n","C0205156;C0678812;C1552607",NULL,NULL,1044
"terminal ileum","C0227327",NULL,NULL,673
"$nmbr$ years or more","C0205172;C0439234",NULL,NULL,1539
"prior mi n n","C0332152;C2826257;C3810814",NULL,NULL,516
"n events","C0369718;C0441471;C0441922;C3541888",NULL,NULL,412
"enrolled from re cover study no","C0180153;C0556581;C0557651;C1999244;C2603343;C2986904;C3888055;C4684790",NULL,NULL,1730
"blood pressure control","C0005823;C0243148;C1271104;C1272641;C1550141;C1882979;C2587213;C3274648;C4553389",NULL,NULL,675
"table $nmbr$ characteristics of patients treated with losartan and atenolol","C0004147;C0039224;C0126174;C0332293;C0815172;C1706074","C0126174","",1939
"rivaroxaban $nmbr$ mg","C0024671;C0026410;C0439269;C1739768;C1960952;C2346927;C4321396;C4521761","C1739768","",1225
"number of females n","C0086287;C0237753;C0449788","C0086287","",1277
"$nmbr$ $nmbr$ $nmbr$ ci $nmbr$ $nmbr$ $nmbr$ $nmbr$ p $nmbr$ $nmbr$","C0008107;C3259781",NULL,NULL,519
"$nmbr$ mg kg n $nmbr$","C0439272",NULL,NULL,207
"pah therapy at baseline","C0030123;C0039798;C0087111;C0168634;C1363945;C1442488;C3203102;C4284467",NULL,NULL,625
"complete clinical response at week $nmbr$","C0205197;C0332174;C0439230;C3853530;C4055223;C4283785",NULL,NULL,1012
"antidiabetic drug","C0935929",NULL,NULL,995
"missing number n","C0237753;C0449788;C1551393;C1705492;C3272743",NULL,NULL,1556
"time in therapeutic range before inclusion","C0007637;C0040223;C0087111;C0302350;C0460097;C1512693;C1554109;C3541383",NULL,NULL,757
"presence of dactylitis","C0150312;C0239161;C0392148;C3854307",NULL,NULL,2365
"aml n $nmbr$","C0023465;C0023467",NULL,NULL,186
"ncep atp iii metabolic syndrome features n","C0369718;C0439070;C0441922;C0524620;C1521970;C1705160;C1706388;C2346469;C2348519;C2744579;C4552600",NULL,NULL,617
"placebo n $nmbr$","C0032042;C1696465;C1706408","C0032042","",28
"previously taken tnfi","C1883727",NULL,NULL,362
"dmard n $nmbr$","C0242708","C0242708",";C0026544",231
"estimated number of pack years","C0237753;C0449788;C0750572;C1277691","C1277691","",1297
"treatment with statins","C0039798;C0087111;C0360714;C1522326;C1533734;C1705169;C3538994;C3887704","C0360714","",872
"baseline pasi score","C0168634;C0449820;C1442488;C4050231;C4528685",NULL,NULL,1522
"lifestyle behaviors","C0004927;C0023676;C0677505",NULL,NULL,1490
"metformin n $nmbr$ $nmbr$","C0025598","C0025598","",1345
"oab therapy","C0039798;C0087111;C1363945",NULL,NULL,236
"golimumab $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C2353893;C4321396;C4521761",NULL,NULL,941
"creatinine mol l median iqr","C0010294;C0347982;C0549183;C0876920;C1561535;C2347635;C2348144;C2939193","C0600061;C0010294","",952
"any albuminuria no","C0001925","C0001925","",375
"$nmbr$ mg $nmbr$ mgb","C0024671;C0026410;C0373680;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"ptca","C2936173","C1532338","",1661
"blood eosinophil count $nmbr$ mm $nmbr$ at screening no","C0200638;C0750879;C1511226;C4330985;C4554674","C0750879","",848
"st segment depression $nmbr$ mm no","C0520887;C4330985;C4554674","C0520887",";C0011570;C0011581;C0344315;C4049644;C0702240;C4085311;C4084909",1856
"ica stenosis $nmbr$ $nmbr$ f","C0016327;C0201519;C0678234;C1261287;C2632116",NULL,NULL,1651
"exacerbations in previous year","C0205156;C0439234;C0439508;C1552607;C4086268","C4086268","",1991
"used","C1273517",NULL,NULL,535
"corticosteroids excluding budesonide","C0001617;C0054201;C0332196;C2828389;C3539185;C3540725;C3540726;C3540727",NULL,NULL,1650
"secondary kidney composite outcome","C0022646;C0027627;C0175668;C0205199;C0205436;C0227665;C1274040;C1547335",NULL,NULL,1484
"swollen joint count n $nmbr$","C0451521",";C0451521","",1140
"haq di score range $nmbr$ $nmbr$ mean sd","C0444504;C0449820;C1514721;C2347634;C2348143;C2348147;C2699239;C3542016;C3826998;C4050231;C4321476",NULL,NULL,1665
"history of diabetes n","C0011847;C0011849;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"olodaterol $nmbr$ jig","C2934193",NULL,NULL,1510
"caffeine user","C3532939","C0006644",";C1710701",1816
"austral ia new zealand","C0020980;C0027978;C0324547;C0694634;C1947960","C0027978",";C0324547",189
"swollen joint count range $nmbr$ $nmbr$ joints","C0451521;C1514721;C2348147;C3542016",";C0451521","",1140
"long term vitamin k antagonist","C0443252;C1096489;C2267235","C0043031","",858
"allopurinol $nmbr$ $nmbr$ mg n $nmbr$","C0002144;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,1507
"fenofibric acid i moderate dose statin","C0021966;C0060179;C0221138;C0360714;C1709056","C0360714","",872
"current other predefined medical conditions","C0012634;C0199168;C0205476;C0348080;C0521116;C1705253;C1705970;C3864998",NULL,NULL,1710
"on metformin ir or metformin xr $nmbr$ mg d","C0022065;C0022071;C0025598;C0038976;C0043309;C0439422;C1448132;C1707968;C1962945","C0025598","",1345
"italy","C0022277",NULL,NULL,1683
"q $nmbr$ $nmbr$ $nmbr$ q $nmbr$ $nmbr$ $nmbr$ number n","C0237753;C0449788",NULL,NULL,1556
"subgroup w r t re cover","C0180153;C0232024;C0556581;C1079230;C1515021;C1999244;C2986904;C3888055",NULL,NULL,1439
"hf hosp","C0018488;C1313497;C1538440;C3273279","C0018801",";C0168634;C1524003",12
"disease severity","C0521117",NULL,NULL,97
"mean diastolic bp mmhg mean sd","C0428883;C0439475;C0444504;C2347634;C2348143;C2699239",NULL,NULL,1287
"mean age years race","C0034510;C0444504;C1510829;C1706779;C2347634;C2348143;C3853635","C1510829","",481
"males $nmbr$ $nmbr$","C0086582","C0086582","",1276
"ms ng","C0017887;C0028074;C2349943;C3539704;C3713294",NULL,NULL,126
"$nmbr$ $nmbr$ mm","C4330985;C4554674",NULL,NULL,297
"met criterion at final n","C0205088;C0243161;C0428210;C1546485;C1550543;C3853528;C4317104",NULL,NULL,39
"amiodarone vs placebo no hazard ratio $nmbr$ $nmbr$ cl","C0002598;C0032042;C0596019;C1696465;C1706408;C2985465","","",1757
"hispanic or non hispanic ethnic group no f","C0015031;C0016327;C0086409;C1518424;C1879937","C0086409","",865
"premature treatment discontinuation","C0039798;C0087111;C0151526;C0205252;C0457454;C1444662;C1522326;C1533734;C1705169;C3538994;C3887704;C4018905;C4552847",NULL,NULL,1562
"nt estimated","C0332126;C0750572;C1449832;C3889152;C4050156;C4283901;C4284038",NULL,NULL,91
"egfr $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"hba $nmbr$ c difference vs placebo $nmbr$ cl","C0019016;C0032042;C0596019;C1696465;C1705241;C1705242;C1706408;C1825777;C3538758","C0032042","",28
"postdose fev fvc at screening","C0220908;C0220909;C0439568;C1698960;C1710031;C1710032;C1710477;C2348164;C3714541",NULL,NULL,1599
"age at asthma diagnosis years","C0004096;C0439234;C1828181;C2984299;C3173302",NULL,NULL,1099
"diuretic no surgery","C0012798;C0038894;C0038895;C0543467;C1274039",NULL,NULL,598
"difference from placebo $nmbr$ ci","C0008107;C0032042;C1696465;C1705241;C1705242;C1706408;C3259781","C0032042","",28
"additional heparin","C0019134;C0770546;C1524062","C0019134","",863
"number standard care","C0237753;C0449788;C1442989;C1947933;C2828392",NULL,NULL,1482
"acq $nmbr$ total score","C2919686;C2964552",NULL,NULL,540
"asia pacific or other","C0003980","C0003980","",1382
"black n $nmbr$","C0005680;C0027567;C0085756;C0439541","C0005680",";C1706779",188
"apo b mg dl mean sd","C0003593;C0439269;C0444504;C2347634;C2348143;C2699239;C3252643","C0003593","",426
"mild moderate","C1299392",NULL,NULL,322
"difference in ls means $nmbr$ ci","C0008107;C0023668;C1704970;C1705241;C1705242;C3259781",NULL,NULL,519
"multiracial n","C1881928",NULL,NULL,778
"neutrophils $nmbr$ nl","C0027778;C0027950;C0560008;C3892223",NULL,NULL,1805
"acute increase in serum creatinine","C0010294;C0201976;C0205178;C0442805;C0600061;C1546542;C1561535","C0600061;C0010294","",952
"statin","C0360714","C0360714","",872
"ease $nmbr$","C1331418",NULL,NULL,100
"baseline daytime nasal symptoms score mean sd","C0168634;C0231918;C0332169;C0444504;C0449820;C1442488;C2347634;C2348143;C2699239;C4050231",NULL,NULL,37
"baseline tg mg dl median iqr","C0168634;C0337445;C0439269;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193",NULL,NULL,635
"mi type unknown","C0332307;C0439673;C1547052;C3541433;C3810814;C4050014",NULL,NULL,93
"systolic bp","C0871470","C0871470","",615
"prior aspirin","C0004057;C0332152;C2826257","C0004057","",1366
"stent","C0038257",NULL,NULL,569
"immunologic","C0152036;C0205470",NULL,NULL,1261
"$nmbr$ ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923","C3811844;C0017654","",307
"continued thienopyridine","C0549178;C1120149",NULL,NULL,1561
"bmi x $nmbr$ kg m $nmbr$","C0578022;C1532718",NULL,NULL,1735
"ontario and mcmaster universities osteoarthritis index womac can range from $nmbr$ to $nmbr$ for the pain subscale $nmbr$ to $nmbr$ for the stiffness","C0029040;C0029408;C0030193;C0041740;C0427008;C0518090;C0600653;C0918012;C1514721;C1552854;C1637833;C1962977;C2348147;C2984058;C2986546;C3542016;C4085210;C4085211;C4085212;C4553004;C4554132","C0030193","",1338
"non pci hospital ambulance","C0002422;C0019994;C1510665;C1518422;C3846685;C4049621","C0002422",";C4049621",191
"unsuccessful procedure","C0184661;C1272705;C2700391;C3274430;C3539779",NULL,NULL,290
"$nmbr$ mg a","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"biomarker high periostin $nmbr$ ng ml or blood eosinophils $nmbr$ cells per pl t","C0005516;C0005773;C0007584;C0007634;C0014467;C0200638;C0205250;C0219433;C0439275;C1299351;C1424662;C2700149;C3812270;C3887512;C3889660;C3897966;C4049765;C4321237;C4522209","C0014467;C0007584","",1806
"tc mg dl mean sd","C0039411;C0040642;C0041405;C0041698;C0439269;C0444504;C1824670;C2347634;C2348143;C2699239;C3272447;C4522122",NULL,NULL,37
"rf positive number","C0035448;C0201660;C0748398;C1547111;C3812269","C0035448","",1435
"median ml","C0439526;C0549183;C0876920;C1705224;C2347635;C2348144;C2939193;C3887665",NULL,NULL,635
"geometric anti dsdna antibody binding level","C0441889;C0449829;C0456079;C1145667;C1167622;C1547707;C2355607;C2746079;C2946261",NULL,NULL,744
"profound thrombocytopenia $nmbr$ x $nmbr$ l","C0040034;C0392386;C0439808",NULL,NULL,624
"total cholesterohhdl cholesterol ratio","C0201950;C0456603;C0543421;C1547037","C0543421","",1504
"score distribution $nmbr$","C0449820;C0520511;C1704711;C4050231",NULL,NULL,892
"pci or cabg surgery for index event","C0010055;C0038894;C0038895;C0441471;C0543467;C0600653;C0918012;C1274039;C1552854;C1637833;C2986546;C4019010;C4049621",NULL,NULL,412
"penetrating no of resections n","C0015252;C0205321",NULL,NULL,1025
"percent of the time that inr was in the therapeutic range","C0040223;C0439165;C0460097;C0525032;C1704538;C3541383",NULL,NULL,757
"positive hla b $nmbr$ status n","C0439178;C0449438;C1426226;C1446409;C1514241;C2825490;C3812269",NULL,NULL,1803
"hormone refractory prostate carcinoma","C1328504",NULL,NULL,1576
"duration $nmbr$ year n","C0439234;C0439508;C0449238;C2926735","C0449238","",1989
"mean serum cholesterol mg dl","C0439269;C0444504;C0587184;C2347634;C2348143",NULL,NULL,192
"bnp n $nmbr$","C0054015;C1095989;C1417808;C2982014",NULL,NULL,1635
"mtx sio mg week","C0024671;C0025677;C0026410;C0332174;C0439230;C0439269;C1039355;C1417487;C1960952;C2346927;C4321396;C4521761",NULL,NULL,1012
"uc history","C0019664;C0019665;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"disease duration $nmbr$ years n $nmbr$","C0439234;C0872146","C0449238","",1989
"patients without diabetes mellitus n $nmbr$","C0011849;C0030705","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"e $nmbr$ s $nmbr$ vs s $nmbr$","C0565930;C2603362;C3846405",NULL,NULL,132
"s $nmbr$ months","C0439231;C0565930;C2603362",NULL,NULL,1530
"glucagon like peptide $nmbr$ agonist","C0014361;C2987634","C0014361;C2987634",";C1422069;C1425391;C1539338",1153
"rosiglitazone versus metformin","C0025598;C0289313","C0289313","",1761
"coronary heart disease n cardiovascular risk per protocol n very high","C0007226;C0442711;C0442804;C1277690;C1507394;C1522729;C1698058;C2348563;C2599718;C3715209;C3887460;C4282383;C4321397",NULL,NULL,1478
"circumflex","C1880089","C1880089","",2218
"alcohol abuse","C0085762;C4050601",";C0001962","",1053
"$nmbr$ min walk distance ft","C0429886;C0702093;C1524029;C1881534;C3813700;C3890579",NULL,NULL,1475
"corticosteroid use at randomization n","C0034656;C0239126","C0239126",";C0168634;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1425988;C1947944",120
"p valuej","C0369773;C2603361",NULL,NULL,1872
"history of cardiovascular disease","C0455539",NULL,NULL,1494
"hemoglobin a $nmbr$ c","C0019020;C3889898","","",1176
"all non mn","C0026327;C0026405;C1518422;C4285072",NULL,NULL,303
"moderate impairment egfr $nmbr$ $nmbr$ n","C0205081;C0221099;C0684336;C1739039;C1881878;C3811844;C3812682;C4049705;C4049706;C4085643;C4321335","C3811844;C0017654","",592
"neither ace i nor arb use","C0021966;C0042153;C0221138;C0457083;C1452534;C1947944;C3888198;C4284014",NULL,NULL,46
"erythrocyte sedimentation rate mm hour","C0439227;C0564385;C1176468;C1619634;C4330985;C4554674","C1619634","",298
"diabetic therapy use n no therapy","C0039798;C0042153;C0087111;C0241863;C0457083;C1363945;C1947944",NULL,NULL,996
"concomitant dvt no baseline nt probnp no","C0149871;C0168634;C0521115;C0669479;C0754710;C1442488;C2926618;C3899446","C0149871","",252
"laboratory examination","C0260877",NULL,NULL,979
"alprostadil n $nmbr$","C0002335",NULL,NULL,883
"mean change in dbp from baseline mg dl mean sd","C0168634;C0392747;C0439269;C0443172;C0444504;C0536221;C1442488;C1705241;C2347634;C2348143;C2699239;C3813197;C4281799;C4319952",NULL,NULL,192
"randomized treatment","C0034656;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3815594;C3887704",NULL,NULL,236
"filtration rate $nmbr$ $nmbr$","C0016107;C0871208;C1521828","C3811844;C0017654","",592
"sulfonylurea no","C0038766;C3536898","C0038766","",752
"risk factors for pad","C0035648;C0182158;C0332568;C1553898;C3540603;C3669270;C3814046;C4319657",NULL,NULL,1752
"ischaemic etiology n","C0015127;C0475224;C1314792;C1524003",NULL,NULL,924
"concomitant antibiotic use n","C0003232;C0042153;C0457083;C0521115;C1947944",NULL,NULL,118
"history of clinical fracture $nmbr$ years","C0205210;C0439234;C1272071",NULL,NULL,1494
"exenatide lar","C0167117;C1419115;C3814448",NULL,NULL,759
"concurrent medication","C0013227;C0205420;C3244316;C4284232",NULL,NULL,366
"medical conditions no","C0012634;C0199168;C0205476;C0348080;C1705253;C3864998",NULL,NULL,1710
"non st elevation ml","C0439526;C0520886;C1518422;C1705224;C3887665","C3810814","",894
"$nmbr$ amlodipine chlorthalidone","C0008294;C0051696","C0008294","",70
"febuxostat $nmbr$ mg","C0024671;C0026410;C0249529;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2282
"maintenance dose","C3714445","C3714445","",1985
"$nmbr$ mg day delayed start","C0205421;C0439422;C0439659;C1545665;C3272602",NULL,NULL,317
"treatment by subgroup interaction p $nmbr$ $nmbr$","C0039798;C0087111;C1079230;C1515021;C1522326;C1533734;C1704675;C1705169;C3538994;C3887704",NULL,NULL,236
"ff vi $nmbr$ $nmbr$ pg od","C0030827;C0072225;C0205999;C0229089;C0439164;C1266240;C1512019;C3273373;C3665488;C4554348",NULL,NULL,515
"number of prior aeds n","C0180309;C0237753;C0332152;C0449788;C2826257",NULL,NULL,1556
"pooled trials n $nmbr$","C0008976;C1709595;C2349200;C4522255",NULL,NULL,1020
"parenteral anticoagulation","C0003281;C0030547;C2917212;C2919015;C3537050;C4522267",NULL,NULL,1011
"egfr ml min $nmbr$ $nmbr$ m $nmbr$ sd","C0369637;C0439445;C0441923;C1739039;C2699239;C3811844;C3812682","C3811844;C0017654","",592
"previous chf n","C0018802;C0205156;C1552607",NULL,NULL,2388
"diabetes no c","C0011847;C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"previous use of digoxin","C0012265;C0205156;C1524063;C1552607","C0012265","",989
"previous vka use stratified randomization","C0042153;C0205156;C0457083;C1552607;C1947944;C4687737",NULL,NULL,1352
"oral glucocorticoid use","C0017710;C1527415","C0017710","",1348
"warfarin events n y","C0043031;C0441471;C3541888",NULL,NULL,412
"hypertrophy n","C0020564","","",1495
"atenolol n $nmbr$ $nmbr$","C0004147","C0004147","",1055
"history of htn","C0019664;C0019665;C0020538;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"arb ccb n $nmbr$","C0006684;C3888198",NULL,NULL,704
"treatment characteristics","C0039798;C0087111;C1521970;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,236
"mucolytic agent","C0026698",NULL,NULL,1608
"qrs width ms","C0487742;C2349943;C3539704;C3713294",NULL,NULL,126
"serum uric acid difference vs placebo $nmbr$ cl","C0032042;C0455272;C0596019;C0700634;C1696465;C1705241;C1705242;C1706408","C0032042","",28
"modified acc aha lesion class b $nmbr$ or c","C0221198;C0392747;C0456387;C1518526;C1546698;C1705943;C3889737;C4072694",NULL,NULL,452
"mean sd mmhg","C0439475;C0444504;C2347634;C2348143;C2699239",NULL,NULL,1287
"dopa and dopa derivativese","C0013023",NULL,NULL,347
"caucasian simva n $nmbr$","C0007457;C0043157","C0043157","",1329
"one or more medications","C0013227;C0205172;C0205447;C0802604;C2598133;C4284232",NULL,NULL,1539
"seizure reduction from baseline","C0036572;C0168634;C0301630;C0392756;C1293152;C1442488;C1959629;C4551656;C4553401",NULL,NULL,730
"history chd","C0019664;C0019665;C0262512;C0262926;C0280604;C1705255;C2004062;C3542407",NULL,NULL,970
"updrs score","C0449820;C3639721;C4050231",NULL,NULL,748
"pbo mtx mtx","C0025677;C0031962;C1417487","C0025677","",1408
"mean ml min $nmbr$ $nmbr$ m $nmbr$ level no","C0369637;C0439445;C0441889;C0441923;C0444504;C0456079;C1547707;C2347634;C2348143;C2946261",NULL,NULL,923
"enrollment strata prior hospitalization","C0019993;C0332152;C1516879;C1696073;C2826257;C3888021",NULL,NULL,294
"alcohol $nmbr$ drinks per week","C0332174;C0439230;C0556297",";C0001962","",1053
"x cr $nmbr$ $nmbr$ x age","C0001779;C0201975;C3539604;C3711669;C4084730;C4553336;C4553337","C0001779","",480
"$nmbr$ l $nmbr$ mmhg","C0439394;C0439475;C1706495;C3642217","C0005823","",1469
"no prior admc","C0332152;C2826257",NULL,NULL,294
"combined major macrovascular events neohrodathv and all cause mortalitv","C0015127;C0205082;C0205164;C0205195;C0441471;C1524003;C3541888;C4318856;C4521762",NULL,NULL,924
"dfisher s exact test","C0022885;C0039593;C0392366;C0456984;C1515976;C2828393;C3831328;C4050514;C4318744",NULL,NULL,242
"baseline post bronchodilator predicted fev $nmbr$","C0168634;C0681842;C1442488;C1882327;C2599594;C3714541",NULL,NULL,680
"fasting glucose mmol l","C0015663;C0017725;C1532563","C0017725;C0015663","",1846
"qualifying risk factor","C0035648;C1514624",NULL,NULL,175
"age yrs mean sd","C0001779;C0444504;C2347634;C2348143;C2699239","C0001779","",480
"fpg mean sd mg dlf","C0024671;C0026410;C0439269;C0444504;C1960952;C2346927;C2347634;C2348143;C2699239;C4321396;C4521761",NULL,NULL,192
"baseline sildenafil dose mg","C0024671;C0026410;C0168634;C0178602;C0439269;C0529793;C0869039;C1114758;C1442488;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"any anti hypertensive agent","C0003364",";C0003364","",1579
"decline ml yr $nmbr$","C0439234;C0439526;C1705224;C3887665",NULL,NULL,300
"history of extra intestinal manifestations of ibd","C0019664;C0019665;C0021853;C0262512;C0262926;C1280464;C1705255;C1883702;C2004062",NULL,NULL,832
"stent thrombosis or mi","C3810814;C3897493",NULL,NULL,622
"any vte or vte related death no","C0425043;C0630906","C1861172","",318
"ala carriers","C0007294;C0523459;C3888236",NULL,NULL,784
"region n","C0017446;C0205147","C0017446","",369
"systemic sle medications n","C0013227;C0024141;C0205373;C0802604;C2598133;C4284232",NULL,NULL,366
"glucosamine","C0017718","C0017718","",1161
"clopidogrel pretreatment duration","C0070166;C0449238;C1550147;C2709094;C2926735;C3539075;C3539076","C0070166",";C0369286;C0033727;C4049621",217
"ltg naive","C1420817;C4521367;C4521846",NULL,NULL,210
"highest tertile range $nmbr$ $nmbr$ $nmbr$ $nmbr$ mg dl mean sd $nmbr$ $nmbr$ $nmbr$ $nmbr$ mg dl","C0024671;C0026410;C0439269;C0444504;C1514721;C1522410;C1960952;C2346927;C2347634;C2348143;C2348147;C2699239;C3539687;C3542016;C4321396;C4521761",NULL,NULL,37
"mtx other csomards","C0025677;C1417487","C0025677","",1408
"hospitalized heart failure","C0018801;C0018802;C0701159;C4554158","C0018801",";C0168634;C1524003",12
"all participants","C0679646",NULL,NULL,1033
"demographic characteristics","C0683970",NULL,NULL,583
"$nmbr$ mg dl eze simva","C0439269",NULL,NULL,192
"smoking past","C0037369;C0453996;C1444637;C1881674;C4284302","C0037369","",420
"db baseline week $nmbr$","C0168634;C0332174;C0439230;C1418892;C1442488",NULL,NULL,1012
"entocort ec n $nmbr$","C1170256","","",-10
"any blood product transfusion","C0005841;C0199960;C0281867;C0456388;C1514468;C1547007;C1704444;C1879316","C0005841","",1241
"$nmbr$ to $nmbr$ kg m $nmbr$","C1532718",";C1305855","",206
"coronary artery bypass grafting n","C0010055","C0010055","",1843
"$nmbr$ mo $nmbr$ y","C0026544;C0332177",NULL,NULL,1476
"median albumin creatinine ratio g mg","C0024671;C0026410;C0439267;C0439269;C0486293;C0549183;C0876920;C1318293;C1960952;C2346927;C2347635;C2348144;C2939193;C4321396;C4521761",NULL,NULL,1902
"education in years mean sd","C0013621;C0013622;C0013658;C0039401;C0439234;C0444504;C2347634;C2348143;C2699239","C0013658","",1990
"nonsevere hypoglycemia","C0020615;C4553659","C0020615","",35
"no history of mi n $nmbr$ $nmbr$","C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C3810814",NULL,NULL,832
"$nmbr$ regardless of historical count","C0750480;C1552658;C1552723;C1705566;C2004062",NULL,NULL,1389
"lv ejection fraction $nmbr$ and $nmbr$","C0023128;C0489482;C0731033;C1881413;C2700378",NULL,NULL,2106
"hctz hydrochlorothiazide data were missing for some patients","C0020261;C0030705;C1511726;C1551393;C1705492;C3245479;C3272743;C3714741",NULL,NULL,1149
"qmax ml s","C0439390",NULL,NULL,299
"cabg or ptca","C0010055;C2936173","C2936173;C0010055","",1524
"vascular intervention","C0005847;C0184661;C0886296;C1273869;C1558950;C1801960",NULL,NULL,743
"drug therapy at admission no aspirin","C0004057;C0013216;C0013217;C0184666;C0809949","C0004057","",1366
"antiplatelet within $nmbr$ mo before randomization","C0026544;C0034656;C0332177","","",1191
"adverse events leading to premature treatment discontinuation","C0039798;C0087111;C0151526;C0205252;C0332152;C0457454;C0877248;C1444662;C1522326;C1522538;C1533734;C1705169;C1705413;C3538994;C3887704;C4018905;C4552847","C0877248","",1974
"ethnicity not hispanic latino n","C0015031;C0086528;C0243103;C1518424","C0086409","",865
"physical exam oedema","C0013604;C0031809;C1717255",NULL,NULL,690
"fecal calprotectin pg g","C0015733;C0950624;C1335798;C1366582;C1638318","","",780
"age in years mean sd","C0444504;C1510829;C2347634;C2348143;C2699239","C1510829","",481
"$nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ to $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ to $nmbr$ $nmbr$","C0040363;C0041260;C1883351",NULL,NULL,431
"re cover $nmbr$ warfarin","C0043031;C0180153;C0556581;C1999244;C2986904;C3888055","C0043031","",858
"y es","C0013754;C0205944","","",-10
"post bronchodilator fev l","C2599594;C3714541",NULL,NULL,680
"concomitant immunosuppressive and or prior anti tnf use","C0021081;C0042153;C0332152;C0457083;C0521115;C1448177;C1947944;C2826257","C0021081","",1424
"aspirin use at randomization","C0004057;C0034656;C0042153;C0457083;C1947944","C0004057","",1366
"no cs and imm","C0010182;C0205470;C0271160;C3540510;C4085345",NULL,NULL,136
"age s $nmbr$ yr","C0001779;C0439234","C0001779","",480
"very g ood ex cellent","C0439267;C0442824;C2984081;C4267693",NULL,NULL,1485
"female gender","C0086287","C0086287","",1277
"very severe n z $nmbr$","C3641272;C4050419","C3641272",";C0018026;C1304897;C1412502;C4050419;C4050465;C4050466",913
"sf $nmbr$ mcs","C0037712",NULL,NULL,1782
"active cancer at randomisation","C0006826;C0034656;C0205177;C0998265;C1306459;C3853793;C3888249","C0006826","",1819
"retinopathy no","C0035309;C1962966",NULL,NULL,1719
"nominal change","C0392747;C0443172;C1705241;C4319952",NULL,NULL,767
"previous ischemic heart disease no","C0010054;C0151744;C0205156;C1552607","C0010054;C0151744","",1361
"pah etiology","C0015127;C0030123;C1314792;C1524003;C3203102;C4284467",NULL,NULL,924
"dapagliflozin placebo no of events no of patients","C0030705;C0032042;C0441471;C1696465;C1706408;C2353951;C3541888","C0032042","",28
"lipid lowering drug","C0086440","C0086440","",1773
"postoperative glucocorticoid use post randomisation characteristic","C0017710;C0032790;C0034656;C0042153;C0457083;C0687676;C1521970;C1704687;C1947944;C3469826","C0017710","",1348
"weeks","C0439230",NULL,NULL,1012
"female simva $nmbr$","C0043210;C0086287;C1705497;C1705498",NULL,NULL,586
"age at randomization","C0001779;C0034656","C0001779","",480
"autonomic neuropathy","C0259749",NULL,NULL,1718
"male sex no medical history no total no","C0086582;C0262926;C0439175;C0439810;C1704706","C0086582","",1276
"$nmbr$ yr of education no","C0013621;C0013622;C0013658;C0039401;C0439234",NULL,NULL,1099
"medication at time of randomization","C0013227;C0034656;C0040223;C3244316;C3541383;C4284232",NULL,NULL,2263
"mn population n","C0026327;C0026405;C0032659;C1257890;C4285072",NULL,NULL,303
"coronary angioplasty or stenting","C0002997;C0038257;C0190211;C2348535",NULL,NULL,569
"$nmbr$ tob $nmbr$ months","C0439231;C1420851",NULL,NULL,1530
"hdl cholesterol sd mg dl","C0023822;C0392885;C0439269;C2699239","C0023822","",821
"fev $nmbr$ fvc prebronchodilator mean sd","C0444504;C2347634;C2348143;C2599602;C2699239;C3714541",NULL,NULL,1599
"follow up in trial at $nmbr$ yr","C0008976;C0439234;C0589120;C1522577;C1704685;C3274571",NULL,NULL,1099
"other cause n","C0015127;C1524003",NULL,NULL,924
"question $nmbr$ discomfort from any areas tender to touch pressure","C0033095;C0152054;C0205146;C0234234;C0439815;C0460139;C0702221;C1306345;C1522634;C2364135;C4284008;C4319729",NULL,NULL,2238
"tnt and ideal pooled","C1512612;C1709595;C2349200;C4522255","C1709595;C1524024","",211
"history of paroxysmal atrial fibrillation n","C0205311;C0729790","C0235480","",1446
"normal or increased gfr $nmbr$ ml mln per $nmbr$ $nmbr$ m","C0017654;C0205217;C0205307;C0231683;C0369637;C0439166;C0439526;C0441923;C0442805;C1417190;C1424601;C1705224;C2347086;C3815103;C3887665;C4553972",NULL,NULL,300
"cat $nmbr$ n n","C0007450;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282",NULL,NULL,255
"adjusted mean se","C0036919;C0444504;C0456081;C2347634;C2348143",NULL,NULL,37
"antihypertensive treatment n","C0003364;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704",";C0003364","",1579
"incident or worsening nephropathy","C0022658;C0332271;C1457868;C1546960;C1551358","C0332271",";C1538440;C3273279;C1412502",282
"first serum creatinine","C0201976;C0205435;C0600061;C1279901","C0600061;C0010294","",952
"pravastatin vs usual care","C0085542;C1947933;C3538928","C0085542","",1841
"pre bd fvc s $nmbr$ of predicted","C0005126;C0332152;C0681842;C0740175;C1882327;C2257086;C2344255;C3669034;C3714541;C4050145",NULL,NULL,294
"fpg mmol l mean s d","C0439433;C0444504;C2347634;C2348143",NULL,NULL,37
"multivariable or $nmbr$ ci p value","C0008107;C1709380;C3259781",NULL,NULL,7
"pulmonary medications","C0013227;C0024109;C0802604;C2598133;C2707265;C2709248;C4284232;C4522268",NULL,NULL,572
"urinary albumin creatinine ratio median mg g range","C0455271;C0549183;C0876920;C1300563;C1318330;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016",NULL,NULL,635
"took prior antihyperglycemic agent any","C0020616;C0332152;C0450442;C1254351;C1515187;C1521826;C2826257","C0020616",";C0013227;C3244316;C4284232;C0450442;C1254351;C1515187;C1521826;C2826257",33
"female no","C0043210;C0086287;C1705497;C1705498","C0086287","",1277
"dm n $nmbr$ $nmbr$","C0011816;C3250443",NULL,NULL,955
"non cabg related bleeding at $nmbr$ h","C0010055;C0019080;C0033727;C0369286;C0439849;C0441932;C0445223;C0564385;C1518422;C4528284",NULL,NULL,308
"dd n $nmbr$","C3538867;C3814791","","",-10
"other sulfonylurea no","C0038766;C3536898","C0038766","",752
"arterial hypertension","C0020538","C0020538","",1364
"new des n $nmbr$","C0011702;C0205314;C4551552",NULL,NULL,1079
"less than $nmbr$ mm hg","C0439092;C0439475","C0439092","",1749
"hypertension t","C0020538;C1963138","C0020538","",1364
"ticlopidine after completion of study drug","C0013175;C0013227;C0040207;C0205197;C1254351;C1554962;C2348557",NULL,NULL,1837
"serum $nmbr$ oh d concentrations ng ml mean sd","C0220853;C0439275;C0444504;C0683149;C2347634;C2348143;C2699239",NULL,NULL,37
"patent foramen ovale","C0016522;C0344724",NULL,NULL,1745
"no of deaths","C0011065;C1306577",NULL,NULL,323
"associated with corrected congenital shunts","C0009678;C0205202;C0232180;C0332281;C0542331;C1442858;C1744681",NULL,NULL,876
"black and other","C0005680;C0027567;C0085756;C0439541",NULL,NULL,966
"serious infections","C0205404;C3714514",NULL,NULL,916
"duration of diabetes by tertiles","C0011847;C0011849;C0449238;C2926735","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"ldl cholesterol mmol l median iqr","C0023824;C0202117;C0549183;C0876920;C1532563;C2347635;C2348144;C2939193","C0023824","",1068
"apoa $nmbr$ mg dl","C0003592;C0439269;C0523508;C4553344;C4553379",NULL,NULL,2269
"body weiqht","C0242821;C0460148;C1268086;C4082212","C0005910","",1250
"vildagliptin $nmbr$ mg daily glimepiride","C0024671;C0026410;C0061323;C0332173;C0439269;C1570906;C1960952;C2346927;C4321396;C4521761","C1570906","",2068
"prebronchodilator fevj predicted","C0681842;C1882327;C2599602",NULL,NULL,682
"baseline hba $nmbr$ c $nmbr$ $nmbr$ $nmbr$ mmol mol","C0019016;C0168634;C1442488;C1825777;C3538758;C3829066","","",820
"usual care","C1947933;C3538928",NULL,NULL,1849
"$nmbr$ to $nmbr$ ml per $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439526;C0441923;C1705224;C3887665",NULL,NULL,300
"family history of cad diagnosed at $nmbr$ yr of age no cigarette smoker no","C0001779;C0011900;C0241889;C0337667;C0439234;C1504769;C2239547;C3813548;C4284121",NULL,NULL,86
"history of ml or ischemic stroke","C0019664;C0019665;C0262512;C0262926;C0439526;C0948008;C1705224;C1705255;C2004062;C3887665",NULL,NULL,832
"prior lgi event","C0332152;C0441471;C2826257;C4019010",NULL,NULL,294
"semaglutide exposure nmol l","C0274281;C0332157;C0439282;C3885068",NULL,NULL,1567
"low density lipoprotein cholesterol","C0023824","C0023824","",1068
"other vascular disease cvd or pad","C0007222;C0042373;C0182158;C0332568;C3540603;C3669270;C3814046;C4319657",NULL,NULL,742
"monthly","C0332177",NULL,NULL,1476
"luts bph characteristics","C0005001;C0574785;C1521970;C1704272",NULL,NULL,1658
"positive ctnl n $nmbr$","C0439178;C1446409;C1514241;C2825490;C3812269",NULL,NULL,1163
"evaluable for acr $nmbr$ at week $nmbr$ n","C0332174;C0439230;C1412134;C1515941;C1516986",NULL,NULL,1012
"family history ol diabetes","C1313937",NULL,NULL,1491
"patients treated with insulin","C0021641;C0030705;C0332293;C1533581;C1579433;C3714501",NULL,NULL,157
"systolic bp mmhg","C0439475;C0871470","C0005823","",1469
"high sensitivity c reactive protein mg ltt","C0006560;C0024671;C0026410;C0439269;C1413716;C1441604;C1960952;C2346927;C4048285;C4321396;C4521761","C0006560","",286
"mean sd baseline scores","C0168634;C0444504;C0449820;C1442488;C2347634;C2348143;C2699239;C4050231",NULL,NULL,1287
"severity of copd n","C0024117;C0439793;C0522510;C1412502;C3714496",NULL,NULL,1546
"labs at randomization","C0034656;C0587081",NULL,NULL,805
"egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n $nmbr$ $nmbr$","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"time from onset of pain to randomization median $nmbr$ th $nmbr$ th percentiles n","C0030193;C0034656;C0039725;C0039738;C0449244;C0518090;C0549183;C0876920;C1264641;C1420718;C1962977;C2347635;C2348144;C2939193;C2984058;C4085210;C4085211;C4085212;C4282123;C4285344;C4553004;C4554132","C0030193;C0449244;C0034656","",2169
"age at randomization years","C0034656;C1510829","C1510829","",481
"hosp for hf","C0018488;C1313497;C1538440;C3273279","C0018801",";C0168634;C1524003",12
"aspirin use p $nmbr$ $nmbr$ t","C0004057;C0042153;C0457083;C1947944","C0004057","",1366
"nfs $nmbr$ $nmbr$ low","C0205251;C1550472;C1555018;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"s $nmbr$ vs placebo","C0032042;C0565930;C1696465;C1706408;C2603362","C0032042","",28
"index pci performed","C0600653;C0884358;C0918012;C1552854;C1637833;C2986546;C4049621",NULL,NULL,576
"creatinine mg dl urinary albumin to creatinine ratio","C0010294;C0439269;C0456603;C1547037;C1561535;C2362049","C0600061;C0010294","",952
"cvd or mi","C0007222;C3810814",NULL,NULL,516
"congestive hf","C0018488;C0742742;C1313497;C1538440;C3273279","C0018801",";C0168634;C1524003",12
"creatinine mg dl mean","C0010294;C0439269;C0444504;C1561535;C2347634;C2348143","C0600061;C0010294","",952
"connective tissue disease","C0009782","C0009782","",108
"no cardiac disease","C0018799","C0018799","",1278
"modified rankin scale no","C2984908;C3854213",NULL,NULL,89
"baseline killip class","C0168634;C1442488;C1881332","C1881332","",846
"all cause mortality per $nmbr$ person years","C0015127;C0026565;C0026566;C0027361;C0439234;C0444868;C1524003;C2347489;C3539085",NULL,NULL,1099
"biack non hispanic","C1518424","C0086409","",865
"dulaglutide $nmbr$ $nmbr$ mgf","C1366394;C3179549;C3712803;C3887684",NULL,NULL,1568
"predicted fev $nmbr$","C0681842;C1882327;C3714541",NULL,NULL,1599
"ras target dose","C0034678;C0178602;C0525678;C0869039;C1114758;C1521840;C2986546",NULL,NULL,110
"with acei arb","C3888198",NULL,NULL,44
"mean s d total pcsk $nmbr$ ng ml","C0439175;C0439275;C0439810;C0444504;C2347634;C2348143",NULL,NULL,37
"fevt fvc ratio","C0016529;C0456603;C1547037;C3714541",NULL,NULL,1599
"overall study period","C0282416;C0439531;C0557651;C1561607;C1948053;C2603343",NULL,NULL,575
"and infusion","C0574032;C1827465",NULL,NULL,1242
"ipss ls mean se","C0023668;C0036919;C0444504;C1019118;C1998280;C2347634;C2348143;C2827405;C3811063",NULL,NULL,567
"symptomatic hypotension sbp $nmbr$ mmhg","C0020649;C0085805;C0231220;C0439475;C3163620","C0020649","",1048
"gds score","C0449820;C0451184;C1149049;C1418244;C4050231",NULL,NULL,748
"renal function egfr according to mdrd n","C0232804;C0680240;C1739039;C3811844;C3812682;C3839656","C0232804","",1532
"abbreviations ace angiotensin converting enzyme bmi body mass index calculated as weight in kilograms divided by height in meters squared dm diabetes mellitus hba $nmbr$ c hemoglobin a $nmbr$ c hmg coa $nmbr$ hydroxy $nmbr$ methylglutaryl coenzyme a asome subjects took more than $nmbr$ oral anti dm drug in addition to metformin and thus the total number of concomitant oral anti dm drugs in the columns exceed the n values in the colesevelam hydrochloride and placebo group headings bsulfonylureas include chlorpropamide glibenclamide glimepiride glipizide and tolazamide cthiazolidinediones include pioglitazone pioglitazone hydrochloride rosiglitazone and rosiglitazone maleate d glucosidase inhibitors include acarbose or miglitol","C0000723;C0005910;C0008287;C0009226;C0011816;C0011849;C0013227;C0017628;C0017642;C0019016;C0019046;C0022709;C0025598;C0029167;C0032042;C0040372;C0042295;C0043100;C0050393;C0061323;C0066535;C0073187;C0175795;C0205120;C0205172;C0289313;C0304289;C0332173;C0332257;C0332287;C0332849;C0369718;C0439209;C0441074;C0441833;C0441922;C0442027;C0444686;C0489786;C0521115;C0541154;C0681850;C0687744;C0700307;C0795660;C0872972;C1185738;C1254351;C1257890;C1305855;C1305866;C1441506;C1512211;C1515187;C1519504;C1550501;C1552595;C1552866;C1696465;C1705104;C1705428;C1705429;C1706132;C1706203;C1706408;C1825777;C2349001;C2697811;C2700399;C3250443;C3538758;C4288115;C4484261;C4521986;C4553328","","",-10
"rf or acpa positive","C0035448;C0201660;C0439178;C0748398;C1446409;C1514241;C1525410;C1547111;C1706063;C2825490;C3812269",NULL,NULL,2059
"spondylitis","C0038012","C0038012","",269
"acq $nmbr$ score mean sd e","C0444504;C0449820;C2347634;C2348143;C2699239;C2919686;C4050231","C2919686","",1293
"white other","C0007457;C0043157;C0220938","C0043157","",1402
"imm only","C0205171;C0205470;C1720467",NULL,NULL,1261
"body mass indexf $nmbr$","C0518010","C1305855","",1734
"aspirin at enrollment","C0004057;C1516879;C1696073;C3888021","C0004057","",1366
"vka only reason","C0205171;C0392360;C1720467",NULL,NULL,1713
"mean bmi sd","C0444504;C0578022;C2347634;C2348143;C2699239",NULL,NULL,1287
"selected medications no","C0013227;C0802604;C1707391;C2598133;C4284232",NULL,NULL,366
"lv function $nmbr$ $nmbr$ and $nmbr$ $nmbr$ n medications n of patients","C0013227;C0023128;C0030705;C0031843;C0369718;C0441922;C0542341;C0700205;C0731033;C0802604;C1705273;C1881413;C2598133;C4284232",NULL,NULL,1531
"central eastern","C0205099;C1707877;C1879652",NULL,NULL,677
"uncontrolled on basal insulin","C0205318;C0650607","C0205318","",332
"ics tiotropium n $nmbr$ placebo n $nmbr$","C0032042;C0213771;C0815320;C1696465;C1706408;C4551720","C0032042","",28
"insulin tx difference vs pbo median change from baseline se $nmbr$","C0021641;C0031962;C0036919;C0041403;C0168634;C0392747;C0443172;C0549183;C0876920;C1442488;C1533581;C1579433;C1705241;C1705242;C2347635;C2348144;C2939193;C3714501;C4319952",NULL,NULL,435
"body mass index categories no c","C0005893;C0578022;C0683312;C1305855","C1305855","",1734
"bmi $nmbr$ no $","C0578022",NULL,NULL,1735
"$nmbr$ $nmbr$ ft","C1881534;C3890579",NULL,NULL,248
"duration of clopidogrel pretreatment hr median","C0070166;C0449238;C0549183;C0876920;C1550147;C2347635;C2348144;C2709094;C2926735;C2939193;C3539075;C3539076","C0070166",";C0369286;C0033727;C4049621",217
"gastrointestinal gi disorders","C0017178;C1708130;C3539617;C4050121",NULL,NULL,1610
"eosinophils $nmbr$ $nmbr$ x $nmbr$ $nmbr$ itt n $nmbr$","C0014467;C0200638","C0014467","",849
"due to drug relateda sae","C0013227;C1254351;C1519255;C1622657;C4553214","C1519255","",1282
"dyslipidaemia n","C0242339","C0242339","",1770
"glycemic status f","C0016327;C1320980","C1320980","",2174
"serum glucose mmol l","C0202041;C1532563;C3534430",NULL,NULL,670
"asia excluding japan","C0003980;C0022341;C0332196;C2828389",NULL,NULL,1864
"n analysed","C0369718;C0441922",NULL,NULL,1553
"baseline heart failure severity nyha class i","C0018801;C0018802;C0168634;C0439793;C0522510;C1442488;C1882084;C4554158","C0018802;C1882083","",453
"any of the above","C1282910;C1552828",NULL,NULL,739
"$nmbr$ cl interaction","C0596019;C1704675",NULL,NULL,658
"asdas crp $nmbr$ $nmbr$","C3890735;C4048285",NULL,NULL,1545
"racea white","C0007457;C0043157;C0220938",NULL,NULL,2004
"nausea","C0027497;C1963179;C2984057;C3829611;C4084796;C4085222;C4085661;C4085862;C4255480;C4552888;C4552889;C4553767","C0027497","",2230
"hormone replacement therapy use","C0042153;C0282402;C0457083;C1947944",NULL,NULL,549
"su tzd","C0038642;C1705534","C0038766","",752
"patients randomised n","C0030705;C0369718;C0441922",NULL,NULL,1035
"pfo asa","C0004057;C3853627",NULL,NULL,60
"no of coronary vessels with $nmbr$ diameter stenosis","C0010075;C0678234;C1261287;C1301886;C2632116",NULL,NULL,1651
"ldl c $nmbr$ $nmbr$ mmol l","C1532563","C0023824","",1068
"intermediate risk ri $nmbr$","C0035487;C1826843;C3640764",NULL,NULL,172
"any pulmonary medication n","C0013227;C0024109;C2707265;C2709248;C3244316;C4284232;C4522268",NULL,NULL,572
"heart failure criteria met","C0018801;C0018802;C0243161;C0428210;C1550543;C4317104;C4554158","C0018801",";C0168634;C1524003",12
"ace inhibitor at last follow up","C0003015;C0589120;C1522577;C1704685;C3274571;C4541021","C0003015","",811
"hip fracture $nmbr$","C0019557;C0149531;C4552776","C0019557","",1114
"prior cabg before index acs","C0010055;C0332152;C0600653;C0742343;C0918012;C1552854;C1637833;C2826257;C2986546;C4318612","C0010055","",389
"history of diabetes n $nmbr$","C0011847;C0011849;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"mean age y","C0001779;C0444504;C2347634;C2348143","C0001779","",480
"received $nmbr$ prior anti tnf therapies n","C0279936;C0332152;C0432633;C1514756;C2826257",NULL,NULL,294
"prior om","C0028971;C0332152;C1705272;C2826257",NULL,NULL,294
"atherosclerosis n","C0003850;C0004153","C0004153","",1698
"osteoporosis","C0029456;C4554622",NULL,NULL,564
"n $nmbr$ fatty acit","C0369718;C0441922",NULL,NULL,1553
"syncope","C0039070;C3541349;C4554644",NULL,NULL,616
"age category n","C0001779;C0683312;C3889287",NULL,NULL,562
"woman","C0043210;C4281745","C0043210",";C3541888;C1720467",1323
"abl sc n n","C0023139;C0282380;C1704928;C3890208","C4042342","",1284
"current non smoker","C0425311","C0037369","",420
"patients with $nmbr$ $nmbr$ ml increase in fev $nmbr$ post bronchodilator","C0030705;C0439526;C0442805;C1705224;C2599594;C3714541;C3887665",NULL,NULL,300
"canakinumab il $nmbr$ middle tertile","C0020898;C0021764;C0022271;C0444598;C0549183;C1552826;C2718773","C2718773","",372
"arbs or ace inhibitors","C0003015;C3888198",NULL,NULL,44
"standing after $nmbr$ minute change from baseline","C0168634;C0231472;C0392747;C0439232;C0443172;C0700321;C0702093;C1282918;C1442488;C1705241;C2347166;C4319952",NULL,NULL,625
"ii chiorthaiidone amiodipine","C1710602;C4082587",NULL,NULL,521
"previous vte n","C0205156;C0630906;C1552607","C1861172","",2399
"patients with glycated hemoglobin $nmbr$ $nmbr$ and no severe hypoglycemia or diabetic ketoacidosis","C0011880;C0017853;C0020615;C0030705;C0205082;C4050465;C4050466;C4553659",NULL,NULL,313
"mean difference seb","C0059386;C0444504;C1309881;C1423585;C1705241;C1705242;C2347634;C2348143;C3815268",NULL,NULL,37
"emphysema itt n $nmbr$","C0013990;C0034067",NULL,NULL,1672
"romania","C0035826",NULL,NULL,998
"mild iief ef $nmbr$ $nmbr$","C2945599;C3641331",NULL,NULL,329
"low molecular weight heparin","C0019139;C3536766","C3536766","",1343
"fpg mmol l mean sd","C0444504;C1532563;C2347634;C2348143;C2699239","C0015663;C0202042","",1960
"waist circumference mean sd cm","C0444504;C0455829;C2347634;C2348143;C2699239","C0455829","",1413
"n l $nmbr$","C0369718;C0441922",NULL,NULL,1553
"rate ratio mepo pbo $nmbr$ ci","C0008107;C0031962;C0456603;C0871208;C1521828;C1547037;C3259781",NULL,NULL,973
"not on metformin","C0025598;C1518422",NULL,NULL,85
"corticosteroids $nmbr$","C0001617;C3539185;C3540725;C3540726;C3540727",NULL,NULL,1650
"previous antiparkinson medication no","C0003405;C0205156;C1552607",NULL,NULL,1045
"urine albumin creatinine mg mmol","C0455271;C0567349;C1318330;C2348885","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"ls mean difference vs placebo $nmbr$ ci","C0008107;C0023668;C0032042;C0444504;C1696465;C1705241;C1705242;C1706408;C2347634;C2348143;C3259781","C0032042","",28
"medications at discharge","C0806915","C0806915","",1946
"mean sd n","C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"karnofsky score $nmbr$","C0206065;C0449820;C4050231",NULL,NULL,748
"ace inhibitors or arbs","C0003015;C3888198",NULL,NULL,44
"a $nmbr$ c mmol mol","C3829066",NULL,NULL,668
"history of second prior mi n","C0019664;C0019665;C0205436;C0262512;C0262926;C0332152;C0457385;C0565930;C1561503;C1705190;C1705255;C2004062;C2826257;C3810814",NULL,NULL,832
"smoking status current smoker n $nmbr$","C1519386;C3173209;C3241966","C3241966","",1420
"sokoiow lyon voitage mv","C1454484;C1705503;C4281602",NULL,NULL,1776
"estimated gfr no $nmbr$","C0017654;C0750572;C1424601","C3811844;C0017654","",592
"mean crp level mg l sd","C0439268;C0441889;C0444504;C0456079;C1547707;C2347634;C2348143;C2699239;C2946261;C3890735;C4048285","C0006560","",286
"$nmbr$ ae","C3887670","C0877248","",47
"gold group b","C0018026;C1304897;C4522078","C0024117;C0521117","",213
"ischaemic n $nmbr$ l $nmbr$","C0475224",NULL,NULL,1670
"np tercile $nmbr$ bnp $nmbr$ pg ml nt probnp $nmbr$ $nmbr$ pg ml n $nmbr$","C0054015;C0065827;C0439297;C1095989;C1317554;C1417808;C1706141;C2825907;C2982014;C3887659;C4284038",NULL,NULL,1635
"fasting triglyceride level mean sd mg dl","C0015663;C0428475;C0439269;C0444504;C2347634;C2348143;C2699239",NULL,NULL,2281
"alt units l","C0439339;C1266129;C4553172",NULL,NULL,460
"structural","C0678594",NULL,NULL,585
"ff $nmbr$ pg n $nmbr$","C0030827;C0072225;C1266240;C4554348",NULL,NULL,208
"ejection fraction based on local reading","C0034754;C0205276;C0489482;C1527178;C1705179;C1705938;C2700378;C4284139","C2700378","",887
"china","C0008115",NULL,NULL,772
"less than $nmbr$ $nmbr$","C0439092","C0439092","",1749
"moderate severity","C0205081;C0439793;C0522510;C1881878;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"physical characteristics","C0031809;C0205485;C1509143;C1521970",NULL,NULL,1519
"urgent vascular hospitalization","C0005847;C0019993;C0439609;C1558950;C1801960;C3272275",NULL,NULL,743
"death or stent thrombosis","C0011065;C1306577;C3897493;C4082313;C4552775",NULL,NULL,622
"no atopy n $nmbr$","C0392707;C3539705","C0392707","",1412
"hba $nmbr$ c mean sd","C0019016;C0444504;C1825777;C2347634;C2348143;C2699239;C3538758","","",820
"evening mealb","C0587117",NULL,NULL,800
"s $nmbr$ $nmbr$ s $nmbr$ $nmbr$","C0565930;C2603362",NULL,NULL,1784
"p interactio n","C0369773;C2603361",NULL,NULL,1874
"night time awakenings in past $nmbr$ weeks prior to baseline","C0168634;C0860510;C1442488;C2987125",NULL,NULL,1014
"ace arb","C1452534;C3888198;C4284014",NULL,NULL,46
"sitagliptin oad","C1565750","C1565750","",1184
"history ol chd at baselines","C0019664;C0019665;C0168634;C0262512;C0262926;C0280604;C1705255;C2004062;C3542407",NULL,NULL,970
"all subjects n","C0369718;C0441922;C0681850;C1550501;C1706203;C2349001;C2697811",NULL,NULL,1655
"elderly","C0001792;C1999167",NULL,NULL,1489
"score $nmbr$ $nmbr$","C0449820;C4050231",NULL,NULL,748
"exercise status","C0015259;C0449438;C1522704","C0015259","",1380
"time since diagnosis of heart failure","C0011900;C0018801;C0018802;C0040223;C1704338;C1704656;C3541383;C4554158","C0018801",";C0168634;C1524003",12
"coexisting conditions","C0679225",NULL,NULL,1710
"previous antihypertensive treatment","C0003364;C0039798;C0087111;C0205156;C1522326;C1533734;C1552607;C1705169;C3538994;C3887704",";C0003364","",1579
"perianal gi tract","C0017189;C0442158","C0442158","",1039
"hrql mean sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,1287
"atrial fibrillation duration no","C0004238;C0344434;C0449238;C1963067;C2926735","C0004238","",90
"no stroke tia","C0007787;C0038454;C0917805;C1054154;C4554100",NULL,NULL,1762
"killip class ii iii or iv","C0022326;C0439070;C1705160;C1710602;C2697845;C2697846;C4082587;C4265176",NULL,NULL,524
"cardiac medications during index hospital stay and or discharge","C0012621;C0013227;C0030685;C0428776;C0802604;C2598133;C2926602;C3489408;C4284232",NULL,NULL,390
"everolimus","C0541315",NULL,NULL,633
"abl sc mean","C0023139;C0282380;C0444504;C1704928;C2347634;C2348143;C3890208","C4042342","",1284
"enoxaparin only","C0205171;C0206460;C1720467",NULL,NULL,925
"$nmbr$ type","C0332307;C1547052",NULL,NULL,603
"symptomatic hypotension","C0020649;C0231220;C3163620","C0020649","",1048
"linagliptin","C2746078","C2746078","",1185
"history of falls in year before randomization","C0034656;C0439234;C0439508;C1561668;C2919132",NULL,NULL,1099
"ada yes","C1060325;C1549445;C1705108;C1710701;C3811629",NULL,NULL,1076
"age mean sd years n","C0444504;C1510829;C2347634;C2348143;C2699239","C1510829","",481
"concomitant pd medications at baseline n c d","C0013227;C0168634;C0521115;C0802604;C1442488;C2598133;C4284232;C4553228;C4553229",NULL,NULL,366
"systolic bp mm hg mean sd","C0039155;C0439475;C0444504;C0488053;C0871470;C2347634;C2348143;C2699239","C0005823","",1469
"no previous dmard mean sd","C0205156;C0242708;C0444504;C1552607;C2347634;C2348143;C2699239",NULL,NULL,37
"medication use at baseline no","C0168634;C0240320;C1442488",NULL,NULL,625
"pcr after acs","C0032520;C0742343;C3853643;C4050242;C4318612",NULL,NULL,1294
"omega $nmbr$ fatty acid vs placebo least squares mean $nmbr$ cl","C0015684;C0023189;C0032042;C0444504;C0596019;C1696465;C1706408;C1719844;C2347634;C2348143","C0032042","",28
"median body weight kg","C0005910;C0022718;C0043100;C0439209;C0549183;C0876920;C1305866;C1705104;C2347635;C2348144;C2939193;C3821165;C4054209",NULL,NULL,2326
"no pts","C1419129;C2698747",NULL,NULL,1512
"any cardiovascular diseased","C0007226;C3887460",NULL,NULL,649
"symptom onset to hospitalization","C0019993;C4086878",NULL,NULL,612
"motor updrs subscore baseline mean sd","C0168634;C0444504;C1442488;C1513492;C1705994;C2347634;C2348143;C2699239;C3639721",NULL,NULL,1473
"pain vas","C0042815",NULL,NULL,1751
"menopause and ht","C0018510;C0025320;C0567312;C0677607","C0282402","",1043
"sbp sd","C0085805;C2699239",NULL,NULL,607
"drug relateda","C0013227;C1254351",NULL,NULL,367
"beyond popliteal pedal","C0016504;C0442037;C0687080",NULL,NULL,936
"$nmbr$ $nmbr$ o $nmbr$ s i $nmbr$","C0021966;C0221138;C0483204","","",-10
"$nmbr$ aspirin n $nmbr$ $nmbr$","C0004057","C0004057","",1366
"recent","C0332185","","",413
"risk factors no","C0035648;C1553898",NULL,NULL,175
"$nmbr$ to $nmbr$ iu l","C0439457",NULL,NULL,1252
"baseline egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$","C0168634;C0369637;C0439445;C0441923;C1442488;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"crp concentration $nmbr$ mg l n \","C0086045;C0439268;C1446561;C3827302;C3890735;C4048285",NULL,NULL,1545
"seropositivity","C0521143","C0521143","",1318
"cv medication of patients","C0013227;C0030705;C3244316;C3538987;C4048877;C4284232;C4318503",NULL,NULL,2266
"death with pe not","C0011065;C0070939;C1306577;C1518422;C1880476;C4082313;C4284304;C4552775",NULL,NULL,1516
"ii iii","C0439070;C1705160;C1710602;C4082587",NULL,NULL,524
"of patients","C0030705",NULL,NULL,1035
"czp mtx","C0025677;C0054841;C1417487;C1861828;C1872109","C0025677;C1872109","",2217
"definite","C0439544;C1704787",NULL,NULL,915
"q wave mi","C0861151","C1305738","",385
"hdl female","C0043210;C0086287;C1705497;C1705498;C3715113","C0023822","",821
"phospholipid omega $nmbr$ levels $nmbr$ n $nmbr$","C0031676;C0202177;C0441889;C1719844","C0015684","",1236
"b those on inhaled corticosteroids and long acting bronchodilators as previous treatment use","C0001617;C0004048;C0006280;C0039798;C0042153;C0079613;C0087111;C0205156;C0205166;C0457083;C1522326;C1533734;C1552607;C1704930;C1705169;C1706317;C1869853;C1947944;C3538994;C3539185;C3540725;C3540726;C3540727;C3887704;C3890007;C4048375",NULL,NULL,1650
"time since first copd diagnosis years","C0011900;C0024117;C0040223;C0205435;C0439234;C1279901;C1412502;C1704338;C1704656;C3541383;C3714496",NULL,NULL,1099
"rvalue for interaction","C1704675",NULL,NULL,1010
"demographic disease characteristics at baseline","C0011298;C0012634;C0168634;C0599878;C0683970;C1442488;C4684572",NULL,NULL,1652
"pioglitazone group n $nmbr$","C0071097;C0441848",NULL,NULL,1638
"bp control","C0037623;C0243148;C1415692;C1550141;C1708288;C1882979;C2587213;C3274648;C4318478;C4553389",NULL,NULL,675
"methotrexate use at randomization","C0025677;C0034656;C0042153;C0457083;C1947944","C0025677","",716
"elevated hscrp","C0205250;C3163633",NULL,NULL,833
"any adverse event leading to study drug discontinuation n","C0013175;C0040363;C0041260;C0332152;C0457454;C0877248;C1444662;C1522538;C1883351;C4552847","C0877248","",1974
"ige ku l median range c","C0439340;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016",NULL,NULL,635
"age is $nmbr$ vrs significant ecg changes and no positive bi omark ers","C0001779;C0237881;C0439178;C0458261;C0750502;C0855329;C1446409;C1514241;C1546944;C1704489;C2825490;C2931783;C3273608;C3812269",NULL,NULL,1311
"$nmbr$ $nmbr$ $nmbr$ $nmbr$ mm","C4330985;C4554674",NULL,NULL,297
"cvd without ml stroke","C0007222;C0038454;C0439526;C1705224;C3887665;C4554100","C0007222","",1790
"atherothrombotic infarction n","C0021308","C0021308","",1288
"patients with $nmbr$ exacerbations resulting in hospital admission","C0030705;C0184666;C0678226;C4086268","C4086268","",889
"estimated glomerular filtration rate n","C3811844","C3811844;C0017654","",592
"not localized","C0392752;C1518422",NULL,NULL,85
"spacer use during the study","C0221874;C0869040",NULL,NULL,535
"systolic blood pressure mean sd mm hg","C0039155;C0428886;C0439475;C0444504;C0488055;C0871470;C1306620;C2347634;C2348143;C2699239","C0005823","",1469
"southern europe","C0037724","","",-10
"secondary prevention cohort","C0009247;C0599755;C0679699","C0599755;C0679699","",2210
"l compared wit","C0043197;C0439394;C1706495;C1707455;C3642217","","",-10
"previous mi n","C0205156;C1552607;C3810814",NULL,NULL,516
"between treatment comparison of percentage change from baseline in total hip bmd","C0019552;C0022122;C0168634;C0439165;C0439175;C0439810;C1299575;C1442488;C1505163;C1549488;C1561533;C1707455;C3538851;C4284725",NULL,NULL,508
"previous stroke or transient ischemic attack no total","C0007787;C0038454;C0205156;C0439175;C0439810;C0917805;C1552607;C4554100",NULL,NULL,1762
"mean bmi kg m $nmbr$ s d","C0022718;C0439209;C0444504;C0578022;C1512018;C2347634;C2348143;C4054209",NULL,NULL,1735
"ci confidence interval na not applicable or not analyzed","C0008107;C0009667;C0597484;C0936012;C1272460;C1518422;C1546968;C1879645;C3259781;C4049872;C4552882",NULL,NULL,519
"median c reactive protein mg liter","C0006560;C0024671;C0026410;C0439269;C0475211;C0549183;C0876920;C1413716;C1960952;C2346927;C2347635;C2348144;C2939193;C4048285;C4321396;C4521761",NULL,NULL,192
"cardiovascular medication usage","C0007220;C0457083","C0007220","",897
"odds ratio $nmbr$ cl","C0028873;C0596019",NULL,NULL,974
"valve repair replacement only","C0035139;C0043240;C0184252;C0205171;C0374711;C0559956;C1186983;C1555302;C1704414;C1720467;C3888056;C4319951;C4553149","C0374711;C0184252",";C1704414;C3888056;C0035139;C0043240;C4553149;C1720467",8
"nptercile $nmbr$ bnp $nmbr$ $nmbr$ pg ml nt probnp $nmbr$ $nmbr$ $nmbr$ pg ml n $nmbr$","C0054015;C0439297;C1095989;C1317554;C1417808;C2825907;C2982014;C4284038",NULL,NULL,1635
"d mi idr st","C0036056;C0073187;C0332173;C3272372;C3810814;C4484261",NULL,NULL,1833
"sokolow lyon voltage mm","C0598352;C4330985;C4554674",NULL,NULL,297
"re medy","C0556581;C2986904",NULL,NULL,1439
"baseline triglycerides $nmbr$ mg dl","C0041004;C0168634;C0439269;C1442488","C0041004","",368
"lack of efficacy with $nmbr$ bdmard","C0235828",NULL,NULL,2151
"index event","C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010",NULL,NULL,412
"previous $nmbr$ ari use","C0042153;C0205156;C0457083;C1412533;C1552607;C1947944;C4521376",NULL,NULL,1044
"previous digoxin use","C0012265;C0042153;C0205156;C0457083;C1552607;C1947944","C0012265","",989
"valsartan n n","C0216784","C0216784","",1206
"p o","C0369773;C2603361",NULL,NULL,1823
"hospitaiization for angina","C0002962","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"no symptoms","C0683368;C1457887",NULL,NULL,613
"triglyceride mmol l t","C0041004;C1532563","C0041004","",368
"geographic region other","C0017446","C0017446","",369
"bmi kg m $nmbr$ n","C0578022;C1532718",NULL,NULL,1735
"apo a i","C0085201;C1677784","C0085201","",1852
"age years median n $nmbr$ $nmbr$","C0549183;C0876920;C1510829;C2347635;C2348144;C2939193","C1510829","",481
"$nmbr$ years of age n","C1510829","C1510829","",481
"insulins","C0021641;C3537244;C4049919",NULL,NULL,161
"biguanide","C0005382;C3537187;C4317165","C0005382","",685
"time from symptom onset to enrollment","C0040223;C0449244;C1457887;C1516879;C1696073;C3541383;C3854129;C3888021;C4086878",NULL,NULL,339
"placebo adjusted mean difference in hba $nmbr$ c $nmbr$ ci p value","C0008107;C0019016;C0032042;C0444504;C0456081;C1696465;C1705241;C1705242;C1706408;C1709380;C1825777;C2347634;C2348143;C3259781;C3538758",NULL,NULL,519
"non ischaemic cause","C0015127;C0475224;C1518422;C1524003",NULL,NULL,1670
"mean diastolic blood pressure sd mm hg","C0012000;C0428883;C0428886;C0439475;C0444504;C0488053;C1305849;C2347634;C2348143;C2699239","C0005823","",1469
"baseline pfd m","C0016065;C0168634;C0369637;C0441923;C1442488;C1839454;C2827389;C3889643",NULL,NULL,625
"ls mean change from baseline","C0023668;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C4319952",NULL,NULL,767
"median iqr cholesterol","C0008377;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"neutropenia","C0023530;C0027947;C0853697",NULL,NULL,505
"elevated troponin $nmbr$ $nmbr$ mg l","C0041199;C0205250;C0439268;C3163633",NULL,NULL,1605
"nyha functional class n","C0205245;C0542341;C1882083;C2700217",NULL,NULL,1531
"with highest hba $nmbr$ cc","C0008318;C0019016;C1522410;C1825777;C3538758;C3538933","","",820
"ldl cholesterol mg dl mean sd available for $nmbr$ patients","C0023824;C0030705;C0202117;C0439269;C0444504;C0470187;C2347634;C2348143;C2699239","C0023824","",1963
"iga mod $nmbr$ score n","C0011860;C0449820;C2825347;C4050231",NULL,NULL,1768
"supplemental oxygen","C4534306","C4534306","",1327
"ics use at screening n","C0042153;C0220908;C0220909;C0457083;C0815320;C1698960;C1710031;C1710032;C1710477;C1947944;C2348164;C4551720","C3540778","",2182
"egfrmdrd ml min $nmbr$ $nmbr$ $nmbr$ m_ $nmbr$","C0369637;C0439445;C0441923","C3811844;C0017654","",592
"final a $nmbr$ c","C0205088;C1546485;C3853528",NULL,NULL,1680
"latin american","C1553378",";C0023122","",1461
"long i $nmbr$ years duration of diabetes","C0011847;C0011849;C0021966;C0221138;C0439234;C0439591","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"previous stenting previous pci","C0038257;C0205156;C1552607;C2348535;C4049621",NULL,NULL,569
"no cvd","C0007222","C0007222","",1790
"race or ethnic background no f","C0015031;C0016327;C0034510;C1706779;C3853635",";C0034510","",1107
"patient assessment of disease activity mm","C0679830;C1292728;C4330985;C4554674",NULL,NULL,491
"with alogliptin $nmbr$ mg","C0024671;C0026410;C0439269;C1958126;C1960952;C2346927;C4321396;C4521761","C1958126","",1183
"efficacy","C1280519;C1707887","C1707887;C2349179","",1122
"macce death mi stroke","C0011065;C0038454;C1306577;C3810814;C4082313;C4552775;C4554100",NULL,NULL,323
"adjusted rate of pneumonia events per patient year mean $nmbr$ ci","C0008107;C0030705;C0032285;C0439234;C0439508;C0441471;C0444504;C0456081;C0871208;C1521828;C2347634;C2348143;C3259781;C3541888",NULL,NULL,519
"first disease progression outcome to occur","C0040363;C0041260;C0205435;C0242656;C0449258;C0679250;C1274040;C1279901;C1335499;C1709305;C1883351;C1947900;C2745955;C3542417;C4284875;C4552808",NULL,NULL,431
"hr $nmbr$ $nmbr$ $nmbr$ cl $nmbr$ $nmbr$ $nmbr$ $nmbr$ p $nmbr$ $nmbr$","C0596019",NULL,NULL,658
"single vessel disease n","C0037179;C0042373;C0087136;C0205171",NULL,NULL,102
"rosiglitazone $nmbr$ mg daily","C0024671;C0026410;C0289313;C0332173;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2298
"baseline serum k meq l","C0168634;C0302353;C0439375;C1442488",NULL,NULL,625
"lung","C0024109",NULL,NULL,477
"continuous lvef $nmbr$ treatment interaction","C0039798;C0087111;C0428772;C0488728;C0549178;C1522326;C1533734;C1704675;C1705169;C3538994;C3887704","C0018801;C0428772","",1273
"prior mesalazine use","C0042153;C0127615;C0332152;C0457083;C1947944;C2826257",NULL,NULL,118
"gastrointestinal major bleed","C0017181;C0205082;C0205164;C4318856;C4521762","C0019080;C0205082","",2076
"framingham $nmbr$ year cv risk score","C0035647;C0439234;C0439508;C0449820;C3166866;C3538987;C4048877;C4050231;C4318503;C4552904",NULL,NULL,1099
"beta blocker at last follow up","C0001645;C0589120;C1522577;C1704685;C3274571","C0001645","",959
"depressed only","C0205171;C0344315;C0549249;C1720467",NULL,NULL,925
"estimated cv risk at baseline","C0168634;C1442488;C1519101;C3538987;C4048877;C4318503",NULL,NULL,1777
"risk group","C0242444",NULL,NULL,172
"any antihypertensive drug","C0003364",";C0003364","",1579
"ltg exposed","C0332157;C1420817;C4521367;C4521846","C0332157",";C0274281;C0231491;C1420817;C4521367;C4521846;C1552607",27
"$nmbr$ $nmbr$ yr no","C0439234",NULL,NULL,1099
"previous coronary intervention","C0018787;C0184661;C0205156;C0886296;C1273869;C1552607","C1532338","",1661
"p value int","C1709380;C3272375",NULL,NULL,1264
"caucasians n $nmbr$","C0007457;C0043157","C0043157","",1329
"first generation stentt","C0079411;C0205435;C1279901;C3146294",NULL,NULL,806
"high risk and fewer symptoms group c","C0205388;C0332167;C0441837;C0683368;C1457887;C3272283;C4050568;C4319571","C4319571","",837
"patient assessment of arthritis pain mm","C0679830;C4317006;C4330985;C4554674",NULL,NULL,491
"medical characteristics","C0199168;C0205476;C1521970","C1521970","",1110
"hba $nmbr$ c category","C0019016;C0683312;C1825777;C3538758;C3889287","","",820
"$nmbr$ $nmbr$ to $nmbr$ $nmbr$ mmhg","C0439475",NULL,NULL,1888
"mexico","C0025885","C0025885","",1462
"untreated at baseline mean sd mm hg","C0168634;C0332155;C0439475;C0444504;C1442488;C2347634;C2348143;C2699239","C0005823","",1469
"door to balloon time hr","C4296144","C3494202","",433
"ischemia on cecg n $nmbr$ $nmbr$","C0022116;C4321499",NULL,NULL,1668
"baseline sd","C0168634;C1442488;C2699239",NULL,NULL,625
"mean eosinophil count per ml","C0200638;C0439526;C0444504;C0750879;C1705224;C2347634;C2348143;C3887665",NULL,NULL,37
"physical activity kcal wk","C0015259;C0026606;C0332174;C0439230;C0439259","C0015259","",1380
"ace l arbs","C1452534;C3888198;C4284014",NULL,NULL,46
"history of stroke or tia no","C0007787;C0019664;C0019665;C0038454;C0262512;C0262926;C0917805;C1054154;C1705255;C2004062;C4554100",NULL,NULL,1762
"females only","C0086287;C0205171;C1720467","C0086287","",1277
"biochemical events","C0205474;C0441471;C3541888",NULL,NULL,412
"digitalis","C0012252;C0304520","C0012265","",989
"pav mean $nmbr$ ci","C0008107;C0058890;C0444504;C2347634;C2348143;C3259781",NULL,NULL,519
"baseline ldl cholesterol derived","C0023824;C0168634;C0202117;C1441547;C1442488;C3245521","C0023824","",1068
"without dm","C0011816;C3250443",NULL,NULL,955
"vi $nmbr$ g","C0205999;C0439267",NULL,NULL,515
"time since first psoriasis diagnosis y mean sd","C0011900;C0033860;C0040223;C0205435;C0444504;C1279901;C1704338;C1704656;C2347634;C2348143;C2699239;C3541383",NULL,NULL,37
"no previous diagnosis of diabetes mellitus","C0011849;C0332132",NULL,NULL,1045
"former n z $nmbr$","C0205156;C0750523",NULL,NULL,13
"$nmbr$ st $nmbr$ $nmbr$ $nmbr$ pmol l","C0036056;C0439284;C3272372",NULL,NULL,246
"mean arterial pressure last","C0428886;C1517741",NULL,NULL,457
"asa or antiplatelet agent","C0004057;C0085826;C3853627","","",1191
"fatal myocardial infarction","C0027051;C0428953;C1302234;C1705232;C2926063;C3810814;C4552959",NULL,NULL,646
"metastatic disease","C0027627;C2939419;C2939420",NULL,NULL,884
"dapagliflozin $nmbr$ mg group n $nmbr$","C0024671;C0026410;C0439269;C0441848;C1960952;C2346927;C2353951;C4321396;C4521761",NULL,NULL,2275
"recurrent heart failure","C0018801;C0018802;C1455761;C2945760;C4554158","C0018801",";C0168634;C1524003",12
"upadacitinib $nmbr$ mg n l $nmbr$","C0439268",NULL,NULL,2314
"l $nmbr$ $nmbr$ vs placebo","C0032042;C0439394;C1696465;C1706408;C1706495;C3642217","","",-10
"zoledronic acid","C0257685","C0257685","",2092
"triglycerides at baseline","C0041004;C0168634;C1442488",NULL,NULL,625
"nyha class $nmbr$ or higher","C0205250;C1882083","C0018802;C1882083","",453
"troponin or ckmb value","C0010290;C0041199;C0523584;C1522609",NULL,NULL,9
"laba users","C1706077",NULL,NULL,534
"ls mean $nmbr$ ci a","C0008107;C0023668;C0444504;C2347634;C2348143;C3259781",NULL,NULL,519
"non mtx csdmards","C0025677;C1417487;C1518422","C0242708",";C0026544",231
"ldl cholesterol lowering therapy","C0023824;C0039798;C0087111;C0202117;C0441994;C1363945;C2003888","C0086440","",1773
"ticagrelor $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C1999375;C2346927;C4321396;C4521761",NULL,NULL,2299
"eze simva $nmbr$ $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761","C0360714;C1142985","",1862
"patients with deep vein thrombosis only","C0030705;C0149871;C0205171;C1720467",NULL,NULL,1643
"minor","C0026193;C0205165",NULL,NULL,1474
"s $nmbr$ n $nmbr$","C2986823","","",-10
"major and crnm bleeds","C0019080;C0205082;C0205164;C4318856;C4521762",NULL,NULL,1472
"mean percentage of nights without heartburn","C0018834;C0240526;C0439165;C0444504;C1549488;C1561533;C2347634;C2348143",NULL,NULL,291
"negative","C0205160;C1513916;C2825415;C2825491;C3853545",NULL,NULL,1569
"nonblack race no f","C0016327;C0034510;C1706779;C3853635",";C0034510","",1107
"$nmbr$ or $nmbr$ d wk","C0073187;C0332173;C0332174;C0439230;C4484261",NULL,NULL,1833
"mean eq $nmbr$ d response $nmbr$ ci","C0008107;C0205163;C0439185;C0444504;C0871261;C1704632;C1706817;C2347634;C2348143;C2911692;C3259781",NULL,NULL,519
"$nmbr$ $nmbr$ ld","C0694649",NULL,NULL,1677
"yes no","C1512698",NULL,NULL,464
"any medication","C0013227;C3244316;C4284232",NULL,NULL,366
"mean fecal calprotectin level mg g stool sd","C0015733;C0183622;C0441889;C0444504;C0456079;C0950624;C1300563;C1335798;C1366582;C1547707;C2347634;C2348143;C2699239;C2946261","","",780
"h pylori serology","C0036745;C0079488;C0220911;C0455278",NULL,NULL,573
"hyperkalemia","C0020461;C4552983","C0020461;C4552983",";C0439375;C0700287;C0684224;C0035173",30
"history of bowel resections n","C0019664;C0019665;C0262512;C0262926;C0741614;C1705255;C2004062",NULL,NULL,832
"h pylori infection","C0850666",NULL,NULL,573
"caucasian simva $nmbr$","C0007457;C0043157","C0043157","",1329
"treated patients with baseline and $nmbr$ post baseline ef cacy measurement bp value for treatment group comparison proactive intervention vs usual care was calculated based on a $nmbr$ sample t test for continuous variables and chi square test for categorical variables cbp values were measured at baseline week $nmbr$ whereas information on all of the other variables listed was collected during screening abbreviations bmi body mass index bp blood pressure chd coronary heart disease crucial cluster randomized usual care vs caduet investigation assessing long term risk dbp diastolic blood pressure dm diabetes mellitus hdl c high density lipoprotein cholesterol ldl c low density lipoprotein cholesterol sd standard deviation sbp systolic blood pressure tc total cholesterol tg triglyceride","C0000723;C0005823;C0008041;C0011849;C0012641;C0018787;C0023822;C0030705;C0034656;C0035647;C0037623;C0039411;C0039798;C0040642;C0041004;C0041405;C0041698;C0042295;C0065055;C0085805;C0087111;C0168634;C0184661;C0201950;C0205251;C0220825;C0220908;C0220909;C0237403;C0242485;C0280604;C0332174;C0332293;C0370003;C0374505;C0428883;C0439230;C0439828;C0441833;C0443252;C0444686;C0444706;C0488055;C0543421;C0549178;C0683312;C0687676;C0687744;C0745732;C0871420;C0871470;C0871472;C0886296;C1149372;C1257890;C1261322;C1273869;C1305855;C1306620;C1330119;C1415692;C1419788;C1441506;C1442488;C1516048;C1516695;C1516698;C1519504;C1522326;C1522609;C1527178;C1533716;C1533734;C1550472;C1552578;C1698960;C1704687;C1705169;C1705428;C1705429;C1705938;C1705981;C1707455;C1708288;C1710031;C1710032;C1710477;C1824670;C1947933;C2347026;C2348164;C2699239;C2986530;C3272378;C3272447;C3274822;C3469826;C3538928;C3538994;C3539643;C3541902;C3542407;C3815594;C3887704;C3887980;C3889287;C3890211;C4048187;C4318478;C4321351;C4522122;C4522223;C4552904",NULL,NULL,1012
"with dyspnoea","C0013404;C1963100","C0013404","",1227
"blood eosinophils count","C0014467;C0750480;C1705566","C0014467","",849
"current smoking no","C0037369;C0453996;C0521116;C1705970;C1881674","C0037369","",420
"valve replacement repair with or without cabg","C0010055;C0035139;C0043240;C0184252;C0374711;C0559956;C1186983;C1555302;C1704414;C3888056;C4319951;C4553149","C0374711;C0184252",";C1704414;C3888056;C0035139;C0043240;C4553149;C1720467",8
"$nmbr$ or $nmbr$ n","C0369718;C0441922",NULL,NULL,1540
"impacts","C1825598;C4049986",NULL,NULL,1629
"dvt","C0149871;C2926618;C3899446","C0149871","",252
"race non white","C0007457;C0034510;C0043157;C0220938;C1518422;C1706779;C3853635","C0034510;C1518422;C0043157","",1401
"fbs $nmbr$ mg dl","C0439269;C3812213",NULL,NULL,192
"seizure history n","C0019664;C0019665;C0036572;C0262512;C0262926;C1705255;C1959629;C2004062;C4553401",NULL,NULL,832
"a glucosidase inhibitors $nmbr$","C1512211",NULL,NULL,814
"duration antiplatelet use as of study duration sd","C0557651;C1881378;C2603343;C2699239;C2826775","","",1191
"focal","C0205234",NULL,NULL,1127
"$nmbr$ $nmbr$ mg bid","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"demographic characteristics mean sd unless otherwise indicated","C0444504;C0683970;C1444656;C2347634;C2348143;C2699239",NULL,NULL,583
"i $nmbr$ $nmbr$ $nmbr$ i $nmbr$","C0021966;C0221138",NULL,NULL,1021
"ratio of hrs $nmbr$ ci p for sex interaction","C0008107;C0009253;C0036864;C0079399;C0456603;C0804628;C1314687;C1522384;C1547037;C1568891;C1704675;C3259781",NULL,NULL,519
"symptomatic localization related","C0231220;C0439849;C0445223;C0475264;C1744691",NULL,NULL,1947
"body mass index kg m meanisd","C0005893;C0578022;C1305855;C1532718","C1305855","",1734
"one of the above","C0205447",NULL,NULL,737
"bmi category kg m $nmbr$","C0578022;C0683312;C1532718;C3889287",NULL,NULL,1735
"modified rankin scale score","C0449820;C2984908;C3854213;C4050231",NULL,NULL,2054
"glycatedhemoglobin category","C0683312;C3889287",NULL,NULL,562
"placebo ls means n","C0023668;C0032042;C1696465;C1704970;C1706408","C0032042","",28
"$nmbr$ asa compounds n","C0004057;C0205198;C1706082;C3853627","C0368663","",1691
"mean bmi s d kg m $nmbr$","C0444504;C0578022;C1532718;C2347634;C2348143",";C1305855","",206
"crcl $nmbr$ ml min","C0439445;C1846718","C3811844;C0017654","",307
"factor","C1521761;C2827422",NULL,NULL,1111
"dpp $nmbr$ inhibitors","C0243077;C1414174",NULL,NULL,610
"chd history n","C0019664;C0019665;C0262512;C0262926;C0280604;C1705255;C2004062;C3542407",NULL,NULL,970
"ancestry f","C0016327","","",-10
"mean ipss storage sub score sd","C0337174;C0542339;C1019118;C1264637;C1698986;C1753314;C1998280;C2699239;C2827405;C3533236;C3811063",NULL,NULL,539
"hps","C0242994",NULL,NULL,142
"$nmbr$ vessels treated","C0005847;C1522326",NULL,NULL,743
"rate control group n $nmbr$","C0441848;C0489879",NULL,NULL,1638
"control n $nmbr$","C0243148;C1550141;C1882979;C2587213;C3274648;C4553389",NULL,NULL,675
"timi flow grade $nmbr$ of mi culprit vessel pre pci","C0005847;C0332152;C0441800;C0740175;C0919553;C2257086;C3244287;C3272266;C3669034;C3810814;C4049621",NULL,NULL,743
"mean change at week $nmbr$","C0332174;C0392747;C0439230;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952",NULL,NULL,767
"medication use no total no","C0013227;C0042153;C0439175;C0439810;C0457083;C1947944;C3244316;C4284232",NULL,NULL,441
"pad lower extremities","C0023216;C0182158;C0332568;C3540603;C3669270;C3814046;C4319657",NULL,NULL,1752
"sulphonylureas only","C0038766;C0205171;C1720467","C0038766","",752
"death st","C0011065;C0036056;C1306577;C3272372;C4082313;C4552775",NULL,NULL,246
"acitretin","C0050559",NULL,NULL,994
"hba $nmbr$ c levels","C0019016;C0441889;C1825777;C3538758","","",820
"inferior","C0542339;C0678975",NULL,NULL,1245
"populations","C0032659;C1257890",NULL,NULL,904
"sustained mucosal healingc n n","C0026724;C0443318",NULL,NULL,328
"hmg coa reductase inhibitors","C0360714;C2756999;C3539119",NULL,NULL,560
"implantable cardioverter defibrillator n","C0162589;C2825184",NULL,NULL,1628
"undetermined etiology n","C0478157","C0478157","",1087
"enalapril lcz $nmbr$ n $nmbr$ n $nmbr$","C0014025",NULL,NULL,164
"time since as diagnosis years mean sd","C0011900;C0040223;C0439234;C0444504;C1704338;C1704656;C2347634;C2348143;C2699239;C3541383",NULL,NULL,1099
"duration $nmbr$ years n","C0439234;C0449238;C2926735","C0449238","",1989
"age distribution years n","C0001782;C0439234;C0520511;C1510829;C1704711","C1510829","",481
"first medical contact in ambulance","C0002422;C0199168;C0205435;C0205476;C0332158;C0337611;C1279901;C1705415;C3812666;C3846685","C0002422",";C4049621",191
"body weight at randonization ixrs","C0005910;C1305866","C0005910","",1250
"edss stratification no","C0451246;C1514983;C3887783",NULL,NULL,1062
"cornell voltage duration product mm ms","C0449238;C0598352;C1514468;C1704444;C2349943;C2926735;C3539704;C3713294;C4330985;C4554674",NULL,NULL,126
"mean qmax score by bmi $nmbr$ $nmbr$ to $nmbr$ $nmbr$ kg m $nmbr$","C0578022;C1532718;C3533236",";C1305855","",206
"microalbuminuria at baseline $nmbr$ of patients treated","C0030705;C0168634;C0730345;C1442488;C1522326",NULL,NULL,625
"area of retinal thickening within the grid mean sd dab","C0017446;C0086162;C0205146;C0444504;C1081457;C1302690;C1415284;C2347634;C2348143;C2348395;C2699239;C2825313;C4522144",NULL,NULL,370
"fair poor","C0032854;C0542537;C2700379;C2911689","C2700379","",234
"current smoker no","C3173209;C3241966","C0037369","",420
"mean sd crp mg l","C0439268;C0444504;C2347634;C2348143;C2699239;C3890735;C4048285","C0006560","",286
"dopamine agonist use no","C0042153;C0178601;C0457083;C1947944;C3536925",NULL,NULL,118
"$nmbr$ $nmbr$ $nmbr$ l l","C3539687","","",-10
"ppg post meal test mmol l","C0022885;C0039593;C0376674;C0392366;C0456984;C1418888;C1515976;C1532563;C3831328;C4318744",NULL,NULL,242
"n observed","C0369718;C0441922;C1441672",NULL,NULL,1553
"demographic characteristic","C0011298;C1521970","C1521970","",1110
"established ascvd or $nmbr$ cv risk factors","C0035648;C0443211;C1272684;C1553898;C3538987;C3665365;C4048877;C4318503","C0004153","",1698
"number of vessels disease","C0042373;C0237753;C0449788",NULL,NULL,1556
"fvc predicted","C0681842;C1882327;C3714541",NULL,NULL,1599
"sesbp mmhg mean _sd a","C0439475;C0444504;C2347634;C2348143;C2699239",NULL,NULL,2127
"mean bmi $nmbr$ ci","C0008107;C0444504;C0578022;C2347634;C2348143;C3259781",NULL,NULL,1735
"baseline dbp","C0168634;C0536221;C1442488;C3813197;C4281799",NULL,NULL,605
"female sex n race n","C0034510;C0086287;C1706779;C3853635",NULL,NULL,2014
"multivariate logistic modelb","C0242415",NULL,NULL,1563
"gold stage iv","C0018026;C0022326;C0205390;C1300072;C1304897;C1306673;C4265176",NULL,NULL,541
"post bronchodilator fev $nmbr$ l mean sd","C0444504;C2347634;C2348143;C2599594;C2699239;C3714541",NULL,NULL,2142
"selexipag n $nmbr$","C2000145",NULL,NULL,799
"prebronchodilator fev $nmbr$ l t","C2599602;C3714541",NULL,NULL,1599
"fasting lipid levels mmol l","C0015663;C0428460;C1532563","C0023779;C0015663","",1847
"prior hf hospitalization","C0018488;C0019993;C0332152;C1313497;C1538440;C2826257;C3273279",NULL,NULL,2359
"placebo famotidine $nmbr$","C0015620;C0032042;C1696465;C1706408","C0015620","",74
"symptomatic padt","C0231220",NULL,NULL,611
"thiazolidinedione yes","C0289779;C1257987;C1549445;C1705108;C1710701;C3537039",NULL,NULL,147
"humerus fracture","C0020162",";C0020162","",1115
"without dm n $nmbr$ i $nmbr$","C0011816;C0021966;C0221138;C0369718;C0441922;C3250443",NULL,NULL,955
"other uc related gi surgical procedure","C0439849;C0445223;C0543467;C1708130;C3539617;C4050121",NULL,NULL,1128
"$nmbr$ $nmbr$ s $nmbr$ $nmbr$ t","C0718146","","",-10
"any serious teaes","C0205404",NULL,NULL,916
"hospitalized exacerbation rates","C0701159;C0871208;C1521828;C4086268","C4086268","",889
"baseline cardiovascular disease","C0007222;C0168634;C1442488","C0007222","",1790
"apremilast","C1678805","C1678805","",1789
"duration of previous use of vka months","C0205156;C0439231;C1552607;C1881378;C2826775",NULL,NULL,1530
"lisinopril","C0065374","C0065374","",847
"$nmbr$ blood eosinophils at baseline","C0014467;C0168634;C1442488",NULL,NULL,625
"haq","C0102923;C0451208",NULL,NULL,1667
"ldl c mmol l sd","C1532563;C2699239","C0023824","",1068
"proactive intervention n $nmbr$ a","C0184661;C0886296;C1273869",NULL,NULL,290
"acr deciles","C1412134;C1515941",NULL,NULL,52
"mean weight sd kg","C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209",NULL,NULL,37
"patient s ga $nmbr$ $nmbr$ mm vas","C0016993;C0030705;C0042815;C3536884;C3827561;C4330985;C4554674",NULL,NULL,1750
"smoking history n","C1519384","C1519384","",1147
"black non hispanic","C0005680;C0027567;C0085756;C0439541;C1518422;C1518424;C1533017;C1533018","C0086409","",865
"managed medically no total no","C0439175;C0439810;C1273870",NULL,NULL,508
"cv death mi or stroke","C0011065;C0038454;C1306577;C3538987;C3810814;C4048877;C4082313;C4318503;C4552775;C4554100",NULL,NULL,323
"ratio of women to men","C0025266;C0043210;C0456603;C1547037","","",306
"beta bloekers","C0330390;C0439096;C2004068","C0001645","",959
"ex smoker","C0337671;C4555205","C0037369","",420
"history ol coronary revascularization","C0019664;C0019665;C0262512;C0262926;C0877341;C1705255;C2004062","C0877341",";C4049621;C1552607",223
"recent treatment $nmbr$ months mmf ggs","C0039798;C0083765;C0087111;C0209368;C0332185;C0439231;C1522326;C1533734;C1705169;C3538994;C3848524;C3887704","C0209368","",304
"fasting triglycerides mean sd mg dl","C0015663;C0041004;C0439269;C0444504;C2347634;C2348143;C2699239",NULL,NULL,2281
"coronary artery bypass grafting","C0010055","C0010055","",1843
"severe n $nmbr$ $nmbr$","C0205082;C4050465;C4050466",NULL,NULL,313
"adjusted hazard ratio $nmbr$ cl","C0456081;C0596019;C2985465","C2985465","",975
"diabetes $nmbr$","C0011847;C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"anti coagulants no","C0848112","C0003280","",450
"handihaler only n","C0205171;C1720467",NULL,NULL,925
"paroxysmal nocturnal dyspnea","C1956415","C1956415","",1226
"time since diagnosis of pah yrf","C0011900;C0030123;C0040223;C1704338;C1704656;C3203102;C3541383;C4284467",NULL,NULL,841
"time since diagnosis of type $nmbr$ diabetes no","C0011847;C0011849;C0011900;C0040223;C1320657;C1550351;C1704338;C1704656;C3541383","C0011849;C1320657","",907
"severity of airflow limitation gold $nmbr$ $nmbr$ n","C0018026;C0231999;C0439793;C0443288;C0449295;C0522510;C1304897","C0024117;C0521117","",213
"statin ezetimibe n","C0360714;C1142985","C0360714;C1142985","",1862
"renal dysfunction","C1565489;C3279454","C1565489","",937
"mi no","C3810814",NULL,NULL,516
"tcomparison of proportion of patients with nyha class lll iv heart failure","C0018801;C0018802;C0030705;C1261077;C1709707;C1882087;C4554158","C0018802;C1882083","",453
"musculoskeletal stiffness","C0427008;C0497254;C2707260",NULL,NULL,1656
"lixisenatide","C2973895",NULL,NULL,759
"allhat llt","C2347090",NULL,NULL,1265
"baseline total pcsk $nmbr$ level","C0168634;C0439175;C0439810;C0441889;C0456079;C1442488;C1547707;C2946261",NULL,NULL,625
"dyspnea at rest nyha iv","C0022326;C0743330;C1275491;C4265176",NULL,NULL,151
"prior antiinflammatory antirheumatic products n","C0003191;C0003209;C0332152;C1514468;C1515999;C2826257",NULL,NULL,2382
"non ischemic","C0475224;C1518422",NULL,NULL,1670
"distal lower","C0205108;C0441994;C1548802;C2003888;C4522154",NULL,NULL,1612
"taking antihypertensive medication at baseline no e","C0003364;C0168634;C1442488;C1515187",";C0003364","",1579
"i intensive $nmbr$ mg of atorvastatin n $nmbr$","C0021966;C0024671;C0026410;C0162425;C0221138;C0286651;C0439269;C0522510;C1283828;C1550453;C1960952;C2346927;C4321396;C4521761","C0286651","",885
"on aspirin at baseline","C0004057;C0168634;C1442488","C0004057","",1366
"change in sesbp ls mean se","C0023668;C0036919;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952",NULL,NULL,567
"age at screening","C0001779;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164","C0001779","",480
"african american n","C0085756","C0005680",";C1706779",188
"current $nmbr$ cigs day","C0332173;C0439228;C0439505;C0521116;C1570610;C1705970","C0037369;C0521116","",2224
"pre bronchodilator fvc l","C2599602;C3714541",NULL,NULL,682
"triglycerides $nmbr$ mg dl $nmbr$ $nmbr$ mmol l","C0041004;C0439269;C1532563","C0041004","",368
"aortic stenosis","C0003507",NULL,NULL,565
"js $nmbr$ agonists","C0243192;C1552154;C2987634",NULL,NULL,116
"dyslipidemia n","C0242339","C0242339","",1770
"baseline sitting sbp $nmbr$ mm hg","C0085805;C0168634;C0277814;C0439475;C1442488;C2584297;C4050224","C0005823","",1469
"venous graft","C0042449;C0181074;C0332835;C0348013;C1961139",NULL,NULL,917
"recent cardiovascular eventf","C0007226;C0332185;C3887460","C1320716","",414
"prior statin use n $nmbr$","C0042153;C0332152;C0360714;C0457083;C1947944;C2826257","C2826257;C0360714","",2186
"chylomicron cholesterol","C0008377;C0008731;C1325761","C0008731","",1499
"female simva","C0043210;C0086287;C1705497;C1705498",NULL,NULL,586
"inadequate","C0205412;C0439856","C0205412","",403
"ami $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4319936;C4321396;C4521761",NULL,NULL,192
"male gender","C0086582;C1706180","C0086582","",1276
"tadalafil $nmbr$ $nmbr$ mg","C0024671;C0026410;C0439269;C1176316;C1960952;C2346927;C4321396;C4521761","C1176316","",855
"fev_ l","C3714541",NULL,NULL,1599
"time to balloon needle min","C0027551;C0040223;C0336867;C0441144;C0702093;C1524029;C1882041;C3541383;C3813700",NULL,NULL,1475
"iuss score mean sd","C0439453;C0444504;C0449820;C2347634;C2348143;C2699239;C4050231",NULL,NULL,1287
"obstructive subscore","C0549186",NULL,NULL,982
"hispanic latin american","C0019576","C0019576","",2257
"$nmbr$ ng ml","C0439275",NULL,NULL,204
"digoxin or digitalis preparation","C0012265;C0304520","C0012265","",989
"$nmbr$ and $nmbr$ predicted arr n $nmbr$ $nmbr$","C0681842;C1882327;C2170357;C4084934",NULL,NULL,51
"canvas n $nmbr$ placebo n $nmbr$ cana $nmbr$ mg n $nmbr$ cana $nmbr$ mg n $nmbr$","C0032042;C1319635;C1418845;C1696465;C1706408;C3281223",NULL,NULL,1302
"factors that confer a","C1521761;C2827422",NULL,NULL,1111
"nyha class n i","C0021966;C0221138;C0369718;C0441922;C1882083","C0018802;C1882083","",453
"p int f","C0016327;C0369773;C2603361;C3272375",NULL,NULL,1264
"age mean sd years","C0444504;C1510829;C2347634;C2348143;C2699239",NULL,NULL,1907
"metformin n","C0025598","C0025598","",1345
"sri response","C0871261;C1420401;C1704632;C1706817;C2911692",NULL,NULL,726
"sleep","C0037313",NULL,NULL,571
"ccq score","C0449820;C4050231",NULL,NULL,748
"mean sd sdai","C0444504;C2347634;C2348143;C2699239;C3871128","C3871128","",1355
"endpoints","C2349179","C2349179","",1136
"placebo estimated mean","C0032042;C0444504;C0750572;C1696465;C1706408;C2347634;C2348143",NULL,NULL,37
"effect of covariates on slopes","C0807955;C1280500;C1518681;C2348382",NULL,NULL,1807
"bifurcation","C0184906;C3146289",NULL,NULL,893
"age yrs mean","C0001779;C0444504;C2347634;C2348143","C0001779","",480
"first hospitalization for chf or cv death","C0011065;C0018802;C0019993;C0205435;C1279901;C1306577;C3538987;C4048877;C4082313;C4318503;C4552775",NULL,NULL,769
"hscrp $nmbr$ $nmbr$ mga","C0065879","C0006560","",286
"western europe australia new zealand","C0043129;C4289954","","",599
"long term vka therapy","C0039798;C0087111;C0443252;C1363945",NULL,NULL,236
"severe impairment egfr $nmbr$","C0205082;C0221099;C0684336;C1739039;C3811844;C3812682;C4050465;C4050466",NULL,NULL,313
"aclidinium $nmbr$ g bid n $nmbr$","C0439267;C2699757",NULL,NULL,1485
"percentage of time in therapeutic inr range mean sd","C0040223;C0439165;C0444504;C0460097;C0525032;C1549488;C1561533;C1704538;C2347634;C2348143;C2699239;C3541383",NULL,NULL,757
"cv mortality","C0026565;C0026566;C3538987;C4048877;C4318503",NULL,NULL,1777
"age s $nmbr$","C0001779","C0001779","",480
"time since psa onset mean years sd","C0040223;C0206132;C0332162;C0439234;C0444504;C2347634;C2348143;C2699239;C3541383;C3810537;C3813209",NULL,NULL,736
"c $nmbr$ unit sgrq total score increase","C0439148;C0439453;C0442805;C1509845;C1519795;C1704753;C1880519;C2964552;C3853603",NULL,NULL,540
"resistant htn spiro n $nmbr$","C0020538;C0332325;C1514892;C1550464;C2827757","C0020538","",1365
"or severe","C0205082;C4050465;C4050466",NULL,NULL,313
"left sided colitisz","C0205091;C0443246",NULL,NULL,42
"peri op statins no n $nmbr$","C0347985;C0360714;C0369718;C0441922","C0360714","",872
"difference glargine standard care lsm se mm year","C0036919;C0439234;C0439508;C0907402;C1442989;C1705241;C1705242;C1947933;C2828392;C4330985;C4554674",NULL,NULL,1099
"postmenopausal and current hrt","C0232970;C0282402;C0521116;C1705970",NULL,NULL,549
"baseline hba $nmbr$ c n","C0019016;C0168634;C1442488;C1825777;C3538758","","",820
"wrist fracture","C0435630;C4553927",NULL,NULL,2029
"change from","C0392747;C0443172;C1705241;C4319952",NULL,NULL,767
"triglyceride mmol l","C0041004;C1532563","C0041004","",368
"without dvt dvt alone","C0149871;C0205171;C0439044;C0679994;C2926618;C3899446","C0149871","",252
"weeks_measured","C0439230;C0444706;C3541902",";C0444706;C3541902",";C2699239;C0439230",1
"serum sodium meq l","C0439375;C0523891","C0523891","",1379
"anaesthesia analgesia","C0002905",NULL,NULL,53
"any early adverse event","C0877248;C1279919","C0877248","",47
"oam use n","C0042153;C0457083;C1947944",NULL,NULL,24
"mild ed severe ed","C0205082;C2945599;C3538926;C4050465;C4050466",NULL,NULL,329
"fibrous mm","C0016059;C0439709;C4330985;C4554674",NULL,NULL,1733
"non hispanicwhite","C1518422",NULL,NULL,85
"diabetic status","C0241863;C0449438",NULL,NULL,996
"usual care n $nmbr$ a","C1947933;C3538928",NULL,NULL,1849
"nonwhite race no ejection fraction","C0034510;C0489482;C1706779;C2700378;C3853635","C0034510;C1518422;C0043157","",1401
"not hispanic or latino n $nmbr$","C0086528;C1518424","C0086409","",865
"previous exposure to a vitamin k antagonist no current or former never","C0042839;C0087161;C0205156;C0231491;C0332157;C0521116;C0597277;C0750523;C1552607;C1705970;C1708601;C2003901;C2825076;C3714656",NULL,NULL,13
"$nmbr$ $nmbr$ to $nmbr$ $nmbr$ mu l $ mmol l","C0439190;C0439342",NULL,NULL,671
"patients with previous loss of response to infliximab","C0030705;C0205156;C0666743;C0871261;C1517945;C1552607;C1704632;C1706817;C2911692",NULL,NULL,726
"vi $nmbr$ mg n $nmbr$","C0024671;C0026410;C0205999;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,515
"rate $nmbr$ patient years","C0030705;C0439234;C0871208;C1521828",NULL,NULL,2009
"duration of ulcerative colitis","C0009324;C0449238;C2926735",NULL,NULL,901
"african american african heritage n $nmbr$","C0085756;C2986513","C0005680",";C1706779",188
"non fatal mi","C1302234;C1518422;C1705232;C3810814",NULL,NULL,1682
"tender joint count $nmbr$ $nmbr$ per tender joint","C0451530","C0451530","",1139
"p valuer","C0369773;C0401806;C2603361",NULL,NULL,1872
"high sensitivity c reactive protein stratification","C0006560;C1413716;C1441604;C1514983;C4048285","C0006560","",286
"medium normal n $nmbr$","C0009458;C0205307;C0231683;C0439166;C0439536;C1705217;C2347086;C3244283;C4085196;C4522282;C4522283;C4553972",NULL,NULL,687
"male","C0086582;C1706180;C1706428;C1706429","C0086582","",1276
"any history of congestive heart failure","C0455531;C0742742","C0018801",";C0168634;C1524003",12
"ranolazine n i $nmbr$ i $nmbr$","C0021966;C0073633;C0221138",NULL,NULL,71
"time sec","C0040223;C0565930;C3541383",NULL,NULL,757
"heart rate","C0018810","C0018810","",1105
"hs crp j $nmbr$ $nmbr$ mg l","C0439268;C3890735;C4048285",NULL,NULL,1545
"participants with metabolic syndrome","C0524620;C0679646",NULL,NULL,617
"intracranial disease of major artery","C0205082;C0205164;C0524466;C0852949;C4318856;C4521762",NULL,NULL,1472
"black hispanic n","C1533017;C1533018","C0086409","",865
"tadalafil $nmbr$ mg mean change sd","C0024671;C0026410;C0392747;C0439269;C0443172;C0444504;C1176316;C1705241;C1960952;C2346927;C2347634;C2348143;C2699239;C4319952;C4321396;C4521761","C1176316","",855
"number of stent l or $nmbr$ or $nmbr$","C0038257;C0237753;C0449788",NULL,NULL,569
"ipss storage subscore","C0337174;C1019118;C1698986;C1753314;C1998280;C2827405;C3811063",NULL,NULL,539
"lama tiotropium b n","C0213771;C0999593;C1416775","C0213771","",1372
"whitea","C1021495","","",-10
"neither deep vein thrombosis nor pulmonary embolism","C0034065;C0149871",NULL,NULL,630
"baseline pasi mean sd","C0168634;C0444504;C1442488;C2347634;C2348143;C2699239;C4528685",NULL,NULL,1287
"previous exposure to non biologic systemic psoriasis therapyb yes n","C0005515;C0033860;C0205156;C0205373;C0205460;C0332157;C1518422;C1549445;C1552607;C1705108;C1710701","C0033860;C0205156;C0332157;C0205373","",2181
"adjusted hr $nmbr$ cl","C0456081;C0596019",NULL,NULL,658
"or $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ p $nmbr$ $nmbr$","C0369773;C2603361",NULL,NULL,1541
"neither unfractionated heparin nor low molecular weight heparin","C0019134;C0019139;C2825026;C3536766","C0019134","",864
"ls mean change from baseline se","C0023668;C0036919;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C4319952",NULL,NULL,567
"mean femoral neck t score","C0015815;C3533236",NULL,NULL,511
"distal anastomosis","C0448964","C0448964","",1845
"basal plus bolus","C0205112;C0332287;C1186706;C1511237;C1705509;C3812160",NULL,NULL,632
"all men","C0025266",NULL,NULL,1842
"history of intermittent claudication and abi $nmbr$ $nmbr$ or substantial peripheral arterial stenosis $nmbr$","C0205267;C1328319;C2315493;C3888326;C4025272",NULL,NULL,1492
"fondaparinux n $nmbr$ $nmbr$","C1098510","C1098510","",859
"no pci","C4049621",NULL,NULL,1736
"extensive pancolitis","C0205231;C0868908","C0868908","",270
"change in hbalc after $nmbr$ weeks etd $nmbr$ cl","C0392747;C0439230;C0443172;C0596019;C1180255;C1705241;C4319952",NULL,NULL,767
"cardiovascular risk factors alone n $nmbr$","C0205171;C0439044;C0679994;C0850624",NULL,NULL,651
"clow potency stratum simvastatin $nmbr$ mg pravastatin $nmbr$ mg fluvastatin $nmbr$ mg atorvastatin $nmbr$ mg high potency stratum simvastatin $nmbr$ mg atorvastatin","C0074554;C0082608;C0085542;C0205250;C0286651;C1299351;C1319635;C2700149;C2985073;C3245505;C3887512;C3889660;C4321237;C4522209",NULL,NULL,882
"history of hypertension","C0455527",NULL,NULL,1498
"hdl c level $nmbr$ mg dld","C0024671;C0026410;C0439269;C0441889;C0456079;C1414063;C1547707;C1960952;C2346927;C2826331;C2946261;C3715113;C4321396;C4521761","C0023822","",1962
"no of patients with ra","C0030705;C3538806;C4048756",NULL,NULL,1755
"ticagrelor $nmbr$ mg vs placebo hr $nmbr$ ci","C0008107;C0024671;C0026410;C0032042;C0439269;C1696465;C1706408;C1960952;C1999375;C2346927;C3259781;C4321396;C4521761",NULL,NULL,1544
"$nmbr$ diseased vessels","C0005847",NULL,NULL,743
"stenosis core lab","C0678234;C1261287;C2632116;C4684837",NULL,NULL,1651
"ongoing atopic or allergic condition no","C0392707;C0549178;C0851444","C0851444","",2246
"$nmbr$ ci for difference","C0008107;C1705241;C1705242;C3259781",NULL,NULL,1466
"recurrent vte during overall study period","C0282416;C0439531;C0557651;C0630906;C1455761;C1561607;C1948053;C2603343;C2945760",NULL,NULL,575
"prior lipid modifying therapy","C0023779;C0392747;C1514463",NULL,NULL,574
"clopidogrel loading dose $nmbr$ mg","C0024671;C0026410;C0070166;C0439269;C1960952;C2346927;C3714444;C4321396;C4521761","C0070166",";C0369286;C0033727;C4049621",217
"no prior aspirin","C0004057;C0332152;C2826257","C0004057","",1366
"pen label empagliflozin $nmbr$ mg baseline hba $nmbr$ c $nmbr$","C0019016;C0024671;C0026410;C0168634;C0181496;C0439269;C1424886;C1442488;C1825777;C1960952;C2346927;C2827499;C3273588;C3490348;C3538758;C4319659;C4321396;C4521761;C4522130;C4551445",NULL,NULL,1928
"moderate dysfunction crcl $nmbr$ $nmbr$ ml min n $nmbr$ $nmbr$ $nmbr$","C0439445;C1846718;C3274776",NULL,NULL,1535
"trial","C0008976",NULL,NULL,1020
"tiotropium $nmbr$ m g","C0213771;C0456715","C0213771","",1372
"simvastatin","C0074554","C0074554","",1840
"sbp mmhg mean sd","C0085805;C0439475;C0444504;C2347634;C2348143;C2699239",NULL,NULL,2127
"cardiovascular death or hospitalized hf","C0007226;C0011065;C0018488;C0701159;C1306577;C1313497;C1538440;C3273279;C3887460;C4082313;C4552775","C0018801",";C0168634;C1524003",12
"no history of chf","C0018802;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"state","C1301808;C1442792;C3148680",NULL,NULL,980
"platelets xlooo mm","C0005821;C0443116;C1963076;C4330985;C4554674",NULL,NULL,2385
"other antiplatelet agents n","C0085826","","",1191
"swollen joint count $nmbr$ $nmbr$ joints mean sd","C0444504;C0451521;C2347634;C2348143;C2699239",";C0451521","",1140
"anacetrapib n $nmbr$","C2604745","C2604745","",856
"duration of hf y","C0018488;C0449238;C1313497;C1538440;C2926735;C3273279","C0018801",";C0168634;C1524003",12
"uacra mg g gmean gcv","C0017066;C1300563",NULL,NULL,2315
"mean number of exacerbations in previous $nmbr$ months sd","C0205156;C0237753;C0439231;C0444504;C0449788;C1552607;C2347634;C2348143;C2699239;C4086268",NULL,NULL,37
"hr vs control $nmbr$ cl","C0243148;C0596019;C1550141;C1882979;C2587213;C3274648;C4553389",NULL,NULL,1542
"bivariate frailty model statin users vs non users","C0360714;C0424594;C1518422;C1706077;C3161035;C3274659;C3714583;C3853906",NULL,NULL,534
"males","C0086582","C0086582","",1276
"mean sd weight kg","C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209",NULL,NULL,37
"fatal chd and nonfatal mia","C0280604;C1302234;C1417154;C1705232;C3542407",NULL,NULL,1682
"prior therapy with omalizumab yes","C0966225;C1514463;C1549445;C1705108;C1710701","C0966225","",940
"control n z $nmbr$","C0243148;C1550141;C1882979;C2587213;C3274648;C4553389",NULL,NULL,675
"smoking status previous n","C0205156;C1519386;C1552607",NULL,NULL,1044
"renal function bn","C0005005;C0034700;C0232804;C1706574;C4551963","C0232804","",1532
"time from randomization to pci st elevation mi min","C0034656;C0040223;C0520886;C0702093;C1524029;C3541383;C3810814;C3813700;C4049621",NULL,NULL,1945
"prior aortocoronary bypass surgery","C0010055;C0455610","C0010055","",219
"spondylitis with peripheral arthritis","C0038012;C0238694","C0003864","",274
"north america oceania","C0028405;C0282279;C4085681","C0028405","",1463
"$nmbr$ $nmbr$ bpm current smoker","C3173209;C3241966","C3241966","",1420
"medications","C0013227;C0802604;C2598133;C4284232",NULL,NULL,2263
"p $nmbr$ vs placebo","C0032042;C0369773;C1696465;C1706408;C2603361","C0032042","",28
"serious decline in kidney function $nmbr$","C0205404;C0232804",NULL,NULL,916
"total population n","C3258257",NULL,NULL,510
"open label phase baseline week $nmbr$","C0168634;C0205390;C0332174;C0439230;C1442488;C1709323;C1710475",NULL,NULL,1012
"non smokers at baseline","C0168634;C0337672;C1442488;C4554605",NULL,NULL,625
"known thrombophilia no","C0205309;C0398623",NULL,NULL,623
"other drugs no","C0013227;C3687832",NULL,NULL,740
"hospitalization for heart failure or cv","C3538987;C3898876;C4048877;C4318503",NULL,NULL,1777
"infarction date not reported","C0011008;C0021308;C0684224;C0700287;C1518422;C2348077;C4319718",NULL,NULL,85
"japan n $nmbr$","C0022341","C0022341","",1815
"stent placement","C0522776","C0522776","",364
"fc ldl c friedewald calculated","C0444686;C1441506;C2983605","C0023824","",1068
"dpp $nmbr$ inhibitor","C1414174;C1999216",NULL,NULL,610
"priorbone disease","C0012634",NULL,NULL,1279
"baseline hemoglobin aj values","C0004486;C0019046;C0042295;C0168634;C0230613;C1442488","C0019046","",1177
"exacerbations in past $nmbr$ mo no","C0026544;C0332177;C1444637;C4086268;C4284302",NULL,NULL,1476
"randomized to receive aspirin yes","C0004057;C0034656;C0040363;C0041260;C1514756;C1549445;C1705108;C1710701;C1883351;C3815594",NULL,NULL,431
"male vs female","C0043210;C0086287;C0086582;C1705497;C1705498;C1706180;C1706428;C1706429","C0086287","",1970
"parental history of ml before age $nmbr$ y yes","C0001779;C0019664;C0019665;C0030551;C0262512;C0262926;C0439526;C1549445;C1705108;C1705224;C1705255;C1710701;C2004062;C3887665",NULL,NULL,147
"fev $nmbr$ pred","C0032952;C0044955;C3714541","C3714541","",296
"rosiglitazone n $nmbr$","C0289313","C0289313","",1761
"hbaj mmol mol","C3829066","","",820
"concomitant therapies n","C1707479",NULL,NULL,446
"hla b $nmbr$ positive n","C0439178;C1426226;C1446409;C1514241;C2825490;C3812269",NULL,NULL,1803
"women $nmbr$ mg dl $nmbr$ $nmbr$ mmol l","C0043210;C0439269;C1532563",NULL,NULL,670
"smoker current former","C0205156;C0337664;C0521116;C0750523;C1705970",NULL,NULL,13
"laboratory variables at baseline","C0022877;C0168634;C0439828;C1442488;C3244292;C4283904",NULL,NULL,978
"previous loss of response to infliximab n","C0205156;C0666743;C0871261;C1517945;C1552607;C1704632;C1706817;C2911692",NULL,NULL,726
"heart rate sd bpm blood pressure mm hg","C0005823;C0018810;C0439475;C1271104;C1272641;C2699239","C0018810","",1105
"$nmbr$ n qi","C0369718;C0376586;C0441922",NULL,NULL,1553
"previous hospitalization for unstable angina","C0002965;C0019993;C0205156;C1552607",NULL,NULL,2360
"percutaneous coronary intervention","C1532338","C1532338","",1661
"ics users qvai $nmbr$ sfc","C0815320;C1706077;C4521536;C4551720",NULL,NULL,1283
"black african american $nmbr$ $nmbr$","C0085756","C0005680",";C1706779",188
"bmi mean sd kg m $nmbr$","C0444504;C0578022;C1532718;C2347634;C2348143;C2699239",NULL,NULL,1735
"lansoprazole n $nmbr$","C0050940",NULL,NULL,1506
"smoking pack year years fl","C0037369;C0439234;C0439508;C0453996;C1277691;C1300812;C1708024;C1881674","C0037369","",420
"abatacept open label abatacept","C1619966;C1709323","C1619966","",1190
"lieum only n","C0205171;C1720467",NULL,NULL,925
"treatment arm","C1522541",NULL,NULL,950
"hypertension receiving treatment n","C0578998;C1514756",NULL,NULL,725
"aml val $nmbr$ $nmbr$ mg rr $nmbr$","C0023465;C0023467;C0024671;C0026410;C0042285;C0439269;C0523975;C1960952;C2346927;C4321396;C4521761;C4554402",NULL,NULL,222
"any infarct","C0021308","C0021308","",1288
"calcium channel blocker bmi body","C0006684;C0242821;C0460148;C0578022;C1268086;C3536851;C4082212;C4521885","C0006684","",1884
"insulin administration","C0199782",NULL,NULL,162
"time to treatment","C3494202","C3494202","",433
"white race","C0007457;C0043157",NULL,NULL,2003
"baseline insulin","C0021641;C0168634;C1442488;C1533581;C1579433;C3714501",NULL,NULL,157
"statin during admission","C0184666;C0360714;C0809949","C0360714","",872
"sudden cardiac death","C0085298",NULL,NULL,645
"prior surgery no","C0455610",NULL,NULL,2040
"post bronchodilator fev $nmbr$ fvc ratio mean sd","C0444504;C0456603;C1547037;C2347634;C2348143;C2599594;C2699239;C3714541",NULL,NULL,1599
"intermediate risk","C3640764",NULL,NULL,172
"ischemic cause","C0015127;C0475224;C1524003",NULL,NULL,1670
"mtx use at randomization n","C0025677;C0034656;C0042153;C0457083;C1417487;C1947944","C0025677","",1408
"cystoscopic procedure","C0184661;C0560573;C2700391;C3274430;C3539779",NULL,NULL,290
"outcome type","C0332307;C1274040;C1547052",NULL,NULL,603
"fondaparinux n $nmbr$","C1098510","C1098510","",859
"history of atrial arrhythmia n","C0019664;C0019665;C0085611;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"week $nmbr$ itt population","C0032659;C0332174;C0439230;C1257890",NULL,NULL,1012
"no glucocorticoids or immunosuppressants","C0017710;C0021081;C3540777;C3540778","C0021081","",1424
"ezetimibe use","C0042153;C0457083;C1142985;C1947944",NULL,NULL,118
"rf and acpa positive n","C0035448;C0201660;C0439178;C0748398;C1446409;C1514241;C1525410;C1547111;C1706063;C2825490;C3812269","C0035448","",1435
"hazard ratio for cardiovascular death","C0007226;C0011065;C1306577;C2985465;C3887460;C4082313;C4552775",NULL,NULL,323
"reslizumab $nmbr$ $nmbr$ mg kg n $nmbr$","C0439272;C1869620",NULL,NULL,947
"prior oabg surgery","C0455610","C0010055","",219
"bmi $nmbr$ kg m $nmbr$ n $nmbr$ $nmbr$","C0578022;C1532718",";C1305855","",206
"history of other medical conditions n","C0012634;C0262926;C0348080;C1705253;C3864998",NULL,NULL,1812
"time from end of fit years meanisd","C0036572;C0439234;C1522314;C2349186;C4048158;C4553125","C0036572","",1394
"diabetes no","C0011847;C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"no prior cabg","C0010055;C0332152;C2826257","C0010055","",389
"race non white","C0007457;C0034510;C0043157;C0220938;C1518422;C1706779;C3853635",";C0034510","",1107
"fatal or nonlatal myocardial inlarctlon","C0027061;C1302234;C1522564;C1705232",NULL,NULL,641
"study medication pre dose","C0013227;C0439565;C0557651;C2603343;C3244316;C3812758;C4284232",NULL,NULL,2383
"sexually active $nmbr$","C0241028",NULL,NULL,497
"$nmbr$ events $nmbr$ $nmbr$ per $nmbr$ py $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0030428;C0441471;C3538810;C3541888",NULL,NULL,1517
"median range","C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016",NULL,NULL,635
"blood eosinophil proportion","C0014467;C1709707","C0014467","",849
"severe renal impairment","C0205082;C1565489;C4050465;C4050466","C1565489","",937
"patients taking mtx no","C0025677;C0030705;C1417487;C1515187","C0025677","",1334
"long acting nitrate","C0028125;C0079613;C0205166;C0699857;C1704930;C1706317;C1869853;C3848573;C3890007;C4048375",NULL,NULL,499
"renin angiotensin aldosterone system blocker","C0086907",NULL,NULL,963
"hemoglobin gl","C0018229;C0019046;C1423073;C1427674",NULL,NULL,1804
"predicted post bronchodilator fev $nmbr$ mean sd l","C0444504;C0681842;C1882327;C2347634;C2348143;C2599594;C2699239;C3714541",NULL,NULL,680
"mortality outcomes","C0026565;C0026566;C1274040","C0026565","",1312
"triglycerides median ql q $nmbr$ mmol l","C0041004;C0549183;C0876920;C1532563;C2347635;C2348144;C2939193","C0041004","",368
"modified has bled $nmbr$","C0019080;C0392747;C3889737",NULL,NULL,767
"both adalimumab groups n $nmbr$ no baseline cd related antibiotic use","C0003232;C0007928;C0034283;C0042153;C0168634;C0369718;C0439849;C0441833;C0441922;C0445223;C0457083;C0687744;C1122087;C1257890;C1442488;C1519504;C1552839;C1705428;C1705429;C1947944;C4552032",NULL,NULL,942
"serum potassium meq l","C0302353;C0439375;C0543465","C0302353","",1959
"diclofenac $nmbr$ mg n $nmbr$ n","C0012091;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761","C0012091","",1324
"uacr mg g median $nmbr$ th $nmbr$ th percentile","C0039725;C0039738;C0549183;C0876920;C1264641;C1300563;C1420718;C2347635;C2348144;C2939193;C4282123;C4285344",NULL,NULL,1433
"clinical atherosclerotic disease","C0012634;C0205210;C0333482",NULL,NULL,2116
"with lipid lowering agents","C0086440","C0086440","",1773
"postbronchodilator","C2599594",NULL,NULL,680
"fpg mean sd mmol l","C0444504;C1532563;C2347634;C2348143;C2699239","C0015663;C0202042","",1960
"chlorthalidone n $nmbr$","C0008294","C0008294","",70
"placebo n l $nmbr$","C0032042;C1696465;C1706408","C0032042","",28
"hong kong","C0019907;C2987742",NULL,NULL,475
"patients with pneumonia resulting in death n","C0011065;C0030705;C0032285;C0332294;C1306577;C4082313;C4552775",NULL,NULL,323
"atopic based on phadiatop test","C0022885;C0039593;C0392366;C0392707;C0456984;C1441070;C1515976;C1527178;C1705938;C3831328;C4318744",NULL,NULL,2351
"major cardiovascular event","C0205082;C0205164;C1320716;C4318856;C4521762","C1320716;C0205082","",2077
"change in hdl c","C0392747;C0443172;C1705241;C3715113;C4319952",NULL,NULL,767
"fev $nmbr$ predicted post albuterol","C0001927;C0681842;C0687676;C1704687;C1882327;C3469826;C3714541",NULL,NULL,1599
"non lad artery","C0003842;C0226004;C1518422",NULL,NULL,785
"withdrawals n n","C1710677;C2349954;C2825032;C3812880;C4049634",NULL,NULL,879
"insulin mu ml","C0021641;C0439339;C1533581;C1579433;C3714501",NULL,NULL,157
"$nmbr$ tob $nmbr$ months n","C0439231;C1420851",NULL,NULL,1530
"hazard ratiof","C0598697",NULL,NULL,345
"$nmbr$ patients","C0030705",NULL,NULL,1035
"mean se $nmbr$ year rates per $nmbr$ population","C0036919;C0439234;C0439508;C0871208;C1521828;C2347634",NULL,NULL,567
"ckd prognosis by kdigo","C0033325;C1561643;C3854082","C1561643","",967
"pfo closure","C0185003;C1521802",NULL,NULL,2211
"egfr in $nmbr$ classes","C0456387;C1518526;C1705943;C1739039;C3811844;C3812682;C4019422",NULL,NULL,452
"$nmbr$ days new mi","C0205314;C0439228;C3810814",NULL,NULL,1621
"right","C0205090;C0444532",NULL,NULL,1798
"basal alone","C0205112;C0205171;C0439044;C0679994",NULL,NULL,926
"efficacy and safety net adverse clinical events","C0036043;C0205210;C0877248;C1280519;C1456447;C1705187;C1705413;C1707887;C3853572;C3887809;C3890893","C1707887;C2349179","",1122
"family history of cancera","C0241889","C0241889","",1493
"pv ml","C0030840;C0032463;C0439526;C1705224;C3887665",NULL,NULL,300
"pooled non canvas studies n $nmbr$ non cana n $nmbr$ cana $nmbr$ mg n $nmbr$ cana $nmbr$ mg n $nmbr$","C0369718;C0441922;C0557651;C0947630;C1319635;C1418845;C1518422;C1709595;C2349200;C2603343;C3281223;C4522255",NULL,NULL,1302
"hbalc median","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,1897
"previous treatment failure no","C0162643;C0205156;C0235828;C0521983;C1547544;C1552607",NULL,NULL,1044
"clopidogrel plus aspirin yr","C0004057;C0070166;C0332287;C0439234","C0070166",";C0369286;C0033727;C4049621",217
"bm $nmbr$ kg m $nmbr$","C0006416;C1532718",";C1305855","",206
"$nmbr$ $nmbr$ ls t score","C0023668;C0449820;C4050231",NULL,NULL,748
"never smoker","C0425293","C0037369","",420
"referent","C1706462",NULL,NULL,1464
"t $nmbr$ dm","C0011816;C2603360;C3250443",NULL,NULL,955
"at goal","C0018017;C1571704",NULL,NULL,1688
"p value low vs high nfs","C0205250;C0205251;C1299351;C1550472;C1555018;C1709380;C2700149;C3887512;C3889660;C3890211;C4048187;C4321237;C4321351;C4522209;C4522223",NULL,NULL,834
"rheumatoid factor","C0035448;C0201660","C0035448","",1435
"anti tnf na ve n","C0042469;C0432633;C0597484;C1272460;C1448177;C1546968;C1879645;C3714652;C4049872;C4321495;C4552882",NULL,NULL,419
"percentage of predicted pre bronchodilator fev","C0439165;C0681842;C1549488;C1561533;C1882327;C2599602;C3714541",NULL,NULL,682
"tender joint count","C0451530","C0451530","",1139
"glycated hemoglobin standardized level","C0017853;C0441889;C0456079;C1547707;C2946261","","",1176
"first severe asthma exacerbation","C0205082;C0205435;C0349790;C0581126;C1279901;C4050465;C4050466;C4086268",NULL,NULL,313
"ami $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C4319936;C4321396;C4521761",NULL,NULL,192
"insulin glargine slope lsm se mm year","C0036919;C0439234;C0439508;C0807955;C0907402;C4330985;C4554674",NULL,NULL,1099
"minor bleeding","C0019080;C0026193;C0205165",NULL,NULL,1474
"beta blocker target dose","C0001645;C0178602;C0869039;C1114758;C1521840;C2986546","C0001645","",959
"ara functional class no","C0205245;C0325983;C0456387;C0542341;C1518526;C1705943;C2316832;C2700217;C3890184;C4282437;C4321455",NULL,NULL,452
"gender female male","C0043210;C0079399;C0086287;C0086582;C1522384;C1705497;C1705498;C1706180;C1706428;C1706429","C0086287","",1277
"$nmbr$ sbp $nmbr$ mmhg n $nmbr$","C0085805;C0439475",NULL,NULL,607
"mean s d metformin dose mg day","C0025598;C0178602;C0439422;C0444504;C0869039;C1114758;C2347634;C2348143",NULL,NULL,110
"duration of rheumatoid arthritis years","C0003873;C0439234;C0449238;C2926735","C0003873","",1848
"of t $nmbr$ dm years","C0011816;C0439234;C2603360;C3250443",NULL,NULL,1099
"north america hr $nmbr$ cl","C0028405;C0596019",NULL,NULL,658
"mean diastolic blood pressure mm hg","C0012000;C0428883;C0428886;C0439475;C0444504;C0488053;C1305849;C2347634;C2348143","C0005823","",1469
"additional subgroup analyses","C1524062;C2986480",NULL,NULL,1636
"b agonists short acting a","C0079613;C0243192;C1282927;C1704930;C1806781;C1869853;C2350002;C2987634;C3890007;C4048375",NULL,NULL,499
"killip class iv at randomization","C0034656;C2697847","C1881332","",846
"baseline fecal caicrctectin","C0015733;C0168634;C1442488",NULL,NULL,625
"$nmbr$ oral agents","C0442027;C0450442;C1254351;C1521826;C4521986",NULL,NULL,484
"age $nmbr$ vears n $nmbr$","C0001779","C0001779","",480
"lis","C2247545",NULL,NULL,127
"race no total","C0034510;C0439175;C0439810;C1706779;C3853635",";C0034510","",1107
"$nmbr$ l $nmbr$ l $nmbr$ $nmbr$","C3539687","","",-10
"intracranial disease of major artery disease t","C0012634;C0205082;C0205164;C0752138;C4318856;C4521762",NULL,NULL,1472
"non hispanic white","C0007457;C0043157;C0220938;C1518424","C0043157","",1402
"sri $nmbr$ response rate","C0237629;C1420401",NULL,NULL,727
"selexipag","C2000145",NULL,NULL,799
"$nmbr$ days new mi or definite acute st","C0036056;C0205178;C0205314;C0439228;C0439544;C1704787;C3272372;C3810814",NULL,NULL,1621
"plus minus values are means sd there were no significant differences at","C0042295;C0237881;C0332288;C0750502;C1546944;C1704970;C1705241;C1705242;C2699239",NULL,NULL,1466
"high sensitivity crp mg liter","C0024671;C0026410;C0439269;C0475211;C1441604;C1960952;C2346927;C3890735;C4048285;C4321396;C4521761","C0006560","",286
"age $nmbr$ yr no","C0001779;C0439234","C0001779","",480
"low $nmbr$ baseline hba $nmbr$ c","C0019016;C0168634;C0205251;C1442488;C1550472;C1825777;C3538758;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"dipeptidyl peptidase $nmbr$ inhibitor","C0003015;C2757044;C3536837",NULL,NULL,1854
"no corticosteroids or immunosuppressants","C0001617;C0021081;C3539185;C3540725;C3540726;C3540727",NULL,NULL,1650
"peri op beta blockers no n $nmbr$","C0001645;C0347985;C0369718;C0441922","C0001645","",959
"lipid lowering agent n","C0086440","C0086440","",1773
"baseline hba $nmbr$ c subgroup","C0019016;C0168634;C1079230;C1442488;C1515021;C1825777;C3538758",NULL,NULL,1637
"ppi use at baseline","C0042153;C0168634;C0358591;C0457083;C0871125;C1442488;C1947944;C3811894",NULL,NULL,625
"urinary albumimcreatinine ratio","C1273442","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"linagliptin n z $nmbr$","C2746078","C2746078","",1185
"llv wlalil $nmbr$ statin","C0360714","C0360714","",872
"male acr definition g mg","C0024671;C0026410;C0086582;C0439267;C0439269;C1412134;C1515941;C1550452;C1704788;C1706180;C1706428;C1706429;C1960952;C2346927;C3539107;C3888054;C4321396;C4521761",NULL,NULL,192
"total invasive cancer","C0439175;C0439810;C0677898",NULL,NULL,508
"high $nmbr$ $nmbr$ u ml","C0205250;C0439340;C1299351;C1880521;C2700149;C2945590;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"cd duration y","C0007928;C0034283;C0449238;C2926735;C4552032",NULL,NULL,699
"history of atrial fibrillation","C0729790",";C0004238","",1009
"no culprit vessel identified","C0005847;C0205396;C1550043",NULL,NULL,743
"$nmbr$ h pmg mg dl","C0033727;C0369286;C0439269;C0441932;C0564385;C4528284",NULL,NULL,192
"no current tobacco use","C0040335;C0521116;C0543414;C0841002;C1705970;C3853727",NULL,NULL,23
"ipss","C1019118;C1998280;C2827405;C3811063","C1998280",";C1019118;C3811063;C4050465;C4050466;C4049706;C0168634;C1705273;C1880519;C3853603",124
"at c change","C0392747;C0443172;C1705241;C4319952",NULL,NULL,767
"th $nmbr$","C0039725;C0039738;C1420718;C4282123;C4285344",NULL,NULL,1433
"$nmbr$ moderate disease","C0012634;C0205081;C1881878;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"weight median $nmbr$ th $nmbr$ th percentiles kg","C0022718;C0039725;C0039738;C0439209;C0549183;C0552346;C0876920;C1420718;C2347635;C2348144;C2939193;C4054209;C4282123;C4285344","C0005910","",2235
"fev auc i $nmbr$ h","C0021966;C0033727;C0221138;C0369286;C0376690;C0441932;C0564385;C3714541;C4528284",NULL,NULL,308
"females","C0086287","C0086287","",1277
"hypertension severity at baseline n","C0168634;C1442488;C4013784",NULL,NULL,625
"placebo n n","C0032042;C1696465;C1706408","C0032042","",28
"estimated glomerular filtration rate $nmbr$","C3811844","C3811844;C0017654","",592
"congestive heart failure $nmbr$ wk","C0018802;C0332174;C0439230","C0018801",";C0168634;C1524003",12
"history of diabetes","C0011847;C0011849;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"all ez simva","C0206578","C0360714;C1142985","",1862
"detected during tumor evaluation","C0027651;C0220825;C0442726;C1261322;C1511790;C1578706;C3273930",NULL,NULL,418
"ascvd as per protocol","C1698058;C3665365",NULL,NULL,344
"diastolic blood pressure","C0428883;C1305849","C0428883","",842
"cornell voltage duration mv ms","C0449238;C0598352;C1454484;C1705503;C2349943;C2926735;C3539704;C3713294;C4281602",NULL,NULL,1776
"latin america or south africa","C0023122;C0037712","C0037713","",580
"less than $nmbr$ y ears","C0013443;C0439092;C0521421",NULL,NULL,149
"pressure","C0033095;C0460139;C1306345;C4284008",NULL,NULL,1444
"organ system involvement no","C0460002;C1314939",NULL,NULL,1090
"anti gad positive","C0270549;C0439178;C1414925;C1446409;C1514241;C2825490;C3812269",NULL,NULL,2061
"mean pasi score $nmbr$ ci","C0008107;C3259781;C3533236;C4528685",NULL,NULL,519
"hypoglycaemic therapy","C0020616;C0039798;C0087111;C1363945","C0020616",";C0013227;C3244316;C4284232;C0450442;C1254351;C1515187;C1521826;C2826257",33
"hyperlipidaemia n yes","C0020473;C0428465;C1549445;C1705108;C1710701;C4555212","C0020473;C4555212",";C0439810;C1710701",29
"febuxostat $nmbr$ mg daily n $nmbr$ n n","C0024671;C0026410;C0249529;C0332173;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2282
"active pso wi $nmbr$ bsa $nmbr$ n y","C0043193;C0205177;C1520135;C3853793;C3888249",NULL,NULL,496
"women ethnic origin","C0015031;C0043210",NULL,NULL,787
"terol hdl c high density lipoprotein cholesterol","C0023822","C0023822","",821
"oral","C0442027;C4521986",NULL,NULL,1746
"acute respiratory insufficiency","C0865850",NULL,NULL,977
"bmi","C0578022",NULL,NULL,1735
"lce l dopa carbidopa entacapone lc l dopa carbidopa pd parkinson disease updrs rating scale adl activities of daily living pdq $nmbr$ parkinson disease questionnaire","C0001288;C0030567;C0034394;C0165921;C0353697;C0441655;C0681889;C1420005;C1423759;C1521736;C3273355;C3639721;C4552744",NULL,NULL,1231
"duration of chronic kidney disease years","C0022658;C0205191;C0439234;C0449238;C2926735","C0022658","",104
"chondroitin","C0008454","C0008454","",2216
"relative risk $nmbr$ ci","C0008107;C0242492;C3259781",NULL,NULL,519
"not hispanic or latino","C0086528;C1518424","C0086409","",865
"severe","C0205082;C4050465;C4050466",NULL,NULL,313
"$nmbr$ $nmbr$ week","C0332174;C0439230",NULL,NULL,1012
"hazard ratio","C2985465","C2985465","",975
"prevention n patients on llt other than statin n","C0030705;C0199176;C0360714;C1706420;C2347090;C2700409","C0360714","",872
"anti tnf naive patients","C0030705;C1448177",NULL,NULL,362
"extensive disease other","C0849867",NULL,NULL,742
"adjusted mean se ml","C0036919;C0439526;C0444504;C0456081;C1705224;C2347634;C2348143;C3887665",NULL,NULL,567
"$ $nmbr$ to $nmbr$ n $nmbr$","C0369718;C0441922",NULL,NULL,1063
"full analysis set n","C0002778;C0036849;C0443225;C0936012;C1442518;C1524024;C1705195",NULL,NULL,183
"median time delay interquartile range min","C0522486;C0549183;C0702093;C0876920;C1524029;C1711350;C2347635;C2348144;C2939193;C3813700",NULL,NULL,635
"duration diabetes years","C0011847;C0011849;C0439234;C0449238;C2926735","C2926735;C0011849","",1988
"events consistent with volume depletion","C0332290;C0441471;C0546884;C3541888",NULL,NULL,412
"percentage of patients receiving dose adjustment","C0030705;C0439165;C1514756;C1549488;C1561533;C2826232",NULL,NULL,113
"diabetes mellitust","C0011847;C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"geometric mean ofcrp mg liter range","C0024671;C0026410;C0439269;C0475211;C1514721;C1960952;C2346927;C2348147;C2986759;C3542016;C4321396;C4521761",NULL,NULL,192
"ace inhibitor arb therapy","C1444755;C3888198",NULL,NULL,44
"investigator determined myocardial infarction","C0027051;C0035173;C0428953;C2926063;C3810814;C4552959",NULL,NULL,646
"mini mental state examination mean sd d","C0444504;C0451306;C2347634;C2348143;C2699239","C0451306","",305
"tgs mg dl","C0439269;C1156212;C1537574",NULL,NULL,128
"type of af","C0332307;C0344434;C1547052;C4049859",NULL,NULL,603
"umec $nmbr$ $nmbr$ ig n $nmbr$","C0021027;C0305052;C0360506",NULL,NULL,1260
"baseline crcl ml min","C0168634;C0439445;C1442488;C1846718","C3811844;C0017654","",307
"other bdmards no tnfi taken t n","C1883727;C2986835",NULL,NULL,1615
"selena sledai total score","C0451528;C2964552",NULL,NULL,540
"severe ipss $nmbr$ age group","C0027362;C0205082;C1019118;C1998280;C2348001;C2827405;C3811063;C4050465;C4050466","C1998280",";C1019118;C3811063;C4050465;C4050466;C4049706;C0168634;C1705273;C1880519;C3853603",124
"oral hypoglycemic drug","C0359086","C0359086","",1744
"baseline ecrq $nmbr$ $nmbr$ to $nmbr$ ml min","C0168634;C0439445;C1442488","C3811844;C0017654","",307
"cognitive","C1516691",NULL,NULL,1570
"pioglitazone n $nmbr$","C0071097",NULL,NULL,1760
"hospitalization in previous year with management of heart failure","C0001554;C0018801;C0018802;C0019993;C0205156;C0376636;C0439234;C0439508;C1273870;C1552607;C3273539;C4554158",NULL,NULL,2395
"mean s d hdl cholesterol","C0023822;C0392885;C0444504;C2347634;C2348143",NULL,NULL,37
"change in mtss mean","C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952",NULL,NULL,767
"current cvd diabetes n","C0007222;C0011847;C0011849;C0521116;C1705970","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"actual treatment strategy","C0039798;C0087111;C0237400;C0679199;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,236
"fascng plasma glucose a medan","C0202042;C0455280","C0455280;C0015663",";C0168634",21
"estimated gfr ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$ sd a","C0017654;C0369637;C0439445;C0441923;C0750572;C1424601;C2699239","C3811844;C0017654","",592
"prior ml or stroke at baseline","C0038454;C0168634;C0332152;C0439526;C1442488;C1705224;C2826257;C3887665;C4554100",NULL,NULL,294
"aqlq s $nmbr$ scored","C0449820;C4055434",NULL,NULL,2057
"glucocorticoids and immunosuppressants","C0017710;C0021081;C3540777;C3540778","C0021081","",1424
"yes unknown","C0439673;C1549445;C1705108;C1710701;C3541433;C4050014",NULL,NULL,147
"fluticasone furoate n $nmbr$","C1948374",NULL,NULL,19
"mean sd tender joint count","C0444504;C0451530;C2347634;C2348143;C2699239","C0451530","",1139
"prior anti tnf therapy no","C0281481;C0332152;C2826257",NULL,NULL,2375
"prior history of bleeding on oac","C0019080;C0019664;C0019665;C0262512;C0262926;C0332152;C1705255;C2004062;C2826257",NULL,NULL,294
"primary trial end point","C0008976;C2986535","C2986535","",230
"saxa $nmbr$ mg n $nmbr$ $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"czp mtx to mtx","C0025677;C0054841;C1417487;C1861828;C1872109","C0025677;C1872109","",2217
"absolute reversibility in fev $nmbr$ ml","C0205344;C0439526;C0449261;C1705224;C3714541;C3887665","C0449261;C0231999","",1315
"oral contraceptive pills no total no","C0009905;C0009906;C0029151;C0439175;C0439810",NULL,NULL,508
"chd coronary heart disease eze simva ezetimibe simvastatin combination tablet fpg fasting plasma glucose pvd peripheral vascular disease","C0010068;C0015663;C0039225;C0074554;C0085096;C0202042;C0455280;C1532737;C1705223;C4319774","","",-10
"duration of copd years mean sd","C0024117;C0439234;C0444504;C0449238;C1412502;C2347634;C2348143;C2699239;C2926735;C3714496",NULL,NULL,1726
"aclidinium $nmbr$ g n $nmbr$ b","C0439267;C2699757",NULL,NULL,1485
"telmisartan n $nmbr$ $nmbr$","C0248719","C0248719","",1205
"years of follow up mean sd maximum","C0439234;C0444504;C0589120;C0806909;C1522577;C1552615;C1704685;C2347634;C2348143;C2699239;C2826546;C3274571",NULL,NULL,1099
"diabetes duration years","C0011847;C0011849;C0439234;C0449238;C2926735","C2926735;C0011849","",1988
"saxagliptin $nmbr$ mg","C0024671;C0026410;C0439269;C1611934;C1960952;C2346927;C4321396;C4521761","C1611934","",2069
"origin n","C0079946;C0439659;C1550512",NULL,NULL,283
"canvas","C3281223",NULL,NULL,1302
"male eze simva $nmbr$","C0086582;C1706180;C1706428;C1706429",NULL,NULL,586
"microvascular outcome","C0443258;C1274040",NULL,NULL,1602
"former smoker n","C0337671","C0037369","",420
"syst bp mmhg","C0037623;C0439475;C1415692;C1708288;C4318478",NULL,NULL,608
"rofecoxib","C0762662",NULL,NULL,2034
"amlodipine lisinopril chlorthalidone comparison","C0008294;C0051696;C0065374;C1707455","C0008294","",70
"mesalamine use n a","C0042153;C0127615;C0457083;C1947944",NULL,NULL,118
"c group n $nmbr$","C0441848",NULL,NULL,1638
"lm bifurcation not treated","C0184906;C1261082;C1518422;C1522326;C1551056;C3146289",NULL,NULL,893
"at least one drug eluting stent","C0205447;C1322815","C1322815","",365
"valsartan","C0216784","C0216784","",1206
"unstable angina n $nmbr$ $nmbr$","C0002965","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"baseline composite mayo clinic score","C0002424;C0168634;C0442592;C0454788;C1077578;C1442488;C4055211",NULL,NULL,425
"calcification n","C0006660;C0006663;C0175895;C1533591;C1879982;C2242558","C1533591","",264
"time in therapeutic range","C0040223;C0087111;C0302350;C0460097;C1554109;C3541383",NULL,NULL,757
"randomization to arterial sheath insertion","C0003842;C0021107;C0034656;C0221464;C0227952;C0441587;C1512796;C1883719",NULL,NULL,1709
"comparison cat $nmbr$ vs cat $nmbr$","C0007450;C0325090;C0524517;C1443200;C1707455;C3665481;C4050461;C4284282",NULL,NULL,255
"any vascular diasease","C0005847;C1558950;C1801960",NULL,NULL,743
"intensive bp lowering $nmbr$ mm hg n $nmbr$","C0037623;C0162425;C0439475;C0441994;C0522510;C1283828;C1415692;C1550453;C1708288;C2003888;C4318478",NULL,NULL,608
"haq score","C0102923;C0449820;C0451208;C4050231",NULL,NULL,1667
"aqlq score mean","C0444504;C0449820;C2347634;C2348143;C4050231;C4055434",NULL,NULL,2057
"number of copd exacerbations within $nmbr$ months mean sd","C0237753;C0439231;C0444504;C0449788;C0740304;C2347634;C2348143;C2699239",NULL,NULL,1556
"type no of valves repaired replaced mitral","C0184252;C0205340;C0332307;C0559956;C0746591;C1186983;C1299987;C1547052",NULL,NULL,603
"drugs used in diabetes n","C0011847;C0011849;C0013227;C1273517;C3687832","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"febuxostat $nmbr$ mg n $nmbr$","C0024671;C0026410;C0249529;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2282
"gold ii","C0018026;C1304897;C1710602;C4082587","C0024117;C0521117","",213
"ics use yes","C0042153;C0457083;C0815320;C1549445;C1705108;C1710701;C1947944;C4551720",NULL,NULL,147
"male sex n","C0086582","C0086582","",1276
"liraglutide n $nmbr$","C1456408","C1456408","",1566
"acei and or arb","C3888198",NULL,NULL,44
"kaplan meier rates i i","C0021966;C0221138;C0871208;C1521828",NULL,NULL,2008
"risk factors for stroke no","C0035648;C0038454;C1553898;C4554100",NULL,NULL,175
"hba $nmbr$ c median iqr","C0019016;C0549183;C0876920;C1825777;C2347635;C2348144;C2939193;C3538758",NULL,NULL,1897
"cv event years","C0439234;C0441471;C3538987;C4019010;C4048877;C4318503",NULL,NULL,1099
"very severe gold $nmbr$","C0018026;C1304897;C3641272;C4050419","C0024117;C0205082",";C4050419;C1412502;C3714496;C0018026;C1304897;C4050465;C4050466",1836
"noncomplex anatomy n $nmbr$ $nmbr$","C0002808;C0700276;C1384516",NULL,NULL,693
"at randomization","C0034656",NULL,NULL,692
"screening prebronchodilator fev $nmbr$ l","C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C2599602;C3714541",NULL,NULL,682
"bp goal no","C0018017;C0037623;C1415692;C1571704;C1708288;C4318478",NULL,NULL,608
"$nmbr$ mg $nmbr$ $nmbr$ $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"$nmbr$ $nmbr$ fo $nmbr$ o q i","C0021966;C0221138",NULL,NULL,1065
"modified braunwald class","C0392747;C0456387;C1518526;C1705943;C3889737",NULL,NULL,452
"reversibility b $nmbr$ agonist mean sd $nmbr$","C0444504;C0449261;C2347634;C2348143;C2699239;C2987634","C0449261;C0231999","",1315
"mild $nmbr$","C2945599",NULL,NULL,329
"use of parenteral antithrombotic","C0030547;C1524063;C4522267",NULL,NULL,25
"baseline total pcsk $nmbr$ level by median","C0168634;C0439175;C0439810;C0441889;C0456079;C0549183;C0876920;C1442488;C1547707;C2347635;C2348144;C2939193;C2946261",NULL,NULL,635
"i ii fev $nmbr$ $nmbr$ predicted","C0021966;C0221138;C0681842;C1710602;C1882327;C3714541;C4082587",NULL,NULL,523
"non asian","C0078988;C1518422","C0078988","",1369
"daily dose of study medication prescribed","C0013175;C0278329;C2348070",NULL,NULL,1488
"de $nmbr$ mg bid n $nmbr$ $nmbr$","C0011198;C0017480;C0024671;C0026410;C0439269;C1960952;C2346927;C3541240;C4321396;C4521761",NULL,NULL,1620
"one lesion","C0205447;C0221198;C1546698",NULL,NULL,737
"chlorthalidone vs lisinopril","C0008294;C0065374","C0008294","",70
"hemorrhagic stroke","C0553692",NULL,NULL,581
"stratum ii","C1710602;C4082587",NULL,NULL,546
"ls mean difference se vs placebo","C0023668;C0032042;C0036919;C0444504;C1696465;C1705241;C1705242;C1706408;C2347634;C2348143","C0032042","",28
"previous use of other biologic agents in addition to tne","C0005515;C0205156;C1524063;C1552607;C3896585",NULL,NULL,2391
"coronary heart disease risk equivalents n c","C0439185;C1277690;C4049980","","",170
"daily activities","C0871707",NULL,NULL,1653
"beta $nmbr$ selective","C0036576;C0330390;C0439096;C1707391;C2004068",NULL,NULL,1429
"uacr mg g","C1300563",NULL,NULL,2315
"n terminal pro bnp pg ml","C0439297;C0669479",NULL,NULL,1511
"linear regression","C0023733;C2346679",NULL,NULL,468
"disseminated tuberculosis","C0152915",NULL,NULL,915
"middle tertile $nmbr$ $nmbr$ to b $nmbr$ $nmbr$","C0444598;C0549183;C1552826",NULL,NULL,331
"om $nmbr$ mg hctz $nmbr$ mg","C0020261;C0028971;C1319635;C1705272",NULL,NULL,1149
"major st depression or","C0036056;C0041696;C0205082;C0205164;C0520887;C1269683;C3272372;C4318856;C4521762","C0520887","",1091
"chronic heart failure class ii iii","C0018802;C0264716;C0439070;C0441886;C0441887;C1705160;C1710602;C2698968;C2698969;C4082587","C0018801",";C0168634;C1524003",12
"demographic and clinical","C0011298;C0205210",NULL,NULL,582
"ertugliflozin $nmbr$ mg n $nmbr$ $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4079805;C4321396;C4521761","C4079805","",1180
"trandolapril","C0076891",NULL,NULL,620
"psa modified mases score $nmbr$ $nmbr$","C0392747;C0449820;C3810537;C3813209;C3889737;C4050231",NULL,NULL,125
"diuretic subgroup","C0012798;C1079230;C1515021",NULL,NULL,1637
"hospital factor $nmbr$","C0019994;C1510665;C1521761;C2827422",NULL,NULL,1111
"esrd on placebo","C0022661;C0032042;C0035078;C1696465;C1706408;C2316810","C0032042","",28
"history of bowel resection ref","C0019664;C0019665;C0262512;C0262926;C0741614;C1425988;C1705255;C2004062",NULL,NULL,1880
"pci no","C4049621",NULL,NULL,1736
"myocardial infarction before index acs no","C0027051;C0428953;C0600653;C0742343;C0918012;C1552854;C1637833;C2926063;C2986546;C3810814;C4318612;C4552959",NULL,NULL,2150
"lama use at screening","C0042153;C0220908;C0220909;C0457083;C0999593;C1416775;C1698960;C1710031;C1710032;C1710477;C1947944;C2348164",NULL,NULL,798
"total cholesterol","C0201950;C0543421","C0543421","",1504
"cd gemini $nmbr$","C0007928;C0034283;C4552032",NULL,NULL,699
"pbo statin n $nmbr$","C0031962;C0360714",NULL,NULL,435
"ck $nmbr$ xuln","C0009212;C0010287;C1872855",NULL,NULL,1675
"systolic blood pressure subgroups","C0488055;C0871470;C1079230;C1306620","C0871470","",615
"fasting triglycerides $nmbr$ mg dl","C0015663;C0041004;C0439269","C0041004","",368
"inappropriate","C1548788;C3537135;C3542467",NULL,NULL,1574
"less than $nmbr$ kg m $nmbr$","C0439092;C1532718","C0439092","",1749
"ethnicity location","C0015031;C0243103;C0450429;C1515974;C4284930;C4284931",NULL,NULL,906
"orc $nmbr$ cl","C0596019;C1167125",NULL,NULL,658
"crohn s disease","C0010346",NULL,NULL,105
"valvular heart disease n","C0018824;C1963123","C0018824","",103
"angina or acute mi","C0002962;C0155626","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"fibrillation flutter","C0016385;C0232197;C2242390",";C0004238","",1009
"steroid sparing remission","C0038317;C0544452;C0687702",NULL,NULL,1712
"waist to hip female","C0019552;C0022122;C0043210;C0086287;C0230097;C1505163;C1705497;C1705498;C3538851;C4284725","C0205682","",1409
"current cigarette n","C0521116;C0677453;C1704760;C1705970;C3890423","C0037369","",420
"thyroid disease","C0040128",NULL,NULL,105
"mean lipid values mg dl","C0023779;C0042295;C0439269;C0444504;C2347634;C2348143","C0023779","",1772
"bdi focal score","C0006448;C0205234;C0449820;C0451022;C3714938;C3889415;C4050231",NULL,NULL,1127
"current lra use","C0042153;C0457083;C0521116;C1705970;C1947944",NULL,NULL,118
"requiring assistance","C0018896;C1269765",NULL,NULL,1202
"serum k level and drug treatment","C0150270;C0302353;C0441889;C0456079;C1547707;C2946261;C3469597",NULL,NULL,1007
"renal impairmentf","C0022646","C1565489","",937
"prasugrel or ticagrelor","C1620287;C1999375","C1620287","",4
"ratio","C0456603;C1547037",NULL,NULL,973
"non hdl","C1518422;C3715113","C0023822","",821
"post fvc pred","C0032952;C0044955;C0687676;C1704687;C3469826;C3714541",NULL,NULL,680
"renal function subgroups","C0232804;C1079230",NULL,NULL,1637
"yes non insulin treated","C0021641;C1518422;C1522326;C1533581;C1549445;C1579433;C1705108;C1710701;C3714501",NULL,NULL,157
"$nmbr$ e h","C0033727;C0369286;C0441932;C0564385;C4528284",NULL,NULL,308
"dual iv end of trial hba $nmbr$ c","C0008976;C0019016;C0205173;C0444930;C0444972;C1554184;C1825777;C2746065;C3538758",NULL,NULL,1020
"total number of patients","C0439175;C0439810;C2360800",NULL,NULL,508
"ldl c concentration","C0086045;C1446561;C3827302",NULL,NULL,676
"black hispanic","C1533017;C1533018","C0086409","",865
"mean fev $nmbr$ l sd","C0444504;C2347634;C2348143;C2699239;C3714541",NULL,NULL,1287
"hdl cd","C0007928;C0034283;C3715113;C4552032","C0023822","",821
"effect size","C0814843","C0814843","",2080
"total cholesterol level mg dl","C0439269;C0878805;C1445957","C1445957","",1968
"thrombus aspiration","C0087086;C0220787;C0302148;C0349707;C0700198;C2712334;C2827071;C3146237",NULL,NULL,1641
"$nmbr$ to $nmbr$ ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923","C3811844;C0017654","",307
"risedronate n $nmbr$","C0246719",NULL,NULL,1573
"patients who had ulcerations at","C0030705;C0041582",NULL,NULL,1035
"disposition index","C0600653;C0743223;C0918012;C1552854;C1637833;C1705555;C2986546",NULL,NULL,734
"cuban","C1553379","C1553379","",238
"hdl cholesterol mg dl triglycerides mg dl","C0023822;C0024671;C0026410;C0041004;C0392885;C0439269;C1960952;C2346927;C3539687;C4321396;C4521761","C0023822","",1962
"serum creatinine pmol l mean sd","C0201976;C0439284;C0444504;C0600061;C2347634;C2348143;C2699239","C0600061;C0010294","",952
"mean sd age y race n","C0001779;C0034510;C0444504;C1706779;C2347634;C2348143;C2699239;C3853635","C0001779","",480
"rheumatoid factor positive n","C0035448;C0201660;C0439178;C1446409;C1514241;C2825490;C3812269",NULL,NULL,2060
"race white n","C0007457;C0034510;C0043157;C0220938;C1706779;C3853635",";C0034510","",1107
"table $nmbr$ baseline characteristics of total study sample and stratified by treatment assignment and testosterone levela","C0039224;C0039601;C0039798;C0087111;C0168634;C0205363;C0370003;C0947343;C1315074;C1442488;C1516050;C1522326;C1533734;C1705169;C1706074;C2347026;C3538994;C3887704;C4684572",NULL,NULL,236
"coronary heart disease","C0010054;C0010068;C1956346","C0010068;C1956346",";C0026410;C1710701",226
"previous tia","C0007787;C0205156;C0917805;C1054154;C1552607",NULL,NULL,1592
"duration of disease since","C0872146","C0449238;C0872146","",903
"favors dabigatran","C0309049;C2348066",NULL,NULL,775
"general and lumbar epidural","C0205246;C0581283;C3812897;C3891294;C4521767",NULL,NULL,1558
"ind glyb n $nmbr$","C1415124;C4049864","C3814772;C1722260","",1509
"hscrp exp ls mean change se","C0023668;C0036919;C0392747;C0443172;C0444504;C1417055;C1705241;C2347634;C2348143;C4319952",NULL,NULL,567
"nyha functional class","C0205245;C0542341;C1882083;C2700217",NULL,NULL,1531
"$nmbr$ mg dl baseline high sensitivity crp","C0168634;C0439269;C1441604;C1442488;C3890735;C4048285",NULL,NULL,1545
"$nmbr$ months median min max","C0439231;C0549183;C0702093;C0876920;C1524029;C2347635;C2348144;C2939193;C3813700",NULL,NULL,1475
"inclusion criteria no","C1512693",NULL,NULL,1860
"subcutaneous injections","C0021499",NULL,NULL,1662
"antihypertensive medication","C0003364",";C0003364","",1579
"history myocardial infarction","C0155668;C1275835",NULL,NULL,641
"atrial flutter","C0004239;C0344423;C1963068",";C0004238","",1009
"diuretic drugs n","C0012798;C0013227;C3687832",NULL,NULL,992
"admission grace score","C0184666;C0449820;C0809949;C4050231",NULL,NULL,748
"family history of coronary disease","C0018787;C0850707",NULL,NULL,1481
"other vascular disease","C0042373",NULL,NULL,742
"km rates p s","C0234833;C0722388;C0871208;C1521828;C3887676",NULL,NULL,2008
"spain n $nmbr$","C0037747","C0037747","",2170
"concomitant atorvastatin dose mg","C0024671;C0026410;C0178602;C0286651;C0439269;C0521115;C0869039;C1114758;C1960952;C2346927;C4321396;C4521761","C0286651","",885
"heart failure nyha ii iii","C0018801;C0018802;C0439070;C1275491;C1705160;C1710602;C4082587;C4554158",NULL,NULL,151
"fev $nmbr$ fvc mean sd $nmbr$","C0444504;C2347634;C2348143;C2699239;C3714541",NULL,NULL,2126
"n $nmbr$ fatty acids placebo lsm $nmbr$ cl","C0015684;C0032042;C0369718;C0441922;C0596019;C1696465;C1706408",NULL,NULL,1553
"parameter $nmbr$ ci","C0008107;C0549193;C1704769;C2350001;C3259781","C0549193","",1186
"all participants history of cabg","C0010055;C0019664;C0019665;C0262512;C0262926;C0679646;C1705255;C2004062","C0010055","",389
"$nmbr$ tcz mtx","C0025677;C1417487",NULL,NULL,84
"jejunum","C0022378","","",-10
"total baseline insulin dose","C0021641;C0168634;C0366513;C0439175;C0439810;C1442488;C1533581;C1579433;C2986497;C3714501",NULL,NULL,157
"concomitant drug treatment","C0150270;C0521115;C3469597",NULL,NULL,1007
"stroke non","C0038454;C1518422;C4554100",NULL,NULL,1762
"undetermined etiology","C0478157","C0478157","",1087
"parameter mean s d","C0444504;C0549193;C1704769;C2347634;C2348143;C2350001","C0549193","",1186
"baseline asdas crp","C0168634;C1442488;C3890735;C4048285",NULL,NULL,1545
"rate per $nmbr$ patient years control vs alirocumab","C0030705;C0243148;C0439234;C0871208;C1521828;C1550141;C1882979;C2587213;C3274648;C3491162;C4553389",NULL,NULL,2009
"male sex no weight no","C0005910;C0043100;C0086582;C1305866;C1705104","C0005910","",1250
"nonobese $nmbr$ kg nr","C0022718;C0027496;C0439209;C3844738;C4054209",NULL,NULL,1477
"creat clearance $nmbr$ ml min","C0201975;C0439445;C0449297;C1382187;C2825073;C4554548","C3811844;C0017654","",307
"crcl ml min mean sd","C0439445;C0444504;C1846718;C2347634;C2348143;C2699239","C3811844;C0017654","",307
"type of antihypertensive medication use among patients using antihypertensive medications n","C0003364;C0030705;C0332307;C1524063;C1547052",";C0003364","",1579
"ipeated measures state examinatioi","C0079809;C1301808;C1442792;C1879489;C3148680",NULL,NULL,980
"non hishnic","C1518422",NULL,NULL,85
"mmol l n","C1532563",NULL,NULL,670
"leukotriene modifier","C0023545;C0205349;C1514623;C1516451;C3542952","","",-10
"bmi kg m $nmbr$ mean sd","C0444504;C0578022;C1532718;C2347634;C2348143;C2699239",NULL,NULL,2125
"prior mi diagnosis","C0332132;C3810814",NULL,NULL,516
"mean sd fev $nmbr$ l","C0444504;C2347634;C2348143;C2699239;C3714541",NULL,NULL,2142
"o $nmbr$","C0483204","","",-10
"age at enrollment years","C1510829;C1516879;C1696073;C3888021","C1510829","",481
"major bleeding","C0019080;C0205082;C0205164;C4318856;C4521762","C0019080;C0205082","",2076
"c reactive protein","C0006560;C1413716;C4048285","C0006560","",286
"gold group d","C0018026;C0441838;C1304897","C0024117;C0521117","",213
"previous bypass surgery n","C0205156;C1536078;C1552607",NULL,NULL,2040
"history of disease refractory to treatment with tnf antagonist no","C0039798;C0087111;C0205269;C0231491;C0683519;C0730226;C0850708;C0944983;C1448177;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,184
"$nmbr$ $nmbr$ n $nmbr$","C0369718;C0441922",NULL,NULL,1553
"lvef $nmbr$ n $nmbr$ $nmbr$","C0428772;C0488728","C0018801;C0428772","",1273
"no ckd standard n $nmbr$","C1442989;C1561643;C2828392","C1561643","",967
"western europe australia new zealand and middle east","C0026068;C0043129;C4289954","","",599
"ag gg","C0002037;C0017454;C0018370;C0051080;C0152305;C3888235",NULL,NULL,854
"previous dm n","C0011816;C0205156;C1552607;C3250443",NULL,NULL,955
"eze statin","C0360714","C0360714","",872
"established renal disease egfr $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m with any uacr mg g or egfr $nmbr$ $nmbr$ ml inin l $nmbr$ m $nmbr$ with an uacr $nmbr$ mg g without previous maerovaseular and albuminuria disease","C0001925;C0012634;C0022658;C0205156;C0369637;C0439445;C0439526;C0441923;C0443211;C0456616;C1272684;C1300563;C1552607;C1705224;C1739039;C3811844;C3812682;C3887665","C1561643","",967
"high density lipoprotein mg dl","C0023821;C0439269",NULL,NULL,835
"known duration of t $nmbr$ dm y","C0011816;C0205309;C0449238;C2926735;C3250443",NULL,NULL,901
"enoxaparin vka","C0206460","C0206460","",862
"gold a","C0018026;C1304897","C0024117;C0521117","",213
"glycoprotein iib iiia inhibitor","C0016011;C1999216",NULL,NULL,808
"minimum maximum focal seizure fre quency $nmbr$ days at baseline","C0168634;C0439228;C0751495;C0806909;C1414819;C1442488;C1524031;C1552614;C1552615;C2826545;C2826546","C0751495","",2203
"urinary protein creatinine ratioa mg mg","C0042027;C0369901;C0428627;C1319635;C1524119",NULL,NULL,2318
"indacaterol n $nmbr$","C1722260","C1722260","",1875
"initial symptomatic pe","C0070939;C0205265;C0231220;C1279901;C1555582;C1705685;C1880476;C4284304",NULL,NULL,1516
"no chd eze simva n $nmbr$","C0280604;C3542407",NULL,NULL,970
"hf or lvef $nmbr$ associated with index event","C0018488;C0332281;C0428772;C0441471;C0488728;C0600653;C0918012;C1313497;C1538440;C1552854;C1637833;C2986546;C3273279;C4019010","C0018801;C0428772","",1273
"arthritis","C0003864;C4552845","C0003864","",274
"outcomes","C1274040",NULL,NULL,1602
"previous cabg before index acs","C0010055;C0205156;C0600653;C0742343;C0918012;C1552607;C1552854;C1637833;C2986546;C4318612",NULL,NULL,2149
"heart rate min_ $nmbr$ mean","C0018810;C0444504;C0702093;C1524029;C2347634;C2348143;C3813700","C0018810","",1105
"lower risk","C3272281;C3538919",NULL,NULL,174
"onset $nmbr$ $nmbr$","C0206132;C0332162",NULL,NULL,736
"plasma cholesterol mg dl","C0439269;C0858034",NULL,NULL,192
"antihypertensive agents","C0003364",";C0003364","",1579
"apoa i","C0085201;C1677784","C0085201","",1852
"concurrent illness","C0205420;C0221423",NULL,NULL,1418
"duration of copd","C0024117;C0449238;C1412502;C2926735;C3714496",NULL,NULL,1726
"ecg at time of qualifying symptoms","C0040223;C0683368;C1457887;C1514624;C1623258;C3541383",NULL,NULL,757
"post bronchodilator fev $nmbr$ predicted","C0681842;C1882327;C2599594;C3714541",NULL,NULL,680
"ga","C0016993",NULL,NULL,1750
"asian n $nmbr$","C0078988","C0078988","",1369
"$ $nmbr$ n $nmbr$","C0369718;C0441922",NULL,NULL,1553
"oral treprostinil n $nmbr$","C0442027;C1145760;C4521986",NULL,NULL,1746
"all randomized","C0034656;C3815594",NULL,NULL,692
"low dose corticosteroid user","C0001617;C0445550;C1548600;C1706077;C1708745;C3536709",NULL,NULL,534
"lean $nmbr$ kg m $nmbr$","C1532718",";C1305855","",206
"baseline lipid lipoprotem values","C0023779;C0042295;C0168634;C1442488",NULL,NULL,2190
"treated","C1522326",NULL,NULL,552
"family history of coronary artery disease","C2317524",NULL,NULL,1494
"joint swelling effusion or both on clinical examination no","C0013604;C0013687;C0031809;C0038999;C0152031;C1253936;C1963136;C2317432;C4554335","C0152031","",1138
"n r","C0205090;C0369718;C0441922;C0684010;C2603358",NULL,NULL,1553
"age median iqr years","C0549183;C0876920;C1510829;C2347635;C2348144;C2939193",NULL,NULL,1890
"hemoglobin $nmbr$ men $nmbr$ women","C0019046;C0025266;C0043210","","",306
"disease duration year median","C0439234;C0439508;C0549183;C0872146;C0876920;C2347635;C2348144;C2939193","C0449238;C0872146","",903
"overall pp n $nmbr$","C0030375;C0063017;C0282416;C1561607;C4319755",NULL,NULL,1743
"inhibitors no se $nmbr$ physical functioning score","C0036919;C0205245;C0243077;C0542341;C4483112;C4552744",NULL,NULL,1531
"male eze simva","C0086582;C1706180;C1706428;C1706429",NULL,NULL,586
"ischaemic aetiology","C0015127;C0475224;C1314792;C1524003",NULL,NULL,924
"gusto moderate or severe","C0205081;C0205082;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335",NULL,NULL,321
"alc at weeko","C1424945;C3811058",NULL,NULL,395
"history of hypercholesterolemia n","C1533076",NULL,NULL,1498
"edss score","C0449820;C0451246;C3887783;C4050231",NULL,NULL,748
"visit $nmbr$ sbp mm hg","C0085805;C0439475;C0545082;C1512346;C2826704","C0005823","",1469
"$nmbr$ subjects","C0681850;C1550501;C1706203;C2349001;C2697811",NULL,NULL,1655
"bone fracture due to fall","C0016658;C0085639;C0238715;C0678226;C4553726",NULL,NULL,2026
"fev $nmbr$ mean predicted","C0444504;C0681842;C1882327;C2347634;C2348143;C3714541",NULL,NULL,1599
"hypertension at baseline","C0020538;C0168634;C1442488;C1963138",NULL,NULL,625
"dlqi $nmbr$ $nmbr$ mean sd","C0444504;C2347634;C2348143;C2699239;C3899393",NULL,NULL,527
"pfor heterogeneity","C0019409;C0242960;C1151635",NULL,NULL,235
"enoxaparin n $nmbr$","C0206460","C0206460","",862
"$nmbr$ mg q $nmbr$ w","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"no of vessels treated","C0005847;C1522326",NULL,NULL,743
"duration of epilepsy years","C0014544;C0439234;C0449238;C2926735","C0014544;C0449238","",1993
"placebo plus statin n $nmbr$","C0032042;C0332287;C0360714;C1696465;C1706408","C0032042","",28
"baseline a $nmbr$ c","C0168634;C1442488",NULL,NULL,625
"total","C0439175;C0439810",NULL,NULL,508
"impaired fasting giucose levei n $nmbr$","C0015663;C0221099","C0017725;C0015663","",1846
"creatinine","C0010294;C1561535","C0600061;C0010294","",952
"site","C0205145;C1515974;C2825164",NULL,NULL,1193
"jsn score $nmbr$ $nmbr$ scale","C0175659;C0349674;C0449820;C1947916;C4050231",NULL,NULL,2055
"systolic bp at baseline","C0168634;C0871470;C1442488","C0871470","",615
"gastrointestinal event","C0441471;C0521362;C4019010",NULL,NULL,412
"ac tve cancer","C0001246;C0003354;C0006826;C0998265;C1306459;C1412573;C2000891;C3539770","C0006826","",1819
"duration of asthma years","C0004096;C0439234;C0449238;C2926735;C2984299",NULL,NULL,694
"individuals without diabetes n $nmbr$ $nmbr$","C0011847;C0011849;C0027361;C0237401","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"chronic respiratory failure","C0264492",NULL,NULL,977
"enrolment through hf","C0018488;C1313497;C1516879;C1538440;C1696073;C3273279;C3888021","C0018801",";C0168634;C1524003",12
"pharmaco invasive n $nmbr$","C0205281;C1334278",NULL,NULL,762
"clinical vertebral fractures","C0080179;C0205210",NULL,NULL,2023
"familv historv of cad","C1504769;C2239547;C3813548;C4284121",NULL,NULL,698
"average weekly mtx dose mg week t","C0024671;C0026410;C0332174;C0366550;C0439230;C0439269;C1510992;C1960952;C2346927;C2825518;C4321396;C4521761","C0025677","",716
"knees n","C0022742","C0022742","",1080
"mean doseb","C0444504;C2347634;C2348143",NULL,NULL,37
"south asia","C0037723;C1519427","C0037713","",580
"hbalc a $nmbr$ mmol mol $nmbr$ $nmbr$ n $nmbr$ $nmbr$","C3829066","","",820
"sesbp mmhg mean sd d","C0439475;C0444504;C2347634;C2348143;C2699239",NULL,NULL,2127
"rate y","C0871208;C1521828",NULL,NULL,2009
"oral blood glucose lowering","C0005802;C0441994;C0442027;C2003888;C4521986",NULL,NULL,1746
"a $nmbr$ kg m $nmbr$","C1532718",";C1305855","",206
"body mass index mean sd kg m $nmbr$","C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239","C1305855","",1734
"long term","C0443252","C0443252","",1858
"loop or thiazide diuretic","C0012802;C0445022;C3536861","","",993
"rosuvastatin n $nmbr$","C0965129","C0965129","",886
"chloroquine","C0008269",NULL,NULL,1965
"pbo to czp week $nmbr$ dose combined","C0031962;C0054841;C0178602;C0205195;C0332174;C0439230;C0869039;C1114758;C1861828;C1872109",NULL,NULL,435
"mean s d baseline fpg mmol l","C0168634;C0444504;C1442488;C1532563;C2347634;C2348143",NULL,NULL,670
"male patients n","C0150904",";C0150904","",1037
"ibdq domain scores mean sd","C0444504;C0449820;C1880389;C1883221;C2347634;C2348143;C2699239;C3541951;C4050231",NULL,NULL,1287
"modified has bled score mean sd","C0019080;C0392747;C0444504;C0449820;C2347634;C2348143;C2699239;C3889737;C4050231",NULL,NULL,767
"s $nmbr$ yrs","C0565930;C2603362",NULL,NULL,1784
"bmi kg m $nmbr$ sd","C0578022;C1532718;C2699239",";C1305855","",206
"moderate n a","C0205081;C1881878;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"history of diabetes requiring drugs","C0011847;C0011849;C0019664;C0019665;C0020616;C0262512;C0262926;C1553893;C1705255;C2004062","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"pint","C0560012;C3811619;C3890014;C3890556",NULL,NULL,1134
"metabolic syndrome visit $nmbr$ low density lipoprotein cholesterol strata","C0023824;C0524620;C0545082;C1512346;C2826704",NULL,NULL,617
"cough leading to study drug discontinuation","C0010200;C0013175;C0040363;C0041260;C0332152;C0457454;C1444662;C1522538;C1883351;C1961131;C3274924;C4084725;C4084726;C4084727;C4552847",NULL,NULL,431
"integrated analysis set n $nmbr$","C0002778;C0036849;C0369718;C0441922;C0936012;C1158478;C1442518;C1524024;C1705195;C1705422",NULL,NULL,183
"rituximab $nmbr$ x $nmbr$ mg mtx","C0024671;C0025677;C0026410;C0393022;C0439269;C1417487;C1960952;C2346927;C4321396;C4521761",NULL,NULL,946
"prior pci or cabg surgery","C0010055;C0038894;C0038895;C0332152;C0543467;C1274039;C2826257;C4049621",NULL,NULL,598
"homa_ir tx difference vs pbo median change from baseline se $nmbr$","C0022065;C0022071;C0031962;C0036919;C0041403;C0168634;C0392747;C0443172;C0549183;C0876920;C1442488;C1448132;C1705241;C1705242;C2347635;C2348144;C2939193;C4319952",NULL,NULL,567
"asqol ls mean change se","C0023668;C0036919;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952",NULL,NULL,567
"history of omalizumab treatment","C0019664;C0019665;C0039798;C0087111;C0262512;C0262926;C0966225;C1522326;C1533734;C1705169;C1705255;C2004062;C3538994;C3887704","C0966225","",940
"mild $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$ n","C0369637;C0439445;C0441923;C2945599","C3811844;C0017654","",307
"gm geometric mean gmr geometric mean ratio over baseline uacr urinary albumimcreatinine ratio reduction $nmbr$ x $nmbr$ ratio of gmr for losartan versus gmr for placebo amean of change with change calculated as difference between time indicated and baseline as measured for each participant difference of changes between treatment groups cp values compare differences from no change","C0006938;C0017480;C0032042;C0039798;C0042295;C0087111;C0126174;C0168634;C0301630;C0392747;C0392756;C0441833;C0443172;C0444686;C0444706;C0456603;C0679646;C0687744;C1257890;C1273442;C1293152;C1441506;C1442103;C1442488;C1444656;C1519504;C1522326;C1522544;C1533734;C1547037;C1547049;C1552839;C1696465;C1704695;C1705169;C1705241;C1705242;C1705428;C1705429;C1706408;C1707455;C2698741;C2986759;C3538994;C3541902;C3854019;C3887704;C4050020;C4319952;C4551656;C4554048","","",-10
"with dm","C0011816;C3250443",NULL,NULL,955
"bl bml $nmbr$ ke m","C0005918;C0006413;C0022558;C0369637;C0441923;C1552663;C2827109",NULL,NULL,655
"insulin only","C0021641;C0205171;C1533581;C1579433;C1720467;C3714501",NULL,NULL,157
"biologic therapeutic failure","C0005515;C0087111;C0205460;C0231174;C0302350;C0680095",NULL,NULL,214
"risk level at admission","C0184666;C0809949;C2923839",NULL,NULL,470
"others classes i and iiic","C0441885;C1319793;C1955473;C2698967;C3539125",NULL,NULL,454
"ttf fv","C1332112;C1705840;C4087167","","",-10
"preferred term","C1709637;C2347664",NULL,NULL,949
"$nmbr$ early intervention n $nmbr$","C0242687;C1964029",NULL,NULL,1714
"p value versus placebo","C0032042;C1696465;C1706408;C1709380","C0032042","",28
"f","C0016327","","",-10
"omega $nmbr$ fa intake $nmbr$ nd third","C0205437;C1512806;C1719844",NULL,NULL,1585
"angiotensin eonverting enzyme inhibitors angiotensin reeeptor bloekers","C0003018;C0014432;C1152555;C2756995;C4521302","C0003015","",811
"pre diabetes mellitus","C0362046","C0362046",";C0168634;C1334085;C1708411",910
"males n","C0086582","C0086582","",1276
"antihypertensive treatment","C0003364;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704",";C0003364","",1579
"no men","C0025266",NULL,NULL,1842
"$nmbr$ mg dl simva n $nmbr$","C0439269",NULL,NULL,192
"non smoker n $nmbr$ $nmbr$","C0337672;C0425293;C4554605","C0037369","",420
"omega $nmbr$ fatty acids","C0015684;C1719844","C0015684","",1236
"question $nmbr$ length of morning stiffness since arising","C0332284;C0457086;C1444754;C1522634;C1706316;C4019053;C4318616",NULL,NULL,754
"ace arb users","C1452534;C1706077;C3888198;C4284014",NULL,NULL,46
"race ethnicity chinese","C0008120;C0015031;C0034510;C0152035;C0243103;C1706779;C3853635",";C0034510","",1107
"central eosinophil count","C0200638;C0205099;C0750879;C1879652",NULL,NULL,677
"ics subset","C0815320;C1515021;C4551720",NULL,NULL,1359
"antihyperglycemic medication usage","C0013227;C0020616;C0457083;C3244316;C4284232","C0020616",";C0013227;C3244316;C4284232;C0450442;C1254351;C1515187;C1521826;C2826257",33
"rf mg dl","C0035448;C0201660;C0439269;C0748398;C1547111","C0035448","",1435
"indacaterol glycopyrronium group","C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1722260;C3814772",NULL,NULL,1526
"ss years","C0439234;C2699257;C3891295;C4551874",NULL,NULL,1099
"additional endpoints","C1524062;C2349179","C2349179","",1136
"randomised patients n","C0030705",NULL,NULL,1035
"south africa","C0037712","C0037713","",580
"median y range","C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016",NULL,NULL,635
"antithrombotic therapy","C0039798;C0087111;C1363945","","",1191
"eze statin n $nmbr$","C0360714","C0360714","",872
"coronary artery osteochondrosis","C0029376;C0029429;C0205042;C0729346","C0205042","",228
"left ventricular ejection fraction $nmbr$","C0428772;C0488728","C0018801;C0428772","",1273
"sensitive responders n $nmbr$","C0020517;C0332324;C1522640","C0332324","",1164
"dysglycaemia or mets","C0812270;C1705694;C1960636;C2939420",NULL,NULL,921
"standing after $nmbr$ minutes change from baseline","C0168634;C0231472;C0392747;C0439232;C0443172;C0700321;C0702093;C1282918;C1442488;C1705241;C2347166;C4319952",NULL,NULL,625
"prior a blocker use","C0042153;C0332152;C0457083;C1947944;C2826257",NULL,NULL,1926
"european subcategories","C0239307;C1515010;C1535514","C0239307","",504
"$nmbr$ st quartile","C0036056;C2828255;C3272372",NULL,NULL,246
"baseline heart rate beat min","C0168634;C0425583;C0702093;C0871208;C1442488;C1521828;C1524029;C3813700","C0018810","",1105
"current smoker no","C3173209;C3241966","C3241966","",1420
"experimental treatment group","C0441833;C0687744;C0949266;C1257890;C1519504;C1705428;C1705429;C2585119",NULL,NULL,1526
"no chd simva $nmbr$","C0280604;C3542407",NULL,NULL,970
"$nmbr$ years of age","C1510829","C1510829","",481
"patient s global assessment of disease activity $nmbr$ $nmbr$ mm vas mean sd","C0042815;C0444504;C2347634;C2348143;C2699239;C3536884;C3827561;C4054228;C4330985;C4554674",NULL,NULL,2143
"renal impairment","C1565489","C1565489","",937
"colectomy partial or total","C0009274;C0439175;C0439810;C0728938;C1550516",NULL,NULL,508
"non hispanic black or african american","C0005680;C0027567;C0085756;C0439541;C1518424","C0005680",";C1706779",188
"heart failure n","C0018801;C0018802;C4554158","C0018801",";C0168634;C1524003",12
"per body weight u kg","C0005910;C1300561;C1305866","C0005910","",1250
"copd severity severe very severe","C0024117;C0439793;C0442824;C0522510;C1412502;C2984081;C3714496",NULL,NULL,1546
"peripheral revascularization n $nmbr$","C0205100;C0581603",NULL,NULL,932
"other blood pressure lowering drugs","C0003364",";C0003364","",1579
"il $nmbr$ ng l","C0020898;C0021764;C0022271;C0439297",NULL,NULL,672
"female sex number","C0086287;C0237753;C0449788",NULL,NULL,1556
"patients with diabetic nephropathy","C0011881;C0030705;C1442864",NULL,NULL,1035
"qrs $ $nmbr$ ms $nmbr$ cl n $nmbr$","C0596019;C2349943;C3539704;C3713294",NULL,NULL,126
"killip class lll iv","C1261077;C2697847","C1881332","",846
"mean s d non hdl cholesterol","C0444504;C0729627;C1535899;C2347634;C2348143",NULL,NULL,37
"aliskiren valsartan n $nmbr$","C2733073","C1120110","",1172
"age at diagnosis of ln years","C0439234;C0861352;C1428884;C1828181;C3173302;C3714709","C1828181","",483
"olodaterol $nmbr$ pg","C0030827;C0072225;C1266240;C2934193",NULL,NULL,1510
"white race n $nmbr$ $nmbr$","C0007457;C0043157",NULL,NULL,2003
"haq pain scale mean","C0102923;C0444504;C0451208;C1504479;C2347634;C2348143",NULL,NULL,37
"non cv mortality","C0026565;C0026566;C1518422;C3538987;C4048877;C4318503",NULL,NULL,1777
"lef mtx n $nmbr$","C0025677;C1417487","C0025677","",1408
"duration of epilepsy years mean sd","C0014544;C0439234;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735","C0014544;C0449238","",1993
"mean yearly decline","C0332181;C0439508;C0444504;C2347634;C2348143",NULL,NULL,37
"cholesterol mg dl mean sd","C0008377;C0439269;C0444504;C2347634;C2348143;C2699239","C0008377","",1501
"normoglycemic $nmbr$","C0580545",NULL,NULL,34
"alirocumab $nmbr$ mg q $nmbr$ w","C0024671;C0026410;C0439269;C1960952;C2346927;C3491162;C4321396;C4521761",NULL,NULL,948
"mesothelin ng ml","C0380162;C0439275;C1334533",NULL,NULL,204
"$nmbr$ mwt m","C0369637;C0441923",NULL,NULL,923
"war","C0043027",NULL,NULL,232
"femoral neck n $nmbr$ $nmbr$ bmd g cm $nmbr$ sd","C0015815;C0439267;C2699239",NULL,NULL,701
"mild ed","C2945599;C3538926",NULL,NULL,329
"insulin glargine n $nmbr$","C0907402","C0907402",";C1998602;C0004446;C0005126;C2344255;C4050145;C0229089;C0439164;C1512019;C3273373;C3665488",69
"short term","C0443303",NULL,NULL,949
"no of patients with stroke","C0030705;C0038454;C4554100",NULL,NULL,1762
"fragile","C0302113",NULL,NULL,1741
"liraglutide $nmbr$","C1456408","C1456408","",1566
"triglyceride level","C0428475",NULL,NULL,314
"education y","C0013621;C0013622;C0013658;C0039401","C0013658","",902
"south america n $nmbr$","C0037713","C0037713","",580
"estimated glomerular filtration rate ml min per $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C3811844",NULL,NULL,923
"ml without st segment elevation","C0439526;C0520886;C1705224;C3887665","C3810814","",894
"cvd mortality","C0007222;C0026565;C0026566",NULL,NULL,2157
"week $nmbr$ mean sd","C0332174;C0439230;C0444504;C2347634;C2348143;C2699239",NULL,NULL,1287
"use of antiplatelet agents n","C0085826;C1524063","","",1191
"patients with $nmbr$ co aeds","C0030705;C0180309;C3245499",NULL,NULL,1035
"operative procedure","C0543467;C0677612",NULL,NULL,598
"polyvascular disease status","C3176928",NULL,NULL,98
"cromoglicate","C0010347","C0205199","",1631
"still taking alendronate at study entry n","C0102118;C0557651;C1515187;C1705654;C2603343",NULL,NULL,1573
"arterial hypertension no","C0020538","C0020538","",1364
"sex p $nmbr$","C0009253;C0036864;C0079399;C0804628;C1314687;C1522384",NULL,NULL,568
"tg mg dl","C0337445;C0439269","C0041004","",368
"time from median iqr h","C0033727;C0040223;C0369286;C0441932;C0549183;C0564385;C0876920;C2347635;C2348144;C2939193;C3541383;C4528284",NULL,NULL,635
"clinical presentation","C2708283",NULL,NULL,790
"inhaled glucocorticoid use at screening","C0004048;C0017710;C0042153;C0220908;C0220909;C0457083;C1698960;C1710031;C1710032;C1710477;C1947944;C2348164","C3540778","",2182
"positive family history of type $nmbr$ diabetes","C0332307;C0439178;C1313937;C1446409;C1514241;C1547052;C2825490;C3812269",NULL,NULL,1491
"diet n $nmbr$","C0012155;C0012159;C1519433;C2983588;C3668949","C0012155","",1199
"adl subscale range $nmbr$ $nmbr$","C0001288;C1420005;C1514721;C2348147;C3542016","C0001288","",1976
"$nmbr$ $nmbr$ $nmbr$ obese class ii","C3853263",NULL,NULL,845
"ipss voiding subscore","C0042034;C1019118;C1998280;C2827405;C3811063;C4067975",NULL,NULL,753
"hematocrit","C0018935;C0518014","C0518014","",1292
"a new vertebral fractures mfas","C0080179;C0205314;C1549796;C1549980","C0080179","",1038
"vka therapy","C0039798;C0087111;C1363945",NULL,NULL,236
"age mean sd years","C0444504;C1510829;C2347634;C2348143;C2699239","C1510829","",481
"angina pectoris","C0002962","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"map mmhg","C0024779;C0439475;C1706473;C4050322","C0005823","",1469
"long acting b $nmbr$ agonists","C0079613;C0205166;C0243192;C1704930;C1706317;C1869853;C2987634;C3890007;C4048375",NULL,NULL,499
"normal cognitive","C2712133",NULL,NULL,688
"europe plus south africa","C0015176;C0037712;C0332287","C0015176","",337
"type of reflux disease","C0232483;C0457464;C1882919;C4317146","C0017168","",99
"qualifying events","C0441471;C1514624;C3541888",NULL,NULL,412
"previous intervention","C0184661;C0205156;C0886296;C1273869;C1552607",NULL,NULL,290
"baseline fpg mg dl","C0168634;C0439269;C1442488",NULL,NULL,192
"thienopyridine at baseline","C0168634;C1120149;C1442488",NULL,NULL,625
"hip femur","C0015811;C0019552;C0022122;C1505163;C3538851;C4284725",NULL,NULL,830
"time from acs to randomization median iqr","C0034656;C0040223;C0549183;C0742343;C0876920;C2347635;C2348144;C2939193;C3541383;C4318612",NULL,NULL,1709
"annualized rate ind gly sfc","C0017890;C0523677;C0871208;C1521828;C4049864;C4521536",NULL,NULL,1283
"peripheral arterial disease n","C0085096;C1704436","C0085096","",933
"intended clopidogrel dose $nmbr$ mg","C0024671;C0026410;C0070166;C0178602;C0439269;C0869039;C1114758;C1283828;C1551357;C1960952;C2346927;C4321396;C4521761",NULL,NULL,110
"without psoriasis zi $nmbr$","C0033860;C0043476","C0033860","",1358
"previous hf hospitalization n","C0018488;C0019993;C0205156;C1313497;C1538440;C1552607;C3273279","C0018801",";C0168634;C1524003",12
"health practices","C0018684;C0237607;C3245512",NULL,NULL,325
"$nmbr$ $nmbr$ $nmbr$ ci $nmbr$ $nmbr$ to $nmbr$ $nmbr$ p $nmbr$ $nmbr$","C0008107;C3259781",NULL,NULL,519
"prior tnf antagonist failure no","C0231174;C0231491;C0332152;C0680095;C1448177;C2826257",NULL,NULL,2375
"any thiazide diuretic","C0012802;C3536861","","",993
"diastolic blood pressure mm hg sd","C0428883;C0439475;C1305849;C2699239","C0005823","",1469
"$nmbr$ mg l n $nmbr$","C0439268","C0006560","",193
"diabetes n","C0011847;C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"expanded mace","C0205229;C0349381;C0949745;C1445339","C1320716","",414
"isolated systolic hypertension","C0745133","C0745133","",1051
"tx","C0041403",NULL,NULL,84
"icd n","C0021122","C0972395","",1360
"$nmbr$ up and or aza at baseline","C0004482;C0168634;C1442488",NULL,NULL,56
"unstable angina n","C0002965",NULL,NULL,1002
"headache","C0018681;C4553197",NULL,NULL,2402
"adp antagonist","C0231491;C0523452",NULL,NULL,184
"comparator","C1707454;C4553389;C4553390",NULL,NULL,1632
"race or ethnicity","C0015031;C0034510;C0243103;C1706779;C3853635",NULL,NULL,787
"thrombolysis","C0520997",NULL,NULL,621
"tadalafil","C1176316","C1176316","",855
"alcohol","C0001962;C0001975",";C0001962","",1053
"fasting insulin giu ml","C0015663;C0021641;C0439526;C1533581;C1579433;C1705224;C3714501;C3887665",NULL,NULL,157
"patient s global assessment of response to therapy score","C0039798;C0087111;C0449820;C0871261;C1363945;C1704632;C1706817;C2911692;C4050231;C4054229",NULL,NULL,491
"age\\yr","C0001779;C0439234","C0001779","",480
"atherosclerosis","C0003850;C0004153","C0004153","",1698
"with concomitant ics","C0521115;C0815320;C4551720","C3540778","",2182
"moderate impairment egfr $nmbr$ $nmbr$ ml min m","C0205081;C0221099;C0369637;C0439445;C0441923;C0684336;C1739039;C1881878;C3811844;C3812682;C4049705;C4049706;C4085643;C4321335","C3811844;C0017654","",592
"men total n $nmbr$","C0025266;C0439175;C0439810",NULL,NULL,1842
"no readmission n $nmbr$","C1548168;C4489276","C1548168","",1857
"total ses cd score at","C0007928;C0034283;C2964552;C4552032",NULL,NULL,540
"p for interaction","C0369773;C1704675;C2603361",NULL,NULL,888
"remission n","C0544452;C0687702",NULL,NULL,1712
"qualifying mi type","C0332307;C1514624;C1547052;C3810814",NULL,NULL,516
"ldl cholesterol mmol","C0023824;C0202117;C0439190","C0023824","",1068
"moderate severe exacerbations patient subgroups n","C0030705;C0205081;C0205082;C1079230;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4086268;C4321335",NULL,NULL,313
"type $nmbr$ diabetes duration mean sd years","C0439234;C0444504;C0449238;C1320657;C2347634;C2348143;C2699239;C2926735",NULL,NULL,1099
"vs warfarin","C0043031","C0043031","",858
"region ofenrollment","C0017446;C0205147","C0017446","",369
"pharmacological therapy for hf","C0013217;C0018488;C1313497;C1538440;C3273279","C0018801",";C0168634;C1524003",12
"percentage points","C0439165;C1549488;C1552961;C1561533;C2347617;C3714763",NULL,NULL,291
"apob g l mean sd","C0003593;C0439294;C0444504;C0456615;C2347634;C2348143;C2699239;C3252643",NULL,NULL,37
"baricitinib $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C4044947;C4321396;C4521761","C4044947","",1956
"statin ezetimibe n $nmbr$ $nmbr$","C0360714;C1142985","C0360714;C1142985","",1862
"no colchicine n $nmbr$","C0009262","C0009262","",81
"difference vs placebo $nmbr$ cl","C0032042;C0596019;C1696465;C1705241;C1705242;C1706408","C0032042","",28
"mtss units","C0439148;C1519795;C3853603",NULL,NULL,94
"placebo n $nmbr$ o","C0032042;C1696465;C1706408","C0032042","",28
"western eu australia new zealand","C0015179;C0027978;C0043128;C0324547;C1705493;C3665627;C4289954",NULL,NULL,533
"all with diabetes n $nmbr$","C0011847;C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"cvd stroke see","C0007222;C0038454;C0042789;C1947903;C4554100","C4554100","",336
"insulin lispro mix $nmbr$","C0205430;C0293359;C1421951;C1720722;C4553942",NULL,NULL,985
"patient status after wake up of days patient woke","C0439228;C0442696;C0449437;C0585034;C1170730",NULL,NULL,1621
"change in erosion score mean","C0333307;C0392747;C0443172;C1705241;C1880549;C1959609;C3533236;C3887524;C4319952",NULL,NULL,1046
"total hip","C0019552;C0022122;C0439175;C0439810;C1505163;C3538851;C4284725",NULL,NULL,508
"cv death ml or stroke","C0011065;C0038454;C0439526;C1306577;C1705224;C3538987;C3887665;C4048877;C4082313;C4318503;C4552775;C4554100",NULL,NULL,323
"presentation to tertiary care hospital","C0337954;C0449450",NULL,NULL,287
"bl alc $nmbr$ $nmbr$","C0005918;C0006413;C1424945;C1552663;C2827109;C3811058",NULL,NULL,655
"ace i or arb use","C0021966;C0042153;C0221138;C0457083;C1452534;C1947944;C3888198;C4284014",NULL,NULL,46
"of prior non tnfi bdmards","C0332152;C1518422;C2826257",NULL,NULL,2377
"$nmbr$ years or $nmbr$ crcl n","C0439234;C1846718",NULL,NULL,706
"$nmbr$ yr rate $nmbr$ participants","C0439234;C0679646;C0871208;C1521828",NULL,NULL,2008
"c reactive protein median q $nmbr$ q $nmbr$","C0006560;C0549183;C0876920;C1413716;C2347635;C2348144;C2939193;C4048285","C0006560","",286
"mean age y median range","C0001779;C0444504;C0549183;C0876920;C1514721;C2347634;C2347635;C2348143;C2348144;C2348147;C2939193;C3542016",NULL,NULL,635
"other bp drug","C0013227;C0037623;C1254351;C1415692;C1708288;C4318478",NULL,NULL,608
"mdrd egfr ml min per $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682;C3839656","C3811844;C0017654","",592
"nonfatal stroke n $nmbr$","C0038454;C4554100",NULL,NULL,507
"device watchman filter","C0180860;C0335390",NULL,NULL,1330
"united states and canada","C0006823;C0041703",NULL,NULL,1550
"disease duration years mean s d","C0439234;C0444504;C0872146;C2347634;C2348143","C0449238","",1989
"insulin metformin sulphonylureas","C0021641;C0025598;C0038766;C1533581;C1579433;C3714501","C0038766","",752
"mean body mass index sd kg m $nmbr$","C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239","C1305855","",1734
"diagnosis at presentation","C0011900;C0449450;C1704338;C1704656",NULL,NULL,841
"of prior tnfi among non tnfi naive","C0332152;C1518422;C2826257",NULL,NULL,11
"angiotensin","C0003018;C4521302","","",-10
"weight mean sd kg","C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209",NULL,NULL,2326
"within $nmbr$ h after first procedure","C0033727;C0184661;C0205435;C0369286;C0441932;C0564385;C1279901;C2700391;C3274430;C3539779;C4528284",NULL,NULL,290
"chd simva","C0280604;C3542407",NULL,NULL,970
"demographic $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0011298",NULL,NULL,582
"postoperative nsaid or glucocorticoid use","C0003211;C0017710;C0032790;C0042153;C0457083;C1947944;C3536840","C0017710","",1348
"rate of atrial fibrillation","C0004238;C0344434;C0871208;C1521828;C1963067",";C0004238","",1009
"mean $nmbr$ year cvd risk","C0007222;C0035647;C0439234;C0439508;C0444504;C2347634;C2348143;C4552904",NULL,NULL,1099
"female n z $nmbr$","C0043210;C0086287;C1705497;C1705498","C0086287","",1277
"calcium level","C0201925;C0428302",NULL,NULL,314
"intermediate $nmbr$ n $nmbr$ $nmbr$ $nmbr$","C0205103;C1550465;C2827755;C3889971","C0205103",";C0015663;C1550465;C2827755;C3889971;C0079613;C1704930;C1869853;C3890007;C4048375",1096
"history of hypercholesterolemia","C1533076",NULL,NULL,1498
"placebo statin n $nmbr$ $nmbr$","C0032042;C0360714;C1696465;C1706408","C0032042","",28
"a compared w","C1707455",NULL,NULL,1633
"antiarrhythmic therapy","C0003195;C0039798;C0087111;C1363945;C3537142","C0003195","",379
"rs $nmbr$ cc rs $nmbr$","C0008318;C0035970;C3538933;C3714753;C3813325",NULL,NULL,705
"laboratory evaluations","C0022877;C0220825;C3244292;C4283904",NULL,NULL,978
"change from baseline to week $nmbr$ in weekly iss","C0168634;C0332174;C0392747;C0439230;C0443172;C1442488;C1705241;C1740819;C1845118;C4319952",NULL,NULL,1013
"fpg range mmol l","C1514721;C1532563;C2348147;C3542016","C0015663;C0202042","",1960
"baseline nbp","C0168634;C1442488",NULL,NULL,606
"baseline $nmbr$ asa","C0004057;C0168634;C1442488;C3853627",NULL,NULL,60
"topical therapy","C0039798;C0087111;C0332237;C1363945",NULL,NULL,236
"telmisartan amlodipine telmisartan amlodipine hydrochlorothiazide","C0020261;C0051696;C0939233;C2733369",NULL,NULL,1149
"$nmbr$ mg dl simva $nmbr$ $nmbr$","C0439269",NULL,NULL,192
"we recorded no significant interactions for any subgroup analysis pufa polyunsaturated fatty acids nyha new york heart association lvef left ventricular ejection fraction $nmbr$ cl was calculated with a cox proportional hazards model tmedian value data for total cholesterol were available for $nmbr$ patients $nmbr$ n $nmbr$ pufa $nmbr$ placebo","C0004083;C0018623;C0018787;C0027976;C0030705;C0032042;C0032615;C0034869;C0042508;C0201950;C0205091;C0205351;C0237688;C0237881;C0428772;C0439849;C0443246;C0444686;C0470187;C0488728;C0543421;C0596019;C0596306;C0699792;C0750502;C1079230;C1275491;C1441506;C1515021;C1546944;C1552822;C1565830;C1696465;C1704610;C1704675;C1706408;C2986480;C3853788","C0032042","",28
"$nmbr$ a n $nmbr$","C0369718;C0441922",NULL,NULL,1553
"sustain $nmbr$","C0443318;C2732140",NULL,NULL,1031
"comparison","C1707455",NULL,NULL,1633
"erosion score mean $nmbr$ sd","C0333307;C0444504;C0449820;C1880549;C1959609;C2347634;C2348143;C2699239;C3887524;C4050231",NULL,NULL,2133
"diabetic kidney disease","C0011881","C0022658","",104
"composite ocular end point","C0015392;C0042789;C0205199;C0700042;C1299003;C1547335;C2349179;C2826544;C4521296","C0205199","",1631
"ltg subgroup n $nmbr$","C1079230;C1420817;C1515021;C4521367;C4521846",NULL,NULL,210
"established atherosclerotic","C0333482;C0443211;C1272684","C0004153","",1698
"bmi kg m $nmbr$ median q $nmbr$ q $nmbr$","C0549183;C0578022;C0876920;C1532718;C2347635;C2348144;C2939193","C1305855","",1891
"fvc l mean sd","C0444504;C2347634;C2348143;C2699239;C3714541",NULL,NULL,2136
"on step $nmbr$ drug","C0013227;C1254351;C1261552;C1704379;C1705117;C2825408;C3814463",NULL,NULL,571
"intensity $nmbr$","C0522510",NULL,NULL,561
"peri op ace inhibitors arbs no n $nmbr$","C0003015;C0347985;C0369718;C0441922;C3888198",NULL,NULL,44
"caribbean","C0043122;C0206155;C1331005","","",-10
"mean s d","C0444504;C2347634;C2348143",NULL,NULL,37
"cardiovascular metabolic syndrome risk lactors","C0007226;C0035647;C0524620;C3887460;C4552904",NULL,NULL,617
"cha $nmbr$ ds $nmbr$ vasc $nmbr$ $nmbr$","C1420648;C3714751",NULL,NULL,968
"region europe","C0015176;C0017446;C0205147","C0015176","",337
"normal cognitive function spmsq $nmbr$ n $nmbr$ $nmbr$ n participants with the event of interest","C0009240;C0392335;C0441471;C0679646;C1276356;C4019010;C4050130",NULL,NULL,1033
"use of concomitant lipid lowering therapy no","C0521115;C0585943;C1524063","C0585943;C0086440","",1774
"pulmonary medication during baseline","C0013227;C0024109;C0168634;C1442488;C2707265;C2709248;C3244316;C4284232;C4522268",NULL,NULL,572
"sd ml min","C0439445;C2699239","C3811844;C0017654","",307
"at baseline no","C0168634;C1442488",NULL,NULL,625
"mn na ve population","C0026327;C0026405;C0032659;C0042469;C0597484;C1257890;C1272460;C1546968;C1879645;C3714652;C4049872;C4285072;C4321495;C4552882",NULL,NULL,303
"north america","C0028405","C0028405","",1463
"no of participants per $nmbr$ patient yr","C0030705;C0439234;C0679646",NULL,NULL,1099
"mouth ulceration","C0149745",NULL,NULL,1026
"microvascular disease","C0012634;C0443258",NULL,NULL,1869
"baseline hdl c level n $nmbr$ $nmbr$ $nmbr$ $nmbr$ mg dl","C0168634;C0439269;C0441889;C0456079;C1442488;C1547707;C2946261;C3715113",NULL,NULL,2001
"$nmbr$ mg ld","C0024671;C0026410;C0439269;C0694649;C1960952;C2346927;C4321396;C4521761",NULL,NULL,1677
"hemoglobin concentration g liter","C0019029;C0086045;C0439267;C0475211;C1314664;C1318517;C1319312;C1446561;C3827302","C0019046","",1177
"p blocker","C0369773;C2603361",NULL,NULL,1823
"haq di range $nmbr$ $nmbr$ mean sd","C0444504;C1514721;C2347634;C2348143;C2348147;C2699239;C3542016;C3826998;C4321476",NULL,NULL,1665
"u s black patients","C0005680;C0027567;C0030705;C0041703;C0085756;C0439541",NULL,NULL,1035
"pbo mtx","C0025677;C0031962;C1417487","C0025677","",1408
"oral anticoagulant n","C0354604","C0354604","",1747
"pci for index event","C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010;C4049621",NULL,NULL,412
"ct ratio","C0007673;C0456603;C1547037;C3540513;C3813556;C3888140",NULL,NULL,257
"teaes cases per $nmbr$ patient years ci","C0008107;C0030705;C0439234;C0868928;C1533148;C3259781",NULL,NULL,114
"t","C2603360","","",-10
"aged a $nmbr$ years","C0001779;C0001792;C0439234;C1999167",NULL,NULL,148
"sex n male","C0086582","C0086582","",1276
"hba $nmbr$ c mean sd range","C0019016;C0444504;C1514721;C1825777;C2347634;C2348143;C2348147;C2699239;C3538758;C3542016","","",820
"anemia no","C0002871;C1000483;C4554633",NULL,NULL,152
"baseline body mass index","C0005893;C0168634;C0578022;C1305855;C1442488","C1305855","",1734
"uric acid tertile $nmbr$ $nmbr$ $nmbr$ mg dl","C0041980;C0439269",NULL,NULL,2310
"neuropathy","C0442874",NULL,NULL,1718
"previous chf no","C0018802;C0205156;C1552607",NULL,NULL,2388
"esrd or death","C0011065;C0022661;C0035078;C1306577;C2316810;C4082313;C4552775","C0035078","",342
"uncertain","C0087130;C4085655","C0087130","",1982
"prednisone","C0032952","C0032952","",2384
"history of hypertension for $nmbr$ mo or more","C0026544;C0205172;C0332177;C0455527",NULL,NULL,1498
"current bone disease","C0005940;C0521116;C1705970","C0521116;C0005940","",2221
"type $nmbr$ diabetes history n","C0019664;C0019665;C0262512;C0262926;C1320657;C1705255;C2004062","C0011849;C1320657","",907
"a from baseline","C0168634;C1442488",NULL,NULL,625
"gall bladder adverse event n $nmbr$","C0016976;C0877248","C0877248;C0016976","",1456
"$nmbr$ $nmbr$ mg dl","C0439269",NULL,NULL,192
"pre hospital ticagrelor","C0019994;C0332152;C0740175;C1510665;C1999375;C2257086;C3669034",NULL,NULL,2379
"lmwh within $nmbr$ days before randomization no total no","C0019139;C0034656;C0439175;C0439228;C0439810;C3536766","C3536766","",1343
"events","C0441471;C3541888",NULL,NULL,412
"clinical ae n","C0205210;C3887670","C0877248","",47
"smoking habit n","C4505437",NULL,NULL,797
"mean sitting sbp mmhg","C0085805;C0277814;C0439475;C0444504;C2347634;C2348143;C2584297;C4050224",NULL,NULL,607
"lvh by minnesota code no","C0009219;C0026183;C0149721;C0805701;C3889831","C0149721","",1272
"concomitant therapy n","C1707479",NULL,NULL,446
"fasting insulin median iqr gu ml","C0015663;C0021641;C0120446;C0439526;C0549183;C0876920;C1533581;C1579433;C1705224;C2347635;C2348144;C2939193;C3714501;C3887515;C3887665",NULL,NULL,157
"minor major","C0026193;C0205082;C0205164;C0205165;C4318856;C4521762",NULL,NULL,1472
"areas","C0205146;C4319729","","",-10
"screening and baseline lung function characteristics","C0035245;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C4684572",NULL,NULL,798
"adjusted for all baseline variables interaction between acei and baseline up and declines in sbp and up","C0085805;C0168634;C0439828;C0456081;C1442488;C1704675",NULL,NULL,606
"time since start of fit mean sd y","C0036572;C0040223;C0439659;C0444504;C1711239;C2347634;C2348143;C2349186;C2699239;C3541383;C4048158;C4553125",NULL,NULL,37
"large mi","C0549177;C3810814",NULL,NULL,516
"min","C0702093;C1524029;C3813700",NULL,NULL,1475
"sample size n by treatment","C0037793;C0039798;C0087111;C0242618;C0456389;C1522326;C1533734;C1705169;C3538994;C3887704","C0242618","",1194
"number of tender joints $nmbr$ $nmbr$","C0234234;C0449813","C0451530","",1139
"height loss","C0424641","C0489786","",1249
"$ $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923","C3811844;C0017654","",307
"clinical outcome","C0205210;C1274040",NULL,NULL,1602
"hrt","C0282402",NULL,NULL,549
"swollen joint count $nmbr$ mean sd","C0444504;C0451521;C2347634;C2348143;C2699239",";C0451521","",1140
"sirolimus eluting stent","C0038257;C0072980",NULL,NULL,633
"creatine clearance category","C0373595;C0683312;C3889287",NULL,NULL,562
"first cv hospitalization","C0019993;C0205435;C1279901;C3538987;C4048877;C4318503",NULL,NULL,1777
"ich","C0019191;C3272597;C3281105",NULL,NULL,1363
"tachyarrhythmias n","C0080203","C0080203","",381
"troponin t pg ml","C0077404;C0439297;C1420827",NULL,NULL,2322
"depression","C0011570;C0011581;C0344315;C0460137;C4049644;C4084909;C4085311;C4553827",NULL,NULL,469
"no second mi","C0205436;C0457385;C0565930;C1561503;C1705190;C3810814",NULL,NULL,1783
"pt baseline week $nmbr$","C0032743;C0168634;C0332174;C0439230;C0699718;C1442488",NULL,NULL,1012
"$nmbr$ to $nmbr$ $nmbr$","C0040363;C0041260;C1883351",NULL,NULL,431
"adjusted p value for interaction","C0456081;C1704675;C1709380",NULL,NULL,7
"subgroup p value $nmbr$","C1079230;C1515021;C1709380",NULL,NULL,7
"intravenous vasoactive drugs y","C0683092;C1980011",";C1980011;C0683092","",2071
"dyslipidemia no","C0242339","C0242339","",1770
"data represent number of patients or mean standard deviation unless otherwise indicated a self reported information bc physician diagnosed diabetes or fasting plasma glucose $nmbr$ mg dl or hemoglobin a $nmbr$ c $nmbr$ $nmbr$ d physician diagnosed hypertension or systolic blood pressure $nmbr$ mmhg or diastolic blood pressure $nmbr$ mmhg median interquartile range ldl low density lipoprotein hdl high density lipoprotein tg triglyceride","C0006041;C0011847;C0011849;C0011900;C0015663;C0019020;C0020538;C0023820;C0031831;C0062152;C0073187;C0178587;C0202042;C0205251;C0332173;C0337445;C0428883;C0439269;C0439475;C0444504;C0455280;C0488055;C0549183;C0681906;C0804815;C0871420;C0871470;C0876920;C1305849;C1306620;C1442989;C1444656;C1511726;C1533716;C1550472;C1711350;C1828170;C1882932;C1963138;C2347634;C2347635;C2348143;C2348144;C2360800;C2700446;C2828392;C2939193;C2984916;C3245479;C3714741;C3889898;C3890211;C4048187;C4321351;C4484261;C4522223",NULL,NULL,635
"apo b g l","C0003593;C0439294;C0456615;C3252643","C0003593","",426
"weight $nmbr$ $nmbr$","C0005910;C0043100;C1305866;C1705104","C0005910","",1250
"triglycerides mg dl mean sd available for $nmbr$ patients","C0030705;C0041004;C0439269;C0444504;C0470187;C2347634;C2348143;C2699239","C0041004","",368
"spironolactone","C0037982","C0037982","",1405
"history of high cholesterol a $nmbr$","C0019664;C0019665;C0020443;C0262512;C0262926;C1522133;C1705255;C2004062",NULL,NULL,832
"baseline nihss score median range","C0168634;C0449820;C0549183;C0876920;C1442488;C1514721;C1697238;C2347635;C2348144;C2348147;C2939193;C3542016;C4050231",NULL,NULL,748
"daily insulin dose mean sd iu","C0021641;C0049272;C0332173;C0366513;C0439453;C0444504;C0694756;C1533581;C1579433;C2347634;C2348070;C2348143;C2699239;C3714501",NULL,NULL,157
"non insulin treated dm","C0011816;C0021641;C1518422;C1522326;C1533581;C1579433;C3250443;C3714501",NULL,NULL,955
"moderately high risk","C0205081;C0332167;C1881878;C3272283;C4050568;C4085643;C4319571;C4321491","C4319571","",837
"$nmbr$ a g","C0439267",NULL,NULL,1486
"cardioversion in previous $nmbr$ wk","C0013778;C0205156;C0332174;C0439230;C1552607",NULL,NULL,2386
"co morbidities a n","C0009488;C0369718;C0441922",NULL,NULL,765
"no persistent wrf n $nmbr$ $nmbr$","C0205322;C0332996",NULL,NULL,719
"gold $nmbr$ groups n","C0018026;C0369718;C0441833;C0441922;C0687744;C1257890;C1304897;C1519504;C1552839;C1705428;C1705429","C0024117;C0521117","",213
"sensitive","C0020517;C0332324;C1522640","C0332324","",1164
"prednisone equivalent dose mg","C0024671;C0026410;C0032952;C0178602;C0205163;C0439185;C0439269;C0869039;C1114758;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"baseline ics $nmbr$ pg per day fluticasone propionate dpi or equivalent and laba","C0117996;C0168634;C0205163;C0439185;C0815320;C1442488;C2827928;C4551720","C3540778","",2182
"q $nmbr$ $nmbr$ $nmbr$ to $nmbr$ $nmbr$ kg n $nmbr$ vs $nmbr$","C0022718;C0439209;C4054209",NULL,NULL,132
"caffeine consumption","C0948365","C0006644",";C1710701",1816
"parameter n","C0549193;C1704769;C2350001","C0549193","",1186
"tjc $nmbr$ joints","C0022417;C0392905","C0451530","",1139
"das $nmbr$ $nmbr$ esr","C0051767;C0057671;C3811131","C1619634","",298
"former smoking","C0037369;C0205156;C0453996;C0750523;C1881674",NULL,NULL,13
"hiatal hernia yes n","C1549445;C1705108;C1710701;C3489393",NULL,NULL,590
"moderate $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$ n","C0205081;C0369637;C0439445;C0441923;C1881878;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"hip other nonvertebral fractures","C0016658;C0019552;C0022122;C1505163;C3538851;C4284725",NULL,NULL,2026
"$nmbr$ days n $nmbr$","C0439228",NULL,NULL,1621
"placebo lsm","C0032042;C1696465;C1706408","C0032042","",28
"high $nmbr$ baseline hbalc","C0168634;C0205250;C1299351;C1442488;C2700149;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"primary and secondary prevention subgroups adjusted for age gender hypertension diabetes mellitus and smoking hr indicates hazard ratio $nmbr$ cl $nmbr$ confidence interval tia transient ischemic attack","C0007787;C0011849;C0020538;C0037369;C0079399;C0205225;C0237529;C0439612;C0439631;C0453996;C0596019;C0679699;C1079230;C1272706;C1522384;C1552654;C1552713;C1704725;C1704726;C1881674;C1963138;C2985465;C4300468","","",-10
"ill","C0231218",NULL,NULL,660
"median feno ppb f","C0016327;C0549183;C0876920;C1415800;C2347635;C2348144;C2939193",NULL,NULL,1737
"dose mg day","C0178602;C0439422;C0869039;C1114758","","",198
"intent to treat population","C0032659;C0087111;C0162425;C1257890;C1283828;C1292734;C1522326;C1550453",NULL,NULL,1975
"hyperlipidemia yes","C0020473;C0428465;C1549445;C1705108;C1710701;C4555212","C0020473;C4555212",";C0439810;C1710701",29
"lyear mean change from baseline","C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C4319952",NULL,NULL,767
"high school graduate","C0870649;C1549971","C0870649","",838
"duration of asthma y","C0004096;C0449238;C2926735;C2984299",NULL,NULL,694
"americas","C0002454;C0596070","C0002454","",392
"detemir insulin glargine","C0537270;C0907402",NULL,NULL,163
"time to treatment min t","C0702093;C1524029;C3494202;C3813700",NULL,NULL,1475
"age category","C0001779;C0683312;C3889287",NULL,NULL,562
"edema n","C0013604;C1717255",NULL,NULL,690
"image only","C0205171;C1704254;C1704922;C1720467;C3542466",NULL,NULL,925
"rales","C0034642;C0240859","C0034642","",1104
"about $nmbr$ mg l","C0439268","C0006560","",193
"pde $nmbr$ i","C0021966;C0221138",NULL,NULL,1021
"type of reference treatment strategy","C0455708;C0679199;C1514811;C1706462",NULL,NULL,1464
"least squares mean between treatment difference $nmbr$ ci","C0008107;C0023189;C0039798;C0087111;C0444504;C1522326;C1533734;C1705169;C1705241;C1705242;C2347634;C2348143;C3259781;C3538994;C3887704",NULL,NULL,519
"result","C1274040;C1546471;C2825142",NULL,NULL,1602
"fenofibric acid","C0060179",NULL,NULL,1696
"total bilirubin mg dl","C0005437;C0368753;C0439269",";C0005437","",1684
"coronary endpoint","C0018787;C2349179;C2826544",NULL,NULL,2039
"aes leading to dose reduction of study drugb","C0178602;C0557651;C0861063;C0869039;C1114758;C1412268;C2603343;C2699274","C0877248","",47
"mean sd bmi kg m $nmbr$","C0444504;C0578022;C1532718;C2347634;C2348143;C2699239",";C1305855","",206
"exacerbations in previous $nmbr$ mo n mean sd","C0026544;C0205156;C0332177;C0444504;C1552607;C2347634;C2348143;C2699239;C4086268",NULL,NULL,1476
"$nmbr$ mg dl reference","C0439269;C1514811;C1706462",NULL,NULL,1464
"baseline fev $nmbr$","C0168634;C1442488;C3714541",NULL,NULL,1599
"univariate p value","C1709380",NULL,NULL,7
"estimated creatinine clearance","C0750572;C0812399","C0812399",";C3889287;C0452249;C0522467;C1337213;C1576800;C3890003;C0005910;C0022718;C1305866;C1705104;C1705224;C3887665",79
"qva $nmbr$ $nmbr$ pg once daily n $nmbr$","C0030827;C0072225;C0332173;C1266240",NULL,NULL,208
"hdl c level mg dl","C0439269;C0441889;C0456079;C1547707;C2946261;C3715113","C0023822","",1962
"any antihypertensive agent","C0003364",";C0003364","",1579
"bp variable mm hg","C0037623;C0439475;C0439828;C1415692;C1708288;C4318478;C4553760",NULL,NULL,608
"valvular heart disease no","C0018824;C1963123","C0018824","",103
"shs mean sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"american indian or native alaskan","C0002460;C0682125",NULL,NULL,637
"placebo group n $nmbr$ f","C0016327;C0032042;C0441848;C1696465;C1706408","C0032042","",28
"ms $nmbr$ $nmbr$ n","C2349943;C3539704;C3713294",NULL,NULL,126
"egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"median c reactive protein mg dl","C0006560;C0439269;C0549183;C0876920;C1413716;C2347635;C2348144;C2939193;C4048285","C0006560","",286
"duration of heart failure years","C0018801;C0018802;C0439234;C0449238;C2926735;C4554158","C0018801;C0449238","",1994
"week $nmbr$ changea","C0332174;C0439230;C4349366",NULL,NULL,1012
"ischaemic stroke n","C0948008",NULL,NULL,1669
"difference vs placebo $nmbr$ ci","C0008107;C0032042;C1696465;C1705241;C1705242;C1706408;C3259781","C0032042","",28
"elevated creatinine $nmbr$ pmol l","C0151578;C0439284;C0700225","C0600061;C0010294","",952
"systolic pressure mm hg","C0439475;C0871470","C0005823","",1469
"$nmbr$ stenosis of major artery n","C0038449;C0205082;C0205164;C4318856;C4521762",NULL,NULL,1472
"egfr ml minute $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439232;C0439526;C0441923;C0700321;C0702093;C1282918;C1705224;C1739039;C2347166;C3811844;C3812682;C3887665",NULL,NULL,1475
"sbp $nmbr$ mnn hg","C0025424;C0085805;C0428257;C2347108;C2347109;C2348272","C0871470","",615
"baseline tg level n $nmbr$ $nmbr$ $nmbr$ $nmbr$ mg dl","C0168634;C0337445;C0439269;C0441889;C0456079;C1442488;C1547707;C2946261","C0041004","",209
"copd severity gold stage","C0018026;C0024117;C0205390;C0439793;C0522510;C1300072;C1304897;C1306673;C1412502;C3714496",NULL,NULL,541
"cardiovascular risk factors no total no","C0439175;C0439810;C0850624",NULL,NULL,651
"converting enzyme inhibitor","C0014432;C0919438;C4521603","C0003015","",811
"$nmbr$ to $nmbr$ ml min $nmbr$ $nmbr$ m","C0369637;C0439445;C0441923","C3811844;C0017654","",307
"e major non vertebral fragility fractures fas","C0016658;C0205082;C0205164;C0302113;C0549207;C1518422;C4318856;C4521762",NULL,NULL,2026
"ischaemic heart disease n","C0010054;C0151744","C0010054;C0151744","",1361
"timi major","C0205082;C0205164;C4318856;C4521762",NULL,NULL,2079
"placebo $nmbr$ mg d of simvastatin","C0032042;C0074554;C0439422;C1696465;C1706408","C0074554","",873
"hdl cholesterol week $nmbr$ a","C0023822;C0332174;C0392885;C0439230","C0023822","",821
"chronic treatment with aspirin","C0004057;C0039798;C0087111;C0205191;C1522326;C1533734;C1705169;C3538994;C3887704","C0004057","",1366
"any drug related ae n","C0013227;C0439849;C0445223;C1254351;C3887670","C0877248","",47
"eze ezetimibe $nmbr$ mg pooled sinva simvastatin pooled across doses pooled eze sinva ezetimibe simvastatin tablet pooled across doses bni body mass index ldl c low density lipoprotein cholesterol t g triglycerides t c total cholesterol hdl c high density lipoprotein cholesterol apo apolipoprotein c rp c neactive protein rlp c remnant like particle cholesterol","C0003591;C0003594;C0008377;C0023821;C0023824;C0024671;C0026410;C0031529;C0033684;C0039225;C0041004;C0074554;C0178602;C0201950;C0242821;C0439267;C0439269;C0460148;C0543421;C0577559;C0577573;C0600653;C0674390;C0918012;C1096155;C1142985;C1268086;C1306372;C1532737;C1538326;C1552854;C1637833;C1705223;C1709595;C1960952;C2346927;C2349200;C2986546;C3152252;C3539882;C3541325;C3891451;C4054077;C4082212;C4283905;C4319774;C4321396;C4521761;C4522255",NULL,NULL,192
"plaque n","C0011389;C0241148;C0332461;C0333463;C4316797",NULL,NULL,6
"quartiles of fgf $nmbr$ ru ml","C0016026;C0035970;C0439526;C0919505;C1425796;C1705224;C2828255;C3887665",NULL,NULL,300
"$nmbr$ $nmbr$ ls t score $nmbr$ $nmbr$","C0023668;C0449820;C4050231",NULL,NULL,748
"unrelated to effectiveness","C0445356;C1280519;C1704623;C4553491",NULL,NULL,432
"heart failure cause","C0015127;C0018801;C0018802;C1524003;C4554158","C0018801",";C0168634;C1524003",12
"worldwide non black patients","C0005680;C0027567;C0085756;C0439541;C1829939","C0005680",";C1706779",188
"endoscopy subscore n","C0014245",NULL,NULL,1728
"fpi m u ml pmol l","C0369637;C0439192;C0439284;C0439340;C0441923;C0456616;C1880521;C2945590",NULL,NULL,666
"disease duration","C0872146","C0449238;C0872146","",903
"ns","C0038944;C1112705;C1705982",NULL,NULL,129
"patients not receiving immunosuppressive agents at baseline","C0021081;C0030705;C0168634;C1442488;C1514756;C1518422",NULL,NULL,1035
"baseline ecro $nmbr$ mumin","C0168634;C1442488",NULL,NULL,625
"cangrelor dyspnoea vs no dyspnoea","C0013404;C1121991;C1963100","C0013404","",1227
"insulin glargine n x","C0907402","C0907402",";C1998602;C0004446;C0005126;C2344255;C4050145;C0229089;C0439164;C1512019;C3273373;C3665488",69
"cdmard experience n","C0237607;C0596545",NULL,NULL,1460
"t wave inversion only","C0205171;C0520888;C1720467",NULL,NULL,925
"copd placebo $nmbr$ pt n","C0024117;C0032042;C0032743;C0699718;C1412502;C1696465;C1706408;C3714496","C0032042","",28
"homa ir median ql q $nmbr$ $nmbr$","C0022065;C0022071;C0549183;C0876920;C1448132;C2347635;C2348144;C2939193",NULL,NULL,634
"upper respiratory tract infection $nmbr$ $nmbr$ $nmbr$","C0041912",";C0041912","",1289
"aspirin alone group no of events total n","C0004057;C0439175;C0439810;C0441471;C2826346;C3541888","C0004057","",1366
"modified total sharp score","C0392747;C1444775;C1539835;C2964552;C3889737;C3890003",NULL,NULL,767
"coumadin","C0699129",NULL,NULL,998
"former n","C0205156;C0750523",NULL,NULL,13
"who functional class","C0205245;C0456387;C0542341;C1518526;C1705943;C2700217",NULL,NULL,452
"py","C0030428;C3538810",NULL,NULL,1517
"pci data","C1511726;C3245479;C3714741;C4049621",NULL,NULL,1427
"without tamsulosin","C0257343","C0257343","",1346
"anti ccp antibody u","C0003241;C0003242;C0021027;C0439148;C1167408;C1525410;C1704514;C3665580;C4318437","C4318437","",360
"triglyceride median mg dl $nmbr$ $nmbr$ $nmbr$ percentile","C0041004;C0439269;C0549183;C0876920;C1264641;C2347635;C2348144;C2939193","C0041004","",368
"asian","C0078988","C0078988","",1369
"peripheral artery disease","C1704436;C4025272",NULL,NULL,934
"cardiovascular history no","C1880008",NULL,NULL,650
"black region or country","C0005680;C0017446;C0027567;C0085756;C0205147;C0439541;C0454664;C1511538",NULL,NULL,1560
"sustain $nmbr$ semaglutide vs placebo","C0032042;C0443318;C1696465;C1706408;C2732140;C3885068",NULL,NULL,1031
"smoking n","C0037369;C0453996;C1881674","C0037369","",420
"vascular disease indicator no n $nmbr$","C0021212;C0042373;C0369718;C0441922;C1235732;C1522602",NULL,NULL,102
"mean sd baseline","C0168634;C0444504;C1442488;C2347634;C2348143;C2699239",NULL,NULL,1287
"people without diabetes n $nmbr$","C0011847;C0011849;C0027361","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"number of concomitant csdmards n","C0237753;C0449788;C0521115",NULL,NULL,1556
"mean sd fev $nmbr$ l post bronchodilator","C0444504;C2347634;C2348143;C2599594;C2699239;C3714541",NULL,NULL,1599
"duration ofdiabetes yr","C0439234;C0449238;C2926735","C2926735;C0011849","",1988
"calima overalldhigh dosage ics laba and baseline blood eosinophils $nmbr$ cells ml n $nmbr$","C0014467;C0168634;C0178602;C0815320;C1442488;C2699156;C2986497;C4551720",NULL,NULL,1359
"baricitinib $nmbr$ mg qd","C0024671;C0026410;C0332173;C0439269;C1960952;C2346927;C4044947;C4321396;C4521761","C4044947","",1956
"lvef no i","C0021966;C0221138;C0428772;C0488728",NULL,NULL,1021
"race ethnicity n","C0015031;C0034510;C0243103;C1706779;C3853635",NULL,NULL,787
"caffeine users n","C3532939","C0006644",";C1710701",1816
"hf symptom worsened","C0018488;C1313497;C1457868;C1457887;C1538440;C3273279;C3854129;C4084902","C0332271",";C1538440;C3273279;C1412502",282
"clopidogrel ticlopidine or prasugrel","C0040207;C0070166;C1620287","C0070166","",216
"biomarker high","C0005516;C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"atio pla","C0456170",NULL,NULL,1514
"no ilb iiia inhibitors","C0243077;C4697913",NULL,NULL,808
"safety","C0036043;C1705187","C0036043","",1198
"cbz exposed","C0006949;C0332157",NULL,NULL,764
"history of major cardiovascular disease n","C0205082;C0205164;C0455539;C4318856;C4521762",NULL,NULL,1472
"mild moderate ipss $nmbr$","C1019118;C1299392;C1998280;C2827405;C3811063","C1998280",";C1019118;C3811063;C4050465;C4050466;C4049706;C0168634;C1705273;C1880519;C3853603",124
"median change in atheroma volume","C0264956;C0392747;C0443172;C0449468;C0549183;C0876920;C1690016;C1705102;C1705241;C2347635;C2348144;C2700258;C2939193;C4319952",NULL,NULL,1119
"cerebrovascular disease n","C0007820",NULL,NULL,728
"insulin glucose ratio","C0017725;C0021641;C0456603;C1533581;C1547037;C1579433;C3714501",NULL,NULL,157
"serum ldl cholesterol","C0428474","C0023824","",1068
"obesity","C0028754;C1963185",NULL,NULL,710
"previous ics labd","C0205156;C0396059;C0815320;C1552607;C4551720",NULL,NULL,1305
"bilateral disease j j","C1511113",NULL,NULL,931
"no of patients with fingernail involvement","C0030705;C0222001;C1314939",NULL,NULL,1090
"cholesterol mg dl","C0008377;C0439269",NULL,NULL,2000
"raas inhibitor","C1999216",NULL,NULL,812
"concomitant medications yes n","C0013227;C0521115;C0802604;C1549445;C1705108;C1710701;C2598133;C4284232",NULL,NULL,147
"acei arb therapy n","C0039798;C0087111;C1363945;C3888198",NULL,NULL,44
"prior mi n $nmbr$","C0332152;C2826257;C3810814",NULL,NULL,516
"time of symptom onset to balloon inflation hrs","C0021398;C0336867;C0441144;C1318493;C1320528;C1568891",NULL,NULL,142
"use at baseline","C0042153;C0168634;C0457083;C1442488;C1947944",NULL,NULL,625
"median duration of diabetes yr","C0011847;C0011849;C0439234;C0449238;C0549183;C0876920;C2347635;C2348144;C2926735;C2939193","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"prior biologic therapy including anti tnfs","C0278947;C0332257;C1448177",NULL,NULL,362
"paroxysmal af","C0235480","C0235480","",1446
"prior disease","C0012634;C0332152;C2826257",NULL,NULL,2120
"history of pci no total no t","C0019664;C0019665;C0262512;C0262926;C0439175;C0439810;C1705255;C2004062;C2603360;C4049621",NULL,NULL,1736
"previous dm","C0011816;C0205156;C1552607;C3250443",NULL,NULL,955
"acute coronary syndrome $nmbr$","C0948089","C0948089",";C0026544",225
"prior cardiovascular event no","C0332152;C1320716;C2826257",NULL,NULL,2378
"postoperative glucocorticoid use","C0017710;C0032790;C0042153;C0457083;C1947944","C0017710","",1348
"number of stent $nmbr$","C0038257;C0237753;C0449788",NULL,NULL,569
"time to treatment initiation min","C0589507;C0702093;C1158830;C1524029;C1704686;C3494202;C3813700",NULL,NULL,1475
"age $nmbr$ yearsa","C0001779",NULL,NULL,148
"impaired fasting glucose $nmbr$ mg dl","C0439269;C1272092",NULL,NULL,2286
"eplerenone n $nmbr$","C0961485",NULL,NULL,1759
"patientswith bp $nmbr$ $nmbr$ mmhg abpm at baseline n","C0037623;C0168634;C0439475;C1415692;C1442488;C1708288;C4318478",NULL,NULL,608
"history of upper gastrointestinal event","C0019664;C0019665;C0262512;C0262926;C0441471;C1705255;C2004062;C3203348;C4019010",NULL,NULL,781
"in trial $nmbr$ year rates per $nmbr$ se total events number at risk","C0008976;C0036919;C0150312;C0332285;C0439175;C0439234;C0439508;C0439810;C0441471;C0871208;C1264674;C1444641;C1521828;C1707101;C3541888;C4288115",NULL,NULL,412
"sexy","C0009253;C0036864;C0079399;C0804628;C1314687;C1522384",NULL,NULL,568
"placebo $nmbr$ $nmbr$ pt yrs","C0032042;C0032743;C0699718;C1696465;C1706408","C0032042","",28
"lvh by echocardiogram","C0013516;C0149721;C2243117","C0149721","",1272
"use of medication from randomization through $nmbr$ hr no total no","C0013227;C0034656;C0439175;C0439810;C1524063;C3244316;C4284232",NULL,NULL,827
"randomised patients with $nmbr$ bsa psoriasis skin involvement at baseline","C0030705;C0033860;C0168634;C0444099;C1123023;C1314939;C1442488;C4520765",NULL,NULL,625
"previous stroke or tia n","C0007787;C0038454;C0205156;C0917805;C1054154;C1552607;C4554100",NULL,NULL,1762
"any secukinumab n $nmbr$","C3179547",NULL,NULL,944
"habitual fish intake $nmbr$ servings wk n $nmbr$","C0205353;C0332174;C0439230;C0556216;C1519269",NULL,NULL,1012
"sinus rhythm","C0232201",NULL,NULL,1673
"risk of bleeding","C3251812","C3251812","",1089
"never smoked","C0037366;C0439994;C1881674;C2003901","C0037369","",420
"bp and fasting glucose results","C0015663;C0017725;C0037623;C1274040;C1415692;C1546471;C1708288;C2825142;C4318478",NULL,NULL,608
"assoc with connective tissue disease","C0009782","C0009782","",108
"tertiary end points","C0205372;C2349179",NULL,NULL,1645
"use of medication at baseline no","C0013227;C0168634;C1442488;C1524063;C3244316;C4284232",NULL,NULL,366
"american indian alaska native","C0002460;C0682125",NULL,NULL,763
"time since diagnosis mo","C0011900;C0026544;C0040223;C0332177;C1704338;C1704656;C3541383",NULL,NULL,1476
"placebo n $nmbr$ a","C0032042;C1696465;C1706408","C0032042","",28
"non black worldwide","C0005680;C0027567;C0085756;C0439541;C1518422","C0005680",";C1706779",188
"cerebrovascular or peripheral arterial disease","C0085096;C1704436;C1880018","C0085096","",933
"asa $nmbr$ mg","C0004057;C0024671;C0026410;C0439269;C1960952;C2346927;C3853627;C4321396;C4521761",NULL,NULL,192
"stating","C1301808;C1442792;C3148680",NULL,NULL,980
"fasting triglycerides mean sd mg dl","C0015663;C0041004;C0439269;C0444504;C2347634;C2348143;C2699239","C0041004","",368
"fibrate or other lipid lowering agent","C0086440","C0086440","",1773
"no baseline characteristics","C4684572",NULL,NULL,627
"rectum","C0034896","C0034896","",2237
"induction trial group assignment no","C0205263;C0857127;C1320290;C1516050",NULL,NULL,158
"low density lipoprotein cholesterol mg dltt","C0023824;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761","C0023824","",1963
"prior transient ischaemic","C0040704;C0205374;C0332152;C0475224;C2826257",NULL,NULL,722
"non st elevation myocardial infarction","C1536221;C1536222;C3537184;C4255010",NULL,NULL,529
"warfarin group n $nmbr$","C0043031;C0441848","C0043031","",858
"europe non eu","C0015176;C0015179;C1518422;C3665627","C0015176","",337
"mar itt n $nmbr$","C3829202;C4255469",NULL,NULL,232
"bmi $nmbr$ kg m n $nmbr$ $nmbr$","C0578022;C1532718",NULL,NULL,1735
"placebo n $nmbr$ $nmbr$ $nmbr$","C0032042;C1696465;C1706408","C0032042","",28
"mean ucsd sobq score sd","C2699239;C3533236",NULL,NULL,1287
"serum creatinine mol","C0027960;C0201976;C0324740;C0439189;C0600061;C1456781;C1824986;C3665593",NULL,NULL,667
"stents per lesion n","C0038257;C0221198;C1546698",NULL,NULL,472
"mate","C0682323;C1260875",NULL,NULL,1000
"no statin llt","C0360714;C2347090","C0360714","",872
"gold $nmbr$ groups","C0018026;C0441833;C0687744;C1257890;C1304897;C1519504;C1552839;C1705428;C1705429","C0024117;C0521117","",213
"no dm","C0011816;C3250443",NULL,NULL,955
"tertile of total cholesterol at baseline mean sd mmol l","C0168634;C0201950;C0444504;C0543421;C1442488;C1532563;C2347634;C2348143;C2699239",NULL,NULL,670
"on bp medication n","C0013227;C0037623;C1415692;C1708288;C3244316;C4284232;C4318478",NULL,NULL,608
"etiology","C0015127;C1314792;C1524003",NULL,NULL,924
"ischaemic n","C0475224",NULL,NULL,1670
"randomized group by subgroup interaction","C0034656;C0441833;C0687744;C1079230;C1257890;C1515021;C1519504;C1704675;C1705428;C1705429;C3815594",NULL,NULL,1526
"highly sensitive","C0439822","C0332324","",1164
"inadequate response","C0205412;C0439856;C0871261;C1704632;C1706817;C2911692",NULL,NULL,726
"cardiovascular mortality","C0007226;C0026565;C0026566;C3887460",NULL,NULL,2157
"previous angioplasty n","C0162577;C0205156;C1548817;C1552607","C0162577","",1722
"free fatty acids mmol liter","C0015688;C0439190;C0475211",NULL,NULL,987
"aii participants n $nmbr$","C0679646;C1424250;C2698414",NULL,NULL,63
"age mean years sd gender n","C0079399;C0444504;C1510829;C1522384;C2347634;C2348143;C2699239",NULL,NULL,1907
"ldl c goal attainment","C0680230",NULL,NULL,1687
"renal function","C0232804","C0232804","",1532
"non trial treatment during hospital stay","C0008976;C0039798;C0087111;C1518422;C1522326;C1533734;C1705169;C3489408;C3538994;C3887704",NULL,NULL,1020
"bolus alone","C0205171;C0439044;C0679994;C1186706;C1511237;C1705509;C3812160",NULL,NULL,632
"triglyceride mm","C0041004;C4330985;C4554674",NULL,NULL,297
"no inducer at core study entry","C0444669;C0557651;C1167518;C1705654;C1706352;C1882467;C2603343;C3274653;C3898767",NULL,NULL,1730
"number of diseased vessels mean sd","C0005847;C0237753;C0444504;C0449788;C2347634;C2348143;C2699239",NULL,NULL,743
"primary","C0205225;C0439612;C0439631",NULL,NULL,229
"open label clopidogrel after completion of study drug","C0013227;C0070166;C0205197;C1254351;C1554962;C1709323","C0070166",";C0369286;C0033727;C4049621",217
"diet $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0012155;C0012159;C1519433;C2983588;C3668949","C0012155","",1199
"gfr as assessed by mdrd","C0017654;C1424601;C1516048;C3839656","C3811844;C0017654","",592
"basal insulin analogue insulin","C0205112;C0243071;C0650607;C2825028","C0650607","",354
"treatment duration days","C0439228;C0444921;C3259042",NULL,NULL,1621
"median q $nmbr$ q $nmbr$ duration of insulin use years","C0021641;C0439234;C0549183;C0876920;C1533581;C1579433;C1881378;C2347635;C2348144;C2826775;C2939193;C3714501",NULL,NULL,1099
"without insulin or insulin modifying therapy","C0021641;C0039798;C0087111;C0392747;C1363945;C1533581;C1579433;C3714501",NULL,NULL,157
"eosinophils cells ll inclusion criteria n","C0682547;C1512693",NULL,NULL,662
"no concomitant antiplatelet","C0521115",NULL,NULL,447
"intended duration of anticoagulation","C0003281;C0449238;C1283828;C1551357;C2917212;C2919015;C2926735;C3537050",NULL,NULL,1011
"extended release niacin plus statin n $nmbr$","C0027996;C0332287;C0360714;C1142562;C1707968","C0360714","",872
"age gd lesion","C0001779;C0221198;C1546698",NULL,NULL,472
"constipation","C0009806;C1963087;C3641755;C4084722;C4084723;C4084724",NULL,NULL,1711
"vhd event rate year n","C0439234;C0439508;C0441471;C0871208;C1521828;C4019010",NULL,NULL,2011
"msdbp sd mmhg","C0439475;C2699239",NULL,NULL,1471
"$nmbr$ mg dl","C0439269",NULL,NULL,192
"$nmbr$ $nmbr$ hrs min n $nmbr$","C0702093;C1524029;C1568891;C3813700",NULL,NULL,1475
"pyrexia","C0015967","C0015967","",2243
"blood pressure mmhg","C0005823;C0439475;C1271104;C1272641","C0005823","",15
"stroke or see","C0038454;C0042789;C1947903;C4554100","C4554100","",336
"ace inhibitor or angiotensin receptor blocker","C0003015;C0034787;C1622222;C4541021","C0003015","",811
"tc hdl c ratio","C0039411;C0040642;C0041405;C0041698;C0456603;C1547037;C1824670;C3272447;C3715113;C4522122",NULL,NULL,2236
"loss of response","C0871261;C1517945;C1704632;C1706817;C2911692",NULL,NULL,726
"stroke or systemic embolism","C0013922;C0038454;C0205373;C1704212;C4554100",NULL,NULL,1762
"family history of diabetes no","C1313937",NULL,NULL,1491
"known chd","C0205309;C0280604;C3542407",NULL,NULL,970
"$nmbr$ $nmbr$ to $nmbr$ $nmbr$","C0040363;C0041260;C1883351",NULL,NULL,431
"concomitant therapies at hospital discharge","C0586003;C1707479",NULL,NULL,446
"combined efficacy and safety endpoint","C0036043;C0205195;C1280519;C1705187;C1707887;C2349179;C2826544","C1707887;C2349179","",1122
"waist cm","C0230097",NULL,NULL,702
"mean ics use at enrolment pg","C0030827;C0042153;C0072225;C0444504;C0457083;C0815320;C1266240;C1516879;C1696073;C1947944;C2347634;C2348143;C3888021;C4551720","C3540778","",2182
"$nmbr$ kg mj reference","C0022718;C0439209;C0439254;C1514811;C1706462;C4054209;C4284025",NULL,NULL,1464
"history of strokea","C0019664;C0019665;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"good","C0205170","C0205170","",212
"intermediate $nmbr$","C0205103;C1550465;C2827755;C3889971","C0205103",";C0015663;C1550465;C2827755;C3889971;C0079613;C1704930;C1869853;C3890007;C4048375",1096
"$nmbr$ mg dl simva","C0439269",NULL,NULL,192
"bodily pain","C3890602","C0030193","",1338
"diagnosis at presentation no","C0011900;C0449450;C1704338;C1704656",NULL,NULL,841
"no of vessels with $nmbr$ stenosis","C0005847;C0678234;C1261287;C2632116",NULL,NULL,1651
"teriparatide n n","C0070093",NULL,NULL,1015
"any llt other than statins n b","C0360714;C2347090","C0360714","",872
"initial timi flow grade $nmbr$","C0205265;C0441800;C0919553;C1279901;C1555582;C1705685;C3244287;C3272266",NULL,NULL,806
"tx $nmbr$","C0041403",NULL,NULL,84
"body mass index kg nr","C0005893;C0022718;C0027496;C0439209;C0578022;C1305855;C3844738;C4054209","C1305855","",1734
"glucose lowering drug","C0013227;C0017725;C0441994;C1254351;C2003888",NULL,NULL,1022
"placebo monthly n $nmbr$","C0032042;C0332177;C1696465;C1706408",NULL,NULL,1476
"smoking status n former","C0205156;C0750523;C1519386",NULL,NULL,13
"renal impairmentt","C0022646","C1565489","",937
"for patients not using personal cgm","C0030705;C1518422;C1519021;C1524063",NULL,NULL,1035
"years since myocardial infarction","C0027051;C0428953;C0439234;C2926063;C3810814;C4552959",NULL,NULL,646
"sl $nmbr$ mm hg","C0439475","C0005823","",1469
"american","C0596070","C0596070","",2256
"$nmbr$ h postprandial c peptide ng ml","C0006558;C0376674;C2827809",NULL,NULL,593
"primary pci no","C0205225;C0439612;C0439631;C4049621",NULL,NULL,2340
"supplementary table $nmbr$ change from baseline in urine albumin to creatinine ratio by hba $nmbr$ c at baseline in patients with normoalbuminuria microalbuminuria and macroalbuminuria","C0019016;C0030705;C0039224;C0168634;C0392747;C0443172;C0455271;C0730345;C1318330;C1442488;C1705241;C1706074;C1825777;C3538758;C4319952","","",-10
"duration of chf months","C0018802;C0439231;C0449238;C2926735",NULL,NULL,901
"method used to diagnose the incident pulmonary embolism no","C0011900;C0025663;C0034065;C0040363;C0041260;C0449851;C0871511;C1273517;C1551358;C1883351",NULL,NULL,431
"ua n $nmbr$","C0041580;C0042014",NULL,NULL,237
"n o diabetes","C0011847;C0011849;C0369718;C0441922","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"associated with ctd","C0332281;C1335071;C1442905",NULL,NULL,876
"treatment of the index ml","C0039798;C0087111;C0439526;C0600653;C0918012;C1522326;C1533734;C1552854;C1637833;C1705169;C1705224;C2986546;C3538994;C3887665;C3887704",NULL,NULL,300
"geographic region number","C0017446;C0237753;C0449788","C0017446","",369
"aspirin before admission","C0004057;C0184666;C0809949","C0004057","",1366
"biomarker levels","C0005516;C0441889","C0005516","",1455
"age $nmbr$ yr","C0001779;C0439234","C0001779","",480
"mild n $nmbr$ $nmbr$ $nmbr$","C2945599",NULL,NULL,329
"duration of crohn s disease yrs","C0010346;C0449238;C2926735",NULL,NULL,138
"topical non prescription","C0033080;C0332237;C1518422;C1521941",NULL,NULL,1125
"tnfi na ve n","C0042469;C0597484;C1272460;C1546968;C1879645;C3714652;C4049872;C4321495;C4552882",NULL,NULL,419
"new zealand","C0027978;C0324547","C0027978",";C0324547",189
"canakinumab $nmbr$ month on treatment il $nmbr$ above the median value $nmbr$ $nmbr$ ng l n $nmbr$","C0020898;C0021764;C0022271;C0039798;C0087111;C0332177;C0439231;C0439297;C0549183;C0876920;C1522326;C1522609;C1533734;C1705169;C2347635;C2348144;C2718773;C2939193;C3538994;C3887704",NULL,NULL,672
"atrial fibrillation","C0004238;C0344434;C1963067",";C0004238","",1009
"subjects n","C0369718;C0441922;C0681850;C1550501;C1706203;C2349001;C2697811",NULL,NULL,1655
"duration from clopidogrel placebo to pci min median iqr","C0032042;C0070166;C0449238;C0549183;C0702093;C0876920;C1524029;C1696465;C1706408;C2347635;C2348144;C2926735;C2939193;C3813700;C4049621","C0032042","",28
"n lesions","C0221198;C0369718;C0441922;C1546698",NULL,NULL,1553
"second co primary","C0205225;C0205436;C0439612;C0439631;C0457385;C0565930;C1561503;C1705190;C3245499",NULL,NULL,2341
"history of diagnosed hypertension prior to randomization n","C0011900;C0034656;C0455527",NULL,NULL,1709
"no vhd event rate year n","C0439234;C0439508;C0441471;C0871208;C1521828;C4019010",NULL,NULL,2008
"serum cholesterol mg dl","C0439269;C0587184","C0008377","",1501
"stage $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$","C0439445;C0456533","C3811844;C0017654","",592
"$nmbr$ n $nmbr$","C0369718;C0441922",NULL,NULL,1553
"$nmbr$ n","C0369718;C0441922",NULL,NULL,1553
"diastolic blood pressure mm hg","C0428883;C0439475;C1305849","C0428883","",842
"weight mean sd lbs","C0005910;C0043100;C0439219;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C3161851","C0005910","",1250
"potassium mmol liter","C0032821;C0202194;C0304475;C0439190;C0475211;C0597277;C3714637","C0032821","",1371
"high i $nmbr$ baseline hba $nmbr$ c","C0019016;C0021966;C0168634;C0205250;C0221138;C1299351;C1442488;C1825777;C2700149;C3538758;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"nt probnp pg ml h","C0030827;C0033727;C0072225;C0369286;C0439297;C0439391;C0439526;C0441932;C0564385;C0669479;C0754710;C1266240;C1705224;C2827929;C3887665;C4528284",NULL,NULL,1511
"no epa group no of events","C0441471;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C3541888",NULL,NULL,408
"non metsyn","C1518422",NULL,NULL,464
"azathioprine","C0004482",NULL,NULL,56
"cvd mi stroke urgent vascular hospitalization","C0005847;C0007222;C0019993;C0038454;C0439609;C1558950;C1801960;C3272275;C3810814;C4554100",NULL,NULL,1762
"fasting plasma glucose mg dl","C0015663;C0202042;C0439269;C0455280","C0455280;C0015663",";C0168634",21
"esr mm hour","C0439227;C0564385;C3811131;C4330985;C4554674","C1619634","",298
"moderate ckd","C0205081;C1561643;C1881878;C4049705;C4049706;C4085643;C4321335","C1561643","",967
"sulfonylurea based","C0038766;C1527178;C1705938;C3536898","C0038766","",752
"history of pvd n","C4534349","C0241889","",1493
"angina status no","C0002962;C0449438",NULL,NULL,543
"stsd $nmbr$ mm on admission n $nmbr$ $nmbr$","C0184666;C0809949;C4330985;C4554674",NULL,NULL,297
"nocad mi","C3810814",NULL,NULL,516
"treatment difference ml","C0039798;C0087111;C0439526;C1522326;C1533734;C1705169;C1705224;C1705241;C1705242;C3538994;C3887665;C3887704",NULL,NULL,236
"mild impairment","C0221099;C0684336;C2945599",NULL,NULL,329
"das $nmbr$ crp mean sd","C0051767;C0057671;C0444504;C2347634;C2348143;C2699239;C3890735;C4048285",NULL,NULL,143
"treated with losartan n $nmbr$","C0126174;C0332293","C0126174","",1939
"peripheral revascularisation","C0205100;C0581603",NULL,NULL,932
"weight $nmbr$","C0005910;C0043100;C1305866;C1705104","C0005910","",1250
"demographic variable","C0011298;C0439828;C4553760",NULL,NULL,582
"pci orcabg","C4049621",NULL,NULL,1736
"crp $nmbr$ mg $nmbr$ n","C0024671;C0026410;C0439269;C1960952;C2346927;C3890735;C4048285;C4321396;C4521761","C0006560","",286
"normal $nmbr$ ml minute","C0205307;C0231683;C0439166;C0439232;C0439526;C0700321;C0702093;C1282918;C1705224;C2347086;C2347166;C3887665;C4553972",NULL,NULL,1475
"secondary cardiovascular endpoint","C0007226;C3887460;C4528314",NULL,NULL,649
"large shunt","C0232180;C0542331;C0549177;C1442858",NULL,NULL,478
"anticyclic citrullinated peptide positive n","C0439178;C1320283;C1446409;C1514241;C2825490;C3812269","C4318437","",360
"no depression","C0011570;C0011581;C0344315;C0460137;C4049644;C4084909;C4085311;C4553827",NULL,NULL,469
"no of previous tne inhibitors","C0205156;C0243077;C1552607;C3896585",NULL,NULL,809
"all n $nmbr$","C0369718;C0441922",NULL,NULL,396
"stage iv","C0022326;C0205390;C1300072;C1306673;C4265176",NULL,NULL,541
"index events","C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C3541888",NULL,NULL,412
"a mini mental state examination omega $nmbr$ fatty acids vs placebo","C0015684;C0032042;C0451306;C1696465;C1706408;C1719844","","",-10
"severe exacerbations itt population n","C0032659;C0205082;C1257890;C4050465;C4050466;C4086268",NULL,NULL,900
"atherosclerotic disease","C0012634;C0333482","C0004153","",1698
"primary cardiovascular endpoint","C0007226;C2986535;C3887460",NULL,NULL,649
"dbp at visit $nmbr$","C0536221;C0545082;C1512346;C2826704;C3813197;C4281799","C0005823","",15
"das $nmbr$ esr remission","C0051767;C0057671;C0544452;C0687702;C3811131","C1619634","",298
"provoked","C1444748",NULL,NULL,335
"ct calcitonin cv cardiovascular egfr estimated glomerular filtration rate hbalc glycated hemoglobin h $nmbr$ histamine $nmbr$ iqr interquartile range n number of patients sd standard deviation","C0006668;C0007226;C0017654;C0019588;C0033727;C0062408;C0369286;C0441932;C0564385;C0750572;C0871420;C1561549;C1711350;C1739039;C2360800;C2699239;C3538987;C3666909;C3811844;C3812682;C3887460;C4048877;C4318503;C4528284",NULL,NULL,1179
"spine","C0037949;C2752558",NULL,NULL,2037
"gly $nmbr$ $nmbr$ mg b i d n $nmbr$","C0024671;C0026410;C0152277;C0439269;C1415124;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"i idl cholesterol mg dl","C0021966;C0123167;C0221138;C0439269;C0523559;C0619865",NULL,NULL,1021
"rosuvastatin $nmbr$ $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C0965129;C1960952;C2346927;C4321396;C4521761","C0965129","",886
"hbak median","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"copd duration y","C0024117;C0449238;C1412502;C2926735;C3714496",NULL,NULL,1726
"bmi kg m $nmbr$ uac no","C0578022;C1532718",NULL,NULL,1590
"placebo group","C0032042;C0441833;C0687744;C1257890;C1519504;C1696465;C1705428;C1705429;C1706408","C0032042","",28
"one or more exacerbations","C0205172;C0205447;C4086268",NULL,NULL,1539
"blood pressure $nmbr$ $nmbr$ mmhg n","C0005823;C0439475;C1271104;C1272641","C0005823","",15
"$nmbr$ mg dl $nmbr$ $nmbr$ mmol l","C0439269;C1532563",NULL,NULL,670
"tg mmol l c","C0337445;C1532563","C0041004","",209
"age yr","C0001779;C0439234","C0001779","",480
"no prior stroke","C0038454;C0332152;C2826257;C4554100","C0038454;C0332152","",2380
"vs placebo","C0032042;C1696465;C1706408","C0032042","",28
"p value c","C1709380",NULL,NULL,7
"medical historv","C0199168;C0205476",NULL,NULL,639
"prior bb plus acbi plus arb use","C0004739;C0042153;C0332152;C0332287;C0332297;C0457083;C1947944;C2826257;C3888198",NULL,NULL,44
"prior lipid lowering agent use","C0042153;C0086440;C0332152;C0457083;C1947944;C2826257",NULL,NULL,294
"iv fev $nmbr$ $nmbr$ predicted","C0022326;C0681842;C1882327;C3714541;C4265176",NULL,NULL,1599
"baseline corticosteroidst mean dose $nmbr$ $nmbr$ mg day n","C0168634;C0178602;C0439422;C0444504;C0869039;C1114758;C1442488;C2347634;C2348143","C0017710","",1348
"stage $nmbr$ a","C0205390;C1300072;C1306673",NULL,NULL,541
"corticosteroid azathioprine $nmbr$ mercaptopurine","C0000618;C0001617;C0004482;C3536709","C0000618","",77
"any disease","C0012634",NULL,NULL,1279
"rate ratio lebrikizumab vs placebo $nmbr$ cl","C0032042;C0456603;C0596019;C0871208;C1521828;C1547037;C1696465;C1706408;C2981360","C2981360","",373
"epilepsy with grand mal seizures on awakening","C0014549;C0494475;C1720052","C0014549","",1940
"de $nmbr$ n $nmbr$","C0011198;C0017480;C3541240",NULL,NULL,1620
"$nmbr$ $nmbr$ n $nmbr$ $nmbr$","C0369718;C0441922",NULL,NULL,1553
"score on modified rankin scale","C0449820;C2984908;C3854213;C4050231",NULL,NULL,2053
"metformin sulphonylureas","C0025598;C0038766","C0038766;C0025598","",2253
"helicobacter pylori infection n","C0850666",NULL,NULL,573
"presenting signs and symptoms","C0220912;C0220913;C0311392;C0449450;C0683368;C1457887",NULL,NULL,613
"repaired congenital shunts","C0009678;C0205340;C0232180;C0542331;C1442858;C1744681",NULL,NULL,478
"western europe australia israel","C0004340;C0015176;C0022271;C0043128;C0043129","C0015176","",337
"$nmbr$ $nmbr$ men","C0025266","","",306
"time to rx","C0040223;C1425688;C1521941;C2709207;C3541383",";C0040223","",1438
"atv $nmbr$ mg n $nmbr$","C0024671;C0026410;C0210243;C0439269;C0674679;C1145759;C1334862;C1960952;C2346927;C4321396;C4521761",NULL,NULL,1411
"mmse $nmbr$ $nmbr$","C0451306","C0451306","",305
"locafon of index dvt","C0149871;C0600653;C0918012;C1552854;C1637833;C2926618;C2986546;C3899446","C0149871","",252
"jugular venous distention $nmbr$ cm","C0425687","C0425687","",918
"percent activity impairment due to asthma","C0004096;C0221099;C0439167;C0678226;C0684336;C2984299",NULL,NULL,694
"tiotropium group n $nmbr$","C0213771;C0441848","C0213771","",1372
"median","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"patients with at least one concomitant disease","C0030705;C0205447;C0243087",NULL,NULL,1035
"smokers at baseline","C0168634;C0337664;C1442488","C0037369","",420
"overall n $nmbr$ vs $nmbr$","C0282416;C1561607",NULL,NULL,1743
"xi $nmbr$ $nmbr$ p o l","C1720296",NULL,NULL,520
"type of vessel involved","C1282017;C1314939",NULL,NULL,312
"events statin group","C0360714;C0441471;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C3541888",NULL,NULL,412
"tiotropium olodaterol $nmbr$ $nmbr$ $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C4032878;C4321396;C4521761",NULL,NULL,2301
"mean ml min $nmbr$ $nmbr$ m $nmbr$ of body surface area","C0017446;C0205146;C0369637;C0439445;C0441923;C0444504;C0489451;C2347634;C2348143",NULL,NULL,37
"type $nmbr$ diabetes meiiitus","C1320657","C0011849;C1320657","",907
"no of events patients yr","C0030705;C0439234;C0441471;C3541888",NULL,NULL,1099
"waist circumference cmj","C0455829","C0455829","",1413
"erosion score $nmbr$ $nmbr$","C0333307;C0449820;C1880549;C1959609;C3887524;C4050231",NULL,NULL,1046
"data are expressed as n total unless otherwise speci ed systeme international unit conversion to convert creatinine clearance to ml s multiply by $nmbr$ $nmbr$ estimated with cockroft gault equation at discharge ace angiotensin converting enzyme cabg coronary artery bypass graft ccsc canadian cardiovascular society classi cation mi myocardial infarction pci percutaneous coronary intervention","C0007226;C0007447;C0010055;C0012621;C0018787;C0022709;C0027051;C0030685;C0037455;C0040363;C0041260;C0184661;C0238884;C0439175;C0439453;C0439526;C0439810;C0439836;C0522523;C0552449;C0565930;C0750572;C0812399;C0886296;C1273869;C1511726;C1516705;C1705224;C1719797;C1883351;C2603362;C2911648;C2926602;C3245479;C3538926;C3714741;C3887460;C3887665;C4049621","","",-10
"af or atrial flutter","C0004239;C0344423;C0344434;C1963068;C4049859",";C0004238","",1009
"years range","C0439234;C1514721;C2348147;C3542016",NULL,NULL,1099
"by gfr stratum for diabetic participants mt min per $nmbr$ $nmbr$ m","C0017654;C0241863;C0369637;C0441923;C0679646;C0702093;C1424601;C1524029;C3813700",NULL,NULL,996
"reversibility to salbutamolc d mean sd","C0444504;C0449261;C2347634;C2348143;C2699239","C0449261;C0231999","",1315
"age $nmbr$ yrs","C0001779","C0001779","",480
"antihypertensive medication open label no","C0003364;C1709323",";C0003364","",1579
"ulcer n a","C0041582;C3887532","C0041582","",1451
"dyspnoea n $nmbr$","C0013404;C1963100","C0013404","",1227
"mean sd change from pre to post bronchodilator fevi nil","C0332152;C0442734;C0444504;C0687676;C0740175;C1704687;C2257086;C2347634;C2348143;C2599594;C2599602;C2699239;C3469826;C3481639;C3669034",NULL,NULL,2142
"female","C0043210;C0086287;C1705497;C1705498","C0086287","",1277
"ls mean change sea","C0023668;C0036493;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952",NULL,NULL,37
"non st elevation mi","C0520886;C1518422;C3810814",NULL,NULL,516
"previous use of niacin or niaspan","C0027996;C0205156;C1142562;C1161310;C1524063;C1552607",NULL,NULL,1044
"pfor interaction","C1151635;C1704675",NULL,NULL,888
"blood pressure while seated mm hg","C0005823;C0277814;C0439475;C1271104;C1272641;C1283233","C0005823","",15
"ankle brachial index $nmbr$ $nmbr$ no","C1328319;C3888326","C1328319","",1233
"$nmbr$ $nmbr$ $nmbr$ $nmbr$ kg","C0022718;C0439209;C4054209",NULL,NULL,205
"radial","C0442038;C0920847","","",-10
"fev $nmbr$ la","C0023031;C0023749;C0230347;C2346906;C3714541;C4553351","C0024119","",288
"previous cancerc","C0205156;C1552607",NULL,NULL,1044
"no prior revascularization n $nmbr$ $nmbr$","C0332152;C0581603;C2826257","C0581603","",1213
"patient years","C0030705;C0439234",NULL,NULL,1099
"$nmbr$ no total no","C0439175;C0439810",NULL,NULL,508
"normalfunction or mild impairment","C0221099;C0684336;C2945599",NULL,NULL,329
"serum creatinine mean sd mg dl","C0201976;C0439269;C0444504;C0600061;C2347634;C2348143;C2699239","C0600061;C0010294","",952
"pro active intervention","C0033382;C0184661;C0205177;C0523852;C0886296;C1273869;C2987124;C3853793;C3888249",NULL,NULL,290
"proton pump inhibitors","C0358591;C1384478;C3540020",NULL,NULL,1582
"systolic bp mm hg mean nyha class","C0039155;C0439475;C0444504;C0488053;C0871470;C1882083;C2347634;C2348143","C0005823","",1469
"patients receiving any uc medication n","C0013227;C0030705;C1514756;C3244316;C4284232",NULL,NULL,366
"subgroup level","C0441889;C0456079;C1079230;C1515021;C1547707;C2946261",NULL,NULL,1637
"weight kg median range","C0005910;C0022718;C0043100;C0439209;C0549183;C0876920;C1305866;C1514721;C1705104;C2347635;C2348144;C2348147;C2939193;C3542016;C4054209","C0005910","",1250
"mtx exposure mg week","C0024671;C0025677;C0026410;C0274281;C0332157;C0332174;C0439230;C0439269;C1417487;C1960952;C2346927;C4321396;C4521761",NULL,NULL,1012
"pfor trend","C1151635;C1521798;C4554533",NULL,NULL,550
"mean sd range duration of epilepsy years","C0014544;C0439234;C0444504;C0449238;C1514721;C2347634;C2348143;C2348147;C2699239;C2926735;C3542016",NULL,NULL,1099
"$nmbr$ egfr ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"statin open","C0175566;C0360714","C0360714","",2167
"glyceryl trinitrate infusion","C0017887;C0574032;C1827465",NULL,NULL,1242
"plus minus values are means sd cabg denotes coronary artery by pass graft ptca percutaneous transluminal coronary angioplasty and ace angiotensin converting enzyme hypertension and diabetes were de fined by clinical history a more complete list of base line characteristics is given in rubins et al $nmbr$ nitrates includes all preparations except as needed nitroglycerin any antianginal drug includes any nitrate as defined above calcium channel blocker or beta blocker the body mass index is the weight in kilograms divided by the square of the height in meters to convert values for cholesterol to millimoles per liter multiply by $nmbr$ $nmbr$ to convert values for triglycerides to millimoles per liter multiply by $nmbr$ $nmbr$","C0001645;C0005893;C0005910;C0006448;C0006539;C0006684;C0008377;C0010055;C0011198;C0011847;C0011849;C0013227;C0017480;C0017887;C0019664;C0019665;C0020538;C0022709;C0028125;C0030125;C0040028;C0040363;C0041004;C0041260;C0042295;C0043100;C0181074;C0202311;C0205042;C0205120;C0205172;C0205197;C0205210;C0205232;C0252873;C0262512;C0262926;C0332257;C0332288;C0332835;C0332849;C0439190;C0439209;C0441074;C0475211;C0489786;C0578022;C0687757;C0699857;C0745732;C0885378;C1254351;C1305855;C1305866;C1442162;C1452534;C1521827;C1532563;C1550718;C1552595;C1552866;C1704788;C1704970;C1705104;C1705255;C1719797;C1820373;C1874267;C1879745;C1883351;C1883728;C1947971;C1961139;C1963138;C2004062;C2699239;C2700399;C2828386;C2911648;C2936173;C3244317;C3272378;C3536851;C3537168;C3539106;C3541240;C3812761;C3848573;C3853530;C3854028;C4283785;C4284014;C4321248;C4521885;C4522126;C4684572",NULL,NULL,832
"dose adjusted","C0178602;C0456081;C0869039;C1114758",NULL,NULL,110
"baseline tc mg dl","C0039411;C0040642;C0041405;C0041698;C0168634;C0439269;C1442488;C1824670;C3272447;C4522122","C0041004","",368
"pace no $nmbr$","C0287990;C1552930;C4048252",NULL,NULL,1298
"patients with uncomplicated events","C0030705;C0441471;C0443334;C3541888",NULL,NULL,1035
"risk factor","C0035648",NULL,NULL,175
"simvastatin $nmbr$ mg plus fenofibrate $nmbr$ mg n $nmbr$","C0033228;C0074554;C0332287;C1319635","C0033228","",803
"cvd mi stroke or recurrent ischemia urgent revascularization or hospitalization for unstable angina","C0002965;C0007222;C0019993;C0022116;C0038454;C0439609;C0581603;C1455761;C2945760;C3272275;C3810814;C4321499;C4554100",NULL,NULL,1002
"anti tnf naive patients $nmbr$","C0030705;C1448177",NULL,NULL,362
"$nmbr$ $nmbr$ hours","C0439227",NULL,NULL,828
"percentage difference $nmbr$ cl","C0439165;C0596019;C1549488;C1561533;C1705241;C1705242",NULL,NULL,1466
"age $nmbr$ years old","C0580836;C1510829","C1510829","",481
"diagnostic angiography","C0002978",NULL,NULL,1723
"hispanic ethnic group no f","C0015031;C0016327;C0086409;C1879937","C0086409","",865
"any recurrent stroke","C2242682",NULL,NULL,1419
"mean baseline n","C0168634;C0444504;C1442488;C2347634;C2348143",NULL,NULL,625
"no revascularization for index acs event no","C0441471;C0581603;C0600653;C0742343;C0918012;C1552854;C1637833;C2986546;C4019010;C4318612",NULL,NULL,412
"mean change in total updrs scores adjusted according to baseline updrs","C0168634;C0392747;C0439175;C0439810;C0443172;C0444504;C0456081;C0680240;C1442488;C1705241;C2347634;C2348143;C2964552;C3533236;C3639721;C4319952",NULL,NULL,37
"geographic region no","C0017446",NULL,NULL,1060
"potassium","C0032821;C0202194;C0304475;C0597277;C3714637","C0032821","",1371
"hormone therapy","C0279025",NULL,NULL,558
"vdz pla n $nmbr$","C0456170",NULL,NULL,1514
"sf $nmbr$ pcs ls mean change from baseline se","C0023668;C0036919;C0037712;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C1864389;C1882368;C2347634;C2348143;C4319952",NULL,NULL,1782
"mm hg","C0439475","C0005823","",1469
"primary outcome","C0205225;C0439612;C0439631;C1274040",NULL,NULL,2339
"modified rankin score","C0392747;C0449820;C3889737;C4050231",NULL,NULL,2054
"oral hypoglycaemics only","C0205171;C0359086;C1720467",NULL,NULL,925
"participants no","C0679646",NULL,NULL,1033
"history pack years","C0019664;C0019665;C0262512;C0262926;C1277691;C1705255;C2004062",NULL,NULL,832
"allopurinol","C0002144",NULL,NULL,1507
"mean sd fasting insulin uu ml","C0015663;C0021641;C0439342;C0444504;C1533581;C1579433;C2347634;C2348143;C2699239;C3714501",NULL,NULL,157
"no of previous venous thromboembolic events","C0205156;C1552607;C1861172;C1997614;C3160733","C1861172","",2399
"older than $nmbr$ years","C0439234;C0580836",NULL,NULL,1099
"$nmbr$ bh i","C0004684;C0004952;C0021966;C0221138;C1412800;C2986890;C4284594;C4321407",NULL,NULL,1021
"other llt at randomization","C0034656;C2347090",NULL,NULL,692
"aspirin use $nmbr$ mg","C0004057;C0024671;C0026410;C0042153;C0439269;C0457083;C1947944;C1960952;C2346927;C4321396;C4521761","C0004057","",1366
"aspirin alone","C0004057;C0205171;C0439044;C0679994","C0004057","",1366
"european quality of life $nmbr$ dimensions $nmbr$ level eq $nmbr$ d","C0034380;C0205163;C0239307;C0439185;C0439534;C0441889;C0456079;C0518214;C1535514;C1547707;C2946261",NULL,NULL,744
"p $nmbr$ y $nmbr$ antagonists","C0243076;C0369773;C2603361",NULL,NULL,1823
"time since diagnosis of type $nmbr$ diabetes mellitus","C0011900;C0040223;C1320657;C1704338;C1704656;C3541383","C0011849;C1320657","",907
"no pad n $nmbr$ $nmbr$","C0182158;C0332568;C3540603;C3669270;C3814046;C4319657",NULL,NULL,1752
"pure sensory stroke","C0038454;C0445254;C2247561;C4554100",NULL,NULL,1762
"cv death mi stroke or urgent coronary revascularization","C0011065;C0038454;C0439609;C0877341;C1306577;C3272275;C3538987;C3810814;C4048877;C4082313;C4318503;C4552775;C4554100",NULL,NULL,323
"pad n $nmbr$ $nmbr$","C0182158;C0332568;C3540603;C3669270;C3814046;C4319657",NULL,NULL,1752
"leukotriene receptor antagonist","C0595726;C3537183;C4521995",NULL,NULL,185
"st elevation","C0520886","C0520886","",1944
"$nmbr$ kg m","C1532718",";C1305855","",206
"change $nmbr$","C0392747;C0443172;C1705241;C4319952",NULL,NULL,767
"fasting blood glucose mg dl","C0428568;C0439269;C1261430","C0017725;C0015663","",2280
"haq di $nmbr$ $nmbr$ mean sd","C0444504;C2347634;C2348143;C2699239;C3826998;C4321476",NULL,NULL,2138
"any mi","C3810814",NULL,NULL,516
"ics non users at screening","C0220908;C0220909;C0815320;C1518422;C1698960;C1706077;C1710031;C1710032;C1710477;C2348164;C4551720","C3540778","",2182
"atenolol n $nmbr$","C0004147","C0004147","",1055
"ethnicity n b","C0015031;C0243103",NULL,NULL,787
"fasting glucose level mg dl","C0202045;C0439269","C0017725;C0015663","",2280
"pci n","C4049621",NULL,NULL,1736
"swollen joint count $nmbr$ $nmbr$","C0451521",";C0451521","",1140
"antidiabetic","C0935929",NULL,NULL,995
"tiotropium placeb n $nmbr$","C0213771","C0213771","",1372
"intermediate long acting fast acting","C0015663;C0079613;C0205103;C0205166;C0456962;C1550465;C1704930;C1706317;C1869853;C2827755;C2985769;C3889971;C3890007;C4048375","C0205103",";C0015663;C1550465;C2827755;C3889971;C0079613;C1704930;C1869853;C3890007;C4048375",1096
"tchdl c mean sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"cardiac failure n","C0018801;C0018802","C0018801",";C0168634;C1524003",12
"tofacitinib $nmbr$ mg two times a day","C0024671;C0026410;C0332173;C0439228;C0439269;C0439505;C1948050;C1960952;C2346927;C2930696;C4321396;C4521761","C2930696","",857
"interventional or surgical procedures","C0184661;C0543467;C3274035",NULL,NULL,598
"mean s d duration of diabetes years","C0011847;C0011849;C0439234;C0444504;C0449238;C2347634;C2348143;C2926735",NULL,NULL,1099
"antiplatelet drug","C0085826","","",1191
"ischaemic skin lesions","C0037284;C0475224",NULL,NULL,1670
"time since asthma diagnosis years","C0004096;C0011900;C0040223;C0439234;C1704338;C1704656;C2984299;C3541383",NULL,NULL,757
"female sex no","C0086287","C0086287","",1277
"apixaban $nmbr$ $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1831808;C1960952;C2346927;C4321396;C4521761","C1831808","",1224
"history of dyslipidemia","C0019664;C0019665;C0242339;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"individuals with prediabetes","C0027361;C0237401;C0362046",NULL,NULL,588
"fracture","C0016658",NULL,NULL,2026
"aceis angiotensin converting enzyme inhibitors c candesartan des drug eluting stent egfr estimated glomerular filtration rate hdl high density lipoprotein ldl low density lipoprotein nc non candesartan","C0003015;C0011702;C0013227;C0017654;C0023821;C0023823;C0027964;C0028407;C0038257;C0067895;C0265987;C0717550;C0750572;C1254351;C1518422;C1561549;C1739039;C2757044;C3811844;C3812682;C4551552","","",-10
"south american","C0425359","C0037713","",580
"patient characterization data are reproduced from morrow et al $nmbr$","C0040028;C0202311;C1880022;C2707520",NULL,NULL,1333
"$nmbr$ year risk of chd $nmbr$ $nmbr$","C0439234;C0439508;C1282512",NULL,NULL,1099
"male sex no risk factors","C0035648;C0086582;C1553898",NULL,NULL,175
"$nmbr$ hour masbp mm hg","C0439227;C0439475;C0564385","C0005823","",15
"heart rate bpm $nmbr$","C0018810","C0018810","",1105
"e aza treatment ref","C0004482;C0039798;C0087111;C1425988;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,1881
"concomitant treatment no","C0039798;C0087111;C0521115;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,236
"ldl cholesterohhdl cholesterol ratio","C0023824;C0202117;C0456603;C1547037","C0023824","",1068
"hba $nmbr$ c range","C0019016;C1514721;C1825777;C2348147;C3538758;C3542016","","",820
"bmi $nmbr$","C0578022",NULL,NULL,1735
"ideglira ideg","C4308663",NULL,NULL,774
"latin america hr $nmbr$ cl","C0023122;C0596019",";C0023122","",1461
"disease characteristics n unless otherwise stated","C0599878;C1301808;C1442792",NULL,NULL,980
"mean change from baseline bp at week $nmbr$","C0168634;C0332174;C0392747;C0439230;C0443172;C0444504;C0488053;C1268766;C1442488;C1705241;C2347634;C2348143;C4319952",NULL,NULL,767
"nyha_class","C1882083","C0018802;C1882083","",453
"indian subpopulation","C1257890;C1524069",NULL,NULL,904
"aspirin plus placebo n $nmbr$","C0004057;C0032042;C0332287;C1696465;C1706408","C0004057","",1366
"patients with complicated events","C0030705;C0231242;C0441471;C3541888",NULL,NULL,412
"ezetimibe simvastatin","C1532737","C0074554","",1840
"cv death mi or ischemic stroke","C0011065;C0948008;C1306577;C3538987;C3810814;C4048877;C4082313;C4318503;C4552775",NULL,NULL,323
"acute dvt study","C0149871;C0205178;C0557651;C2603343;C2926618;C3899446","C0149871","",252
"crcl median iqr ml min","C0439445;C0549183;C0876920;C1846718;C2347635;C2348144;C2939193","C3811844;C0017654","",307
"section $nmbr$ a","C0152060;C0700320;C1522472;C1552923;C1705191;C3714523","C2700378","",887
"tiotropium $nmbr$ $nmbr$ mg","C0024671;C0026410;C0213771;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2300
"$nmbr$ $nmbr$ g l","C0439294;C0456615",NULL,NULL,1706
"sitagliptin n $nmbr$","C1565750","C1565750","",1184
"metsyn with ldl $nmbr$ $nmbr$ mg dl","C0439269",NULL,NULL,192
"no corticosteroid no imm","C0001617;C0205470;C3536709",NULL,NULL,1650
"medan $nmbr$ year old","C0439234;C0439508;C0580836",NULL,NULL,1099
"nt probnp pg mla iqr","C0030827;C0072225;C0599973;C0669479;C0754710;C1266240",NULL,NULL,1263
"changes in serum creatinine pmol l","C0201976;C0392747;C0439284;C0443172;C0600061",NULL,NULL,767
"placebo mean n","C0032042;C0444504;C1696465;C1706408;C2347634;C2348143","C0032042","",28
"c reactive protein mg dl","C0006560;C0439269;C1413716;C4048285","C0006560","",286
"sbp during the follow up period mmhg","C0085805;C0439475;C0439531;C0589120;C1522577;C1704685;C1948053;C3274571",NULL,NULL,607
"lovastatin $nmbr$ mg","C0024027;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2290
"incidence o $nmbr$ $nmbr$ cl","C0021149;C0220856;C0596019","C0021149","",1467
"time from last dose of p $nmbr$ y $nmbr$ inhibitor days","C0439228;C0946444;C1999216",NULL,NULL,756
"net composite","C0205199;C1456447;C1547335;C3853572;C3887809;C3890893",NULL,NULL,1081
"mean mm hg","C0439475;C0444504;C2347634;C2348143","C0005823","",1469
"who functional class ii iii","C0205245;C0439070;C0441886;C0441887;C0542341;C1705160;C1710602;C2698968;C2698969;C2700217;C4082587",NULL,NULL,845
"kccq $nmbr$ months","C0439231;C3476798",NULL,NULL,1530
"geo graphic region asia","C0003980;C0017446;C0017454;C0205147","C0003980","",1382
"uc disease duration y","C0872146","C0449238;C0872146","",903
"saba inhaled c n","C0004048","","",1281
"arteriosclerosis","C0003850","C0004153","",1698
"standard $nmbr$","C1442989;C2828392",NULL,NULL,1482
"dual i extension end of trial hba $nmbr$ c","C0008976;C0019016;C0021966;C0205173;C0221138;C0231448;C0444930;C1554184;C1825777;C1880641;C2746065;C3538758",NULL,NULL,1021
"concomitant drug therapies n","C0013216;C0521115",NULL,NULL,447
"asian n","C0078988","C0078988","",1369
"proportion","C1709707",NULL,NULL,1047
"established n $nmbr$","C0443211;C1272684","C0443211","",179
"patient history of disease","C0030705;C0683519;C0730226;C0850708;C0944983",NULL,NULL,105
"time since asthma diagnosis years median range","C0004096;C0011900;C0040223;C0439234;C0549183;C0876920;C1514721;C1704338;C1704656;C2347635;C2348144;C2348147;C2939193;C2984299;C3541383;C3542016",NULL,NULL,757
"$nmbr$ events","C0441471;C3541888",NULL,NULL,412
"exacerbations in previous year requiring hospitalization n","C0019993;C0205156;C0439234;C0439508;C1552607;C4086268","C4086268","",1991
"reversible to bronchodilator b","C0006280;C0205343",NULL,NULL,733
"chd risk equivalents n","C0439185;C1282512;C4049980",NULL,NULL,972
"parenteral anticoagulalion before randomization","C0030547;C0034656;C4522267",NULL,NULL,692
"mean age sd yr","C0001779;C0439234;C0444504;C2347634;C2348143;C2699239","C0001779","",480
"acpa positive no","C0439178;C1446409;C1514241;C1525410;C1706063;C2825490;C3812269",";C0439178","",2051
"fasting serum glucose mg dl","C0015663;C0202041;C0439269;C3534430","C0017725;C0015663","",2280
"heart rate bpm","C0018810","C0018810","",1105
"total death","C0011065;C0439175;C0439810;C1306577;C4082313;C4552775",NULL,NULL,508
"baseline dbp mm hg","C0168634;C0439475;C0536221;C1442488;C3813197;C4281799",NULL,NULL,605
"olmesartan n $nmbr$","C1098320","C1098320","",2087
"metabolic syndrome n $nmbr$","C0524620",NULL,NULL,617
"cutoffs","C1442160","","",-10
"clopidogrel plus aspirin","C0004057;C0070166;C0332287","C0070166",";C0369286;C0033727;C4049621",217
"reason for discontinuation of previous tnfa inhibitor","C0205156;C0392360;C0457454;C1444662;C1448177;C1552607;C1710304;C1999216;C4552847",NULL,NULL,2392
"fenofibric acid n $nmbr$","C0060179",NULL,NULL,1696
"brv dosage mg d","C0155502;C0178602;C0439422;C2986497","","",198
"characteristics","C1521970","C1521970","",1110
"aqe i $nmbr$","C0021966;C0221138","","",-10
"cvd mi stroke or recurrent ischemia urgent revascularization","C0007222;C0022116;C0038454;C0439609;C0581603;C1455761;C2945760;C3272275;C3810814;C4321499;C4554100",NULL,NULL,516
"severe episodes in previous year no patient","C0030705;C0205082;C0205156;C0332189;C0439234;C0439508;C1552607;C4050465;C4050466",NULL,NULL,2393
"alcohol intake","C0001948","C0001948","",875
"bone erosion score mean sd","C0444504;C0449820;C0587240;C2347634;C2348143;C2699239;C4050231",NULL,NULL,1287
"antiplatelet or anticoagulant","C0003280;C0848112;C3536711","C0085826","",451
"pulmonary disease","C0024115",NULL,NULL,106
"bmi $nmbr$ kg m $nmbr$ n","C0578022;C1532718",NULL,NULL,1735
"diabetic yes","C0241863;C1549445;C1705108;C1710701",NULL,NULL,147
"mean blood pressure mm hg","C0428886;C0439475;C0488053","C0005823","",1469
"mildlydecreased baseline gfr $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$","C0017654;C0168634;C0369637;C0439445;C0441923;C1424601;C1442488","C3811844;C0017654","",307
"immunosuppressant","C0021081","C0021081","",1424
"regular alcohol consumption per week no","C0001948;C0205272;C0332174;C0439230","C0001948","",875
"baseline mean sd mmol mol","C0168634;C0444504;C1442488;C2347634;C2348143;C2699239;C3829066",NULL,NULL,1287
"all without diabetes n $nmbr$","C0011847;C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"mild impairment $nmbr$ to $nmbr$ ml min","C0221099;C0439445;C0684336;C2945599",NULL,NULL,329
"at home diastolic pressure $nmbr$ mm hg","C0428883;C0439475;C4534363","C0005823","",1469
"before index acs event","C0441471;C0600653;C0742343;C0918012;C1552854;C1637833;C2986546;C4019010;C4318612",NULL,NULL,2147
"history of stroke $nmbr$","C0019664;C0019665;C0038454;C0262512;C0262926;C1705255;C2004062;C4554100",NULL,NULL,832
"age years geographical distribution of patients","C0030705;C0681686;C1510829","C1510829","",481
"$nmbr$ severe disease","C1836348",NULL,NULL,97
"other chd","C0280604;C3542407",NULL,NULL,970
"classification of af no","C0008902;C0008903;C0344434;C0678229;C4049859",NULL,NULL,265
"tpm subgroup n $nmbr$","C0076829;C1079230;C1515021",NULL,NULL,1637
"left side of colon","C0227388",NULL,NULL,43
"diabetes t","C0011847;C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"mean dlco sd","C0444504;C1516251;C2347634;C2348143;C2699239",NULL,NULL,37
"fpg mmol lt","C0023376;C0230426;C0439190;C3887647;C4521399",NULL,NULL,1678
"$nmbr$ min walk distance m","C0369637;C0429886;C0441923;C0702093;C1524029;C3813700",NULL,NULL,1475
"patients who received $nmbr$ or $nmbr$ drugs","C0013227;C0030705;C1514756;C3687832",NULL,NULL,731
"pre bronchodilator fev $nmbr$","C2599602;C3714541",NULL,NULL,1599
"baseline scales median range","C0168634;C0175659;C0222045;C0349674;C0549183;C0876920;C1442488;C1514721;C1947916;C2347635;C2348144;C2348147;C2939193;C3542016",NULL,NULL,635
"africa","C0001737",NULL,NULL,48
"hba $nmbr$ c n","C0019016;C1825777;C3538758","","",820
"metformin no yes","C0025598;C1549445;C1705108;C1710701",NULL,NULL,147
"body mass index kg mj previous diagnosis","C0005893;C0022718;C0332132;C0439209;C0439254;C0578022;C1305855;C4054209;C4284025","C1305855","",1734
"sbp mmhg $nmbr$","C0085805;C0439475",NULL,NULL,607
"paresthesia","C0030554;C4553220",NULL,NULL,53
"ileum and colon","C0009368;C0020885;C3888384","C0020885;C0009368","",1054
"prostate volume cm $nmbr$","C1441416","C1441416","",1575
"received $nmbr$ prior biologic therapies n","C0278947;C1514756",NULL,NULL,731
"both adalimumab groups n $nmbr$ baseline immunosuppressant use","C0021081;C0042153;C0168634;C0369718;C0441833;C0441922;C0457083;C0687744;C1122087;C1257890;C1442488;C1519504;C1552839;C1705428;C1705429;C1947944","C0021081","",1424
"p losartan versus placebo","C0032042;C0126174;C0369773;C1696465;C1706408;C2603361","C0126174","",1207
"abatacept","C1619966","C1619966","",1190
"lvh by electrocardiogram n","C0013798;C0149721;C1547122;C1623258","C0149721","",1496
"days with asthma symptoms week","C0004096;C0677547;C0683368;C1457887;C2984299",NULL,NULL,613
"ls mean treatment difference $nmbr$ ci","C0008107;C0023668;C0039798;C0087111;C0444504;C1522326;C1533734;C1705169;C1705241;C1705242;C2347634;C2348143;C3259781;C3538994;C3887704",NULL,NULL,519
"cv death mi stroke ucr","C0011065;C0038454;C1306577;C3538987;C3810814;C4048877;C4082313;C4318503;C4552775;C4554100","C0011065","",220
"secondary end points","C0027627;C0175668;C0205436;C2349179",NULL,NULL,1484
"age at lipid randomization y","C0001779;C0034656;C0065033","C0001779","",480
"luts severity","C0439793;C0522510;C0574785",NULL,NULL,1658
"$nmbr$ prior tnf antagonist failures n b","C0231174;C0231491;C0332152;C0680095;C2826257;C3887647",NULL,NULL,2372
"re cover ii","C0180153;C0556581;C1999244;C2986904;C3888055",NULL,NULL,523
"congestive heart failure chf in past $nmbr$ weeks","C0018802;C2987125","C0018801",";C0168634;C1524003",12
"benralizumab $nmbr$ mg q $nmbr$ w","C0024671;C0026410;C0439269;C1960952;C2346927;C2982078;C4321396;C4521761",NULL,NULL,947
"af alone","C0205171;C0344434;C0439044;C0679994;C4049859",NULL,NULL,1794
"arthritis type","C0003864;C0332307;C1547052;C4552845","C0003864","",274
"no prior llt","C0332152;C2347090;C2826257",NULL,NULL,294
"wml load at follow up mri","C0024485;C0589120;C1522577;C1550025;C1704685;C1704782;C1708715;C1824234;C3274571;C3890166",NULL,NULL,1056
"patient s preference not to take vka only reason","C0040363;C0041260;C0205171;C0376409;C0392360;C1515187;C1518422;C1720467;C1883351",NULL,NULL,431
"direction of hr","C0449738",NULL,NULL,825
"change meantse","C0392747;C0443172;C1705241;C4319952",NULL,NULL,767
"bsa involved $nmbr$","C1314939",NULL,NULL,311
"thiazide at last follow up","C0541746;C0589120;C1522577;C1704685;C3274571","","",993
"direct stenting per lesion","C0038257;C0221198;C0439851;C1546698;C1947931;C2348535",NULL,NULL,472
"pre specified hr $nmbr$ cl","C0596019;C2826245",NULL,NULL,658
"hdl cholesterol mmol l","C0023822;C0392885;C1532563","C0023822","",821
"heart failure class l lll","C0018801;C0018802;C0456387;C1261077;C1518526;C1705943;C4554158",NULL,NULL,452
"baseline mm hg","C0168634;C0439475;C1442488","C0005823","",1469
"rest of world n z $nmbr$","C0035253;C1622890;C2700280","C2700280","",247
"treatment randomization","C0034656;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,692
"duration of assigned regimen before surgery post randomisation characteristic","C0034656;C0038894;C0038895;C0040808;C0449238;C0543467;C0687676;C1274039;C1516050;C1521970;C1552601;C1704687;C2926735;C2945654;C3469826",NULL,NULL,901
"dalteparin n $nmbr$","C0206461","C0206461","",1933
"patients meeting the criteria to receive $nmbr$ mg of","C0024671;C0026410;C0030705;C0040363;C0041260;C0243161;C0439269;C0556656;C1514756;C1883351;C1960952;C2346927;C4321396;C4521761",NULL,NULL,431
"left atrial anteroposterior diameter mm","C0225860;C0225861;C1301886;C4330985;C4554674","C0225860","",1196
"febuxostat febuxostat lesinurad $nmbr$","C0249529;C3886073",NULL,NULL,26
"intensive glycemia lowering","C0005802;C0162425;C0441994;C0522510;C1283828;C1550453;C2003888",NULL,NULL,561
"lower than normal range","C0086715;C0441994;C1548802;C2003888",NULL,NULL,1612
"glucosamine chondroitin sulfate","C0008454;C0008466;C0017718;C0017720;C0038720;C0474702;C0475337;C0876712;C3536965",";C0008466","",1404
"number of swollen joints $nmbr$ $nmbr$","C0038999;C0449813",NULL,NULL,1764
"lower risk n $nmbr$","C3272281;C3538919",NULL,NULL,174
"oad at screening n","C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164",NULL,NULL,798
"stemi","C1536220;C3538872",NULL,NULL,570
"insulin detemir","C0537270",NULL,NULL,163
"ne","C0027608;C0028219;C3538705","","",-10
"duration of as years","C0439234;C0449238;C2926735","C0449238","",1989
"treated with pci no total no","C0332293;C0439175;C0439810;C4049621",NULL,NULL,508
"lipid and lipoprotein values mg dl","C0023779;C0023820;C0042295;C0439269","C0023779","",1967
"no antiplatelet therapy","C1096021","","",1191
"pollen exposure","C0032385;C0274281;C0332157;C0795585;C1320238",NULL,NULL,1905
"antiplatelet agents","C0085826","","",1191
"never","C2003901",NULL,NULL,316
"amiodarone n $nmbr$","C0002598","","",1757
"$nmbr$ day","C0332173;C0439228;C0439505",NULL,NULL,1621
"estimated glomerular filtration rate $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C3811844",NULL,NULL,923
"heparin tirofiban n $nmbr$","C0019134;C0247025;C0770546",NULL,NULL,804
"tender joint count of $nmbr$ joints examined","C0332128;C0451530","C0451530","",1139
"$nmbr$ to $nmbr$ mo","C0026544;C0332177",NULL,NULL,1476
"asian $nmbr$ $nmbr$","C0078988","C0078988","",1369
"baseline hdl c level n s $nmbr$ $nmbr$ $nmbr$ $nmbr$ mg dl","C0168634;C0439269;C0441889;C0456079;C1442488;C1547707;C2946261;C3715113",NULL,NULL,2001
"current smoking no total no","C0037369;C0439175;C0439810;C0453996;C0521116;C1705970;C1881674","C0037369","",420
"mean $nmbr$ ci difference vs saxa dapa met","C0008107;C0428210;C0444504;C1550543;C1705241;C1705242;C2347634;C2348143;C3259781;C4317104",NULL,NULL,39
"ace inhibitor or angiotensin ii receptor","C0003011;C0003015;C4541021","C0003015","",811
"baseline a $nmbr$ c lsm se","C0036919;C0168634;C1442488",NULL,NULL,567
"residual perfusion defect $nmbr$ on lung scan no","C1457869;C1518040;C1609982",NULL,NULL,477
"$nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923","C3811844;C0017654","",307
"non inhaled steroid use n","C0586793;C1518422",NULL,NULL,463
"comorbidities","C0009488",NULL,NULL,765
"bodyweight kg","C0005910;C0022718;C0439209;C1305866;C4054209",NULL,NULL,2326
"amputation due to diabetes no","C0598284;C0678226","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"pre bronchodilator fevi fvc","C0802741;C2599602;C3815113",NULL,NULL,1600
"histor y of heart failure","C0018801;C0018802;C4554158","C0018801",";C0168634;C1524003",12
"fracture history n","C0016658;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062",NULL,NULL,2026
"glomerular filtration rate $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$","C0017654;C0369637;C0439445;C0441923;C1561549",NULL,NULL,923
"reversibility t","C0449261","C0449261","",2160
"ms $nmbr$ n","C2349943;C3539704;C3713294",NULL,NULL,126
"ex smoker n z $nmbr$","C0337671;C4555205","C0037369","",420
"history of diagnosed hypertension n","C0011900;C0455527",NULL,NULL,1498
"mean change in sbp from baseline mmhg mean sd","C0085805;C0168634;C0392747;C0439475;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C2699239;C4319952",NULL,NULL,607
"patient classification","C0008902;C0008903;C0030705;C0678229",NULL,NULL,265
"ibdq total score","C2964552",NULL,NULL,2313
"lesion characteristics","C1286326",NULL,NULL,1652
"minimum maxim um","C0024968;C1524031;C1552614;C2826545",";C1524031;C0806909","",1376
"other drug therapy n","C0013216;C0013217",NULL,NULL,554
"crp $nmbr$ mg l n","C0439268;C3890735;C4048285","C0006560","",286
"total vdh s score $nmbr$ $nmbr$ n","C2964552",NULL,NULL,540
"physician s global assessment mean $nmbr$ sd","C0444504;C2347634;C2348143;C2699239;C4050369",NULL,NULL,1525
"passive smoker","C0425309","C0037369","",420
"$nmbr$ hour ppg mmol l","C0439227;C0564385;C1418888;C1532563",NULL,NULL,671
"without p blockers","C0369773;C2603361",NULL,NULL,960
"patients per $nmbr$ patient years","C0030705;C0439234",NULL,NULL,1099
"randomization to angiography distribution time","C0002978;C0034656;C0681683",NULL,NULL,1723
"hypercholesterolemia","C0020443;C1522133","","",1390
"czp baseline","C0054841;C0168634;C1442488;C1861828;C1872109","C1872109","",1406
"medication at randomization n","C0013227;C0034656;C3244316;C4284232",NULL,NULL,2263
"cardiovascular and respiratory","C0007226;C0521346;C1546767;C3887460",NULL,NULL,649
"prior myocardial infarction","C0155668",NULL,NULL,647
"any treatment emergent ae","C0039798;C0087111;C0750573;C1522326;C1533734;C1705169;C3538994;C3887670;C3887704",NULL,NULL,236
"haematological","C0018943;C0200627",NULL,NULL,1606
"years with gout","C0018099;C0439234",NULL,NULL,1099
"no of subjects","C0681850;C1550501;C1706203;C2349001;C2697811",NULL,NULL,1655
"baseline trl c by quintiles","C0168634;C1442488;C1508496",NULL,NULL,625
"uric acid tertile $nmbr$ $nmbr$ $nmbr$ to $nmbr$ $nmbr$ mg dl","C0041980;C0439269",NULL,NULL,2310
"fvc change","C0392747;C0443172;C1705241;C3714541;C4319952",NULL,NULL,1599
"intercourse satisfac","C0009253",NULL,NULL,568
"acute reaction","C0205178;C0443286",NULL,NULL,1577
"ptca cabg","C0010055;C2936173","C2936173;C0010055","",1524
"with long acting j $nmbr$ agonists","C0079613;C0205166;C0243192;C1704930;C1706317;C1869853;C2987634;C3890007;C4048375",NULL,NULL,499
"withdrew consent","C1511481;C1554192;C2349954;C2923685",NULL,NULL,879
"tamsulosin $nmbr$ $nmbr$ mg n $nmbr$","C0024671;C0026410;C0257343;C0439269;C1960952;C2346927;C4321396;C4521761","C0257343","",1346
"oral hypoglycemic drugs only","C0205171;C0359086;C1720467",NULL,NULL,925
"lvh by echocardiography","C0013516;C0149721","C0149721","",1272
"special interest categories","C0205555;C0543488;C0683312",NULL,NULL,1098
"dose of atorvastatin","C0178602;C0286651;C0869039;C1114758","C0286651","",885
"bmi body mass index dbp diastolic blood pressure gm geometric mean sbp systolic blood pressure the analysis was based on observed data without imputation on missing values asubgroup of patients in whom $nmbr$ h urine was collected see materials and methods section","C0002778;C0017480;C0025663;C0025664;C0030705;C0033727;C0039155;C0042036;C0042037;C0042295;C0042789;C0085805;C0152060;C0369286;C0428883;C0428886;C0441932;C0444504;C0449829;C0449851;C0488053;C0488055;C0520510;C0564385;C0700320;C0871470;C0936012;C1305855;C1306620;C1441672;C1511726;C1516695;C1516698;C1522472;C1524024;C1527178;C1551393;C1552923;C1705191;C1705492;C1705938;C1947903;C2347634;C2348143;C2699638;C2963137;C3245479;C3272743;C3714523;C3714741;C3854019;C4528284",NULL,NULL,956
"early eptifibatide group n $nmbr$","C0253563;C0441848;C1279919",NULL,NULL,1487
"chronic obstructive pulmonary disease","C0024117",NULL,NULL,1726
"anti gad positive n $nmbr$","C0270549;C0432633;C0439178;C1414925;C1446409;C1514241;C2825490;C3812269",NULL,NULL,2061
"high dose edoxaban","C0444956;C2975435","C0444956","",111
"macrovascular disease n","C0012634",NULL,NULL,2113
"$nmbr$ mg liter","C0024671;C0026410;C0439269;C0475211;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"new dm","C0011816;C0205314;C3250443",NULL,NULL,955
"czp $nmbr$ mg n n","C0024671;C0026410;C0054841;C0439269;C1861828;C1872109;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2274
"difference from placeboa","C1705241;C1705242",NULL,NULL,38
"k m","C0369637;C0441923;C0597277;C1708601",NULL,NULL,923
"statin alone","C0205171;C0360714;C0439044;C0679994","C0360714","",872
"p $nmbr$ $nmbr$ between the study groups in any of the baseline characteristics ace","C0369773;C0441849;C0557651;C0681848;C1452534;C1959644;C2603343;C2603361;C4284014;C4684572",NULL,NULL,627
"bowel stricturing n","C0267465","C0267465","",2163
"history of dyspepsia","C0013395;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C4552968","C0013395","",467
"no diabetes","C0011847;C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"composite endpoint of doubling of serum creatinine esrd","C0022661;C0035078;C0201976;C0205173;C0205199;C0600061;C1547335;C1705764;C2316810;C2349179;C2826544","C0600061;C0010294","",952
"vitamin k antagonists","C3653316",";C0043031","",868
"ambition","C0870128","C0870128","",266
"antihypertensive agent use","C0003364;C0042153;C0457083;C1947944",";C0003364","",1579
"former smoker n $nmbr$","C0337671","C0037369","",420
"rr $nmbr$ cl","C0596019;C4554402",NULL,NULL,1542
"baseline dad n $nmbr$ $nmbr$","C0168634;C1442488;C3641946",NULL,NULL,625
"hypoglycemic agent","C0020616","C0020616",";C0013227;C3244316;C4284232;C0450442;C1254351;C1515187;C1521826;C2826257",33
"diuretic drugs","C0012798;C0013227;C3687832",NULL,NULL,992
"time since as diagnosis mean sd years","C0011900;C0040223;C0439234;C0444504;C1704338;C1704656;C2347634;C2348143;C2699239;C3541383",NULL,NULL,37
"ta n $nmbr$","C0039297;C1506978;C1705538;C3272501;C4553364","","",-10
"beta blocker use","C0001645;C0042153;C0457083;C1947944","C0001645","",959
"death from cardiovascular causes","C0007226;C0007465;C3887460",NULL,NULL,649
"asui score mean sd","C0444504;C0449820;C2347634;C2348143;C2699239;C4050231",NULL,NULL,37
"niacin statin","C0027996;C0360714;C1142562","C0027996","",871
"erosion score mean sd","C0333307;C0444504;C0449820;C1880549;C1959609;C2347634;C2348143;C2699239;C3887524;C4050231",NULL,NULL,2133
"accord acr $nmbr$ $nmbr$","C0680240;C1412134;C1515941",NULL,NULL,52
"study population","C2348561",NULL,NULL,1732
"is years","C0439234",NULL,NULL,1099
"blood glucose lowering treatments n","C0005802;C0017725;C0087111;C0441994;C0596197;C2003888","C0005802","",1349
"sal n $nmbr$ $nmbr$","C0036140;C0037494;C0206136",NULL,NULL,853
"baseline median iq range","C0168634;C0549183;C0876920;C1442488;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016",NULL,NULL,635
"high density lipoprotein cholesterol metabolic syndrome patients were to","C0023822;C0030705;C0040363;C0041260;C0524620;C1883351",NULL,NULL,617
"glucose mmol liter","C0017725;C0439190;C0475211","C0202042","",1958
"c right sided vhd n $nmbr$","C0205090;C0444532","","",-10
"$nmbr$ kg m obesity","C0028754;C1532718;C1963185",";C1305855","",206
"drosuvastatin fenofibric acid vs fenofibric acid monotherapy","C0060179",NULL,NULL,1696
"entire cohort gender","C0009247;C0079399;C0439751;C0444667;C0599755;C1522384","C0599755","",2208
"serum values","C0042295;C0229671;C1546774;C1550100",NULL,NULL,951
"goncomitant treatment with age inhibitors angiotensin","C0001779;C0003018;C0039798;C0087111;C0243077;C1522326;C1533734;C1705169;C3538994;C3887704;C4521302","","",-10
"atrial fibrillation type n","C0004238;C0332307;C0344434;C1547052;C1963067",";C0004238","",1009
"symptom onset","C4086878",NULL,NULL,612
"treatment lipid interaction","C0023779;C0039798;C0087111;C1522326;C1533734;C1704675;C1705169;C3538994;C3887704",NULL,NULL,236
"african americans","C0085756","C0005680",";C1706779",188
"duration of infusion before cabg hr","C0010055;C0449238;C0574032;C1827465;C2926735",NULL,NULL,825
"low feno subgroup $nmbr$ $nmbr$ ppb n $nmbr$","C0205251;C1079230;C1415800;C1515021;C1550472;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"mexico central south america","C0007674;C0025885;C0037713;C0205099;C1710133;C1879652","C0025885","",1462
"high risk","C0332167;C3272283;C4050568;C4319571","C4319571","",837
"nihss at baseline","C0168634;C1442488;C1697238",NULL,NULL,625
"relative risk $nmbr$ ci ofprimary end point","C0008107;C0242492;C2349179;C2826544;C3259781",NULL,NULL,519
"time from hospital admission to pci h median q $nmbr$ q $nmbr$","C0019994;C0033727;C0040223;C0369286;C0441932;C0549183;C0564385;C0876920;C1510665;C1959907;C2347635;C2348144;C2939193;C3541383;C4049621;C4528284",NULL,NULL,635
"diagnosis of heterozygous familial hypercholester","C0011900;C0015576;C0019425;C0241888;C1704338;C1704656","","",-10
"ticagrelor $nmbr$ mg no diabetes n $nmbr$","C0011847;C0011849;C0024671;C0026410;C0439269;C1960952;C1999375;C2346927;C4321396;C4521761",NULL,NULL,2299
"exploratory cardiovascular and death outcomes","C0007226;C0011065;C1274040;C1306577;C3887460;C4082313;C4552775",NULL,NULL,323
"negative for helicobacter pylori no total no","C0439175;C0439810;C4688581",NULL,NULL,573
"$nmbr$ yrs of age n $nmbr$ $nmbr$","C0001779","C0001779","",480
"flex baseline bmd g cm meanisd","C0168634;C0439267;C1442488",NULL,NULL,701
"treatment by egfr stage","C0815181;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"total cholesterol mmol lt","C0023376;C0201950;C0230426;C0439190;C0543421;C3887647;C4521399","C0543421","",1504
"individuals with t $nmbr$ dm scale diabetes","C0011816;C0011847;C0011849;C0027361;C0175659;C0237401;C0349674;C1947916;C3250443","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"current alcohol use no total no","C0001962;C0001975;C0042153;C0439175;C0439810;C0457083;C0521116;C1705970;C1947944",NULL,NULL,508
"white ethnicity","C0007457;C0015031;C0043157;C0220938;C0243103",NULL,NULL,787
"use of aspirin at time of qualifying event","C0004057;C0040223;C0441471;C1514624;C1524063;C3541383;C4019010",NULL,NULL,412
"bnp indicates brain natriuretic peptide and nyha new york heart association","C0004083;C0018787;C0027976;C0054015;C0439849;C0596306;C0699792;C1095989;C1275491;C1417808;C2982014",NULL,NULL,1635
"alcohol consumption yes n","C0001948;C1549445;C1705108;C1710701","C0001948","",875
"non dm","C0011816;C1518422;C3250443",NULL,NULL,955
"eze simva $nmbr$ $nmbr$ mg feno $nmbr$ mg dn $nmbr$","C1319635;C1333964;C1707618","C0360714;C1142985","",1862
"pasi score","C0449820;C4050231;C4528685",NULL,NULL,1522
"concomitant medications for ulcerative colitis no","C0009324;C0013227;C0521115;C0802604;C2598133;C4284232",NULL,NULL,1026
"duration of infusion during medical management hr","C0001554;C0199168;C0205476;C0376636;C0449238;C0574032;C1273870;C1827465;C2926735;C3273539",NULL,NULL,825
"no smoking","C0037369;C0453996;C1881674","C0037369","",420
"because of drug relateda sae","C0013227;C1254351;C1519255;C1622657;C4553214",NULL,NULL,367
"antithrombotic use before enrollment no","C0042153;C0457083;C1516879;C1696073;C1947944;C3888021",NULL,NULL,118
"kg m","C1532718",";C1305855","",206
"crp mg l","C0439268;C3890735;C4048285",NULL,NULL,1545
"s asa compounds at baseline","C0004057;C0010139;C0043474;C0168634;C1442488;C3853627",NULL,NULL,60
"pulmonary function tests of predicted","C0024119;C0681842;C1882327;C2598152","C0024119","",288
"body weight kg mean sd","C0005910;C0022718;C0439209;C0444504;C1305866;C2347634;C2348143;C2699239;C4054209","C0005910","",1250
"$nmbr$ kg m $nmbr$ smokers","C0337664;C1532718","C0037369","",420
"symptom onset to hospital arrival hours","C0019994;C0439227;C1510665;C1555577;C1706079;C4086878",NULL,NULL,612
"ff vi $nmbr$ $nmbr$ $nmbr$","C0205999;C4554348",NULL,NULL,1597
"ankle edema","C0235439",NULL,NULL,691
"cdai score $nmbr$","C0449820;C0683448;C1413248;C3273706;C4050231",NULL,NULL,697
"no metformin use","C0025598;C0042153;C0457083;C1947944","C0025598","",1345
"total patients n $nmbr$","C0030705;C0439175;C0439810",NULL,NULL,508
"concomitant aspirin use","C0004057;C0042153;C0457083;C0521115;C1947944",NULL,NULL,118
"tiotropium salmeterol no of patients total no","C0030705;C0073992;C0213771;C0439175;C0439810",NULL,NULL,508
"patient reported outcomes","C2987124","C4277735","",1336
"extracranial","C0580586","","",-10
"white or caucasian n","C0007457;C0043157;C0220938","C0043157","",1329
"mean treatment exposure wk","C0039798;C0087111;C0274281;C0332157;C0332174;C0439230;C0444504;C1522326;C1533734;C1705169;C2347634;C2348143;C3538994;C3887704",NULL,NULL,236
"endoscopic disease severity","C0014245;C0442418;C0521117",NULL,NULL,97
"final","C0205088;C1546485;C3853528",NULL,NULL,1680
"no mtx at baseline","C0025677;C0168634;C1417487;C1442488","C0025677","",1408
"baseline disease and quality of life scores","C0012634;C0034380;C0168634;C0449820;C0518214;C1442488;C4050231","C0034380","",1116
"$nmbr$ minor symptoms no limitations","C0026193;C0205165;C0449295;C0683368;C1457887",NULL,NULL,613
"measure","C0079809;C0242485",NULL,NULL,2
"$nmbr$ gi","C1708130;C3539617;C4050121",NULL,NULL,525
"presence of enthesitis n","C0150312;C0392148;C1282952;C3854307",NULL,NULL,2367
"p valued","C0369773;C1522609;C2603361",NULL,NULL,1872
"no history of migraine","C0455512","C0241889","",1493
"cryptogenic","C0332240",NULL,NULL,1604
"qualifying acs event no","C0441471;C0742343;C1514624;C4019010;C4318612",NULL,NULL,2147
"most frequent gi disorders","C0012634;C0205393;C0332183;C1708130;C3539617;C4050121",NULL,NULL,1279
"primary pcit","C0205225;C0439612;C0439631",NULL,NULL,2340
"egfr s $nmbr$ ml min $nmbr$ $nmbr$ m","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"tender or painful joint count of $nmbr$ joints assessed no","C0003862;C0234234;C0750480;C1516048;C1705566","C0451530","",1139
"fenofibric acid i low dose statin","C0021966;C0060179;C0221138;C0360714;C0445550;C1708745","C0445550","",112
"primary endpoint at $nmbr$ days","C0439228;C2986535","C2986535","",230
"cluster seizures","C0036572;C1555715;C1704332","C0036572","",1394
"percent improvement baseline to week $nmbr$ median iqr","C0168634;C0332174;C0439165;C0439230;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193;C2986411",NULL,NULL,635
"cohort","C0009247;C0599755","C0599755","",2208
"patients with possible new dm at randomization hba $nmbr$ c $nmbr$ $nmbr$ $nmbr$","C0011816;C0019016;C0030705;C0034656;C0205314;C0332149;C1705910;C1825777;C2362652;C3250443;C3538758",NULL,NULL,1928
"$nmbr$ $nmbr$ very severe","C3641272;C4050419","C3641272",";C0018026;C1304897;C1412502;C4050419;C4050465;C4050466",913
"normonatremic $nmbr$ meq l at baseline","C0168634;C0439375;C1442488",NULL,NULL,625
"other clinical characteristics","C0683325",NULL,NULL,789
"baseline calcium yes","C0006675;C0006726;C0168634;C1442488;C1549445;C1705108;C1710701;C2936886;C3540037;C3714611",NULL,NULL,147
"known prothrombotic genotype","C0017431;C0205309",NULL,NULL,602
"age $nmbr$ years n $nmbr$ $nmbr$","C1510829","C1510829","",481
"unstable","C0443343;C1883468",NULL,NULL,1002
"overall dlqi score","C0282416;C0449820;C1561607;C3899393;C4050231",NULL,NULL,527
"duration of hypercholesterolemia yr","C0020443;C0439234;C0449238;C1522133;C2926735","C0020443;C0449238","",1995
"iwqol lite physical score arbitrary units","C0439183;C4483112",NULL,NULL,749
"$nmbr$ corticosteroids or immunosuppressants","C0001617;C0021081;C3539185;C3540725;C3540726;C3540727",NULL,NULL,1650
"i placebo n $nmbr$","C0021966;C0032042;C0221138;C1696465;C1706408","C0032042","",28
"interruption n $nmbr$","C0332453;C1512900",NULL,NULL,1714
"sample sizea","C0370003;C2347026",NULL,NULL,1004
"placebo insulin glargine award $nmbr$ n $nmbr$","C0004446;C0032042;C0907402;C1696465;C1706408","C0907402",";C1998602;C0004446;C0005126;C2344255;C4050145;C0229089;C0439164;C1512019;C3273373;C3665488",69
"impaired fasting glucosex","C0015663;C0221099","C0017725;C0015663","",1846
"angiotensin converting enzyme inhibitor or angiotensin receptor blocker use mitt population","C0003015;C0032659;C0034787;C0042153;C0457083;C1257890;C1622222;C1947944;C2757044;C3536837;C4541021",NULL,NULL,963
"qd","C0332173",NULL,NULL,1457
"avm n $nmbr$","C0003857;C0279476",NULL,NULL,387
"mean sd e etdrs visual acuity letter score snellen equivalent","C0042812;C0183370;C0205163;C0439185;C1096774;C2360551;C2699239;C3533236",NULL,NULL,1287
"post bronchodilator fev $nmbr$ fvc a","C2599594;C3714541",NULL,NULL,680
"epa aa ratio","C0282379;C0456603;C1235746;C1547037;C1882141;C4554792",NULL,NULL,1754
"alteplase n $nmbr$","C0032143",NULL,NULL,1594
"randomly assigned to ace","C1452534;C1516050;C1552601;C4284014",NULL,NULL,46
"alcohol consumption no","C0001948","C0001948","",875
"total ige lu ml","C0439175;C0439810;C2697941",NULL,NULL,508
"mucosal healingf","C0026724",NULL,NULL,328
"no history of hypertension n $nmbr$","C0455527",NULL,NULL,1498
"race or ethnic group no total no f","C0015031;C0016327;C0034510;C0439175;C0439810;C1706779;C1879937;C3853635",NULL,NULL,787
"antihypertensive medication $nmbr$","C0003364",";C0003364","",1579
"endothelin $nmbr$ pg ml","C0079284;C0439297",NULL,NULL,2324
"psoriasis duration mean sd years","C0033860;C0439234;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735",NULL,NULL,1099
"low density lipoprotein cholesterol mean sd mmol l","C0023824;C0444504;C1532563;C2347634;C2348143;C2699239","C0023824","",1068
"no of prior aeds n $nmbr$ $nmbr$","C0180309;C0332152;C2826257",NULL,NULL,2374
"prior transient ischemic attack","C0007787;C0332152;C0917805;C2826257","C0038454;C0332152","",2380
"southern hemisphere","C0205139;C1710133",NULL,NULL,1559
"ifg and igt","C1334085;C1708411",NULL,NULL,1259
"creatine clearance ml min","C0373595;C0439445","C3811844;C0017654","",307
"anticoagulant no","C0003280;C0848112;C3536711","C0003280","",450
"risk categories","C0035647;C0683312;C4552904","C0035647","",173
"because of sae","C1519255;C1622657;C4553214","C1519255","",1282
"rate","C0871208;C1521828",NULL,NULL,2009
"electrocardiograph results no","C0013798;C0180600;C1274040;C1546471;C1623258;C2825142","C1623258","",1129
"patients with $nmbr$ co aed","C0030705;C0887457;C3245499",NULL,NULL,1035
"current smoking n","C0037369;C0453996;C0521116;C1705970;C1881674","C0037369;C0521116","",2224
"pef post bronchodilator predicted normal","C0030771;C0205307;C0231683;C0439166;C0681842;C1518922;C1542834;C1882327;C2347086;C2599594;C4553972","C0024119","",288
"atherosclerotic cvdj","C0333482","C0004153","",1698
"prior smoker","C0337671","C0037369","",420
"sita $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"secondary prevention subgroup","C0679699;C1079230;C1515021",NULL,NULL,1637
"egfr $nmbr$ ml min $nmbr$ $nmbr$ mz","C0026655;C0439445;C1705291;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"pre mixed insulin","C0021641;C0205430;C0332152;C0740175;C1533581;C1579433;C2257086;C3160715;C3669034;C3714501",NULL,NULL,157
"lipid concentrations","C0023779;C0086045","C0023779","",1772
"non diabetics n $nmbr$","C0241863;C1518422",NULL,NULL,996
"previous angina n","C0002962;C0205156;C1552607","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"lvef $nmbr$ n $nmbr$ $nmbr$ a","C0428772;C0488728","C0018801;C0428772","",1273
"hgb g dl","C0019029;C0019046;C0439267;C0518015;C1424337",NULL,NULL,1486
"ssomgdayp eq","C0205163;C0439185",NULL,NULL,1625
"$nmbr$ to less than $nmbr$","C0040363;C0041260;C1883351",NULL,NULL,431
"bisphosphonates","C0012544;C3541401","","",-10
"weight category","C0005910;C0043100;C0683312;C1305866;C1705104;C3889287","C0005910","",1250
"screening visit $nmbr$","C0220908;C0220909;C0545082;C1512346;C1698960;C1710031;C1710032;C1710477;C2348164;C2826704",NULL,NULL,798
"haemoglobin mmol l","C0019046;C0439190;C0635222;C1532563",NULL,NULL,670
"numbers of events","C4330837","C4330837","",1810
"entry hip fracture location n","C1705654;C3260017",NULL,NULL,1588
"no of patients with as","C0030705",NULL,NULL,1035
"tender joint count $nmbr$ mean sd","C0444504;C0451530;C2347634;C2348143;C2699239","C0451530","",1139
"placebo simva","C0032042;C1696465;C1706408","C0032042","",28
"s","C0565930;C2603362",NULL,NULL,1784
"ratio of urinary albumin mg to creatinine g median","C0010294;C0024671;C0026410;C0439267;C0439269;C0456603;C0549183;C0876920;C1547037;C1561535;C1960952;C2346927;C2347635;C2348144;C2362049;C2939193;C4321396;C4521761","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"sedentary","C0205254",NULL,NULL,1484
"ipss s","C1019118;C1998280;C2827405;C3811063","C1998280",";C1019118;C3811063;C4050465;C4050466;C4049706;C0168634;C1705273;C1880519;C3853603",124
"ace i or arb n","C0021966;C0221138;C1452534;C3888198;C4284014",NULL,NULL,46
"non st segment elevation mi","C0520886;C1518422;C3810814","C3810814","",894
"elderly $nmbr$ years","C0001792;C0439234;C1999167",NULL,NULL,1099
"with beta blocker","C0001645","C0001645","",959
"apixaban vs placebo","C0032042;C1696465;C1706408;C1831808","C1831808","",1224
"missing n a","C1551393;C1705492;C3272743","C1705492","",1144
"hs crp $nmbr$ $nmbr$ mg l","C0439268;C3890735;C4048285",NULL,NULL,1545
"all strokes","C0038454;C4554100",NULL,NULL,1762
"gff mdi","C0993596;C1839839;C4049613",NULL,NULL,518
"bivalirudin n $nmbr$ $nmbr$","C0168273",NULL,NULL,776
"oa","C0029408;C3887876","C0029408","",1356
"continue thienopyridine n $nmbr$","C0549178;C1120149",NULL,NULL,1561
"$nmbr$ step","C1261552;C1704379;C1705117;C2825408;C3814463",NULL,NULL,571
"previous coronary artery disease n","C0010054;C0010068;C0205156;C1552607;C1956346","C0010068;C1956346",";C0026410;C1710701",226
"lv function","C0023128;C0031843;C0542341;C0700205;C0731033;C1705273;C1881413",NULL,NULL,1531
"median time in therapeutic range for warfarin recipients","C0040223;C0043031;C0087111;C0302350;C0460097;C0549183;C0876920;C1554109;C1709854;C2347635;C2348144;C2939193;C3541383","C0043031","",858
"total cholesterol mmol l","C0201950;C0543421;C1532563","C0543421","",1504
"diuretic agents","C0012798;C0450442;C1254351;C1521826",NULL,NULL,992
"history of cvd","C0007222;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"weight mean sd kg","C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209","C0043100","",1915
"week $nmbr$ overall population","C0032659;C0282416;C0332174;C0439230;C1257890;C1561607",NULL,NULL,1012
"goal","C0018017;C1571704",NULL,NULL,1688
"total events n","C0439175;C0439810;C0441471;C3541888",NULL,NULL,412
"mean change from baseline points","C0168634;C0392747;C0443172;C0444504;C1442488;C1552961;C1705241;C2347617;C2347634;C2348143;C3714763;C4319952",NULL,NULL,1135
"pci performed","C0884358;C4049621",NULL,NULL,576
"mean baseline bmi","C0168634;C0444504;C0578022;C1442488;C2347634;C2348143",NULL,NULL,1735
"$nmbr$ hour madbp mm hg","C0439227;C0439475;C0564385","C0005823","",15
"arbs","C3888198",NULL,NULL,44
"study protocol","C1507394;C2348563;C2599718",NULL,NULL,678
"treatment comparison mg day t","C0039798;C0087111;C0439422;C1522326;C1533734;C1705169;C1707455;C3538994;C3887704",NULL,NULL,1633
"thiazide diuretic","C0012802;C3536861","","",993
"severe iief ef $nmbr$","C0205082;C3641331;C4050465;C4050466",NULL,NULL,313
"bmi group kg m","C0022718;C0439209;C0441833;C0441847;C0578022;C0687744;C1257890;C1519504;C1532718;C1705428;C1705429;C4054209",";C1305855","",206
"atorvastatin $nmbr$ mg ezetimibe $nmbr$ mg n $nmbr$","C0286651;C1142985;C1319635","C0286651","",885
"other lipid lowering medication","C0013227;C0023779;C0441994;C2003888;C3244316;C4284232",NULL,NULL,366
"target vessel","C0449618",NULL,NULL,747
"current smoker no total no","C0439175;C0439810;C3173209;C3241966","C0037369","",420
"within $nmbr$ h","C0033727;C0369286;C0441932;C0564385;C4528284",NULL,NULL,308
"homa ir median q $nmbr$ q $nmbr$","C0022065;C0022071;C0549183;C0876920;C1448132;C2347635;C2348144;C2939193",NULL,NULL,634
"type of insulin therapy no $nmbr$","C0039798;C0087111;C0457592;C1363945",NULL,NULL,162
"high risk with atherosclerotic vascular disease","C0004153;C0332167;C3272283;C4050568;C4319571","C0004153","",1698
"diltiazem or verapamil","C0012373;C0042523","C0042523;C0012373","",2244
"entry category","C0683312;C1705654;C3889287",NULL,NULL,562
"ccv history condition","C0683519",NULL,NULL,262
"centre","C0205099;C3810851",NULL,NULL,677
"$nmbr$ mg eow n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"creatinine clearance at randomization","C0034656;C0812399","C0812399",";C3889287;C0452249;C0522467;C1337213;C1576800;C3890003;C0005910;C0022718;C1305866;C1705104;C1705224;C3887665",79
"acr response acr $nmbr$","C0871261;C1412134;C1515941;C1704632;C1706817;C2911692",NULL,NULL,52
"days with heartburna days","C0439228",NULL,NULL,1621
"any other antihyperglycaemic drugs","C0013227;C0020616;C3687832",NULL,NULL,740
"duration of symptoms $nmbr$ min","C0436359;C0702093;C1524029;C3813700",NULL,NULL,1475
"asia pacific and other","C0003980","C0003980","",1382
"placebo analysed","C0032042;C1696465;C1706408","C0032042","",28
"sulfasalazine","C0036078",NULL,NULL,71
"all patients n","C0030705",NULL,NULL,1035
"medial distal diag","C0205098;C0205108;C0348026;C4522154",NULL,NULL,352
"asa n","C0004057;C3853627",NULL,NULL,60
"previous cvd","C0007222;C0205156;C1552607",NULL,NULL,2390
"sdai mean sd","C0444504;C2347634;C2348143;C2699239;C3871128","C3871128","",1355
"baseline fasting plasma glucose","C0015663;C0168634;C0202042;C0455280;C1442488","C0455280;C0015663",";C0168634",21
"prior cad","C0332152;C1504769;C2239547;C2826257;C3813548;C4284121",NULL,NULL,698
"baseline t score at femoral neck n","C0015815;C0168634;C0449820;C1442488;C4050231",NULL,NULL,625
"lda","C4553195",NULL,NULL,1266
"hydroxychloroquine","C0020336","C0020336","",1403
"calcium channel blockersubgroup","C0006685","C0006684","",1884
"cfisher s exact test","C0022885;C0039593;C0392366;C0456984;C1515976;C2828393;C3831328;C4050514;C4318744",NULL,NULL,242
"missing data initial diagnosis no","C0011900;C0205265;C1279901;C1555582;C1704338;C1704656;C1705685;C4684714",NULL,NULL,806
"who fc ii symptoms at baselinef","C0683368;C1457887;C1710602;C2983605;C4082587",NULL,NULL,521
"diabetes mellitus classification","C0008902;C0008903;C0011849;C0678229","C0011849;C1320657","",907
"heparin dose regimen","C0019134;C0770546;C2348331","C0019134","",863
"cardiac arrhythmia n","C0003811;C0264886;C1560249","C0003811","",380
"change from baseline in","C0168634;C0392747;C0443172;C1442488;C1705241;C4319952",NULL,NULL,767
"troponin level","C0041199;C0441889;C0456079;C1547707;C2946261",NULL,NULL,744
"modified hachinski ischemia scale mean sd c","C0022116;C0175659;C0349674;C0392747;C0444504;C1947916;C2347634;C2348143;C2699239;C3889737;C4321499",NULL,NULL,37
"thrombocytopenia","C0040034;C0392386",NULL,NULL,624
"disease duration $nmbr$ years $nmbr$ disease activity s","C0205177;C0439167;C0439234;C0441655;C0449238;C0872146;C1292728;C1561536;C2926735;C3668946;C4049938;C4049939","C0449238;C0872146","",903
"baseline dyspnea index score","C0449820;C1511069;C4050231",NULL,NULL,748
"st elevation mi","C0520886;C3810814","C0520886","",1944
"active cancer at any timeb","C0006826;C0205177;C0998265;C1306459;C3853793;C3888249","C0006826","",1819
"patient global assessment of disease activity vas $nmbr$ $nmbr$ mm","C0042815;C3536884;C3827561;C4054228;C4330985;C4554674",NULL,NULL,1751
"type of drug eluting stent n","C0038257;C0332307;C0457591;C1322815;C1547052","C1322815","",365
"number of stents per patient","C0030705;C0038257;C0237753;C0449788",NULL,NULL,569
"patient s global assessment vas","C0042815;C3536884;C3827561;C4054229",NULL,NULL,1751
"mean total serum psa","C0229671;C0444504;C1546774;C1550100;C2347634;C2348143;C2986589",NULL,NULL,951
"ics usage","C0457083;C0815320;C4551720","C3540778","",2182
"cardiac valve surgery no n $nmbr$","C0018821;C0018826;C0038894;C0038895;C0184252;C0369718;C0441922;C0524727;C0543467;C1186983;C1274039;C1704414;C3888056",NULL,NULL,598
"ua","C0041580;C0042014",NULL,NULL,237
"rv and pulmonary vascular","C0035190;C0459963;C1508661;C3889272",NULL,NULL,2090
"japanese","C0376247;C1556094","C0022341","",1815
"abnormal","C0205161;C2347472;C2699333",NULL,NULL,686
"middle third","C0442050",NULL,NULL,331
"$nmbr$ ml s","C0439390",NULL,NULL,299
"number of e","C0237753;C0449788",NULL,NULL,1556
"febuxostat febuxostat lesinurad $nmbr$ febuxostat lesinurad $nmbr$","C0249529;C3886073",NULL,NULL,26
"six study placebo controlled set","C0036849;C0205452;C0557651;C1442518;C1705195;C1706408;C2603343",NULL,NULL,1730
"or esrd","C0022661;C0035078;C2316810","C0035078","",342
"subgroup overall","C0282416;C1079230;C1515021;C1561607",NULL,NULL,1637
"maximum cimt median","C0549183;C0806909;C0876920;C1552615;C2347635;C2348144;C2826546;C2939193",NULL,NULL,635
"baseline fc ldl c","C0168634;C1442488;C2983605","C0023824","",1068
"region us","C0017446;C0205147","C0017446","",369
"median ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C0549183;C0876920;C2347635;C2348144;C2939193","C3811844;C0017654","",307
"mild to moderate renal impairment","C1299392;C1565489","C1565489","",937
"pctindopnl indapamide n $nmbr$","C0021186","C1273169","",1232
"blood pressure medications at randomization no total no","C0005823;C0013227;C0033095;C0034656;C0439175;C0439810;C0460139;C0802604;C0849164;C1271104;C1272641;C1306345;C2598133;C4284008;C4284232",NULL,NULL,366
"fpg tx difference vs pbo median change from baseline se $nmbr$","C0031962;C0036919;C0041403;C0168634;C0392747;C0443172;C0549183;C0876920;C1442488;C1705241;C1705242;C2347635;C2348144;C2939193;C4319952",NULL,NULL,435
"prior therapy","C1514463",NULL,NULL,574
"$nmbr$ h postprandial proinsulin pmol l","C0033362;C0376674;C2827799;C3813208",NULL,NULL,665
"strain","C0080194;C0456178;C1518614;C2987481",NULL,NULL,1739
"prior clinical fracture since age $nmbr$","C0001779;C0016658;C0205210;C0332152;C2826257",NULL,NULL,2026
"mean s d systolic blood pressure mm hg","C0039155;C0428886;C0439475;C0444504;C0488053;C0488055;C0871470;C1306620;C2347634;C2348143","C0005823","",1469
"rosuva rosuvastatin sd standard deviation t $nmbr$ dm type $nmbr$ diabetes mellitus","C0011816;C0011849;C0332307;C0871420;C0965129;C1320657;C1547052;C2699239;C3250443","C0965129","",886
"treatment n","C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,236
"history of venous","C0019664;C0019665;C0042449;C0262512;C0262926;C0348013;C1705255;C2004062",NULL,NULL,832
"asas $nmbr$","C0004057;C3853627",NULL,NULL,60
"change in tg","C0337445;C0392747;C0443172;C1705241;C4319952","C0041004","",209
"pioglitazone only","C0071097;C0205171;C1720467",NULL,NULL,925
"laboratory data","C0022877;C1511726;C3244292;C3245479;C3714741;C4283904","C1511726;C0022877","",2232
"r elative risk $nmbr$ ci","C0008107;C0035647;C0205090;C0233492;C0684010;C2603358;C3259781;C4552904",NULL,NULL,519
"ii death from coronary heart disease nonfatal mi coronary revascularization $nmbr$ days","C0011065;C0018799;C0439228;C0545743;C0581603;C1306577;C1710602;C3810814;C4082313;C4082587;C4552775",NULL,NULL,516
"colombia","C3245499",NULL,NULL,1557
"previous heart failure","C0018801;C0018802;C0205156;C1552607;C4554158","C0018801",";C0168634;C1524003",12
"ischemic stroke or see","C0042789;C0948008;C1947903","C4554100","",336
"scale diabetes","C0011847;C0011849;C0175659;C0349674;C1947916","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"cox bsl yr $nmbr$ hbd","C0439234;C1549954;C1565830",NULL,NULL,656
"previous pci total","C0205156;C0439175;C0439810;C1552607;C4049621","C1532338","",1661
"liraglutide $nmbr$ $nmbr$ mg n $nmbr$ $nmbr$","C0024671;C0026410;C0439269;C1456408;C1960952;C2346927;C4321396;C4521761","C1456408","",1566
"estimated gfr ml min $nmbr$ $nmbr$ m","C0017654;C0369637;C0439445;C0441923;C0750572;C1424601","C3811844;C0017654","",592
"major cvd","C0007222;C0205082;C0205164;C4318856;C4521762",NULL,NULL,1472
"qualifying diagnosis","C0011900;C1514624;C1704338;C1704656",NULL,NULL,841
"indeterminate or unknown","C0205258;C0439673;C3541433;C4050014",NULL,NULL,93
"baseline hemoglobin median iqr g dl","C0019046;C0168634;C0439267;C0549183;C0876920;C1319312;C1442488;C2347635;C2348144;C2939193;C3642216",NULL,NULL,1486
"dense calcium","C0006675;C0006726;C0439794;C2936886;C3540037;C3714611","C0006675","",1373
"renal events","C0022646;C0441471;C3541888","C0022646","",1951
"to randomization","C0034656",NULL,NULL,692
"apixaban $nmbr$ mg bid","C0024671;C0026410;C0439269;C1831808;C1960952;C2346927;C4321396;C4521761","C1831808","",1224
"mean acrn","C0444504;C2347634;C2348143",NULL,NULL,37
"lvef within $nmbr$ mo","C0026544;C0332177;C0428772;C0488728",NULL,NULL,1476
"chd simva $nmbr$","C0280604;C3542407",NULL,NULL,970
"$nmbr$ mg kg","C0439272",NULL,NULL,207
"elevated crp n","C0742906","C0006560","",286
"race ethnicity","C0015031;C0034510;C0243103;C1706779;C3853635",";C0034510","",1107
"q $nmbr$ $nmbr$ q $nmbr$ $nmbr$ $nmbr$ number n","C0237753;C0449788",NULL,NULL,1556
"no of diseased vessels of group","C0005847;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429",NULL,NULL,1526
"alpha blockers","C0001641","C0001641","",961
"no atrial fibrillation","C0004238;C0344434;C1963067",";C0004238","",1009
"gold $nmbr$","C0018026;C1304897","C0024117;C0521117","",213
"all patients p $nmbr$ $nmbr$","C0030705",NULL,NULL,1035
"infarction $nmbr$ $nmbr$ days","C0021308;C0439228",NULL,NULL,1621
"nighttime mean sbp abpm at week $nmbr$ mmhg","C0085805;C0240526;C0332174;C0439230;C0439475;C0444504;C2347634;C2348143",NULL,NULL,607
"sex male female n","C0043210;C0086287;C0086582;C1705497;C1705498;C1706180;C1706428;C1706429","C0086582","",1276
"upper respiratory tract infection","C0041912",";C0041912","",1289
"fevi predicted","C0681842;C0849974;C1561566;C1882327;C4528367",NULL,NULL,1601
"mean sd baseline score","C0168634;C1442488;C2699239;C3533236",NULL,NULL,1287
"ii iv","C0022326;C1710602;C4082587;C4265176",NULL,NULL,1257
"hazard ratio $nmbr$","C2985465","C2985465","",975
"body mass index range kg m $nmbr$","C0005893;C0578022;C1305855;C1514721;C1532718;C2348147;C3542016",";C1305855","",206
"baseline lipids mean sd mmol $nmbr$","C0023779;C0168634;C0439190;C0444504;C1442488;C2347634;C2348143;C2699239",NULL,NULL,2190
"estimated gfr","C0017654;C0750572;C1424601","C3811844;C0017654","",592
"ics non users","C0815320;C1518422;C1706077;C4551720","C3540778","",2182
"patients with prior ml hr $nmbr$ cl","C0030705;C0332152;C0439526;C0596019;C1705224;C2826257;C3887665",NULL,NULL,1542
"short $nmbr$ years duration of diabetes","C0011847;C0011849;C0439234;C0439593","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"duration of disease median","C0549183;C0872146;C0876920;C2347635;C2348144;C2939193","C0449238;C0872146","",903
"arr","C2170357;C4084934",NULL,NULL,51
"glucocorticoids plus immunosuppressive agents","C0017710;C0021081;C3540777;C3540778","C0021081","",1424
"baseline heart rate","C0018810;C0168634;C1442488","C0018810","",1105
"abatacept $nmbr$ $nmbr$ mg kg n $nmbr$","C0439272;C1619966","C1619966","",1190
"$nmbr$ $nmbr$ mg g","C1300563",NULL,NULL,196
"copd severity mild moderate","C0024117;C0439793;C0522510;C1299392;C1412502;C3714496",NULL,NULL,1546
"premenopausal","C0279752","C0279752","",1042
"acs treatment","C0039798;C0087111;C0742343;C1522326;C1533734;C1705169;C3538994;C3887704;C4318612",NULL,NULL,2147
"vasodilator therapy","C0039798;C0042402;C0087111;C1363945;C3537240","C0042402","",817
"p $nmbr$ vs no treatment $nmbr$","C0039798;C0087111;C0369773;C1522326;C1533734;C1705169;C2603361;C3538994;C3887704",NULL,NULL,135
"no of $nmbr$ mg tablets of acetaminophen","C0024671;C0026410;C0439269;C1243102;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2292
"insulin iu ml median q $nmbr$ q $nmbr$","C0021641;C0439458;C0549183;C0876920;C1533581;C1579433;C2347635;C2348144;C2939193;C3714501",NULL,NULL,157
"egfr $nmbr$ $nmbr$ $nmbr$ $nmbr$ vs egfr $nmbr$","C1739039;C3811844;C3812682","C3811844;C0017654","",592
"male n $nmbr$ $nmbr$","C0086582;C1706180;C1706428;C1706429","C0086582","",1276
"body mass indexa median","C0518010;C0549183;C0876920;C2347635;C2348144;C2939193","C1305855","",1734
"anti ccp antibodies","C0003241;C1525410;C1624602;C1704514;C4318437","C4318437","",360
"use of pci or thrombolysis within one day of randomization","C0034656;C0520997;C1524063;C3844320;C4049621",NULL,NULL,621
"hemoglobin","C0019046","C0019046","",1177
"primary study joint n","C0022417;C0205225;C0392905;C0439612;C0439631;C0557651;C1706309;C2603343",NULL,NULL,229
"hdl c mg dl mean sd","C0439269;C0444504;C2347634;C2348143;C2699239;C3715113",NULL,NULL,37
"primary angioplasty n $nmbr$","C0162577;C0205225;C0439612;C0439631;C1548817",NULL,NULL,2340
"physical component summary","C0031809;C0205485;C0449432;C1509143;C1552616;C1705248;C1706244",NULL,NULL,1519
"control group n $nmbr$","C0243148;C0441848;C1550141;C1882979;C2587213;C3274648;C4553389",NULL,NULL,675
"nace primary endpoint","C2986535","C2986535","",230
"cabg or pci","C0010055;C4049621","C0010055","",389
"inducing","C0205263",NULL,NULL,158
"pla","C0456170",NULL,NULL,1514
"psa modified shs $nmbr$ $nmbr$","C0392747;C3810537;C3813209;C3889737",NULL,NULL,125
"p value for interaction vertebral fracture at flex baseline","C0080179;C0168634;C1442488;C1704675;C1709380",NULL,NULL,7
"glycaemic parameters","C0005802;C0449381",NULL,NULL,1187
"immunosuppressive agents at baseline","C0021081;C0168634;C1442488",NULL,NULL,625
"fasting plasma glucose median","C0015663;C0202042;C0455280;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,1896
"$nmbr$ days warfarin","C0043031;C0439228",NULL,NULL,1621
"no clinical or lesion rfs for st","C0036056;C0205210;C0221198;C0341703;C1546698;C3272372",NULL,NULL,793
"neck pain","C0007859;C1963180;C4553909","C0007859","",2168
"n liraglutide $nmbr$ placebo","C0032042;C0369718;C0441922;C1456408;C1696465;C1706408","C1456408","",1566
"ls mean between group difference $nmbr$ ci","C0008107;C0023668;C1705241;C1705242;C2347634;C3259781",NULL,NULL,519
"obese bmi $nmbr$ kg m $nmbr$","C0028754;C0578022;C1532718",";C1305855","",206
"ivc n $nmbr$","C4085887",NULL,NULL,1258
"time from symptoms to treatment","C0039798;C0040223;C0087111;C0683368;C1457887;C1522326;C1533734;C1705169;C3538994;C3541383;C3887704",NULL,NULL,236
"egfr","C1739039;C3811844;C3812682","C3811844;C0017654","",592
"previous treatment with tnf antagonist no","C0039798;C0087111;C0205156;C0231491;C1448177;C1522326;C1533734;C1552607;C1705169;C3538994;C3887704",NULL,NULL,236
"cohort $nmbr$ n $nmbr$ f","C0009247;C0016327;C0599755","C0599755","",2208
"antihypertensive","C0003364",";C0003364","",1579
"myopathy","C0026848",NULL,NULL,1718
"years","C0439234",NULL,NULL,1099
"fgf $nmbr$ high $nmbr$ elevated biomarkers","C0005516;C0016026;C0205250;C0919505;C1299351;C2700149;C3163633;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"percutaneous coronary intervention or coronary artery bypass grafting for index acute coronary syndrome no","C0010055;C0600653;C0918012;C0948089;C1532338;C1552854;C1637833;C2986546","C1532338","",1661
"low periostin subgroup $nmbr$ ng ml n $nmbr$","C0205251;C0219433;C0439275;C1079230;C1424662;C1515021;C1550472;C3812270;C3890211;C4048187;C4321351;C4522223","C3812270","",1027
"predicted fev at baseline","C0168634;C0681842;C1442488;C1882327;C3714541",NULL,NULL,1599
"serum n propeptide of type $nmbr$ collagen","C0009325;C0229671;C0332307;C1546774;C1547052;C1550100;C1709708;C1875696",NULL,NULL,951
"elevated natriuretic peptide level n $nmbr$","C0205250;C0441889;C0456079;C1144709;C1547707;C2709270;C2946261;C3163633;C3537020",NULL,NULL,744
"monitoring n $nmbr$","C0150369;C1283169",NULL,NULL,1024
"$nmbr$ n of patients","C0030705;C0369718;C0441922",NULL,NULL,1035
"hospitalisation for heart failure","C3898876","C0018801",";C0168634;C1524003",12
"aqlq s score","C0449820;C4050231;C4055434",NULL,NULL,2057
"peripheral sensory neuropathy","C0151313;C4554142",NULL,NULL,1718
"aml","C0023465;C0023467",NULL,NULL,186
"number of lesions n a","C0449791",NULL,NULL,1870
"renal insufficiency $nmbr$","C0035078;C1565489","C1565489","",937
"elevated symptomatic serum creatinine hypotension $nmbr$ $nmbr$ mg dl","C0020649;C0231220;C0439269;C0700225;C3163620",NULL,NULL,192
"age when diabetes first diagnosed yr","C0001779;C0011847;C0011849;C0011900;C0205435;C0439234;C1279901",NULL,NULL,841
"tcz $nmbr$ mg kg n $nmbr$","C0439272",NULL,NULL,207
"j the body mass index is the weight in kilograms divided by the square of the","C0005893;C0005910;C0043100;C0205120;C0332849;C0439209;C0578022;C1305855;C1305866;C1552595;C1705104","C1305855","",1734
"section $nmbr$ b","C0152060;C0700320;C1522472;C1552923;C1705191;C3714523","C2700378","",887
"major bleeding statin use vs non use","C0019080;C0042153;C0205082;C0205164;C0360714;C0457083;C1518422;C1947944;C4318856;C4521762",NULL,NULL,118
"ejection fraction group","C0441833;C0489482;C0687744;C1257890;C1519504;C1705428;C1705429;C2700378","C2700378","",887
"patients with dm vs patients without dm","C0011816;C0030705;C3250443",NULL,NULL,955
"stented vessel","C0183521",NULL,NULL,745
"apo a l mg dl mean sd","C0439269;C0444504;C1447574;C2347634;C2348143;C2699239;C4521365",NULL,NULL,1909
"transient ischemic attack","C0007787;C0917805",NULL,NULL,1592
"weight kg bmi kg m $nmbr$","C0005910;C0043100;C0369637;C0441923;C0578022;C1305866;C1319635;C1705104","C0005910","",1250
"aspirin $nmbr$ mg","C0004057;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761","C0004057","",1366
"pulse pressure mmhg","C0439475;C0949236","C0949236","",1118
"education $nmbr$ y","C0013621;C0013622;C0013658;C0039401","C0013658","",902
"baseline tg level n $nmbr$ $nmbr$ s $nmbr$ $nmbr$ mg dl","C0168634;C0337445;C0439269;C0441889;C0456079;C1442488;C1547707;C2946261","C0041004","",209
"unstable angina","C0002965",NULL,NULL,1002
"prior use of conventional dmards only biologic nai ve n","C0042469;C0205171;C0332152;C0439858;C1524063;C1720467;C2826257;C3537218;C3714652;C4055380;C4321495",NULL,NULL,294
"median urine acr mg g iqr","C0042036;C0042037;C0549183;C0876920;C1300563;C1412134;C1515941;C2347635;C2348144;C2939193;C2963137",NULL,NULL,2315
"chronic cvd","C0007222;C0205191",NULL,NULL,1701
"p atients with $nmbr$ exacerbations resulting in emergency department visit","C0332294;C0369773;C0545082;C0553618;C0562508;C1512346;C1704729;C2603361;C2826704;C4086268","C4086268","",889
"t $nmbr$ $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C2603360;C4321396;C4521761",NULL,NULL,192
"l l","C3539687","","",-10
"kaplan meier rates","C0871208;C1521828",NULL,NULL,2008
"anterior","C0205094","C0205094","",1243
"lcz $nmbr$ treatment n","C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,964
"interquartile range","C1711350",NULL,NULL,1015
"rest of the world","C0035253;C1622890;C2700280","C2700280","",247
"high fracture risk stratum","C0016658;C0332167;C3272283;C4050568;C4319571","C4319571","",837
"current or previous atrial fibrillation","C0004238;C0205156;C0344434;C0521116;C1552607;C1705970;C1963067",NULL,NULL,1417
"calcium channel antagonists","C0006684;C2757014","C0006684","",1884
"serum albumin g dl","C0036773;C0439267;C0728877",NULL,NULL,953
"qualifying stroke","C0038454;C1514624;C4554100",NULL,NULL,1762
"ventricular tachycardia or fibrillation","C0042514;C0232197;C0344428;C1963247;C4554446","C3827656","",1217
"corticosteroid free remissioni","C0001617;C0332296;C1880497;C1996904;C3536709",NULL,NULL,999
"sotalol","C0037707",NULL,NULL,1006
"doubling of serum creatinine","C0201976;C0205173;C0600061;C1705764","C0600061;C0010294","",952
"revascularization in $nmbr$ days","C0439228;C0581603","C0581603","",1213
"age y median min max","C0001779;C0549183;C0702093;C0876920;C1524029;C2347635;C2348144;C2939193;C3813700","C0001779","",480
"mean change","C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952",NULL,NULL,767
"geographic region north america","C0017446;C0028405","C0028405","",1463
"fsn score mean sd","C0444504;C0449820;C2347634;C2348143;C2699239;C4050231",NULL,NULL,1287
"p blocker yes","C0369773;C1549445;C1705108;C1710701;C2603361",NULL,NULL,960
"updrs total ii iii","C0439070;C0439175;C0439810;C1705160;C1710602;C3639721;C4082587",NULL,NULL,524
"high trs $nmbr$ $nmbr$ n $nmbr$ $nmbr$","C0205250;C0266427;C0968917;C1150746;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"prior asa use","C0004057;C0042153;C0332152;C0457083;C1947944;C2826257;C3853627",NULL,NULL,60
"ace inhibitors or angiotensin receptor blockers","C0003015;C0521942;C0815017","C0003015","",811
"oxypurinol n $nmbr$","C0030086",NULL,NULL,1507
"dilatative","C0002940;C0012359;C0700124;C1322279",NULL,NULL,1170
"ii lisinopril i","C0021966;C0065374;C0221138;C1710602;C4082587","C0065374","",847
"non hdl c mmol l mean","C0444504;C1518422;C1532563;C2347634;C2348143;C3715113","C0023822","",821
"baseline hbalc $nmbr$ mmol mol $nmbr$ $nmbr$","C0168634;C1442488;C3829066",NULL,NULL,2188
"$nmbr$ $nmbr$ to $nmbr$ $nmbr$ mu l mmol l","C0439190;C0439342",NULL,NULL,671
"arthritis characteristics","C0003864;C1521970;C4552845","C0003864","",274
"no previous stroke tia","C0007787;C0038454;C0205156;C0917805;C1054154;C1552607;C4554100",NULL,NULL,1762
"non fibrin specific","C0015982;C0205370",NULL,NULL,802
"without baseline vertebral fracture","C0080179;C0168634;C1442488",NULL,NULL,625
"mean s d ldl particle size nm","C0203634;C0312860;C0444504;C2347634;C2348143;C3641256;C3890923",NULL,NULL,1030
"angina class iii or iv prior myocardial infarction","C0022326;C0155668;C0264677;C4265176",NULL,NULL,647
"n events n at risk","C0369718;C0441471;C0441922;C1444641;C3541888",NULL,NULL,1553
"timi risk score $nmbr$","C0035647;C0449820;C4050231;C4552904",NULL,NULL,2052
"history of coronary heart disease at","C0018787;C0683519;C0730226;C0850708;C0944983",NULL,NULL,105
"hs crp","C3890735;C4048285",NULL,NULL,1545
"higher dose edoxaban n $nmbr$ n y","C0444956;C2975435","C0444956","",111
"treatmentofpulmonary embolismpriorto randomization","C0034656",NULL,NULL,692
"total back pain score $nmbr$ $nmbr$ mm scale mean sd","C0004604;C0175659;C0349674;C0444504;C1947916;C1963071;C2347634;C2348143;C2699239;C2964552;C4330985;C4553945;C4554674","C0004604","",1337
"maternal history n","C0559473",NULL,NULL,1492
"cardiometabolic syndrome n","C0039082",NULL,NULL,617
"method of insulin administration","C0025663;C0199782;C0449851;C0871511",NULL,NULL,162
"race caucasian","C0007457;C0034510;C0043157;C1706779;C3853635","C0043157","",1329
"no ocs use no nasal polyps pre bd fvc s $nmbr$ of predicted and age at diagnosis $nmbr$ years","C0005126;C0027430;C0042153;C0332152;C0439234;C0457083;C0681842;C0740175;C1828181;C1882327;C1947944;C2257086;C2344255;C3173302;C3669034;C3714541;C4050145","","",-10
"moderate thrombocytopenia $nmbr$ x $nmbr$ l","C0040034;C0205081;C0392386;C1881878;C4049705;C4049706;C4085643;C4321335",NULL,NULL,624
"values are presented as mean sd unless stated otherwise data shown are for the randomized population body mass index values were missing from $nmbr$ patients in the aliskiren group and $nmbr$ patients in the hydrochlorothiazide group obesity was defined as body mass index $nmbr$ kg m $nmbr$ metabolic syndrome was defined according to the third report of the national cholesterol education program expert panel on detection evaluation and treatment of high blood cholesterol in adults adult treatment panel iii criteria $nmbr$ as any $nmbr$ of the following waist circumference $nmbr$ cm for men or $nmbr$ cm for women triglycerides $nmbr$ mg dl high density lipoprotein cholesterol $nmbr$ mg dl for men or $nmbr$ mg dl for women mssbp $nmbr$ mm hg or msdbp $nmbr$ mm hg fasting glucose $nmbr$ mg dl by medical history aliskiren n $nmbr$ hydrochlorothiazide n $nmbr$","C0001675;C0005893;C0008377;C0015663;C0017725;C0020261;C0023822;C0024671;C0025266;C0026410;C0028754;C0030705;C0032659;C0034656;C0039798;C0041004;C0042295;C0043210;C0086858;C0087111;C0150375;C0205437;C0220825;C0231290;C0243161;C0262926;C0332282;C0376691;C0439070;C0439269;C0439475;C0441833;C0444504;C0449450;C0455829;C0518010;C0524620;C0578022;C0600653;C0680240;C0684224;C0687744;C0700287;C0918012;C1120110;C1257890;C1261322;C1301808;C1305855;C1442792;C1511726;C1511790;C1519504;C1522326;C1532718;C1533734;C1547282;C1551393;C1552854;C1637833;C1704706;C1704788;C1705160;C1705169;C1705428;C1705429;C1705492;C1706365;C1709697;C1960952;C1963185;C1999270;C2241628;C2346927;C2347634;C2348143;C2699239;C2728259;C2986546;C3245479;C3245503;C3272743;C3273238;C3484370;C3538994;C3539106;C3539687;C3714741;C3815594;C3842522;C3887704;C4068104;C4255046;C4321396;C4521761","","",-10
"il $nmbr$ pg ml","C0020898;C0021764;C0022271;C0439297",NULL,NULL,672
"pasi $nmbr$ no total no $nmbr$","C0439175;C0439810;C4528685",NULL,NULL,1522
"alt ast or both $nmbr$ x uln","C1519815;C3831581",NULL,NULL,1676
"p blockers n","C0369773;C2603361",NULL,NULL,960
"crusade bleeding score","C0019080;C0449820;C4050231",NULL,NULL,2056
"lipids mean sd mg dlt","C0023779;C0024671;C0026410;C0439269;C0444504;C1413248;C1960952;C2346927;C2347634;C2348143;C2699239;C3273706;C4321396;C4521761","C0023779","",1967
"non tnf inhibitors","C0243077;C1448177;C1518422",NULL,NULL,809
"any cause","C0015127;C1524003",NULL,NULL,924
"prior aortocoronary bypass surgery no","C0010055;C0455610","C0010055","",219
"fair control $nmbr$ $nmbr$ $nmbr$","C0243148;C1550141;C1882979;C2587213;C2911689;C3274648;C4553389",NULL,NULL,675
"framingham risk score","C0035647;C0449820;C3166866;C4050231;C4552904","C3166866;C0035647","",1952
"heterogeneity or trend p value","C0019409;C0242960;C1521798;C1709380;C4554533",NULL,NULL,7
"estimated glomerular filtration rate ml min $nmbr$ $nmbr$ m $nmbr$ tt","C0369637;C0439445;C0441923;C1452561;C3811844;C4554543","C3811844;C0017654","",592
"histor y of myocardial infarction","C0027051;C0428953;C2926063;C3810814;C4552959",NULL,NULL,646
"intensity of statin therapy at baseline no","C0168634;C0522510;C1278454;C1442488","C0360714","",872
"bleeding events during the entire study","C0019080;C0439751;C0441471;C0444667;C0557651;C2603343;C3541888",NULL,NULL,707
"stent implanted","C0522776","C0522776","",364
"swollen joint count of $nmbr$","C0451521",";C0451521","",1140
"qualifying mi stemi","C1514624;C1536220;C3538872;C3810814",NULL,NULL,570
"duration of rheumatoid arthritis year","C0003873;C0439234;C0439508;C0449238;C2926735","C0003873;C0449238","",1997
"fibrinolytic agent given","C0016018;C1442162;C1550718;C1947971;C3244317",NULL,NULL,487
"age mean years sd","C0444504;C1510829;C2347634;C2348143;C2699239",NULL,NULL,1907
"ciass ll iv","C0022326;C4265176",NULL,NULL,1257
"intra abdominal abscess past","C0243001;C1444637;C4284302",NULL,NULL,456
"ratio of urinary albumin mg to creatinine g","C0010294;C0024671;C0026410;C0439267;C0439269;C0456603;C1547037;C1561535;C1960952;C2346927;C2362049;C4321396;C4521761","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"calcium aniagonisi","C0006675;C0006726;C2936886;C3540037;C3714611","C0006684","",1884
"control warfarin","C0043031;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389",NULL,NULL,675
"previous treatment with infliximab","C0039798;C0087111;C0205156;C0666743;C1522326;C1533734;C1552607;C1705169;C3538994;C3887704","C0666743","",154
"$nmbr$ predicted arr n $nmbr$","C0681842;C1882327;C2170357;C4084934",NULL,NULL,51
"serum potassium mmol l","C0302353;C0543465;C1532563","C0302353","",1959
"bnp pg mlt","C0030827;C0054015;C0072225;C1095989;C1266240;C1417808;C2982014;C4553833",NULL,NULL,1635
"american indian","C0002460",NULL,NULL,637
"dapagliflozin $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C2353951;C4321396;C4521761",NULL,NULL,2275
"creatinine $nmbr$ $nmbr$ x baseline and above uln","C0010294;C0168634;C1282910;C1442488;C1519815;C1552828;C1561535",NULL,NULL,625
"insufficient","C0205412;C0231180;C0439856","C0205412","",403
"diabetes status n","C1317301",NULL,NULL,544
"the plot shows hazard ratios and $nmbr$ confidence intervals for the primary outcome with patients stratified according to eight sub groups prespecified in the statistical analysis plan no heterogeneity was observed for these subgroups","C0009667;C0019409;C0205225;C0205363;C0205454;C0242960;C0270724;C0439612;C0439631;C0441833;C0542339;C0599880;C0680240;C0687744;C0871424;C1079230;C1257890;C1264637;C1301732;C1441672;C1519504;C1547282;C1547647;C1552839;C1705428;C1705429;C2985465",NULL,NULL,1637
"secondary outcomes","C0027627;C0175668;C0205436;C1274040",NULL,NULL,1484
"dyslipidemia","C0242339","C0242339","",1770
"non smokers receiving lipid lowering drugs p blockers","C0086440;C0337672;C1514756;C4554605","C0086440","",1773
"hr $nmbr$ ci","C0008107;C3259781",NULL,NULL,519
"previous pci","C0205156;C1552607;C4049621","C1532338","",1661
"age year","C0001779;C0439234;C0439508","C0001779","",480
"fasting plasma glucose mg dl mean sd b","C0015663;C0202042;C0439269;C0444504;C0455280;C2347634;C2348143;C2699239","C0455280;C0015663",";C0168634",21
"diastolic","C0012000","C0012000","",844
"cad death","C0011065;C1306577;C1504769;C2239547;C3813548;C4082313;C4284121;C4552775",NULL,NULL,698
"previous hospital admission for heart failure","C0018801;C0018802;C0184666;C0205156;C1552607;C4554158","C0018801",";C0168634;C1524003",12
"time from randomization to study drug initiation hr","C0013175;C0013227;C0034656;C0040223;C0040227;C0589507;C1158830;C1254351;C1704686;C2349982;C3541383",NULL,NULL,1709
"women men","C0025266;C0043210","","",306
"rf positive $nmbr$ iu ml n","C0035448;C0201660;C0439178;C0439458;C0748398;C1446409;C1514241;C1547111;C2825490;C3812269","C0035448","",1435
"history of stroke","C0019664;C0019665;C0038454;C0262512;C0262926;C1705255;C2004062;C4554100",NULL,NULL,832
"baseline adas cog $nmbr$","C0168634;C1442488;C3539026",NULL,NULL,625
"hospitalizations n","C0019993",NULL,NULL,2358
"controlled $nmbr$ no","C2587213;C2911690",NULL,NULL,675
"dronedarone","C0766326","C0766326","",1923
"cardiac procedure","C1279986",NULL,NULL,643
"previous stroke no","C0038454;C0205156;C1552607;C4554100",NULL,NULL,1762
"bmi $nmbr$ kg nr","C0022718;C0027496;C0439209;C0578022;C3844738;C4054209","C1305855","",1734
"ischemic stroke with hemnrrhnaic cnnversinn","C0948008",NULL,NULL,1669
"two or more","C0205172;C0205448",NULL,NULL,429
"on antihypertensive medication at baseline n","C0003364;C0168634;C1442488",";C0003364","",1579
"treatment and parameter","C0039798;C0087111;C0549193;C1522326;C1533734;C1704769;C1705169;C2350001;C3538994;C3887704",NULL,NULL,236
"type of surgery cabg","C0010055;C0038894;C0038895;C0332307;C0543467;C1274039;C1547052",NULL,NULL,598
"patients randomized n","C0030705;C0034656;C0369718;C0441922;C3815594",NULL,NULL,692
"femur fracture","C0015802",NULL,NULL,2027
"hba $nmbr$ c \n","C0019016;C1825777;C3538758","","",820
"american indian alaskan native or aboriginal canadian","C0002460;C0238611;C0238884;C0302891;C0935542",NULL,NULL,637
"mean sd improvement from baseline to week $nmbr$ in basdai questions","C0168634;C0332174;C0439230;C0444504;C1442488;C1522634;C1998004;C2347634;C2348143;C2699239;C2986411",NULL,NULL,1287
"no of events sample size","C0370003;C0441471;C0456389;C2347026;C3541888",NULL,NULL,1004
"two vessel disease","C0581375",NULL,NULL,746
"sufficient","C0205410",NULL,NULL,720
"other anti hypertensive","C0003364",";C0003364","",1579
"clopidogrel plus aspirin n $nmbr$","C0004057;C0070166;C0332287","C0070166",";C0369286;C0033727;C4049621",217
"migraine duration h","C0033727;C0149931;C0369286;C0441932;C0449238;C0564385;C2926735;C4528284",NULL,NULL,308
"unspecified","C0205370;C1549663;C2983689;C4048188",NULL,NULL,95
"since diagnosis","C0011900;C1704338;C1704656",NULL,NULL,841
"loop diuretics","C0354100","C0354100","",991
"hs graduate ged","C0588053;C1547183;C1880947",NULL,NULL,1622
"enox","C3147679",NULL,NULL,87
"arial flutter or fibrillation","C0016385;C0232197;C2242390",";C0004238","",1009
"baseline high density lipoprotein cholesterol mg dl","C0023822;C0168634;C0439269;C1442488","C0023822","",821
"combined insulin oral hypoglycaemic agent use","C0205195;C0240016;C0359086",NULL,NULL,997
"gastrointestinal area involved no total no","C0017446;C0205146;C0439175;C0439810;C0521362;C1314939",NULL,NULL,508
"any copd medication","C0013227;C0024117;C1412502;C3244316;C3714496;C4284232",NULL,NULL,1726
"$nmbr$ low n $nmbr$","C0205251;C1550472;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"memantine use at baseline no","C0025242;C0042153;C0168634;C0457083;C1442488;C1947944",NULL,NULL,625
"patients not treated with statins n $nmbr$","C0030705;C0332293;C0360714;C1518422",NULL,NULL,1035
"ace inhibitors or arb","C0003015;C3888198",NULL,NULL,44
"serum creatinine mol l","C0201976;C0347982;C0600061","C0600061;C0010294","",952
"angiotensin receptor blocker yes","C0034787;C1549445;C1622222;C1705108;C1710701",NULL,NULL,963
"age mean sd yr","C0001779;C0439234;C0444504;C2347634;C2348143;C2699239","C0001779","",480
"alprostadil n n","C0002335",NULL,NULL,883
"nonmetabolic syndrome n $nmbr$","C0039082",NULL,NULL,617
"with treatment","C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,236
"medion $nmbr$ days","C0439228",NULL,NULL,1621
"tg $nmbr$ hdl $nmbr$ mg dl $nmbr$","C0337445;C0439269;C3715113","C0041004","",368
"freedom from gtc seizures n","C1299590",NULL,NULL,83
"patients with specific disease characteristics n","C0030705;C0205369;C0599878;C1552740",NULL,NULL,1652
"aspirin $nmbr$ hours","C0004057;C0439227",NULL,NULL,828
"anticholinergic drug","C0242896",NULL,NULL,1704
"menopausal status and hormone therapy use","C0042153;C0279025;C0457083;C1513126;C1947944",NULL,NULL,558
"phototherapy","C0031765",NULL,NULL,553
"copd no medication use","C0024117;C0240320;C1412502;C3714496",NULL,NULL,1726
"previous cabg","C0010055;C0205156;C1552607","C0010055","",389
"baseline laboratory values median iqr d","C0022877;C0042295;C0168634;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193;C3244292;C4283904",NULL,NULL,978
"patients total no","C0030705;C0439175;C0439810",NULL,NULL,508
"uacr pg mg","C1627892",NULL,NULL,2318
"time from symptoms to randomization h","C0033727;C0034656;C0040223;C0369286;C0441932;C0564385;C0683368;C1457887;C3541383;C4528284",NULL,NULL,308
"highest","C1522410",NULL,NULL,840
"statins used during follow up","C0360714;C0589120;C1273517;C1522577;C1704685;C3274571",NULL,NULL,1584
"estimated means and difference","C0750572;C1704970;C1705241;C1705242",NULL,NULL,1466
"intravenous anticoagulant prior to pre pci angiography","C0002978;C0003280;C0332152;C0348016;C0740175;C0848112;C2257086;C3536711;C3669034;C4049621",NULL,NULL,1723
"persistent permanent","C0205322;C0205355;C0332996",NULL,NULL,718
"interval between clinical evaluation and initiation oftreatment no","C0205210;C0589507;C1158830;C1261322;C1272706;C1552654;C1552713;C1704686;C2826267;C4084924","C1272706","",1097
"fpg median q $nmbr$ q $nmbr$ mmol l","C0549183;C0876920;C1532563;C2347635;C2348144;C2939193","C0015663;C0202042","",1960
"cases","C0868928;C1533148",NULL,NULL,114
"simvastatin $nmbr$ $nmbr$ mg d","C0074554;C0439422","C0074554","",1840
"risk reduction","C1137094",NULL,NULL,171
"history of diabetes nyha class","C0011847;C0011849;C0019664;C0019665;C0262512;C0262926;C1705255;C1882083;C2004062",NULL,NULL,832
"spirometric values at baseline","C0037981;C0042295;C0168634;C0183441;C1442488",";C0037981","",1197
"history of tia or stroke","C0007787;C0019664;C0019665;C0038454;C0262512;C0262926;C0917805;C1054154;C1705255;C2004062;C4554100",NULL,NULL,832
"hf hospitalization","C0018488;C0019993;C1313497;C1538440;C3273279",NULL,NULL,2359
"age $nmbr$ years t","C1510829","C1510829","",481
"total updrs score range $nmbr$ $nmbr$","C0439175;C0439810;C0449820;C1514721;C2348147;C3542016;C3639721;C4050231",NULL,NULL,479
"algorithm $nmbr$","C0002045;C1553907",NULL,NULL,577
"other medications","C0013227;C0802604;C2598133;C4284232",NULL,NULL,366
"total daily insulin dose u","C0021641;C0439148;C1533581;C1579433;C2348070;C3714501",NULL,NULL,157
"$nmbr$ locf","C2825507",NULL,NULL,965
"egfr $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n $nmbr$ $nmbr$ $nmbr$","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"asas partial remission","C0004057;C1521726;C3853627;C4552913;C4552914",NULL,NULL,60
"type $nmbr$ diabetes mellitus n","C1320657","C0011849;C1320657","",907
"reversible","C0205343",NULL,NULL,733
"major macrovascular events","C0205082;C0205164;C0441471;C3541888;C4318856;C4521762","C1320716;C0205082","",2077
"median seconds","C0457385;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"bypass surgery","C1536078",NULL,NULL,2040
"median blood eosinophil count cells per pla","C0200638;C0456170;C0549183;C0876920;C2347635;C2348144;C2939193","C0750879","",848
"weight kg m $nmbr$ median $nmbr$ th to $nmbr$ th percentile","C0039725;C0039738;C0549183;C0552346;C0876920;C1420718;C1532718;C2347635;C2348144;C2939193;C4282123;C4285344","C0005910","",2235
"micro albuminuria","C0001925;C0085672;C1553035;C3811161;C4049106","C0001925","",375
"rerapamil sr strategy n $nmbr$","C0679199;C0753208;C1709991;C3813610;C3890900;C3891546",NULL,NULL,981
"low risk and more symptoms group b","C0205172;C0683368;C1457887;C3272281;C3538919;C4522078",NULL,NULL,1640
"elevated natriuretic peptides in previous $nmbr$ days no","C0205156;C0205250;C0439228;C1144709;C1552607;C3163633",NULL,NULL,1621
"concomitant medications n","C0013227;C0521115;C0802604;C2598133;C4284232","C0013227;C0521115","",1916
"patients who received positive results on test for antibodies to infliximabt","C0003241;C0030705;C1335447;C1514756",NULL,NULL,731
"chf on placebo","C0018802;C0032042;C1696465;C1706408","C0032042","",28
"cough investigator reported","C0010200;C0035173;C0684224;C0700287;C1961131;C3274924;C4084725;C4084726;C4084727;C4319718","C0010200","",1388
"sitagliptin","C1565750","C1565750","",1184
"pga subscore","C0016410;C3541266;C4050369",NULL,NULL,1525
"clopidogrel given before procedure","C0070166;C0184661;C1442162;C1550718;C1947971;C2700391;C3244317;C3274430;C3539779","C0070166",";C0369286;C0033727;C4049621",217
"diabetes etiology","C0011847;C0011849;C0015127;C1314792;C1524003",NULL,NULL,924
"adjusted mean difference $nmbr$ ci","C0008107;C0444504;C0456081;C1705241;C1705242;C2347634;C2348143;C3259781",NULL,NULL,519
"non hispanic latino","C0086528;C1518424","C0086409","",865
"hba $nmbr$ c $ $nmbr$ $nmbr$ $nmbr$ mmol mol","C0019016;C1825777;C3538758;C3829066","","",820
"for baseline hemoglobin $nmbr$ g $nmbr$","C0168634;C1319312;C1442488","C0019046","",1177
"non sulfonylurea secretagogues","C0038766;C1518422;C3536898;C4704833","C0038766","",752
"fev $nmbr$ predicteda","C3714541",NULL,NULL,1599
"urinary albumin creatinine ratio","C0455271;C1318330","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"ldl c mmol l mg dl","C3642216;C3898312","C0023824","",1068
"placebo dm vs dm","C0011816;C0032042;C1696465;C1706408;C3250443","C0032042","",28
"patients not receiving corticosteroids at baseline","C0001617;C0030705;C0168634;C1442488;C1514756;C1518422;C3539185;C3540725;C3540726;C3540727",NULL,NULL,1650
"s $nmbr$ $nmbr$ s","C0565930;C2603362",NULL,NULL,1784
"cholesterol","C0008377","C0008377","",1501
"pain in extremity","C0030196;C4553007",NULL,NULL,1132
"screening","C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164",NULL,NULL,798
"dual antiplatelet","C0205173;C1554184","","",1191
"caucasian eze simva","C0007457;C0043157","C0043157","",1329
"albumin to creatinine ratio acr","C0486293;C1318293;C1412134;C1515941","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"x $nmbr$ years","C0439234",NULL,NULL,1099
"$nmbr$ $nmbr$ month","C0332177;C0439231",NULL,NULL,1476
"median h","C0033727;C0369286;C0441932;C0549183;C0564385;C0876920;C2347635;C2348144;C2939193;C4528284",NULL,NULL,635
"bypass graft","C0185098",NULL,NULL,2032
"dapagliflozin $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C2353951;C4321396;C4521761",NULL,NULL,2275
"duration of infusion hr","C0449238;C0574032;C1827465;C2926735",NULL,NULL,825
"mean difference $nmbr$ ci","C0008107;C0444504;C1705241;C1705242;C2347634;C2348143;C3259781",NULL,NULL,519
"category $nmbr$ and $nmbr$","C0683312;C3889287",NULL,NULL,562
"atherectomy","C0162513",NULL,NULL,548
"$nmbr$ to $nmbr$ years","C0439234",NULL,NULL,1099
"xi $nmbr$ $nmbr$ p $nmbr$ l","C1720296",NULL,NULL,520
"ls ul $nmbr$ $nmbr$","C0023668;C1300557",NULL,NULL,127
"stent abciximab stent placebo","C0032042;C0038257;C0288672;C1696465;C1706408",NULL,NULL,569
"median crohn s disease duration y range","C0010346;C0449238;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2926735;C2939193;C3542016",NULL,NULL,901
"fatal and nonfatal stroke","C0038454;C1302234;C1705232;C4554100",NULL,NULL,507
"arterial access","C0003842;C0221464;C0444454;C1554204",NULL,NULL,493
"enrollment in lmwh substudy","C0019139;C1516879;C1696073;C3536766;C3888021",NULL,NULL,339
"pefpm l min","C0702093;C1524029;C3813700",NULL,NULL,1475
"ilb iiia inhibitors","C0243077;C4697913",NULL,NULL,808
"native latin","C0302891",NULL,NULL,763
"due to drug relateda ae","C0013227;C1254351;C3887670","C0877248","",47
"probability of event","C0033204;C0441471;C4019010",NULL,NULL,412
"age group no","C0027362;C2348001",NULL,NULL,45
"no estimate","C0750572",NULL,NULL,536
"randomization","C0034656",NULL,NULL,692
"symptom onset to hospital admission","C0184666;C4086878",NULL,NULL,612
"patients with perianal fistulae n","C0030705;C0267561",NULL,NULL,1035
"mtx ir","C0022065;C0022071;C0025677;C1417487;C1448132","","",1397
"delayed eptifibatide group n $nmbr$","C0205421;C0253563;C0441848;C1545665;C3272602",NULL,NULL,317
"diet diet pravastatin","C0012155;C0012159;C0085542;C1519433;C2983588;C3668949","C0012155","",1199
"active inflammatory bowel disease","C0021390;C0205177;C3853793;C3888249","C0021390","",107
"cardiovascular disease history n","C0007222;C0007226;C0012634;C0019664;C0019665;C0262512;C0262926;C0683519;C1705255;C1880008;C2004062;C3887460","C0007222","",1790
"fasting glucose $nmbr$ mg dl","C0015663;C0017725;C0439269","C0017725;C0015663","",2280
"patients with $nmbr$ exacerbation requiring er visit or admission to hospital in the $nmbr$ months before screening","C0184666;C0220908;C0220909;C0439231;C1512346;C1698960;C1710031;C1710032;C1710477;C2348164;C3810541;C3811131;C4086268",NULL,NULL,798
"lvef $nmbr$","C0428772;C0488728","C0018801;C0428772","",1273
"male female","C0043210;C0086287;C0086582;C1705497;C1705498;C1706180;C1706428;C1706429","C0086582","",1276
"middle tertile range $nmbr$ $nmbr$ $nmbr$ $nmbr$ mg dl mean sd $nmbr$ $nmbr$ $nmbr$ $nmbr$ mg dl","C0024671;C0026410;C0439269;C0444504;C0444598;C0549183;C1514721;C1552826;C1960952;C2346927;C2347634;C2348143;C2348147;C2699239;C3539687;C3542016;C4321396;C4521761",NULL,NULL,331
"orthopaedic","C0029355","","",-10
"median min max","C0549183;C0702093;C0876920;C1524029;C2347635;C2348144;C2939193;C3813700",NULL,NULL,1475
"calcium channel blocker","C0006684;C3536851;C4521885","C0006684","",1884
"concomitant antihyperglycaemic drugs n","C0013227;C0020616;C0521115;C3687832",NULL,NULL,447
"mild impairment egfr $nmbr$ $nmbr$ ml min m","C0221099;C0369637;C0439445;C0441923;C0684336;C1739039;C2945599;C3811844;C3812682",NULL,NULL,329
"canakinumab $nmbr$ month on treatment il $nmbr$ below the median value $nmbr$ $nmbr$ ng l n $nmbr$","C0020898;C0021764;C0022271;C0039798;C0087111;C0332177;C0439231;C0439297;C0549183;C0876920;C1522326;C1522609;C1533734;C1705169;C2347635;C2348144;C2718773;C2939193;C3538994;C3887704","C2718773","",372
"cardiac medications during indexhospitalization and or discharge","C0012621;C0013227;C0018787;C0030685;C0802604;C1522601;C2598133;C2926602;C4284232",NULL,NULL,390
"l $nmbr$ $nmbr$ vs l $nmbr$ $nmbr$ $nmbr$","C0439394;C1706495;C3642217","","",-10
"treatment group","C0039798;C0087111;C0441833;C0687744;C1257890;C1519504;C1522326;C1533734;C1705169;C1705428;C1705429;C3538994;C3887704",NULL,NULL,236
"mild impairment $nmbr$ to $nmbr$","C0221099;C0684336;C2945599",NULL,NULL,329
"change from baseline in rescue medication use puffs per day","C0168634;C0240320;C0332173;C0392747;C0439228;C0439505;C0443172;C1442488;C1533107;C1705241;C4319952",NULL,NULL,1621
"data are expressed as n total unless otherwise specified systeme international unit conversion to convert creatinine clearance to ml s multiply by $nmbr$ $nmbr$ estimated with cockroft gault equation","C0040363;C0041260;C0205369;C0439175;C0439390;C0439453;C0439810;C0439836;C0552449;C0750572;C0812399;C1511726;C1719797;C1883351;C2911648;C3245479;C3714741","","",-10
"arterial revascularization","C0003842;C0221464;C0581603","C0581603","",1213
"$ $nmbr$ mg dl $nmbr$ $nmbr$ mmol l","C0439269;C1532563",NULL,NULL,670
"hip fracture","C0019557;C0149531;C4552776","C0019557","",1114
"intervention n $nmbr$","C0184661;C0886296;C1273869",NULL,NULL,290
"lvef mean sd","C0428772;C0444504;C0488728;C2347634;C2348143;C2699239","C0018801;C0428772","",1273
"killip class n i","C0021966;C0221138;C0369718;C0441922;C1881332","C1881332","",846
"resistant htn placebo n $nmbr$","C0020538;C0032042;C0332325;C1514892;C1550464;C1696465;C1706408;C2827757","C0020538","",1365
"type ic","C0020750;C0332307;C1547052;C4554818",NULL,NULL,1593
"rf positive","C0035448;C0201660;C0439178;C0748398;C1446409;C1514241;C1547111;C2825490;C3812269","C0035448","",1435
"immobilization at randomization n","C0020944;C0034656;C4048292",NULL,NULL,1707
"t $nmbr$ lesion volume mm $nmbr$","C0221198;C0449468;C1546698;C1690016;C1705102;C2603360;C2700258;C4330985;C4554674",NULL,NULL,472
"interval clopidogrel to pci","C0070166;C1272706;C1552654;C1552713;C4049621","C0070166",";C0369286;C0033727;C4049621",217
"thiazolidinedione based","C0289779;C1257987;C1527178;C1705938;C3537039","C1257987",";C0289779;C1527178;C1705938;C1552866;C2700399;C0168634",72
"conventional agents","C0439858;C0450442;C1254351;C1521826",NULL,NULL,484
"crp","C3890735;C4048285",NULL,NULL,1545
"ldl c mmol l mean","C0444504;C1532563;C2347634;C2348143","C0023824","",1068
"tt","C1452561;C4554543",NULL,NULL,251
"emotional well being","C2984554;C3641833",NULL,NULL,935
"timi minor bleeding","C0019080;C0026193;C0205165",NULL,NULL,1474
"white n medical history n","C0007457;C0043157;C0220938;C0262926;C1704706",NULL,NULL,832
"male simva","C0086582;C1706180;C1706428;C1706429",NULL,NULL,586
"normal baseline crp","C0168634;C0205307;C0231683;C0439166;C1442488;C2347086;C3890735;C4048285;C4553972",NULL,NULL,687
"microvascular eye diseased","C0015392;C0443258;C0700042",NULL,NULL,597
"unadjusted or $nmbr$ ci p value","C0008107;C1439367;C1709380;C3259781",NULL,NULL,519
"egfr category","C0683312;C1739039;C3811844;C3812682;C3889287","C3811844;C0017654","",592
"rsg $nmbr$ mg day","C0439422","","",198
"baseline bsa involvement","C0168634;C1314939;C1442488",NULL,NULL,625
"aspirin asa $nmbr$ $nmbr$","C0004057;C3853627","C0004057","",1366
"aes leading to discontinuation of study drugb","C0332152;C0457454;C0557651;C1412268;C1444662;C1522538;C2603343;C2699274;C4552847","C0877248","",1974
"adjusted $nmbr$ or $nmbr$ cl","C0456081;C0596019",NULL,NULL,658
"discharge medication n","C0012621;C0013227;C0030685;C2926602;C3244316;C4284232",NULL,NULL,390
"p values of interaction","C1704675;C1709380",NULL,NULL,7
"question $nmbr$ fatigue tiredness","C0015672;C1522634;C3463815;C4050243;C4553152;C4554645","C0015672",";C4050243;C3542016;C0424589;C0542479;C1442080;C4330907;C0444504;C4553152",10
"post bronchodilator screening","C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C2599594",NULL,NULL,798
"mtss mean sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"baseline $nmbr$ min walk distance m","C0168634;C0369637;C0429886;C0441923;C0702093;C1442488;C1524029;C3813700",NULL,NULL,923
"normal or increased egfr","C0205217;C0205307;C0231683;C0439166;C0442805;C1739039;C2347086;C3811844;C3812682;C4553972","C3811844;C0017654","",592
"non diabetic patients","C0241863;C1829939",NULL,NULL,996
"patient presentation","C0030705;C0449450",NULL,NULL,1035
"mitral regurgitation","C0026266",NULL,NULL,1683
"mean kg","C0022718;C0439209;C0444504;C2347634;C2348143;C4054209",NULL,NULL,37
"baseline mwd m","C0168634;C0369637;C0441923;C1442488",NULL,NULL,923
"percentage of females","C0086287;C0439165;C1549488;C1561533",NULL,NULL,291
"prior use of biologic agents","C0005515;C0332152;C1524063;C2826257",NULL,NULL,214
"treatment difference","C0039798;C0087111;C1522326;C1533734;C1705169;C1705241;C1705242;C3538994;C3887704",NULL,NULL,236
"hypotension","C0020649;C3163620","C0020649","",1048
"platelet aggregation inhibitors excluding heparin","C0019134;C0032177;C0332196;C0770546;C2828389",NULL,NULL,813
"hiatus hernia","C3489393",NULL,NULL,590
"total v $nmbr$ $nmbr$","C0439175;C0439810",NULL,NULL,508
"$nmbr$ $nmbr$ to $nmbr$ i iot","C0006196;C0021966;C0221138",NULL,NULL,1021
"history of af","C0019664;C0019665;C0262512;C0262926;C0344434;C1705255;C2004062;C4049859",NULL,NULL,832
"unadjusted irr","C1439367;C4082285",NULL,NULL,221
"nyha class ii","C1882085","C0018802;C1882083","",453
"geographical location n","C4545686",NULL,NULL,906
"lipc","C1416867","C0585943;C0086440","",1774
"non ischaemic n $nmbr$ o $nmbr$","C0475224;C1518422",NULL,NULL,1670
"acr response by baseline mtx use no total no acr $nmbr$","C0025677;C0042153;C0168634;C0439175;C0439810;C0457083;C0871261;C1412134;C1417487;C1442488;C1515941;C1704632;C1706817;C1947944;C2911692",NULL,NULL,52
"years n smoking n current","C0037369;C0439234;C0453996;C0521116;C1705970;C1881674",NULL,NULL,1099
"bmi body mass index hrt hormone replacement therapy lvh left ventricular hypertrophy nsaids nonsteroidal anti inflammatory drugs pvd peripheral vascular disease tia transient ischemic attack ahistory of and or currently taking lipid lowering or antidiabetic medications bp $nmbr$ $nmbr$ for verapamil sustained release sr vs atenolol chistory of or currently have elevated serum creatinine but less than $nmbr$ mg dl dblood pressure control defined as $nmbr$ $nmbr$ or $nmbr$ $nmbr$ in patients with diabetes or a history of renal insufficiency","C0003211;C0004147;C0007787;C0011847;C0011849;C0012634;C0019664;C0019665;C0023779;C0030685;C0030705;C0033095;C0035078;C0037623;C0042523;C0085096;C0149721;C0150936;C0201976;C0205091;C0205250;C0243148;C0262512;C0262926;C0282402;C0340279;C0391871;C0439092;C0439180;C0439269;C0441994;C0443246;C0443318;C0460139;C0521116;C0600061;C0680255;C0753208;C0935929;C0947487;C1283071;C1305855;C1306345;C1415692;C1515187;C1550141;C1552822;C1565489;C1704788;C1705255;C1708288;C1709991;C1882979;C1963578;C2003888;C2004062;C2587213;C3163633;C3274648;C3539106;C3813610;C3890900;C3891546;C4284008;C4318478;C4521226;C4553389","","",-10
"olodaterol $nmbr$ $nmbr$ ig tiotropium n $nmbr$ non tiotropium n $nmbr$","C0021027;C0305052;C0360506;C1518422;C4032878",NULL,NULL,1260
"puerperium","C0034042;C0086839;C1879329","","",-10
"p vs placebo","C0032042;C0369773;C1696465;C1706408;C2603361","C0032042","",28
"duration of diabetes microvascular disease no","C0011847;C0011849;C0443258;C0872146","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"b natriuretic peptide pg ml","C0070338;C0439297;C0597421",NULL,NULL,2323
"no of days to randomization median iqr","C0034656;C0439228;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,1621
"renin inhibitors","C2917241;C3653375",NULL,NULL,813
"arb at last follow up","C0589120;C1522577;C1704685;C3274571;C3888198","C0521942","",779
"control $nmbr$","C0243148;C1550141;C1882979;C2587213;C3274648;C4553389",NULL,NULL,675
"pulmonary embolismb n n","C0024109;C2707265;C2709248;C4522268",NULL,NULL,572
"$nmbr$ iu l","C0439457",NULL,NULL,1252
"previous warfarin use no","C0042153;C0043031;C0205156;C0457083;C1552607;C1947944","C0043031","",858
"lipid lowerinq druq","C0023779","C0023779","",1772
"percent stenosis investigator","C0035173;C0439165;C0678234;C1261287;C2632116",NULL,NULL,1651
"number of exacerbation in the previous $nmbr$ months n","C0205156;C0237753;C0439231;C0449788;C1552607;C4086268","C4086268","",889
"bun mmol l","C1532563",NULL,NULL,670
"initiation of insulin","C0021641;C0589507;C1158830;C1533581;C1579433;C1704686;C3714501",NULL,NULL,157
"$nmbr$ n weight kg","C0005910;C0022718;C0043100;C0369718;C0439209;C0441922;C1305866;C1705104;C4054209","C0005910","",1250
"scdbp mean sd mmhgf","C0444504;C2347634;C2348143;C2699239",NULL,NULL,2127
"mexican","C0240339","C0025885","",1462
"overall efficacy","C0282416;C1280519;C1561607;C1707887","C1707887;C2349179","",1122
"any cv history risk factors n","C0019664;C0019665;C0035648;C0262512;C0262926;C1553898;C1705255;C2004062;C3538987;C4048877;C4318503",NULL,NULL,1777
"any stroke n $nmbr$","C0038454;C4554100",NULL,NULL,1762
"creatinine clearance an","C0812399","C0812399",";C3889287;C0452249;C0522467;C1337213;C1576800;C3890003;C0005910;C0022718;C1305866;C1705104;C1705224;C3887665",79
"crcl mean ml min sd","C0439445;C0444504;C1846718;C2347634;C2348143;C2699239","C3811844;C0017654","",307
"ls mean change","C0023668;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952",NULL,NULL,37
"concomitant treatment","C0039798;C0087111;C0521115;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,236
"mean mm hg level no","C0439475;C0441889;C0444504;C0456079;C1547707;C2347634;C2348143;C2946261",NULL,NULL,744
"ranolazine","C0073633",NULL,NULL,71
"neither pe nor dvt","C0070939;C0149871;C1880476;C2926618;C3899446;C4284304",NULL,NULL,1516
"ls mean change from baseline se","C0023668;C0036919;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C4319952",NULL,NULL,767
"icd","C0021122","C0972395","",1360
"radionuclide ventriculography","C0017200;C0034610","","",-10
"presentation of index event","C0441471;C0449450;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010",NULL,NULL,412
"hscrp $nmbr$ to $nmbr$ mg l","C0439268","C0006560","",286
"aged $nmbr$ years","C0001779;C0001792;C0439234;C1999167",NULL,NULL,148
"present at screening","C0150312;C0220908;C0220909;C0449450;C1698960;C1710031;C1710032;C1710477;C2348164",NULL,NULL,287
"c $nmbr$ e $nmbr$ fab bolus and infusion n $nmbr$","C0574032;C1186706;C1511237;C1705509;C1827465;C3812160",NULL,NULL,1242
"subgroup analysis change from baseline in hba $nmbr$ c at week $nmbr$ per baseline hba $nmbr$ c category","C0019016;C0168634;C0332174;C0392747;C0439230;C0443172;C0683312;C1442488;C1705241;C1825777;C2986480;C3538758;C3889287;C4319952","","",820
"body mass index kg m $nmbr$ baseline systolic blood","C0005767;C0005768;C0005893;C0039155;C0168634;C0229664;C0578022;C1305855;C1442488;C1532718","C1305855","",1734
"no moderate ckd","C0205081;C1561643;C1881878;C4049705;C4049706;C4085643;C4321335","C1561643","",967
"exenatide","C0167117",NULL,NULL,759
"bmi category no","C0578022;C0683312;C3889287",NULL,NULL,1735
"fibrin specific","C0015982;C0205369;C1552740",NULL,NULL,802
"missing data","C4684714","C4684714","",1145
"all n $nmbr$ $nmbr$","C0369718;C0441922",NULL,NULL,396
"normal egfr $nmbr$ n","C0205307;C0231683;C0439166;C1739039;C2347086;C3811844;C3812682;C4553972","C3811844;C0017654","",592
"ish status n","C0449438",NULL,NULL,180
"therapies","C0087111",NULL,NULL,236
"previous pde $nmbr$ i therapy no","C0021966;C0039798;C0087111;C0205156;C0221138;C1363945;C1552607",NULL,NULL,1021
"no previous stroke ortia","C0038454;C0205156;C1552607;C4554100",NULL,NULL,1762
"at femoral neck mean sd","C0015815;C0444504;C2347634;C2348143;C2699239",NULL,NULL,511
"age $nmbr$ y","C0001779","C0001779","",480
"only peripheral artery disease","C0205171;C1704436;C1720467;C4025272",NULL,NULL,934
"nordic countries","C0036273",NULL,NULL,1700
"systolic mean sd mm hg h","C0025424;C0039155;C0428257;C0444504;C0456680;C2347108;C2347109;C2347634;C2348143;C2348272;C2699239",NULL,NULL,2127
"with n $nmbr$","C0369718;C0441922",NULL,NULL,878
"change from baseline at week $nmbr$","C0168634;C0332174;C0392747;C0439230;C0443172;C1442488;C1705241;C4319952",NULL,NULL,767
"overall qvai $nmbr$ sfc","C0282416;C1561607;C4521536",NULL,NULL,1743
"vorapaxar","C2974521","C2974521","",1448
"fibrinolytic for qualifying event","C0040044;C0441471;C1514624;C4019010",NULL,NULL,412
"most common concomitant aeds n","C0180309;C0205214;C0205393;C0521115;C1522138;C3245511",NULL,NULL,448
"ccs class","C1879987",NULL,NULL,455
"non hdl c mg dl","C0439269;C1518422;C3715113",NULL,NULL,2291
"grs","C1412761;C3539564",NULL,NULL,139
"available data","C0470187;C1511726;C3245479;C3714741",NULL,NULL,1427
"long acting nitrate agents","C0028125;C0079613;C0205166;C0450442;C0699857;C1254351;C1521826;C1704930;C1706317;C1869853;C3848573;C3890007;C4048375",NULL,NULL,499
"low risk $nmbr$ $nmbr$","C3272281;C3538919",NULL,NULL,174
"hba","C0019016;C1825777;C3538758","","",820
"ecg abnormality at entry","C0522055;C1705654","C0522055","",1314
"anterior mi","C3536746",NULL,NULL,516
"previous segments resection s","C0205156;C1552607;C2987624",NULL,NULL,1044
"serum creatinine mg dlb","C0024671;C0026410;C0201976;C0439269;C0600061;C0752347;C1960952;C2346927;C3890365;C4321396;C4521761",NULL,NULL,2304
"heart failure no","C0018801;C0018802;C4554158","C0018801",";C0168634;C1524003",12
"f n","C0016327","","",-10
"hispanic ethnic group no total no j","C0015031;C0086409;C0439175;C0439810;C1879937","C0086409","",865
"cohort $nmbr$ n $nmbr$","C0009247;C0599755","C0599755","",2208
"acetaminophen","C0000970;C2917659",NULL,NULL,502
"$nmbr$ $nmbr$ years","C0439234",NULL,NULL,1099
"baseline who function class","C0031843;C0168634;C0456387;C0542341;C0700205;C1442488;C1518526;C1705273;C1705943",NULL,NULL,452
"$nmbr$ obese class iii","C1319441",NULL,NULL,845
"$nmbr$ yearstos is years","C0439234",NULL,NULL,1099
"multivessel disease no","C0012634",NULL,NULL,1867
"salmeterol fluticasone $nmbr$ $nmbr$ g b i d","C0086706;C0939232",NULL,NULL,19
"statin use n","C0042153;C0360714;C0457083;C1947944","C0360714","",872
"lvh by ecg or echo n","C0058928;C0232306;C1655045","C0232306","",406
"fg $nmbr$","C0016703;C0439214;C2348814","C0455280;C0015663",";C0168634",21
"non hdl c","C1518422;C3715113","C0023822","",821
"carotid endarterectomy","C0014099",";C0014099","",2194
"sustain $nmbr$ semaglutide vs exenatide er $nmbr$ $nmbr$ mg","C0024671;C0026410;C0167117;C0439269;C0443318;C1960952;C2346927;C2732140;C3810541;C3811131;C3885068;C4321396;C4521761",NULL,NULL,759
"prior corticosteroid failure only","C0001617;C0205171;C0231174;C0332152;C0680095;C1720467;C2826257;C3536709",NULL,NULL,294
"treatment during or after catheterization","C0007430;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,1619
"glucose lowering therapies","C0017725;C0087111;C0441994;C2003888","C0020616",";C0013227;C3244316;C4284232;C0450442;C1254351;C1515187;C1521826;C2826257",33
"hip circumference cm","C0562350",NULL,NULL,831
"revive i","C0021966;C0221138",NULL,NULL,1021
"age median iqr y","C0001779;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,1890
"met tzd","C0428210;C1550543;C4317104",NULL,NULL,1729
"ale","C0678386;C2632076",NULL,NULL,400
"events n y","C0441471;C3541888",NULL,NULL,412
"add on to met","C0428210;C1550543;C1883712;C4317104",NULL,NULL,39
"higher dose edoxaban regimen","C0205250;C2348331;C2975435","C2975435","",1220
"non hdl cholesterol mg dl","C0439269;C0729627;C1535899","C0023822","",821
"data are mean sd or number pufa polyunsaturated fatty acids bmi body mass index sbp systolic blood pressure dbp diastolic blood pressure nyha newyork heart association lvef left ventricular ejection fraction hf heartfailure ami acute myocardial infarction cabg coronary artery bypass graft pci percutaneous coronary intervention icd implantable cardioverter defibrillator copd chronic obstructive pulmonary disease ace angiotensin converting enzyme arbs angiotensin receptor blockers available for $nmbr$ patients $nmbr$ n $nmbr$ pufa $nmbr$ placebo","C0004083;C0005823;C0010055;C0012000;C0018787;C0018801;C0021122;C0022709;C0024117;C0030705;C0032042;C0032615;C0085805;C0155626;C0162589;C0185098;C0205042;C0237753;C0428772;C0439849;C0444504;C0449788;C0470187;C0488055;C0488728;C0521942;C0536221;C0596306;C0699792;C0815017;C0871470;C1264633;C1271104;C1272641;C1275491;C1305855;C1306620;C1511726;C1532338;C1554103;C1696465;C1706408;C2347634;C2348143;C2699239;C2733342;C2825184;C3245479;C3714741;C3813197;C3888198;C4281799",NULL,NULL,1628
"ifx treatment","C0020823;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704","C0666743","",154
"time to first sare","C0040223;C0205435;C1279901;C3541383",NULL,NULL,757
"diabetes status","C1317301",NULL,NULL,544
"gender male","C0079399;C0086582;C1522384;C1706180;C1706428;C1706429","C0086582","",1276
"edoxaban warfarin","C0043031;C2975435","C0043031","",858
"difference vs placebo kg $nmbr$ cl","C0022718;C0032042;C0439209;C0596019;C1696465;C1705241;C1705242;C1706408;C4054209",NULL,NULL,205
"urticaria","C0042109;C1559188",NULL,NULL,778
"serious","C0205404",NULL,NULL,916
"good control $nmbr$","C0205170;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389",NULL,NULL,675
"steroids","C0038317",NULL,NULL,1648
"patient s preference not to take vka only reason","C0040363;C0041260;C0205171;C0376409;C0392360;C1515187;C1518422;C1720467;C1883351",NULL,NULL,1713
"ff $nmbr$ gg n $nmbr$ $nmbr$","C0017454;C0018370;C4554348",NULL,NULL,1597
"years since diagnosis","C0011900;C0439234;C1704338;C1704656",NULL,NULL,1099
"tiotropium nz $nmbr$","C0027978;C0213771","C0213771","",1372
"gained bmd","C1517378",NULL,NULL,709
"aliskiren dm $nmbr$ non dm $nmbr$","C0011816;C1120110;C1518422;C3250443","C1120110","",1172
"hyperlipidemia","C0020473;C0428465;C4555212","C0020473;C4555212",";C0439810;C1710701",29
"glucocorticoid","C0017710","C0017710","",1348
"difference","C1705241;C1705242",NULL,NULL,1466
"$nmbr$ $nmbr$ kg m $nmbr$ n $nmbr$","C1532718",";C1305855","",206
"tc level mean sd mg dl","C0039411;C0040642;C0041405;C0041698;C0439269;C0441889;C0444504;C0456079;C1547707;C1824670;C2347634;C2348143;C2699239;C2946261;C3272447;C4522122",NULL,NULL,37
"inferior or posterior","C0205095;C0542339;C0678975",NULL,NULL,1245
"volume change mm","C0392747;C0443172;C0449468;C1690016;C1705102;C1705241;C2700258;C4319952;C4330985;C4554674",NULL,NULL,1119
"systolic","C0039155","C0039155","",1917
"hip nonvertebral vertebral","C0019552;C0022122;C0549207;C1505163;C3538851;C4284725",NULL,NULL,928
"second prior mi","C0205436;C0332152;C0457385;C0565930;C1561503;C1705190;C2826257;C3810814",NULL,NULL,516
"serum c terminal telopeptide of","C0229671;C1546774;C1550100;C1707271",NULL,NULL,951
"ckd n","C1561643","C1561643","",967
"previous aorta femoral or lower extremity bypass surgery pta of iliac or infrainguinal artery","C0003483;C0003842;C0015811;C0020889;C0187763;C0205156;C0226004;C0741847;C1552607;C3274435",NULL,NULL,14
"a median","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"mean body mass index kg mq","C0005893;C0022718;C0024853;C0439209;C0444504;C0578022;C1305855;C2347634;C2348143;C4054209","C1305855","",1734
"history of heart failure no","C0455531","C0018801",";C0168634;C1524003",12
"$nmbr$ parameter","C0549193;C1704769;C2350001","C0549193","",1186
"mitral insufficiency","C0026266",NULL,NULL,1683
"eze simva $nmbr$ yr km rale","C0034642;C0439234;C3887676",NULL,NULL,1099
"baseline luts severity","C0168634;C0439793;C0522510;C0574785;C1442488",NULL,NULL,1658
"albuterol use sd puffs day","C0001927;C0042153;C0332173;C0439228;C0439505;C0457083;C1533107;C1947944;C2699239",NULL,NULL,1287
"ra beam","C0338248;C2347880;C3538806;C4048756;C4521565",NULL,NULL,559
"poor outcome at $nmbr$ months","C0439231;C3806166",NULL,NULL,1530
"nasal polyposis or chronic rhinosinusitis no","C0027430;C0149516","C0027430","",353
"nph","C0020258;C0027442",NULL,NULL,151
"weight kg mean sd","C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209","C0043100","",1915
"mg mmol","C0567349;C2348885",NULL,NULL,200
"ckd rate events","C0441471;C0871208;C1521828;C1561643;C3541888","C1561643","",967
"oral medications","C0304289","C0304289;C0009905","",1921
"alive n $nmbr$","C2584946;C4551704",NULL,NULL,496
"smoking history no","C1519384","C1519384","",1147
"history of amputation n","C0002688;C0019664;C0019665;C0262512;C0262926;C0332840;C1546539;C1705255;C2004062",NULL,NULL,832
"dabigatran","C2348066",NULL,NULL,775
"combination therapy","C0009429;C0556895",NULL,NULL,2363
"biochemical measures mean sd","C0079809;C0205474;C0444504;C1879489;C2347634;C2348143;C2699239",NULL,NULL,2
"stroke thought due to atherothrombotic disease","C0012634;C0038454;C0039869;C0678226;C4319827;C4554100",NULL,NULL,1762
"non st segment elevation","C0520886;C1518422","C3810814","",894
"amlodipine vs chlorthalidone normal","C0008294;C0051696;C0205307;C0231683;C0439166;C2347086;C4553972","C0008294","",70
"induction study treatment","C0205263;C0557651;C0857127;C1521826;C2603343;C4049995",NULL,NULL,1730
"$nmbr$ ml mln","C0439526;C1417190;C1705224;C3815103;C3887665",NULL,NULL,300
"any lipid lowering agent use","C0042153;C0086440;C0457083;C1947944","C0086440","",1773
"at or above median","C0549183;C0876920;C1282910;C1552828;C2347635;C2348144;C2939193",NULL,NULL,635
"time since randomization","C0034656;C0040223;C3541383",NULL,NULL,692
"sulfonylurea","C0038766;C3536898","C0038766","",752
"sokolow lyon voltage mv","C0598352;C1454484;C1705503;C4281602",NULL,NULL,1776
"omeract oarsi response","C0871261;C1704632;C1706817;C2911692",NULL,NULL,726
"symmetric t wave inversions","C0332516;C0520888;C2699744","C0520888","",1981
"$nmbr$ $nmbr$ $nmbr$ obesity class $nmbr$","C0028754;C0456387;C1518526;C1705943;C1963185",NULL,NULL,710
"$nmbr$ aes","C1412268;C2699274","C0877248","",47
"s $nmbr$ gallop n","C2986823","","",-10
"high risk receiving treatment for","C0039798;C0087111;C0332167;C1514756;C1522326;C1533734;C1705169;C3272283;C3538994;C3887704;C4050568;C4319571","C4319571","",837
"who fc ii symptoms at baseline","C0168634;C0683368;C1442488;C1457887;C1710602;C2983605;C4082587",NULL,NULL,521
"prior myocardial intarction","C0027061;C0332152;C1522564;C2826257",NULL,NULL,641
"number of treated lesions","C0449791;C1522326",NULL,NULL,1870
"drinking","C0001948;C0684271","C0001948","",875
"not on an aha","C0050451;C0772110;C1518422",NULL,NULL,85
"troy ng ml","C0439275;C1420811;C1883402",NULL,NULL,204
"older patients aged $nmbr$ years","C0001779;C0001792;C0030705;C0439234;C0580836;C1999167",NULL,NULL,148
"yes stopped for trial","C0008976;C1272691;C1549445;C1705108;C1710701",NULL,NULL,147
"lipid lowering agent","C0086440","C0086440","",1773
"minimum","C1524031;C1552614;C2826545","C1524031","",2202
"without ckd $nmbr$","C1561643","C1561643","",967
"prior heart failure yes","C0018801;C0018802;C0332152;C1549445;C1705108;C1710701;C2826257;C4554158","C0018801",";C0168634;C1524003",12
"previous use of nonbiologic systemic therapy n","C0205156;C1515119;C1524063;C1552607",NULL,NULL,2391
"clinical dementia rating sum of boxes mean sd f","C0444504;C0451074;C1515051;C1517104;C2347634;C2348143;C2699239",NULL,NULL,37
"receptor blockers","C0597357",NULL,NULL,962
"test for interaction","C0022885;C0039593;C0392366;C0456984;C1515976;C1704675;C3831328;C4318744",NULL,NULL,242
"components","C0449432",NULL,NULL,1386
"a excludes two randomized patients with unknown diabetes status at baseline","C0034656;C0168634;C0205448;C0332196;C0439673;C1315719;C1442488;C2828389;C3541433;C3815594;C4050014",NULL,NULL,93
"high risk and more symptoms group d","C0205172;C0332167;C0441838;C0683368;C1457887;C3272283;C4050568;C4319571",NULL,NULL,1640
"non hdl c in $nmbr$ classes","C0456387;C1518422;C1518526;C1705943;C3715113;C4019422","C0023822","",821
"duration of diabetes median iqr","C0011847;C0011849;C0449238;C0549183;C0876920;C2347635;C2348144;C2926735;C2939193","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"statin use at baseline","C0042153;C0168634;C0360714;C0457083;C1442488;C1947944","C0360714","",872
"antihypertensive medication or","C0003364",";C0003364","",1579
"change from baseline in das $nmbr$ esr mean $nmbr$ sd","C0051767;C0057671;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C2699239;C3811131;C4319952",NULL,NULL,37
"biguanides","C0005382;C0360396;C3540012","C0005382","",685
"lvh from echocardiogram","C0013516;C0149721;C2243117","C0149721","",1272
"patients receiving mtx","C0025677;C0030705;C1417487;C1514756",NULL,NULL,731
"cognitive functioning","C0392334;C0392335",NULL,NULL,1570
"handihaler and diskus n","C1553480",NULL,NULL,177
"diagnosed diabetes n $nmbr$","C0011847;C0011849;C0011900","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"gender female","C0043210;C0079399;C0086287;C1522384;C1705497;C1705498","C0079399","",1083
"race non white n $nmbr$ $nmbr$","C0007457;C0034510;C0043157;C0220938;C1518422;C1706779;C3853635",";C0034510","",1107
"standard control","C0243148;C1442989;C1550141;C1882979;C2587213;C2828392;C3274648;C4553389",NULL,NULL,1482
"a $nmbr$ c distribution","C0520511;C1704711",NULL,NULL,892
"nyha class within past month no total no","C0439175;C0439810;C1882083;C4331910","C0018802;C1882083","",453
"pasi $nmbr$ a","C4528685",NULL,NULL,1522
"mean ml min","C0439445;C0444504;C2347634;C2348143",NULL,NULL,37
"stiffness min","C0427008;C0702093;C1524029;C3813700",NULL,NULL,1475
"in trial and post trial $nmbr$ year rates per $nmbr$ se total events number at risk","C0008976;C0036919;C0150312;C0332285;C0439175;C0439234;C0439508;C0439810;C0441471;C0687676;C0871208;C1264674;C1444641;C1521828;C1704687;C1707101;C3469826;C3541888;C4288115",NULL,NULL,567
"fasting insulin miu ml","C0015663;C0021641;C0439457;C1533581;C1579433;C3714501",NULL,NULL,157
"ezetimibe simvastatin n $nmbr$","C1532737","C0074554","",1840
"cigarette users","C0677453;C1704760;C1706077;C3890423","C0677453",";C3890423",96
"catheterization laboratory in center","C0007430;C0022877;C0205099;C3244292;C4283904;C4534362",NULL,NULL,978
"assigned treatment by sex interaction","C0009253;C0036864;C0039798;C0079399;C0087111;C0804628;C1314687;C1516050;C1522326;C1522384;C1533734;C1552601;C1704675;C1705169;C3538994;C3887704",NULL,NULL,568
"met n $nmbr$","C0428210;C1550543;C4317104",NULL,NULL,39
"oral anticoagulant no total no","C0354604;C0439175;C0439810","C0354604","",1747
"interval pain onset to admission","C0184666;C0809949;C1272706;C1507009;C1552654;C1552713",NULL,NULL,1708
"fasting serum glucose level mean sd mg dl","C0015663;C0202045;C0229671;C0439269;C0444504;C0583332;C1546774;C1550100;C2347634;C2348143;C2699239","C0017725;C0015663","",2280
"dmard user","C0242708;C1548600;C1706077",NULL,NULL,534
"long acting nitratef","C0079613;C0205166;C1704930;C1706317;C1869853;C3890007;C4048375",NULL,NULL,499
"heparin pre randomization","C0019134;C0034656;C0332152;C0740175;C0770546;C2257086;C3669034",NULL,NULL,294
"ara functional class","C0205245;C0325983;C0456387;C0542341;C1518526;C1705943;C2316832;C2700217;C3890184;C4282437;C4321455",NULL,NULL,452
"coronary artery disease","C0010054;C0010068;C1956346","C0010068;C1956346",";C0026410;C1710701",226
"insulin dose lu day","C0024171;C0024176;C0332173;C0366513;C0439228;C0439505;C2697939",NULL,NULL,1621
"very severe itt n $nmbr$","C3641272;C4050419","C3641272",";C0018026;C1304897;C1412502;C4050419;C4050465;C4050466",913
"low molecular weight only","C0026385;C0041667;C0205171;C0205251;C1521991;C1550472;C1720467;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"race or ethnic group","C0015031;C0034510;C1706779;C1879937;C3853635",NULL,NULL,787
"serum p $nmbr$ np g liter","C0065827;C0229671;C0439267;C0475211;C1546774;C1550100;C1706141;C3887659",NULL,NULL,951
"secondary dvt fe","C0027627;C0149871;C0175668;C0205436;C2926618;C3848561;C3899446",NULL,NULL,1484
"$nmbr$ tq fi i","C0021966;C0221138;C3555502;C4050619",NULL,NULL,1021
"chlorthalidone","C0008294","C0008294","",70
"no new erosions among patients with $nmbr$ uninvolved joint at baseline","C0022417;C0030705;C0168634;C0205314;C0205429;C0333307;C0392905;C1442488;C1706309;C1959609",NULL,NULL,625
"hypoglycaemic agents","C0020616","C0020616",";C0013227;C3244316;C4284232;C0450442;C1254351;C1515187;C1521826;C2826257",33
"seropositive rf ve and or acpa ve subgroup","C0035448;C0042469;C0201660;C0521143;C0748398;C1079230;C1515021;C1525410;C1547111;C1706063;C3714652;C4321495","C0035448","",1435
"acute and delayed reaction","C0205178;C0205421;C0443286;C1545665;C3272602",NULL,NULL,1577
"number of prior aeds n b","C0180309;C0237753;C0332152;C0449788;C2826257",NULL,NULL,1556
"canakinumab il $nmbr$ top tertilec","C0020898;C0021764;C0022271;C1704458;C2718773","C2718773","",372
"renal function ml min","C0232804;C0439445","C3811844;C0017654","",592
"medications before admission","C0013227;C0184666;C0802604;C0809949;C2598133;C4284232",NULL,NULL,2263
"igehigh i $nmbr$ ku l n i $nmbr$","C0021966;C0221138;C0369718;C0439340;C0441922",NULL,NULL,1553
"adolescents aged $nmbr$ $nmbr$ y no","C0001779;C0001792;C0205653;C1999167","C0001779","",480
"never been on a vka","C2003901",NULL,NULL,315
"warfarin n $nmbr$ $nmbr$","C0043031","C0043031","",858
"nonaspirin antiplatelet","C0722138","","",1191
"ckd at baseline","C0168634;C1442488;C1561643","C1561643","",967
"aha status at screeningb n","C0050451;C0449438;C0772110",NULL,NULL,543
"locally advanced","C0205179;C1517927","C0205179","",190
"early routine","C0205547;C1279919",NULL,NULL,1487
"insulin dependentc","C0021641;C1533581;C1579433;C3714501",NULL,NULL,157
"mild to moderate ipss $nmbr$","C1019118;C1299392;C1998280;C2827405;C3811063","C1998280",";C1019118;C3811063;C4050465;C4050466;C4049706;C0168634;C1705273;C1880519;C3853603",124
"troponin negative n $nmbr$","C0041199;C0205160;C1513916;C2825415;C2825491;C3853545",NULL,NULL,1569
"prior cerebrovascular disease","C0007820;C0332152;C2826257",NULL,NULL,728
"omeprazole","C0028978",NULL,NULL,1743
"insulin based","C0021641;C1527178;C1533581;C1579433;C1705938;C3714501",NULL,NULL,157
"pbo n $nmbr$","C0031962",NULL,NULL,435
"p value cangrelor versus clopidogrel in men","C0025266;C0070166;C1121991;C1709380","C1121991;C0070166;C1709380","",2097
"waist to hip male","C0019552;C0022122;C0086582;C0230097;C1505163;C1706180;C1706428;C1706429;C3538851;C4284725",NULL,NULL,830
"mean sd calcium intake in mg daily","C0024671;C0026410;C0332173;C0439269;C0444504;C0489458;C1960952;C2346927;C2347634;C2348143;C2699239;C4321396;C4521761",NULL,NULL,192
"duration of hypertension n","C0020538;C0449238;C1963138;C2926735","C0020538","",1364
"leflunomide","C0063041","","",-10
"number of subjects in analysis","C0002778;C0237753;C0449788;C0681850;C0936012;C1524024;C1550501;C1706203;C2349001;C2697811",NULL,NULL,1655
"atenolol n $nmbr$ no","C0004147","C0004147","",1055
"number of tender joints $nmbr$ $nmbr$ mean sd","C0234234;C0444504;C0449813;C2347634;C2348143;C2699239","C0451530","",1139
"oral anticoagulant drugs","C0354604","C0354604","",1747
"mean s d measured ldl cholesterol","C0023824;C0202117;C0444504;C0444706;C2347634;C2348143;C3541902","C0023824","",1068
"ccsc at $nmbr$ month before enrollment","C0332177;C0439231;C1516705;C1516879;C1696073;C3888021",NULL,NULL,1476
"periprocedural medications n clopidogrel $nmbr$ mg","C0013227;C0024671;C0026410;C0070166;C0439269;C0802604;C1960952;C2346927;C2598133;C4284232;C4321396;C4521761",NULL,NULL,192
"use of medication for pah","C0013227;C0030123;C1524063;C3203102;C3244316;C4284232;C4284467",NULL,NULL,366
"second mi","C0205436;C0457385;C0565930;C1561503;C1705190;C3810814",NULL,NULL,1783
"disease activity n","C1292728","C1292728",";C4050231;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209",101
"high intensity","C4081854",NULL,NULL,836
"death q ml stent thrombosis","C0011065;C0439526;C1306577;C1705224;C3887665;C3897493;C4082313;C4552775",NULL,NULL,622
"kidney disease usrds","C0022658","C0022658","",104
"warf","C0043031","C0043031","",858
"ethnic origin","C0015031",NULL,NULL,787
"basdai score $nmbr$ $nmbr$ mean sd","C0444504;C0449820;C1998004;C2347634;C2348143;C2699239;C4050231",NULL,NULL,37
"pacemaker no","C0030163;C0810633;C1546728;C3275122;C3853703",NULL,NULL,503
"caleitonin ng l females mean sd","C0086287;C0439297;C0444504;C2347634;C2348143;C2699239",NULL,NULL,2111
"one vessel","C0005847;C0205447",NULL,NULL,737
"ischemic stroke vs tia","C0007787;C0917805;C0948008;C1054154",NULL,NULL,1592
"placebo ezetimibe $nmbr$ simvastatin $nmbr$ fenofibrate $nmbr$ ezetimibe $nmbr$ simvastatin $nmbr$ ezetimibe $nmbr$","C0032042;C0033228;C1532737;C1696465;C1706408","C0074554","",1840
"simvastatin $nmbr$ mg n $nmbr$ $nmbr$","C0024671;C0026410;C0074554;C0439269;C1960952;C2346927;C4321396;C4521761","C0074554","",1840
"potential predictor","C2698872;C3245505","","",-10
"pt years $nmbr$","C0032743;C0439234;C0699718",NULL,NULL,1513
"upa $nmbr$ mg qd","C0024671;C0026410;C0042071;C0332173;C0439269;C1706177;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"treatment throughout study","C1521826;C3161471",NULL,NULL,717
"hctz hydrochlorothiazide based on wilcoxon $nmbr$ sample rank sum tests for age and body mass index t tests for systolic and diastolic blood and $nmbr$ tests for categorical variables t data were missing for some patients","C0001779;C0005767;C0005768;C0005893;C0012000;C0020261;C0022885;C0030705;C0039155;C0039593;C0229664;C0242931;C0370003;C0392366;C0439828;C0456984;C0578022;C0871472;C1305855;C1515051;C1515976;C1527178;C1551393;C1705492;C1705938;C2347026;C3272743;C3831328;C4318744;C4684582",NULL,NULL,1149
"total no of events total no of participants","C0439175;C0439810;C0441471;C0679646;C3541888",NULL,NULL,1033
"steroid use at baseline","C0168634;C0281991;C1442488","C0239126",";C0168634;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1425988;C1947944",120
"in thirds","C0205437",NULL,NULL,1644
"mean ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C0444504;C2347634;C2348143",NULL,NULL,37
"hoehn and yahr stage","C0205390;C1300072;C1306673",NULL,NULL,541
"bmi $nmbr$ kg m $nmbr$ population n $nmbr$","C0032659;C0578022;C1257890;C1532718",";C1305855","",206
"nasal polyps n","C0027430","C0027430","",353
"baseline pos frequency per $nmbr$ days","C0168634;C0585290;C1262869;C1442488;C3496112;C3496399",NULL,NULL,625
"with placebo","C0032042;C1696465;C1706408","C0032042","",28
"both iv vasodilator and inotrope","C0022326;C0042402;C1258199;C3537240;C4265176","C0042402","",817
"$nmbr$ wk","C0332174;C0439230",NULL,NULL,1012
"eczema","C0013595;C4553957",NULL,NULL,691
"randomised to canakinumab $nmbr$ mg","C0024671;C0026410;C0040363;C0041260;C0439269;C1883351;C1960952;C2346927;C2718773;C4321396;C4521761",NULL,NULL,431
"severe oa symptoms at baselined","C0029408;C0436345;C3887876","C0029408","",1356
"postoperative nsaid or glucocorticoid use post randomisation characteristic","C0003211;C0017710;C0032790;C0034656;C0042153;C0457083;C0687676;C1521970;C1704687;C1947944;C3469826;C3536840","C0017710","",1348
"cardiac catheterisation or pci for index event","C0018795;C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010;C4049621","C1532338","",1661
"accp bleeding risk at inclusion no f","C0007637;C0016327;C1512693;C3251812","","",-10
"systemic embolism","C0013922;C0205373;C1704212",NULL,NULL,631
"stage $nmbr$ ckd egfr $nmbr$ to $nmbr$ ml min n $nmbr$","C0205390;C0439445;C1300072;C1306673;C1561643;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"discontinuations due to ae","C0457454;C0678226;C3887670","C0877248","",1974
"high $nmbr$ risk factor","C0035648;C0205250;C0332167;C1299351;C1521761;C2700149;C2827422;C3272283;C3887512;C3889660;C4050568;C4319571;C4321237;C4522209","C4319571","",837
"bun mg dl","C0439269","C0005845","",2271
"$nmbr$ $nmbr$ min","C0702093;C1524029;C3813700",NULL,NULL,1475
"body mass index mean sd range a","C0005893;C0444504;C0578022;C1305855;C1514721;C2347634;C2348143;C2348147;C2699239;C3542016","C1305855","",1734
"placebo n rate $nmbr$","C0032042;C0871208;C1521828;C1696465;C1706408","C0032042","",28
"peripheral artery","C0489868",NULL,NULL,934
"all n $nmbr$ f","C0016327;C0369718;C0441922",NULL,NULL,396
"with alogliptin $nmbr$ mg n $nmbr$ $nmbr$","C0024671;C0026410;C0439269;C1958126;C1960952;C2346927;C4321396;C4521761","C1958126","",1183
"high school graduate or ged","C0870649;C1549971;C1880947","C0870649","",838
"rage ng ml","C0034634;C0439275;C3539760;C3815186",NULL,NULL,204
"cat score","C0007450;C0325090;C0449820;C0524517;C1443200;C3665481;C4050231;C4050461;C4284282",NULL,NULL,255
"normal crp and","C0205307;C0231683;C0439166;C2347086;C3890735;C4048285;C4553972",NULL,NULL,687
"af duration n","C0344434;C0449238;C2926735;C4049859",NULL,NULL,901
"duration","C0449238;C2926735",NULL,NULL,901
"patients with a prior mi or stroke at baseline","C0030705;C0038454;C0168634;C0332152;C1442488;C2826257;C3810814;C4554100",NULL,NULL,2378
"poor compliance noncompliance","C0032646;C0376405;C0457432",NULL,NULL,1690
"q wave in the infarct territory at baseline","C0021308;C0168634;C0429089;C1301808;C1305738;C1442488;C2983136",NULL,NULL,2145
"s $nmbr$ mmhg","C0439475;C0565930;C2603362","C0005823","",1469
"femoral neck bmd g cm $nmbr$","C0015815;C0439267",NULL,NULL,701
"mildly impaired","C0221099;C0750532;C2945599",NULL,NULL,329
"arteriai access","C0444454;C1554204",NULL,NULL,493
"swollen joint count $nmbr$ joints mean sd","C0444504;C0451521;C2347634;C2348143;C2699239",";C0451521","",1140
"celecoxib","C0538927",NULL,NULL,2033
"microalbuminuria or proteinuria","C0033687;C0730345;C1962972;C4554346","C0033687","",376
"normal or high egfr $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$ at baseline to low egfr $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$","C0168634;C0205250;C0205251;C0205307;C0231683;C0369637;C0439166;C0439445;C0441923;C1299351;C1442488;C1550472;C1739039;C2347086;C2700149;C3811844;C3812682;C3887512;C3889660;C3890211;C4048187;C4321237;C4321351;C4522209;C4522223;C4553972","C3811844;C0017654","",592
"smoker at baseline","C0168634;C0337664;C1442488","C0037369","",420
"regions n","C0017446;C0205147","C0017446","",369
"fatal nonfatal hospitalized stroke","C0038454;C0701159;C1302234;C1705232;C4554100",NULL,NULL,507
"cabg only","C0010055;C0205171;C1720467",NULL,NULL,925
"linagliptin metformin","C3264599","C3264599","",2252
"p between age groups","C0001779;C0027362;C0369773;C0441849;C1959644;C2603361","C0027362","",482
"elevated biomarkers and st segment changes","C0005516;C0205250;C0232326;C3163633","C0232326;C0005516;C3163633","",2247
"lipid levels mg dl","C0428460;C0439269","C0023779","",1967
"la grade b n f","C0016327;C1881342","","",-10
"time to randomisation hours interaction p $nmbr$ $nmbr$","C0034656;C0040223;C0439227;C1704675;C3541383",NULL,NULL,888
"amlodipine","C0051696","","",78
"killip class interaction p $nmbr$ $nmbr$","C1704675;C1881332","C1881332","",846
"vitality","C0424589",NULL,NULL,2158
"sbp $nmbr$ mmhg or dbp $nmbr$ mmhg","C0085805;C0439475;C0536221;C3813197;C4281799",NULL,NULL,607
"difference from placebo","C0032042;C1696465;C1705241;C1705242;C1706408","C0032042","",28
"overal event rate","C0441471;C0871208;C1521828;C4019010",NULL,NULL,2008
"sdai","C3871128","C3871128","",1355
"$nmbr$ carotid artery sites","C0007272;C0162859;C0205145","C0007272","",1547
"neoplasia","C0027651;C1882062",NULL,NULL,418
"past only","C0205171;C1444637;C1720467;C4284302",NULL,NULL,456
"prior heart failure n","C0018801;C0018802;C0332152;C2826257;C4554158","C0018801",";C0168634;C1524003",12
"history of clinical fracture $nmbr$ years old","C0205210;C0439234;C0580836;C1272071",NULL,NULL,1099
"stroke tia","C0007787;C0038454;C0917805;C1054154;C4554100",NULL,NULL,1592
"life threatening bleed","C0019080;C1546953;C2826244;C3537125","C2826244","",1088
"msdbp mm hg","C0439475","C0005823","",1469
"event n","C0441471;C4019010",NULL,NULL,412
"omega $nmbr$ fa n $nmbr$","C1719844","C0015684","",1236
"macro albuminuria","C0001925;C2984010","C0001925","",375
"exercise n","C0015259;C1522704","C0015259","",1380
"composite vascular endpoint","C0005847;C0205199;C1547335;C1558950;C1801960;C2349179;C2826544","C0205199","",1631
"mi or cad","C1504769;C2239547;C3810814;C3813548;C4284121",NULL,NULL,698
"rec ischemia requiring revasc","C0022116;C0378365;C1424025;C2606415;C4321499",NULL,NULL,1668
"age is $nmbr$ vrs significant ecg changes and positive biomarkers","C0001779;C0005516;C0237881;C0439178;C0458261;C0750502;C0855329;C1446409;C1514241;C1546944;C2825490;C3273608;C3812269",NULL,NULL,1163
"hispanic ethnicity","C0015031;C0086409;C0243103",NULL,NULL,787
"blood eosinophil count $nmbr$ mm $nmbr$ in $nmbr$ months before screening no","C0005767;C0005768;C0014467;C0200638;C0220908;C0220909;C0229664;C0439231;C0750480;C0750879;C1698960;C1705566;C1710031;C1710032;C1710477;C2348164;C4330985;C4554674",NULL,NULL,1530
"duration of paod years mean sd","C0439234;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735",NULL,NULL,1230
"eq $nmbr$ dprofile mobility n","C0080078;C0205163;C0425245;C0439185;C0449580;C4318935",NULL,NULL,1625
"patients on atorvastatin rosuvastatin or simvastatin at","C0030705;C0074554;C0286651;C0965129","C0074554","",1840
"background aha therapy at screening a n","C0039798;C0050451;C0087111;C0220908;C0220909;C0369718;C0441922;C0772110;C1363945;C1698960;C1706907;C1710031;C1710032;C1710477;C2348164",NULL,NULL,236
"hazard","C0598697",NULL,NULL,345
"family history ot chd n","C0241889;C0280604;C1318464;C1418208;C1705587;C3542407",NULL,NULL,970
"haemoglobin mg dl","C0019046;C0439269","C0019046","",1177
"low risk ics","C0815320;C3272281;C3538919;C4551720",NULL,NULL,174
"age range","C0001779;C1514721;C2348147;C3542016","C0001779","",480
"p value for heterogeneity rosiglitazone versus glyburide","C0017628;C0019409;C0242960;C0289313;C1709380","C0289313","",1761
"placebo slope lsm se mm year","C0032042;C0036919;C0439234;C0439508;C0807955;C1696465;C1706408;C4330985;C4554674","C0032042","",28
"pvalue for heterogeneity","C0019409;C0242960",";C1709380","C0242960",5
"with dm n proactive intervention n $nmbr$ a","C0011816;C0184661;C0886296;C1273869;C3250443",NULL,NULL,290
"time from qualifying event to randomization","C0034656;C0040223;C0441471;C1514624;C3541383;C4019010",NULL,NULL,692
"history of myocardial infarction","C1275835",NULL,NULL,641
"hscrp $nmbr$ $nmbr$ mga $nmbr$ $nmbr$ $nmbr$ x $nmbr$ $nmbr$ $nmbr$","C0065879","C0006560","",286
"renal parameters","C0022646;C0449381","C0022646","",1951
"responder analyses achieving alc $nmbr$ $nmbr$","C0002778;C0936012;C1424945;C1524024;C3811058",NULL,NULL,183
"regadenoson n $nmbr$","C1698215",NULL,NULL,471
"bsa affected mean sd","C0392760;C0444504;C1314939;C2347634;C2348143;C2699239",NULL,NULL,311
"air ig n $nmbr$","C0001861;C0021027;C0305052;C0360506;C3536832",NULL,NULL,1260
"aliskiren","C1120110","C1120110","",1172
"estrogens","C0014939;C3537250;C3541386;C3714615","C0014939","",340
"xanthines b n","C0043318;C3541955","C0043318","",359
"includes patients originally randomized to placebo who were switched to secukinumab per the study designs aes that occurred in at least $nmbr$ $nmbr$ of the patients in the any secukinumab group during the $nmbr$ week placebo controlled period and events with an eair of at least $nmbr$ $nmbr$ cases per $nmbr$ patient years in the any secukinumab group during the entire treatment period events listed according to preferred term in the medical dictionary for regulatory activities meddra version $nmbr$ $nmbr$ sorted in descending order of eair in the any secukinumab group for the entire treatment period the entire treatment period for safety data was from baseline to week $nmbr$ visit of the last patient enrolled in these studies ae adverse event as ankylosing spondylitis eair exposure adjusted incidence rates n number of randomized patients sae serious adverse event urti upper respiratory tract infection","C0012113;C0021149;C0030705;C0032042;C0034656;C0035171;C0036043;C0038013;C0039798;C0041912;C0087111;C0168634;C0205386;C0220856;C0220905;C0274281;C0332157;C0332174;C0332257;C0333052;C0374505;C0439230;C0439234;C0439531;C0439751;C0441471;C0441655;C0441833;C0444667;C0456081;C0680240;C0687744;C0745732;C0868928;C0871208;C0877248;C0947630;C1140263;C1257890;C1412268;C1442488;C1511726;C1512346;C1519255;C1519504;C1521828;C1522326;C1533148;C1533734;C1547177;C1547401;C1552866;C1622657;C1696465;C1704735;C1705169;C1705187;C1705428;C1705429;C1706408;C1707719;C1709305;C1709637;C1948053;C2347664;C2360800;C2607870;C2699274;C2700399;C2983265;C2986888;C3179547;C3245479;C3272378;C3538994;C3541888;C3714741;C3815594;C3887670;C3887704;C4553214;C4684790",NULL,NULL,1811
"angiotensin ii receptor blocker","C0521942;C3536793","C0521942","",779
"age at baseline years","C0168634;C1442488;C1510829","C1510829","",481
"$nmbr$ ci $nmbr$","C0008107;C3259781",NULL,NULL,519
"mental status","C0278060",NULL,NULL,350
"ankle fracture","C0159877;C4552974",NULL,NULL,2024
"history of ischemic heart disease no","C0018787;C0475224;C0683519;C0730226;C0850708;C0944983",NULL,NULL,105
"concurrent treatment at study entry no","C0009247;C0039798;C0087111;C0205420;C0557651;C0679827;C1521826;C1522326;C1533734;C1705169;C1705654;C2603343;C3161471;C3538994;C3887704",NULL,NULL,1730
"ptx $nmbr$ ng ml","C0030899;C0439275",NULL,NULL,204
"upper tertile $nmbr$ $nmbr$","C1282910",NULL,NULL,739
"disorders soc","C0012634",NULL,NULL,1279
"multiracial or other","C1881928",NULL,NULL,778
"reversibility to salbutamol","C1271924","C0449261;C0231999","",1315
"$nmbr$ nil","C0442734","C1697238",";C3484372;C0442734",169
"no amiodarone","C0002598","","",1757
"p values for interaction","C1704675;C1709380",NULL,NULL,888
"ischemic tvr","C0475224",NULL,NULL,1779
"allopurinol $nmbr$ $nmbr$ mg daily n $nmbr$","C0002144;C0024671;C0026410;C0332173;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,1507
"loop at last follow up","C0445022;C0589120;C1522577;C1704685;C3274571","C0354100","",991
"rheumatoid factor positive","C0035448;C0201660;C0439178;C1446409;C1514241;C2825490;C3812269","C0035448","",1435
"prior tnfi n","C0332152;C2826257",NULL,NULL,2375
"fev $nmbr$ pre bronchodilator l mean sd c","C0444504;C2347634;C2348143;C2599602;C2699239;C3714541",NULL,NULL,1599
"amlodipine chlorthalidone","C0008294;C0051696","C0008294","",70
"median fasting serum glucose mg dl iqr","C0015663;C0202041;C0439269;C0549183;C0876920;C2347635;C2348144;C2939193;C3534430",NULL,NULL,192
"a acr $nmbr$","C1412134;C1515941",NULL,NULL,52
"imputed","C2699638",NULL,NULL,1627
"statin only n","C0205171;C0360714;C1720467",NULL,NULL,925
"cholesterol nmol l","C0008377;C0439282",NULL,NULL,669
"time from hospital admission to enrollment","C0019994;C0040223;C1510665;C1516879;C1696073;C1959907;C3541383;C3888021",NULL,NULL,339
"albumin creatinine ratio mg mmol median iqr","C0486293;C0549183;C0567349;C0876920;C1318293;C2347635;C2348144;C2348885;C2939193","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"mab","C0003250;C0369637",NULL,NULL,923
"dilated cardiomyopathy","C0007193;C2984282",NULL,NULL,816
"baseline fev $nmbr$ l","C0168634;C1442488;C3714541",NULL,NULL,1599
"p treatment by region interaction","C0017446;C0039798;C0087111;C0205147;C0369773;C1522326;C1533734;C1704675;C1705169;C2603361;C3538994;C3887704","C0017446","",369
"c kza treatment ref","C0039798;C0087111;C1425988;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,1881
"other determined etiology","C0015127;C0521095;C1314792;C1524003",NULL,NULL,924
"latvia","C0023128",NULL,NULL,2105
"randomized to receive vitamin e","C0034656;C0040363;C0041260;C0042874;C1514756;C1883351;C3714803;C3815594","C0042874","",869
"insulin therapy n","C0021641;C0039798;C0087111;C1363945;C1533581;C1579433;C3714501",NULL,NULL,2347
"ptca only","C0205171;C1720467;C2936173",NULL,NULL,925
"subgoup_name","C0027365;C1547383;C4522128",NULL,NULL,1571
"clinically evident vascular disease","C0042373;C3887511","C0042373","",914
"egfr ml min per $nmbr$ $nmbr$ m","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"elevated cardiac markers","C0205250;C1271630;C3163633",NULL,NULL,415
"seizure frequency during $nmbr$ week baseline median range","C0149775;C0168634;C0332174;C0439230;C0549183;C0876920;C1442488;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016",NULL,NULL,479
"current smoker n $nmbr$ $nmbr$ former smoker n $nmbr$ $nmbr$","C0205156;C0750523;C3173209;C3241966","C3241966","",1420
"other antiplatelet agent no","C0085826","","",1191
"without mets","C0812270;C1705694;C2939420",NULL,NULL,921
"graft occlusionsa","C0181074;C0332835;C1961139",NULL,NULL,462
"vascular risk score","C0005847;C0035647;C0449820;C1558950;C1801960;C4050231;C4552904","C1801960;C0449820;C0035647","",1953
"diclofenac n $nmbr$","C0012091","C0012091","",1324
"pre specified trial endpoints","C0008976;C2349179;C2826245",NULL,NULL,1019
"required hospitalization","C1708385","C0018801",";C0168634;C1524003",12
"no prior lgi event","C0332152;C0441471;C2826257;C4019010",NULL,NULL,294
"moderate or severe exacerbations in the previous year range","C0205081;C0205082;C0205156;C0439234;C0439508;C1514721;C1552607;C1881878;C2348147;C3542016;C4049705;C4049706;C4050465;C4050466;C4085643;C4086268;C4321335",NULL,NULL,2394
"continued treatment study","C0549178;C3161471",NULL,NULL,717
"adjusted exacerbation rate per patient peryear","C0030705;C0456081;C0871208;C1521828;C4086268",NULL,NULL,2005
"class iii iii v","C0439070;C0457166;C1705160;C1880098",NULL,NULL,524
"no concomitant cortcosteroid use","C0042153;C0457083;C0521115;C1947944",NULL,NULL,118
"previous cardiovascular disease","C0007222;C0205156;C1552607",NULL,NULL,2390
"non colorectal cancer","C0009402;C0346629;C1518422;C1527249;C2984278;C3542412","C1527249","",1818
"$nmbr$ th $nmbr$ th percentiles","C0039725;C0039738;C1264641;C1420718;C4282123;C4285344",NULL,NULL,1433
"history of h pylori eradication","C0019664;C0019665;C0079488;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"bmi in kg m $nmbr$ mean sd","C0444504;C0578022;C1532718;C2347634;C2348143;C2699239",NULL,NULL,2125
"recent use of allopurinol within $nmbr$ days of","C0002144;C0332185;C0439228;C1524063",NULL,NULL,1621
"$nmbr$ $nmbr$ months n $nmbr$","C0439231",NULL,NULL,1530
"interquartile range mm","C1711350;C4330985;C4554674",NULL,NULL,1015
"tg","C0337445","C0041004","",209
"h pylori status n","C0079488;C0449438",NULL,NULL,543
"psychogenic","C0458006",NULL,NULL,1671
"egfr $nmbr$ n","C1739039;C3811844;C3812682","C3811844;C0017654","",592
"ace inhibitor or arb","C0003015;C3888198;C4541021",NULL,NULL,44
"ifg igt","C1334085;C1708411",NULL,NULL,1259
"education mean sd y","C0013621;C0013622;C0013658;C0039401;C0444504;C2347634;C2348143;C2699239","C0013658","",902
"fpg data","C1511726;C3245479;C3714741",NULL,NULL,1427
"chf history","C0018802;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"ulnand $nmbr$ ng l","C0439297",NULL,NULL,202
"hemoglobin category","C0019046;C0683312;C3889287","C0019046","",1177
"serious gi disorder","C0012634;C0205404;C1708130;C3539617;C4050121",NULL,NULL,1279
"hazard ratio $nmbr$ confi dence interval","C1272706;C1552654;C1552713;C2985465","C2985465","",975
"swollen joint count of $nmbr$ joints examined","C0332128;C0451521",";C0451521","",1140
"estimated proportions and odds ratios","C0028873;C0750572;C1709707",NULL,NULL,1047
"mean a sdt","C0444504;C2347634;C2348143",NULL,NULL,37
"previous use of antiarrhythmic drugs","C0003195;C0205156;C1524063;C1552607","C0003195","",379
"ics no laba tiotropium n $nmbr$ placebo n $nmbr$","C0032042;C0213771;C0815320;C1696465;C1706408;C4551720","C3540778","",2182
"bowel function","C0011135",NULL,NULL,1321
"baseline bmi $nmbr$ kg m $nmbr$ n $nmbr$","C0168634;C0578022;C1442488;C1532718",";C1305855","",206
"or primary outcome","C0205225;C0439612;C0439631;C1274040",NULL,NULL,2339
"ovary","C0029939;C0227898",NULL,NULL,1745
"hf duration y n","C0018488;C0449238;C1313497;C1538440;C2926735;C3273279","C0018801",";C0168634;C1524003",12
"geographical region n","C0017446","C0017446","",369
"zoledronic acid n $nmbr$","C0257685","C0257685","",2092
"south america","C0037713","C0037713","",580
"history of cvd and of cv risk factors no","C0007222;C0019664;C0019665;C0035648;C0262512;C0262926;C1553898;C1705255;C2004062;C3538987;C4048877;C4318503",NULL,NULL,175
"baseline lp a in $nmbr$ classes","C0065058;C0168634;C0456387;C1439335;C1442488;C1518526;C1705943;C4019422;C4553379",NULL,NULL,452
"creatinine mg dl_","C0010294;C0439269;C1561535","C0600061;C0010294","",952
"lipid lowering therapy no","C0585943","C0585943;C0086440","",1774
"data are mean standard deviation for continuous variables and number for categoric variables p","C0237753;C0439828;C0444504;C0449788;C0549178;C0683312;C0871420;C1442989;C1511726;C1828170;C2347634;C2348143;C2828392;C3245479;C3714741;C3889287",NULL,NULL,1561
"medication use before enrollment no","C0240320;C1516879;C1696073;C3888021",NULL,NULL,119
"history of ml or stroke","C0019664;C0019665;C0038454;C0262512;C0262926;C0439526;C1705224;C1705255;C2004062;C3887665;C4554100",NULL,NULL,832
"$nmbr$ u kg day","C1532634",NULL,NULL,207
"$nmbr$ $nmbr$ mg dl triglycerides","C0041004;C0439269","C0041004","",368
"serious teaes","C0205404",NULL,NULL,916
"no draining fistulas","C0544791",NULL,NULL,1596
"antiarrhythmic agent","C0003195;C0301380",NULL,NULL,486
"mean sd duration of smoking pack years","C0037369;C0444504;C0449238;C0453996;C1277691;C1881674;C2347634;C2348143;C2699239;C2926735",NULL,NULL,37
"$nmbr$ lisinopril","C0065374","C0065374","",847
"heparin fondaparinux or brvalirudin use between oex event","C0019134;C0042153;C0441471;C0457083;C0770546;C1098510;C1947944;C4019010","C1098510","",859
"subjects with prevalent vertebral fracture n prevalent vertebral fracture","C0033105;C0080179;C0220900;C0681850;C1550501;C1706203;C2349001;C2697811",NULL,NULL,1655
"flex ain","C0347129",NULL,NULL,62
"underlying disease","C0012634;C4067746",NULL,NULL,1279
"myocardial infarction","C0027051;C0428953;C2926063;C3810814;C4552959",NULL,NULL,646
"cardiac and echocardiography parameters","C0013516;C0018787;C0449381;C1522601",NULL,NULL,1481
"glyburide n $nmbr$","C0017628","C0017628","",1350
"intervention in complex lesions","C0221198;C1292781",NULL,NULL,472
"hoehn and yahr stage range $nmbr$ $nmbr$","C0205390;C1300072;C1306673;C1514721;C2348147;C3542016",NULL,NULL,541
"apob mg dl","C0003593;C0439269;C3252643",NULL,NULL,2269
"history of mi or stroke d","C0019664;C0019665;C0038454;C0262512;C0262926;C1705255;C2004062;C3810814;C4554100",NULL,NULL,832
"control","C0243148;C1550141;C1882979;C2587213;C3274648;C4553389",NULL,NULL,675
"$nmbr$ $nmbr$ $nmbr$ $nmbr$ continued","C0549178",NULL,NULL,1561
"change from baseline mmhg","C0168634;C0392747;C0439475;C0443172;C1442488;C1705241;C4319952","C0005823","",1469
"methotrexate use at randomization n","C0025677;C0034656;C0042153;C0457083;C1947944","C0025677","",716
"dabigatran $nmbr$ vs dabigatran $nmbr$ mg bid","C0024671;C0026410;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761",NULL,NULL,775
"figure $nmbr$ least squares ls mean differences between ro umilast and placebo in a pre and b postbronchodilator fev $nmbr$ in the itt population and subpopulations copd chronic obstructive pulmonary disease fev $nmbr$ forced expiratory volume in $nmbr$ s ics inhaled corticosteroid itt intent to treat laba long acting b $nmbr$ agonist","C0001617;C0004048;C0016529;C0023189;C0023668;C0024117;C0032042;C0032659;C0035826;C0040363;C0041260;C0079613;C0087111;C0162425;C0205166;C0332152;C0444504;C0740175;C0815320;C1257890;C1283828;C1292734;C1306036;C1413096;C1522326;C1550453;C1696465;C1704930;C1705241;C1705242;C1706317;C1706408;C1869853;C1883351;C2257086;C2347634;C2348143;C2599594;C2987048;C2987634;C3536709;C3669034;C3714541;C3890007;C4048375;C4551720","C0032042","",28
"$nmbr$ mg l","C0439268","C0006560","",193
"presentation","C0449450",NULL,NULL,287
"patients no","C0030705",NULL,NULL,1035
"nt probnp median iqr pg ml","C0439297;C0549183;C0669479;C0754710;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"any ae","C3887670","C0877248","",47
"cardiac history","C0018787;C0019664;C0019665;C0262512;C0262926;C1522601;C1705255;C2004062",NULL,NULL,832
"total sgrq score","C0439175;C0439810;C0449820;C4050231",NULL,NULL,508
"nonbiologic disease modifying drug other than methotrexate","C0025677;C0392747;C4036059","C0242708",";C0026544",231
"low perceived social support only","C0030971;C0037438;C0205171;C0205251;C0748877;C1540833;C1550472;C1720467;C3669642;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"on statins at baseline","C0168634;C0360714;C1442488",NULL,NULL,625
"paclitaxel","C0144576",NULL,NULL,500
"hba $nmbr$ c cholesterol mmol l","C0008377;C0019016;C1532563;C1825777;C3538758","C0008377","",1501
"pulmonary embolism deep vein thrombosis","C0034065;C0149871;C0226514;C0852030",NULL,NULL,630
"met criterion at finalt","C0243161;C0428210;C1550543;C4317104",NULL,NULL,39
"no acs","C0742343;C4318612",NULL,NULL,2147
"baseline cardiovascular medications n","C0007220;C0168634;C1442488","C0007220","",897
"baseline hba $nmbr$ c $nmbr$ $nmbr$ to $nmbr$ $nmbr$ $nmbr$ $nmbr$ mmol mol","C0019016;C0168634;C1442488;C1825777;C3538758;C3829066","","",820
"i amiodarone","C0002598;C0021966;C0221138",NULL,NULL,1021
"physician global assessment of disease activity $nmbr$ $nmbr$ cm vas","C0042815;C3536884;C3827561;C4050369",NULL,NULL,1751
"entacapone","C0165921",NULL,NULL,1231
"subgroups","C1079230",NULL,NULL,1637
"participants with hf at baseline","C0018488;C0168634;C0679646;C1313497;C1442488;C1538440;C3273279",NULL,NULL,1033
"final mg dl","C0205088;C0439269;C1546485;C3853528",NULL,NULL,1680
"triglyceride mg dl","C0041004;C0439269","C0041004","",368
"upper limb fractures","C0016658;C1140618",NULL,NULL,1554
"presence of mets a","C0150312;C0392148;C0812270;C1705694;C2939420;C3854307",NULL,NULL,921
"non ischaemic n $nmbr$","C0475224;C1518422",NULL,NULL,1670
"crp median mg dl","C0439269;C0549183;C0876920;C2347635;C2348144;C2939193;C3890735;C4048285","C0006560","",286
"cardiovascular status","C0007226;C0449438;C3887460",NULL,NULL,649
"median egfr interquartile range","C0549183;C0876920;C1711350;C1739039;C2347635;C2348144;C2939193;C3811844;C3812682",NULL,NULL,635
"cancer surgery","C0920424","C0920424","",218
"male nyha class","C0086582;C1706180;C1706428;C1706429;C1882083","C0086582","",1276
"airway reversibility","C0178987;C0449261;C0458827","C0449261;C0231999","",1315
"impaired cognitive function spmsq $nmbr$ n $nmbr$ n participants with the event of interest","C0009240;C0221099;C0392335;C0441471;C0543488;C0679646;C4019010;C4050130",NULL,NULL,1033
"row","C1552840;C1552846",NULL,NULL,852
"indacaterol $nmbr$ mg n z $nmbr$","C0024671;C0026410;C0439269;C1722260;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2285
"mra at baseline","C0168634;C0243032;C1442488;C1609165;C3891069","","",239
"bm i $nmbr$","C0006416;C0021966;C0221138",NULL,NULL,1735
"site of disease no","C0012634;C2945843",NULL,NULL,1279
"ics yes","C0815320;C1549445;C1705108;C1710701;C4551720",NULL,NULL,147
"types of antihypertensive medications at last visit","C0003364;C0332307;C0545082;C1512346;C1517741;C2826704",";C0003364","",1579
"any vascular efficacy","C0005847;C1280519;C1558950;C1707887;C1801960",NULL,NULL,743
"ethnicity hispanic latino n","C0015031;C0086409;C0086528;C0243103",NULL,NULL,787
"eastern and central europe","C0682369;C1707877",NULL,NULL,505
"$nmbr$ to $nmbr$ kg","C0022718;C0439209;C4054209",NULL,NULL,205
"avp pg ml","C0439297;C1098706;C1568204;C1708407",NULL,NULL,202
"ambulatory sbp difference vs placebo $nmbr$ cl","C0032042;C0085805;C0439841;C0596019;C1696465;C1705241;C1705242;C1706408","C0032042","",28
"ventricular tachyarrhythmias","C3827656","C3827656","",1217
"no japanese","C0376247;C1556094","C0022341","",1815
"gender no","C0079399;C1522384","C0079399","",1083
"p $nmbr$ $nmbr$ for between treatment difference with same dose of simvastatin for entire cohort data are expressed as least squares mean standard error simva simvastatin eze ezetimibe chd coronary heart disease","C0009247;C0012634;C0018787;C0023189;C0039798;C0074554;C0087111;C0178602;C0280604;C0369773;C0439751;C0444504;C0444667;C0445247;C0599755;C0869039;C1114758;C1142985;C1511726;C1522326;C1533734;C1705169;C1705241;C1705242;C1710181;C2347634;C2348143;C2603361;C3245479;C3538994;C3542407;C3714741;C3887704",NULL,NULL,970
"native american or alaska native","C0282204;C0682125;C1515945","C0282204","",2254
"adcs adl score","C0449820;C3641947;C4050231","C3641947","",1070
"subgroup name level","C0027365;C0441889;C0456079;C1079230;C1515021;C1547383;C1547707;C2946261;C4522128",NULL,NULL,1637
"tofacitinib $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C2930696;C4321396;C4521761","C2930696","",857
"history of peripheral artery disease no","C0489868;C0683519;C0730226;C0850708;C0944983",NULL,NULL,934
"aldosterone antagonist","C0002007;C2757004;C3536833","C0002007",";C0034678;C0525678;C1514727",1758
"crp mg l b median min max","C0439420;C0549183;C0876920;C2347635;C2348144;C2939193;C3890735;C4048285","C0006560","",286
"medication use at baseline n","C0168634;C0240320;C1442488",NULL,NULL,625
"any sulfonylurea","C0038766;C3536898","C0038766","",752
"high intensity statin vs medium or low intensity statin at randomization","C0009458;C0034656;C0360714;C0439536;C0596836;C1705217;C3244283;C4081854;C4085196;C4522282;C4522283","C0360714","",872
"age is $nmbr$ vrs positive biomarkers and no si gni fi canr ecg changes","C0001779;C0005516;C0392747;C0439178;C0443172;C0458261;C1446409;C1514241;C1623258;C1705241;C2825490;C3273608;C3812269;C4050619;C4319952",NULL,NULL,1311
"cc","C0008318;C3538933",NULL,NULL,705
"fatal or nonlatal stroke","C0038454;C1302234;C1705232;C4554100",NULL,NULL,507
"no immunosuppressive agents at baseline","C0021081;C0168634;C1442488",NULL,NULL,625
"least squares mean difference $nmbr$ ci","C0008107;C0023189;C0444504;C1705241;C1705242;C2347634;C2348143;C3259781",NULL,NULL,519
"$nmbr$ mg biw $nmbr$ $nmbr$ pt yrs","C0024671;C0026410;C0032743;C0439269;C0699718;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"frail","C0871754",NULL,NULL,1741
"pneumonia","C0032285","C0032285","",589
"p for i","C0021966;C0221138;C0369773;C2603361",NULL,NULL,1874
"time point","C2348792",NULL,NULL,1134
"number s of features present","C0150312;C0237753;C0449450;C0449788;C1521970;C1706388;C2346469;C2348519",NULL,NULL,287
"hr bpm sd","C2699239",NULL,NULL,954
"nonfatal myocardial infarction","C0027051;C0428953;C2926063;C3810814;C4552959",NULL,NULL,646
"body mass index bmi kg m $nmbr$ n $nmbr$ kg m $nmbr$","C0005893;C0022718;C0439209;C0578022;C1305855;C1709500;C4054209","C1305855","",1734
"periostin","C0219433;C1424662;C3812270","C3812270","",1027
"lesion length $nmbr$ mm","C0221198;C1444754;C1546698;C1706316;C4330985;C4554674",NULL,NULL,472
"p blocking agents selective","C0036576;C0233660;C0332206;C0369773;C0450442;C1254351;C1521826;C1707391;C2603361",NULL,NULL,1823
"category $nmbr$","C0683312;C3889287",NULL,NULL,562
"patients with fingernail involvement","C0030705;C0222001;C1314939",NULL,NULL,1090
"mean or n","C0369718;C0441922;C0444504;C2347634;C2348143",NULL,NULL,37
"pregnancy","C0032961",NULL,NULL,2370
"mean sd bmd in g cm $nmbr$","C0439267;C0444504;C2347634;C2348143;C2699239",NULL,NULL,701
"planned valve surgery n","C0038894;C0038895;C0184252;C0543467;C1186983;C1274039;C1301732;C1704414;C3888056",NULL,NULL,598
"years since menopause","C0025320;C0439234;C0567312",NULL,NULL,1099
"endovascular no","C0524425","C0524425","",1218
"sbp sd mm hg","C0085805;C0439475;C2699239",NULL,NULL,607
"dm duration","C0011816;C0449238;C2926735;C3250443",NULL,NULL,901
"other glp $nmbr$ receptor agonist","C0018301;C1422069;C1425391;C1539338;C2350813;C4543206","C0014361;C2987634",";C1422069;C1425391;C1539338",1153
"undetermined other or cardioembolism","C0205258;C3536725;C4082977",NULL,NULL,628
"insulin secretagogue","C0021641;C1533581;C1579433;C3714501;C4704833",NULL,NULL,157
"nasal polyps at baseline yes","C0027430;C0168634;C1442488;C1549445;C1705108;C1710701","C0027430","",353
"st segment deviation $nmbr$ mm no total no","C0012727;C0036056;C0205419;C0429029;C0429066;C0439175;C0439810;C0441635;C1114722;C1116089;C1705236;C3272372;C4330985;C4554674",NULL,NULL,2356
"mycophenolate any derivative","C0883242;C1527240","C0209368","",304
"extensive colitis n","C0009319;C0205231;C1963084","C0205231;C0009319","",2063
"symptom onset to hospital arrival median iqr h","C0019994;C0033727;C0369286;C0441932;C0549183;C0564385;C0876920;C1510665;C1555577;C1706079;C2347635;C2348144;C2939193;C4086878;C4528284",NULL,NULL,612
"ophthalmologic events","C0029087;C0205481;C0441471;C3541888",NULL,NULL,412
"tg mmol l mg dl","C0337445;C3642216;C3898312",NULL,NULL,1977
"mean sd disease duration years","C0439234;C0444504;C0872146;C2347634;C2348143;C2699239","C0449238;C0872146","",903
"hba $nmbr$ c at $nmbr$ weeks","C0019016;C0439230;C1825777;C3538758","","",820
"c reactive protein mg l","C0006560;C0439268;C1413716;C4048285","C0006560","",286
"prior ugi event","C0332152;C0441471;C0560042;C2826257;C4019010",NULL,NULL,294
"lvh n $nmbr$","C0149721","C0149721","",1272
"anemia","C0002871;C1000483;C4554633",NULL,NULL,152
"emotional function","C0013987;C0031843;C0542341;C0700205;C0849912;C1705273",NULL,NULL,1531
"history of congestive heart failure","C0455531;C0742742","C0018801",";C0168634;C1524003",12
"other vasodilator","C0042402;C3537240","C0042402","",817
"aes","C1412268;C2699274","C0877248","",47
"micro or macroalbuminuria n","C0085672;C1553035;C3811161;C4049106","C0033687","",376
"foot fracture","C0272774",NULL,NULL,2027
"$nmbr$ minute walk distance m","C0369637;C0429886;C0439232;C0441923;C0700321;C0702093;C1282918;C2347166",NULL,NULL,923
"post bronchodilator fev $nmbr$ predictedb","C2599594;C3714541",NULL,NULL,680
"less than the median","C0439092;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"$nmbr$ no symptoms","C0683368;C1457887",NULL,NULL,613
"alone","C0205171;C0439044;C0679994",NULL,NULL,926
"estimated gfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ no","C0017654;C0369637;C0439445;C0441923;C0750572;C1424601","C3811844;C0017654","",592
"baseline tophusa","C0168634;C1442488",NULL,NULL,625
"other hypoglycemic agent n","C0020616","C0020616",";C0013227;C3244316;C4284232;C0450442;C1254351;C1515187;C1521826;C2826257",33
"median median","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"lowering drugs","C0013227;C0441994;C2003888;C3687832",NULL,NULL,367
"region","C0017446;C0205147","C0017446","",369
"oral glucocorticoid dose mg prednisone equivalent","C0017710;C0024671;C0026410;C0032952;C0178602;C0205163;C0439185;C0439269;C0442027;C0869039;C1114758;C1960952;C2346927;C4321396;C4521761;C4521986","C0017710","",1348
"persistent or permanent immobilization","C0020944;C0205322;C0205355;C0332996;C4048292",NULL,NULL,718
"stroke no","C0038454;C4554100",NULL,NULL,1762
"biologic","C0005515;C0205460",NULL,NULL,214
"favors amlodipine favors chlorthalidone","C0008294;C0051696;C0309049","C0008294","",70
"egfr by creatinine ml min per $nmbr$ $nmbr$ m $nmbr$","C0010294;C0369637;C0439445;C0441923;C1561535;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"fev $nmbr$ fvc prebronchodilatort","C3714541",NULL,NULL,1599
"with rehospitalization urgent coronary revascularization","C0439609;C0877341;C3272275","C0877341;C3272275","",1212
"atopy by phadiatop test n","C0022885;C0039593;C0392366;C0392707;C0456984;C1441070;C1515976;C3539705;C3831328;C4318744",NULL,NULL,2351
"ethacrynic acid","C0014963",NULL,NULL,346
"laba use at enrolment","C0042153;C0457083;C1516879;C1696073;C1947944;C3888021",NULL,NULL,118
"treatment at randomization","C0034656;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,692
"cardiovascu lar subg roup","C0276828;C1419115;C3814448",NULL,NULL,2155
"primary mace endpoint","C0349381;C0949745;C1445339;C2986535","C1320716","",414
"smoking","C0037369;C0453996;C1881674","C0037369","",420
"fish oil n $nmbr$","C0016157",NULL,NULL,1681
"previous stroke or tl a","C0038454;C0205156;C0220928;C1552607;C4554100",NULL,NULL,1762
"restriction in normal activities in the past $nmbr$ weeks","C0443288;C2987125;C4697852",NULL,NULL,1014
"final analysis all patients","C0002778;C0030705;C0205088;C0936012;C1524024;C1546485;C3853528",NULL,NULL,183
"arrhythmias","C0003811","C0003811","",380
"baseline medications","C0013227;C0168634;C0802604;C1442488;C2598133;C4284232",NULL,NULL,366
"prior sulfasalazine use","C0036078;C0042153;C0332152;C0457083;C1947944;C2826257",NULL,NULL,71
"post bronchodilation fvc","C0439576;C3714541",NULL,NULL,1599
"arthralgia","C0003862;C4551938","C0003862","",378
"current tobacco use","C0040335;C0521116;C0543414;C0841002;C1705970;C3853727",NULL,NULL,23
"yes previous revascularization","C0205156;C0581603;C1549445;C1552607;C1705108;C1710701","C1532338","",1661
"$nmbr$ kg body weight at randomization","C0005910;C0022718;C0034656;C0242821;C0439209;C0460148;C1268086;C1305866;C2985844;C4054209;C4082212","C0005910","",1250
"$nmbr$ $nmbr$ ne ne","C0027608;C0028219;C3538705","","",-10
"previous mi no","C0205156;C1552607;C3810814",NULL,NULL,516
"enrolled into osler","C4684790",NULL,NULL,334
"or $nmbr$ cl $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0596019",NULL,NULL,658
"zoledronic acid arm","C0257685;C0446516;C3715044;C4553528","C0257685","",2092
"efficacy endpoint","C1280519;C1707887;C2349179;C2826544","C1707887;C2349179","",1122
"aspirin","C0004057","C0004057","",1366
"hemoglobin g r $nmbr$","C0205090;C0684010;C1319312;C2603358","C0019046","",1177
"fluticasone furoate and vilanterol n $nmbr$","C1948374;C2935023",NULL,NULL,930
"chronic kidney disease","C1561643;C4553188","C1561643","",967
"nsaid","C0003211;C3536840",NULL,NULL,2121
"no chd eze simva $nmbr$ $nmbr$","C0280604;C3542407",NULL,NULL,970
"base","C0002055;C0178499;C1880279",NULL,NULL,100
"within last $nmbr$ d","C1517741",NULL,NULL,457
"pio $nmbr$","C0030800;C2347712",NULL,NULL,437
"prior aeds $nmbr$ n","C0180309;C0332152;C2826257",NULL,NULL,294
"baseline bmi kg m","C0168634;C0578022;C1442488;C1532718",NULL,NULL,1735
"stent length per lesion mm","C0038257;C0221198;C1444754;C1546698;C1706316;C4330985;C4554674",NULL,NULL,569
"mdrd egfr ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682;C3839656","C3811844;C0017654","",592
"potassium sparing at last follow up","C0032821;C0202194;C0304475;C0589120;C0597277;C1522577;C1704685;C3274571;C3714637","C0304490","",1966
"$nmbr$ or $nmbr$ step","C1261552;C1704379;C1705117;C2825408;C3814463",NULL,NULL,571
"angina","C0002962","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"ischaemic or unknown stroke","C0038454;C0439673;C0475224;C3541433;C4050014;C4554100",NULL,NULL,93
"sa acs","C0036243;C0038702;C0742343;C1539696;C1825840;C3539736;C4318612;C4521691","","",-10
"minimum maximum","C0806909;C1524031;C1552614;C1552615;C2826545;C2826546",";C1524031;C0806909","",1376
"medium or low intensity statin","C0009458;C0360714;C0439536;C0596836;C1705217;C3244283;C4085196;C4522282;C4522283","C0360714","",2205
"week $nmbr$ crp","C0332174;C0439230;C3890735;C4048285",NULL,NULL,1012
"asp","C0206293;C0206298;C1332656;C1528298;C3541260;C3890396;C4048238;C4321307;C4553371",NULL,NULL,459
"percentage of p","C0439165;C1549488;C1561533",NULL,NULL,291
"prior bypass graft surgery","C0185098;C0455610",NULL,NULL,2032
"atherosclerotic coronary heart disease ischaemic stroke or peripheral arterial disease n n number of people in phase $nmbr$ studies only high intensity statins were defined as atorvastatin $nmbr$ to $nmbr$ mg rosuvastatin $nmbr$ to $nmbr$ mg or simvastatin $nmbr$ mg daily","C0003842;C0010054;C0010068;C0012634;C0018787;C0024671;C0026410;C0027361;C0074554;C0205100;C0205171;C0205390;C0221464;C0237753;C0286651;C0332173;C0333482;C0360714;C0439269;C0449788;C0557651;C0947630;C0948008;C0965129;C1704788;C1710475;C1720467;C1956346;C1960952;C2346927;C2603343;C3539106;C4081854;C4321396;C4521761","C0010068;C1956346",";C0026410;C1710701",226
"infliximab $nmbr$ mg kg","C0439272;C0666743",NULL,NULL,2327
"metformin","C0025598","C0025598","",1345
"tiotropium olodaterol $nmbr$ $nmbr$ $nmbr$ pg","C0030827;C0072225;C1266240;C4032878",NULL,NULL,1510
"previous or current cs use no","C0010182;C0042153;C0205156;C0271160;C0457083;C0521116;C1552607;C1705970;C1947944;C3540510;C4085345",NULL,NULL,136
"glycoprotein iib iiiareceptorinhibitor","C0017968",NULL,NULL,807
"age median iqr","C0001779;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,1890
"ed duration $nmbr$ yr n","C0439234;C0449238;C2926735;C3538926",NULL,NULL,411
"total resolution of enthesitisc","C0439175;C0439810;C1514893;C1706463;C2699488",NULL,NULL,508
"extended cardiovascular endpoint","C0007226;C0231448;C0231449;C0439792;C2349179;C2826544;C3887460",NULL,NULL,649
"msasss mean sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"ischemia on cecg","C0022116;C4321499",NULL,NULL,1668
"moderate severe","C0205081;C0205082;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335",NULL,NULL,321
"egfr ml min per $nmbr$ $nmbr$ m $nmbr$ t","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"gpifeellla inhibitor use before angography","C0042153;C0457083;C1947944;C1999216",NULL,NULL,812
"corticosteroids only","C0001617;C0205171;C1720467;C3539185;C3540725;C3540726;C3540727",NULL,NULL,1650
"lelt ventricular hypertrophy","C0340279","C0149721","",1496
"apob apoa l ratio","C0003592;C0003593;C0456603;C0523508;C1547037;C3252643;C4553344;C4553379","C0003592","",427
"insulin treatment n","C0745343","C0745343","",2075
"age y o","C0001779","C0001779","",480
"basal insulin doset","C0650607","C0650607","",354
"proteinuria $nmbr$ g day","C0033687;C0439417;C1962972;C4554346","C0033687","",285
"stratification factor menopausal status n","C1513126;C1514984",NULL,NULL,2020
"mtx average weekly dose mg week mean sd","C0024671;C0026410;C0332174;C0366550;C0439230;C0439269;C0444504;C1510992;C1960952;C2346927;C2347634;C2348143;C2699239;C2825518;C4321396;C4521761","C0025677","",716
"$nmbr$ mg sirukumab every $nmbr$ weeks n $nmbr$","C0024671;C0026410;C0439230;C0439269;C1960952;C2346927;C3254570;C4321396;C4521761",NULL,NULL,192
"cardio renal risk","C0018787;C0022646;C0035647;C4552904","C0035647","",173
"mixed n $nmbr$","C0205430;C3160715",NULL,NULL,985
"$nmbr$ nd $nmbr$ $nmbr$ $nmbr$ $nmbr$ pmol l","C0439284",NULL,NULL,666
"time in trial","C0008976;C0040223;C0150312;C0332285;C1707101;C3541383",NULL,NULL,1020
"tnf ir","C0022065;C0022071;C1448132;C1448177","","",1397
"area of fluorescein leakage within the grid mean sd dab","C0017446;C0086162;C0205146;C0444504;C1081457;C1415284;C2347634;C2348143;C2348395;C2699239;C2825313;C4476700;C4522144",NULL,NULL,370
"urine qmax ml s","C0042036;C0042037;C0439390;C2963137",NULL,NULL,299
"time from randomisation to $nmbr$ st balloon inflation h","C0021398;C0033727;C0034656;C0036056;C0040223;C0336867;C0369286;C0441144;C0441932;C0564385;C1318493;C3272372;C3541383;C4528284",NULL,NULL,434
"elevated serum potassium $nmbr$ $nmbr$ mmol l","C0553704;C1532563","C0032821","",1371
"tnfi na ve","C0042469;C0597484;C1272460;C1546968;C1879645;C3714652;C4049872;C4321495;C4552882",NULL,NULL,419
"less than $nmbr$ year","C0439092;C0439234;C0439508",NULL,NULL,1099
"by treatment arm","C1522541",NULL,NULL,950
"time from qualifying myocardial infarction","C0027051;C0040223;C0428953;C1514624;C2926063;C3541383;C3810814;C4552959",NULL,NULL,646
"age in $nmbr$ classes","C0001779;C0456387;C1518526;C1705943;C4019422",NULL,NULL,452
"or morbidity and mortality","C0026538;C0026565;C0026566;C0220880","C0026565","",1312
"absence","C0332197;C1689985",NULL,NULL,485
"coronary bypass n","C0010055","C0010055","",389
"pasi i","C0021966;C0221138;C4528685",NULL,NULL,1522
"bosentan","C0252643","C0252643","",1328
"$nmbr$ years eze simva baseline ldl c","C0168634;C0439234;C1442488",NULL,NULL,1099
"blood pressure pbo y patients with diabe teristics ncep atp i","C0005823;C0021966;C0030705;C0031962;C0221138;C1271104;C1272641;C2744579;C4552600",NULL,NULL,435
"ind gly $nmbr$ $nmbr$ mg once daily n $nmbr$","C0017890;C0024671;C0026410;C0332173;C0439269;C0523677;C1960952;C2346927;C4049864;C4321396;C4521761",NULL,NULL,192
"clinical criteria $nmbr$","C0205210;C0243161",NULL,NULL,793
"sbp mm hg mean $nmbr$ h mean sd","C0025424;C0085805;C0428257;C0444504;C0456680;C2347108;C2347109;C2347634;C2348143;C2348272;C2699239",NULL,NULL,37
"baseline cv medications n","C0013227;C0168634;C0802604;C1442488;C2598133;C3538987;C4048877;C4284232;C4318503",NULL,NULL,1777
"patients taking mtx n","C0025677;C0030705;C1417487;C1515187","C0025677","",1334
"amlodipine valsartan $nmbr$ to $nmbr$ $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C1962523;C2346927;C4321396;C4521761","","",78
"number of exacerbations","C0237753;C0449788;C4086268","C4086268","",889
"history of carotid disease n","C0683519;C0730226;C0741968;C0850708;C0944983","C0007273","",2195
"unknown no","C0439673;C3541433;C4050014",NULL,NULL,93
"retinopathy","C0035309;C1962966",NULL,NULL,1719
"nonfatal myocardiail infarction","C0021308",NULL,NULL,2144
"overall treatment effect","C0282416;C1518681;C1561607",NULL,NULL,1743
"serum urate mg dl n","C0439269;C0455272",NULL,NULL,2308
"fev $nmbr$ auc $nmbr$ mine $nmbr$ h","C0033727;C0369286;C0376690;C0441932;C0564385;C3714541;C4528284",NULL,NULL,308
"insulin alone","C0021641;C0205171;C0439044;C0679994;C1533581;C1579433;C3714501",NULL,NULL,157
"czech repumc","C0337799","","",-10
"most frequent aesa","C0205393;C0332183",NULL,NULL,2352
"forearm","C0016536","C0016536","",1211
"sitting pulse bpma","C0232117;C0277814;C0391850;C1947910;C2584297;C4050224","C0232117","",1117
"patients with dactylitis at week $nmbr$ n","C0030705;C0239161;C0332174;C0439230",NULL,NULL,1012
"$nmbr$ $nmbr$ or more","C0205172",NULL,NULL,1539
"diet controlled or no","C0743195","C0743195","",333
"serum triglycerides mg dle","C0024138;C0024671;C0026410;C0439269;C0542495;C1960952;C2346927;C3542918;C4321396;C4521761",NULL,NULL,2306
"$nmbr$ mg g","C1300563",NULL,NULL,196
"no of participants with events","C0441471;C0679646;C3541888",NULL,NULL,1033
"week $nmbr$","C0332174;C0439230",NULL,NULL,1012
"other multiple","C0439064",NULL,NULL,330
"type","C0332307;C1547052",NULL,NULL,603
"baseline trig $nmbr$ millycerides g dl","C0168634;C0202236;C0439267;C1442488;C1519533",NULL,NULL,1486
"score distribution","C0449820;C0520511;C1704711;C4050231",NULL,NULL,892
"number of treated patients","C1522326;C2360800",NULL,NULL,1811
"time from randomization to coronary angiography hr","C0034656;C0040223;C0085532;C1548829;C3541383",NULL,NULL,1724
"st george s respiratory questionnaire total score","C0439175;C0439810;C3472502",NULL,NULL,751
"week $nmbr$ fpg mean s e","C0332174;C0439230;C0444504;C2347634;C2348143",NULL,NULL,37
"previous balloon angioplasty n","C0002996;C0002997;C0205156;C1552607","C0002996","",1721
"deviation tg triglyceride","C0012727;C0041004;C0205419;C1705236","C0041004","",368
"p $nmbr$ y $nmbr$ inhibitor maintenance","C0024501;C0369773;C1999216;C2603361",NULL,NULL,812
"size cm $nmbr$ mean standard deviation","C0444504;C0456389;C0871420;C1442989;C1828170;C2347634;C2348143;C2828392",NULL,NULL,1482
"dbp mmghg mean sd","C0444504;C0536221;C2347634;C2348143;C2699239;C3813197;C4281799",NULL,NULL,605
"duration of diabetes years t","C0011847;C0011849;C0439234;C0449238;C2926735","C2926735;C0011849","",1988
"normal egfr $nmbr$","C0205307;C0231683;C0439166;C1739039;C2347086;C3811844;C3812682;C4553972","C3811844;C0017654","",592
"lesion length $ $nmbr$ mm","C0221198;C1444754;C1546698;C1706316;C4330985;C4554674",NULL,NULL,472
"acs n $nmbr$ $nmbr$","C0742343;C4318612",NULL,NULL,2147
"bph luts severity","C0005001;C0439793;C0522510;C0574785;C1704272",NULL,NULL,1658
"group b n $nmbr$","C0441848",NULL,NULL,1638
"sex no total no","C0009253;C0036864;C0079399;C0439175;C0439810;C0804628;C1314687;C1522384",NULL,NULL,568
"health habits","C0679786",NULL,NULL,2403
"caucasian $nmbr$","C0007457;C0043157","C0043157","",1329
"congestive heart failure no","C0018802","C0018801",";C0168634;C1524003",12
"fatty acid composition","C0015684;C0486616;C1555710","C0015684","",1236
"vorapaxar placebo $nmbr$ yr km","C0032042;C0439234;C1696465;C1706408;C2974521;C3887676","C0032042","",28
"non hdl cholesterol apob ratio","C0003593;C0456603;C0729627;C1518422;C1535899;C1547037;C2938854;C3252643","C0023822","",821
"p interaction women vs men","C0025266;C0043210;C0369773;C1704675;C2603361",NULL,NULL,888
"cumulative events","C0441471;C1511559;C3541888",NULL,NULL,412
"bnp o $nmbr$ pg ml or nt pro bnp o $nmbr$ pg ml n","C0033382;C0054015;C0439297;C0523852;C1095989;C1417808;C2982014;C2987124;C4284038",NULL,NULL,1635
"pef","C0030771;C1518922;C1542834",NULL,NULL,566
"time since last dose of","C0946444",NULL,NULL,756
"treatment de vs warfarin by thrombophilia interaction","C0011198;C0017480;C0039798;C0043031;C0087111;C0398623;C1522326;C1533734;C1704675;C1705169;C3538994;C3541240;C3887704",NULL,NULL,1620
"pairwise comparison","C1707455",NULL,NULL,1633
"daytime nasal symptoms score change from baseline mean se","C0036919;C0168634;C0231918;C0332169;C0392747;C0443172;C0444504;C0449820;C1442488;C1705241;C2347634;C2348143;C4050231;C4319952",NULL,NULL,567
"laboratory determinations","C0022877;C0680730;C3244292;C4283904",NULL,NULL,978
"patients without syndesmophytes at baseline","C0030705;C0168634;C0221690;C1442488",NULL,NULL,625
"time since diagnosis of sle years","C0011900;C0024141;C0040223;C0439234;C1704338;C1704656;C3541383",NULL,NULL,1099
"age $nmbr$ yr and elevated biomarkers","C0001779;C0005516;C0205250;C0439234;C3163633","C0001779","",480
"distribution time","C0040223;C0520511;C1704711;C3541383",NULL,NULL,892
"active cancer at baseline","C0006826;C0168634;C0205177;C0998265;C1306459;C1442488;C3853793;C3888249","C0006826","",1819
"aspirin use p $nmbr$ $nmbr$","C0004057;C0042153;C0457083;C1947944","C0004057","",1366
"white caucasian","C0043157","C0043157","",1329
"chd at baseline","C0168634;C0280604;C1442488;C3542407",NULL,NULL,970
"percent impairment while working due to asthma","C0004096;C0043227;C0221099;C0439165;C0678226;C0684336;C2984299",NULL,NULL,694
"eastern europe n $nmbr$ $nmbr$","C0015177","C0239309","",601
"cholesterol $nmbr$ $nmbr$ mmol l n","C0008377;C1532563","C0008377","",1501
"elevated vs normalc","C0205250;C3163633",NULL,NULL,415
"with prior mi stroke n $nmbr$","C0038454;C0332152;C2826257;C3810814;C4554100",NULL,NULL,2378
"tjc $nmbr$ $nmbr$ mean sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,1589
"hispanic or latino","C0086409;C0086528","C0086528;C0086409;C0015031","",363
"$nmbr$ to o $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C0483204","C3811844;C0017654","",307
"former or never","C0205156;C0750523;C2003901",NULL,NULL,13
"weight $nmbr$ $nmbr$ kg n","C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209","C0005910","",1250
"d $nmbr$ mg vs warfarin","C0024671;C0026410;C0043031;C0073187;C0332173;C0439269;C1960952;C2346927;C4321396;C4484261;C4521761",NULL,NULL,192
"class iv only","C0205171;C0441888;C1720467;C2698970",NULL,NULL,1258
"hazard ratio with low $nmbr$ cl","C0205251;C0596019;C1550472;C2985465;C3890211;C4048187;C4321351;C4522223","C2985465","",975
"patients having exacerbation","C0030705;C4086268","C4086268","",889
"tamsulosin n $nmbr$","C0257343","C0257343","",1346
"placebo secukinumab pooled","C0032042;C1696465;C1706408;C1709595;C2349200;C3179547;C4522255","C0032042","",28
"number of patients with event","C0441471;C2360800;C4019010",NULL,NULL,412
"any cough","C0010200;C1961131;C3274924;C4084725;C4084726;C4084727","C0010200","",1388
"life threatening bleeding disabling stroke and death","C0011065;C0019080;C0038454;C1306577;C1546953;C2826244;C3537125;C4082313;C4552775;C4554100","C2826244","",1088
"alc group","C0441833;C0687744;C1257890;C1424945;C1519504;C1705428;C1705429;C3811058",NULL,NULL,395
"presence of mets","C0150312;C0392148;C0812270;C1705694;C2939420;C3854307",NULL,NULL,921
"prior myocardial infarction no total no","C0155668;C0439175;C0439810",NULL,NULL,647
"patients receiving immunosuppressive agents at baseline","C0021081;C0030705;C0168634;C1442488;C1514756",NULL,NULL,1035
"patients with dm n $nmbr$","C0011816;C0030705;C3250443",NULL,NULL,955
"presence of tophi","C0150312;C0221248;C0392148;C3854307",NULL,NULL,2369
"$nmbr$ mg cohort","C0009247;C0024671;C0026410;C0439269;C0599755;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"$nmbr$ ng l n $nmbr$","C0439297",NULL,NULL,202
"treatments at randomisation","C0034656;C0087111",NULL,NULL,692
"copd severity stage gold","C0018026;C0024117;C0205390;C0439793;C0522510;C1300072;C1304897;C1306673;C1412502;C3714496",NULL,NULL,541
"country n","C0454664;C1511538",NULL,NULL,1560
"sfc n $nmbr$","C4521536",NULL,NULL,1283
"liraglutide $nmbr$ $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1456408;C1960952;C2346927;C4321396;C4521761","C1456408","",1566
"statin only","C0205171;C0360714;C1720467",NULL,NULL,925
"arb or ace inhibitor","C0003015;C3888198;C4541021",NULL,NULL,44
"p value for interaction dosage with dabigatran $nmbr$ mg","C0024671;C0026410;C0178602;C0439269;C1704675;C1709380;C1960952;C2346927;C2348066;C2986497;C4321396;C4521761",NULL,NULL,888
"other blood glucose lowering agents","C0005802;C0441994;C0450442;C1254351;C1521826;C2003888",NULL,NULL,1612
"ex smokers $nmbr$","C0337671;C4555205","C0037369","",420
"no of patients ind gly sfc","C0017890;C0030705;C0523677;C4049864;C4521536","C3814772;C1722260","",1509
"normal egfr $nmbr$ egfr $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$ at baseline to high egfr $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$","C0168634;C0205250;C0205307;C0231683;C0369637;C0439166;C0439445;C0441923;C1299351;C1442488;C1739039;C2347086;C2700149;C3811844;C3812682;C3887512;C3889660;C4321237;C4522209;C4553972","C3811844;C0017654","",592
"urinary albumin to creatinine ratio","C0455271;C1318330","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"bronchial reversibility","C0205039;C0449261;C1442216","C0449261;C0231999","",1315
"$nmbr$ year rates in placebo groups","C0032042;C0439234;C0439508;C0441833;C0687744;C0871208;C1257890;C1519504;C1521828;C1552839;C1696465;C1705428;C1705429;C1706408","C0032042","",28
"caucasian eze simva $nmbr$","C0007457;C0043157","C0043157","",1329
"hr or rr $nmbr$ ci","C0008107;C3259781;C4554402",NULL,NULL,1544
"lipid treatment","C0023779;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704","C0086440","",1773
"total subjects","C0439175;C0439810;C0681850;C1550501;C1706203;C2349001;C2697811",NULL,NULL,1655
"empagliflozin n with event n","C0441471;C3490348;C4019010","C3490348","",1182
"cholecystectomy n $nmbr$","C0008320","C0162522","",1393
"abatacept $nmbr$ $nmbr$ n $nmbr$","C1619966","C1619966","",1190
"control nz $nmbr$","C0027978;C0243148;C1550141;C1882979;C2587213;C3274648;C4553389",NULL,NULL,675
"disease duration baseline mean","C0168634;C0444504;C0872146;C1442488;C2347634;C2348143","C0449238;C0872146","",903
"or placebo treatment","C0032042;C0039798;C0087111;C1522326;C1533734;C1696465;C1705169;C1706408;C3538994;C3887704","C0032042","",28
"combined end points","C0205195;C2349179","C2349179","",1136
"alcohol use drinks wk","C0001948;C0332174;C0439230;C0452428",NULL,NULL,178
"china tjapan","C0008115",NULL,NULL,772
"clinically relevant non","C1518422;C2347946",NULL,NULL,85
"normal left ventricular ejection fraction no j","C0205091;C0205307;C0231683;C0428772;C0439166;C0443246;C0488728;C1535947;C1552822;C2347086;C4553972",NULL,NULL,687
"$nmbr$ h postprandial insulin miu ml","C0021641;C0033727;C0369286;C0376674;C0439457;C0441932;C0564385;C1533581;C1579433;C3714501;C4528284",NULL,NULL,157
"psa ng ml","C0439275;C3810537;C3813209",NULL,NULL,204
"before admission","C0184666;C0809949",NULL,NULL,470
"osteitis","C0029400","","",-10
"st depression and t wave inversion","C0520887;C0520888","C0520887","",1091
"moderate severe n $nmbr$ n $nmbr$","C0205081;C0205082;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335",NULL,NULL,321
"rate $nmbr$ pyo","C0033809;C0871208;C1521828",NULL,NULL,2009
"bonferroni adjusted p value c vs a","C1709380;C1879894",NULL,NULL,7
"placebo add on to basal insulin","C0032042;C0650607;C1696465;C1706408;C1883712","C0650607","",354
"$nmbr$ drinks dav","C0452428",NULL,NULL,178
"major or clinically relevant non major bleed","C0019080;C0205082;C0205164;C1518422;C2347946;C4318856;C4521762",NULL,NULL,85
"non caucasian simva $nmbr$","C0007457;C0043157;C1518422","C0043157","",1329
"ntprobnp pg ml","C0439297;C0669479;C0754710",NULL,NULL,1511
"asdas crp","C3890735;C4048285",NULL,NULL,1545
"respiratory medication taken at baseline n","C0168634;C0418986;C1442488;C1883727",NULL,NULL,625
"im use no","C0042153;C0457083;C1947944",NULL,NULL,118
"prior tobacco use n","C0040335;C0332152;C0543414;C0841002;C2826257;C3853727",NULL,NULL,23
"structural heart disease","C1290384",NULL,NULL,585
"first n $nmbr$","C0205435;C1279901",NULL,NULL,806
"hyperkalemia $nmbr$ $nmbr$ meq l","C0020461;C0439375;C4552983","C0020461;C4552983",";C0439375;C0700287;C0684224;C0035173",30
"hdl c mean sd mg dl","C0439269;C0444504;C2347634;C2348143;C2699239;C3715113","C0023822","",1962
"azl m cldb","C0369637;C0441923",NULL,NULL,923
"non biological systemic","C0205373;C0445097",NULL,NULL,215
"concomitant oral anti dm drugs no a","C0011816;C0029167;C0175795;C0304289;C0521115;C3250443",NULL,NULL,955
"mace","C0349381;C0949745;C1445339","C1320716","",414
"adalimumab n $nmbr$","C1122087",NULL,NULL,942
"adjudicated mace $nmbr$","C0349381;C0949745;C1445339","C1320716","",414
"qmaxi rn l s","C2827110;C3540639;C4281819","","",-10
"aspirin group n $nmbr$","C0004057;C0441848","C0004057","",1366
"chronic renal disease no","C0022661;C1561643","C1561643","",967
"fatal or non fatal stroke","C0038454;C1302234;C1518422;C1705232;C4554100",NULL,NULL,507
"cv death ml ischemic stroke","C0011065;C0439526;C0948008;C1306577;C1705224;C3538987;C3887665;C4048877;C4082313;C4318503;C4552775",NULL,NULL,1669
"duration of diabetes y","C0011847;C0011849;C0449238;C2926735","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"symptomatic pad of lower extremities","C0023216;C0182158;C0231220;C0332568;C3540603;C3669270;C3814046;C4319657",NULL,NULL,1752
"ldl particle size week $nmbr$","C0332174;C0439230;C3641256","C0023824","",1068
"notes","C1317574",NULL,NULL,131
"ics use at baseline no","C0042153;C0168634;C0457083;C0815320;C1442488;C1947944;C4551720","C3540778","",2182
"immunosuppressants onlyff","C0021081","C0021081","",1424
"active versus placebo","C0032042;C0205177;C1696465;C1706408;C3853793;C3888249","C0032042","",28
"high $nmbr$ kg m baseline bmi","C0168634;C0205250;C0578022;C1299351;C1442488;C1532718;C2700149;C3887512;C3889660;C4321237;C4522209",";C1305855","",206
"left ventricular systolic dysfunction n","C1277187;C1963159;C4553199",NULL,NULL,40
"arb angiotensin ii receptor blocker ccb","C0006684;C0521942;C3536793;C3888198",NULL,NULL,704
"creatine clearance category $nmbr$ to $nmbr$ ml min $nmbr$ $nmbr$","C0373595;C0439445;C0683312;C3889287",NULL,NULL,562
"overall population n $nmbr$","C0032659;C0282416;C1257890;C1561607",NULL,NULL,1743
"death mi idr st or gusto severe bleeding","C0011065;C0019080;C0036056;C0205082;C1306577;C3272372;C3810814;C4050465;C4050466;C4082313;C4552775","C0011065","",220
"class iv iv v","C0022326;C0457166;C1880098;C4265176",NULL,NULL,1257
"less severe oa symptoms at baseline","C0029408;C0168634;C0436345;C0439092;C0547044;C1442488;C3887876","C0029408","",1356
"white race no total no f","C0007457;C0016327;C0034510;C0043157;C0220938;C0439175;C0439810;C1706779;C3853635","C0043157","",1402
"warfarin","C0043031","C0043031","",858
"medications antihypertensive drugs","C0003364;C0013227;C0802604;C2598133;C4284232",";C0003364","",1579
"severity ofcopd gold $nmbr$ n","C0018026;C0439793;C0522510;C1304897","C0024117;C0521117","",213
"vertebral fracture","C0080179",NULL,NULL,2023
"all with coenzyme q $nmbr$ n $nmbr$ $nmbr$","C0041536",NULL,NULL,1395
"prior nonvertebral fracture at age $nmbr$ years","C0016658;C0332152;C1510829;C2826257",NULL,NULL,2026
"treatment","C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,236
"to goal","C0018017;C1571704",NULL,NULL,1688
"no myocardial infarction at presentation n $nmbr$","C0027051;C0428953;C0449450;C2926063;C3810814;C4552959",NULL,NULL,646
"thiazolidinedione","C0289779;C1257987;C3537039","C1257987",";C0289779;C1527178;C1705938;C1552866;C2700399;C0168634",72
"claudication","C0021775;C0311395;C1456822","C0021775","",263
"remaining patients","C0030705;C1527428",NULL,NULL,1035
"cvd risk factors age $nmbr$","C0001779;C0001783;C0007222;C0035647;C0035648;C1553898;C4552904","C0001779","",480
"ct tt","C0007673;C1452561;C3540513;C3813556;C3888140;C4554543",NULL,NULL,257
"geometric mean ige on loge scale u ml","C0175659;C0349674;C0439340;C1880521;C1947916;C2697934;C2945590;C2986759","","",241
"timi major or","C0205082;C0205164;C4318856;C4521762",NULL,NULL,2079
"unacceptable adverse events","C0877248;C1705413;C1883420","C0877248","",47
"no glucocorticoids at baseline","C0017710;C0168634;C1442488;C3540777;C3540778","C0017710","",1348
"score of $ $nmbr$ no","C0449820;C4050231",NULL,NULL,748
"with mets","C0812270;C1705694;C2939420",NULL,NULL,921
"hemoglobin g l","C0019046;C0439267;C0439294;C0456615;C0635222","C0019046","",1177
"budesonide n","C0054201","C0054201","",1160
"moderate decrease $nmbr$ $nmbr$ mlymin per $nmbr$ $nmbr$ m $nmbr$","C0205081;C0369637;C0392756;C0441923;C0547047;C1881878;C4049705;C4049706;C4085643;C4321335",NULL,NULL,528
"atherothrombotic stroke n","C0038454;C4554100",NULL,NULL,1762
"il $nmbr$ range ng l","C0020898;C0021764;C0022271;C0439297;C1514721;C2348147;C3542016",NULL,NULL,479
"qualifying index event as pe","C0070939;C0441471;C0600653;C0918012;C1514624;C1552854;C1637833;C1880476;C2986546;C4019010;C4284304",NULL,NULL,734
"subjects with imputed value for end of treatment body weight","C0039798;C0087111;C0681850;C1522326;C1522609;C1533734;C1550501;C1705169;C1706203;C2349001;C2697811;C2699638;C2983672;C3538994;C3887704",NULL,NULL,1627
"all cancer","C0006826;C0998265;C1306459","C0006826","",1819
"paroxysmal atrial fibrillation no","C0235480;C4050122","C0235480","",1446
"alcohol useb","C0001962;C0001975",";C0001962","",1053
"indian american or alaskan native","C0238611;C0302891;C0596070;C1524069","C0596070;C0302891;C0238611","",2255
"history of nicotine use","C0019664;C0019665;C0028040;C0262512;C0262926;C1524063;C1705255;C2004062",NULL,NULL,832
"rest of world n $nmbr$","C0035253;C1622890;C2700280","C2700280","",247
"history of ml at baseline","C0019664;C0019665;C0168634;C0262512;C0262926;C0439526;C1442488;C1705224;C1705255;C2004062;C3887665",NULL,NULL,300
"irbesartan","C0288171","C0288171","",1209
"age median interquartile range y","C0001779;C0549183;C0876920;C1711350;C2347635;C2348144;C2939193","C0001779","",480
"mean sd triglycerides mg dl","C0041004;C0439269;C0444504;C2347634;C2348143;C2699239",NULL,NULL,192
"thienopyridine alone","C0205171;C0439044;C0679994;C1120149",NULL,NULL,926
"airway compromise","C4055482",NULL,NULL,1630
"concomitant treatments at randomization","C0034656;C0087111;C0521115",NULL,NULL,692
"tg $nmbr$ $nmbr$","C0337445","C0041004","",209
"calima japandhigh dosage ics laba and baseline blood eosinophils $nmbr$ cells ml n $nmbr$ y","C0014467;C0168634;C0178602;C0815320;C1442488;C2699156;C2986497;C4551720","C0014467","",849
"renal function normal mild","C0205307;C0231683;C0232804;C0439166;C2347086;C2945599;C4553972",NULL,NULL,329
"final median mg l","C0205088;C0439268;C0549183;C0876920;C1546485;C2347635;C2348144;C2939193;C3853528","C0006560","",193
"body mass index kg m $nmbr$ mean sd c","C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239","C1305855","",1734
"systolic treated at baseline","C0039155;C0168634;C1442488;C1522326",NULL,NULL,625
"ckd stages","C1306673;C1561643",NULL,NULL,541
"cancer no","C0006826;C0998265;C1306459","C0006826","",1819
"others","C1955473;C3539125",NULL,NULL,741
"proton pump inhibitor","C0358591;C3536754;C4521480",NULL,NULL,1582
"new york heart association class","C1882083","C0018802;C1882083","",453
"egfrmdrd ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923","C3811844;C0017654","",592
"aga group","C0441833;C0687744;C1257890;C1519504;C1705428;C1705429",NULL,NULL,1526
"p value for variance","C1709380;C1711260;C2348152",NULL,NULL,7
"postbronchodilator fev $nmbr$ fvc","C2599594;C3714541",NULL,NULL,1599
"enrolled in the americas","C0002454;C0596070;C4684790","C0002454","",392
"antiplatelet only group n $nmbr$","C0205171;C0441848;C1720467","","",1191
"older subjects aged $nmbr$ years","C0001779;C0001792;C0439234;C0580836;C0681850;C1550501;C1706203;C1999167;C2349001;C2697811",NULL,NULL,148
"ics laba","C0815320;C4551720",NULL,NULL,1650
"women t","C0043210","C0043210",";C3541888;C1720467",1323
"ocs use","C0042153;C0457083;C1947944",NULL,NULL,24
"exacerbations in the prev year $nmbr$","C0439234;C0439508;C1552852;C4086268","C4086268","",1991
"egfr ml min per $nmbr$ $nmbr$ m $nmbr$ mean sd","C0369637;C0439445;C0441923;C0444504;C1739039;C2347634;C2348143;C2699239;C3811844;C3812682","C3811844;C0017654","",592
"general","C0205246;C3812897;C3891294;C4521767",NULL,NULL,1085
"$nmbr$ years placebo n $nmbr$ $nmbr$ saxagliptin n $nmbr$ $nmbr$","C0032042;C0439234;C1611934;C1696465;C1706408",NULL,NULL,1099
"fractures","C0016658",NULL,NULL,2026
"usa and canada","C0006823;C0041703",NULL,NULL,1550
"mean sgrq total score","C0439175;C0439810;C0444504;C2347634;C2348143;C2964552;C3533236",NULL,NULL,540
"other cause","C0015127;C1524003",NULL,NULL,924
"post bronchodilator fevi n","C0429706;C0849974;C1561566;C2599594;C4528367",NULL,NULL,1601
"tamsulosin $nmbr$ $nmbr$ mg vs $nmbr$ $nmbr$ mg","C0024671;C0026410;C0257343;C0439269;C1960952;C2346927;C4321396;C4521761","C0257343","",1346
"indacaterol $nmbr$ ug n $nmbr$","C0041573;C0439211;C1722260","C1722260","",1875
"stage $nmbr$ chronic kidney disease","C0205390;C1300072;C1306673;C1561643;C4553188","C1561643","",967
"rib","C0035561",NULL,NULL,1440
"mean sd y","C0444504;C2347634;C2348143;C2699239",NULL,NULL,1287
"change in pav mean $nmbr$ cl","C0058890;C0392747;C0443172;C0444504;C0596019;C1705241;C2347634;C2348143;C4319952",NULL,NULL,658
"left main disease","C0012634;C0205091;C0205225;C0443246;C1542147;C1552822",NULL,NULL,42
"diabetes duration","C0011847;C0011849;C0449238;C2926735","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"czp $nmbr$ mg every $nmbr$ weeks n $nmbr$","C0024671;C0026410;C0054841;C0439230;C0439269;C1861828;C1872109;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2274
"mean lvef","C0428772;C0444504;C0488728;C2347634;C2348143","C0018801;C0428772","",1273
"hr $nmbr$ ci p value for interaction","C0008107;C1704675;C1709380;C3259781",NULL,NULL,519
"quintile range mg dl","C0439269;C1508496;C1514721;C2348147;C3542016",NULL,NULL,1017
"empaglifiozin $nmbr$ mg w $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2277
"acei arb","C3888198",NULL,NULL,44
"$nmbr$ to $nmbr$ mmhg","C0439475",NULL,NULL,1888
"positive orthostatic test","C0022885;C0039593;C0231472;C0392366;C0439178;C0456984;C1446409;C1514241;C1515976;C2825490;C3812269;C3831328;C4318744",NULL,NULL,242
"glargine","C0907402","C0907402",";C1998602;C0004446;C0005126;C2344255;C4050145;C0229089;C0439164;C1512019;C3273373;C3665488",69
"statins no","C0360714","C0360714","",872
"with highest bwa","C0006041;C1522410",NULL,NULL,840
"obesity body mass index $nmbr$ kg m $nmbr$","C0005893;C0028754;C0578022;C1305855;C1532718;C1963185",";C1305855","",206
"no use of $nmbr$ asa compounds","C0004057;C0205198;C1524063;C1706082;C3853627","C0368663","",1691
"low dose statin","C0360714;C0445550;C1708745","C0445550","",112
"gold stage n","C0018026;C0205390;C1300072;C1304897;C1306673",NULL,NULL,541
"mean sd bmi kg m $nmbr$","C0444504;C0578022;C1532718;C2347634;C2348143;C2699239",NULL,NULL,1735
"hyponatremic $nmbr$ meq l at baseline","C0168634;C0439375;C0857122;C1442488",NULL,NULL,625
"$nmbr$ moderate or high bleeding risk no total","C0019080;C0035647;C0205081;C0205250;C0439175;C0439810;C1299351;C1881878;C2700149;C3887512;C3889660;C4049705;C4049706;C4085643;C4321237;C4321335;C4522209;C4552904","C0035647","",173
"race ethnicity zz","C0015031;C0034510;C0243103;C1706779;C2347310;C3853635",";C0034510","",1107
"fatal stroke","C0038454;C1302234;C1705232;C4554100",NULL,NULL,507
"history of pad","C0019664;C0019665;C0182158;C0262512;C0262926;C0332568;C1705255;C2004062;C3540603;C3669270;C3814046;C4319657",NULL,NULL,832
"insulin dependent diabetes","C0011854",NULL,NULL,160
"qrs $nmbr$ ms n available for $nmbr$ patients","C0030705;C0470187;C2349943;C3539704;C3713294",NULL,NULL,126
"ldl c mg dl mean sd","C0439269;C0444504;C2347634;C2348143;C2699239","C0023824","",1963
"duration of t $nmbr$ dm","C0011816;C0449238;C2926735;C3250443",NULL,NULL,901
"prior peripheralarterialdisease","C0332152;C2826257",NULL,NULL,294
"median m kg $nmbr$ iqr","C0022718;C0369637;C0439209;C0441923;C0549183;C0876920;C2347635;C2348144;C2939193;C4054209",NULL,NULL,2326
"place of randomization","C0034656;C0442504;C1533810;C1704765;C1882509",NULL,NULL,1299
"intravenous nitrates","C0028125;C0348016",NULL,NULL,537
"all randomized all cause mortality","C0015127;C0026565;C0026566;C0034656;C0444868;C1524003;C3539085;C3815594",NULL,NULL,924
"long $nmbr$ mm stenting yes n $nmbr$","C0038257;C0205166;C1549445;C1705108;C1706317;C1710701;C2348535;C4330985;C4554674",NULL,NULL,147
"placebo glimepiride","C0032042;C0061323;C1696465;C1706408","C0061323","",1155
"dose adjustment reason $nmbr$ kg","C0022718;C0439209;C2826286;C4054209",NULL,NULL,205
"vessels with stenosis $nmbr$","C0679403",NULL,NULL,745
"fasting triglycerides","C0015663;C0041004","C0041004","",368
"$nmbr$ some restrictions no help needed","C0027552;C0443288;C0686904;C1269765;C1552861",NULL,NULL,1062
"vital signs mean sd","C0150404;C0444504;C0518766;C2347634;C2348143;C2699239",NULL,NULL,1287
"proportion of days without heartburn at week $nmbr$ percentage","C0018834;C0332174;C0439165;C0439228;C0439230;C1549488;C1561533;C1709707",NULL,NULL,291
"history of tia stroke","C0007787;C0019664;C0019665;C0038454;C0262512;C0262926;C0917805;C1054154;C1705255;C2004062;C4554100",NULL,NULL,1592
"change in psa modified shs baseline to week $nmbr$","C0168634;C0332174;C0392747;C0439230;C0443172;C1442488;C1705241;C3810537;C3813209;C3889737;C4319952",NULL,NULL,767
"elevated at wk $nmbr$ no $nmbr$","C0205250;C0332174;C0439230;C3163633",NULL,NULL,415
"gold stage nf","C0018026;C0205390;C1300072;C1304897;C1306673",NULL,NULL,541
"peripheral vascular disease","C0085096","C0085096","",933
"non hispanic or latino","C0086528;C1518424","C0086409","",865
"mayo clinic score mean sd","C0002424;C0442592;C0444504;C0449820;C0454788;C1077578;C2347634;C2348143;C2699239;C4050231",NULL,NULL,425
"ics use at enrollment mean mg d","C0042153;C0439422;C0444504;C0457083;C0815320;C1516879;C1696073;C1947944;C2347634;C2348143;C3888021;C4551720",NULL,NULL,37
"long term treatment with aspirin no total no","C0004057;C0023977;C0439175;C0439810",NULL,NULL,508
"right coronary","C0225808","C1261316","",224
"emotional status","C0013987;C0449438;C0849912",NULL,NULL,543
"mtx mean dose $nmbr$ $nmbr$ mg wk","C0366550;C0444504;C1881833;C2347634;C2348143","C0025677","",716
"budesonide formoterol n $nmbr$","C1276807","C1276807","",1159
"standard care n","C1442989;C1947933;C2828392",NULL,NULL,1482
"baseline ldlc level n $nmbr$ $nmbr$ $nmbr$ $nmbr$ mgzdl","C0168634;C0441889;C0456079;C1416822;C1442488;C1547707;C2946261","C0023824","",1068
"after $nmbr$ h","C0033727;C0369286;C0441932;C0564385;C4528284",NULL,NULL,1618
"qualifying event no","C0441471;C1514624;C4019010",NULL,NULL,412
"baseline albumin $nmbr$","C0001924;C0168634;C1442488",NULL,NULL,625
"prior cv event at randomization","C0034656;C0332152;C0441471;C2826257;C3538987;C4019010;C4048877;C4318503",NULL,NULL,1777
"end point","C2349179;C2826544","C2349179","",1136
"current nonsmoker","C0337672;C0425293;C0521116;C1705970;C4554605","C0037369","",420
"anti hypertensives","C0003364",";C0003364","",1579
"amlodipine n $nmbr$","C0051696","","",78
"homa ir","C0022065;C0022071;C1448132","","",1397
"elevated bnp $nmbr$ pg ml n $nmbr$ $nmbr$","C0054015;C0205250;C0439297;C1095989;C1417808;C2982014;C3163633",NULL,NULL,1635
"mepolizumab $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C0969324;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2307
"chd eze simva $nmbr$","C0280604;C3542407",NULL,NULL,970
"$nmbr$ yr n","C0439234",NULL,NULL,1099
"placebo simvastatin","C0032042;C0074554;C1696465;C1706408","C0074554","",873
"current inhaled corticosteroid use","C0004048;C0239126;C0521116;C1705970","C3540778","",2182
"all cana","C1418845",NULL,NULL,1302
"acs","C0742343;C4318612",NULL,NULL,2147
"prior or new diabetes","C0011847;C0011849;C0205314;C0332152;C2826257","C0011849","",912
"intestinal area involved no","C0017446;C0021853;C0205146;C1314939","C0009368;C1879646","",2088
"history of statin use","C0019664;C0019665;C0262512;C0262926;C0360714;C1524063;C1705255;C2004062","C0360714","",872
"phenytoin","C0031507;C0202454",NULL,NULL,619
"brachial","C0445456",NULL,NULL,357
"improvement in enthesitis score at week $nmbr$ n","C0332174;C0439230;C0449820;C1282952;C2986411;C4050231","C1282952","",271
"year of publication of primary results","C0034036;C0034037;C0205225;C0439234;C0439508;C0439612;C0439631;C1274040;C1546471;C1704324;C2825142",NULL,NULL,229
"$nmbr$ h","C0033727;C0369286;C0441932;C0564385;C4528284",NULL,NULL,308
"ain no","C0347129",NULL,NULL,62
"coronary artery bypass graft no","C0010055;C1260596","C0010055","",1843
"the $nmbr$ substrata with baseline bl ldl cholesterol $nmbr$ to $nmbr$ mg dl and $nmbr$ to $nmbr$ mg dl were combined to make $nmbr$ group with bl ldl cholesterol $nmbr$ to $nmbr$ mg dl because of small numbers of patients included in the substrata with $nmbr$ to $nmbr$ mg dl bl hdl cholesterol cutoffs were $nmbr$ or $nmbr$ mg dl for men and $nmbr$ or $nmbr$ mg dl for women bars indicate se bmi body mass index e ezetimibe $nmbr$ mg hdl c hdl cholesterol ldl c ldl cholesterol tg triglycerides","C0005918;C0006413;C0023822;C0023824;C0024671;C0025266;C0026410;C0036919;C0040363;C0041260;C0043210;C0168634;C0202117;C0205195;C0332257;C0337445;C0368910;C0392885;C0439269;C0441833;C0687744;C0687760;C0700321;C1142985;C1257890;C1305855;C1442160;C1442488;C1519504;C1552663;C1704759;C1705428;C1705429;C1707156;C1881534;C1883351;C1960952;C2346927;C2360800;C2827109;C3274014;C3541345;C3642216;C3715113;C3889135;C4321396;C4521761","","",-10
"previous exposure to biologic systemic psoriasis therapyb yes n","C0005515;C0033860;C0205156;C0205373;C0205460;C0332157;C1549445;C1552607;C1705108;C1710701","C0033860;C0205156;C0332157;C0205373","",2181
"patients in the placebo group nt probnp values were reported for $nmbr$ patients","C0030705;C0032042;C0042295;C0441833;C0588446;C0669479;C0687744;C0754710;C1257890;C1519504;C1696465;C1705428;C1705429;C1706408","C0032042","",28
"s $nmbr$ kg m","C0565930;C1532718;C2603362",";C1305855","",206
"edge ii","C0205154;C1710602;C2697523;C4082587",NULL,NULL,595
"present smoker","C0150312;C0337664;C0449450","C0037369","",420
"thrombolytic agents","C0016018",NULL,NULL,487
"patients with enthesitis at week $nmbr$ n","C0030705;C0332174;C0439230;C1282952","C1282952","",271
"not reported in ecrf","C0684224;C0700287;C1518422;C4319718;C4551412",NULL,NULL,1335
"baseline medical therapy n","C0168634;C0418981;C1442488",NULL,NULL,625
"czech republic","C0206578",NULL,NULL,1407
"value for nteraction","C1522609",NULL,NULL,9
"angiotension converting enzyme inhibitor","C0014432;C0919438;C4521603","C0003015","",811
"baseline ldl c mg dl","C0168634;C0439269;C1442488","C0023824;C1442488","",1964
"risk marker and model","C1519104;C3161035;C3274659;C3714583;C3853906",NULL,NULL,1320
"mild reduction in egfr","C0301630;C0392756;C1293152;C1739039;C2945599;C3811844;C3812682;C4551656","C3811844;C0017654","",592
"grip strength kg","C0022718;C0429271;C0439209;C2598165;C4054209",NULL,NULL,205
"insulin glargine oad od prandial","C0229089;C0439164;C0907402;C1512019;C1998602;C3273373;C3665488;C4553624","C0907402",";C1998602;C0004446;C0005126;C2344255;C4050145;C0229089;C0439164;C1512019;C3273373;C3665488",69
"anti thrombotics","C0087086",NULL,NULL,1641
"number reporting migraine on $nmbr$ month questionnaire","C0034394;C0149931;C0237753;C0332177;C0439231;C0449788;C0700287",NULL,NULL,1556
"non elderly","C0001792;C1518422;C1999167",NULL,NULL,1489
"periprocedural anticoagulant","C0003280;C0848112;C3536711","C0085826","",451
"other antihyperglycemic agents not listed","C0020616;C0745732;C1518422;C3272378",NULL,NULL,1616
"aspirin n $nmbr$ $nmbr$","C0004057","C0004057","",1366
"etn $nmbr$ mg mtx n $nmbr$","C0014758;C0024671;C0025677;C0026410;C0439269;C0717758;C1417487;C1960952;C2346927;C4321396;C4521761","C0025677","",1408
"timi major minor","C4441842",NULL,NULL,530
"fish oil","C0016157",NULL,NULL,1681
"of variation iu","C0049272;C0205419;C0439453;C0694756",NULL,NULL,1253
"egfr ml kg per $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439526;C0441923;C1300574;C1532718;C1705224;C1739039;C3811844;C3812682;C3887665",";C1305855","",206
"cardiac rhythm disorder at baseline no","C0168634;C0264886;C1442488",NULL,NULL,1674
"iv $nmbr$ mg","C0022326;C0024671;C0026410;C0439269;C1960952;C2346927;C4265176;C4321396;C4521761",NULL,NULL,192
"native american or alaskan native","C0238611;C0282204;C0302891;C1515945","C0282204","",2254
"baseline triglycerides by quintiles","C0041004;C0168634;C1442488;C1508496",NULL,NULL,625
"statin s","C0360714","C0360714","",872
"rf and acpa negative n","C0035448;C0201660;C0205160;C0748398;C1513916;C1525410;C1547111;C1706063;C2825415;C2825491;C3853545",NULL,NULL,1569
"time to first cv hospitalization or death from any cause","C0007465;C0019993;C0040223;C0205435;C1279901;C3538987;C3541383;C4048877;C4318503",NULL,NULL,323
"post bronchodilator ratio of fev $nmbr$ to fvc","C0456603;C1547037;C2599594;C3714541",NULL,NULL,680
"immunosuppressant use","C0021081;C0042153;C0457083;C1947944","C0021081","",1424
"personal relationships","C1552027","","",-10
"proportion of predicted normal fev $nmbr$ value","C0086715;C0520835;C0681842;C1522609;C1709707;C1882327;C3714541",";C0037981","",1197
"available baseline blood specimen n","C0168634;C0178913;C0470187;C1442488",NULL,NULL,625
"baseline sbp p o $nmbr$","C0085805;C0168634;C1442488",NULL,NULL,606
"general alone","C0205171;C0205246;C0439044;C0679994;C3812897;C3891294;C4521767",NULL,NULL,1085
"cards","C2930619;C3275277",NULL,NULL,391
"diuretic agents excluding antialdosterone","C0012798;C0332196;C0450442;C1254351;C1521826;C2828389",NULL,NULL,992
"hscrp level","C0441889;C0456079;C1547707;C2946261",NULL,NULL,744
"mean score min max range","C0702093;C1514721;C1524029;C2348147;C3533236;C3542016;C3813700",NULL,NULL,1475
"history of stroke see tia","C0007787;C0019664;C0019665;C0038454;C0042789;C0262512;C0262926;C0917805;C1054154;C1705255;C1947903;C2004062;C4554100",NULL,NULL,832
"pump","C0182537",NULL,NULL,1582
"hypercholesterolaemia","C0020443;C1522133","","",1390
"angiotensin receptor blocker","C0034787;C1622222",NULL,NULL,963
"chads $nmbr$ mean sd","C0007928;C0444504;C1413373;C2347634;C2348143;C2699239","","",2128
"fev $nmbr$ fvc ratio","C0456603;C1547037;C3714541",NULL,NULL,1599
"nyha class no $","C1882083","C0018802;C1882083","",453
"rf positive n","C0035448;C0201660;C0439178;C0748398;C1446409;C1514241;C1547111;C2825490;C3812269","C0035448","",1435
"joint swelling effusion or both on clinical examination","C0013604;C0013687;C0031809;C0038999;C0152031;C1253936;C1963136;C2317432;C4554335","C0152031","",1138
"cochranemantelehaenszel repeated $nmbr$ $nmbr$ ci c","C0008107;C0205341;C3259781",NULL,NULL,519
"ez simva n $nmbr$ n","C0206578","C0360714;C1142985","",1862
"$nmbr$ year mortality","C0026565;C0026566;C0439234;C0439508",NULL,NULL,1099
"$nmbr$ month follow up median iq range","C0332177;C0439231;C0549183;C0589120;C0876920;C1514721;C1522577;C1704685;C2347635;C2348144;C2348147;C2939193;C3274571;C3542016",NULL,NULL,1476
"proctosigmoiditis","C0033252","","",-10
"puva","C0853073;C1704892",NULL,NULL,1515
"overall cohort post hoc analysis excluding metformin users","C0025598;C0086027;C0282416;C0332196;C0687676;C1561607;C1704687;C1706077;C2828389;C3469826","C0025598","",1345
"patients treated with losartan n $nmbr$","C0030705;C0126174;C0332293","C0126174","",1939
"corticosteroids immunosuppressants and antimalarials","C0001617;C0003374;C0021081;C3539185;C3540725;C3540726;C3540727",NULL,NULL,1650
"relative risk $nmbr$ confidence interval","C0009667;C0242492","C0009667","",2260
"previous anti tnf therapy n","C0205156;C0279936;C0432633;C1552607",NULL,NULL,2387
"triglyceride median mg dl a $nmbr$ $nmbr$ percentile","C0041004;C0439269;C0549183;C0876920;C1264641;C2347635;C2348144;C2939193","C0041004","",368
"log rank","C0667477;C0699794;C1708728;C2986775",NULL,NULL,1740
"placebo no diabetes n $nmbr$","C0011847;C0011849;C0032042;C1696465;C1706408","C0032042","",28
"sinus tracts perforation n","C0544791;C0549099;C0854572;C1185740;C1881710",NULL,NULL,1596
"tobacco use no","C0040335;C0543414;C0841002;C3853727",NULL,NULL,23
"$nmbr$ l_ min","C0439393","C3811844;C0017654","",307
"duration of copd years","C0024117;C0439234;C0449238;C1412502;C2926735;C3714496",NULL,NULL,1726
"cardiac failurec","C0018787;C1522601","C0018801",";C0168634;C1524003",12
"methotrexate dose at baseline","C0025677;C0168634;C0178602;C0869039;C1114758;C1442488",NULL,NULL,625
"age $nmbr$ y n $nmbr$","C0001779","C0001779","",480
"van der heijde mtss mean sd","C0444504;C0557775;C1511780;C2347634;C2348143;C2699239",NULL,NULL,37
"linagliptin patients with events total patients","C0030705;C0439175;C0439810;C0441471;C2746078;C3541888","C2746078","",1185
"location of infarction no","C0021308;C0450429;C1515974;C4284930;C4284931","C1515974;C0021308","",1948
"fatal aes","C1302234;C1412268;C1705232;C2699274","C0877248","",47
"ptrend across doses","C0178602",NULL,NULL,110
"gfr $nmbr$ $nmbr$","C0017654;C1424601","C3811844;C0017654","",592
"medical history at randomization no","C0034656;C0262926;C1704706",NULL,NULL,832
"event rate year","C0439234;C0439508;C0441471;C0871208;C1521828;C4019010",NULL,NULL,2007
"baseline medication","C0013227;C0168634;C1442488;C3244316;C4284232",NULL,NULL,625
"ii n $nmbr$","C1710602;C4082587",NULL,NULL,521
"data are given as percentage of subjects unless otherwise specified ptca indicates percutaneous transluminal coronary angioplasty cabg coronary artery bypass graft ace angiotensin converting enzyme bmi body mass index calculated as weight in kilograms divided by square of height in meters hdl c high density lipoprotein cholesterol ldl c low density lipoprotein cholesterol fpg fasting plasma glucose and fpi fasting plasma insulin tto convert cholesterol values to micromoles per liter multiply by $nmbr$ $nmbr$ to convert triglycerides to micromoles per liter multiply by $nmbr$ $nmbr$ to convert fpg to micromoles per liter multiply by $nmbr$ $nmbr$ to convert fpi to picomoles per liter multiply by $nmbr$ $nmbr$","C0003842;C0005910;C0008377;C0010055;C0015663;C0022709;C0023821;C0023824;C0040363;C0041004;C0041061;C0041260;C0042295;C0043100;C0185098;C0202042;C0205120;C0205369;C0226004;C0332849;C0439165;C0439192;C0439194;C0439209;C0441074;C0444686;C0455280;C0475211;C0489786;C0681850;C0857690;C1305855;C1305866;C1441506;C1442162;C1511726;C1549488;C1550501;C1550718;C1552595;C1561533;C1705104;C1706203;C1719797;C1883351;C1947971;C2349001;C2697811;C2911648;C2936173;C3244317;C3245479;C3714741","","",-10
"region no","C0017446;C0205147",NULL,NULL,1060
"total c hdl c","C0439175;C0439810;C3715113","C0023822","",821
"ff $nmbr$ pgod","C4554348",NULL,NULL,1597
"type of lipid lowering regimen","C0023779;C0040808;C0332307;C0441994;C1547052;C2003888;C2945654",NULL,NULL,603
"background treatment n","C0039798;C0087111;C1522326;C1533734;C1705169;C1706907;C3538994;C3887704",NULL,NULL,236
"sf $nmbr$ pcs ls mean change se","C0023668;C0036919;C0037712;C0392747;C0443172;C0444504;C1705241;C1864389;C1882368;C2347634;C2348143;C4319952",NULL,NULL,1782
"use of concomitant lipid modifying therapy","C0023779;C0392747;C1524063;C1707479",NULL,NULL,446
"diuretics","C0012798",NULL,NULL,992
"new or suspected thrombus","C0087086;C0205314;C0302148;C0332147;C0750491;C3146237",NULL,NULL,1641
"time from symptom onset to randomization","C0034656;C0040223;C0449244;C1457887;C3541383;C3854129;C4086878",NULL,NULL,692
"history of peripheral artery disease","C0489868;C0683519;C0730226;C0850708;C0944983",NULL,NULL,934
"oral antihyperglycaemic n","C0359086","C0359086","",1744
"prior chf","C0018802;C0332152;C2826257",NULL,NULL,769
"pack years iqr","C1277691",NULL,NULL,233
"iv inotropic drug","C1971835",NULL,NULL,1008
"hyperkalemia n","C0020461;C4552983","C0020461;C4552983",";C0439375;C0700287;C0684224;C0035173",30
"lixisenatide n $nmbr$ o","C2973895",NULL,NULL,759
"albuterol reversibility","C0001927;C0449261","C0449261;C0231999","",1315
"age s $nmbr$ years n $nmbr$ $nmbr$","C1510829","C1510829","",481
"unbound pcsk $nmbr$ nmol l","C0439282",NULL,NULL,669
"both unfractionated heparin and low molecular weight heparin","C0019134;C0019139;C2825026;C3536766","C0019134","",864
"coronary revascularization","C0877341","C0877341",";C4049621;C1552607",223
"prior therapy with tnf antagonist n","C0231491;C0279936;C0332152;C1448177;C1514463;C2826257",NULL,NULL,2376
"tc mmol l","C0039411;C0040642;C0041405;C0041698;C1532563;C1824670;C3272447;C4522122","C0041004","",368
"vte vte related deathsb n n","C0439849;C0445223;C0630906","C1861172","",318
"infliximab","C0666743","C0666743","",154
"unfractionated heparin within $nmbr$ hr before randomization no total no","C0019134;C0034656;C0439175;C0439810;C2825026","C0019134","",864
"pasi score mean sd","C0444504;C0449820;C2347634;C2348143;C2699239;C4050231;C4528685",NULL,NULL,37
"strategy","C0679199",NULL,NULL,981
"erlugliflozin $nmbr$ mg vs placebo glimepiride","C0024671;C0026410;C0032042;C0061323;C0439269;C1696465;C1706408;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2278
"baseline pulmonary medications","C0013227;C0024109;C0168634;C0802604;C1442488;C2598133;C2707265;C2709248;C4284232;C4522268",NULL,NULL,572
"median time since diagnosis range yr","C0011900;C0040223;C0439234;C0549183;C0876920;C1514721;C1704338;C1704656;C2347635;C2348144;C2348147;C2939193;C3541383;C3542016",NULL,NULL,635
"hba $nmbr$ c mmol mol","C0019016;C1825777;C3538758;C3829066","","",820
"cardiovascular risk n","C0007226;C0035647;C3887460;C4552904",NULL,NULL,649
"thrombolytic treatment before randomization","C0016018;C0034656;C0039798;C0087111;C0520997;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,236
"perindopril indapamide","C1273169","C1273169","",1232
"years since diagnosis mean","C0011900;C0439234;C0444504;C1704338;C1704656;C2347634;C2348143",NULL,NULL,1099
"pla $nmbr$","C0456170",NULL,NULL,1514
"region of enrollment no","C0017446;C0205147;C1516879;C1696073;C3888021","C0017446","",369
"methotrexate dose on day $nmbr$ mg per wl $nmbr$","C0025677;C0178602;C0332173;C0439228;C0439422;C0439505;C0869039;C1114758;C4086581","C0025677","",1408
"left ventricular ejection","C2733342",NULL,NULL,40
"mtx at baseline n","C0025677;C0168634;C1417487;C1442488","C0025677","",1408
"$nmbr$ exacerbation in prev $nmbr$ m n $nmbr$","C0369637;C0441923;C1552852;C4086268","C4086268","",889
"apob","C0003593;C3252643","C0003593","",426
"c peptide nmol l","C0006558;C0439282","C0006558","",1154
"prior angina pectoris","C0002962;C0332152;C2826257","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"diabetes mellitus duration sd y","C0011849;C0449238;C2699239;C2926735","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"cdr sob","C0013404;C4521843",NULL,NULL,696
"number of stents implanted","C0021102;C0038257;C0237753;C0449788;C2828363",NULL,NULL,569
"atorvastatin factorial study","C0286651;C2826344","C0286651","",885
"mean s d hbalc mmol mol","C0444504;C2347634;C2348143;C3829066","","",1176
"ex smokers qvai $nmbr$ sfc","C0337671;C4521536;C4555205","C0037369","",420
"$nmbr$ ml $nmbr$ to $nmbr$ n $nmbr$ $nmbr$","C0439526;C1705224;C3887665",NULL,NULL,300
"moderate risk","C0035647;C0205081;C1881878;C4049705;C4049706;C4085643;C4321335;C4552904",NULL,NULL,321
"baseline statin use","C0042153;C0168634;C0360714;C0457083;C1442488;C1947944","C0360714","",872
"multivessel cad","C1504769;C2239547;C3813548;C4284121",NULL,NULL,698
"mean proportion","C0444504;C1709707;C2347634;C2348143",NULL,NULL,1047
"uacra mg g n","C1300563",NULL,NULL,2315
"arb monotherapy","C3888198",NULL,NULL,44
"amlodipine amlodipine valsartan","C1962523","","",78
"no change","C0392747;C0443172;C1705241;C4319952",NULL,NULL,767
"patients with $nmbr$ exacerbation in previous $nmbr$ months","C0030705;C0205156;C0439231;C1552607;C4086268","C4086268","",889
"medical history n","C0262926;C1704706",NULL,NULL,832
"left ventricular ejection fraction no total no","C0428772;C0439175;C0439810;C0488728","C0018801;C0428772","",1273
"baseline copd exacerbation history n","C0019664;C0019665;C0168634;C0262512;C0262926;C0740304;C1442488;C1705255;C2004062",NULL,NULL,832
"diclofenac group n $nmbr$ $nmbr$","C0012091;C0441848",NULL,NULL,1638
"diabetes mellitus duration y","C0011849;C0449238;C2926735","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"a severe hypoglycemia","C0020615;C0205082;C4050465;C4050466;C4553659",NULL,NULL,313
"on antihypertensive treatment n","C0003364;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704",";C0003364","",1579
"planned thienopyridine at enrollment","C1120149;C1709561","C1120149",";C0039798;C0087111;C1363945;C1709561;C1947944",73
"difference n $nmbr$ fa placebo lsm se mm year","C0032042;C0036919;C0439234;C0439508;C1696465;C1705241;C1705242;C1706408;C4330985;C4554674","C0032042","",28
"diary variables mean sd","C0376660;C0439828;C0444504;C2347634;C2348143;C2699239",NULL,NULL,1018
"beta blocker n","C0001645","C0001645","",959
"amiodarone use at baseline","C0002598;C0042153;C0168634;C0457083;C1442488;C1947944","","",1757
"hba $nmbr$ c in patients with baseline hba $nmbr$ c $nmbr$ to $nmbr$ $nmbr$ to $nmbr$ mmol mol mmol mol la n baseline sd adjusted mean change $nmbr$ ci placebo subtracted change se","C0008107;C0019016;C0023031;C0023749;C0030705;C0032042;C0036919;C0040363;C0041260;C0168634;C0230347;C0392747;C0443172;C0444504;C0456081;C1442488;C1696465;C1705241;C1706408;C1719767;C1825777;C1883351;C2346906;C2347634;C2348143;C2348589;C2699239;C3259781;C3538758;C3829066;C4319952;C4553351",NULL,NULL,2139
"alcohol intake drinks week","C0001948;C0332174;C0439230;C0452428","C0001948","",875
"prior years taking warfarin","C0043031;C0332152;C0439234;C1515187;C2826257",NULL,NULL,1099
"untreated at baseline mm hg sbp mean sd","C0085805;C0168634;C0332155;C0439475;C0444504;C1442488;C2347634;C2348143;C2699239","C0005823","",1469
"$nmbr$ oral antidiabetic medication","C0175795;C0442027;C0935929;C4521986",NULL,NULL,995
"fasting glucose $nmbr$ mg dl n","C0015663;C0017725;C0439269","C0017725;C0015663","",2280
"$nmbr$ point reduction in selena sledai score","C0301630;C0392756;C0449820;C0451528;C1293152;C1552961;C2347617;C3714763;C4050231;C4551656",NULL,NULL,730
"ipah hpah","C0152171;C0340543;C0637939;C1150929",NULL,NULL,1664
"mssbp $nmbr$ mmhg","C0439475","C0005823","",1469
"median disease duration yr","C0439234;C0549183;C0872146;C0876920;C2347635;C2348144;C2939193",NULL,NULL,1099
"dbp mm hg mean sdc","C0439475;C0444504;C0536221;C1419891;C2347634;C2348143;C3273112;C3813197;C4281799",NULL,NULL,605
"rosuvastatin","C0965129","C0965129","",886
"$nmbr$ $nmbr$ kg m $nmbr$ hypertension","C0020538;C1532718;C1963138",";C1305855","",206
"pe only","C0070939;C0205171;C1720467;C1880476;C4284304",NULL,NULL,1516
"erythrocyte sedimentation rate mm hr","C1176468;C1619634;C4330985;C4554674","C1619634","",298
"baseiine acei arb","C3888198",NULL,NULL,44
"non diabetic","C0241863;C1518422",NULL,NULL,996
"renin angiotensin system inhibitor use","C0035096;C0042153;C0457083;C1947944;C1999216;C2984247",NULL,NULL,812
"event rates per $nmbr$ patient years $nmbr$ ci","C0008107;C0030705;C0439234;C0441471;C0871208;C1521828;C3259781;C4019010",NULL,NULL,2007
"patients with egfr $nmbr$ $nmbr$ to $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n","C0030705;C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"$nmbr$ $nmbr$ kg m $nmbr$","C1532718",";C1305855","",206
"renin angiotensin system inhibitor","C0035096;C1999216;C2984247",NULL,NULL,812
"dabigatran $nmbr$ mg bid","C0024671;C0026410;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761",NULL,NULL,775
"dyslipidaemia and hypertensiont","C0242339","C0020538","",1364
"weight ab","C0005910;C0043100;C1305866;C1705104","C0005910","",1250
"das $nmbr$ esr lda","C0051767;C0057671;C3811131;C4553195","C1619634","",298
"fracture history predefined n","C0016658;C0019664;C0019665;C0262512;C0262926;C0369718;C0441922;C1705255;C2004062",NULL,NULL,2026
"ed history n yes","C0019664;C0019665;C0262512;C0262926;C1549445;C1705108;C1705255;C1710701;C2004062;C3538926",NULL,NULL,147
"all mis","C0687670;C1333208;C1412384;C3538735",NULL,NULL,397
"concomitant use of nsaids to week $nmbr$","C0003211;C0332174;C0439230;C0521115;C1524063",NULL,NULL,1012
"prior history ml or stroke","C0019664;C0019665;C0038454;C0262512;C0262926;C0332152;C0439526;C1705224;C1705255;C2004062;C2826257;C3887665;C4554100",NULL,NULL,300
"$nmbr$ ug g","C0439272",NULL,NULL,207
"laba plus ics n","C0332287;C0815320;C4551720",NULL,NULL,2193
"pedal edema slight moderate marked","C0205081;C0522501;C0574002;C1706089;C1881878;C2937276;C2945599;C4049705;C4049706;C4050469;C4085643;C4321335",NULL,NULL,321
"sex men","C0009253;C0025266;C0036864;C0079399;C0804628;C1314687;C1522384",NULL,NULL,1842
"diuretic use at baseline","C0012798;C0042153;C0168634;C0457083;C1442488;C1947944",NULL,NULL,992
"subjects who did not receive labd prior to the study","C0332152;C0396059;C0557651;C0681850;C1514756;C1518422;C1550501;C1706203;C2349001;C2603343;C2697811",NULL,NULL,1655
"oma oat","C0028753;C0331496;C0939905;C3539067;C3897364",NULL,NULL,254
"etoricoxib n $nmbr$","C0972314","C0972314","",1130
"secondary pci","C0027627;C0175668;C0205436;C4049621",NULL,NULL,1484
"normal albuminuria uacr $nmbr$","C0001925;C0205307;C0231683;C0439166;C2347086;C4553972",NULL,NULL,687
"time since diagnosis of t $nmbr$ dm y n","C0011816;C0011900;C0040223;C1704338;C1704656;C3250443;C3541383",NULL,NULL,841
"o $nmbr$ o $nmbr$ loto $nmbr$ $nmbr$","C0483204","","",-10
"xi $nmbr$","C1720296",NULL,NULL,520
"ticagrelor $nmbr$ mg $nmbr$ year km","C0024671;C0026410;C0439234;C0439269;C0439508;C1960952;C1999375;C2346927;C3887676;C4321396;C4521761",NULL,NULL,2299
"patients with psoriasis bsa $nmbr$","C0030705;C0033860","C0005902;C0033860","",2177
"placebo famotidine $nmbr$ famotidine $nmbr$","C0015620;C0032042;C1696465;C1706408","C0015620","",74
"angina past $nmbr$ weeks","C0002962;C2987125",NULL,NULL,1014
"solifenacin n $nmbr$","C1099677","C1099677","",1938
"tdi e septal cm sec","C0205976;C0439392;C0442004;C2674784;C3714807",NULL,NULL,958
"exacerbations requiring hospitalisation past year","C0019993;C4086268;C4086728",NULL,NULL,2345
"enoxaparin vka n n $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0206460","C0206460","",862
"hr $nmbr$ $nmbr$ $nmbr$ cl $nmbr$ $nmbr$ $nmbr$","C0596019",NULL,NULL,658
"stage $nmbr$ b $nmbr$ and $nmbr$","C0441781",NULL,NULL,542
"p value for interaction","C1704675;C1709380",NULL,NULL,7
"time of symptom onset to randomization hrs","C0034656;C1320528;C1568891",NULL,NULL,142
"fenofibric acid moderate dose statin","C0060179;C0360714;C1709056",NULL,NULL,1696
"pci duration","C0449238;C2926735;C4049621",NULL,NULL,901
"adjusted hr $nmbr$ cl pvalue","C0456081;C0596019",NULL,NULL,658
"mean systolic bp mmhg mean sd","C0439475;C0444504;C0871470;C2347634;C2348143;C2699239","C0005823","",1469
"left sided disease only","C0012634;C3842976",NULL,NULL,43
"baseline crp $nmbr$ mg l","C0168634;C0439268;C1442488;C3890735;C4048285",NULL,NULL,1545
"comparison with baseline","C0168634;C1442488;C1707455",NULL,NULL,1633
"hospitalisation","C0019993",NULL,NULL,2358
"entry criteria","C0243161;C1705654",NULL,NULL,783
"safety variable","C0036043;C0439828;C1705187;C4553760","C0036043","",1198
"udy entry","C1705654",NULL,NULL,1588
"bolus of heparin given","C0019134;C0770546;C1186706;C1442162;C1511237;C1550718;C1705509;C1947971;C3244317;C3812160",NULL,NULL,632
"median iqr change from baseline to week $nmbr$ in psa modified total shs score","C0168634;C0332174;C0392747;C0439175;C0439230;C0439810;C0443172;C0449820;C0549183;C0876920;C1442488;C1705241;C2347635;C2348144;C2939193;C3810537;C3813209;C3889737;C4050231;C4319952",NULL,NULL,635
"western europe","C0043129","","",599
"without hx of hf","C0018488;C0262926;C1313497;C1538440;C3273279;C3814444","C0018801",";C0168634;C1524003",12
"serum mg $nmbr$ $nmbr$ mmol l normal mg hvpermagnesemia","C0205307;C0229671;C0231683;C0439166;C0439190;C1546774;C1550100;C2347086;C2827881;C4553972",NULL,NULL,687
"post bronchodilator fev predicted","C0681842;C1882327;C2599594;C3714541",NULL,NULL,680
"us site","C0205145;C1515974;C2825164",NULL,NULL,1193
"absolute decrease $nmbr$","C0205344;C0392756;C0547047",NULL,NULL,1578
"no pah therapy","C0030123;C0039798;C0087111;C1363945;C3203102;C4284467",NULL,NULL,236
"albumin to creatinine ratio","C0486293;C1318293","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"and or discharge","C0012621;C0030685;C2926602",NULL,NULL,390
"baseline spirometry","C0037981;C0168634;C1442488",";C0037981","",1197
"duration of t $nmbr$ d y","C0449238;C2926735",NULL,NULL,901
"body mass index mg m $nmbr$","C0005893;C0024671;C0026410;C0369637;C0439269;C0441923;C0578022;C1305855;C1960952;C2346927;C4321396;C4521761","C1305855","",1734
"simvastatin $nmbr$ mg","C0024671;C0026410;C0074554;C0439269;C1960952;C2346927;C4321396;C4521761","C0074554","",1840
"primary composite","C0205199;C0205225;C0439612;C0439631;C1547335",NULL,NULL,2339
"potent phosphorylated glycoprotein inhibitor use","C0017968;C0042153;C0457083;C1947944;C1999216;C3245505",NULL,NULL,807
"as duration y mean sd","C0444504;C0449238;C2347634;C2348143;C2699239;C2926735",NULL,NULL,37
"hr enl vs lcz $nmbr$ cl","C0596019",NULL,NULL,1542
"patient history of disease n","C0030705;C0683519;C0730226;C0850708;C0944983",NULL,NULL,105
"pci during index hospitalization","C0019993;C0600653;C0918012;C1552854;C1637833;C2986546;C4049621","C1532338","",1661
"patients with $nmbr$ bsa","C0030705",NULL,NULL,1308
"low potencyc","C0205251;C1550472;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"patella fracture","C0159849",NULL,NULL,2025
"mpo ng ml","C0439275",NULL,NULL,204
"diet plus pravastatin group n $nmbr$","C0012155;C0012159;C0085542;C0332287;C0441848;C1519433;C2983588;C3668949","C0012155","",1199
"events n","C0441471;C3541888",NULL,NULL,412
"history of lvh on electrocardiogram","C0013798;C0019664;C0019665;C0149721;C0262512;C0262926;C1547122;C1623258;C1705255;C2004062","C0149721","",1496
"bolus and infusion","C0574032;C1186706;C1511237;C1705509;C1827465;C3812160",NULL,NULL,1242
"stroke or pvd","C0038454;C0085096;C4521226;C4554100",NULL,NULL,1515
"previous stroke yes n previous myocardial infarction","C0027051;C0205156;C0428953;C1552607;C2926063;C3810814;C3841753;C4552959",NULL,NULL,646
"week $nmbr$ czp dose combined","C0054841;C0178602;C0205195;C0332174;C0439230;C0869039;C1114758;C1861828;C1872109","C1872109","",1406
"blisibimod n $nmbr$","C3713826",NULL,NULL,1771
"dbp mean sd mm hg glycaemic parameters","C0005802;C0439475;C0444504;C0449381;C0536221;C2347634;C2348143;C2699239;C3813197;C4281799",NULL,NULL,605
"$nmbr$ $nmbr$ ng ml","C0439275",NULL,NULL,204
"concordant stress test abnormalities","C0000768;C0000769;C0015260;C3494508;C4553529",NULL,NULL,1693
"aplxaban $nmbr$ $nmbr$ mg bid","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761","C1831808","",1224
"$nmbr$ hrs","C1568891",NULL,NULL,142
"untreated at baseline","C0168634;C0332155;C1442488",NULL,NULL,551
"proportion of patients in corticosteroid free clinical remission at week $nmbr$","C0001617;C0030705;C0205210;C0332174;C0332296;C0439230;C0544452;C0687702;C1709707;C1880497;C1996904;C3536709",NULL,NULL,1012
"statin monotherapy","C0360714",NULL,NULL,553
"telmisartan","C0248719","C0248719","",1205
"mean sd mg kg $nmbr$","C0439272;C0444504;C2347634;C2348143;C2699239",NULL,NULL,207
"tnf r $nmbr$ a ng ml","C0439275;C1363984;C1706001",NULL,NULL,204
"patients with psoriasis $nmbr$ of body surface area","C0017446;C0030705;C0033860;C0205146;C0489451","C0005902;C0033860","",2177
"prior upper gi clinical event","C0203057;C0205210;C0332152;C0441471;C2826257;C4019010",NULL,NULL,294
"loop diureties","C0445022","C0354100","",991
"sbp mm hg office measurement mean sd","C0085805;C0242485;C0439475;C0442603;C0444504;C2347634;C2348143;C2699239",NULL,NULL,607
"number of events","C4330837","C4330837","",1810
"rate per $nmbr$ patient years","C0030705;C0439234;C0871208;C1521828",NULL,NULL,2009
"hba $nmbr$ c subgroups","C0019016;C1079230;C1825777;C3538758","","",820
"onset of chest pain","C0024902;C0206132;C0332162",NULL,NULL,736
"p blocker use","C0042153;C0369773;C0457083;C1947944;C2603361",NULL,NULL,1926
"at least $nmbr$ mo","C0026544;C0332177",NULL,NULL,1476
"mean sd duration of t $nmbr$ dm y","C0011816;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735;C3250443",NULL,NULL,901
"systolic blood pressure","C0488055;C0871470;C1306620","C0871470","",615
"at screening","C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164",NULL,NULL,798
"men n $nmbr$ $nmbr$","C0025266",NULL,NULL,1842
"anti platelet agents n","C0005821;C0432633;C0450442;C1254351;C1521826",NULL,NULL,484
"primary composite end point","C0205199;C1547335;C2986535","C0205199","",1631
"penetrating","C0205321",NULL,NULL,1025
"concomitant medications","C0013227;C0521115;C0802604;C2598133;C4284232","C0013227;C0521115","",1916
"thromboembolism","C0040038","C1861172","",2399
"dysfunction ef erectile function iief i","C0021966;C0030847;C0031843;C0031847;C0221138;C0277785;C0542341;C0700205;C1705273;C3641331;C3887504;C3887505","C0242350",";C0221138;C0277785;C0542341;C0700205;C1705273;C3887505",1536
"glycemic variability mmol lc","C0005802;C0439190;C2827666","C0005802","",1349
"no of predictors of cardiovascular risk","C0007226;C0035647;C2698872;C3887460;C4552904",NULL,NULL,649
"any llt other than nutraceuticals n","C1518478;C2347090",NULL,NULL,1660
"major coronary","C0018787;C0205082;C0205164;C4318856;C4521762",NULL,NULL,1481
"estimated glomerular filtration rate","C3811844","C3811844;C0017654","",592
"no of patients with events","C0030705;C0441471;C3541888",NULL,NULL,1035
"apoe e $nmbr$ carriers no","C0003595;C0007294;C0523511;C1412481",NULL,NULL,784
"triglycerides mg l","C0041004;C0439268","C0041004","",368
"or $nmbr$ ci","C0008107;C3259781",NULL,NULL,519
"rr $nmbr$ ci c","C0008107;C3259781;C4554402",NULL,NULL,1544
"gfr ckd epi","C0017654;C0162734;C1424601;C1561643;C4281721","C1561643","",967
"endothelin receptor antagonists","C1134681;C2266875",NULL,NULL,185
"heart rate mean sd","C0018810;C0444504;C2347634;C2348143;C2699239","C0018810","",1105
"vedolizumab cohort $nmbr$ n $nmbr$","C0009247;C0599755;C2742797",NULL,NULL,943
"$nmbr$ day l","C0332173;C0439228;C0439505",NULL,NULL,1621
"systolic blood pressure $nmbr$ mm hg or diastolic","C0012000;C0439475;C0488055;C0871470;C1306620","C0005823","",1469
"ci denotes confidence interval","C0008107;C0009667;C3259781",NULL,NULL,519
"$nmbr$ predicted arr n $nmbr$ $nmbr$","C0681842;C1882327;C2170357;C4084934",NULL,NULL,51
"high vs normalb","C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"b h n $nmbr$","C0033727;C0369286;C0441932;C0564385;C4528284",NULL,NULL,308
"non end stage renal dysfunction","C0205088;C1518422;C1565489;C3279454","C1565489","",937
"comorbidities no","C0009488",NULL,NULL,765
"antidiabetes drug usage n","C0242510",NULL,NULL,995
"kdl cholesterol mmol","C0008377;C0439190","C0023822","",821
"glucocorticoids only","C0017710;C0205171;C1720467;C3540777;C3540778","C0017710","",1348
"weight $ $nmbr$ $nmbr$ kg n","C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209","C0005910","",1250
"positive vs negative","C0205160;C0439178;C1446409;C1513916;C1514241;C2825415;C2825490;C2825491;C3812269;C3853545",NULL,NULL,1163
"$nmbr$ to $nmbr$ ml min","C0439445","C3811844;C0017654","",307
"time from randomization to cabg hr","C0010055;C0034656;C0040223;C3541383",NULL,NULL,757
"renal function moderate","C0205081;C0232804;C1881878;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"intracranial hemorrhage","C0151699;C4554169","C0151699","",384
"bph related health status","C0005001;C0018759;C0439849;C0445223;C1704272",NULL,NULL,319
"cardiac disorder n","C0018799","C0018799","",1278
"europe $nmbr$ n $nmbr$","C0015176","C0015176","",337
"fatal or non fatal myocardial infarction","C0027051;C0428953;C1302234;C1518422;C1705232;C2926063;C3810814;C4552959",NULL,NULL,1682
"family history n","C0241889","C0241889","",1493
"number of copd exacerbations in the previous year n","C0205156;C0237753;C0439234;C0439508;C0449788;C0740304;C1552607",NULL,NULL,1099
"pre dose","C0439565;C3812758",NULL,NULL,2383
"azl m","C0369637;C0441923",NULL,NULL,923
"imaged artery","C0003842;C0226004;C1704254;C1704922;C3542466",NULL,NULL,785
"baseline value","C0168634;C1442488;C1522609",NULL,NULL,9
"cvd without miatroke","C0007222","C0007222","",1790
"patients with negative anti dsdna","C0030705;C0205160;C0741099;C1513916;C2825415;C2825491;C3853545",NULL,NULL,1569
"lama use n","C0042153;C0457083;C0999593;C1416775;C1947944",NULL,NULL,1300
"pulmonary embolism","C0034065",NULL,NULL,630
"cv death non fatal mi or non fatal stroke","C0011065;C0038454;C1302234;C1306577;C1518422;C1705232;C3538987;C3810814;C4048877;C4082313;C4318503;C4552775;C4554100",NULL,NULL,1682
"internal carotid artery sites","C0007276;C0205145","C0007276","",2199
"subgroup levels","C0441889;C1079230;C1515021",NULL,NULL,1637
"incidence n n rate per $nmbr$ person years","C0027361;C0439234;C1708485;C2347489","C0021149","",1998
"lei mean sd","C0023401;C0428209;C0444504;C2347634;C2348143;C2699239",NULL,NULL,526
"hba $nmbr$ c category n","C0019016;C0683312;C1825777;C3538758;C3889287","","",820
"risk factors for recurrent vte no f","C0016327;C0035648;C0630906;C1455761;C1553898;C2945760",NULL,NULL,175
"chronic renal failure","C0022661;C1561643;C2316810","C1561643","",967
"mean aqlq total score t","C0439175;C0439810;C0444504;C2347634;C2348143;C2964552;C3533236;C4055434",NULL,NULL,750
"interval between clinical evaluation and initiation of treatment no","C0039798;C0087111;C0205210;C0589507;C1158830;C1261322;C1272706;C1522326;C1533734;C1552654;C1552713;C1704686;C1705169;C2826267;C3538994;C3887704;C4084924","C1272706","",1097
"yr","C0439234",NULL,NULL,1099
"non black","C0005680;C0027567;C0085756;C0439541;C1518422",NULL,NULL,966
"white race no t","C0007457;C0034510;C0043157;C0220938;C1706779;C2603360;C3853635","C0043157","",1402
"interim analysis all patients","C0030705;C4684691",NULL,NULL,182
"$nmbr$ death from any cause major coronary event or nonfatal stroke","C0011065;C0015127;C0038454;C0205082;C0205164;C0741923;C1306577;C1524003;C4082313;C4318856;C4521762;C4552775;C4554100",NULL,NULL,1762
"$nmbr$ $nmbr$ ml min","C0439445","C3811844;C0017654","",307
"baseline post bronchodilator predicted fev $nmbr$ and no prior ics use","C0042153;C0168634;C0332152;C0457083;C0681842;C0815320;C1442488;C1882327;C1947944;C2599594;C2826257;C3714541;C4551720",NULL,NULL,1359
"qualifying hba $nmbr$ c","C0019016;C1514624;C1825777;C3538758","","",820
"cdai score","C0449820;C0683448;C1413248;C3273706;C4050231",NULL,NULL,697
"individuals with type $nmbr$ diabetes n","C0027361;C0237401;C1320657",NULL,NULL,588
"proportion of $nmbr$ responder rates","C0871208;C1521828;C1709707",NULL,NULL,1047
"second generation stent","C0038257;C0079411;C0205436;C0457385;C0565930;C1561503;C1705190;C3146294",NULL,NULL,1783
"qrs $nmbr$ msec $nmbr$ min walk test","C0439223;C0702093;C1524029;C3813700;C4277740",NULL,NULL,1475
"$nmbr$ mg ew n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"baseline glycated hemoglobin","C0017853;C0168634;C1442488","","",1176
"$nmbr$ to $nmbr$ ml min l $nmbr$ nr","C0027496;C0702093;C1524029;C1635169;C3813700;C3844738",NULL,NULL,1475
"ejection fraction mean","C0444504;C0489482;C2347634;C2348143;C2700378",NULL,NULL,37
"women qva $nmbr$ sfc","C0043210;C4521536",NULL,NULL,1283
"any placebo","C0032042;C1696465;C1706408","C0032042","",28
"$nmbr$ prior myocardial infarction no","C0155668",NULL,NULL,647
"p for interaetion","C0369773;C2603361",NULL,NULL,1874
"gender n male","C0079399;C0086582;C1522384;C1706180;C1706428;C1706429","C0086582","",1276
"with ckd standard n $nmbr$","C1442989;C1561643;C2828392","C1561643","",967
"$nmbr$ years n","C0439234",NULL,NULL,1099
"postmenopausal current hrt","C0232970;C0282402;C0521116;C1705970",NULL,NULL,549
"dermatitis atopic","C0011603;C0392707","C0392707","",1412
"patient global assessment of disease activity mean sd","C0444504;C2347634;C2348143;C2699239;C4054228",NULL,NULL,2143
"sulphonylureas","C0038766","C0038766","",752
"$nmbr$ mg dl eze simva $nmbr$","C0439269",NULL,NULL,192
"atonic","C0541791","","",-10
"non black us","C0005680;C0027567;C0085756;C0439541;C1518422",NULL,NULL,463
"cv death or hf hospitalization n","C0011065;C0018488;C0019993;C1306577;C1313497;C1538440;C3273279;C3538987;C4048877;C4082313;C4318503;C4552775",NULL,NULL,323
"serum uric acid n","C0455272;C0700634","","",2093
"upper limb","C1140618",NULL,NULL,1554
"albuminuria and previous maerovaseular disease without established renal disease","C0001925;C0012634;C0022658;C0205156;C0443211;C1272684;C1552607","C0022658","",320
"beta carotene n $nmbr$ $nmbr$","C0053396;C0696105","C0053396","",2233
"hdl c $nmbr$ mg dl no","C0439269;C3715113","C0023822","",1962
"diabetic history years x","C0019664;C0019665;C0241863;C0262512;C0262926;C0439234;C1705255;C2004062",NULL,NULL,832
"baseline pulmonary medication b n","C0013227;C0024109;C0168634;C1442488;C2707265;C2709248;C3244316;C4284232;C4522268",NULL,NULL,572
"$nmbr$ $nmbr$ $nmbr$ mm","C4330985;C4554674",NULL,NULL,297
"das $nmbr$ crp ls mean change from baseline se","C0023668;C0036919;C0051767;C0057671;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C3890735;C4048285;C4319952",NULL,NULL,567
"last study visit","C0545082;C0557651;C1512346;C1517741;C2603343;C2826704",NULL,NULL,276
"baseline mean _ sd mg dl","C0168634;C0439269;C0444504;C1442488;C2347634;C2348143;C2699239",NULL,NULL,192
"normal responder n $nmbr$","C0205307;C0231683;C0439166;C2347086;C4553972",NULL,NULL,687
"aqlq s $nmbr$ score","C0449820;C4050231;C4055434",NULL,NULL,2057
"study $nmbr$","C0557651;C2603343",NULL,NULL,1730
"ale $nmbr$","C0678386;C2632076",NULL,NULL,400
"combined therapy vsta msu iosin","C0024776;C0033972;C1412759",NULL,NULL,1646
"$nmbr$ $nmbr$ range $nmbr$ $nmbr$","C1514721;C2348147;C3542016",NULL,NULL,479
"any blood pressure lowering drug no","C0003364",";C0003364","",1579
"alleles","C0002085","","",1452
"serum albumin adjusted calcium mg dl","C0006675;C0006726;C0036773;C0439269;C0456081;C0728877;C2936886;C3540037;C3714611","C0006675","",1373
"statin potency stratum n","C0360714;C3245505","C0360714","",872
"time to first infusion","C0040223;C0205435;C0574032;C1279901;C1827465;C3541383",NULL,NULL,1242
"egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ mdrd","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682;C3839656","C3811844;C0017654","",592
"prior stroke no","C0038454;C0332152;C2826257;C4554100","C0038454;C0332152","",2380
"previous limb or foot amputation","C0015385;C0188605;C0205156;C1552607",NULL,NULL,14
"placebo events patients","C0030705;C0032042;C0441471;C1696465;C1706408;C3541888","C0032042","",28
"aspirin at last follow up","C0004057;C0589120;C1522577;C1704685;C3274571","C0004057","",1366
"overall per protocol n $nmbr$","C0282416;C1561607;C1698058",NULL,NULL,1743
"p value trend","C1521798;C1709380;C4554533",NULL,NULL,7
"dose equivalent mg sd","C0024671;C0026410;C0178602;C0205163;C0439185;C0439269;C0869039;C1114758;C1960952;C2346927;C2699239;C4321396;C4521761",NULL,NULL,192
"i rosuvastatin n $nmbr$","C0021966;C0221138;C0965129","C0965129","",886
"no apparent heart disease","C0018799;C0750489","C0018799","",1278
"the netherlands australia new zealand and south africa","C0027778;C0037712;C4289954",NULL,NULL,55
"$nmbr$ y pathogenesis n","C0543483;C0699748",NULL,NULL,565
"fasting glucose mg dl","C0015663;C0017725;C0439269","C0017725;C0015663","",2280
"systemic hypertension","C0020538","C0020538","",1364
"time of qualifying ecg to balloon inflation hrs","C0021398;C0040223;C0336867;C0441144;C1318493;C1514624;C1568891;C1623258;C3541383",NULL,NULL,142
"composite index of insulin sensitivity isi","C0205199;C0600653;C0918012;C0920563;C1547335;C1552854;C1637833;C2986546;C4049919",NULL,NULL,161
"atrial fibrillation ldl cholesterol level","C0004238;C0023824;C0202117;C0344434;C0441889;C0456079;C1547707;C1963067;C2946261","C0023824","",1068
"thrombus containing lesion","C0087086;C0221198;C0302148;C0332256;C1546698;C2700400;C3146237",NULL,NULL,1641
"py $nmbr$","C0030428;C3538810",NULL,NULL,1517
"mean sd fev $nmbr$ l pre bronchodilator","C0444504;C2347634;C2348143;C2599602;C2699239;C3714541",NULL,NULL,1599
"gender female n","C0043210;C0079399;C0086287;C1522384;C1705497;C1705498","C0079399","",1083
"measured at home with automated device","C0025080;C0205554;C0444706;C0699733;C3541902;C4534363",NULL,NULL,732
"total mortality","C0026565;C0026566;C0439175;C0439810",NULL,NULL,508
"fcal mg g mean sd","C0444504;C1300563;C2347634;C2348143;C2699239",NULL,NULL,196
"balloon angioplasty","C0002996;C0002997","C0002996","",1721
"tadalafil $nmbr$ mg","C0024671;C0026410;C0439269;C1176316;C1960952;C2346927;C4321396;C4521761","C1176316","",855
"smoking history ex smoker","C0337664;C1519384","C0037369","",420
"riva roxa ban n n $nmbr$ $nmbr$ $nmbr$","C0683610;C4553947","C1739768;C0004057","",1792
"adalimumab croup n n","C0010380;C1122087",NULL,NULL,942
"diastolic bp mmhg","C0428883;C0439475","C0428883","",842
"ldl cholesterol","C0023824;C0202117","C0023824","",1068
"prostate biopsy","C0194804","C0194804","",292
"pool of fh i and ii studies","C0337051;C0557651;C0947630;C1260386;C1509144;C2349200;C2603343",NULL,NULL,1730
"daily bowel movements","C0011135;C0332173","C0332173;C0011135","",2164
"weight kg median m n max","C0005910;C0043100;C0549183;C0876920;C1305866;C1532718;C1705104;C2347635;C2348144;C2939193","C0005910","",1250
"mental component","C0229992;C0449432;C1705248",NULL,NULL,350
"csf cholesterol","C0008377;C3540512;C3889436",NULL,NULL,1781
"education mean sd ya","C0013621;C0013622;C0013658;C0039401;C0444504;C2347634;C2348143;C2699239","C0013658","",902
"radial access no total no","C0439175;C0439810;C0442038;C0444454;C0920847;C1554204","C0589360;C0442038","",356
"hazard ratio $nmbr$ cl $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0596019;C2985465","C2985465","",975
"history of stroke see tia n","C0007787;C0019664;C0019665;C0038454;C0042789;C0262512;C0262926;C0917805;C1054154;C1705255;C1947903;C2004062;C4554100",NULL,NULL,832
"adj hr $nmbr$ cl a","C0001552;C0596019;C2826286",NULL,NULL,658
"feno $nmbr$ dn $nmbr$","C1333964;C1707618","C0033228","",803
"aldosterone use","C0002006;C0042153;C0457083;C1947944",NULL,NULL,118
"fluticasone fluticasone salmeterol","C0939232",NULL,NULL,19
"events requiring assistance","C0018896;C0441471;C1269765;C3541888",NULL,NULL,1202
"free fatty acids mmol l","C0015688;C1532563","C0015688","",1961
"dose n","C0178602;C0869039;C1114758",NULL,NULL,110
"aes in $nmbr$ japanese patients in a study arm n","C0030705;C0376247;C0446516;C0557651;C1412268;C1556094;C2603343;C2699274;C3715044;C4553528","C0877248","",47
"other end points","C2349179","C2349179","",1136
"anticholinergic use n","C0042153;C0242896;C0457083;C1947944;C3537004",NULL,NULL,1704
"non hdl mg dl $nmbr$","C0439269;C1518422;C3715113",NULL,NULL,2291
"calculated ldl cholesterol week $nmbr$","C0023824;C0202117;C0332174;C0439230;C0444686;C1441506",NULL,NULL,1012
"canagliflozin","C2974540","C2974540","",1181
"history of cerebrovascular disease no","C0585890",NULL,NULL,1494
"hyperkalemia potassium $nmbr$ $nmbr$ mmol l","C0020461;C0032821;C0202194;C0304475;C0597277;C1532563;C3714637;C4552983","C0032821","",1371
"renin inhibitor","C1960108;C3537174;C4521920",NULL,NULL,813
"former smoker","C0337671","C0037369","",420
"ae per cm s","C0439392;C3887670",NULL,NULL,958
"weight median sd kg","C0005910;C0022718;C0043100;C0439209;C0549183;C0876920;C1305866;C1705104;C2347635;C2348144;C2699239;C2939193;C4054209",NULL,NULL,2326
"corticosteroid use at randomization","C0034656;C0239126","C0239126",";C0168634;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1425988;C1947944",120
"scalp psoriasis n","C0406326","C0406326","",2178
"hr $nmbr$ and $nmbr$ cl","C0596019",NULL,NULL,658
"current alcohol use n","C0001948;C0521116;C1705970","C0001948","",875
"vascular risk score no","C0005847;C0035647;C0449820;C1558950;C1801960;C4050231;C4552904","C1801960;C0449820;C0035647","",1953
"crp normal range $nmbr$ $nmbr$ $nmbr$ mg dl mean sd","C0086715;C0439269;C0444504;C2347634;C2348143;C2699239;C3890735;C4048285","C0006560","",286
"postmenopausal","C0232970","C0232970","",1041
"no of events total n","C0439175;C0439810;C0441471;C3541888",NULL,NULL,412
"triacylglycerol mmol l mean sd","C0041004;C0444504;C1532563;C2347634;C2348143;C2699239",NULL,NULL,670
"mean s d free pcsk $nmbr$ ng ml","C0332296;C0439275;C0444504;C1880497;C1996904;C2347634;C2348143",NULL,NULL,37
"wc cm","C0013123;C2825512",NULL,NULL,703
"edoxaban","C2975435","C2975435","",1220
"composite microvascular end point","C0205199;C0443258;C1547335;C2349179;C2826544","C0205199","",1631
"non black race and ss $nmbr$ n $nmbr$ vs $nmbr$","C0005680;C1518422;C2699257;C3891295;C4551874",NULL,NULL,966
"duration of prior statin therapy","C0332152;C0360714;C0444917;C2826257",NULL,NULL,294
"baseline cdai score mean sd","C0168634;C0444504;C0449820;C0683448;C1413248;C1442488;C2347634;C2348143;C2699239;C3273706;C4050231",NULL,NULL,697
"no of tnfi among non tnfi naive","C1518422",NULL,NULL,85
"cardiac troponin t level $nmbr$ $nmbr$ pg l","C0439278;C0441889;C0456079;C1547707;C2946261;C3538889",NULL,NULL,744
"drug eluting","C0013227;C1254351","C1322815","",365
"expanded cv endpoint","C0205229;C2349179;C2826544;C3538987;C4048877;C4318503",NULL,NULL,1777
"cause of dvt or pe no","C0015127;C0070939;C0149871;C1524003;C1880476;C2926618;C3899446;C4284304",NULL,NULL,1516
"octave induction $nmbr$","C0205263;C0857127",NULL,NULL,158
"time since as diagnosis years mean sd","C0011900;C0040223;C0439234;C0444504;C1704338;C1704656;C2347634;C2348143;C2699239;C3541383",NULL,NULL,37
"number of antidiabetes drugs at screening n","C0013227;C0220908;C0220909;C0237753;C0449788;C1698960;C1710031;C1710032;C1710477;C2348164;C3687832",NULL,NULL,1556
"mean sd age y","C0001779;C0444504;C2347634;C2348143;C2699239","C0001779","",480
"usual care n $nmbr$","C1947933;C3538928",NULL,NULL,1849
"history of systemic hypertension","C0205373;C0455527",NULL,NULL,1498
"time since cabg","C0010055;C0040223;C3541383",NULL,NULL,757
"no heart failure","C0018801;C0018802;C4554158","C0018801",";C0168634;C1524003",12
"hradjusted $nmbr$ ci b","C0008107;C3259781",NULL,NULL,519
"follow up","C0589120;C1522577;C1704685;C3274571",NULL,NULL,1584
"infarct size","C0021308;C0456389","C0021308","",1288
"other anticoagulant","C0003280;C0848112;C3536711","C0003280","",450
"hs crp $nmbr$ $nmbr$ nlg l","C3890735;C4048285",NULL,NULL,1545
"associated with hiv infection","C0019693;C0332281",NULL,NULL,876
"apob apoa i","C0003593;C0085201;C1677784;C3252643","C0003593","",426
"copd severitya n","C0024117;C1412502;C3714496",NULL,NULL,1546
"other ics versus no ics","C0815320;C4551720","C3540778","",2182
"korea","C0022771","C0022771","",2089
"toast classification","C1710306;C4521230",NULL,NULL,265
"sbp median n $nmbr$","C0085805;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"intensive blood glucose control","C0162425;C0522510;C1283828;C1550453;C3267174",NULL,NULL,561
"permanent af","C0205355;C0344434;C4049859",NULL,NULL,718
"bifurcation lesion with side branch $nmbr$ $nmbr$ mm stented","C0038257;C0184906;C0205384;C0221198;C0441987;C1253959;C1546698;C1881507;C2700383;C2826234;C3146289;C4330985;C4554674",NULL,NULL,893
"aspirin only n $nmbr$ $nmbr$","C0004057;C0205171;C1720467","C0004057","",1366
"rankin grade","C0441800;C0919553;C3244287",NULL,NULL,683
"statin and or ezetimibe","C0360714;C1142985","C0360714;C1142985","",1862
"creatinine clearance n","C0812399","C0812399",";C3889287;C0452249;C0522467;C1337213;C1576800;C3890003;C0005910;C0022718;C1305866;C1705104;C1705224;C3887665",79
"pre h","C0033727;C0332152;C0369286;C0441932;C0564385;C0740175;C2257086;C3669034;C4528284",NULL,NULL,294
"ambulatory sbp n","C0085805;C0439841",NULL,NULL,607
"multivessel coronary artery disease","C0010054;C0010068;C1956346","C0010068;C1956346",";C0026410;C1710701",226
"body mass index mean kg m $nmbr$ sd","C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239","C1305855","",1734
"congestion","C0700148;C2826600",NULL,NULL,1564
"hypokalemia","C0020621;C4553966","C4553966;C0020621",";C0032821;C0202194;C0304475;C0597277;C1532563;C3714637",32
"inflix yes","C0666743;C1549445;C1705108;C1710701","C0666743","",154
"moderate severe exacerbations itt population n","C0032659;C0205081;C0205082;C1257890;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4086268;C4321335",NULL,NULL,900
"facit f","C3272505",NULL,NULL,1235
"convulsion","C0036572;C4048158","C0036572","",1394
"pci history","C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C4049621","C1532338","",1661
"antiplatelet no total no","C0439175;C0439810","","",1191
"some walking","C0080331;C4283795;C4321241;C4321242","C0080331","",1146
"severe dysfunction","C3274777",NULL,NULL,1535
"p value vs placebo","C0032042;C1696465;C1706408;C1709380",NULL,NULL,7
"unstable angina biomarker negative","C0002965;C0005516;C0205160;C1513916;C2825415;C2825491;C3853545",NULL,NULL,1569
"fev $nmbr$ reversibilityz pre post ipratropium","C0027235;C0332152;C0687676;C0740175;C1704687;C2257086;C3469826;C3669034;C3714541",NULL,NULL,1599
"mean sd total asthma symptom scores","C0004096;C0444504;C2347634;C2348143;C2699239;C2984299;C3533163",NULL,NULL,37
"other prespecified end points","C2349179","C2349179","",1136
"urine acr geometric mean cv a b mg g","C0042036;C0042037;C1300563;C1412134;C1515941;C2963137;C2986759;C3538987;C4048877;C4318503",NULL,NULL,2315
"any use","C0042153;C0457083;C1947944",NULL,NULL,118
"hba $nmbr$ c mean sd mmol mol","C0019016;C0444504;C1825777;C2347634;C2348143;C2699239;C3538758;C3829066","","",820
"haq di range $nmbr$ $nmbr$","C1514721;C2348147;C3542016;C3826998;C4321476",NULL,NULL,1665
"previously untreated isolated systolic hypertension","C0332155;C0745133","C0745133","",1051
"total cataract","C3665439",";C0086543","",1290
"early invasive strategy n $nmbr$ $nmbr$","C0205281;C0679199;C1279919;C1334278",NULL,NULL,762
"creatinine clearance ml min mean sd","C0439445;C0444504;C0812399;C2347634;C2348143;C2699239","C3811844;C0017654","",307
"normal hscrp","C0205307;C0231683;C0439166;C2347086;C4553972",NULL,NULL,687
"$nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$ n","C0369637;C0439445;C0441923","C3811844;C0017654","",307
"predose fev at screening","C0220908;C0220909;C0439565;C1698960;C1710031;C1710032;C1710477;C2348164;C3714541;C3812758","C3714541;C0439565","",295
"hispanic no","C0086409","C0086409","",865
"p valuey","C0369773;C2603361",NULL,NULL,1872
"plasma glucose mmol per liter","C0202042;C0439190;C0455280;C0475211","C0202042","",1958
"diabetes mellitus n n","C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"triglycerides sd mg dl","C0041004;C0439269;C2699239","C0041004","",368
"metformin dose mg","C0024671;C0025598;C0026410;C0178602;C0439269;C0869039;C1114758;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"hbalc $nmbr$ $nmbr$ mmol mol $nmbr$ $nmbr$ $nmbr$ $nmbr$ n $nmbr$ $nmbr$","C3829066","","",1176
"antidiabetic agents","C0935929",NULL,NULL,995
"high nfs nfs $nmbr$ $nmbr$ n $nmbr$","C0205250;C1299351;C1513839;C2700149;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"indian american or alaska native","C0596070;C0682125;C1524069",NULL,NULL,637
"$nmbr$ yr sex","C0009253;C0036864;C0079399;C0439234;C0804628;C1314687;C1522384",NULL,NULL,568
"placebo pioglitazone n $nmbr$","C0032042;C0071097;C1696465;C1706408","C0032042","",28
"fev $nmbr$ reversibility pre post albuterol","C0001927;C0332152;C0449261;C0687676;C0740175;C1704687;C2257086;C3469826;C3669034;C3714541",NULL,NULL,1599
"cbz naive","C0006949",NULL,NULL,764
"current nonsmokers","C0337672;C0521116;C1705970;C4554605","C0037369;C0521116","",2224
"fractures site not specified","C0016658;C0205145;C0205369;C1515974;C1518422;C2825164",NULL,NULL,1193
"age mean sd y ethnicity no","C0001779;C0015031;C0243103;C0444504;C2347634;C2348143;C2699239",NULL,NULL,787
"no current smoking","C0037369;C0453996;C0521116;C1705970;C1881674","C0037369","",420
"candesartan group n $nmbr$","C0441848;C0717550","","",1208
"mayo clinic scoreb","C0002424;C0442592;C0454788;C1077578",NULL,NULL,425
"previous ml","C0205156;C0439526;C1552607;C1705224;C3887665",NULL,NULL,300
"safety non cabg related bleeding","C0010055;C0019080;C0036043;C0439849;C0445223;C1518422;C1705187","C0036043","",1198
"subgroup $nmbr$","C1079230;C1515021",NULL,NULL,1637
"hypertension $nmbr$","C0020538;C1963138","C0020538","",1364
"angiotensin receptor","C0034787;C1622222","C0521942","",779
"screening l","C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164",NULL,NULL,798
"ipss o","C1019118;C1998280;C2827405;C3811063","C1998280",";C1019118;C3811063;C4050465;C4050466;C4049706;C0168634;C1705273;C1880519;C3853603",124
"sgrq total score units","C0439148;C1519795;C2964552;C3853603",NULL,NULL,540
"antithrombin","C0003438;C0003440;C4521254",NULL,NULL,1642
"peripheral artery occlusive disease stage $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0205390;C1300072;C1306673;C1306889","C0085096","",933
"week $nmbr$ ertugliflozin $nmbr$ mg vs placebo","C0024671;C0026410;C0032042;C0332174;C0439230;C0439269;C1696465;C1706408;C1960952;C2346927;C4079805;C4321396;C4521761",NULL,NULL,192
"with laba n pretreatment","C1550147;C2709094;C3539075;C3539076",NULL,NULL,715
"baseline post bronchodilator fev $nmbr$ sd ml","C0168634;C0439526;C1442488;C1705224;C2599594;C2699239;C3714541;C3887665",NULL,NULL,680
"egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"thienopyridine drug at start of open label period","C0439531;C1120149;C1709323;C1948053;C2348346",NULL,NULL,575
"coronary artery","C0205042","C0205042","",228
"previous congestive heart failure","C0018802;C0205156;C1552607","C0018801",";C0168634;C1524003",12
"at end of follow up no","C0444930;C0589120;C1522577;C1704685;C2746065;C3274571",NULL,NULL,1584
"white race","C0007457;C0043157","C0043157","",1402
"r tpa","C0032143",NULL,NULL,1594
"baseline dyspnea index mean total score","C0439175;C0439810;C0444504;C1511069;C2347634;C2348143;C2964552;C3533236",NULL,NULL,37
"north america n z $nmbr$","C0028405","C0028405","",1463
"randomized","C0034656;C3815594",NULL,NULL,692
"chads $nmbr$ score $nmbr$ $nmbr$ n","C0007928;C0369718;C0441922;C0449820;C1413373;C4050231","","",2128
"hospitalization","C0019993",NULL,NULL,2358
"death from","C0011065;C1306577;C4082313;C4552775",NULL,NULL,323
"conieosieroids and or $nmbr$ mp","C0024944",NULL,NULL,1540
"$nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923",NULL,NULL,923
"ckd n t","C1561643","C1561643","",967
"class $nmbr$ or no symptoms","C0456387;C0683368;C1457887;C1518526;C1705943",NULL,NULL,613
"procedures after discharge no","C0012621;C0025664;C0030685;C0184661;C2700391;C2926602;C3538935",NULL,NULL,290
"all randomized coronary end point","C0018787;C0034656;C2349179;C2826544;C3815594",NULL,NULL,2039
"time to first infusion from hip surgery days n","C0040223;C0205435;C0439228;C0574032;C0596706;C1279901;C1827465;C3541383",NULL,NULL,1242
"receptor blockers n baseline lipid and apolipoprotein levels","C0003591;C0023779;C0168634;C0441889;C0597357;C1442488",NULL,NULL,962
"indacaterol $nmbr$ mg","C0024671;C0026410;C0439269;C1722260;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2285
"joint space narrowing score","C0449820;C1859695;C4050231",NULL,NULL,2055
"chronic inflammatory disease","C1290886","C0021390","",107
"serum trap $nmbr$ b u liter","C0184047;C0229671;C0439148;C0475211;C1336677;C1546774;C1550100;C1566918;C1706005;C1710330;C3887583",NULL,NULL,951
"median dose range b","C0178602;C0549183;C0869039;C0876920;C1114758;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016",NULL,NULL,479
"duration of qualifying atrial fibrillation $nmbr$ days no","C0004238;C0344434;C0439228;C0449238;C1514624;C1963067;C2926735","C0004238","",90
"$nmbr$ $nmbr$ l g l","C0439267;C3539687","","",-10
"vitamin k antagonist experienced n","C0237607;C0369718;C0441922;C0596545;C1096489;C2267235",";C0043031","",868
"gusto moderate severe bleed","C0019080;C0205081;C0205082;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335",NULL,NULL,707
"crusade score","C0449820;C4050231",NULL,NULL,2056
"region of world no","C0017446;C0205147;C2700280","C0017446","",369
"moderate iief ef $nmbr$ $nmbr$","C0205081;C1881878;C3641331;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"coronary artery treated no","C0205042;C1522326",NULL,NULL,552
"crp uln","C1519815;C3890735;C4048285",NULL,NULL,1545
"lv ejection fractionb","C0023128;C0302131;C0336969;C0731033;C0812388;C1881413",NULL,NULL,2106
"previous major bleeding","C0019080;C0205082;C0205156;C0205164;C1552607;C4318856;C4521762","C0019080;C0205082","",2076
"index mi n $nmbr$ $nmbr$","C0600653;C0918012;C1552854;C1637833;C2986546;C3810814",NULL,NULL,734
"trough fev response l i","C0021966;C0221138;C0444506;C0871261;C1704632;C1706817;C2911692;C3714541",NULL,NULL,726
"previous stroke","C0038454;C0205156;C1552607;C4554100",NULL,NULL,1762
"no revascularization for index acs event","C0441471;C0581603;C0600653;C0742343;C0918012;C1552854;C1637833;C2986546;C4019010;C4318612",NULL,NULL,412
"c peptide tx difference vs pbo median change from baseline se $nmbr$","C0006558;C0031962;C0036919;C0041403;C0168634;C0392747;C0443172;C0549183;C0876920;C1442488;C1705241;C1705242;C2347635;C2348144;C2939193;C4319952","C0006558","",1154
"cataract removal","C0007389",";C0086543","",1290
"estimated mean $nmbr$ cl","C0444504;C0596019;C0750572;C2347634;C2348143",NULL,NULL,658
"monteiukast vs placebo","C0032042;C1696465;C1706408",NULL,NULL,1528
"$nmbr$ rd tertile $nmbr$ mg dl $nmbr$ $nmbr$ mmol l d","C0439190;C0439269;C0475219;C0567349;C0694666;C2348885;C3642216;C4553350",NULL,NULL,1436
"isoiated systoiic hypertension","C0020538;C1963138","C0020538","",1364
"oral anticoagulant drugs n","C0354604","C0354604","",1747
"alanine aminotransferase u l","C0001899;C0057041;C0439339;C1415274;C3887708",NULL,NULL,1572
"baseline numberf of adm classes n","C0168634;C0215825;C0456387;C1442488;C1518526;C1705943;C4019422;C4521767",NULL,NULL,1368
"concomitant methotrexate n","C0025677;C0521115","C0025677","",1408
"measures of lung function","C0035245;C0079809;C1879489",NULL,NULL,2
"activity limitation","C0205177;C0439167;C0441655;C0443288;C0449295;C1561536;C3668946;C4049938;C4049939",NULL,NULL,494
"transfusion","C0005841;C0199960;C1879316","C0005841","",1241
"mild or no dysfunction crcl $nmbr$ ml min n $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0031847;C0277785;C0439445;C1846718;C2945599;C3887504;C3887505","C3811844;C0017654","",307
"mmse points","C0451306;C1552961;C2347617;C3714763","C0451306","",305
"uac $nmbr$ mg g","C1300563",NULL,NULL,2315
"concomitant cardiovascular therapy","C0007226;C0521115;C0587038;C1707479;C3887460",NULL,NULL,648
"valvular disease","C3258293","C0018824","",103
"rec ischemia leading to hasp","C0022116;C0332152;C1424025;C1522538;C2606415;C4321499",NULL,NULL,1668
"oxidative stress","C0242606","","",-10
"non enzyme inducing","C0014442;C0205263;C1518422;C4521602",NULL,NULL,158
"draining cutaneous fistula at baseline n","C0013103;C0168634;C0180499;C0423772;C1442488;C4265177",NULL,NULL,625
"diet pravastatin $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0012155;C0012159;C0085542;C1519433;C2983588;C3668949","C0012155","",1199
"men $nmbr$ mg dl $nmbr$ $nmbr$ mmol l","C0025266;C0439269;C1532563",NULL,NULL,1842
"number resulting in hospital admission","C0184666;C0237753;C0449788;C0678226",NULL,NULL,1556
"composite of doubling of serum creatinine end stage kidney disease or death from renal causes","C0007465;C0022646;C0022658;C0201976;C0205088;C0205173;C0205199;C0600061;C1547335;C1705764","C0205199","",1631
"medication prior to admission","C0013227;C0184666;C0332152;C0809949;C3244316;C4284232",NULL,NULL,1708
"stage of pda","C0013274;C0205390;C0226047;C1300072;C1306673;C4282128",NULL,NULL,541
"p $nmbr$ cl","C0369773;C0596019;C2603361",NULL,NULL,658
"number of swollen joints $nmbr$ assessed","C0038999;C0449813;C1516048",NULL,NULL,1764
"persistent wrf n $nmbr$","C0205322;C0332996",NULL,NULL,719
"glatiramer acetate no","C0289884",NULL,NULL,442
"peripheral embolism","C0013922;C0205100;C1704212",NULL,NULL,631
"tender joint count $nmbr$ joints mean sd","C0444504;C0451530;C2347634;C2348143;C2699239","C0451530","",1139
"no prior hf hospitalization n $nmbr$ $nmbr$","C0018488;C0019993;C0332152;C1313497;C1538440;C2826257;C3273279",NULL,NULL,2359
"heart rate sd","C0018810;C2699239","C0018810","",1105
"height in meters","C0441074;C0489786",NULL,NULL,920
"history of upper","C0019664;C0019665;C0262512;C0262926;C1282910;C1705255;C2004062",NULL,NULL,832
"included in analysis","C0002778;C0332257;C0936012;C1524024",NULL,NULL,183
"biological","C0005532;C0205460",NULL,NULL,215
"high intensity statins","C0360714;C4081854","C0360714","",872
"number of antihypertensive medications at study entry","C0003364;C0557651;C1705654;C1718138;C2603343",";C0003364","",1579
"median infusions no range","C0549183;C0574032;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016",NULL,NULL,1242
"baseline peripheral artery disease","C0168634;C1442488;C1704436;C4025272",NULL,NULL,934
"acei vs non acei","C1518422",NULL,NULL,44
"cornell voltage x duration product mm x ms","C0449238;C0598352;C1514468;C1704444;C2349943;C2926735;C3539704;C3713294;C4330985;C4554674",NULL,NULL,126
"arr $nmbr$ cl","C0596019;C2170357;C4084934",NULL,NULL,51
"extended duration enoxaparin n n","C0206460;C0231448;C0231449;C0439792;C0449238;C2926735",NULL,NULL,901
"any cardiovascular disease history n","C0007222;C0007226;C0012634;C0019664;C0019665;C0262512;C0262926;C0683519;C1705255;C1880008;C2004062;C3887460","C0007222","",1790
"stroke or transient ischemic attack","C0007787;C0038454;C0917805;C4554100",NULL,NULL,1762
"glycated hemoglobin level","C0202054","","",1176
"prior diagnosis no","C0332132",NULL,NULL,1045
"opaqb physical function score","C0031843;C0449820;C0516981;C0542341;C0700205;C1705273;C4049916;C4050231;C4483112",NULL,NULL,1533
"pasi $nmbr$ response","C0871261;C1704632;C1706817;C2911692;C4528685",NULL,NULL,726
"mean change in radiographic end points shs mean sd","C0392747;C0443172;C0444504;C0444708;C1705241;C2347634;C2348143;C2349179;C2699239;C4319952",NULL,NULL,37
"fc $nmbr$ mg dl _ $nmbr$ $nmbr$ mmol l or history of diabetes","C0011847;C0011849;C0019664;C0019665;C0262512;C0262926;C0439269;C1532563;C1705255;C2004062;C2983605",NULL,NULL,670
"baseline $nmbr$ mlnute walk distance","C0168634;C0429886;C1442488",NULL,NULL,625
"cumulative incidence lyear","C0021149;C0220856;C1511559","C0021149","",1467
"immunosuppressants only","C0021081;C0205171;C1720467","C0021081","",1424
"q wave","C0429089;C1305738","C1305738","",385
"cvd mi or stroke","C0007222;C0038454;C3810814;C4554100",NULL,NULL,516
"carotid imt","C0334121;C0741968;C1704614;C4318736","","",1262
"muscle spasms","C0037763","C0037763","",1150
"hazard ratio $nmbr$ c","C2985465","C2985465","",975
"treatment effect hr","C1518681",NULL,NULL,402
"ics no laba","C0815320;C4551720","C3540778","",2182
"left ventricular ejection fraction mean sd","C0428772;C0444504;C0488728;C2347634;C2348143;C2699239",NULL,NULL,2140
"severity of airflow obstruction","C0028778;C0231999;C0439793;C0522510;C1882136",NULL,NULL,561
"history of coronary arteiy disease","C0018787;C0683519;C0730226;C0850708;C0944983",NULL,NULL,105
"cv death","C0011065;C1306577;C3538987;C4048877;C4082313;C4318503;C4552775",NULL,NULL,323
"cholinesterase inhibitor use","C0008425;C0042153;C0457083;C1947944;C3536756;C4521309",NULL,NULL,118
"eastern europe n $nmbr$","C0015177","C0239309","",601
"polyvascular disease n $nmbr$","C0012634",NULL,NULL,1868
"sustained decrease of $nmbr$ in egfr","C0392756;C0443318;C0547047;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"metformin only","C0025598;C0205171;C1720467",NULL,NULL,925
"fasting plasma glucose change from baseline","C0168634;C0392747;C0443172;C0583513;C1442488;C1705241;C4319952",NULL,NULL,767
"proportion of patients who achieved acr $nmbr$ n n","C0030705;C1412134;C1515941;C1709707",NULL,NULL,1035
"haq alternative disability score","C0102923;C0231170;C0449820;C0451208;C1523987;C4050231",NULL,NULL,1667
"cancer medications","C0006826;C0013227;C0802604;C0998265;C1306459;C2598133;C4284232","C0006826","",1819
"stroke total","C0038454;C0439175;C0439810;C4554100",NULL,NULL,1762
"fasting plasma glucose $nmbr$ medan","C0015663;C0202042;C0455280","C0455280;C0015663",";C0168634",21
"interaction p value","C1704675;C1709380",NULL,NULL,7
"pooled analysis of sustain $nmbr$ $nmbr$ trials","C0002778;C0008976;C0443318;C0936012;C1524024;C1709595;C2349200;C2732140;C4522255","C1709595;C1524024","",211
"age $nmbr$ years $nmbr$","C1510829","C1510829","",481
"parameter","C0549193;C1704769;C2350001","C0549193","",1186
"antiplatelet therapy","C1096021","","",1191
"history of non hemor rhagic stroke","C0019664;C0019665;C0038454;C0262512;C0262926;C1518422;C1705255;C2004062;C4554100",NULL,NULL,832
"stroke or tia","C0007787;C0038454;C0917805;C1054154;C4554100",NULL,NULL,1762
"histor y of unstable angina","C0002965",NULL,NULL,1002
"corticosteroid imm","C0001617;C0205470;C3536709",NULL,NULL,1650
"mtx othetcsdmards","C0025677;C1417487","C0025677","",1408
"vorapaxar placebo","C0032042;C1696465;C1706408;C2974521","C2974521","",1448
"creatinine mean sd mg dl","C0010294;C0439269;C0444504;C1561535;C2347634;C2348143;C2699239","C0600061;C0010294","",952
"ind pbo n $nmbr$","C0031962;C4049864",NULL,NULL,435
"treatment groups n nb","C0028101;C0039798;C0087111;C0441848;C0919442;C1522326;C1533734;C1705169;C1705347;C3538994;C3887704;C4553907",NULL,NULL,236
"disease site n","C0012634;C0205145;C1515974;C2825164",NULL,NULL,1193
"traditional nsaid use","C0003211;C3536840;C3897349",NULL,NULL,2121
"medium","C0009458;C0439536;C1705217;C3244283;C4085196;C4522282;C4522283",NULL,NULL,1377
"$nmbr$ years and $nmbr$ years","C0439234",NULL,NULL,1099
"immunomodulatory agents","C0005525","C1527392","",1425
"baseline trl c in $nmbr$ classes","C0168634;C0456387;C1442488;C1518526;C1705943;C4019422",NULL,NULL,452
"hba $nmbr$ c mmol mol mean","C0019016;C0444504;C1825777;C2347634;C2348143;C3538758;C3829066","","",820
"ff vi $nmbr$ $nmbr$ ig n $nmbr$","C0021027;C0205999;C0305052;C0360506;C4554348",NULL,NULL,1260
"single vessel coronary artery disease","C0581374",NULL,NULL,786
"cardiovascular risk factors no","C0850624",NULL,NULL,651
"baseiine diuretic","C0012798",NULL,NULL,992
"any blood","C0005767;C0005768;C0229664",NULL,NULL,17
"sbp $nmbr$ mm hg and or dbp $nmbr$ mm hg $nmbr$ $nmbr$","C0085805;C0439475;C0536221;C3813197;C4281799",NULL,NULL,607
"type of basal insulin n","C0205112;C0332307;C0457592;C0650607;C1547052",NULL,NULL,162
"medication at entry","C0013227;C1705654;C3244316;C4284232",NULL,NULL,2263
"compression stockings","C0038348",NULL,NULL,794
"mi n","C3810814",NULL,NULL,516
"$nmbr$ year framingham chd risk","C0439234;C0439508;C1282512;C3166866",NULL,NULL,1099
"apixaban n $nmbr$","C1831808","C1831808","",1224
"predicted post bronchodilator fev sd ml","C0439526;C0681842;C1705224;C1882327;C2599594;C2699239;C3714541;C3887665",NULL,NULL,1599
"baseline tbp","C0168634;C1442488",NULL,NULL,606
"low risk ri $nmbr$ $nmbr$","C0035487;C1826843;C3272281;C3538919",NULL,NULL,174
"comorbidity score mean sd t","C0009488;C0444504;C0449820;C2347634;C2348143;C2699239;C4050231",NULL,NULL,1287
"mn population","C0026327;C0026405;C0032659;C1257890;C4285072",NULL,NULL,303
"n responders","C0369718;C0441922",NULL,NULL,727
"heart failurea","C0018787","C0018801",";C0168634;C1524003",12
"ileum only n","C0020885;C0205171;C1720467","C0020885","",1341
"$nmbr$ $nmbr$ $nmbr$ ml min","C0439445","C3811844;C0017654","",307
"hba $nmbr$ c tx difference vs pbo median change from baseline se $nmbr$","C0019016;C0031962;C0036919;C0041403;C0168634;C0392747;C0443172;C0549183;C0876920;C1442488;C1705241;C1705242;C1825777;C2347635;C2348144;C2939193;C3538758;C4319952",NULL,NULL,1897
"recurrent hf","C0018488;C1313497;C1455761;C1538440;C2945760;C3273279","C0018801",";C0168634;C1524003",12
"use of proton inhibitors n","C0033727;C0243077;C1524063",NULL,NULL,25
"sustain","C0443318;C2732140",NULL,NULL,1031
"copd medication taken for at least $nmbr$ months before st","C0013227;C0024117;C0036056;C0439231;C1412502;C1883727;C3244316;C3272372;C3714496;C4284232",NULL,NULL,246
"apo apolipoprotein dm diabetes mellitus hdl c high density lipoprotein cholesterol ldl c low density lipoprotein cholesterol tc total cholesterol","C0003591;C0003594;C0008377;C0011849;C0023824;C0039411;C0040642;C0041405;C0041698;C0392885;C0428471;C1824670;C3272447;C3715113;C4522122","","",-10
"dmard biologic ir","C0005515;C0022065;C0022071;C0205460;C0242708;C1448132","","",1397
"$nmbr$ c i","C1547546","","",-10
"prior cabg","C0010055;C0332152;C2826257","C0010055","",389
"trend het test","C0022885;C0039593;C0392366;C0456984;C0898753;C1335803;C1515976;C1521798;C1704827;C3831328;C4318744;C4554533",NULL,NULL,242
"gastroenteritis","C0017160",NULL,NULL,782
"octi mate $nmbr$","C0682323;C1260875",NULL,NULL,1000
"lp a mg dl median q $nmbr$ q $nmbr$","C0065058;C0439269;C0549183;C0876920;C1439335;C2347635;C2348144;C2939193;C4553379",NULL,NULL,635
"lama only monotherapy","C0205171;C0999593;C1416775;C1720467",NULL,NULL,925
"reteplase abciximab facilitated pci n $nmbr$","C0256103;C0288672;C4049621","C0288672","",374
"icd therapy vs placebo no hazard ratio $nmbr$ $nmbr$ cl","C0021122;C0032042;C0039798;C0087111;C0596019;C1363945;C1696465;C1706408;C2985465",NULL,NULL,236
"baseline subgroup","C0168634;C1079230;C1442488;C1515021",NULL,NULL,1637
"warfarin n $nmbr$ n n","C0043031","C0043031","",858
"$nmbr$ mq kq","C0024853",NULL,NULL,1626
"b reslizumab $nmbr$ $nmbr$ mg kg n n","C0439272;C1869620",NULL,NULL,947
"dexlansoprazole mr n $nmbr$","C0024485;C1417249;C2347167;C2348248;C3254418;C4050513",NULL,NULL,1506
"intravenous anticoagulant during hospitalization","C0003280;C0019993;C0348016;C0848112;C3536711","C0003280;C0019993;C0348016","",2070
"intermediate acting","C0205103;C1550465;C2827755;C3889971","C0205103",";C0015663;C1550465;C2827755;C3889971;C0079613;C1704930;C1869853;C3890007;C4048375",1096
"heart failure nyha ii iii n","C0018801;C0018802;C0439070;C1275491;C1705160;C1710602;C4082587;C4554158",NULL,NULL,151
"diet alone","C0012155;C0012159;C0205171;C0439044;C0679994;C1519433;C2983588;C3668949","C0012155","",1199
"nt probnp pg ml q $nmbr$ q $nmbr$","C0439297;C0669479;C0754710",NULL,NULL,1511
"patients aged $nmbr$ y no ss","C0001779;C0001792;C0030705;C1999167;C2699257;C3891295;C4551874","C0001779","",480
"salmeterol fluticasone $nmbr$ $nmbr$ pg twice daily","C0030827;C0072225;C0585361;C0939232;C1266240",NULL,NULL,19
"hospitaiization for heart faiiure","C0018787",NULL,NULL,1481
"blood pressure at baseline","C0005767;C0005768;C0005823;C0168634;C0229664;C0443150;C1271104;C1272641;C1442488","C0005823","",1469
"sbp baseline","C0085805;C0168634;C1442488",NULL,NULL,606
"p value for heterogeneity","C0019409;C0242960;C1709380",";C1709380","C0242960",5
"american indian or alaska native","C0002460;C0682125",NULL,NULL,763
"urgency episodes $nmbr$ h","C0033727;C0332189;C0369286;C0439609;C0441932;C0564385;C4528284",NULL,NULL,308
"percentages of patients with event","C0030705;C0439165;C0441471;C1549488;C1561533;C4019010",NULL,NULL,291
"$nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ nt pro bnp","C0369637;C0439445;C0441923;C0669479;C0754710",NULL,NULL,923
"flex baseline bmd t score at femoral neck meanisd","C0015815;C0168634;C0449820;C1442488;C4050231",NULL,NULL,748
"coronary artery disease n","C0010054;C0010068;C1956346","C0010068;C1956346",";C0026410;C1710701",226
"tamsulosin w $nmbr$ $nmbr$ $nmbr$","C0257343","C0257343","",1346
"tertiary endpoints","C0205372;C2349179",NULL,NULL,1645
"first diagnosed","C0011900;C0205435;C1279901",NULL,NULL,841
"nyha lll iv","C0022326;C1261077;C1275491;C4265176","C0018802;C1882083","",453
"baseline smoking status","C0168634;C1442488;C1519386",NULL,NULL,796
"steroid use at baseline n","C0168634;C0281991;C1442488","C0239126",";C0168634;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1425988;C1947944",120
"cha $nmbr$ ds $nmbr$ vasc","C1420648;C3714751",NULL,NULL,968
"first hhf","C0205435;C1279901",NULL,NULL,1929
"fev $nmbr$ l pre bronchodilator","C2599602;C3714541",NULL,NULL,682
"active control study","C0243148;C0557651;C1550141;C1706449;C1882979;C2347179;C2587213;C2603343;C3274648;C4553389",NULL,NULL,675
"triglycerides level mg dl","C0428475;C0439269","C0041004","",368
"baseline hbalc","C0168634;C1442488",NULL,NULL,2188
"established atherosclerotic cv disease","C0007222;C0333482;C0443211;C1272684","C0004153","",1698
"asthma","C0004096;C2984299",NULL,NULL,694
"body mass index","C0005893;C0578022;C1305855","C1305855","",1734
"time from ld to pci min median q $nmbr$ q $nmbr$","C0040223;C0549183;C0694649;C0702093;C0876920;C1524029;C2347635;C2348144;C2939193;C3541383;C3813700;C4049621",NULL,NULL,1677
"morning stiffness severity $nmbr$ $nmbr$ scale","C0175659;C0349674;C0439793;C0457086;C0522510;C1947916",NULL,NULL,561
"chronic bronchitis itt n $nmbr$","C0008677","C0006277","",268
"no of cardiovascular events cardiovascular events $nmbr$ person years","C0027361;C0439234;C1320716;C2347489",NULL,NULL,1099
"category no total no","C0439175;C0439810;C0683312;C3889287",NULL,NULL,508
"stroke","C0038454;C4554100",NULL,NULL,1762
"ethnicity $nmbr$","C0015031;C0243103",NULL,NULL,787
"treated at baseline mean sd mm hg","C0168634;C0439475;C0444504;C1442488;C1522326;C2347634;C2348143;C2699239",NULL,NULL,1287
"randomization stratum","C0034656",NULL,NULL,546
"discontinuation of lama prior to baseline n","C0168634;C0457454;C0999593;C1416775;C1442488;C1444662;C4552847",NULL,NULL,1562
"crp mg liter","C0024671;C0026410;C0439269;C0475211;C1960952;C2346927;C3890735;C4048285;C4321396;C4521761","C0006560","",286
"hyperlipidaemia therapy use n no lipid lowering agent therapy","C0020473;C0039798;C0042153;C0086440;C0087111;C0428465;C0450442;C0457083;C0585943;C1254351;C1363945;C1521826;C1947944;C4555212","C0585943;C0086440","",1774
"serum total cholesterol mmol l sd","C0587184;C1287371;C1532563;C2699239","C0543421","",1504
"hip wrist or spine","C0019552;C0022122;C0037949;C0043262;C1322271;C1505163;C2752558;C3538851;C4284725",NULL,NULL,1310
"hdl $nmbr$ $nmbr$ mg dl $nmbr$ $nmbr$ $nmbr$ $nmbr$ mmol l for men women","C0025266;C0043210;C3642216;C3715113;C3898312","","",306
"heparin","C0019134;C0770546","C0019134","",863
"cabg surgery by no of vessels $nmbr$","C0010055;C0042381;C3714645","C0010055","",389
"$nmbr$ $nmbr$ pmol liter","C0439192;C0475211",NULL,NULL,987
"duration of disease n","C0872146","C0449238;C0872146","",903
"stroke at entry","C0038454;C1705654;C4554100",NULL,NULL,1762
"pnd","C1417807;C1956415;C4552608","C1956415","",1226
"ls mean change from baseline _ se","C0023668;C0036919;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C4319952",NULL,NULL,567
"additional radiographic findings at week $nmbr$","C0332174;C0439230;C0444708;C1524062;C2607943;C2926606;C3539655",NULL,NULL,1141
"all ischemic stroke","C0948008",NULL,NULL,1669
"cs use no","C0010182;C0042153;C0271160;C0457083;C1947944;C3540510;C4085345",NULL,NULL,136
"western europe australia new zealand middle east","C0026068;C0043129;C4289954","","",599
"ukraine","C0041580",NULL,NULL,2349
"composite of $nmbr$ reduction in egfr end stage kidney disease or death from renal causes","C0007465;C0022646;C0022661;C0205199;C0301630;C0392756;C1293152;C1547335;C1739039;C2316810;C3811844;C3812682;C4551656","C0035078","",342
"patients with previous loss of response to and intolerance of infliximab","C0030705;C0205156;C0231199;C0666743;C0871261;C1517945;C1552607;C1704632;C1706817;C1744706;C2355652;C2911692","C1744706;C0666743","",1094
"post bronchodilator fev $nmbr$ reversibility a","C0449261;C2599594;C3714541","C0449261;C0231999","",1315
"chlorthalidone vs amlodipine","C0008294;C0051696","","",78
"biguanides metformin","C0005382;C0025598;C0360396;C3540012","C0005382","",685
"alpha reductase inhibitors","C0439095;C0597153;C1655741;C2003941;C2350010",NULL,NULL,57
"paclitaxel eluting stent use n","C0038257;C0042153;C0144576;C0457083;C1947944",NULL,NULL,500
"male n n","C0086582;C1706180;C1706428;C1706429","C0086582","",1276
"time of randomization","C0034656;C0040223;C3541383",NULL,NULL,692
"interleukin $nmbr$ pg ml","C0021764;C0439297;C1527200",NULL,NULL,2322
"r $nmbr$","C0205090;C0684010;C2603358","","",-10
"qualifying myocardial infarction","C0027051;C0428953;C1514624;C2926063;C3810814;C4552959",NULL,NULL,646
"geographic distribution no","C0681686",NULL,NULL,1062
"hypertension absent","C0020538;C0332197;C1963138;C4285062",NULL,NULL,485
"concomitant drug therapy at discharge","C0012621;C0013216;C0013217;C0013227;C0030685;C0039798;C0087111;C0521115;C1254351;C1363945;C1707479;C2926602;C3850077",NULL,NULL,390
"former current smoker n $nmbr$ $nmbr$","C0205156;C0337671;C0521116;C0750523;C1705970;C3173209;C3241966",NULL,NULL,13
"hospitalization for due to","C0019993",NULL,NULL,2358
"previous venous thromboembolism no","C0205156;C1552607;C1861172","C1861172","",2399
"idm","C0270221",NULL,NULL,1255
"history of myocardial infarction n","C1275835",NULL,NULL,641
"changes in shs","C0392747;C0443172",NULL,NULL,767
"not anterior","C0205094;C1518422","C0205094","",1243
"hi ah","C0018619;C0239849;C1412082;C1412316;C1431594;C1836672;C4552857",NULL,NULL,1664
"interquartile range ml min","C0439445;C1711350","C3811844;C0017654","",307
"hoehn yahr stage on n","C0205390;C1300072;C1306673",NULL,NULL,541
"index event information","C0441471;C0600653;C0918012;C1533716;C1552854;C1637833;C2986546;C4019010",NULL,NULL,412
"rate of non progression defined as cfb in mtss $nmbr$ $nmbr$ n n","C0009002;C0871208;C1521828;C1704788;C1824728;C3539106;C3839460",NULL,NULL,2010
"randomization to first balloon inflation min","C0021398;C0034656;C0205435;C0336867;C0441144;C0702093;C1279901;C1318493;C1524029;C3813700",NULL,NULL,1475
"sustain $nmbr$ semaglutide vs sitagliptin $nmbr$ mg","C0024671;C0026410;C0439269;C0443318;C1565750;C1960952;C2346927;C2732140;C3885068;C4321396;C4521761",NULL,NULL,1567
"arb n","C3888198",NULL,NULL,44
"time since diagnosis of diabetesa n","C0011900;C0040223;C1704338;C1704656;C3541383",NULL,NULL,841
"iop mm hg","C0439475;C0578862",NULL,NULL,1887
"use of ace inhibitor","C0003015;C1524063;C4541021","C0003015","",811
"total group","C0439175;C0439810;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429",NULL,NULL,1526
"prevalent vertebral fracture n","C0033105;C0080179;C0220900",NULL,NULL,2023
"reduction in risk $nmbr$ ci","C0008107;C0035647;C0520870;C1137094;C3259781;C4552904",NULL,NULL,171
"race asian n","C0034510;C0078988;C1706779;C3853635",";C0034510","",1107
"beta blocker at enrollment","C0001645;C1516879;C1696073;C3888021","C0001645","",959
"hba $nmbr$ c median sd","C0019016;C0549183;C0876920;C1825777;C2347635;C2348144;C2699239;C2939193;C3538758","","",820
"cvd events","C0007222;C0441471;C3541888",NULL,NULL,412
"changes from baseline in mssbp and msdbp are shown as least squares mean sem p $nmbr$ $nmbr$ vs $nmbr$ y","C0023189;C0168634;C0392747;C0443172;C0444504;C1442488;C1547282;C2347634;C2348143",NULL,NULL,1471
"carvedilol n","C0054836","C0054836","",1972
"duration of diabetes in years median iqr","C0011847;C0011849;C0439234;C0449238;C0549183;C0876920;C2347635;C2348144;C2926735;C2939193","C2926735;C0011849","",1988
"mean dlqi score $nmbr$ ci","C0008107;C0444504;C0449820;C2347634;C2348143;C3259781;C3899393;C4050231",NULL,NULL,527
"ldl c mean sd mg dl","C0439269;C0444504;C2347634;C2348143;C2699239","C0023824","",1963
"coronary revascularization procedure","C0877341","C0877341",";C4049621;C1552607",223
"established maerovaseular disease and albuminuria","C0001925;C0012634;C0443211;C1272684","C0443211","",179
"ohs graduate","C0268353;C0588053;C1547183;C1861455",NULL,NULL,1622
"fevi reversibility","C3830088","C0449261;C0231999","",1315
"$nmbr$ mg bid","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"km event rate","C0441471;C0871208;C1521828;C3887676;C4019010",NULL,NULL,2008
"interaction p vaiue","C1704675",NULL,NULL,888
"post bronchodilator fev $nmbr$ l","C2599594;C3714541",NULL,NULL,680
"$nmbr$ $nmbr$ mg mmol","C0567349;C2348885",NULL,NULL,200
"two dimensional echocardiography","C0013524","","",-10
"severe gold $nmbr$","C0018026;C0205082;C1304897;C4050465;C4050466","C0024117;C0521117","",213
"hyperlipidemia no total no","C0020473;C0428465;C0439175;C0439810;C4555212","C0020473;C4555212",";C0439810;C1710701",29
"olmesartan ccb olmesartan diuretic","C0006684;C0012798;C1098320",NULL,NULL,704
"$nmbr$ ms score","C0449820;C2349943;C3539704;C3713294;C4050231",NULL,NULL,126
"pbo no","C0031962",NULL,NULL,435
"without diabetes","C0011847;C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"menopausal status and hormone therapy use premenopausal","C0042153;C0279025;C0279752;C0457083;C1513126;C1947944","C0279752","",1042
"stenosis investigator","C0035173;C0678234;C1261287;C2632116",NULL,NULL,1651
"albuminuria acr $nmbr$ m g g at baseline to normoalbuminuria","C0001925;C0168634;C0369637;C0441923;C1319635;C1412134;C1442488;C1515941",NULL,NULL,52
"ze statin","C0360714",NULL,NULL,1832
"insulin dose iu day median","C0366513;C0439465;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,1899
"previous stroke or tl a $nmbr$ $nmbr$","C0038454;C0205156;C0220928;C1552607;C4554100",NULL,NULL,1762
"body mass index mean sd t","C0005893;C0444504;C0578022;C1305855;C2347634;C2348143;C2699239","C1305855","",1734
"limited to left side of colon","C0227388;C0439801;C2674459;C3542948;C4050251",NULL,NULL,43
"total cholesterol mean sd mg dl","C0201950;C0439269;C0444504;C0543421;C2347634;C2348143;C2699239","C0543421","",1504
"dha intake on food frequency questionnaire mean sd mg d","C0034394;C0142831;C0439422;C0444504;C1286336;C1512806;C2347634;C2348143;C2348308;C2699239;C2986698",NULL,NULL,1287
"patients analyzed n","C0030705;C0369718;C0441922;C0936012",NULL,NULL,1553
"no of events rate","C0441471;C0871208;C1521828;C3541888",NULL,NULL,2008
"aspirin antiplatelet","C0004057","C0004057","",1366
"other drugs","C0013227;C3687832",NULL,NULL,740
"nyha iv n","C0022326;C1275491;C4265176",NULL,NULL,151
"necessitating hospitalization in previous year no","C0019993;C0205156;C0439234;C0439508;C1552607",NULL,NULL,1099
"colon only","C0009368;C0205171;C1720467;C3888384","C0009368","",1971
"placebo events n","C0032042;C0441471;C1696465;C1706408;C3541888","C0032042","",28
"n $nmbr$ l $nmbr$","C0369718;C0441922",NULL,NULL,1553
"plus minus values are means sd race or ethnic group was self determined the body mass index is the weight in kilograms divided by","C0005893;C0005910;C0015031;C0034510;C0036595;C0042295;C0043100;C0332288;C0332849;C0439209;C0578022;C1305855;C1305866;C1704970;C1705104;C1706779;C1879937;C2699239;C3853635",NULL,NULL,787
"stage $nmbr$ a egfr $nmbr$ and $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$","C0205390;C0369637;C0439445;C0441923;C1300072;C1306673;C1739039;C3811844;C3812682",NULL,NULL,541
"$nmbr$ $nmbr$ cm vas","C0042815;C3536884;C3827561",NULL,NULL,1751
"ast u l","C0439339;C1415181;C3891303",NULL,NULL,459
"hospitalized fatal heart failure","C0018801;C0018802;C0701159;C1302234;C1705232;C4554158","C0018801",";C0168634;C1524003",12
"rates per $nmbr$ patient years","C0030705;C0439234;C0871208;C1521828",NULL,NULL,2009
"post bronchodilator fev $nmbr$ predicted mean sd","C0444504;C0681842;C1882327;C2347634;C2348143;C2599594;C2699239;C3714541",NULL,NULL,680
"cardiac troponin t level median iqr pg l","C0439278;C0441889;C0456079;C0549183;C0876920;C1547707;C2347635;C2348144;C2939193;C2946261;C3538889",NULL,NULL,744
"azl m cld n $nmbr$","C0369637;C0441923",NULL,NULL,923
"hr $nmbr$ s ci","C0008107;C3259781",NULL,NULL,519
"crcl ml min","C0439445;C1846718","C3811844;C0017654","",307
"percutaneous coronary revascularization","C1532338","C1532338","",1661
"stent group n $nmbr$","C0038257;C0441848",NULL,NULL,569
"ivabradine group n $nmbr$","C0257190;C0441848","C0257190",";C0687744;C1257890;C1519504;C1705428;C1705429;C0441848",68
"no resistant htn n $nmbr$ $nmbr$","C0020538;C0332325;C1514892;C1550464;C2827757","C0020538","",1365
"psa modified shs of hands and feet","C0016504;C0018563;C0347981;C0392747;C1552914;C3810537;C3813209;C3889737",NULL,NULL,249
"all randomly assigned","C1516050;C1552601",NULL,NULL,1173
"calcium channelantagonist","C0006675;C0006726;C2936886;C3540037;C3714611","C0006684","",1884
"met criterion at bl n","C0005918;C0006413;C0243161;C0428210;C1550543;C1552663;C2827109;C4317104",NULL,NULL,39
"adjusted mean of difference se ml","C0036919;C0439526;C0444504;C0456081;C1705224;C1705241;C1705242;C2347634;C2348143;C3887665",NULL,NULL,37
"adjusted hazard ratio","C0456081;C2985465","C2985465","",975
"all treatments","C0087111",NULL,NULL,1454
"current smoker no blood pressure mm hg","C0005823;C0439475;C1271104;C1272641;C3173209;C3241966","C0037369","",420
"of patients $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0030705",NULL,NULL,1035
"upper","C1282910",NULL,NULL,739
"baseline hstni","C0168634;C1442488",NULL,NULL,625
"contusion","C0009938",NULL,NULL,1710
"lifestyle","C0023676",NULL,NULL,1490
"major gl bleeding","C0018229;C0019080;C0205082;C0205164;C1423073;C1427674;C4318856;C4521762","C0019080;C0205082","",2076
"subjects stratified by baseline pra","C0168634;C0205363;C0633231;C0681850;C1141951;C1419788;C1442488;C1550501;C1706203;C2349001;C2697811;C3274822;C3669212;C4283900",NULL,NULL,713
"mean baseline nasal congestion score","C0027424;C0168634;C1442488;C3533236;C4554631",NULL,NULL,625
"serum creatinine $nmbr$ mmol l n","C0201976;C0600061;C1532563","C0600061;C0010294","",952
"egfr ml min $nmbr$ $nmbr$ m $nmbr$ mdrd","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682;C3839656","C3811844;C0017654","",592
"mhis score","C0449820;C4050231",NULL,NULL,748
"history of coronary artery disease no","C1881055",NULL,NULL,786
"obese $nmbr$ kg m $nmbr$","C0028754;C1532718",NULL,NULL,710
"time to first inhaled corticosteroid","C0001617;C0004048;C0040223;C0205435;C1279901;C3536709;C3541383",NULL,NULL,1650
"non mets","C0812270;C1518422;C1705694;C2939420",NULL,NULL,921
"$nmbr$ baseline killip class","C0168634;C1442488;C1881332","C1881332","",846
"body mass index kgm _ $nmbr$","C0005893;C0578022;C1305855","C1305855","",1734
"dissatisfied with stopped $ $nmbr$ prior systemic therapies because of side effects","C0001688;C0205373;C0332152;C0870433;C0877248;C0879626;C1272691;C1514463;C1515119;C2826257;C4085546",NULL,NULL,294
"rolofylline dose","C0166128;C0178602;C0869039;C1114758","C0166128",";C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1114758;C1425688;C1521941;C2709207",67
"timi risk score category no","C0035647;C0449820;C0683312;C3889287;C4050231;C4552904",NULL,NULL,1954
"trial completers","C0008976",NULL,NULL,1020
"median pulse pressure mm hg iqr","C0439475;C0549183;C0876920;C0949236;C2347635;C2348144;C2939193",NULL,NULL,635
"not receiving","C1514756;C1518422",NULL,NULL,731
"multiple diagnoses","C0011900;C0439064",NULL,NULL,330
"dense calcium mm","C0006675;C0006726;C0439794;C2936886;C3540037;C3714611;C4330985;C4554674","C0006675","",1373
"hydrochlorothiazide","C0020261",NULL,NULL,1149
"hrqol","C4279947;C4300252","C4279947","",1799
"ever smoked current former","C0037366;C0205156;C0439994;C0521116;C0750523;C1705970;C1881674",NULL,NULL,13
"poor","C0032854;C0542537;C2700379","C2700379","",234
"placebo n $nmbr$ b","C0032042;C1696465;C1706408","C0032042","",28
"qva $nmbr$ $nmbr$ $nmbr$ ig od n $nmbr$","C0021027;C0229089;C0305052;C0360506;C0439164;C1512019;C3273373;C3665488",NULL,NULL,1260
"baseline mdrd","C0168634;C1442488;C3839656",NULL,NULL,625
"index event n","C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010",NULL,NULL,412
"all countries","C0454664",NULL,NULL,396
"itt cohort overall study period","C0009247;C0282416;C0439531;C0557651;C0599755;C1561607;C1948053;C2603343",NULL,NULL,1383
"$nmbr$ $nmbr$ cv disease n $nmbr$ $nmbr$","C0007222","C0007222","",1790
"permanent n","C0205355",NULL,NULL,718
"$nmbr$ med at baseline cardiac disorder","C0018799;C0168634;C1442488;C4321267",NULL,NULL,625
"fibrinolytic agent before randomisation","C0016018;C0034656",NULL,NULL,487
"diabetes mellitus no","C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"triglyceride mmol l blood pressure","C0005823;C0041004;C1271104;C1272641;C1532563","C0041004","",368
"gp llb llla inhibitors","C0243077;C1705010;C3811116",NULL,NULL,810
"cgi s n z","C4526016",NULL,NULL,773
"control of sitting bp at week $nmbr$","C0037623;C0243148;C0277814;C0332174;C0439230;C1415692;C1550141;C1708288;C1882979;C2584297;C2587213;C3274648;C4050224;C4318478;C4553389",NULL,NULL,675
"mtx plus infliximab","C0025677;C0332287;C0666743;C1417487","C0025677","",1408
"baseline mean se","C0036919;C0168634;C0444504;C1442488;C2347634;C2348143",NULL,NULL,567
"sbp mean sd mmhg","C0085805;C0439475;C0444504;C2347634;C2348143;C2699239",NULL,NULL,2127
"mean involved bsa $nmbr$ ci","C0008107;C0444504;C1314939;C2347634;C2348143;C3259781",NULL,NULL,311
"male gender n","C0086582;C1706180","C0086582","",1276
"postmenopausal and no hrt","C0232970;C0282402",NULL,NULL,549
"polyvascular disease and type $nmbr$ diabetes status","C0012634;C0332307;C0449438;C1317301;C1320657;C1547052",NULL,NULL,544
"interquartile range height cm","C0489786;C1711350",NULL,NULL,1015
"neither t $nmbr$ dm nor mets","C0011816;C0812270;C1705694;C2603360;C2939420;C3250443",NULL,NULL,955
"age","C0001779","C0001779","",480
"height loss cm","C0424641","C0489786","",1249
"medical history cancer","C0006826;C0262926;C0998265;C1306459;C1704706","C0006826","",1819
"americas excluding us","C0002454;C0332196;C0596070;C2828389","C0002454","",392
"hospitalization stratum n","C0019993",NULL,NULL,2358
"post menopausal a","C0232970","C0232970","",1041
"central or south america","C0037713;C0205099;C1879652","C0037713","",580
"sexually active with female","C0043210;C0086287;C0241028;C1705497;C1705498",NULL,NULL,497
"hs crp $nmbr$ $nmbr$ g l","C0439294;C0456615;C3890735;C4048285",NULL,NULL,1545
"$nmbr$ years baseline ldl c","C0168634;C0439234;C1442488",NULL,NULL,625
"median blood eosinophil count cells per pl t","C0200638;C0549183;C0876920;C2347635;C2348144;C2939193;C3897966;C4049765","C0014467;C0007584","",1806
"serum creatinine umol lf","C0201976;C0439194;C0600061;C1416933;C2986618;C4554443",NULL,NULL,1679
"mean cdai score sd","C0444504;C0449820;C0683448;C1413248;C2347634;C2348143;C2699239;C3273706;C4050231",NULL,NULL,697
"moderate risk $nmbr$ $nmbr$","C0035647;C0205081;C1881878;C4049705;C4049706;C4085643;C4321335;C4552904","C0035647","",173
"$nmbr$ $nmbr$ o $nmbr$ $nmbr$ o $nmbr$","C0483204","","",-10
"sex men women","C0009253;C0025266;C0036864;C0043210;C0079399;C0804628;C1314687;C1522384","","",306
"insulin sulphonylureas","C0021641;C0038766;C1533581;C1579433;C3714501","C0038766","",752
"no of background glucose lowering therapies no","C0017725;C0087111;C0441994;C1706907;C2003888",NULL,NULL,236
"distal forearm","C0588203","C0016536","",1211
"serum gastrint pg ml","C0229671;C0439297;C1546774;C1550100",NULL,NULL,951
"prior tnfi treatment","C1514463",NULL,NULL,574
"abx facil pci","C4049621",NULL,NULL,1736
"glucose lowering medication","C0013227;C0017725;C0441994;C2003888;C3244316;C4284232","C0020616",";C0013227;C3244316;C4284232;C0450442;C1254351;C1515187;C1521826;C2826257",33
"other vasodilators","C0042402","C0042402","",817
"geographic location","C0017446","C0017446","",369
"females $nmbr$ $nmbr$","C0086287","C0086287","",1277
"eastern europe and africa","C0001737;C0015177","C0239309","",601
"number of exacerbations $nmbr$ months before randomisation","C0034656;C0237753;C0439231;C0449788;C4086268","C4086268","",889
"$nmbr$ point mace $nmbr$ point mace plus hospitalization for unstable angina","C0002965;C0019993;C0349381;C0949745;C1445339;C1552961;C2347617;C3714763","C1320716","",414
"mild $nmbr$ to $nmbr$","C2945599",NULL,NULL,329
"deterioration in renal function investigator reported","C0035173;C0232804;C0684224;C0700287;C0868945;C4319718","C0232804","",1532
"asastoppedat randomization n","C0034656",NULL,NULL,692
"qmax category n","C0683312;C3889287",NULL,NULL,562
"$nmbr$ $nmbr$ $nmbr$ $nmbr$ kg m $nmbr$","C1532718",";C1305855","",206
"duration of current flare median range months n $nmbr$ $nmbr$ $nmbr$","C0439231;C0449238;C0521116;C0549183;C0876920;C1514721;C1517205;C1705970;C2347635;C2348144;C2348147;C2926735;C2939193;C3540542;C3542016",NULL,NULL,479
"feet","C0016504;C0347981",NULL,NULL,249
"previous smokers","C0337671","C0037369","",420
"patients with prior dmard use n a","C0030705;C0042153;C0242708;C0332152;C0457083;C1947944;C2826257",NULL,NULL,1035
"median iq range","C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016",NULL,NULL,635
"triglycerides $nmbr$ st third","C0036056;C0041004;C0205437;C3272372","C0041004","",209
"mean s d hba $nmbr$ c","C0019016;C0444504;C1825777;C2347634;C2348143;C3538758","","",820
"disease duration median range years","C0439234;C0549183;C0872146;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016","C0449238","",1989
"stable angina","C0340288",NULL,NULL,1003
"nsclc","C0007131",NULL,NULL,2044
"a $nmbr$ c at baseline $nmbr$ $nmbr$","C0168634;C1442488",NULL,NULL,625
"for treatment of index event","C0039798;C0087111;C0441471;C0600653;C0918012;C1522326;C1533734;C1552854;C1637833;C1705169;C2986546;C3538994;C3887704;C4019010",NULL,NULL,412
"mg dl fpg mmol l","C0439269;C1532563",NULL,NULL,670
"type of end point","C0332307;C1547052;C2349179;C2826544",NULL,NULL,603
"total patients","C0030705;C0439175;C0439810",NULL,NULL,508
"new diabetes","C0011847;C0011849;C0205314","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"glycoprotein iib iiia inhibitors","C0016011;C0243077",NULL,NULL,808
"peak systolic pressure gradient","C0039155;C4687747","C4687747","",1919
"oral corticosteroid use at enrolmentt","C0001617;C0239126;C0442027;C1527415;C3536709;C4521986",NULL,NULL,1650
"patients with egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n","C0030705;C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"suit index nmol mmol","C0600653;C0918012;C1532564;C1533073;C1552854;C1637833;C2986546",NULL,NULL,734
"am_delta","C0439097;C1705241;C3146239;C3538806;C3540585;C3815527",NULL,NULL,38
"$nmbr$ no of events","C0441471;C3541888",NULL,NULL,1059
"p value vs previous time point","C0205156;C1552607;C1709380;C2348792",NULL,NULL,1134
"glucose lowering therapy","C0017725;C0039798;C0087111;C0441994;C1363945;C2003888","C0020616",";C0013227;C3244316;C4284232;C0450442;C1254351;C1515187;C1521826;C2826257",33
"total deaths n","C0011065;C0439175;C0439810;C1306577",NULL,NULL,508
"chads $nmbr$ $nmbr$","C0007928;C1413373","","",2128
"losartan plus placebo n $nmbr$","C0032042;C0126174;C0332287;C1696465;C1706408","C0126174","",1207
"comorbid diseasesa diabetesb","C0009488","C0011849","",912
"dlqi score","C0449820;C3899393;C4050231",NULL,NULL,527
"lebrikizumab $nmbr$ $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C2981360;C4321396;C4521761",NULL,NULL,2287
"albuminuria g g","C0001925;C1319635","C0001925","",375
"severe ipss $nmbr$","C0205082;C1019118;C1998280;C2827405;C3811063;C4050465;C4050466","C1998280",";C1019118;C3811063;C4050465;C4050466;C4049706;C0168634;C1705273;C1880519;C3853603",124
"bare metal stent n","C2825200","C2825200","",348
"$nmbr$ drug related","C0013227;C0439849;C0445223;C1254351",NULL,NULL,367
"bmp kg m $nmbr$","C0053932;C0279266;C1532718;C4281808",";C1305855","",206
"age y n $nmbr$","C0001779","C0001779","",480
"concomitant use of mtx to week $nmbr$","C0025677;C0332174;C0439230;C0521115;C1417487;C1524063","C0025677","",1408
"peripheral artery revascularization without amputation","C0002688;C0332840;C0489868;C0581603;C1546539",NULL,NULL,934
"arterial hypertension n","C0020538","C0020538","",1364
"peak procedural act sec","C0025664;C0079613;C0184661;C0444505;C0565930;C1704930;C1869853;C2700391;C3274430;C3538935;C3539779;C3890007;C4048375",NULL,NULL,499
"ls mean s e primary endpoint change from baseline to week $nmbr$","C0023668;C0168634;C0332174;C0392747;C0439230;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C2986535;C4319952",NULL,NULL,37
"asia","C0003980","C0003980","",1382
"resection performed no","C0015252;C0728940;C0884358",NULL,NULL,576
"metabolic syndrome b","C0524620",NULL,NULL,617
"$nmbr$ mercaptopurine","C0000618","C0000618","",77
"age median years","C0549183;C0876920;C1510829;C2347635;C2348144;C2939193","C1510829","",481
"latin america n $nmbr$","C0023122",";C0023122","",1461
"leading to discontinuation","C0332152;C0457454;C1444662;C1522538;C4552847",NULL,NULL,1063
"kellgren and lawrence radiographic reading grade $nmbr$ no","C0034754;C0441800;C0444708;C0919553;C1705179;C3244287;C4284139",NULL,NULL,683
"mdi","C0993596;C1839839;C4049613",NULL,NULL,518
"change from baseline mean s e","C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C4319952",NULL,NULL,767
"acd","C4554601","","",-10
"prior biologic use","C0005515;C0042153;C0205460;C0332152;C0457083;C1947944;C2826257",NULL,NULL,2381
"participants with an event per $nmbr$ patient years","C0030705;C0439234;C0441471;C0679646;C4019010",NULL,NULL,1099
"u s site","C0041703;C0205145;C1515974;C2825164",NULL,NULL,1193
"vitamin k antagonist naive","C1096489;C2267235",";C0043031","",868
"placebo n z $nmbr$","C0032042;C1696465;C1706408","C0032042","",28
"serious decline in kidney function","C0205404;C0232804",NULL,NULL,916
"no asa use at baseline","C0004057;C0042153;C0168634;C0457083;C1442488;C1947944;C3853627",NULL,NULL,60
"bifurcation n","C0184906;C3146289",NULL,NULL,893
"overall early morning copd symptom severity scorec","C0024117;C0282416;C0332170;C1279919;C1319166;C1412502;C1561607;C3714496",NULL,NULL,1487
"lipoprotein a tx difference vs pbo ls mean change from baseline se","C0023668;C0031962;C0036919;C0041403;C0065058;C0125953;C0168634;C0392747;C0443172;C0444504;C1096202;C1439335;C1442488;C1705241;C1705242;C2347634;C2348143;C4319952",NULL,NULL,767
"prior pci or cabg","C0010055;C0332152;C2826257;C4049621","C1532338","",1661
"placebo group n $nmbr$ $nmbr$ $nmbr$ $nmbr$ person years","C0027361;C0032042;C0439234;C0441848;C1696465;C1706408;C2347489","C0032042","",28
"no statin during admission","C0184666;C0360714;C0809949","C0360714","",872
"atm locm","C3711796",NULL,NULL,695
"patient s assessment of pain","C0030193;C0030198;C0030705;C0518090;C0679830;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132","C0030193","",1338
"adcs adl","C3641947","C3641947","",1070
"commercially available fondaparinux","C0470187;C1098510","C1098510","",859
"oat n $nmbr$","C0028753;C0331496;C0939905;C3539067;C3897364",NULL,NULL,254
"baseline diastolic blood","C0005767;C0005768;C0012000;C0168634;C0229664;C1442488","C0005823","",1469
"thienopyridine at randomization","C0034656;C1120149",NULL,NULL,692
"education y mean sd","C0013621;C0013622;C0013658;C0039401;C0444504;C2347634;C2348143;C2699239","C0013658","",902
"apolipoprotein b tx difference vs pbo ls mean change from baseline se","C0003593;C0023668;C0031962;C0036919;C0041403;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C1705242;C2347634;C2348143;C4319952","C0003591","",1028
"abi $nmbr$ $nmbr$","C1328319;C3888326","C1328319","",1233
"af alone refers to atrial fi brillation without coexisting cardiovascular conditions but with left atrial dilatation ace denotes angiotensin con verting enzyme hf heart failure and lvd left ventricular dysfunction","C0003018;C0007226;C0012634;C0014442;C0018792;C0018801;C0205171;C0205543;C0242698;C0344434;C0344720;C0348080;C0387288;C0439044;C0679994;C1452534;C1705253;C3864998;C3887460;C4049859;C4050619;C4284014;C4521302;C4521602",NULL,NULL,40
"bmi a $nmbr$","C0578022",NULL,NULL,1735
"postmenopausal current hormone therapy use","C0019932;C0042153;C0232970;C0279025;C0457083;C0521116;C1705970;C1947944;C2827774;C4521914","C0232970;C0279025","",2225
"presenting history or diagnosis no","C0011900;C0019664;C0019665;C0262512;C0262926;C0449450;C1704338;C1704656;C1705255;C2004062",NULL,NULL,841
"p inter","C0205103;C0369773;C1548610;C2603361","C1709380","",1986
"abi","C1328319;C3888326","C1328319","",1233
"mean years since menopause","C0025320;C0439234;C0444504;C0567312;C2347634;C2348143",NULL,NULL,1099
"$nmbr$ wk kaplan meier rate","C0332174;C0439230;C0871208;C1521828",NULL,NULL,1012
"vka experienced","C0237607;C0596545",NULL,NULL,1460
"baseline feature","C0168634;C1442488;C1521970;C1706388;C2346469;C2348519","C1521970","",1110
"cv death or ml","C0011065;C0439526;C1306577;C1705224;C3538987;C3887665;C4048877;C4082313;C4318503;C4552775",NULL,NULL,323
"thienopyridine use","C0042153;C0457083;C1120149;C1947944","C1120149",";C0039798;C0087111;C1363945;C1709561;C1947944",73
"microvascular complicationsb","C0443258","C0443258;C0009566","",1214
"hispanic or latino n $nmbr$","C0086409;C0086528","C0086528;C0086409;C0015031","",363
"no prior statin use","C0042153;C0332152;C0360714;C0457083;C1947944;C2826257",NULL,NULL,118
"met criterion at blt n","C0243161;C0428210;C1550543;C1563149;C1708627;C4317104",NULL,NULL,39
"p $nmbr$ $nmbr$ for eze simva pooled across doses vs simva pooled across doses for the entire cohort data are presented as least squares mean standard error median se for tg for the entire cohort and also for each selected subgroup simva simvastatin eze ezetimibe tc total cholesterol tg triglycerides hdl c high density lipoprotein cholesterol non hdl c non high density lipoprotein cholesterol apo apolipoprotein","C0003591;C0008377;C0009247;C0023189;C0023821;C0023822;C0036919;C0039411;C0040642;C0041004;C0041405;C0041698;C0062152;C0065055;C0074554;C0178587;C0178602;C0201950;C0205250;C0337445;C0369773;C0439175;C0439751;C0439810;C0444504;C0444667;C0449450;C0543421;C0549183;C0599755;C0729627;C0876920;C1079230;C1142985;C1299351;C1511726;C1515021;C1518422;C1707391;C1708438;C1709595;C1710181;C1824670;C2347634;C2347635;C2348143;C2348144;C2349200;C2603361;C2700149;C2939193;C3245479;C3272447;C3714741;C3715113;C3887512;C3889660;C4321237;C4522122;C4522209;C4522255","","",-10
"previous stroke no concomitant treatment no","C0038454;C0039798;C0087111;C0205156;C0521115;C1522326;C1533734;C1552607;C1705169;C3538994;C3887704;C4554100",NULL,NULL,1762
"intense","C0522510",NULL,NULL,561
"doxazosin","C0114873","C0114873","",1219
"placebo mtx n $nmbr$","C0025677;C0032042;C1417487;C1696465;C1706408","C0032042","",28
"olodaterol $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C2934193;C4321396;C4521761",NULL,NULL,2294
"$nmbr$ yr km n","C0439234;C3887676",NULL,NULL,1099
"patients without diabetes","C0011847;C0011849;C0030705","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"$nmbr$ crcl","C1846718",NULL,NULL,706
"medical history of diabetic retinopathy","C0011884;C0262926",NULL,NULL,832
"eze simva $nmbr$ $nmbr$ mg dr $nmbr$","C0013014;C0024671;C0026410;C0031831;C0439269;C1707664;C1960952;C2346927;C2348314;C3540849;C4321396;C4521761","C0360714;C1142985","",1862
"age at baseline in years mean sd","C0001779;C0168634;C0439234;C0444504;C1442488;C2347634;C2348143;C2699239",NULL,NULL,1907
"adas cog","C3539026","C3539026","",1075
"fev $nmbr$ at week $nmbr$ mean ml se difference mepo pbo $nmbr$ ci","C0031962;C0036919;C0332174;C0439230;C0444504;C1705241;C1705242;C2347634;C2348025;C2348143;C3714541",NULL,NULL,567
"history of microvascular eye disease n","C0015392;C0015397;C0019664;C0019665;C0262512;C0262926;C0443258;C0683519;C0700042;C0730226;C0850708;C0944983;C1705255;C2004062",NULL,NULL,105
"greater than or equal to $nmbr$ mm hg","C0205163;C0439093;C0439475",NULL,NULL,1617
"estimated difference","C0750572;C1705241;C1705242",NULL,NULL,1466
"hard mace","C0018599;C0349381;C0949745;C1445339","C1320716","",414
"lisinopril vs amlodipineb","C0065374",NULL,NULL,1931
"no of vessels","C0005847",NULL,NULL,743
"disease duration y median m n max","C0369637;C0441923;C0549183;C0872146;C0876920;C2347635;C2348144;C2939193","C0449238;C0872146","",903
"statin no total no","C0360714;C0439175;C0439810",NULL,NULL,508
"no of pack yr","C0439234;C1968515;C2825051;C2828395",NULL,NULL,1099
"risk factors of group","C0035648;C0441833;C0687744;C1257890;C1519504;C1553898;C1705428;C1705429",NULL,NULL,1526
"sdc ng ml","C0439275;C1419891;C3273112",NULL,NULL,204
"serum creatinine concentration and randomization to losartan","C0010294;C0034656;C0086045;C0126174;C0201976;C0600061;C0683149;C1446561;C1561535;C3827302","C0600061;C0010294","",952
"lv hypertrophy per ecg","C0232306","C0232306","",406
"hyperlipidaemia","C0020473;C0428465;C4555212","C0020473;C4555212",";C0439810;C1710701",29
"multivessel disease n","C0012634",NULL,NULL,1867
"baseline bmi $nmbr$ to $nmbr$ kg m $nmbr$ n $nmbr$","C0168634;C0578022;C1442488;C1532718",";C1305855","",206
"cerebral thrombosis","C0079102;C0151945;C0795687",NULL,NULL,929
"major surgery","C0679637",NULL,NULL,2335
"rolofylline $nmbr$ mg n $nmbr$","C0024671;C0026410;C0166128;C0439269;C1960952;C2346927;C4321396;C4521761","C0166128",";C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1114758;C1425688;C1521941;C2709207",67
"israel","C0022271",NULL,NULL,672
"$nmbr$ $nmbr$ vs $nmbr$ $nmbr$ to $nmbr$ $nmbr$","C0040363;C0041260;C1883351",NULL,NULL,431
"copd severity n","C0024117;C0439793;C0522510;C1412502;C3714496",NULL,NULL,1546
"lixisenatide n $nmbr$","C2973895",NULL,NULL,759
"p value for interaction age groups","C0027362;C1704675;C1709380",NULL,NULL,7
"n event rate","C0369718;C0441471;C0441922;C0871208;C1521828;C4019010",NULL,NULL,2008
"rr $nmbr$ ci","C0008107;C3259781;C4554402",NULL,NULL,1544
"received $nmbr$ prior anti tnf therapy n","C0279936;C0332152;C0432633;C1514756;C2826257",NULL,NULL,294
"steroids other","C0038317",NULL,NULL,1648
"percentage of patients using ics or ics laba on entry","C0030705;C0439165;C0815320;C1524063;C1549488;C1561533;C1705654;C4551720",NULL,NULL,1305
"eosinophil high","C0014467;C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"fasting blood glucose mmol liter","C0428568;C0439190;C0475211;C1261430","C0015663;C0202042","",1960
"primary gusto severe bleeding","C0019080;C0205082;C0205225;C0439612;C0439631;C4050465;C4050466",NULL,NULL,707
"inter p value","C0205103;C1548610;C1709380","C1709380","",1986
"unadjusted model hr $nmbr$ ci p value","C0008107;C1439367;C1709380;C3161035;C3259781;C3274659;C3714583;C3853906","C1439367","",2162
"sitagliptin $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ h postprandial plasma glucose ppg mmol l","C0202042;C0376674;C0455280;C1418888;C1565750;C2827804","C1565750","",1184
"km rate","C0871208;C1521828;C3887676",NULL,NULL,2008
"combined therapy vsdutasteride","C0033972",NULL,NULL,1646
"intravenous vasodilators","C0443081",";C1980011;C0683092","",2071
"low risk and fewer symptoms group a","C0205388;C0441835;C0683368;C1457887;C3272281;C3538919;C4522145",NULL,NULL,174
"pooled analysis sample","C0002778;C0936012;C1303103;C1524024;C1709595;C2349200;C4522255","C1709595;C1524024","",211
"hba $nmbr$ c at randomization","C0019016;C0034656;C1825777;C3538758","","",820
"difference $nmbr$ ci","C0008107;C1705241;C1705242;C3259781",NULL,NULL,519
"sitagliptin $nmbr$","C1565750","C1565750","",1184
"amended dabigatran protocol","C0442711;C1507394;C1522729;C1691222;C2348066;C2348563;C2599718;C3715209;C4282383",NULL,NULL,775
"gallbladder related aes","C0016976;C0439849;C0445223;C1412268;C2699274","C0877248","",47
"haq di mean sd","C0444504;C2347634;C2348143;C2699239;C3826998;C4321476",NULL,NULL,2138
"triglycerides $nmbr$ mg dl","C0041004;C0439269","C0041004","",368
"saxa $nmbr$ $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"r $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C0687673;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"i $nmbr$ mg d n $nmbr$","C0021966;C0024671;C0026410;C0152277;C0221138;C0439269;C0439422;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"mean sd d","C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"oral hypoglycemic","C0359086","C0359086","",1744
"new diabetes no","C0011847;C0011849;C0205314","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"other bph luts therapy","C0005001;C0039798;C0087111;C0574785;C1363945;C1704272",NULL,NULL,1658
"anatomical extent of qualifying event no t","C0220784;C0439792;C0441471;C1514624;C2603360;C4019010",NULL,NULL,412
"se tf","C0036919;C4048299;C4048587",NULL,NULL,567
"nyha functional classification no i","C0021966;C0205245;C0221138;C0542341;C1275491;C2700217",NULL,NULL,1531
"years male gender n","C0086582;C0439234;C1706180","C0086582","",1276
"by genotyping","C1285573",NULL,NULL,618
"antidepressant","C0003289",NULL,NULL,469
"time since primary diagnosis","C0040223;C0332137;C0801658;C3541383",NULL,NULL,757
"ldl c mean sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"baseline cdai","C0168634;C0683448;C1413248;C1442488;C3273706",NULL,NULL,697
"tc hdlc","C0039411;C0040642;C0041405;C0041698;C1704429;C1824670;C3272447;C4522122",NULL,NULL,2236
"baseiine aspirin","C0004057","C0004057","",1366
"change in bp mm hg","C0439475;C1268766","C0005823","",1469
"density lipoprotein csf","C0023820;C0178587;C3540512;C3889436",NULL,NULL,1781
"other diabetes interaction p $nmbr$ $nmbr$","C0011847;C0011849;C1704675","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"pvd","C0085096;C4521226",NULL,NULL,1515
"pool of long term hefh patients only and high fh","C0030705;C0205171;C0205250;C0337051;C0443252;C1299351;C1509144;C1720467;C2349200;C2700149;C3887512;C3889660;C4321237;C4522209",NULL,NULL,475
"g c","C0439267",NULL,NULL,1486
"black race","C0005680",NULL,NULL,966
"active treatment","C1704532",NULL,NULL,723
"time from ra diagnosis years median","C0011900;C0549183;C0556970;C0876920;C1704338;C1704656;C2347635;C2348144;C2939193;C3538806;C4048756",NULL,NULL,635
"pgi s n y","C0523816;C1333690;C1412792;C1704947;C2975867;C3810522;C4522133",NULL,NULL,1738
"blood eosinophil concentration $nmbr$ cells per l","C0014467;C0086045;C0347983;C0427728;C0699870;C1313904;C1446561;C3827302",NULL,NULL,676
"galectin $nmbr$ ng ml","C0439275;C0607430",NULL,NULL,204
"no aminosalicylates n","C0368663","C0368663","",1691
"prior biologic exposure","C0005515;C0205460;C0274281;C0332152;C0332157;C2826257",NULL,NULL,2381
"a those receiving no inhaled pre treatment maintenance medication","C0004048;C0013227;C0021459;C0024501;C0039798;C0087111;C0332152;C0740175;C1514756;C1522326;C1533734;C1705169;C2257086;C2347660;C3244316;C3469597;C3538994;C3669034;C3887704;C4284232",NULL,NULL,167
"the null hypothesis is that there are no differences among subgroups for age and time since randomization the inter","C0001779;C0034656;C0040223;C0205103;C1079230;C1548610;C1705241;C1705242;C3541383;C4684719",NULL,NULL,692
"related to study druga","C0040363;C0041260;C0439849;C0445223;C0557651;C1883351;C2603343",NULL,NULL,1730
"outcomes during accord","C0680240;C1274040",NULL,NULL,1602
"fraction","C1264633;C1554103","C2700378","",887
"subgroup treatment","C0039798;C0087111;C1079230;C1515021;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,236
"median $nmbr$ year old","C0439234;C0439508;C0549183;C0580836;C0876920;C2347635;C2348144;C2939193",NULL,NULL,1099
"chronic cox $nmbr$ inhibitors","C0085387;C0205191",NULL,NULL,1701
"extensive colitis","C0009319;C0205231;C1963084","C0205231;C0009319","",2063
"t $nmbr$ dm duration years","C0011816;C0439234;C0449238;C2603360;C2926735;C3250443",NULL,NULL,1099
"acr $nmbr$ response n n","C0871261;C1412134;C1515941;C1704632;C1706817;C2911692",NULL,NULL,52
"mean sd fev $nmbr$ postbronchodilator l","C0444504;C2347634;C2348143;C2599594;C2699239;C3714541",NULL,NULL,1599
"$nmbr$ in previous","C0205156;C1552607",NULL,NULL,1044
"least square mean se","C0023189;C0036919;C0444504;C2347634;C2348143",NULL,NULL,37
"antiplatelet agent n","C0085826","","",1191
"without psoriasis zi $nmbr$ $nmbr$","C0033860;C0043476","C0033860","",1358
"cardiovascular death n $nmbr$","C0007226;C0011065;C1306577;C3887460;C4082313;C4552775",NULL,NULL,323
"t $nmbr$ dm duration y","C0011816;C0449238;C2603360;C2926735;C3250443",NULL,NULL,901
"current smoker n post bronchodilator screening","C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C2599594;C3173209;C3241966",NULL,NULL,798
"dmard or corticosteroid","C0001617;C0242708;C3536709",NULL,NULL,1650
"baseline egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ c","C0168634;C0369637;C0439445;C0441923;C1442488;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"cardiovascular risk factors","C0850624",NULL,NULL,651
"congestive heart failure at randomisation","C0018802;C0034656","C0018801",";C0168634;C1524003",12
"baseline statin","C0168634;C0360714;C1442488","C0360714","",872
"primary end point no of events total no","C0439175;C0439810;C0441471;C2986535;C3541888",NULL,NULL,1059
"bivalirudin used during pci","C0168273;C1273517;C4049621",NULL,NULL,776
"baseline mmol l","C0168634;C1442488;C1532563",NULL,NULL,670
"no corticosteroid no imm n","C0001617;C0205470;C3536709",NULL,NULL,1650
"overall cohort primary analysis","C0086027;C0205225;C0282416;C0439612;C0439631;C1561607",NULL,NULL,229
"primary hemorrhagic stroke","C0205225;C0439612;C0439631;C0553692",NULL,NULL,581
"prior tia","C0007787;C0332152;C0917805;C1054154;C2826257","C0038454;C0332152","",2380
"lrg","C1428862",NULL,NULL,210
"ugt induction status as randomizeda n","C0205263;C0449438;C0857127;C1420188;C4284131",NULL,NULL,180
"triglyceride mg dl $nmbr$","C0041004;C0439269","C0041004","",368
"unadjusted p value for interaction","C1439367;C1704675;C1709380",NULL,NULL,1581
"sitting blood pressure mmhg","C0439475;C0580946","C0005823","",1469
"characteristic no","C1521970","C1521970","",1110
"symptomatic hypoglycaemia","C0020615;C0231220;C4553659",NULL,NULL,611
"non user $nmbr$","C1518422;C1548600;C1706077",NULL,NULL,534
"neuropathy no","C0442874",NULL,NULL,1718
"rheumatoid factor positive","C0035448;C0201660;C0439178;C1446409;C1514241;C2825490;C3812269",NULL,NULL,2060
"renal impairment n","C1565489","C1565489","",937
"history of cardiovascular events","C0019664;C0019665;C0262512;C0262926;C0441471;C1320716;C1705255;C1880008;C2004062;C3541888",NULL,NULL,832
"alav per ml","C0439526;C1705224;C3887665",NULL,NULL,300
"hr $nmbr$ cl pvalue","C0596019",NULL,NULL,658
"ng n $nmbr$ $nmbr$","C0017887;C0028074",NULL,NULL,203
"single vessel pci","C0005847;C0037179;C0087136;C0205171;C4049621",NULL,NULL,1736
"albiglutide events patients","C0030705;C0441471;C2607479;C3541888","C2607479","",277
"mean annualized exacerbation rate","C0444504;C0871208;C1521828;C2347634;C2348143;C4086268",NULL,NULL,37
"mean sd n","C0444504;C2347634;C2348143;C2699239",NULL,NULL,1287
"interaction between treatment and baseline bmi category","C0039798;C0087111;C0168634;C0578022;C0683312;C1442488;C1522326;C1533734;C1704675;C1705169;C3538994;C3887704;C3889287",NULL,NULL,562
"factors dabigatran event incidence n","C0021149;C0220856;C0441471;C1521761;C2348066;C2827422;C4019010",NULL,NULL,775
"prior known stenosis $nmbr$","C0205309;C0332152;C0678234;C1261287;C2632116;C2826257",NULL,NULL,1651
"corticosteroid use at baseline yes","C0168634;C0239126;C1442488;C1549445;C1705108;C1710701",NULL,NULL,147
"simvastatin $nmbr$ $nmbr$ mg d n $nmbr$","C0074554;C0439422","C0074554","",1840
"ab $nmbr$ pg n $nmbr$","C0030827;C0072225;C1266240",NULL,NULL,208
"$nmbr$ $nmbr$ risk not disease n $nmbr$ $nmbr$","C0012634;C0035647;C1518422;C4552904",NULL,NULL,1279
"seated sbp n","C0085805;C0277814;C1283233",NULL,NULL,711
"cause of death unknown","C0007465;C0439673;C3541433;C4050014;C4050444","C0007465","",1423
"history of","C0019664;C0019665;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"first dose admin $nmbr$ $nmbr$ h $nmbr$ $nmbr$ h post onset of symptoms","C0033727;C0205435;C0369286;C0439568;C0441932;C0564385;C1279901;C4084955;C4086878;C4528284",NULL,NULL,113
"estimated gfr no","C0017654;C0750572;C1424601","C3811844;C0017654","",592
"left anterior descending n","C0205386;C0441998;C1547177","C0226032","",2098
"abbreviations acei angiotensin converting enzyme inhibitor arb angiotensin receptor blocker bpm beats per minute ccb calcium channel blocker msdbp mean sitting diastolic blood pressure mssbp mean sitting systolic blood pressure values are no unless otherwise indicated amean sd bmore severe $nmbr$ and $nmbr$ mm hg $nmbr$ and $nmbr$ mm hg less severe $nmbr$ and $nmbr$ mm hg $nmbr$ and $nmbr$ mm hg blood pressure at baseline is with monotherapy ie before switch to amlodipine valsar tan therapy","C0000723;C0003015;C0005767;C0005768;C0005823;C0006684;C0014122;C0022067;C0025424;C0039798;C0040363;C0041260;C0042295;C0051696;C0087111;C0168634;C0205082;C0229664;C0277814;C0302595;C0332152;C0428257;C0439092;C0439385;C0439453;C0439475;C0443150;C0444504;C0488055;C0547044;C0597357;C0871470;C1271104;C1272641;C1306620;C1319894;C1363945;C1442488;C1444656;C1537110;C1705850;C1707719;C1881173;C1883351;C2347108;C2347109;C2347634;C2348143;C2348272;C2584297;C2699239;C2757044;C3275241;C3536837;C3536851;C3888198;C4050224;C4050465;C4050466;C4330985;C4521885;C4541021;C4554371;C4554674",NULL,NULL,625
"i $nmbr$ i $nmbr$","C0021966;C0221138",NULL,NULL,1021
"aed inducer status","C0449438;C0887457;C3898767",NULL,NULL,543
"preoperative serum creatinine $nmbr$ pmol l","C0201976;C0439284;C0445204;C0600061","C0600061;C0010294","",952
"sbp mm hg","C0085805;C0439475","C0005823","",1469
"tjc $nmbr$ joints mean sd","C0022417;C0392905;C0444504;C2347634;C2348143;C2699239","C0451530","",1139
"reported diabetes mellitus","C0011849;C0684224;C0700287;C4319718","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"lisinopril vs chlorthalidone overweight","C0008294;C0065374;C0497406","C0497406","",1248
"hospitalized pneumonia events n","C0032285;C0441471;C0701159;C3541888","C0701159","",260
"with baseline crp level of $nmbr$ mg liter","C0024671;C0026410;C0168634;C0439269;C0441889;C0456079;C0475211;C1442488;C1547707;C1960952;C2346927;C2946261;C3890735;C4048285;C4321396;C4521761",NULL,NULL,192
"nyha functional class iii","C0205245;C0542341;C1882086;C2700217","C0018802;C1882083","",453
"mean serum potassium mg dl","C0302353;C0439269;C0444504;C0543465;C2347634;C2348143",NULL,NULL,192
"diabetes duration known of patients","C0011847;C0011849;C0030705;C0205309;C0449238;C2926735","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"normal","C0205307;C0231683;C0439166;C2347086;C4553972",NULL,NULL,687
"median duration of study drug administration","C0013175;C0549183;C0876920;C2347635;C2348144;C2348354;C2939193",NULL,NULL,1731
"prior anti tnf exposure","C0274281;C0332152;C0332157;C1448177;C2826257",NULL,NULL,2375
"cardiac rhythm disorder at baseline yes","C0168634;C0264886;C1442488;C1549445;C1705108;C1710701",NULL,NULL,147
"dabigatran $nmbr$ mg vs warfarin","C0024671;C0026410;C0043031;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761",NULL,NULL,775
"severe aes","C0205082;C1412268;C2699274;C4050465;C4050466",NULL,NULL,313
"glycemic indexes","C1136206","C1136206","",1351
"ecg findings","C0438154","C1623258","",1129
"triglycerides mg dl","C0041004;C0439269","C0041004","",368
"all doses","C0178602",NULL,NULL,110
"week and","C0332174;C0439230",NULL,NULL,1012
"$nmbr$ cit","C0008864;C0523573;C1427027;C4553421",NULL,NULL,255
"cox $nmbr$ selective inhibitor use","C0036576;C0042153;C0085387;C0457083;C1707391;C1947944",NULL,NULL,2123
"czp mtx n $nmbr$","C0025677;C0054841;C1417487;C1861828;C1872109","C0025677;C1872109","",2217
"rs breathlessnessb","C0035970;C3714753;C3813325","","",-10
"diabetes therapy at baseline alone or in combination","C0168634;C0205171;C0205195;C0439044;C0679994;C1442488;C1947911;C3274787;C3539002;C3811910",NULL,NULL,556
"age at randomisation","C0001779;C0034656","C0001779","",480
"history of cabg surgery","C0010055;C0455610","C0010055","",389
"treatment before catheterization","C0007430;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,236
"e $nmbr$ s $nmbr$ n $nmbr$","C3846405","","",-10
"no digoxin scd no y","C0012265","C0012265","",989
"uvb","C0454530;C0564461","","",-10
"normal or mild iief ef $nmbr$ $nmbr$ n","C0205307;C0231683;C0439166;C2347086;C2945599;C3641331;C4553972",NULL,NULL,329
"medication useb","C0013227;C3244316;C4284232",NULL,NULL,2263
"factor present","C0150312;C0449450;C1521761;C2827422",NULL,NULL,287
"interaction $nmbr$","C1704675",NULL,NULL,888
"ocn","C1412791;C2347392","","",-10
"diabetes present $nmbr$ $nmbr$ $nmbr$","C0011847;C0011849;C0150312;C0449450","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"year n","C0439234;C0439508",NULL,NULL,1099
"baseline therapy","C0039798;C0087111;C0168634;C1363945;C1442488",NULL,NULL,625
"ischaemic n $nmbr$","C0475224",NULL,NULL,1670
"lowest tg tertile","C0337445;C1708760","C0041004","",209
"major st depression or t wave","C0036056;C0041696;C0205082;C0205164;C0429103;C0520887;C1269683;C3272372;C4318856;C4521762","C0520887","",1091
"moderate or less airflow limitation","C0205081;C0231999;C0439092;C0443288;C0449295;C0547044;C1881878;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"location of crohn s disease","C0010346;C0450429;C1515974;C4284930;C4284931",NULL,NULL,906
"no baseline corticosteroids","C0001617;C0168634;C1442488;C3539185;C3540725;C3540726;C3540727",NULL,NULL,1650
"troponin i pg ml","C0077401;C0439297",NULL,NULL,2322
"bmi median iqr","C0549183;C0578022;C0876920;C2347635;C2348144;C2939193",NULL,NULL,1735
"predicted fev","C0681842;C1882327;C3714541",NULL,NULL,1599
"age mean age years sex","C0009253;C0036864;C0079399;C0444504;C0804628;C1314687;C1510829;C1522384;C2347634;C2348143","C1510829","",481
"unstable anginat","C0443343;C1883468",NULL,NULL,1002
"baseline lipid therapy","C0023779;C0039798;C0087111;C0168634;C1363945;C1442488",NULL,NULL,2190
"graft","C0181074;C0332835;C1961139",NULL,NULL,462
"injection site reaction n","C0151735;C4551923","C0151735","",1983
"denosumab","C1690432",NULL,NULL,943
"type $nmbr$ diabetes duration years","C0439234;C0449238;C1320657;C2926735",NULL,NULL,1099
"eze simva $nmbr$ $nmbr$ mg feno $nmbr$ mg dn $nmbr$","C1319635;C1333964;C1707618","C0033228","",803
"ace i or angiotensin receptor blocker","C0021966;C0034787;C0221138;C1452534;C1622222;C4284014",NULL,NULL,963
"ada ifg","C1060325;C1334085;C1708411;C3811629",NULL,NULL,1259
"potassium meq dl mean","C0032821;C0202194;C0304475;C0444504;C0597277;C1532568;C2347634;C2348143;C3714637","C0032821","",1371
"$nmbr$ $nmbr$ o $nmbr$ o o $nmbr$","C0483204","","",-10
"receiving concomitant nsaids and or cox $nmbr$ inhibitors","C0003211;C0085387;C0521115;C1514756",NULL,NULL,448
"duration of epilepsy mean sd years","C0014544;C0439234;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735","C0014544;C0449238","",1993
"any glucocorticoid","C0017710","C0017710","",1348
"because of drug relateda ae","C0013227;C1254351;C3887670",NULL,NULL,367
"current cigarette smoker or within past year","C0337667;C0521116;C0677453;C1704760;C1705970;C3173209;C3241966;C3890423;C4086728","C3241966","",1420
"female eze simva n $nmbr$","C0043210;C0086287;C1705497;C1705498","C0086287","",1277
"no mra at baseline","C0168634;C0243032;C1442488;C1609165;C3891069","","",239
"combined chd","C0205195;C0280604;C3542407",NULL,NULL,970
"albuminuria_p_interaction","C0001925;C1704675","C0001925","",375
"months since first ra symptom mean sd f","C0016327;C0205435;C0439231;C0444504;C1279901;C1457887;C2347634;C2348143;C2699239;C3538806;C3854129;C4048756",NULL,NULL,37
"placebo dn $nmbr$","C0032042;C1333964;C1696465;C1706408;C1707618","C0032042","",28
"potassium mg dl","C0032821;C0202194;C0304475;C0439269;C0597277;C3714637","C0032821","",1371
"normal high renin pra $nmbr$ $nmbr$ ng ml h n $nmbr$","C0205307;C0231683;C0439166;C0633231;C0855390;C1141951;C1419788;C1533072;C2347086;C3274822;C3669212;C4050009;C4283900;C4553972",NULL,NULL,687
"minimal important change threshold improvement a","C0449864;C2986411;C3845594;C3898777;C4084912",NULL,NULL,638
"catecholamines or corticosteroids without hospitalization","C0001617;C0007412;C0019993;C3539185;C3540725;C3540726;C3540727",NULL,NULL,1650
"antithrombotic agents","C1704311",NULL,NULL,1705
"exlertl ot disease","C0012634;C1318464;C1418208;C1705587","","",-10
"who fc iii symptoms at baseline","C0168634;C0439070;C0683368;C1442488;C1457887;C1705160;C2983605",NULL,NULL,524
"long term n $nmbr$","C0443252","C0443252","",1858
"male sex race or ethnic group f","C0015031;C0016327;C0034510;C0086582;C0441840;C0680174;C1706779;C1879937;C3853635",NULL,NULL,787
"high subgroup","C0205250;C1079230;C1299351;C1515021;C2700149;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"time from symptom onset of ra years median","C0439234;C0549183;C0876920;C1320528;C2347635;C2348144;C2939193;C3538806;C4048756",NULL,NULL,635
"$nmbr$ bmi $nmbr$","C0578022",NULL,NULL,1735
"egfr crcl ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C1739039;C1846718;C3811844;C3812682","C3811844;C0017654","",592
"number of previous anti tnf treatments for psa n","C0087111;C0205156;C0237753;C0449788;C1448177;C1552607;C3810537;C3813209",NULL,NULL,1556
"stented vessels","C0183521",NULL,NULL,745
"absolute risk reductions","C3179139",NULL,NULL,171
"estimated gfr $nmbr$ ml min $nmbr$ $nmbr$ m no","C0017654;C0369637;C0439445;C0441923;C0750572;C1424601","C3811844;C0017654","",592
"hscrp mg l median minimum maximum","C0439268;C0549183;C0806909;C0876920;C1524031;C1552614;C1552615;C2347635;C2348144;C2826545;C2826546;C2939193","C0006560","",286
"no prior statin n $nmbr$ $nmbr$","C0332152;C0360714;C2826257",NULL,NULL,294
"adjusted rate of fev $nmbr$ decline se ml yr","C0036919;C0439234;C0439526;C0456081;C0871208;C1521828;C1705224;C3714541;C3887665",NULL,NULL,300
"azathioprine $nmbr$ mercaptopurine","C0000618;C0004482",NULL,NULL,56
"white no","C0007457;C0043157;C0220938","C0043157","",1402
"blood glucose lowering treatment","C0005802;C0017725;C0039798;C0087111;C0441994;C0596197;C1522326;C1533734;C1705169;C2003888;C3538994;C3887704","C0005802","",1349
"faster aspart mealtime","C0015663;C0123677;C0456962;C0587119;C2985769",NULL,NULL,157
"european or arab","C0239307;C0282540;C1535514;C1561448","C0239307","",504
"pretreatment concomitant treatment","C0039798;C0087111;C0521115;C1522326;C1533734;C1550147;C1705169;C2709094;C3538994;C3539075;C3539076;C3887704",NULL,NULL,236
"absolute decline in fvc $nmbr$ predicted","C0205344;C0681842;C1882327;C3714541",NULL,NULL,1599
"previous ami","C0205156;C1552607;C4319936",NULL,NULL,1044
"heart rate bpm mean sd","C0018810;C0444504;C2347634;C2348143;C2699239","C0018810","",1105
"medal","C0524670",NULL,NULL,936
"number of agents","C0237753;C0449788;C0450442;C1254351;C1521826",NULL,NULL,484
"placebo r","C0032042;C0205090;C0684010;C1696465;C1706408;C2603358","C0032042","",28
"mean sd hba $nmbr$ c level","C0019016;C0441889;C0444504;C0456079;C1547707;C1825777;C2347634;C2348143;C2699239;C2946261;C3538758","","",820
"baseline fev l","C0168634;C1442488;C3714541",NULL,NULL,1599
"aml val $nmbr$ $nmbr$ mg","C0023465;C0023467;C0024671;C0026410;C0042285;C0439269;C0523975;C1960952;C2346927;C4321396;C4521761",NULL,NULL,186
"insulin treated dm","C0011816;C0021641;C1522326;C1533581;C1579433;C3250443;C3714501",NULL,NULL,157
"subset of patients on metformin","C0025598;C0030705;C1515021",NULL,NULL,1657
"overall itt n $nmbr$","C0282416;C1561607",NULL,NULL,1743
"age categories n","C2916832","C1510829","",481
"$nmbr$ mg day early start delayed start","C0205421;C0439422;C0439659;C1279919;C1545665;C3272602",NULL,NULL,317
"diastolic blood pressure mmhg mean sd","C0012000;C0428883;C0428886;C0439475;C0444504;C1305849;C2347634;C2348143;C2699239","C0005823","",1469
"previous acute hypersensitivity reaction to infliximab no of patients","C0030705;C0205156;C0413234;C0666743;C1552607",NULL,NULL,1035
"baseline triglycerides in $nmbr$ classes","C0041004;C0168634;C0456387;C1442488;C1518526;C1705943;C4019422",NULL,NULL,452
"history of cvd n","C0007222;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"median duration of chf mo","C0018802;C0026544;C0332177;C0449238;C0549183;C0876920;C2347635;C2348144;C2926735;C2939193",NULL,NULL,1476
"oral anticoagulant agent","C0354604","C0354604","",1747
"$nmbr$ mg vs placebo","C0024671;C0026410;C0032042;C0439269;C1696465;C1706408;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"ics no laba n","C0815320;C4551720","C3540778","",2182
"fdc $nmbr$ $nmbr$ pg vs formoterol $nmbr$ pg","C0030827;C0060657;C0072225;C0340427;C1266240;C1413520;C3539652",NULL,NULL,208
"asian oriental","C0078988;C0699027","C0078988","",284
"gender male female","C0043210;C0079399;C0086287;C0086582;C1522384;C1705497;C1705498;C1706180;C1706428;C1706429","C0086582","",1276
"ecg abnormality resting","C0035253;C1512899;C1623258;C1704258","C1623258","",1129
"without lipid lowering agents","C0086440","C0086440","",1773
"previous bdmard received","C0205156;C1514756;C1552607",NULL,NULL,2391
"race no c","C0034510;C1706779;C3853635",";C0034510","",1107
"peripheral vasodilators","C0724804",NULL,NULL,932
"coronary syndrome ci confidence interval hr hazard ratio","C0008107;C0009667;C0018787;C0039082;C2985465;C3259781",NULL,NULL,519
"erythrocyte sedimentation rate mm h","C0456680;C1176468;C1619634","C1619634","",298
"smoking status n","C1519386",NULL,NULL,796
"double vessel disease n","C0042373;C0205173;C1705764;C1705765",NULL,NULL,102
"pefam l min","C0702093;C1524029;C3813700",NULL,NULL,1475
"left ventricular ejection fraction af history","C0019664;C0019665;C0262512;C0262926;C0344434;C0428772;C0488728;C1705255;C2004062;C4049859","C0018801;C0428772","",1273
"$nmbr$ mg rosuvastatin $nmbr$ mg","C0965129;C1319635","C0965129","",886
"nutraceuticals n","C1518478",NULL,NULL,1660
"multivitamin use","C0042153;C0301532;C0457083;C1947944","C0301532",";C1710701;C1705970",1032
"non usa","C0041703;C1518422",NULL,NULL,1550
"dose of rosuvastatin","C0178602;C0869039;C0965129;C1114758","C0965129","",886
"oradj $nmbr$ ci","C0008107;C3259781",NULL,NULL,519
"crohn s disease related medication at baseline n","C0010346;C0013227;C0168634;C0439849;C0445223;C1442488;C3244316;C4284232",NULL,NULL,625
"end stage renal disease","C0022661;C2316810","C0035078","",342
"lei mean sd c","C0023401;C0428209;C0444504;C2347634;C2348143;C2699239",NULL,NULL,526
"angiography","C0002978",NULL,NULL,1723
"eosinophils $nmbr$ n $nmbr$","C0014467;C0200638","C0014467","",849
"baseline lipid lipoprotein values","C0042295;C0168634;C0443602;C1442488",NULL,NULL,2190
"medications n","C0013227;C0802604;C2598133;C4284232",NULL,NULL,2263
"former n $nmbr$ $nmbr$","C0205156;C0750523",NULL,NULL,13
"primary nonresponse","C0205225;C0439612;C0439631",NULL,NULL,229
"fasting glucose mean sd mg dl","C0015663;C0017725;C0439269;C0444504;C2347634;C2348143;C2699239","C0017725;C0015663","",2280
"fev $nmbr$ predicted mean sd","C0444504;C0681842;C1882327;C2347634;C2348143;C2699239;C3714541",NULL,NULL,1599
"dabigatran $nmbr$ mg versu swarfarin","C0024671;C0026410;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761",NULL,NULL,775
"attack","C0277793;C1261512;C1304680","","",-10
"monitoring group n $nmbr$","C0150369;C0441848;C1283169",NULL,NULL,1024
"ulcer","C0041582;C3887532","C0041582","",1451
"w europe","C0015176","C0015176","",337
"menopausal status and use of ht","C0018510;C0677607;C1513126;C1524063",NULL,NULL,25
"mmol l","C1532563",NULL,NULL,670
"total length of implanted stents mm mean sd","C0021102;C0439175;C0439810;C0444504;C0449462;C2347634;C2348143;C2699239;C2828363;C4330985;C4554674",NULL,NULL,297
"fev $nmbr$ fvc mean sd","C0444504;C2347634;C2348143;C2699239;C3714541",NULL,NULL,2126
"type ii diabetes","C0011860","","",2081
"score $nmbr$ of patients","C0030705;C0449820;C4050231",NULL,NULL,748
"coronary heart disease n t","C0010054;C0010068;C1956346","C0010068;C1956346",";C0026410;C1710701",226
"dmard","C0242708","C0242708",";C0026544",231
"irregular or ulcerated ica plaquef","C0041582;C0201519;C0205271;C3887532",NULL,NULL,2245
"hscrp $nmbr$ mg l","C0439268","C0006560","",286
"adjusted mean change from baseline se","C0036919;C0168634;C0392747;C0443172;C0444504;C0456081;C1442488;C1705241;C2347634;C2348143;C4319952",NULL,NULL,567
"previous coronary heart disease","C0010054;C0010068;C0205156;C1552607;C1956346","C0010068;C1956346",";C0026410;C1710701",226
"$nmbr$ $nmbr$ mmhg","C0439475",NULL,NULL,1888
"baseline ics use n","C0042153;C0168634;C0369718;C0441922;C0457083;C0815320;C1442488;C1947944;C4551720","C3540778","",2182
"dapagliflozin n","C2353951","C2353951","",2066
"ldl c hdl cx","C3715113","C0023822","",821
"sfc n $nmbr$ $nmbr$","C4521536",NULL,NULL,1283
"intensification of antianginal therapy","C1511484;C1874267;C3537168","C3537168","",382
"bl h y bilateral","C0005918;C0006413;C0033727;C0238767;C0369286;C0441932;C0564385;C1552663;C2827109;C4528284",NULL,NULL,655
"sd l min acq $nmbr$ score mean sd","C0444504;C0449820;C0702093;C1524029;C2347634;C2348143;C2699239;C2919686;C3813700;C4050231","C2919686","",1293
"normal $nmbr$ $nmbr$ u ml","C0205307;C0231683;C0439166;C0439340;C1880521;C2347086;C2945590;C4553972",NULL,NULL,687
"smoking $nmbr$ pack years","C0037369;C0453996;C1277691;C1881674","C0037369","",420
"tender joint count $nmbr$ $nmbr$","C0451530","C0451530","",1139
"type $nmbr$ n","C0332307;C1547052",NULL,NULL,603
"fasting glucose mg dl diabetes classification","C0008902;C0008903;C0011847;C0011849;C0015663;C0017725;C0439269;C0678229","C0017725;C0015663","",2280
"current enthesitis n","C0521116;C1282952;C1705970","C1282952;C0521116","",2223
"arb ace","C1452534;C3888198;C4284014",NULL,NULL,46
"propionic acid derivatives","C0033482;C0695274;C3540752",NULL,NULL,346
"prior angina pectoris no total no","C0002962;C0332152;C0439175;C0439810;C2826257","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"v total n $nmbr$","C0439175;C0439810",NULL,NULL,508
"a cardiovascular death or hospitalization for heart failure","C0007226;C0011065;C1306577;C3887460;C3898876;C4082313;C4552775",NULL,NULL,323
"dabigatran $nmbr$ mg b i d","C0021966;C0024671;C0026410;C0152277;C0221138;C0439269;C0439422;C1960952;C2346927;C2348066;C4321396;C4521761",NULL,NULL,775
"baseline cv treatment n y","C0039798;C0087111;C0168634;C1442488;C1522326;C1533734;C1705169;C3538987;C3538994;C3887704;C4048877;C4318503",NULL,NULL,625
"antagonist","C0231491",NULL,NULL,184
"$nmbr$ $nmbr$ $nmbr$ $nmbr$ t","C2603360","","",-10
"lumbar spine bmd t score","C0024091;C0449820;C3887615;C4050231",NULL,NULL,1551
"psoriasis duration yrs","C0033860;C0449238;C2926735",NULL,NULL,138
"background laba use","C0042153;C0457083;C1706907;C1947944",NULL,NULL,118
"presence of honeycombing $nmbr$ n","C0150312;C0332468;C0349384;C0392148;C3854307",NULL,NULL,2371
"main effect baseline hormone","C0019932;C0168634;C0205225;C1280500;C1442488;C1518681;C1542147;C2348382;C4521914",NULL,NULL,402
"duration of diabetes y mean sd","C0011847;C0011849;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"mean change se","C0036919;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952",NULL,NULL,567
"diuretic use","C0012798;C0042153;C0457083;C1947944",NULL,NULL,992
"facilitated pci n $nmbr$","C4049621",NULL,NULL,1736
"post bronchodilator fev $nmbr$ of predicted value","C0681842;C1522609;C1882327;C2599594;C3714541",NULL,NULL,680
"copd assessment test cat score","C0007450;C0325090;C0449820;C0524517;C1443200;C3665481;C4050231;C4050461;C4284282",NULL,NULL,255
"former current smoker n","C0205156;C0337671;C0521116;C0750523;C1705970;C3173209;C3241966",NULL,NULL,13
"dbp mm hg mean $nmbr$ h mean sd","C0025424;C0428257;C0444504;C0456680;C0536221;C2347108;C2347109;C2347634;C2348143;C2348272;C2699239;C3813197;C4281799",NULL,NULL,605
"nocturnal symptoms in past week","C0240526;C0683368;C1457887;C2987125",NULL,NULL,613
"a bmi subgroups","C0578022;C1079230",NULL,NULL,1735
"pvaluefor any mi versus no mi","C3810814",NULL,NULL,516
"st t wave changes","C0036056;C0392747;C0429103;C0443172;C1705241;C3272372;C4319952",NULL,NULL,2356
"non stemi","C3537184",NULL,NULL,529
"history of coronary revascularization no","C0019664;C0019665;C0262512;C0262926;C0877341;C1705255;C2004062","C0877341",";C4049621;C1552607",223
"$nmbr$ $nmbr$ s n $nmbr$ $nmbr$ $nmbr$","C2986823","","",-10
"chd status","C0280604;C0449438;C3542407",NULL,NULL,970
"preamendment","C1548596",NULL,NULL,489
"c reactive protein median iqr mg l","C0006560;C0439268;C0549183;C0876920;C1413716;C2347635;C2348144;C2939193;C4048285","C0006560","",286
"diastolic bp mm hg","C0428883;C0439475","C0428883","",842
"dbp mean sd mmhg","C0439475;C0444504;C0536221;C2347634;C2348143;C2699239;C3813197;C4281799",NULL,NULL,605
"europe $nmbr$","C0015176","C0015176","",337
"type of af n","C0332307;C0344434;C1547052;C4049859",NULL,NULL,603
"estimated gfr ml min $nmbr$ $nmbr$ m $nmbr$ lipid baseline lipid profile","C0017654;C0023779;C0168634;C0369637;C0439445;C0441923;C0750572;C1424601;C1442488;C1979963;C2003903","C3811844;C0017654","",592
"baseline bmi $nmbr$ kg m $nmbr$ n $nmbr$ $nmbr$","C0168634;C0578022;C1442488;C1532718",";C1305855","",206
"types of antihypertensive medications at $nmbr$ year","C0003364;C0332307;C0439234;C0439508",";C0003364","",1579
"cr mh crpnorr","C0026514;C0201975;C2930980;C3539604;C3711669;C4084730;C4553336;C4553337",NULL,NULL,700
"c reactive protein u l","C0006560;C0439339;C1413716;C4048285","C0006560","",286
"interactior p value","C1709380",NULL,NULL,888
"bsl baseline cl confidence interval esrd end stage renal disease hb hemoglobin k rate of events per $nmbr$ patient years of follow up rrr relative risk reduction yr year treatment effect of losartan versus placebo interaction test between treatment group and hemoglobin group $nmbr$ or $nmbr$ g i $nmbr$ cmultivariate cox model with baseline log urinary albumimcreatinine ratio serum albumin serum creatinine and hemoglobin as covariates dmultivariate cox model with baseline log urinary albumimcreatinine ratio serum albumin serum creatinine and hemoglobin and change in hemoglobin at year $nmbr$ as covariates","C0001924;C0009667;C0010294;C0019046;C0022661;C0022885;C0030705;C0032042;C0036773;C0039593;C0042027;C0080103;C0086706;C0126174;C0168634;C0201976;C0205345;C0229671;C0237455;C0242492;C0301630;C0374505;C0392366;C0392747;C0392756;C0439234;C0439508;C0441471;C0441833;C0443172;C0455271;C0456603;C0456984;C0486293;C0589120;C0596019;C0597277;C0600061;C0687744;C0728877;C0871208;C1137094;C1257890;C1293152;C1318330;C1442488;C1515976;C1518681;C1519504;C1521828;C1522577;C1524119;C1546774;C1547037;C1547039;C1549954;C1550100;C1561535;C1565830;C1626828;C1696465;C1704675;C1704685;C1705241;C1705428;C1705429;C1706408;C1708601;C1708728;C2986775;C3161035;C3274571;C3274659;C3541888;C3714583;C3831328;C3853906;C4281686;C4318744;C4319952;C4551656",NULL,NULL,658
"mean g dl","C0439267;C0444504;C2347634;C2348143",NULL,NULL,37
"use of rescue medication","C0240320",NULL,NULL,119
"prior coronary artery bypass grafting","C0010055;C0332152;C2826257","C0010055","",389
"ldl cholesterol mmol lt","C0023376;C0023824;C0202117;C0230426;C0439190;C3887647;C4521399",NULL,NULL,1678
"cerebrovascular disorders n","C0007820",NULL,NULL,728
"adjusted mean _ se change from baseline","C0036919;C0168634;C0392747;C0443172;C0444504;C0456081;C1442488;C1705241;C2347634;C2348143;C4319952",NULL,NULL,567
"nitrates n","C0028125;C0369718;C0441922;C0699857;C3848573",NULL,NULL,537
"number of previous tnfa inhibitors","C0205156;C0237753;C0243077;C0449788;C1448177;C1552607;C1710304",NULL,NULL,2398
"other supraventricular tachycardia","C0039240;C1963244;C3815188",NULL,NULL,1660
"one vessel disease","C3275121",NULL,NULL,738
"plasma creatine mg dl","C0010286;C0032105;C0439269;C1550098;C4521445","C0600061;C0010294","",952
"syncope no","C0039070;C3541349;C4554644",NULL,NULL,616
"brv overall n $nmbr$","C0155502;C0282416;C1561607",NULL,NULL,1743
"cholesterol mg dl total","C0201950;C0439269;C0543421","C0543421","",1504
"drinker n","C0556338",NULL,NULL,176
"tion os overall satisfaction qmax maximal urinary flow rate","C0229090;C0230028;C0262950;C0393706;C0429784;C1561953;C4086680",NULL,NULL,130
"a stroke","C0038454;C4554100",NULL,NULL,1762
"the american college of rheumatology","C0035452;C0557806;C0596070",NULL,NULL,1120
"medical history and risk factors","C0035648;C0262926;C1553898;C1704706",NULL,NULL,832
"background laba use yes n","C0042153;C0457083;C1549445;C1705108;C1706907;C1710701;C1947944",NULL,NULL,118
"total number of events participants","C0439175;C0439810;C0679646;C4330837",NULL,NULL,508
"aii patients n $nmbr$","C0030705;C1424250;C2698414",NULL,NULL,63
"pbo n","C0031962",NULL,NULL,435
"fasting insulin","C0015663;C0021641;C1533581;C1579433;C3714501",NULL,NULL,157
"years since pd diagnosis mean sd","C0011900;C0439234;C0444504;C1704338;C1704656;C2347634;C2348143;C2699239;C4553228;C4553229",NULL,NULL,1099
"total hip bmd t score","C0019552;C0022122;C1505163;C2964552;C3538851;C4284725",NULL,NULL,830
"area","C0017446;C0205146",NULL,NULL,370
"angiography and revascularization","C0002978;C0581603",NULL,NULL,1723
"ezetimibe $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1142985;C1960952;C2346927;C4321396;C4521761","C1142985","",1165
"dual bp ldl c goal attainment","C0037623;C0205173;C0680230;C1415692;C1554184;C1708288;C4318478",NULL,NULL,1687
"doubling of creatinine","C0010294;C0205173;C1561535;C1705764","C0600061;C0010294","",952
"ileum and colon n","C0009368;C0020885;C3888384","C0020885;C0009368","",1054
"atorvastatin $nmbr$ mg zi $nmbr$","C0024671;C0026410;C0043476;C0286651;C0439269;C1960952;C2346927;C4321396;C4521761","C0286651","",885
"hypertension n","C0020538;C1963138","C0020538","",1364
"serum creatinine pmol liter","C0201976;C0439192;C0475211;C0600061",NULL,NULL,987
"glp $nmbr$ receptor agonist","C0018301;C1422069;C1425391;C1539338;C2350813;C4543206","C0014361;C2987634",";C1422069;C1425391;C1539338",1153
"rectal bleeding subscore","C0018932;C0267596",NULL,NULL,753
"ezetimibe simvastatin $nmbr$ $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1532737;C1960952;C2346927;C4321396;C4521761","C1142985","",1165
"intracranial bleed","C0151699","C0151699","",384
"periprocedural medications no total no","C0013227;C0439175;C0439810;C0802604;C2598133;C4284232",NULL,NULL,2267
"time since most recent myocardial","C0027061;C0040223;C0332185;C1522564;C3541383",NULL,NULL,757
"p inte faction","C0369773;C2603361",NULL,NULL,1874
"geometric c $nmbr$ concentration mg dl","C0086045;C0439269;C0449829;C1446561;C3827302",NULL,NULL,676
"thienopyridine dipyridamole","C0012582;C1120149","C1120149",";C0039798;C0087111;C1363945;C1709561;C1947944",73
"conversion to sinus rhythm in $nmbr$ days","C0439228;C1321500",NULL,NULL,1621
"post bronchodilator fev $nmbr$ l mean sd c","C0444504;C2347634;C2348143;C2599594;C2699239;C3714541",NULL,NULL,2142
"neither ics nor laba","C0815320;C4551720",NULL,NULL,919
"nos $nmbr$ $nmbr$ c t n","C0326287;C1518425",NULL,NULL,131
"multivessel pci","C4049621",NULL,NULL,1736
"white race no t","C0007457;C0034510;C0043157;C0220938;C1706779;C2603360;C3853635",";C0034510","",1107
"stroke no total no","C0038454;C0439175;C0439810;C4554100",NULL,NULL,1762
"primary analysis","C0002778;C0205225;C0439612;C0439631;C0936012;C1524024",NULL,NULL,229
"insulin median ql q $nmbr$ pmol l","C0021641;C0439284;C0549183;C0876920;C1533581;C1579433;C2347635;C2348144;C2939193;C3714501",NULL,NULL,1899
"cvd subjects","C0007222;C0681850;C1550501;C1706203;C2349001;C2697811",NULL,NULL,1655
"cumulative incidence $nmbr$ years","C0021149;C0220856;C0439234;C1511559","C0021149","",1467
"type $nmbr$ diabetes mellitusa","C1320657","C0011849;C1320657","",907
"basdai","C1998004","C1998004","",1354
"amlodipine $nmbr$ to $nmbr$ mg n $nmbr$","C0024671;C0026410;C0051696;C0439269;C1960952;C2346927;C4321396;C4521761","","",78
"subpopulation analyses according to bmi","C0578022;C0680240;C1514228",NULL,NULL,1735
"bmi kg m mean s d","C0022718;C0369637;C0439209;C0439493;C0441923;C0444504;C0578022;C1275571;C1513009;C2347634;C2348143;C4054209",NULL,NULL,1735
"nontatal ml","C0439526;C1705224;C3887665",NULL,NULL,300
"therapy fatigue facit f $nmbr$ $nmbr$","C0015672;C0039798;C0087111;C1363945;C3272505;C3463815;C4050243;C4554645",NULL,NULL,1235
"hf lvd or both","C0018488;C1313497;C1538440;C3273279","C0018801",";C0168634;C1524003",12
"p interaction","C0369773;C1704675;C2603361",NULL,NULL,888
"bmi kg m $nmbr$ n","C0578022;C1532718",";C1305855","",206
"allopurinol $nmbr$ mg n $nmbr$","C0002144;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,1507
"severity of copd no f","C0016327;C0024117;C0439793;C0522510;C1412502;C3714496",NULL,NULL,1546
"reversibility median range c","C0449261;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016","C0449261","",2160
"eastern europe africa","C0001737;C0001741;C0015176;C0015177","C0239309","",601
"healthy weight","C0005910;C0043100;C1305866;C1705104;C3898900","C0005910","",1250
"eligibility risk factors","C0013893;C0035648;C1548635;C1553898","C0013893;C0035648","",1317
"asubset of the $nmbr$ years subgroup","C0439234;C1079230;C1515021",NULL,NULL,1637
"class iv","C0441888;C2698970",NULL,NULL,1258
"with ckd $nmbr$","C1561643","C1561643","",967
"rr $nmbr$ cl p value","C0596019;C1709380;C4554402",NULL,NULL,1542
"fasting c peptide ng ml","C0006558;C0015663;C0439275",NULL,NULL,204
"systolic blood pressure mmhg mean sd","C0039155;C0428886;C0439475;C0444504;C0488055;C0871470;C1306620;C2347634;C2348143;C2699239","C0005823","",1469
"prior aspirin use","C0004057;C0042153;C0332152;C0457083;C1947944;C2826257","C0004057","",1366
"a $nmbr$ ez n $nmbr$ a $nmbr$ n $nmbr$","C0206578",NULL,NULL,1407
"target vessel diameter","C0449618;C1301886",NULL,NULL,747
"age of onset $nmbr$ years n $nmbr$","C0206132;C0439234;C3175530",NULL,NULL,736
"race of patients","C0030705;C0034510;C1706779;C3853635",";C0034510","",1107
"lvedv ml","C0439526;C1705224;C3887665",NULL,NULL,300
"median prednisone dose n","C0032952;C0178602;C0549183;C0869039;C0876920;C1114758;C2347635;C2348144;C2939193",NULL,NULL,110
"resistant htn n $nmbr$","C0020538;C0332325;C1514892;C1550464;C2827757","C0020538","",1365
"other ascvd no","C3665365",NULL,NULL,344
"eligibility risk factors n","C0013893;C0035648;C1548635;C1553898","C0013893;C0035648","",1317
"airway reversibility mean","C0178987;C0444504;C0449261;C0458827;C2347634;C2348143","C0449261;C0231999","",1315
"st t wave abnormality d","C0036056;C1839341;C3272372",NULL,NULL,2356
"abaloparatide sc n","C0282380;C4042342","C4042342","",1284
"vitamin k antagonist e g warfarin coumarol","C0043031;C1096489;C2267235",";C0043031","",868
"median range duration of asthma years","C0004096;C0439234;C0449238;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2926735;C2939193;C2984299;C3542016",NULL,NULL,694
"therapy use","C0039798;C0042153;C0087111;C0457083;C1363945;C1947944",NULL,NULL,118
"bl updrs low","C0005918;C0006413;C0205251;C1550472;C1552663;C2827109;C3639721;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"e rs total scoreb","C0035970;C0439175;C0439810;C3714753;C3813325","","",-10
"$nmbr$ med at baseline","C0168634;C1442488;C4321267",NULL,NULL,625
"epilepsy drug","C0013227;C0014544;C1254351",NULL,NULL,367
"l value","C0439394;C1522609;C1706495;C3642217",NULL,NULL,9
"r $nmbr$ mg fa $nmbr$","C0024671;C0026410;C0205090;C0439269;C0684010;C1960952;C2346927;C2603358;C4321396;C4521761",NULL,NULL,192
"cad","C1504769;C2239547;C3813548;C4284121",NULL,NULL,698
"a demographics","C0011298;C1704791",NULL,NULL,582
"inhaled corticosteroid yes n","C0001617;C0004048;C1549445;C1705108;C1710701;C3536709",NULL,NULL,1650
"other multiracial","C1881928",NULL,NULL,778
"das $nmbr$ c reactive protein","C0006560;C0051767;C0057671;C1413716;C4048285","C0006560","",286
"calcium antagonist no","C0006684","C0006684","",1884
"antiplatelet or anti inflammatory drugs","C0003209","","",1191
"microvascular disease n","C0012634;C0443258",NULL,NULL,1869
"residual deep vein thrombosis no","C0149871;C1609982",NULL,NULL,1643
"total cholesterol week $nmbr$","C0201950;C0332174;C0439230;C0543421",NULL,NULL,1012
"age mean range years","C0444504;C1510829;C1514721;C2347634;C2348143;C2348147;C3542016","C1510829","",481
"baseline predicted fev $nmbr$","C0168634;C0681842;C1442488;C1882327;C3714541",NULL,NULL,1599
"most common aes in any group","C0205214;C0205393;C0441833;C0687744;C1257890;C1412268;C1519504;C1522138;C1705428;C1705429;C2699274;C3245511","C0877248","",47
"type $nmbr$ diabetes mellitus $nmbr$","C1320657","C0011849;C1320657","",907
"esrd only rr ci","C0008107;C0022661;C0035078;C0205171;C1720467;C2316810;C3259781;C4554402",NULL,NULL,1544
"systolic blood pressure mm hg","C0439475;C0488055;C0871470;C1306620","C0005823","",1469
"infarct territory","C0021308;C1301808;C2983136","C0021308","",1288
"ischemic hf n","C0018488;C0475224;C1313497;C1538440;C3273279","C0018801",";C0168634;C1524003",12
"$nmbr$ to $nmbr$ mm hg","C0439475",NULL,NULL,1888
"myocardial infarction n","C0027051;C0428953;C2926063;C3810814;C4552959",NULL,NULL,646
"int p","C3272375",NULL,NULL,1264
"potassium supplement","C0304475","C0032821","",1371
"$nmbr$ $nmbr$ s s","C0565930;C2603362",NULL,NULL,1784
"beta adrenergic blocker","C0001645;C2757061;C3536830","C0001645","",959
"high dose edoxaban vs warfarin","C0043031;C0444956;C2975435","C0444956","",111
"$nmbr$ yr n $nmbr$","C0439234",NULL,NULL,1099
"other stent","C0038257",NULL,NULL,569
"multi racial","C0034510;C0439064;C1706779;C3266262;C3669213;C3853635",NULL,NULL,357
"bmi kg m $nmbr$ $nmbr$","C0578022;C1532718",";C1305855","",206
"rf iu ml","C0035448;C0201660;C0439458;C0748398;C1547111","C0035448","",1435
"predominant type of heparin","C0019134;C0332307;C0770546;C1542147;C1547052",NULL,NULL,603
"ecg lvh sokolow lyon","C0232306","C0232306","",406
"black non black","C0005680;C0027567;C0085756;C0439541;C1518422","C0005680",";C1706779",188
"glp $nmbr$ analogue","C0018301;C0243071;C1422069;C1425391;C1539338;C2350813","C0014361;C2987634",";C1422069;C1425391;C1539338",1153
"spain","C0037747","C0037747","",2170
"type of intervention","C3274412",NULL,NULL,604
"less than median","C0439092;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"background lipid therapy per acc aha definition n a","C0023767;C0039798;C0087111;C1363945;C1550452;C1704788;C1706907;C3539107;C3888054;C4072694",NULL,NULL,236
"hydroxychloroquine treatment","C0020336;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704","C0020336","",1403
"maximal diameter stenosis","C0205289;C0678234;C0806909;C1261287;C1301886;C2632116;C4049713",NULL,NULL,1651
"methotrexate use","C0025677;C0042153;C0457083;C1947944","C0025677","",716
"global ischemia","C0022116;C0205246;C2348867;C4321499",NULL,NULL,1668
"$nmbr$ focal seizure frequency responders","C0149775;C0205234;C0376249;C0439603;C0751495;C0871396;C1561548;C1705502;C3898838;C4321352",NULL,NULL,1127
"question $nmbr$ pain swelling in joints other than neck back hips","C0003862;C0004600;C0013604;C0019552;C0027530;C0038999;C0205095;C0460009;C1522634;C1995000;C3159206",NULL,NULL,1764
"lvh by ecg minnesota code","C0009219;C0026183;C0232306;C0805701;C3889831","C0232306","",406
"gemfibrozil n $nmbr$","C0017245",NULL,NULL,1695
"gfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$","C0017654;C0369637;C0439445;C0441923;C1424601","C3811844;C0017654","",592
"blood glucose","C0005802","C0005802","",1349
"fpg median ql q $nmbr$ mmol l","C0549183;C0876920;C1532563;C2347635;C2348144;C2939193","C0015663;C0202042","",1960
"month $nmbr$","C0332177;C0439231",NULL,NULL,1476
"randomly assigned to calcium channel blocker","C0006684;C1516050;C1552601;C3536851;C4521885",NULL,NULL,960
"low dose edoxaban","C0445550;C1708745;C2975435","C0445550;C2975435","",2091
"men women","C0025266;C0043210",NULL,NULL,1842
"no with event incidence rate per $nmbr$ patient y","C0030705;C0441471;C1708485;C4019010","C1708485","",1106
"physical and cognitive examination","C0031809;C0205485;C1509143;C1516691;C4321457",NULL,NULL,1570
"preoperative use p blocker","C0042153;C0445204;C0457083;C1947944",NULL,NULL,1926
"left ventricular hypertrophy no","C0149721;C3484363","C0149721","",1496
"$nmbr$ ci h","C0008107;C0033727;C0369286;C0441932;C0564385;C3259781;C4528284",NULL,NULL,519
"left main","C0205091;C0205225;C0443246;C1542147;C1552822",NULL,NULL,42
"death mi idr st or gusto mod sev bleeding","C0011065;C0011860;C0019080;C0036056;C0439793;C0458216;C1306577;C2983285;C3272372;C3810814;C4082313;C4552775",NULL,NULL,246
"time since copd diagnosis yrs","C0011900;C0024117;C0040223;C1412502;C1704338;C1704656;C3541383;C3714496",NULL,NULL,140
"value","C1522609",NULL,NULL,9
"hazard ratio vs placebo","C0032042;C1696465;C1706408;C2985465","C2985465","",975
"adjusted","C0456081",NULL,NULL,1580
"pre rtous eptscde s d dvt pe","C0070939;C0149871;C0332152;C0740175;C1880476;C2257086;C2926618;C3669034;C3899446;C4284304",NULL,NULL,1516
"physician s judgment that vka inappropriate","C0022423;C0031831;C0804815;C1548788;C3537135;C3542467",NULL,NULL,1520
"baseline ics use no","C0042153;C0168634;C0457083;C0815320;C1442488;C1947944;C4551720","C3540778","",2182
"$nmbr$ $nmbr$ $nmbr$ $nmbr$ l l","C3539687","","",-10
"gusto moderate","C0205081;C1881878;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"perianal n","C0442158","C0442158","",1039
"baseline concomitant cardiovascular medications","C0007220;C0168634;C0521115;C1442488","C0007220","",897
"alcohol $nmbr$ wk","C0001962;C0001975;C0332174;C0439230",";C0001962","",1053
"oral adrenergics n","C0001637;C0442027;C4521986",NULL,NULL,1746
"repaired chd","C0205340;C0280604;C3542407",NULL,NULL,970
"severe ed","C0205082;C3538926;C4050465;C4050466",NULL,NULL,313
"number of antihypertensive agent reported","C0003364;C0237753;C0449788;C0684224;C0700287;C4319718",NULL,NULL,1556
"patient characteristic","C0030705;C1521970","C1521970","",1110
"placebo no total","C0032042;C0439175;C0439810;C1696465;C1706408","C0032042","",28
"atorvastatin n $nmbr$ $nmbr$","C0286651","C0286651","",885
"igelow i $nmbr$ ku l n i $nmbr$","C0021966;C0221138;C0369718;C0439340;C0441922",NULL,NULL,850
"stent n $nmbr$","C0038257",NULL,NULL,569
"malaysia","C0024552",NULL,NULL,59
"epa group n $nmbr$","C0441848",NULL,NULL,1638
"regular ppi use","C0042153;C0205272;C0358591;C0457083;C0871125;C1947944;C3811894",NULL,NULL,1738
"chf score u","C0018802;C0439148;C0449820;C4050231",NULL,NULL,748
"rolofylline rx","C0166128;C1425688;C1521941;C2709207","C0166128",";C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1114758;C1425688;C1521941;C2709207",67
"$nmbr$ $nmbr$ mild","C2945599",NULL,NULL,329
"psa","C3810537;C3813209",NULL,NULL,125
"antihyperglycemic medications","C0013227;C0020616;C0802604;C2598133;C4284232","C0020616",";C0013227;C3244316;C4284232;C0450442;C1254351;C1515187;C1521826;C2826257",33
"previous hospitalization for heart failure","C0205156;C1552607;C3898876",NULL,NULL,824
"basdai total mean sd","C0439175;C0439810;C0444504;C1998004;C2347634;C2348143;C2699239",NULL,NULL,37
"type ia","C0020980;C0332307;C0694634;C1547052;C1947960",NULL,NULL,1399
"ipss hrql","C1019118;C1998280;C2827405;C3811063","C1998280",";C1019118;C3811063;C4050465;C4050466;C4049706;C0168634;C1705273;C1880519;C3853603",124
"hdl $nmbr$ c","C3715113","C0023822","",821
"ldl hdl cholesterol ratio mean sd","C0008377;C0428621;C0444504;C2347634;C2348143;C2699239","C0023824","",1068
"previous transient ischemic attack","C0007787;C0205156;C0917805;C1552607",NULL,NULL,1592
"esrd saxa $nmbr$ $nmbr$ mg n $nmbr$","C0022661;C0024671;C0026410;C0035078;C0439269;C1960952;C2316810;C2346927;C4321396;C4521761",NULL,NULL,192
"in h","C0033727;C0369286;C0441932;C0564385;C4528284",NULL,NULL,1132
"nitrates oral or topical","C0028125;C0332237;C0442027;C0699857;C3848573;C4521986",NULL,NULL,537
"other n $nmbr$ $nmbr$","C0369718;C0441922",NULL,NULL,742
"history of smoking","C1519384","C1519384","",1147
"ppi use p $nmbr$ $nmbr$ t","C0042153;C0358591;C0369773;C0457083;C0871125;C1947944;C2603361;C3811894",NULL,NULL,1738
"valsartan hctz","C0020261;C0216784","C0216784","",1206
"education $nmbr$ yr","C0013621;C0013622;C0013658;C0039401;C0439234","C0013658","",902
"adjusted mean se fevi auco_ $nmbr$ ml","C0036919;C0429706;C0439526;C0444504;C0456081;C0849974;C1561566;C1705224;C2347634;C2348143;C3887665;C4528367",NULL,NULL,567
"$nmbr$ h plasma glucose during ogtt mmol l","C0029161;C0202042;C0455280;C2827804",NULL,NULL,22
"lsms difference $nmbr$ ci $nmbr$","C0008107;C1705241;C1705242;C3259781",NULL,NULL,519
"no prior oma use n $nmbr$","C0042153;C0332152;C0457083;C1947944;C2826257",NULL,NULL,294
"history of fistulizing disease n","C0683519;C0730226;C0850708;C0944983",NULL,NULL,105
"post bronchodilator fev i reversibility b","C0021966;C0221138;C0449261;C2599594;C3714541","C0449261;C0231999","",1315
"the p value is from the test statistic for testing the interaction between the treatment group and diabetes group","C0011847;C0011849;C0039593;C0237913;C0374505;C0392366;C0441833;C0687744;C1257890;C1519504;C1704675;C1705428;C1705429;C1709380",NULL,NULL,7
"clinical responsed","C0205210",NULL,NULL,793
"body mass index kg m $nmbr$ mean sd","C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239","C1305855","",1734
"dyslipidaemia including hypercholesterol no","C0242339;C0332257","C0242339","",1770
"a $nmbr$ ez $nmbr$ a $nmbr$ n $nmbr$ n $nmbr$","C0206578;C0369718;C0441922",NULL,NULL,1407
"duration of diabetes years mean sd","C0011847;C0011849;C0439234;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"mi","C3810814",NULL,NULL,516
"extent of disease n","C0449279;C4553144","C0449279","",1809
"reversibility to","C0449261","C0449261","",2160
"intensified $nmbr$ months n $nmbr$","C0439231",NULL,NULL,1529
"anterior circulation","C0005775;C0205094;C1516559",NULL,NULL,1245
"urgent revascularisation due to unstable angina","C0002965;C0439609;C0581603;C0678226;C3272275","C0877341;C3272275","",1212
"$nmbr$ or $nmbr$ if female only","C0043210;C0086287;C0205171;C1705497;C1705498;C1720467",NULL,NULL,1537
"copd rosuvastatin $nmbr$ pt n","C0024117;C0032743;C0699718;C0965129;C1412502;C3714496","C0965129","",886
"potassium sparing diuretic","C0304490;C3536751","C0304490","",1966
"baseline ldlc level n $nmbr$ $nmbr$ $nmbr$ $nmbr$ mg dl","C0168634;C0439269;C0441889;C0456079;C1416822;C1442488;C1547707;C2946261","C0023824;C1442488","",1964
"pfo with large shunt and atrial septal aneurysm","C0232180;C0521533;C0542331;C0549177;C1442858",NULL,NULL,478
"fevi fvc","C0802741;C3815113",NULL,NULL,1600
"number of target vessels","C0237753;C0449618;C0449788",NULL,NULL,747
"anti cholinergics long acting","C0079613;C0205166;C0242896;C1704930;C1706317;C1869853;C3890007;C4048375",NULL,NULL,499
"no dyspnoea n $nmbr$","C0013404;C1963100","C0013404","",1227
"on pump","C3842462",NULL,NULL,1582
"ldl cholesterol mmol l","C0023824;C0202117;C1532563","C0023824","",1068
"multivessel cad n","C1504769;C2239547;C3813548;C4284121",NULL,NULL,698
"tnfi no other bdmard taken t n","C1883727;C2986835",NULL,NULL,1615
"cha $nmbr$ ds $nmbr$ vasc $ $nmbr$","C1420648;C3714751",NULL,NULL,968
"$nmbr$ $nmbr$ mo","C0026544;C0332177",NULL,NULL,1476
"femoral neck t score mean sd","C0015815;C0444504;C0449820;C2347634;C2348143;C2699239;C4050231",NULL,NULL,2132
"chronic kidney diseased","C2364010","C0022658","",104
"secondary $nmbr$","C0027627;C0175668;C0205436",NULL,NULL,1484
"pre bronchodilator fevi change","C0392747;C0443172;C0849974;C1561566;C1705241;C2599602;C4319952;C4528367",NULL,NULL,1601
"infarct characteristics","C0021308;C1521970",NULL,NULL,2016
"anatomic complexity characteristics","C0439855;C0502371;C1704241",NULL,NULL,1652
"anti hyperglycaemic agent n","C0432633;C1321567","C1321567","",361
"gender women n","C0043210;C0079399;C1522384","C0043210",";C3541888;C1720467",1323
"pervious cerebrovascular event","C0205326;C0441471;C1880018;C4019010",NULL,NULL,412
"esr $nmbr$ $nmbr$ mm hour","C0439227;C0564385;C3811131;C4330985;C4554674","C1619634","",298
"ethnic minority group no","C0015031;C0026192;C0680174;C1879937",NULL,NULL,801
"c peptide","C0006558","C0006558","",1154
"ibdq mean sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,1287
"etoricoxib dose","C0178602;C0869039;C0972314;C1114758","C0972314","",1130
"index event subtype","C0441471;C0449560;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010",NULL,NULL,734
"qrs $nmbr$ ms","C2349943;C3539704;C3713294",NULL,NULL,126
"exercise at least weekly a","C0015259;C0332174;C1522704","C0015259","",1380
"xanthine","C0043314;C0043318","C0043318","",359
"$nmbr$ kg i","C0021966;C0022718;C0221138;C0439209;C4054209",NULL,NULL,205
"$nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ no","C0369637;C0439445;C0441923",NULL,NULL,923
"progression to diabetes","C1735364","C0011849;C1320657","",907
"duration of diabetes $nmbr$ years","C0011847;C0011849;C0439234;C0449238;C2926735","C2926735;C0011849","",1988
"biventricular pacemaker","C1719274",NULL,NULL,503
"age y mean range","C0001779;C0444504;C1514721;C2347634;C2348143;C2348147;C3542016","C0001779","",480
"fpi mean sd pu rnff","C0018387;C0444504;C2347634;C2348143;C2699239",NULL,NULL,2135
"death or myocardial infarction","C0011065;C0027051;C0428953;C1306577;C2926063;C3810814;C4082313;C4552775;C4552959",NULL,NULL,323
"non diuretics","C0012798;C1518422",NULL,NULL,85
"ckd egfr $nmbr$ n","C1561643;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"medications at baselinet","C0013227;C0802604;C2598133;C4284232",NULL,NULL,2263
"mean sd duration of copd years","C0024117;C0439234;C0444504;C0449238;C1412502;C2347634;C2348143;C2699239;C2926735;C3714496",NULL,NULL,1726
"pasi median range","C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016;C4528685",NULL,NULL,635
"anti arthritic medications","C0013227;C0802604;C2598133;C4284232",NULL,NULL,366
"weekly number of hives score","C0042109;C0237753;C0332174;C0449788;C0449820;C4050231",NULL,NULL,2058
"cerebrovascular accident tia","C0007787;C0038454;C0917805;C1054154",NULL,NULL,1762
"patients with serum $nmbr$ oh d $nmbr$ $nmbr$ and $nmbr$ ng ml n n","C0030705;C0220853;C0229671;C0439275;C1546774;C1550100",NULL,NULL,951
"previous vascular disease","C0042373;C0205156;C1552607",NULL,NULL,1044
"anthropometry mean sd","C0003188;C0444504;C2347634;C2348143;C2699239",NULL,NULL,1908
"previous hf","C0018488;C0205156;C1313497;C1538440;C1552607;C3273279","C0018801",";C0168634;C1524003",12
"time since psoriasis diagnosis years $nmbr$","C0011900;C0033860;C0040223;C0439234;C1704338;C1704656;C3541383",NULL,NULL,1099
"$nmbr$ to $nmbr$ cel","C0208736;C0346421;C0439237;C1413336",NULL,NULL,432
"sama $nmbr$","C1075468",NULL,NULL,1300
"a $nmbr$ e $nmbr$ n $nmbr$","C1272460",NULL,NULL,419
"concomitant corticosteroid use","C0239126;C0521115","C0239126",";C0168634;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1425988;C1947944",120
"pvr volume ml mean sd","C0242852;C0439526;C0444504;C0449468;C0456261;C1419141;C1690016;C1705102;C1705224;C2347634;C2348143;C2699239;C2700258;C3887665",NULL,NULL,300
"durable clinical remissionh","C0205210",NULL,NULL,793
"mean yr age group no","C0027362;C0439234;C0444504;C2347634;C2348001;C2348143",NULL,NULL,1099
"number of exacerbations in the $nmbr$ months before screening","C0220908;C0220909;C0237753;C0439231;C0449788;C1698960;C1710031;C1710032;C1710477;C2348164;C4086268",NULL,NULL,1556
"prior ptca or pci","C0332152;C2826257;C2936173;C4049621","C1532338","",1661
"smokers n","C0337664","C0037369","",420
"post bronchodilator screening fev $nmbr$ ml","C0220908;C0220909;C0439526;C1698960;C1705224;C1710031;C1710032;C1710477;C2348164;C2599594;C3714541;C3887665",NULL,NULL,680
"atrial fibrillation no","C0004238;C0344434;C1963067",";C0004238","",1009
"glinide","C2266929","C2266929","",1157
"measured at clinic visit with usual device","C0008952;C0025080;C0444706;C0699733;C3538928;C3541902",NULL,NULL,732
"hradj $nmbr$ ci","C0008107;C3259781",NULL,NULL,519
"korean","C1556095","C0022771","",2089
"apob apoal","C0003593;C3252643","C0003593","",426
"diabetes therapy","C3274787;C3539002",NULL,NULL,556
"estrogen containing hormones","C0014939;C0019932;C0332256;C2700400;C2936882;C4542544","C0019932","",280
"study drug","C0013175",NULL,NULL,1731
"rosuvastatin events patients","C0030705;C0441471;C0965129;C3541888","C0965129","",886
"history of cardiovascular disease no","C0455539",NULL,NULL,1494
"estimated treatment difference","C0039798;C0087111;C0750572;C1522326;C1533734;C1705169;C1705241;C1705242;C3538994;C3887704",NULL,NULL,1466
"non endstage renal dysfunction","C0205088;C1518422;C1565489;C3279454","C1565489","",937
"type of tnf antagonist failure n o","C0231174;C0231491;C0332307;C0680095;C1448177;C1547052",NULL,NULL,11
"creatinine clearance ml min $nmbr$","C0439445;C0812399","C3811844;C0017654","",307
"mace category n ir","C0022065;C0022071;C0349381;C0683312;C0949745;C1445339;C1448132;C3889287","C1320716","",414
"age sd yrs","C0001779;C2699239",NULL,NULL,148
"iop lowering medication","C0013227;C0441994;C0578862;C2003888;C3244316;C4284232",NULL,NULL,366
"aspirin erdp n $nmbr$ $nmbr$","C0004057","C0004057","",1366
"egfr $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"$nmbr$ s scandinavian simvastatin survival study $nmbr$ woscops west of scotland coronary prevention study $nmbr$ care cholesterol and recurrent events $nmbr$ post cabg post coronary artery bypass graft $nmbr$ afcaps texcaps air force texas coronary atherosclerosis prevention study $nmbr$ lipid long term intervention with pravastatin in ischaemic disease $nmbr$ gissi prevention gruppo italiano per lo studio della sopravvivenza nell infarto miocardico $nmbr$ lips lescol intervention prevention study $nmbr$ hps heart protection study $nmbr$ prosper prospective study of pravastatin in the elderly at risk $nmbr$ allhat llt antihypertensive and lipid lowering treatment to prevent heart attack trial $nmbr$ ascot lla anglo scandinavian cardiac outcomes trial lipid lowering arm $nmbr$ alert assessment of lescol in renal transplantation $nmbr$ cards collaborative atorvastatin diabetes study $nmbr$ s simvastatin l lovastatin p pravastatin f uvastatin a atorvastatin mean duration of follow up based on survival times within each trial overall mean is weighted by trial speci c variances of logrank o e for major vascular events all trials included dietary intervention woscops gissi prevention lipid $nmbr$ s lips and hps provided dietary advice afcaps texcaps post cabg care allhat alert cards and prosper used american heart association aha step $nmbr$ diet and care intensi ed to step $nmbr$ diet if ldl cholesterol $nmbr$ $nmbr$ mmol l $nmbr$ mg dl other chd includes patients with a history of other symptomatic chd but excludes those with a history of mi as already counted in mi column other vascular includes history of intracerebral bleed transient ischaemic attack ischaemic stroke unknown stroke and peripheral artery disease none includes individuals without a history of mi symptomatic chd intracerebral bleed transient ischaemic attack ischaemic stroke unknown stroke or peripheral artery disease","C0001792;C0002458;C0003364;C0005847;C0005910;C0008377;C0008976;C0010054;C0010055;C0011847;C0011849;C0012155;C0012159;C0012171;C0016327;C0018787;C0019664;C0019665;C0022671;C0023759;C0023779;C0023824;C0023981;C0024027;C0027051;C0027361;C0030705;C0033522;C0035647;C0036453;C0038454;C0038952;C0039711;C0039798;C0040363;C0040704;C0041260;C0043100;C0050451;C0074554;C0085542;C0085565;C0086153;C0087111;C0150158;C0184661;C0199176;C0202117;C0204932;C0205082;C0205164;C0205374;C0206579;C0220921;C0231220;C0237401;C0239110;C0240951;C0242994;C0262512;C0262926;C0277793;C0280604;C0282416;C0286651;C0309872;C0332196;C0332257;C0420180;C0439394;C0439673;C0441471;C0441994;C0444504;C0446516;C0449238;C0455536;C0475224;C0489835;C0557651;C0565930;C0589120;C0591720;C0679698;C0680782;C0681804;C0687676;C0718674;C0745413;C0750480;C0772110;C0870136;C0886296;C0948008;C1096775;C1185738;C1232424;C1260596;C1261512;C1261552;C1273517;C1273869;C1304680;C1305866;C1455761;C1519433;C1522326;C1522577;C1522601;C1527178;C1533734;C1545588;C1552866;C1558950;C1561607;C1704379;C1704436;C1704685;C1704687;C1705117;C1705169;C1705255;C1705493;C1705566;C1705938;C1706132;C1706420;C1706495;C1709709;C1711260;C1736144;C1801960;C1883351;C1947933;C1999167;C1999230;C2003888;C2004062;C2004580;C2347090;C2347634;C2348143;C2348152;C2603343;C2603362;C2700399;C2700409;C2825408;C2828389;C2919552;C2926735;C2930619;C2937358;C2945760;C2983588;C3274571;C3275277;C3469826;C3538926;C3538994;C3541433;C3541888;C3542407;C3642216;C3642217;C3665546;C3668949;C3669039;C3715044;C3810814;C3814463;C3887704;C3889123;C3898312;C4025272;C4050014;C4084853;C4318856;C4521762;C4552904;C4553014;C4553528;C4554100","","",-10
"ticagrelor $nmbr$ mg km","C0024671;C0026410;C0439269;C1960952;C1999375;C2346927;C3887676;C4321396;C4521761",NULL,NULL,2299
"participated in a previous febuxostat studyb n","C0205156;C0249529;C1552607",NULL,NULL,26
"age yrf","C0001779","C0001779","",480
"aggressive $nmbr$","C0001807;C0580822",NULL,NULL,468
"$nmbr$ week n $nmbr$","C0332174;C0439230",NULL,NULL,1012
"a decrease of $nmbr$ points in the cdai score","C0392756;C0449820;C0547047;C0683448;C1413248;C2924612;C3273706;C4050231",NULL,NULL,697
"infarct location no total no","C0021308;C0439175;C0439810;C0450429;C1515974;C4284930;C4284931","C1515974;C0021308","",1948
"hemorrhagic stroke n $nmbr$","C0553692",NULL,NULL,581
"baseline mssbp mmhg mean sd","C0168634;C0439475;C0444504;C1442488;C2347634;C2348143;C2699239",NULL,NULL,1471
"olodaterol $nmbr$ ig tiotropium n $nmbr$ non tiotropium n $nmbr$","C0021027;C0305052;C0360506;C1518422;C4032878",NULL,NULL,1260
"periostin ng ml","C0219433;C0439275;C1424662;C3812270","C3812270","",1027
"median vr","C0549183;C0876920;C2347635;C2348144;C2939193;C3476815",NULL,NULL,635
"mean change in sgrq","C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952",NULL,NULL,767
"elective procedure","C0747973","C0747973","",1169
"non statin n $nmbr$","C0360714;C1518422","C0360714","",872
"systolic blood pressure $nmbr$ mm hg or diastolic blood pressure $nmbr$ mm hg","C0428883;C0439475;C0488055;C0871470;C1305849;C1306620","C0005823","",1469
"peripheral artery diseaseb","C0489868",NULL,NULL,934
"latin america","C0023122",";C0023122","",1461
"mepolizumab group","C0441833;C0687744;C0969324;C1257890;C1519504;C1705428;C1705429",NULL,NULL,943
"low tt $nmbr$ $nmbr$ n $nmbr$","C0205251;C1452561;C1550472;C3890211;C4048187;C4321351;C4522223;C4554543",NULL,NULL,251
"favors lisinopril favors chlorthalidone","C0008294;C0065374;C0309049","C0008294","",70
"ipss qol ls","C0023668;C0518214;C1019118;C1998280;C2827405;C3811063","C0034380","",1116
"ratio fp sal sal $nmbr$ ci","C0008107;C0016704;C0036140;C0037494;C0206136;C0456603;C1419068;C1419906;C1547037;C3259781;C3541238;C3541412",NULL,NULL,1820
"no of prior bdmards","C0332152;C2826257",NULL,NULL,1063
"placebo n","C0032042;C1696465;C1706408","C0032042","",28
"education years mean sd","C0013621;C0013622;C0013658;C0039401;C0439234;C0444504;C2347634;C2348143;C2699239","C0013658","",1990
"middle","C0444598;C0549183;C1552826",NULL,NULL,331
"prebronchodilator fev $nmbr$","C2599602;C3714541",NULL,NULL,682
"uacr mgg $nmbr$ gm","C0017480;C3854019",NULL,NULL,187
"hyponatremia","C0020625;C4553967","C4553967","",31
"any type according to daily dose","C0332307;C0680240;C1547052;C2348070",NULL,NULL,1432
"dm n $nmbr$","C0011816;C3250443",NULL,NULL,955
"ace inhibitor or arb at last follow up","C0003015;C0589120;C1522577;C1704685;C3274571;C3888198;C4541021","C0003015","",811
"very high risk","C0035647;C0332167;C0442804;C0442824;C2984081;C3272283;C4050568;C4319571;C4321397;C4552904","C4319571","",837
"during overall study period","C0282416;C0439531;C0557651;C1561607;C1948053;C2603343",NULL,NULL,575
"tc mean sd","C0039411;C0040642;C0041405;C0041698;C0444504;C1824670;C2347634;C2348143;C2699239;C3272447;C4522122",NULL,NULL,37
"cardiac stretch","C0018787;C0600080;C1522601",NULL,NULL,1481
"canagliflozin n $nmbr$","C2974540","C2974540","",1181
"diastolic blood pressurea mmhg","C0005767;C0005768;C0012000;C0229664;C0439475","C0005823","",1469
"treatment with drugeluting stent","C0039798;C0087111;C1322815;C1522326;C1533734;C1705169;C3538994;C3887704","C1322815","",365
"body mass indexb","C0518010","C1305855","",1734
"mean sd aqlq","C0444504;C2347634;C2348143;C2699239;C4055434",NULL,NULL,1287
"medical treatment n","C0679624",NULL,NULL,725
"total bilirubin $nmbr$ x uln $nmbr$","C0005437;C0368753;C1519815",";C0005437","",1684
"history of copd","C0019664;C0019665;C0024117;C0262512;C0262926;C1412502;C1705255;C2004062;C3714496",NULL,NULL,832
"estradiol pmol l","C0014912;C0439284",NULL,NULL,666
"ii lisinopril","C0065374;C1710602;C4082587",NULL,NULL,521
"placebo $nmbr$ o $nmbr$","C0032042;C1696465;C1706408","C0032042","",28
"iief ef domain score visit $nmbr$ y","C0449820;C0545082;C1512346;C1880389;C1883221;C2826704;C3541951;C3641331;C4050231",NULL,NULL,998
"non carrier n $nmbr$","C2986416",NULL,NULL,1239
"any statin versus no statin at randomization","C0034656;C0360714","C0360714","",872
"recurrent vte statin use vs non use","C0042153;C0360714;C0457083;C0630906;C1455761;C1518422;C1947944;C2945760",NULL,NULL,118
"index event to randomization median iqr h","C0033727;C0034656;C0369286;C0441471;C0441932;C0549183;C0564385;C0600653;C0876920;C0918012;C1552854;C1637833;C2347635;C2348144;C2939193;C2986546;C4019010;C4528284",NULL,NULL,635
"lowzmedium intensity","C0522510",NULL,NULL,561
"insulin pmol l","C0021641;C0439284;C1533581;C1579433;C3714501",NULL,NULL,157
"serum potassium mean sd mmol l","C0302353;C0444504;C0543465;C1532563;C2347634;C2348143;C2699239","C0302353","",1959
"clinical fracture","C0016658;C0205210",NULL,NULL,2026
"placebo dr $nmbr$","C0013014;C0031831;C0032042;C1696465;C1706408;C1707664;C2348314;C3540849","C0032042","",28
"serum creatinine $nmbr$ $nmbr$ mg dl","C0201976;C0439269;C0600061","C0600061;C0010294","",952
"regadenoson","C1698215",NULL,NULL,471
"poland","C0032356","","",-10
"north america plus australia and new zealand","C0004340;C0027978;C0028405;C0324547;C0332287","C0027978",";C0324547",189
"congestive heart failure n","C0018802","C0018801",";C0168634;C1524003",12
"apixaban dose or matching placebo","C0032042;C0150103;C0178602;C0869039;C1114758;C1696465;C1706408;C1708943;C1831808","C1831808","",1224
"laboratory ae n","C0022877;C3244292;C3887670;C4283904","C0877248","",47
"race n t","C0034510;C1706779;C3853635",";C0034510","",1107
"predicted pre bd","C0005126;C0332152;C0681842;C0740175;C1882327;C2257086;C2344255;C3669034;C4050145",NULL,NULL,294
"anti tnf ir","C0022065;C0022071;C1448132;C1448177","","",1397
"moderate","C0205081;C1881878;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"secukinumab","C3179547",NULL,NULL,944
"men n $nmbr$","C0025266",NULL,NULL,1842
"below knee popliteal crural","C0022742;C0022745;C0023216;C0442037;C0542339;C1140621;C1552829;C1963703","C0442037","",1979
"$nmbr$ or incident vitrectomy or photocoagulation","C0023694;C0042903;C1328010;C1551358",NULL,NULL,548
"other selected aes","C1412268;C1707391;C2699274","C0877248","",47
"weekly iss","C0332174;C1740819;C1845118",NULL,NULL,1013
"bdi focal score $nmbr$","C0006448;C0205234;C0449820;C0451022;C3714938;C3889415;C4050231",NULL,NULL,1127
"at least $nmbr$ flare","C1517205;C3540542",NULL,NULL,2101
"time since diagnosis of pah years","C0011900;C0030123;C0040223;C0439234;C1704338;C1704656;C3203102;C3541383;C4284467",NULL,NULL,1099
"left main coronary artery n","C1261082","C1261082","",1342
"duration of infusion after pci hr","C0449238;C0574032;C1827465;C2926735;C4049621",NULL,NULL,825
"history of microvascular disease no","C0443258;C0683519;C0730226;C0850708;C0944983",NULL,NULL,105
"gusto moderate or severe bleeding","C0019080;C0205081;C0205082;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335",NULL,NULL,321
"nerd grade","C0441800;C0919553;C3244287",NULL,NULL,683
"alternative disability","C0231170;C1523987",NULL,NULL,983
"non pci procedure","C0184661;C1518422;C2700391;C3274430;C3539779;C4049621","C1532338","",1661
"antihypertensive drugs","C0003364",";C0003364","",1579
"duration of ra","C0449238;C2926735;C3538806;C4048756",NULL,NULL,901
"ivabradine group","C0257190;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429","C0257190",";C0687744;C1257890;C1519504;C1705428;C1705429;C0441848",68
"ethnicity t","C0015031;C0243103",NULL,NULL,787
"ldl cholesterol level","C0023824;C0201950;C0202117;C0428466;C0441889;C0456079;C1547707;C2946261","C0023824","",1068
"pci percutaneous coronary intervention cabg coronary artery bypass graft for hope $nmbr$ mg l for europa $nmbr$ mg l or on a lipid lowering treatment for peace data are mean sd data are mean sd unless otherwise indicated","C0010055;C0023779;C0039798;C0087111;C0184661;C0189695;C0242751;C0392347;C0441994;C0444504;C0522523;C0545743;C0680443;C0886296;C1273869;C1444656;C1511726;C1522326;C1533734;C1705169;C2003888;C2347634;C2348143;C2699239;C2827881;C3245479;C3538994;C3714741;C3887704;C4049621","","",-10
"risk factor profile index event","C0035648;C0441471;C0600653;C0918012;C1552854;C1637833;C1979963;C2003903;C2986546;C4019010",NULL,NULL,175
"normai fasting giucose levei n $nmbr$","C0015663","C0017725;C0015663","",1846
"blood pressure systolic diastolic mm hg mean sd","C0439475;C0444504;C2347634;C2348143;C2699239;C2704328","C0005823","",1469
"moderate severe exacerbation","C0205081;C0205082;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4086268;C4321335",NULL,NULL,313
"alcohol drinker n","C0001962;C0001975;C0556338",NULL,NULL,176
"history of chf n","C0018802;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"other n $nmbr$","C0369718;C0441922",NULL,NULL,742
"rest pain","C0234253","C0030193","",1338
"prior percutaneous coronary intervention n","C0332152;C1532338;C2826257","C1532338","",1661
"male n $nmbr$","C0086582;C1706180;C1706428;C1706429","C0086582","",1276
"normal weight bmi $nmbr$","C0005910;C0043100;C0578022;C1305866;C1705104;C2712185;C4229017",NULL,NULL,1735
"insulin sensitivity","C0920563;C4049919",NULL,NULL,161
"certolizumab group n $nmbr$","C0441848;C1872109",NULL,NULL,1638
"fev $nmbr$ litres pre salbutamol mean sd","C0001927;C0332152;C0444504;C0475211;C0740175;C2257086;C2347634;C2348143;C2699239;C3669034;C3714541",NULL,NULL,1599
"euroscore logistic median $nmbr$ th $nmbr$ th","C0039725;C0039738;C0242415;C0549183;C0876920;C1420718;C2347635;C2348144;C2939193;C3164744;C4282123;C4285344",NULL,NULL,1433
"prior angina n $nmbr$ $nmbr$","C0002962;C0332152;C2826257","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"lvef median iqr","C0428772;C0488728;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"us site of enrollment","C1516879;C1696073;C2945843;C3888021",NULL,NULL,339
"lipids mean sd mg dlf","C0023779;C0024671;C0026410;C0439269;C0444504;C1960952;C2346927;C2347634;C2348143;C2699239;C4321396;C4521761","C0023779","",1967
"prior immunnosupressive failure but no anti tnf failure","C0231174;C0332152;C0680095;C1448177;C2826257",NULL,NULL,11
"males n $nmbr$","C0086582","C0086582","",1276
"no statin","C0360714","C0360714","",872
"ularitide n n","C0077910",NULL,NULL,1568
"low eosinophil subgroup $nmbr$ ml n $nmbr$","C0014467;C0205251;C0439526;C1079230;C1515021;C1550472;C1705224;C3887665;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"no betablocker use","C0001645;C0042153;C0457083;C1947944","C0001645","",959
"volume depletion related aes","C0439849;C0445223;C0546884;C1412268;C2699274","C0877248","",47
"p value interaction","C1704675;C1709380",NULL,NULL,7
"hscrp mean sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"change from baseline mg dl mean sd","C0168634;C0392747;C0439269;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C2699239;C4319952",NULL,NULL,192
"direct thrombin inhibitors","C0003440;C3541936",NULL,NULL,1642
"range","C1514721;C2348147;C3542016",NULL,NULL,479
"serum $nmbr$ hydroxyvitamin d ng ml","C0020337;C0229671;C0439275;C1546774;C1550100",NULL,NULL,951
"lvef $nmbr$ $nmbr$","C0428772;C0488728","C0018801;C0428772","",1273
"proximal mainleft","C0205107;C4489236","C0205107","",1447
"subject group","C0441833;C0681850;C0687744;C1257890;C1519504;C1550501;C1705428;C1705429;C1706203;C2349001;C2697811",NULL,NULL,1526
"placebo n $nmbr$ i","C0021966;C0032042;C0221138;C0369718;C0441922;C1696465;C1706408","C0032042","",28
"cerebrovascuiar disease","C0012634",NULL,NULL,2115
"tofacitinib $nmbr$ mg bid n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C2930696;C4321396;C4521761","C2930696","",857
"left ventricular dysfunction","C0242698",NULL,NULL,40
"medications at coronary angiography","C0013227;C0085532;C0802604;C1548829;C2598133;C4284232",NULL,NULL,2263
"$nmbr$ yr no","C0439234",NULL,NULL,1099
"type of surgery cabg only","C0010055;C0038894;C0038895;C0205171;C0332307;C0543467;C1274039;C1547052;C1720467",NULL,NULL,925
"saxagliptin $nmbr$ $nmbr$ mg","C0024671;C0026410;C0439269;C1611934;C1960952;C2346927;C4321396;C4521761","C1611934","",2069
"$nmbr$ $nmbr$ $nmbr$ js","C1552154",NULL,NULL,116
"ace inhibitor and or arb","C0003015;C3888198;C4541021",NULL,NULL,44
"indacaterol $nmbr$ ug versus placebo","C0032042;C0041573;C0439211;C1696465;C1706408;C1722260","C1722260","",1875
"any therapy no","C0039798;C0087111;C1363945",NULL,NULL,236
"lvh from electrocardiogram","C0013798;C0149721;C1547122;C1623258","C0149721","",1496
"fev $nmbr$ post bronchodilator","C2599594;C3714541",NULL,NULL,1599
"apolipoprotein a i","C0085201;C1677784","C0003591","",1028
"durable clinical responseg","C0205210",NULL,NULL,793
"tnl ultrapositive $nmbr$ $nmbr$ pg l $nmbr$ $nmbr$","C0439278;C1540071",NULL,NULL,854
"sf $nmbr$ pcs score","C0037712;C0449820;C1864389;C1882368;C4050231",NULL,NULL,1782
"days without albuterol use","C0001927;C0042153;C0439228;C0457083;C1947944",NULL,NULL,118
"patient characteristics","C0815172",NULL,NULL,1652
"age yt","C0001779;C1412122","C0001779","",480
"xi oo p o $nmbr$","C1720296",NULL,NULL,520
"chads $nmbr$ score mean sd","C0007928;C0444504;C0449820;C1413373;C2347634;C2348143;C2699239;C4050231","","",2128
"no of events","C0441471;C3541888",NULL,NULL,1059
"demographics","C0011298;C1704791",NULL,NULL,582
"metabolizer phenotype","C0031437;C1285572",NULL,NULL,619
"bl mean mg dl mmol $nmbr$","C0005918;C0006413;C0439190;C0439269;C0444504;C0567349;C1552663;C2347634;C2348143;C2348885;C2827109;C3642216",NULL,NULL,200
"ace inhibitors arbs","C0003015;C3888198",NULL,NULL,44
"undiagnosed diabetes mellitus n $nmbr$","C0011849;C1408353","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"fema le","C0023190;C0439090;C1423767;C2697858",NULL,NULL,1274
"egfr ml min per $nmbr$ $nmbr$ kg m","C0369637;C0439402;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"change in nt probnp at $nmbr$ months log transformed","C0392747;C0439231;C0443172;C0669479;C0754710;C1510411;C1705241;C1708728;C2986775;C4319952",NULL,NULL,1530
"atrial fibrillation or flutter no","C0004238;C0016385;C0344434;C1963067;C2242390",";C0004238","",1009
"race","C0034510;C1706779;C3853635",";C0034510","",1107
"percent change from baseline to week $nmbr$ in auc mean sem","C0332174;C0376690;C0439230;C0444504;C2347634;C2348143;C3272907",NULL,NULL,36
"parameter mg dl","C0439269;C0549193;C1704769;C2350001","C0549193","",1186
"tnf antagonist naive subgroup n $nmbr$","C0231491;C1079230;C1448177;C1515021",NULL,NULL,362
"p value for heterogeneity rosiglitazone versus metformin","C0019409;C0025598;C0242960;C0289313;C1709380",";C1709380","C0242960",5
"a compared wi","C0043193;C1520135;C1707455",NULL,NULL,1633
"stage $nmbr$ b","C0441781",NULL,NULL,542
"anti inflammatory drugs","C0003209",NULL,NULL,156
"psa duration years mean sd","C0439234;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735;C3810537;C3813209",NULL,NULL,1099
"dihydropyridine calcium channel blocker","C2945601","C0006684","",1884
"variables","C0439828",NULL,NULL,1018
"acei or arb post randomisation","C0034656;C0687676;C1704687;C3469826;C3888198",NULL,NULL,44
"hemispheric stroke n $nmbr$","C0038454;C0205139;C4554100",NULL,NULL,1762
"total c mmol l mean","C0439175;C0439810;C0444504;C1532563;C2347634;C2348143","C0543421","",1504
"factor at baseline","C0168634;C1442488;C1521761;C2827422",NULL,NULL,1111
"pga $nmbr$ $nmbr$","C0016410;C3541266;C4050369",NULL,NULL,1525
"beam values mg dl mean sd","C0042295;C0338248;C0439269;C0444504;C2347634;C2347880;C2348143;C2699239;C4521565",NULL,NULL,37
"geometric mean uacr","C2986759","","",241
"low $nmbr$ kg m baseline bmi","C0168634;C0205251;C0578022;C1442488;C1532718;C1550472;C3890211;C4048187;C4321351;C4522223",";C1305855","",206
"$nmbr$ vitamin e n $nmbr$ $nmbr$","C0042874;C3714803","C0042874","",869
"history of chf before index event","C0018802;C0019664;C0019665;C0262512;C0262926;C0441471;C0600653;C0918012;C1552854;C1637833;C1705255;C2004062;C2986546;C4019010",NULL,NULL,412
"ct findings","C0007673;C2607943;C2926606;C3539655;C3540513;C3813556;C3888140",NULL,NULL,2357
"background therapy","C0039798;C0087111;C1363945;C1706907",NULL,NULL,236
"preoperative heart rate beats per minute","C0018810;C0439385;C0445204","C0018810","",1105
"$nmbr$ event $nmbr$ $nmbr$ per $nmbr$ py $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0030428;C0441471;C3538810;C4019010",NULL,NULL,1517
"germany","C0017480",NULL,NULL,1620
"inferior posterior","C0205095;C0542339;C0678975",NULL,NULL,1245
"arb","C3888198",NULL,NULL,44
"number of tender joints $nmbr$ assessed","C0234234;C0449813;C1516048","C0451530","",1139
"prior antihypertensive medication n","C0003364;C0332152;C2826257",";C0003364","",1579
"cigarette smoking mean pack years sd","C0037369;C0444504;C0453996;C1303175;C1881674;C2347634;C2348143;C2699239",NULL,NULL,37
"on treatment","C4684449","C0025677","",716
"empagliflozin n $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$","C3490348","C3490348","",1182
"elevation of cardiac biomarker levels no total no","C0439175;C0439775;C0439810;C0441889;C0702240;C1271630",NULL,NULL,643
"level $nmbr$ immobility","C0231441;C0441889;C0456079;C1547707;C2946261",NULL,NULL,744
"no of events women men","C0025266;C0043210;C0441471;C3541888","","",306
"entire cohort","C0009247;C0439751;C0444667;C0599755","C0599755","",2208
"add on to met su","C0038642;C0428210;C1550543;C1705534;C1883712;C4317104",NULL,NULL,39
"study medication no","C0013227;C0557651;C2603343;C3244316;C4284232",NULL,NULL,441
"blood urea nitrogen mg dl","C0005845;C0439269;C0600137","C0005845","",2271
"characteristics no of participants","C0679646;C1521970",NULL,NULL,1033
"number of prior csdmards n","C0237753;C0332152;C0449788;C2826257",NULL,NULL,1556
"high feno subgroup $nmbr$ $nmbr$ ppb n $nmbr$","C0205250;C1079230;C1299351;C1415800;C1515021;C2700149;C3887512;C3889660;C4321237;C4522209",NULL,NULL,1737
"primary ischemic stroke","C0205225;C0439612;C0439631;C0948008",NULL,NULL,2344
"triglycerides mmol l","C0041004;C1532563","C0041004","",368
"index pe event during","C0070939;C0441471;C0600653;C0918012;C1552854;C1637833;C1880476;C2986546;C4019010;C4284304",NULL,NULL,734
"crosuvastatin fenofibric acid vs rosuvastatin monotherapy","C0060179;C0965129","C0965129","",886
"none or diet","C0012155;C0012159;C1519433;C2983588;C3668949","C0012155","",1199
"glinide no","C2266929","C2266929","",1157
"physical examinations","C0031809",NULL,NULL,1519
"factor absent","C0332197;C1521761;C2827422;C4285062",NULL,NULL,485
"calcium channel blockers n","C0006684;C2757014","C0006684","",1884
"tics no","C0040188;C0278076;C2169806;C3889970",NULL,NULL,445
"previous revascularization","C0205156;C0581603;C1552607",NULL,NULL,1044
"basmi linear mean sd","C0205132;C0444504;C2347634;C2348143;C2699239",NULL,NULL,1287
"standard control n $nmbr$ no of patients percent","C0030705;C0243148;C0439165;C1442989;C1550141;C1882979;C2587213;C2828392;C3274648;C4553389",NULL,NULL,1482
"use of diuretics n","C0012798;C1524063",NULL,NULL,25
"subgroups were defined on the basis of variables assessed before randomization the lipid levels represent the averages of the values measured four weeks before randomization and those measured at randomization to convert values for cholesterol to millimoles per liter multiply by $nmbr$ $nmbr$ to convert values for triglycerides to millimoles per liter multiply by $nmbr$ $nmbr$ ci denotes confidence interval ldl low density lipoprotein and hdl high density lipoprotein tests for heterogeneity of treatment effect were undertaken across each of the subgroups in addition we performed tests for interaction between treatment and the following continuous base line variables age total ldl and hdl cholesterol and triglyceride levels there was no evidence of significant heterogeneity of treat ment effect in any prespecified subgroup p $nmbr$ $nmbr$ data were missing for three patients two in the placebo group and one in the pravastatin group","C0001779;C0008107;C0008377;C0009667;C0019409;C0022885;C0023820;C0023821;C0030705;C0032042;C0034656;C0039593;C0039798;C0040363;C0041004;C0041260;C0042295;C0084844;C0085542;C0087111;C0168634;C0178587;C0205251;C0205447;C0205448;C0205449;C0205450;C0231290;C0237881;C0242960;C0332282;C0332287;C0392366;C0428460;C0428475;C0439175;C0439190;C0439230;C0439810;C0439828;C0441833;C0444706;C0456984;C0475211;C0549178;C0687744;C0750502;C0884358;C1079230;C1257890;C1280500;C1292734;C1442488;C1510992;C1511726;C1515021;C1515976;C1516048;C1518681;C1519504;C1522326;C1527178;C1532563;C1533734;C1538994;C1546944;C1550472;C1551393;C1696465;C1704675;C1704788;C1705169;C1705428;C1705429;C1705492;C1706408;C1719797;C1874451;C1882932;C1883351;C1883712;C2348382;C2825518;C2911648;C3245479;C3259781;C3272743;C3538994;C3539106;C3541902;C3714741;C3715113;C3831328;C3887511;C3887704;C3890211;C4048187;C4318744;C4321351;C4522223","","",-10
"chlorthalidone vs doxazosin","C0008294;C0114873","C0008294","",70
"concomitant lipid modifying therapy no","C0023779;C0392747;C1707479",NULL,NULL,446
"$nmbr$ $nmbr$ mmol liter","C0439190;C0475211",NULL,NULL,987
"$nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"repaired s p shunts","C0205340;C0232180;C0542331;C1442858",NULL,NULL,478
"daily dose of vitamin d iu day","C0014695;C0042866;C0439465;C2348070;C2936842;C3537249;C3714503","C0042866","",866
"prebronchodilator fev $nmbr$ predicted normal t","C0205307;C0231683;C0439166;C0681842;C1882327;C2347086;C2599602;C3714541;C4553972","C0024119","",288
"cardiovascular death and hospital admission for heart failure","C0007226;C0011065;C0018801;C0018802;C0184666;C1306577;C3887460;C4082313;C4552775;C4554158",NULL,NULL,323
"urinary albumin creatinine ratio mg g","C0455271;C1300563;C1318330","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"dip joint arthritis","C0003864;C0932510;C4552845","C0003864","",274
"hypertension n n","C0020538;C1963138","C0020538","",1364
"parameter variable","C0439828;C0549193;C1704769;C2350001;C4553760","C0549193","",1186
"microalbuminuria","C0730345","C0033687","",376
"moderate iief ef $nmbr$ $nmbr$ n","C0205081;C1881878;C3641331;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"$nmbr$ uln","C1519815",NULL,NULL,1676
"concomitant medications no","C0013227;C0521115;C0802604;C2598133;C4284232","C0013227;C0521115","",1916
"amlodipione chlorthalidone","C0008294","C0008294","",70
"insulin glargine air insulin insulin glargine","C0001861;C0907402;C3536832",NULL,NULL,61
"plaque score $nmbr$ $nmbr$","C0429153",NULL,NULL,6
"total diuretic dose iv oral on day $nmbr$ mg","C0012798;C0022326;C0439422;C0442027;C2986497;C4265176;C4521986",NULL,NULL,992
"epistaxis","C0014591;C4554627",NULL,NULL,884
"levosimendan n $nmbr$","C0246904","C0246904","",2166
"latin and north america","C0028405","C0028405","",1463
"body weight mean sd kg","C0005910;C0022718;C0439209;C0444504;C1305866;C2347634;C2348143;C2699239;C4054209","C0005910","",1250
"body mass index blood pressure mm hg","C0005823;C0005893;C0439475;C0578022;C1271104;C1272641;C1305855","C0005823","",15
"contrast angiography","C0002978;C0009924;C1979874",NULL,NULL,1723
"$nmbr$ mo n","C0026544;C0332177",NULL,NULL,1476
"change from baseline in morning pef during weeks $nmbr$ $nmbr$ mean l min se","C0030771;C0036919;C0168634;C0332170;C0392747;C0439230;C0443172;C0444504;C0702093;C1442488;C1518922;C1524029;C1542834;C1705241;C2347634;C2348143;C3813700;C4319952",NULL,NULL,567
"thiazolidinedione no","C0289779;C1257987;C3537039","C1257987",";C0289779;C1527178;C1705938;C1552866;C2700399;C0168634",72
"impaired glucose tolerance or impaired fasting glucose no","C0271650;C1272092","C1272092","",20
"average weekly mtx dose mg week","C0024671;C0026410;C0332174;C0366550;C0439230;C0439269;C1510992;C1960952;C2346927;C2825518;C4321396;C4521761","C0025677","",716
"history of cardiac arrhythmia","C3494593",NULL,NULL,1492
"mmrm estimates ls mean se $nmbr$ ci","C0008107;C0023668;C0036919;C0444504;C0750572;C2347634;C2348143;C3259781",NULL,NULL,519
"im or cs use no","C0010182;C0042153;C0271160;C0457083;C1947944;C3540510;C4085345",NULL,NULL,136
"ambulance","C0002422;C3846685","C0002422",";C4049621",191
"l i $nmbr$ $nmbr$","C0021966;C0221138;C0439394;C1706495;C3642217","","",-10
"no of infusions","C0574032",NULL,NULL,1242
"other blood pressure drug","C0003364",";C0003364","",1579
"p interaction $nmbr$ $nmbr$","C0369773;C1704675;C2603361",NULL,NULL,888
"mean score on haq di","C3533236;C3826998;C4321476",NULL,NULL,1665
"very high","C0442804;C4321397",NULL,NULL,1478
"abrupt vessel closure","C0005847;C0185003;C1276802;C1521802","C0005847;C1521802;C1276802","",1385
"normal $nmbr$ mlvmin per $nmbr$ $nmbr$ m $nmbr$","C0205307;C0231683;C0369637;C0439166;C0441923;C2347086;C4553972",NULL,NULL,687
"a $nmbr$ ez n $nmbr$","C0206578",NULL,NULL,1407
"carotid revascularization","C0581603;C0741968","C0007272","",1547
"multivitamins","C0301532;C3714835","C0301532",";C1710701;C1705970",1032
"infections and infestations","C0851341;C3714514","C3714514","",1093
"concomitant use of bosentan n","C0252643;C0521115;C1524063","C0252643","",1328
"hypertension","C0020538;C1963138","C0020538","",1364
"proportion of responders n n","C1709707",NULL,NULL,1047
"premature discontinuation","C0151526;C0205252;C0457454;C1444662;C4018905;C4552847",NULL,NULL,1562
"stroke see or death","C0011065;C0038454;C0042789;C1306577;C1947903;C4082313;C4552775;C4554100","C4554100","",336
"complete healinga","C0205197;C0725685;C3853530;C4283785",NULL,NULL,327
"standard care","C1442989;C1947933;C2828392",NULL,NULL,1482
"lcl","C3658298","C0023824","",1068
"associated with drug toxin","C0013221;C0332281",NULL,NULL,876
"some college tech","C0557806;C1826596",NULL,NULL,1120
"p value n n","C1709380",NULL,NULL,7
"insulin requiring diabetes","C0011847;C0011849;C0021641;C1533581;C1579433;C3714501",NULL,NULL,157
"angioedema adjudicated n","C0002994",NULL,NULL,689
"duration of alendronate use mean sd y","C0102118;C0444504;C1881378;C2347634;C2348143;C2699239;C2826775",NULL,NULL,37
"prior angiography showing stenosis $nmbr$ n $nmbr$","C0002978;C0332152;C0678234;C1261287;C1547282;C2632116;C2826257",NULL,NULL,1651
"$nmbr$ $nmbr$ mmol mol","C3829066",NULL,NULL,668
"africa or near east","C0001737;C0205674",NULL,NULL,48
"i w i $nmbr$","C0021966;C0221138",NULL,NULL,1021
"versus tiotropium $nmbr$ $nmbr$ pg","C0030827;C0072225;C0213771;C1266240","C0213771","",1372
"all mn na ve patients","C0026327;C0026405;C0030705;C0042469;C0597484;C1272460;C1546968;C1879645;C3714652;C4049872;C4285072;C4321495;C4552882",NULL,NULL,1035
"acr response by baseline weight","C0871261;C1303013;C1412134;C1515941;C1704632;C1706817;C2911692",NULL,NULL,52
"week $nmbr$ czp $nmbr$ mg q $nmbr$ w","C0024671;C0026410;C0054841;C0332174;C0439230;C0439269;C1861828;C1872109;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"initiated use during double blind treatment period","C0013072;C0039798;C0042153;C0087111;C0439531;C0457083;C1522326;C1533734;C1548602;C1704686;C1705169;C1947944;C1948053;C3538994;C3887704",NULL,NULL,118
"other lipid modifying drug no","C0013227;C0023779;C0392747;C1254351",NULL,NULL,441
"$nmbr$ year n","C0439234;C0439508",NULL,NULL,1099
"race white n of patients","C0007457;C0030705;C0034510;C0043157;C0220938;C1706779;C3853635",NULL,NULL,1035
"renal insufficiency","C0035078;C1565489","C1565489","",937
"heparin ondaparinux or brvalirudin use between rxjex event","C0019134;C0042153;C0441471;C0457083;C0770546;C1947944;C4019010",NULL,NULL,412
"nc group n $nmbr$","C0027964;C0028407;C0067895;C0265987;C0441848",NULL,NULL,1591
"mild teaes","C2945599",NULL,NULL,329
"glycoprotein llb llla inhibitors","C0017968;C0243077",NULL,NULL,2104
"aspirin alone n $nmbr$ $nmbr$ $nmbr$","C0004057;C0205171;C0439044;C0679994","C0004057","",1366
"microvascular disease history no","C0443258;C0683519",NULL,NULL,105
"hdl mmol l","C1532563;C3715113","C0023822","",821
"america","C0002454","C0002454","",2258
"race or ethnic group no white","C0007457;C0015031;C0034510;C0043157;C0220938;C1706779;C1879937;C3853635",NULL,NULL,787
"western europe australia","C0004340;C0015176;C0043128;C0043129","C0015176","",337
"antithrombotic use","C0042153;C0457083;C1947944",NULL,NULL,118
"activity $nmbr$ $nmbr$ vas","C0042815;C0205177;C0439167;C0441655;C1561536;C3536884;C3668946;C3827561;C4049938;C4049939",NULL,NULL,1751
"total by baseline diabetic status","C0168634;C0241863;C0439175;C0439810;C0449438;C1442488",NULL,NULL,996
"lad artery","C0003842;C0226004",NULL,NULL,785
"in previous year mean sd","C0205156;C0439234;C0439508;C0444504;C1552607;C2347634;C2348143;C2699239",NULL,NULL,37
"total cholesterol mmol l mean sd","C0201950;C0444504;C0543421;C1532563;C2347634;C2348143;C2699239","C0543421","",1504
"hba $nmbr$ c sd mmol mol","C0019016;C1825777;C2699239;C3538758;C3829066","","",820
"killip class no i","C0021966;C0221138;C1881332","C1881332","",846
"baseline ppasi score mean sd","C0168634;C0444504;C0449820;C1442488;C2347634;C2348143;C2699239;C4050231",NULL,NULL,1287
"prior stroke mi n","C0038454;C0332152;C2826257;C3810814;C4554100","C0038454;C0332152","",2380
"dysglycemic categories n","C0683312;C1960636",NULL,NULL,562
"patients receiving enl no","C0030705;C1514756",NULL,NULL,1035
"fatal nonfatal mi excluding silent mi","C0332196;C0443304;C1302234;C1705232;C2828389;C3810814;C3816734",NULL,NULL,516
"ascvd including tia","C0007787;C0332257;C0917805;C1054154;C3665365",NULL,NULL,344
"smokinq status","C0449438",NULL,NULL,543
"absolute risk difference $nmbr$ cl","C0035647;C0596019;C1519101;C1549031;C1705241;C1705242;C4552904","C0035647;C1549031","",2259
"$nmbr$ $nmbr$ mg day","C0439422","","",198
"any death","C0011065;C1306577;C4082313;C4552775",NULL,NULL,1855
"no total no t","C0439175;C0439810;C2603360",NULL,NULL,508
"p values","C1709380",NULL,NULL,7
"unadjusted hazard ratio $nmbr$ cl","C0596019;C1439367;C2985465","C2985465","",975
"asian n $nmbr$ $nmbr$","C0078988","C0078988","",1369
"hba $nmbr$ c mmol mol median q $nmbr$ q $nmbr$","C0019016;C0549183;C0876920;C1825777;C2347635;C2348144;C2939193;C3538758;C3829066","","",820
"prior angina","C0002962;C0332152;C2826257","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"gender m f","C0079399;C1306057;C1522384","C0079399","",1083
"baseline mean mtss","C0168634;C0444504;C1442488;C2347634;C2348143",NULL,NULL,625
"sys ns dia $nmbr$ $nmbr$","C0038944;C1112705;C1425041;C1705982;C1706546",NULL,NULL,129
"mean $nmbr$ th to $nmbr$ thquartile bnp pg ml","C0039725;C0039738;C0054015;C0439297;C0444504;C1095989;C1417808;C1420718;C2347634;C2348143;C2982014;C4282123;C4285344",NULL,NULL,1635
"prior llt","C0332152;C2347090;C2826257",NULL,NULL,294
"hematologic","C0018943;C0205488",NULL,NULL,1606
"laboratory tests","C0022885",NULL,NULL,242
"n $nmbr$ fatty acids slope lsm se mm year","C0015684;C0036919;C0369718;C0439234;C0439508;C0441922;C0807955;C4330985;C4554674",NULL,NULL,1553
"am s e","C3813124;C3890196;C4520798",NULL,NULL,695
"education $nmbr$ $nmbr$ years","C0013621;C0013622;C0013658;C0039401;C0439234","C0013658","",1990
"dose reduction at randomization","C0034656;C0178602;C0301630;C0392756;C0869039;C1114758;C1293152;C4551656",NULL,NULL,110
"cha $nmbr$ ds $nmbr$ vasc score mean sd","C0444504;C0449820;C1420648;C2347634;C2348143;C2699239;C3714751;C4050231",NULL,NULL,968
"physician global assessment of disease","C0012634;C4050369",NULL,NULL,1525
"$nmbr$ months n $nmbr$ $nmbr$","C0439231",NULL,NULL,1530
"change in hba $nmbr$ c $nmbr$ to month $nmbr$","C0019016;C0332177;C0392747;C0439231;C0443172;C1705241;C1825777;C3538758;C4319952",NULL,NULL,1476
"patients with previous intolerance of infliximab","C0030705;C0205156;C0231199;C0666743;C1552607;C1744706;C2355652","C1744706;C0666743","",1094
"all patients","C0030705",NULL,NULL,1035
"diet pravastatin group","C0012155;C0012159;C0085542;C0441833;C0687744;C1257890;C1519433;C1519504;C1705428;C1705429;C2983588;C3668949","C0012155","",1199
"baseline ckd egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$","C0168634;C0369637;C0439445;C0441923;C1442488;C1561643;C1739039;C3811844;C3812682","C3811844;C0017654","",307
"heterogeneity trend test","C0019409;C0022885;C0039593;C0242960;C0392366;C0456984;C1515976;C1521798;C3831328;C4318744;C4554533",NULL,NULL,242
"$nmbr$ ci a","C0008107;C3259781",NULL,NULL,519
"lathosterol jimol l","C0064673",NULL,NULL,1502
"lev n $nmbr$","C0023556",NULL,NULL,1275
"in stent restenosis","C3272317","C3272317","",2035
"previous myocardiaunfarction","C0205156;C1552607",NULL,NULL,2390
"sgrq total score","C2964552",NULL,NULL,540
"coronary angiography no","C0085532;C1548829",NULL,NULL,1724
"inversion","C0021943;C0021945;C1705687;C2349984","","",-10
"systolic mean sd","C0039155;C0444504;C2347634;C2348143;C2699239",NULL,NULL,2127
"a mini mental state examination insulin glargine vs standard care","C0451306;C0907402;C1442989;C1947933;C2828392",NULL,NULL,1482
"dose reduction n","C0178602;C0301630;C0392756;C0869039;C1114758;C1293152;C4551656",NULL,NULL,110
"cs and is","C0010182;C0271160;C3540510;C4085345",NULL,NULL,136
"ocs reduced stopped","C0392756;C1272691",NULL,NULL,730
"stage $nmbr$ b egfr $nmbr$ and $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441781;C0441923;C1739039;C3811844;C3812682",NULL,NULL,542
"no known frtrontxtfufoc cond aon","C0205309;C1856054;C2826243;C4597943",NULL,NULL,1238
"low density lipoprotein cholesterol mg dl","C0023824;C0439269","C0023824","",1963
"ischemic stroke incl uncertain","C0087130;C0948008;C4085655",NULL,NULL,1762
"high $nmbr$","C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"weight at randomization kg","C0022718;C0439209;C2985844;C4054209",NULL,NULL,2326
"moderate $nmbr$ $nmbr$","C0205081;C1881878;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"target nail napsi score $nmbr$ $nmbr$ scale","C0027342;C0175659;C0349674;C0449820;C1432728;C1521840;C1947916;C2986546;C3538766;C4050231",NULL,NULL,748
"history of atrial fibrillation or flutter treatment at randomisation","C0016385;C0034656;C0039798;C0087111;C0729790;C1522326;C1533734;C1705169;C2242390;C3538994;C3887704",";C0004238","",1009
"nonsmoker","C0337672;C0425293;C4554605","C0037369","",420
"three point mace","C0205449;C0349381;C0949745;C1445339;C1552961;C2347617;C3714763","C1320716","",414
"current laba use","C0042153;C0457083;C0521116;C1705970;C1947944",NULL,NULL,118
"atv n","C0210243;C0674679;C1145759;C1334862",NULL,NULL,1411
"stage $nmbr$ four variable modification of diet in kidney disease","C0022658;C0086153;C0205390;C0205450;C0439828;C1300072;C1306673;C3671772;C4553760",NULL,NULL,541
"csdmard use at baseline","C0042153;C0168634;C0457083;C1442488;C1947944",NULL,NULL,625
"age in years mean","C0444504;C1510829;C2347634;C2348143","C1510829","",481
"womac stiffness score","C0427008;C0449820;C4050231",NULL,NULL,754
"$nmbr$ n gender n","C0079399;C0369718;C0441922;C1522384","C0079399","",1083
"hdl cy","C0010622;C0332298;C2239193;C3715113","C0023822","",821
"prior conventional synthetic dmards n","C0242708;C0332152;C0439858;C1883254;C2826257",NULL,NULL,294
"devices","C0025080;C0220819;C0699733",NULL,NULL,732
"upper respiratory tract inflammation","C0877266",";C0041912","",1289
"high crp or esr","C0205250;C1299351;C2700149;C3811131;C3887512;C3889660;C3890735;C4048285;C4321237;C4522209",NULL,NULL,834
"tio i $nmbr$ mcg n $nmbr$","C0021966;C0221138;C0439211;C3463985",NULL,NULL,199
"$nmbr$ $nmbr$ kg","C0022718;C0439209;C4054209",NULL,NULL,205
"baseline ldl mg","C0024671;C0026410;C0168634;C0439269;C1442488;C1960952;C2346927;C4321396;C4521761","C0023824;C1442488","",1964
"absolute change","C1549031",NULL,NULL,1578
"cangrelor n $nmbr$ n n","C1121991","C1121991","",1247
"other region no","C0017446;C0205147",NULL,NULL,1060
"severe impairment $nmbr$","C0205082;C0221099;C0684336;C4050465;C4050466",NULL,NULL,313
"time since start insulin years","C0021641;C0040223;C0439234;C0439659;C1533581;C1579433;C1711239;C3541383;C3714501",NULL,NULL,1099
"hosp worsening hf","C0018488;C0332271;C1313497;C1457868;C1538440;C1546960;C3273279","C0018801",";C0168634;C1524003",12
"motor subscale range $nmbr$ $nmbr$","C1513492;C1514721;C1705994;C2348147;C3542016",NULL,NULL,479
"no ischemia n $nmbr$ $nmbr$","C0022116;C4321499",NULL,NULL,1668
"baseline glycemic control","C0005802;C0168634;C0243148;C1442488;C1550141;C1882979;C2587213;C3274648;C4553389",NULL,NULL,675
"moderate or severe impairment","C0205081;C0205082;C0221099;C0684336;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335",NULL,NULL,321
"classes on the canadian cardiovascular society ccs scale range from i to iv","C0007226;C0021966;C0022326;C0037455;C0175659;C0221138;C0238884;C0349674;C1514721;C1879987;C1947916;C2348147;C3542016;C3887460;C4265176",NULL,NULL,479
"dabigatran $nmbr$ mg n $nmbr$ $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761",NULL,NULL,775
"fev $nmbr$ liters","C0475211;C3714541",NULL,NULL,1599
"p value $nmbr$","C1709380",NULL,NULL,7
"ace angiotensin converting enzyme arb angiotensin receptor blockers","C0022709;C0597357;C3888198","C0003015","",811
"rosuvastatin of patients rate","C0030705;C0871208;C0965129;C1521828","C0965129","",886
"total cholesterol $nmbr$ mg dl","C0201950;C0439269;C0543421","C0543421","",1504
"left ventricular hypertrophy n","C0149721;C3484363","C0149721","",1496
"familial","C0015576;C0241888","","",-10
"$nmbr$ hour postload glucose","C0017725;C0439227;C0564385",NULL,NULL,828
"baseline erosion","C0168634;C0333307;C1442488;C1880549;C1959609;C3887524",NULL,NULL,1046
"unfractionated heparin","C0019134;C2825026","C0019134","",864
"ileum ses cd score mean sd","C0007928;C0020885;C0034283;C0444504;C0449820;C2347634;C2348143;C2699239;C4050231;C4552032",NULL,NULL,37
"event rates","C0441471;C0871208;C1521828;C4019010",NULL,NULL,2007
"alcohol use","C0001948","C0001948","",875
"white n","C0007457;C0043157;C0220938","C0043157","",1402
"no total no","C0439175;C0439810",NULL,NULL,508
"saxagliptin $nmbr$ mg n z $nmbr$","C0024671;C0026410;C0439269;C1611934;C1960952;C2346927;C4321396;C4521761","C1611934","",2069
"hd edoxaban vs warfarin","C0043031;C2975435","C0043031;C2975435","",1458
"percent change","C0392747;C0439165;C0443172;C1705241;C4319952",NULL,NULL,767
"warfarin s $nmbr$ cl","C0043031;C0596019","C0043031","",858
"ls mean change from baseline $nmbr$ ci","C0008107;C0023668;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C3259781;C4319952",NULL,NULL,519
"end points","C2349179","C2349179","",1136
"lll iv","C0022326;C1261077;C4265176",NULL,NULL,1257
"general health","C0424575;C4018875",NULL,NULL,325
"thiazide diuretics","C0012802","","",993
"past treatment for paod","C2945691","C0025677","",716
"$nmbr$ $nmbr$ kg m","C1532718",";C1305855","",206
"values expressed as mean sd or number percent two patients were missing values for body mass index other forms of atherosclerosis are peripheral arterial disease abdom inal aortic aneurysm symptomatic carotid artery disease transient isch emic attack and stroke family history of premature chd de ned as chd in male rst degree relative aged $nmbr$ years or female rst degree relative $nmbr$ years blood pressure $nmbr$ $nmbr$ mm hg on antihypertensive medication or diagnosis of hypertension based on medical history n number of randomly assigned patients ncep atp national cholesterol education program adult treatment panel","C0001675;C0001779;C0001792;C0003364;C0003486;C0003850;C0004153;C0005823;C0005893;C0007273;C0008377;C0011198;C0011900;C0015576;C0017480;C0019664;C0019665;C0020538;C0030688;C0030705;C0038454;C0040704;C0042295;C0043210;C0080103;C0085096;C0086287;C0086582;C0151526;C0205252;C0205345;C0205374;C0205448;C0231220;C0237753;C0262512;C0262926;C0277793;C0280604;C0340629;C0348078;C0376315;C0439165;C0439234;C0439475;C0441833;C0441889;C0444504;C0449286;C0449788;C0542560;C0578022;C0679841;C1261512;C1271104;C1272641;C1304680;C1305855;C1425219;C1516050;C1518340;C1527178;C1547039;C1551393;C1552601;C1704338;C1704436;C1704656;C1704727;C1705255;C1705492;C1705497;C1705498;C1705938;C1706180;C1706365;C1706428;C1706429;C1706450;C1963138;C1999167;C1999270;C2004062;C2347634;C2348088;C2348143;C2699239;C2744579;C3245503;C3272743;C3541240;C3542407;C4018905;C4552600;C4554100","","",-10
"low density lipoprotein cholesterol tx difference vs pbo ls mean change from baseline se","C0023668;C0023824;C0031962;C0036919;C0041403;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C1705242;C2347634;C2348143;C4319952",NULL,NULL,767
"cardiovascular mortality mi or revascularization","C0007226;C0026565;C0026566;C0581603;C3810814;C3887460",NULL,NULL,2157
"severity","C0439793;C0522510",NULL,NULL,561
"ranolazine n $nmbr$ placebo n $nmbr$","C0032042;C0073633;C1696465;C1706408","C0032042","",28
"use oforal glucose lowering agent no","C0017725;C0042153;C0441994;C0450442;C0457083;C1254351;C1521826;C1947944;C2003888",NULL,NULL,118
"gold iii iv","C0018026;C0022326;C0439070;C1304897;C1705160;C4265176","C0024117;C0205082",";C4050419;C1412502;C3714496;C0018026;C1304897;C4050465;C4050466",1836
"ig n $nmbr$","C0021027;C0305052;C0360506",NULL,NULL,1260
"lioid trial participants","C1997894;C2242969",NULL,NULL,278
"$nmbr$ $nmbr$ severe","C0205082;C4050465;C4050466",NULL,NULL,313
"secukinumab $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C3179547;C4321396;C4521761",NULL,NULL,2297
"patients with evaluable endoscopy","C0014245;C2986511",NULL,NULL,1728
"no po","C0032729;C0442027",NULL,NULL,88
"cd complications","C0007928;C0009566;C0034283;C1171258;C4552032",NULL,NULL,699
"diet controlled","C0743195","C0743195","",333
"overweight $nmbr$ to $nmbr$ kg m $nmbr$","C0497406;C1532718","C0497406","",1248
"cv risk factors","C0035648;C1553898;C3538987;C4048877;C4318503",NULL,NULL,1777
"saxa $nmbr$ $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"lipid measures at baseline mg dl","C0023779;C0079809;C0168634;C0242485;C0439269;C1442488;C1879489","C0023779","",1967
"pasi response by baseline mtx use no total no pasi $nmbr$","C0025677;C0042153;C0168634;C0439175;C0439810;C0457083;C0871261;C1417487;C1442488;C1704632;C1706817;C1947944;C2911692;C4528685",NULL,NULL,1522
"week $nmbr$ a","C0332174;C0439230",NULL,NULL,1012
"heart failure $nmbr$ mo before admission","C0018801;C0018802;C0026544;C0184666;C0332177;C0809949;C4554158","C0018801",";C0168634;C1524003",12
"st str $nmbr$ pre ci","C0008107;C0036056;C0332152;C0740175;C2257086;C3259781;C3272372;C3669034",NULL,NULL,294
"cabg or valve","C0010055;C0184252;C1186983;C1704414;C3888056","C0374711;C0184252",";C1704414;C3888056;C0035139;C0043240;C4553149;C1720467",8
"cardiac index l mn m $nmbr$","C0026327;C0026405;C0369637;C0428776;C0441923;C4285072",NULL,NULL,303
"mtx dose $nmbr$ mg week","C0024671;C0026410;C0332174;C0366550;C0439230;C0439269;C1960952;C2346927;C4321396;C4521761","C0025677","",716
"iv","C0022326;C4265176",NULL,NULL,1257
"coronary bypass graft","C1260596","C0010055","",1843
"by who simon broome criteria","C0243161;C0443058",NULL,NULL,783
"age groups","C0027362","C0027362","",482
"basal insulin","C0650607","C0650607","",354
"no women","C0043210","C0043210",";C3541888;C1720467",1323
"hospitalized for heart failure during that time period","C0018801;C0018802;C0701159;C1948053;C4554158","C0018801",";C0168634;C1524003",12
"mild fev $nmbr$ predicted","C0681842;C1882327;C2945599;C3714541",NULL,NULL,1599
"$nmbr$ ml min n $nmbr$","C0439445","C3811844;C0017654","",307
"azl m $nmbr$ mg n $nmbr$","C0024671;C0026410;C0369637;C0439269;C0441923;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"median dose range","C0178602;C0549183;C0869039;C0876920;C1114758;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016",NULL,NULL,479
"no diuretic therapy","C0948575",NULL,NULL,556
"low $nmbr$ kg m $nmbr$ baseline bmi","C0168634;C0205251;C0578022;C1442488;C1532718;C1550472;C3890211;C4048187;C4321351;C4522223",";C1305855","",206
"prior angina n n","C0002962;C0332152;C2826257","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"black n","C0005680;C0027567;C0085756;C0439541","C0005680",";C1706779",188
"s $nmbr$ $nmbr$ mg mmol","C0565930;C0567349;C2348885;C2603362",NULL,NULL,200
"antiplatelet or anticoagulant therapy","C0150457","","",1191
"number of medications n","C1718138",NULL,NULL,1811
"arb arb ccb","C0006684;C3888198",NULL,NULL,704
"balloon angioplasty no","C0002996;C0002997","C0002996","",1721
"ics lama","C0815320;C0999593;C1416775;C4551720",NULL,NULL,1650
"combined","C0205195",NULL,NULL,997
"pacemaker n","C0030163;C0810633;C1546728;C3275122;C3853703",NULL,NULL,503
"hdl c mg dl mean sd","C0439269;C0444504;C2347634;C2348143;C2699239;C3715113","C0023822","",1962
"amputations n","C0002688","C0002688","",895
"baseline pav median n $nmbr$ $nmbr$","C0058890;C0168634;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193",NULL,NULL,635
"physical functioning","C0516981;C4049916",NULL,NULL,1533
"baseline ibdq total score mean","C0168634;C0444504;C1442488;C2347634;C2348143;C2964552",NULL,NULL,2313
"subjects who did receive labd prior to the study","C0332152;C0396059;C0557651;C0681850;C1514756;C1550501;C1706203;C2349001;C2603343;C2697811",NULL,NULL,1655
"ls mean $nmbr$ ci mmol mol","C0008107;C0023668;C0444504;C2347634;C2348143;C3259781;C3829066",NULL,NULL,668
"isolated deep vein thrombosis","C0149871;C0205409;C1548221",NULL,NULL,1643
"net clinical benefit on treatment vte or major bleeding","C0019080;C0039798;C0087111;C0205082;C0205164;C0630906;C0814225;C1456447;C1516635;C1522326;C1533734;C1705169;C3538994;C3853572;C3887704;C3887809;C3890893;C4318856;C4521762;C4684590",NULL,NULL,1472
"duration of copd yr f","C0016327;C0024117;C0439234;C0449238;C1412502;C2926735;C3714496",NULL,NULL,1726
"crude rate","C0871208;C1521828",NULL,NULL,2009
"geographic region europe","C0015176;C0017446","C0015176","",337
"other dmard use","C0042153;C0242708;C0457083;C1947944","C0242708",";C0026544",231
"co morbidities n","C0009488",NULL,NULL,765
"antialdosterone agents","C0450442;C1254351;C1521826",NULL,NULL,484
"prior hypertension yes","C0020538;C0332152;C1549445;C1705108;C1710701;C1963138;C2826257","C0020538","",1365
"$nmbr$ e $nmbr$ years","C0439234",NULL,NULL,1099
"no of previous csdmards n","C0205156;C1552607",NULL,NULL,1045
"missing hb at yr $nmbr$","C0019046;C0439234;C1551393;C1705492;C3272743","C1705492","",1144
"medication n","C0013227;C3244316;C4284232",NULL,NULL,2263
"prior ed therapy","C1514463;C3538926",NULL,NULL,411
"mtx","C0025677;C1417487","C0025677","",1408
"aspartate aminotransferase u l","C0004002;C0439339",NULL,NULL,1572
"naproxen","C0027396","C0027396","",338
"prior lev use","C0023556;C0042153;C0332152;C0457083;C1947944;C2826257",NULL,NULL,294
"placebo n $nmbr$ i $nmbr$","C0021966;C0032042;C0221138;C0369718;C0441922;C1696465;C1706408","C0032042","",28
"log rank p value","C0667477;C0699794;C1708728;C1709380;C2986775",NULL,NULL,1740
"family history of cad","C0241889;C1504769;C2239547;C3813548;C4284121",NULL,NULL,698
"medical history duration of heart failure years primary cause of heart failure","C0015127;C0199168;C0205225;C0205476;C0439234;C0439612;C0439631;C0449238;C0455531;C1524003;C2926735",NULL,NULL,2343
"first recorded event no and of patients","C0030705;C0034869;C0205435;C0441471;C1279901;C3853788;C4019010",NULL,NULL,806
"fatty acid group n $nmbr$","C0015684;C0441848","C0015684","",1236
"$nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ i $nmbr$ i","C0021966;C0221138",NULL,NULL,1021
"hrt use","C0042153;C0282402;C0457083;C1947944",NULL,NULL,549
"presence of erosions n","C0150312;C0333307;C0392148;C1959609;C3854307","C1959609;C0150312","",293
"statin only n $nmbr$ $nmbr$","C0205171;C0360714;C1720467",NULL,NULL,925
"week $nmbr$ mmol l","C0332174;C0439230;C1532563",NULL,NULL,1012
"major coronary disease event fatal non fatal mi","C0010068;C0012634;C0205082;C0205164;C0441471;C0741923;C1302234;C1518422;C1705232;C1956346;C3810814;C4019010;C4318856;C4521762","C1320716;C0205082","",2077
"aspirin no","C0004057","C0004057","",1366
"diabetic patients","C0030705;C0241863",NULL,NULL,996
"$nmbr$ obesity class $nmbr$","C0028754;C0456387;C1518526;C1705943;C1963185",NULL,NULL,710
"current corticosteroid use n","C0239126;C0521116;C1705970",NULL,NULL,1417
"orthopnea frequent continuous","C0085619;C0332183;C0549178","C0085619","",279
"empagliflozin $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C3490348;C4321396;C4521761","C3490348","",1182
"all cause mortality","C0015127;C0026565;C0026566;C0444868;C1524003;C3539085",NULL,NULL,924
"ace or arb","C1452534;C3888198;C4284014",NULL,NULL,46
"age categories y n","C2916832","C1510829","",481
"history of mi n $nmbr$ $nmbr$","C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C3810814",NULL,NULL,832
"ex smokers","C0337671;C4555205","C0037369","",420
"left atrial diameter mm sd","C0225860;C0225861;C1301886;C2699239;C4330985;C4554674","C0225860","",1196
"pci duration in min median iqr","C0449238;C0549183;C0702093;C0876920;C1524029;C2347635;C2348144;C2926735;C2939193;C3813700;C4049621",NULL,NULL,901
"delayed eptifibatide","C0205421;C0253563;C1545665;C3272602",NULL,NULL,317
"american indian or alaskan","C0002460;C0238611",NULL,NULL,637
"mean weight kg sd","C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209",NULL,NULL,37
"angiogenin ng ml","C0051844;C0439275;C1367482",NULL,NULL,204
"total cholesterol mean sd","C0201950;C0444504;C0543421;C2347634;C2348143;C2699239","C0543421","",1504
"never smoked no","C0037366;C0439994;C1881674;C2003901","C0037369","",420
"abciximab no total","C0288672;C0439175;C0439810","C0288672","",374
"red blood cell counting $nmbr$ l","C0005767;C0005768;C0022827;C0229664;C0332575;C0750480;C1260956;C1705566;C4049926",NULL,NULL,17
"worldwide black patients","C0005680;C0027567;C0030705;C0085756;C0439541",NULL,NULL,1035
"multiple $nmbr$ chd risk","C0439064;C1282512",NULL,NULL,972
"lvh by ecg","C0232306","C0232306","",406
"age $nmbr$ $nmbr$ yr","C0001779;C0439234","C0001779","",480
"physical function","C0516981;C4049916",NULL,NULL,1533
"change in das $nmbr$ esr mean i physical function outcomes week $nmbr$","C0021966;C0051767;C0057671;C0221138;C0332174;C0392747;C0439230;C0443172;C0444504;C0516981;C1274040;C1705241;C2347634;C2348143;C3811131;C4049916;C4319952",NULL,NULL,767
"total no of events of participants total no of participants","C0439175;C0439810;C0441471;C0679646;C3541888",NULL,NULL,1033
"copd worsening","C0024117;C0332271;C1412502;C1457868;C1546960;C3714496","C0332271",";C1538440;C3273279;C1412502",282
"age n","C0001779","C0001779","",480
"qualifying risk factors no","C0035648;C1514624;C1553898",NULL,NULL,175
"no nadroparin n $nmbr$","C0206232","C0206232","",860
"standard care n $nmbr$","C1442989;C1947933;C2828392",NULL,NULL,1482
"$nmbr$ $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"east asian","C0078988;C1707877","C0078988","",1369
"event rate of primary endpoints","C0441471;C0871208;C1521828;C2986535;C4019010",NULL,NULL,2007
"patient reported hypertension no","C0020538;C0030705;C0684224;C0700287;C1963138;C4319718","C0020538","",1364
"fasting insulin iiiu ml mean sd","C0015663;C0021641;C0439526;C0444504;C1533581;C1579433;C1705224;C2347634;C2348143;C2699239;C3714501;C3887665",NULL,NULL,157
"with t $nmbr$ dm n $nmbr$","C0011816;C2986835;C3250443",NULL,NULL,955
"bmi kg m $nmbr$ median $nmbr$ th to $nmbr$ th percentile","C0039725;C0039738;C0549183;C0876920;C1420718;C1532718;C2347635;C2348144;C2923536;C2939193;C4282123;C4285344","C1305855","",1891
"patients with baseline crp concentration $nmbr$ mg l","C0030705;C0086045;C0168634;C0439268;C1442488;C1446561;C3827302;C3890735;C4048285",NULL,NULL,1545
"baseline creatinine clearance","C0168634;C0812399;C1442488",NULL,NULL,625
"proximal","C0205107;C4489236","C0205107","",1447
"discontinuation of ics laba prior to baseline n","C0168634;C0457454;C0815320;C1442488;C1444662;C4551720;C4552847",NULL,NULL,1359
"pretreatment hdl c","C1550147;C2709094;C3539075;C3539076;C3715113",NULL,NULL,715
"history of hf or lvef b $nmbr$ with index event no","C0018488;C0019664;C0019665;C0262512;C0262926;C0428772;C0441471;C0488728;C0600653;C0918012;C1313497;C1538440;C1552854;C1637833;C1705255;C2004062;C2986546;C3273279;C4019010","C0018801;C0428772","",1273
"homa median","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,634
"liraglutide $nmbr$ $nmbr$ mg","C0024671;C0026410;C0439269;C1456408;C1960952;C2346927;C4321396;C4521761","C1456408","",1566
"timi risk score","C0035647;C0449820;C4050231;C4552904",NULL,NULL,2052
"week $nmbr$ before ee","C0332174;C0439230",NULL,NULL,1012
"fpg mean sd mg dl","C0439269;C0444504;C2347634;C2348143;C2699239",NULL,NULL,192
"patients without ra as or psa n $nmbr$ $nmbr$","C0030705;C3538806;C3810537;C3813209;C4048756",NULL,NULL,1755
"panel a","C0441833;C1706365;C1999270",NULL,NULL,1527
"rr reduction $nmbr$ $nmbr$ $nmbr$ $nmbr$ cl","C0301630;C0392756;C0596019;C1293152;C4551656;C4554402",NULL,NULL,1542
"number stent $nmbr$","C0038257;C0237753;C0449788",NULL,NULL,569
"$nmbr$ ell ll non hdl c","C1427925;C1518422;C3273466;C3715113",NULL,NULL,664
"time since onset h","C0033727;C0040223;C0206132;C0332162;C0369286;C0441932;C0564385;C3541383;C4528284",NULL,NULL,736
"age yr mean sd","C0001779;C0439234;C0444504;C2347634;C2348143;C2699239","C0001779","",480
"good tried previous glucocorticoid","C0017710;C0205156;C0205170;C1552607","C0017710","",1348
"asia australia new zealand","C0003980;C4289954",NULL,NULL,55
"cardiovascular disease history","C0007222;C0007226;C0012634;C0019664;C0019665;C0262512;C0262926;C0683519;C1705255;C1880008;C2004062;C3887460","C0007222","",1790
"nc","C0027964;C0028407;C0067895;C0265987",NULL,NULL,1591
"other forms of atherosclerosis","C0003850;C0004153;C0348078;C0376315","C0004153","",1698
"baseline pos frequency per $nmbr$ days median min max","C0168634;C0549183;C0585290;C0702093;C0876920;C1262869;C1442488;C1524029;C2347635;C2348144;C2939193;C3496112;C3496399;C3813700",NULL,NULL,1475
"swollen joints $nmbr$ joint count mean sd","C0444504;C0451521;C2347634;C2348143;C2699239",";C0451521","",1140
"diet only","C0012155;C0012159;C0205171;C1519433;C1720467;C2983588;C3668949","C0012155","",1199
"small medium","C0009458;C0439536;C0700321;C1705217;C3244283;C4085196;C4522282;C4522283",NULL,NULL,1377
"subgroup sex","C0009253;C0036864;C0079399;C0804628;C1079230;C1314687;C1515021;C1522384",NULL,NULL,568
"number ste t $nmbr$","C0237753;C0449788;C1420459;C3811127",NULL,NULL,1556
"physician s global assessment vas","C0042815;C3536884;C3827561;C4050369",NULL,NULL,1751
"main etiology of heart failure","C0015127;C0018801;C0018802;C0205225;C1314792;C1524003;C1542147;C4554158",NULL,NULL,924
"certolizumab pegol n $nmbr$","C1872109","C1872109","",1406
"pulmonary embolism only","C0034065;C0205171;C1720467",NULL,NULL,925
"cabg no","C0010055","C0010055","",389
"asas $nmbr$ $nmbr$","C0004057;C3853627",NULL,NULL,60
"post bronchodilator fev $nmbr$ mean sd l","C0444504;C2347634;C2348143;C2599594;C2699239;C3714541",NULL,NULL,2142
"hoehn yahr stage off n","C0205390;C1300072;C1306673",NULL,NULL,541
"severe hyperkalemia s","C0020461;C0205082;C4050465;C4050466;C4552983",NULL,NULL,313
"active comparatorb","C0205177;C3853793;C3888249",NULL,NULL,496
"permanently stopped study drug because of adverse events","C0041755;C0557651;C1272691;C2603343",NULL,NULL,1730
"budesonide $nmbr$ g n $nmbr$","C0054201;C0439267","C0054201","",1160
"pbo mtx n $nmbr$","C0025677;C0031962;C1417487","C0025677","",1408
"baseline lvef","C0168634;C0428772;C0488728;C1442488","C0018801;C0428772","",1273
"ldl to hdl cholesterol ratio mean sd","C0008377;C0428621;C0444504;C1171408;C2347634;C2348143;C2699239","C0023824","",1068
"fibrinogen","C0016006;C1167394;C2587184;C3540039","C0016006","",1142
"duration of diabetes mellitus y mean sd","C0011849;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"extreme tortuosity","C0205403;C0333076;C3641272;C4085555","","",-10
"ls t score $nmbr$ $nmbr$","C0023668;C0449820;C4050231",NULL,NULL,748
"moderate or severe renal disease b n","C0022646;C0022658;C0205081;C0205082;C1836348;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335","C1565489","",937
"other sglt $nmbr$ inhibitor","C1999216",NULL,NULL,812
"chd nonfatal mi fatal chd","C0280604;C1302234;C1705232;C3542407;C3810814",NULL,NULL,1682
"number of patients or mean sd","C0444504;C2347634;C2348143;C2360800;C2699239",NULL,NULL,1287
"a $nmbr$ $nmbr$ $nmbr$ median","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"uc duration y mean range","C0444504;C0449238;C1514721;C2347634;C2348143;C2348147;C2926735;C3542016",NULL,NULL,1589
"acetyl salicylic acid","C0004057","C0004057","",1366
"with diabetes","C0011847;C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"no previous myocardial infarction","C0027051;C0205156;C0428953;C1552607;C2926063;C3810814;C4552959",NULL,NULL,646
"adherence to study regimen no","C0040363;C0040808;C0041260;C0557651;C1510802;C1883351;C2603343;C2945654",NULL,NULL,431
"previous episode of heart failure","C0018801;C0018802;C0205156;C0332189;C1552607;C4554158",NULL,NULL,2395
"previous cardiovascular event","C0205156;C1320716;C1552607","C1320716","",414
"non hdl c mmol l mean sd","C0444504;C1518422;C1532563;C2347634;C2348143;C2699239;C3715113","C0023822","",821
"b myocardial infarction","C0027051;C0428953;C2926063;C3810814;C4552959",NULL,NULL,646
"p blockersubgroup","C0369773;C2603361",NULL,NULL,1823
"p value for adjusted hr","C0456081;C1709380",NULL,NULL,1580
"reversibility predicted fev $nmbr$","C0449261;C0681842;C1882327;C3714541","C0449261;C0231999","",1315
"i with mets n $nmbr$","C0021966;C0221138;C0812270;C1705694;C2939420",NULL,NULL,921
"vasp pri defined hpr patients","C0030705;C0034044;C0255567;C1337105;C1421428;C1704788;C1826843;C3539106;C3539761;C3539762",NULL,NULL,1200
"male sex no of patients","C0030705;C0086582",NULL,NULL,1035
"$nmbr$ $nmbr$ o $nmbr$ o $nmbr$ o","C0483204","","",-10
"use of statins","C0360714;C1524063","C0360714","",872
"traditional nsaid","C0003211;C0443324;C1548559;C3536840",NULL,NULL,2121
"nitrate","C0028125;C0699857;C3848573",NULL,NULL,537
"\mean sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"esrd or $nmbr$ dedine in gfr","C0017654;C0022661;C0035078;C1424601;C2316810","C0035078",";C1424601",1828
"clopidogrel $nmbr$ mg loading dose","C0024671;C0026410;C0070166;C0439269;C1708715;C1960952;C2346927;C3714444;C4086581;C4321396;C4521761","C0070166",";C0369286;C0033727;C4049621",217
"p value heart failure vs no heart failure","C0018801;C0018802;C1709380;C4554158",NULL,NULL,7
"haq di score $nmbr$ $nmbr$ mean sd","C0444504;C0449820;C2347634;C2348143;C2699239;C3826998;C4050231;C4321476",NULL,NULL,1665
"in clinic uask","C0002424;C0150312;C0332285;C0442592;C1707101",NULL,NULL,1552
"number of antihypertensive medications used n no antihypertensive therapy","C0003364;C0369718;C0441922;C0585941;C1273517;C1718138",";C0003364","",1579
"egfr ckd epi cystatin c ml min $nmbr$ $nmbr$ m $nmbr$","C0071744;C0162734;C0369637;C0439445;C0441923;C1413772;C1561643;C1739039;C3811844;C3812682;C4281721","C3811844;C0017654","",592
"pre procedure","C3272300","C3272300","",2241
"week $nmbr$ geometric mean cv","C0332174;C0439230;C2986759;C3538987;C4048877;C4318503",NULL,NULL,1012
"m f","C1306057","","",-10
"das $nmbr$ $nmbr$ esr $nmbr$ $nmbr$ t","C0051767;C0057671;C3811131","C1619634","",298
"normoalbuminuria uacr $nmbr$ mg g","C1300563",NULL,NULL,2315
"usa n $nmbr$ $nmbr$","C0041703",NULL,NULL,1550
"individual endpoints","C0027361;C0237401;C2349179",NULL,NULL,588
"normal renal function","C0232805",NULL,NULL,688
"ls mean change se","C0023668;C0036919;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952",NULL,NULL,567
"mean sd ldl c mg dl","C0439269;C0444504;C2347634;C2348143;C2699239",NULL,NULL,192
"budesonide no","C0054201","C0054201","",1160
"percutaneous transluminal coronary angioplasty","C2936173","C1532338","",1661
"fev $nmbr$ fvc at baseline randomization","C0034656;C0168634;C1442488;C3714541",NULL,NULL,1599
"stage $nmbr$ b $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441781;C0441923",NULL,NULL,542
"vildagliptin $nmbr$ mg qd","C0024671;C0026410;C0332173;C0439269;C1570906;C1960952;C2346927;C4321396;C4521761","C1570906","",2068
"patients without","C0030705",NULL,NULL,1035
"sco ita rojs dvt pe","C0022277;C0070939;C0149871;C1880476;C2926618;C2986561;C3899446;C4284304",NULL,NULL,1516
"qualifying risk factor no","C0035648;C1514624",NULL,NULL,175
"upper abdominal pain","C0232492","C0232492","",2172
"gusto severe bleed","C0019080;C0205082;C4050465;C4050466",NULL,NULL,707
"racial category","C0034510;C0683312;C1706779;C3669213;C3853635;C3889287",NULL,NULL,562
"stage $nmbr$ cockcroft gault","C0205390;C1300072;C1306673",NULL,NULL,541
"ct","C0007673;C3540513;C3813556;C3888140",NULL,NULL,257
"other osteoporosis medication","C0013227;C0029456;C3244316;C4284232;C4554622",NULL,NULL,740
"number of concomitant aedsc","C0237753;C0449788;C0521115",NULL,NULL,1556
"factor v leiden or prothrombin mutation","C0380964;C0584960;C1414509;C1610621;C3542419",NULL,NULL,2019
"tiotropium $nmbr$ $nmbr$ pg","C0030827;C0072225;C0213771;C1266240","C0213771","",1372
"event total","C0439175;C0439810;C0441471;C4019010",NULL,NULL,412
"risedronate n n","C0246719",NULL,NULL,1573
"gold group","C0018026;C0441833;C0687744;C1257890;C1304897;C1519504;C1705428;C1705429","C0024117;C0521117","",213
"mean sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"k mmol l","C0597277;C1532563;C1708601","C0302353","",1959
"favors favors lisinopril chlorthalidone","C0008294;C0065374;C0309049","C0008294","",70
"treated vessel s","C0005847;C1522326",NULL,NULL,743
"cardiomyopathy","C0878544",NULL,NULL,816
"triglycerides mean mg dl sd","C0041004;C0439269;C0444504;C2347634;C2348143;C2699239","C0041004","",368
"history of alcohol use","C0551571;C0552479",";C0001962","",1053
"alteplase group n $nmbr$","C0032143;C0441848",NULL,NULL,1594
"premixed insulin only","C0021641;C0205171;C1533581;C1579433;C1720467;C3714501",NULL,NULL,157
"swollen joints $nmbr$ n","C0152031",";C0451521","",1140
"bmi median sd kg m $nmbr$","C0549183;C0578022;C0876920;C1532718;C2347635;C2348144;C2699239;C2939193","C1305855","",1891
"apixaban $nmbr$ $nmbr$ mg","C0024671;C0026410;C0439269;C1831808;C1960952;C2346927;C4321396;C4521761","C1831808","",1224
"baseline gfr $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$ n","C0017654;C0168634;C0369637;C0439445;C0441923;C1424601;C1442488","C3811844;C0017654","",592
"any vascular disease","C0042373",NULL,NULL,102
"esam ng ml","C0439275;C1424976",NULL,NULL,204
"ifrerence vs placebo $nmbr$ cl","C0032042;C0596019;C1696465;C1706408","C0032042","",28
"active cancer at randomization n","C0006826;C0034656;C0205177;C0998265;C1306459;C3853793;C3888249","C0006826","",1819
"angiotensin converting enzyme inhibitor angiotensin receptor blocker","C0003015;C0597357;C2757044;C3536837;C4541021","C0003015","",811
"self rated health status","C0018759;C0036588;C0871208;C1551994",NULL,NULL,325
"pack years","C1277691","C1277691","",1297
"umec $nmbr$ $nmbr$ mcg n $nmbr$","C0439211;C3463985",NULL,NULL,199
"fixed triple n $nmbr$","C0205174;C0443218;C2827483;C3714578",NULL,NULL,1201
"intensity of statin therapy","C0522510;C1278454","C0360714","",872
"low trauma fracture since age $nmbr$ n","C0001779;C0521170","C0001779","",480
"prior carotid intervention","C0184661;C0332152;C0741968;C0886296;C1273869;C2826257",NULL,NULL,290
"six minute walk distance m","C0012751;C0369637;C0441923;C3900196",NULL,NULL,923
"temporary discontinuation of study drug","C0013175;C0205374;C0457454;C1444662;C1548539;C3245481;C4552847",NULL,NULL,1731
"controls n $nmbr$","C0243148;C0369718;C0441922;C1550141;C1882979;C2587213;C3274648;C4553389",NULL,NULL,675
"history of mi n","C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C3810814",NULL,NULL,832
"pasi response by baseline weight no total no pasi $nmbr$","C0439175;C0439810;C0871261;C1303013;C1704632;C1706817;C2911692;C4528685",NULL,NULL,726
"dabigatran $nmbr$ mg bid events n y","C0024671;C0026410;C0439269;C0441471;C1960952;C2346927;C2348066;C3541888;C4321396;C4521761",NULL,NULL,775
"p value $nmbr$ vs $nmbr$ years","C0439234;C1709380",NULL,NULL,7
"ics users","C0815320;C1706077;C4551720","C3540778","",2182
"bl bmioo kg m","C0005918;C0006413;C1532718;C1552663;C2827109",NULL,NULL,655
"apo b mean sd","C0003593;C0444504;C2347634;C2348143;C2699239;C3252643",NULL,NULL,1910
"asthma duration sd years","C0004096;C0439234;C0449238;C2699239;C2926735;C2984299",NULL,NULL,1099
"pain mm","C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4330985;C4553004;C4554132;C4554674",NULL,NULL,297
"baseline ckd epi","C0162734;C0168634;C1442488;C1561643;C4281721","C1561643","",967
"no n $nmbr$","C0369718;C0441922",NULL,NULL,445
"pah mctd ctd other","C0026272;C0030123;C1335071;C1442905;C3203102;C4284467",NULL,NULL,1663
"cangrelor clopidogrel no of events total no","C0070166;C0439175;C0439810;C0441471;C1121991;C3541888","C1121991","",1247
"access site","C0589360",NULL,NULL,493
"indeterminate nfs $nmbr$ $nmbr$ nfs $nmbr$ $nmbr$ n $nmbr$","C0205258;C1513839",NULL,NULL,1086
"plp c mean sd mg dl","C0034266;C0439269;C0444504;C1175541;C1257874;C1705623;C2347634;C2348143;C2699239",NULL,NULL,37
"mean body weight sd kg","C0005910;C0022718;C0439209;C0444504;C1305866;C2347634;C2348143;C2699239;C4054209",NULL,NULL,2326
"chd primary outcome","C0205225;C0280604;C0439612;C0439631;C1274040;C3542407",NULL,NULL,2339
"dose of aspirin","C4696290","C0004057","",1366
"hb decrease $nmbr$ g dl","C0019046;C0392756;C0439267;C0547047;C3642216;C3843510",NULL,NULL,1486
"glycosylated hemoglobin","C0017853","","",1176
"all cause death stroke see","C0011065;C0015127;C0038454;C0042789;C1306577;C1524003;C1947903;C4082313;C4552775;C4554100",NULL,NULL,1855
"pasi mean sd","C0444504;C2347634;C2348143;C2699239;C4528685",NULL,NULL,37
"etoricoxib group n $nmbr$ $nmbr$","C0441848;C0972314","C0972314","",1130
"use of beta blockers","C0001645;C1524063","C0001645","",959
"change in sbp","C0085805;C0392747;C0443172;C1705241;C4319952",NULL,NULL,607
"patients with enthesitis lei $nmbr$","C0023401;C0030705;C0428209;C1282952",NULL,NULL,526
"heart failure no total no","C0018801;C0018802;C0439175;C0439810;C4554158","C0018801",";C0168634;C1524003",12
"local eosinophil count cells l median range","C0200638;C0205276;C0347983;C0549183;C0750879;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016","C0750879","",848
"characteristics of the index ml","C0439526;C0600653;C0918012;C1521970;C1552854;C1637833;C1705224;C2986546;C3887665",NULL,NULL,300
"placebo mtx","C0025677;C0032042;C1417487;C1696465;C1706408","C0032042","",28
"diabetic subjects n $nmbr$","C0241863;C0681850;C1550501;C1706203;C2349001;C2697811",NULL,NULL,1655
"blood pressure lowering treatment","C0005823;C0033095;C0039798;C0087111;C0441994;C0460139;C0596197;C1271104;C1272641;C1306345;C1522326;C1533734;C1705169;C2003888;C3538994;C3887704;C4284008","C0005823","",15
"full analysis set","C0002778;C0036849;C0443225;C0936012;C1442518;C1524024;C1705195",NULL,NULL,183
"current atrial fibrillation or flutter on ecg","C0004238;C0016385;C0344434;C0521116;C1623258;C1705970;C1963067;C2242390",";C0004238","",1009
"only coronary artery disease","C0010054;C0010068;C0205171;C1720467;C1956346","C0010068;C1956346",";C0026410;C1710701",226
"hormonal therapy no","C0279025",NULL,NULL,558
"systolic blood pressure mm hg mean sd","C0039155;C0428886;C0439475;C0444504;C0488055;C0871470;C1306620;C2347634;C2348143;C2699239","C0005823","",1469
"ipss qol","C0518214;C1019118;C1998280;C2827405;C3811063","C0034380","",1116
"hypertension requiring medical treatment","C0020538;C0679624;C1963138",NULL,NULL,725
"peri or postmenopausal","C0232970;C0347985","C0232970","",1041
"major cardiovascular","C0007226;C0205082;C0205164;C3887460;C4318856;C4521762","C1320716;C0205082","",2077
"$nmbr$ $nmbr$ yr","C0439234",NULL,NULL,1099
"age y meantsd","C0001779","C0001779","",480
"baseline statin usec","C0168634;C0360714;C0439224;C1442488","C0360714","",872
"no chd eze simva","C0280604;C3542407",NULL,NULL,970
"angiographic findings","C0002978;C2607943;C2926606;C3539655",NULL,NULL,1723
"linagliptin n $nmbr$","C2746078","C2746078","",1185
"first co primary","C0205225;C0205435;C0439612;C0439631;C1279901;C3245499",NULL,NULL,2339
"pre menopausal without hormone replacement","C0206158;C0282402",NULL,NULL,549
"m being","C0369637;C0441923",NULL,NULL,923
"previous oral glucose lowering agents of patients","C0205156;C0441994;C0600419;C1552607;C1955477;C2003888",NULL,NULL,14
"history","C0019664;C0019665;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"controlled acq $nmbr$ $nmbr$ $nmbr$","C2587213;C2911690;C2919686",NULL,NULL,675
"drugs used in diabetes","C0011847;C0011849;C0013227;C1273517;C3687832","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"no patients","C0030705",NULL,NULL,1035
"simvastatin n $nmbr$","C0074554","C0074554","",1840
"received antihypertensive within last $nmbr$ days n","C0003364;C0439228;C1514756",";C0003364","",1579
"qrs $nmbr$ ms n","C2349943;C3539704;C3713294",NULL,NULL,126
"presence of angioedema at baseline","C0002994;C0150312;C0168634;C0392148;C1442488;C3854307",NULL,NULL,2366
"fracture during follow up","C0016658;C0589120;C1522577;C1704685;C3274571",NULL,NULL,1584
"non black participants","C0005680;C0027567;C0085756;C0439541;C0679646;C1518422","C0005680",";C1706779",188
"parameter statistics","C0681933",NULL,NULL,181
"diuretic therapy","C0948575",NULL,NULL,556
"bonferroni adjusted p value d vs a","C1709380;C1879894",NULL,NULL,7
"weight in kg median iqr","C0005910;C0022718;C0043100;C0439209;C0549183;C0876920;C1305866;C1705104;C2347635;C2348144;C2939193;C4054209","C0005910","",1250
"msfc timed $nmbr$ foot walk test","C0016504;C0347981;C0392761;C2346504;C2348613;C2348704;C4277740",NULL,NULL,249
"week $nmbr$ mayo endoscopy subscorea","C0014245;C0332174;C0439230;C0454788;C1077578",NULL,NULL,425
"ezetimibe simvastatin group","C0441833;C0687744;C1257890;C1519504;C1532737;C1705428;C1705429",NULL,NULL,1526
"triglycerides $nmbr$ $nmbr$ mmol l","C0041004;C1532563","C0041004","",368
"prior cardiovascular event no j","C0332152;C1320716;C2826257",NULL,NULL,2378
"exacerbations requiring oral steroids antibiotics past year","C0003232;C0003237;C0038317;C0442027;C3540704;C3540705;C3540706;C3540707;C3540708;C3540709;C3540710;C4086268;C4086728;C4521986",NULL,NULL,1654
"itch nrs $nmbr$ $nmbr$ at $nmbr$","C0033774;C1422257;C2240043;C4050142","C0033774;C4050142","",1362
"diabetes mellitus","C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"no with visit","C0545082;C1512346;C2826704",NULL,NULL,276
"did not meet atopy and ige $nmbr$ $nmbr$ ku lcriteriaa n $nmbr$ $nmbr$","C0022804;C0392707;C1337080;C1518422;C1532717;C1550543;C1881335;C3539705",NULL,NULL,1729
"former or never diabetes","C0011847;C0011849;C0205156;C0750523;C2003901",NULL,NULL,13
"clinical efficacy at week $nmbr$","C0087113;C0332174;C0439230",NULL,NULL,1012
"airflow reversibility no","C0231999;C0449261","C0449261;C0231999","",1315
"mtx $nmbr$ mg week","C0024671;C0025677;C0026410;C0332174;C0439230;C0439269;C1417487;C1960952;C2346927;C4321396;C4521761","C0025677","",716
"eosinophils","C0014467;C0200638","C0014467","",849
"patients with microalbuminuria at baseline","C0030705;C0168634;C0730345;C1442488","C0033687","",376
"heart failure hospitalized or fatal","C0018801;C0018802;C0701159;C1302234;C1705232;C4554158","C0018801",";C0168634;C1524003",12
"type of event","C1561488",NULL,NULL,604
"with ics n","C0815320;C4551720","C3540778","",2182
"insulin naive n","C0021641;C1533581;C1579433;C3714501",NULL,NULL,157
"length of stay randomization to discharge h","C0012621;C0023303;C0030685;C0033727;C0034656;C0040363;C0041260;C0369286;C0441932;C0564385;C1883351;C2926602;C4528284",NULL,NULL,431
"mean number of antihypertensive medications at $nmbr$ year","C0003364;C0439234;C0439508;C0444504;C1718138;C2347634;C2348143",";C0003364","",1579
"third primary change in updrs score wk wk $nmbr$ $nmbr$","C0205225;C0205437;C0332174;C0392747;C0439230;C0439612;C0439631;C0443172;C0449820;C1705241;C3639721;C4050231;C4319952",NULL,NULL,229
"demographic characteristics mean sd unless otherwise stated","C0444504;C0683970;C1301808;C1442792;C2347634;C2348143;C2699239",NULL,NULL,583
"atorvastatin monotherapy n $nmbr$","C0286651","C0286651","",885
"fastng plasma glucose median","C0202042;C0455280;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,1896
"history of coronary artery disease","C1881055",NULL,NULL,786
"minor bleed","C0019080;C0026193;C0205165",NULL,NULL,1474
"tg mg dl median sd","C0337445;C0439269;C0549183;C0876920;C2347635;C2348144;C2699239;C2939193","C0041004","",368
"age years sd","C1510829;C2699239","C1510829","",481
"centrilobular emphysema","C0221227",NULL,NULL,1672
"baseline of induction","C0168634;C0205263;C0857127;C1442488",NULL,NULL,625
"any thiazolidinedione","C0289779;C1257987;C3537039","C1257987",";C0289779;C1527178;C1705938;C1552866;C2700399;C0168634",72
"statins ezetimibe","C0360714;C1142985","C0360714;C1142985","",1862
"duration of diabetes mellitus","C0011849;C0449238;C2926735","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"octave induction $nmbr$ and $nmbr$","C0205263;C0857127",NULL,NULL,158
"baseline pava","C0135567;C0168634;C1442488",NULL,NULL,625
"aspirin group","C0004057;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429","C0004057","",1366
"crp mg dl","C0439269;C3890735;C4048285","C0006560","",286
"hba $nmbr$ ca mean sd","C0019016;C0444504;C1825777;C2347634;C2348143;C2699239;C3538758;C3887642",NULL,NULL,37
"clean n a","C1947930",NULL,NULL,37
"no in trial stroke n $nmbr$ $nmbr$","C0008976;C0038454;C0150312;C0332285;C1707101;C4554100",NULL,NULL,1020
"participants taking insulin","C0021641;C0679646;C1515187;C1533581;C1579433;C3714501",NULL,NULL,157
"treated for hypertension","C0020538;C1522326;C1963138","C0020538","",1364
"angiographic data","C0002978;C1511726;C3245479;C3714741","C1511726;C0002978","",2231
"diabetes duration years mean sd","C0011847;C0011849;C0439234;C0444504;C0449238;C2347634;C2348143;C2699239;C2926735","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"postmenopausal and current ht","C0018510;C0232970;C0521116;C0677607;C1705970","C0282402","",1043
"b i","C0021966;C0221138",NULL,NULL,1021
"cat total score","C0007450;C0325090;C0524517;C1443200;C2964552;C3665481;C4050461;C4284282",NULL,NULL,255
"ldl c hdl c ratio mean sd","C0428621;C0444504;C2347634;C2348143;C2699239","C0023824","",1068
"iii fev $nmbr$ $nmbr$ $nmbr$ predicted","C0439070;C0681842;C1705160;C1882327;C3714541",NULL,NULL,1599
"baseline dbp mean sd mm hg","C0168634;C0439475;C0444504;C0536221;C1442488;C2347634;C2348143;C2699239;C3813197;C4281799",NULL,NULL,605
"measurements","C0242485",NULL,NULL,490
"time from parkinson s disease diagnosis in months mean sd","C0011900;C0030567;C0040223;C0439231;C0444504;C1704338;C1704656;C2347634;C2348143;C2699239;C3541383",NULL,NULL,1287
"myocardial infarction at presentation n $nmbr$","C0027051;C0428953;C0449450;C2926063;C3810814;C4552959",NULL,NULL,646
"baseline cdai mean sd","C0168634;C0444504;C0683448;C1413248;C1442488;C2347634;C2348143;C2699239;C3273706",NULL,NULL,697
"ejection fraction percent sd","C0439165;C0489482;C2699239;C2700378","C2700378","",887
"ls mean change from baseline ml se a","C0023668;C0036919;C0168634;C0392747;C0439526;C0443172;C0444504;C1442488;C1705224;C1705241;C2347634;C2348143;C3887665;C4319952",NULL,NULL,567
"aspirin antiplatelet medication","C0004057;C0013227;C0085826;C3244316;C4284232","","",1191
"raas inhibitor use","C0042153;C0457083;C1947944;C1999216",NULL,NULL,812
"intention to treat without st segment elevation myocardial infarction","C0040363;C0041260;C0087111;C0162425;C1283828;C1292734;C1522326;C1536220;C1883351",NULL,NULL,431
"hdl cholesterol mmol l men mean sd","C0023822;C0025266;C0392885;C0444504;C1532563;C2347634;C2348143;C2699239","C0023822","",821
"final timi flow grade $nmbr$","C0205088;C0441800;C0919553;C1546485;C3244287;C3272266;C3853528",NULL,NULL,531
"fvc $nmbr$ predicted","C0681842;C1882327;C3714541",NULL,NULL,1599
"baseline prednisone or oral prednisone equivalent daily dose","C0032952;C0168634;C0205163;C0439185;C0442027;C1442488;C2348070;C4521986",NULL,NULL,1746
"diabetes","C0011847;C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"itt population n","C0032659;C1257890",NULL,NULL,900
"egfrmdrd ml min $nmbr$ $nmbr$ m $nmbr$ bsa","C0369637;C0439445;C0441923","C3811844;C0017654","",592
"event rate per $nmbr$","C0441471;C0871208;C1521828;C4019010",NULL,NULL,2007
"patients with no prior cvd primary","C0007222;C0030705;C0205225;C0332152;C0439612;C0439631;C2826257","C0007222","",1790
"haq di number","C0237753;C0449788;C3826998;C4321476",NULL,NULL,1665
"$nmbr$ vessels or left main","C0005847;C0205091;C0205225;C0443246;C1542147;C1552822",NULL,NULL,743
"brv overalla n $nmbr$","C0155502",NULL,NULL,1743
"prior history of mi or ischaemic stroke","C0019664;C0019665;C0262512;C0262926;C0332152;C0948008;C1705255;C2004062;C2826257;C3810814",NULL,NULL,516
"body mass index $","C0005893;C0578022;C1305855","C1305855","",1734
"vorapaxar placebo $nmbr$ yr km rate","C0032042;C0439234;C0871208;C1521828;C1696465;C1706408;C2974521;C3887676",NULL,NULL,1099
"mean sd of predicted normal fev $nmbr$","C0444504;C0520835;C0681842;C1882327;C2347634;C2348143;C2699239","C0024119","",288
"egfr and albuminuria","C0001925;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"poor tried previous glucocorticoid non laba","C0017710;C0032854;C0205156;C0542537;C1518422;C1552607;C2700379","C3540778","",2182
"total cataract extraction","C0007389;C0185115;C0439175;C0439810;C0684295;C3665439",";C0086543","",1290
"ngml total mean ipss score","C0439175;C0439810;C0444504;C1019118;C1998280;C2347634;C2348143;C2827405;C2964552;C3533236;C3811063","C1998280",";C1019118;C3811063;C4050465;C4050466;C4049706;C0168634;C1705273;C1880519;C3853603",124
"aspirin use","C0004057;C0042153;C0457083;C1947944","C0004057","",1366
"non white","C0007457;C0043157;C0220938;C1518422","C0034510;C1518422;C0043157","",1401
"ics use at screening","C0042153;C0220908;C0220909;C0457083;C0815320;C1698960;C1710031;C1710032;C1710477;C1947944;C2348164;C4551720","C3540778","",2182
"ramus","C3538818",NULL,NULL,2013
"patients with event n","C0030705;C0441471;C4019010",NULL,NULL,1035
"pressure mm hg","C0033095;C0439475;C0460139;C1306345;C4284008","C0439475","",2239
"patients receiving lcz no","C0030705;C1514756",NULL,NULL,964
"copd exacerbation no","C0740304","C0740304","",891
"$nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923","C3811844;C0017654","",307
"cv risk factor no","C0035648;C3538987;C4048877;C4318503",NULL,NULL,1777
"non hdlc concentration","C0086045;C1446561;C1518422;C1704429;C3827302","C0023822","",821
"ascot lla","C0718674",NULL,NULL,1266
"symptom onset to start of reperfusion treatment tenecteplase or arterial sheath insertion","C0003842;C0021107;C0035124;C0039798;C0040363;C0041260;C0087111;C0221464;C0227952;C0439659;C0441587;C0684253;C0872913;C1512796;C1522326;C1533734;C1705169;C1883351;C1883719;C3538994;C3887704;C4086878","C0872913","",417
"history of osteoporotic fracture n a","C4075937",NULL,NULL,1494
"no beta blocker","C0001645","C0001645","",959
"$nmbr$ prior tnf antagonist failure n b","C0231174;C0231491;C0332152;C0680095;C2826257;C3887647",NULL,NULL,2372
"observed","C1441672",NULL,NULL,115
"middle east africa or asia pacific","C0001737;C0001741;C0003980;C0026068;C0444598;C0549183;C1552826",NULL,NULL,48
"extracranial carotid stenosis n","C0007282;C0580586","C0007282","",2196
"comorbidity no","C0009488",NULL,NULL,765
"ns cardiac cisease","C0018787;C0038944;C1112705;C1522601;C1705982",NULL,NULL,129
"use of oral glucocorticoids","C0017710;C0442027;C1524063;C3540777;C3540778;C4521986","C0017710","",1348
"in patients with a history of chronic angina who have presented with an acute","C0002962;C0205178;C0205191;C0449450;C0679831",NULL,NULL,1701
"never rarely","C0522498;C2003901",NULL,NULL,547
"ii $nmbr$ i $nmbr$ $nmbr$","C0021966;C0221138;C1710602;C4082587",NULL,NULL,523
"$nmbr$ yrs or more","C0205172",NULL,NULL,1539
"open","C0175566",NULL,NULL,1322
"median iqr h","C0033727;C0369286;C0441932;C0549183;C0564385;C0876920;C2347635;C2348144;C2939193;C4528284",NULL,NULL,635
"asthma symptoms in the past $nmbr$ weeks","C0004096;C0683368;C1457887;C2984299;C2987125",NULL,NULL,613
"associated with corrected","C0205202;C0332281",NULL,NULL,876
"sd standard deviation bmi body mass index ed erectile","C0030847;C0871420;C1305855;C2699239;C3538926",NULL,NULL,411
"c $nmbr$ e $nmbr$ fab bolus","C1186706;C1511237;C1705509;C3812160",NULL,NULL,632
"randomized to canakinumab $nmbr$ mg","C0024671;C0026410;C0034656;C0040363;C0041260;C0439269;C1883351;C1960952;C2346927;C2718773;C3815594;C4321396;C4521761",NULL,NULL,192
"lumbar","C0024090",NULL,NULL,1558
"immobilization no","C0020944;C4048292",NULL,NULL,1707
"previous ml or abnormal angiogram","C0002978;C0205156;C0205161;C0439526;C1548816;C1552607;C1705224;C2347472;C2699333;C3887665;C3891555;C4255126",NULL,NULL,686
"sites","C0205145",NULL,NULL,1193
"amiodarone use at baseline yes $nmbr$ $nmbr$","C0002598;C0042153;C0168634;C0457083;C1442488;C1549445;C1705108;C1710701;C1947944",NULL,NULL,147
"baseline ste in worst lead mm","C0023175;C0168634;C0181586;C1420459;C1442488;C1442948;C1522166;C1522538;C2348269;C3275067;C3811127;C4330985;C4554674",NULL,NULL,297
"placebo symptom days a week","C0032042;C0332174;C0439228;C0439230;C1457887;C1696465;C1706408;C3854129",NULL,NULL,613
"prevalent cvd","C0007222;C0033105;C0220900",NULL,NULL,721
"baseline egfr ml min per $nmbr$ $nmbr$ m","C0168634;C0369637;C0439445;C0441923;C1442488;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"difference in ls means $nmbr$ ci $nmbr$","C0008107;C0023668;C1704970;C1705241;C1705242;C3259781",NULL,NULL,519
"lsm $nmbr$ ci","C0008107;C3259781",NULL,NULL,519
"qol","C0518214","C0034380","",1116
"ecg changes t","C0392747;C0443172;C1623258;C1705241;C2603360;C4319952",NULL,NULL,767
"placebo group n $nmbr$ j","C0032042;C0441844;C1696465;C1706408","C0032042","",28
"beta blockers","C0001645","C0001645","",959
"aspirin and thienopyridine therapy","C0004057;C0039798;C0087111;C1120149;C1363945","C1120149",";C0039798;C0087111;C1363945;C1709561;C1947944",73
"unadjusted hr $nmbr$ ci a","C0008107;C1439367;C3259781",NULL,NULL,1581
"total body without head","C0018670;C0229960;C1706305",NULL,NULL,1685
"ml with st segment elevation","C0439526;C0520886;C1705224;C3887665","C3810814","",894
"alogliptin","C1958126","C1958126","",1183
"no smo king","C1311076;C1364142;C1423784","C0037369","",420
"tiotropium $nmbr$ mg n $nmbr$","C0024671;C0026410;C0213771;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2300
"mental component summary","C0229992;C0449432;C1552616;C1705248;C1706244",NULL,NULL,350
"total hipc","C0439175;C0439810",NULL,NULL,508
"sample statistics","C2348149",NULL,NULL,181
"oad plus insulin","C0021641;C1533581;C1579433;C3714501",NULL,NULL,157
"corticosteroid or azathioprine $nmbr$ mercaptopurine","C0000618;C0001617;C0004482;C3536709",NULL,NULL,56
"mean age years s d","C0444504;C1510829;C2347634;C2348143","C1510829","",481
"left main disease n","C0012634;C0205091;C0205225;C0443246;C1542147;C1552822",NULL,NULL,42
"treatment period index dvt event","C0039798;C0087111;C0149871;C0439531;C0441471;C0600653;C0918012;C1522326;C1533734;C1552854;C1637833;C1705169;C1948053;C2926618;C2986546;C3538994;C3887704;C3899446;C4019010","C0149871","",252
"crp mg dl median","C0439269;C0549183;C0876920;C2347635;C2348144;C2939193;C3890735;C4048285","C0006560","",286
"canrenone n z $nmbr$","C0006882",NULL,NULL,1759
"mean arterial pressure baseline","C0168634;C0428886;C1442488",NULL,NULL,625
"sex male n","C0086582","C0086582","",1276
"gastrointestinal bleeding","C0017181",NULL,NULL,782
"tnf failurea","C1448177",NULL,NULL,362
"a $nmbr$ $nmbr$ n $nmbr$","C0369718;C0441922",NULL,NULL,1553
"post bronchodilator fevx l","C2599594",NULL,NULL,680
"$nmbr$ or $nmbr$ d mo","C0026544;C0073187;C0332173;C0332177;C4484261",NULL,NULL,1476
"candesartan $nmbr$ $nmbr$","C0717550","","",1208
"australia and new zealand","C0004340;C0027978;C0324547","C0027978",";C0324547",189
"younger subjects aged $nmbr$ years","C0001779;C0001792;C0332239;C0439234;C0681850;C1550501;C1706203;C1999167;C2349001;C2697811",NULL,NULL,148
"baseline upgr mg mmole n $nmbr$ $nmbr$ $nmbr$","C0168634;C0567349;C1442488;C2348885",NULL,NULL,625
"median q $nmbr$ q $nmbr$","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"methotrexate alone","C0025677;C0205171;C0439044;C0679994","C0025677","",716
"type of des at index procedure","C0011702;C0184661;C0332307;C0600653;C0918012;C1547052;C1552854;C1637833;C2700391;C2986546;C3274430;C3539779;C4551552",NULL,NULL,603
"op concomitant medications","C0013227;C0521115;C0802604;C2598133;C4284232",NULL,NULL,366
"egfr from the mdrd equation sd ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C0552449;C1739039;C2699239;C3811844;C3812682;C3839656","C3811844;C0017654","",592
"$nmbr$ months mean sd","C0439231;C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"percent overall work impairment due to asthma","C0004096;C0043227;C0221099;C0282416;C0439165;C0678226;C0684336;C1561607;C2984299",NULL,NULL,694
"crp mg dl per unit","C0024671;C0026410;C0439148;C0439269;C0439453;C1509845;C1519795;C1532632;C1638407;C1704753;C1880519;C1960952;C2346927;C3642216;C3853603;C3890735;C4048285;C4321396;C4521761","C0006560","",286
"infarction yr history of congestive heart failure","C0021308;C0439234;C0455531;C0742742","C0018801",";C0168634;C1524003",12
"hemoglobin a c","C0019020;C3889898","","",1176
"ace inhibitors arb","C0003015;C3888198",NULL,NULL,44
"lue for interaction","C1704675",NULL,NULL,888
"duration of disease y","C0872146","C0449238;C0872146","",903
"current cigarette use","C0521116;C0694535;C1705970","C0037369","",420
"continued thienopyridine n $nmbr$ subjects","C0549178;C0681850;C1120149;C1550501;C1706203;C2349001;C2697811",NULL,NULL,1561
"aminosalicylates","C0368663","C0368663","",1691
"non tiotropium","C0213771;C1518422","C0213771","",1372
"south africa south america","C0001737;C0002454;C0037712;C0037713","C0037713","",580
"time since diagnosis of diabetes n","C0011847;C0011849;C0011900;C0040223;C1704338;C1704656;C3541383","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"data are presented as mean sd n $nmbr$ for ldl cholesterol n $nmbr$ for ldl cholesterol signi cantly different from baseline values by repeated measures analysis of variance p $nmbr$ $nmbr$ signi cantly different from baseline values by repeated measures analysis of variance p $nmbr$ $nmbr$ signi cantly different from baseline values by repeated measures analysis of variance p $nmbr$ $nmbr$","C0002778;C0002780;C0023824;C0042295;C0168634;C0202117;C0369718;C0441922;C0444504;C0449450;C0565965;C0871881;C0936012;C1442488;C1511726;C1524024;C1705242;C1711260;C2347634;C2348143;C2348152;C2699239;C3245479;C3714741","","",-10
"no ics","C0815320;C4551720","C3540778","",2182
"hdl male","C0086582;C1706180;C1706428;C1706429;C3715113","C0023822","",821
"topical prescription","C0033080;C0332237;C1521941",NULL,NULL,1125
"after bronchodilation","C1371299;C3537072",NULL,NULL,681
"$nmbr$ $nmbr$ mmol l","C1532563",NULL,NULL,670
"eosinoohil count","C0750480;C1705566","C0014467","",849
"combined fatal nonfatal outcomes","C0205195;C0206277",NULL,NULL,997
"chads score n","C0007928;C0369718;C0441922;C0449820;C1413373;C4050231","","",2128
"no concomitant immunosuppressive and or prior anti tnf use","C0021081;C0042153;C0332152;C0457083;C0521115;C1448177;C1947944;C2826257","C0021081","",1424
"history of tnf antagonist treatment failure no","C0019664;C0019665;C0162643;C0231491;C0235828;C0262512;C0262926;C0521983;C1448177;C1547544;C1705255;C2004062",NULL,NULL,362
"initial heparin treatment duration on or after randomization","C0019134;C0034656;C0205265;C0444921;C0770546;C1279901;C1555582;C1705685;C3259042","C0019134","",863
"history of ischemic stroke","C0019664;C0019665;C0262512;C0262926;C0948008;C1705255;C2004062",NULL,NULL,832
"no of patients total no","C0030705;C0439175;C0439810",NULL,NULL,508
"noncardiovascular death","C0011065;C1306577;C4082313;C4552775",NULL,NULL,645
"diet and exercise","C0012155;C0012159;C0015259;C1519433;C1522704;C2983588;C3668949","C0012155","",1199
"nyha class not reported","C0684224;C0700287;C1518422;C1882083;C4319718","C0018802;C1882083","",453
"copd placebo n $nmbr$","C0024117;C0032042;C1412502;C1696465;C1706408;C3714496","C0032042","",28
"la grade a n f","C0016327;C0023031;C0023749;C0230347;C0369718;C0441800;C0441922;C0919553;C2346906;C3244287;C4553351",NULL,NULL,683
"fluindione no","C0117899",NULL,NULL,88
"sex women men","C0009253;C0025266;C0036864;C0043210;C0079399;C0804628;C1314687;C1522384","","",306
"tender joint count $nmbr$ $nmbr$ joints mean sd","C0444504;C0451530;C2347634;C2348143;C2699239","C0451530","",1139
"previous bowel resection performed no of patients","C0030705;C0205156;C0741614;C0884358;C1552607",NULL,NULL,1035
"anti hypertensive","C0003364",";C0003364","",1579
"necrotic core","C0027540;C0444669;C1167518;C1706352;C1882467;C3274653",NULL,NULL,1548
"mean change from baseline","C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C4319952",NULL,NULL,625
"positive stress test","C0015260;C0439178;C1446409;C1514241;C2825490;C3494508;C3812269",NULL,NULL,1163
"fev $nmbr$ mean l","C0444504;C2347634;C2348143;C3714541",NULL,NULL,1599
"mean sd age","C0001779;C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"untreated","C0332155",NULL,NULL,551
"dyslipidaemia and hypertension n","C0020538;C0242339;C1963138","C0242339","",1770
"outcome n","C1274040",NULL,NULL,1602
"peripheral arterial disease","C0085096;C1704436","C0085096","",933
"body mass index no $","C0005893;C0578022;C1305855","C1305855","",1734
"fev $nmbr$ predicted at baseline","C0168634;C0681842;C1442488;C1882327;C3714541",NULL,NULL,1599
"quality of life","C0034380;C0518214","C0034380","",1116
"biomarker high periostin $nmbr$ ng ml or blood eosinophils $nmbr$ cells per pl na","C0005516;C0005773;C0007584;C0007634;C0014467;C0200638;C0205250;C0219433;C0439275;C0597484;C1272460;C1299351;C1424662;C1546968;C1879645;C2700149;C3812270;C3887512;C3889660;C3897966;C4049765;C4049872;C4321237;C4522209;C4552882",NULL,NULL,834
"median interquartile range","C0549183;C0876920;C1711350;C2347635;C2348144;C2939193",NULL,NULL,635
"charm","C0849759",NULL,NULL,968
"score of $nmbr$ $nmbr$","C0449820;C4050231",NULL,NULL,748
"baseline crp category mg l","C0168634;C0439268;C0683312;C1442488;C3889287;C3890735;C4048285","C0006560","",286
"estimated glomerular filtration rate ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C3811844","C3811844;C0017654","",592
"medication no","C0013227;C3244316;C4284232",NULL,NULL,2263
"pulse rate bpm","C0232117","C0018810","",1105
"agi","C1299007","","",-10
"$nmbr$ coronary stenosis","C0242231","C0205042","",228
"benazepril hydrochlorothiazide group n $nmbr$","C0441848;C0717481",NULL,NULL,1638
"mayo clinic score","C0002424;C0442592;C0449820;C0454788;C1077578;C4050231",NULL,NULL,425
"hispanic non hispanic","C0086409;C1518422","C0086409","",865
"symptoms of atrial fibrillation in the $nmbr$ months before randomiza","C0004238;C0344434;C0439231;C0683368;C1457887;C1963067","C0004238","",90
"no of previous ciu csu medications","C0013227;C0205156;C0578870;C0802604;C1552607;C2598133;C4284232",NULL,NULL,366
"currentother notpredefined medical conditions","C0012634;C0199168;C0205476;C0348080;C1705253;C3864998",NULL,NULL,1710
"total population","C3258257",NULL,NULL,510
"previous coronary revascularization no","C0205156;C0877341;C1552607","C0877341",";C4049621;C1552607",223
"bmi $nmbr$ n","C0578022",NULL,NULL,1735
"clinical characteristics","C0683325",NULL,NULL,789
"$nmbr$ mg n $nmbr$ $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"subacute $nmbr$ $nmbr$ days","C0205365;C0439228",NULL,NULL,1621
"formoterol $nmbr$ gg n $nmbr$","C0017454;C0018370;C0060657","C0060657;C0073992","",1508
"racial group n","C0034510;C0441848;C1706779;C3669213;C3853635",NULL,NULL,1638
"baseline characteristics","C4684572",NULL,NULL,627
"low to medium microalbuminuria n $nmbr$","C0009458;C0205251;C0439536;C0730345;C1550472;C1705217;C3244283;C3890211;C4048187;C4085196;C4321351;C4522223;C4522282;C4522283","C0730345","",2204
"relative risk $nmbr$ cl","C0242492;C0596019",NULL,NULL,658
"males $nmbr$","C0086582","C0086582","",1276
"baseline parameter","C0168634;C0549193;C1442488;C1704769;C2350001","C0549193","",1186
"hormone replacement","C0282402",NULL,NULL,549
"ischemic aetiology n","C0015127;C0475224;C1314792;C1524003",NULL,NULL,924
"absolute difference estimate vs placebo $nmbr$ ci","C0008107;C0032042;C0750572;C1549031;C1696465;C1706408;C3259781","C0032042","",28
"duration since diagnosis years","C0011900;C0439234;C0449238;C1704338;C1704656;C2926735",NULL,NULL,1099
"coronary artery bypass","C0010055","C0010055","",389
"model n","C3161035;C3274659;C3714583;C3853906",NULL,NULL,1320
"dbp mean over $nmbr$ h mmhg","C0033727;C0369286;C0439475;C0441932;C0444504;C0536221;C0564385;C2347634;C2348143;C3813197;C4281799;C4528284",NULL,NULL,605
"current use of hormone therapy","C0019932;C0279025;C0521116;C1524063;C1705970;C2827774;C4521914",NULL,NULL,1417
"total atients","C0439175;C0439810",NULL,NULL,508
"average maximum cimt mm","C0806909;C1510992;C1552615;C2825518;C2826546;C4330985;C4554674","","",1262
"patient population","C0030705;C0032659;C1257890",NULL,NULL,904
"renal fmclicn creatntoe clearance","C0232813;C0699829","C0812399",";C3889287;C0452249;C0522467;C1337213;C1576800;C3890003;C0005910;C0022718;C1305866;C1705104;C1705224;C3887665",79
"lipid","C0023779","C0023779","",1772
"mean sd eevi ml","C0439526;C0444504;C1705224;C2347634;C2348143;C2699239;C3887665",NULL,NULL,1287
"glomerular filtration rate ml min $nmbr$ $nmbr$ ma","C0017654;C0024443;C0439445;C1561549;C3887485","C3811844;C0017654","",592
"any anticoagulant","C0003280;C0848112;C3536711","C0085826","",451
"outcome and metabolizer phenotype","C0031437;C1274040;C1285572",NULL,NULL,619
"brain volume cm","C1113695",NULL,NULL,1739
"rosiglitazone versus glyburide","C0017628;C0289313","C0289313","",1761
"number of visits median","C0549183;C0876920;C1549755;C2347635;C2348144;C2939193",NULL,NULL,635
"infarct localization","C0021308;C0475264;C1744691","C0021308;C0475264","",899
"physician s assessment of disease activity vas mm","C0031831;C0042815;C0456681;C0804815;C1261322;C1292728;C1516048;C3536884;C3827561",NULL,NULL,1751
"mean prebronchodilator fev $nmbr$ sd predicted","C0444504;C0681842;C1882327;C2347634;C2348143;C2599602;C2699239;C3714541",NULL,NULL,1599
"statin without other llt","C0360714;C2347090","C0360714","",872
"ischaemic heart disease","C0010054;C0151744","C0010054;C0151744","",1361
"received $nmbr$ prior biologic therapy n","C0278947;C1514756",NULL,NULL,731
"rivastigmine n $nmbr$","C0649350","C0649350","",1937
"patients in analysis n","C0002778;C0030705;C0936012;C1524024",NULL,NULL,183
"medication within $nmbr$ days before enrolment","C0013227;C0439228;C1516879;C1696073;C3244316;C3888021;C4284232",NULL,NULL,1621
"n n","C0369718;C0441922",NULL,NULL,1553
"post bronchodilator reversibility fev $nmbr$ mean sd","C0444504;C0449261;C2347634;C2348143;C2599594;C2699239;C3714541",NULL,NULL,2142
"yes any","C1549445;C1705108;C1710701",NULL,NULL,147
"severity of copd airflow limitation n","C0024117;C0231999;C0439793;C0443288;C0449295;C0522510;C1412502;C3714496",NULL,NULL,561
"nyha","C1275491",NULL,NULL,151
"ace inhibitor or angiotensin receptor blocker no total no","C0003015;C0034787;C0439175;C0439810;C1622222;C4541021","C0003015","",811
"highly sensitive responders n $nmbr$","C0439822","C0332324","",1164
"duration of copd yr","C0024117;C0439234;C0449238;C1412502;C2926735;C3714496",NULL,NULL,1726
"physical activity hours walking wk","C0015259;C0026606;C0080331;C0332174;C0439227;C0439230;C4283795;C4321241;C4321242","C0080331","",1146
"very good or excellent","C1548784;C1961136;C3641222","","",-10
"disease duration years","C0439234;C0872146","C0449238","",1989
"b u s black and non black patients","C0005680;C0027567;C0041703;C0085756;C0439541;C1829939","C0005680",";C1706779",188
"clopidogrel dyspnoea vs no dyspnoea","C0013404;C0070166;C1963100","C0013404","",1227
"ruled out non fatal pe with or","C0070939;C0439787;C0849355;C1302234;C1446409;C1518422;C1705232;C1880476;C4284304",NULL,NULL,1516
"stratified hazard ratio $nmbr$ ci","C0008107;C0205363;C2985465;C3259781",NULL,NULL,519
"sita pio $nmbr$ $nmbr$","C0030800;C2347712",NULL,NULL,1400
"estimated response rate and odds ratio","C0028873;C0237629;C0750572","C0028873","",1078
"$nmbr$ cv risk factors or established atherosclerotic cv disease","C0007222;C0035648;C0333482;C0443211;C1272684;C1553898;C3538987;C4048877;C4318503","C0004153","",1698
"other forms of","C0348078;C0376315",NULL,NULL,1812
"interruption","C0332453;C1512900",NULL,NULL,1714
"history of hypertension n $nmbr$","C0455527",NULL,NULL,1498
"intracranial","C0524466","","",-10
"study druga","C0557651;C2603343",NULL,NULL,1730
"diabetes medication","C0011847;C0011849;C0013227;C3244316;C4284232","C0020616",";C0013227;C3244316;C4284232;C0450442;C1254351;C1515187;C1521826;C2826257",33
"_ $nmbr$ $nmbr$ mmol l hdl c women $nmbr$ mg dl $nmbr$ $nmbr$ mmol l men $nmbr$ mg dl","C0025266;C0043210;C3539687;C3715113;C3898312","","",306
"ics laba therapy n","C0039798;C0087111;C0815320;C1363945;C4551720","C3540778","",2182
"oad only","C0205171;C1720467",NULL,NULL,925
"reduction in odds","C0301630;C0392756;C1293152;C4551656",NULL,NULL,730
"indication for index pci","C0392360;C0600653;C0918012;C1552854;C1637833;C2986546;C3146298;C4049621",NULL,NULL,1713
"upper gastrointestinal","C3203348",NULL,NULL,781
"western europe and israel","C0022271;C0043129",NULL,NULL,672
"time from pah diagnosis months","C0011900;C0030123;C0556969;C1704338;C1704656;C3203102;C4284467",NULL,NULL,1663
"verapamil sr $nmbr$ $nmbr$","C1527129","C0042523","",1450
"no n $nmbr$ $nmbr$","C0369718;C0441922",NULL,NULL,445
"jsn score mean $nmbr$ sd","C0444504;C0449820;C2347634;C2348143;C2699239;C4050231",NULL,NULL,2055
"n terminal pro brain natriuretic peptide pg ml","C0439297;C3272900",NULL,NULL,2323
"normal responder","C0205307;C0231683;C0439166;C2347086;C4553972",NULL,NULL,687
"lisinopril vs chlorthalidone","C0008294;C0065374","C0008294","",70
"baseline mean sd","C0168634;C0444504;C1442488;C2347634;C2348143;C2699239",NULL,NULL,1287
"ace i arb","C0021966;C0221138;C1452534;C3888198;C4284014",NULL,NULL,46
"patients who used insulin pump","C0030705;C1140609;C1273517",NULL,NULL,1035
"overall w $nmbr$ $nmbr$ $nmbr$","C0282416;C1561607",NULL,NULL,1743
"no diabetes mellitus","C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"brazil","C0006137",NULL,NULL,1742
"previous infliximab therapy","C0205156;C1552607;C4076075",NULL,NULL,2387
"middle tg tertile","C0337445;C0444598;C0549183;C1552826","C0041004","",209
"left ventricular ef mean sd","C0225897;C0444504;C2347634;C2348143;C2699239",NULL,NULL,36
"sex male female","C0043210;C0086287;C0086582;C1705497;C1705498;C1706180;C1706428;C1706429","C0086582","",1276
"nyha class iii n","C1882086","C0018802;C1882083","",453
"$nmbr$ $nmbr$ women","C0043210","C0043210",";C3541888;C1720467",1323
"irritative subscore","C0441723;C1706307;C2700617",NULL,NULL,753
"$nmbr$ cells ul","C0439378",NULL,NULL,662
"pulmonary rales n","C0034642","C0034642","",1104
"differences between indacaterol tiotropium versus tiotropium placebo","C0032042;C0213771;C1696465;C1705241;C1705242;C1706408;C1722260","C0032042","",28
"concomitant mtx use n","C0025677;C0042153;C0457083;C0521115;C1417487;C1947944","C0025677","",1408
"vents patients","C0030705",NULL,NULL,1035
"gastroesophageal reflux disease","C0017168;C4553201","C0017168","",99
"egfr mean sd ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C0444504;C1739039;C2347634;C2348143;C2699239;C3811844;C3812682","C3811844;C0017654","",592
"statin intolerant","C0231200;C0360714","C0360714","",872
"treated with laba","C0332293","C0060657;C0073992","",1508
"primary pci n $nmbr$","C0205225;C0439612;C0439631;C4049621",NULL,NULL,2340
"bp in pre treated patients","C0030705;C0037623;C0332152;C0740175;C1415692;C1522326;C1708288;C2257086;C3669034;C4318478",NULL,NULL,608
"cohort $nmbr$ uacr $nmbr$ $nmbr$ mg g","C0009247;C0599755;C1300563",NULL,NULL,2315
"pasi score $nmbr$ $nmbr$ d","C0449820;C4050231;C4528685",NULL,NULL,1522
"placebo linagliptin","C0032042;C1696465;C1706408;C2746078","C2746078","",1185
"pfo closure group n $nmbr$","C0185003;C0441848;C1521802",NULL,NULL,2211
"mild impairment egfr $nmbr$ $nmbr$ n","C0221099;C0684336;C1739039;C2945599;C3811844;C3812682",NULL,NULL,329
"no previous alpha blocker use","C0001641;C0042153;C0205156;C0457083;C1552607;C1947944","C0001641","",961
"$nmbr$ min walk distance m","C0369637;C0429886;C0441923;C0702093;C1524029;C3813700",NULL,NULL,923
"difference $nmbr$","C1705241;C1705242",NULL,NULL,1466
"egfr at baseline $nmbr$ ml min b","C0168634;C0439445;C1442488;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"$nmbr$ or $nmbr$ high risk categories","C0332167;C0683312;C3272283;C4050568;C4319571","C4319571","",837
"extent of index dvt n of dvt patients","C0030705;C0149871;C0439792;C0600653;C0918012;C1552854;C1637833;C2926618;C2986546;C3899446",NULL,NULL,734
"in clinic uas $nmbr$","C0002424;C0150312;C0332285;C0442592;C1707101",NULL,NULL,1552
"primary enrollment diagnoses n","C0332137;C0801658;C1516879;C1696073;C3888021",NULL,NULL,339
"total cholesterol mg dl mean sd available for $nmbr$ patients","C0030705;C0201950;C0439269;C0444504;C0470187;C0543421;C2347634;C2348143;C2699239","C0543421","",1504
"overall event rate","C0282416;C0441471;C0871208;C1521828;C1561607;C4019010",NULL,NULL,2008
"trandolapril n $nmbr$","C0076891",NULL,NULL,620
"lipid lowering drugs n","C0086440","C0086440","",1773
"stable angina n $nmbr$ $nmbr$","C0340288",NULL,NULL,1003
"diuretic","C0012798",NULL,NULL,992
"white non hispanic n","C0007457;C0043157;C0220938;C1518422;C1518424;C1533020;C1533021","C0043157","",1402
"treatment after admission","C0039798;C0087111;C0184666;C0809949;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,470
"fistula n","C0016169",NULL,NULL,1595
"clinical indication at the index procedure n","C0205210;C0600653;C0918012;C1552854;C1637833;C2315323;C2347896;C2986546",NULL,NULL,734
"antiplatelet agent or anticoagulant","C0003280;C0085826;C0848112;C3536711","C0085826","",451
"no of patients no of events $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0030705;C0441471;C3541888",NULL,NULL,412
"absolute litres","C0205344;C0475211",NULL,NULL,1578
"very elderly patients n $nmbr$","C0442824;C0870602;C2984081",NULL,NULL,1489
"cardiac biomarker elevation","C0439775;C0702240;C1271630",NULL,NULL,643
"nyha class iii","C1882086","C0018802;C1882083","",453
"fp n $nmbr$","C0016704;C1419068;C1419906;C3541238;C3541412",NULL,NULL,1820
"adults aged $nmbr$ y no","C0001675;C0001779;C0001792;C1999167","C0001779","",480
"clinical remissione","C0205210",NULL,NULL,793
"laboratory findings","C0587081",NULL,NULL,805
"prior use of synthetic dmards n","C0242708;C0332152;C1524063;C1883254;C2826257",NULL,NULL,2377
"baseline hba $nmbr$ c concentration","C0019016;C0086045;C0168634;C1442488;C1446561;C1825777;C3538758;C3827302","","",820
"baseline ckd egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$","C0168634;C0369637;C0439445;C0441923;C1442488;C1561643;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"nt pro bnp","C0669479;C0754710",NULL,NULL,1511
"revascularization","C0581603","C0581603","",1213
"estimated gfr ml min","C0017654;C0439445;C0750572;C1424601","C3811844;C0017654","",592
"prior coronary artery bypass graft surgery","C0010055;C0332152;C2826257","C0010055","",389
"h dl cholesterol $nmbr$ mg dl","C0008377;C0024671;C0026410;C0033727;C0369286;C0439269;C0441932;C0564385;C1960952;C2346927;C3539687;C4321396;C4521761;C4528284","C0023822","",1962
"prior coronary intervention or coronary artery bypass grafting","C0010055;C0018787;C0184661;C0332152;C0886296;C1273869;C2826257","C0010055","",389
"q $nmbr$ $nmbr$ $nmbr$ q $nmbr$ $nmbr$ number n","C0237753;C0449788",NULL,NULL,1556
"both adalimumab groups n $nmbr$ baseline cd related antibiotic use","C0003232;C0007928;C0034283;C0042153;C0168634;C0369718;C0439849;C0441833;C0441922;C0445223;C0457083;C0687744;C1122087;C1257890;C1442488;C1519504;C1552839;C1705428;C1705429;C1947944;C4552032",NULL,NULL,1428
"infarct location anterior","C0021308;C0205094;C0450429;C1515974;C4284930;C4284931",NULL,NULL,1244
"total haq $nmbr$ $nmbr$","C0102923;C0439175;C0439810;C0451208",NULL,NULL,508
"$nmbr$ $nmbr$ reference","C1514811;C1706462",NULL,NULL,1464
"dyslipidaemia no","C0242339","C0242339","",1770
"p $nmbr$ y $nmbr$ inhibitor loading dos","C0369773;C1428722;C1708715;C1999216;C2603361",NULL,NULL,812
"patients without prevalent kidney disease at baseline","C0022646;C0030705;C0168634;C0227665;C0683921;C1442488",NULL,NULL,1035
"perfusion defectsatinclusion","C0031001;C4281794",NULL,NULL,1049
"role emotional","C0013987;C0035820;C0849912;C1705810;C3871154",NULL,NULL,506
"median $nmbr$ days","C0439228;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"rs $nmbr$ ac rs $nmbr$","C0001246;C0003354;C0035970;C1412573;C2000891;C3539770;C3714753;C3813325","","",-10
"other cardiovascular risk factors","C0850624",NULL,NULL,651
"n participants","C0369718;C0441922;C0679646",NULL,NULL,1033
"baseline cardiac biomarkers elevated","C0168634;C0205250;C1442488;C2735101;C2735102;C3163633",NULL,NULL,625
"mean time since diagnosis years","C0011900;C0040223;C0439234;C0444504;C1704338;C1704656;C2347634;C2348143;C3541383",NULL,NULL,1099
"female race ethnicity","C0015031;C0034510;C0043210;C0086287;C0243103;C1705497;C1705498;C1706779;C3853635",NULL,NULL,2014
"apo a $nmbr$ mg dl","C0003592;C0439269;C0523508;C4553344;C4553379",NULL,NULL,2269
"bmi mean sd kg rn $nmbr$","C0022718;C0439209;C0444504;C0578022;C2347634;C2348143;C2699239;C2827110;C3540639;C4054209;C4281819","C1305855","",1734
"pooled pah mctd and pah","C0026272;C0030123;C1709595;C2349200;C3203102;C4284467;C4522255",NULL,NULL,1663
"p value anova","C0753802;C1709380",NULL,NULL,7
"nste acs","C0742343;C4318612",NULL,NULL,2146
"calcium antagonist strategy cas events n","C0006684;C0441471;C0679199;C3541888","C0006684","",1884
"hemoglobin gm dl","C0017480;C0019046;C3642216;C3854019",NULL,NULL,1620
"sc belimumab $nmbr$ mg n $nmbr$","C0024671;C0026410;C0282380;C0439269;C1723401;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"acq score mean","C0444504;C0449820;C2347634;C2348143;C2919686;C4050231","C2919686","",1293
"angina n","C0002962","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"use of ace inhibitor arb or both no","C0003015;C1524063;C3888198;C4541021",NULL,NULL,44
"age group","C0027362;C2348001",NULL,NULL,45
"carotid artery intervention","C0007272;C0162859;C0184661;C0397581;C0741968;C0886296;C1273869","C0007272;C0184661","",2197
"systolic mean sd mm hg","C0039155;C0439475;C0444504;C2347634;C2348143;C2699239","C0005823","",1469
"aqlq si $nmbr$ score","C0449820;C4050231;C4055434",NULL,NULL,2057
"lower","C0441994;C1548802;C2003888",NULL,NULL,1612
"previous lev only","C0023556;C0205156;C0205171;C1552607;C1720467",NULL,NULL,925
"fasting indices","C0015663;C4033634",NULL,NULL,358
"mean bmi sd kg m $nmbr$","C0444504;C0578022;C1532718;C2347634;C2348143;C2699239",";C1305855","",206
"ldl cholesterol mmol lf","C0023824;C0202117;C0439190;C1416933;C2986618;C4554443","C0023824","",1068
"amlodipine valsartan $nmbr$ $nmbr$ vs $nmbr$ $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C1962523;C2346927;C4321396;C4521761","","",78
"total macular volume mean sd mm $nmbr$","C0332574;C0444504;C0449468;C2347634;C2348143;C2699239;C4330985;C4554674",NULL,NULL,1287
"trial $nmbr$","C0008976",NULL,NULL,1020
"antihyperglycaemic medication at baseline","C0013227;C0020616;C0168634;C1442488;C3244316;C4284232",NULL,NULL,625
"receptor blocker","C0597357",NULL,NULL,962
"history of coronary revascularization d","C0019664;C0019665;C0262512;C0262926;C0877341;C1705255;C2004062",NULL,NULL,832
"total cholesterol hdl c","C0023822;C0201950;C0439175;C0439810;C0543421;C3715113","C0023822","",821
"carisbamate $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1871983;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2273
"menopause and hrt","C0025320;C0282402;C0567312","C0282402","",1043
"treatment duration mean sd","C0444504;C0444921;C2347634;C2348143;C2699239;C3259042",NULL,NULL,37
"lipid lowering drugs","C0086440","C0086440","",1773
"egfr_p_interaction","C1704675;C1739039;C3811844;C3812682",NULL,NULL,888
"inflammatory bowel disease","C0021390","C0021390","",107
"$nmbr$ $nmbr$ lo $nmbr$ $nmbr$","C0206579;C1232424",NULL,NULL,1057
"tr jet velocity m sec","C0108801;C0336862;C0439493;C0439830;C1539482;C1547053;C1705610;C1872943;C3811249;C3811250;C3814152",NULL,NULL,1634
"median age $nmbr$ $nmbr$ y","C0001779;C0549183;C0876920;C2347635;C2348144;C2939193","C0001779","",480
"early death","C1836407","C1836407","",324
"hba $nmbr$ c $nmbr$ n $nmbr$","C0019016;C1825777;C3538758","","",820
"patients with dactylitisa","C0030705","C0239161","",492
"hbalca median","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,1897
"omega $nmbr$ allocation","C1706778;C1719844",NULL,NULL,905
"grade $nmbr$ moderate copd n","C0024117;C0205081;C0441800;C0919553;C1412502;C1881878;C3244287;C3714496;C4049705;C4049706;C4085643;C4321335",NULL,NULL,1726
"without aspirin n $nmbr$ $nmbr$","C0004057","C0004057","",1366
"$nmbr$ yr from the united states","C0041703;C0439234",NULL,NULL,1099
"mean predicted fvc sd","C0444504;C0681842;C1882327;C2347634;C2348143;C2699239;C3714541",NULL,NULL,1599
"$nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ os","C0229090;C0230028;C0262950;C0393706;C1561953",NULL,NULL,130
"diclofenac $nmbr$ mg n $nmbr$ $nmbr$ n","C0012091;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761","C0012091","",1324
"das $nmbr$ esr","C0051767;C0057671;C3811131","C1619634","",298
"time to admission min","C0702093;C1524029;C3813700;C3854258;C3854259",NULL,NULL,1475
"hispanic n","C0086409","C0086409","",865
"non fatal ml","C0439526;C1302234;C1518422;C1705224;C1705232;C3887665",NULL,NULL,300
"naire can range from $nmbr$ to $nmbr$ for the alternative disability portion and from $nmbr$ to $nmbr$ for the pain portion scores for the medical outcomes","C0030193;C0040363;C0041260;C0199168;C0205476;C0231170;C0449719;C0449820;C0518090;C1274040;C1514721;C1523987;C1883351;C1962977;C2348147;C2984058;C3542016;C4050231;C4085210;C4085211;C4085212;C4553004;C4554132",NULL,NULL,983
"vegfr ng ml","C0439275;C1568520",NULL,NULL,204
"placebo group n $nmbr$","C0032042;C0441848;C1696465;C1706408","C0032042","",28
"$nmbr$ i $nmbr$ $nmbr$ i $nmbr$","C0021966;C0221138",NULL,NULL,1021
"age at first seizure years mean sd","C0036572;C0205435;C0444504;C1279901;C1510829;C1959629;C2347634;C2348143;C2699239;C4553401",NULL,NULL,1907
"acs management no","C0001554;C0376636;C0742343;C1273870;C3273539;C4318612",NULL,NULL,488
"ed severity no a","C0439793;C0522510;C3538926",NULL,NULL,561
"full po pulatio n","C0443225;C0946289",NULL,NULL,437
"lung infection","C0876973;C4552950",NULL,NULL,477
"patient assessment of pain $nmbr$ $nmbr$ cm vas","C0042815;C0679830",NULL,NULL,491
"tlmi risk score","C0035647;C0449820;C4050231;C4552904",NULL,NULL,2052
"$nmbr$ $nmbr$ o $nmbr$ i o $nmbr$","C0021966;C0221138;C0483204","","",-10
"total study population n $nmbr$","C0439175;C0439810;C0557651;C2348561;C2603343;C3258257",NULL,NULL,510
"long term warfarin n $nmbr$","C0043031;C0443252","C0043031","",858
"medications at enrollment n","C0013227;C0802604;C1516879;C1696073;C2598133;C3888021;C4284232",NULL,NULL,339
"race_white","C0007457;C0034510;C0043157;C0220938;C1706779;C3853635","C0043157","",1402
"ib $nmbr$ $nmbr$","C2744579;C3890035;C4283819",NULL,NULL,1398
"mean change from baseline in acq overall score sd","C0168634;C0282416;C0392747;C0443172;C0444504;C0449820;C1442488;C1561607;C1705241;C2347634;C2348143;C2699239;C2919686;C4050231;C4319952",NULL,NULL,625
"asian pacific islander n","C0078988;C0242191",NULL,NULL,1609
"prebronchodilator fevi predicted","C0681842;C0849974;C1561566;C1882327;C2599602;C4528367",NULL,NULL,1601
"rate of oral or systemic corticosteroid","C0442027;C0871208;C1521828;C4053960;C4521986",NULL,NULL,1649
"$nmbr$ to $nmbr$ years vs $nmbr$ years","C0439234",NULL,NULL,1099
"high probability ventilation perfusion lung scanning","C0024109;C0560738;C4699572",NULL,NULL,477
"icd therapy n","C0021122;C0039798;C0087111;C1363945",NULL,NULL,236
"body mass kg","C0022718;C0439209;C0518010;C4054209","C1305855","",1734
"patients receiving $nmbr$ mg of edoxaban at randomization no f","C0016327;C0024671;C0026410;C0030705;C0034656;C0439269;C1514756;C1960952;C2346927;C2975435;C4321396;C4521761",NULL,NULL,192
"fracture history","C0016658;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062",NULL,NULL,2026
"sgrq total score $nmbr$","C2964552",NULL,NULL,540
"symbol digit score","C0449820;C0582802;C0679214;C1698987;C3241971;C4050231",NULL,NULL,1005
"time since diagnosis of copd years","C0011900;C0024117;C0040223;C0439234;C1412502;C1704338;C1704656;C3541383;C3714496",NULL,NULL,1099
"total ics dose at entry xg d","C0017209;C0815320;C1292284;C1421532;C1705654;C2986497;C4551720","C3540778","",2182
"isolated igt","C0205409;C1548221","C0271650","",818
"glargine n n loopy","C0181687;C0445022;C0907402",NULL,NULL,1727
"good moderate response","C0205170;C4085643","C0205170","",212
"use of blood pressure lowering medication","C0013227;C0020649;C1524063;C3244316;C4284232",";C0003364","",1579
"pbo simva $nmbr$ yr km rale","C0031962;C0034642;C0439234;C3887676",NULL,NULL,435
"ls mean difference seb","C0023668;C0059386;C0444504;C1309881;C1423585;C1705241;C1705242;C2347634;C2348143;C3815268",NULL,NULL,37
"both deep vein thrombosis and pulmonary embolism","C0034065;C0149871",NULL,NULL,630
"stent thrombosis related mi","C0439849;C0445223;C3810814;C3897493",NULL,NULL,622
"patients without diabetesb","C0030705",NULL,NULL,1035
"positive for rheumatoid factor no t","C0035448;C0201660;C0439178;C1446409;C1514241;C2603360;C2825490;C3812269","C0035448","",1435
"ifx n $nmbr$","C0020823","C0666743","",154
"medications in use at baseline no total no","C0013227;C0042153;C0150312;C0168634;C0332285;C0439175;C0439810;C0457083;C0802604;C1442488;C1707101;C1947944;C2598133;C4284232",NULL,NULL,508
"no $nmbr$ person yr","C0027361;C0439234;C2347489",NULL,NULL,1099
"pci","C4049621",NULL,NULL,1736
"race nonwhite","C0034510;C1706779;C3853635",";C0034510","",1107
"composite physiologic index","C0205199;C0205463;C0600653;C0918012;C1547335;C1552854;C1637833;C2986546",NULL,NULL,734
"use of antihypertensive drugs","C0003364;C1524063",";C0003364","",1579
"daily iglar dose at week $nmbr$ u","C0560588;C2348070",NULL,NULL,1488
"caucasian ethnicity","C0007457;C0015031;C0043157;C0243103","C0043157","",1329
"normal function crcl $nmbr$ ml min n $nmbr$ $nmbr$ $nmbr$","C0439445;C1846718;C4296962","C3811844;C0017654","",307
"subgroup analyses","C2986480",NULL,NULL,1636
"vitamin k antagonist","C1096489;C2267235",";C0043031","",868
"secondary end points ii","C0027627;C0175668;C0205436;C1710602;C2349179;C4082587",NULL,NULL,1484
"percentage of fevj reversibility","C0439165;C0449261;C1549488;C1561533",NULL,NULL,291
"omalizumab","C0966225","C0966225","",940
"das $nmbr$ crp ls mean change from baseline se","C0023668;C0036919;C0051767;C0057671;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C3890735;C4048285;C4319952",NULL,NULL,143
"prebronchodilator fev $nmbr$ fvc","C2599602;C3714541",NULL,NULL,1599
"bifurcation lesion","C0184906;C0221198;C1546698;C3146289",NULL,NULL,893
"contrast volume ml","C0009924;C0439526;C0449468;C1690016;C1705102;C1705224;C1979874;C2700258;C3887665",NULL,NULL,2030
"duration of coronary artery disease yr","C0018787;C0439234;C0449238;C0852949;C2926735","C0102118;C0449238","",1992
"baseline cardiovascular medication","C0007220;C0168634;C1442488","C0007220","",897
"sa","C0036243;C0038702;C1539696;C1825840;C3539736;C4521691","","",-10
"prior coronary revascularization n n","C0332152;C0877341;C2826257","C0877341",";C4049621;C1552607",223
"estradiol e $nmbr$ pmol l","C0014912;C0439284",NULL,NULL,666
"death mi idr st gusto defined moderate or severe bleeding","C0011065;C0019080;C0036056;C0205081;C0205082;C1306577;C1704788;C1881878;C3272372;C3539106;C3810814;C4049705;C4049706;C4050465;C4050466;C4082313;C4085643;C4321335;C4552775",NULL,NULL,313
"current alendronate use","C0042153;C0102118;C0457083;C0521116;C1705970;C1947944",NULL,NULL,1573
"haq di score","C0449820;C3826998;C4050231;C4321476",NULL,NULL,1665
"medical therapy during index hospitalization","C0019993;C0418981;C0600653;C0918012;C1552854;C1637833;C2986546",NULL,NULL,258
"tamsulosin","C0257343","C0257343","",1346
"cana $nmbr$ met n $nmbr$","C0369718;C0428210;C0441922;C1418845;C1550543;C4317104",NULL,NULL,39
"$nmbr$ mg dl simva $nmbr$","C0439269",NULL,NULL,192
"moderate $nmbr$ ipss $nmbr$","C0205081;C1019118;C1881878;C1998280;C2827405;C3811063;C4049705;C4049706;C4085643;C4321335","C1998280",";C1019118;C3811063;C4050465;C4050466;C4049706;C0168634;C1705273;C1880519;C3853603",124
"total score","C2964552",NULL,NULL,540
"pre menopausal with hormone replacement","C0206158;C0282402",NULL,NULL,549
"rate ratio $nmbr$ cl","C0456603;C0596019;C0871208;C1521828;C1547037",NULL,NULL,973
"lpa mg dl","C0439269;C1096202;C1439335;C3539666;C4049711;C4553379",NULL,NULL,192
"bmi kg m $nmbr$ mean sd","C0444504;C0578022;C1532718;C2347634;C2348143;C2699239",NULL,NULL,1735
"total cholesterol to hdl cholesterol ratio","C0428619","C0543421","",1504
"smokers no","C0337664","C0037369","",420
"with metabolic syndrome","C0524620",NULL,NULL,617
"gender n men","C0025266;C0079399;C1522384","","",306
"family history of chd n $nmbr$ $nmbr$","C0241889;C0280604;C3542407","C0241889","",1493
"previous chf","C0018802;C0205156;C1552607",NULL,NULL,2388
"predicted prebronchodilator fev $nmbr$ mean sd l","C0444504;C0681842;C1882327;C2347634;C2348143;C2599602;C2699239;C3714541",NULL,NULL,1599
"chd total","C0280604;C0439175;C0439810;C3542407",NULL,NULL,970
"mean sd change from pre to post bronchodilator fevi ml","C0332152;C0439526;C0444504;C0687676;C0740175;C1704687;C1705224;C2257086;C2347634;C2348143;C2599594;C2599602;C2699239;C3469826;C3481639;C3669034;C3887665",NULL,NULL,771
"st t wave","C0036056;C0429103;C3272372",NULL,NULL,2356
"low hdl c for men $nmbr$ mg dl for women $nmbr$ mg dl","C0025266;C0043210;C0151691;C0439269","","",306
"cana $nmbr$ n $nmbr$","C1418845",NULL,NULL,1302
"creatinine clearanceb ml min","C0010294;C0439445;C1561535","C0812399",";C3889287;C0452249;C0522467;C1337213;C1576800;C3890003;C0005910;C0022718;C1305866;C1705104;C1705224;C3887665",79
"e a ratio","C0456603;C1547037",NULL,NULL,973
"fasting glucose mmol l mean sd","C0015663;C0017725;C0444504;C1532563;C2347634;C2348143;C2699239","C0017725;C0015663","",1846
"$nmbr$ kg n","C0022718;C0439209;C4054209",NULL,NULL,205
"prior use of osteoporosis medications n","C0013227;C0029456;C0332152;C0802604;C1524063;C2598133;C2826257;C4284232;C4554622",NULL,NULL,2264
"primary prevention subgroup","C0033144;C1079230;C1515021",NULL,NULL,1637
"qualifying peripheral arterial disease","C0085096;C1514624;C1704436","C0085096","",933
"montelukast n $nmbr$","C0298130",NULL,NULL,1528
"patients randomly assigned","C0030705;C1516050;C1552601",NULL,NULL,1173
"not tested","C0392366;C1518422",NULL,NULL,85
"congenital heart disease","C0152021",NULL,NULL,97
"normal $nmbr$","C0205307;C0231683;C0439166;C2347086;C4553972",NULL,NULL,687
"il $nmbr$","C0020898;C0021764;C0022271",NULL,NULL,672
"age $nmbr$ gd lesion $nmbr$ n $nmbr$","C0001779;C0221198;C1546698",NULL,NULL,472
"stable coronary artery disease","C0010054;C0010068;C0205360;C1547311;C1956346","C0010068;C1956346",";C0026410;C1710701",226
"lp a","C0065058;C1439335;C4553379","C0065058","",1769
"center level ihr percent time in therapeutic range for warfarin subjects","C0040223;C0043031;C0087111;C0205099;C0302350;C0439165;C0441889;C0456079;C0460097;C0681850;C1547707;C1550501;C1554109;C1706203;C2349001;C2697811;C2946261;C3541383;C3810851",NULL,NULL,677
"placebo vonoprazan $nmbr$ vonoprazan $nmbr$","C0032042;C1696465;C1706408;C4080009","C0032042","",28
"cardiovascular mortality or mi","C0007226;C0026565;C0026566;C3810814;C3887460",NULL,NULL,2157
"sbp difference vs placebo $nmbr$ cl","C0032042;C0085805;C0596019;C1696465;C1705241;C1705242;C1706408","C0032042","",28
"mild impairment egfr $nmbr$ $nmbr$","C0221099;C0684336;C1739039;C2945599;C3811844;C3812682",NULL,NULL,329
"baseline low density lipoprotein cholesterol mg dl","C0023824;C0168634;C0439269;C1442488","C0023824;C1442488","",1964
"corneii product mm ms","C1514468;C1704444;C2349943;C3539704;C3713294;C4330985;C4554674",NULL,NULL,126
"bmi category","C0578022;C0683312;C3889287",NULL,NULL,1735
"dual antiplatelet therapy","C0205173;C1096021;C1554184","","",1191
"baseline no","C0168634;C1442488",NULL,NULL,625
"insulin glargine dose at screening visit iu","C0049272;C0178602;C0220908;C0220909;C0366513;C0439453;C0545082;C0694756;C0869039;C0907402;C1114758;C1512346;C1698960;C1710031;C1710032;C1710477;C2348164;C2826704",NULL,NULL,2100
"use of antiplatelet agents","C0085826;C1524063","","",1191
"mean bmi kg m $nmbr$ sd","C0444504;C0578022;C1532718;C2347634;C2348143;C2699239",NULL,NULL,1735
"australasia","C0282279;C1257882",NULL,NULL,54
"disease activity outcomes itt population week $nmbr$","C0032659;C0205177;C0332174;C0439167;C0439230;C0441655;C0679250;C1257890;C1274040;C1292728;C1561536;C3542417;C3668946;C4049938;C4049939",NULL,NULL,1012
"acei use","C0042153;C0457083;C1947944",NULL,NULL,535
"mean sd age y mean bmi category","C0001779;C0444504;C0578022;C0683312;C2347634;C2348143;C2699239;C3889287",NULL,NULL,562
"chronic kidney disease n","C1561643;C4553188","C1561643","",967
"use of antiplatelet agents no total no","C0085826;C0439175;C0439810;C1524063","","",1191
"sex female n","C0086287","C0086287","",1277
"hypertension severity","C0020538;C0439793;C0522510;C1963138",NULL,NULL,561
"study $nmbr$ item short form general health survey sf $nmbr$ can range from $nmbr$ to $nmbr$ for the physical component and from $nmbr$ to $nmbr$ for the mental","C0031809;C0037712;C0040363;C0041260;C0205485;C0229992;C0348078;C0376315;C0449432;C0557651;C1282927;C1509143;C1514721;C1522492;C1551338;C1705248;C1806781;C1883351;C2348147;C2350002;C2603343;C3481509;C3542016;C4255237;C4554251",NULL,NULL,1519
"overweight bmi $nmbr$ $nmbr$ $nmbr$","C0497406;C0578022","C0497406","",1248
"race n a","C0034510;C1706779;C3853635",";C0034510","",1107
"$nmbr$ to $nmbr$ symptom days per week","C0677547;C1457887;C3854129",NULL,NULL,613
"ssed as ls means","C0023668;C1704970",NULL,NULL,127
"female subjects n $nmbr$","C0043210;C0086287;C0369718;C0441922;C0681850;C1550501;C1705497;C1705498;C1706203;C2349001;C2697811",NULL,NULL,1655
"total patients n","C0030705;C0439175;C0439810",NULL,NULL,508
"$nmbr$ to $nmbr$ bpm n $nmbr$","C0040363;C0041260;C1883351",NULL,NULL,431
"clopidogrel n $nmbr$ $nmbr$","C0070166","C0070166",";C0369286;C0033727;C4049621",217
"bnp $nmbr$ pg ml or nt pro bnp $nmbr$ pg ml n","C0033382;C0054015;C0439297;C0523852;C1095989;C1417808;C2982014;C2987124;C4284038",NULL,NULL,1635
"study treatment no total no","C0439175;C0439810;C1521826",NULL,NULL,717
"ischaemic stroke","C0948008",NULL,NULL,1669
"predose fvc l","C0439565;C3714541;C3812758","C3714541;C0439565","",295
"documented symptomatic chdb","C0231220;C1301725;C1609436","C0010054;C0151744","",1361
"age at enrollment years mean sd","C0444504;C1510829;C1516879;C1696073;C2347634;C2348143;C2699239;C3888021",NULL,NULL,1907
"diskus only n","C0205171;C1553480;C1720467",NULL,NULL,177
"history of coronary revascularization","C0019664;C0019665;C0262512;C0262926;C0877341;C1705255;C2004062",NULL,NULL,832
"s $nmbr$ $nmbr$ vs placebo","C0032042;C0565930;C1696465;C1706408;C2603362","C0032042","",28
"year","C0439234;C0439508",NULL,NULL,1099
"baseline sgrq score","C0168634;C0449820;C1442488;C4050231",NULL,NULL,625
"egfr $nmbr$ to $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n $nmbr$","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"patients with normoalbuminuria at baseline","C0030705;C0168634;C1442488","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"anatomy","C0002808;C0700276;C1384516",NULL,NULL,693
"yes","C1549445;C1705108;C1710701",NULL,NULL,147
"cat total score $nmbr$","C0007450;C0325090;C0524517;C1443200;C2964552;C3665481;C4050461;C4284282",NULL,NULL,255
"metrex modified intention to treat population with an eosinophilic phenotypey","C0032659;C0087111;C0162425;C0333930;C0392747;C1257890;C1283828;C1292734;C1522326;C3889737",NULL,NULL,1064
"normal mild ckd","C0205307;C0231683;C0439166;C1561643;C2347086;C2945599;C4553972",NULL,NULL,329
"baseline ldl c strata n o","C0168634;C1442488",NULL,NULL,2189
"overall quality of life","C3641830",NULL,NULL,1813
"asia n $nmbr$","C0003980","C0003980","",1382
"receiving antihypertensive treatment","C0003364;C0039798;C0087111;C1514756;C1522326;C1533734;C1705169;C3538994;C3887704",";C0003364","",1579
"anticoagulant therapy","C0150457",NULL,NULL,555
"patients receiving immunotherapy no","C0005525;C0021083;C0030705;C1514756",NULL,NULL,1035
"patients with syndesmophytes at baseline","C0030705;C0168634;C0221690;C1442488",NULL,NULL,625
"without previous surgery","C0038894;C0038895;C0205156;C0543467;C1274039;C1552607",NULL,NULL,598
"pathologic q waves n","C0429090",NULL,NULL,1606
"enalapril aliskiren dm $nmbr$ non dm $nmbr$","C0011816;C0014025;C1120110;C1518422;C3250443","C1120110","",1172
"patients with $nmbr$ exacerbation requiring admission to hospital in the $nmbr$ months before screening","C0019994;C0030673;C0220908;C0220909;C0439231;C1510665;C1698960;C1710031;C1710032;C1710477;C2348164;C4086268",NULL,NULL,798
"multivessel coronary artery disease no total no","C0010054;C0010068;C0439175;C0439810;C1956346","C0010068;C1956346",";C0026410;C1710701",226
"use of cgm interaction test p value","C0022885;C0039593;C0392366;C0456984;C1515976;C1524063;C1704675;C1709380;C3831328;C4318744",NULL,NULL,7
"dabigatran $nmbr$ mg bid n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761",NULL,NULL,775
"prior electrical cardioversion for af n $nmbr$ $nmbr$","C0013778;C0332152;C0344434;C0542380;C2826257;C4049859",NULL,NULL,1794
"patients without a prior mi or stroke at baseline","C0030705;C0038454;C0168634;C0332152;C1442488;C2826257;C3810814;C4554100",NULL,NULL,2378
"sample size","C0242618","C0242618","",1194
"antihyperglycemic oral agent therapy","C0020616;C0039798;C0087111;C0442027;C0450442;C1254351;C1363945;C1521826;C4521986","C0020616",";C0013227;C3244316;C4284232;C0450442;C1254351;C1515187;C1521826;C2826257",33
"history of carotid artery disease","C0007273;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062","C0007273","",2195
"primary key efficacy endpoint","C1280519;C1707887;C1709665;C2349179;C2826544","C1707887;C2349179","",1122
"anti hypertensive therapy","C0585941",";C0003364","",1579
"risk at","C0035647;C4552904","C0035647","",173
"serum albumin concentration g l","C0001924;C0036773;C0086045;C0229671;C0439294;C0456615;C0486291;C0683149;C0728877;C1446561;C1546774;C1550100;C3827302",NULL,NULL,953
"nilvadipine","C0132512","","",-10
"no of events patients","C0030705;C0441471;C3541888",NULL,NULL,412
"cure trial","C0008976;C1880198",NULL,NULL,1019
"ratio of ldl to hdl","C0456603;C1547037;C3715113","C0023822","",821
"$nmbr$ $nmbr$ crcl","C1846718",NULL,NULL,706
"bleeding outcomes","C0019080;C1274040",NULL,NULL,707
"eosinophils $nmbr$ $nmbr$ x $nmbr$ $nmbr$ l n $nmbr$","C0014467;C0200638","C0014467","",849
"n iqr","C0369718;C0441922",NULL,NULL,1553
"angina or positive stress test","C0002962;C0015260;C0439178;C1446409;C1514241;C2825490;C3494508;C3812269",NULL,NULL,1163
"duration of asthma","C0004096;C0449238;C2926735;C2984299",NULL,NULL,694
"bdi total score baseline","C0006448;C0168634;C0451022;C1442488;C2964552;C3714938;C3889415",NULL,NULL,540
"combination facilitated pci n $nmbr$","C0205195;C1947911;C3811910;C4049621",NULL,NULL,997
"legs only","C0205171;C1140621;C1720467",NULL,NULL,925
"$nmbr$ p value","C1709380",NULL,NULL,7
"urgent coronary revascularization","C0439609;C0877341;C3272275","C0877341;C3272275","",1212
"p gp use","C0042153;C0369773;C0457083;C1705010;C1947944;C2603361;C3811116",NULL,NULL,118
"in hospital medication","C0013227;C0019994;C1510665;C3244316;C4284232","C0019994",";C4049621",261
"placebo w $nmbr$","C0032042;C1696465;C1706408","C0032042","",28
"previous pci cabg n","C0010055;C0205156;C1552607;C4049621","C1532338","",1661
"minority","C0026192",NULL,NULL,801
"no use ofdiabetes drugs no","C0240320",NULL,NULL,119
"uac $nmbr$ $nmbr$ mg g","C1300563",NULL,NULL,2315
"fpg mg dl x","C0439269",NULL,NULL,192
"fev $nmbr$ reversibilityz pre post salbutamol","C0001927;C0332152;C0687676;C0740175;C1704687;C2257086;C3469826;C3669034;C3714541",NULL,NULL,1599
"combination","C0205195;C1947911;C3811910",NULL,NULL,997
"post cabg","C0010055;C0687676;C1704687;C3469826","C0010055","",389
"secukinumab $nmbr$ mg n $nmbr$ $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C3179547;C4321396;C4521761",NULL,NULL,944
"insulin aspart","C0123677;C1708521",NULL,NULL,163
"bmi body mass index hctz hydrochlorothiazide msdbp mean sitting diastolic blood pressure mssbp mean sitting systolic blood pressure sd standard deviation","C0020261;C0277814;C0444504;C0488055;C0871420;C0871470;C1305855;C1306620;C1319894;C2347634;C2348143;C2584297;C2699239;C4050224",NULL,NULL,1471
"patients entering pt period n $nmbr$","C0030705;C0032743;C0439531;C0699718;C1522196;C1948053",NULL,NULL,1513
"history of oxygen use yes n","C0019664;C0019665;C0030054;C0262512;C0262926;C1524063;C1549445;C1705108;C1705255;C1710701;C2004062",NULL,NULL,832
"tiotropium $nmbr$ meg n $nmbr$","C0024489;C0025175;C0072225;C0213771","C0213771","",1372
"renal function egfr ml min $nmbr$ $nmbr$ m $nmbr$","C0232804;C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"index event not confirmed","C0441471;C0521093;C0600653;C0750484;C0918012;C1518422;C1552854;C1637833;C2986546;C4019010",NULL,NULL,412
"never drink","C0452428;C2003901",NULL,NULL,316
"exploratory kidney and microvascular outcomes","C0022646;C0227665;C0443258;C1274040",NULL,NULL,1602
"voiding subscore","C0042034;C4067975",NULL,NULL,753
"treatment with open label perindopril","C0136123;C3640652",NULL,NULL,620
"pre treatedforhypertension n","C0332152;C0740175;C2257086;C3669034",NULL,NULL,294
"tender joint count n $nmbr$","C0451530","C0451530","",1139
"native hawaiian or other pacific islander","C0242191;C0337920","C0337920;C0242191","",1331
"baseline mean","C0168634;C0444504;C1442488;C2347634;C2348143",NULL,NULL,625
"$nmbr$ lisinopril chlorthalidone","C0008294;C0065374","C0008294","",70
"ppg mg dl","C0439269;C1418888",NULL,NULL,192
"dbp office measurement mmhg","C0242485;C0439475;C0442603;C0536221;C3813197;C4281799",NULL,NULL,605
"white ethnic origin","C0007457;C0015031;C0043157;C0220938",NULL,NULL,787
"short acting anticholinergics","C0079613;C0242896;C1282927;C1704930;C1806781;C1869853;C2350002;C3537307;C3540711;C3890007;C4048375",NULL,NULL,1704
"type of atrial fibrillation n","C0004238;C0332307;C0344434;C1547052;C1963067",";C0004238","",1009
"laa closure","C0185003;C1521802",NULL,NULL,1307
"north","C1709269",NULL,NULL,579
"no des","C0011702;C4551552",NULL,NULL,465
"men n $nmbr$ n n","C0025266",NULL,NULL,1842
"height inches","C0439204;C0489786","C0489786","",1249
"previously taken any other dmards n","C0242708;C1883727","C0242708",";C0026544",231
"ticlopidine","C0040207",NULL,NULL,1837
"chronic pulmonary disease","C0746102",NULL,NULL,106
"previous chronic use of antiplatelet drugs","C0085826;C0205156;C0205191;C1524063;C1552607;C2963157","","",1191
"fev $nmbr$ percent predicted sd","C0439165;C0681842;C1882327;C2699239;C3714541",NULL,NULL,1599
"tolal choleslerol lo hdl choleslerol ralio","C0206579;C1232424;C3715113","C0543421","",1504
"duration of t $nmbr$ dm $nmbr$ years","C0011816;C0439234;C0449238;C2926735;C3250443",NULL,NULL,901
"igm n $nmbr$","C1706005",NULL,NULL,956
"anti tnf agent s","C0221141;C0313162;C0450442;C1254351;C1448177;C1521826",NULL,NULL,362
"previous metformin use","C0025598;C0042153;C0205156;C0457083;C1552607;C1947944","C0025598","",1345
"age mean min max yrs","C0001779;C0444504;C0702093;C1524029;C2347634;C2348143;C3813700","C0001779","",480
"o $nmbr$ o oo $nmbr$ o $nmbr$ o","C0483204",NULL,NULL,434
"crohn s disease related surgery","C0010346;C0038894;C0038895;C0439849;C0445223;C0543467;C1274039",NULL,NULL,598
"nihss at randomization","C0034656;C1697238",NULL,NULL,692
"index percutaneous coronary intervention","C0600653;C0918012;C1532338;C1552854;C1637833;C2986546","C1532338","",1661
"$nmbr$ $nmbr$ o $nmbr$ i $nmbr$","C0021966;C0221138;C0483204","","",-10
"mmp $nmbr$ median iqr gg l","C0017454;C0018370;C0549183;C0623362;C0876920;C0919336;C2347635;C2348144;C2939193",NULL,NULL,201
"asa use at baseline","C0004057;C0042153;C0168634;C0457083;C1442488;C1947944;C3853627",NULL,NULL,60
"chondroitin sulfate","C0008466",";C0008466","",1404
"n $nmbr$ pufa","C0032615;C0369718;C0441922",NULL,NULL,1553
"metastatic","C0036525;C1522484;C4085632",NULL,NULL,884
"hr $nmbr$ ci","C0008107;C3259781",NULL,NULL,1544
"cl $nmbr$","C0596019",NULL,NULL,658
"ment","C0084844;C1538994","","",306
"acpa positive $nmbr$ iu ml n","C0439178;C0439458;C1446409;C1514241;C1525410;C1706063;C2825490;C3812269",";C0439178","",2051
"previous pneumonia","C0032285;C0205156;C1552607","C0032285","",589
"total c hdl c ratio","C0439175;C0439810;C0456603;C1547037;C3715113","C0023822","",821
"coping","C0009967","C0009967","",1148
"$nmbr$ year mean change from baseline","C0168634;C0392747;C0439234;C0439508;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C4319952",NULL,NULL,767
"previous cancer","C0006826;C0205156;C0998265;C1306459;C1552607","C0006826","",1819
"western friroce","C1705493",NULL,NULL,600
"duration of psoriasis years","C0033860;C0439234;C0449238;C2926735","C0033860;C2926735","",1996
"blood pressure at entry mm hg","C0005823;C0439475;C1271104;C1272641;C1705654","C0005823","",15
"cerebral embolism","C0007780",NULL,NULL,929
"st segment elevation mi","C0520886;C3810814","C3810814","",894
"a $nmbr$ years","C0439234",NULL,NULL,1099
"groups","C0441833;C0687744;C1257890;C1519504;C1552839;C1705428;C1705429",NULL,NULL,1526
"evolocumab","C3529352",NULL,NULL,948
"amlodipine valsartan $nmbr$ $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C1962523;C2346927;C4321396;C4521761","","",78
"previous copd treatment n","C0024117;C0039798;C0087111;C0205156;C1412502;C1522326;C1533734;C1552607;C1705169;C3538994;C3714496;C3887704",NULL,NULL,1726
"age yrs median iqr","C0001779;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,148
"metabolic syndrome","C0524620",NULL,NULL,617
"black or african","C0005680;C0027567;C0085756;C0439541","C0005680",";C1706779",188
"medical history and risk factors no","C0035648;C0262926;C1553898;C1704706",NULL,NULL,832
"all bleed","C0019080",NULL,NULL,707
"total periventricular wml score mean sd","C0444504;C2347634;C2348143;C2699239;C2964552",NULL,NULL,1287
"concomitant aedsa","C0521115",NULL,NULL,448
"$nmbr$ ml min per $nmbr$ $nmbr$ m","C0369637;C0439445;C0441923","C3811844;C0017654","",307
"predictive factor","C0683956",NULL,NULL,2022
"eosinophil counf cells pl","C0682547;C3897966;C4049765","C0014467;C0007584","",1806
"death due to renal failure or sustained esrd","C0011065;C0022661;C0035078;C0443318;C0678226;C1306577;C1963154;C2316810;C4082313;C4552775","C0035078;C0011065","",939
"oxcarbazepine","C0069751","","",-10
"empagliflozin $nmbr$ mg day n $nmbr$","C0439422;C3490348","C3490348","",1182
"heartburn severity during the run in periodt","C0018834;C0439793;C0522510;C3274438",NULL,NULL,561
"years mean sd","C0439234;C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"no of participants","C0679646",NULL,NULL,1033
"all grafts","C0181074;C0332835;C1527362;C1961139",NULL,NULL,462
"sdai $nmbr$ $nmbr$","C3871128","C3871128","",1355
"fibrinolytics","C0040044",NULL,NULL,1703
"raas inhibitors","C0243077",NULL,NULL,809
"diabetics yes n $nmbr$ $nmbr$","C0241863;C1549445;C1705108;C1710701",NULL,NULL,147
"treatment with sulphonylurea biguanide n","C0005382;C0038766;C0039798;C0087111;C1522326;C1533734;C1705169;C3536898;C3537187;C3538994;C3887704;C4317165","C0038766","",752
"saxa $nmbr$ mg $nmbr$ metformin n $nmbr$ $nmbr$","C0024671;C0025598;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"rec ischemia","C0022116;C1424025;C2606415;C4321499",NULL,NULL,1668
"colon or rectum","C0009368;C0034896;C3888384","C0009368","",1971
"week $nmbr$ of patients","C0030705;C0332174;C0439230",NULL,NULL,1012
"pre fev $nmbr$","C0332152;C0740175;C2257086;C3669034;C3714541",NULL,NULL,1599
"moderate disease activity $nmbr$ $nmbr$ to $nmbr$ $nmbr$ n","C0012634;C0205081;C1292728;C1513375;C1881878;C3833417;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"death or absolute fvc decrease $nmbr$","C0011065;C0205344;C0392756;C0547047;C1306577;C3714541;C4082313;C4552775",NULL,NULL,1578
"ischemia driven revascularization","C0022116;C0581603;C4321499;C4683688",NULL,NULL,1668
"cardiothoracic ratio $nmbr$ $nmbr$","C0456603;C1547037;C4055270",NULL,NULL,973
"elevated crp ulnt n","C0742906","C0006560","",286
"macroalbuminuria no total no","C0439175;C0439810",NULL,NULL,508
"$nmbr$ mg dl chd status","C0280604;C0439269;C0449438;C3542407",NULL,NULL,970
"beta blocker no","C0001645","C0001645","",959
"nyha functional classification no","C0205245;C0542341;C1275491;C2700217",NULL,NULL,1531
"pioglitazone","C0071097",NULL,NULL,1760
"oriental","C0078988;C0699027","C0078988","",284
"hscrp median iqr mg l","C0439268;C0549183;C0876920;C2347635;C2348144;C2939193","C0006560","",286
"potential injection site reactions","C0151735;C3245505","C0151735","",1983
"intravenous n $nmbr$","C0348016","C0348016","",1189
"post fibrinolysis angioplasty n $nmbr$","C0016017;C0162577;C0687676;C1305868;C1548817;C1704687;C3469826","C0162577","",1722
"unfractionated heparin n $nmbr$ $nmbr$","C0019134;C2825026","C0019134","",864
"baseline hdl c in $nmbr$ classes","C0168634;C0456387;C1442488;C1518526;C1705943;C3715113;C4019422","C0023822","",821
"controllertreatment before entry","C1705654",NULL,NULL,1588
"systolic bp mmhg mean sd","C0039155;C0439475;C0444504;C0488053;C0871470;C2347634;C2348143;C2699239","C0005823","",1469
"$nmbr$ days until end of study landmark analysis","C0002778;C0444930;C0936012;C1524024;C2746065;C2826182",NULL,NULL,183
"duration of diabetes","C0011847;C0011849;C0449238;C2926735","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"tolvaptan","C1176308","C1176308","",1223
"use","C0042153;C0457083;C1947944",NULL,NULL,118
"obesity bmi $nmbr$ kg m $nmbr$","C0028754;C0578022;C1532718;C1963185",";C1305855","",206
"range race n","C0034510;C1514721;C1706779;C2348147;C3542016;C3853635",NULL,NULL,479
"pulse pressure mm hg","C0439475;C0949236","C0949236","",1118
"symptoms","C0683368;C1457887",NULL,NULL,613
"antiplatelets or anticoagulants","C0003280","C0085826","",451
"reduced ef","C0392756","C2700378","",887
"type $nmbr$ diabetes n $nmbr$ $nmbr$","C1320657","C0011849;C1320657","",907
"chi square p value","C1552646;C1709380",NULL,NULL,7
"micro macroalbuminuria","C0085672;C1553035;C3811161;C4049106","C0033687","",376
"with tamsulosin","C0257343","C0257343","",1346
"ls mean change from baseline $nmbr$","C0023668;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C4319952",NULL,NULL,767
"comparator linagliptin","C1707454;C2746078;C4553389;C4553390","C2746078","",1185
"stent implanted no","C0522776","C0522776","",364
"duration of disease yr t","C0439234;C0872146","C0449238;C0872146","",903
"effect estimate","C0750572;C1280500;C1518681;C2348382",NULL,NULL,402
"medications in use at baseline no","C0013227;C0042153;C0150312;C0168634;C0332285;C0457083;C0802604;C1442488;C1707101;C1947944;C2598133;C4284232",NULL,NULL,2263
"prior lev treatment","C0023556;C1514463",NULL,NULL,574
"total back pain mean sd","C0004604;C0439175;C0439810;C0444504;C1963071;C2347634;C2348143;C2699239;C4553945","C0004604","",1337
"genotype specific treatment effect hazard ratio $nmbr$ ci","C0008107;C0017431;C0205369;C1518681;C1552740;C2985465;C3259781","C2985465","",975
"form bud","C0348078;C0376315;C1522492;C2700462;C2945744;C4255237",NULL,NULL,708
"change in haq di mean t","C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C3826998;C4319952;C4321476",NULL,NULL,1665
"heart rates beats minutes","C0018810;C0439232;C0700321;C0702093;C1282918;C2347166","C0018810","",1105
"eo","C0332120",NULL,NULL,1058
"no methotrexate hydroxychloroquine or sulfasalazine treatment","C0020336;C0025677;C0036078;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704","C0020336","",1403
"tnglycendes median","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"angiographic data and treatment","C0002978;C0039798;C0087111;C1511726;C1522326;C1533734;C1705169;C3245479;C3538994;C3714741;C3887704","C1511726;C0002978","",2231
"immunosuppressants","C0021081","C0021081","",1424
"adhere","C3714578",NULL,NULL,1201
"fev $nmbr$ mean sd pre bd fev $nmbr$ fvc","C0005126;C0332152;C0444504;C0740175;C2257086;C2344255;C2347634;C2348143;C2699239;C3669034;C3714541;C4050145",NULL,NULL,2126
"drinker $nmbr$ $nmbr$ drinks week","C0332174;C0439230;C0452428;C0556338",NULL,NULL,178
"itch nrs $nmbr$ v $nmbr$","C0033774;C1422257;C2240043;C4050142","C0033774;C4050142","",1362
"homa ir mean sd","C0022065;C0022071;C0444504;C1448132;C2347634;C2348143;C2699239",NULL,NULL,1287
"niacin n","C0027996;C1142562","C0027996","",871
"eos serum k meq l","C0302353;C0439375;C1623465;C1861303",NULL,NULL,1626
"fasting triglycerides mg dl","C0015663;C0041004;C0439269","C0041004","",368
"medication at time of randomization no","C0013227;C0034656;C0040223;C3244316;C3541383;C4284232",NULL,NULL,2263
"weeko mean sem","C0444504;C2347634;C2348143",NULL,NULL,36
"copd duration mean sd yr","C0024117;C0439234;C0444504;C0449238;C1412502;C2347634;C2348143;C2699239;C2926735;C3714496",NULL,NULL,1099
"insulin iu","C0021641;C0049272;C0439453;C0694756;C1533581;C1579433;C3714501",NULL,NULL,157
"fev $nmbr$ pre albuterol l","C0001927;C0332152;C0740175;C2257086;C3669034;C3714541",NULL,NULL,1599
"glp $nmbr$ receptor agonists","C0018301;C1422069;C1425391;C1539338;C2350813;C4543206","C0014361;C2987634",";C1422069;C1425391;C1539338",1153
"severe $nmbr$ ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$ n","C0205082;C0369637;C0439445;C0441923;C4050465;C4050466",NULL,NULL,313
"ldl cholesterol mg dl","C0023824;C0202117;C0439269","C0023824","",1963
"allergic disease by historyb n","C0020517;C0851444","C0851444","",2246
"education $nmbr$ to $nmbr$ y","C0013621;C0013622;C0013658;C0039401","C0013658","",902
"electrocardiography","C0013798;C1623258","C1623258","",1129
"family history","C0241889","C0241889","",1493
"time from qualifying mi yrs","C0040223;C1514624;C3541383;C3810814",NULL,NULL,757
"percentage of days without heartburn","C0018834;C0439165;C0439228;C1549488;C1561533",NULL,NULL,291
"past or never","C1444637;C2003901;C4284302",NULL,NULL,456
"patient global assessment of pain vas $nmbr$ $nmbr$ mm","C0042815;C4054229;C4330985;C4554674",NULL,NULL,297
"long acting intermediate long acting fast acting","C0015663;C0079613;C0205103;C0205166;C0456962;C1550465;C1704930;C1706317;C1869853;C2827755;C2985769;C3889971;C3890007;C4048375","C0205103",";C0015663;C1550465;C2827755;C3889971;C0079613;C1704930;C1869853;C3890007;C4048375",1096
"evolocumab soc n $nmbr$","C3529352","C3529352","",1285
"e $nmbr$ s $nmbr$ vs e $nmbr$","C3846405",NULL,NULL,132
"crp mg dl $nmbr$ $nmbr$","C0439269;C3890735;C4048285","C0006560","",286
"combo vs primary","C0205225;C0439612;C0439631",NULL,NULL,229
"patient s global assessment of disease activity mean sd","C0444504;C2347634;C2348143;C2699239;C4054228",NULL,NULL,2143
"major cardiovascular events","C0205082;C0205164;C1320716;C4318856;C4521762","C1320716;C0205082","",2077
"hemodynamic parameters at baseline in the patients enrolled in the hemodynamic substudy","C0019010;C0030705;C0168634;C0449381;C1442488;C4281788;C4684790",NULL,NULL,1187
"vessel treated n","C0005847;C0369718;C0441922;C1522326",NULL,NULL,743
"lisinopril vs chlorthalidone obese","C0008294;C0028754;C0065374","C0008294","",70
"indian indian subcontinent","C0454693",NULL,NULL,637
"bmi $nmbr$ $nmbr$ kg ni n $nmbr$ $nmbr$","C0022718;C0028075;C0439209;C0578022;C2348274;C3869926;C3869927;C4054209","C1305855","",1734
"number of individuals","C1549735",NULL,NULL,1811
"mild ipss $nmbr$","C1019118;C1998280;C2827405;C2945599;C3811063","C1998280",";C1019118;C3811063;C4050465;C4050466;C4049706;C0168634;C1705273;C1880519;C3853603",124
"placebo km","C0032042;C1696465;C1706408;C3887676","C0032042","",28
"ics laba n z $nmbr$","C0815320;C4551720",NULL,NULL,1650
"ldl c mmol l","C1532563","C0023824","",1068
"required corticosteroid and or antibiotic without hospitalization","C0001617;C0003232;C0019993;C1514873;C3536709",NULL,NULL,1650
"western europe n $nmbr$ $nmbr$","C0043129","","",599
"fasting plasma glucose","C0015663;C0202042;C0455280","C0455280;C0015663",";C0168634",21
"etd $nmbr$ ci","C0008107;C1180255;C3259781",NULL,NULL,519
"baseline median mg dl","C0168634;C0439269;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193",NULL,NULL,635
"modified acc aha lesion class b $nmbr$ or cj","C0007481;C0221198;C0392747;C0456387;C1518526;C1546698;C1705943;C3889737;C4072694",NULL,NULL,452
"fasting glucose","C0015663;C0017725","C0017725;C0015663","",1846
"primary renal endpoint","C0022646;C2986535","C2986535;C0022646","",938
"weight $nmbr$ kg n","C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209",NULL,NULL,2326
"no new a or and no more than $nmbr$ new bilag b domain score","C0205172;C0205314;C0449820;C1880389;C1883221;C3541951;C4050231",NULL,NULL,1539
"time from acute coronary syndrome to randomization days","C0034656;C0040223;C0439228;C0948089;C3541383","C0948089",";C0026544",225
"vascular","C0005847;C1558950;C1801960",NULL,NULL,743
"hospitalization for hf","C0018488;C0019993;C1313497;C1538440;C3273279",NULL,NULL,2359
"digoxin n","C0012265","C0012265","",989
"n a","C1272460",NULL,NULL,419
"cardiac medications during index hospitalization","C0013227;C0019993;C0428776;C0802604;C2598133;C4284232",NULL,NULL,2266
"om $nmbr$ aml $nmbr$","C0023465;C0023467;C0028971;C1705272",NULL,NULL,186
"because of ae","C3887670","C0877248","",47
"age mean sd year","C0001779;C0439234;C0439508;C0444504;C2347634;C2348143;C2699239","C0001779","",480
"a aza treatment ref","C0004482;C0039798;C0087111;C1425988;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,1881
"mtx other csdmards","C0025677;C1417487","C0025677","",1408
"score improvement baseline to week $nmbr$ median iqr","C0168634;C0332174;C0439230;C0449820;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193;C2986411;C4050231",NULL,NULL,635
"history of atrial fibrillation or fl utter","C0729790;C1300812;C1708024",";C0004238","",1009
"gly $nmbr$ $nmbr$ pg b i d n $nmbr$","C0030827;C0072225;C0152277;C1266240;C1415124",NULL,NULL,208
"copd","C0024117;C1412502;C3714496",NULL,NULL,1726
"complete mayo clinic score median min max","C0002424;C0205197;C0442592;C0449820;C0454788;C0549183;C0702093;C0725685;C0876920;C1077578;C1524029;C2347635;C2348144;C2939193;C3813700;C3853530;C4050231;C4283785",NULL,NULL,425
"threatened abrupt vessel closure","C0005847;C0185003;C1276802;C1521802","C0005847;C1521802;C1276802","",1385
"heart failure lvef $nmbr$ or both","C0018801;C0018802;C0428772;C0488728;C4554158","C0018801;C0428772","",1273
"north american","C0425358;C2700615",NULL,NULL,579
"proton pump inhibitor n","C0358591;C3536754;C4521480",NULL,NULL,1582
"icd or crt d","C0021122",NULL,NULL,256
"$nmbr$ months n","C0439231",NULL,NULL,1530
"prior gestational diabetes","C0085207;C0332152;C2826257","C0011849","",912
"alvedv per ml","C0439526;C1705224;C3887665",NULL,NULL,300
"body mass index median iqr","C0005893;C0549183;C0578022;C0876920;C1305855;C2347635;C2348144;C2939193","C1305855","",1891
"laba use at screening n","C0042153;C0220908;C0220909;C0457083;C1698960;C1710031;C1710032;C1710477;C1947944;C2348164",NULL,NULL,798
"ertuglifldzin $nmbr$ mg vs placebo glinepiride","C0024671;C0026410;C0032042;C0439269;C1696465;C1706408;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2278
"number of exacerbations in previous $nmbr$ months","C0205156;C0237753;C0439231;C0449788;C1552607;C4086268","C4086268","",889
"cv disease history no","C0007222;C0019664;C0019665;C0262512;C0262926;C0683519;C1705255;C2004062;C3538987;C4048877;C4318503",NULL,NULL,1777
"anti ccp positive","C0439178;C1446409;C1514241;C2825490;C3812269;C4318437","C4318437","",360
"duration of ra years","C0439234;C0449238;C2926735;C3538806;C4048756",NULL,NULL,901
"erosion","C0333307;C1880549;C1959609;C3887524",NULL,NULL,1046
"ace inhibitor at enrollment","C0003015;C1516879;C1696073;C3888021;C4541021",NULL,NULL,339
"pah origin cause","C0015127;C1418251;C1524003",NULL,NULL,924
"myocardial infarction cabg pci","C0010055;C0027051;C0428953;C2926063;C3810814;C4049621;C4552959",NULL,NULL,646
"eu","C0015179;C3665627",NULL,NULL,533
"usa canada","C0006823;C0041703",NULL,NULL,1550
"reported high cholesterol","C0020443;C0684224;C0700287;C1522133;C4319718","","",1390
"no prior pci","C0332152;C2826257;C4049621",NULL,NULL,1063
"rasagiline $nmbr$ mg day","C0439422;C0525678",NULL,NULL,2321
"low normal n $nmbr$","C0205251;C0205307;C0231683;C0439166;C1550472;C2347086;C3890211;C4048187;C4321351;C4522223;C4553972",NULL,NULL,851
"south asian","C1519427","C0037713","",580
"black us","C0005680;C0027567;C0085756;C0439541","C0005680",";C1706779",188
"data n","C1511726;C3245479;C3714741",NULL,NULL,1427
"systolic mm hg","C0039155;C0439475","C0005823","",1469
"egfr $nmbr$ ml min $nmbr$ $nmbr$","C0439445;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"urgent cor revasc","C0018787;C0056331;C0378365;C0439609;C3272275",NULL,NULL,1481
"mean body weight kg range","C0005910;C0022718;C0439209;C0444504;C1305866;C1514721;C2347634;C2348143;C2348147;C3542016;C4054209",NULL,NULL,2326
"postbaseline binding antibodies","C0003241;C1145667;C1167622",NULL,NULL,594
"telmisartan n $nmbr$","C0248719","C0248719","",1205
"background csdmard category","C0683312;C1706907;C3889287",NULL,NULL,562
"diabetes absent $nmbr$ $nmbr$ $nmbr$","C0011847;C0011849;C0332197;C4285062","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"$nmbr$ vessels","C0005847",NULL,NULL,743
"heparin use","C0239945",NULL,NULL,122
"baseline skin pain vas mean sd","C0042815;C0168634;C0241136;C0444099;C0444504;C1123023;C1442488;C1963195;C2347634;C2348143;C2699239;C3536884;C3827561;C4520765",NULL,NULL,1751
"coronary disease","C0010068;C1956346","C0010068;C1956346",";C0026410;C1710701",226
"secondary ip","C0027627;C0175668;C0205436;C1308226;C4049997",NULL,NULL,1484
"weekly","C0332174",NULL,NULL,1013
"w event rate","C0441471;C0871208;C1521828;C4019010",NULL,NULL,2011
"laba use at screening","C0042153;C0220908;C0220909;C0457083;C1698960;C1710031;C1710032;C1710477;C1947944;C2348164",NULL,NULL,798
"cu index test n $nmbr$","C0022885;C0039593;C0392366;C0456984;C0600653;C0918012;C1177210;C1515976;C1552854;C1637833;C2347872;C2986546;C3831328;C4318744",NULL,NULL,242
"cg ld","C0043444;C0694649;C1567075;C3540479",NULL,NULL,1677
"ff vi","C0205999;C4554348",NULL,NULL,1597
"cr mh","C0026514;C0201975;C2930980;C3539604;C3711669;C4084730;C4553336;C4553337",NULL,NULL,302
"insulin plus $nmbr$ oral agent","C0021641;C0442027;C0450442;C1254351;C1521826;C1533581;C1579433;C3714501;C4521986",NULL,NULL,157
"exenatide oad","C0167117",NULL,NULL,759
"screening reversibility fev $nmbr$","C0220908;C0220909;C0449261;C1698960;C1710031;C1710032;C1710477;C2348164;C3714541","C0449261;C0231999","",1315
"acr mg mmol","C0567349;C1412134;C1515941;C2348885","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"treated lesions","C0221198;C1522326",NULL,NULL,552
"quintile $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ n $nmbr$","C1508496",NULL,NULL,1017
"admission crcl","C0184666;C0809949;C1846718",NULL,NULL,706
"fev $nmbr$ prebronchodilator pn mean sd","C0219433;C0444504;C1549735;C2347634;C2348143;C2599602;C2699239;C3541307;C3714541;C4049640;C4049767",NULL,NULL,1599
"lama use at screening n","C0042153;C0220908;C0220909;C0457083;C0999593;C1416775;C1698960;C1710031;C1710032;C1710477;C1947944;C2348164",NULL,NULL,798
"lateral","C0205093",NULL,NULL,931
"patients with complicated events p $nmbr$ $nmbr$","C0030705;C0231242;C0441471;C3541888",NULL,NULL,412
"noncompliant","C0457432",NULL,NULL,1690
"no of patients with $nmbr$ bsa affected","C0030705;C0392760;C1314939",NULL,NULL,311
"infarction $nmbr$ days previously","C0021308;C0439228",NULL,NULL,1621
"odds ratios $nmbr$ ci","C0008107;C0028873;C3259781",NULL,NULL,519
"hba $nmbr$ c $nmbr$ $nmbr$ n $nmbr$","C0019016;C1825777;C3538758","","",820
"hdl cholesterol mean sd mg dl","C0023822;C0392885;C0439269;C0444504;C2347634;C2348143;C2699239","C0023822","",1962
"lvesv ml","C0439526;C1705224;C3887665",NULL,NULL,300
"serum glucose mg dl","C0202041;C0439269;C3534430",NULL,NULL,2305
"ace inhibitors sartans","C0003015;C1563745","C0003015","",811
"plasma dha mean sd weight","C0005910;C0032105;C0043100;C0142831;C0444504;C1305866;C1550098;C1705104;C2347634;C2348143;C2348308;C2699239;C4521445",NULL,NULL,1623
"patients with cardiac disorders n","C0012634;C0018799;C0030705;C0741926","C0018799","",1278
"angiographic characteristics no","C0002978;C1521970",NULL,NULL,2018
"rescue medication use mean inhalations previous $nmbr$ d","C0004048;C0205156;C0240320;C0354922;C0444504;C1552607;C2347634;C2348143",NULL,NULL,37
"use of low dose aspirin $nmbr$","C1524063;C2608320","C0004057","",1366
"long standing persistent","C0205166;C0205322;C0231472;C0332996;C1706317",NULL,NULL,719
"rales n","C0034642;C0240859","C0034642","",1104
"total study itt population n $nmbr$","C0439175;C0439810;C0557651;C2348561;C2603343;C3258257",NULL,NULL,510
"creatinine clearance $nmbr$ ml min no total","C0439175;C0439445;C0439810;C0812399","C0812399",";C3889287;C0452249;C0522467;C1337213;C1576800;C3890003;C0005910;C0022718;C1305866;C1705104;C1705224;C3887665",79
"placebo open label abatacept","C0032042;C1619966;C1696465;C1706408;C1709323","C1619966","",1190
"week $nmbr$ mg liter","C0024671;C0026410;C0332174;C0439230;C0439269;C0475211;C1960952;C2346927;C4321396;C4521761",NULL,NULL,1012
"diabetic treatments","C0087111;C0241863",NULL,NULL,996
"$nmbr$ predicted to $nmbr$ predicted","C0681842;C1882327","C0024119","",288
"current smokers n","C3173209;C3241966","C3241966","",1420
"thiazide","C0541746","","",993
"$nmbr$ sae","C1519255;C1622657;C4553214","C1519255","",1282
"total $nmbr$","C0439175;C0439810",NULL,NULL,508
"lymphadenopathy","C0497156;C4282165","","",-10
"study end concentration","C0086045;C0444930;C0557651;C1446561;C2603343;C2746065;C3827302",NULL,NULL,410
"inconsistent fao n $nmbr$","C0016457;C0442809",NULL,NULL,1065
"serum","C0229671;C1546774;C1550100",NULL,NULL,951
"insulin n","C0021641;C1533581;C1579433;C3714501",NULL,NULL,157
"leading to study withdrawal","C0040363;C0041260;C0332152;C0557651;C1522538;C1710677;C1883351;C2349954;C2603343;C2825032;C3812880;C4049634",NULL,NULL,431
"mixed","C0205430;C3160715",NULL,NULL,985
"cv historya","C3538987;C4048877;C4318503",NULL,NULL,1777
"previous receipt of therapy against tnf a no","C0039798;C0087111;C0205156;C1363945;C1448177;C1552607;C1710304",NULL,NULL,2398
"trough seated sbp mmhg a","C0085805;C0277814;C0439475;C0444506;C1283233",NULL,NULL,607
"sfc $nmbr$ $nmbr$ pg b i d n $nmbr$","C0021966;C0030827;C0072225;C0152277;C0221138;C1266240;C2827928;C4521536",NULL,NULL,208
"acuity major","C0205082;C0205164;C0750509;C4318856;C4521762",NULL,NULL,1472
"increased risk for thrombotic cardiovascular event n","C0087086;C0205217;C0442805;C1273410",";C1273410;C0205217","",2228
"current alcohol n","C0001962;C0001975;C0521116;C1705970",";C0001962","",1053
"mean glycated hemoglobin reduction during characteristic follow up $nmbr$ ci percent","C0017853;C0439165;C0444504;C0520870;C0589120;C1521970;C1522577;C1704685;C2347634;C2348143;C3274571","","",1176
"erosive reflux disease","C0012634;C0232483;C0439679;C1882919;C4317146","C0017168","",99
"chads $nmbr$ score per outcome stroke or systemic embolism","C0007928;C0013922;C0038454;C0205373;C0449820;C1274040;C1413373;C1704212;C4050231;C4554100","","",2128
"anticoagulant","C0003280;C0848112;C3536711","C0003280","",450
"mean sd values are presented for all variables except medical history race or ethnic group and sex n and urinary albumin creatinine ratio median range abody mass index is the weight in kilograms divided by the square of the height in meters bto convert values to micromoles per liter multiply by $nmbr$ $nmbr$ estimated using the modified equation from the modification of diet in renal disease study dto convert values to millimoles per liter multiply by $nmbr$ $nmbr$ eto convert values to millimoles per liter multiply by $nmbr$ $nmbr$ to convert values to millimoles per liter multiply by $nmbr$ $nmbr$","C0005910;C0009253;C0015031;C0019664;C0019665;C0034510;C0036864;C0040363;C0041260;C0042027;C0042295;C0043100;C0079399;C0199168;C0205120;C0205476;C0262512;C0262926;C0332849;C0392747;C0439190;C0439194;C0439209;C0439828;C0441074;C0444504;C0449450;C0457987;C0475211;C0486293;C0489786;C0549183;C0552449;C0557651;C0577559;C0577573;C0600653;C0724655;C0750572;C0804628;C0876920;C0918012;C1096155;C1305866;C1306372;C1314687;C1318293;C1514721;C1522384;C1524063;C1524119;C1552595;C1552854;C1554963;C1637833;C1705104;C1705255;C1706779;C1719797;C1879937;C1883351;C2004062;C2347634;C2347635;C2348143;C2348144;C2348147;C2603343;C2699239;C2911648;C2939193;C2986546;C3152252;C3539882;C3542016;C3840684;C3853635;C3889737;C4283905","","",-10
"dmard ir","C0022065;C0022071;C0242708;C1448132","","",1397
"$nmbr$ to $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923","C3811844;C0017654","",307
"aapo $nmbr$ at rest mm hg","C0035253;C0439475;C1622890","","",-10
"black participants","C0005680;C0027567;C0085756;C0439541;C0679646","C0005680",";C1706779",188
"history of diabetes mellitus no","C0455488",NULL,NULL,1491
"faster aspart","C0015663;C0123677;C0456962;C2985769",NULL,NULL,157
"low dose edoxaban n $nmbr$","C0445550;C1708745;C2975435","C0445550;C2975435","",2091
"ls means difference $nmbr$ ci a","C0008107;C0023668;C1704970;C1705241;C1705242;C3259781",NULL,NULL,519
"hba $nmbr$ c mmol mol se","C0019016;C0036919;C1825777;C3538758;C3829066","","",820
"benazepril amlodipine group n $nmbr$","C0051696;C0053091;C0441848",NULL,NULL,1638
"mean selena sledai score sd","C0444504;C0449820;C0451528;C2347634;C2348143;C2699239;C4050231","C0451528","",2175
"isolated pulmonary embolism","C0034065;C0205409;C1548221",NULL,NULL,630
"placebo statin","C0032042;C0360714;C1696465;C1706408","C0032042","",28
"atorvastatin $nmbr$ mg and simvastatin $nmbr$ $nmbr$ mg zi $nmbr$","C0024671;C0026410;C0043476;C0074554;C0286651;C0439269;C1960952;C2346927;C4321396;C4521761","C0074554","",1840
"octave sustain","C0443318;C2732140",NULL,NULL,1031
"stage $nmbr$ a ckd cohort secondary analysis","C0027627;C0086027;C0175668;C0205390;C0205436;C1300072;C1306673;C1561643",NULL,NULL,541
"prior insulin use years","C0240016;C0332152;C0439234;C2826257",NULL,NULL,122
"c $nmbr$ ml decrease in trough fev $nmbr$","C0392756;C0439526;C0444506;C0547047;C1705224;C3714541;C3887665",NULL,NULL,1599
"baseline alc category","C0168634;C0683312;C1424945;C1442488;C3811058;C3889287",NULL,NULL,395
"basal only","C0205112;C0205171;C1720467",NULL,NULL,925
"$nmbr$ with no historical count $nmbr$","C0750480;C1552658;C1552723;C1705566;C2004062",NULL,NULL,1389
"ecfr ml min per $nmbr$ $nmbr$ m","C0369637;C0439445;C0441923","C3811844;C0017654","",307
"c peptide median ql q $nmbr$ nmol l","C0006558;C0439282;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,1892
"rf negative and acpa positive n","C0035448;C0201660;C0205160;C0439178;C0748398;C1446409;C1513916;C1514241;C1525410;C1547111;C1706063;C2825415;C2825490;C2825491;C3812269;C3853545","C0035448","",1435
"qualifying mi $ $nmbr$ yrs prior","C0332152;C1514624;C2826257;C3810814",NULL,NULL,516
"stratified analyses","C0002778;C0205363;C0936012;C1524024",NULL,NULL,183
"modified has bled","C0019080;C0392747;C3889737",NULL,NULL,767
"male sex \ no","C0086582","C0086582","",1276
"dx at presentation n","C0449450;C3538936",NULL,NULL,287
"black no","C0005680;C0027567;C0085756;C0439541","C0005680",";C1706779",188
"q waves in the infarct territory at baseline","C0021308;C0168634;C0429089;C1301808;C1305738;C1442488;C2983136",NULL,NULL,2145
"prior stroke or tza","C0038454;C0039298;C0332152;C2826257;C4554100","C0038454;C0332152","",2380
"mean $nmbr$ sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"participants with heart failure","C0018801;C0018802;C0679646;C4554158","C0018801",";C0168634;C1524003",12
"borg dyspnea score who functional class n","C0013404;C0205245;C0449820;C0456387;C0542341;C1518526;C1705943;C1963100;C2700217;C4050231",NULL,NULL,452
"dip involvement n","C1314939;C3539618",NULL,NULL,312
"aldosterone blockers","C0002006",NULL,NULL,963
"o oo $nmbr$ $nmbr$ $nmbr$ to $nmbr$ $nmbr$","C0483204",NULL,NULL,434
"percent change from baseline at week $nmbr$","C0332174;C0439230;C3272907",NULL,NULL,1012
"mean sgrq total score sd","C0439175;C0439810;C0444504;C2347634;C2348143;C2699239;C2964552;C3533236",NULL,NULL,540
"race while","C0034510;C1706779;C3853635","C0043157","",1402
"lipid lowering therapies n","C0585943","C0585943;C0086440","",1774
"africa asia or the middle east","C0001737;C0003980;C0026068",NULL,NULL,48
"mean time since diagnosis y","C0011900;C0040223;C0444504;C1704338;C1704656;C2347634;C2348143;C3541383",NULL,NULL,37
"current dactylitis n","C0239161;C0521116;C1705970","C0239161","",492
"benign prostatic hyperplasia","C1704272","C1704272","",1942
"postoperative use of p blocker","C0032790;C1524063",NULL,NULL,25
"low density lipoprotein cholesterol median $nmbr$ th $nmbr$ th percentiles mg dl","C0023824;C0039725;C0039738;C0439269;C0549183;C0876920;C1264641;C1420718;C2347635;C2348144;C2939193;C4282123;C4285344","C0023824","",1963
"om $nmbr$ aml $nmbr$ hctz $nmbr$ $nmbr$ mg","C0020261;C0023465;C0023467;C0024671;C0026410;C0028971;C0439269;C1705272;C1960952;C2346927;C4321396;C4521761",NULL,NULL,1149
"has bled $nmbr$","C0019080",NULL,NULL,707
"not hispanic","C1518424","C0086409","",865
"previous stroke ortia","C0038454;C0205156;C1552607;C4554100",NULL,NULL,1762
"caucasian n","C0007457;C0043157","C0043157","",1329
"apo a $nmbr$ mean sd","C0003592;C0444504;C0523508;C2347634;C2348143;C2699239;C4553344;C4553379","C0003592","",427
"haq di total score mean sd","C0444504;C2347634;C2348143;C2699239;C2964552;C3826998;C4321476",NULL,NULL,2138
"history of mi","C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C3810814",NULL,NULL,832
"sodium glucose cotransporter $nmbr$ inhibitor","C0017725;C0037473;C0597484;C1999216;C3541959;C3714642",NULL,NULL,2206
"extensive colitis or pancolitis","C0009319;C0205231;C0868908;C1963084","C0205231;C0009319","",2063
"olodaterol $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C2934193;C4321396;C4521761",NULL,NULL,2294
"patients with pneumonia event n","C0030705;C0032285;C0441471;C4019010",NULL,NULL,1035
"asia pacific hr $nmbr$ cl","C0003980;C0596019","C0003980","",1382
"fev $nmbr$ reversibility b","C0449261;C3714541","C0449261;C0231999","",1315
"history of second prior mi","C0019664;C0019665;C0205436;C0262512;C0262926;C0332152;C0457385;C0565930;C1561503;C1705190;C1705255;C2004062;C2826257;C3810814",NULL,NULL,516
"cr imputation random n $nmbr$","C0034656;C0201975;C0439605;C2699638;C3539604;C3711669;C4084730;C4553336;C4553337",NULL,NULL,700
"current n z $nmbr$","C0521116;C1705970",NULL,NULL,1417
"waist circumference mean sd in","C0444504;C0455829;C2347634;C2348143;C2699239","C0455829","",1413
"age at diagnosis y","C1828181;C3173302","C1828181","",483
"patients with diabetesb","C0030705",NULL,NULL,1035
"ace inhibitor n","C0003015;C4541021","C0003015","",811
"corticosteroids","C0001617;C3539185;C3540725;C3540726;C3540727",NULL,NULL,1650
"risk of moderate severe exacerbations","C0205082;C0332166;C4050465;C4050466;C4086268",NULL,NULL,313
"neuropilin ng ml","C0287275;C0439275",NULL,NULL,204
"ischaemic cause","C0015127;C0475224;C1524003",NULL,NULL,1670
"non rheumatic valvular heart disease","C0264757;C1518422","C0018824","",103
"hdl cholesterol mg dl mean sd","C0023822;C0392885;C0439269;C0444504;C2347634;C2348143;C2699239","C0023822","",1962
"care","C1947933",NULL,NULL,391
"valsartan hctz n $nmbr$","C0020261;C0216784","C0216784","",1206
"no of patients no of events","C0030705;C0441471;C3541888",NULL,NULL,412
"coronary artery disease no","C0010054;C0010068;C1956346","C0010068;C1956346",";C0026410;C1710701",226
"glycated hemoglobin median iqr","C0017853;C0549183;C0876920;C2347635;C2348144;C2939193","","",1176
"placebo mortality rate events per $nmbr$ person y","C0026565;C0027361;C0032042;C0205848;C0441471;C1696465;C1706408;C2347489;C3541888","C0032042","",28
"unknown or missing","C0439673;C1551393;C1705492;C3272743;C3541433;C4050014","C1705492","",1144
"tngtycendes a median","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"alt and or ast $nmbr$ times uln consecutive","C0040223;C1266129;C1415181;C1519815;C1632851;C1707491;C3891303;C4553172",NULL,NULL,1676
"no yes","C1549445;C1705108;C1710701",NULL,NULL,147
"ranolazine vs placebo km failure rate","C0032042;C0073633;C0231174;C0680095;C0871208;C1521828;C1696465;C1706408;C3887676","C0032042","",28
"neither uh or lmw heparin","C0019134;C0770546","C0019134","",863
"ex smokers itt n $nmbr$","C0337671;C4555205","C0037369","",420
"anti arrhythmic","C0003195;C3537142","C0003195","",379
"$nmbr$ chlorthalidone amlodipine","C0008294;C0051696","C0008294","",70
"glycoprotein llb llia inhibitor","C0017968;C1999216",NULL,NULL,2104
"sgrq total score week","C0332174;C0439230;C2964552",NULL,NULL,1012
"fasting plasma glucose in mmol l median q $nmbr$ q $nmbr$ n","C0549183;C0583513;C0876920;C1532563;C2347635;C2348144;C2939193",NULL,NULL,1896
"drug discontinuation not due to death","C0011065;C0013227;C0457454;C0678226;C1254351;C1306577;C1444662;C1518422;C4082313;C4552775;C4552847",NULL,NULL,323
"placebo n $nmbr$ $nmbr$","C0032042;C1696465;C1706408","C0032042","",28
"heart rate beats min mean sd","C0018810;C0444504;C0702093;C1524029;C2347634;C2348143;C2699239;C3813700","C0018810","",1105
"baseline tav median n $nmbr$ $nmbr$","C0168634;C0279686;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193",NULL,NULL,635
"mean bmii s d kg m $nmbr$","C0444504;C1532718;C2347634;C2348143",";C1305855","",206
"risk factors for atherosclerosis","C0003850;C0004153;C0035648;C1553898","C0004153","",1698
"education high school or higher","C0205250;C0683862",NULL,NULL,834
"symptom onset to","C4086878",NULL,NULL,612
"time from presentation to randomization hr","C0034656;C0040223;C0449450;C3541383",NULL,NULL,692
"xho p o $nmbr$","C4050013",NULL,NULL,443
"mean bmi","C0444504;C0578022;C2347634;C2348143",NULL,NULL,1735
"cardiovascular death or nonfatal mi excluding silent mi","C0007226;C0011065;C0332196;C0443304;C1306577;C2828389;C3810814;C3816734;C3887460;C4082313;C4552775",NULL,NULL,516
"aspirin $nmbr$","C0004057","C0004057","",1366
"fair or poor","C0032854;C0542537;C2700379;C2911689","C2700379","",234
"apolipoprotein a $nmbr$ mg dl","C0003592;C0439269;C0523508","C0003591","",1028
"depressed and low perceived social support","C0030971;C0037438;C0205251;C0344315;C0549249;C0748877;C1540833;C1550472;C3669642;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"iv nitrates","C0022326;C0028125;C0699857;C3848573;C4265176",NULL,NULL,537
"cv risk factors of patients","C0030705;C0035648;C1553898;C3538987;C4048877;C4318503",NULL,NULL,175
"hazard ratio $nmbr$ confidence interval","C0009667;C2985465","C2985465","",975
"egfr $nmbr$ ml min per $nmbr$ $nmbr$ m","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"percentage","C0439165;C1549488;C1561533",NULL,NULL,291
"fev $nmbr$ post albuterol l","C0001927;C0687676;C1704687;C3469826;C3714541",NULL,NULL,1599
"body mass index kg mq","C0005893;C0022718;C0024853;C0439209;C0578022;C1305855;C4054209","C1305855","",1734
"mild n $nmbr$","C2945599",NULL,NULL,329
"oral anticoagulant","C0354604","C0354604","",1747
"chd n","C0280604;C3542407",NULL,NULL,970
"rheumatoid arthritis","C0003873","C0003873","",1848
"a glucosidase inhibitor","C1512211",NULL,NULL,814
"colchicine n $nmbr$","C0009262","C0009262","",81
"current n $nmbr$ $nmbr$","C0521116;C1705970",NULL,NULL,1417
"no prior hf n $nmbr$ $nmbr$","C0018488;C0332152;C1313497;C1538440;C2826257;C3273279","C0018801",";C0168634;C1524003",12
"fev $nmbr$ of predicted normal post bronchodilator","C0520835;C0681842;C1882327;C2599594","C0024119","",288
"blood glucose control","C3267174",NULL,NULL,18
"eze $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761","C1142985","",1165
"duration of copd days","C0024117;C0439228;C0449238;C1412502;C2926735;C3714496",NULL,NULL,1726
"time intervals","C0872291",NULL,NULL,756
"$nmbr$ $nmbr$ to $nmbr$ ng l n $nmbr$ n","C0439297",NULL,NULL,202
"concomitant mtx","C0025677;C0521115;C1417487","C0025677","",1408
"acpa positive n","C0439178;C1446409;C1514241;C1525410;C1706063;C2825490;C3812269",";C0439178","",2051
"age $nmbr$ years median","C0549183;C0876920;C1510829;C2347635;C2348144;C2939193","C1510829","",481
"mean change s in fasting blood glucose mg dl mmol l","C0392747;C0428568;C0443172;C0444504;C1261430;C1532563;C1705241;C2347634;C2348143;C2827883;C3642216;C4319952",NULL,NULL,670
"sustained mucosal healingc","C0026724;C0443318",NULL,NULL,328
"geographic region","C0017446","C0017446","",369
"non caucasian","C0007457;C0043157;C1518422","C0043157","",1329
"motor weakness","C1513492;C1705994;C3714552",NULL,NULL,1473
"angiographic complications site reported no total no","C0002978;C0009566;C0205145;C0439175;C0439810;C0684224;C0700287;C1171258;C1515974;C2825164;C4319718",NULL,NULL,508
"flex baseline bmd t score","C0168634;C0449820;C1442488;C4050231",NULL,NULL,625
"baseline mean mg dl","C0168634;C0439269;C0444504;C1442488;C2347634;C2348143",NULL,NULL,192
"mssbp mmhg sd","C0439475;C2699239",NULL,NULL,1471
"contrast volume $nmbr$ ml","C0009924;C0439526;C0449468;C1690016;C1705102;C1705224;C1979874;C2700258;C3887665",NULL,NULL,2030
"median bnp iqr pg ml","C0054015;C0439297;C0549183;C0876920;C1095989;C1417808;C2347635;C2348144;C2939193;C2982014",NULL,NULL,1635
"symptoms of atrial fibrillation in the $nmbr$ months before randomization no","C0004238;C0034656;C0344434;C0439231;C0683368;C1457887;C1963067","C0004238","",90
"race or ethnic origin","C0015031;C0034510;C1706779;C3853635",NULL,NULL,787
"testosterone tt nmol l","C0039601;C0439282;C1452561;C4554543",NULL,NULL,669
"cat score mean sd","C0007450;C0325090;C0444504;C0449820;C0524517;C1443200;C2347634;C2348143;C2699239;C3665481;C4050231;C4050461;C4284282",NULL,NULL,255
"$nmbr$ $nmbr$ $nmbr$ obese class i","C3853264",NULL,NULL,115
"slowest third","C0205437;C0439834",NULL,NULL,1644
"so $nmbr$","C0037640","","",-10
"severe hyperkalemiac","C0205082;C4050465;C4050466",NULL,NULL,313
"ivabradine n $nmbr$","C0257190","C0257190",";C0687744;C1257890;C1519504;C1705428;C1705429;C0441848",68
"waist hip ratio","C0205682","C0205682","",1409
"no dm n $nmbr$","C0011816;C3250443",NULL,NULL,955
"hawaiian pacific","C0337920","C0337920;C0242191","",1331
"budesonide n $nmbr$","C0054201","C0054201","",1160
"mssbp mm hg","C0439475","C0005823","",1469
"$nmbr$ h pmg mmol l mean sd","C0444504;C2347634;C2348143;C2699239;C2827804",NULL,NULL,671
"$nmbr$ cl","C0596019",NULL,NULL,658
"baseline mean seated sbp mm hg sd","C0085805;C0168634;C0277814;C0439475;C0444504;C1283233;C1442488;C2347634;C2348143;C2699239",NULL,NULL,607
"formoterol $nmbr$ pg","C0030827;C0060657;C0072225;C1266240",NULL,NULL,2330
"white","C0007457;C0043157;C0220938","C0043157","",1402
"baseline bmi $nmbr$ to $nmbr$ kg m $nmbr$ n $nmbr$ $nmbr$","C0168634;C0578022;C1442488;C1532718",";C1305855","",206
"demographic feature","C0683970",NULL,NULL,583
"laba only monotherapy","C0205171;C1720467",NULL,NULL,925
"age $nmbr$ $nmbr$ y n $nmbr$","C0001779","C0001779","",480
"yes proliferative","C0334094;C1549445;C1705108;C1710701",NULL,NULL,147
"white race no y left ventricular ejection fraction","C0007457;C0034510;C0043157;C0220938;C0428772;C0488728;C1706779;C3853635","C0018801;C0428772","",1273
"steroids inhaled a","C0004048;C0038317",NULL,NULL,1648
"facit fatigue mean $nmbr$ sd range $nmbr$ $nmbr$","C0015672;C0444504;C1514721;C2347634;C2348143;C2348147;C2699239;C3463815;C3476791;C3542016;C4050243;C4554645","C0015672",";C4050243;C3542016;C0424589;C0542479;C1442080;C4330907;C0444504;C4553152",10
"ertugliflozin $nmbr$ mg vs placebo giimepiride","C0024671;C0026410;C0032042;C0439269;C1696465;C1706408;C1960952;C2346927;C4079805;C4321396;C4521761","C4079805","",1180
"number of previous anti tnf treatments for psoriatic arthritis","C0003872;C0087111;C0205156;C0237753;C0449788;C1448177;C1552607",NULL,NULL,362
"difference vs pbo $nmbr$ ci","C0008107;C0031962;C1705241;C1705242;C3259781",NULL,NULL,1466
"class $nmbr$ antiarrhythmic agents","C0003195;C0301380;C0456387;C1518526;C1705943",NULL,NULL,486
"no psa","C3810537;C3813209",NULL,NULL,125
"distal","C0205108;C4522154",NULL,NULL,352
"dipyridamole alone","C0012582;C0205171;C0439044;C0679994","C0012582","",1228
"etiology n","C0015127;C1314792;C1524003",NULL,NULL,924
"paroxysmal n","C0205311",NULL,NULL,1886
"inhaled","C0004048",NULL,NULL,167
"glucose test","C0337438;C0595310",NULL,NULL,2317
"argentina","C0003761;C1504311",NULL,NULL,1565
"any ae n","C3887670","C0877248","",47
"large artery atherosclerosis","C0003850;C0004153;C0226003","C0004153","",1698
"alvmi per g m $nmbr$","C0456715",NULL,NULL,528
"hf hospitalizations median iqr","C0018488;C0019993;C0549183;C0876920;C1313497;C1538440;C2347635;C2348144;C2939193;C3273279",NULL,NULL,2359
"dapagliflozin $nmbr$ mg insulin n $nmbr$","C0021641;C0024671;C0026410;C0439269;C1533581;C1579433;C1960952;C2346927;C2353951;C3714501;C4321396;C4521761","C2353951","",2066
"geographic region n","C0017446","C0017446","",369
"gold classification","C0008902;C0008903;C0018026;C0678229;C1304897","C0024117;C0521117","",213
"median q $nmbr$ q $nmbr$ duration of diabetes years","C0011847;C0011849;C0439234;C0449238;C0549183;C0876920;C2347635;C2348144;C2926735;C2939193",NULL,NULL,1099
"glycaemic control hba $nmbr$ c n","C0005802;C0019016;C0243148;C1550141;C1825777;C1882979;C2587213;C3274648;C3538758;C4553389",NULL,NULL,675
"risk factors specified as inclusion criteria no f","C0016327;C0035648;C0205369;C1512693;C1553898",NULL,NULL,175
"risk factors and immobility level n","C0035648;C0231441;C0441889;C0456079;C1547707;C1553898;C2946261",NULL,NULL,744
"tier $nmbr$ aes","C1412268;C2699274","C0877248","",47
"albumin g dl","C0001924;C0439267","C0001924","",1071
"$nmbr$ chlorthalidone","C0008294","C0008294","",70
"dyspnea","C0013404;C1963100","C0013404","",1227
"fev $nmbr$ predicted","C0681842;C1882327;C3714541",NULL,NULL,1599
"race or ethnic group no","C0015031;C0034510;C1706779;C1879937;C3853635",";C0034510","",1107
"level of renal impairment","C0441889;C0456079;C1547707;C1565489;C2946261","C1565489","",937
"prior anti tnf therapy","C0281481;C0332152;C2826257",NULL,NULL,2375
"jbs $nmbr$ secondary prevention only $nmbr$","C0175692;C0205171;C0679699;C0795841;C1416527;C1720467",NULL,NULL,925
"baseline lipoprotein a nmol l median iqr","C0065058;C0125953;C0168634;C0439282;C0549183;C0876920;C1096202;C1439335;C1442488;C2347635;C2348144;C2939193","C0065058","",1769
"age group $nmbr$ no","C0027362;C2348001",NULL,NULL,45
"history of amputation no","C0002688;C0019664;C0019665;C0262512;C0262926;C0332840;C1546539;C1705255;C2004062","C0002688","",1973
"global trial population","C0008976;C0032659;C0205246;C1257890;C2348867",NULL,NULL,904
"alcohol intake never rarely","C0001948;C0522498;C2003901","C0001948","",875
"remission","C0544452;C0687702",NULL,NULL,1712
"below median","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"rate ratio","C0456603;C0871208;C1521828;C1547037",NULL,NULL,973
"methotrexate plus other csdmardfl","C0025677","C0025677","",1408
"carisbamate $nmbr$ $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1871983;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2273
"heart rate beats min","C0018810;C0702093;C1524029;C3813700","C0018810","",1105
"nighttime mean dbp abpm at week $nmbr$ mmhg","C0240526;C0332174;C0439230;C0439475;C0444504;C0536221;C2347634;C2348143;C3813197;C4281799","C0005823","",1469
"no needed to treat $nmbr$ cl","C0027552;C0040363;C0041260;C0087111;C0596019;C0686904;C1292734;C1522326;C1883351",NULL,NULL,432
"bw kg","C0005910;C0006041;C0022718;C0439209;C2986891;C4054209",NULL,NULL,2326
"bp goal attainment","C0037623;C0680230;C1415692;C1708288;C4318478",NULL,NULL,1687
"paroxysmal","C0205311",NULL,NULL,1886
"bmi group no","C0441833;C0578022;C0687744;C1257890;C1519504;C1705428;C1705429",NULL,NULL,1526
"baseiine ccb","C0006684",NULL,NULL,704
"statin with other llt","C0360714;C2347090","C0360714","",872
"mean serum glucose mg dl mean sd","C0202041;C0439269;C0444504;C2347634;C2348143;C2699239;C3534430",NULL,NULL,192
"beta blockers all n","C0001645;C0369718;C0441922","C0001645","",959
"serum hdl cholesterol mmol l mean sd","C0428472;C0444504;C1532563;C2347634;C2348143;C2699239",NULL,NULL,670
"hyperkalaemia serum potassium $nmbr$ $nmbr$ mmol l","C0020461;C0302353;C0543465;C1532563;C4552983","C0032821","",1371
"lvh by ecg or echocardiography no","C0013516;C0232306","C0232306","",406
"early n $nmbr$","C1279919",NULL,NULL,1487
"prerandomization pci","C4049621",NULL,NULL,1736
"$nmbr$ $nmbr$ flex fn f score $nmbr$","C0016327;C0449820;C1570610;C4050231",NULL,NULL,748
"etoricoxib $nmbr$ mg n $nmbr$ n","C0024671;C0026410;C0439269;C0972314;C1960952;C2346927;C4321396;C4521761","C0972314","",1130
"i $nmbr$ i $nmbr$ i","C0021966;C0221138",NULL,NULL,1021
"hazard ratio $nmbr$ ci vs placebo","C0008107;C0032042;C1696465;C1706408;C2985465;C3259781","C2985465","",975
"diabetes duration median iqr years","C0011847;C0011849;C0439234;C0449238;C0549183;C0876920;C2347635;C2348144;C2926735;C2939193","C2926735;C0011849","",1988
"unadjusted","C1439367",NULL,NULL,1581
"anti histamines","C0019590","C0019590","",870
"all bare metal stents","C2825200","C2825200","",348
"troponin","C0041199",NULL,NULL,1605
"creatinine clearance category ml min no b","C0439445;C0683312;C0812399;C3889287","C0812399",";C3889287;C0452249;C0522467;C1337213;C1576800;C3890003;C0005910;C0022718;C1305866;C1705104;C1705224;C3887665",79
"moderate or severe decrease in gfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$","C0017654;C0205081;C0205082;C0369637;C0392756;C0439445;C0441923;C0547047;C1424601;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335","C3811844;C0017654","",307
"ischemic stroke without hemorrhagic conversior","C0333275;C0475224;C0553692;C0948008",NULL,NULL,581
"cv death mi ischemic stroke hospitalization for hf coronary revascularization ua","C0011065;C0018488;C0019993;C0041580;C0042014;C0376297;C0581603;C0877341;C0948008;C1306577;C1313497;C1538440;C3273279;C3538987;C3810814;C4048877;C4082313;C4318503;C4552775",NULL,NULL,323
"$nmbr$ except for female alone","C0043210;C0086287;C0205171;C0439044;C0679994;C1705497;C1705498",NULL,NULL,926
"concomitant medications at baseline","C0013227;C0168634;C0521115;C0802604;C1442488;C2598133;C4284232","C0013227;C0521115","",1916
"hypertensive","C0857121","C0020538","",1364
"no treatment or antihistamines only","C0019590;C0039798;C0087111;C0205171;C1522326;C1533734;C1705169;C1720467;C3538994;C3887704",NULL,NULL,1060
"and microalbuminuria or macroalbuminuria","C0730345","C0033687","",376
"time from qualifying mi","C0040223;C1514624;C3541383;C3810814",NULL,NULL,757
"heparins and fondaparinux","C0019134;C1098510","C1098510","",859
"three of seven risk factors","C0035648;C0205449;C0205453;C1553898",NULL,NULL,175
"atenolol","C0004147","C0004147","",1055
"mcs score $nmbr$ $nmbr$ scale","C0175659;C0349674;C0449820;C1947916;C4050231",NULL,NULL,748
"ranotazine vs placebo km failure rate","C0032042;C0231174;C0680095;C0871208;C1521828;C1696465;C1706408;C3887676",NULL,NULL,1103
"index event","C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010",NULL,NULL,734
"alaska native","C0682125",NULL,NULL,763
"us resident","C1320928;C1549439;C2347958;C3835651",NULL,NULL,121
"current smokers n $nmbr$","C3173209;C3241966","C3241966","",1420
"male n","C0086582;C1706180;C1706428;C1706429","C0086582","",1276
"calcium antagonist","C0006684","C0006684","",1884
"batellna c reective protein","C0033684","C0006560","",286
"low dose rivaroxaban aspirin group","C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1739768;C2608320","C1739768","",1225
"st segment depression","C0520887","C0520887",";C0011570;C0011581;C0344315;C4049644;C0702240;C4085311;C4084909",1856
"risk reduction $nmbr$ cl","C0596019;C1137094",NULL,NULL,658
"clopidogrel dose","C0070166;C0178602;C0869039;C1114758",NULL,NULL,110
"hand","C0018563;C1552914",NULL,NULL,1666
"high crp and esr","C0205250;C1299351;C2700149;C3811131;C3887512;C3889660;C3890735;C4048285;C4321237;C4522209",NULL,NULL,834
"budesonide formoterol $nmbr$ g $nmbr$ $nmbr$ g n $nmbr$","C1276807;C1319635","C1276807","",1159
"trough fev $nmbr$","C0444506;C3714541",NULL,NULL,1599
"dactylitis severity score score $nmbr$ no","C0239161;C0449820;C0457451;C4050231","C0239161","",492
"both ptca and cabg","C0010055;C2936173","C2936173;C0010055","",1524
"prior cardiovascular history","C0332152;C1880008;C2826257",NULL,NULL,2378
"number of participants","C0237753;C0449788;C0679646",NULL,NULL,1556
"sleeping problems in the past $nmbr$ weeks","C0700201;C2987125",NULL,NULL,1014
"laba ics free or fixed dose combination","C0178602;C0205195;C0332296;C0443218;C0815320;C0869039;C1114758;C1880497;C1947911;C1996904;C2827483;C3714578;C3811910;C4551720",NULL,NULL,1305
"dissatisfied with stopped $ $nmbr$ prior systemic therapy because of side effects","C0001688;C0205373;C0332152;C0870433;C0877248;C0879626;C1272691;C1514463;C1515119;C2826257;C4085546",NULL,NULL,294
"dactylitis score at baseline median iqr week $nmbr$","C0168634;C0239161;C0332174;C0439230;C0449820;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193;C4050231","C0239161","",492
"time to randomization from symptom onset","C0034656;C0040223;C3541383;C4086878",NULL,NULL,692
"history of lvh on echocardiogram","C0013516;C0019664;C0019665;C0149721;C0262512;C0262926;C1705255;C2004062;C2243117","C0149721","",1272
"ethnic origin n","C0015031",NULL,NULL,787
"sfc $nmbr$ $nmbr$ mg twice daily n $nmbr$ $nmbr$","C0024671;C0026410;C0439269;C0585361;C1960952;C2346927;C4321396;C4521536;C4521761",NULL,NULL,1283
"week $nmbr$ hba $nmbr$ c mean s e","C0019016;C0332174;C0439230;C0444504;C1825777;C2347634;C2348143;C3538758","","",820
"concurrent treatment of crohn s disease at study entry no of patients ff","C0010346;C0030705;C0039798;C0087111;C0205420;C0557651;C1522326;C1533734;C1705169;C1705654;C2603343;C3538994;C3887704;C4554348",NULL,NULL,105
"homa ir mu l mmol l","C0022065;C0022071;C0439190;C0439342;C1448132","","",1397
"hypertension no","C0020538;C1963138","C0020538","",1364
"si gni fi canr ecg changes positive biomarkers and age $nmbr$ vrs","C0001779;C0005516;C0392747;C0439178;C0443172;C0458261;C1446409;C1514241;C1623258;C1705241;C2825490;C3273608;C3812269;C4050619;C4319952",NULL,NULL,1311
"hba $nmbr$ c patients $nmbr$ $nmbr$","C0019016;C0030705;C1825777;C3538758","","",820
"geometric mean of baseline","C0168634;C1442488;C2986759","","",241
"previous antiarrhythmic treatment no","C0003195;C0039798;C0087111;C0205156;C1522326;C1533734;C1552607;C1705169;C3537142;C3538994;C3887704",NULL,NULL,1060
"sbp last","C0085805;C1517741",NULL,NULL,607
"mean a sem","C0444504;C2347634;C2348143",NULL,NULL,36
"pro pro homozygotes","C0019904;C1120626",NULL,NULL,436
"cardiovascular death myocardial infarction stroke","C0011065;C0027051;C0428953;C1306577;C2926063;C3810814;C4082313;C4552775;C4552959",NULL,NULL,323
"chlorthalidone group","C0008294;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429","C0008294","",70
"t $nmbr$ lesion volume mm","C0221198;C0449468;C1546698;C1690016;C1705102;C2603360;C2700258;C4330985;C4554674",NULL,NULL,472
"r ight coronary","C0018787;C0205090;C0684010;C2603358","C1261316","",224
"aminosalicylates n","C0368663","C0368663","",1691
"$nmbr$ $nmbr$ l l","C3539687","","",-10
"disease duration yrs mean sd","C0444504;C0872146;C2347634;C2348143;C2699239",NULL,NULL,138
"duration of assigned regimen before surgery","C0038894;C0038895;C0040808;C0449238;C0543467;C1274039;C1516050;C1552601;C2926735;C2945654",NULL,NULL,901
"mras","C1335594;C1367476",NULL,NULL,140
"history of microvascular disease","C0443258;C0683519;C0730226;C0850708;C0944983",NULL,NULL,105
"randomized double blind reversal phase baseline week $nmbr$","C0013072;C0034656;C0168634;C0205390;C0332174;C0439230;C0443290;C1442488;C1710475;C3815594",NULL,NULL,1012
"$nmbr$ confidence interval","C0009667","C0009667","",2261
"$nmbr$ $nmbr$ vi $nmbr$ $nmbr$","C0205999",NULL,NULL,515
"minutes from symptom onset to prehospital ecg median iqr","C0439232;C0549183;C0700321;C0702093;C0876920;C1282918;C1623258;C2347166;C2347635;C2348144;C2939193;C4086878",NULL,NULL,635
"no prior ugi event","C0332152;C0441471;C0560042;C2826257;C4019010",NULL,NULL,294
"any including corticosteroid","C0001617;C0332257;C3536709",NULL,NULL,1650
"constitutional","C1511487",NULL,NULL,1711
"ffa mmol l","C0015688;C1532563","C0015688","",1961
"prior lev","C0023556;C0332152;C2826257",NULL,NULL,294
"imt $nmbr$","C0334121;C1704614;C4318736","","",-10
"high titre $nmbr$ times of uln n","C0040223;C0205250;C0475208;C1299351;C1519815;C1632851;C2700149;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"all cause mortality no of events","C0015127;C0026565;C0026566;C0441471;C0444868;C1524003;C3539085;C3541888",NULL,NULL,924
"serum creatinine gmol l mean sd","C0201976;C0444504;C0600061;C2347634;C2348143;C2699239","C0600061;C0010294","",952
"baseline egfr $nmbr$ to $nmbr$","C0168634;C1442488;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"i $nmbr$ $nmbr$ i","C0021966;C0221138",NULL,NULL,1021
"clopidogrel aspirin n $nmbr$","C0004057;C0070166","C0070166",";C0369286;C0033727;C4049621",217
"education years","C0013621;C0013622;C0013658;C0039401;C0439234","C0013658","",1990
"secondary","C0027627;C0175668;C0205436",NULL,NULL,1484
"mtx at baseline","C0025677;C0168634;C1417487;C1442488","C0025677","",1408
"without psoriasis n $nmbr$ $nmbr$","C0033860","C0033860","",1358
"single vessel coronary artery disease $nmbr$","C0581374",NULL,NULL,786
"history of pci ptca","C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C2936173;C4049621","C1532338","",1661
"cardiovascular disorder n","C0007222","C0007222","",1790
"bmi kg rrr","C0022718;C0439209;C0578022;C4054209","C1305855","",1734
"bmi mean kg m $nmbr$","C0444504;C0578022;C1532718;C2347634;C2348143",NULL,NULL,1735
"proximal to the splenic flexure","C0205107;C0227387;C4489236","C0205107;C0521362","",2242
"dose weight iu kg","C0005910;C0043100;C0178602;C0439463;C0869039;C1114758;C1305866;C1705104",NULL,NULL,1924
"diastolic blood pressure mm hg","C0428883;C0439475;C1305849","C0005823","",1469
"absolutedifferenceestimate vs placebo $nmbr$ ci","C0008107;C0032042;C1696465;C1706408;C3259781","C0032042","",28
"pad details n","C0182158;C0332568;C0369718;C0441922;C1522508;C1561567;C3540603;C3669270;C3814046;C4319657",NULL,NULL,1752
"pre bronchodilator fvc pred","C0032952;C0044955;C2599602;C3714541",NULL,NULL,682
"jugular venous distension n","C0425687","C0425687","",918
"beta receptor antagonist","C0330390;C0439096;C2004068;C4543207","C0001645","",959
"history of gestational diabetes mellitus no of women","C0043210;C2183115","","",-10
"nice secondary prevention onlyb","C0679699;C4087029",NULL,NULL,1715
"$nmbr$ mgday p eq","C0205163;C0439185",NULL,NULL,1625
"reduction of hba $nmbr$ c from baseline $nmbr$ $nmbr$","C0019016;C0168634;C0301630;C0392756;C1293152;C1442488;C1825777;C3538758;C4551656",NULL,NULL,730
"no copies gly $nmbr$ glu $nmbr$ $nmbr$ c","C0068000;C1948062",NULL,NULL,445
"time since end of fit mean sd y","C0036572;C0040223;C0444504;C0444930;C1711239;C2347634;C2348143;C2349186;C2699239;C2746065;C3541383;C4048158;C4553125",NULL,NULL,37
"ace inhibitor no","C0003015;C4541021","C0003015","",811
"vascular history","C0005847;C0019664;C0019665;C0262512;C0262926;C1558950;C1705255;C1801960;C2004062",NULL,NULL,832
"mean ml sd","C0439526;C0444504;C1705224;C2347634;C2348143;C2699239;C3887665",NULL,NULL,37
"impaired cognitive","C0338656",NULL,NULL,1570
"body weight mean sd kg","C0005910;C0022718;C0439209;C0444504;C1305866;C2347634;C2348143;C2699239;C4054209",NULL,NULL,2326
"fbg mg dl","C0439269","C0017725;C0015663","",2280
"native american alaskan","C0238611;C0282204;C0596070;C0682125;C1515945","C0282204","",2254
"interval study drug to pci","C0013175;C1272706;C1552654;C1552713;C4049621",NULL,NULL,1736
"cdai $nmbr$ $nmbr$","C0683448;C1413248;C3273706",NULL,NULL,697
"hscrp at baseline","C0168634;C1442488","C0006560","",286
"non severe hypoglycaemia","C0020615;C0205082;C1518422;C4050465;C4050466;C4553659",NULL,NULL,85
"q $nmbr$ $nmbr$ number n","C0237753;C0449788",NULL,NULL,1556
"characteristic and treatment","C0039798;C0087111;C1521970;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,236
"congestive heart","C0018787;C0742742","C0018801",";C0168634;C1524003",12
"cyp $nmbr$ a $nmbr$ inhibitors","C0243077;C1418793;C2634343",NULL,NULL,609
"urine albumin to creatinine ratio no","C0455271;C1318330","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"mean total serum ige sd iu ml","C0229671;C0439175;C0439458;C0439810;C0444504;C1546774;C1550100;C2347634;C2348143;C2699239",NULL,NULL,951
"elevated cardiac markers no t","C0205250;C1271630;C2603360;C3163633",NULL,NULL,415
"i $nmbr$","C0021966;C0221138",NULL,NULL,1021
"angiogenesis","C0302600;C1519670","","",-10
"fpg mmol l","C1532563","C0015663;C0202042","",1960
"psa ng ml mean sd","C0439275;C0444504;C2347634;C2348143;C2699239;C3810537;C3813209",NULL,NULL,204
"fpg mmol la","C0023031;C0023749;C0230347;C0439190;C2346906;C4553351",NULL,NULL,671
"cyclosporin","C0010592;C0010594","C0010594","",1384
"cerebrospinal fluid","C0007806;C0007807","","",-10
"ischaemic","C0475224",NULL,NULL,1670
"cardiovascular medications","C0007220","C0007220","",897
"baricitinib $nmbr$ $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C4044947;C4321396;C4521761","C4044947","",1956
"shs mean $nmbr$ sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"no or unknown","C0439673;C3541433;C4050014",NULL,NULL,93
"age group n","C0001779;C0441848","C0001779","",480
"tiotropium","C0213771","C0213771","",1372
"moderate intensity statin","C0360714;C4081855","C0360714","",872
"blood pressure in mm hg mean sd","C0428886;C0439475;C0488053;C2699239","C0005823","",1469
"mean change from baseline in fev $nmbr$ predicted sd","C0168634;C0392747;C0443172;C0444504;C0681842;C1442488;C1705241;C1882327;C2347634;C2348143;C2699239;C3714541;C4319952",NULL,NULL,767
"psoriatic arthritis","C0003872","","",2176
"history of atrial fibrillation flutter","C0016385;C0232197;C0729790;C1998417;C2242390",";C0004238","",1009
"morphine use for index event pci","C0242000;C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010;C4049621",NULL,NULL,412
"body weight kg n","C0005910;C0022718;C0439209;C1305866;C4054209",NULL,NULL,2326
"sr ii b $nmbr$ cjl $nmbr$","C0753208;C1709991;C1710602;C3813610;C3890900;C3891546;C4082587",NULL,NULL,521
"diagnosis at study entry no","C1704656;C1705654;C4068481",NULL,NULL,86
"percentage patients reaching target","C0030705;C0439165;C1521840;C1549488;C1561533;C2584321;C2986546",NULL,NULL,1035
"history of mi or stroke history of coronary","C0018787;C0019664;C0019665;C0038454;C0262512;C0262926;C1705255;C2004062;C3810814;C4554100",NULL,NULL,832
"disease and quality of life scores","C0012634;C0034380;C0449820;C0518214;C4050231","C0034380","",1116
"enthesitis n","C1282952","C1282952","",271
"patients no total no","C0030705;C0439175;C0439810",NULL,NULL,508
"inotropic agent","C0304509",NULL,NULL,487
"patients $nmbr$ y","C0030705",NULL,NULL,1035
"current medication use","C0042153;C0240320;C0457083;C0521116;C0746467;C1705970;C1947944",NULL,NULL,119
"anti hypertensive therapy no","C0585941",";C0003364","",1579
"score no","C0449820;C4050231",NULL,NULL,748
"significant worsening in kccq clinical score $nmbr$ at $nmbr$ months $nmbr$","C0332271;C0439231;C0449820;C1457868;C1546960;C2826293;C3476798;C4050231",NULL,NULL,1530
"patients with weekly iss mid response n v","C0030705;C0332174;C0871261;C1704632;C1706817;C1740819;C1845118;C2911692",NULL,NULL,1013
"egfr ml min mdrd","C0439445;C1739039;C3811844;C3812682;C3839656","C3811844;C0017654","",592
"digoxin digitalis glycoside","C0012253;C0012265","C0012265","",989
"hx stroke tia","C0007787;C0038454;C0262926;C0917805;C1054154;C3814444;C4554100",NULL,NULL,1592
"alirocumab n $nmbr$","C3491162",NULL,NULL,948
"egfr by cystatin c ml min per $nmbr$ $nmbr$ m $nmbr$ mean se","C0036919;C0071744;C0369637;C0439445;C0441923;C0444504;C1413772;C1739039;C2347634;C2348143;C3811844;C3812682","C3811844;C0017654","",592
"irr $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$","C4082285",NULL,NULL,221
"favors ffa i favors placebo","C0015688;C0021966;C0032042;C0221138;C0309049;C1696465;C1706408","C0032042","",28
"mean age years","C0444504;C1510829;C2347634;C2348143","C1510829","",481
"randomization n","C0034656",NULL,NULL,692
"cigarette smoker","C0337667","C0037369","",420
"treatment at baseline","C0039798;C0087111;C0168634;C1442488;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,236
"current tobacco abuse n","C0040336;C0521116;C1705970","C0037369;C0521116","",2224
"calcium channel","C0006685","C0006685","",2200
"actual l","C0237400",NULL,NULL,501
"homa ir index median iqr","C0022065;C0022071;C0549183;C0600653;C0876920;C0918012;C1448132;C1552854;C1637833;C2347635;C2348144;C2939193;C2986546","","",1397
"$nmbr$ g bid n $nmbr$","C0439267","","",-10
"body mass index kg rn \ mean sd","C0005893;C0022718;C0439209;C0444504;C0578022;C1305855;C2347634;C2348143;C2699239;C2827110;C3540639;C4054209;C4281819","C1305855","",1734
"blood leucocyte concentration $nmbr$ cells per l","C0023516;C0086045;C0347983;C0427728;C0699870;C1313904;C1446561;C3827302",NULL,NULL,676
"cor revasc","C0018787;C0056331;C0378365",NULL,NULL,1481
"mean number of caes in past $nmbr$ months number per patient","C0030705;C0237753;C0444504;C0449788;C2347634;C2348143;C4331910",NULL,NULL,37
"triglycerides $nmbr$ nd third","C0041004;C0205437","C0041004","",368
"ldl c in mmol l mean sd for baseline n mean se for week $nmbr$ n","C0036919;C0168634;C0332174;C0439230;C0444504;C1442488;C1532563;C2347634;C2348143;C2699239",NULL,NULL,1287
"ed severity visit $nmbr$","C0439793;C0522510;C0545082;C1512346;C2826704;C3538926",NULL,NULL,276
"exacerbations","C4086268","C4086268","",889
"endpoint","C2349179;C2826544","C2349179","",1136
"hba $nmbr$ c mean $nmbr$ sd","C0019016;C0444504;C1825777;C2347634;C2348143;C2699239;C3538758","","",820
"bp component mm hg","C0037623;C0439475;C0449432;C1415692;C1705248;C1708288;C4318478",NULL,NULL,608
"infarction before age $nmbr$ a","C0001779;C0021308","C0001779","",480
"symptomatic","C0231220",NULL,NULL,611
"body mass index kg ma","C0005893;C0022718;C0024443;C0439209;C0578022;C1305855;C3887485;C4054209","C1305855","",1734
"local eosinophil count cells ml median range","C0200638;C0205276;C0549183;C0750879;C0876920;C1514721;C2347635;C2348144;C2348147;C2699156;C2939193;C3542016","C0750879","",848
"pre bronchodilator fef $nmbr$ $nmbr$ ml s baseline blood eosinophil count","C0005767;C0005768;C0014467;C0168634;C0200638;C0229664;C0439390;C0750480;C0750879;C1442488;C1705566;C2599602",NULL,NULL,682
"$nmbr$ $nmbr$ mmol liter triglyceride level","C0428475;C0439190;C0475211",NULL,NULL,987
"number of exacerbations in the last $nmbr$ months mean sd","C0237753;C0444504;C0449788;C2347634;C2348143;C2699239;C4086268;C4331910","C4086268","",889
"cardiovascular death or heart failure hospitalization","C0007226;C0011065;C1306577;C3887460;C3898876;C4082313;C4552775",NULL,NULL,323
"likelihood test","C0022885;C0033204;C0039593;C0392366;C0456984;C1515976;C3831328;C4318744",NULL,NULL,242
"bone mineral density g cm $nmbr$ mean sd","C0005938;C0177804;C0439267;C0444504;C2347634;C2348143;C2699239",NULL,NULL,701
"difference tiotropium placebo ml $nmbr$ ci","C0008107;C0032042;C0213771;C0439526;C1696465;C1705224;C1705241;C1705242;C1706408;C3259781;C3887665",NULL,NULL,1466
"female premenopausal","C0043210;C0086287;C0279752;C1705497;C1705498","C0279752","",1042
"minor surgery","C0038904",NULL,NULL,2336
"not severe","C4316743",NULL,NULL,92
"baseline aspirin use strata","C0004057;C0042153;C0168634;C0457083;C1442488;C1947944",NULL,NULL,118
"renal functionb","C0022646","C0232804","",1532
"fasting serum glucose mmol l median q $nmbr$ q $nmbr$","C0015663;C0202041;C0549183;C0876920;C1532563;C2347635;C2348144;C2939193;C3534430","C0015663;C0202042","",1960
"mean s e t","C0444504;C2347634;C2348143",NULL,NULL,37
"patients with clinically evident vascular disease","C0030705;C0042373;C3887511","C0042373","",914
"placebo patients with events total","C0030705;C0032042;C0439175;C0439810;C0441471;C1696465;C1706408;C3541888","C0032042","",28
"previous cardiovascular events","C0205156;C1320716;C1552607","C1320716","",414
"malignancy death","C0006826;C0011065;C1306459;C1306577;C4082313;C4282132;C4552775",NULL,NULL,323
"pre operative cardiac medications","C0018787;C1522601;C1882154;C2347660",NULL,NULL,1481
"bocf iike imputation random n $nmbr$","C0034656;C0439605;C2699638;C2984917",NULL,NULL,1627
"met atopy and ige $nmbr$ $nmbr$ ku l criteria n $nmbr$","C0243161;C0392707;C0428210;C0439340;C1550543;C3539705;C4317104","C0392707","",1412
"ci aki risk score","C0008107;C0022660;C0035647;C0330978;C0449820;C3259781;C4050231;C4552904",NULL,NULL,519
"weight group no","C0005910;C0043100;C0441833;C0687744;C1257890;C1305866;C1519504;C1705104;C1705428;C1705429","C0005910","",1250
"adjusted mean change from baseline","C0168634;C0392747;C0443172;C0444504;C0456081;C1442488;C1705241;C2347634;C2348143;C4319952",NULL,NULL,625
"since onset","C0206132;C0332162",NULL,NULL,736
"hba $nmbr$ ca mmol mol","C0019016;C1825777;C3538758;C3829066;C3887642","","",820
"hispanic latino n $nmbr$","C0086409;C0086528","C0086528;C0086409;C0015031","",363
"current past smoker","C1444637;C3173209;C3241966;C4284302","C3241966","",1420
"no prior mi n $nmbr$ $nmbr$","C0332152;C2826257;C3810814",NULL,NULL,516
"with events","C0441471;C3541888",NULL,NULL,412
"tp vs no tp","C0036183;C3541334",NULL,NULL,132
"body mass index mean sd kg m","C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239","C1305855","",1734
"black african american","C0085756","C0005680",";C1706779",188
"ato $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761","C0286651","",885
"lipid modifiers","C0023779;C4284280","C0023779","",1772
"toial cholcsierol mg dl","C0439269","C1445957","",1968
"sf $nmbr$ health survey","C0018762;C0037712",NULL,NULL,1782
"ace inhibitors","C0003015","C0003015","",811
"mini mental state examination","C0451306","C0451306","",305
"subscale and $nmbr$ to $nmbr$ for the function subscale normalized scores can range from $nmbr$ to $nmbr$ scores for the health assessment question","C0031843;C0040363;C0041260;C0175637;C0449820;C0459443;C0542341;C0700205;C1514721;C1522634;C1705273;C1882115;C1883351;C2348147;C3542016",NULL,NULL,1692
"mean number of puffs per day","C0237753;C0332173;C0439228;C0439505;C0444504;C0449788;C1533107;C2347634;C2348143",NULL,NULL,37
"week $nmbr$ czp dose combined n $nmbr$","C0054841;C0178602;C0205195;C0332174;C0369718;C0439230;C0441922;C0869039;C1114758;C1861828;C1872109","C1872109","",1406
"any revascularization","C0581603","C0581603","",1213
"$nmbr$ years n $nmbr$","C0439234",NULL,NULL,1099
"adjusted rate of hospitalized pneumonia events per patient year mean $nmbr$ ci","C0008107;C0030705;C0032285;C0439234;C0439508;C0441471;C0444504;C0456081;C0701159;C0871208;C1521828;C2347634;C2348143;C3259781;C3541888",NULL,NULL,519
"i $nmbr$ $nmbr$ vs $nmbr$ $nmbr$","C0021966;C0221138",NULL,NULL,1021
"fasting proinsulin pmol l","C0015663;C0033362;C0439284;C3813208",NULL,NULL,665
"assoc with corrected congenital shunts","C0009678;C0205202;C0232180;C0542331;C1442858;C1744681",NULL,NULL,478
"prior myocardial infarction n","C0155668",NULL,NULL,647
"hypertension history","C0019664;C0019665;C0020538;C0262512;C0262926;C1705255;C1963138;C2004062","C0020538","",1364
"mass index","C0577559;C0577573;C0600653;C0918012;C1096155;C1306372;C1552854;C1637833;C2986546;C3152252;C3539882;C4283905",NULL,NULL,734
"yes yes","C1549445;C1705108;C1710701",NULL,NULL,147
"placebo n rate","C0032042;C0871208;C1521828;C1696465;C1706408","C0032042","",28
"asian itt population total n $nmbr$","C0032659;C0078988;C0439175;C0439810;C1257890",NULL,NULL,900
"infarct ion w ithin previous $nmbr$ day s","C0021308;C0022023;C0205156;C0332173;C0439228;C0439505;C1552607;C1700702",NULL,NULL,1621
"ifg prediabetes","C0362046;C1334085;C1708411","C0362046",";C0168634;C1334085;C1708411",910
"kg m $nmbr$","C1532718",";C1305855","",206
"previous exposure to systemic psoriasis therapyb yes n","C0033860;C0205156;C0205373;C0332157;C1549445;C1552607;C1705108;C1710701","C0033860;C0205156;C0332157;C0205373","",2181
"laba ics versus indzgly lsm difference $nmbr$ cl","C0596019;C0815320;C1705241;C1705242;C4551720",NULL,NULL,1466
"hba $nmbr$ c","C0019016;C1825777;C3538758","","",820
"symptom onset to first medical contact ambulance or emergency department","C0002422;C0199168;C0205435;C0205476;C0332158;C0337611;C0562508;C1279901;C1705415;C3812666;C3846685;C4086878","C0002422",";C4049621",191
"number of subjects","C0237753;C0449788;C0681850;C1550501;C1706203;C2349001;C2697811",NULL,NULL,1655
"or_value","C1522609",NULL,NULL,9
"death all cause","C0011065;C0015127;C1306577;C1524003;C4082313;C4552775",NULL,NULL,1855
"no previous copd medication","C0013227;C0024117;C0205156;C1412502;C1552607;C3244316;C3714496;C4284232",NULL,NULL,1726
"absolute fvc decrease $nmbr$","C0205344;C0392756;C0547047;C3714541",NULL,NULL,1578
"$nmbr$ o o $nmbr$ o $nmbr$","C0483204","","",-10
"atv atorvastatin ldl c low density lipoprotein cholesterol p values pertain to treatment by stratum interaction test for stratum or treatment by subgroup interaction test for subgroups multiplicity adjustments were not applied to this predefined subgroup analysis of ldl c goal attainment expressed as number of patients reaching ldl c goal at week $nmbr$ number of patients above goal at baseline treatment stratum was defined by intake of atv $nmbr$ or $nmbr$ mg","C0018017;C0022885;C0023824;C0024671;C0026410;C0039593;C0039798;C0087111;C0168634;C0210243;C0237455;C0286651;C0332174;C0376209;C0392366;C0439230;C0439269;C0449822;C0456081;C0456984;C0674679;C0680230;C1079230;C1145759;C1334862;C1442488;C1512806;C1515021;C1515976;C1518422;C1522326;C1533734;C1571704;C1704675;C1704788;C1705169;C1709380;C1960952;C2346927;C2360800;C2584321;C2945673;C2986480;C3538994;C3539106;C3831328;C3887704;C4048755;C4318744;C4321396;C4521761","C0286651","",885
"empa","C2699863",NULL,NULL,408
"systolic blood pressure mmhg","C0439475;C0488055;C0871470;C1306620","C0871470","",615
"rescue medication use inh d","C0022209;C0240320",NULL,NULL,119
"$nmbr$ year km","C0439234;C0439508;C3887676",NULL,NULL,1099
"maximum","C0806909;C1552615;C2826546","C0806909","",2201
"estradiol quartiles","C0014912;C2828255",NULL,NULL,1016
"baseline pulmonary medication n","C0013227;C0024109;C0168634;C1442488;C2707265;C2709248;C3244316;C4284232;C4522268",NULL,NULL,572
"serum sodium mmol liter","C0439190;C0475211;C0523891","C0523891","",1379
"types of fibrinolytic agent","C0016018;C0332307",NULL,NULL,487
"implantable cardioverter defibrillator","C0162589;C2825184",NULL,NULL,1628
"current medication n","C0746467","C0746467","",1416
"$nmbr$ n chads $nmbr$ score","C0007928;C0369718;C0441922;C0449820;C1413373;C4050231","","",2128
"stroke n $nmbr$","C0038454;C4554100",NULL,NULL,1762
"renal function n","C0232804","C0232804","",1532
"age at menopause yr","C0439234;C1625754;C1629609",NULL,NULL,1099
"mean age years range","C0444504;C1510829;C1514721;C2347634;C2348143;C2348147;C3542016","C1510829","",481
"on maximum tolerated medications median $nmbr$ th to $nmbr$ th quartile sua mg dl","C0013227;C0039725;C0039738;C0439269;C0549183;C0802604;C0806909;C0876920;C1420718;C1552615;C2347635;C2348144;C2598133;C2826546;C2828255;C2939193;C4282123;C4284232;C4285344",NULL,NULL,192
"lmwh","C0019139;C3536766","C3536766","",1343
"no previous stroke or tia n $nmbr$","C0007787;C0038454;C0205156;C0917805;C1054154;C1552607;C4554100",NULL,NULL,1592
"p sitosterol lathosterol","C0037215;C0064673;C0220914;C0369773;C2603361",NULL,NULL,1503
"homa ir index","C0022065;C0022071;C0600653;C0918012;C1448132;C1552854;C1637833;C2986546","","",1397
"af pattern","C0344434;C0449774;C4049859",NULL,NULL,1794
"median body mass index kg m $nmbr$ iqr","C0005893;C0549183;C0578022;C0876920;C1305855;C1532718;C2347635;C2348144;C2939193","C1305855","",1734
"hcq mtx n $nmbr$","C0020336;C0025677;C1417487","C0025677","",1408
"any event","C0441471;C4019010",NULL,NULL,412
"total asthma symptom score mean sd","C0004096;C0444504;C2347634;C2348143;C2699239;C2984299;C3533163",NULL,NULL,694
"estimated creatinine clearance $nmbr$ mlvmin","C0750572;C0812399","C0812399",";C3889287;C0452249;C0522467;C1337213;C1576800;C3890003;C0005910;C0022718;C1305866;C1705104;C1705224;C3887665",79
"western europe hr $nmbr$ cl","C0043129;C0596019",NULL,NULL,1542
"sd or","C2699239",NULL,NULL,1287
"benralizumab $nmbr$ mg q $nmbr$ w n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C2982078;C4321396;C4521761",NULL,NULL,947
"low dose aspirin use at baseline yes","C0042153;C0168634;C0457083;C1442488;C1549445;C1705108;C1710701;C1947944;C2608320",NULL,NULL,625
"vertebrobasilar infarct","C0021308;C0545733","C0021308","",1288
"women n $nmbr$","C0043210","C0043210",";C3541888;C1720467",1323
"missing","C1551393;C1705492;C3272743","C1705492","",1144
"anti tnf experienced patients","C0030705;C1448177",NULL,NULL,362
"hdl cholesterol level","C0023822;C0201950;C0392885;C0428466;C0441889;C0456079;C1547707;C2946261;C3715113","C0023822","",821
"tc mmol l mg dl","C0039411;C0040642;C0041405;C0041698;C1824670;C3272447;C3642216;C3898312;C4522122","C0041004","",368
"cardiovascular","C0007226;C3887460",NULL,NULL,649
"statin fibrate or niacin","C0027996;C0360714;C1142562","C0360714","",872
"low ceiling diuretic","C0012798;C0205251;C1550472;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"total cholesterol sd mg dl","C0201950;C0439269;C0543421;C2699239","C0543421","",1504
"asas $nmbr$ $nmbr$ n","C0004057;C3853627",NULL,NULL,60
"mean s d ldl particle number nmol l","C0237753;C0439282;C0444504;C0449788;C2347634;C2348143;C2612459",NULL,NULL,37
"enthesitis score","C0449820;C1282952;C4050231","C1282952","",271
"$nmbr$ year cumulative incidence ci","C0008107;C0021149;C0220856;C0439234;C0439508;C1511559;C3259781","C0021149","",1467
"estimated gfr mean sd mlvmin per $nmbr$ $nmbr$ m","C0017654;C0369637;C0441923;C0444504;C0750572;C1424601;C2347634;C2348143;C2699239","C3811844;C0017654","",592
"no history of tnf antagonist treatment no","C0019664;C0019665;C0039798;C0087111;C0231491;C0262512;C0262926;C1448177;C1522326;C1533734;C1705169;C1705255;C2004062;C3538994;C3887704",NULL,NULL,184
"eosinophil count cells pl median range c","C0007584;C0007634;C0200638;C0549183;C0750879;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016;C3897966;C4049765","C0014467;C0007584","",1806
"cerebral infarction","C0007785",NULL,NULL,929
"simvastatin n $nmbr$ $nmbr$","C0074554","C0074554","",1840
"acr","C1412134;C1515941",NULL,NULL,52
"$nmbr$ $nmbr$ mg week","C0024671;C0026410;C0332174;C0439230;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,1012
"baseline $nmbr$ hour mean sbp mm hg","C0085805;C0168634;C0439227;C0439475;C0444504;C0564385;C1442488;C2347634;C2348143",NULL,NULL,606
"diabetes bl","C0005918;C0006413;C0011847;C0011849;C1552663;C2827109",NULL,NULL,655
"body weight index kg m $nmbr$","C0005910;C0600653;C0918012;C1305866;C1532718;C1552854;C1637833;C2986546","C0005910","",1250
"dupiiumab $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"c das $nmbr$ crp $nmbr$ $nmbr$","C0051767;C0057671;C3890735;C4048285",NULL,NULL,143
"high intensity statin","C0360714;C4081854","C0360714","",872
"any ae leading to discontinuation n","C0332152;C0457454;C1444662;C1522538;C3887670;C4552847","C0877248","",1974
"high density lipoprotein cholesterol mg dl","C0023822;C0439269","C0023822","",821
"smoking status at screening","C0037369;C0220908;C0220909;C0421330;C0453996;C1519386;C1698960;C1710031;C1710032;C1710477;C1881674;C2348164",NULL,NULL,796
"salbutamol","C0001927",NULL,NULL,584
"stage iii","C0441771",NULL,NULL,542
"$nmbr$ mmol mol $nmbr$ $nmbr$ n","C3829066",NULL,NULL,668
"baseline ocs use yes","C0042153;C0168634;C0457083;C1442488;C1549445;C1705108;C1710701;C1947944",NULL,NULL,147
"mild thrombocytopenia $nmbr$ x $nmbr$ l","C1856453",NULL,NULL,624
"current smoker at screeninga n","C3173209;C3241966","C3241966","",1420
"analysis","C0002778;C0936012;C1524024",NULL,NULL,183
"coronary risk factors no","C2024776","","",-10
"sbp mean over $nmbr$ h mmhg","C0033727;C0085805;C0369286;C0439475;C0441932;C0444504;C0564385;C2347634;C2348143;C4528284",NULL,NULL,607
"history of chd n","C0019664;C0019665;C0262512;C0262926;C0280604;C1705255;C2004062;C3542407",NULL,NULL,970
"high risk cvd n","C0007222;C0332167;C3272283;C4050568;C4319571","C4319571","",837
"class ii b blockers","C0441886;C2698968",NULL,NULL,845
"dm duration years","C0011816;C0439234;C0449238;C2926735;C3250443","C2926735;C0011849","",1988
"st segment elevation myocardial infarction no","C1536220",NULL,NULL,570
"infusion administered no total no","C0439175;C0439810;C0574032;C1521801;C1827465",NULL,NULL,508
"hr $nmbr$ ci multivariate cox proportional hazard regression","C0008107;C0205351;C0598697;C0684320;C0684321;C1565830;C1836830;C3259781",NULL,NULL,1544
"$nmbr$ to $nmbr$ n $nmbr$","C0369718;C0441922",NULL,NULL,1063
"baseline bmi $nmbr$ kg m $nmbr$ n $nmbr$ $nmbr$ change from baseline to $nmbr$ weeks","C0168634;C0392747;C0439230;C0443172;C0578022;C1442488;C1532718;C1705241;C4319952",";C1305855","",206
"concomitant medications in $nmbr$ of subjects no","C0013227;C0521115;C0681850;C0802604;C1550501;C1706203;C2349001;C2598133;C2697811;C4284232",NULL,NULL,1655
"gold d","C0018026;C1304897","C0024117;C0521117","",213
"$nmbr$ $nmbr$ values were not collected for $nmbr$ patients $nmbr$ $nmbr$ who were enrolled","C0030705;C0042295;C1516695;C1516698;C1518422;C4684790",NULL,NULL,1035
"enrolled from re cover ii study no","C0180153;C0556581;C0557651;C1999244;C2603343;C2986904;C3888055;C4684790",NULL,NULL,523
"normoalbuminuria or microalbuminuria","C0730345","C0033687","",376
"ascvd no prior ml","C0332152;C0439526;C1705224;C2826257;C3665365;C3887665",NULL,NULL,344
"baseline sulfonylurea yes","C0038766;C0168634;C1442488;C1549445;C1705108;C1710701;C3536898",NULL,NULL,147
"iga $nmbr$ $nmbr$","C2825347",NULL,NULL,1768
"at index acs event","C0441471;C0600653;C0742343;C0918012;C1552854;C1637833;C2986546;C4019010;C4318612",NULL,NULL,734
"endpoint rate","C0871208;C1521828;C2349179;C2826544","C2349179","",1136
"unadjusted $nmbr$ y risk per $nmbr$ population se adjusted rate","C0036919;C0242444;C0456081;C0871208;C1439367;C1521828;C2987720",NULL,NULL,172
"permanent users n","C0205355;C1706077",NULL,NULL,718
"difference in means $nmbr$ cl","C0596019;C1704970;C1705241;C1705242",NULL,NULL,1466
"combined end point","C0205195;C2349179;C2826544","C2349179","",1136
"participants","C0679646",NULL,NULL,1033
"cancer n $nmbr$","C0006826;C0998265;C1306459","C0006826","",1819
"stage $nmbr$","C0205390;C1300072;C1306673",NULL,NULL,541
"age y mean sd","C0001779;C0444504;C2347634;C2348143;C2699239",NULL,NULL,1907
"das $nmbr$ hscrp mean sd","C0051767;C0057671;C0444504;C2347634;C2348143;C2699239",NULL,NULL,1914
"pravastatin n $nmbr$","C0085542","C0085542","",1841
"yes o $nmbr$ cm","C1549445;C1705108;C1710701",NULL,NULL,147
"severity of copda combined assessment of copd n","C0024117;C0205195;C0439793;C0522510;C1261322;C1412502;C1516048;C3714496",NULL,NULL,1546
"efficacy parameter","C0549193;C1280519;C1704769;C1707887;C2350001","C0549193","",1186
"in extension study","C0231448;C0557651;C1880641;C2603343",NULL,NULL,1730
"w est europe","C0015176;C3811127;C3890902","C0015176","",337
"type of atrial fibrillation no total no","C0004238;C0332307;C0344434;C0439175;C0439810;C1547052;C1963067",";C0004238","",1009
"index events dvt n","C0149871;C0441471;C0600653;C0918012;C1552854;C1637833;C2926618;C2986546;C3541888;C3899446",NULL,NULL,412
"no of prior aeds n","C0180309;C0332152;C2826257",NULL,NULL,2374
"fevi l","C0429706;C0849974;C1561566;C4528367",NULL,NULL,1601
"aortic valve disease n $nmbr$ $nmbr$","C1260873;C4553103",NULL,NULL,1700
"ischemic cardiomyopathy","C0349782",NULL,NULL,652
"participants without metabolic syndrome","C0524620;C0679646",NULL,NULL,617
"ipss v","C1019118;C1998280;C2827405;C3811063","C1998280",";C1019118;C3811063;C4050465;C4050466;C4049706;C0168634;C1705273;C1880519;C3853603",124
"baseline median mg l","C0168634;C0439268;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193",NULL,NULL,635
"estimated creatinine clearance ml min","C0439445;C0750572;C0812399","C3811844;C0017654","",307
"prior tnf antagonist failure yes","C0231174;C0231491;C0332152;C0680095;C1448177;C1549445;C1705108;C1710701;C2826257",NULL,NULL,2375
"waist circumference cm","C0455829","C0455829","",1413
"sbp","C0085805",NULL,NULL,607
"outcome severity","C0439793;C0522510;C1274040",NULL,NULL,1602
"demographic and medical variables","C0011298;C0199168;C0205476;C0439828",NULL,NULL,582
"no gi bleed","C0019080;C1708130;C3539617;C4050121",NULL,NULL,525
"lipid parameters mg dl mean sd","C0023779;C0439269;C0444504;C0449381;C2347634;C2348143;C2699239","C0023779","",1967
"previous intolerance of infliximab n","C0205156;C0231199;C0666743;C1552607;C1744706;C2355652","C1744706;C0666743","",1094
"egfr n normal egfr $nmbr$ ml min em","C0205307;C0231683;C0439166;C0439445;C1739039;C2347086;C3811844;C3812682;C4553972","C3811844;C0017654","",592
"total gadolinium enhancing lesion count no","C0439175;C0439810;C0750480;C1333400;C1705566",NULL,NULL,509
"new or worsening vertebral fracture at $nmbr$ months","C0080179;C0205314;C0332271;C0439231;C1457868;C1546960","C0080179","",1038
"mean change $nmbr$ ci","C0008107;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C3259781;C4319952",NULL,NULL,519
"timi score","C0449820;C4050231",NULL,NULL,2052
"bmi $nmbr$ kg m n $nmbr$ $nmbr$","C0578022;C1532718",";C1305855","",206
"characteristic","C1521970","C1521970","",1110
"combined infliximab","C0205195;C0666743","C0666743","",154
"sodium meq l","C0037473;C0439375;C0597484;C3541959;C3714642","C0037473","",1378
"$nmbr$ ito $nmbr$","C0022283",NULL,NULL,1432
"baseline body weight quartile","C1303013;C2828255",NULL,NULL,626
"indacaterol glycopyrronium $nmbr$ $nmbr$ g o d","C0439417;C1722260;C3814772","C3814772;C1722260","",1509
"baseline sua mean sd mg dl","C0168634;C0439269;C0444504;C1442488;C2347634;C2348143;C2699239",NULL,NULL,1766
"congestive heart failure","C0018802","C0018801",";C0168634;C1524003",12
"anti gad negative n $nmbr$","C0205160;C0270549;C0432633;C1414925;C1513916;C2825415;C2825491;C3853545",NULL,NULL,1569
"septal anomaly no","C0332447;C0442004;C1704258",NULL,NULL,351
"enoxaparin n $nmbr$ $nmbr$","C0206460","C0206460","",862
"ultrasound carotid arteries","C0948945","C0007272","",1547
"seizure types reported during baselinee","C0036572;C0332307;C0684224;C0700287;C1959629;C4319718;C4553401","C0036572","",1394
"weight kg median $nmbr$ th $nmbr$ th","C0005910;C0022718;C0039725;C0039738;C0043100;C0439209;C0549183;C0876920;C1305866;C1420718;C1705104;C2347635;C2348144;C2939193;C4054209;C4282123;C4285344","C0005910","",2235
"smoker","C0337664","C0037369","",420
"ige high $nmbr$ ku l n $nmbr$ $nmbr$","C0205250;C0439340;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"scale cognitive portion ldl low","C0175659;C0205251;C0349674;C0449719;C1516691;C1550472;C1947916;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"atopy n $nmbr$ $nmbr$","C0392707;C3539705","C0392707","",1412
"$nmbr$ h pg mmol l","C0030827;C0072225;C0439190;C1266240;C2827798;C2827804",NULL,NULL,208
"teaes $nmbr$ in any treatment group","C0374505",NULL,NULL,1454
"ethnicity","C0015031;C0243103",NULL,NULL,787
"combined estimated gfr and albuminuria status","C0001925;C0017654;C0205195;C0449438;C0750572;C1424601",NULL,NULL,536
"s se mb or death","C0011065;C0024853;C0036919;C0565930;C1306577;C2603362;C4082313;C4552775",NULL,NULL,323
"aa mol","C0027960;C0282379;C0324740;C0439189;C1235746;C1456781;C1824986;C1882141;C3665593;C4554792",NULL,NULL,1754
"cardiovascular death nonfatal myocardial infarction nonfatal stroke","C0011065;C0027051;C0428953;C1306577;C2926063;C3810814;C4082313;C4552775;C4552959",NULL,NULL,646
"$nmbr$ blocker before admission","C0184666;C0809949",NULL,NULL,963
"$nmbr$ per pl at screening","C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C3897966;C4049765",NULL,NULL,798
"second n $nmbr$","C0205436;C0457385;C0565930;C1561503;C1705190",NULL,NULL,1783
"patients with event analyzed","C0030705;C0441471;C0936012;C4019010",NULL,NULL,1035
"concomitant","C0521115",NULL,NULL,447
"cm female cm male","C0043210;C0086287;C0086582;C1705497;C1705498;C1706180;C1706428;C1706429",NULL,NULL,2109
"serum potassium $nmbr$ $nmbr$ mmol l n $nmbr$","C0302353;C0543465;C1532563","C0302353","",1959
"$nmbr$ $nmbr$ mmhg ldl c $nmbr$ mg dl","C0439269;C0439475",NULL,NULL,192
"metabolic syndrome characteristics n","C0524620;C1521970",NULL,NULL,617
"mean sitting systolic blood pressure","C0277814;C0444504;C0488055;C0871470;C1306620;C2347634;C2348143;C2584297;C4050224",NULL,NULL,37
"key tc triglyceride hs crp ldl c low density lipoprotein fc fasting glucose ncep atp this category did not include ar to have _ $nmbr$ of the indicated char least square means except tc an note all treatment by subgroup","C0015663;C0017725;C0023189;C0023823;C0036143;C0039411;C0039798;C0040363;C0040642;C0041004;C0041260;C0041405;C0041698;C0087111;C0327953;C0332257;C0683312;C1079230;C1316572;C1317574;C1436327;C1444656;C1515021;C1518422;C1522326;C1533734;C1552866;C1704970;C1705169;C1824670;C1883351;C2700399;C2744579;C2983605;C2986463;C3272447;C3538994;C3884535;C3887704;C3889287;C3890735;C4048285;C4521369;C4522122;C4552600",NULL,NULL,431
"smedian prednisone dose n","C0032952;C0178602;C0869039;C1114758",NULL,NULL,110
"reversibility median range","C0449261;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016","C0449261","",2160
"gold group d no","C0018026;C0441838;C1304897","C0024117;C0521117","",213
"composite events","C0205199;C0441471;C1547335;C3541888",NULL,NULL,412
"coronary angiography during the index hospitalization","C0002978;C0019993;C0085532;C0428776;C0600653;C0918012;C1548829;C1552854;C1637833;C2986546",NULL,NULL,734
"ticagrelor $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C1999375;C2346927;C4321396;C4521761",NULL,NULL,2299
"participants n","C0679646",NULL,NULL,1033
"cha $nmbr$ ds $nmbr$ vasc mean sd","C0444504;C1420648;C2347634;C2348143;C2699239;C3714751",NULL,NULL,968
"lipoprotein a nmol l","C0065058;C0125953;C0439282;C1096202;C1439335","C0065058","",1769
"standard bp lowering $nmbr$ mm hg n $nmbr$","C0037623;C0439475;C0441994;C1415692;C1442989;C1708288;C2003888;C2828392;C4318478",NULL,NULL,1482
"asians n $nmbr$","C0078988","C0078988","",1369
"daytime symptoms more than twice per week","C0332169;C0332174;C0439230;C0683368;C1457887;C1720725;C1948050",NULL,NULL,1012
"rate of sares","C0871208;C1521828",NULL,NULL,1103
"edema peripheral","C0013604;C0205100;C1717255",NULL,NULL,690
"age $nmbr$ $nmbr$ y","C0001779","C0001779","",480
"patients included in analysis","C0002778;C0030705;C0332257;C0936012;C1524024",NULL,NULL,183
"csdmards mtx n $nmbr$","C0025677;C1417487","C0025677","",1408
"mean ipss qol sd","C0444504;C0518214;C1019118;C1998280;C2347634;C2348143;C2699239;C2827405;C3811063","C0034380","",1116
"systemic corticosteroids n","C4053960",NULL,NULL,1649
"pulmonary vascular resistance dyne s cm $nmbr$","C0308914;C0456261;C0488644;C0600130",NULL,NULL,702
"ae e ratio per $nmbr$ unit","C0439148;C0439453;C0456603;C1509845;C1519795;C1547037;C1704753;C1880519;C3853603;C3887670",NULL,NULL,94
"location of infarction","C0021308;C0450429;C1515974;C4284930;C4284931","C1515974;C0021308","",1948
"$nmbr$ $nmbr$ $nmbr$ cl $nmbr$ $nmbr$ to $nmbr$ $nmbr$","C0596019",NULL,NULL,432
"prior ml stroke","C0038454;C0332152;C0439526;C1705224;C2826257;C3887665;C4554100",NULL,NULL,300
"ease activity","C0205177;C0439167;C0441655;C1331418;C1561536;C3668946;C4049938;C4049939",NULL,NULL,100
"aml $nmbr$","C0023465;C0023467",NULL,NULL,186
"dbp","C0536221;C3813197;C4281799",NULL,NULL,605
"baseline hba $nmbr$ c median $nmbr$ $nmbr$ $nmbr$ mmol mol","C0019016;C0168634;C0549183;C0876920;C1442488;C1825777;C2347635;C2348144;C2939193;C3538758;C3829066","","",820
"mild $nmbr$ $nmbr$","C2945599",NULL,NULL,329
"$nmbr$ cells mm","C0007584;C0007634;C4330985;C4554674","","",-10
"bmultivariate logistic regression with variables forced in the modela","C0206031;C0439828;C0441722;C0443221",NULL,NULL,1563
"central eosinophil count cells per pl","C0007584;C0007634;C0200638;C0205099;C0750879;C1879652;C3897966;C4049765",NULL,NULL,677
"western europe including south africa","C0037712;C0043129;C0332257","","",599
"no prior cv event","C0332152;C0441471;C2826257;C3538987;C4019010;C4048877;C4318503",NULL,NULL,1777
"left bundle branch block","C0023211;C0344420;C2828132",NULL,NULL,965
"ors $nmbr$ cis","C0069590;C1504308;C1742862;C1963718",NULL,NULL,1537
"history of peripheral arterial disease","C0003842;C0205100;C0221464;C0683519;C0730226;C0850708;C0944983",NULL,NULL,105
"age group years","C0027362;C0439234;C0441833;C0687744;C1257890;C1510829;C1519504;C1705428;C1705429;C2348001",NULL,NULL,45
"hdl cholesterol mg dl mean sd available for $nmbr$ patients","C0023822;C0030705;C0392885;C0439269;C0444504;C0470187;C2347634;C2348143;C2699239","C0023822","",1962
"arterial blood pressure mm hg","C0439475;C1272641","C0005823","",15
"prior nsaid n a","C0003211;C0332152;C2826257;C3536840",NULL,NULL,2121
"height cm mean s e","C0439392;C0444504;C0489786;C2347634;C2348143","C0489786","",1249
"obese $nmbr$ kg m $nmbr$","C0028754;C1532718",";C1305855","",206
"crp mg l cv","C0439268;C3538987;C3890735;C4048285;C4048877;C4318503",NULL,NULL,1545
"$nmbr$ to $nmbr$ $nmbr$ mg week","C0024671;C0026410;C0332174;C0439230;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"s fs $nmbr$","C0565930;C1517317;C2603362;C3814419",NULL,NULL,1784
"adjusted mean change from baseline $nmbr$ ci mmol mol","C0008107;C0168634;C0392747;C0439190;C0443172;C0444504;C0456081;C0948922;C1442488;C1705241;C2347634;C2348143;C3259781;C3829066;C4319952",NULL,NULL,625
"data are reported as n event rates in parentheses are kaplan meier estimates at $nmbr$ year cardiovascular cv death myocardial infarction mi or recurrent ischemia cv death mi or severe recurrent ischemia","C0007226;C0011065;C0022116;C0027051;C0205082;C0428953;C0439234;C0439508;C0441471;C0684224;C0700287;C0871208;C1306577;C1455761;C1511726;C1521828;C1720943;C2926063;C2945760;C3245479;C3538987;C3714741;C3810814;C3887460;C4019010;C4048877;C4050465;C4050466;C4082313;C4318503;C4319718;C4321499;C4552775;C4552959","","",-10
"spirometry after bronchodilation","C0037981;C1371299;C3537072",";C0037981","",1197
"$nmbr$ years to $nmbr$ years","C0439234",NULL,NULL,1099
"influenza","C0021400;C0021403",NULL,NULL,405
"creatinine clearance $nmbr$ ml min","C0439445;C0812399","C0812399",";C3889287;C0452249;C0522467;C1337213;C1576800;C3890003;C0005910;C0022718;C1305866;C1705104;C1705224;C3887665",79
"risk reduction $nmbr$ percent confidence interval ci and p value are derived from cox models for risk reductions negative numbers indicate an increase in risk diabetes and hypertension were defined by clinical history a family history was defined as having one or more first degree relatives with either myocardial infarction or sudden death before the age of $nmbr$ hdl cholesterol levels are shown according to the median value $nmbr$ $nmbr$ mg per deciliter $nmbr$ $nmbr$ mmol per liter triglyceride levels are shown according to the median value $nmbr$ mg per deciliter $nmbr$ $nmbr$ mmol per liter ldl cholesterol levels are shown according to the median value $nmbr$ mg per deciliter $nmbr$ $nmbr$ mmol per liter and according to the values that divide the subjects into three equal groups $nmbr$ $nmbr$ to $nmbr$ and $nmbr$ mg per deciliter $nmbr$ $nmbr$ $nmbr$ $nmbr$ to $nmbr$ $nmbr$ and $nmbr$ $nmbr$ mmol per liter","C0008107;C0009667;C0010234;C0019664;C0019665;C0020538;C0023824;C0024671;C0026410;C0027051;C0042295;C0202069;C0202117;C0205163;C0205172;C0205210;C0205447;C0205449;C0241889;C0262512;C0262926;C0332849;C0392885;C0428475;C0428953;C0439165;C0439190;C0439241;C0439269;C0441833;C0441889;C0442805;C0475211;C0549183;C0567349;C0680240;C0681850;C0687744;C0876920;C1137094;C1171304;C1257890;C1276802;C1441547;C1518469;C1519504;C1522609;C1546180;C1547282;C1549782;C1550501;C1552839;C1704788;C1705255;C1705428;C1705429;C1706203;C1709380;C1960952;C1963138;C2004062;C2346927;C2347285;C2347635;C2348144;C2348885;C2349001;C2697811;C2825415;C2926063;C2939193;C3245521;C3259781;C3539106;C3810814;C4321396;C4521761;C4552959",NULL,NULL,171
"t n $nmbr$ $nmbr$","C2986835","","",-10
"glycoprotein ilb iiia inhibitor before pci","C0017968;C1999216;C4049621;C4697913",NULL,NULL,1736
"no previous cv event","C0205156;C0441471;C1552607;C3538987;C4019010;C4048877;C4318503",NULL,NULL,1777
"tertiary amines","C3653356",NULL,NULL,1645
"total c mg dl","C0439175;C0439269;C0439810","C1445957","",1968
"atwo sample t test","C0370003;C0871472;C2347026",NULL,NULL,1004
"type of index event no","C0600653;C0918012;C1552854;C1561488;C1637833;C2986546",NULL,NULL,604
"anacetrapib n $nmbr$ $nmbr$","C2604745","C2604745","",856
"i vitamin e","C0021966;C0042874;C0042890;C0221138;C0683454;C3714803","C0042874","",869
"mra","C0243032;C1609165;C3891069","","",239
"triglycerides mmol lf","C0041004;C0439190;C1416933;C2986618;C4554443",NULL,NULL,1679
"harzar ratio $nmbr$ ci","C0008107;C0456603;C1547037;C3259781",NULL,NULL,519
"history mi or stroke","C0019664;C0019665;C0038454;C0262512;C0262926;C1705255;C2004062;C3810814;C4554100",NULL,NULL,832
"age $nmbr$ years","C1510829","C1510829","",481
"gfr ml min per $nmbr$ $nmbr$ nr","C0017654;C0027496;C0439445;C1424601;C3844738","C3811844;C0017654","",592
"number of er visits in last year prior to baseline","C0168634;C0237753;C0439234;C0439508;C0449788;C0545082;C1442488;C1512346;C2826704;C3810541;C3811131",NULL,NULL,276
"selected clinical characteristics no total no","C0439175;C0439810;C0683325;C1707391",NULL,NULL,789
"uacr mg g q $nmbr$ q $nmbr$","C1300563",NULL,NULL,2315
"left shoulder","C0524469",NULL,NULL,43
"age in years median iqr","C0549183;C0876920;C1510829;C2347635;C2348144;C2939193",NULL,NULL,1890
"prednisone equivalent dose mg","C0024671;C0026410;C0032952;C0178602;C0205163;C0439185;C0439269;C0869039;C1114758;C1960952;C2346927;C4321396;C4521761",NULL,NULL,110
"$nmbr$ or $nmbr$ days","C0439228",NULL,NULL,1621
"pain $nmbr$ $nmbr$ mm vas","C0042815;C4330985;C4554674",NULL,NULL,297
"country argentina n $nmbr$","C0003761;C0454664;C1504311;C1511538",NULL,NULL,1565
"baseline rst segment elevation mm","C0168634;C0439775;C0441635;C0702240;C1425219;C1442488;C4330985;C4554674",NULL,NULL,625
"alanine aminotransferase increased","C0001899;C0057041;C0205217;C0442805;C1415274;C3887708",NULL,NULL,1572
"lower limb arterial no","C0003842;C0023216;C0221464",NULL,NULL,1613
"femoral access no total no","C0015811;C0439175;C0439810;C0444454;C1554204",NULL,NULL,512
"post mi","C0856742","C0856742","",244
"baseline sbp mm hg","C0085805;C0168634;C0439475;C1442488","C0005823","",1469
"role physical","C0031809;C0035820;C0205485;C1509143;C1705810;C3871154",NULL,NULL,506
"actual or estimated weight kg","C0022718;C0237400;C0439209;C4054209;C4329797",NULL,NULL,2326
"oradj $nmbr$ cl","C0596019",NULL,NULL,658
"aetiology","C0015127;C1314792;C1524003",NULL,NULL,924
"smoking mean","C0037369;C0444504;C0453996;C1881674;C2347634;C2348143",NULL,NULL,37
"history of diabetes p $nmbr$ $nmbr$","C0011847;C0011849;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"other i","C0021966;C0221138",NULL,NULL,1021
"p gp inhibitor","C3898062",NULL,NULL,810
"mean sd yr","C0439234;C0444504;C2347634;C2348143;C2699239",NULL,NULL,1099
"temporal data and management strategy","C0001554;C0376636;C0442043;C0679199;C1273870;C1511726;C2362314;C3245479;C3273539;C3714741",NULL,NULL,488
"percent work time missed due to asthma","C0004096;C0040223;C0043227;C0439165;C0678226;C1705492;C2984299;C3541383",NULL,NULL,757
"pravastatin sodium","C0700474","C0085542","",1841
"placebo tolvaptan $nmbr$ mg n $nmbr$ $nmbr$ n $nmbr$ $nmbr$","C0024671;C0026410;C0032042;C0439269;C1176308;C1696465;C1706408;C1960952;C2346927;C4321396;C4521761","C1176308","",1223
"mvd n $nmbr$ $nmbr$","C1417507;C3272839",NULL,NULL,1775
"treated hypertension","C0020538;C1522326;C1963138","C0020538","",1364
"treatment at randomisation","C0034656;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,692
"nyha class iv","C1882087","C0018802;C1882083","",453
"hbaic group","C0441833;C0687744;C1257890;C1519504;C1705428;C1705429",NULL,NULL,1526
"iqr days","C0439228",NULL,NULL,1621
"total glucose mg dl","C0017725;C0439175;C0439269;C0439810",NULL,NULL,2311
"full population","C0032659;C0443225;C1257890",NULL,NULL,904
"previous events no","C0205156;C0441471;C1552607;C3541888",NULL,NULL,1045
"r ight coronar y artery","C0003842;C0205090;C0226004;C0684010;C2603358","C1261316","",224
"current angina","C0002962;C0521116;C1705970","C0002962;C0521116","",2220
"i u uj","C0021966;C0221138;C0439148",NULL,NULL,1021
"black","C0005680;C0027567;C0085756;C0439541",NULL,NULL,966
"all patients $nmbr$ $nmbr$","C0030705",NULL,NULL,1035
"air insulin insulin glargine air insulin insulin glargine","C0001861;C0907402;C3536832",NULL,NULL,61
"af first diagnosis $nmbr$ years n","C0011900;C0205435;C0344434;C0439234;C1279901;C1704338;C1704656;C4049859",NULL,NULL,841
"mean cdai score","C0444504;C0449820;C0683448;C1413248;C2347634;C2348143;C3273706;C4050231",NULL,NULL,697
"clinical copd phenotype","C0024117;C0031437;C0205210;C1285572;C1412502;C3714496",NULL,NULL,1726
"hours from clopidogrel loading mean sd","C0070166;C0439227;C0444504;C1708715;C2347634;C2348143;C2699239",NULL,NULL,1287
"angiotensin ii antagonists","C0003009;C0243076;C1366631;C3714928","C0003015","",811
"previous stroke n","C0038454;C0205156;C1552607;C4554100",NULL,NULL,1762
"heart rate $nmbr$ bpm","C0018810","C0018810","",1105
"emergent urgent surgery","C0750573;C2188405",NULL,NULL,2334
"chads $nmbr$","C0007928;C1413373","","",2128
"statin placebo n $nmbr$","C0032042;C0360714;C1696465;C1706408","C0032042","",28
"duration of symptoms h","C0033727;C0369286;C0436359;C0441932;C0564385;C4528284",NULL,NULL,308
"hba c","C0019016;C1825777;C3538758","","",820
"ls mean se","C0023668;C0036919;C0444504;C2347634;C2348143",NULL,NULL,567
"physician s global assessment of disease status score","C0449820;C3176928;C4050231;C4050369",NULL,NULL,98
"i vitamin e n $nmbr$","C0021966;C0042874;C0042890;C0221138;C0683454;C3714803","C0042874","",869
"chd eze simva n $nmbr$","C0280604;C3542407",NULL,NULL,970
"at least $nmbr$ severe flare","C0205082;C1517205;C3540542;C4050465;C4050466",NULL,NULL,2101
"glycemic characteristics","C0005802;C1521970","C0005802","",1349
"intrathoracic or intraperitoneal surgery","C0038894;C0038895;C0442120;C0543467;C0595836;C1274039","C0442120","",383
"$nmbr$ $nmbr$ $nmbr$ lf","C1416933;C2986618;C4554443",NULL,NULL,1679
"dual therapy","C0039798;C0087111;C0205173;C1363945;C1554184","","",1191
"centrally acting sympathomimetics","C3653511","","",-10
"severe iief ef $nmbr$ $nmbr$ n","C0205082;C3641331;C4050465;C4050466",NULL,NULL,313
"hypertensive n","C0857121","C0020538","",1364
"people with diabetes n $nmbr$","C0011847;C0011849;C0027361","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"usa","C0041703",NULL,NULL,1550
"current smoker n z $nmbr$","C3173209;C3241966","C3241966","",1420
"new hf medication","C0013227;C0018488;C0205314;C1313497;C1538440;C3244316;C3273279;C4284232","C0018801",";C0168634;C1524003",12
"assigned to placebo","C0032042;C1516050;C1552601;C1696465;C1706408","C0032042","",28
"atenolol losartan","C0004147;C0126174","C0126174;C0004147","",2086
"formoterol $nmbr$ gg bid","C0017454;C0018370;C0060657","C0060657;C0073992","",1508
"metabolic syndrome w o t $nmbr$ dm","C0011816;C0524620;C3250443",NULL,NULL,617
"participants randomized","C0034656;C0679646;C3815594",NULL,NULL,692
"no prior oma use","C0042153;C0332152;C0457083;C1947944;C2826257",NULL,NULL,294
"previous use of vitamin k antagonist for $nmbr$ days no","C0205156;C0439228;C1096489;C1524063;C1552607;C2267235",";C0043031","",868
"mean ipss voiding subscore sd","C0042034;C0444504;C1019118;C1998280;C2347634;C2348143;C2699239;C2827405;C3811063;C4067975",NULL,NULL,753
"placebo rosu vastatin","C0032042;C1099881;C1696465;C1706408","C0965129","",886
"aqlq s $nmbr$ score mean sd c f","C0016327;C0444504;C0449820;C2347634;C2348143;C2699239;C4050231;C4055434",NULL,NULL,1287
"western europe israel australia or south africa","C0004340;C0015176;C0022271;C0037712;C0043128;C0043129","C0015176","",337
"mean sd hba $nmbr$ c","C0019016;C0444504;C1825777;C2347634;C2348143;C2699239;C3538758",NULL,NULL,37
"omega $nmbr$ fatty acid n $nmbr$","C0015684;C1719844","C0015684","",1236
"concurrent prednisolone","C0032950;C0205420","C0032950;C0205420","",2226
"laboratory data mean sd","C0022877;C0444504;C1511726;C2347634;C2348143;C2699239;C3244292;C3245479;C3714741;C4283904","C1511726;C0022877","",2232
"psa level ng ml","C0439275;C4086720",NULL,NULL,204
"class ii","C0441886;C2698968",NULL,NULL,845
"lsm $nmbr$ cl","C0596019",NULL,NULL,658
"fev $nmbr$ predicted post salbutamol","C0001927;C0681842;C0687676;C1704687;C1882327;C3469826;C3714541",NULL,NULL,1599
"body weight reduction $nmbr$","C0005910;C0242821;C0301630;C0392756;C0460148;C1262477;C1268086;C1293152;C1305866;C4082212;C4551656","C0005910","",1250
"atenolol strategy n $nmbr$","C0004147;C0679199",NULL,NULL,981
"newly diagnosed asthma n","C0004096;C0011900;C0750546;C2984299",NULL,NULL,694
"body height cm","C0005890;C0487985",";C0005890","",1251
"histor y of stable angina","C0340288",NULL,NULL,1003
"time from most recent qualifying","C0040223;C0332185;C1514624;C3541383",NULL,NULL,757
"$nmbr$ years n z $nmbr$","C0439234",NULL,NULL,1099
"oad use n","C0042153;C0457083;C1947944",NULL,NULL,24
"pciperformed for qualifying event","C0441471;C1514624;C4019010",NULL,NULL,412
"revascularisation n","C0581603","C0581603","",1213
"hazard ratio with dabigatran $nmbr$ mg $nmbr$ cl","C0024671;C0026410;C0439269;C0596019;C1960952;C2346927;C2348066;C2985465;C4321396;C4521761",NULL,NULL,775
"presenting diagnosis","C0011900;C0449450;C1704338;C1704656",NULL,NULL,841
"use of cardiac medication","C0013227;C0018787;C1522601;C1524063;C3244316;C4284232",NULL,NULL,366
"intraperitoneal","C0442120","C0442120","",383
"central eastern europe russia","C0015177;C0035970;C0205099;C0682369;C1707877;C1879652",NULL,NULL,505
"gold c","C0018026;C1304897","C0024117;C0521117","",213
"mi fatal nonfatal","C1302234;C1705232;C3810814",NULL,NULL,1682
"observed case","C0868928;C1441672;C1706255;C1706256",NULL,NULL,115
"improvement in dactylitis score at week $nmbr$ n","C0239161;C0332174;C0439230;C0449820;C2986411;C4050231","C0239161","",492
"methotrexate use at randomisation","C0025677;C0034656;C0042153;C0457083;C1947944","C0025677","",716
"sulfasalazine mean dose $nmbr$ $nmbr$ g day","C0036078;C0178602;C0439417;C0444504;C0869039;C1114758;C2347634;C2348143",NULL,NULL,37
"potassium mmol l","C0032821;C0202194;C0304475;C0597277;C1532563;C3714637","C0032821","",1371
"baseline dyslipidemia","C0168634;C0242339;C1442488","C0242339","",1770
"carotid stenosis","C0007282","C0007282","",2196
"oral antidiabetic drugs","C0029167;C0175795;C0304289;C0442027;C0935929;C4521986",NULL,NULL,1746
"mean sd postbronchodilator fev $nmbr$ fvc","C0444504;C2347634;C2348143;C2599594;C2699239;C3714541",NULL,NULL,1599
"euroscore additive median $nmbr$ th $nmbr$ th","C0039725;C0039738;C0442796;C0549183;C0876920;C1420718;C1550602;C2347635;C2348144;C2939193;C3164744;C4282123;C4285344",NULL,NULL,1433
"baseline non hdl ca","C0168634;C1442488;C1518422;C3715113;C3887642","C0023822","",821
"is only","C0205171;C1720467",NULL,NULL,137
"chd disease death","C0011065;C0012634;C0280604;C1306577;C3542407;C4082313;C4552775",NULL,NULL,970
"infliximab combined $nmbr$ mg kg and $nmbr$ mg kg n","C0205195;C0439272;C0666743",NULL,NULL,2327
"baseline who functional class","C0168634;C0205245;C0456387;C0542341;C1442488;C1518526;C1705943;C2700217",NULL,NULL,452
"$nmbr$ $nmbr$ drinks dav","C0452428",NULL,NULL,178
"heart rate mean sd range beats min","C0018810;C0444504;C0702093;C1514721;C1524029;C2347634;C2348143;C2348147;C2699239;C3542016;C3813700","C0018810","",1105
"duration of disease years","C0439234;C0872146","C0449238","",1989
"coronary","C0018787",NULL,NULL,1481
"former smoker n $nmbr$ $nmbr$","C0337671","C0037369","",420
"hypercholesterolemia n","C0020443;C1522133","","",1390
"tender joint count $nmbr$ $nmbr$ possible joints","C0022417;C0240094;C0332149;C0392905;C0750480;C1705566;C1705910;C2362652;C4554549;C4696258","C0451530","",1139
"fpci vs ppci in women","C0043210","C0043210",";C3541888;C1720467",1323
"score of $nmbr$ no","C0449820;C4050231",NULL,NULL,748
"mean bdi focal score sd","C0006448;C0205234;C0451022;C2699239;C3533236;C3714938;C3889415",NULL,NULL,1127
"bmi kg m $nmbr$ cardiovascular history","C0578022;C1532718;C1880008",NULL,NULL,1735
"cfb at week $nmbr$","C0009002;C0332174;C0439230;C1824728",NULL,NULL,1012
"cardiovascular risk","C0007226;C0035647;C3887460;C4552904",NULL,NULL,649
"patients taking oral corticosteroids at baseline n","C0001617;C0030705;C0168634;C0442027;C1442488;C1515187;C3539185;C3540725;C3540726;C3540727;C4521986",NULL,NULL,1650
"fasting blood glucose $nmbr$ mg dl $nmbr$ $nmbr$ mmol l","C0428568;C0439269;C1261430;C1532563","C0017725;C0015663","",2280
"hypertension n yes","C0020538;C1549445;C1705108;C1710701;C1963138","C0020538","",1364
"crp $ $nmbr$ mg l n","C0439268;C3890735;C4048285","C0006560","",286
"impaired fasting glucose level n $nmbr$","C0202045;C0221099;C0441889;C0456079;C1272092;C1547707;C2946261","C1272092","",20
"use of low dose aspirin $nmbr$ mg daily","C0024671;C0026410;C0332173;C0439269;C1524063;C1960952;C2346927;C2608320;C4321396;C4521761","C0004057","",1366
"amlodipine vs chlorthalidone overweight","C0008294;C0051696;C0497406","","",78
"body mass index kg cm $nmbr$","C0005893;C0578022;C1305855;C4054689","C1305855","",1734
"severe exacerbations","C0205082;C4050465;C4050466;C4086268",NULL,NULL,313
"albumin measurements","C0201838","C0201838","",1347
"non ischaemic aetiology","C0015127;C0475224;C1314792;C1518422;C1524003",NULL,NULL,924
"liraglutide n $nmbr$ $nmbr$","C1456408","C1456408","",1566
"time from randomization to pci non st elevation mi h","C0033727;C0034656;C0040223;C0369286;C0441932;C0520886;C0564385;C1518422;C3541383;C3810814;C4049621;C4528284",NULL,NULL,516
"prior","C0332152;C2826257",NULL,NULL,294
"p valuec","C0369773;C2603361",NULL,NULL,1872
"insulin aspart mealtime","C0123677;C0587119;C1708521",NULL,NULL,163
"weight kg $nmbr$","C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209","C0005910","",1250
"asthma control days","C0004096;C0243148;C0439228;C1550141;C1882979;C2587213;C2984299;C3274648;C4553389",NULL,NULL,675
"concomitant methotrexate use n","C0025677;C0042153;C0457083;C0521115;C1947944","C0025677","",716
"mg dl","C0439269",NULL,NULL,192
"event rate","C0441471;C0871208;C1521828;C4019010",NULL,NULL,2007
"causes of dvt or pe n","C0015127;C0070939;C0149871;C1314792;C1880476;C2926618;C3899446;C4284304",NULL,NULL,1516
"copd history yrs","C0019664;C0019665;C0024117;C0262512;C0262926;C1412502;C1705255;C2004062;C3714496",NULL,NULL,832
"biolimus a $nmbr$ eluting stent","C0038257",NULL,NULL,569
"using hrt or raloxifene at baseline","C0168634;C0244404;C0282402;C1442488;C1524063",NULL,NULL,1538
"white hispanic","C1533020;C1533021","C1533021","",1309
"arterial graft","C0450140",NULL,NULL,2032
"genotyping","C1285573",NULL,NULL,618
"hyperlipidemia n","C0020473;C0428465;C4555212","C0020473;C4555212",";C0439810;C1710701",29
"fibrinolytic agent no t","C0016018;C2603360","C0016018","",1756
"time from first eval","C0040223;C0205435;C1279901;C1707957;C2698624;C3541383",NULL,NULL,757
"enact $nmbr$ trial rerandomization to natalizumab n $nmbr$","C0008976;C1172734",NULL,NULL,1020
"angiotensin receptor blockers","C0521942;C0815017","C0521942","",779
"microalbuminuria or macroalbuminuria","C0730345","C0033687","",376
"severely impaired","C0205082;C0221099",NULL,NULL,313
"center","C0205099;C3810851",NULL,NULL,677
"prior tnf antagonist n","C0231491;C0332152;C1448177;C2826257",NULL,NULL,2375
"tadalafil $nmbr$ $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1176316;C1960952;C2346927;C4321396;C4521761","C1176316","",855
"nyha ll lll patients with lvef $nmbr$ $nmbr$ at baseline","C0030705;C0168634;C0428772;C0488728;C1261077;C1275491;C1442488","C0018801;C0428772","",1273
"duration of rat years","C0034693;C0034721;C0439234;C0449238;C2926735",NULL,NULL,1099
"overall n u $nmbr$","C0282416;C0439148;C1561607",NULL,NULL,1743
"chronic renal disease","C0022661;C1561643","C1561643","",967
"pbo statin","C0031962;C0360714",NULL,NULL,435
"total basdai score mean sd","C0439175;C0439810;C0444504;C0449820;C1998004;C2347634;C2348143;C2699239;C4050231","C1998004","",1354
"coronary intervention","C0018787;C0184661;C0886296;C1273869","C1532338","",1661
"microvascular disease history","C0443258;C0683519",NULL,NULL,105
"major crnm bleed","C0019080;C0205082;C0205164;C4318856;C4521762",NULL,NULL,1472
"small artery occlusion lacune","C0001168;C0011382;C0028778;C0226001;C0241970;C0264995;C0441597;C0700321;C1110554;C1947917",NULL,NULL,1859
"p value for mra vs no mra","C0243032;C1609165;C1709380;C3891069",NULL,NULL,7
"original dabigatran protocol","C0205313;C0442711;C1507394;C1522729;C2347409;C2348066;C2348563;C2599718;C3715209;C4282383",NULL,NULL,775
"hbalc $nmbr$ mmol mol $nmbr$ $nmbr$ n $nmbr$ $nmbr$","C3829066","","",1176
"ileum or colon","C0009368;C0020885;C3888384","C0020885;C0009368","",1054
"$nmbr$ but $nmbr$ mg dl","C0439269",NULL,NULL,192
"ff vi $nmbr$ $nmbr$ $nmbr$","C0205999;C4554348",NULL,NULL,515
"pharyngitis","C0031350;C4553308","C0031350","",273
"body mass index $nmbr$ kg nrn","C0005893;C0022718;C0439209;C0578022;C1305855;C1425210;C4054209","C1305855","",1734
"pulmonary function tests post bronchodilator mean sd","C0024119;C0444504;C2347634;C2348143;C2598152;C2599594;C2699239",NULL,NULL,2142
"antibiotics","C0003232;C0003237;C3540704;C3540705;C3540706;C3540707;C3540708;C3540709;C3540710",NULL,NULL,1654
"heart rate mean sd bpm n $nmbr$ $nmbr$","C0018810;C0444504;C2347634;C2348143;C2699239","C0018810","",1105
"chd eze simva","C0280604;C3542407",NULL,NULL,970
"chads $nmbr$ risk factors n","C0007928;C0035648;C1413373;C1553898","","",2128
"low nafld fibrosis score nfs $nmbr$ $nmbr$","C0205251;C0400966;C1550472;C1555018;C1954436;C1954437;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"hdl c high density lipoprotein cholesterol ldl c low density lipoprotein cholesterol sestandard error tg triglycerides","C0023822;C0337445;C0743559;C0858892;C1608199","C0041004","",209
"no adk e cancer","C0006826;C0998265;C1306459;C1412243","C0006826","",1819
"crp nmol l median range","C0439282;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016;C3890735;C4048285",NULL,NULL,669
"metabolic syndrome no","C0524620",NULL,NULL,617
"type ib","C0332307;C1547052;C2744579;C3890035;C4283819",NULL,NULL,1398
"participants with a history of cabg","C0010055;C0019664;C0019665;C0262512;C0262926;C0679646;C1705255;C2004062","C0010055","",389
"stratified log rank p value","C0205363;C0667477;C0699794;C1708728;C1709380;C2986775",NULL,NULL,1740
"corticosteroid use","C0239126","C0239126",";C0168634;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1425988;C1947944",120
"polyvascular disease and no type $nmbr$ diabetes n $nmbr$","C0012634;C1320657",NULL,NULL,1868
"moderate renal impairment","C0205081;C1565489;C1881878;C4049705;C4049706;C4085643;C4321335","C1565489","",937
"denotes angiotensin converting enzyme","C0022709;C1452534","C0003015","",811
"place","C0442504;C1533810;C1704765;C1882509",NULL,NULL,1299
"new vertebral fracture at $nmbr$ months","C0080179;C0205314;C0439231","C0080179","",1038
"proportion $nmbr$ ci adjusted for baseline hba $nmbr$ c","C0008107;C0019016;C0168634;C0456081;C1442488;C1709707;C1825777;C3259781;C3538758","","",820
"current lama use","C0042153;C0457083;C0521116;C0999593;C1416775;C1705970;C1947944",NULL,NULL,1300
"no type $nmbr$ diabetes n $nmbr$ $nmbr$","C1320657","C0011849;C1320657","",907
"change in tc","C0039411;C0040642;C0041405;C0041698;C0392747;C0443172;C1705241;C1824670;C3272447;C4319952;C4522122",NULL,NULL,767
"common carotid artery sites","C0007272;C0162859;C0205145","C0162859","",2198
"killip class i","C2697844","C1881332","",846
"female race white","C0007457;C0034510;C0043157;C0043210;C0086287;C0220938;C1705497;C1705498;C1706779;C3853635",NULL,NULL,2014
"daily total dose of insulin lu kg","C0021641;C0022718;C0024171;C0024176;C0439209;C1533581;C1579433;C2348070;C2697939;C3714501;C4054209",NULL,NULL,205
"moderate to","C0040363;C0041260;C0205081;C1881878;C1883351;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"or unadjusted","C1439367",NULL,NULL,1581
"ptca or pci","C2936173;C4049621","C2936173;C0010055","",1524
"no severe hypoglycemia","C0020615;C0205082;C4050465;C4050466;C4553659",NULL,NULL,313
"comparison with baseline mean","C0168634;C0444504;C1442488;C1707455;C2347634;C2348143",NULL,NULL,1633
"current tobacco smoker","C0040329;C0086707;C0521116;C0740009;C1705970;C3173209;C3241966;C4505217","C3241966","",1420
"progression of albuminuria","C0001925;C0242656;C0449258","C0001925","",375
"smoker n","C0337664","C0037369","",420
"ace inhibitors n","C0003015","C0003015","",811
"normal hba $nmbr$ c n $nmbr$","C0019016;C0205307;C0231683;C0439166;C1825777;C2347086;C3538758;C4553972",NULL,NULL,687
"africa near east","C0001737;C1707877",NULL,NULL,48
"severe or worse airflow limitation","C0205082;C0231999;C0332271;C0443288;C0449295;C1279889;C1457868;C4050465;C4050466",NULL,NULL,313
"previous respiratory disease other than copd no","C0024117;C0035204;C0035242;C0205156;C1412502;C1552607;C3714496",NULL,NULL,1726
"hazard ratio umec vi vs tio $nmbr$ ci","C0008107;C0205999;C2985465;C3259781","C2985465","",975
"married","C0024841;C0555047",NULL,NULL,49
"current past","C0521116;C1444637;C1705970;C4284302",NULL,NULL,456
"troponin","C0041199",NULL,NULL,1603
"events treatment $nmbr$","C0039798;C0087111;C0441471;C1522326;C1533734;C1705169;C3538994;C3541888;C3887704",NULL,NULL,412
"elevated fasting glucose","C0015663;C0017725;C0205250;C3163633",NULL,NULL,358
"tiotropium $nmbr$ $nmbr$ g n $nmbr$","C0213771;C0439267","C0213771","",1372
"hispanic","C0086409","C0086409","",865
"$nmbr$ $nmbr$ $nmbr$ $nmbr$ f","C0016327","","",-10
"at clinic systolic pressure $nmbr$ mm hg","C0002424;C0439475;C0442592;C0871470","C0005823","",1469
"smoking status","C1519386",NULL,NULL,796
"eastern european","C0239309","C0239309","",601
"urinary albumin creatinine ratio pg mg median iqr","C0455271;C0549183;C0876920;C1318330;C1627892;C2347635;C2348144;C2939193",NULL,NULL,2318
"duration of clopidogrel pretreatment hr median","C0070166;C0449238;C0549183;C0876920;C1550147;C2347635;C2348144;C2709094;C2926735;C2939193;C3539075;C3539076",NULL,NULL,825
"prior myocardial infarction no","C0155668",NULL,NULL,647
"type of hospitalization","C3177060",NULL,NULL,604
"event rate per $nmbr$ person years","C0027361;C0439234;C0441471;C0871208;C1521828;C2347489;C4019010",NULL,NULL,2007
"qids sr $nmbr$","C4331197","","",-10
"lost bmd","C0745777;C3815882",NULL,NULL,709
"carbamazepine","C0006949;C0006950;C0682993",NULL,NULL,764
"history of cabg surgery n","C0010055;C0455610","C0010055","",389
"weight median interquartile range kg","C0005910;C0022718;C0043100;C0439209;C0549183;C0876920;C1305866;C1705104;C1711350;C2347635;C2348144;C2939193;C4054209","C0005910","",1250
"ics mg day","C0439422;C0815320;C4551720","C3540778","",2182
"current smoker","C3173209;C3241966","C3241966","",1420
"phosphate mmol l","C0031603;C0031701;C1532563;C1601799",NULL,NULL,670
"standardized total hip bmd g cm $nmbr$","C0019552;C0022122;C0439175;C0439267;C0439810;C1505163;C3538851;C4284725",NULL,NULL,508
"race no f","C0016327;C0034510;C1706779;C3853635",";C0034510","",1107
"fasting plasma glucose mmol liter","C0015663;C0202042;C0439190;C0455280;C0475211","C0015663;C0202042","",1960
"placebo $nmbr$ mg d of simvastatin n $nmbr$","C0032042;C0074554;C0439422;C1696465;C1706408","","",198
"creatinine clearance","C0812399","C0812399",";C3889287;C0452249;C0522467;C1337213;C1576800;C3890003;C0005910;C0022718;C1305866;C1705104;C1705224;C3887665",79
"patients treated and operated n","C0030705;C1522326;C3242339",NULL,NULL,552
"egfr $nmbr$ to $nmbr$ ml min $nmbr$ $nmbr$","C0439445;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"female patients","C0150905","C0086287","",1970
"fall in last $nmbr$ mo","C0026544;C0085639;C0238715;C0332177;C4553726",NULL,NULL,1476
"number of exacerbations in the past $nmbr$ months","C0237753;C0449788;C4086268;C4331910","C4086268","",889
"hdl cholesterol mmol l mean sd","C0023822;C0392885;C0444504;C1532563;C2347634;C2348143;C2699239","C0023822","",821
"hbalc median ql q $nmbr$","C0549183;C0876920;C2347635;C2348144;C2939193","","",1176
"men","C0025266",NULL,NULL,1842
"total vdh s score","C2964552",NULL,NULL,540
"asia n $nmbr$ $nmbr$","C0003980","C0003980","",1382
"third yeart","C0205437",NULL,NULL,1644
"ace inhibitor yes","C0003015;C1549445;C1705108;C1710701;C4541021",NULL,NULL,147
"triple therapy use at screening n","C0039798;C0042153;C0087111;C0457083;C1363945;C1947944;C2121434",NULL,NULL,118
"antihypertensive agents n per patient","C0003364;C0030705",";C0003364","",1579
"sfc $nmbr$ $nmbr$ ig bid n $nmbr$","C0021027;C0305052;C0360506;C4521536",NULL,NULL,1260
"$nmbr$ exacerbation","C4086268","C4086268","",889
"tnf na ve","C0042469;C0597484;C1272460;C1448177;C1546968;C1879645;C3714652;C4049872;C4321495;C4552882",NULL,NULL,419
"fpg mg dl mean sd","C0439269;C0444504;C2347634;C2348143;C2699239",NULL,NULL,192
"age yr mean sd bmd t score mean sd","C0001779;C0439234;C2699239;C3533236","C0001779","",480
"body weight","C0005910;C1305866","C0005910","",1250
"baseline shs $nmbr$ $nmbr$","C0168634;C1442488",NULL,NULL,625
"stage $nmbr$ a $nmbr$ and $nmbr$","C0205390;C1300072;C1306673",NULL,NULL,541
"upper limb fracture","C0178316",NULL,NULL,1554
"african american n $nmbr$","C0085756","C0005680",";C1706779",188
"randomised patients with dactylitis at baseline","C0030705;C0168634;C0239161;C1442488","C0239161","",492
"lei $nmbr$","C0023401;C0428209",NULL,NULL,526
"s $nmbr$ mg mmol","C0565930;C0567349;C2348885;C2603362",NULL,NULL,200
"act $nmbr$","C0079613;C1704930;C1869853;C3890007;C4048375",NULL,NULL,499
"type of event no","C1561488",NULL,NULL,604
"$nmbr$ and $nmbr$ mg dl","C0439269",NULL,NULL,192
"prestudy treatment a","C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,236
"complete ulcer healing at week $nmbr$","C0205197;C0332174;C0333293;C0439230;C0725685;C3853530;C4283785",NULL,NULL,327
"secukinumab intravenous $nmbr$ mg n $nmbr$","C0024671;C0026410;C0348016;C0439269;C1960952;C2346927;C3179547;C4321396;C4521761",NULL,NULL,2297
"dactylitis","C0239161","C0239161","",492
"high vs normalc","C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"angina class at baseline","C0002962;C0168634;C0456387;C1442488;C1518526;C1705943",NULL,NULL,452
"chronic renal failure n","C0022661;C1561643;C2316810","C1561643","",967
"third heart sound n","C0232237;C0232278",NULL,NULL,1644
"stroke fatal nonfatal","C0038454;C1302234;C1705232;C4554100",NULL,NULL,507
"mean $nmbr$ h dbp","C0033727;C0369286;C0441932;C0444504;C0536221;C0564385;C2347634;C2348143;C3813197;C4281799;C4528284",NULL,NULL,605
"bmi kg per m $nmbr$","C0578022;C1532718",NULL,NULL,1735
"fall in last $nmbr$ months","C0085639;C0238715;C0439231;C4553726",NULL,NULL,1530
"digoxin","C0012265","C0012265","",989
"two arm","C0205448;C0446516;C3715044;C4553528",NULL,NULL,950
"urgent peripheral revascularization","C0205100;C0439609;C0581603;C3272275",NULL,NULL,932
"mean fpg mmol l","C0444504;C1532563;C2347634;C2348143",NULL,NULL,670
"prior biologic therapeutic failures n","C0005515;C0087111;C0205460;C0231174;C0302350;C0332152;C0680095;C2826257",NULL,NULL,214
"age years median range","C0549183;C0876920;C1510829;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016","C1510829","",481
"diabetes mellitus n yes","C0011849;C1549445;C1705108;C1710701",NULL,NULL,147
"ez simva $nmbr$ mg","C0024671;C0026410;C0206578;C0439269;C1960952;C2346927;C4321396;C4521761","C0360714;C1142985","",1862
"baseline medical therapy","C0168634;C0418981;C1442488",NULL,NULL,625
"bmi mean sd b","C0444504;C0578022;C2347634;C2348143;C2699239",NULL,NULL,2125
"participants without a history of cabg","C0010055;C0019664;C0019665;C0262512;C0262926;C0679646;C1705255;C2004062","C0010055","",389
"prior treatment status","C0332152;C0449438;C0749659;C1514463;C2826257",NULL,NULL,717
"baseline ics dose n","C0168634;C0178602;C0815320;C0869039;C1114758;C1442488;C4551720","C3540778","",2182
"left circumflex n","C0205091;C0443246;C1552822;C1880089","C0226037","",1414
"number of patients with events","C0441471;C2360800;C3541888",NULL,NULL,1811
"crcl at baseline $nmbr$ ml min","C0168634;C0439445;C1442488;C1846718","C3811844;C0017654","",307
"no ckd","C1561643","C1561643","",967
"total ho population n $nmbr$","C0019905;C1832110;C3258257;C3889614",NULL,NULL,510
"vdz pbo n $nmbr$","C0031962",NULL,NULL,1073
"sbp $nmbr$ mm hg","C0085805;C0439475","C0005823","",1469
"systolic blood pressure mean sd mm hga","C0039155;C0428886;C0444504;C0488055;C0871470;C1306620;C2347634;C2348143;C2699239;C4330985;C4554674",NULL,NULL,2127
"mean age sd y","C0001779;C0444504;C2347634;C2348143;C2699239","C0001779","",480
"severe itt n $nmbr$","C0205082;C4050465;C4050466",NULL,NULL,313
"$nmbr$ men $nmbr$ women","C0025266;C0043210","C0043210",";C3541888;C1720467",1323
"$nmbr$ s $nmbr$ kg m","C0565930;C1532718;C2603362",";C1305855","",206
"alogliptin n","C1958126","C1958126","",1183
"blood pressure mean sd range mm hg","C0428886;C0439475;C1514721;C2348147;C2699239;C3542016","C0005823","",1469
"age $nmbr$ y n n","C0001779","C0001779","",480
"salmeterol fluticasone group","C0441833;C0687744;C0939232;C1257890;C1519504;C1705428;C1705429",NULL,NULL,1526
"major st depression or t wave inversion","C0036056;C0041696;C0205082;C0205164;C0520887;C0520888;C1269683;C3272372;C4318856;C4521762","C0520887","",1091
"serms","C0732611",NULL,NULL,953
"change from baseline to eos mg dl","C0168634;C0392747;C0439269;C0443172;C1442488;C1623465;C1705241;C1861303;C4319952",NULL,NULL,192
"abbreviations bmi body mass index cabg coronary artery bypass graft nsaids nonsteroidal anti inflammatory drugs pci percutaneous coronary interventions values expressed as number percentage unless otherwise indicated percentages may not equal $nmbr$ due to rounding fhistory of or currently taking antidiabetic or lipid lowering medications history of or currently have elevated serum creatinine level but less than $nmbr$ mg dl_ $nmbr$ pmol l patients with a history of skin prostate and other cancers with long survival expectancy were not excluded lnsulin and or oral hypoglycemics ildata for women only n $nmbr$ for calcium antagonist strategy and n $nmbr$ for non calcium antagonist strategy","C0000723;C0003211;C0006684;C0006826;C0010055;C0023779;C0033572;C0038952;C0042295;C0043210;C0205163;C0205166;C0205171;C0205250;C0220921;C0237753;C0332196;C0332490;C0359086;C0369718;C0439092;C0439165;C0441922;C0441994;C0444099;C0449788;C0521116;C0600061;C0678226;C0679138;C0679199;C0679831;C0935929;C0998265;C1123023;C1305855;C1306459;C1444656;C1515187;C1518422;C1532338;C1549488;C1553893;C1554077;C1561533;C1706317;C1720467;C2003888;C2828389;C3146286;C3163633;C3642216;C3898174;C4520765","","",-10
"limb","C0015385",NULL,NULL,1555
"clinical and patient reported outcomes observed n unless otherwise indicated","C0205210;C0369718;C0441922;C1441672;C1444656;C2987124",NULL,NULL,1553
"$nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"lumbar spine","C0024091;C3887615",NULL,NULL,1551
"systoiic biood pressure mm hg","C0033095;C0439475;C0460139;C1306345;C4284008","C0005823","",1469
"rhabdomyolysis or myopathy","C0026848;C0035410;C4552660",NULL,NULL,815
"unprovoked vte n","C0630906",NULL,NULL,2386
"psa modified shs of hands feet $nmbr$ $nmbr$ $nmbr$","C0016504;C0018563;C0347981;C0392747;C1552914;C3810537;C3813209;C3889737",NULL,NULL,249
"bmi $nmbr$ obese","C0028754;C0578022",NULL,NULL,1735
"laba tiotropium n $nmbr$ placebo n $nmbr$","C0032042;C0213771;C1696465;C1706408","C0032042","",28
"chondroitin sulfate n $nmbr$","C0008466",";C0008466","",1404
"diabetes mellitus type $nmbr$ or $nmbr$","C1320657","C0011849;C1320657","",907
"presence of dactylitis n","C0150312;C0239161;C0392148;C3854307",NULL,NULL,2365
"eq $nmbr$ d mobility","C0080078;C0205163;C0425245;C0439185;C0449580;C4318935",NULL,NULL,1625
"hba $nmbr$ c $nmbr$ n $nmbr$ $nmbr$","C0019016;C1825777;C3538758","","",820
"median n terminal probnp iqr pg ml","C0439297;C0549183;C0669479;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"fatal and nonfatal ml","C0439526;C1302234;C1705224;C1705232;C3887665",NULL,NULL,300
"score on asthma control questionnaire","C4706265",NULL,NULL,751
"vertebral fractures at baseline","C0080179;C0168634;C1442488",NULL,NULL,625
"anti tnf ir patients","C0022065;C0022071;C0030705;C1448132;C1448177","","",1397
"perianal or anus","C0003461;C0442158","C0442158","",1039
"years sd","C0439234;C2699239",NULL,NULL,1287
"age median $nmbr$ th $nmbr$ th y","C0001779;C0039725;C0039738;C0549183;C0876920;C1420718;C2347635;C2348144;C2939193;C4282123;C4285344","C0001779","",2234
"fpi gu ml pmol l","C0120446;C0439192;C0439284;C0439526;C1635169;C1705224;C3887515;C3887665",NULL,NULL,666
"parental history of myocardial infarction before age $nmbr$ y","C0001779;C0030551;C1275835",NULL,NULL,641
"age distribution n","C0001782","C1510829","",481
"erectile dysfunction","C0242350;C1961100","C0242350",";C0221138;C0277785;C0542341;C0700205;C1705273;C3887505",1536
"n $nmbr$","C0369718;C0441922",NULL,NULL,1553
"primary safety outcome","C0036043;C0205225;C0439612;C0439631;C1274040;C1705187","C0036043","",1198
"saba use in past $nmbr$ days","C0042153;C0439228;C0457083;C1444637;C1947944;C4284302",NULL,NULL,2185
"apixaban","C1831808","C1831808","",1224
"$nmbr$ $nmbr$ week n $nmbr$","C0332174;C0439230",NULL,NULL,1012
"systemic arterial hypertension n","C0020538","C0020538","",1364
"haq di scored","C0449820;C3826998;C4321476",NULL,NULL,1665
"$nmbr$ $nmbr$ years n","C0439234",NULL,NULL,1099
"postmenopausal never or past hormone therapy use","C0042153;C0232970;C0279025;C0457083;C1444637;C1947944;C2003901;C4284302","C0232970","",1041
"use $nmbr$ asa compounds","C0004057;C0042153;C0205198;C0457083;C1706082;C1947944;C3853627","C0368663","",1691
"aspirin n $nmbr$ no of participants with events","C0004057;C0441471;C0679646;C3541888","C0004057","",1366
"median iqr yr","C0439234;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"non small cell lung cancer","C0007131;C2984258;C3539721","C0007131","",2096
"dutasteride n $nmbr$","C0754659",NULL,NULL,1647
"m $nmbr$ subgroup","C0369637;C0441923;C1079230;C1515021",NULL,NULL,1637
"se tf hdl c","C0036919;C3715113;C4048299;C4048587",NULL,NULL,567
"known thrombophilia","C0205309;C0398623",NULL,NULL,623
"ai $nmbr$","C0003504;C4551710",NULL,NULL,63
"urgent coronaiy revascularization $nmbr$ days","C0439228;C0439609;C0581603;C3272275","C0877341;C3272275","",1212
"diastolic bp mmhg mean sd","C0012000;C0428883;C0439475;C0444504;C0488053;C2347634;C2348143;C2699239",NULL,NULL,2130
"culprit vessel","C0005847",NULL,NULL,743
"theophylline use at screening","C0220908;C0220909;C0241361;C1698960;C1710031;C1710032;C1710477;C2348164",NULL,NULL,798
"angioedema present n $nmbr$","C0002994;C0150312;C0449450",NULL,NULL,2364
"prior htn n $nmbr$ $nmbr$","C0020538;C0332152;C2826257","C0020538","",1365
"$nmbr$ years to $nmbr$ years n $nmbr$","C0439234",NULL,NULL,1099
"relative risk $nmbr$ cl comparing icd therapy and placebo using a linear interaction term in the model shfmxicd","C0021122;C0023732;C0032042;C0039798;C0087111;C0233324;C0242492;C0596019;C1363945;C1515273;C1524063;C1696465;C1704675;C1705313;C1706408;C1707455;C2826302","C0972395","",1360
"patients with any clinical event","C0030705;C0205210;C0441471;C4019010",NULL,NULL,1035
"antibody binding level at baseline","C0168634;C0428536;C0441889;C0456079;C1145667;C1149306;C1167622;C1442488;C1547707;C2946261",NULL,NULL,625
"unadjusted hazard ratio $nmbr$ ci","C0008107;C1439367;C2985465;C3259781","C2985465","",975
"weight kg a","C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209",NULL,NULL,2326
"cardiac enzyates raised","C0018787;C0442818;C1522601",NULL,NULL,1481
"no of agents","C0450442;C1254351;C1521826",NULL,NULL,484
"other antihypertensive drug","C0003364",";C0003364","",1579
"trough seated hr bpm a","C0277814;C0444506;C1283233",NULL,NULL,711
"total mayo score","C0454788;C1077578;C2964552",NULL,NULL,425
"gold stage no","C0018026;C0205390;C1300072;C1304897;C1306673",NULL,NULL,541
"time from symptoms onset to $nmbr$ st balloon inflation h","C0021398;C0033727;C0036056;C0336867;C0369286;C0441144;C0441932;C0449244;C0564385;C0683368;C1318493;C1457887;C3272372;C4528284",NULL,NULL,434
"cpk $nmbr$ times uln","C0040223;C1519815;C1632851",NULL,NULL,1676
"time from randomization to study drug administration hr","C0013175;C0034656;C0040227;C0150270;C0206209;C2349982;C3469597",NULL,NULL,1709
"$nmbr$ $nmbr$ ng l n $nmbr$","C0439297",NULL,NULL,202
"index acs event","C0441471;C0600653;C0742343;C0918012;C1552854;C1637833;C2986546;C4019010;C4318612",NULL,NULL,2147
"steroid free remission","C0038317;C0332296;C0544452;C0687702;C1880497;C1996904",NULL,NULL,1712
"diagnoses risk factors n","C0011900;C0035648;C1553898",NULL,NULL,175
"group d","C0441838",NULL,NULL,1640
"venous insufficiency","C0042485","C0042485","",1949
"fasting plasma glucose mmol l","C0015663;C0202042;C0455280;C1532563","C0015663;C0202042","",1960
"placebo no $nmbr$ y km","C0032042;C1696465;C1706408;C3887676","C0032042","",28
"abbreviations da disc area e etdrs electronic early treatment diabetic retinopathy study iop intraocular pressure oct optical coherence tomography","C0000723;C0011318;C0011884;C0013850;C0017446;C0021888;C0180459;C0205146;C0920367;C1547561;C1556138;C1705370;C2348299;C3161471;C3668815;C4281784",NULL,NULL,1074
"mean sd bmi","C0444504;C0578022;C2347634;C2348143;C2699239",NULL,NULL,2141
"$nmbr$ mg qd n $nmbr$","C0024671;C0026410;C0332173;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"endothelin receptor antagonists plus phosphodiesterase type $nmbr$ inhibitors","C0031638;C0332307;C1134681;C1547052;C1656262;C2266875;C3539996",NULL,NULL,185
"inhaled corticosteroids","C0001617;C0004048;C3539185;C3540725;C3540726;C3540727",NULL,NULL,1650
"body mass index mean kg m sd","C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239","C1305855","",1734
"no extensive colitis n","C0009319;C0205231;C1963084","C0205231;C0009319","",2063
"mean blood pressure at screening visit mm hg","C0220908;C0220909;C0428886;C0439475;C0488053;C0545082;C1512346;C1698960;C1710031;C1710032;C1710477;C2348164;C2826704",NULL,NULL,798
"fev $nmbr$ post bronchodilator predicted normal","C0205307;C0231683;C0439166;C0681842;C1882327;C2347086;C2599594;C3714541;C4553972",NULL,NULL,680
"ibuprofen","C0020740","C0020740","",1844
"pasi score $nmbr$ $nmbr$","C0449820;C4050231;C4528685",NULL,NULL,1522
"tirofiban n $nmbr$","C0247025",NULL,NULL,804
"total chol mg dl","C0201950;C0439175;C0439269;C0439810","C1445957","",1968
"body mass index kg m $nmbr$ t","C0005893;C0578022;C1305855;C1532718","C1305855","",1734
"placebo control study","C0683952",NULL,NULL,1732
"total included in combined analysis","C0002778;C0205195;C0332257;C0439175;C0439810;C0936012;C1524024",NULL,NULL,183
"ejection fraction","C0489482;C2700378","C2700378","",887
"post bronchodilator fev $nmbr$ predicted mean sd c","C0444504;C0681842;C1882327;C2347634;C2348143;C2599594;C2699239;C3714541",NULL,NULL,1599
"$nmbr$ aminosalicylates","C0368663","C0368663","",1691
"fluticasone propionate salmeterol fdc","C0340427;C1413520;C1622832;C3539652",NULL,NULL,1978
"dpi other than diskus n","C1553480",NULL,NULL,742
"bl","C0005918;C0006413;C1552663;C2827109",NULL,NULL,655
"hs crp median iqr mg l","C0439268;C0549183;C0876920;C2347635;C2348144;C2939193;C3890735;C4048285",NULL,NULL,1545
"glycoprotein llb illa inhibitor","C0017968;C1999216",NULL,NULL,2104
"radial access","C0442038;C0444454;C0920847;C1554204","C0589360;C0442038","",356
"visits $nmbr$ e $nmbr$","C0545082;C1512346;C2826704",NULL,NULL,276
"catheter site femoral","C0015811;C0449652",NULL,NULL,512
"recurrent ischemia","C0022116;C1455761;C2945760;C4321499",NULL,NULL,1668
"mean sd pga vas","C0016410;C0042815;C0444504;C2347634;C2348143;C2699239;C3536884;C3541266;C3827561;C4050369",NULL,NULL,1525
"use of inhaled glucocorticoids at screening no","C0004048;C0017710;C0220908;C0220909;C1524063;C1698960;C1710031;C1710032;C1710477;C2348164;C3540777;C3540778","C3540778","",2182
"mean sd msdbp mm hg","C0439475;C0444504;C2347634;C2348143;C2699239","C0005823","",1469
"years since pah diagnosis","C0011900;C0030123;C0439234;C1704338;C1704656;C3203102;C4284467",NULL,NULL,1099
"tanezumab all doses combined nsaida","C0178602;C0205195;C2346819",NULL,NULL,110
"high risk ics","C0332167;C0815320;C3272283;C4050568;C4319571;C4551720","C4319571","",837
"hdl cholesterol $nmbr$ mg dl","C0023822;C0392885;C0439269","C0023822","",821
"a $nmbr$ c $nmbr$ $nmbr$ median","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"das $nmbr$ esr mean sd","C0051767;C0057671;C0444504;C2347634;C2348143;C2699239;C3811131","C1619634","",298
"migraine with aura","C0154723","C0154723","",881
"significant worsening in kccq clinical score $nmbr$ at $nmbr$ mo","C0026544;C0332177;C0332271;C0449820;C1457868;C1546960;C2826293;C3476798;C4050231",NULL,NULL,748
"more than $nmbr$ vessels stented","C0005847;C0038257;C0205172",NULL,NULL,743
"stroke at entry vs transient ischemic attack","C0007787;C0038454;C0917805;C1705654;C4554100",NULL,NULL,1762
"pa","C0030428;C3541314",NULL,NULL,1517
"bolus","C1186706;C1511237;C1705509;C3812160",NULL,NULL,632
"major bleeding mb","C0019080;C0024853;C0205082;C0205164;C4318856;C4521762","C0019080;C0205082","",2076
"short acting","C0079613;C1282927;C1704930;C1806781;C1869853;C2350002;C3890007;C4048375",NULL,NULL,499
"acq $nmbr$ score","C0449820;C2919686;C4050231","C2919686","",1293
"peripheral artery disease no","C1704436;C4025272",NULL,NULL,934
"atv $nmbr$ mg study protocol","C0024671;C0026410;C0210243;C0439269;C0674679;C1145759;C1334862;C1507394;C1960952;C2346927;C2348563;C2599718;C4321396;C4521761",NULL,NULL,1411
"heart failure $nmbr$ yr before admission","C0018801;C0018802;C0184666;C0439234;C0809949;C4554158",NULL,NULL,1099
"mean blood pressure mmhg s d j","C0428886;C0488053;C2347155",NULL,NULL,1470
"lvh by minnesota code","C0009219;C0026183;C0149721;C0805701;C3889831","C0149721","",1272
"therapy asa $nmbr$ $nmbr$ placebo $nmbr$","C0004057;C0032042;C0039798;C0087111;C1363945;C1696465;C1706408;C3853627","C0032042","",28
"medical treatment","C0679624",NULL,NULL,725
"insulin dependent","C0021641;C0429964;C0429986;C0851827;C1533581;C1579433;C1701901;C3244310;C3714501;C4321395",NULL,NULL,157
"smoking ever","C0037369;C0453996;C1881674",NULL,NULL,316
"change from baseline","C0168634;C0392747;C0443172;C1442488;C1705241;C4319952",NULL,NULL,767
"dyspnea mmrc grade n","C0013404;C0441800;C0919553;C1963100;C3244287;C3826977",NULL,NULL,683
"acr $nmbr$ response","C0871261;C1412134;C1515941;C1704632;C1706817;C2911692",NULL,NULL,52
"time to treatment h","C0033727;C0369286;C0441932;C0564385;C3494202;C4528284","C3494202","",433
"drug related ae","C0013227;C0439849;C0445223;C1254351;C3887670","C0877248","",47
"calcium channel blockerf","C0006685","C0006684","",1884
"central eastern europe and russia hr $nmbr$ cl","C0015177;C0035970;C0205099;C0596019;C0682369;C1707877;C1879652",NULL,NULL,505
"hs crp _ $nmbr$ $nmbr$ mg l","C0439268;C3890735;C4048285",NULL,NULL,1545
"rf positive and acpa negative n","C0035448;C0201660;C0205160;C0439178;C0748398;C1446409;C1513916;C1514241;C1525410;C1547111;C1706063;C2825415;C2825490;C2825491;C3812269;C3853545","C0035448","",1435
"$nmbr$ $nmbr$ i $nmbr$ s","C0021966;C0221138",NULL,NULL,1021
"time from onset to medication h mean sd","C0013227;C0033727;C0369286;C0441932;C0444504;C0449244;C0564385;C2347634;C2348143;C2699239;C3244316;C4284232;C4528284",NULL,NULL,308
"body mass index kg m $nmbr$ median iqr","C0005893;C0549183;C0578022;C0876920;C1305855;C1532718;C2347635;C2348144;C2939193","C1305855","",1734
"$nmbr$ concomitant medication","C0013227;C0521115;C3244316;C4284232",NULL,NULL,2263
"no of strokes no of patients in category and","C0030705;C0038454;C0683312;C3889287",NULL,NULL,1762
"patient","C0030705",NULL,NULL,1035
"pvaluefor trend","C1521798;C4554533",NULL,NULL,550
"sinus rhythm at baseline","C0168634;C0232201;C1442488",NULL,NULL,1673
"renin angiotensin inhibitors","C0003018;C2917241;C3653375;C4521302",NULL,NULL,813
"methotrexate","C0025677","C0025677","",1408
"other ascvd","C3665365",NULL,NULL,344
"ez simva","C0206578","C0360714;C1142985","",1862
"weight mean sd kgb","C0005910;C0043100;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239","C0005910","",1250
"placebo diabetes n $nmbr$","C0011847;C0011849;C0032042;C1696465;C1706408","C0032042","",28
"iii and iv ejection fraction","C0022326;C0439070;C0489482;C1705160;C2700378;C4265176","C0018802;C1882083","",453
"inflotmas io mgluj versus piecew","C1046794;C3146236",NULL,NULL,444
"other lipid lowering drugs","C0086440","C0086440","",1773
"ifg pbo n $nmbr$ vs evomab n $nmbr$","C0031962;C1334085;C1708411",NULL,NULL,435
"prior congestive heart failure","C0018802;C0332152;C2826257",NULL,NULL,769
"time from randomization to pci hr","C0034656;C0040223;C3541383;C4049621",NULL,NULL,692
"current n","C0521116;C1705970",NULL,NULL,1417
"total pack years mean sd","C0439175;C0439810;C0444504;C1277691;C2347634;C2348143;C2699239",NULL,NULL,37
"apolipoprotein b mean sd g l","C0003593;C0439294;C0444504;C0456615;C2347634;C2348143;C2699239",NULL,NULL,1706
"timi risk score no t","C0035647;C0449820;C2603360;C4050231;C4552904",NULL,NULL,2052
"fev $nmbr$ predicted $nmbr$","C0681842;C1882327;C3714541",NULL,NULL,1599
"ics dose of stable maintenance treatment g","C0039798;C0087111;C0178602;C0205360;C0439267;C0814469;C0815320;C0869039;C1114758;C1522326;C1533734;C1547311;C1705169;C3538994;C3714445;C3887704;C4551720","C0017710","",1348
"era and pde $nmbr$ i","C0021966;C0221138;C1521863;C3495919",NULL,NULL,409
"tender","C0234234","C0234234","",1980
"beta blockers n","C0001645","C0001645","",959
"total ipss","C0439175;C0439810;C1019118;C1998280;C2827405;C3811063","C1998280",";C1019118;C3811063;C4050465;C4050466;C4049706;C0168634;C1705273;C1880519;C3853603",124
"$nmbr$ years simva n $nmbr$","C0439234",NULL,NULL,1099
"baseline triglycerides","C0041004;C0168634;C1442488",NULL,NULL,625
"pvr ml","C0242852;C0439526;C0456261;C1419141;C1705224;C3887665",NULL,NULL,300
"cv death or hhf","C0011065;C1306577;C3538987;C4048877;C4082313;C4318503;C4552775",NULL,NULL,323
"no corticosteroid","C0001617;C3536709",NULL,NULL,1650
"laci","C1420705;C3273314;C4281721",NULL,NULL,2152
"patients not receiving statin","C0030705;C0360714;C1514756;C1518422","C0360714","",872
"$nmbr$ ng l n $nmbr$ n","C0439297",NULL,NULL,202
"western european includinq australia israel and south africa","C0004340;C0022271;C0037712;C0043128;C0239307;C0239312;C1535514",NULL,NULL,54
"helicobacter pylori negative n","C4688581",NULL,NULL,573
"prior exposure to levetiracetam","C0274281;C0332152;C0332157;C0377265;C2826257;C3693636",NULL,NULL,777
"exercise times per week minimum","C0015259;C0456698;C1522704;C1524031;C1552614;C2826545","C0015259","",1380
"symptoms mean sd","C0444504;C0683368;C1457887;C2347634;C2348143;C2699239",NULL,NULL,37
"current cigarette smoker n","C0337667;C0521116;C0677453;C1704760;C1705970;C3173209;C3241966;C3890423","C3241966","",1420
"ics plus laba","C0815320;C4551720",NULL,NULL,2193
"laba or lama versus ind gly lsm difference $nmbr$ cl","C0017890;C0523677;C0596019;C0999593;C1416775;C1705241;C1705242;C4049864",NULL,NULL,658
"ics use at baseline yes","C0042153;C0168634;C0457083;C0815320;C1442488;C1549445;C1705108;C1710701;C1947944;C4551720",NULL,NULL,625
"life threatening","C1546953;C2826244;C3537125","C2826244","",1088
"subpopulation analyses according to baseline hba $nmbr$ c","C0002778;C0019016;C0168634;C0441837;C0680240;C0936012;C1442488;C1524024;C1825777;C3538758","","",820
"nonsustained ventricular tachycardia no j","C0750194;C2919575",NULL,NULL,87
"randomization to angiography","C0002978;C0034656",NULL,NULL,1723
"scores for global and pain assessments","C0030198;C0205246;C0449820;C2348867",";C0030198","",1340
"male sex no total no","C0086582;C0439175;C0439810","C0086582","",1276
"at week $nmbr$","C0332174;C0439230",NULL,NULL,1012
"baseline characteristic","C0168634;C1442488;C1521970","C1521970","",1110
"odds ratio adj $nmbr$ cl","C0001552;C0028873;C0596019;C2826286",NULL,NULL,974
"high potencyc","C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"angina pectoris no","C0002962","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"pci postindex event","C0441471;C4019010;C4049621",NULL,NULL,412
"daily dose of inhaled glucocorticoid no","C0004048;C0017710;C2348070","C3540778","",2182
"egfr by creatinine ml min per $nmbr$ $nmbr$ m $nmbr$ geometric mean se","C0010294;C0036919;C0369637;C0439445;C0441923;C1561535;C1739039;C2986759;C3811844;C3812682","C3811844;C0017654","",592
"univariate logistic modela","C0242415",NULL,NULL,1563
"heart rate at baseline bpm","C0018810;C0168634;C1442488","C0018810","",1105
"median range duration of asthma y","C0004096;C0449238;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2926735;C2939193;C2984299;C3542016",NULL,NULL,694
"major cerebrovascular","C0205082;C0205164;C1880018;C4318856;C4521762",NULL,NULL,651
"partial mayo clinic scored","C0002424;C0442592;C0449820;C0454788;C0728938;C1077578;C1550516",NULL,NULL,425
"cardiac biomarker status no total no $","C0005516;C0018787;C0439175;C0439810;C0449438;C0449442;C1271630;C1522601;C1999091;C2735302",NULL,NULL,509
"macroalbuminuria no drug therapy no","C0013216;C0013217",NULL,NULL,554
"total carmelina population","C3258257",NULL,NULL,510
"radial access site","C0442038;C0589360;C0920847","C0589360;C0442038","",356
"intestinal area involved n $","C0017446;C0021853;C0205146;C0369718;C0441922;C1314939","C0009368;C1879646","",2088
"brandomization was stratified by diabetic status","C0205363;C0241863;C0449438",NULL,NULL,996
"empaglifiozin $nmbr$ $nmbr$ mg w $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2277
"fluticasone salmeterol n $nmbr$","C0939232",NULL,NULL,19
"inhibitor","C1999216",NULL,NULL,812
"vorapaxar n $nmbr$ $nmbr$","C2974521","C2974521","",1448
"mean baseline ibdq score sd crp concentration mg l","C0086045;C0168634;C0439268;C1442488;C1446561;C2699239;C3533236;C3827302;C3890735;C4048285",NULL,NULL,2313
"bmi kg m $nmbr$ median iqr","C0549183;C0578022;C0876920;C1532718;C2347635;C2348144;C2939193",NULL,NULL,1735
"th c","C0039725;C0039738;C1420718;C4282123;C4285344",NULL,NULL,1433
"prespecified medical conditions n f","C0012634;C0016327;C0199168;C0205476;C0348080;C1705253;C3864998",NULL,NULL,1710
"eosinophil low","C0014467;C0205251;C1550472;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"casual plasma glucose mg dl","C0202042;C0439269;C0455280","C0455280;C0015663",";C0168634",21
"bnp ntbnp n $nmbr$","C0054015;C1095989;C1417808;C2982014",NULL,NULL,1586
"left circumflex coronary artery","C0226037","C0226037","",1414
"poslmenopausal no ht","C0018510;C0677607","C0282402","",1043
"triglycerides mmolt $nmbr$ gm","C0017480;C0041004;C3854019",NULL,NULL,956
"non fatal myocardial infarction","C0027051;C0428953;C1302234;C1518422;C1705232;C2926063;C3810814;C4552959",NULL,NULL,646
"chads $nmbr$ scoreb","C0007928;C1413373","","",2128
"warfarin at enrollment","C0043031;C1516879;C1696073;C3888021","C0043031","",858
"other lipid modifying drug use at study entry n","C0013175;C0013227;C0023779;C0042153;C0242510;C0392747;C0457083;C0557651;C0869040;C1254351;C1705654;C1947944;C2603343","C0023779","",1772
"drug related teaes","C0013227;C0439849;C0445223;C1254351","C0877248","",47
"radius fracture","C0034628",NULL,NULL,2028
"disease duration mean yr sd","C0439234;C0444504;C0872146;C2347634;C2348143;C2699239","C0449238;C0872146","",903
"oral study drug administered no total no","C0013175;C0439175;C0439810;C0442027;C1521801;C4521986",NULL,NULL,508
"fl $nmbr$ b","C1300812;C1708024","","",-10
"total score on the sgrq c i","C0021966;C0221138;C2964552;C3826872",NULL,NULL,540
"antimalarial","C0003374;C3536844;C4552582",NULL,NULL,1011
"pepsinogen i ii ratio","C0030915;C0456603;C0523817;C1547037",NULL,NULL,973
"lce n $nmbr$","C1423759;C3273355",NULL,NULL,964
"wrist","C0043262;C1322271",NULL,NULL,1310
"acpa positive","C0439178;C1446409;C1514241;C1525410;C1706063;C2825490;C3812269",";C0439178","",2051
"triglycerides median q $nmbr$ q $nmbr$","C0041004;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"mean time to first subcutaneous injectiong h in relation to surgery hr","C0033727;C0038894;C0038895;C0040223;C0205435;C0369286;C0441932;C0443315;C0444504;C0543467;C0564385;C1274039;C1279901;C2347634;C2348143;C3541383;C4528284","C3494202","",433
"treatment before randomization days","C0034656;C0039798;C0087111;C0439228;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,1621
"amlodipine valsartan $nmbr$ $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C1962523;C2346927;C4321396;C4521761","","",78
"lvh by electrocardiogram","C0013798;C0149721;C1547122;C1623258","C0149721","",1496
"acq $nmbr$ scoret","C2919686","C2919686","",1293
"ed severity n","C0439793;C0522510;C3538926",NULL,NULL,561
"sbp mm hg sd","C0085805;C0439475;C2699239",NULL,NULL,607
"triglycerides $ $nmbr$ mg dl $nmbr$ $nmbr$ mmol l","C0041004;C0439269;C1532563","C0041004","",368
"ethnicity hispanic or latino","C0015031;C0086409;C0086528;C0243103",NULL,NULL,787
"age yrs","C0001779","C0001779","",480
"drinker $nmbr$ to $nmbr$ drinks week","C0332174;C0439230;C0452428;C0556338",NULL,NULL,178
"hyperkalaemia investigator reported","C0020461;C0035173;C0684224;C0700287;C4319718;C4552983","C0020461;C4552983",";C0439375;C0700287;C0684224;C0035173",30
"values were reported for $nmbr$ patients in the spironolactone group and $nmbr$","C0037982;C0042295;C0441833;C0588446;C0687744;C1257890;C1519504;C1705428;C1705429","C0037982","",1405
"benazepril hydrochlorothiazide benazepril amlodipine","C0051696;C0717481","","",78
"remission by baseline steroid doses","C0038317;C0168634;C0178602;C0544452;C0687702;C1442488",NULL,NULL,1712
"patients receiving corticosteroids at baseline","C0001617;C0030705;C0168634;C1442488;C1514756;C3539185;C3540725;C3540726;C3540727",NULL,NULL,1650
"baseline $nmbr$ h ppg","C0033727;C0168634;C0369286;C0441932;C0564385;C1418888;C1442488;C4528284",NULL,NULL,625
"antithrombotic and anticoagulant medications","C0003280","C0085826","",451
"hemoglobin a","C0019016",NULL,NULL,2074
"haemoglobin g dl","C0019046;C0439267;C1319312;C3642216",NULL,NULL,1486
"secondary iii","C0027627;C0175668;C0205436;C0439070;C1705160",NULL,NULL,1484
"$nmbr$ month l","C0332177;C0439231",NULL,NULL,1476
"pelvic fractures","C0149531","C0019557","",1114
"prior surgery for cd n","C0007928;C0034283;C0455610;C4552032",NULL,NULL,699
"diabetics no n $nmbr$ $nmbr$","C0241863;C0369718;C0441922",NULL,NULL,1553
"clopidogrel n $nmbr$","C0070166","C0070166",";C0369286;C0033727;C4049621",217
"family history of premature coronary heart disease","C0151526;C0205252;C0260520;C1313980;C2317524;C4018905",NULL,NULL,1494
"diastolic mm hg","C0012000;C0439475","C0005823","",1469
"any immunosuppressive agent","C0021081","C0021081","",1424
"former non drinker","C0205156;C0457801;C0750523",NULL,NULL,176
"previously failed anti tnf treatment no","C0039798;C0087111;C0231175;C1448177;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,717
"moderately impaired","C0205081;C0221099;C1881878;C4085643;C4321491",NULL,NULL,321
"medical history before index acute coronary syndrome no","C0262926;C0600653;C0918012;C0948089;C1552854;C1637833;C1704706;C2986546",NULL,NULL,832
"mean dose","C0178602;C0444504;C0869039;C1114758;C2347634;C2348143",NULL,NULL,37
"parental history of mi before age $nmbr$ y","C0001779;C0019664;C0019665;C0030551;C0262512;C0262926;C1705255;C2004062;C3810814",NULL,NULL,832
"s median","C0549183;C0565930;C0876920;C2347635;C2348144;C2603362;C2939193",NULL,NULL,635
"candesartan","C0717550","","",1208
"no mi","C3810814",NULL,NULL,516
"no multivessel disease","C0012634",NULL,NULL,2118
"p value within category","C0683312;C1709380;C3889287",NULL,NULL,562
"medication taken alone or in combination","C0013227;C0205171;C0205195;C0439044;C0679994;C1883727;C1947911;C3244316;C3811910;C4284232",NULL,NULL,997
"pain vas $nmbr$ $nmbr$ mm","C0042815;C4330985;C4554674",NULL,NULL,297
"no of risk factors","C0035648;C1553898",NULL,NULL,175
"baseline sbp","C0085805;C0168634;C1442488",NULL,NULL,606
"type of treatment n","C0455708",NULL,NULL,604
"periprocedural medications n","C0013227;C0802604;C2598133;C4284232",NULL,NULL,2267
"values are mean sd median quartile range or ace indicates angiotensin converting enzyme arb angiotensin receptor blocker bnp b type natriuretic peptide bp blood pressure bun blood urea nitrogen lvef left ventricular ejection fraction and nt probnp n terminal pro b type natriuretic peptide","C0005823;C0022709;C0033382;C0042295;C0054015;C0205088;C0332307;C0428772;C0444504;C0488728;C0523852;C0549183;C0597357;C0600137;C0876920;C1095989;C1144709;C1291218;C1317554;C1417808;C1452534;C1514721;C1547052;C1705314;C1705315;C2347634;C2347635;C2348143;C2348144;C2348147;C2699239;C2709270;C2825907;C2828255;C2939193;C2982014;C2987124;C3537020;C3542016;C3683557;C3888198;C4284014;C4284038","","",-10
"the metabolic syndrome","C0524620",NULL,NULL,617
"ada impaired fasting glucose","C1060325;C1272092;C3811629",NULL,NULL,1076
"fasting blood glucose mean sd mg dlt","C0024671;C0026410;C0428568;C0439269;C0444504;C1261430;C1413248;C1960952;C2346927;C2347634;C2348143;C2699239;C3273706;C4321396;C4521761","C0017725;C0015663","",2280
"non hdl c hdl c","C1518422;C3715113","C0023822","",821
"dmard at baseline","C0168634;C0242708;C1442488",NULL,NULL,625
"bonferroni adjusted p value b vs a","C1709380;C1879894",NULL,NULL,7
"losartan plus lisinopril n $nmbr$","C0065374;C0126174;C0332287","C0126174;C0065374","",1930
"prior cardiac surgery n","C0018787;C0018821;C0332152;C0455610;C0524727;C1522601;C2826257",NULL,NULL,1481
"lathosterol total c imol mmol","C0064673;C0439175;C0439190;C0439810",NULL,NULL,1502
"discontinuations teaes","C0457454",NULL,NULL,1562
"present","C0150312;C0449450",NULL,NULL,287
"placebo $nmbr$ $nmbr$ ml n $nmbr$","C0032042;C0439526;C1696465;C1705224;C1706408;C3887665",NULL,NULL,300
"acuity defined bleeding","C0019080;C0750509;C1704788;C3539106",NULL,NULL,707
"social interaction","C0037420",NULL,NULL,1098
"ratio of hrs $nmbr$ cl p for sex interaction","C0009253;C0036864;C0079399;C0456603;C0596019;C0804628;C1314687;C1522384;C1547037;C1568891;C1704675",NULL,NULL,658
"all patients with opg n $nmbr$","C0030705;C1262886;C1336645;C1412836;C1710303",NULL,NULL,1035
"hbalc tx difference vs pbo median change from baseline se $nmbr$","C0031962;C0036919;C0041403;C0168634;C0392747;C0443172;C0549183;C0876920;C1442488;C1705241;C1705242;C2347635;C2348144;C2939193;C4319952","","",1176
"no pad baseline","C0168634;C0182158;C0332568;C1442488;C3540603;C3669270;C3814046;C4319657",NULL,NULL,1752
"adjusted hr $nmbr$ ci comparing idm with bl","C0005918;C0006413;C0008107;C0270221;C0456081;C1552663;C1707455;C2827109;C3259781",NULL,NULL,519
"periprocedural medications","C0013227;C0802604;C2598133;C4284232",NULL,NULL,2267
"placebo plus aspirin","C0004057;C0032042;C0332287;C1696465;C1706408","C0032042","",28
"$nmbr$ $nmbr$ months fn $nmbr$ $nmbr$","C0439231;C1570610",NULL,NULL,1530
"disease duration yr","C0439234;C0872146","C0449238;C0872146","",903
"p inleraclion","C0369773;C2603361",NULL,NULL,1874
"prior stroke or tia","C0007787;C0038454;C0332152;C0917805;C1054154;C2826257;C4554100","C0038454;C0332152","",2380
"lamotrigine","C0064636;C0524166","C0064636",";C0524166;C0274281",75
"events consistent with genital infection","C0332290;C0441471;C0729552;C3541888",NULL,NULL,412
"$nmbr$ years","C0439234",NULL,NULL,1099
"age mean sd range y","C0001779;C0444504;C1514721;C2347634;C2348143;C2348147;C2699239;C3542016","C0001779","",480
"ldl c measured","C0444706;C3541902","C0023824","",1068
"cardiovascular death hospitalization for heart failure","C0007226;C0011065;C1306577;C3887460;C3898876;C4082313;C4552775","C0018801",";C0168634;C1524003",12
"index diagnosis","C0011900;C0600653;C0918012;C1552854;C1637833;C1704338;C1704656;C2986546",NULL,NULL,734
"patients with enthesitis","C0030705;C1282952","C1282952","",271
"right ventriculardysfunction atinclusion","C0205090;C0444532","C0242707","",1882
"subcortical wml load diameter mm mean sd","C0552409;C0815275;C1550025;C1704782;C1708715;C2699239;C4330985;C4554674",NULL,NULL,297
"$nmbr$ l $nmbr$ l $nmbr$ $nmbr$ l","C3539687","","",-10
"change from baseline to final apbm","C0168634;C0205088;C0392747;C0443172;C1442488;C1546485;C1705241;C3853528;C4319952",NULL,NULL,1680
"vertebral fracture and or t score $nmbr$ $nmbr$","C0080179;C3854607",NULL,NULL,2023
"genital mycotic infections male $nmbr$","C0086582;C0740330;C1706180;C1706428;C1706429","C0086582","",1276
"without t $nmbr$ dm n $nmbr$","C0011816;C2986835;C3250443",NULL,NULL,955
"gly","C0017890;C0523677","","",-10
"golimumab","C2353893",NULL,NULL,941
"medically important infectionsa","C3898777;C4084912",NULL,NULL,638
"estrogen therapy","C0279494",NULL,NULL,555
"hf without known reduced ef n $nmbr$","C0018488;C0205309;C0392756;C1313497;C1538440;C3273279","C0018801;C0428772","",1273
"stable angina no","C0340288",NULL,NULL,1003
"gi major bleeding","C0017181;C0205082;C0205164;C4318856;C4521762","C0019080;C0205082","",2076
"a prebronchodilator fevl predicted","C0681842;C1882327;C2599602",NULL,NULL,682
"none cdmard naive or past use at baseline","C0042153;C0168634;C0457083;C1442488;C1444637;C1947944;C4284302","C0242708",";C0026544",231
"mean number of antihypertensive medication at last visit","C0003364;C0237753;C0444504;C0449788;C0545082;C1512346;C1517741;C2347634;C2348143;C2826704",";C0003364","",1579
"baseline mean sd","C0168634;C0444504;C1442488;C2347634;C2348143;C2699239",NULL,NULL,625
"race n y","C0034510;C1706779;C3853635",";C0034510","",1107
"crohn s disease activity index score","C0449820;C0451071;C4050231",NULL,NULL,748
"nateglinide and repaglinide","C0246689;C0903898",NULL,NULL,2047
"prior cardiovascular event","C0332152;C1320716;C2826257",NULL,NULL,2378
"intent to use dti","C0040363;C0041260;C0042153;C0162425;C0457083;C1283828;C1537007;C1550453;C1883351;C1947944",NULL,NULL,431
"normal troponin","C0041199;C0205307;C0231683;C0439166;C2347086;C4553972",NULL,NULL,687
"severity of copd","C0024117;C0439793;C0522510;C1412502;C3714496",NULL,NULL,1546
"ecg atrial fibrillation n","C0004238;C0344434;C1623258;C1963067",";C0004238","",1009
"demographics and clinical characteristics","C0011298;C0683325;C1704791",NULL,NULL,789
"bmi $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0578022","C1305855","",1734
"hispanic n $nmbr$","C0086409","C0086409","",865
"ethnic group no","C0015031;C1879937",NULL,NULL,787
"ecg left ventricular","C0225897;C1623258",NULL,NULL,40
"nihss at randomization $nmbr$ $nmbr$","C0034656;C1697238",NULL,NULL,692
"metabolic syndrome $nmbr$ of $nmbr$ characteristics","C0524620;C1521970",NULL,NULL,617
"intravenous loop diuretics","C0348016;C0354100","C0354100","",991
"aldosterone antagonists","C0002007;C2757004","C0002007",";C0034678;C0525678;C1514727",1758
"total bleeding","C0232100",NULL,NULL,1685
"ecrcl $nmbr$ ml min","C0439445","C3811844;C0017654","",307
"apo b mg dl","C0003593;C0439269;C3252643","C0003593","",426
"no antihypertensive medication","C0003364",";C0003364","",1579
"blood transfusion","C0005841;C0281867","C0005841","",1241
"rate n","C0871208;C1521828",NULL,NULL,2009
"cox bsl onlyc","C1549954;C1565830",NULL,NULL,656
"cardiac pacemaker no","C0030163;C0037189",NULL,NULL,503
"ls mean","C0023668;C0444504;C2347634;C2348143",NULL,NULL,37
"the test for heterogeneity interaction indicates whether the treatment effect varied significantly among the sub groups the hochberg method was applied to each of the two comparisons of the treatment groups bmi denotes body mass index the weight in kilograms divided by the square of the height in meters","C0005893;C0005910;C0019409;C0022885;C0025663;C0039593;C0039798;C0043100;C0087111;C0205120;C0205448;C0242960;C0332849;C0392366;C0439209;C0441074;C0441833;C0449851;C0456984;C0489786;C0542339;C0578022;C0687744;C0871511;C1257890;C1264637;C1305855;C1305866;C1515976;C1518681;C1519504;C1522326;C1533734;C1552595;C1552839;C1704675;C1705104;C1705169;C1705428;C1705429;C1707455;C3538994;C3831328;C3887704;C4048755;C4318744","","",-10
"blood pressure mean sd mm hg","C0428886;C0439475;C2699239","C0005823","",1469
"no history of heart failure at baseline","C0168634;C0455531;C1442488","C0018801",";C0168634;C1524003",12
"extent of disease","C0449279;C4553144","C0449279","",1809
"cerebrovascular disease","C0007820",NULL,NULL,728
"reversibility $nmbr$ $nmbr$","C0449261","C0449261","",2160
"high uln","C0205250;C1299351;C1519815;C2700149;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"canakinumab dose","C0178602;C0869039;C1114758;C2718773",NULL,NULL,110
"fvc ml","C0439526;C1705224;C3714541;C3887665",NULL,NULL,300
"high dosage ics plus laba with baseline blood eosinophils $nmbr$ cells per pl n $nmbr$","C0005773;C0007584;C0007634;C0014467;C0168634;C0178602;C0200638;C0205250;C0815320;C1299351;C1442488;C2700149;C2986497;C3887512;C3889660;C3897966;C4049765;C4321237;C4522209;C4551720",NULL,NULL,834
"very high vs normal","C0205307;C0231683;C0439166;C0442804;C2347086;C4321397;C4553972",NULL,NULL,687
"age p o $nmbr$","C0001779","C0001779","",480
"$nmbr$ yr km mortality rate","C0026565;C0205848;C0439234;C3887676",NULL,NULL,1099
"very high vs normalb","C0442804;C4321397",NULL,NULL,1478
"moderate chronic kidney disease","C0205081;C1561643;C1881878;C4049705;C4049706;C4085643;C4321335;C4553188",NULL,NULL,321
"supplementary oxygen","C0030054","C4534306","",1327
"abatacept plus mtx n $nmbr$","C0025677;C1417487;C1619966","C1619966","",1190
"sirolimus","C0072980",NULL,NULL,633
"dutasteride w $nmbr$ $nmbr$ $nmbr$","C0754659",NULL,NULL,1647
"atorvastatin $nmbr$ mg","C0024671;C0026410;C0286651;C0439269;C1960952;C2346927;C4321396;C4521761","C0286651","",885
"no history of diabetes n $nmbr$","C0011847;C0011849;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"aspirin at any dose","C4696290","C0004057","",1366
"l l $nmbr$ $nmbr$","C3539687","","",-10
"d $nmbr$ vs warfarin rr $nmbr$ ci p value","C0008107;C0043031;C0073187;C0332173;C1709380;C3259781;C4484261;C4554402","C0043031","",858
"infliximab experienced n $nmbr$","C0666743","C0666743","",154
"ap $nmbr$ $nmbr$ bp $nmbr$ $nmbr$ cp $nmbr$ $nmbr$ the study speci c bp targets were sbp $nmbr$ mm hg and dbp $nmbr$ mm hg or sbp $nmbr$ mm hg and dbp $nmbr$ mm hg in those with dm the ldl c target was $nmbr$ mg dl or $nmbr$ mg dl depending on risk factor status at baseline in accordance with ncep atp iii guidelines odds ratio and p value calculated based on generalized linear mixed model with generalized estimating equations method that includes compound symmetry covariance matrix for subjects from the same site an interaction between treatment effect and dm status was observed for bp goal attainment p $nmbr$ $nmbr$ and dual bp ldl c goal attainment p $nmbr$ $nmbr$ among patients with or without dm calculated based on a mixed effects linear model not adjusted for differences in baseline values abbreviations bp blood pressure dbp diastolic blood pressure dm diabetes mellitus ldl c low density lipoprotein cholesterol ncep atp iii national cholesterol education program adult treatment panel iii or odds ratio sbp systolic blood pressure","C0000723;C0001675;C0002680;C0005767;C0005768;C0005823;C0006938;C0011816;C0011849;C0023732;C0025424;C0025663;C0028873;C0030705;C0033095;C0035648;C0037623;C0039155;C0039798;C0042295;C0065055;C0085805;C0086858;C0087111;C0162791;C0168634;C0178587;C0205145;C0205173;C0205198;C0205246;C0205251;C0205430;C0220845;C0229664;C0282423;C0332257;C0332516;C0428257;C0428883;C0439070;C0439269;C0439475;C0441833;C0444686;C0445247;C0449438;C0449851;C0456081;C0460139;C0536221;C0552449;C0557651;C0680230;C0681850;C0725813;C0750572;C0871511;C1280500;C1306345;C1415692;C1441506;C1441672;C1442488;C1515974;C1518422;C1518681;C1521840;C1522326;C1527178;C1533734;C1550472;C1550501;C1552866;C1554184;C1704640;C1704675;C1705160;C1705169;C1705241;C1705242;C1705938;C1706082;C1706203;C1706365;C1706450;C1706515;C1708288;C1709380;C1999270;C2347108;C2347109;C2348272;C2349001;C2603343;C2697811;C2700399;C2744579;C2825164;C2825575;C2946465;C2986546;C3160715;C3245503;C3250443;C3538994;C3813197;C3887704;C3887950;C3890211;C4048187;C4050020;C4050026;C4068104;C4281799;C4284008;C4318478;C4319583;C4321351;C4330985;C4522223;C4552600;C4553629;C4554674","","",-10
"duration of t $nmbr$ dm years","C0011816;C0439234;C0449238;C2926735;C3250443",NULL,NULL,901
"known tiromtcch c ccndifeon","C0205309",NULL,NULL,1238
"myocardial infarction cabg pci $nmbr$ years","C0010055;C0027051;C0428953;C0439234;C2926063;C3810814;C4049621;C4552959",NULL,NULL,1099
"baseline heart failure severity amongthose with priorheartfailure","C0018801;C0018802;C0168634;C0439793;C0522510;C1442488;C4554158","C0018801",";C0168634;C1524003",12
"endovascular","C0524425","C0524425","",1218
"not hispanic latino","C0086528;C1518424","C0086409","",865
"$nmbr$ $nmbr$ o $nmbr$ o $nmbr$","C0483204","","",-10
"musculoskeletal","C0497254;C2707260",NULL,NULL,1656
"subject completion status n","C0205197;C0449438;C0681850;C0805732;C1550501;C1554962;C1706203;C2348577;C2349001;C2697811;C3891295",NULL,NULL,1655
"baseline bii mean sd","C0168634;C0444504;C1413059;C1442488;C2347634;C2348143;C2699239",NULL,NULL,1287
"central and south america and mexico","C0025885;C0037713;C0205099;C1879652","C0037713","",580
"number of treated vessels","C0005847;C0237753;C0449788;C1522326",NULL,NULL,743
"leukocytes $nmbr$ nl","C0023516;C0027778;C0560008;C3892223",NULL,NULL,1805
"tiotropium olodaterol $nmbr$ $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C4032878;C4321396;C4521761",NULL,NULL,2301
"psa modified total shs","C0392747;C0439175;C0439810;C3810537;C3813209;C3889737",NULL,NULL,125
"doubling of creatinine level","C0205173;C0428279;C1705764",NULL,NULL,314
"c clinical fractures fas","C0016658;C0205210",NULL,NULL,2026
"mitral regurgitation n","C0026266",NULL,NULL,1683
"ticagrelor $nmbr$ mg diabetes n $nmbr$","C0011847;C0011849;C0024671;C0026410;C0439269;C1960952;C1999375;C2346927;C4321396;C4521761",NULL,NULL,2299
"insulin no","C0021641;C1533581;C1579433;C3714501",NULL,NULL,157
"subgroup by treatment interaction p value","C0039798;C0087111;C1079230;C1515021;C1522326;C1533734;C1704675;C1705169;C1709380;C3538994;C3887704",NULL,NULL,7
"tests for categoric","C0589061",NULL,NULL,235
"asdas inactive disease","C0544452",NULL,NULL,1712
"pts","C1419129;C2698747",NULL,NULL,1512
"$nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923","C3811844;C0017654","",307
"$nmbr$ vessel pci","C0005847;C4049621",NULL,NULL,1736
"gpi used during pci","C1273517;C1415351;C4049621",NULL,NULL,535
"hispanic or latino ethnic groupb","C0015031;C0086409;C0086528;C0680174","C0086528;C0086409;C0015031","",363
"race no t","C0034510;C1706779;C2603360;C3853635",";C0034510","",1107
"ugt induction status per aeda n","C0205263;C0449438;C0857127;C1420188;C4284131",NULL,NULL,543
"om $nmbr$ mg aml $nmbr$ mg hctz $nmbr$ mg","C0020261;C0023465;C0023467;C0028971;C1319635;C1705272",NULL,NULL,1149
"less severe","C0205082;C0439092;C0547044;C4050465;C4050466",NULL,NULL,313
"post svc","C0231957;C0687676;C1704687;C3469826",NULL,NULL,245
"corticosteroid without imm","C0001617;C0205470;C3536709",NULL,NULL,1650
"alcohol use $nmbr$ day","C0001948;C0332173;C0439228;C0439505","C0001948","",875
"elevated serum creatinine $nmbr$ $nmbr$ mg dl_","C0439269;C0700225","C0600061;C0010294","",952
"apo a i mg dl","C0085201;C0439269;C1677784","C0085201","",1852
"pain vas mean change from baselined","C0042815;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952",NULL,NULL,767
"high sensitivity c reactive protein mg liter","C0006560;C0024671;C0026410;C0439269;C0475211;C1413716;C1441604;C1960952;C2346927;C4048285;C4321396;C4521761","C0006560","",286
"sbp mmghg mean sd","C0085805;C0444504;C2347634;C2348143;C2699239",NULL,NULL,2127
"sdc $nmbr$ $nmbr$ $nmbr$ $nmbr$ ng ml","C0439275;C1419891;C3273112",NULL,NULL,204
"xanthines","C0043318;C3541955","C0043318","",359
"abciximab facilitated pci n $nmbr$","C0288672;C4049621",NULL,NULL,1736
"sbp mean sd mm hg","C0085805;C0439475;C0444504;C2347634;C2348143;C2699239",NULL,NULL,607
"non high dose statin n $nmbr$ $nmbr$","C0360714;C0444956;C1518422","C0360714","",872
"sulfonylureas","C0038766;C3653359","C0038766","",752
"waist to hip ratio","C0205682","C0205682","",1409
"current","C0521116;C1705970",NULL,NULL,1417
"interaction treatment by psoriasis p value $nmbr$","C1704675;C1709380;C3258078",NULL,NULL,7
"body mass index blood pressure mmhg","C0005823;C0005893;C0439475;C0578022;C1271104;C1272641;C1305855","C1305855","",1734
"mepolizumab","C0969324",NULL,NULL,943
"hba $nmbr$ c $nmbr$ weeks","C0019016;C0439230;C1825777;C3538758","","",820
"bmi distribution n","C0520511;C0578022;C1704711",NULL,NULL,892
"chd cl all","C0280604;C0596019;C3542407",NULL,NULL,970
"serum creatinine $nmbr$ xmol l n","C0201976;C0600061","C0600061;C0010294","",952
"baseline factor","C0168634;C1442488;C1521761;C2827422",NULL,NULL,1111
"cv death mi ischemic stroke","C0011065;C0948008;C1306577;C3538987;C3810814;C4048877;C4082313;C4318503;C4552775",NULL,NULL,323
"$nmbr$ additional cv risk factors $nmbr$","C0035648;C1524062;C1553898;C3538987;C4048877;C4318503",NULL,NULL,1777
"allergic rhinitis","C1334103;C2607914;C4552864",";C0035455","",272
"outcome","C1274040",NULL,NULL,1602
"serum potassium mmol liter","C0302353;C0439190;C0475211;C0543465","C0302353","",1959
"level of thyroperoxidase antibody at baseline","C0021965;C0168634;C0428536;C0441889;C0456079;C0487652;C1318460;C1364508;C1429427;C1442488;C1547707;C2946261;C3272921",NULL,NULL,625
"glycated hemoglobin nonstandardized level","C0202054","","",1176
"$nmbr$ $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923","C3811844;C0017654","",307
"patients with fistulas at baseline","C0016169;C0030705;C0168634;C1442488",NULL,NULL,1595
"change in fev $nmbr$ at week $nmbr$","C0332174;C0392747;C0439230;C0443172;C1705241;C3714541;C4319952",NULL,NULL,1012
"mtss cfb mean sd","C0009002;C0444504;C1824728;C2347634;C2348143;C2699239",NULL,NULL,145
"patient years hr unadjusted","C0030705;C0439234;C1439367",NULL,NULL,1099
"central eosinophil count cells per pl t","C0007584;C0007634;C0200638;C0205099;C0750879;C1879652;C3897966;C4049765",NULL,NULL,677
"estimated glomerular filtration rate ml min $nmbr$ $nmbr$ m $nmbr$ mean sd","C0369637;C0439445;C0441923;C0444504;C2347634;C2348143;C2699239;C3811844","C3811844;C0017654","",592
"cardiovascular inclusion criteriat","C0007226;C0007637;C1512693;C3887460",NULL,NULL,473
"metabolic syndromeb","C0311400;C1524026;C2707259",NULL,NULL,617
"nonvertebral fracture","C0016658",NULL,NULL,2026
"eo severity by la classification at baseline baseline of the healing study n","C0043240;C0168634;C0205249;C0332120;C0439793;C0522510;C0557651;C1442488;C1881447;C2603343",NULL,NULL,1058
"p women vs men","C0025266;C0043210;C0369773;C2603361","","",306
"lv ejection fraction mean sd range","C0023128;C0444504;C0489482;C0731033;C1514721;C1881413;C2347634;C2348143;C2348147;C2699239;C2700378;C3542016",NULL,NULL,37
"no pci or cabg no","C0010055;C4049621",NULL,NULL,1736
"$nmbr$ mwd m","C0369637;C0441923",NULL,NULL,923
"normal $nmbr$ ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$ n","C0205307;C0231683;C0369637;C0439166;C0439445;C0441923;C2347086;C4553972",NULL,NULL,687
"patients with diabetes mellitus","C0011849;C0030705","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"readmission n $nmbr$","C1548168;C4489276","C1548168","",1857
"placebo $nmbr$ $nmbr$ $nmbr$","C0032042;C1696465;C1706408","C0032042","",28
"egfrmdrd $nmbr$ ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$ n","C0369637;C0439445;C0441923","C3811844;C0017654","",592
"no history of extra intestinal manifestations of ibd ref","C0019664;C0019665;C0021853;C0262512;C0262926;C1280464;C1425988;C1705255;C1883702;C2004062",NULL,NULL,1880
"mean change in fev $nmbr$","C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C3714541;C4319952",NULL,NULL,767
"fl $nmbr$ $nmbr$","C1300812;C1708024","","",-10
"black n $nmbr$ adjusted hazard ratio","C0005680;C0027567;C0085756;C0439541;C0456081;C2985465",NULL,NULL,1580
"interaction treatment by psoriasis p valueb","C1704675;C3258078",NULL,NULL,1010
"angioplasty","C0162577;C1548817","C0162577","",1722
"uti","C0042029;C0077906;C1412376",NULL,NULL,1534
"biologic naive","C0005515;C0205460",NULL,NULL,214
"ejection fraction $nmbr$ n $nmbr$","C0489482;C2700378","C2700378","",887
"hla b $nmbr$ positive at baseline n","C0019737;C0168634;C0439178;C0550853;C1415561;C1442488;C1446409;C1514241;C2825490;C3812269",NULL,NULL,1163
"interquartile range yr","C0439234;C1711350",NULL,NULL,1099
"lebrikizumab n $nmbr$","C2981360","C2981360","",373
"any risk factor for stent thrombosis","C0035648;C3897493",NULL,NULL,175
"egfr s $nmbr$ o ml min $nmbr$ $nmbr$ m","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"south central america","C0007674;C0037713;C0205099;C1710133;C1879652","C0037713","",580
"gold stage c","C0018026;C0441785;C1304897","C0024117;C0521117","",213
"previous clinical stroke or transient ischemic attack","C0007787;C0038454;C0205156;C0205210;C0917805;C1552607;C4554100",NULL,NULL,1762
"symptomatic pad","C0182158;C0231220;C0332568;C3540603;C3669270;C3814046;C4319657",NULL,NULL,611
"sgrq scores mean sd","C0444504;C0449820;C2347634;C2348143;C2699239;C4050231",NULL,NULL,37
"patients with psoriasis n $nmbr$","C0030705;C0033860","C0033860","",1358
"urine acr median","C0042036;C0042037;C0549183;C0876920;C1412134;C1515941;C2347635;C2348144;C2939193;C2963137",NULL,NULL,635
"$nmbr$ $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"of prior bdmards","C0332152;C2826257",NULL,NULL,2377
"drinker a","C0556338",NULL,NULL,176
"pbo mtx to mtx","C0025677;C0031962;C1417487","C0025677","",1408
"eze $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761","C1142985","",1165
"not treated","C1518422;C1522326",NULL,NULL,552
"theophyllines","C0039771","C0039771","",66
"statin non users n $nmbr$","C0360714;C1518422;C1706077","C0360714","",872
"cv death hf hospitalization","C0011065;C0018488;C0019993;C1306577;C1313497;C1538440;C3273279;C3538987;C4048877;C4082313;C4318503;C4552775",NULL,NULL,323
"alogliptin $nmbr$ $nmbr$ mg pioglitazone n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C3535925;C4321396;C4521761",NULL,NULL,1955
"median range duration of hospital stayi d","C0019994;C0449238;C0549183;C0876920;C1510665;C1514721;C2347635;C2348144;C2348147;C2926735;C2939193;C3542016",NULL,NULL,479
"$nmbr$ drinks","C0452428",NULL,NULL,178
"diastolic bp mm hg mean sd","C0012000;C0428883;C0439475;C0444504;C0488053;C2347634;C2348143;C2699239","C0428883","",842
"fatty acid profile","C0015684;C1979963;C2003903","C0015684","",1236
"use of loop diuretics n","C0354100;C1524063","C0354100","",991
"metrex overall modified intention to treat population","C0032659;C0087111;C0162425;C0282416;C0392747;C1257890;C1283828;C1292734;C1522326;C1561607;C3889737",NULL,NULL,1743
"hscrp $nmbr$ $nmbr$ mg l","C0439268","C0006560","",286
"oral hypoglycemics hormone replacement","C0282402;C0359086","C0359086","",1744
"physician s global assessment of dis","C0451119;C1444662;C1970187;C4050369",NULL,NULL,1525
"killip class n","C1881332","C1881332","",846
"baseline hdl c level n $nmbr$ $nmbr$ s $nmbr$ $nmbr$ mg dl","C0168634;C0439269;C0441889;C0456079;C1442488;C1547707;C2946261;C3715113",NULL,NULL,2001
"nyha class i","C1882084","C0018802;C1882083","",453
"prior tnf antagonist failure n b","C0231174;C0231491;C0332152;C0680095;C2826257;C3887647",NULL,NULL,2375
"acute $nmbr$ hr","C0205178",NULL,NULL,1577
"uacr not available","C0686905","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"shock risk indext","C0035647;C0036974;C4552904","C0035647","",173
"outcomes by treatment spironolactone vs placebo","C0032042;C0037982;C0085415;C1696465;C1706408","C0037982","",1405
"electrocardiographic findings at randomization","C0034656;C0438154","C1623258","",1129
"sbp mmhg","C0085805;C0439475",NULL,NULL,607
"concomitant asthma medications n","C0004096;C0013227;C0521115;C0802604;C2598133;C2984299;C4284232",NULL,NULL,366
"ulcers gangrene","C0017086;C0041582","C0041582","",1451
"native hawaiian or other pacific","C0337920","C0337920;C0242191","",1331
"women n $nmbr$ n n","C0043210","C0043210",";C3541888;C1720467",1323
"pooled analysis","C0002778;C0936012;C1524024;C1709595;C2349200;C4522255","C1709595;C1524024","",211
"platelet $nmbr$ l","C0456525","C0456525","",1192
"score at week $nmbr$ mean se difference mepo pbo $nmbr$ ci","C0008107;C0031962;C0036919;C0332174;C0439230;C1705241;C1705242;C3259781;C3533236",NULL,NULL,435
"tocilizumab","C1609165",NULL,NULL,2295
"three or more drugs","C0013227;C0205172;C0205449;C3687832",NULL,NULL,1539
"mean time since as diagnosis years mean sd","C0011900;C0040223;C0439234;C0444504;C1704338;C1704656;C2347634;C2348143;C2699239;C3541383",NULL,NULL,37
"s $nmbr$","C0565930;C2603362",NULL,NULL,1784
"secondary change in total updrs score from baseline to final visit in phase $nmbr$","C0027627;C0168634;C0175668;C0205088;C0205436;C0392747;C0439175;C0439810;C0443172;C0449820;C0545082;C1442488;C1512346;C1705241;C2826704;C3639721;C4050231;C4319952",NULL,NULL,1484
"stent diameter $ $nmbr$ mm","C0038257;C1301886;C4330985;C4554674",NULL,NULL,569
"vildagliptin $nmbr$ mg bid","C0024671;C0026410;C0439269;C1570906;C1960952;C2346927;C4321396;C4521761","C1570906","",2068
"diastolic fmmhff","C0012000","C0012000","",844
"triglycerides","C0041004","C0041004","",368
"body mass index $nmbr$","C0005893;C0578022;C1305855","C1305855","",1734
"metabolism and nutrition","C0025519;C0025520;C0028707;C0392209;C0518896;C1442959",NULL,NULL,629
"uveitis","C0042164;C1963266","","",-10
"medication use aspirin","C0004057;C0240320",NULL,NULL,119
"black worldwide","C0005680;C0027567;C0085756;C0439541","C0005680",";C1706779",188
"antihypertensive drug","C0003364",";C0003364","",1579
"parameter at baseline","C0168634;C0549193;C1442488;C1704769;C2350001","C0549193","",1186
"duration of pci min","C0449238;C0702093;C1524029;C2926735;C3813700;C4049621",NULL,NULL,901
"amiodarone vs placebo","C0002598;C0032042;C1696465;C1706408","","",1757
"sle markers n","C0005516;C0024141","C0024141;C0005516","",2248
"previous cardiovascular event at randomization","C0034656;C0205156;C1320716;C1552607","C1320716","",414
"median age y range","C0001779;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016",NULL,NULL,1901
"time to randomization h","C0033727;C0034656;C0040223;C0369286;C0441932;C0564385;C3541383;C4528284",NULL,NULL,308
"urine acr mg mmol","C0042036;C0042037;C0567349;C1412134;C1515941;C2348885;C2963137","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"previous hypersensitivity reaction no","C0020517;C0205156;C1552607",NULL,NULL,1045
"estimated gfr ml min $nmbr$ $nmbr$ m $nmbr$ mean sd","C0017654;C0369637;C0439445;C0441923;C0444504;C0750572;C1424601;C2347634;C2348143;C2699239","C3811844;C0017654","",592
"non diabetic n $nmbr$","C0241863;C1518422",NULL,NULL,996
"cognitive subscale on alzheimer s disease assessment scale mean sd e","C0444504;C0450989;C1516691;C2347634;C2348143;C2699239",NULL,NULL,37
"dm n","C0011816;C3250443",NULL,NULL,955
"concomitant medication","C0013227;C0521115;C3244316;C4284232","C0013227;C0521115","",1916
"concomitant oads n","C0521115",NULL,NULL,448
"t jj $nmbr$ $nmbr$","C2603360","","",-10
"acute reperfusion","C0035124;C0205178;C0684253",NULL,NULL,1049
"baseline vfx","C0168634;C1442488",NULL,NULL,625
"metabolic syndrome n n","C0524620",NULL,NULL,617
"non calcium antagonist strategy n $nmbr$ $nmbr$","C0006684;C0679199;C1518422","C1518422;C0679199;C0006684","",1374
"hispanic ethnicity n","C0015031;C0086409;C0243103",NULL,NULL,787
"no digoxin n $nmbr$ $nmbr$ $nmbr$","C0012265","C0012265","",989
"lipoprotein a mg dl","C0065058;C0125953;C0439269;C1096202;C1439335","C0065058","",1769
"moderate impairment","C0205081;C0221099;C0684336;C1881878;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"aldosterone inhibitor","C0002007","C0002007",";C0034678;C0525678;C1514727",1758
"female n $nmbr$ $nmbr$","C0043210;C0086287;C1705497;C1705498","C0086287","",1277
"difference se","C0036919;C1705241;C1705242",NULL,NULL,567
"core laboratory percent stenosis","C0022877;C0439165;C0444669;C0678234;C1167518;C1261287;C1706352;C1882467;C2632116;C3244292;C3274653;C4283904",NULL,NULL,1548
"homajr tx difference vs pbo median change from baseline se $nmbr$ lipid parameters","C0031962;C0036919;C0041403;C0168634;C0449381;C0549183;C0876920;C1158406;C1442488;C1705241;C1705242;C2347635;C2348144;C2939193",NULL,NULL,567
"non q wave ml","C0429089;C0439526;C1305738;C1518422;C1705224;C3887665","C1305738","",385
"improved","C0184511;C0332272;C1561611;C4084203","","",-10
"atherosclerotic vascular disease history","C0004153;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062","C0004153","",1698
"variable_level","C0439828;C0441889;C0456079;C1547707;C2946261;C4553760",NULL,NULL,744
"sama b n","C1075468",NULL,NULL,1300
"mean sd $nmbr$ h adbp mm hg","C0033727;C0168370;C0369286;C0439475;C0441932;C0444504;C0564385;C2347634;C2348143;C2699239;C4528284",NULL,NULL,1287
"lone atrial fibrillation no","C0340489","C0004238","",90
"s $nmbr$ exacerbations","C0565930;C2603362;C4086268","C4086268","",889
"medications at timing of randomization n","C0034656;C2359859",NULL,NULL,692
"creatinine $nmbr$ $nmbr$ mg dl medications","C0010294;C0013227;C0439269;C0802604;C1561535;C2598133;C4284232","C0600061;C0010294","",952
"multiple tnfi and other bdmards","C0439064",NULL,NULL,330
"vascular death","C0005847;C0011065;C1306577;C1558950;C1801960;C4082313;C4552775",NULL,NULL,323
"most common concomitant aeds d n","C0180309;C0205214;C0205393;C0521115;C1522138;C3245511",NULL,NULL,448
"index acs no","C0600653;C0742343;C0918012;C1552854;C1637833;C2986546;C4318612",NULL,NULL,2147
"medical management only no","C0001554;C0199168;C0205171;C0205476;C0376636;C1273870;C1720467;C3273539",NULL,NULL,925
"heart rate min $nmbr$","C0018810;C0702093;C1524029;C3813700","C0018810","",1105
"low trs $nmbr$ $nmbr$ n $nmbr$ $nmbr$","C0205251;C0266427;C0968917;C1150746;C1550472;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"left side only","C3842976",NULL,NULL,43
"st depression without st elevation","C0011570;C0011581;C0344315;C0439775;C0460137;C0520886;C0520887;C0702240;C4049644;C4084909;C4085311;C4553827","C0520887",";C0011570;C0011581;C0344315;C4049644;C0702240;C4085311;C4084909",1856
"total comparators n $nmbr$","C0439175;C0439810;C1707454;C4553389;C4553390",NULL,NULL,1632
"weekly iss $nmbr$","C0332174;C1740819;C1845118",NULL,NULL,1013
"migraine severity score","C0149931;C0457451",NULL,NULL,684
"avr","C0449217",NULL,NULL,1779
"lips","C0023759",NULL,NULL,127
"chronic kidney disease stage egfr ml min per $nmbr$ $nmbr$ m $nmbr$","C0007591;C0439445;C0456533;C1561643;C1739039;C3811844;C3812682;C4553188","C3811844;C0017654","",307
"baseline dlqi mean sd","C0168634;C0444504;C1442488;C2347634;C2348143;C2699239;C3899393",NULL,NULL,527
"baseline short acting anticholinergics n","C0079613;C0168634;C0242896;C1282927;C1442488;C1704930;C1806781;C1869853;C2350002;C3537307;C3540711;C3890007;C4048375",NULL,NULL,1704
"shared epitope a positive","C0003316;C0237876;C0439178;C1446409;C1514241;C1522138;C2825490;C3812269",NULL,NULL,1163
"non us n $nmbr$","C0369718;C0441922;C1518422",NULL,NULL,1553
"acute coronary event","C0205178;C0741923","C0948089",";C0026544",225
"indacaterol $nmbr$ pg","C0030827;C0072225;C1266240;C1722260",NULL,NULL,2331
"estimated glomerular filtration rate mdrd ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C3811844;C3839656",NULL,NULL,923
"denosumab n $nmbr$","C1690432",NULL,NULL,943
"feno placebo lsm","C0032042;C1696465;C1706408","C0032042","",28
"male sex no f","C0016327;C0086582","C0086582","",1276
"disease progression composite outcome","C0205199;C0242656;C0449258;C0679250;C1274040;C1335499;C1547335;C1947900;C3542417;C4552808","C0205199","",1631
"change at week $nmbr$","C0332174;C0392747;C0439230;C0443172;C1705241;C4319952",NULL,NULL,767
"local eosinophil count","C0200638;C0205276;C0750879","C0750879","",848
"peri op amiodarone no n $nmbr$","C0002598;C0347985;C0369718;C0441922","","",1757
"documented mi","C1301725;C1609436;C3810814","C0010054;C0151744","",1361
"previous treatment with a laba and or lama n c","C0039798;C0087111;C0205156;C0999593;C1416775;C1522326;C1533734;C1552607;C1705169;C3538994;C3887704",NULL,NULL,1300
"baseline cardiac biomarkers","C0168634;C1442488;C2735101;C2735102",NULL,NULL,625
"second co primary outcome","C0205225;C0205436;C0439612;C0439631;C0457385;C0565930;C1274040;C1561503;C1705190;C3245499",NULL,NULL,2341
"prior vka experience","C0237607;C0332152;C0596545;C2826257",NULL,NULL,1460
"three vessel disease","C3272265",NULL,NULL,746
"short acting b $nmbr$ agonists","C0079613;C0243192;C1282927;C1704930;C1806781;C1869853;C2350002;C2987634;C3890007;C4048375",NULL,NULL,499
"family history of vte","C0241889;C0630906","C0241889","",1493
"patients with endpoin t n","C0030705;C2986835",NULL,NULL,1035
"combined therapy v $nmbr$ $nmbr$ $nmbr$","C0033972",NULL,NULL,1646
"e europe","C0015176","C0015176","",337
"aerobic activity","C0001701",NULL,NULL,1694
"diabetes p oo $nmbr$","C0011847;C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"low c $nmbr$ $nmbr$ $nmbr$ g l","C0205251;C0439294;C0456615;C1550472;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"xi $nmbr$ $nmbr$ p $nmbr$","C1720296",NULL,NULL,520
"no prior hf n $nmbr$","C0018488;C0332152;C1313497;C1538440;C2826257;C3273279","C0018801",";C0168634;C1524003",12
"multivessel two vessel three vessel or left main","C0205091;C0205225;C0205449;C0443246;C1542147;C1552822;C4012475;C4037954",NULL,NULL,42
"laboratory values at admission median and iqr","C0022877;C0042295;C0184666;C0549183;C0809949;C0876920;C2347635;C2348144;C2939193;C3244292;C4283904",NULL,NULL,978
"$nmbr$ meters","C0441074",NULL,NULL,920
"nkf stage","C0205390;C1300072;C1306673",NULL,NULL,541
"model $nmbr$ t","C3161035;C3274659;C3714583;C3853906",NULL,NULL,1320
"mtx plus placebo","C0025677;C0032042;C0332287;C1417487;C1696465;C1706408","C0032042","",28
"black race no total no f","C0005680;C0016327;C0027567;C0034510;C0085756;C0439175;C0439541;C0439810;C1706779;C3853635",NULL,NULL,966
"upper gastrointestinal tract","C3203348",NULL,NULL,781
"sbp mm hg mean sdc","C0085805;C0439475;C0444504;C1419891;C2347634;C2348143;C3273112",NULL,NULL,37
"no history of paroxysmal af","C0019664;C0019665;C0235480;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"interleukin $nmbr$ ng l","C0021764;C0439297;C1527200",NULL,NULL,2322
"homa_ b tx difference vs pbo median change from baseline se $nmbr$","C0031962;C0036919;C0041403;C0168634;C0392747;C0443172;C0549183;C0876920;C1442488;C1705241;C1705242;C2347635;C2348144;C2939193;C4319952",NULL,NULL,635
"cardiac therapy","C3654025",NULL,NULL,644
"early ichaem ic stroke","C0020750;C0038454;C1279919;C4554100;C4554818",NULL,NULL,1593
"bundle branch block","C0006384;C1879286",NULL,NULL,965
"bp goal at week $nmbr$","C0018017;C0037623;C0332174;C0439230;C1415692;C1571704;C1708288;C4318478",NULL,NULL,608
"hf cause","C0015127;C0018488;C1313497;C1524003;C1538440;C3273279","C0018801",";C0168634;C1524003",12
"ranolazine n $nmbr$","C0073633",NULL,NULL,71
"visit","C0545082;C1512346;C2826704",NULL,NULL,276
"female acr definition g mg","C0024671;C0026410;C0043210;C0086287;C0439267;C0439269;C1412134;C1515941;C1550452;C1704788;C1705497;C1705498;C1960952;C2346927;C3539107;C3888054;C4321396;C4521761",NULL,NULL,192
"use of beta blocker","C0001645;C1524063","C0001645","",959
"fasting blood glucose","C0428568;C1261430","C0017725;C0015663","",2280
"non cana n $nmbr$","C1418845;C1518422",NULL,NULL,1302
"past","C1444637;C4284302",NULL,NULL,456
"insulin treated","C0021641;C1522326;C1533581;C1579433;C3714501",NULL,NULL,157
"macce abciximab placebo","C0032042;C0288672;C1696465;C1706408",NULL,NULL,1108
"triglycerides median iqr mg dl","C0041004;C0439269;C0549183;C0876920;C2347635;C2348144;C2939193","C0041004","",368
"patients with $ $nmbr$ dactylitis digit at week $nmbr$ enthesitis","C0030705;C0332174;C0439230;C1282952;C3863761","C1282952","",271
"tofacitinib $nmbr$ mg twice daily","C0024671;C0026410;C0439269;C0585361;C1960952;C2346927;C2930696;C4321396;C4521761",NULL,NULL,2302
"fasting insulin pmol liter","C0015663;C0021641;C0439192;C0475211;C1533581;C1579433;C3714501",NULL,NULL,157
"ptga of disease activity $nmbr$ $nmbr$ mm mean sd","C0444504;C1292728;C2347634;C2348143;C2699239;C4330985;C4554674","C1292728",";C4050231;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209",101
"concomitant lipid lowering therapy any","C0521115;C0585943","C0585943;C0086440","",1774
"erosion score median min max","C0333307;C0449820;C0549183;C0702093;C0876920;C1524029;C1880549;C1959609;C2347635;C2348144;C2939193;C3813700;C3887524;C4050231",NULL,NULL,1475
"ada $nmbr$ $nmbr$ n $nmbr$","C1060325;C3811629",NULL,NULL,1076
"glucose in urine $nmbr$","C0004076",NULL,NULL,22
"medications at discharge or day $nmbr$ if earlier","C0332173;C0439228;C0439505;C0806915;C1279919",NULL,NULL,1621
"diabetes mellitus duration y sd","C0011849;C0449238;C2699239;C2926735","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"l $nmbr$","C0439394;C1706495;C3642217","","",-10
"bivalirudin used","C0168273;C1273517",NULL,NULL,776
"na mmol l","C0597484;C1272460;C1532563;C1546968;C1879645;C4049872;C4552882",NULL,NULL,419
"no reference","C1514811;C1706462",NULL,NULL,1464
"hr is $nmbr$ if pravastatin is better than diet alone","C0012155;C0012159;C0085542;C0205171;C0332272;C0439044;C0679994;C1519433;C2983588;C3668949;C4522046","C0012155","",1199
"duration of sulphonylurea use months mean s d","C0038766;C0439231;C0444504;C1881378;C2347634;C2348143;C2826775;C3536898","C0038766","",752
"egfr $nmbr$ ml min m $nmbr$","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"synovitis","C0039103",NULL,NULL,1839
"range min max","C0702093;C1514721;C1524029;C2348147;C3542016;C3813700",NULL,NULL,1475
"mcs score","C0449820;C4050231",NULL,NULL,748
"mean se","C0036919;C0444504;C2347634;C2348143",NULL,NULL,567
"total comparators patients with events total patients","C0030705;C0439175;C0439810;C0441471;C1707454;C3541888;C4553389;C4553390",NULL,NULL,1632
"baseline hb $nmbr$ g i $nmbr$ n $nmbr$","C0062408;C0086706;C0168634;C1442488",NULL,NULL,2188
"thiazolidinedione includes pioglitazone","C0071097;C0289779;C0332257;C1257987;C1552866;C2700399;C3537039","C1257987",";C0289779;C1527178;C1705938;C1552866;C2700399;C0168634",72
"left ventricular ejection fraction within previous $nmbr$ mo","C0026544;C0205156;C0332177;C0428772;C0488728;C1552607",NULL,NULL,1476
"white race number","C0007457;C0043157;C0237753;C0449788",NULL,NULL,2003
"tiotropium olodaterol $nmbr$ $nmbr$ pg","C0030827;C0072225;C1266240;C4032878",NULL,NULL,1510
"difference in ls means $nmbr$ ci versus placebo","C0008107;C0023668;C0032042;C1696465;C1704970;C1705241;C1705242;C1706408;C3259781",NULL,NULL,519
"lev status n","C0023556;C0449438",NULL,NULL,543
"small artery occlusion","C0001168;C0011382;C0028778;C0226001;C0264995;C0441597;C0700321;C1110554;C1947917",NULL,NULL,1859
"noncardiac death","C0011065;C1306577;C4082313;C4552775",NULL,NULL,323
"anti tnf","C1448177",NULL,NULL,362
"baseline bmi $nmbr$ kg m $nmbr$","C0168634;C0578022;C1442488;C1532718",";C1305855","",206
"previous chronic kidney disease","C0205156;C1552607;C1561643;C4553188",NULL,NULL,1044
"use of concomitant lipid lowering treatment","C0023779;C0039798;C0087111;C0441994;C0521115;C1522326;C1524063;C1533734;C1705169;C2003888;C3538994;C3887704",NULL,NULL,1022
"edge","C0205154;C2697523",NULL,NULL,595
"age yf $nmbr$ $nmbr$","C0001779","C0001779","",480
"tg median interquartile range","C0337445;C0549183;C0876920;C1711350;C2347635;C2348144;C2939193",NULL,NULL,635
"cgfrby ckd epi ml min $nmbr$ $nmbr$ m $nmbr$ median iqr","C0162734;C0369637;C0439445;C0441923;C0549183;C0876920;C1561643;C2347635;C2348144;C2939193;C4281721","C3811844;C0017654","",307
"contrast used ml","C0009924;C0439526;C1273517;C1705224;C1979874;C3887665",NULL,NULL,300
"angina class iii or iv no","C0022326;C0264677;C4265176",NULL,NULL,2102
"baseline ldl c","C0168634;C1442488",NULL,NULL,2189
"$ $nmbr$ n","C0369718;C0441922",NULL,NULL,1553
"history of cancer","C0455471","C0241889","",1493
"ldl c calculated","C0444686;C1441506","C0023824","",1068
"mean dose sd mg week","C0024671;C0026410;C0178602;C0332174;C0439230;C0439269;C0444504;C0869039;C1114758;C1960952;C2346927;C2347634;C2348143;C2699239;C4321396;C4521761",NULL,NULL,192
"cerebrovascular","C1880018",NULL,NULL,651
"caffeine consumption yes n","C0948365;C1549445;C1705108;C1710701","C0006644",";C1710701",1816
"number of stents","C0038257;C0237753;C0449788",NULL,NULL,569
"nonblack participants","C0679646",NULL,NULL,1033
"due to sae","C1519255;C1622657;C4553214","C1519255","",1282
"apo a $nmbr$ mean sd mg dl","C0003592;C0439269;C0444504;C0523508;C2347634;C2348143;C2699239;C4553344;C4553379",NULL,NULL,1909
"concomitant cardiovascular therapy taken $nmbr$ days","C0007226;C0439228;C0521115;C0587038;C1707479;C1883727;C3887460",NULL,NULL,648
"thienopyridine at discharge","C0012621;C0030685;C1120149;C2926602",NULL,NULL,390
"cv medication","C0013227;C3244316;C3538987;C4048877;C4284232;C4318503",NULL,NULL,2266
"baseline weekly iss","C0168634;C0332174;C1442488;C1740819;C1845118",NULL,NULL,1013
"ecg findings at baseline no","C0168634;C0438154;C1442488","C1623258","",1129
"difference in means","C1704970;C1705241;C1705242",NULL,NULL,1466
"estimated glomerular filtration rate ml min $nmbr$ $nmbr$ m $nmbr$ of body surface area","C0017446;C0205146;C0369637;C0439445;C0441923;C0489451;C3811844","C3811844;C0017654","",592
"era monotherapy","C1521863;C3495919",NULL,NULL,409
"air n $nmbr$","C0001861;C3536832",NULL,NULL,61
"hctz","C0020261",NULL,NULL,1149
"leeds enthesitis index mean sd","C0444504;C0451148;C2347634;C2348143;C2699239",NULL,NULL,37
"l compared wi","C0043193;C0439394;C1520135;C1706495;C1707455;C3642217",NULL,NULL,1633
"chf","C0018802",NULL,NULL,769
"c reactive protein mg liter","C0006560;C0024671;C0026410;C0439269;C0475211;C1413716;C1960952;C2346927;C4048285;C4321396;C4521761","C0006560","",286
"secukinumab $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C3179547;C4321396;C4521761",NULL,NULL,944
"diabetes mellitus n $nmbr$","C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"prior copd medicationa n","C0024117;C0332152;C1412502;C2826257;C3714496",NULL,NULL,1726
"nsaid at least once","C0003211;C3536840",NULL,NULL,2121
"time from acs to randomization","C0034656;C0040223;C0742343;C3541383;C4318612",NULL,NULL,1709
"interaction p $nmbr$ $nmbr$","C1704675",NULL,NULL,888
"no statin use","C0042153;C0360714;C0457083;C1947944","C0360714","",872
"gold $nmbr$ $nmbr$","C0018026;C1304897","C0024117;C0521117","",213
"fevj predicted t","C0681842;C1882327","C0024119","",288
"nocturnal heartburn severity","C0018834;C0240526;C0439793;C0522510",NULL,NULL,561
"pla n $nmbr$","C0456170",NULL,NULL,1514
"bivalirudin","C0168273",NULL,NULL,776
"triglycerides mmol liter","C0041004;C0439190;C0475211","C0041004","",368
"atopy specific ige c n","C0205369;C0392707;C1552740;C3539705","C0392707","",1412
"no mtx use at baseline","C0025677;C0042153;C0168634;C0457083;C1417487;C1442488;C1947944","C0025677","",1408
"$nmbr$ rd quartile","C0694666;C2828255;C4553350",NULL,NULL,1436
"oab q score mean sd","C0444504;C0449820;C2347634;C2348143;C2699239;C3641332;C4050231",NULL,NULL,1287
"qmax ml s mean sd","C0439390;C0444504;C2347634;C2348143;C2699239",NULL,NULL,299
"duration of type $nmbr$ diabetes years","C0439234;C0449238;C1320657;C2926735","C0011849;C1320657","",907
"week $nmbr$ non ee responders","C0332174;C0439230;C1518422",NULL,NULL,1012
"pre bronchodilator fev predicted","C0681842;C1882327;C2599602;C3714541",NULL,NULL,682
"nvf at flex baseline $nmbr$ flex fn t score","C0168634;C0449820;C1442488;C1570610;C4050231",NULL,NULL,748
"ileocolonic both ileum and colon","C0009368;C0020885;C3888384","C0020885;C0009368","",1054
"$nmbr$ kg ma $nmbr$","C0022718;C0024443;C0439209;C3887485;C4054209","C1305855","",1734
"previous cabg n","C0010055;C0205156;C1552607","C0010055","",389
"patients with no progression","C0030705;C0242656;C0449258",NULL,NULL,1035
"iglarlixi fixed ratio combination","C0205195;C0443218;C0456603;C1547037;C1947911;C2827483;C3714578;C3811910",NULL,NULL,973
"coronary revascularisation","C0877341","C0877341",";C4049621;C1552607",223
"traditional chinese medicine for respiratory disease no","C0025124;C0035204;C0035242;C1515884",NULL,NULL,88
"mmrc dyspnea scale n","C0013404;C0175659;C0349674;C1947916;C1963100;C3826977","C0013404","",1227
"$nmbr$ t i","C0021966;C0221138;C2603360",NULL,NULL,1021
"demographic features","C0683970",NULL,NULL,583
"fev","C3714541",NULL,NULL,1599
"medical therapy n $nmbr$","C0418981",NULL,NULL,640
"rate ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C0871208;C1521828",NULL,NULL,923
"patients who received negative results on test for antibodies to infliximabt","C0003241;C0030705;C1334932;C1514756",NULL,NULL,731
"patients with pneumonia events n","C0030705;C0032285;C0441471;C3541888",NULL,NULL,412
"laba inhaled d n","C0004048;C0073187;C0332173;C4484261",NULL,NULL,167
"disease and quality of life scores mean sd","C0012634;C0034380;C0444504;C0449820;C0518214;C2347634;C2348143;C2699239;C4050231","C0034380","",1116
"qualifying nstemi n","C1514624;C3537184;C4255010",NULL,NULL,529
"ed duration","C0449238;C2926735;C3538926",NULL,NULL,411
"urgent surgery","C2188405",NULL,NULL,2334
"no statin group","C0360714;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429",NULL,NULL,1526
"diabetes yes","C0011847;C0011849;C1549445;C1705108;C1710701",NULL,NULL,147
"rope score","C0449820;C1563164;C4050231",NULL,NULL,748
"inflammation","C0021368",NULL,NULL,155
"iii $nmbr$","C0439070;C1705160",NULL,NULL,524
"antidiabetic drug i j","C0021966;C0221138;C0935929",NULL,NULL,995
"history of bone disease predefined n","C0005940;C0019664;C0019665;C0262512;C0262926;C0262950;C0369718;C0441922;C0683519;C0730226;C0850708;C0944983;C1705255;C2004062",NULL,NULL,105
"igelow $nmbr$ ku l n $nmbr$ $nmbr$","C0439340",NULL,NULL,850
"concentrations at baseline","C0086045;C0168634;C1442488",NULL,NULL,625
"duration of hypertension years","C0020538;C0439234;C0449238;C1963138;C2926735","C0020538","",1364
"duration of hypercholesterolemia mean sd years","C0020443;C0439234;C0444504;C0449238;C1522133;C2347634;C2348143;C2699239;C2926735","C0020443;C0449238","",1995
"baseline lipids","C0023779;C0168634;C1442488",NULL,NULL,2190
"prebronchodilator","C2599602",NULL,NULL,682
"drug therapy no","C0013216;C0013217",NULL,NULL,554
"health state index score uk algorithm","C0002045;C0041700;C0449820;C0600653;C0683314;C0918012;C1552854;C1553907;C1637833;C2986546;C4050231",NULL,NULL,577
"urinary acr","C0042027;C1412134;C1515941;C1524119",NULL,NULL,52
"r $nmbr$ mg $nmbr$","C0024671;C0026410;C0205090;C0439269;C0684010;C1960952;C2346927;C2603358;C4321396;C4521761",NULL,NULL,192
"size of left atrium normal no","C0205307;C0225860;C0231683;C0439166;C0456389;C2347086;C4553972",NULL,NULL,687
"non hdl cholesterol","C0729627;C1535899","C0023822","",821
"eastern europe","C0015177","C0239309","",601
"femoral","C0015811",NULL,NULL,512
"abatacept n $nmbr$","C1619966","C1619966","",1190
"stroke ortiab","C0038454;C4554100",NULL,NULL,1762
"haq di $nmbr$ $nmbr$","C3826998;C4321476",NULL,NULL,1665
"laboratory testing","C0022885",NULL,NULL,242
"family history of premature","C0151526;C0205252;C0241889;C4018905","C0241889","",1493
"none of the above","C1282910;C1552828",NULL,NULL,739
"no chd at baseline","C0168634;C0280604;C1442488;C3542407",NULL,NULL,970
"$nmbr$ to $nmbr$ h n","C0033727;C0369286;C0441932;C0564385;C4528284",NULL,NULL,308
"mild gold $nmbr$","C0018026;C1304897;C2945599",NULL,NULL,329
"intention to treat","C0040363;C0041260;C0087111;C0162425;C1283828;C1292734;C1522326;C1883351",NULL,NULL,431
"concurrent medications","C0013227;C0205420;C0802604;C2598133;C4284232",NULL,NULL,366
"mnapsi mean sd d","C0444504;C2347634;C2348143;C2699239",NULL,NULL,1029
"p value for interaction by region","C0017446;C0205147;C1704675;C1709380",NULL,NULL,7
"torsemide","C0076840",";C0076840","",2050
"delayed start group n $nmbr$","C0205421;C0439659;C0441848;C1545665;C3272602",NULL,NULL,317
"ascvdor $nmbr$ cv risk factors","C0035648;C1553898;C3538987;C4048877;C4318503",NULL,NULL,1777
"mayo score $nmbr$ $nmbr$","C0449820;C0454788;C1077578;C4050231",NULL,NULL,425
"pulmonary rales","C0034642","C0034642","",1104
"fas range $nmbr$ $nmbr$ mean sd","C0444504;C1514721;C2347634;C2348143;C2348147;C2699239;C3542016",NULL,NULL,37
"blood pressure systolic mm hg","C0005823;C0039155;C0439475;C1271104;C1272641","C0005823","",1469
"lvdd mm","C4330985;C4554674",NULL,NULL,297
"clopidogrel $nmbr$ mg","C0024671;C0026410;C0070166;C0439269;C1960952;C2346927;C4321396;C4521761","C0070166",";C0369286;C0033727;C4049621",217
"prior revascularization","C0332152;C0581603;C2826257","C0581603","",1213
"no previous myocardial infarction $nmbr$ $nmbr$","C0027051;C0205156;C0428953;C1552607;C2926063;C3810814;C4552959",NULL,NULL,646
"no history of bowel resections","C0019664;C0019665;C0262512;C0262926;C0741614;C1705255;C2004062",NULL,NULL,832
"supraventricular tachyarrhythmias incl atrial","C0018792;C1698480;C3853833","C0080203","",381
"duration of prior alendronate use months","C0102118;C0332152;C0439231;C1881378;C2826257;C2826775",NULL,NULL,1530
"subjects $ $nmbr$ years of age n","C0681850;C1510829;C1550501;C1706203;C2349001;C2697811","C1510829","",481
"no ckd rate events","C0441471;C0871208;C1521828;C1561643;C3541888","C1561643","",967
"type $nmbr$ collagen mean sd ng ml","C0009325;C0332307;C0439275;C0444504;C1547052;C2347634;C2348143;C2699239",NULL,NULL,37
"$nmbr$ lesions per vessel","C0005847;C0221198",NULL,NULL,472
"neither ace inhibitor nor arb","C0003015;C3888198;C4541021",NULL,NULL,44
"initial timi flow","C0205265;C1279901;C1555582;C1705685;C3272266",NULL,NULL,806
"concomitant medication no","C0013227;C0521115;C3244316;C4284232","C0013227;C0521115","",1916
"diabetes melitus","C0011847;C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"surgical repair of vsd or pda $nmbr$ year duration","C0013274;C0018818;C0226047;C0374711;C0439234;C0439508;C0449238;C2926735;C4282128",NULL,NULL,1099
"c reactive protein high sensitivity assay mitt modified intent to treat pbo cholesterol cl confidence intervals hdl c high density lipoprotein cholest national cholesterol education program adult treatment panel y patients with diabetes fc _ $nmbr$ mg dl $nmbr$ $nmbr$ mmol l to qualify as having acteristics described in methods ncep atp iii definition baseline values are rr d hs crr for which medians are presented p $nmbr$ $nmbr$ p $nmbr$ $nmbr$ p $nmbr$ $nmbr$ nteractions were not statistically significant p $nmbr$ $nmbr$","C0001675;C0005507;C0006560;C0009667;C0011847;C0011849;C0023822;C0025663;C0025664;C0030705;C0031962;C0040363;C0041260;C0042295;C0065055;C0087111;C0150375;C0162425;C0168634;C0178587;C0205250;C0243073;C0369773;C0392747;C0439070;C0449450;C0449851;C0549183;C0596019;C0679841;C1273937;C1283828;C1292734;C1299351;C1413716;C1441604;C1442488;C1510438;C1522326;C1550452;C1550453;C1552738;C1704788;C1705160;C1706450;C1883351;C2603361;C2700149;C2744579;C2983605;C3245503;C3539107;C3642216;C3887512;C3888054;C3889660;C3889737;C3898312;C4048285;C4321237;C4522209;C4552600;C4554402","","",-10
"hr vs warfarin $nmbr$ ci","C0008107;C0043031;C3259781","C0043031","",858
"s $nmbr$ years n $nmbr$","C0439234;C2986823",NULL,NULL,1099
"colesevelam hydrochloride group n $nmbr$","C0441848;C0541154",NULL,NULL,1638
"symptoms onset to first balloon inflation min","C0021398;C0205435;C0336867;C0441144;C0702093;C1279901;C1318493;C1524029;C3813700;C4086878",NULL,NULL,1475
"change from baseline to week $nmbr$","C0168634;C0332174;C0392747;C0439230;C0443172;C1442488;C1705241;C4319952",NULL,NULL,1012
"number of draining fistulae per patient n","C0030705;C0237753;C0449788;C0544791",NULL,NULL,1596
"$nmbr$ mm","C4330985;C4554674",NULL,NULL,297
"cabg n","C0010055","C0010055","",389
"hypertension no n $nmbr$","C0020538;C0369718;C0441922;C1963138","C0020538","",1364
"hand fracture","C0435632",NULL,NULL,2027
"obese $nmbr$ kg m $nmbr$ b","C0028754;C1532718",NULL,NULL,710
"dlqi $nmbr$ $nmbr$","C3899393",NULL,NULL,527
"c reactive protein mg dl_","C0006560;C0439269;C1413716;C4048285","C0006560","",286
"central south america","C0007674;C0037713;C0205099;C1710133;C1879652","C0037713","",580
"atrial fibrillation or flutter ecg","C0004238;C0016385;C0344434;C1623258;C1963067;C2242390",";C0004238","",1009
"hr vs placebo $nmbr$ ci","C0008107;C0032042;C1696465;C1706408;C3259781",NULL,NULL,1544
"time since diagnosis of diabetes mean sd","C0011847;C0011849;C0011900;C0040223;C0444504;C1704338;C1704656;C2347634;C2348143;C2699239;C3541383",NULL,NULL,37
"lvh","C0149721","C0149721","",1272
"asteria i ii","C0021966;C0221138;C1093020;C1710602;C4082587",NULL,NULL,523
"ldl c level mean sd mg dl","C0439269;C0441889;C0444504;C0456079;C1547707;C2347634;C2348143;C2699239;C2946261","C0023824","",1963
"total occlusion n","C0001168;C0011382;C0028778;C0439175;C0439810;C0441597;C1110554;C1947917",NULL,NULL,474
"methotrexate dose mg","C0024671;C0025677;C0026410;C0178602;C0439269;C0869039;C1114758;C1960952;C2346927;C4321396;C4521761","C0025677","",1408
"voluntary","C0439656;C3543419","","",-10
"duration of procedure","C2346509",NULL,NULL,1230
"patients with hospitalized pneumonia events n","C0032285;C0441471;C0870668;C3541888",NULL,NULL,412
"sf $nmbr$ bodily pain mean change from baselinee","C0037712;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C3890602;C4319952","C0030193","",1338
"mean systolic blood pressure mm hg sd","C0039155;C0428886;C0439475;C0444504;C0488053;C0488055;C0871470;C1306620;C2347634;C2348143;C2699239","C0005823","",1469
"diuretics group n $nmbr$","C0012798;C0441848",NULL,NULL,992
"ertuglrflozin $nmbr$ mg vs placebo glimepiride","C0024671;C0026410;C0032042;C0061323;C0439269;C1696465;C1706408;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2045
"medical management only","C0001554;C0199168;C0205171;C0205476;C0376636;C1273870;C1720467;C3273539",NULL,NULL,925
"ada no","C1060325;C3811629",NULL,NULL,1076
"p value for trend across tertiles","C1521798;C1709380;C4554533",NULL,NULL,7
"group b low risk more symptoms n","C0441848;C0683368;C1457887;C3272281;C3538919",NULL,NULL,174
"hypertension treated","C0020538;C1522326;C1963138","C0020538","",1364
"haemorrhagic","C0333275",NULL,NULL,581
"ldl c $nmbr$ $nmbr$ mg dl","C0439269","C0023824","",1963
"with alogliptin $nmbr$ $nmbr$ mg n $nmbr$ $nmbr$","C0024671;C0026410;C0439269;C1958126;C1960952;C2346927;C4321396;C4521761","C1958126","",1183
"bnp median iqr pg ml","C0054015;C0439297;C0549183;C0876920;C1095989;C1417808;C2347635;C2348144;C2939193;C2982014",NULL,NULL,1635
"europe and canada","C0006823;C0015176","C0015176","",337
"elevated tg","C0205250;C0337445;C3163633","C0041004","",209
"triglyceride mg dl mean sd","C0041004;C0439269;C0444504;C2347634;C2348143;C2699239","C0041004","",368
"normoglycemia","C0580545",NULL,NULL,34
"secondary p","C0027627;C0175668;C0205436",NULL,NULL,1484
"pain vas mean change from baselinea","C0042815;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952",NULL,NULL,767
"fn t score $nmbr$ $nmbr$","C0449820;C1570610;C4050231",NULL,NULL,748
"combined cardiac failure cardiomyopathy or other cardiac disorders","C0018799;C0018801;C0018802;C0205195;C0878544",NULL,NULL,816
"ascvd","C3665365",NULL,NULL,344
"acei arb and bb after randomisation","C0004739;C0034656;C0332297;C3888198",NULL,NULL,714
"insulin dependent diabetes mellitus","C0011854",NULL,NULL,160
"insulin use","C0240016",NULL,NULL,122
"pde $nmbr$ i monotherapy","C0021966;C0221138",NULL,NULL,1021
"mean age yrs","C0001779;C0444504;C2347634;C2348143","C0001779","",480
"prior cv history n","C0019664;C0019665;C0262512;C0262926;C0332152;C1705255;C2004062;C2826257;C3538987;C4048877;C4318503",NULL,NULL,1777
"canakinumab","C2718773","C2718773","",372
"one or more requiring hospitalization in $nmbr$ mo before screening no $nmbr$","C0019993;C0026544;C0205172;C0205447;C0220908;C0220909;C0332177;C1698960;C1710031;C1710032;C1710477;C2348164",NULL,NULL,1476
"oral fi blockers","C0442027;C4050619;C4521986",NULL,NULL,1598
"mental status baseline spmsq scores n","C0168634;C0278060;C0369718;C0441922;C0449820;C1442488;C4050231",NULL,NULL,350
"negative ctnl n $nmbr$ $nmbr$","C0205160;C1513916;C2825415;C2825491;C3853545",NULL,NULL,1569
"additional investigations","C2359834",NULL,NULL,896
"naive to antihyperglycemic agent therapy","C0020616;C0039798;C0087111;C0450442;C1254351;C1363945;C1521826",NULL,NULL,236
"received drug eluting stent","C1322815;C1514756","C1322815","",365
"women n $nmbr$ events","C0043210;C0441471;C3541888","C0043210",";C3541888;C1720467",1323
"smoking current","C0037369;C0453996;C0521116;C1705970;C1881674","C0037369;C0521116","",2224
"partial mayo score $","C0449820;C0454788;C0728938;C1077578;C1550516;C4050231",NULL,NULL,425
"chad $nmbr$ $nmbr$","C0007928;C1413373","","",2128
"composite endpoint a $nmbr$ c $nmbr$ $nmbr$ bp","C0037623;C0205199;C1415692;C1547335;C1708288;C2349179;C2826544;C4318478","C0205199","",1631
"mean sd improvement from baseline to week $nmbr$ in basdai","C0168634;C0332174;C0439230;C0444504;C1442488;C1998004;C2347634;C2348143;C2699239;C2986411",NULL,NULL,1287
"flecainide","C0016229",NULL,NULL,2048
"prior heart failure n n","C0018801;C0018802;C0332152;C2826257;C4554158","C0018801",";C0168634;C1524003",12
"history pci","C0019664;C0019665;C0262512;C0262926;C1705255;C2004062;C4049621",NULL,NULL,832
"$nmbr$ yr","C0439234",NULL,NULL,1099
"$nmbr$ ml","C0439526;C1705224;C3887665",NULL,NULL,300
"as needed inhalations day","C0004048;C0332173;C0354922;C0439228;C0439505;C1879745;C1883728",NULL,NULL,1621
"n n $nmbr$ $nmbr$","C0369718;C0441922",NULL,NULL,1553
"transient ischemic attack type of lacunar syndrome","C0007787;C0332307;C0917805;C1547052;C3178801",NULL,NULL,1592
"antiplatelet agent","C0085826","","",1191
"history congestive heart failure","C0018802;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"cld $nmbr$ mg n l $nmbr$","C0439268","C0006560","",193
"p inter action","C0205103;C0369773;C0441472;C1548610;C2603361;C3266814","C1709380","",1986
"activity","C0205177;C0439167;C0441655;C1561536;C3668946;C4049938;C4049939",NULL,NULL,494
"apob apoa i ratio","C0003593;C0085201;C0456603;C1547037;C1677784;C3252643","C0003593","",426
"time of randomization interaction p $nmbr$ $nmbr$","C0034656;C0040223;C1704675;C3541383",NULL,NULL,692
"disease location","C0012634;C0450429;C1515974;C4284930;C4284931",NULL,NULL,906
"omega $nmbr$ fa intake $nmbr$ d third","C0205437;C1512806;C1719844","C0015684","",1236
"previous dmards use n","C0042153;C0205156;C0242708;C0369718;C0441922;C0457083;C1552607;C1947944",NULL,NULL,2391
"male subjects n $nmbr$ $nmbr$","C0086582;C0369718;C0441922;C0681850;C1550501;C1706180;C1706203;C1706428;C1706429;C2349001;C2697811",NULL,NULL,1655
"cardiac glycosides","C0007158","C0012265","",989
"no reperfusion","C0035124;C0684253",NULL,NULL,1049
"lisinopril n $nmbr$","C0065374","C0065374","",847
"thienopyridine type","C0332307;C1120149;C1547052","C1120149",";C0039798;C0087111;C1363945;C1709561;C1947944",73
"ics use at baseline","C0042153;C0168634;C0457083;C0815320;C1442488;C1947944;C4551720",NULL,NULL,625
"nt probnp pg mlt","C0030827;C0072225;C0669479;C0754710;C1266240;C4553833",NULL,NULL,208
"lp a pmol l","C0065058;C0439284;C1439335;C4553379","C0065058","",1769
"loop","C0445022","C0354100","",991
"perindopril","C0136123",NULL,NULL,620
"i placebo","C0021966;C0032042;C0221138;C1696465;C1706408","C0032042","",28
"prior immunosuppressant failurec","C0021081;C0332152;C2826257",NULL,NULL,294
"xi o $nmbr$ p o $nmbr$","C1720296",NULL,NULL,520
"no of events womenmen","C0441471;C3541888",NULL,NULL,412
"l $nmbr$ kg","C1637390",NULL,NULL,207
"tc mean sd rrig dl","C0039411;C0040642;C0041405;C0041698;C0444504;C1824670;C2347634;C2348143;C2699239;C3272447;C3642216;C4522122",NULL,NULL,37
"rate reduction","C0301630;C0392756;C0871208;C1293152;C1521828;C4551656",NULL,NULL,730
"nste mi","C3537184;C4255010",NULL,NULL,529
"lower dose edoxaban regimen","C0441994;C1548802;C2003888;C2348331;C2975435","C0445550;C2975435","",2091
"quintile n","C1508496",NULL,NULL,1017
"normal fasting glucose level n $nmbr$","C0015663;C0202045;C0205307;C0231683;C0439166;C0522082;C2347086;C4553972",NULL,NULL,687
"body mass indexa","C0518010","C1305855","",1734
"xanthines $nmbr$","C0043318;C3541955","C0043318","",359
"any lipid lowering agent","C0086440","C0086440","",1773
"fevi auc $nmbr$ $nmbr$ l","C0376690;C0429706;C0849974;C1561566;C4528367",NULL,NULL,1601
"a reslizumab $nmbr$ $nmbr$ mg kg n n","C0439272;C1869620",NULL,NULL,947
"prior stroke n $nmbr$","C0038454;C0332152;C2826257;C4554100","C0038454;C0332152","",2380
"crude analysis n","C0002778;C0936012;C1524024",NULL,NULL,1422
"prior thienopyridine","C0332152;C1120149;C2826257","C1120149",";C0039798;C0087111;C1363945;C1709561;C1947944",73
"contrast nephropathy risk score","C0009924;C0022658;C0035647;C0449820;C1979874;C4050231;C4552904","C0022658","",320
"primary endpoint","C2986535","C2986535","",230
"aldl cholesterol","C0008377","C0023824","",1068
"number and of participants with events and incidence rate per $nmbr$ person year","C0027361;C0237753;C0439234;C0439508;C0441471;C0449788;C0679646;C1708485;C2347489;C3541888","C1708485","",1106
"mitt population n $nmbr$","C0032659;C1257890",NULL,NULL,900
"tender joints $nmbr$ joint count mean sd","C0444504;C0451530;C2347634;C2348143;C2699239","C0451530","",1139
"ldl c hdl c","C3715113","C0023822","",821
"favors comparator","C0309049;C1707454;C4553389;C4553390",NULL,NULL,1632
"waisthip ratio","C0205682;C0456603;C1547037",NULL,NULL,973
"deep vein thrombosis only","C0149871;C0205171;C1720467",NULL,NULL,1643
"glyburide dose duringthe study mg","C0017628;C0024671;C0026410;C0178602;C0439269;C0557651;C0869039;C1114758;C1960952;C2346927;C2603343;C4321396;C4521761","C0017628","",1350
"glycated hemoglobin mean sd","C0017853;C0444504;C2347634;C2348143;C2699239","","",1176
"good tried previous glucocorticoid laba","C0017710;C0205156;C0205170;C1552607","C0017710","",1348
"years since mi median","C0439234;C0549183;C0876920;C2347635;C2348144;C2939193;C3810814",NULL,NULL,635
"crp mg l","C0439268;C3890735;C4048285","C0006560","",286
"ace arb use","C0042153;C0457083;C1452534;C1947944;C3888198;C4284014",NULL,NULL,44
"$nmbr$ days urgent revascularization","C0439228;C0439609;C0581603;C3272275","C0581603","",1213
"embolism","C0013922;C1704212",NULL,NULL,631
"ace angiotensin converting enzyme cabg coronary artery bypass graft ccsc canadian cardiovascular society classification mi myocardial infarction pci percutaneous coronary","C0010055;C0022709;C0027051;C0189695;C0545743;C3640258","","",-10
"mean mmse score","C0451306;C3533236","C0451306","",305
"years with gout mean sd","C0018099;C0439234;C0444504;C2347634;C2348143;C2699239",NULL,NULL,1099
"prior nonvertebral fracture","C0016658;C0332152;C2826257",NULL,NULL,2026
"russia georgia","C0017452;C0017454;C0035970","C0035970;C0017452","",123
"all major cardiovascular events","C0205082;C0205164;C1320716;C4318856;C4521762","C1320716;C0205082","",2077
"with psoriasis n $nmbr$","C0033860","C0033860","",1358
"subgroup statistics","C0038215;C0600673;C1079230;C1515021",NULL,NULL,181
"source","C0449416;C1705919;C4521696",NULL,NULL,540
"age $ $nmbr$ years","C1510829","C1510829","",481
"intravenous inotropes or vasopressors","C0042397;C0348016;C1258199",NULL,NULL,1541
"no prior cvd","C0007222;C0332152;C2826257","C0007222","",1790
"slo days","C0439228;C1416602;C3539661",NULL,NULL,1621
"n $nmbr$ fatty acids n $nmbr$","C0015684;C0369718;C0441922",NULL,NULL,1553
"secukinumab $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C3179547;C4321396;C4521761",NULL,NULL,2297
"blood pressure at target level","C0005823;C0441889;C0456079;C1271104;C1272641;C1521840;C1547707;C2946261;C2986546","C0005823","",15
"ancova result","C0814908;C1274040;C1546471;C2825142",NULL,NULL,1602
"reduction","C0301630;C0392756;C1293152;C4551656",NULL,NULL,730
"apob apoa $nmbr$","C0003592;C0003593;C0523508;C3252643;C4553344;C4553379","C0003592","",427
"overall $nmbr$ $nmbr$","C0282416;C1561607",NULL,NULL,1743
"low dose rivaroxaban aspirin n n","C1739768;C2608320","C1739768","",1225
"patients with level $nmbr$ pg ml","C0030705;C0439297;C0441889;C0456079;C1547707;C2946261",NULL,NULL,1035
"atrial flutter fibrillation","C0155709",";C0004238","",1009
"primary composite endpoint","C0205199;C1547335;C2986535","C0205199","",1631
"ratio of fev $nmbr$ to fvc","C0456603;C1547037;C3714541",NULL,NULL,1599
"duration of diabetes yrs","C0011847;C0011849;C0449238;C2926735","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"gender male n","C0079399;C0086582;C1522384;C1706180;C1706428;C1706429","C0086582","",1276
"$nmbr$ to $nmbr$ mg g","C1300563",NULL,NULL,196
"om $nmbr$ mg aml $nmbr$ mg n $nmbr$","C0023465;C0023467;C0028971;C1319635;C1705272",NULL,NULL,186
"asthma control test score at baseline","C0168634;C1442488;C2733224",NULL,NULL,625
"fasting blood glucose $nmbr$ mg dl","C0428568;C0439269;C1261430","C0017725;C0015663","",2280
"smoking classification n","C0008902;C0008903;C0037369;C0453996;C0678229;C1881674","C0037369","",420
"patients receiving mtx n","C0025677;C0030705;C1417487;C1514756",NULL,NULL,731
"physician s global assessment","C4050369",NULL,NULL,1525
"diet","C0012155;C0012159;C1519433;C2983588;C3668949","C0012155","",1199
"participants without heart failure","C0018801;C0018802;C0679646;C4554158","C0018801",";C0168634;C1524003",12
"male sex no race no","C0034510;C0086582;C1706779;C3853635","C0086582","",1276
"other vascular disease no","C0042373",NULL,NULL,102
"pre bronchodilator fevr pred","C0032952;C0044955;C1708033;C2599602",NULL,NULL,682
"adjusted hr","C0456081",NULL,NULL,1580
"tcz mtx n","C0025677;C1417487",NULL,NULL,84
"tnf inhibitor","C1448177;C1999216",NULL,NULL,362
"previous or current use of im or cs no","C0010182;C0205156;C0271160;C0521116;C1524063;C1552607;C1705970;C3540510;C4085345",NULL,NULL,136
"daily dose $nmbr$ $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C2348070;C4321396;C4521761",NULL,NULL,192
"medical therapy only","C0205171;C0418981;C1720467",NULL,NULL,640
"iglar insulin glargine l $nmbr$ u","C0439148;C0907402","C0907402",";C1998602;C0004446;C0005126;C2344255;C4050145;C0229089;C0439164;C1512019;C3273373;C3665488",69
"race ethnicity white","C0007457;C0015031;C0034510;C0043157;C0220938;C0243103;C1706779;C3853635",NULL,NULL,787
"subgroup no","C1079230;C1515021",NULL,NULL,1637
"tanezumab $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346819;C2346927;C4321396;C4521761",NULL,NULL,2309
"patients with enthesitis no","C0030705;C1282952","C1282952","",271
"median $nmbr$ $nmbr$ years number n","C0237753;C0439234;C0449788;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"europa n $nmbr$ l $nmbr$","C0242751",NULL,NULL,505
"with lowest bwb","C1708760",NULL,NULL,1344
"imm without corticosteroid","C0001617;C0205470;C3536709",NULL,NULL,1650
"long $nmbr$ years duration of diabetes","C0011847;C0011849;C0439234;C0439591","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"w eight k g","C0205454;C0439267;C0597277;C1708601","C0005910","",1250
"treatment for latent tuberculosis","C0039798;C0087111;C0205275;C0749724;C1522326;C1533734;C1609538;C1705169;C3538994;C3887704",NULL,NULL,236
"non rollover","C0517067;C0543436;C1518422",NULL,NULL,85
"nt pro bnp pmol liter j","C0439192;C0475211;C0669479;C0754710",NULL,NULL,1511
"mmse score","C0449820;C0451306;C4050231","C0451306","",305
"$nmbr$ mg mtx","C0024671;C0025677;C0026410;C0439269;C1417487;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"notable abnormalities","C0000768;C0000769;C4288581",NULL,NULL,1693
"prior oma use","C0042153;C0332152;C0457083;C1947944;C2826257",NULL,NULL,294
"bladder","C0005682;C4319531",NULL,NULL,1609
"charlson comorbidity index mean sd","C0444504;C2347634;C2348143;C2699239;C4546361",NULL,NULL,766
"fatal nonfatal stroke","C0038454;C1302234;C1705232;C4554100",NULL,NULL,507
"other major risk factors","C0035648;C0205082;C0205164;C1553898;C4318856;C4521762",NULL,NULL,175
"central south america and mexico","C0007674;C0025885;C0037713;C0205099;C1710133;C1879652","C0037713","",580
"drug therapy n","C0013216;C0013217",NULL,NULL,554
"mean bmi kg m $nmbr$","C0444504;C0578022;C1532718;C2347634;C2348143",NULL,NULL,1735
"median change","C0392747;C0443172;C0549183;C0876920;C1705241;C2347635;C2348144;C2939193;C4319952",NULL,NULL,635
"acute infection without septic shock","C0036983;C0275518","C3714514","",1093
"combined trials","C0008976;C0205195",NULL,NULL,997
"most frequent serious teaes","C0205393;C0205404;C0332183",NULL,NULL,2352
"death large mi","C0011065;C0549177;C1306577;C3810814;C4082313;C4552775",NULL,NULL,516
"estimated creatinine clearance $nmbr$ ml mint","C0439526;C0452249;C0522467;C0750572;C0812399;C1337213;C1576800;C1705224;C3887665;C3890003","C0812399",";C3889287;C0452249;C0522467;C1337213;C1576800;C3890003;C0005910;C0022718;C1305866;C1705104;C1705224;C3887665",79
"any condition","C0012634;C0348080;C1705253;C3864998",NULL,NULL,1710
"prior statin n $nmbr$ $nmbr$","C0332152;C0360714;C2826257","C0360714","",872
"$nmbr$ antianginal drug","C0013227;C1254351;C1874267;C3537168","C3537168","",382
"infliximab naive n $nmbr$","C0666743","C0666743","",154
"blood pressure mm hg systolic","C0005823;C0039155;C0439475;C1271104;C1272641","C0005823","",1469
"aqlq score","C0449820;C4050231;C4055434",NULL,NULL,2057
"abciximab","C0288672","C0288672","",374
"seated sbp mean sd mmhg","C0085805;C0277814;C0439475;C0444504;C1283233;C2347634;C2348143;C2699239",NULL,NULL,2127
"most frequent infections","C0205393;C0239998",NULL,NULL,2353
"previous number of ciu csu medications","C0205156;C0578870;C1552607;C1718138",NULL,NULL,1811
"mdi hfa n","C0015458;C0993596;C1839839;C4049613",NULL,NULL,518
"interval from onset of symptoms","C1272706;C1552654;C1552713;C4086878","C1272706","",1097
"with tiotropium","C0213771","C0213771","",1372
"mdg mmol l","C0024443;C1417239;C1532563;C2986643",NULL,NULL,670
"$nmbr$ $nmbr$ ng l n $nmbr$ n","C0439297",NULL,NULL,202
"ertugliflozin","C4079805","C4079805","",1180
"ever smoker","C0337664;C3887636","C0037369","",420
"week $nmbr$ n $nmbr$ or for cana vs pbo $nmbr$ ci","C0008107;C0031962;C0332174;C0439230;C1418845;C3259781",NULL,NULL,1302
"st t waveft","C0036056;C3272372",NULL,NULL,2356
"mild or moderate copd","C0024117;C0205081;C1412502;C1881878;C2945599;C3714496;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"tnf antagonist exposed","C0231491;C0332157;C1448177","C0332157",";C0274281;C0231491;C1420817;C4521367;C4521846;C1552607",27
"or per unit for continuous variables","C0439148;C0439453;C0439828;C0549178;C1509845;C1519795;C1704753;C1880519;C3853603",NULL,NULL,94
"egfr mean sd","C0444504;C1739039;C2347634;C2348143;C2699239;C3811844;C3812682",NULL,NULL,37
"diabetes mellitus type $nmbr$ n","C1320657","C0011849;C1320657","",907
"randomisation scheme","C0034656;C1519193",NULL,NULL,692
"ratio of ldl to hdl cholesterol","C0023822;C0392885;C0456603;C1547037","C0023824","",1068
"pbo n $nmbr$ $nmbr$","C0031962",NULL,NULL,435
"outcome according to no of risk factors for vte","C0035648;C0630906;C0680240;C1274040;C1553898",NULL,NULL,1602
"mer s disease assessment","C0012634;C0673013;C1261322;C1516048;C3810521;C4281714",NULL,NULL,1279
"no prior mi n $nmbr$","C0332152;C2826257;C3810814",NULL,NULL,516
"we recorded no significant interactions for any subgroup analysis nyha new york heart association lvef left ventricular ejection fraction $nmbr$ cl was calculated by cox proportional hazards model tmedian value data for total cholesterol were available for $nmbr$ patients $nmbr$ rosuvastatin $nmbr$ placebo","C0004083;C0018787;C0027976;C0030705;C0032042;C0033489;C0034869;C0201950;C0237688;C0237881;C0428772;C0439849;C0444686;C0470187;C0543421;C0596019;C0596306;C0699792;C0750502;C0965129;C1079230;C1275491;C1441506;C1515021;C1546944;C1565830;C1696465;C1704610;C1704675;C1706408;C2986480;C3853788","C0032042","",28
"duration of diabetes years median iqr","C0011847;C0011849;C0439234;C0449238;C0549183;C0876920;C2347635;C2348144;C2926735;C2939193","C2926735;C0011849","",1988
"$nmbr$ mg twice daily n $nmbr$","C0024671;C0026410;C0439269;C0585361;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"year from randomization","C0034656;C0439234;C0439508",NULL,NULL,1099
"received pci","C1514756;C4049621",NULL,NULL,731
"unstable but no rest angina","C0002965;C0152172;C0443343;C1883468","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"na","C0597484;C1272460;C1546968;C1879645;C4049872;C4552882",NULL,NULL,419
"fdc $nmbr$ $nmbr$ pg","C0030827;C0072225;C0340427;C1266240;C1413520;C3539652",NULL,NULL,208
"non pci intravenous unfractionated heparin","C0354566;C1518422;C4049621","C0019134","",864
"clinical endpoint","C2347784",NULL,NULL,791
"no prior htn n $nmbr$ $nmbr$","C0020538;C0332152;C2826257","C0020538","",1365
"disease duration years median range","C0439234;C0549183;C0872146;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016","C0449238","",1989
"periostin high","C0205250;C0219433;C1299351;C1424662;C2700149;C3812270;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"i h","C0021966;C0033727;C0221138;C0369286;C0441932;C0564385;C4528284",NULL,NULL,308
"sudden death","C0011071;C1964022;C4554103",NULL,NULL,2401
"bmi kg m","C0578022;C1532718",NULL,NULL,1735
"budesonide symptom days a week","C0054201;C0332174;C0439228;C0439230;C1457887;C3854129","C0054201","",1160
"glycoprotein iib iiia inhibitort","C0016011",NULL,NULL,808
"second year","C0205436;C0439234;C0439508;C0457385;C0565930;C1561503;C1705190",NULL,NULL,1783
"health assessment questionnaire $nmbr$ $nmbr$ range","C0451208;C1514721;C2348147;C3542016",NULL,NULL,479
"eligibility strata","C0013893;C1548635","C0013893","",2161
"pe dvt","C0070939;C0149871;C1880476;C2926618;C3899446;C4284304",NULL,NULL,1516
"somnolence","C0013144;C2830004;C4553740",NULL,NULL,1468
"blood eosinophil count cells mm","C0005773;C0200638;C0750879;C4330985;C4554674","C0750879","",848
"race no white","C0007457;C0034510;C0043157;C0220938;C1706779;C3853635","C0043157","",1402
"$nmbr$ n n","C0369718;C0441922",NULL,NULL,1553
"renal disease","C0022658","C0022658","",320
"time to randomization","C0034656;C0040223;C3541383",NULL,NULL,692
"patients $nmbr$","C0030705",NULL,NULL,1035
"lifestyle behaviours","C0004927;C0023676;C0677505",NULL,NULL,1490
"cdai score median min max","C0449820;C0549183;C0683448;C0702093;C0876920;C1413248;C1524029;C2347635;C2348144;C2939193;C3273706;C3813700;C4050231",NULL,NULL,697
"non black","C0005680;C0027567;C0085756;C0439541;C1518422","C0005680",";C1706779",188
"weight in kg mean sd","C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C2699239;C4054209","C0043100","",1915
"basfi mean sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,1029
"erosion mean sd","C0333307;C0444504;C1880549;C1959609;C2347634;C2348143;C2699239;C3887524",NULL,NULL,1046
"cox hr $nmbr$ ci","C0008107;C1565830;C3259781",NULL,NULL,1544
"nonglycemic cardiovascular risk factors","C0850624",NULL,NULL,651
"non europe","C0015176;C1518422","C0015176","",337
"saba reversibility","C0449261","C0449261;C0231999","",1315
"hgb g dl $nmbr$ men $nmbr$ women","C0019029;C0019046;C0025266;C0043210;C0439267;C0518015;C1424337",NULL,NULL,1486
"or $nmbr$ ci a","C0008107;C3259781",NULL,NULL,519
"$nmbr$ vessel","C0005847",NULL,NULL,743
"tenecteplase and pci n $nmbr$","C0872913;C4049621",NULL,NULL,1736
"baseline mdrd egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$","C0168634;C0369637;C0439445;C0441923;C1442488;C1739039;C3811844;C3812682;C3839656",NULL,NULL,625
"chronic bronchitis n $nmbr$","C0008677","C0006277","",268
"infarct location interactsn $ p $nmbr$ $nmbr$","C0021308;C0450429;C1515974;C4284930;C4284931","C1515974;C0021308","",1948
"time since diagnosis of ciu csu years $nmbr$","C0011900;C0040223;C0439234;C0578870;C1704338;C1704656;C3541383",NULL,NULL,841
"lebrikizumab $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C2981360;C4321396;C4521761",NULL,NULL,2287
"prior exposure to lamotrigine","C0064636;C0274281;C0332152;C0332157;C0524166;C2826257","C0064636",";C0524166;C0274281",75
"hba $nmbr$ c sd","C0019016;C1825777;C2699239;C3538758","","",820
"low density lipoprotein choles","C0023823","C0023823","",1932
"n $nmbr$ n $nmbr$","C0369718;C0441922",NULL,NULL,1553
"prehospital ticagrelor n $nmbr$","C1999375","C1999375;C1510665","",1246
"dbp sd","C0536221;C2699239;C3813197;C4281799",NULL,NULL,605
"time since diagnosis of osteoarthritis yr","C0011900;C0029408;C0040223;C0439234;C1704338;C1704656;C3541383",NULL,NULL,1099
"weight lbs","C0005910;C0043100;C0439219;C1305866;C1705104;C3161851","C0005910","",1250
"male simva $nmbr$","C0086582;C1706180;C1706428;C1706429",NULL,NULL,586
"mental activities updrs subscore baseline mean sd","C0168634;C0229992;C0441655;C0444504;C1442488;C2347634;C2348143;C2699239;C3639721",NULL,NULL,625
"$nmbr$ years simva $nmbr$","C0439234",NULL,NULL,1099
"apixaban $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1831808;C1960952;C2346927;C4321396;C4521761","C1831808","",1224
"insulin glargin arm","C0021641;C0446516;C1533581;C1579433;C3714501;C3715044;C4553528",NULL,NULL,157
"number of hospitalizations in last year prior to baseline","C0168634;C0332152;C0439234;C0439508;C1442488;C1517741;C4086639",NULL,NULL,1099
"p heterogeneity","C0019409;C0242960;C0369773;C2603361",NULL,NULL,1873
"rosuvastain fenofibric acid n $nmbr$","C0060179",NULL,NULL,1696
"positive","C0439178;C1446409;C1514241;C2825490;C3812269",NULL,NULL,1163
"previous infarction","C0021308;C0205156;C1552607",NULL,NULL,2390
"fracture status prevalent vertebral fractured","C0016658;C0033105;C0220900;C0449438;C0549207;C4554413",NULL,NULL,721
"age yr mean sd","C0001779;C0439234;C0444504;C2347634;C2348143;C2699239",NULL,NULL,1099
"rate ratio $nmbr$ ci","C0008107;C0456603;C0871208;C1521828;C1547037;C3259781",NULL,NULL,973
"tobacco abuse","C0040336",NULL,NULL,23
"lv heart structure","C0018787;C0023128;C0731033;C1881413",NULL,NULL,1271
"$nmbr$ or $nmbr$ no total no","C0439175;C0439810",NULL,NULL,508
"bronchitis","C0006277","C0006277","",268
"positive for anti cyclic citrullinated peptide antibody no f","C0016327;C0741132;C1320283",NULL,NULL,1825
"valsartan n","C0216784","C0216784","",1206
"japanese subpopulation","C0376247;C1257890;C1556094","C0022341","",1815
"azathioprine n $nmbr$","C0004482",NULL,NULL,56
"csf","C3540512;C3889436",NULL,NULL,1781
"worsening heart failure","C0018801;C0018802;C0332271;C1457868;C1546960;C4554158","C0018801",";C0168634;C1524003",12
"other biologic agent","C0005515",NULL,NULL,214
"higher target group n $nmbr$","C0205250;C0441848;C1521840;C2986546",NULL,NULL,735
"hospitalization for unstable ap","C0002680;C0019993;C0443343;C1883468;C3887950",NULL,NULL,2360
"peripheral artery diseasef","C0489868",NULL,NULL,934
"patient s global assessment of disease","C0012634;C4054229",NULL,NULL,491
"prior treatment","C1514463",NULL,NULL,574
"low dose aspirin use at baseline","C0042153;C0168634;C0457083;C1442488;C1947944;C2608320",NULL,NULL,2183
"location","C0450429;C1515974;C4284930;C4284931",NULL,NULL,906
"insulin treated diabetes","C0011847;C0011849;C0021641;C1522326;C1533581;C1579433;C3714501",NULL,NULL,157
"lp a mol l","C0065058;C0347982;C1439335;C4553379","C0065058","",1769
"monitoring treatment","C0039798;C0087111;C0150369;C1283169;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,1024
"bmi kg m $nmbr$ cardiac parameters","C0018787;C0449381;C0578022;C1522601;C1532718",NULL,NULL,1735
"coronary angiography and intervention","C0085532;C0184661;C0886296;C1273869;C1548829","C1532338","",1661
"ato $nmbr$ mg and sim $nmbr$ $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1420068;C1960952;C2346927;C4321396;C4521761","C0074554","",1840
"clinical disease activity index","C3869583","C1292728",";C4050231;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209",101
"mean platelet volume fl","C0200665;C0344388;C1300812;C1708024",NULL,NULL,1802
"$nmbr$ hba $nmbr$ c $nmbr$ n $nmbr$ $nmbr$","C0019016;C1825777;C3538758","","",820
"medication use","C0240320",NULL,NULL,119
"tngtycerides a median","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"gender of patients","C0030705;C0079399;C1522384","C0079399","",1083
"ml","C0439526;C1705224;C3887665",NULL,NULL,300
"first loading dose","C0205435;C1279901;C3714444",NULL,NULL,806
"weight kg median min max","C0005910;C0043100;C0549183;C0876920;C1305866;C1532757;C1705104;C2347635;C2348144;C2939193","C0005910","",1250
"ldi mean sd b","C0444504;C2347634;C2348143;C2699239",NULL,NULL,1030
"rhythm control group n $nmbr$","C0243148;C0441848;C0871269;C1523018;C1550141;C1882979;C2587213;C3274648;C3828331;C4553389",NULL,NULL,675
"cvd total","C0007222;C0439175;C0439810","C0007222","",1790
"micturitions $nmbr$ h","C0033727;C0042034;C0369286;C0441932;C0564385;C4528284",NULL,NULL,308
"with lowest hba $nmbr$ cd","C0007928;C0019016;C0034283;C1708760;C1825777;C3538758;C4552032","","",820
"multivessel intervention n","C0184661;C0886296;C1273869",NULL,NULL,290
"pin","C0175718;C1168556;C1704584","","",-10
"dyslipidaemia","C0242339","C0242339","",1770
"glycated hemoglobin median","C0017853;C0549183;C0876920;C2347635;C2348144;C2939193","","",1176
"prior af ablation n","C0332152;C0344434;C0547070;C1261381;C2826257;C4049859",NULL,NULL,1794
"baseline focal seizure frequency $nmbr$ days median q $nmbr$ q $nmbr$","C0149775;C0168634;C0205234;C0376249;C0439228;C0439603;C0549183;C0751495;C0871396;C0876920;C1442488;C1561548;C1705502;C2347635;C2348144;C2939193;C3898838;C4321352",NULL,NULL,1621
"hf symptoms and signs","C0018488;C0220912;C0220913;C0311392;C0683368;C1313497;C1457887;C1538440;C3273279","C0018801",";C0168634;C1524003",12
"relative risk reduction $nmbr$ cl percent","C0080103;C0205345;C0242492;C0301630;C0392756;C0439165;C0596019;C1137094;C1293152;C1547039;C4551656",NULL,NULL,658
"change in retinal pathology","C0030664;C0035298;C0205469;C0392747;C0443172;C0677042;C1705241;C4319952",NULL,NULL,767
"data missing or no drug given","C0013227;C1254351;C1442162;C1511726;C1550718;C1551393;C1705492;C1947971;C3244317;C3245479;C3272743;C3714741","C1705492","",1144
"symptomatic deep vein thrombosis","C0149871;C0231220",NULL,NULL,611
"yes non proliferative","C0334094;C1518422;C1549445;C1705108;C1710701",NULL,NULL,147
"deep vein thrombosis","C0149871",NULL,NULL,1643
"australia new zealand","C4289954",NULL,NULL,55
"number of concomitant aeds n","C0180309;C0237753;C0449788;C0521115",NULL,NULL,448
"placebo n $nmbr$ l","C0032042;C1696465;C1706408","C0032042","",28
"renal composite","C0022646;C0205199;C1547335","C0205199","",1631
"location n","C0450429;C1515974;C4284930;C4284931",NULL,NULL,906
"diastolic blood pressure mm hq","C0428883;C1305849;C4330985;C4554674","C0428883","",842
"lipid lowering medications","C0013227;C0023779;C0441994;C0802604;C2003888;C2598133;C4284232",NULL,NULL,2265
"st t wave no","C0036056;C0429103;C3272372",NULL,NULL,2356
"baseline hba c","C0019016;C0168634;C1442488;C1825777;C3538758","","",820
"creatinine mol l","C0010294;C0347982;C1561535","C0600061;C0010294","",952
"baseline use of hormone therapy","C0168634;C0279025;C1442488;C1524063",NULL,NULL,558
"yes n","C1549445;C1705108;C1710701",NULL,NULL,147
"transient ischaemic attack","C0007787;C0917805",NULL,NULL,1592
"previous vte no","C0205156;C0630906;C1552607","C1861172","",2399
"ejection fraction mean sd","C0444504;C0489482;C2347634;C2348143;C2699239;C2700378",NULL,NULL,2131
"rate of non progression defined as cfb in mtss $nmbr$ n n","C0009002;C0871208;C1521828;C1704788;C1824728;C3539106;C3839460",NULL,NULL,2010
"patients with prior copd related","C0024117;C0030705;C0332152;C0439849;C0445223;C1412502;C2826257;C3714496",NULL,NULL,1726
"atrial fibrillation on baseline ecg n","C0168634;C0344434;C1442488",";C0004238","",1009
"duration of metformin therapy months","C0025598;C0439231;C0444917",NULL,NULL,1530
"geometric mean blood eosinophil count sd on a loge scale cells mm $nmbr$","C0175659;C0200638;C0349674;C1947916;C2697934;C2699239;C2986759;C4330985;C4554674","C0014467","",849
"annt or bnnh $nmbr$ ci","C0008107;C3259781",NULL,NULL,519
"class i or iii aad use in $nmbr$ months before enrollment","C0042153;C0439070;C0439231;C0441885;C0457083;C1319793;C1516879;C1696073;C1705160;C1947944;C2698967;C3888021",NULL,NULL,524
"stroke subtype n","C0038454;C0449560;C4554100",NULL,NULL,1762
"unfractionated heparin only","C0019134;C0205171;C1720467;C2825026",NULL,NULL,925
"current cigarette use n","C0521116;C0694535;C1705970","C0037369","",420
"chd risk no","C0035647;C0280604;C3542407;C4552904",NULL,NULL,970
"$nmbr$ yr risk of coronary heart disease","C0439234;C1277690","","",170
"post albuterol predicted fev $nmbr$ mean sd e","C0001927;C0444504;C0681842;C0687676;C1704687;C1882327;C2347634;C2348143;C2699239;C3469826;C3714541",NULL,NULL,1599
"mean number of exacerbations per patient year $nmbr$ ci","C0008107;C0030705;C0237753;C0439234;C0439508;C0444504;C0449788;C2347634;C2348143;C3259781;C4086268",NULL,NULL,519
"absolute risk difference ci","C0008107;C0035647;C1519101;C1549031;C1705241;C1705242;C3259781;C4552904","C0035647;C1549031","",2259
"eosinophil count cells per pl","C0007584;C0007634;C0200638;C0750879;C3897966;C4049765","C0014467;C0007584","",1806
"age per $nmbr$ years","C1510829","C1510829","",481
"total adjusted weight of $nmbr$ $nmbr$ for gastrointestinal bleeding","C0005910;C0017181;C0043100;C0439175;C0439810;C0456081;C1305866;C1705104",NULL,NULL,782
"primary outcome $nmbr$ decrease in womac pain score","C0205225;C0392756;C0439612;C0439631;C0547047;C0582148;C1274040",NULL,NULL,2339
"diastolic blood pressure mm hg mean sd","C0012000;C0428883;C0428886;C0439475;C0444504;C1305849;C2347634;C2348143;C2699239","C0005823","",1469
"placebo no total no","C0032042;C0439175;C0439810;C1696465;C1706408","C0032042","",28
"ifx aza n $nmbr$","C0004482;C0020823","","",2099
"$nmbr$ mean sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"age $nmbr$ qvai $nmbr$ sfc","C0001779;C4521536",NULL,NULL,1283
"ras agents","C0034678;C0450442;C0525678;C1254351;C1521826",NULL,NULL,484
"mean s d age years","C0444504;C1510829;C2347634;C2348143","C1510829","",481
"mental component score mcs","C0229992;C0449432;C0449820;C1705248;C4050231",NULL,NULL,350
"nt probnp $nmbr$ pmol l $nmbr$","C0439284;C0669479;C0754710",NULL,NULL,1511
"b i d twice daily cat copd assessment test copd chronic obstructive pulmonary disease fev $nmbr$ forced expiratory volume in $nmbr$ s fvc forced vital capacity gold global initiative for chronic obstructive lung disease ics inhaled corticosteroid mcid minimum clinically important difference mmrc modified medical research council o d once daily sd standard deviation sgrq c st george s respiratory questionnaire for copd","C0001617;C0004048;C0007450;C0016529;C0018026;C0024115;C0024117;C0034394;C0079816;C0152277;C0205191;C0205246;C0325090;C0332173;C0392747;C0424093;C0521346;C0524517;C0549186;C0585361;C0815320;C0871420;C1304897;C1306036;C1412502;C1443200;C1546767;C1551807;C1553316;C2348867;C2699239;C3536709;C3665481;C3714496;C3714541;C3826872;C3826977;C3889737;C4050461;C4277733;C4284282;C4551720","","",-10
"of predicted","C0681842;C1882327","C0024119","",288
"safety population","C0032659;C0036043;C1257890;C1705187",NULL,NULL,904
"peripheral limb vascular efficacy","C0015385;C0150936;C0947487;C1280519;C1707887","C1707887;C2349179","",1122
"severity of airflow limitation gold $nmbr$ n","C0018026;C0231999;C0439793;C0443288;C0449295;C0522510;C1304897","C0024117;C0521117","",213
"killip at baseline","C0168634;C1442488",NULL,NULL,625
"past smoking","C0037369;C0453996;C1444637;C1881674;C4284302","C0037369","",420
"ppi use","C0042153;C0358591;C0457083;C0871125;C1947944;C3811894",NULL,NULL,1738
"the square of the height in meters patient s and physician s global assessment scores can range from $nmbr$ to $nmbr$ scores for the western","C0030705;C0205120;C0441074;C0449820;C0489786;C1514721;C1552595;C1705493;C2348147;C3542016;C4050369",NULL,NULL,1525
"mases $nmbr$ $nmbr$ mean sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"presenting condition n","C0012634;C0348080;C0449450;C1705253;C3864998",NULL,NULL,1710
"lack of efficacy","C0235828",NULL,NULL,2151
"combined statin and other lipid lowering agent use","C0042153;C0086440;C0205195;C0360714;C0457083;C1947944",NULL,NULL,997
"exsmoker","C0337671;C4555205","C0037369","",420
"no prior hf hospitalization","C0018488;C0019993;C0332152;C1313497;C1538440;C2826257;C3273279",NULL,NULL,2359
"total cholesterol $nmbr$ $nmbr$ mg dl","C0201950;C0439269;C0543421","C0543421","",1504
"age groups n","C0001779;C0441848","C0001779","",480
"intravenous dobutamine","C0012963;C0348016","C0348016;C0012963","",2072
"augment copd","C0024117;C0205217;C1412502;C3714496",NULL,NULL,1726
"erysipelas","C0014733","","",-10
"mean sd post bronchodilator fev $nmbr$ fvc","C0444504;C2347634;C2348143;C2599594;C2699239;C3714541",NULL,NULL,2142
"lower limbs","C0023216",NULL,NULL,1613
"canakinumab $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C2718773;C4321396;C4521761","C2718773","",372
"diuretic n","C0012798",NULL,NULL,992
"heart failure hospitalisation or cv death","C0011065;C1306577;C3538987;C3898876;C4048877;C4082313;C4318503;C4552775",NULL,NULL,1777
"standard n $nmbr$","C1442989;C2828392",NULL,NULL,1482
"selena sledai range u $nmbr$ u $nmbr$ t","C0439148;C0451528;C1514721;C2348147;C3542016",NULL,NULL,479
"any statin with without llt","C0360714;C2347090","C0360714","",872
"weight kg blood pressure mm hg","C0005823;C0005910;C0022718;C0043100;C0439209;C0439475;C1271104;C1272641;C1305866;C1705104;C4054209","C0005823","",15
"interaction p values are as follows amlodipine vs chlorthalidone age p $nmbr$ $nmbr$ gender p $nmbr$ $nmbr$ race p $nmbr$ $nmbr$ history of chd p $nmbr$ $nmbr$ history of diabetes p $nmbr$ $nmbr$ lisinopril vs chlorthalidone age p $nmbr$ $nmbr$ gender p $nmbr$ $nmbr$ race p $nmbr$ $nmbr$ history of chd p $nmbr$ $nmbr$ history of diabetes p $nmbr$ $nmbr$ peripheral arterial disease refers to in trial hospitalization or lower extremity revascularization procedure","C0001779;C0008294;C0008976;C0011847;C0011849;C0015385;C0019664;C0019665;C0019993;C0034510;C0040363;C0041260;C0051696;C0065374;C0079399;C0085096;C0184661;C0205543;C0262512;C0262926;C0280604;C0332283;C0369773;C0441994;C0581603;C1522384;C1548802;C1704436;C1704675;C1705255;C1706779;C1709380;C1719822;C1883351;C2003888;C2004062;C2603361;C2700391;C3274430;C3539779;C3542407;C3853635;C4281991",NULL,NULL,290
"yes z $nmbr$ cm","C1549445;C1705108;C1710701",NULL,NULL,147
"ra duration years mean s e","C0439234;C0444504;C0449238;C2347634;C2348143;C2926735;C3538806;C4048756",NULL,NULL,1099
"predominant cardiac diagnosis no","C0011900;C0018787;C1522601;C1542147;C1704338;C1704656",NULL,NULL,841
"history of diabetes a","C0011847;C0011849;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"des previous stenting","C0011702;C0038257;C0205156;C1552607;C2348535;C4551552",NULL,NULL,465
"cardiovascular death nonfatal mi excluding silent mi or stroke","C0007226;C0011065;C0038454;C0332196;C0443304;C1306577;C2828389;C3810814;C3816734;C3887460;C4082313;C4552775;C4554100",NULL,NULL,516
"meloxicam","C0083381",NULL,NULL,215
"immunosuppressants and antimalarials only","C0003374;C0021081;C0205171;C1720467",NULL,NULL,925
"$nmbr$ coenzyme q $nmbr$ subgroups for time to first hospitalization number of patients variable","C0019993;C0040223;C0041536;C0205435;C0439828;C1079230;C1279901;C2360800;C3541383;C4553760",NULL,NULL,1395
"taiwan","C0039260",";C0039260","",1332
"esophageal hiatal hernia","C3489393",NULL,NULL,590
"joint space narrowing score mean sd","C0444504;C0449820;C1859695;C2347634;C2348143;C2699239;C4050231",NULL,NULL,2055
"salmeterol","C0073992","C0060657;C0073992","",1508
"history of cerebrovascular disease","C0585890",NULL,NULL,1494
"with stent l","C0038257",NULL,NULL,569
"mean sd $nmbr$ h asbp mm hg","C0033727;C0369286;C0439475;C0441932;C0444504;C0564385;C2347634;C2348143;C2699239;C4528284",NULL,NULL,1287
"outcome according to primary cancer site no total no","C0439175;C0439810;C0680240;C0872338;C1274040",NULL,NULL,1602
"atrial fibrillation flutter","C0155709",";C0004238","",1009
"baseline ecg with lvh n","C0168634;C0232306;C1442488",NULL,NULL,625
"age yr n","C0001779;C0439234","C0001779","",480
"baseline $nmbr$ $nmbr$ meq l eos $nmbr$ $nmbr$ meq l","C0168634;C0439375;C1442488;C1623465;C1861303",NULL,NULL,1626
"preoperative p blocker use yes","C0042153;C0445204;C0457083;C1549445;C1705108;C1710701;C1947944",NULL,NULL,1926
"timi risk score $nmbr$ $nmbr$","C0035647;C0449820;C4050231;C4552904",NULL,NULL,1954
"increased risk for falls","C0000921;C0035647;C0085639;C1849142;C4552904;C4699158","C0035647","",173
"dbp mm hg","C0439475;C0536221;C3813197;C4281799",NULL,NULL,605
"watchman n $nmbr$","C0335390",NULL,NULL,1330
"time from symptom onset to balloon inflation","C0021398;C0040223;C0336867;C0441144;C0449244;C1318493;C1457887;C3541383;C3854129;C4086878",NULL,NULL,434
"hdl cholesterol","C0023822;C0392885","C0023822","",821
"week $nmbr$ mean se","C0036919;C0332174;C0439230;C0444504;C2347634;C2348143",NULL,NULL,567
"low or moderate","C0205081;C0205251;C1550472;C1881878;C3890211;C4048187;C4049705;C4049706;C4085643;C4321335;C4321351;C4522223",NULL,NULL,851
"gold $nmbr$ $nmbr$ n $nmbr$","C0018026;C1304897","C0024117;C0521117","",213
"$nmbr$ placebo n $nmbr$ $nmbr$","C0032042;C1696465;C1706408","C0032042","",28
"total basdai mean sd","C0439175;C0439810;C0444504;C1998004;C2347634;C2348143;C2699239","C1998004","",1354
"suit quartile $nmbr$ $nmbr$ $nmbr$ nmol mmol n $nmbr$","C1532564;C1533073;C2828255",NULL,NULL,1016
"low nfs nfs $nmbr$ $nmbr$ n $nmbr$","C0205251;C1513839;C1550472;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"d includes cardiac glycosides antiarrhythmics classes i and iii vasodilators used in cardiac disease and other cardiac preparations","C0003195;C0007158;C0018787;C0018799;C0042402;C0073187;C0332173;C0332257;C0439070;C0441885;C1273517;C1319793;C1521827;C1522601;C1552866;C1705160;C2698967;C2700399;C3812761;C4484261","","",-10
"estimated creatinine clearance ml min i","C0021966;C0023806;C0221138;C0439445;C0702093;C0750572;C0812399;C1524029;C3813700","C3811844;C0017654","",307
"nordic","C0331873",NULL,NULL,1700
"baseline corticosteroids","C0001617;C0168634;C1442488;C3539185;C3540725;C3540726;C3540727",NULL,NULL,1650
"white race n","C0007457;C0043157","C0043157","",1402
"affected body surface area $nmbr$ no","C0005902;C0205148;C0392760;C1314939;C1879646","C0005902;C1879646","",1210
"$nmbr$ to $nmbr$ ml min $nmbr$ $nmbr$","C0439445","C3811844;C0017654","",307
"ldl c mg dl $nmbr$","C0439269","C0023824","",1963
"albumin mg dl","C0001924;C0439269","C0001924","",1071
"pioglitazone events n","C0071097;C0441471;C3541888",NULL,NULL,1760
"single","C0037179;C0087136;C0205171",NULL,NULL,926
"killip class $nmbr$ $nmbr$","C1881332","C1881332","",846
"estimated gfr ml min $nmbr$ $nmbr$ m $nmbr$ of body surface area","C0017446;C0017654;C0205146;C0369637;C0439445;C0441923;C0489451;C0750572;C1424601","C3811844;C0017654","",592
"c peptide median q $nmbr$ q $nmbr$ nmol l","C0006558;C0439282;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,1892
"glycoprotein llb llla receptor inhibitor","C0017968;C0597357;C1999216",NULL,NULL,2104
"$ race was determined by the investigator during the patient s interview","C0034510;C0035173;C0521095;C0683518;C1706779;C3853635",";C0034510","",1107
"death or $nmbr$ mwd decrease $nmbr$ m","C0011065;C0369637;C0392756;C0441923;C0547047;C1306577;C4082313;C4552775",NULL,NULL,923
"hypertension $nmbr$ $nmbr$ mm hg or taking","C0020538;C0439475;C1515187;C1963138","C0020538","",1364
"no prior stroke n $nmbr$","C0038454;C0332152;C2826257;C4554100","C0038454;C0332152","",2380
"cabg $nmbr$ month ago","C0010055;C0332177;C0439231","C0010055","",389
"dactylitis score $nmbr$ $nmbr$","C0239161;C0449820;C4050231","C0239161","",492
"nyha iii n","C0439070;C1275491;C1705160",NULL,NULL,151
"homa ir b","C0022065;C0022071;C1448132","","",1397
"nih stroke scale","C1697238;C3484372","C1697238",";C3484372;C0442734",169
"all patients n $nmbr$","C0030705",NULL,NULL,1035
"mean dose sd mg day","C0178602;C0439422;C0444504;C0869039;C1114758;C2347634;C2348143;C2699239","","",198
"inferior n","C0542339;C0678975",NULL,NULL,1245
"change in fpg $nmbr$ to month $nmbr$ mg dl","C0332177;C0392747;C0439231;C0439269;C0443172;C1705241;C4319952",NULL,NULL,192
"use of medications for pah no","C0013227;C0030123;C0802604;C1524063;C2598133;C3203102;C4284232;C4284467",NULL,NULL,366
"famotidine $nmbr$ famotidine $nmbr$","C0015620","C0015620","",74
"non caucasian eze simva","C0007457;C0043157;C1518422","C0043157","",1329
"eosinophils $nmbr$ $nmbr$ x $nmbr$ itt n $nmbr$","C0014467;C0200638","C0014467","",849
"waist hip median","C0019552;C0022122;C0230097;C0549183;C0876920;C1505163;C2347635;C2348144;C2939193;C3538851;C4284725",NULL,NULL,635
"unstable angina age","C0001779;C0002965","C0001779","",480
"enthesitis count","C0750480;C1282952;C1705566","C1282952;C0750480","",2213
"patients with glycated hemoglobin $nmbr$ $nmbr$ and $nmbr$ episode ofdiabetic ketoacidosis","C0017853;C0030705;C1859860","","",1176
"left anterior descending artery n","C0226032","C0226032","",2098
"htn","C0020538","C0020538","",1365
"gusto defined bleeding","C0019080;C1704788;C3539106",NULL,NULL,707
"hispanic ethnic group n","C0015031;C0086409;C0441848;C0680174","C0086409","",865
"any prior anti tnf treatment failure","C0162643;C0231174;C0235828;C0332152;C0521983;C0680095;C1448177;C1514463;C1547544;C2826257",NULL,NULL,11
"left main coronary artery","C1261082","C1261082","",1342
"treated at baseline","C0168634;C1442488;C1522326",NULL,NULL,625
"baseline estimated gfr","C0017654;C0168634;C0750572;C1424601;C1442488",NULL,NULL,536
"body mass index group $nmbr$ kg m $nmbr$ no","C0005893;C0022718;C0439209;C0441833;C0441847;C0578022;C0687744;C1257890;C1305855;C1519504;C1532718;C1705428;C1705429;C4054209",";C1305855","",206
"lp a mean sd","C0065058;C0444504;C1439335;C2347634;C2348143;C2699239;C4553379",NULL,NULL,37
"apolipoprotein","C0003591","C0003591","",1028
"insulin yes","C0021641;C1533581;C1549445;C1579433;C1705108;C1710701;C3714501",NULL,NULL,157
"randomisation","C0034656",NULL,NULL,692
"drug eluting stent no","C1322815","C1322815","",365
"low density lipoprotein cholesterol mg dlf","C0023824;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761","C0023824","",1963
"$nmbr$ to $nmbr$ ml minute","C0439232;C0439526;C0700321;C0702093;C1282918;C1705224;C2347166;C3887665",NULL,NULL,1475
"$nmbr$ $nmbr$ i i","C0021966;C0221138",NULL,NULL,1021
"hf hospitalisation","C0018488;C0019993;C1313497;C1538440;C3273279","C0018801",";C0168634;C1524003",12
"heart rate median $nmbr$ $nmbr$","C0018810;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,1898
"tnf naive patientsa","C1448177",NULL,NULL,362
"triglycerides $nmbr$ d third","C0041004;C0205437","C0041004","",368
"$nmbr$ mi min","C0702093;C1524029;C3810814;C3813700",NULL,NULL,1475
"medical therapy only n $nmbr$","C0205171;C0418981;C1720467",NULL,NULL,640
"rest angina but not past $nmbr$ h","C0002965;C0033727;C0152172;C0369286;C0441932;C0564385;C1444637;C1518422;C4284302;C4528284","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"change from baseline in acq $nmbr$","C0168634;C0392747;C0443172;C1442488;C1705241;C2919686;C4319952",NULL,NULL,767
"bmi $nmbr$ kg m $nmbr$ n $nmbr$ $nmbr$","C0578022;C1532718",NULL,NULL,1735
"lipid lowering medication","C0013227;C0023779;C0441994;C2003888;C3244316;C4284232",NULL,NULL,2265
"digoxin at enrollment","C0012265;C1516879;C1696073;C3888021","C0012265","",989
"doubling statin dose","C0178602;C0205173;C0360714;C0869039;C1114758;C1705764",NULL,NULL,110
"safety n b","C0036043;C1705187","C0036043","",1198
"mineralocorticoid receptor antagonist n","C1579268",NULL,NULL,185
"copd or asthma","C0004096;C0024117;C1412502;C2984299;C3714496",NULL,NULL,1726
"other race","C0034510;C1706779;C3853635",";C0034510","",1107
"events control group","C0009932;C0441471;C3541888",NULL,NULL,1639
"baseline systolic blood pressure mean sd mm hg","C0439475;C0444504;C2347634;C2348143;C2699239;C4274438","C0005823","",1469
"dpp $nmbr$","C1414174",NULL,NULL,610
"patients on antihypertensive medications n","C0003364;C0030705",";C0003364","",1579
"zotarolimus eluting","C1700035",NULL,NULL,633
"american indian alaskan native","C0002460;C0238611;C0302891",NULL,NULL,763
"age mean s e","C0001779;C0444504;C2347634;C2348143","C0001779","",480
"su met","C0038642;C0428210;C1550543;C1705534;C4317104","C0038766;C0025598","",2253
"hbalc mmol mol","C3829066","","",1176
"black or african american","C0005680;C0027567;C0085756;C0439541","C0005680",";C1706779",188
"progestins","C0033306",NULL,NULL,1565
"modi fied la grade","C0023031;C0023749;C0230347;C0342276;C0441800;C0919553;C2346906;C3244287;C4553351",NULL,NULL,683
"severe impairment egfr $nmbr$ n","C0205082;C0221099;C0684336;C1739039;C3811844;C3812682;C4050465;C4050466",NULL,NULL,313
"physician s global assessment of disease activity $nmbr$ $nmbr$ mm vas mean sd","C0042815;C0444504;C2347634;C2348143;C2699239;C3536884;C3827561;C4050369;C4330985;C4554674",NULL,NULL,1751
"median $nmbr$ days","C0439228;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,1621
"planned conservative therapy subgroup","C0459914;C1079230;C1301732;C1515021",NULL,NULL,984
"high on treatment platelet reactivity","C0005821;C0039798;C0087111;C0205250;C0443286;C1299351;C1522326;C1533734;C1705169;C2700149;C3538994;C3887512;C3887704;C3889660;C4321237;C4522209",NULL,NULL,834
"piacebo n $nmbr$ no of participants with events","C0441471;C0679646;C3541888",NULL,NULL,449
"low hdl c","C0151691","C0023822","",821
"adl","C0001288;C1420005","C0001288","",1976
"history of gi bleeding or ulcer no total no","C0017181;C0019664;C0019665;C0041582;C0262512;C0262926;C0439175;C0439810;C1705255;C2004062;C3887532",NULL,NULL,508
"$nmbr$ $nmbr$ $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923","C3811844;C0017654","",307
"migraine no $","C0149931",NULL,NULL,684
"care use","C0042153;C0457083;C1947933;C1947944",NULL,NULL,391
"median daily dose iu","C0049272;C0439453;C0549183;C0694756;C0876920;C2347635;C2348070;C2348144;C2939193",NULL,NULL,635
"ace inhibitor monotherapy","C0003015;C4541021","C0003015","",811
"median days","C0439228;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,1621
"hemoglobin aj","C0004486;C0019046;C0230613","C0019046","",1177
"other outcomes","C1274040",NULL,NULL,1602
"r $nmbr$ ezio n $nmbr$","C0687673",NULL,NULL,1834
"exacerbation rate per year","C0439234;C0439508;C0871208;C1521828;C4086268",NULL,NULL,2006
"ustekinumab","C1608841","C1608841","",371
"$nmbr$ at screening","C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164",NULL,NULL,798
"age mean sd yearsa","C0001779;C0444504;C2347634;C2348143;C2699239","C0001779","",480
"any gusto bleeding","C0019080",NULL,NULL,707
"tonic clonic","C3543842",NULL,NULL,1702
"serum creatinine mean sd pmol l","C0201976;C0439284;C0444504;C0600061;C2347634;C2348143;C2699239","C0600061;C0010294","",952
"cardiac resynchronization therapy","C1167956",NULL,NULL,1885
"semaglutide n $nmbr$","C3885068",NULL,NULL,1567
"comorbid illnesses","C0009488;C0221423",NULL,NULL,765
"non diabetics","C0241863;C1518422",NULL,NULL,996
"unadjusted hr $nmbr$ ci for $nmbr$ standard deviation increment","C0008107;C0871420;C1439367;C1705117;C3259781",NULL,NULL,1581
"atenolol strategy n $nmbr$ $nmbr$","C0004147;C0679199",NULL,NULL,981
"st $nmbr$ ng ml","C0036056;C0439275;C3272372",NULL,NULL,246
"previous use of amiodarone","C0002598;C0205156;C1524063;C1552607",NULL,NULL,1044
"american indian native alaskan","C0002460;C0682125",NULL,NULL,637
"other countries","C0454664",NULL,NULL,1560
"type of des","C0011702;C0332307;C1547052;C4551552",NULL,NULL,603
"$nmbr$ kg mtx use","C0022718;C0025677;C0042153;C0439209;C0457083;C1417487;C1947944;C4054209",NULL,NULL,205
"idiopathic familial","C0015576;C0241888;C0332240","C0332240","",843
"igg $nmbr$ $nmbr$ g l","C0439294;C0456615",NULL,NULL,1260
"belimumab $nmbr$ mg sc n $nmbr$","C0024671;C0026410;C0282380;C0439269;C1723401;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2272
"canvas r","C0205090;C0684010;C2603358;C3281223","","",-10
"previous disease","C0012634;C0205156;C1552607",NULL,NULL,2120
"cat scoreff","C0007450;C0325090;C0524517;C1443200;C3665481;C4050461;C4284282",NULL,NULL,255
"cr crpnorr","C0201975;C3539604;C3711669;C4084730;C4553336;C4553337",NULL,NULL,700
"height cm mean s d","C0439392;C0444504;C0489786;C2347634;C2348143","C0489786","",1249
"medications during hospitalization or at discharge","C0012621;C0013227;C0019993;C0030685;C0802604;C2598133;C2926602;C4284232",NULL,NULL,390
"updrs part iii motor","C0439070;C0449719;C1513492;C1705160;C1705994;C1709471;C3639721",NULL,NULL,1473
"mg dl sd","C0439269;C2699239",NULL,NULL,192
"median fecal calprotectin mg kg gi areas involved no","C0015733;C0205146;C0439272;C0549183;C0876920;C0950624;C1314939;C1335798;C1366582;C1708130;C2347635;C2348144;C2939193;C3539617;C4050121;C4319729","","",780
"chd deaths","C0011065;C0280604;C1306577;C3542407",NULL,NULL,970
"stratum $nmbr$ inadequate response or intolerance to $nmbr$ $nmbr$ bdmards of same moa","C0205412;C0231199;C0439856;C0445247;C0871261;C1704632;C1706817;C1744706;C2355652;C2911692;C4551881",NULL,NULL,726
"median minimum maximum focal seizure frequency $nmbr$ days at baseline","C0149775;C0168634;C0205234;C0376249;C0439228;C0439603;C0549183;C0751495;C0806909;C0871396;C0876920;C1442488;C1524031;C1552614;C1552615;C1561548;C1705502;C2347635;C2348144;C2826545;C2826546;C2939193;C3898838;C4321352",";C1524031;C0806909","",1376
"asas partial remission n","C0004057;C1521726;C3853627;C4552913;C4552914",NULL,NULL,60
"$nmbr$ tmol liter no","C0475211",NULL,NULL,987
"previous mi","C0205156;C1552607;C3810814",NULL,NULL,516
"rate per $nmbr$ patient years control vs alirocumab i","C0021966;C0030705;C0221138;C0243148;C0439234;C0871208;C1521828;C1550141;C1882979;C2587213;C3274648;C3491162;C4553389",NULL,NULL,2009
"duration of disease y median min max","C0549183;C0702093;C0872146;C0876920;C1524029;C2347635;C2348144;C2939193;C3813700","C0449238;C0872146","",903
"corticosteroid and immunosuppressant","C0001617;C0021081;C3536709",NULL,NULL,1650
"all participants mm hg sbp mean sd","C0085805;C0439475;C0444504;C0679646;C2347634;C2348143;C2699239",NULL,NULL,1033
"high","C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"p $nmbr$ y $nmbr$ antagonist","C0231491;C0369773;C2603361",NULL,NULL,1823
"cluster $nmbr$ diuretic n $nmbr$","C0012798;C1555715;C1704332",NULL,NULL,992
"nasal polyps","C0027430","C0027430","",353
"$nmbr$ i $nmbr$ $nmbr$ ai","C0003504;C0021966;C0221138;C4551710",NULL,NULL,63
"no hemoconcentration hemoconcentration","C0549409;C0854379",NULL,NULL,1061
"rolofylline n","C0166128","C0166128",";C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1114758;C1425688;C1521941;C2709207",67
"bleeding events during first $nmbr$ days of treatmen","C0019080;C0205435;C0439228;C0441471;C1279901;C3541888",NULL,NULL,707
"baseline microalbumin $nmbr$","C0168634;C0201838;C1442488;C2362049","C0201838","",1347
"mean sitting dbp mmhg","C0277814;C0439475;C0444504;C0536221;C2347634;C2348143;C2584297;C3813197;C4050224;C4281799",NULL,NULL,605
"no dm n $nmbr$ $nmbr$","C0011816;C3250443",NULL,NULL,955
"jsn score","C0449820;C4050231",NULL,NULL,2055
"medications in the hospital after randomization no","C0013227;C0019994;C0034656;C0802604;C1510665;C2598133;C4284232","C0019994",";C4049621",261
"categorical variables no","C0439828;C0683312;C3889287",NULL,NULL,1018
"mean age s d years","C0444504;C1510829;C2347634;C2348143","C1510829","",481
"body mass index kg m","C0005893;C0578022;C1305855;C1532718",";C1305855","",206
"body mass index kg m mean sd","C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239","C1305855","",1734
"previous myocardial infarction n","C0027051;C0205156;C0428953;C1552607;C2926063;C3810814;C4552959",NULL,NULL,646
"history of major bleeding","C0019080;C0019664;C0019665;C0205082;C0205164;C0262512;C0262926;C1705255;C2004062;C4318856;C4521762",NULL,NULL,832
"fatal nonfatal ml","C0439526;C1302234;C1705224;C1705232;C3887665",NULL,NULL,300
"college degree or higher","C0205250;C0441889;C0449286;C0542560;C0557806;C2348088",NULL,NULL,834
"azathioprine monotherapy","C0004482",NULL,NULL,56
"persistent faod n $nmbr$","C0205322;C0332996",NULL,NULL,719
"body mass index \ kg m $nmbr$","C0005893;C0578022;C1305855;C1532718","C1305855","",1734
"diuretics n","C0012798",NULL,NULL,992
"central europe","C0682369",NULL,NULL,505
"baseline egfr ml min $nmbr$ $nmbr$ m $nmbr$","C0168634;C0369637;C0439445;C0441923;C1442488;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"$nmbr$ yr km rate","C0439234;C0871208;C1521828;C3887676",NULL,NULL,2008
"no incident dm or change in fg $nmbr$","C0011816;C0016703;C0392747;C0439214;C0443172;C1551358;C1705241;C2348814;C3250443;C4319952",NULL,NULL,767
"era","C1521863;C3495919",NULL,NULL,409
"vitamins","C0042890;C3540032;C3714649","C0042890","",867
"concomitant use of conventional synthetic dmard up to $nmbr$ mo no methotrexate","C0025677;C0026544;C0242708;C0332177;C0439858;C0521115;C1524063;C1883254","C0242708",";C0026544",231
"dynamic measure of cell function s change from baseline assessed for mmtt subset only","C0007613;C0079809;C0168634;C0205171;C0242485;C0392747;C0443172;C0729333;C1442488;C1515021;C1516048;C1705241;C1720467;C4319952",NULL,NULL,661
"o total randomized","C0034656;C0439175;C0439810;C0483204;C3815594",NULL,NULL,508
"prior corticosteroid treatment","C0001617;C1514463;C3536709",NULL,NULL,1650
"history of chronic hf","C0018488;C0019664;C0019665;C0205191;C0262512;C0262926;C1313497;C1538440;C1705255;C2004062;C3273279",NULL,NULL,832
"time from psoriatic arthritis diagnosis a years","C0003872;C0011900;C0040223;C0439234;C1704338;C1704656;C3541383","","",2176
"infrequent exacerbator","C0521114",NULL,NULL,405
"prestudy treatment status","C0749659",NULL,NULL,717
"prior hf n $nmbr$","C0018488;C0332152;C1313497;C1538440;C2826257;C3273279","C0018801",";C0168634;C1524003",12
"prior failure of anti tnf therapy no","C0231174;C0281481;C0332152;C0680095;C2826257",NULL,NULL,294
"europe and russia","C0015176;C0035970","C0035970;C0017452","",123
"urinary tract infection","C0042029;C0262655;C4554638",NULL,NULL,1534
"screening visit","C0220908;C0220909;C0545082;C1512346;C1698960;C1710031;C1710032;C1710477;C2348164;C2826704",NULL,NULL,798
"p blockers","C0369773;C2603361",NULL,NULL,960
"orthopnea","C0085619","C0085619","",279
"american indian alaskan native n","C0002460;C0238611;C0302891;C0886378;C1524069",NULL,NULL,763
"alendronate","C0102118",NULL,NULL,1573
"proportion of individuals control alirocumab","C0027361;C0237401;C0243148;C1550141;C1709707;C1882979;C2587213;C3274648;C3491162;C4553389",NULL,NULL,675
"pe with or without dvt","C0070939;C0149871;C1880476;C2926618;C3899446;C4284304",NULL,NULL,1516
"standard care slope lsm se mm year","C0036919;C0439234;C0439508;C0807955;C1442989;C1947933;C2828392;C4330985;C4554674",NULL,NULL,1099
"allergic rhinitis duration mean sd y","C0444504;C0449238;C1334103;C2347634;C2348143;C2607914;C2699239;C2926735;C4552864",";C0035455","",272
"heart rate beats per minute","C0018810;C0439385","C0018810","",1105
"mean age years sd","C0444504;C1510829;C2347634;C2348143;C2699239",NULL,NULL,37
"n o","C0369718;C0441922",NULL,NULL,1553
"placebo arm","C0032042;C0446516;C1696465;C1706408;C3715044;C4553528","C0032042","",28
"recurrent infections $nmbr$ per year","C0239998;C0439234;C0439508",NULL,NULL,1099
"overall population","C0032659;C0282416;C1257890;C1561607",NULL,NULL,1743
"high cv risk","C0332167;C3272283;C3538987;C4048877;C4050568;C4318503;C4319571","C4319571","",837
"europe including south africa","C0015176;C0037712;C0332257","C0015176","",337
"fevi percent predicted","C0429706;C0439165;C0681842;C0849974;C1561566;C1882327;C4528367",NULL,NULL,1601
"aliskiren n $nmbr$","C1120110","C1120110","",1172
"high dose aspirin","C0004057;C0444956","C0004057","",1366
"vedolizumab n $nmbr$","C2742797",NULL,NULL,943
"two sided p value for hetero geneity","C0205448;C0441987;C1709380",NULL,NULL,429
"statin intolerance $nmbr$ n","C0231199;C0360714;C1744706;C2355652","C1744706;C0360714","",1999
"biochemical parameters at randomization mean","C0034656;C0205474;C0444504;C0449381;C2347634;C2348143",NULL,NULL,37
"fgf $nmbr$ low egfr $nmbr$","C0016026;C0205251;C0919505;C1550472;C1739039;C3811844;C3812682;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"brv $nmbr$ mg day","C0155502;C0439422","","",198
"peripheral vascular disease n","C0085096","C0085096","",933
"comorbidities n a","C0009488",NULL,NULL,765
"risk category points","C0035647;C0683312;C1552961;C2347617;C3714763;C3889287;C4552904","C0035647","",173
"pravastatin $nmbr$ mg","C0024671;C0026410;C0085542;C0439269;C1960952;C2346927;C4321396;C4521761","C0085542","",1841
"unstable anginad","C0443343;C1883468",NULL,NULL,1002
"mean sd range","C0444504;C1514721;C2347634;C2348143;C2348147;C2699239;C3542016",NULL,NULL,37
"$nmbr$ i","C0021966;C0221138",NULL,NULL,1021
"has bled score $nmbr$","C0019080;C0449820;C4050231",NULL,NULL,707
"baseline serum urate mg dl a","C0168634;C0439269;C0455272;C1442488",NULL,NULL,192
"losmapimod","C3272847",NULL,NULL,1771
"prothrombin mutation","C1610621","","",-10
"disease characteristics duration of psoriatic arthritis yr","C0003872;C0439234;C0449238;C0599878;C0872146;C1521970;C2926735","C0449238;C0872146","",903
"prior to index event","C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010",NULL,NULL,412
"reslizumab n $nmbr$","C1869620",NULL,NULL,947
"ck mb ng ml","C0010290;C0439275",NULL,NULL,204
"number omega $nmbr$ number placeb fatty acid","C0015684;C0237753;C0449788;C1719844","C0015684","",1236
"study drug loading days actual $nmbr$ n $nmbr$","C0013175;C0237400;C0439228;C1708715",NULL,NULL,501
"non early crohn s disease","C0010346;C1279919;C1518422",NULL,NULL,1487
"$nmbr$ mmhg","C0439475",NULL,NULL,1888
"by gfr stratum tor diabetic participants ml min per $nmbr$ $nmbr$ m","C0017654;C0076836;C0241863;C0369637;C0439445;C0441923;C0679646;C1199517;C1419603;C1424601;C3539732",NULL,NULL,996
"time to randomisation from symptom onset h","C0033727;C0034656;C0040223;C0369286;C0441932;C0564385;C3541383;C4086878;C4528284",NULL,NULL,692
"probable","C0033204;C0332148",NULL,NULL,1001
"non caucasian simva n $nmbr$","C0007457;C0043157;C1518422","C0043157","",1329
"baseline fpg mean s e","C0168634;C0444504;C1442488;C2347634;C2348143",NULL,NULL,1821
"indacaterol $nmbr$ ug versus indacaterol $nmbr$ ug","C0041573;C0439211;C1722260","C1722260","",1875
"thiazide users","C0541746;C1706077","","",993
"prior anti tnf treatment","C1448177;C1514463",NULL,NULL,574
"history of coronary artery disease n","C1881055",NULL,NULL,786
"no thienopyridine","C1120149","C1120149",";C0039798;C0087111;C1363945;C1709561;C1947944",73
"criterion reached first n","C0205435;C0243161;C1279901;C2584321;C4321250",NULL,NULL,806
"intent to treatb","C0162425;C1283828;C1550453",NULL,NULL,1975
"alc","C1424945;C3811058",NULL,NULL,395
"reversibility anticholinergic mean sd $","C0242896;C0444504;C0449261;C2347634;C2348143;C2699239;C3537004","C0449261;C0231999","",1315
"cvd mi stroke revascularization urgent vascular hospitalization","C0005847;C0007222;C0019993;C0038454;C0439609;C0581603;C1558950;C1801960;C3272275;C3810814;C4554100",NULL,NULL,743
"ankle brachial index $nmbr$ $nmbr$","C1328319;C3888326","C1328319","",1233
"non extensive","C0205231;C1518422","C0205231","",1167
"statin fibrate or","C0360714","C0360714","",872
"chd death","C0011065;C0280604;C1306577;C3542407;C4082313;C4552775",NULL,NULL,970
"baseline fev $nmbr$ predicted","C0168634;C0681842;C1442488;C1882327;C3714541",NULL,NULL,1599
"tiotropium vs salmeterol","C0073992;C0213771","C0213771","",1372
"barc types $nmbr$ $nmbr$ or $nmbr$","C0332307",NULL,NULL,1541
"weight kg","C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209",NULL,NULL,2326
"luts lower urinary tract symptoms is","C0574785",NULL,NULL,1658
"core cardiovascular endpoint","C0007226;C0444669;C1167518;C1706352;C1882467;C2349179;C2826544;C3274653;C3887460",NULL,NULL,649
"itch nrs $nmbr$ $nmbr$ v $nmbr$","C0033774;C1422257;C2240043;C4050142","C0033774;C4050142","",1362
"b agonists long acting a","C0079613;C0205166;C0243192;C1704930;C1706317;C1869853;C2987634;C3890007;C4048375",NULL,NULL,499
"baseline characteristics mean sd a","C0444504;C2347634;C2348143;C2699239;C4684572",NULL,NULL,1287
"myocardial infarction no","C0027051;C0428953;C2926063;C3810814;C4552959",NULL,NULL,646
"history of dyslipidaemia","C0019664;C0019665;C0242339;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"left main treated","C0205091;C0205225;C0443246;C1522326;C1542147;C1552822",NULL,NULL,42
"type $nmbr$ diabetes no","C1320657","C0011849;C1320657","",907
"$nmbr$ $nmbr$ ml rain","C0034640;C0439526;C1705224;C3887665",NULL,NULL,300
"pain vas range $nmbr$ $nmbr$ mean sd","C0042815;C0444504;C1514721;C2347634;C2348143;C2348147;C2699239;C3542016",NULL,NULL,37
"not japan n $nmbr$ $nmbr$","C0022341;C1518422","C0022341","",1815
"aspirin alone n n","C0004057;C0205171;C0439044;C0679994","C0004057","",1366
"paternal history n","C0424909",NULL,NULL,1492
"cvd ckd","C0007222;C1561643","C1561643","",967
"placebo abatacept $nmbr$ $nmbr$ abatacept $nmbr$ $nmbr$","C0032042;C1619966;C1696465;C1706408","C1619966","",1190
"e characteristic n","C1521970","C1521970","",1110
"copd severityy","C0024117;C1412502;C3714496",NULL,NULL,1546
"nyha functional class at randomization","C0034656;C0205245;C0542341;C1882083;C2700217",NULL,NULL,1531
"established atherosclerotic disease no","C0012634;C0333482;C0443211;C1272684",NULL,NULL,2113
"race $","C0034510;C1706779;C3853635",";C0034510","",1107
"diabetes at randomization","C0011847;C0011849;C0034656","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"bl mean cm","C0005918;C0006413;C0444504;C1552663;C2347634;C2348143;C2827109",NULL,NULL,655
"mean $nmbr$ ci change from $nmbr$ $nmbr$ to $nmbr$ $nmbr$ mg points","C0008107;C0024671;C0026410;C0392747;C0439269;C0443172;C0444504;C1552961;C1705241;C1960952;C2346927;C2347617;C2347634;C2348143;C3259781;C3714763;C4319952;C4321396;C4521761",NULL,NULL,519
"death or mi at $nmbr$ days","C0011065;C0439228;C1306577;C3810814;C4082313;C4552775",NULL,NULL,323
"non u s","C0041703;C1518422",NULL,NULL,85
"post bronchodilator fev $nmbr$ ml","C0439526;C1705224;C2599594;C3714541;C3887665",NULL,NULL,680
"baseline fasting tgs mg dl","C0015663;C0168634;C0439269;C1156212;C1442488;C1537574",NULL,NULL,128
"$nmbr$ mm hg no","C0439475",NULL,NULL,1888
"non black race n $nmbr$ vs $nmbr$","C0005680;C1518422",NULL,NULL,966
"average of maximum common carotid cimt mm","C0205214;C0741968;C0806909;C1510992;C1522138;C1552615;C2825518;C2826546;C3245511;C4330985;C4554674","","",1262
"mean mg dl","C0439269;C0444504;C2347634;C2348143",NULL,NULL,192
"history of atrial fibrillation n","C0729790",";C0004238","",1009
"antithrombotic i","C0021966;C0221138",NULL,NULL,1021
"serum urate mg dl","C0439269;C0455272",NULL,NULL,2308
"gmi men","C0025266","","",306
"enalapril n $nmbr$","C0014025",NULL,NULL,164
"tnf inhibitors","C0243077;C1448177",NULL,NULL,809
"active smoking","C0037369;C0205177;C0453996;C1881674;C3853793;C3888249",NULL,NULL,496
"vonoprazan $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4080009;C4321396;C4521761",NULL,NULL,192
"hscrp nmol l","C0439282",NULL,NULL,669
"cardiovascular risk factor no","C0850624",NULL,NULL,651
"family history of myocardial infarction prior to age $nmbr$","C0001779;C0455406","C0001779","",480
"rs $nmbr$ aa rs $nmbr$","C0035970;C0282379;C1235746;C1882141;C3714753;C3813325;C4554792","","",-10
"cardiovascular death or hospitalization for heart failure","C0007226;C0011065;C1306577;C3887460;C3898876;C4082313;C4552775",NULL,NULL,323
"congenital shunts","C0009678;C0232180;C0542331;C1442858;C1744681",NULL,NULL,478
"swollen joint count of $nmbr$ joints","C0451521",";C0451521","",1140
"anacetrapib $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C2604745;C4321396;C4521761","C2604745","",856
"shs $nmbr$ $nmbr$ per $nmbr$ score","C0449820;C4050231",NULL,NULL,748
"nt probnp values were reported in $nmbr$ of $nmbr$ patients enrolled in this stratum","C0042295;C0588446;C0669479;C0754710;C4684790",NULL,NULL,334
"$nmbr$ $nmbr$ $nmbr$ ci $nmbr$ $nmbr$ $nmbr$ $nmbr$ n $nmbr$ a $nmbr$ $nmbr$ p $nmbr$ $nmbr$","C0008107;C3259781",NULL,NULL,519
"type $nmbr$ diabetes n d","C1320657","C0011849;C1320657","",907
"vitamin e","C0042874;C3714803","C0042874","",869
"central america and south america","C0007674;C0037713","C0037713","",580
"dyspepsia","C0013395;C4552968","C0013395","",467
"symptomatic pe","C0070939;C0231220;C1880476;C4284304",NULL,NULL,1516
"history of $nmbr$ previous vte excluding index event","C0019664;C0019665;C0205156;C0262512;C0262926;C0332196;C0441471;C0600653;C0630906;C0918012;C1552607;C1552854;C1637833;C1705255;C2004062;C2828389;C2986546;C4019010",NULL,NULL,832
"n n yr","C0369718;C0439234;C0441922",NULL,NULL,1099
"tc hdl c","C0039411;C0040642;C0041405;C0041698;C1824670;C3272447;C3715113;C4522122",NULL,NULL,2236
"non diabetic subjects n $nmbr$","C0241863;C0681850;C1518422;C1550501;C1706203;C2349001;C2697811",NULL,NULL,996
"individuals with diabetes n $nmbr$","C0011847;C0011849;C0027361;C0237401","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"subject disposition n","C0681850;C0743223;C1550501;C1705555;C1706203;C2349001;C2697811",NULL,NULL,1655
"diastoiic biood pressure mm hg","C0033095;C0439475;C0460139;C1306345;C4284008","C0005823","",1469
"glucosamine chondroitin sulfate n $nmbr$","C0008454;C0008466;C0017718;C0017720;C0038720;C0474702;C0475337;C0876712;C3536965","C0017718","",1161
"duration of ra time from symptom onset years","C0040223;C0439234;C0449238;C2926735;C3538806;C3541383;C4048756;C4086878",NULL,NULL,901
"evolocumab $nmbr$ mg monthly n $nmbr$","C0024671;C0026410;C0332177;C0439269;C1960952;C2346927;C3529352;C4321396;C4521761",NULL,NULL,948
"low molecular weight lmw heparin before randomisation","C0019139;C0034656;C3536766","C3536766","",1343
"risk factor for venous thromboembolism no","C1521761;C2827422;C3495424;C3496592",NULL,NULL,1111
"cwt mean se mm","C0036919;C0444504;C2347634;C2348143;C4330985;C4554674",NULL,NULL,567
"lisinopril vs chlorthalidone normal","C0008294;C0065374;C0205307;C0231683;C0439166;C2347086;C4553972","C0008294","",70
"dose iu","C0049272;C0178602;C0439453;C0694756;C0869039;C1114758",NULL,NULL,1253
"utis","C0042029",NULL,NULL,1534
"$nmbr$ mg d n $nmbr$","C0439422","","",198
"fvc l proportion taking pulmonary medications b","C0013227;C0024109;C0802604;C1515187;C1709707;C2598133;C2707265;C2709248;C3714541;C4284232;C4522268",NULL,NULL,572
"without acei arb","C3888198",NULL,NULL,44
"medication use n","C0240320",NULL,NULL,119
"hormone therapy use","C0042153;C0279025;C0457083;C1947944",NULL,NULL,558
"location of disease n","C0012634;C0450429;C1515974;C4284930;C4284931",NULL,NULL,906
"cardiac biomarker status","C0005516;C0018787;C0449438;C0449442;C1271630;C1522601;C1999091;C2735302",NULL,NULL,643
"mmse $nmbr$","C0451306","C0451306","",305
"associated with connective tissue disease","C0009782;C0332281","C0009782","",108
"non caucasian simva","C0007457;C0043157;C1518422","C0043157","",1329
"mean $nmbr$ mwd m sd","C0369637;C0441923;C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"intent to treat population n","C0032659;C0087111;C0162425;C1257890;C1283828;C1292734;C1522326;C1550453",NULL,NULL,1975
"smoking pack yearsb n","C0037369;C0453996;C1881674;C1968515;C2825051;C2828395","C0037369","",420
"mg g","C1300563",NULL,NULL,196
"bdmard ir","C0022065;C0022071;C1448132","","",1397
"troponin t","C0077404;C1420827",NULL,NULL,1605
"$nmbr$ ppb","C1415800",NULL,NULL,1737
"losartan placebo","C0032042;C0126174;C1696465;C1706408","C0126174","",1207
"dvt only","C0149871;C0205171;C1720467;C2926618;C3899446","C0149871","",252
"tamong those enrolling via bnp stratum the study qualifying bnp or","C0054015;C0557651;C1095989;C1417808;C1514624;C2603343;C2982014",NULL,NULL,1635
"major bleeding $nmbr$ to $nmbr$","C0019080;C0205082;C0205164;C4318856;C4521762","C0019080;C0205082","",2076
"randomised patients with basdai assessment at baseline and week $nmbr$ n","C0168634;C0332174;C0439230;C0679830;C1442488;C1998004",NULL,NULL,1012
"cvd deaths","C0007222;C0011065;C1306577",NULL,NULL,323
"total population n $nmbr$","C3258257",NULL,NULL,510
"mtx $nmbr$ mg week","C0024671;C0025677;C0026410;C0332174;C0439230;C0439269;C1417487;C1960952;C2346927;C4321396;C4521761",NULL,NULL,1012
"baseline demographics","C0011298;C0168634;C1442488;C1704791",NULL,NULL,625
"metformin su","C0025598;C0038642;C1705534","C0038766;C0025598","",2253
"period i","C0021966;C0221138;C0439531;C1948053",NULL,NULL,575
"fsg mg dl mean sd","C0439269;C0444504;C2347634;C2348143;C2699239",NULL,NULL,192
"chd plus cerebral infarction","C0007785;C0280604;C3542407",NULL,NULL,929
"coronary heart disease no","C0010054;C0010068;C1956346","C0010068;C1956346",";C0026410;C1710701",226
"ff vi $nmbr$ $nmbr$ gg n $nmbr$ $nmbr$","C0017454;C0018370;C0205999;C4554348",NULL,NULL,1597
"oral agents use","C0042153;C0442027;C0450442;C0457083;C1254351;C1521826;C1947944;C4521986",NULL,NULL,484
"type of stent at index procedure","C0038257;C0184661;C0332307;C0600653;C0918012;C1547052;C1552854;C1637833;C2700391;C2986546;C3274430;C3539779",NULL,NULL,603
"number of patients $nmbr$ years","C0439234;C2360800",NULL,NULL,1099
"ics users at baseline n","C0168634;C0815320;C1442488;C1706077;C4551720","C3540778","",2182
"initiation of dialysis renal transplantation or creatinine $nmbr$ $nmbr$ mg dl $nmbr$ mmol l","C0010294;C0011945;C0011946;C0019004;C0022671;C0040732;C0040733;C0439269;C0589507;C1059964;C1158830;C1532563;C1561535;C1704686;C4551529",NULL,NULL,192
"region asia paafic","C0003980;C0017446;C0205147","C0003980","",1382
"physician global assessment of disease activity mean sd","C0444504;C2347634;C2348143;C2699239;C4050369",NULL,NULL,1525
"female sex","C0086287","C0086287","",1277
"mtx n","C0025677;C1417487","C0025677","",1408
"probable stent thrombosis","C0033204;C0332148;C3897493",NULL,NULL,1001
"variable","C0439828;C4553760",NULL,NULL,1018
"duration of morning","C0332170;C0449238;C2926735",NULL,NULL,901
"seizure worry","C0036572;C0233481;C1959629;C4553401","C0036572","",1394
"self reported descent n","C0205386;C0369718;C0441922;C0680043;C0681906;C2700446",NULL,NULL,1203
"stage $nmbr$ ckd egfr $nmbr$ ml n $nmbr$","C0205390;C0439526;C1300072;C1306673;C1561643;C1705224;C1739039;C3811844;C3812682;C3887665","C3811844;C0017654","",592
"zi $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0043476",NULL,NULL,1832
"known duration","C0205309;C0449238;C2926735",NULL,NULL,901
"placebo mean change sd","C0032042;C0392747;C0443172;C0444504;C1696465;C1705241;C1706408;C2347634;C2348143;C2699239;C4319952","C0032042","",28
"predicted value sd","C0681842;C1522609;C1882327;C2699239","C0024119","",288
"biologic agents","C0005515",NULL,NULL,214
"percent of predicted normal value","C0205307;C0231683;C0439166;C1882327;C2347086;C4553972",NULL,NULL,687
"bp blood pressure egfr estimated glomerular filtration rate men $nmbr$ en $nmbr$ x cr $nmbr$ $nmbr$ x age $nmbr$ $nmbr$ x $nmbr$ $nmbr$ hdl high density lipoprotein","C0001779;C0005823;C0014908;C0017654;C0023821;C0025266;C0201975;C0750572;C1417861;C1561549;C1739039;C2987294;C3539604;C3711669;C3811844;C3812682;C3889152;C4084730;C4553336;C4553337","C3811844;C0017654","",592
"condition $nmbr$ $nmbr$ $nmbr$","C0012634;C0348080;C1705253;C3864998",NULL,NULL,1710
"dexlansoprazole mr","C0024485;C1417249;C2347167;C2348248;C3254418;C4050513",NULL,NULL,1506
"egfr ml min m $nmbr$","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"antidiabetic agent","C0935929",NULL,NULL,995
"any serious ae n","C0205404;C3887670",NULL,NULL,916
"clopidogrel total no of patients","C0030705;C0070166;C0439175;C0439810","C0070166",";C0369286;C0033727;C4049621",217
"never or past","C1444637;C2003901;C4284302",NULL,NULL,456
"hdl cholesterol mg dl","C0023822;C0392885;C0439269","C0023822","",821
"patients who did not use insulin pump","C0030705;C0042153;C0457083;C1140609;C1518422;C1947944",NULL,NULL,1035
"statin use","C0042153;C0360714;C0457083;C1947944","C0360714","",872
"triglycerides median range","C0041004;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016",NULL,NULL,635
"peripherai arteriai disease","C0012634",NULL,NULL,2114
"no anemia bsl hb $nmbr$ g i $nmbr$ yr $nmbr$ $nmbr$ g i $nmbr$","C0002871;C0019046;C0021966;C0221138;C0439234;C1000483;C1319635;C1549954;C4554633",NULL,NULL,152
"thienopyridine at enrollment","C1120149;C1516879;C1696073;C3888021",NULL,NULL,339
"without beta blocker","C0001645","C0001645","",959
"aspirin or other antiplatelet agent","C0004057;C0085826","","",1191
"diet pravastatin","C0012155;C0012159;C0085542;C1519433;C2983588;C3668949","C0012155","",1199
"gt tt","C1435727;C1452561;C1704693;C2697657;C4554543",NULL,NULL,250
"history of mi or stroke no","C0019664;C0019665;C0038454;C0262512;C0262926;C1705255;C2004062;C3810814;C4554100",NULL,NULL,832
"a $nmbr$ ezio a $nmbr$ n $nmbr$ n $nmbr$","C0369718;C0441922",NULL,NULL,1553
"high dose statin use at screening","C0042153;C0220908;C0220909;C0360714;C0444956;C0457083;C1698960;C1710031;C1710032;C1710477;C1947944;C2348164","C0444956","",111
"creatinine clearance at admission ml min","C0151280;C0184666;C0809949","C0812399",";C3889287;C0452249;C0522467;C1337213;C1576800;C3890003;C0005910;C0022718;C1305866;C1705104;C1705224;C3887665",79
"egfr ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"calima japan n $nmbr$","C0022341","C0022341","",1815
"prior angioplasty","C0162577;C0332152;C1548817;C2826257","C0162577","",1722
"corticosteroid or immunosuppressant","C0001617;C0021081;C3536709",NULL,NULL,1650
"anacetrapib $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C2604745;C4321396;C4521761","C2604745","",856
"swollen joint count of $nmbr$ joints assessed no","C0451521;C1516048",";C0451521","",1140
"hbajc mmol mol mean sd","C0444504;C2347634;C2348143;C2699239;C3829066","","",820
"cabg or ptca pci","C0010055;C2936173;C4049621","C2936173;C0010055","",1524
"sd of sbp","C0085805;C2699239",NULL,NULL,607
"on steroid at baseline","C0038317;C0168634;C1442488",NULL,NULL,625
"event during on","C0441471;C4019010",NULL,NULL,412
"ag","C0002037;C0051080;C0152305;C3888235",NULL,NULL,854
"$nmbr$ o $nmbr$ o $nmbr$ $nmbr$ $nmbr$","C0483204","","",-10
"patients with diabetes","C0011847;C0011849;C0030705","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"thiazide at enrollment","C0541746;C1516879;C1696073;C3888021","","",993
"no in the $nmbr$ mo before screening","C0026544;C0220908;C0220909;C0332177;C1698960;C1710031;C1710032;C1710477;C2348164",NULL,NULL,1476
"fpg mmol $nmbr$","C0439190",NULL,NULL,671
"hscrp mg l median min max","C0439420;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"tass","C0559483",NULL,NULL,146
"mixed hispanic","C0086409;C0205430;C3160715",NULL,NULL,985
"tolvaptan n $nmbr$","C1176308","C1176308","",1223
"geographic site","C0017446","C0017446","",369
"use of ics at baseline","C0168634;C0815320;C1442488;C1524063;C4551720","C3540778","",2182
"sex no","C0009253;C0036864;C0079399;C0804628;C1314687;C1522384",NULL,NULL,568
"prior oac","C0332152;C2826257",NULL,NULL,294
"$nmbr$ $nmbr$ mga n $nmbr$","C0065879",NULL,NULL,1767
"no of prior aeds c n","C0180309;C0332152;C2826257",NULL,NULL,2374
"hdl c $nmbr$ mg dl $nmbr$ $nmbr$ mmol l","C0439269;C1532563;C3715113","C0023822","",821
"other plain vitamin preparations","C0042890","C0042890","",867
"night time awakenings week","C0332174;C0439230;C0860510",NULL,NULL,1012
"undiagnosed diabetes mellitus","C0011849;C1408353","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"previousdistaldeep veinthrombosisorsuperficial vein thrombosis","C0042487",NULL,NULL,1643
"olmesartan $nmbr$ olmesartan $nmbr$ hydrochlorothiazide $nmbr$ $nmbr$","C0020261;C1098320",NULL,NULL,1149
"nonfatal mi n $nmbr$","C3810814",NULL,NULL,516
"overall night time copd symptom severity scorec","C0024117;C0240526;C0282416;C1319166;C1412502;C1561607;C3714496",NULL,NULL,1726
"ldl cholesterol mg dl mean sd","C0023824;C0202117;C0439269;C0444504;C2347634;C2348143;C2699239","C0023824","",1963
"aspirin other antiplatelet agents n","C0004057;C0085826","","",1191
"testosterone nmol l","C0039601;C0439282",NULL,NULL,669
"o $nmbr$ kg n","C0022718;C0439209;C0483204;C4054209",NULL,NULL,205
"reversibility $nmbr$ n $nmbr$","C0449261","C0449261","",2160
"liraglutide n","C1456408","C1456408","",1566
"i no of events","C0021966;C0221138;C0441471;C3541888",NULL,NULL,412
"residence in asia n","C0003980;C0237096","C0003980","",1382
"population","C0032659;C1257890",NULL,NULL,904
"no steroid use at baseline ref","C0168634;C0281991;C1425988;C1442488","C0239126",";C0168634;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1425988;C1947944",120
"women $nmbr$ years","C0043210;C0439234",NULL,NULL,1099
"number of patients with dose available","C0178602;C0470187;C0869039;C1114758;C2360800",NULL,NULL,1811
"symptom bother","C1457887;C3854129",NULL,NULL,613
"blood eosinophils cells ml","C0014467;C2699156","C0014467","",849
"womac function score","C0031843;C0449820;C0542341;C0700205;C1705273;C4050231",NULL,NULL,748
"latin american subgroup","C1079230;C1515021;C1553378",NULL,NULL,1637
"das $nmbr$ $nmbr$ esr $nmbr$ $nmbr$","C0051767;C0057671;C3811131","C1619634","",298
"after pci","C4049621",NULL,NULL,1736
"chylomicron triglycerides","C0008731;C0041004;C1325761","C0008731","",1499
"estimated difference $nmbr$ ci","C0008107;C0750572;C1705241;C1705242;C3259781",NULL,NULL,519
"lipoprotein a median ql q $nmbr$ nmol l","C0065058;C0125953;C0439282;C0549183;C0876920;C1096202;C1439335;C2347635;C2348144;C2939193","C0065058","",1769
"patients treated for $nmbr$ weeks","C0030705;C0439230;C1522326",NULL,NULL,552
"fasting free fatty acids mol liter","C0015663;C0015688;C0347982",NULL,NULL,988
"serum total cholesterol mmol l mean sd","C0444504;C0587184;C1287371;C1532563;C2347634;C2348143;C2699239","C0543421","",1504
"severity of hypertensionb","C0439793;C0522510",NULL,NULL,561
"type of insulin","C0457592",NULL,NULL,162
"mean ics fluticasone propionate dpi or equivalent pg per day","C0117996;C0205163;C0439185;C0444504;C0815320;C2347634;C2348143;C2827928;C4551720",NULL,NULL,37
"relative risk of outcome in acei group iw control group bbaseline variables for models included logarithm of age reciprocal of serum creatinine sbp up excretion treatment assignment and terms for studies $nmbr$ $nmbr$ $nmbr$ and $nmbr$ see footnotes of table $nmbr$ other baseline variables considered for analysis p $nmbr$ $nmbr$ in univariate analysis included dp mean arterial pressure type of antihypertensive regimen in the control group planned duration of follow up whether or not the investigators were blinded whether or not dietary advice was given and the year of publication","C0001779;C0002778;C0003364;C0009932;C0034036;C0034037;C0035173;C0039224;C0039798;C0040808;C0042789;C0085805;C0087111;C0150108;C0168634;C0201976;C0204932;C0221102;C0232108;C0233324;C0242492;C0243148;C0332257;C0332307;C0439234;C0439508;C0439828;C0441833;C0444504;C0504085;C0600061;C0683962;C0687744;C0750591;C0936012;C0947630;C1257890;C1272641;C1274040;C1442162;C1442488;C1515273;C1516050;C1518422;C1519504;C1522326;C1524024;C1531217;C1533734;C1547052;C1550141;C1550718;C1704324;C1705169;C1705313;C1705428;C1705429;C1706074;C1882911;C1882979;C1947903;C1947971;C2347634;C2348143;C2587213;C2699704;C2825232;C2826302;C2945654;C2986775;C3161035;C3244317;C3274648;C3538994;C3887704;C4288391;C4553389","","",-10
"cough n","C0010200;C1961131;C3274924;C4084725;C4084726;C4084727","C0010200","",1388
"clinical","C0205210",NULL,NULL,793
"contrast volume","C0009924;C0449468;C1690016;C1705102;C1979874;C2700258",NULL,NULL,2030
"asia pacific other","C0003980","C0003980","",1382
"estimated creatinine clearance $nmbr$ ml min","C0439445;C0750572;C0812399","C3811844;C0017654","",307
"hl $nmbr$ $nmbr$","C1453952;C4085347",NULL,NULL,823
"heart failure at entry no","C0018801;C0018802;C1705654;C4554158","C0018801",";C0168634;C1524003",12
"cv disease","C0007222","C0007222","",1790
"mean sd fevi evc","C0013903;C0429706;C0429711;C0444504;C0849974;C1414479;C1561566;C2347634;C2348143;C2699239;C4528367",NULL,NULL,1601
"location of ml","C0439526;C0450429;C1515974;C1705224;C3887665;C4284930;C4284931","C1515974;C0021308","",1948
"thienopyridine","C1120149","C1120149",";C0039798;C0087111;C1363945;C1709561;C1947944",73
"baseline mean fev $nmbr$ sd ml","C0168634;C0439526;C0444504;C1442488;C1705224;C2347634;C2348143;C2699239;C3714541;C3887665",NULL,NULL,1287
"$nmbr$ drinks week","C0332174;C0439230;C0452428",NULL,NULL,178
"multivariable adjusted hr $nmbr$ ci","C0008107;C0456081;C3259781","C2985465","",975
"hispanic or latino ethnic group","C0015031;C0086409;C0086528;C1879937","C0086528;C0086409;C0015031","",363
"warfarin n n","C0043031","C0043031","",858
"pre bronchodilator fev $nmbr$ fvc ratio","C0456603;C1547037;C2599602;C3714541",NULL,NULL,1599
"hands","C0018563;C1552914",NULL,NULL,1666
"hla b $nmbr$ n","C1426226",NULL,NULL,1803
"with alogliptin $nmbr$ $nmbr$ mg","C0024671;C0026410;C0439269;C1958126;C1960952;C2346927;C4321396;C4521761","C1958126","",1183
"blood oxygenation mean sd","C0005767;C0005768;C0229664;C0231940;C0282636;C0444504;C2347634;C2348143;C2699239",NULL,NULL,1287
"median $nmbr$ mm","C0549183;C0876920;C2347635;C2348144;C2939193;C4330985;C4554674",NULL,NULL,635
"african american black","C0005680;C0027567;C0085756;C0439541","C0005680",";C1706779",188
"a $nmbr$ ez $nmbr$","C0206578",NULL,NULL,1407
"rate year","C0439234;C0439508;C0871208;C1521828",NULL,NULL,2009
"ischemic stroke subtype","C0449560;C0948008",NULL,NULL,1669
"laboratory measurements","C0681902",NULL,NULL,979
"gold stage ii","C0018026;C0441767;C1304897",NULL,NULL,542
"statin use no","C0042153;C0360714;C0457083;C1947944","C0360714","",872
"low risk n $nmbr$ $nmbr$","C3272281;C3538919",NULL,NULL,174
"with aspirin n $nmbr$ $nmbr$","C0004057","C0004057","",1366
"number of females","C0086287;C0237753;C0449788","C0086287","",1277
"pdqol scale","C0175659;C0349674;C1947916",NULL,NULL,1800
"$nmbr$ $nmbr$ with cv risk but not disease n $nmbr$","C0012634;C0035647;C1518422;C3538987;C4048877;C4318503;C4552904",NULL,NULL,1279
"dyspnea t","C0013404;C1963100","C0013404","",1227
"hungary","C0020174",NULL,NULL,2040
"all of the above","C1282910;C1552828",NULL,NULL,739
"active cancer","C0006826;C0205177;C0998265;C1306459;C3853793;C3888249","C0006826","",1819
"length of stent median","C0449462;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,1900
"race n b","C0034510;C1706779;C3853635",";C0034510","",1107
"vein bypass graft stented","C0038257;C0398147",NULL,NULL,569
"non hdlc","C1518422;C1704429","C0023822","",821
"aunivariate logistic regression","C0206031",NULL,NULL,1563
"active n $nmbr$","C0205177;C3853793;C3888249",NULL,NULL,496
"supine after $nmbr$ minutes change from baseline","C0038846;C0168634;C0392747;C0439232;C0443172;C0700321;C0702093;C1282918;C1442488;C1705241;C2347166;C4319952",NULL,NULL,625
"erectile function ipss","C0030847;C0031843;C0542341;C0700205;C1019118;C1705273;C1998280;C2827405;C3811063","C1998280",";C1019118;C3811063;C4050465;C4050466;C4049706;C0168634;C1705273;C1880519;C3853603",124
"including hypertension","C0020538;C0332257;C1963138","C0020538","",1364
"unfractionated heparin n $nmbr$","C0019134;C2825026","C0019134","",864
"l","C0439394;C1706495;C3642217","","",-10
"interval from clopidogrel loading h","C0033727;C0070166;C0369286;C0441932;C0564385;C1272706;C1552654;C1552713;C1708715;C4528284","C0070166",";C0369286;C0033727;C4049621",217
"saxagliptin $nmbr$ mg n $nmbr$ $nmbr$","C0024671;C0026410;C0439269;C1611934;C1960952;C2346927;C4321396;C4521761","C1611934","",2069
"previous loss of response to and intolerance of infliximab n","C0205156;C0231199;C0666743;C0871261;C1517945;C1552607;C1704632;C1706817;C1744706;C2355652;C2911692",NULL,NULL,726
"ind $nmbr$ gg q d n n","C0017454;C0018370;C4049864",NULL,NULL,201
"sex n","C0009253;C0036864;C0079399;C0804628;C1314687;C1522384",NULL,NULL,568
"total aim high study","C0205250;C0439175;C0439810;C0557651;C1299351;C1947946;C2603343;C2700149;C2744535;C2948600;C3540471;C3540472;C3887512;C3889660;C3890193;C4321237;C4522209",NULL,NULL,834
"stage ii","C0441767",NULL,NULL,542
"gp iib iiia inhibitor used","C0016011;C1273517;C1999216",NULL,NULL,808
"number of prevalent vertebral fractures","C0033105;C0080179;C0220900;C0237753;C0449788",NULL,NULL,2023
"and either an ace inhibitor or angiotension receptor blocker","C0003015;C0597357;C3844638;C4541021",NULL,NULL,962
"tni ultrapositive $nmbr$ $nmbr$ g l n $nmbr$ $nmbr$","C0077401;C0439294;C0456615",NULL,NULL,1706
"systolic pulmonary arterial pressure mean sd mm hg","C0024109;C0039155;C0439475;C0444504;C0871470;C1168098;C2347634;C2348143;C2699239;C2707265;C2709248;C4522268","C0005823","",1469
"gold stage f","C0016327;C0018026;C0205390;C1300072;C1304897;C1306673",NULL,NULL,541
"tiotropium n $nmbr$ non tiotropium n $nmbr$","C0213771;C1518422","C0213771","",1372
"previous oral antidiabetic medication use n","C0205156;C0935929;C1527415;C1552607",NULL,NULL,995
"two agents","C0205448;C0450442;C1254351;C1521826",NULL,NULL,429
"prior ml or abnormal angiogram","C0002978;C0205161;C0332152;C0439526;C1548816;C1705224;C2347472;C2699333;C2826257;C3887665;C3891555;C4255126",NULL,NULL,686
"stroke or se s se","C0036919;C0038454;C4554100",NULL,NULL,1762
"pharmacotherapy","C0013216;C0013217",NULL,NULL,554
"glucagon like peptide $nmbr$ receptor agonist","C0014361;C4543206","C0014361;C2987634",";C1422069;C1425391;C1539338",1153
"killip class i no","C2697844","C1881332","",846
"killip class at admission no total no","C0184666;C0439175;C0439810;C0809949;C1881332","C1881332","",846
"aortic valve replacement","C0003506",NULL,NULL,1700
"hip fracture only","C0019557;C0149531;C0205171;C1720467;C4552776","C0019557","",1114
"prior tnf antagonist treatment yes","C0231491;C1448177;C1514463;C1549445;C1705108;C1710701",NULL,NULL,147
"glucose mg dl","C0017725;C0439269",NULL,NULL,2283
"angiotensin converting enzyme or angiotensin receptor blocker","C0022709;C0034787;C1452534;C1622222",NULL,NULL,963
"boost intensify all pan asian patient population","C0030705;C0032659;C0078988;C0085999;C1257890;C1511253;C1874596;C3887654",NULL,NULL,904
"hscrp median min max mg l","C0549183;C0876920;C2347635;C2348144;C2827895;C2939193",NULL,NULL,635
"ecfr ml min per $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923","C3811844;C0017654","",307
"baseline hba $nmbr$ c in $nmbr$ classes","C0019016;C0168634;C0456387;C1442488;C1518526;C1705943;C1825777;C3538758;C4019422","","",820
"percentage unless otherwise noted cabg indicates coronary artery bypass graft lvh left ventricular hypertrophy nsaids nonsteroidal antiinflammatory drugs pvd peripheral vascular disease tia transient ischemic attack history of hypercholesterolemia or reporting use of lipid lowering medications at baseline thistory of or currently have elevated serum creatinine level $nmbr$ mg dl tbased on participant history or review of chart","C0003211;C0007787;C0010055;C0013227;C0019664;C0019665;C0020443;C0023779;C0042373;C0085096;C0149721;C0168634;C0205100;C0205250;C0229671;C0262512;C0262926;C0439165;C0439269;C0441889;C0441994;C0455536;C0456079;C0521116;C0541653;C0600061;C0679646;C0700225;C0700287;C0802604;C0917805;C1054154;C1260596;C1442488;C1522133;C1524063;C1546774;C1547707;C1549488;C1550100;C1561533;C1705255;C2003888;C2004062;C2598133;C2698741;C2946261;C3163633;C3671888;C4284232;C4288581;C4521226;C4554048",NULL,NULL,461
"secukinumab $nmbr$ mg no load n $nmbr$","C0024671;C0026410;C0439269;C1550025;C1704782;C1708715;C1960952;C2346927;C3179547;C4321396;C4521761",NULL,NULL,2297
"$nmbr$ $nmbr$ mmol liter estimated gfr","C0017654;C0439190;C0475211;C0750572;C1424601",NULL,NULL,536
"diabetes mellitus n","C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"verapamil sr strategy","C0679199;C1527129","C0042523","",1450
"placebo event rate n $nmbr$","C0032042;C0441471;C0871208;C1521828;C1696465;C1706408;C4019010","C0032042","",28
"male sex","C0086582","C0086582","",1276
"$nmbr$ weeks","C0439230",NULL,NULL,1012
"score","C0449820;C4050231",NULL,NULL,748
"ptgada mm","C4330985;C4554674",NULL,NULL,297
"pre bronchodilator screening","C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C2599602",NULL,NULL,798
"potassium meq l","C0032821;C0202194;C0304475;C0439375;C0597277;C3714637","C0032821","",1371
"$nmbr$ fe black","C0005680;C0027567;C0085756;C0439541;C3848561",NULL,NULL,966
"no estrogen","C0014939;C2936882;C4542544","C0014939","",340
"laba lama ics","C0815320;C0999593;C1416775;C4551720",NULL,NULL,1305
"diabetes duration at baseline","C0011847;C0011849;C0168634;C0449238;C1442488;C2926735",NULL,NULL,625
"background aha therapy at screening n","C0039798;C0050451;C0087111;C0220908;C0220909;C0772110;C1363945;C1698960;C1706907;C1710031;C1710032;C1710477;C2348164",NULL,NULL,236
"incidence $nmbr$ person year","C0021149;C0027361;C0220856;C0439234;C0439508;C2347489","C0021149","",1998
"pad symptoms","C0182158;C0332568;C0683368;C1457887;C3540603;C3669270;C3814046;C4319657",NULL,NULL,1752
"antimalarials only","C0003374;C0205171;C1720467",NULL,NULL,925
"copd type","C0024117;C0332307;C1412502;C1547052;C3714496",NULL,NULL,1726
"abbreviations chd coronary heart disease cl confidence interval ml myocardial infarction rr relative risk defined as a composite end point comprising the first of any of these events nonfatal ml nonfatal stroke or cardiovascular death tp value for interaction $nmbr$ for major cardiovascular event no other interactions are significant calculated as weight in kilograms divided by the square of height in meters hypertension was defined as a self reported systolic blood pressure $nmbr$ mm hg a diastolic blood pressure $nmbr$ mm hg or physician diagnosed hypertension hyperlipidemia was defined as a self reported total cholesterol $nmbr$ mg dl_ $nmbr$ $nmbr$ mmol l or physician diagnosed high cholesterol diabetes defined by self report calculated using the framingham risk score among $nmbr$ $nmbr$ women who provided a blood sample at baseline","C0000723;C0005767;C0005768;C0005910;C0007226;C0008377;C0009667;C0010068;C0011065;C0011847;C0011849;C0011900;C0020473;C0020538;C0021308;C0027061;C0031831;C0033095;C0035647;C0036183;C0038454;C0039155;C0043100;C0043210;C0168634;C0178913;C0201950;C0205082;C0205120;C0205164;C0205199;C0205250;C0205435;C0229664;C0237881;C0242492;C0332849;C0428465;C0428883;C0439209;C0439269;C0439475;C0439526;C0441074;C0441471;C0444686;C0444930;C0449820;C0460139;C0475209;C0489786;C0543421;C0596019;C0681906;C0750502;C0804815;C1279901;C1299351;C1305849;C1305866;C1306345;C1306577;C1320716;C1441506;C1442488;C1522564;C1522609;C1524063;C1532563;C1546944;C1547335;C1552595;C1704675;C1704788;C1705104;C1705224;C1706378;C1963138;C1999230;C2700149;C2700400;C2700446;C2746065;C2924612;C3166866;C3539106;C3541334;C3541888;C3887460;C3887512;C3887665;C3889660;C4050231;C4082313;C4284008;C4318856;C4321237;C4521762;C4522209;C4552775;C4552904;C4554100;C4554402;C4555212","","",-10
"female $nmbr$","C0043210;C0086287;C1705497;C1705498","C0086287","",1277
"$nmbr$ $nmbr$ $nmbr$ $nmbr$ mm hg","C0439475",NULL,NULL,1888
"mean se auc p l","C0036919;C0376690;C0444504;C2347634;C2348143",NULL,NULL,567
"metformin monotherapy","C0025598","C0025598","",1345
"medication after enrolment","C0013227;C1516879;C1696073;C3244316;C3888021;C4284232",NULL,NULL,339
"ethnic group","C0015031;C1879937",NULL,NULL,787
"ef mean sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,36
"hyperlipidemia n n","C0020473;C0428465;C4555212","C0020473;C4555212",";C0439810;C1710701",29
"australia nz","C0004340;C0027978",NULL,NULL,54
"change in lp a","C0065058;C0392747;C0443172;C1439335;C1705241;C4319952;C4553379","C0065058","",1769
"peripheral revascularization","C0205100;C0581603",NULL,NULL,932
"cardiovascular mortality per $nmbr$ person years","C0007226;C0026565;C0026566;C0027361;C0439234;C2347489;C3887460",NULL,NULL,2157
"time since diagnosis of diabetes years median iqr","C0011847;C0011849;C0011900;C0040223;C0439234;C0549183;C0876920;C1704338;C1704656;C2347635;C2348144;C2939193;C3541383",NULL,NULL,1099
"completed trial","C0008976;C0205197;C3854010",NULL,NULL,1020
"hbalc mean sd","C0444504;C2347634;C2348143;C2699239","","",820
"physician s judgment that vka","C0022423;C0031831;C0804815",NULL,NULL,1520
"priorvascular disease","C0012634",NULL,NULL,2113
"total ige geometric","C0439175;C0439810;C0449829",NULL,NULL,508
"oad history years","C0019664;C0019665;C0262512;C0262926;C0439234;C1705255;C2004062",NULL,NULL,832
"severe or moderate","C0205081;C0205082;C1881878;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335",NULL,NULL,321
"ics no","C0815320;C4551720","C3540778","",2182
"esr median range mm hour","C0439227;C0549183;C0564385;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016;C3811131;C4330985;C4554674","C1619634","",298
"loss of response s","C0871261;C1517945;C1704632;C1706817;C2911692",NULL,NULL,726
"aspirin or other antiplatelet or anticoagulant agent","C0003280;C0004057","C0085826","",451
"recurrent hf hospitalization","C0018488;C0019993;C1313497;C1455761;C1538440;C2945760;C3273279","C0018801",";C0168634;C1524003",12
"zotarolimus","C1700035",NULL,NULL,633
"death mi idr st","C0011065;C0036056;C1306577;C3272372;C3810814;C4082313;C4552775",NULL,NULL,246
"involved gl areas","C0018229;C1423073;C1427674;C1879646",NULL,NULL,1804
"bw mean sd kg","C0005910;C0006041;C0022718;C0439209;C0444504;C2347634;C2348143;C2699239;C2986891;C4054209",NULL,NULL,1287
"clinical presentation of vte at initial diagnosis no","C0011900;C0205265;C0630906;C1279901;C1555582;C1704338;C1704656;C1705685;C2708283",NULL,NULL,790
"$nmbr$ kg nr","C0022718;C0027496;C0439209;C3844738;C4054209",NULL,NULL,205
"previous cv events","C0205156;C0441471;C1552607;C3538987;C3541888;C4048877;C4318503",NULL,NULL,1777
"indeterminate","C0205258",NULL,NULL,1086
"hf symptom unchanged","C0018488;C0442739;C1313497;C1457887;C1538440;C2346711;C3273279;C3854129","C0018801",";C0168634;C1524003",12
"risk","C0035647;C4552904","C0035647","",173
"$nmbr$ ci $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0008107;C3259781",NULL,NULL,519
"previous cabg total","C0010055;C0205156;C0439175;C0439810;C1552607",NULL,NULL,508
"no dysglycaemia or mets","C0812270;C1705694;C1960636;C2939420",NULL,NULL,921
"uacr $nmbr$ mg mmol","C0567349;C2348885","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"a ga","C0016993",NULL,NULL,1750
"l t","C0439394;C1706495;C3642217","","",-10
"new york heart association congestive heart failure class","C0018802;C1882083","C0018802;C1882083","",453
"jbs $nmbr$ primary prevention only $nmbr$","C0033144;C0175692;C0205171;C0795841;C1416527;C1720467",NULL,NULL,925
"fenofibric acid low dose statin","C0060179;C0360714;C0445550;C1708745","C0445550","",112
"bnp nt probnp","C0054015;C0669479;C0754710;C1095989;C1417808;C2982014",NULL,NULL,1635
"baseline mean _ sd mg mg","C0168634;C0444504;C1319635;C1442488;C2347634;C2348143;C2699239",NULL,NULL,1287
"killip class","C1881332","C1881332","",846
"demographic","C0011298",NULL,NULL,582
"tanezumab $nmbr$ mg nsaid","C0003211;C0024671;C0026410;C0439269;C1960952;C2346819;C2346927;C3536840;C4321396;C4521761",NULL,NULL,2309
"tiotropium placebo n $nmbr$","C0032042;C0213771;C1696465;C1706408","C0032042","",28
"om $nmbr$","C0028971;C1705272",NULL,NULL,957
"tj $nmbr$ $nmbr$","C0039247",NULL,NULL,1430
"cholesterol absorption inhibitor ezetimibe","C0000854;C0003277;C1142985;C1999216;C2347023;C2347080;C2698776;C2825050;C2945742","C1142985","",1165
"more severe","C0205082;C0205172;C4050465;C4050466",NULL,NULL,313
"baseline mtss subgroup","C0168634;C1079230;C1442488;C1515021",NULL,NULL,1637
"colonic area involved","C0009368;C0017446;C0205146;C1314939","C0009368;C1879646","",2088
"on drug treatment","C0150270;C3469597",NULL,NULL,1007
"acei or arb pre randomisation","C0034656;C0332152;C0740175;C2257086;C3669034;C3888198",NULL,NULL,44
"esrd","C0022661;C0035078;C2316810","C0035078","",342
"sex male ethnic origin","C0015031;C0086582",NULL,NULL,787
"scsbp mean sd mmhge","C0444504;C2347634;C2348143;C2699239",NULL,NULL,2127
"baseline su dose $nmbr$ $nmbr$ maximal","C0038642;C0168634;C0178602;C0205289;C0806909;C0869039;C1114758;C1442488;C1705534;C4049713","C0038766","",752
"fevi l mean sd $nmbr$","C0429706;C0444504;C0849974;C1561566;C2347634;C2348143;C2699239;C4528367",NULL,NULL,37
"limited i","C0021966;C0221138;C0439801;C2674459;C3542948;C4050251",NULL,NULL,278
"$nmbr$ $nmbr$ o $nmbr$ o i i $nmbr$","C0021966;C0221138;C0483204","","",-10
"a $nmbr$ s hydroxy","C0700307",NULL,NULL,1497
"antiarrhythmics","C0003195","C0003195","",379
"median pasi score range i i","C0021966;C0221138;C0449820;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016;C4050231;C4528685",NULL,NULL,1522
"lipid modulating drug","C0013227;C0023779;C0443264;C1254351",NULL,NULL,367
"bmi kg m","C0578022;C1532718",";C1305855","",206
"duration of infusion before pci hr","C0449238;C0574032;C1827465;C2926735;C4049621",NULL,NULL,825
"no of exacerbations in past year","C4086268;C4086728",NULL,NULL,2345
"fluvastatin $nmbr$ mg","C0024671;C0026410;C0082608;C0439269;C1960952;C2346927;C4321396;C4521761","C0082608","",1222
"pleased","C3829994;C4264468",NULL,NULL,416
"insulin requiring","C0021641;C1533581;C1579433;C3714501",NULL,NULL,157
"persistent af","C0205322;C0332996;C0344434;C4049859",NULL,NULL,719
"history of hypertension no","C0455527",NULL,NULL,1498
"other glucose status","C0017725;C0449438",NULL,NULL,543
"diuretic agent","C0012798;C0450442;C1254351;C1521826",NULL,NULL,992
"post bronchodilator fvc l a","C2599594;C3714541",NULL,NULL,680
"european union","C0015179",NULL,NULL,533
"ta","C0039297;C1506978;C1705538;C3272501;C4553364","","",-10
"some college","C0557806",NULL,NULL,1120
"$nmbr$ ft","C1881534;C3890579",NULL,NULL,248
"antiepileptic drug type at baseline","C0003299;C0168634;C0332307;C0457591;C1442488;C1547052;C3537002",NULL,NULL,625
"enzyme inducing","C0014442;C0205263;C4521602",NULL,NULL,158
"previous coronary angioplasty n","C2114427","C0162577","",1722
"ufh only","C0205171;C1720467",NULL,NULL,1583
"sou ti africa","C0001737;C0039247;C0040302;C1553045;C1704756",NULL,NULL,48
"csf lathosterol jlg cll","C0023434;C0064673;C3540512;C3889436",NULL,NULL,1502
"previous tnf antagonist exposure n","C0205156;C0231491;C0274281;C0332157;C1448177;C1552607","C0332157",";C0274281;C0231491;C1420817;C4521367;C4521846;C1552607",27
"number of off periods","C0237753;C0439531;C0449788;C1948053",NULL,NULL,1811
"body mass index $nmbr$ t","C0005893;C0578022;C1305855","C1305855","",1734
"hypercholesterolemia no","C0020443;C1522133","","",1390
"without psoriasis n $nmbr$","C0033860","C0033860","",1358
"sitagliptin no total no","C0439175;C0439810;C1565750","C1565750","",1184
"golimumab $nmbr$ mg kg mtx","C0025677;C0439272;C1417487;C2353893",NULL,NULL,2328
"lv mass","C0455825",NULL,NULL,146
"hr $nmbr$ ci p value","C0008107;C1709380;C3259781",NULL,NULL,519
"baseline if have $nmbr$ yr follow up","C0168634;C0439234;C0589120;C1442488;C1522577;C1704685;C3274571",NULL,NULL,1099
"adjusted hazard ratio $nmbr$ ci","C0008107;C0456081;C2985465;C3259781","C2985465","",975
"hispanic latino ethnicity","C0015031;C0086409;C0086528;C0243103",NULL,NULL,787
"nonischemic cardiomyopathy","C0878544",NULL,NULL,652
"no of previous ciu csu medications mean median","C0013227;C0205156;C0444504;C0549183;C0578870;C0802604;C0876920;C1552607;C2347634;C2347635;C2348143;C2348144;C2598133;C2939193;C4284232",NULL,NULL,366
"tj $nmbr$","C0039247",NULL,NULL,1430
"associated with an atrial septal defect","C0018817;C0332281",NULL,NULL,876
"pasi","C4528685",NULL,NULL,1522
"hdl c $nmbr$ mg dl_","C0439269;C3715113","C0023822","",1962
"pah ctd","C0030123;C1335071;C1442905;C3203102;C4284467",NULL,NULL,1663
"iv n z $nmbr$","C0022326;C4265176",NULL,NULL,1257
"mean sd waist circumference cm","C0444504;C0455829;C2347634;C2348143;C2699239","C0455829","",1413
"p for interaction between rhtn and no rhtn and treatmenta","C0369773;C1704675;C2603361",NULL,NULL,888
"fatal nonfatal mi n","C1302234;C1705232;C3810814",NULL,NULL,1682
"clinical details","C0205210;C1522508",NULL,NULL,793
"bud fm $nmbr$ $nmbr$ atg n $nmbr$","C2700462;C2945744;C3540627;C3815109",NULL,NULL,708
"$nmbr$ f $nmbr$ l $nmbr$","C0016327","","",-10
"age years mean _ sd","C0444504;C1510829;C2347634;C2348143;C2699239","C1510829","",481
"facit f score","C0449820;C3272505;C4050231",NULL,NULL,748
"ab ff $nmbr$ $nmbr$ pg n $nmbr$","C0030827;C0072225;C1266240;C4554348",NULL,NULL,208
"women no","C0043210","C0043210",";C3541888;C1720467",1323
"timi minor","C0026193;C0205165",NULL,NULL,1474
"diastolic blood pressure mm hg median range","C0428883;C0439475;C0549183;C0876920;C1305849;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016","C0428883","",842
"current weekly alcohol use","C0001948;C0332174;C0521116;C1705970","C0001948","",875
"mean sd ng ml","C0439275;C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"fasting plasma glucose mg dl mean sd","C0015663;C0202042;C0439269;C0444504;C0455280;C2347634;C2348143;C2699239","C0455280;C0015663",";C0168634",21
"mean pulmonary artery pressure mm hg","C0439475;C3854605","C0005823","",1469
"fatal bleeding","C0019080;C1302234;C1705232",NULL,NULL,707
"avm se","C0003857;C0036919;C0279476",NULL,NULL,387
"multivariable adjusted model hr $nmbr$ ci","C0008107;C0456081;C3161035;C3259781;C3274659;C3714583;C3853906","C2985465","",975
"total stent length mm mean sd","C0038257;C0439175;C0439810;C0444504;C1444754;C1706316;C2347634;C2348143;C2699239;C4330985;C4554674","C0038257;C1444754","",1748
"hba $nmbr$ c at baseline","C0019016;C0168634;C1442488;C1825777;C3538758","","",820
"$nmbr$ $nmbr$ fn t score $nmbr$ $nmbr$","C0449820;C1570610;C4050231",NULL,NULL,748
"no diuretics group n $nmbr$","C0012798;C0441848",NULL,NULL,992
"baseline ldl cholesterol","C0023824;C0168634;C0202117;C1442488","C0023824","",1068
"rates","C0871208;C1521828",NULL,NULL,2009
"modmy al randcnxzaton","C0202311",NULL,NULL,1174
"no nasal polyps","C0027430","C0027430","",353
"stroke or","C0038454;C4554100",NULL,NULL,1762
"crusade bleeding score mean sd","C0019080;C0444504;C0449820;C2347634;C2348143;C2699239;C4050231",NULL,NULL,2056
"p value f","C0016327;C1709380",NULL,NULL,7
"age at disease onset n","C0012634;C0206132;C3870509",NULL,NULL,736
"chronic cardiovascular disease no","C1290380",NULL,NULL,88
"atorvastatin dose","C0178602;C0286651;C0869039;C1114758","C0286651","",885
"ldl cholesterol mean","C0023824;C0202117;C0444504;C2347634;C2348143","C0023824","",1068
"adalimumab group n $nmbr$ t","C0036669;C1122087",NULL,NULL,942
"non cortical","C0001613;C0007776;C0022655;C1518422",NULL,NULL,792
"severity of airflow limitation","C0231999;C0439793;C0443288;C0449295;C0522510",NULL,NULL,561
"telmisartan group n $nmbr$","C0248719;C0441848","C0248719","",1205
"$nmbr$ $nmbr$ to $nmbr$ kg m $nmbr$","C1532718",";C1305855","",206
"neither n $nmbr$ $nmbr$","C0369718;C0441922",NULL,NULL,1553
"p value $nmbr$ $nmbr$","C1709380",NULL,NULL,7
"cyp $nmbr$ a $nmbr$","C1418793;C2634343",NULL,NULL,609
"high dose arb n $nmbr$","C0444956;C3888198","C0444956","",111
"fev $nmbr$ reversibility","C0449261;C3714541","C0449261;C0231999","",1315
"urinary albumin creatinine ratioa mg g","C0455271;C1300563;C1318330","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"warfarin group","C0043031;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429","C0043031","",858
"time from onset to randomization h mean sd","C0033727;C0034656;C0369286;C0441932;C0444504;C0449244;C0564385;C2347634;C2348143;C2699239;C4528284",NULL,NULL,308
"predose fev fvc","C0439565;C3714541;C3812758","C3714541;C0439565","",295
"iii iv","C0022326;C0439070;C1705160;C4265176",NULL,NULL,1257
"odds ratio and $nmbr$ cl","C0028873;C0596019",NULL,NULL,974
"low $nmbr$ $nmbr$","C0205251;C1550472;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"mental health","C0025353",NULL,NULL,325
"ttr warfarin arm only","C0032923;C0043031;C0205171;C0446516;C1421224;C1720467;C3715044;C4553528","C0043031","",858
"$nmbr$ $nmbr$ i $nmbr$ $nmbr$ n $nmbr$","C0021966;C0221138",NULL,NULL,1021
"latino","C0086528","C0086528;C0086409;C0015031","",363
"type $nmbr$ diabetes mellitus","C1320657","C0011849;C1320657","",907
"stent diameter $nmbr$ mm","C0038257;C1301886;C4330985;C4554674",NULL,NULL,569
"by baseline diabetic status","C0168634;C0241863;C0449438;C1442488",NULL,NULL,996
"screening predicted fev $nmbr$","C0220908;C0220909;C0681842;C1698960;C1710031;C1710032;C1710477;C1882327;C2348164;C3714541",NULL,NULL,1599
"implanted cardioverter defibrillator","C0021102;C0810516;C2828363",NULL,NULL,1628
"erosion score $nmbr$ $nmbr$ scale","C0175659;C0333307;C0349674;C0449820;C1880549;C1947916;C1959609;C3887524;C4050231",NULL,NULL,1046
"$nmbr$ kg no","C0022718;C0439209;C4054209",NULL,NULL,205
"stroke risk score","C0449820;C1277291;C4050231",NULL,NULL,748
"previous renal disease n","C0022658;C0205156;C1552607","C0022658","",320
"incidence","C0021149;C0220856","C0021149","",1467
"medication continued into double blind treatment period","C0013072;C0013227;C0039798;C0087111;C0439531;C0549178;C1522326;C1533734;C1705169;C1948053;C3244316;C3538994;C3887704;C4284232",NULL,NULL,2263
"taci","C0666480;C1425349;C4284230",NULL,NULL,2094
"egfr mdrd ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682;C3839656","C3811844;C0017654","",592
"opg ng ml","C0439275;C1262886;C1336645;C1412836;C1710303",NULL,NULL,204
"$nmbr$ only $nmbr$ distal","C0205108;C0205171;C1720467;C4522154",NULL,NULL,925
"ras antagonist","C0034678;C0231491;C0525678",NULL,NULL,184
"serum fg mg dl","C0016703;C0229671;C0439214;C0439269;C1546774;C1550100;C1638318;C2348814;C3642216","C0455280;C0015663",";C0168634",21
"prior revascularization n $nmbr$ $nmbr$","C0332152;C0581603;C2826257","C0581603","",1213
"rs cough sputumc","C0010200;C0035970;C1961131;C3274924;C3714753;C3813325;C4084725;C4084726;C4084727","C0010200","",1388
"glycemic drugs","C0005802;C0013227;C3687832",NULL,NULL,367
"accord primary n","C0205225;C0439612;C0439631;C0680240",NULL,NULL,229
"mean sd number of exacerbations","C0237753;C0444504;C0449788;C2347634;C2348143;C2699239;C4086268",NULL,NULL,37
"renal function creatinine clearance","C0232804;C0812399","C0232804","",1532
"stenosis $nmbr$","C0678234;C1261287;C2632116",NULL,NULL,1651
"losartan n n","C0126174","C0126174","",1207
"serum creatinine mmol l","C0201976;C0600061;C1532563","C0600061;C0010294","",952
"at clinic diastolic pressure $nmbr$ mm hg","C0002424;C0428883;C0439475;C0442592","C0005823","",1469
"diabetes history mean sd years","C0011847;C0011849;C0019664;C0019665;C0262512;C0262926;C0439234;C0444504;C1705255;C2004062;C2347634;C2348143;C2699239","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"dactylitis in $nmbr$ digit","C3863761","C0239161","",492
"current oral corticosteroid use","C0001617;C0239126;C0442027;C0521116;C1527415;C1705970;C3536709;C4521986",NULL,NULL,1650
"hispanic latino ethnicity n","C0015031;C0086409;C0086528;C0243103",NULL,NULL,787
"previous ics alone","C0205156;C0205171;C0439044;C0679994;C0815320;C1552607;C4551720",NULL,NULL,926
"llt other than statin at randomization","C0034656;C0360714;C2347090",NULL,NULL,692
"duration of diabetes yr","C0011847;C0011849;C0439234;C0449238;C2926735","C2926735;C0011849","",1988
"established cvd age $nmbr$","C0001779;C0007222;C0443211;C1272684","C0001779","",480
"valve surgery n","C0038894;C0038895;C0184252;C0543467;C1186983;C1274039;C1704414;C3888056",NULL,NULL,598
"short form $nmbr$ sf $nmbr$","C0037712;C2964478",NULL,NULL,1782
"pre hospital","C0019994;C0332152;C0740175;C1510665;C2257086;C3669034",NULL,NULL,294
"ckd","C1561643","C1561643","",967
"ischemic","C0475224",NULL,NULL,1670
"mean age yr","C0001779;C0439234;C0444504;C2347634;C2348143","C0001779","",480
"$nmbr$ stenosis of coronary carotid or lower extremity arteries","C0007282;C0018787;C0226415;C0242231;C0741968","C0007272","",1547
"lesions treated per patient","C0030705;C0221198;C1522326",NULL,NULL,552
"age mean years sd","C0444504;C1510829;C2347634;C2348143;C2699239","C1510829","",481
"age categories","C2916832","C1510829","",481
"no of stents","C0038257",NULL,NULL,569
"history of recurrent venous thromboembolism","C0042449;C0348013;C0455533;C1455761;C2945760","C1861172","",2399
"category","C0683312;C3889287",NULL,NULL,562
"no prior stroke tia","C0007787;C0038454;C0332152;C0917805;C1054154;C2826257;C4554100","C0038454;C0332152","",2380
"das $nmbr$","C0051767;C0057671",NULL,NULL,143
"one antihypertensive medication","C0003364;C0205447",";C0003364","",1579
"blood glucose lowering drugs excluding insulin n","C0005802;C0013227;C0017725;C0018938;C0021641;C0332196;C0441994;C1533581;C1579433;C2003888;C2828389;C3687832;C3714501",NULL,NULL,367
"baseline free pcsk $nmbr$ level","C0168634;C0332296;C0441889;C0456079;C1442488;C1547707;C1880497;C1996904;C2946261",NULL,NULL,625
"age $nmbr$ years n","C1510829","C1510829","",481
"$nmbr$ mg clopidogrel load","C0024671;C0026410;C0070166;C0439269;C1550025;C1704782;C1708715;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"edoxaban vs warfarin","C0043031;C2975435","C0043031","",858
"fvc pre bronchodilator","C2599602;C3714541",NULL,NULL,682
"white $nmbr$ $nmbr$","C0007457;C0043157;C0220938","C0043157","",1402
"sotagliflozin $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C3896939;C4321396;C4521761","C3896939","",2067
"etoricoxib $nmbr$ mg n $nmbr$ $nmbr$ n","C0024671;C0026410;C0439269;C0972314;C1960952;C2346927;C4321396;C4521761","C0972314","",1130
"male simva n $nmbr$","C0086582;C1706180;C1706428;C1706429",NULL,NULL,586
"enalapril dm $nmbr$ non dm $nmbr$","C0011816;C0014025;C1518422;C3250443",NULL,NULL,164
"angiography no","C0002978",NULL,NULL,1723
"enrollment by region no","C0017446;C0205147;C1516879;C1696073;C3888021",NULL,NULL,1060
"previous a blocker use","C0042153;C0205156;C0457083;C1552607;C1947944",NULL,NULL,13
"intolerance","C0231199;C1744706;C2355652","C1744706","",1984
"mean total ipss mean ipss by bmi $nmbr$ $nmbr$ to $nmbr$ $nmbr$ kg m $nmbr$","C0439175;C0439810;C0444504;C0578022;C1019118;C1532718;C1998280;C2347634;C2348143;C2827405;C3811063",";C1305855","",206
"dm medication n c","C0011816;C0013227;C3244316;C3250443;C4284232",NULL,NULL,955
"valve repair replacement with or without cabg","C0010055;C0035139;C0043240;C0184252;C0374711;C0559956;C1186983;C1555302;C1704414;C3888056;C4319951;C4553149","C0374711;C0184252",";C1704414;C3888056;C0035139;C0043240;C4553149;C1720467",8
"previous coronary artery bypass grafting","C2144990","C2144990","",227
"adiusted hazard ratio","C2985465","C2985465","",975
"age years mean $nmbr$ sd","C0444504;C1510829;C2347634;C2348143;C2699239","C1510829","",481
"other anti hypertensives","C0003364",";C0003364","",1579
"concomitant medication after randomisation","C0013227;C0034656;C0521115;C3244316;C4284232","C0013227;C0521115","",1916
"chlorthalidone amlodipine lisinopril","C0008294;C0051696;C0065374","","",78
"mitral insufficiency n","C0026266",NULL,NULL,1683
"invasive","C0205281;C1334278",NULL,NULL,762
"favors ff vi favors placebo","C0032042;C0205999;C0309049;C1696465;C1706408;C4554348",NULL,NULL,515
"nesiritide z","C0054015",NULL,NULL,1635
"p value d $nmbr$ mg vs warfarin","C0024671;C0026410;C0043031;C0439269;C1709380;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"moderate impairment $nmbr$ to $nmbr$","C0205081;C0221099;C0684336;C1881878;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"biomarkers at baseline","C0005516;C0168634;C1442488",NULL,NULL,625
"azl m $nmbr$ mg $nmbr$ cld $nmbr$ mg n l $nmbr$","C0369637;C0441923;C2827881",NULL,NULL,923
"dactylitis n","C0239161","C0239161","",492
"gp mdi","C0993596;C1705010;C1839839;C3811116;C4049613",NULL,NULL,518
"secondary end points iii","C0027627;C0175668;C0205436;C0439070;C1705160;C2349179",NULL,NULL,1484
"time from qualifying ecg to balloon inflation","C0021398;C0040223;C0336867;C0441144;C1318493;C1514624;C1623258;C3541383",NULL,NULL,434
"d mi idfvst","C0073187;C0332173;C3810814;C4484261",NULL,NULL,1833
"subsets","C1515021",NULL,NULL,1657
"overall","C0282416;C1561607",NULL,NULL,1743
"any clinical or lesion rf for st","C0035448;C0036056;C0201660;C0205210;C0221198;C0748398;C1546698;C1547111;C3272372",NULL,NULL,793
"disease activity","C1292728","C1292728",";C4050231;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209",101
"multivitamin use current","C0042153;C0301532;C0457083;C0521116;C1705970;C1947944","C0301532",";C1710701;C1705970",1032
"af type","C0332307;C0344434;C1547052;C4049859",NULL,NULL,603
"age $nmbr$ years no","C1510829","C1510829","",481
"previous use of antiplatelet drugs","C0085826;C0205156;C1524063;C1552607;C2963157","","",1191
"established atherosclerotic disease n","C0012634;C0333482;C0443211;C1272684","C0004153","",1698
"$nmbr$ previous venous thromboembolisms","C0205156;C1552607;C1997614","C1861172","",2399
"nondisabling nonfatal stroke","C0038454;C4554100",NULL,NULL,507
"exenatide n $nmbr$","C0167117",NULL,NULL,759
"pulse pressure","C0949236","C0949236","",1118
"sglt $nmbr$ inhibitors","C3665045",NULL,NULL,813
"ldl c at baseline","C0168634;C1442488",NULL,NULL,625
"heterogeneity or trend p vaiue","C0019409;C0242960;C1521798;C4554533",NULL,NULL,550
"multi vessel coronary artery disease","C1299432",NULL,NULL,786
"adherence to study regimen no ff","C0040363;C0040808;C0041260;C0557651;C1510802;C1883351;C2603343;C2945654;C4554348",NULL,NULL,431
"predicted normal t","C0205307;C0231683;C0439166;C0681842;C1882327;C2347086;C4553972","C0024119","",288
"malignancy at randomization","C0006826;C0034656;C1306459;C4282132",NULL,NULL,692
"killip class no total no i","C0021966;C0221138;C0439175;C0439810;C1881332","C1881332","",846
"education in years mean","C0013621;C0013622;C0013658;C0039401;C0439234;C0444504;C2347634;C2348143","C0013658","",1990
"$nmbr$ or greater","C1704243",NULL,NULL,1617
"age years","C1510829","C1510829","",481
"$nmbr$ $nmbr$ hdl cholesterol level","C0023822;C0201950;C0392885;C0428466;C0441889;C0456079;C1547707;C2946261;C3715113","C0023822","",821
"inhaled corticosteroid","C0001617;C0004048;C3536709",NULL,NULL,1650
"des implantation for restenosis n","C0011702;C0021107;C0029976;C0333186;C4551552",NULL,NULL,465
"ics use at baseline n","C0042153;C0168634;C0457083;C0815320;C1442488;C1947944;C4551720",NULL,NULL,625
"$nmbr$ rd $nmbr$ $nmbr$ $nmbr$ $nmbr$ pmol l","C0439284;C0694666;C4553350",NULL,NULL,666
"number of previous dmards","C0205156;C0237753;C0242708;C0449788;C1552607",NULL,NULL,1556
"pacific islander","C0242191",NULL,NULL,1609
"prior percutaneous coronary intervention","C0332152;C1532338;C2826257","C1532338","",1661
"hiv","C0019682;C0019699",NULL,NULL,831
"lipid parameters","C0023779;C0449381",NULL,NULL,1187
"cross clamp","C0175721;C1883710;C2828360;C3810601",NULL,NULL,1549
"i","C0021966;C0221138",NULL,NULL,1021
"proton pump inhibitor use","C0042153;C0358591;C0457083;C1947944;C3536754;C4521480",NULL,NULL,1582
"selena sledai $nmbr$","C0451528","C0451528","",2175
"calcium channel blockers","C0006684;C2757014","C0006684","",1884
"copd exacerbation yes","C0740304;C1549445;C1705108;C1710701",NULL,NULL,147
"event during overall","C0282416;C0441471;C1561607;C4019010",NULL,NULL,412
"n $nmbr$ lesions","C0221198;C0369718;C0441922;C1546698",NULL,NULL,1553
"baseline risk factors","C0035648;C0168634;C1442488;C1553898",NULL,NULL,175
"$nmbr$ to $nmbr$ n z $nmbr$","C0369718;C0441922",NULL,NULL,1063
"body mass index median","C0005893;C0549183;C0578022;C0876920;C1305855;C2347635;C2348144;C2939193","C1305855","",1891
"mar imputation random n $nmbr$","C0034656;C0439605;C2699638;C3829202;C4255469",NULL,NULL,232
"exposure","C0274281;C0332157","C0332157",";C0274281;C0231491;C1420817;C4521367;C4521846;C1552607",27
"sex no male","C0009253;C0036864;C0079399;C0086582;C0804628;C1314687;C1522384;C1706180;C1706428;C1706429",NULL,NULL,568
"women men","C0025266;C0043210","C0043210",";C3541888;C1720467",1323
"mtss median min max","C0549183;C0702093;C0876920;C1524029;C2347635;C2348144;C2939193;C3813700",NULL,NULL,1475
"time from study drug administration to coronary revascularization median iqr h","C0013175;C0033727;C0040227;C0150270;C0206209;C0369286;C0441932;C0549183;C0564385;C0876920;C0877341;C2347635;C2348144;C2349982;C2939193;C3469597;C4528284",NULL,NULL,635
"american hispanic n $nmbr$","C0086409;C0596070","C0086409","",865
"mean s d baseline hba $nmbr$ c","C0019016;C0168634;C0444504;C1442488;C1825777;C2347634;C2348143;C3538758","","",820
"of patients meeting criterion total no of patients","C0030705;C0243161;C0439175;C0439810;C0556656",NULL,NULL,508
"phi n $nmbr$","C1333690;C1704947;C1706536;C2975867;C4084801",NULL,NULL,1738
"patients with bw decrease of $ $nmbr$ in patients with baseline bmi of $ $nmbr$ kg m $nmbr$","C0005910;C0006041;C0030705;C0168634;C0392756;C0547047;C0578022;C1442488;C1532718;C2986891",";C1305855","",206
"prior anti tnf failure","C0231174;C0332152;C0680095;C1448177;C2826257",NULL,NULL,11
"anti hypertensive treatment history n","C0019664;C0019665;C0039798;C0087111;C0262512;C0262926;C0432633;C0857121;C1522326;C1533734;C1705169;C1705255;C2004062;C3538994;C3887704",";C0003364","",1579
"hospitalization to enrollment","C0019993;C1516879;C1696073;C3888021",NULL,NULL,339
"inclusion criteria","C1512693",NULL,NULL,1860
"bare metal","C0025552","C2825200","",348
"hf","C0018488;C1313497;C1538440;C3273279","C0018801",";C0168634;C1524003",12
"placebo n $nmbr$ n","C0032042;C1696465;C1706408","C0032042","",28
"egfr median sd ml min","C0439445;C0549183;C0876920;C1739039;C2347635;C2348144;C2699239;C2939193;C3811844;C3812682","C3811844;C0017654","",592
"inferior mi","C0340305;C3542426",NULL,NULL,516
"cvdeath ml or ischemic stroke","C0439526;C0948008;C1705224;C3887665",NULL,NULL,1669
"region of enrollment","C0017446;C0205147;C1516879;C1696073;C3888021","C0017446","",369
"dbp $nmbr$ $nmbr$ $nmbr$ $nmbr$ baseline lipid profile mg dl mean sd","C0023779;C0168634;C0439269;C0444504;C0536221;C1442488;C1979963;C2003903;C2347634;C2348143;C2699239;C3813197;C4281799",NULL,NULL,192
"baseline dlco mmol kpa","C0168634;C0263428;C0439190;C0439474;C1442488;C1516251",NULL,NULL,625
"creatinine clearance ml min","C0439445;C0812399","C3811844;C0017654","",307
"body weight kg","C0005910;C0022718;C0439209;C1305866;C4054209",NULL,NULL,2326
"legend","C2729544","","",-10
"current alcohol drinking n","C0001948;C0521116;C0556297;C1705970","C0001948;C0521116","",2219
"simplified disease activity index score","C0449820;C3869582;C4050231","C1292728",";C4050231;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209",101
"acs event","C0441471;C0742343;C4019010;C4318612",NULL,NULL,2147
"tertile $nmbr$ $nmbr$ $nmbr$ ng ml n $nmbr$","C0439275",NULL,NULL,204
"anterior infarct location","C0340293;C0450429;C1515974;C2349195;C4284930;C4284931","C1515974;C0021308","",1948
"$nmbr$ rd $nmbr$ $nmbr$","C0694666;C4553350",NULL,NULL,1436
"verapamil sr no $nmbr$","C1527129","C0042523","",1450
"all randomized patients range","C0030705;C0034656;C1514721;C2348147;C3542016;C3815594",NULL,NULL,1035
"dexlansoprazole mr $nmbr$ mg n $nmbr$","C0024485;C0024671;C0026410;C0439269;C1417249;C1960952;C2346927;C2347167;C2348248;C3254418;C4050513;C4321396;C4521761",NULL,NULL,1506
"non east asian","C0078988;C1518422;C1707877","C0078988","",1369
"fgf $nmbr$ high egfr $nmbr$","C0016026;C0205250;C0919505;C1299351;C1739039;C2700149;C3811844;C3812682;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"microalbuminuria n","C0730345","C0033687","",376
"sf $nmbr$ physical component summaryjj","C0031809;C0037712;C0205485;C0449432;C1509143;C1705248",NULL,NULL,1519
"no history of tia stroke","C0007787;C0019664;C0019665;C0038454;C0262512;C0262926;C0917805;C1054154;C1705255;C2004062;C4554100",NULL,NULL,1592
"fev at baseline","C0168634;C1442488;C3714541",NULL,NULL,1599
"prior tnf inhibitor exposure no","C0274281;C0332152;C0332157;C1448177;C1999216;C2826257",NULL,NULL,362
"no prior hf hospitalization n $nmbr$ $nmbr$","C0018488;C0019993;C0332152;C1313497;C1538440;C2826257;C3273279","C0018801",";C0168634;C1524003",12
"no of prior tnfi","C0332152;C2826257",NULL,NULL,2373
"antiarrhythmic drugs n","C0003195","C0003195","",379
"seated dbp mean sd mmhg","C0277814;C0439475;C0444504;C0536221;C1283233;C2347634;C2348143;C2699239;C3813197;C4281799",NULL,NULL,605
"double dummy phase","C0205390;C1710475;C4684647",NULL,NULL,1523
"type of atrial fibrillation n $nmbr$ $nmbr$","C0004238;C0332307;C0344434;C1547052;C1963067",";C0004238","",1009
"mean lumbar spine t score","C0024091;C3533236;C3887615",NULL,NULL,1551
"general health self reported","C0424575;C0681906;C2700446;C4018875",NULL,NULL,325
"timi defined bleeding","C0019080;C1704788;C3539106",NULL,NULL,707
"no of treated vessels","C0005847;C1522326",NULL,NULL,743
"hospitalization for hf previous year","C0018488;C0019993;C0205156;C0439234;C0439508;C1313497;C1538440;C1552607;C3273279","C0018801",";C0168634;C1524003",12
"interval after index event","C0441471;C0600653;C0918012;C1272706;C1552654;C1552713;C1552854;C1637833;C2986546;C4019010",NULL,NULL,734
"ixekizumab every $nmbr$ weeks n $nmbr$","C0439230;C3489764",NULL,NULL,1012
"isolated impaired glucose tolerance no","C0205409;C0271650;C1548221","C0271650","",818
"factor xa inhibitor","C2825027;C4553708",NULL,NULL,2021
"use of loop diuretics","C0354100;C1524063","C0354100","",991
"low $nmbr$","C0205251;C1550472;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"while ethnic origin","C0015031",NULL,NULL,787
"multivariate p value","C1709380",NULL,NULL,7
"adverse event","C0877248","C0877248","",47
"women only","C0043210;C0205171;C1720467","C0043210",";C3541888;C1720467",1323
"primary endpoint $nmbr$","C2986535","C2986535","",230
"baseline egfr $nmbr$","C0168634;C1442488;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"high $nmbr$ n $nmbr$ $nmbr$ $nmbr$","C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"median age iqr years","C0549183;C0876920;C1510829;C2347635;C2348144;C2939193",NULL,NULL,1901
"time from event to randomization days","C0034656;C0040223;C0439228;C0441471;C3541383;C4019010",NULL,NULL,1621
"planned treatment duration n","C4528394","C0025677","",716
"characteristic_level","C0441889;C0456079;C1521970;C1547707;C2946261",NULL,NULL,744
"difference in sbp between treatment","C0039798;C0085805;C0087111;C1522326;C1533734;C1705169;C1705241;C1705242;C3538994;C3887704",NULL,NULL,1466
"prior ptca pci","C0332152;C2826257;C2936173;C4049621","C1532338","",1661
"salmeterol fluticasone group n $nmbr$","C0441848;C0939232",NULL,NULL,19
"not reported unknown","C0439673;C0684224;C0700287;C1518422;C3541433;C4050014;C4319718",NULL,NULL,85
"one tnfi","C0205447",NULL,NULL,737
"black or asian","C0005680;C0027567;C0078988;C0085756;C0439541","C0078988","",1369
"ed visit related to exacerbation n","C0439849;C0445223;C0545082;C1512346;C2826704;C3538926;C4086268",NULL,NULL,276
"elevated creatine kinase mb $nmbr$ u l","C0010290;C0024853;C0151576;C0205250;C0439339;C0523584;C3163633",NULL,NULL,460
"weight","C0005910;C0043100;C1305866;C1705104","C0005910","",1250
"prediabetes no $nmbr$","C0362046","C0362046",";C0168634;C1334085;C1708411",910
"post bronchodilator fev fvc","C2599594;C3714541",NULL,NULL,680
"multivessel coronary artery bypass grafting","C0010055",NULL,NULL,2032
"peripheral arterial disease n $nmbr$ $nmbr$","C0085096;C1704436","C0085096","",933
"patients not receiving mtx n","C0025677;C0030705;C1417487;C1514756;C1518422",NULL,NULL,731
"both impaired glucose tolerance and impaired fasting glucose tolerance no","C0013220;C0015663;C0020963;C0220929;C0231197;C0271650;C1272092;C1704410","C1272092","",20
"statin users n $nmbr$","C0360714;C1706077","C0360714","",872
"$nmbr$ sitosterol p mol l","C0037215;C0220914;C0347982",NULL,NULL,1503
"change from baseline in mean $nmbr$ h sbp mmhg","C0033727;C0085805;C0168634;C0369286;C0392747;C0439475;C0441932;C0443172;C0444504;C0564385;C1442488;C1705241;C2347634;C2348143;C4319952;C4528284",NULL,NULL,607
"heart failure class i iii","C0018801;C0018802;C0021966;C0221138;C0439070;C0441885;C0441887;C1319793;C1705160;C2698967;C2698969;C4554158","C0018802;C1882083","",453
"risk factors and diabetes status","C0035648;C1317301;C1553898",NULL,NULL,544
"waist circumference cm mean sd","C0444504;C0455829;C2347634;C2348143;C2699239","C0455829","",1413
"elevation of cardiac biomarker levels or st seg ment deviation $nmbr$ mm no total no","C0084844;C0439175;C0439775;C0439810;C0441889;C0702240;C1114722;C1116089;C1271630;C1519133;C1538994;C1705293;C4330985;C4554674",NULL,NULL,297
"average maximum common and bifurcation cimt mm","C0184906;C0205214;C0806909;C1510992;C1522138;C1552615;C2825518;C2826546;C3146289;C3245511;C4330985;C4554674","","",1262
"hemorrhagic","C0333275",NULL,NULL,581
"elevated serum creatinine $nmbr$ $nmbr$ mg dl","C0439269;C0700225","C0600061;C0010294","",952
"no history of cancer","C0455471","C0241889","",1493
"medians iqr","C0549183",NULL,NULL,635
"randomization group","C0034656;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429",NULL,NULL,1526
"baseline weight kg","C0022718;C0439209;C1303013;C4054209",NULL,NULL,2326
"bnp pg ml h","C0030827;C0033727;C0054015;C0072225;C0369286;C0439297;C0439391;C0439526;C0441932;C0564385;C1095989;C1266240;C1417808;C1705224;C2827929;C2982014;C3887665;C4528284",NULL,NULL,1635
"mtx $nmbr$ and $nmbr$ mg week","C0024671;C0025677;C0026410;C0332174;C0439230;C0439269;C1417487;C1960952;C2346927;C4321396;C4521761","C0025677","",716
"use of statin at any follow up visit","C0360714;C0589121;C1524063","C0360714","",872
"baseline renal function eclcr","C0168634;C0232804;C1442488","C0232804","",1532
"disabling or fatal","C1302234;C1705232",NULL,NULL,1682
"moderate dose statin","C0360714;C1709056","C0360714","",872
"medication $nmbr$ $nmbr$ $nmbr$","C0013227;C3244316;C4284232",NULL,NULL,2263
"race or ethnic group no f","C0015031;C0016327;C0034510;C1706779;C1879937;C3853635",NULL,NULL,787
"nitrate use","C0028125;C0042153;C0457083;C0699857;C1947944;C3848573",NULL,NULL,537
"alendronate n $nmbr$","C0102118",NULL,NULL,1573
"non diabetes","C0011847;C0011849;C1518422","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"high dose statin","C0360714;C0444956","C0444956","",111
"weight no","C0005910;C0043100;C1305866;C1705104","C0005910","",1250
"des type at index procedure","C0011702;C0455713;C0600653;C0918012;C1552854;C1637833;C2986546;C4551552",NULL,NULL,734
"estrogen","C0014939;C2936882;C4542544","C0014939","",340
"combinations of aspirin and ppi use p $nmbr$ $nmbr$ t","C0004057;C0042153;C0358591;C0453882;C0457083;C0871125;C1947944;C3539181;C3539182;C3539954;C3539955;C3539956;C3539957;C3539959;C3539960;C3539961;C3539962;C3539963;C3539964;C3539965;C3539966;C3539967;C3539968;C3539969;C3539970;C3539971;C3539972;C3539973;C3539974;C3539975;C3539976;C3539977;C3539978;C3539979;C3540026;C3540027;C3540028;C3540030;C3540031;C3540719;C3540720;C3540721;C3540722;C3540723;C3540724;C3540740;C3811894;C3854036",NULL,NULL,1738
"african america","C0085756","C0005680",";C1706779",188
"pasi $nmbr$ at week $nmbr$","C0332174;C0439230;C4528685",NULL,NULL,1012
"lipid values mean sd","C0023779;C0042295;C0444504;C2347634;C2348143;C2699239","C0023779","",1772
"clopidogrel dose on before pci","C0070166;C0178602;C0869039;C1114758;C4049621",NULL,NULL,1736
"lower limb fracture","C0016658;C0023216;C0441994;C0596838;C1548802;C2003888",NULL,NULL,1613
"use of h $nmbr$ bloekers n","C0033727;C0369286;C0441932;C0564385;C1524063;C4528284",NULL,NULL,308
"time to death due to pah or hospitalization due to pah up to the end of the treatment periodd","C0019993;C0030123;C0039798;C0087111;C0444930;C0547043;C0678226;C1301931;C1522326;C1533734;C1705169;C2746065;C3203102;C3538994;C3887704;C4284467",NULL,NULL,258
"any dynamic st segment shift","C0333051;C0429029;C0729333;C2347509","C0429029","",1204
"antiarrhythmic","C0003195;C3537142","C0003195","",379
"established","C0443211;C1272684","C0443211","",179
"sal $nmbr$ pg n $nmbr$","C0030827;C0036140;C0037494;C0072225;C0206136;C1266240",NULL,NULL,853
"alc $nmbr$ $nmbr$","C1424945;C3811058",NULL,NULL,395
"grade $nmbr$ severe copd n","C0024117;C0205082;C0441800;C0919553;C1412502;C3244287;C3714496;C4050465;C4050466",NULL,NULL,313
"chronic bronchitis","C0008677","C0006277","",268
"number of antihypertensive medications n","C0003364;C1718138",";C0003364","",1579
"uncontrolled acq $nmbr$ $nmbr$ $nmbr$","C0205318;C2919686","C2919686","",1293
"asia and pacific islands","C0003980;C0030168","C0003980","",1382
"hr $nmbr$ ci univariate cox proportional hazard regression","C0008107;C0205351;C0598697;C0684320;C0684321;C1565830;C1836830;C3259781",NULL,NULL,1544
"itt population","C0032659;C1257890",NULL,NULL,900
"unified parkinson disease","C0030567;C1521736;C1548174;C1706076",NULL,NULL,95
"bolus insulin doseh","C0021641;C1186706;C1511237;C1533581;C1579433;C1705509;C3714501;C3812160",NULL,NULL,157
"hr and $nmbr$ ci","C0008107;C3259781",NULL,NULL,1544
"improvement from baseline $nmbr$","C0168634;C1442488;C2986411",NULL,NULL,625
"betablocker","C0001645","C0001645","",959
"with placebo n $nmbr$ $nmbr$","C0032042;C1696465;C1706408","C0032042","",28
"p value for interactiont","C1709380",NULL,NULL,7
"medication effects","C1319171","C1319171","",898
"esr mm hr","C3811131;C4330985;C4554674","C1619634","",298
"reversibility stratum","C0449261","C0449261","",2160
"overall mortality","C0026565;C0026566;C0282416;C1561607","C0026565","",1312
"hx of diabetes n","C0011847;C0011849;C0262926;C3814444","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"ldl cholesterol at baseline mmol l ldl cholesterol at screening","C0023824;C0168634;C0202117;C0220908;C0220909;C1442488;C1532563;C1698960;C1710031;C1710032;C1710477;C2348164",NULL,NULL,625
"rosuvastatin n rate","C0871208;C0965129;C1521828","C0965129","",886
"range ed etiology n","C0015127;C1314792;C1514721;C1524003;C2348147;C3538926;C3542016",NULL,NULL,924
"african","C0027567","C0005680",";C1706779",188
"stroke deaths","C0011065;C0038454;C1306577;C4554100",NULL,NULL,323
"all death","C0011065;C1306577;C4082313;C4552775",NULL,NULL,1855
"ppi use within $nmbr$ months of randomization","C0034656;C0358591;C0439231;C0871125;C1524063;C3811894",NULL,NULL,1530
"titre u ml t","C0439340;C0475208;C1880521;C2945590",NULL,NULL,301
"mean s d egfr ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C0444504;C1739039;C2347634;C2348143;C3811844;C3812682","C3811844;C0017654","",592
"laser or vitrectomy","C0023089;C0042903;C0458142;C1023865;C1706315",NULL,NULL,1617
"no of non tnfi","C1518422",NULL,NULL,85
"rivaroxaban aspirin","C0004057;C1739768","C1739768","",1225
"esr","C3811131","C1619634","",298
"history of currently treated hypertension n","C0455527;C0521116;C1522326",NULL,NULL,1417
"homa_ b median q $nmbr$ q $nmbr$","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"baseline height cm","C0168634;C0489786;C1442488","C0489786","",1249
"verapamil sr n $nmbr$ no","C1527129","C0042523","",1450
"nteraction p value","C1709380",NULL,NULL,7
"fev $nmbr$ prebronchodilator l mean sd","C0444504;C2347634;C2348143;C2599602;C2699239;C3714541",NULL,NULL,1599
"admission k mmol l","C0184666;C0597277;C0809949;C1532563;C1708601","C0302353","",1959
"heparin only","C0019134;C0205171;C0770546;C1720467","C0019134","",863
"diastolic bp","C0428883","C0428883","",842
"diabetes status no","C1317301",NULL,NULL,544
"receiving insulin therapy","C0021641;C0039798;C0087111;C1363945;C1514756;C1533581;C1579433;C3714501",NULL,NULL,236
"cat score category","C0007450;C0325090;C0449820;C0524517;C0683312;C1443200;C3665481;C3889287;C4050231;C4050461;C4284282",NULL,NULL,255
"insulin treatment","C0745343","C0745343","",2075
"drug eluting stent implanted no","C0021102;C1322815;C2828363","C1322815","",365
"$nmbr$ hr after glucose challenge","C3840385",NULL,NULL,1618
"retinal severity change","C0035298;C0392747;C0439793;C0443172;C0522510;C1705241;C4319952",NULL,NULL,767
"overall hr $nmbr$ cl","C0282416;C0596019;C1561607",NULL,NULL,658
"categorical variables","C0439828;C0683312;C3889287",NULL,NULL,1018
"atorvastatin","C0286651","C0286651","",885
"hemispheric tia n $nmbr$","C0007787;C0205139;C0917805;C1054154",NULL,NULL,1592
"history of diabetes mellitus n","C0455488",NULL,NULL,1491
"gpifo llia inhibitor use before angography","C0042153;C0457083;C1947944;C1999216",NULL,NULL,812
"major clinical response","C0205082;C0205164;C4055223;C4318856;C4521762","C1320716;C0205082","",2077
"symptom score sd","C2699239;C3476546",NULL,NULL,1287
"duration of diabetes years","C0011847;C0011849;C0439234;C0449238;C2926735","C2926735;C0011849","",1988
"europe and australia","C0004340;C0015176","C0015176","",337
"lipid profile","C0023779;C1979963;C2003903","C0023779","",1772
"baseline triglycerides $nmbr$ mg dl and","C0041004;C0168634;C0439269;C1442488","C0041004","",368
"previously taken dmards other than methotrexate","C0025677;C0242708;C1883727","C0242708",";C0026544",231
"timi major bleeding","C0019080;C0205082;C0205164;C4318856;C4521762",NULL,NULL,2079
"albuminuria","C0001925","C0001925","",375
"no fingernails","C0222001",NULL,NULL,1090
"patients who received indeterminate results on test for antibodies to infliximabt","C0003241;C0030705;C0205258;C0456984;C1514756",NULL,NULL,1086
"statin n","C0360714","C0360714","",872
"all patients n $nmbr$ $nmbr$","C0030705",NULL,NULL,1035
"assessment of physical function $nmbr$ $nmbr$ haq di","C0031809;C0031843;C0516981;C0542341;C0700205;C1261322;C1516048;C1705273;C3826998;C4049916;C4321476",NULL,NULL,1665
"combined end poir","C0205195;C0444930;C2746065",NULL,NULL,410
"use of ace inhibitors arbs n","C0003015;C1524063;C3888198",NULL,NULL,44
"number of exacerbations in the last $nmbr$ months","C0237753;C0449788;C4086268;C4331910","C4086268","",889
"female n $nmbr$","C0043210;C0086287;C1705497;C1705498","C0086287","",1277
"$nmbr$ ref","C1425988","","",-10
"interaction p valuef","C1704675",NULL,NULL,1010
"pooled simva","C1709595;C2349200;C4522255","C0074554","",1840
"oma oat n $nmbr$","C0028753;C0331496;C0939905;C3539067;C3897364",NULL,NULL,254
"ezetimibe $nmbr$ mg statin n $nmbr$ $nmbr$","C0024671;C0026410;C0360714;C0439269;C1142985;C1960952;C2346927;C4321396;C4521761","C0360714;C1142985","",1862
"score $nmbr$ at $nmbr$ monthsb unadjusted or","C0449820;C1439367;C4050231",NULL,NULL,1581
"copd disease severity","C0024117;C0521117;C1412502;C3714496",NULL,NULL,1546
"duration of copd y","C0024117;C0449238;C1412502;C2926735;C3714496",NULL,NULL,1726
"$nmbr$ $nmbr$ $nmbr$ $nmbr$ mg mmol","C0567349;C2348885",NULL,NULL,200
"duration of pci min median","C0449238;C0549183;C0702093;C0876920;C1524029;C2347635;C2348144;C2926735;C2939193;C3813700;C4049621",NULL,NULL,901
"$nmbr$ $nmbr$ h","C0033727;C0369286;C0441932;C0564385;C4528284",NULL,NULL,308
"family history of diabetes mellitus no","C0260526;C1313937",NULL,NULL,1491
"asia pacific n $nmbr$","C0003980","C0003980","",1382
"$nmbr$ mol liter no","C0347982",NULL,NULL,988
"non ics","C0815320;C1518422;C4551720",NULL,NULL,1359
"serum potassium $nmbr$ $nmbr$ mmol l","C0302353;C0543465;C1532563","C0302353","",1959
"timi risk score n n","C0035647;C0449820;C4050231;C4552904",NULL,NULL,1954
"not estimable","C1518422",NULL,NULL,85
"$nmbr$ mmol l","C1532563",NULL,NULL,670
"mi $nmbr$ months","C0439231;C3810814",NULL,NULL,1530
"moderate disease","C0012634;C0205081;C1881878;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"sf $nmbr$ mcs score","C0037712;C0449820;C4050231",NULL,NULL,1782
"comorbid conditionsb","C0009488",NULL,NULL,765
"ldl c hdl c ratio","C0428621","C0023824","",1068
"tofacitinib","C2930696","C2930696","",857
"triglyceride a","C0041004","C0041004","",368
"as major component no","C0205082;C0205164;C0449432;C1705248;C4318856;C4521762",NULL,NULL,1472
"high hdl c for men $nmbr$ mg dl for women $nmbr$ mg dl","C0025266;C0043210;C0205250;C0439269;C1299351;C2700149;C3715113;C3887512;C3889660;C4321237;C4522209","","",306
"anti dsdna positive","C0439178;C0741099;C1446409;C1514241;C2825490;C3812269",NULL,NULL,1163
"$nmbr$ $nmbr$ to $nmbr$ $nmbr$ mm hg","C0439475",NULL,NULL,1888
"ascvd n","C3665365",NULL,NULL,344
"reference","C1514811;C1706462",NULL,NULL,1464
"not assessable","C1883425",NULL,NULL,92
"coronary heart disease n b","C0010054;C0010068;C1956346","C0010068;C1956346",";C0026410;C1710701",226
"adjusted hr $nmbr$ ci","C0008107;C0456081;C3259781",NULL,NULL,519
"primary end point death mi idr st","C0011065;C0036056;C1306577;C2986535;C3272372;C3810814;C4082313;C4552775","C2986535","",230
"rivaroxaban plus aspirin n $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0004057;C0332287;C1739768","C1739768","",1225
"$nmbr$ $nmbr$ low risk","C3272281;C3538919",NULL,NULL,174
"selected clinical characteristics","C0683325;C1707391",NULL,NULL,789
"hip","C0019552;C0022122;C1505163;C3538851;C4284725",NULL,NULL,830
"pack years mean sd","C0444504;C1277691;C2347634;C2348143;C2699239",NULL,NULL,37
"concomitant aminosalicylates n concomitant corticosteroids n mayo score mean sd","C0001617;C0368663;C0444504;C0449820;C0454788;C0521115;C1077578;C2347634;C2348143;C2699239;C3539185;C3540725;C3540726;C3540727;C4050231","C0368663","",1691
"white n $nmbr$","C0007457;C0043157;C0220938","C0043157","",1402
"mixed itt n $nmbr$","C0205430;C3160715",NULL,NULL,985
"clinical characteristics n","C0683325",NULL,NULL,789
"killip class ii iv n","C0022326;C1710602;C2697845;C2697847;C4082587;C4265176","C1881332","",846
"oct center point thickness pm","C0030266;C0205099;C1280412;C1552961;C2347617;C3714763;C3810851;C3828732;C4049155",NULL,NULL,1135
"psa reported n","C0369718;C0441922;C0684224;C0700287;C3810537;C3813209;C4319718",NULL,NULL,125
"hyper tension","C0020538;C1963138","C0020538","",1364
"proportion taking pulmonary medications b","C0013227;C0024109;C0802604;C1515187;C1709707;C2598133;C2707265;C2709248;C4284232;C4522268",NULL,NULL,572
"exercise once weekly","C0015259;C0558293;C1522704","C0015259","",1380
"$nmbr$ $nmbr$ mu l $ mmol l","C0439190;C0439342",NULL,NULL,671
"femoral neck f score at flex baseline","C0015815;C0016327;C0168634;C0449820;C1442488;C4050231",NULL,NULL,625
"demographics age years","C0011298;C1510829;C1704791",NULL,NULL,582
"msdbp mm hga","C4330985;C4554674",NULL,NULL,297
"total sample $nmbr$","C0370003;C0439175;C0439810;C2347026",NULL,NULL,1004
"treatment before randomization","C0034656;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,236
"u c mg g","C0024671;C0026410;C0439148;C0439267;C0439269;C1300563;C1532633;C1638407;C1960952;C2346927;C2608091;C4321396;C4521761",NULL,NULL,192
"receptor blockers n","C0597357",NULL,NULL,962
"feature","C1521970;C1706388;C2346469;C2348519","C1521970","",1110
"dronedarone n $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0766326","C0766326","",1923
"valdecoxib","C0913246",NULL,NULL,2034
"cholinesterase inhibitor use at baseline no","C0008425;C0042153;C0168634;C0457083;C1442488;C1947944;C3536756;C4521309",NULL,NULL,118
"cardiac resynchronization therapy n","C1167956",NULL,NULL,1885
"early invasive","C0205281;C1279919;C1334278",NULL,NULL,762
"mets","C0812270;C1705694;C2939420",NULL,NULL,921
"$nmbr$ da of capillary nonperfusion in the eyec","C0006901;C0011318;C0935624;C3668815",NULL,NULL,1074
"anterior n","C0205094","C0205094","",1243
"severity of the disease gold $nmbr$ n","C0018026;C0521117;C1304897","C0024117;C0521117","",213
"subjects randomized","C0034656;C0681850;C1550501;C1706203;C2349001;C2697811;C3815594",NULL,NULL,1655
"$nmbr$ $nmbr$ cl $nmbr$ to $nmbr$","C0596019",NULL,NULL,432
"dbp mean sd","C0444504;C0536221;C2347634;C2348143;C2699239;C3813197;C4281799",NULL,NULL,605
"other antiarrhythmics","C0003195","C0003195","",379
"genotype by treatment interaction p values","C0017431;C0039798;C0087111;C1522326;C1533734;C1704675;C1705169;C1709380;C3538994;C3887704",NULL,NULL,7
"urine acr mg g","C0042036;C0042037;C1300563;C1412134;C1515941;C2963137",NULL,NULL,2315
"prior hospitalizations n","C0019993;C0332152;C2826257",NULL,NULL,294
"rivaroxaban $nmbr$ $nmbr$ mg bid aspirin $nmbr$ mg od","C0004057;C0229089;C0439164;C1319635;C1512019;C1739768;C3273373;C3665488","C1739768;C0004057","",1792
"history of cabg n","C0010055;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062","C0010055","",389
"sitagliptin $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ fasting plasma glucose fpg mmol l","C0015663;C0202042;C0455280;C1532563;C1565750",NULL,NULL,670
"pre bronchodilator fevr l","C1708033;C2599602",NULL,NULL,682
"prior heart failure","C0018801;C0018802;C0332152;C2826257;C4554158","C0018801",";C0168634;C1524003",12
"qualifying symptomatic event n a","C0231220;C0441471;C1514624;C4019010",NULL,NULL,412
"calcium channel antagonists n","C0006684;C2757014","C0006684","",1884
"hdl","C3715113","C0023822","",821
"event incidence n","C0021149;C0220856;C0441471;C4019010","C0021149","",1467
"uncontrolled on oad s","C0205318","C0205318","",332
"hypertension no total no medications in use at baseline no total no","C0013227;C0020538;C0042153;C0150312;C0168634;C0332285;C0439175;C0439810;C0457083;C0802604;C1442488;C1707101;C1947944;C1963138;C2598133;C4284232","C0020538","",1364
"diarrhea","C0011991;C1963091;C3641756;C4084784;C4084802;C4085317",NULL,NULL,50
"alt $nmbr$ x uln on two consecutive visits","C0205448;C0545082;C1266129;C1512346;C1519815;C1707491;C4553172",NULL,NULL,1676
"device group","C1706365",NULL,NULL,1527
"iduration of symptoms $nmbr$ min","C0683368;C0702093;C1457887;C1524029;C3813700",NULL,NULL,1475
"severe or very severe","C0205082;C3641272;C4050419;C4050465;C4050466","C3641272",";C0018026;C1304897;C1412502;C4050419;C4050465;C4050466",913
"mild impairment $nmbr$ to","C0221099;C0684336;C2945599",NULL,NULL,329
"major secondary end pointf","C0027627;C0175668;C0205082;C0205164;C0205436;C0444930;C2746065;C4318856;C4521762",NULL,NULL,1472
"uc disease durslion","C0012634",NULL,NULL,1279
"sex female","C0086287","C0086287","",1277
"patients with microvascular complications n","C0009566;C0030705;C0443258;C1171258","C0443258;C0009566","",1214
"$nmbr$ $nmbr$ $nmbr$ continued","C0549178",NULL,NULL,1561
"favors favors amlodipine chlorthalidone","C0008294;C0051696;C0309049","C0008294","",70
"philippines","C0031529","","",-10
"bmi $nmbr$ $nmbr$ kg m n $nmbr$ $nmbr$","C0578022;C1532718",NULL,NULL,1735
"previous history of cardiovascular events","C0007226;C2004062;C3887460",NULL,NULL,649
"glycopyrrolate eflow cs $nmbr$ meg n $nmbr$","C0010182;C0017970;C0024489;C0025175;C0072225;C0271160;C3540510;C4085345",NULL,NULL,136
"remission component of variable","C0439828;C0449432;C0544452;C0687702;C1705248;C4553760",NULL,NULL,1712
"no of previous anti tnf drugs no","C0013227;C0205156;C1448177;C1552607;C3687832",NULL,NULL,367
"mean sd fpg mg dl","C0439269;C0444504;C2347634;C2348143;C2699239",NULL,NULL,192
"d value","C1522609",NULL,NULL,9
"pasi score $nmbr$","C0449820;C4050231;C4528685",NULL,NULL,1522
"hazard ratio glp $nmbr$ analogue vs placebo $nmbr$ cl","C0018301;C0032042;C0243071;C0596019;C1422069;C1425391;C1539338;C1696465;C1706408;C2350813;C2985465",NULL,NULL,1861
"verifynow pru defined hpr patients","C0030705;C1337105;C1704788;C3539106",NULL,NULL,1200
"female male","C0043210;C0086287;C0086582;C1705497;C1705498;C1706180;C1706428;C1706429","C0086582","",1276
"patients with specific disease characteris","C0205369;C0683521;C1552740",NULL,NULL,878
"this study","C0557651;C2603343",NULL,NULL,1730
"mean sd number of albuterol per day puff","C0001927;C0237753;C0332173;C0439228;C0439505;C0444504;C0449788;C1533107;C1882376;C2347634;C2348143;C2699239",NULL,NULL,37
"$nmbr$ $nmbr$ mmol mol $nmbr$ $nmbr$ $nmbr$ $nmbr$ n","C3829066",NULL,NULL,668
"first mace","C0205435;C0349381;C0949745;C1279901;C1445339","C1320716","",414
"no ckd intensive n $nmbr$","C0162425;C0522510;C1283828;C1550453;C1561643","C1561643","",967
"tenecteplase","C0872913","C0872913","",417
"treated with atenolol n $nmbr$","C0004147;C0332293","C0004147","",877
"heart failure ci confidence interval","C0008107;C0009667;C0018801;C0018802;C3259781;C4554158",NULL,NULL,519
"hemoglobin level","C0019029;C1314664","C0019046","",1177
"pci alone n $nmbr$","C0205171;C0439044;C0679994;C4049621",NULL,NULL,926
"history of stroke or tia n","C0007787;C0019664;C0019665;C0038454;C0262512;C0262926;C0917805;C1054154;C1705255;C2004062;C4554100",NULL,NULL,832
"chinese subgroup","C0008120;C0152035;C1079230;C1515021",NULL,NULL,770
"patients with moderate to severe pain womac pain score $nmbr$ $nmbr$","C0030705;C0205081;C0205082;C0278140;C0449820;C0582148;C1881878;C4049705;C4049706;C4050231;C4050465;C4050466;C4085643;C4321335;C4521229",NULL,NULL,321
"current inhaler","C0021461;C0521116;C1705970;C1881212;C4319647",NULL,NULL,1417
"gold group n","C0018026;C0441848;C1304897","C0024117;C0521117","",213
"myocardial infarction or angina","C0002962;C0027051;C0428953;C2926063;C3810814;C4552959","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"acq $nmbr$ score mean sd","C0444504;C0449820;C2347634;C2348143;C2699239;C2919686;C4050231","C2919686","",1293
"medical history n of patients","C0679831;C1369882;C1609576",NULL,NULL,1492
"at index event","C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010",NULL,NULL,734
"duration of type $nmbr$ diabetes mellitus years","C0439234;C0449238;C1320657;C2926735","C0011849;C1320657","",907
"multiracial","C1881928",NULL,NULL,778
"hdl $nmbr$ mg dl","C0439269;C3715113","C0023822","",1962
"all others","C1955473;C3539125",NULL,NULL,741
"lower target group n $nmbr$","C0441848;C0441994;C1521840;C1548802;C2003888;C2986546",NULL,NULL,735
"history of chd","C0019664;C0019665;C0262512;C0262926;C0280604;C1705255;C2004062;C3542407",NULL,NULL,970
"drinker","C0556338",NULL,NULL,176
"education","C0013621;C0013622;C0013658;C0039401","C0013658","",902
"apo b apo a l","C0003592;C0523508;C1447574;C4521365;C4553344","C0003592","",427
"age years geographic region","C0017446;C1510829","C1510829","",481
"dbp $nmbr$ or sbp $nmbr$ mm hg laboratory determinations","C0022877;C0085805;C0439475;C0536221;C0680730;C3244292;C3813197;C4281799;C4283904",NULL,NULL,978
"baseline sitosterol cholesterol","C0008377;C0037215;C0168634;C0220914;C1442488",NULL,NULL,625
"severity ofhypertension n b","C0439793;C0522510",NULL,NULL,561
"years since diagnosis of type $nmbr$ diabetes n","C0011847;C0011849;C0011900;C0439234;C1320657;C1550351;C1704338;C1704656","C0011849;C1320657","",907
"osteoporosis drug","C0013227;C0029456;C1254351;C4554622",NULL,NULL,564
"mayo score mean sd","C0444504;C0449820;C0454788;C1077578;C2347634;C2348143;C2699239;C4050231",NULL,NULL,425
"adjusted $nmbr$ risk reduction losartan vs placebo $nmbr$ cl","C0032042;C0126174;C0456081;C0596019;C1137094;C1696465;C1706408","C0126174","",1207
"ics users at baseline","C0168634;C0815320;C1442488;C1706077;C4551720","C3540778","",2182
"type of concomitant statin","C0332307;C0360714;C0521115;C1547052","C0360714","",872
"bone erosion judged by physician n","C0031831;C0221191;C0587240;C0804815",NULL,NULL,1520
"atrial fibrillation atrial flutter","C0155709",";C0004238","",1009
"diabetes related medication use n","C0011847;C0011849;C0240320;C0439849;C0445223","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"stroke and tia n","C0007787;C0038454;C0917805;C1054154;C4554100",NULL,NULL,1762
"odds ratio","C0028873","C0028873","",1078
"treatment with sulphonylurea n","C0038766;C0039798;C0087111;C1522326;C1533734;C1705169;C3536898;C3538994;C3887704","C0038766","",752
"postbronchodilator $nmbr$ $nmbr$ $nmbr$ $nmbr$","C2599594",NULL,NULL,680
"low density lipoprotein","C0023823","C0023823","",1932
"stroke of any etiology","C0015127;C0038454;C1314792;C1524003;C4554100",NULL,NULL,1762
"basal insulin dose at run in u day","C0178602;C0205112;C0366513;C0456683;C0650607;C0869039;C1114758;C3274438","C0650607","",354
"atherosclerotic cvd","C0007222;C0333482","C0004153","",1698
"subset of patients not on metformin","C0025598;C0030705;C1515021;C1518422",NULL,NULL,1657
"long term aspirin","C0004057;C0443252","C0004057","",1366
"posterior circulation","C0005775;C0205095;C1516559",NULL,NULL,1245
"nice primary prevention onlyb","C0033144;C4087029",NULL,NULL,1715
"emphysema n $nmbr$","C0013990;C0034067",NULL,NULL,1672
"hazard ratio $nmbr$ ci $nmbr$ with vs without psoriasis","C0008107;C0033860;C2985465;C3259781",NULL,NULL,519
"knee","C0022742;C0022745;C1963703","C0022742","",1080
"low dose rivaroxaban plus aspirin n $nmbr$","C0332287;C1739768;C2608320","C1739768","",1225
"triple vessel disease n","C0856738",NULL,NULL,746
"$nmbr$ baricitinib $nmbr$ mg baricitinib $nmbr$ mg","C1319635;C4044947","C4044947","",1956
"exacerbations in previous year requiring hospitalization and or ed visit n","C0019993;C0205156;C0439234;C0439508;C0545082;C1512346;C1552607;C2826704;C3538926;C4086268","C4086268","",1991
"micro macroaibuminuria","C0085672;C1553035;C3811161;C4049106","C0033687","",376
"elective peripheral revascularization","C0205100;C0206058;C0439608;C0581603","C0581603;C0206058;C0205100","",2064
"triglycerides mmol l median iqr","C0041004;C0549183;C0876920;C1532563;C2347635;C2348144;C2939193","C0041004","",368
"patients ft","C0030705;C1881534;C3890579",NULL,NULL,248
"history presence of tophi","C0019664;C0019665;C0150312;C0221248;C0262512;C0262926;C0392148;C1705255;C2004062;C3854307",NULL,NULL,2369
"week $nmbr$ czp $nmbr$ mg q $nmbr$ w n $nmbr$","C0024671;C0026410;C0054841;C0332174;C0439230;C0439269;C1861828;C1872109;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"investigator reported hypoglycaemia","C0020615;C0035173;C0684224;C0700287;C4319718;C4553659","C0020615","",35
"baseline ics use yes","C0042153;C0168634;C0457083;C0815320;C1442488;C1549445;C1705108;C1710701;C1947944;C4551720",NULL,NULL,147
"history ol mi or stroke","C0019664;C0019665;C0038454;C0262512;C0262926;C1705255;C2004062;C3810814;C4554100",NULL,NULL,832
"$nmbr$ mo to $nmbr$ yr","C0026544;C0332177;C0439234",NULL,NULL,1099
"indication for pci","C0392360;C3146298;C4049621",NULL,NULL,1713
"cerebral vascular disease","C0007820",NULL,NULL,728
"egfr $nmbr$ $nmbr$ vs egfr $nmbr$","C1739039;C3811844;C3812682","C3811844;C0017654","",592
"critical site","C0205145;C1511545;C1515974;C2825164",NULL,NULL,1193
"asian black white hispanic other clinical parameters","C0005680;C0007457;C0027567;C0043157;C0078988;C0085756;C0205210;C0220938;C0439541;C0449381;C1533017;C1533018;C1533020;C1533021","C0043157","",1402
"total study population","C0439175;C0439810;C0557651;C2348561;C2603343;C3258257",NULL,NULL,510
"included in this study n $nmbr$","C0332257;C0557651;C2603343",NULL,NULL,1730
"mean $nmbr$ h sbp","C0033727;C0085805;C0369286;C0441932;C0444504;C0564385;C2347634;C2348143;C4528284",NULL,NULL,37
"vorapaxar n $nmbr$ n","C2974521","C2974521","",1448
"systemic glucocorticoid use at randomisation","C0017710;C0034656;C0042153;C0205373;C0457083;C1947944","C0017710","",1348
"i $nmbr$ i $nmbr$ $nmbr$","C0021966;C0221138",NULL,NULL,1021
"ischemic coronary artery disease","C0852149",NULL,NULL,786
"left","C0205091;C0443246;C1552822",NULL,NULL,42
"proportions n","C1709707",NULL,NULL,1047
"duration yr","C0439234;C0449238;C2926735",NULL,NULL,1099
"fevi $nmbr$ l","C0429706;C0849974;C1561566;C4528367",NULL,NULL,1601
"prior congestive heart failure yes","C0018802;C0332152;C1549445;C1705108;C1710701;C2826257",NULL,NULL,769
"general andthoracic epidural","C0205246;C0228134;C0812144;C3812897;C3891294;C4521767",NULL,NULL,1085
"weekly size of largest hives score","C0042109;C0332174;C0443228;C0449820;C0456389;C4050231",NULL,NULL,2058
"change from baseline in pre bd","C0005126;C0168634;C0332152;C0392747;C0443172;C0740175;C1442488;C1705241;C2257086;C2344255;C3669034;C4050145;C4319952",NULL,NULL,625
"stage $nmbr$ $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$","C0439445;C0456533","C3811844;C0017654","",592
"itch nrs $nmbr$ $nmbr$ \ $nmbr$","C0033774;C1422257;C2240043;C4050142","C0033774;C4050142","",1362
"randomization to end of study","C0034656;C0040363;C0041260;C0444930;C0557651;C1883351;C2603343;C2746065",NULL,NULL,431
"all randomized women","C0034656;C0043210;C3815594",NULL,NULL,692
"region latin america","C0017446;C0023122;C0205147","C0017446","",369
"pre bronchodilator mean sd fev $nmbr$ l","C0444504;C2347634;C2348143;C2599602;C2699239;C3714541",NULL,NULL,1599
"use of verapamil or quinidine","C0034414;C0042523;C1524063","C0042523","",1450
"dyspnea frequent continuous","C0013404;C0332183;C0549178;C1963100","C0013404","",1227
"age years $nmbr$ $nmbr$","C1510829","C1510829","",481
"llraglutide $nmbr$ $nmbr$ mg mean n","C0024671;C0026410;C0439269;C0444504;C1960952;C2346927;C2347634;C2348143;C4321396;C4521761","C1456408","",1566
"years of education mean sd","C0013621;C0013622;C0013658;C0039401;C0439234;C0444504;C2347634;C2348143;C2699239",NULL,NULL,1099
"white race no f","C0007457;C0016327;C0034510;C0043157;C0220938;C1706779;C3853635","C0043157","",1402
"endpoint baselinec","C2349179;C2826544",NULL,NULL,627
"apasp per mmhg","C0439475",NULL,NULL,1889
"egfr category ml min $nmbr$ $nmbr$ m $nmbr$ n","C0369637;C0439445;C0441923;C0683312;C1739039;C3811844;C3812682;C3889287","C3811844;C0017654","",592
"total no of events participants","C0439175;C0439810;C0441471;C0679646;C3541888",NULL,NULL,1033
"physical component score pcs","C0449432;C1705248;C1864389;C1882368;C4483112",NULL,NULL,749
"one or more blood pressure medications n","C0005823;C0013227;C0033095;C0205172;C0205447;C0460139;C0802604;C0849164;C1271104;C1272641;C1306345;C2598133;C4284008;C4284232",NULL,NULL,1539
"monoamine oxidase b inhibitors","C2917290;C3653412",NULL,NULL,814
"east europe","C0015176;C1707877","C0015176","",337
"fa $nmbr$ mg $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"medication at enrollment no","C0013227;C1516879;C1696073;C3244316;C3888021;C4284232",NULL,NULL,339
"previous cv event","C0205156;C0441471;C1552607;C3538987;C4019010;C4048877;C4318503",NULL,NULL,1777
"sustain $nmbr$ semaglutide vs iglar","C0443318;C2732140;C3885068",NULL,NULL,1031
"$nmbr$ n z $nmbr$","C0369718;C0441922",NULL,NULL,1553
"hba $nmbr$ c mmol mol mean sd","C0019016;C0444504;C1825777;C2347634;C2348143;C2699239;C3538758;C3829066","","",820
"established disease","C0012634;C0443211;C1272684","C0443211","",179
"all cause hospitalization","C0015127;C0019993;C1524003",NULL,NULL,924
"symptom onset to randomization","C0034656;C4086878",NULL,NULL,692
"cs only","C0010182;C0205171;C0271160;C1720467;C3540510;C4085345",NULL,NULL,136
"calculated ldl c in $nmbr$ classes","C0444686;C0456387;C1441506;C1518526;C1705943;C4019422",NULL,NULL,452
"mean sd mtx dose mg week","C0024671;C0026410;C0332174;C0366550;C0439230;C0439269;C0444504;C1960952;C2346927;C2347634;C2348143;C2699239;C4321396;C4521761",NULL,NULL,192
"elderly patients n $nmbr$","C0870602",NULL,NULL,1489
"ra ndosii zat ion","C0022023;C1700702;C3538806;C4048756",NULL,NULL,253
"body mass index $nmbr$ kg m n","C0005893;C0578022;C1305855;C1532718","C1305855","",1734
"elevated natriuretic peptides in previous $nmbr$ days no $","C0205156;C0205250;C0439228;C1144709;C1552607;C3163633",NULL,NULL,1621
"heterozygous familial hypercholesterolemia","C0342882","C0342882","",1391
"atients with event","C0441471;C4019010",NULL,NULL,412
"concomitant statin use","C0042153;C0360714;C0457083;C0521115;C1947944","C0360714","",872
"cluster $nmbr$ reversible no diuretic n $nmbr$","C0012798;C0205343;C1555715;C1704332",NULL,NULL,992
"fvc predicted t","C0681842;C1882327;C2603360;C3714541",NULL,NULL,1599
"neither glucocorticoids nor immunosuppressive agents","C0017710;C0021081;C3540777;C3540778","C0021081","",1424
"hope patients with coronary artery disease n $nmbr$","C0010054;C0010068;C0030705;C0392347;C1956346","C0010068;C1956346",";C0026410;C1710701",226
"$nmbr$ s f $nmbr$","C0016327;C0565930;C2603362",NULL,NULL,1784
"median serum periostin ng ml t","C0219433;C0229671;C0439275;C0549183;C0876920;C1424662;C1546774;C1550100;C2347635;C2348144;C2939193;C3812270",NULL,NULL,951
"st arc definite only","C0036056;C0205171;C0439544;C1704787;C1720467;C3272372",NULL,NULL,246
"subcutaneous n $nmbr$","C0443315",NULL,NULL,1662
"prior percutaneous coronary intervention no total no","C0332152;C0439175;C0439810;C1532338;C2826257","C1532338","",1661
"eastern eu","C0015179;C1707877;C3665627",NULL,NULL,533
"hba $nmbr$ c at week $nmbr$","C0019016;C0332174;C0439230;C1825777;C3538758","","",820
"environmental stimuli","C0450025","","",-10
"itch nrs","C0033774;C1422257;C2240043;C4050142","C0033774;C4050142","",1362
"selena sledai activity n","C0205177;C0439167;C0441655;C0451528;C1561536;C3668946;C4049938;C4049939",NULL,NULL,494
"mycophenolate mofetil","C0209368","C0209368","",304
"all n $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0369718;C0441922",NULL,NULL,396
"p all vs all","C0369773;C2603361",NULL,NULL,135
"prior hypertensiona yes","C0332152;C1549445;C1705108;C1710701;C2826257",NULL,NULL,147
"saba puffs per day at baseline","C0168634;C0332173;C0439228;C0439505;C1442488;C1533107",NULL,NULL,1621
"$nmbr$ y incidence rate se per $nmbr$ participants","C0036919;C0679646;C1708485","C1708485","",1106
"in emergency department before ambulance transfer","C0002422;C0040671;C0562508;C1705822;C3846685;C4319192","C0002422",";C4049621",191
"work and school","C0036375;C0043227",NULL,NULL,514
"postbaseline new onset diabetes n","C0011847;C0011849;C0746890","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"medical history no","C0262926;C1704706",NULL,NULL,832
"$nmbr$ $nmbr$ drinks wk","C0332174;C0439230;C0452428",NULL,NULL,178
"or death","C0011065;C1306577;C4082313;C4552775",NULL,NULL,323
"aspirin use at randomization n","C0004057;C0034656;C0042153;C0457083;C1947944","C0004057","",1366
"hba $nmbr$ c in patients with baseline hba $nmbr$ c $nmbr$ $nmbr$ mmol l mmol mol la n baseline sd adjusted mean change $nmbr$ ci placebo subtracted change se","C0008107;C0019016;C0023031;C0023749;C0027960;C0030705;C0032042;C0036919;C0168634;C0230347;C0324740;C0392747;C0439189;C0443172;C0444504;C0456081;C1442488;C1456781;C1696465;C1705241;C1706408;C1719767;C1824986;C1825777;C1960955;C2346906;C2347634;C2348143;C2348589;C2699239;C3259781;C3538758;C3665593;C4319952;C4553351","","",820
"body mass index group kg m $nmbr$ $nmbr$ kg m $nmbr$ no","C0005893;C0022718;C0439209;C0441833;C0578022;C0687744;C1257890;C1305855;C1519504;C1705428;C1705429;C1709500;C4054209","C1305855","",1734
"laboratory parameters median iqr","C0022877;C0449381;C0549183;C0876920;C2347635;C2348144;C2939193;C3244292;C4283904",NULL,NULL,635
"omalizumab $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C0966225;C1960952;C2346927;C4321396;C4521761","C0966225","",940
"no p value for ischemia ischemia hr $nmbr$ ci interaction","C0008107;C0022116;C1704675;C1709380;C3259781;C4321499",NULL,NULL,1668
"patients treated","C0030705;C1522326",NULL,NULL,552
"thyroid hormone","C0040135;C4522017","","",-10
"killip class ii","C2697845","C1881332","",846
"dihydropyridine","C0012315;C0220821","","",1229
"blood eosinophils mean range cells ml","C0014467;C0444504;C1514721;C2347634;C2348143;C2348147;C2699156;C3542016",NULL,NULL,37
"all patients with fistulas n $nmbr$","C0016169;C0030705",NULL,NULL,1035
"not rando in na","C0597484;C1272460;C1518422;C1546968;C1879645;C4049872;C4552882",NULL,NULL,419
"characteristic at baseline","C0168634;C1442488;C1521970","C1521970","",1110
"treated with cabg no total no","C0010055;C0332293;C0439175;C0439810","C0010055","",389
"iii and iv","C0022326;C0439070;C1705160;C4265176",NULL,NULL,1257
"t wave inversion","C0520888","C0520888","",1981
"colon ses cd score mean sd","C0007928;C0009368;C0034283;C0444504;C0449820;C2347634;C2348143;C2699239;C3888384;C4050231;C4552032",NULL,NULL,37
"history of pci or cabg before index event","C0010055;C0019664;C0019665;C0262512;C0262926;C0441471;C0600653;C0918012;C1552854;C1637833;C1705255;C2004062;C2986546;C4019010;C4049621",NULL,NULL,412
"patients with diabetes mellitus n $nmbr$","C0011849;C0030705","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"laba inhaled glucocorticoid use at screening","C0004048;C0017710;C0042153;C0220908;C0220909;C0457083;C1698960;C1710031;C1710032;C1710477;C1947944;C2348164","C3540778","",2182
"ipf related","C0034069;C0439849;C0445223;C1800706",NULL,NULL,319
"black or african america","C0005680;C0027567;C0085756;C0439541","C0005680",";C1706779",188
"ace inhibitor or arb use","C0003015;C0042153;C0457083;C1947944;C3888198;C4541021","C0003015","",811
"prior use of biologics n","C0005515;C0005522;C0332152;C1524063;C2826257;C4553887",NULL,NULL,214
"no prior ml or stroke","C0038454;C0332152;C0439526;C1705224;C2826257;C3887665;C4554100",NULL,NULL,300
"age years mean sd","C0444504;C1510829;C2347634;C2348143;C2699239",NULL,NULL,1907
"niacin","C0027996;C1142562","C0027996","",871
"insulin tu ml","C0021641;C0041400;C0439526;C1532464;C1533581;C1579433;C1705224;C2700314;C3714501;C3811255;C3887665",NULL,NULL,157
"elevated troponin","C0041199;C0205250;C3163633",NULL,NULL,1605
"steroid free cr $nmbr$","C0038317;C0201975;C0332296;C1880497;C1996904;C3539604;C3711669;C4084730;C4553336;C4553337",NULL,NULL,700
"three or more lesions","C0205172;C0205449;C0221198;C1546698",NULL,NULL,472
"mean sd egfr ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C0444504;C1739039;C2347634;C2348143;C2699239;C3811844;C3812682","C3811844;C0017654","",592
"all subjects","C0681850;C1550501;C1706203;C2349001;C2697811",NULL,NULL,1655
"low density lipoprotein mg dl","C0023823;C0439269","C0023823","",1932
"hypotension n","C0020649;C3163620","C0020649","",1048
"characteristic a","C1521970","C1521970","",1110
"s s $nmbr$","C0565930;C2603362",NULL,NULL,1784
"median fasting insulin iqr pu per milliliter","C0015663;C0018387;C0021641;C0439242;C0549183;C0876920;C1533581;C1579433;C2347635;C2348144;C2939193;C3714501",NULL,NULL,157
"$nmbr$ vessels with $nmbr$ stenosis","C0679403",NULL,NULL,745
"hf symptomatic improvement","C0018488;C0231220;C1313497;C1538440;C2986411;C3273279","C0018801",";C0168634;C1524003",12
"p value overall","C0282416;C1561607;C1709380",NULL,NULL,7
"ccb","C0006684",NULL,NULL,704
"country","C0454664;C1511538",NULL,NULL,1560
"immunosuppressive agents only","C0021081;C0205171;C1720467","C0021081","",1424
"persistent","C0205322;C0332996",NULL,NULL,719
"sensitive responder n $nmbr$","C0020517;C0332324;C1522640","C0332324","",1164
"current use of an ace inhibitor","C0003015;C0521116;C1524063;C1705970;C4541021","C0003015","",811
"parental history of myocardial infarction before age $nmbr$ y yes","C0001779;C0030551;C1275835;C1549445;C1705108;C1710701",NULL,NULL,641
"pulse rate bpm mean $nmbr$ h mean sd","C0033727;C0232117;C0369286;C0441932;C0444504;C0564385;C2347634;C2348143;C2699239;C4528284","C0018810","",1105
"coronary revascularization $nmbr$ days after randomization","C0034656;C0439228;C0877341",NULL,NULL,692
"$nmbr$ ell ll","C1427925;C3273466",NULL,NULL,664
"pci hospital","C0019994;C1510665;C4049621","C1532338","",1661
"prior dm","C0011816;C0332152;C2826257;C3250443",NULL,NULL,955
"fibrinogen pmol l c","C0016006;C0439284;C1167394;C2587184;C3540039","C0016006","",1142
"duration dm in dm years","C0011816;C0439234;C0449238;C2926735;C3250443","C2926735;C0011849","",1988
"severe impairment egfr $nmbr$ ml min m","C0205082;C0221099;C0369637;C0439445;C0441923;C0684336;C1739039;C3811844;C3812682;C4050465;C4050466",NULL,NULL,313
"left ventricular systolic or diastolic dysfunction","C0039155;C0225897;C0520863",NULL,NULL,40
"acute rheumatic disorders","C0001314",NULL,NULL,1950
"psa subtypes n","C0449560;C3810537;C3813209",NULL,NULL,125
"fp $nmbr$ mg","C0016704;C0024671;C0026410;C0439269;C1419068;C1419906;C1960952;C2346927;C3541238;C3541412;C4321396;C4521761",NULL,NULL,1820
"age interaction","C0001779;C1704675","C0001779","",480
"ldl mmol l","C1532563","C0023824","",1068
"events patient year n","C0030705;C0439234;C0439508;C0441471;C3541888",NULL,NULL,412
"ethnicity no","C0015031;C0243103",NULL,NULL,787
"fatal nonfatal stroke n","C0038454;C1302234;C1705232;C4554100",NULL,NULL,507
"mean se auc $nmbr$ $nmbr$ l","C0036919;C0376690;C0444504;C2347634;C2348143",NULL,NULL,567
"bmi $nmbr$ $nmbr$ kg m $nmbr$","C0578022;C1532718",NULL,NULL,1735
"verapamil sr","C1527129","C0042523","",1450
"initial type of heparin treatment received","C0019134;C0205265;C0455708;C0770546;C1279901;C1514756;C1555582;C1705685",NULL,NULL,604
"left atrial diameter $nmbr$ mm n $nmbr$","C0225860;C0225861;C1301886;C4330985;C4554674","C0225860","",1196
"blood pressure mm hg","C0005823;C0439475;C1271104;C1272641","C0005823","",15
"months since ra was first diagnosed mean sd","C0011900;C0205435;C0439231;C0444504;C1279901;C2347634;C2348143;C2699239;C3538806;C4048756",NULL,NULL,1755
"austrafca and new zealand","C0027978;C0324547","C0027978",";C0324547",189
"absolute time spent on without troublesome dyskinesia h day","C0013384;C0033727;C0332173;C0369286;C0439228;C0439505;C0439546;C0441932;C0564385;C0680968;C4528284","C0013384","",1131
"acute stroke of other determined cause","C0015127;C0521095;C0751956;C1524003",NULL,NULL,924
"$nmbr$ nd tertile $nmbr$ to $nmbr$ mg dl $nmbr$ $nmbr$ to $nmbr$ $nmbr$ mmol l c","C0439269;C1532563",NULL,NULL,670
"health related quality of life","C4279947","C4279947","",1799
"hba $nmbr$ c $nmbr$ $nmbr$ without gi adverse reactions","C0019016;C0559546;C1708130;C1825777;C3538758;C3539617;C4050121","","",820
"or no microalbuminuria or macroalbuminuria","C0730345","C0033687","",376
"creatinine clearance at randomization ixrs","C0034656;C0812399","C0812399",";C3889287;C0452249;C0522467;C1337213;C1576800;C3890003;C0005910;C0022718;C1305866;C1705104;C1705224;C3887665",79
"$nmbr$ non mtx","C0025677;C1417487;C1518422","C0025677","",1408
"no of $nmbr$ mg acetaminophen tablets day","C0439422;C1243102","","",198
"coronary artery disease n $nmbr$ $nmbr$","C0010054;C0010068;C1956346","C0010068;C1956346",";C0026410;C1710701",226
"race n","C0034510;C1706779;C3853635",";C0034510","",1107
"$nmbr$ l l $nmbr$","C3539687","","",-10
"adverse outcome","C1274040",NULL,NULL,1602
"time since qualifying event","C0040223;C0441471;C1514624;C3541383;C4019010",NULL,NULL,412
"aspirin n","C0004057","C0004057","",1366
"non hdl cholesterol mmol l","C0729627;C1532563;C1535899","C0023822","",821
"chronic obstructive pulmonary disease no","C0024117",NULL,NULL,1726
"sitting diastolic blood pressure mm hg","C0439475;C1319894","C0005823","",1469
"lvef","C0428772;C0488728","C0018801;C0428772","",1273
"ejection fraction category","C0489482;C0683312;C2700378;C3889287","C2700378","",887
"gp iib iiia inhibitors","C0016011;C0243077",NULL,NULL,808
"gold b","C0018026;C1304897","C0024117;C0521117","",213
"bronchodilator response ml","C0006280;C0439526;C0871261;C1704632;C1705224;C1706817;C2911692;C3887665",NULL,NULL,726
"os domain","C0229090;C0230028;C0262950;C0393706;C1561953;C1880389;C1883221;C3541951",NULL,NULL,130
"combined macro micro","C0085672;C0205195;C1553035;C2984010;C3811161;C4049106",NULL,NULL,997
"methotrexate use at baseline","C0025677;C0042153;C0168634;C0457083;C1442488;C1947944",NULL,NULL,625
"skull and facial bone fractures","C0015455;C0016658;C0037303;C2951888",NULL,NULL,2028
"no high intensity statin","C0360714;C4081854","C0360714","",872
"moderate low","C0205081;C0205251;C1550472;C1881878;C3890211;C4048187;C4049705;C4049706;C4085643;C4321335;C4321351;C4522223",NULL,NULL,851
"total back pain $nmbr$ $nmbr$ mm vas mean sd","C0004600;C0042815;C0205095;C0439175;C0439810;C0444504;C0460009;C1995000;C2347634;C2348143;C2699239;C4330985;C4554674",NULL,NULL,297
"any blood pressure medications","C0005823;C0013227;C0033095;C0460139;C0802604;C0849164;C1271104;C1272641;C1306345;C2598133;C4284008;C4284232",";C0003364","",1579
"temporary factors","C0205374;C1521761;C1548539;C2827422;C3245481",NULL,NULL,1111
"prior coronary artery bypass surgery","C0010055;C0332152;C2826257","C0010055","",389
"patients assessed","C0030705;C1516048",NULL,NULL,1035
"fondaparinux","C1098510","C1098510","",859
"fibrinolysis primary pci n $nmbr$ n $nmbr$ no of patients total no","C0016017;C0030705;C0205225;C0439175;C0439612;C0439631;C0439810;C1305868;C4049621",NULL,NULL,2340
"week $nmbr$ n j","C0332174;C0439230",NULL,NULL,1012
"gpiib iiia inhibitors","C0016011;C0243077",NULL,NULL,808
"type of concomitant statin by daily dose no","C0332307;C0360714;C0521115;C1547052;C2348070","C0360714","",872
"dabigatran $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761",NULL,NULL,775
"glargine $nmbr$","C0907402","C0907402",";C1998602;C0004446;C0005126;C2344255;C4050145;C0229089;C0439164;C1512019;C3273373;C3665488",69
"class iv glomerulonephritis","C0017658;C0441888;C2698970",NULL,NULL,2103
"myalgia","C0231528;C4552646",NULL,NULL,59
"on sulfonylurea","C0038766;C3536898","C0038766","",752
"white tcz mtx n","C0007457;C0025677;C0043157;C0220938;C1417487",NULL,NULL,84
"systolic bp mmhg sd","C0439475;C0871470;C2699239","C0005823","",1469
"hdl cholesterol $nmbr$ men or $nmbr$ mg dl women","C0023822;C0025266;C0043210;C0392885;C0439269","","",-10
"betablocker use","C0001645;C0042153;C0457083;C1947944","C0001645","",959
"caleitonin ng l males mean sd","C0086582;C0439297;C0444504;C2347634;C2348143;C2699239",NULL,NULL,2109
"global assessment of disease status score","C0281858;C0449820;C3176928;C4050231",NULL,NULL,98
"score on nih stroke scale median iqr","C0449820;C0549183;C0876920;C1697238;C2347635;C2348144;C2939193;C3484372;C4050231",NULL,NULL,635
"ics laba subset","C0815320;C1515021;C4551720",NULL,NULL,2193
"apolipoprotein e carrier","C0003595;C0007294;C0560175;C1325398;C1706209;C3273162",NULL,NULL,784
"h $nmbr$ blocker n long term vka therapy","C0033727;C0039798;C0087111;C0369286;C0441932;C0443252;C0564385;C1363945;C4528284",NULL,NULL,236
"estimated glomerular filtration rate ml min median iqr","C0439445;C0549183;C0876920;C2347635;C2348144;C2939193;C3811844","C3811844;C0017654","",592
"less than high school","C0439092;C0599395;C0683862;C0870649","C0870649","",838
"$nmbr$ year predicted risk of","C0035647;C0439234;C0439508;C0681842;C1882327;C4552904",NULL,NULL,1099
"atenolol use at $nmbr$ month","C0004147;C0042153;C0332177;C0439231;C0457083;C1947944",NULL,NULL,1476
"any overt bleed","C0019080",NULL,NULL,707
"at any time","C0040223;C3541383",NULL,NULL,757
"abbreviations ace angiotensin converting enzyme iqr interquartile range ml myocardial infarction si conversion to convert creatinine clearance to ml s multiply by $nmbr$ $nmbr$ data are expressed as no total unless otherwise specified festimated using cockroft gault equation tthe timi risk score was used to categorize patients at low $nmbr$ $nmbr$ intermediate $nmbr$ $nmbr$ and high $nmbr$ $nmbr$ risk $nmbr$","C0000723;C0021308;C0022709;C0027061;C0030705;C0035647;C0040363;C0041260;C0205103;C0205250;C0205251;C0205369;C0439175;C0439390;C0439526;C0439810;C0439836;C0449820;C0552449;C0812399;C0871968;C1273517;C1299351;C1511726;C1514721;C1522564;C1524063;C1550465;C1550472;C1705224;C1719797;C1883351;C2348147;C2700149;C2827755;C2911648;C3245479;C3542016;C3714741;C3887512;C3887665;C3889660;C3889971;C3890211;C4048187;C4050231;C4321237;C4321351;C4522209;C4522223;C4552904",NULL,NULL,748
"acr $nmbr$","C1412134;C1515941",NULL,NULL,52
"previous dmards mean sd","C0205156;C0242708;C0444504;C1552607;C2347634;C2348143;C2699239",NULL,NULL,37
"incidence rate","C1708485","C1708485","",1106
"patients randomized no","C0030705;C0034656;C3815594",NULL,NULL,692
"olmesartan along with diuretic n $nmbr$","C0012798;C1098320","C1098320","",2087
"age when diabetes first diagnosed years mean sd","C0001779;C0011847;C0011849;C0011900;C0205435;C0439234;C0444504;C1279901;C2347634;C2348143;C2699239",NULL,NULL,1907
"any oral hypoglycemic drug no","C0359086","C0020616",";C0013227;C3244316;C4284232;C0450442;C1254351;C1515187;C1521826;C2826257",33
"asa use at baseline n","C0004057;C0042153;C0168634;C0457083;C1442488;C1947944;C3853627",NULL,NULL,60
"overall ctd","C0282416;C1335071;C1442905;C1561607",NULL,NULL,1743
"prior tnf antagonist treatment no","C0231491;C1448177;C1514463",NULL,NULL,574
"former","C0205156;C0750523",NULL,NULL,13
"group d high risk more symptoms n","C0332167;C0441848;C0683368;C1457887;C3272283;C4050568;C4319571","C4319571","",837
"nitrate no","C0028125;C0699857;C3848573",NULL,NULL,537
"coronar y artery disease","C0852949",NULL,NULL,786
"rs chest symptomsd","C0035970;C0817096;C1527391;C3714753;C3813325","","",-10
"sexually active","C0241028",NULL,NULL,497
"eosinophil count cells microlitre","C0200638;C0439378;C0750879",NULL,NULL,662
"visit $nmbr$ dbp mm hg","C0439475;C0536221;C0545082;C1512346;C2826704;C3813197;C4281799",NULL,NULL,605
"mean sd on loge scale u ml","C0175659;C0349674;C0439340;C0444504;C1880521;C1947916;C2347634;C2348143;C2697934;C2699239;C2945590",NULL,NULL,37
"randomized to receive beta carotene","C0034656;C0040363;C0041260;C0053396;C0696105;C1514756;C1883351;C3815594","C0053396","",2233
"fdc $nmbr$ $nmbr$ g n $nmbr$","C0340427;C0439267;C1413520;C3539652",NULL,NULL,1077
"mostly dissatisfied","C0205393;C0750554;C0870433;C4085546",NULL,NULL,2354
"non trial antiplatelet","C0008976;C1518422","","",1191
"hba $nmbr$ c distribution at baseline","C0019016;C0168634;C0520511;C1442488;C1704711;C1825777;C3538758","","",820
"no infarct visible","C0021308;C0205379","C0021308","",1288
"men n $nmbr$ vs $nmbr$","C0025266",NULL,NULL,1842
"data are mean sd or n ace angiotensin converting enzyme arb angiotensin receptor blocker chf congestive heart failure any use in $nmbr$ h before surgery except for aspirin which only required any use in the $nmbr$ days before surgery","C0004057;C0018802;C0022709;C0033727;C0034787;C0038894;C0038895;C0042153;C0205171;C0369286;C0369718;C0439228;C0441922;C0441932;C0444504;C0457083;C0543467;C0564385;C1274039;C1511726;C1514873;C1622222;C1720467;C1947944;C2347634;C2348143;C2699239;C3245479;C3714741;C3888198;C4528284","","",-10
"net adverse clinical events at day $nmbr$","C0205210;C0332173;C0439228;C0439505;C0877248;C1456447;C1705413;C3853572;C3887809;C3890893","C0877248","",47
"pre bronchodilator","C2599602",NULL,NULL,682
"no family history of chd n $nmbr$ $nmbr$","C0241889;C0280604;C3542407","C0241889","",1493
"stenosis as assessed by core laboratory","C0022877;C0444669;C0678234;C1167518;C1261287;C1516048;C1706352;C1882467;C2632116;C3244292;C3274653;C4283904",NULL,NULL,1548
"mean sd swollen joint count","C0444504;C0451521;C2347634;C2348143;C2699239",";C0451521","",1140
"total bleeds","C0232100",NULL,NULL,1685
"number of co aeds n","C0180309;C0237753;C0449788;C3245499",NULL,NULL,1557
"adjusted mean change kg","C0022718;C0392747;C0439209;C0443172;C0444504;C0456081;C1705241;C2347634;C2348143;C4054209;C4319952",NULL,NULL,2326
"bmi kg m $nmbr$ a","C0578022;C1532718",NULL,NULL,1735
"age y gender n","C0001779;C0079399;C1522384","C0001779","",480
"ace inhibitors and arb","C0003015;C3888198",NULL,NULL,44
"group a","C0441835;C4522145",NULL,NULL,1640
"class ib","C0456387;C1518526;C1705943;C2744579;C3890035;C4283819",NULL,NULL,1398
"dlqi improvement from baseline to week $nmbr$","C0168634;C0332174;C0439230;C1442488;C2986411;C3899393",NULL,NULL,527
"bw at $nmbr$ weeks kg","C0005910;C0006041;C0022718;C0439209;C0439230;C2986891;C4054209",NULL,NULL,2326
"tiotropium n z $nmbr$","C0213771","C0213771","",1372
"placebo $nmbr$ year km","C0032042;C0439234;C0439508;C1696465;C1706408;C3887676","C0032042","",28
"diabetes p $nmbr$","C0011847;C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"deviation mm","C0012727;C0205419;C1705236;C4330985;C4554674",NULL,NULL,297
"ihd","C0151744","C0010054;C0151744","",1361
"apo b apo a l ratio mean","C0003592;C0444504;C0456603;C0523508;C1447574;C1547037;C2347634;C2348143;C4521365;C4553344","C0003592","",427
"primary indication","C1549995","C2986535","",230
"no ascvd","C3665365",NULL,NULL,344
"diabetes classificationa","C0011847;C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"baseline hdl c mg dl","C0168634;C0439269;C1442488;C3715113",NULL,NULL,2001
"men qvai $nmbr$ sfc","C0025266;C4521536",NULL,NULL,1283
"uric acid fertile $nmbr$ $nmbr$ $nmbr$ mg dl","C0015895;C0041980;C0439269",NULL,NULL,2310
"mean pga score sd","C0016410;C2699239;C3533236;C3541266;C4050369",NULL,NULL,1525
"no mi n $nmbr$ $nmbr$","C3810814",NULL,NULL,516
"crp mg dl mean sd","C0439269;C0444504;C2347634;C2348143;C2699239;C3890735;C4048285","C0006560","",286
"morphometric vertebral","C0200760;C0549207",NULL,NULL,928
"i $nmbr$ $nmbr$ ii","C0021966;C0221138;C1710602;C4082587",NULL,NULL,523
"bmi kg m $nmbr$","C0578022;C1532718",";C1305855","",206
"psoriatic arthropathy","C0003872","","",2176
"ics laba free or fdc","C0332296;C0340427;C0815320;C1413520;C1880497;C1996904;C3539652;C4551720",NULL,NULL,1650
"duration of t $nmbr$ dm y","C0011816;C0449238;C2926735;C3250443",NULL,NULL,901
"history of atherosclerotic vascular disease no","C0005847;C0333482;C0683519;C0730226;C0850708;C0944983;C1558950;C1801960","C0004153","",1698
"$nmbr$ $nmbr$ months","C0439231",NULL,NULL,1530
"net clinical benefit","C1456447;C3853572;C3887809;C3890893;C4684590",NULL,NULL,1081
"sbp difference","C0085805;C1705241;C1705242",NULL,NULL,1466
"previous diagnosis","C0332132",NULL,NULL,1045
"medication use at entry","C0240320;C1705654",NULL,NULL,119
"usa n $nmbr$","C0041703",NULL,NULL,1550
"physical activity kcal wk $nmbr$","C0015259;C0026606;C0332174;C0439230;C0439259","C0015259","",1380
"pretreatment triglycerides","C0041004;C1550147;C2709094;C3539075;C3539076","C0041004","",368
"mean s e","C0444504;C2347634;C2348143",NULL,NULL,37
"probenecid","C0033209","","",-10
"gastroduodenal","C0450199","C0450199","",341
"fvc post bronchodilator","C2599594;C3714541",NULL,NULL,680
"ischemic cerebrovascular disease n","C0007820;C0475224",NULL,NULL,728
"heart rate min","C0018810;C0702093;C1524029;C3813700","C0018810","",1105
"ldl cz","C0206578",NULL,NULL,1407
"ctn i ng ml","C0021966;C0221138;C0439275;C0917591",NULL,NULL,204
"total psa modified shs","C0392747;C2986589;C3889737",NULL,NULL,767
"additional antihypertensive subgroup","C0003364;C1079230;C1515021;C1524062",";C0003364","",1579
"duration of as n","C0369718;C0441922;C0449238;C2926735",NULL,NULL,1553
"fev $nmbr$ l","C3714541",NULL,NULL,1599
"ischemic aetiology","C0015127;C0475224;C1314792;C1524003",NULL,NULL,924
"ipf","C0034069;C1800706",";C1800706","",1254
"remission in overall population","C0032659;C0282416;C0544452;C0687702;C1257890;C1561607",NULL,NULL,1712
"lv hypertrophy n","C0149721","C0149721","",1496
"other risk factors","C0035648;C1553898",NULL,NULL,175
"$nmbr$ vitamin e","C0042874;C3714803","C0042874","",869
"kim $nmbr$ pg ml","C0439297",NULL,NULL,202
"fbg baseline","C0168634;C1442488",NULL,NULL,625
"ocs dose mean sd","C0178602;C0444504;C0869039;C1114758;C2347634;C2348143;C2699239",NULL,NULL,37
"adjusted or $nmbr$ ci p value","C0008107;C0456081;C1709380;C3259781",NULL,NULL,519
"oral hypoglycemic agentsj","C0359086","C0359086","",1744
"pre fev $nmbr$ pred","C0032952;C0044955;C0332152;C0740175;C2257086;C3669034;C3714541","C3714541","",296
"history of hypertension n","C0455527",NULL,NULL,1498
"ccbs","C0006684",NULL,NULL,704
"europe eu","C0015176;C0015179;C3665627","C0015176","",337
"uacr median iqr mg g","C0549183;C0876920;C1300563;C2347635;C2348144;C2939193",NULL,NULL,2315
"delayed reaction","C0205421;C0443286;C1545665;C3272602",NULL,NULL,317
"p value w","C1709380",NULL,NULL,7
"alpha $nmbr$ blockers","C0001641","C0001641","",961
"baseline data","C0168634;C1442488;C1511726;C3245479;C3714741",NULL,NULL,1427
"chads $nmbr$ score n","C0007928;C0369718;C0441922;C0449820;C1413373;C4050231","","",2128
"prevalent kidney disease egfr $nmbr$ ml min usm or maeroalbuminuria uacr $nmbr$ mg g","C0022658;C0033105;C0220900;C0439445;C1300563;C1739039;C3811844;C3812682",NULL,NULL,2315
"egfr median iqr ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C0549183;C0876920;C1739039;C2347635;C2348144;C2939193;C3811844;C3812682","C3811844;C0017654","",592
"p for trend","C0369773;C1521798;C2603361;C4554533",NULL,NULL,550
"crcl $nmbr$ $nmbr$ ml min","C0439445;C1846718","C3811844;C0017654","",307
"ga a","C0016993",NULL,NULL,1750
"angioedema present n","C0002994;C0150312;C0449450",NULL,NULL,2364
"efficacy n a","C1280519;C1707887","C1707887;C2349179","",1122
"age $nmbr$ years n $nmbr$","C1510829","C1510829","",481
"concomitant corticosteroid use n","C0239126;C0521115","C0239126",";C0168634;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1425988;C1947944",120
"black race n","C0005680",NULL,NULL,966
"femoral access","C0015811;C0444454;C1554204",NULL,NULL,512
"exact pro total score mean sd","C0033382;C0444504;C0523852;C2347634;C2348143;C2699239;C2828393;C2964552;C2987124;C4050514",NULL,NULL,1291
"ratet $nmbr$ cl","C0596019",NULL,NULL,974
"fp sal $nmbr$ $nmbr$ pg n $nmbr$","C0016704;C0030827;C0036140;C0037494;C0072225;C0206136;C1266240;C1419068;C1419906;C3541238;C3541412",NULL,NULL,853
"chronic sinusitis nasal polypsd n","C0028429;C0149516;C4520890",NULL,NULL,1838
"dose ratio at week $nmbr$ $nmbr$ cl","C0178602;C0332174;C0439230;C0456603;C0596019;C0869039;C1114758;C1547037",NULL,NULL,1012
"no ppi","C0358591;C0871125;C3811894",NULL,NULL,438
"sex male n $nmbr$","C0086582","C0086582","",1276
"total no of patients","C0030705;C0439175;C0439810",NULL,NULL,508
"pci $nmbr$ month ago","C0332177;C0439231;C4049621",NULL,NULL,1476
"beta blocker users","C0001645;C1706077","C0001645","",959
"qrs $nmbr$ ms $nmbr$ cl n $nmbr$ $nmbr$","C0596019;C2349943;C3539704;C3713294",NULL,NULL,126
"common study baseline","C0168634;C0205214;C0557651;C1442488;C1522138;C2603343;C3245511",NULL,NULL,625
"no st depression or elevation","C0439775;C0520887;C0702240",NULL,NULL,469
"periostin low","C0205251;C0219433;C1424662;C1550472;C3812270;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"nternational index of","C0600653;C0918012;C1552854;C1637833;C2986546",NULL,NULL,734
"prior tnf antagonist failure n","C0231174;C0231491;C0332152;C0680095;C1448177;C2826257",NULL,NULL,2375
"any statin other llt","C0360714;C2347090","C0360714","",872
"p for inter act","C0079613;C0205103;C0369773;C1548610;C1704930;C1869853;C2603361;C3890007;C4048375","C1709380","",1986
"anti platelet therapy","C0005821;C0039798;C0087111;C1363945","","",1191
"prevalent vertebral fracture status","C0033105;C0080179;C0220900;C0449438",NULL,NULL,2023
"incidence rate n a","C1708485","C1708485","",1106
"symptomatic ich","C0019191;C0231220;C3272597;C3281105",NULL,NULL,1363
"n $nmbr$ allocation","C0369718;C0441922;C1706778",NULL,NULL,905
"py $nmbr$ $nmbr$","C0030428;C3538810",NULL,NULL,1517
"lm bifurcation treated","C0184906;C1261082;C1522326;C1551056;C3146289",NULL,NULL,893
"no prior stemi","C0332152;C1536220;C2826257;C3538872",NULL,NULL,570
"hazard ratiof $nmbr$ ci","C0008107;C0598697;C3259781",NULL,NULL,345
"disease location type terminal ileum","C0227327;C0450429;C0457464;C1515974;C4284930;C4284931",NULL,NULL,673
"$nmbr$ yrs sex","C0009253;C0036864;C0079399;C0804628;C1314687;C1522384",NULL,NULL,568
"$nmbr$ mm n $nmbr$","C4330985;C4554674",NULL,NULL,297
"p value placebo group p value hyponatremia normonatremic group tolvaptan vs hyponatremic vs placebo","C0020625;C0032042;C0441833;C0687744;C0857122;C1176308;C1257890;C1519504;C1696465;C1705428;C1705429;C1706408;C1709380;C4553967","","",-10
"radiographic progression based on change from baseline sdc","C0168634;C0242656;C0392747;C0443172;C0444708;C0449258;C1419891;C1442488;C1527178;C1705241;C1705938;C3273112;C4319952",NULL,NULL,625
"randomisation visit baseline","C0034656;C0168634;C0545082;C1442488;C1512346;C2826704",NULL,NULL,276
"systolic blood pressure $nmbr$ mm hg n","C0439475;C0488055;C0871470;C1306620","C0005823","",1469
"xi $nmbr$ l p $nmbr$ $nmbr$","C1720296",NULL,NULL,520
"heparin plus gpi n $nmbr$ $nmbr$","C0019134;C0332287;C0770546;C1415351","C0019134","",863
"ld","C0694649",NULL,NULL,1677
"renal function $nmbr$ egfr ml min $nmbr$ $nmbr$ m $nmbr$","C0232804;C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"overall study population","C0282416;C1561607;C2348561",NULL,NULL,1732
"glycaemic control group","C0005802;C0009932",NULL,NULL,1639
"patients with bp $ $nmbr$ $nmbr$ mmhg abpm at baseline nt","C0030705;C0037623;C0168634;C0332126;C0439475;C1415692;C1442488;C1449832;C1708288;C3889152;C4050156;C4283901;C4284038;C4318478",NULL,NULL,608
"type b $nmbr$ c lesions n","C0221198;C0369718;C0441922;C1546698;C4264484",NULL,NULL,1553
"baseline ecrcl k $nmbr$ to $nmbr$ ml min","C0168634;C0439445;C0597277;C1442488;C1708601",NULL,NULL,625
"alc $nmbr$ $nmbr$ at baseline n","C0168634;C1424945;C1442488;C3811058",NULL,NULL,395
"non hdl cholesterol week $nmbr$","C0332174;C0439230;C0729627;C1535899","C0023822","",821
"trough seated dbp mmhg a","C0277814;C0439475;C0444506;C0536221;C1283233;C3813197;C4281799",NULL,NULL,605
"elevated troponin t $nmbr$ $nmbr$ xg l","C0017209;C0077404;C0205250;C1292284;C1420827;C1421532;C3163633",NULL,NULL,1605
"mean s d duration of t $nmbr$ dm years","C0011816;C0439234;C0444504;C0449238;C2347634;C2348143;C2926735;C3250443",NULL,NULL,901
"cigarette smoking in the past year","C0239059;C0700219;C4086728",NULL,NULL,797
"combined cardiac failure cardiomyopathy or other cardiac disorder n luts severity n","C0018787;C0018799;C0018801;C0018802;C0205195;C0439793;C0521117;C0522510;C0574785;C0878544;C1292730;C1522601","C0018801",";C0168634;C1524003",12
"smoking index pack yr","C0037369;C0439234;C0453996;C0600653;C0918012;C1552854;C1637833;C1881674;C1968515;C2825051;C2828395;C2986546",NULL,NULL,1099
"prediabetes n","C0362046","C0362046",";C0168634;C1334085;C1708411",910
"ischemic heart disease no","C0010054;C0151744","C0010054;C0151744","",1361
"pain","C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132","C0030193","",1338
"$nmbr$ ml min $nmbr$ $nmbr$ m no","C0369637;C0439445;C0441923",NULL,NULL,923
"czp $nmbr$ mg n $nmbr$ $nmbr$","C0024671;C0026410;C0054841;C0439269;C1861828;C1872109;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2274
"l $nmbr$ years","C0439234;C0439394;C1706495;C3642217",NULL,NULL,1099
"pre fvc pred","C0032952;C0044955;C0332152;C0740175;C2257086;C3669034;C3714541","C3714541","",296
"atrial fibrillation or flutter","C0004238;C0016385;C0344434;C1963067;C2242390",";C0004238","",1009
"hazard ratio and $nmbr$ confidence interval","C0009667;C2985465","C2985465","",975
"any established peripheral arterial disease","C0085096;C0443211;C1272684;C1704436","C0085096","",933
"all patients n $nmbr$ b","C0030705",NULL,NULL,1035
"amiodarone ote at baseline","C0002598;C0168634;C1442488","","",1757
"with p blockers","C0369773;C2603361",NULL,NULL,960
"duration of hypertension y","C0020538;C0449238;C1963138;C2926735","C0020538","",1364
"previous labd only","C0205156;C0205171;C0396059;C1552607;C1720467",NULL,NULL,925
"timi major minor bleeding","C0019080;C4441842",NULL,NULL,530
"univariable or $nmbr$ ci p value","C0008107;C1709380;C3259781",NULL,NULL,2154
"major gastro intestinal bleeding","C0017181;C0205082;C0205164;C4318856;C4521762","C0019080;C0205082","",2076
"l eft anterior descending coronary artery","C0226032;C0439394;C0451214;C1706495;C3642217","C0226032","",2098
"smoking history pack years","C1277691;C1519384","C1277691","",1297
"interval of $nmbr$ yr since diagnosis of type $nmbr$ diabetes no","C0011847;C0011849;C0011900;C0439234;C1272706;C1320657;C1550351;C1552654;C1552713;C1704338;C1704656",NULL,NULL,1099
"carrier n $nmbr$","C0007294;C0560175;C1325398;C1706209;C3273162",NULL,NULL,784
"diuretic no total no","C0012798;C0439175;C0439810",NULL,NULL,508
"baseline tava","C0168634;C1442488",NULL,NULL,625
"conventional synthetic dmard use at baseline","C0042153;C0168634;C0242708;C0439858;C0457083;C1442488;C1883254;C1947944",NULL,NULL,625
"death q mi idr","C0011065;C1306577;C3810814;C4082313;C4552775","C0011065","",220
"previous ischemic stroke ortia","C0205156;C0948008;C1552607",NULL,NULL,1669
"mca","C0149566",NULL,NULL,1123
"hr $nmbr$ cl $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0596019",NULL,NULL,658
"creatinine ciearance","C0010294;C1561535","C0812399",";C3889287;C0452249;C0522467;C1337213;C1576800;C3890003;C0005910;C0022718;C1305866;C1705104;C1705224;C3887665",79
"patients","C0030705",NULL,NULL,1035
"enthesitis score at baseline median iqr week $nmbr$","C0168634;C0332174;C0439230;C0449820;C0549183;C0876920;C1282952;C1442488;C2347635;C2348144;C2939193;C4050231","C1282952","",271
"standard therapy","C2936643",NULL,NULL,1646
"poslmenopausal ht","C0018510;C0677607","C0282402","",1043
"p blocker intake at randomisation n $nmbr$","C0034656;C0369773;C1512806;C2603361",NULL,NULL,1823
"investigations","C1261322",NULL,NULL,896
"any vte related death","C0425043;C0630906","C1861172","",318
"data are number of patients or mean sd unless otherwise indicated cabg coronary artery bypass grafting ptca percutaneous transluminal coronary angioplasty ldl low density lipoprotein hdl high density lipoprotein iqr i nterquarti le range hmg coa ri $nmbr$ hydroxy $nmbr$ methylglutaryl coenzyme a reductase inhibitor bmi body mass index which is weight in kg divided by the square of height in metres median iqr","C0005910;C0009235;C0010055;C0021966;C0022718;C0023190;C0023821;C0023823;C0035487;C0043100;C0047420;C0162577;C0189695;C0205120;C0221138;C0332849;C0439090;C0439209;C0444504;C0475209;C0489786;C0522520;C0522523;C0545743;C0549183;C0597153;C0700307;C0876920;C1305855;C1305866;C1423767;C1444656;C1511726;C1514721;C1522231;C1548817;C1552595;C1655741;C1705104;C1826843;C2347634;C2347635;C2348143;C2348144;C2348147;C2360800;C2697858;C2699239;C2936173;C2939193;C3245479;C3542016;C3714741;C4054209",NULL,NULL,1287
"uric acid mg dl","C0041980;C0439269",NULL,NULL,2310
"pe with without dvt","C0070939;C0149871;C1880476;C2926618;C3899446;C4284304",NULL,NULL,1516
"week","C0332174;C0439230",NULL,NULL,1012
"chronic obstructive lung disease","C0024117",NULL,NULL,1726
"aes related to","C0040363;C0041260;C0439849;C0445223;C1412268;C1883351;C2699274","C0877248","",47
"epa treatment n $nmbr$","C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,236
"previous balloon angioplasty","C0002996;C0002997;C0205156;C1552607","C0002996","",1721
"prebronchodilator fev $nmbr$ mean sd l","C0444504;C2347634;C2348143;C2599602;C2699239;C3714541",NULL,NULL,1599
"percent stenosis core lab","C0439165;C0678234;C1261287;C2632116;C4684837",NULL,NULL,1651
"high dose edoxaban n $nmbr$","C0444956;C2975435","C0444956","",111
"high i $nmbr$ kg m $nmbr$ baseline bmi","C0021966;C0168634;C0205250;C0221138;C0578022;C1299351;C1442488;C1532718;C2700149;C3887512;C3889660;C4321237;C4522209",";C1305855","",206
"previous tia or stroke","C0007787;C0038454;C0205156;C0917805;C1054154;C1552607;C4554100",NULL,NULL,1592
"statin treatment","C0039798;C0087111;C0360714;C1522326;C1533734;C1705169;C3538994;C3887704","C0360714","",872
"control baseline n $nmbr$","C0168634;C0243148;C1442488;C1550141;C1882979;C2587213;C3274648;C4553389",NULL,NULL,675
"diameter stenosis mean sd","C0552409;C0678234;C1261287;C2632116;C2699239",NULL,NULL,1651
"smoking ex smoker","C0037369;C0337671;C0453996;C1881674;C4555205","C0037369","",420
"$nmbr$ ky nr","C0027496;C3844738",NULL,NULL,1477
"angiographic extent of disease","C0002978;C0449279;C4553144","C0449279","",1809
"race or ethnicity n","C0015031;C0034510;C0243103;C1706779;C3853635",NULL,NULL,787
"deaths n","C0011065;C1306577",NULL,NULL,1855
"diabetic","C0241863",NULL,NULL,996
"duration from hospital admission to pci h median iqr","C0019994;C0033727;C0369286;C0441932;C0449238;C0549183;C0564385;C0876920;C1510665;C1959907;C2347635;C2348144;C2926735;C2939193;C4049621;C4528284",NULL,NULL,635
"baseline glycated","C0168634;C1442488;C3666909",NULL,NULL,625
"antiarrhythmic drug","C0003195;C0301380","C0003195","",379
"baseline diabetes mellitus therapy n","C0168634;C0948092;C1442488","C0011849;C1442488","",2191
"statin with fibrate","C0360714","C0360714","",872
"$nmbr$ antihypertensive medication","C0003364",";C0003364","",1579
"npi $nmbr$ score","C0449820;C1412208;C1549728;C3539727;C4050231",NULL,NULL,748
"hba $nmbr$ c distribution","C0019016;C0520511;C1704711;C1825777;C3538758","","",820
"mean sd extent of exposure days","C0274281;C0332157;C0439228;C0439792;C0444504;C2347634;C2348143;C2699239",NULL,NULL,1621
"severe moderate","C1299393",NULL,NULL,322
"cardiovascular death myocardial infarction or stroke","C0007226;C0011065;C0027051;C0038454;C0428953;C1306577;C2926063;C3810814;C3887460;C4082313;C4552775;C4552959;C4554100",NULL,NULL,323
"laboratory variables","C0022877;C0439828;C3244292;C4283904",NULL,NULL,978
"t score categories lumbar spineb","C0024090;C0683312;C3854607",NULL,NULL,562
"bempedoic acid n $nmbr$","C3659310",NULL,NULL,1234
"treated at baseline mm hg sbp mean sd","C0085805;C0168634;C0439475;C0444504;C1442488;C1522326;C2347634;C2348143;C2699239","C0005823","",1469
"placebo patients with events","C0030705;C0032042;C0441471;C1696465;C1706408;C3541888","C0032042","",28
"diabetic status n","C0241863;C0449438",NULL,NULL,996
"pbo","C0031962",NULL,NULL,435
"baseline systolic bp","C0168634;C0871470;C1442488","C0871470","",615
"mean acq $nmbr$ score at randomization","C0034656;C0444504;C0449820;C2347634;C2348143;C2919686;C4050231",NULL,NULL,37
"aspirin dipyridamole n $nmbr$","C0732279","C0004057","",1366
"combined dutasteride ta msu losi n","C0024776;C0039297;C0205195;C0754659;C1412759;C1506978;C1705538;C3272501;C4553364",NULL,NULL,1647
"moderate $nmbr$ and $nmbr$","C0205081;C1881878;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"changes a in metabolic syndrome parameters hdl cholesterol","C0392747;C0443172;C0449381;C0524620;C1705241;C2357172;C4319952",NULL,NULL,617
"female $nmbr$ years postmenopausal","C0043210;C0086287;C0232970;C0439234;C1705497;C1705498","C0232970","",1041
"risk score category points","C0035647;C0449820;C0683312;C1552961;C2347617;C3714763;C3889287;C4050231;C4552904","C0035647","",173
"previous infarction of group","C0021308;C0205156;C0441833;C0687744;C1257890;C1519504;C1552607;C1705428;C1705429",NULL,NULL,2390
"haq di mcide","C3826998;C4321476",NULL,NULL,1665
"mean a sd mmhg","C0439475;C0444504;C2347634;C2348143;C2699239",NULL,NULL,1287
"hemoglobin ale","C0019046;C0678386;C2632076",NULL,NULL,400
"percutaneous coronary intervention n","C1532338","C1532338","",1661
"p blocker","C0369773;C2603361",NULL,NULL,960
"refractory to such therapy no","C0039798;C0087111;C0205269;C1363945",NULL,NULL,236
"aliskiren dm vs dm","C0011816;C1120110;C3250443","C1120110","",1172
"moderate copd","C0024117;C0205081;C1412502;C1881878;C3714496;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"$nmbr$ ml minute","C0439232;C0439526;C0700321;C0702093;C1282918;C1705224;C2347166;C3887665",NULL,NULL,1475
"major hypoglycemia","C0020615;C0205082;C0205164;C4318856;C4521762;C4553659","C0020615","",35
"pfo with large shunt without atrial septal aneurysm","C0232180;C0521533;C0542331;C0549177;C1442858",NULL,NULL,478
"n v n $nmbr$","C0369718;C0441922",NULL,NULL,1553
"ezetimibe","C1142985","C1142985","",1165
"hba $nmbr$ c $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0019016;C1825777;C3538758","","",820
"other glucose lowering drugs","C0013227;C0017725;C0441994;C2003888;C3687832",NULL,NULL,740
"$nmbr$ years education","C0013621;C0013622;C0013658;C0039401;C0439234",NULL,NULL,1099
"insulin na ive","C0021641;C0597484;C1272460;C1533581;C1546968;C1579433;C1879645;C3435805;C3714501;C4049872;C4552882;C4554334",NULL,NULL,419
"intervention group n $nmbr$","C0184661;C0441848;C0886296;C1273869",NULL,NULL,290
"diabetes with use of oral diabetes drugs","C0011847;C0011849;C0020616;C0029167;C0175795;C0304289;C0442027;C1524063;C4521986",NULL,NULL,25
"symptomatic remissionb n n","C0231220",NULL,NULL,611
"prior myocardial infarction yes","C0155668;C1549445;C1705108;C1710701",NULL,NULL,647
"long acting or short acting nitrates","C0028125;C0079613;C0205166;C1282927;C1704930;C1706317;C1806781;C1869853;C2350002;C3890007;C4048375",NULL,NULL,499
"ace i or arb use at baseline","C0021966;C0042153;C0168634;C0221138;C0457083;C1442488;C1452534;C1947944;C3888198;C4284014",NULL,NULL,46
"bronchial reversibility sd","C0205039;C0449261;C1442216;C2699239","C0449261;C0231999","",1315
"body weight kg","C0005910;C0022718;C0439209;C1305866;C4054209","C1305855","",1734
"coenzyme q $nmbr$ g ml","C0041536;C1300565",NULL,NULL,1395
"prerandomization statin therapy","C1278454",NULL,NULL,1646
"angina class iii or iv prior","C0022326;C0264677;C0332152;C2826257;C4265176",NULL,NULL,2102
"ischemic heart failure etiology","C0015127;C0018801;C0018802;C0475224;C1314792;C1524003;C4554158",NULL,NULL,924
"non q wave myocardial infarction","C0542269;C3537181","C1305738","",385
"ace arb medication","C0013227;C1452534;C3244316;C3888198;C4284014;C4284232",NULL,NULL,46
"ct ratio $nmbr$ $nmbr$","C0007673;C0456603;C1547037;C3540513;C3813556;C3888140",NULL,NULL,257
"ace inhibitors or angiotensin ii","C0003009;C0003015;C1366631;C3714928","C0003015","",811
"elevated high sensitivity crp no","C0742906;C1441604","C0006560","",286
"val hctz n $nmbr$","C0020261;C0042285;C0523975",NULL,NULL,1149
"cardiac biomarker n","C1271630",NULL,NULL,643
"p $nmbr$ interaction women vs men","C0025266;C0043210;C0369773;C1704675;C2603361","","",306
"hypertension serum lipid values","C0020538;C0042295;C0428462;C1963138","C0020538","",1364
"duration of initial anticoagulation mean sd mo","C0003281;C0026544;C0205265;C0332177;C0444504;C0449238;C1279901;C1555582;C1705685;C2347634;C2348143;C2699239;C2917212;C2919015;C2926735;C3537050",NULL,NULL,1476
"bp lowering treatment n $nmbr$","C0037623;C0039798;C0087111;C0441994;C1415692;C1522326;C1533734;C1705169;C1708288;C2003888;C3538994;C3887704;C4318478",NULL,NULL,608
"prior pad","C0182158;C0332152;C0332568;C2826257;C3540603;C3669270;C3814046;C4319657",NULL,NULL,294
"lipid values","C0023779;C0042295","C0023779","",1772
"ls mean difference $nmbr$ cl","C0023668;C0444504;C0596019;C1705241;C1705242;C2347634;C2348143",NULL,NULL,658
"total intravenous loop diuretic mg median","C0024671;C0026410;C0348016;C0354100;C0439175;C0439269;C0439810;C0549183;C0876920;C1960952;C2346927;C2347635;C2348144;C2939193;C3536704;C4321396;C4521761","C0354100","",991
"toast classification of qualifying stroke","C0038454;C1514624;C1710306;C4521230;C4554100",NULL,NULL,1762
"angiotensin ii receptor blockers","C0521942;C2757003","C0521942","",779
"low molecular weight","C0026385;C0041667;C0205251;C1521991;C1550472;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"with psoriasis zi $nmbr$","C0033860;C0043476","C0033860","",1358
"prior coronary revascularization no","C0332152;C0877341;C2826257","C0877341",";C4049621;C1552607",223
"body mass index median $nmbr$ th $nmbr$ th percentiles kg m $nmbr$","C0005893;C0039725;C0039738;C0549183;C0578022;C0876920;C1264641;C1305855;C1420718;C1532718;C2347635;C2348144;C2939193;C4282123;C4285344","C1305855","",1734
"$nmbr$ decrease in womac pain score","C0392756;C0547047;C0582148",";C0030198","",1340
"estimated gfr at baseline ml min $nmbr$","C0017654;C0168634;C0439445;C0750572;C1424601;C1442488","C3811844;C0017654","",592
"bmi $nmbr$ no f","C0016327;C0578022",NULL,NULL,1735
"vorapaxar n $nmbr$","C2974521","C2974521","",1448
"randomised patients with enthesitis at baselinet","C0030705;C1282952","C1282952","",271
"baseline n","C0168634;C1442488",NULL,NULL,625
"cardiovascular disease n","C0007222","C0007222","",1790
"treatment difference $nmbr$ cl","C0039798;C0087111;C0596019;C1522326;C1533734;C1705169;C1705241;C1705242;C3538994;C3887704",NULL,NULL,658
"ngal ng ml","C0215955;C0439275;C1416806;C2346625",NULL,NULL,204
"ng","C0017887;C0028074",NULL,NULL,203
"clinical disease activity index score $nmbr$ $nmbr$","C0449820;C3869583;C4050231","C1292728",";C4050231;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209",101
"subgroup_level","C0441889;C0456079;C1079230;C1515021;C1547707;C2946261",NULL,NULL,1637
"organic","C0747055","C0747055","",1357
"postmenopausal and no ht","C0018510;C0232970;C0677607","C0282402","",1043
"early load","C1279919;C1550025;C1704782;C1708715",NULL,NULL,1056
"week $nmbr$ outcomes","C0332174;C0439230;C1274040",NULL,NULL,1012
"patients with eot data n","C2707520",NULL,NULL,1333
"apolipoprotein b","C0003593","C0003591","",1028
"diagnosis of diabetes n","C0011847;C0011849;C0011900;C1704338;C1704656","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"serum cholesterol median iqr mg dl","C0439269;C0549183;C0587184;C0876920;C2347635;C2348144;C2939193","C0008377","",1501
"incidence of each outcome","C0021149;C0220856;C1274040","C0021149","",1467
"ldl c mmol l mean sd","C0444504;C1532563;C2347634;C2348143;C2699239","C0023824","",1068
"difference vs placebo","C0032042;C1696465;C1705241;C1705242;C1706408","C0032042","",28
"aspirin group n $nmbr$ $nmbr$ $nmbr$ $nmbr$ person years","C0004057;C0027361;C0439234;C0441848;C2347489",NULL,NULL,1099
"trochanter","C0162370",NULL,NULL,538
"antithrombotic agents n","C1704311",NULL,NULL,1705
"median mg dl","C0439269;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"glu $nmbr$ asp g t","C0125690;C0439267",NULL,NULL,1486
"$nmbr$ week","C0332174;C0439230",NULL,NULL,1012
"by cause of death","C0007465;C4050444","C0007465","",1423
"n america","C0002454;C0369718;C0441922","C0028405","",1463
"urine albumin creatinine ratio mg mmol","C0455271;C0567349;C1318330;C2348885","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"current smoker n $nmbr$","C3173209;C3241966","C3241966","",1420
"previous cad","C0205156;C1504769;C1552607;C2239547;C3813548;C4284121",NULL,NULL,698
"n nt","C0332126;C0369718;C0441922;C1449832;C3889152;C4050156;C4283901;C4284038",NULL,NULL,91
"incidence rate of cv events n","C0441471;C1708485;C3538987;C3541888;C4048877;C4318503",NULL,NULL,1777
"bare metal stent no","C2825200","C2825200","",348
"$nmbr$ month n $nmbr$","C0332177;C0439231",NULL,NULL,1476
"white not of hispanic origin","C0007457;C0043157;C0079946;C0086409;C0220938;C0439659;C1518422;C1518424;C1550512","C0086409","",865
"mean sd $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"stroke m l hf hospitalization","C0018488;C0019993;C0038454;C0456616;C1313497;C1538440;C3273279;C4554100","C0018801",";C0168634;C1524003",12
"serum phosphate mmol l","C0036820;C1532563",NULL,NULL,670
"moderate copdb n z $nmbr$","C0205081;C1881878;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"stroke vs tia","C0007787;C0038454;C0917805;C1054154;C4554100",NULL,NULL,1592
"troponin positive n $nmbr$","C0041199;C0439178;C1446409;C1514241;C2825490;C3812269",NULL,NULL,1163
"rate per year","C0439234;C0439508;C0871208;C1521828",NULL,NULL,2009
"placebo $nmbr$","C0032042;C1696465;C1706408","C0032042","",28
"prior statin use","C0042153;C0332152;C0360714;C0457083;C1947944;C2826257","C2826257;C0360714","",2186
"baseline mean serum uric acid pmol l sd","C0168634;C0439284;C0444504;C0455272;C0700634;C1442488;C2347634;C2348143;C2699239","","",2093
"cardiovascular death or nonfatal myocardial infarction","C0007226;C0011065;C0027051;C0428953;C1306577;C2926063;C3810814;C3887460;C4082313;C4552775;C4552959",NULL,NULL,646
"other asian","C0078988","C0078988","",1369
"iv vasodilator","C0022326;C0042402;C3537240;C4265176","C0042402","",817
"$nmbr$ $nmbr$ $nmbr$ ng l n $nmbr$","C0439297",NULL,NULL,202
"apolipoprotein a $nmbr$ g l","C0003592;C0439294;C0456615;C0523508","C0003591","",1028
"index event asymptomatic or unconfirmed","C0231221;C0441471;C0600653;C0918012;C1547326;C1552854;C1637833;C2986546;C4019010",NULL,NULL,412
"death mi idr or st","C0011065;C0036056;C1306577;C3272372;C3810814;C4082313;C4552775",NULL,NULL,246
"clinical variables median iqr","C0205210;C0439828;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"pre bronchodilator fev l","C2599602;C3714541",NULL,NULL,682
"no of target vessels","C0449618",NULL,NULL,747
"age yr age group no","C0027362;C0439234;C2348001",NULL,NULL,45
"hr $nmbr$ cl $nmbr$ $nmbr$ b $nmbr$ $nmbr$ $nmbr$","C0596019",NULL,NULL,658
"hypercholesterolemia was defined as a low density lipoprotein cholesterol level at enrollment of more than $nmbr$ mg per deciliter $nmbr$ $nmbr$ mmol per liter after an overnight fast nonsustained ventricular tachycardia was defined as $nmbr$ or more consecutive ventricular beats at a heart rate of more than $nmbr$ beats per minute to convert weight to kilograms divide by $nmbr$ $nmbr$ to convert values for creatinine to micromoles per liter multiply by $nmbr$ $nmbr$ data for follow up medication were available for $nmbr$ patients amiodarone $nmbr$ placebo $nmbr$ and icd $nmbr$ ace de notes angiotensin converting enzyme and arb angiotensin ii receptor blocker p $nmbr$ $nmbr$ for the comparison among the groups","C0002598;C0005910;C0010294;C0011198;C0013227;C0015663;C0017480;C0018827;C0020443;C0021122;C0022709;C0023824;C0030705;C0032042;C0040363;C0041260;C0042295;C0043100;C0205172;C0332849;C0369773;C0425583;C0439209;C0439241;C0439300;C0439385;C0439583;C0441833;C0441889;C0456079;C0456962;C0470187;C0475211;C0521942;C0567349;C0589120;C0687744;C0750194;C0871208;C1257890;C1305866;C1316572;C1317574;C1452534;C1511726;C1516879;C1519504;C1521828;C1522133;C1522565;C1522577;C1547707;C1552839;C1561535;C1696073;C1696465;C1704685;C1704788;C1705104;C1705428;C1705429;C1706408;C1707455;C1707491;C1719797;C1883351;C2347285;C2348885;C2603361;C2911648;C2919575;C2946261;C2985769;C3244316;C3245479;C3274571;C3536793;C3539106;C3541240;C3714741;C3888021;C3888198;C4284014;C4284232","","",-10
"china japan","C0008115;C0022341",NULL,NULL,772
"amiodarone","C0002598","","",1757
"mean time to first oral dose postsurgeryh hr","C0040223;C0178602;C0205435;C0442027;C0444504;C0869039;C1114758;C1279901;C2347634;C2348143;C3541383;C4521986",NULL,NULL,757
"severity n","C0439793;C0522510",NULL,NULL,561
"ace inhibitor arb","C0003015;C3888198;C4541021",NULL,NULL,44
"heart rate sd bpm","C0018810;C2699239","C0018810","",1105
"dbp mm hg median iqr","C0439475;C0536221;C0549183;C0876920;C2347635;C2348144;C2939193;C3813197;C4281799",NULL,NULL,605
"qualifying high risk features","C0332167;C1514624;C1521970;C1706388;C2346469;C2348519;C3272283;C4050568;C4319571","C4319571","",837
"current smoker n of patients","C0030705;C3173209;C3241966","C3241966","",1420
"age years mean s d","C0444504;C1510829;C2347634;C2348143","C1510829","",481
"baseline uas $nmbr$","C0168634;C1442488",NULL,NULL,625
"history of major microvascular disease n","C0205082;C0205164;C0443258;C0683519;C0730226;C0850708;C0944983;C4318856;C4521762",NULL,NULL,105
"mean sd change from pre to post bronchodilator fev $nmbr$ l","C0332152;C0392747;C0443172;C0444504;C0687676;C0740175;C1704687;C1705241;C2257086;C2347634;C2348143;C2599594;C2599602;C2699239;C3469826;C3669034;C3714541;C4319952",NULL,NULL,771
"cdai $nmbr$ t","C0683448;C1413248;C3273706",NULL,NULL,697
"history of stroke at baseline","C0019664;C0019665;C0038454;C0168634;C0262512;C0262926;C1442488;C1705255;C2004062;C4554100",NULL,NULL,832
"smoking a","C0037369;C0453996;C1881674","C0037369","",420
"rosiglitazone","C0289313","C0289313","",1761
"hope n $nmbr$","C0392347",NULL,NULL,604
"duration of disease yr","C0439234;C0872146","C0449238;C0872146","",903
"data are reported as percentage or mean standard deviation unless otherwise indicated ng normoglycemia igm impaired glucose metabolism ldl low density lipoprotein hdl high density lipoprotein fpg fasting plasma glucose a median interquartile range p $nmbr$ $nmbr$ vs non epa p $nmbr$ $nmbr$ vs non epa","C0015663;C0017725;C0017887;C0023820;C0023821;C0028074;C0178587;C0202042;C0205251;C0221099;C0439165;C0444504;C0455280;C0549183;C0580545;C0596620;C0684224;C0700287;C0871420;C0876920;C1154908;C1442989;C1444656;C1511726;C1518422;C1549488;C1550472;C1561533;C1706005;C1711350;C1828170;C2347634;C2347635;C2348143;C2348144;C2828392;C2939193;C3245479;C3714741;C3890211;C4048187;C4319718;C4321351;C4522223",NULL,NULL,629
"disease","C0012634",NULL,NULL,1279
"timi clinically significant","C0237881;C0750502;C1546944",NULL,NULL,788
"ind gly $nmbr$ $nmbr$ mg once daily n $nmbr$ $nmbr$","C0017890;C0024671;C0026410;C0332173;C0439269;C0523677;C1960952;C2346927;C4049864;C4321396;C4521761",NULL,NULL,192
"$nmbr$ cells pl","C0007584;C0007634;C3897966;C4049765","","",-10
"warfarin no","C0043031","C0043031","",858
"overall dlqi score $nmbr$","C0282416;C0449820;C1561607;C3899393;C4050231",NULL,NULL,527
"age y median range","C0001779;C0549183;C0876920;C1514721;C2347635;C2348144;C2348147;C2939193;C3542016","C0001779","",480
"stroke any","C0038454;C4554100",NULL,NULL,1762
"noncurrent smoker","C0337664","C0037369","",420
"exposure to study drug days","C0013175;C0332157;C0439228",NULL,NULL,1621
"crcl $nmbr$ $nmbr$","C1846718",NULL,NULL,706
"prior ms treatment with ifn beta or glatiramer acetate no","C0015980;C0289884;C1514463;C2349943;C3539704;C3713294",NULL,NULL,574
"rivaroxaban plus aspirin $nmbr$ cl","C0004057;C0332287;C0596019;C1739768","C1739768","",1225
"accp score","C0449820;C4050231",NULL,NULL,748
"post bronchodilator fev $nmbr$ at screening","C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C2599594;C3714541",NULL,NULL,798
"crp ng ml","C0439275;C3890735;C4048285",NULL,NULL,204
"hscrp mg l median first third quartiles","C0205435;C0205437;C0439268;C0549183;C0876920;C1279901;C2347635;C2348144;C2828255;C2939193","C0006560","",286
"no diabetes n $nmbr$ $nmbr$","C0011847;C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"baseline to eom placebo n $nmbr$","C0032042;C0168634;C0241886;C1442488;C1696465;C1706408","C0032042","",28
"sal $nmbr$ mg","C0024671;C0026410;C0036140;C0037494;C0206136;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,853
"history of chf nyha class ii or iii no","C0018802;C0019664;C0019665;C0262512;C0262926;C0439070;C1705160;C1705255;C1882085;C2004062",NULL,NULL,832
"diabetes n $nmbr$ $nmbr$","C0011847;C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"$nmbr$ days to $nmbr$ year n $nmbr$","C0556972",NULL,NULL,1410
"blood bilirubin increased","C0005437;C0005767;C0005768;C0205217;C0229664;C0442805",";C0005437","",1684
"aspirin alone n $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0004057;C0205171;C0439044;C0679994","C0004057","",1366
"history of ml before index event","C0019664;C0019665;C0262512;C0262926;C0439526;C0441471;C0600653;C0918012;C1552854;C1637833;C1705224;C1705255;C2004062;C2986546;C3887665;C4019010",NULL,NULL,412
"bumetanide","C0006376","C0054201","",1160
"pramlintide","C0537551",NULL,NULL,2289
"diclofenac n $nmbr$ $nmbr$","C0012091","C0012091","",1324
"dapa met n $nmbr$","C0369718;C0428210;C0441922;C1550543;C4317104",NULL,NULL,39
"el n","C1416870;C1447747;C1823249;C3811107;C3811848;C3815598",NULL,NULL,664
"$nmbr$ min twice week","C0332174;C0439230;C0702093;C1524029;C1720725;C1948050;C3813700",NULL,NULL,1012
"frailty status","C0424594;C0449438",NULL,NULL,543
"ca channel blockers n","C0870261;C3887642","C0006684","",1884
"ldl cholesterol mmol l mean sd","C0023824;C0202117;C0444504;C1532563;C2347634;C2348143;C2699239","C0023824","",1068
"ex smoker smoker","C0337671;C4555205","C0037369","",420
"both adalimumab groups n $nmbr$","C0369718;C0441833;C0441922;C0687744;C1122087;C1257890;C1519504;C1552839;C1705428;C1705429",NULL,NULL,942
"phototherapy previous systemic treatment n","C0031765;C0205156;C0678812;C1552607",NULL,NULL,553
"change from pre to","C0332152;C0392747;C0443172;C0740175;C1705241;C2257086;C3669034;C4319952",NULL,NULL,771
"reversibility","C0449261","C0449261","",2160
"angina symptoms","C0858277","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"involved intestinal area n","C0021853;C1879646","C0009368;C1879646","",2088
"adas cog score","C0449820;C3539026;C4050231","C3539026","",1075
"apolipoprotein a","C0003592;C0523508","C0003591","",1028
"penetrating disease","C0012634;C0205321",NULL,NULL,1025
"egfr ml min","C0439445;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"some physical activity","C0015259;C0026606","C0015259","",1380
"baseline geometric mean $nmbr$ l","C0168634;C1442488;C2986759","","",241
"crp normal $nmbr$ $nmbr$ mg dl","C0205307;C0231683;C0439166;C0439269;C2347086;C3890735;C4048285;C4553972","C0006560","",286
"statistic","C2348149;C2828391",NULL,NULL,181
"lto $nmbr$ symptom days per week","C0677547;C1457887;C3854129",NULL,NULL,1410
"diabetic n","C0241863",NULL,NULL,996
"median range total ige level iuml $nmbr$","C0439175;C0439810;C0441889;C0456079;C0549183;C0876920;C1514721;C1547707;C2347635;C2348144;C2348147;C2939193;C2946261;C3542016",NULL,NULL,635
"overall pad","C0182158;C0282416;C0332568;C1561607;C3540603;C3669270;C3814046;C4319657",NULL,NULL,1743
"change from baseline in sgrq","C0168634;C0392747;C0443172;C1442488;C1705241;C4319952",NULL,NULL,767
"total mortality all","C0026565;C0026566;C0439175;C0439810",NULL,NULL,508
"oral antidiabetic drugs insulin","C0021641;C0029167;C0175795;C0304289;C0442027;C0935929;C1533581;C1579433;C3714501;C4521986",NULL,NULL,1746
"additional angiography","C0002978;C1524062",NULL,NULL,1723
"established cvd chronic kidney disease age $nmbr$","C0001779;C0007222;C0443211;C1272684;C1561643;C4553188","C0001779","",480
"om $nmbr$ mg aml $nmbr$ mg","C0023465;C0023467;C0028971;C1319635;C1705272",NULL,NULL,186
"hx mi or stroke","C0038454;C0262926;C3810814;C3814444;C4554100",NULL,NULL,1762
"baseline hba $nmbr$ c $nmbr$ mmol mol $nmbr$ $nmbr$ n","C0019016;C0168634;C1442488;C1825777;C3538758;C3829066","","",820
"cardiovascular disorder","C0007222","C0007222","",1790
"patients with any clinical","C0030705;C0205210",NULL,NULL,1035
"coenzyme q $nmbr$","C0041536",NULL,NULL,1395
"patient demographics age yr","C0011298;C0439234;C1704791;C4698447",NULL,NULL,582
"chlorthalidone $nmbr$","C0008294","C0008294","",70
"unacceptable side effects","C0001688;C0877248;C0879626;C1883420","C0877248","",47
"body mass index kq nrn","C0005893;C0578022;C1305855;C1425210","C1305855","",1734
"iee at baseline $nmbr$ iu l","C0168634;C0439457;C1442488",NULL,NULL,1252
"baseline bmd t score at femoral neck","C0015815;C0168634;C0449820;C1442488;C4050231",NULL,NULL,748
"total updrs score baseline mean sd","C0168634;C0439175;C0439810;C0444504;C0449820;C1442488;C2347634;C2348143;C2699239;C3639721;C4050231",NULL,NULL,37
"mmrc dyspnea scale score t t","C0013404;C1963100;C3826977;C4049715","C0013404","",1227
"female eze simva","C0043210;C0086287;C1705497;C1705498",NULL,NULL,586
"tiotropium $nmbr$ mg","C0024671;C0026410;C0213771;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2300
"hypertension bp $nmbr$ $nmbr$ mmhg or using antihypertensive medication","C0003364;C0020538;C0037623;C0439475;C1415692;C1524063;C1708288;C1963138;C4318478",";C0003364","",1579
"beta blocker","C0001645","C0001645","",959
"therapy at discharge","C0012621;C0030685;C0039798;C0087111;C1363945;C2926602",NULL,NULL,390
"bmi kg m mean sd","C0444504;C0578022;C1532718;C2347634;C2348143;C2699239",NULL,NULL,2125
"western europe australia new zealand middle eai","C0043129;C0444598;C0549183;C1552826;C4289954",NULL,NULL,331
"qualifying mi $nmbr$ yrs prior","C0332152;C1514624;C2826257;C3810814",NULL,NULL,516
"race p o $nmbr$","C0034510;C1706779;C3853635",";C0034510","",1107
"sita $nmbr$ pio $nmbr$","C0030800;C2347712",NULL,NULL,1400
"s $nmbr$ ml min","C0439445;C0565930;C2603362","C3811844;C0017654","",307
"duration of full dose warfarin therapy before enrollment mo","C0026544;C0332177;C0366686;C0443225;C0444917;C1516879;C1696073;C3888021",NULL,NULL,1476
"i $nmbr$ i i $nmbr$","C0021966;C0221138",NULL,NULL,1021
"sf $nmbr$ health transition score","C0037712;C0376627;C0449820;C4050231",NULL,NULL,1782
"severe life ttireatening","C0205082;C0376558;C4050465;C4050466",NULL,NULL,313
"age x","C0001779","C0001779","",480
"omega $nmbr$ fa intake $nmbr$ st third","C0036056;C0205437;C1512806;C1719844;C3272372","C0015684","",1236
"predose fev $nmbr$ l","C0439565;C3714541;C3812758","C3714541;C0439565","",295
"hdl c mean sd","C0444504;C2347634;C2348143;C2699239;C3715113",NULL,NULL,37
"standard therapyy n $nmbr$","C1442989;C2828392",NULL,NULL,1482
"daily exercise","C0015259;C0332173;C1522704","C0015259","",1380
"p vaiue interaction","C0369773;C1704675;C2603361",NULL,NULL,888
"concomitant aeds n","C0180309;C0521115",NULL,NULL,448
"methotrexate user","C0025677;C1548600;C1706077","C0025677","",1408
"tg mmol l median","C0337445;C0549183;C0876920;C1532563;C2347635;C2348144;C2939193",NULL,NULL,635
"randomized to receiveaspirin","C0034656;C3815594",NULL,NULL,692
"prebronchodilator fevi liters","C0429706;C0475211;C0849974;C1561566;C2599602;C4528367",NULL,NULL,1601
"na ve","C0042469;C0597484;C1272460;C1546968;C1879645;C3714652;C4049872;C4321495;C4552882",NULL,NULL,419
"non hispanic and latino","C0086528;C1518424","C0086409","",865
"fasting","C0015663",NULL,NULL,358
"in ibdq total score at week $nmbr$ mean se","C0036919;C0332174;C0439175;C0439230;C0439810;C0444504;C2347634;C2348143;C2964552;C3533236",NULL,NULL,567
"history of coronary heart disease no","C0018787;C0683519;C0730226;C0850708;C0944983",NULL,NULL,105
"phenobarbital","C0031412","","",-10
"prebronchodilator fev $nmbr$ predicted","C0681842;C1882327;C2599602;C3714541",NULL,NULL,1599
"data are mean sd or number bmi body mass index sbp systolic blood pressure dbp diastolic blood pressure lvef left ventricular ejection fraction hf heart failure ami acute myocardial infarction cabg coronary artery bypass graft pci percutaneous coronary intervention icd implantable cardioverter de brillator copd chronic obstructive pulmonary disease ace angiotensin converting enzyme arbs angiotensin receptor blockers available for $nmbr$ patients $nmbr$ rosuvastatin $nmbr$ placebo","C0010055;C0011198;C0014442;C0017480;C0018801;C0021122;C0024117;C0030705;C0032042;C0042508;C0085805;C0155626;C0162589;C0205091;C0237753;C0428772;C0428883;C0443246;C0444504;C0449788;C0470187;C0488055;C0488728;C0521942;C0815017;C0871470;C0965129;C1305855;C1306620;C1452534;C1511726;C1532338;C1552822;C1696465;C1706408;C2347634;C2348143;C2699239;C3245479;C3541240;C3714741;C3888198;C4284014;C4521602",NULL,NULL,1726
"low risk","C3272281;C3538919",NULL,NULL,174
"oral corticosteroid use at baseline","C0001617;C0168634;C0239126;C0442027;C1442488;C1527415;C3536709;C4521986",NULL,NULL,1650
"p value nominal","C1709380",NULL,NULL,7
"specific risk of bleeding","C0205369;C1552740;C3251812","C3251812","",1089
"baseline cv medications","C0013227;C0168634;C0802604;C1442488;C2598133;C3538987;C4048877;C4284232;C4318503",NULL,NULL,1777
"arthritis mutilans","C0702102","","",-10
"age group y","C0001779;C0441858","C0001779","",480
"after bronchodilator use","C0006280;C0042153;C0457083;C1947944",NULL,NULL,118
"baseline mean ambulatory sbp mm hg sd","C0085805;C0168634;C0439475;C0439841;C0444504;C1442488;C2347634;C2348143;C2699239",NULL,NULL,607
"patients with egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ at baseline","C0030705;C0168634;C0369637;C0439445;C0441923;C1442488;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"western europe n $nmbr$","C0043129","","",599
"individual intended study duration no","C0027361;C0237401;C0489652;C1283828;C1551357",NULL,NULL,1064
"mean s d apoc ll $nmbr$ mg dl","C0003594;C0439269;C0444504;C2347634;C2348143",NULL,NULL,192
"high intensity statin use","C0042153;C0360714;C0457083;C1947944;C4081854","C0360714","",872
"proadm ng ml","C0439275",NULL,NULL,204
"$nmbr$ $nmbr$ per $nmbr$ py","C0030428;C3538810",NULL,NULL,1517
"type of concomitant statin by daily dose","C0332307;C0360714;C0521115;C1547052;C2348070","C0360714","",872
"pasi score $nmbr$ $nmbr$ scale","C0175659;C0349674;C0449820;C1947916;C4050231;C4528685",NULL,NULL,1522
"highly sensitive responder n $nmbr$","C0439822","C0332324","",1164
"concomitant medication n d","C0013227;C0521115;C3244316;C4284232","C0013227;C0521115","",1916
"type of ml no","C0332307;C0439526;C1547052;C1705224;C3887665",NULL,NULL,300
"patients with only mrf hr $nmbr$ cl","C0030705;C0205171;C0312443;C0596019;C1412879;C1720467",NULL,NULL,1543
"event p $nmbr$ $nmbr$ o","C0441471;C4019010",NULL,NULL,412
"associated with drug or toxin exposure","C0013227;C0040537;C0332281;C1254351",NULL,NULL,876
"chest x ray","C0039985",NULL,NULL,768
"body mass index bmi kg m $nmbr$","C0005893;C0578022;C1305855;C1532718","C1305855","",1734
"ambulance n","C0002422;C3846685","C0002422",";C4049621",191
"feno $nmbr$ mg dn $nmbr$","C0024671;C0026410;C0439269;C1333964;C1707618;C1960952;C2346927;C4321396;C4521761","C0033228","",803
"cilostazol","C0055729",NULL,NULL,1503
"prior exposure to carbamazepine","C0006949;C0006950;C0274281;C0332152;C0332157;C0682993;C2826257",NULL,NULL,764
"patients with established cv disease aged $nmbr$ years","C0007222;C0030705;C0443211;C1272684;C1510829","C0007222","",1790
"ml c","C0439526;C1705224;C3887665",NULL,NULL,300
"suit quartile $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ nmol mmol n $nmbr$","C1532564;C1533073;C2828255",NULL,NULL,1016
"sbp at visit $nmbr$","C0085805;C0545082;C1512346;C2826704","C0005823","",15
"ci b","C0008107;C3259781",NULL,NULL,519
"fasting serum glucose mg dl median iqr","C0015663;C0202041;C0439269;C0549183;C0876920;C2347635;C2348144;C2939193;C3534430","C0017725;C0015663","",2280
"both ace inhibitor and arb","C0003015;C3888198;C4541021",NULL,NULL,44
"blood pressure mmhg mean sd","C0428886;C0439475;C2699239","C0005823","",1469
"primary outcome n $nmbr$","C0205225;C0439612;C0439631;C1274040",NULL,NULL,2339
"smoking history","C1519384","C1519384","",1147
"new anti anginal therapy","C1874267;C3242274;C3537168","C3537168","",382
"sildenafil n $nmbr$","C0529793","C0529793","",874
"baseline los angeles grade of eo n","C0024015;C0168634;C0332120;C0441800;C0919553;C1442488;C3244287",NULL,NULL,683
"non ischaemic","C0475224;C1518422",NULL,NULL,1670
"statin at enrollment","C0360714;C1516879;C1696073;C3888021","C0360714","",872
"reversibility $nmbr$","C0449261","C0449261","",2160
"piroxicam","C0031990",NULL,NULL,215
"no use","C0042153;C0457083;C1947944",NULL,NULL,118
"sbp systolic blood pressure sd standard deviation dbp diastolic blood pressure b p m beats per minute mi myocardial infarction tia transient ischaemic attack","C0007787;C0027051;C0085805;C0369637;C0428883;C0439385;C0441923;C0488055;C0871420;C0871470;C1306620;C2699239",NULL,NULL,607
"age group $nmbr$ years no","C0027362;C0439234;C0441833;C0687744;C1257890;C1510829;C1519504;C1705428;C1705429;C2348001","C1510829","",481
"erosion score","C0333307;C0449820;C1880549;C1959609;C3887524;C4050231",NULL,NULL,1046
"acute stent thrombosis","C0205178;C3897493",NULL,NULL,622
"medications taken at time of randomization statins","C0013227;C0034656;C0040223;C0360714;C0802604;C1883727;C2598133;C3541383;C4284232",NULL,NULL,2263
"bmi $nmbr$ $nmbr$ overweight","C0497406;C0578022","C0497406","",1248
"higher dose","C0444956","C0444956","",111
"heparin plus a gpi n $nmbr$","C0019134;C0770546;C1415351","C0019134","",863
"epa hr events","C0441471;C3541888",NULL,NULL,408
"gfr $nmbr$","C0017654;C1424601","C3811844;C0017654","",592
"comorbidities and concomitant medications","C0009488;C0013227;C0521115;C0802604;C2598133;C4284232",NULL,NULL,366
"placebo every $nmbr$ weeks n $nmbr$","C0032042;C0439230;C1696465;C1706408","C0032042","",28
"patients with cardiac disorders n c","C0012634;C0018799;C0030705;C0741926","C0018799","",1278
"post fev $nmbr$","C0687676;C1704687;C3469826;C3714541",NULL,NULL,1599
"no revascularisation","C0581603","C0581603","",1213
"pooled simvastatin factorial studies","C0074554;C1709595;C2349200;C2826344;C4522255","C0074554","",873
"thiazolidinedione use at baseline","C0042153;C0168634;C0289779;C0457083;C1257987;C1442488;C1947944;C3537039","C1257987",";C0289779;C1527178;C1705938;C1552866;C2700399;C0168634",72
"total score $nmbr$ $nmbr$ scale","C0175659;C0349674;C1947916;C2964552",NULL,NULL,540
"baseline dipeptidyl peptidase $nmbr$","C0022709;C0168634;C1442488",NULL,NULL,625
"severe disease","C1836348",NULL,NULL,97
"moderate intensity statin use","C0042153;C0360714;C0457083;C1947944;C4081855","C0360714","",872
"id","C0009450;C0600091;C1441613",NULL,NULL,1255
"$nmbr$ l $nmbr$ l","C3539687","","",-10
"lv mass index mg m $nmbr$","C0024671;C0026410;C0369637;C0439269;C0441923;C0455825;C0600653;C0918012;C1552854;C1637833;C1960952;C2346927;C2986546;C4321396;C4521761",NULL,NULL,146
"group","C0441833;C0687744;C1257890;C1519504;C1705428;C1705429",NULL,NULL,1526
"companion wake up stroke","C0031268;C0038454;C0335343;C0682323;C1170730;C4554100",NULL,NULL,1000
"igt or ifg","C1334085;C1708411",NULL,NULL,1259
"other antihypertensive agents","C0003364",";C0003364","",1579
"egfr category n","C0683312;C1739039;C3811844;C3812682;C3889287","C3811844;C0017654","",592
"test for interaction p value","C0022885;C0039593;C0392366;C0456984;C1515976;C1704675;C1709380;C3831328;C4318744",NULL,NULL,7
"hr $nmbr$ $nmbr$ $nmbr$ cl $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0596019",NULL,NULL,658
"ldlc hdlc","C1416822;C1704429","C0023822","",821
"min max","C0702093;C1524029;C3813700",NULL,NULL,1475
"neither corticosteroid nor immunosuppressant","C0001617;C0021081;C3536709",NULL,NULL,1650
"hoehn yahr stage","C0205390;C1300072;C1306673",NULL,NULL,541
"incontinence episodes $nmbr$ h","C0021167;C0033727;C0332189;C0369286;C0441932;C0564385;C4528284",NULL,NULL,308
"om $nmbr$ mg hctz $nmbr$ mg n $nmbr$","C0020261;C0028971;C1319635;C1705272",NULL,NULL,1149
"laboratory investigations","C0022877;C1261322;C3244292;C4283904",NULL,NULL,896
"range of sbp","C0085805;C1514721;C2348147;C3542016",NULL,NULL,479
"roflumilast n $nmbr$ $nmbr$","C0965618",NULL,NULL,1877
"$nmbr$ to $nmbr$ yr","C0439234",NULL,NULL,1099
"hemoglobin mg dl","C0019046;C0439269","C0019046","",1177
"$nmbr$ kg","C0022718;C0439209;C4054209",NULL,NULL,205
"clopidogrel ticlopidine","C0040207;C0070166","C0070166","",216
"relative risk vs placebo $nmbr$ cl","C0032042;C0242492;C0596019;C1696465;C1706408",NULL,NULL,658
"fev $nmbr$ l mean sd","C0444504;C2347634;C2348143;C2699239;C3714541",NULL,NULL,2126
"any hba $nmbr$ c","C0019016;C1825777;C3538758","","",820
"edoxaban higher dose vs warfarin","C0043031;C0444956;C2975435","C0444956","",111
"difference median","C0549183;C0876920;C1705241;C1705242;C2347635;C2348144;C2939193",NULL,NULL,635
"age mean yrs sd","C0001779;C0444504;C2347634;C2348143;C2699239","C0001779","",480
"mean hba $nmbr$ c","C0019016;C0444504;C1825777;C2347634;C2348143;C3538758","","",820
"pbo sc every other week n $nmbr$","C0031962;C0282380;C0332174;C0439230",NULL,NULL,435
"d dimer level mean sd ng mld","C0017887;C0023522;C0028074;C0060323;C0441889;C0444504;C0456079;C1539265;C1547707;C2347634;C2348143;C2699239;C2946261;C3539688;C3539689",NULL,NULL,2325
"no stroke n $nmbr$","C0038454;C4554100",NULL,NULL,1762
"hb g dl","C0019046;C0439267;C3642216;C3843510",NULL,NULL,1486
"low $nmbr$ baseline hbalc","C0168634;C0205251;C1442488;C1550472;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"others n","C1955473;C3539125",NULL,NULL,741
"tg triglycerides median values standard deviation for medians","C0041004;C0042295;C0399532;C0549183;C1442989;C2828392","C0041004","",368
"syndrome n","C0039082",NULL,NULL,617
"epa mol","C0027960;C0324740;C0439189;C1456781;C1824986;C3665593",NULL,NULL,667
"biomarker low","C0005516;C0205251;C1550472;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"diffusion capacity of the lung for carbon monoxide predicted","C0007018;C0231971;C0681842;C1882327;C4520712","C0024119","",288
"no metabolic syndrome","C0524620",NULL,NULL,617
"stent type implanted","C0021102;C0038257;C0332307;C1547052;C2828363",NULL,NULL,603
"overall vero population","C0032659;C0282416;C1257890;C1561607",NULL,NULL,1743
"colesevelam n $nmbr$","C0541155","","",-10
"anti ccp $nmbr$ units","C0439148;C1519795;C3853603;C4318437","C4318437","",360
"sbp $nmbr$ mmhg","C0085805;C0439475",NULL,NULL,607
"re cover re cover ii","C0180153;C0556581;C1999244;C2986904;C3888055",NULL,NULL,523
"ex smoker current","C0337671;C0521116;C1705970;C4555205","C0037369","",420
"placebo croup n n","C0010380;C0032042;C1696465;C1706408","C0032042","",28
"average daily dose","C1510992;C2348070;C2825518",NULL,NULL,1488
"placebo patients events n","C0030705;C0032042;C0441471;C1696465;C1706408;C3541888","C0032042","",28
"refractory to corticosteroids n","C0001617;C0205269;C3539185;C3540725;C3540726;C3540727",NULL,NULL,1650
"diastolic blood pressure mm hg medications","C0013227;C0428883;C0439475;C0802604;C1305849;C2598133;C4284232","C0428883","",842
"rituximab n $nmbr$","C0393022",NULL,NULL,946
"cha $nmbr$ s $nmbr$ score","C0449820;C1420648;C4050231",NULL,NULL,748
"single vessel disease","C0037179;C0042373;C0087136;C0205171",NULL,NULL,102
"peace n $nmbr$","C0680443",NULL,NULL,1298
"total cholesterol median iqr mg dl","C0201950;C0439269;C0543421;C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"placebo mdi","C0032042;C0993596;C1696465;C1706408;C1839839;C4049613","C0032042","",28
"non smokers receiving lipid lowering drugs p blockers and either an ace inhibitor or angiotension receptor blocker","C0003015;C0086440;C0337672;C0597357;C1514756;C3844638;C4541021;C4554605","C0086440","",1773
"non trial p blocker","C0008976;C1518422",NULL,NULL,1020
"plus metformin","C0025598;C0332287","C0025598","",1345
"iii n z $nmbr$","C0439070;C1705160",NULL,NULL,524
"smoking history ever","C1519384;C3887636","C1519384","",1147
"st segment depression $nmbr$ $nmbr$ mv on admission","C0457453;C0520887;C1454484;C1705503;C4281602","C0520887","",1920
"sirolimus eluting stent use n","C0038257;C0042153;C0072980;C0457083;C1947944",NULL,NULL,633
"non us","C1518422",NULL,NULL,463
"re cover $nmbr$ dabigatran","C0180153;C0556581;C1999244;C2348066;C2986904;C3888055",NULL,NULL,775
"use of antiarrhythmic agent","C0003195;C0301380;C1524063",NULL,NULL,486
"dha n $nmbr$","C0142831;C2348308",NULL,NULL,1623
"measured at clinic visit with automated device","C0008952;C0025080;C0205554;C0444706;C0699733;C3541902",NULL,NULL,732
"reported by physicians tdata are median iqr all data are mean sd or number unless otherwise indicated","C0031831;C0237753;C0444504;C0449788;C0549183;C0876920;C1444656;C1511726;C1709908;C2347634;C2347635;C2348143;C2348144;C2699239;C2939193;C3245479;C3714741",NULL,NULL,37
"mild to moderate","C1299392",NULL,NULL,322
"mean age range yr","C0001779;C0439234;C0444504;C1514721;C2347634;C2348143;C2348147;C3542016","C0001779","",480
"no with event total no","C0439175;C0439810;C0441471;C4019010",NULL,NULL,412
"baseline hba $nmbr$ c $nmbr$ $nmbr$","C0019016;C0168634;C1442488;C1825777;C3538758","","",820
"adjusted change from baseline mean s e","C0168634;C0392747;C0443172;C0444504;C0456081;C1442488;C1705241;C2347634;C2348143;C4319952",NULL,NULL,625
"p value for dm vs no dm","C0011816;C3250443;C4086240",NULL,NULL,955
"former or current smokers","C0205156;C0750523;C3173209;C3241966","C3241966","",1420
"losmapimod n $nmbr$","C3272847",NULL,NULL,1771
"active a","C0205177;C3853793;C3888249",NULL,NULL,496
"systolic blood pressurea mm hg","C0005767;C0005768;C0039155;C0229664;C0439475","C0005823","",1469
"smoking status no","C1519386",NULL,NULL,796
"fdc $nmbr$ $nmbr$ pg vs placebo","C0030827;C0032042;C0072225;C0340427;C1266240;C1413520;C1696465;C1706408;C3539652",NULL,NULL,208
"median duration oftype $nmbr$ diabetes iqr yr","C0011847;C0011849;C0439234;C0449238;C0549183;C0876920;C2347635;C2348144;C2926735;C2939193",NULL,NULL,635
"t score at femoral neck","C0015815;C3854607",NULL,NULL,511
"full cohort","C0009247;C0443225;C0599755","C0599755","",2208
"gold groups a d using mmrcb","C0018026;C0441833;C0687744;C0718133;C1257890;C1304897;C1519504;C1524063;C1552839;C1705428;C1705429","C0024117;C0521117","",213
"simplified disease activity index","C3869582","C1292728",";C4050231;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209",101
"option","C1518601;C1550456",NULL,NULL,906
"obesity t","C0028754;C1963185",NULL,NULL,710
"normoalbuminuria at baseline $nmbr$ of patients treated","C0030705;C0168634;C1442488;C1522326",NULL,NULL,552
"of predicted normal value","C0086715;C0681842;C1882327","C0024119","",288
"baseline age","C0001779;C0168634;C1442488","C0001779","",480
"stroke or cerebrovascular disease","C0007820;C0038454;C4554100",NULL,NULL,728
"outcome according to stage of cancer no total no","C0027646;C0439175;C0439810;C0680240;C1274040",NULL,NULL,1602
"chd cerebral infarction","C0007785;C0280604;C3542407",NULL,NULL,929
"no cad mi","C1504769;C2239547;C3810814;C3813548;C4284121",NULL,NULL,698
"wt second median","C0205436;C0457385;C0549183;C0565930;C0876920;C1561503;C1705190;C1883559;C2347635;C2348144;C2700323;C2939193",NULL,NULL,635
"$nmbr$ to $nmbr$ ppb","C1415800",NULL,NULL,1737
"nt probnp pg ml","C0439297;C0669479;C0754710",NULL,NULL,1511
"ltbr ng ml","C0439275;C1416931",NULL,NULL,204
"stent plus medical therapy","C0038257;C0418981",NULL,NULL,640
"abciximab facilitated pci","C0288672;C4049621","C0288672","",374
"concomitant medication use","C0240320;C0521115",NULL,NULL,119
"type of surgery","C0038894;C0038895;C0332307;C0543467;C1274039;C1547052",NULL,NULL,598
"moderate $nmbr$ risk factor","C0035648;C0205081;C1881878;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"$ $nmbr$ years n $nmbr$","C0439234",NULL,NULL,1099
"pbo no o o","C0031962;C0483204",NULL,NULL,435
"low","C0205251;C1550472;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"fev $nmbr$","C3714541",NULL,NULL,1599
"olodaterol sgg","C2934193",NULL,NULL,1510
"ecrcl ml min","C0439445","C3811844;C0017654","",307
"permanent","C0205355",NULL,NULL,718
"main concomitant treatments no","C0087111;C0205225;C0521115;C1542147",NULL,NULL,447
"men $nmbr$ cm","C0025266",NULL,NULL,1842
"hba $nmbr$ c baseline","C0019016;C0168634;C1442488;C1825777;C3538758","","",820
"hospital stay days","C0439228;C3489408",NULL,NULL,1621
"glucose metabolism","C0596620",NULL,NULL,629
"previously on acei arb","C3888198",NULL,NULL,44
"age groiro $nmbr$ years","C1510829","C1510829","",481
"$nmbr$ year or more","C0205172;C0439234;C0439508",NULL,NULL,1099
"mtx $nmbr$ $nmbr$ mg week","C0024671;C0025677;C0026410;C0332174;C0439230;C0439269;C1417487;C1960952;C2346927;C4321396;C4521761","C0025677","",716
"race no b","C0034510;C1706779;C3853635",";C0034510","",1107
"overall freedom population n $nmbr$","C0016694;C0032659;C0282416;C1257890;C1561607",NULL,NULL,904
"diastolic mean sd mm hg","C0012000;C0439475;C0444504;C2347634;C2348143;C2699239","C0005823","",1469
"troponin $nmbr$ at baseline","C0041199;C0168634;C1442488",NULL,NULL,1603
"sulfasalazine use at randomization","C0034656;C0036078;C0042153;C0457083;C1947944",NULL,NULL,2184
"i ii","C0021966;C0221138;C1710602;C4082587",NULL,NULL,521
"patients with digits with dactylitis n","C0030705;C0239161;C0582802","C0239161","",492
"prior cvd","C0007222;C0332152;C2826257","C0007222","",1790
"csdmard otherthan methotrexate","C0025677","C0025677","",1408
"ffa i","C0015688;C0021966;C0221138",NULL,NULL,1021
"tiotropium n $nmbr$ placebo n","C0032042;C0213771;C1696465;C1706408","C0032042","",28
"tobacco use yes n","C0040335;C0543414;C0841002;C1549445;C1705108;C1710701;C3853727",NULL,NULL,23
"diabetic retinopathy at baseline","C0011884;C0168634;C1442488",NULL,NULL,625
"revascularisation antiplatelets lipid lowering agents p blockers","C0086440;C0581603","C0086440","",1773
"other antihypertensive","C0003364",";C0003364","",1579
"anterior myocardial infarction no","C0340293",NULL,NULL,647
"patients with early cd n $nmbr$","C0007928;C0030705;C0034283;C1279919;C4552032",NULL,NULL,1487
"sirolimus eluting","C0072980",NULL,NULL,633
"hazard ratio for event $nmbr$ ci","C0008107;C0441471;C2985465;C3259781;C4019010","C2985465","",975
"egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n $nmbr$","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"e e septal","C0442004",NULL,NULL,351
"baseline post bronchodilator predicted fev $nmbr$ and prior ics use","C0042153;C0168634;C0332152;C0457083;C0681842;C0815320;C1442488;C1882327;C1947944;C2599594;C2826257;C3714541;C4551720",NULL,NULL,680
"days of study drug administration $nmbr$ day","C0150270;C2826182;C3469597",NULL,NULL,1007
"therapy","C0039798;C0087111;C1363945",NULL,NULL,236
"primary ep cvd mi ri","C0007222;C0035487;C0205225;C0439612;C0439631;C1826843;C1880476;C3810814;C4321526","C2986535","",230
"bone fracture","C0016658",NULL,NULL,2026
"st str $nmbr$ post pci","C0036056;C0687676;C1704687;C3272372;C3469826;C4049621",NULL,NULL,2356
"cv endpoints n","C2349179;C3538987;C4048877;C4318503",NULL,NULL,1777
"delayed","C0205421;C1545665;C3272602",NULL,NULL,317
"tender and swollen joints mean no","C0152031;C0234234;C0444504;C2347634;C2348143","C0152031","",1138
"famotidine $nmbr$ mg n $nmbr$","C0015620;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2279
"b h","C0033727;C0369286;C0441932;C0564385;C4528284",NULL,NULL,308
"russia georgia n $nmbr$","C0017452;C0017454;C0035970","C0035970;C0017452","",123
"pulse rate mean $nmbr$ h bpm","C0033727;C0232117;C0369286;C0441932;C0444504;C0564385;C2347634;C2348143;C4528284","C0018810","",1105
"south or central america","C0007674;C1710133",NULL,NULL,1559
"saxa met n $nmbr$","C0369718;C0428210;C0441922;C1550543;C4317104",NULL,NULL,39
"$nmbr$ fevi $nmbr$ pred","C0032952;C0044955;C0849974;C1561566;C4528367",NULL,NULL,1601
"plac","C0048838",NULL,NULL,1299
"question $nmbr$ neck back hip pain","C0004600;C0004604;C0007859;C0019552;C0019559;C0022122;C0027530;C0205095;C0460009;C1505163;C1522634;C1963071;C1963180;C1995000;C3159206;C3538851;C4284725;C4551516;C4553909;C4553945","C0004604","",1337
"active","C0205177;C3853793;C3888249",NULL,NULL,496
"fasting serum glucose median sd mg dl","C0015663;C0202041;C0439269;C0549183;C0876920;C2347635;C2348144;C2699239;C2939193;C3534430","C0017725;C0015663","",2280
"amlodipine wlsartan i $nmbr$ $nmbr$ mg","C0021966;C0024671;C0026410;C0051696;C0221138;C0439269;C1960952;C2346927;C4321396;C4521761","","",78
"use of anti hypertensive agents n","C0432633;C0450442;C0857121;C1254351;C1521826;C1524063",";C0003364","",1579
"rolofylline n $nmbr$ $nmbr$","C0166128","C0166128",";C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1114758;C1425688;C1521941;C2709207",67
"age at diagnosis of sle years","C0024141;C0439234;C1828181;C3173302","C1828181","",483
"peripheral edema","C0085649",NULL,NULL,691
"cgm use","C0042153;C0457083;C1947944",NULL,NULL,118
"aortic stenosis n","C0003507",NULL,NULL,565
"naive no treatment for current flare","C1517205;C2827774;C3540542",NULL,NULL,723
"prior lev treatment n","C0023556;C1514463",NULL,NULL,574
"prior ischemic stroke","C0332152;C0948008;C2826257",NULL,NULL,1669
"duration of osteoarthritis symptoms yr","C0029408;C0436359;C0439234","C0029408","",1356
"angiotensin ll receptor blocker","C0003018;C0597357;C4521302","C0521942","",779
"not perfused","C1518422;C1549542",NULL,NULL,85
"steroid use at baseline mg day","C0168634;C0281991;C0439422;C1442488","C0017710","",1348
"n of patients","C0030705;C0369718;C0441922",NULL,NULL,1035
"three or more agents","C0205172;C0205449;C0450442;C1254351;C1521826",NULL,NULL,484
"baseline acq $nmbr$ score","C0168634;C0449820;C1442488;C2919686;C4050231",NULL,NULL,625
"statin ezetimibe","C0360714;C1142985","C0360714;C1142985","",1862
"ldl c level mg dl","C0439269;C0441889;C0456079;C1547707;C2946261","C0023824","",1963
"devices for heart failure at screening visit","C0018787;C0018801;C0018802;C0025078;C0025080;C0220819;C0220908;C0220909;C0231174;C0545082;C0680095;C0699733;C1512346;C1698960;C1710031;C1710032;C1710477;C2024216;C2348164;C2826704;C4554158",NULL,NULL,798
"m o nito ring treatment","C0039798;C0087111;C0369637;C0441923;C0521164;C1260969;C1522326;C1533734;C1705169;C1882954;C3538994;C3887704",NULL,NULL,923
"duration of asthma $nmbr$ years","C0004096;C0439234;C0449238;C2926735;C2984299",NULL,NULL,694
"reversibility s $nmbr$ itt n $nmbr$","C0449261","C0449261","",2160
"number of previous reported aeds","C0180309;C0205156;C0237753;C0449788;C0684224;C0700287;C1552607;C4319718",NULL,NULL,1556
"fvc liters","C0475211;C3714541",NULL,NULL,1599
"patient s history of","C0679831;C1369882",NULL,NULL,1492
"i or ii","C0021966;C0221138",NULL,NULL,523
"hospitalization for heart failure or cv death","C0011065;C1306577;C3538987;C3898876;C4048877;C4082313;C4318503;C4552775",NULL,NULL,1777
"$nmbr$ placebo n $nmbr$","C0032042;C1696465;C1706408","C0032042","",28
"biomarker low periostin $nmbr$ ng ml or blood eosinophils $nmbr$ cells per pl na","C0005516;C0005773;C0007584;C0007634;C0014467;C0200638;C0205251;C0219433;C0439275;C0597484;C1272460;C1424662;C1546968;C1550472;C1879645;C3812270;C3890211;C3897966;C4048187;C4049765;C4049872;C4321351;C4522223;C4552882",NULL,NULL,204
"pre bronchodilator fev $nmbr$ predicted normal","C0205307;C0231683;C0439166;C0681842;C1882327;C2347086;C2599602;C3714541;C4553972",NULL,NULL,682
"r $nmbr$ mg fa","C0024671;C0026410;C0205090;C0439269;C0684010;C1960952;C2346927;C2603358;C4321396;C4521761",NULL,NULL,192
"night time awakenings in past $nmbr$ weeks sd","C0860510;C2699239;C2987125",NULL,NULL,1014
"sf $nmbr$ bodily pain mean change from baselineb","C0037712;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C3890602;C4319952","C0030193","",1338
"new anemia bsl hb $nmbr$ g i $nmbr$ yr $nmbr$ $nmbr$ g i $nmbr$","C0002871;C0019046;C0021966;C0205314;C0221138;C0439234;C1000483;C1319635;C1549954;C4554633",NULL,NULL,152
"prostate cancer","C0376358;C0600139;C2984325;C3541264","C0376358","",1866
"swollen joint count","C0451521",";C0451521","",1140
"ldl c measured mean sd","C0444504;C0444706;C2347634;C2348143;C2699239;C3541902","C0023824","",1068
"hdl c","C3715113","C0023822","",821
"eze simva $nmbr$ $nmbr$ mg dn $nmbr$ c $nmbr$","C0024671;C0026410;C0439269;C1333964;C1707618;C1960952;C2346927;C4321396;C4521761","C0360714;C1142985","",1862
"tpm exposed","C0076829;C0332157",NULL,NULL,755
"crcl $nmbr$","C1846718",NULL,NULL,706
"lower dose","C0445550;C1708745","C0445550","",112
"iglar dose at randomization u day","C0034656;C0178602;C0456683;C0869039;C1114758",NULL,NULL,1174
"patientswith bp $ $nmbr$ $nmbr$ mmhg abpm at baseline nt","C0037623;C0168634;C0332126;C0439475;C1415692;C1442488;C1449832;C1708288;C3889152;C4050156;C4283901;C4284038;C4318478",NULL,NULL,608
"fibula fracture","C0149699",NULL,NULL,2024
"no diabetes p o $nmbr$","C0011847;C0011849","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"american indian or alaska","C0001905;C0002460",NULL,NULL,637
"asian itt population by treatment group","C0032659;C0039798;C0078988;C0087111;C0374505;C1257890;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,236
"$nmbr$ $nmbr$ lo i","C0021966;C0206579;C0221138;C1232424",NULL,NULL,1057
"charlson comobility score n","C0449820;C4050231",NULL,NULL,766
"baseline use of adm n","C0168634;C0215825;C1442488;C1524063;C4521767",NULL,NULL,1368
"creatinine p mol l","C0010294;C0347982;C1561535","C0600061;C0010294","",952
"time from sx onset to baseline ecg min","C0168634;C0449244;C0702093;C1442488;C1519428;C1524029;C1623258;C3539997;C3813700;C3815196",NULL,NULL,1475
"tiotropium olodaterol $nmbr$ $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4032878;C4321396;C4521761",NULL,NULL,2301
"males itt n $nmbr$","C0086582","C0086582","",1276
"baseline anti hyperglycemic medications","C0013227;C0168634;C0802604;C1442488;C2598133;C4284232","C0020616",";C0013227;C3244316;C4284232;C0450442;C1254351;C1515187;C1521826;C2826257",33
"age at completion of highest level of","C0001779;C0205197;C1554962;C4321237","C0001779","",480
"japan","C0022341","C0022341","",1815
"mean sd das $nmbr$ $nmbr$ esr","C0051767;C0057671;C0444504;C2347634;C2348143;C2699239;C3811131",NULL,NULL,37
"hispanic n $nmbr$ l $nmbr$","C0086409","C0086409","",865
"mean blood eosinophil count cells per pl","C0200638;C0444504;C2347634;C2348143;C3897966;C4049765",NULL,NULL,37
"$nmbr$ with historical count $nmbr$","C0750480;C1552658;C1552723;C1705566;C2004062",NULL,NULL,1389
"nd not due to swelling or ich","C0013604;C0019191;C0038999;C0678226;C1518422;C3272597;C3281105",NULL,NULL,1363
"caucasian","C0007457;C0043157","C0043157","",1329
"post bronchodilator fev $nmbr$ predicted of normal value","C0086715;C0681842;C1882327;C2599594;C3714541",NULL,NULL,680
"sf $nmbr$ summary scores","C0037712;C0449820;C1552616;C1706244;C4050231",NULL,NULL,1782
"adjusted hr losartan vs atenolol","C0004147;C0126174;C0456081","C0126174;C0004147","",2086
"no history of hf","C0018488;C0019664;C0019665;C0262512;C0262926;C1313497;C1538440;C1705255;C2004062;C3273279",NULL,NULL,832
"back pain","C0004604;C1963071;C4553945","C0004604","",1337
"glycated haemoglobin","C0017853","","",1176
"concomitant therapy no","C1707479",NULL,NULL,446
"c reactive protein concentration mg l","C0006560;C0086045;C0439268;C1413716;C1446561;C3827302;C4048285","C0006560","",286
"without stent","C0038257",NULL,NULL,569
"edoxaban at randomization n","C0034656;C2975435",NULL,NULL,692
"$nmbr$ st tertile $nmbr$ mg dl $nmbr$ $nmbr$ mmol l b","C0036056;C0439269;C1532563;C3272372",NULL,NULL,670
"pbo n $nmbr$ vs","C0031962",NULL,NULL,435
"from baseline $nmbr$ ci","C0008107;C0168634;C1442488;C3259781",NULL,NULL,519
"baseline std mm","C0168634;C1442488;C4330985;C4554674",NULL,NULL,297
"any antianginal drug","C0013227;C1254351;C1874267;C3537168","C3537168","",382
"total hip n $nmbr$ $nmbr$ bmd g cm $nmbr$ sd","C0019552;C0022122;C0439175;C0439267;C0439810;C1505163;C2699239;C3538851;C4284725",NULL,NULL,508
"mean sd nonstudy eye e etdrs visual acuity letter score","C0015392;C0042812;C0700042;C1096774;C2360551;C2699239;C3533236",NULL,NULL,1287
"hospitalized","C0701159","C0701159","",260
"first episode of atrial fibrillation vs recurrent episode no f","C0004238;C0016327;C0205435;C0332189;C0344434;C0443287;C1279901;C1963067",";C0004238","",1009
"act total score $nmbr$","C0079613;C1704930;C1869853;C2964552;C3890007;C4048375",NULL,NULL,499
"creatinine level","C0428279",NULL,NULL,314
"other medications at enrollment","C0013227;C0802604;C1516879;C1696073;C2598133;C3888021;C4284232",NULL,NULL,339
"screening bmi kg m $nmbr$","C0220908;C0220909;C0578022;C1532718;C1698960;C1710031;C1710032;C1710477;C2348164",NULL,NULL,1735
"aqlq s $nmbr$ scorets","C4055434",NULL,NULL,750
"non steroidal anti inflammatory drugs","C0003211",NULL,NULL,2122
"initial diagnosis no","C0011900;C0205265;C1279901;C1555582;C1704338;C1704656;C1705685",NULL,NULL,806
"age years median $nmbr$ th to $nmbr$ th percentile","C0039725;C0039738;C0549183;C0876920;C1264641;C1420718;C1510829;C2347635;C2348144;C2939193;C4282123;C4285344","C1510829","",481
"physiological measures","C0079809;C0205463;C1879489",NULL,NULL,2
"long acting nitrates","C0028125;C0079613;C0205166;C1704930;C1706317;C1869853;C3890007;C4048375",NULL,NULL,499
"baseline tjc mean s e","C0168634;C0444504;C1442488;C2347634;C2348143",NULL,NULL,1589
"triacylglycerol mmol le","C0023190;C0041004;C0439090;C0439190;C1423767;C2697858",NULL,NULL,1274
"nyha class iii or iv n","C0022326;C1882086;C4265176","C0018802;C1882083","",453
"exacerbation rate in the previous year range","C0205156;C0439234;C0439508;C0871208;C1514721;C1521828;C1552607;C2348147;C3542016;C4086268",NULL,NULL,2006
"female subgroup","C0043210;C0086287;C1079230;C1515021;C1705497;C1705498",NULL,NULL,1637
"patient global assessment of disease","C0012634;C4054229",NULL,NULL,491
"type of tnf failure n b","C0231174;C0332307;C0680095;C1547052;C3887647",NULL,NULL,11
"ldl cihdl c mean sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"gold grades $nmbr$ $nmbr$ percent predicted fev n","C0018026;C0439165;C0441800;C0681842;C0919553;C1304897;C1882327;C3244287;C3714541",NULL,NULL,1599
"difference from placebo $nmbr$ cl","C0032042;C0596019;C1696465;C1705241;C1705242;C1706408","C0032042","",28
"budesonide formoterol fdc","C0340427;C1276807;C1413520;C3539652",NULL,NULL,1978
"serum ctx $nmbr$ ng ml median iqr","C0010377;C0229671;C0439275;C0549183;C0631180;C0876920;C1546774;C1550100;C2347635;C2348144;C2939193;C3539598",NULL,NULL,951
"asthma control","C0004096;C0243148;C1550141;C1882979;C2587213;C2984299;C3274648;C4553389",NULL,NULL,675
"baseline prediabetes","C0168634;C0362046;C1442488","C0362046",";C0168634;C1334085;C1708411",910
"change in sedbp ls mean se","C0023668;C0036919;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952",NULL,NULL,567
"median iqr mean $nmbr$ sdchange from baseline to week $nmbr$ by weight group and mtx use weight","C0005910;C0025677;C0042153;C0043100;C0168634;C0332174;C0439230;C0441833;C0444504;C0457083;C0549183;C0687744;C0876920;C1257890;C1305866;C1417487;C1442488;C1519504;C1705104;C1705428;C1705429;C1947944;C2347634;C2347635;C2348143;C2348144;C2939193","C0025677","",1408
"no of strokes","C0038454",NULL,NULL,1762
"dual i extension","C0021966;C0205173;C0221138;C0231448;C1554184;C1880641",NULL,NULL,1021
"ischemic stroke","C0948008",NULL,NULL,1669
"oropharyngeal pain","C2363731;C4554669","C2363731","",2171
"schwab england score","C0014282;C0449820;C4050231",NULL,NULL,748
"low no risk factor","C0035648;C0205251;C1550472;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"adjusted change from baseline","C0168634;C0392747;C0443172;C0456081;C1442488;C1705241;C4319952",NULL,NULL,625
"management of event no","C0001554;C0376636;C0441471;C1273870;C3273539;C4019010",NULL,NULL,1059
"combined n $nmbr$","C0205195",NULL,NULL,997
"sbp $nmbr$ mmhg and or dbp $nmbr$ mmhg","C0085805;C0439475;C0536221;C3813197;C4281799",NULL,NULL,607
"copd n","C0024117;C1412502;C3714496",NULL,NULL,1726
"patients who received $nmbr$ drug","C0013227;C0030705;C1254351;C1514756",NULL,NULL,731
"warfarin naive","C0043031","C0043031","",858
"microalbuminuria no total no","C0439175;C0439810;C0730345","C0033687","",376
"psychosocial risk factors","C0033963;C0035647;C0035648;C0542298;C1458132;C1553898;C4552904",NULL,NULL,175
"body weight kg mean sd","C0005910;C0022718;C0439209;C0444504;C1305866;C2347634;C2348143;C2699239;C4054209","C0005910","",1912
"cardiac rhythm","C0232187",NULL,NULL,1674
"saxagliptin n $nmbr$","C1611934","C1611934","",2069
"serum vitamin d nmol l","C0014695;C0042866;C0229671;C0439282;C1546774;C1550100;C2936842;C3537249;C3714503","C0042866","",866
"age distribution","C0001782","C1510829","",481
"$nmbr$ th $nmbr$ $nmbr$ $nmbr$ pmol l","C0039725;C0039738;C0439284;C1420718;C4282123;C4285344",NULL,NULL,1433
"cs and imm","C0010182;C0205470;C0271160;C3540510;C4085345",NULL,NULL,136
"non spondylitis","C0038012;C1518422",NULL,NULL,85
"glucose lowering therapies no","C0017725;C0087111;C0441994;C2003888","C0020616",";C0013227;C3244316;C4284232;C0450442;C1254351;C1515187;C1521826;C2826257",33
"sgrq score mean sd","C0444504;C0449820;C2347634;C2348143;C2699239;C4050231",NULL,NULL,37
"increase creatinine $nmbr$ $nmbr$ mg dl","C0010294;C0439269;C0442805;C1561535",NULL,NULL,2284
"aspirin use n","C0004057;C0042153;C0457083;C1947944","C0004057","",1366
"arm","C0446516;C3715044;C4553528",NULL,NULL,950
"sulfasalazine treatment","C0036078;C0039798;C0087111;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,236
"low renin pra $nmbr$ $nmbr$ ng ml h n $nmbr$","C0633231;C0855389;C1141951;C1419788;C1533072;C3274822;C3669212;C4050009;C4283900",NULL,NULL,1057
"history of cad mi","C0019664;C0019665;C0262512;C0262926;C1504769;C1705255;C2004062;C2239547;C3810814;C3813548;C4284121",NULL,NULL,832
"cardiovascular hospitalisation","C0007226;C0019993;C3887460",NULL,NULL,649
"ii or iii","C0439070;C1705160",NULL,NULL,524
"mean age sd","C0001779;C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"hormones","C0019932","C0019932","",280
"feno $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761","C0033228","",803
"spironolactone n $nmbr$","C0037982","C0037982","",1405
"history of falls","C1561668;C2919132",NULL,NULL,1494
"dactylitis count","C0239161;C0750480;C1705566","C0239161","",492
"age $nmbr$ $nmbr$","C0001779","C0001779","",480
"known t rc iitoji cccndilon","C0205309;C1167159;C1419366",NULL,NULL,1238
"angiotensin eonverting enzyme inhibitors","C0003018;C0014432;C1152555;C2756995;C4521302","C0003015","",811
"ff vi $nmbr$ $nmbr$ ci $nmbr$ $nmbr$","C0008107;C0205999;C3259781;C4554348",NULL,NULL,515
"difference in ls mean vs placebo $nmbr$ ci mmol mol","C0008107;C0023668;C0032042;C0444504;C1696465;C1705241;C1705242;C1706408;C2347634;C2348143;C3259781;C3829066",NULL,NULL,519
"$nmbr$ to $nmbr$","C0040363;C0041260;C1883351",NULL,NULL,431
"notatincreased fall risk n $nmbr$ $nmbr$","C1268740","C1268740","",1850
"time since diagnosis of diabetes","C0011847;C0011849;C0011900;C0040223;C1704338;C1704656;C3541383","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"duration alendronate use years meanisd","C0042153;C0102118;C0439234;C0449238;C0457083;C1947944;C2926735","C0102118;C0449238","",1992
"dapagliflozin n $nmbr$","C2353951","C2353951","",2066
"nadroparin n $nmbr$","C0206232","C0206232","",860
"hba $nmbr$ c mmol mole","C0019016;C1825777;C3538758;C3829066","","",820
"crp mg l median min max","C0439268;C0549183;C0702093;C0876920;C1524029;C2347635;C2348144;C2939193;C3813700;C3890735;C4048285",NULL,NULL,1475
"current smokers itt n $nmbr$","C3173209;C3241966","C3241966","",1420
"etn yes","C0014758;C0717758;C1549445;C1705108;C1710701",NULL,NULL,147
"b acr $nmbr$","C1412134;C1515941",NULL,NULL,52
"no randomized","C0034656;C3815594",NULL,NULL,692
"corticosteroid","C0001617;C3536709",NULL,NULL,1650
"no hx of hf n $nmbr$","C0018488;C0262926;C1313497;C1538440;C3273279;C3814444","C0018801",";C0168634;C1524003",12
"tim $nmbr$ nsk score","C0449820;C1313407;C3541335;C3711667;C3827754;C3890185;C4050231;C4319633",NULL,NULL,2052
"$nmbr$ mg qw $nmbr$ $nmbr$ pt yrs","C0024671;C0026410;C0032743;C0043011;C0439269;C0699718;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"beam $nmbr$ mg dl at week $nmbr$ n","C0332174;C0338248;C0439230;C0439269;C2347880;C4521565",NULL,NULL,559
"biguanide use at baseline","C0005382;C0042153;C0168634;C0457083;C1442488;C1947944;C3537187;C4317165","C0005382","",685
"amiodarone n","C0002598","","",1757
"vka at randomization","C0034656",NULL,NULL,1352
"$nmbr$ years eze simva","C0439234",NULL,NULL,1099
"nintedanib n $nmbr$","C2930789","C2930789","",1095
"concomitant drugs","C0013227;C0521115;C3687832",NULL,NULL,447
"no rest angina","C0002965;C0152172","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"values are expressed as percentages unless otherwise indicated bmi body mass index cabg coronary artery bypass ischemic attack nsaids nonsteroidal anti inflammatory drugs sbp systolic bp dbp diastolic bp history of or currently taking antidiabetic or lipid lowering medications","C0003209;C0003211;C0010055;C0012000;C0013227;C0019664;C0019665;C0023779;C0042295;C0085805;C0242821;C0262512;C0262926;C0439165;C0441994;C0460148;C0521116;C0536221;C0577559;C0577573;C0578022;C0600653;C0745413;C0802604;C0871470;C0918012;C0935929;C1096155;C1268086;C1306372;C1444656;C1515187;C1549488;C1552854;C1561533;C1637833;C1705255;C2003888;C2004062;C2598133;C2986546;C3152252;C3539882;C3813197;C4082212;C4281799;C4283905;C4284232",NULL,NULL,156
"elms n","C0330531;C2980688",NULL,NULL,1787
"patients treated with statins n $nmbr$","C0030705;C0332293;C0360714",NULL,NULL,1035
"family history of diabetes","C1313937",NULL,NULL,1491
"duration of macular edema mo","C0024440;C0026544;C0271051;C0332177;C0449238;C2926735",NULL,NULL,1476
"lvef $nmbr$ $nmbr$ and nyha class ii iii at baseline","C0168634;C0428772;C0439070;C0488728;C1442488;C1705160;C1710602;C1882085;C1882086;C4082587","C0018801;C0428772","",1273
"not reported","C0684224;C0700287;C1518422;C4319718",NULL,NULL,85
"cha $nmbr$ ds $nmbr$ vasc score n","C0449820;C1420648;C3714751;C4050231",NULL,NULL,968
"saxagliptin $nmbr$ $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1611934;C1960952;C2346927;C4321396;C4521761","C1611934","",2069
"micro or macroalbuminuria no","C0085672;C1553035;C3811161;C4049106","C0033687","",376
"das $nmbr$ crp $nmbr$ $nmbr$ n","C0051767;C0057671;C3890735;C4048285",NULL,NULL,143
"angiotensin converting enzyme inhibitors","C0003015;C2757044","C0003015","",811
"change from baseline in post bd","C0005126;C0168634;C0392747;C0443172;C0687676;C1442488;C1704687;C1705241;C2344255;C3469826;C4050145;C4319952",NULL,NULL,625
"stratification factors","C1514984","C1514984","",1112
"f $nmbr$ $nmbr$ i $nmbr$ $nmbr$","C0016327;C0021966;C0221138",NULL,NULL,1021
"ularitide n $nmbr$","C0077910",NULL,NULL,1568
"older des n $nmbr$","C0011702;C0580836;C4551552",NULL,NULL,465
"tdi total score week $nmbr$","C0205976;C0332174;C0439230;C2674784;C2964552;C3714807",NULL,NULL,1012
"corticosteroid use $nmbr$ n","C0239126","C0239126",";C0168634;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1425988;C1947944",120
"gemfibrozil","C0017245",NULL,NULL,1695
"fatal or nonfatal myocardial infarction","C0027051;C0428953;C1302234;C1705232;C2926063;C3810814;C4552959",NULL,NULL,1682
"level $nmbr$","C0441889;C0456079;C1547707;C2946261",NULL,NULL,744
"in hospital ticagrelor n $nmbr$","C0019994;C1510665;C1999375","C1999375;C1510665","",1246
"inadequate response intolerance to prior therapy","C0039798;C0087111;C0205412;C0231199;C0332152;C0439856;C0871261;C1363945;C1704632;C1706817;C1744706;C2355652;C2911692",NULL,NULL,726
"renin inhibitor e g aliskerin","C1960108;C3537174;C4521920",NULL,NULL,813
"gly $nmbr$ $nmbr$ gg b i d n n","C0017454;C0018370;C0152277;C1415124",NULL,NULL,201
"baseiine statin","C0360714","C0360714","",872
"no previous cd related surgery $nmbr$","C0007928;C0034283;C0038894;C0038895;C0205156;C0439849;C0445223;C0543467;C1274039;C1552607;C4552032",NULL,NULL,598
"who fc ii symptoms at baseline $nmbr$","C0168634;C0683368;C1442488;C1457887;C1710602;C2983605;C4082587",NULL,NULL,521
"odds ratio $nmbr$ ci","C0008107;C0028873;C3259781",NULL,NULL,519
"previous smoker","C0337671","C0037369","",420
"gold stage iii","C0018026;C0441771;C1304897",NULL,NULL,542
"baseline sedbp mean sd mm hg","C0168634;C0439475;C0444504;C1442488;C2347634;C2348143;C2699239","C0005823","",1469
"swollen joint count $nmbr$ $nmbr$ joints","C0451521",";C0451521","",1140
"mean change in acq score","C0392747;C0443172;C1705241;C2919686;C3533236;C4319952",NULL,NULL,767
"ae a ratio per $nmbr$ $nmbr$ unit","C0439148;C0439453;C0456603;C1509845;C1519795;C1547037;C1704753;C1880519;C3853603;C3887670",NULL,NULL,94
"plasma triglyceride mg dl","C0032105;C0041004;C0439269;C1550098;C4521445","C0041004","",368
"nonglycemic cardiovascular risk factors systolic blood pressure mmhg","C0439475;C0488055;C0850624;C0871470;C1306620","C0871470","",615
"$nmbr$ vr no","C3476815",NULL,NULL,86
"glycemic status","C1320980","C1320980","",2174
"disease stage","C0699749",NULL,NULL,98
"patient s global assessment of disease status score","C0449820;C3176928;C4050231;C4054229",NULL,NULL,491
"proprotein convertase subtil kexin typ $nmbr$ ng ml baseline median n $nmbr$ $nmbr$","C0165249;C0168634;C0439275;C0549183;C0876920;C1100660;C1414185;C1442488;C2347635;C2348144;C2939193;C3811813",NULL,NULL,204
"pure motor hemiparesis","C0018989;C1513492;C1705994;C2247561",NULL,NULL,1473
"positive atopic status","C0392707;C0439178;C0449438;C1446409;C1514241;C2825490;C3812269",NULL,NULL,1163
"placebo to ustekinumab $nmbr$ mgt","C0032042;C1608841;C1696465;C1706408","C0032042","",28
"$nmbr$ hr plasma glucose mg dl","C0202042;C0439269;C0455280","C0455280;C0015663",";C0168634",21
"sensorimotor stroke","C0038454;C4554100",NULL,NULL,1762
"high blood pressure","C0020538;C2926615","C0020538","",1365
"fatal bleed","C0019080;C1302234;C1705232",NULL,NULL,707
"dapagliflozin $nmbr$ mg day n $nmbr$","C0439422;C2353951","","",198
"other dmards","C0242708","C0242708",";C0026544",231
"antihypertensives n","C0003364",";C0003364","",1579
"baseline bmi kg m $nmbr$","C0168634;C0578022;C1442488;C1532718",NULL,NULL,1735
"infarct localisation","C0021308;C0475264;C1744691","C0021308;C0475264","",899
"no of patients","C0030705",NULL,NULL,1035
"none n $nmbr$","C0369718;C0441922",NULL,NULL,738
"tnf failure patientsa","C0231174;C0680095;C1448177",NULL,NULL,11
"median $nmbr$ kg","C0022718;C0439209;C0549183;C0876920;C2347635;C2348144;C2939193;C4054209",NULL,NULL,635
"insulin dose u","C0366513;C0439148",NULL,NULL,94
"baseline presence of nasal polyps","C0027430;C0150312;C0168634;C0392148;C1442488;C3854307",NULL,NULL,2368
"pga score mean sd","C0016410;C0444504;C0449820;C2347634;C2348143;C2699239;C3541266;C4050231;C4050369",NULL,NULL,1525
"salmeterol n $nmbr$","C0073992","C0060657;C0073992","",1508
"iief ef domain score visit $nmbr$","C0449820;C0545082;C1512346;C1880389;C1883221;C2826704;C3541951;C3641331;C4050231",NULL,NULL,998
"swollen joint count $nmbr$ $nmbr$ per swollen joint","C0451521",";C0451521","",1140
"ls mean $nmbr$ ci","C0008107;C0023668;C0444504;C2347634;C2348143;C3259781",NULL,NULL,519
"determined by investigator to be possibly probably or definitely related to study drug tmyopathy defined as cpk $nmbr$ x uln with associated muscle symptoms with no other plausible etiology consecutive defined as two or more measurements at least one week apart or one measurement $nmbr$ days after the last dose of study drug presumed consecutive two patients had incomplete data to assess chd status simva simvastatin eze ezetimibe ae adverse event alt alanine aminotransferase ast aspartate aminotransferase cpk creatine phosphokinase uln upper limit of normal","C0010287;C0013175;C0015127;C0026845;C0030705;C0035173;C0040363;C0041260;C0074554;C0178602;C0205172;C0205448;C0242485;C0280604;C0332281;C0439849;C0445223;C0449438;C0521095;C0683368;C0750492;C0805162;C0869039;C0877248;C1114758;C1142985;C1266129;C1314792;C1415181;C1442452;C1457887;C1516048;C1519815;C1524003;C1704788;C1707491;C1883351;C2362652;C3242203;C3539106;C3542407;C3844320;C3887670;C3891303;C4083049;C4553172",NULL,NULL,490
"atrial fibrillation no total no","C0004238;C0344434;C0439175;C0439810;C1963067",";C0004238","",1009
"pain subscale","C0030193;C0518090;C1962977;C2984058;C4085210;C4085211;C4085212;C4553004;C4554132","C0030193","",1338
"egfr mdrd ml min $nmbr$ $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682;C3839656","C3811844;C0017654","",592
"no steroids n $nmbr$ vs $nmbr$","C0038317",NULL,NULL,1648
"metformin dose","C0025598;C0178602;C0869039;C1114758",NULL,NULL,110
"losartan lisinopril","C0065374;C0126174","C0126174;C0065374","",1930
"insulins and analogs","C0021641;C0243071;C3537244;C4049919",NULL,NULL,161
"aml vs lis","C0023465;C0023467;C2247545",NULL,NULL,127
"medical history no total no","C0262926;C0439175;C0439810;C1704706",NULL,NULL,832
"das $nmbr$ crp","C0051767;C0057671;C3890735;C4048285",NULL,NULL,143
"gold grade $nmbr$ and ics users at screening","C0018026;C0220908;C0220909;C0441800;C0815320;C0919553;C1304897;C1698960;C1706077;C1710031;C1710032;C1710477;C2348164;C3244287;C4551720",NULL,NULL,1359
"aspirin $nmbr$ day","C0004057;C0332173;C0439228;C0439505",NULL,NULL,1621
"time from onset of symptoms to randomization days","C0034656;C0439228;C1320528",NULL,NULL,1621
"events consistent with uti","C0042029;C0077906;C0332290;C0441471;C1412376;C3541888",NULL,NULL,1534
"dactylitis score","C0239161;C0449820;C4050231","C0239161","",492
"race nonwhitet","C0034510;C1706779;C3853635",";C0034510","",1107
"tcz sc $nmbr$ mg every other week n $nmbr$","C0024671;C0026410;C0282380;C0332174;C0439230;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,1012
"vascular disease","C0042373",NULL,NULL,102
"western europe and australia","C0004340;C0043129",NULL,NULL,54
"st segment elevation","C0520886","C0520886","",1944
"medications at the time of randomization no","C0013227;C0034656;C0040223;C0802604;C2598133;C3541383;C4284232",NULL,NULL,2263
"main accord endpoint","C0205225;C0680240;C1542147;C2349179;C2826544","C2349179","",1136
"ed etiology no","C0015127;C1314792;C1524003;C3538926",NULL,NULL,924
"rarely","C0522498",NULL,NULL,547
"no prior tnf inhibitor exposure","C0274281;C0332152;C0332157;C1448177;C1999216;C2826257",NULL,NULL,362
"change in ldl c","C0392747;C0443172;C1705241;C4319952",NULL,NULL,767
"fatigue","C0015672;C3463815;C4050243;C4554645","C0015672",";C4050243;C3542016;C0424589;C0542479;C1442080;C4330907;C0444504;C4553152",10
"disease extent n","C0012634;C0439792",NULL,NULL,1279
"body mass index $nmbr$ n","C0005893;C0578022;C1305855","C1305855","",1734
"bleeding end points","C0019080;C2349179",NULL,NULL,2038
"heart rate b p m","C0018810;C0369637;C0441923","C0018810","",1105
"india","C0021201;C2700456",NULL,NULL,168
"post bronchodilator fev reversibility","C0449261;C2599594;C3714541","C0449261;C0231999","",1315
"median age yr","C0001779;C0439234;C0549183;C0876920;C2347635;C2348144;C2939193","C0001779","",480
"history of percutaneous coronary intervention","C1320647;C4554713",NULL,NULL,1714
"adjusted mean change","C0392747;C0443172;C0444504;C0456081;C1705241;C2347634;C2348143;C4319952",NULL,NULL,37
"morning stiffness duration min","C0449238;C0457086;C0702093;C1524029;C2926735;C3813700",NULL,NULL,1475
"hospitalization for","C0019993",NULL,NULL,2358
"characteristic_name","C0027365;C1521970;C1547383;C4522128",NULL,NULL,1571
"$nmbr$ $nmbr$ mg l","C0439268","C0006560","",193
"daily dose $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C2348070;C4321396;C4521761",NULL,NULL,192
"percentage of bsa involved","C0439165;C1314939;C1549488;C1561533",NULL,NULL,291
"bud $nmbr$ ptg n $nmbr$","C0039512;C1418830;C2700462;C2945744",NULL,NULL,708
"emphysema","C0013990;C0034067",NULL,NULL,1672
"group no","C0441833;C0687744;C1257890;C1519504;C1705428;C1705429",NULL,NULL,1526
"comorbidities concomitant medications","C0009488;C0013227;C0521115;C0802604;C2598133;C4284232",NULL,NULL,366
"overall effect","C0282416;C1280500;C1518681;C1561607;C2348382",NULL,NULL,1743
"change from baseline stage $nmbr$ ckd","C0168634;C0597205;C0679846;C1442488;C1561643","C1561643","",967
"crp mg l median sd","C0439268;C0549183;C0876920;C2347635;C2348144;C2699239;C2939193;C3890735;C4048285","C0006560","",286
"secondary mace endpoint","C0349381;C0949745;C1445339;C4528314","C1320716","",414
"smoking status ongoing n","C0549178;C1519386",NULL,NULL,796
"psoriasis characteristics","C0033860;C1521970","C0033860","",1358
"baseline total ipss","C0168634;C0439175;C0439810;C1019118;C1442488;C1998280;C2827405;C3811063","C1998280",";C1019118;C3811063;C4050465;C4050466;C4049706;C0168634;C1705273;C1880519;C3853603",124
"age group no y","C0027362;C2348001",NULL,NULL,45
"not hispanic latino n $nmbr$ $nmbr$","C0086528;C1518424","C0086409","",865
"nt probnp pmol h","C0033727;C0369286;C0439192;C0441932;C0564385;C0669479;C0754710;C4528284",NULL,NULL,1511
"haemorrhagic stroke no","C0553692",NULL,NULL,581
"ldl cholesterol mean mg dl sd","C0023824;C0202117;C0439269;C0444504;C2347634;C2348143;C2699239",NULL,NULL,37
"baseline nih stroke scale no","C0168634;C1442488;C1697238;C3484372",NULL,NULL,625
"aclidinium $nmbr$ g n $nmbr$","C0439267;C2699757",NULL,NULL,1485
"change in psa modified shs baseline to week $nmbr$","C0168634;C0332174;C0392747;C0439230;C0443172;C1442488;C1705241;C3810537;C3813209;C3889737;C4319952",NULL,NULL,625
"vitamin c","C0003968;C2349136;C3714687;C4522080",";C2349136","",1936
"high risk n $nmbr$ $nmbr$","C0332167;C3272283;C4050568;C4319571","C4319571","",837
"$nmbr$ to $nmbr$ ng l n $nmbr$ n","C0439297",NULL,NULL,202
"hdl cholesterol mmol le","C0023190;C0023822;C0392885;C0439090;C0439190;C1423767;C2697858","C0023822","",821
"pre bronchodilator fevj","C2599602",NULL,NULL,682
"hemoglobin ale median iqr","C0019046;C0549183;C0678386;C0876920;C2347635;C2348144;C2632076;C2939193",NULL,NULL,400
"race zz","C0034510;C1706779;C2347310;C3853635",";C0034510","",1107
"any albuminuria","C0001925","C0001925","",375
"canakinumab dose per month","C0178602;C0332177;C0439231;C0869039;C1114758;C2718773",NULL,NULL,110
"smoking history pack years mean sd","C0444504;C1277691;C1519384;C2347634;C2348143;C2699239",NULL,NULL,37
"patients with an event per $nmbr$ patient years","C0030705;C0439234;C0441471;C4019010",NULL,NULL,1099
"tertile $nmbr$ index pci performed","C0600653;C0884358;C0918012;C1552854;C1637833;C2986546;C4049621",NULL,NULL,576
"with revascularisation","C0581603","C0877341;C3272275","",1212
"age at time of first seizure","C0001779;C0036572;C0040223;C0205435;C1279901;C1959629;C3541383;C4553401","C0001779","",480
"changes at baseline","C0168634;C0392747;C0443172;C1442488",NULL,NULL,625
"lebrikizumab $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C2981360;C4321396;C4521761",NULL,NULL,2287
"hazard ratio $nmbr$ ci","C0008107;C2985465;C3259781",NULL,NULL,519
"rotablator use n","C0042153;C0457083;C1260867;C1947944",NULL,NULL,118
"corticosteroids and antimalarials only","C0001617;C0003374;C0205171;C1720467;C3539185;C3540725;C3540726;C3540727",NULL,NULL,1650
"prior amputation","C0002688;C0332152;C0332840;C1546539;C2826257","C0002688","",895
"charlson index","C0600653;C0918012;C1552854;C1637833;C2986546",NULL,NULL,734
"definite probable stent thrombosis","C0033204;C0332148;C0439544;C1704787;C3897493",NULL,NULL,915
"polyvascular disease and type $nmbr$ diabetes n $nmbr$","C0012634;C1320657",NULL,NULL,1868
"$nmbr$ antihypertensive medications","C0003364",";C0003364","",1579
"post bronchodilator fev $nmbr$ liters","C0475211;C2599594;C3714541",NULL,NULL,680
"cox $nmbr$ selective nsaid","C0003211;C0036576;C1565830;C1707391;C3536840",NULL,NULL,2123
"p value men versus women","C0025266;C0043210;C1709380","","",-10
"previous stroke tia","C0007787;C0038454;C0205156;C0917805;C1054154;C1552607;C4554100",NULL,NULL,1762
"tia n","C0007787;C0917805;C1054154",NULL,NULL,1592
"hdl c median iqr mg dl","C0439269;C0549183;C0876920;C2347635;C2348144;C2939193;C3715113","C0023822","",1962
"major diabetic eye disease n","C0205082;C0205164;C0342245;C4318856;C4521762","C0342245","",596
"calcium antagonists","C0006684","C0006684","",1884
"budesonide formoterol $nmbr$ $nmbr$ $nmbr$ g n $nmbr$","C0439267;C1276807","C1276807","",1159
"egfr ml min bsa","C0439445;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"estimate $nmbr$ cl","C0596019;C0750572",NULL,NULL,658
"d aza treatment ref","C0004482;C0039798;C0073187;C0087111;C0332173;C1425988;C1522326;C1533734;C1705169;C3538994;C3887704;C4484261",NULL,NULL,1881
"creatinine clearance $nmbr$ ml min","C0439445;C0812399","C3811844;C0017654","",307
"allergic rhinitis no","C1334103;C2607914;C4552864",";C0035455","",272
"amlodipine vs chlorthalidone obese","C0008294;C0028754;C0051696","","",78
"lipoprotein a mmol l","C0065058;C0125953;C1096202;C1439335;C1532563",NULL,NULL,670
"alogliptin $nmbr$ mg pioglitazone n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C3535925;C4321396;C4521761",NULL,NULL,1955
"ethnicity n","C0015031;C0243103",NULL,NULL,787
"n blood pressure mean sd mm hg","C0369718;C0428886;C0439475;C0441922;C2699239","C0005823","",1469
"hzard ratio","C0456603;C1547037",NULL,NULL,973
"dactylitis count $nmbr$ $nmbr$ mean sd","C0239161;C0444504;C0750480;C1705566;C2347634;C2348143;C2699239","C0239161","",492
"mean total stent length per lesion mm sd","C0038257;C0221198;C0439175;C0439810;C0444504;C1444754;C1546698;C1706316;C2347634;C2348143;C2699239;C4330985;C4554674",NULL,NULL,569
"b nonsevere hypoglycemia","C0020615;C4553659","C0020615","",35
"placebo golimumab $nmbr$ mg $nmbr$ mga b","C0024671;C0026410;C0032042;C0065879;C0439269;C1696465;C1706408;C1960952;C2346927;C2353893;C4321396;C4521761",NULL,NULL,1767
"mod sev exacerbation rate","C0011860;C0439793;C0458216;C0871208;C1521828;C2983285;C4086268","C4086268;C1521828;C0439793","",1195
"analgesic medication n","C0002771",NULL,NULL,58
"two of the above","C0205448",NULL,NULL,429
"previous transient ischaemic attack ischaemic stroke previous warfarin use","C0007787;C0038454;C0042153;C0043031;C0205156;C0457083;C0917805;C1552607;C1947944;C4554100","C0043031","",858
"thienopyridine n $nmbr$","C1120149","C1120149",";C0039798;C0087111;C1363945;C1709561;C1947944",73
"absolute decline in fvc $nmbr$ predicted or death n","C0011065;C0205344;C0681842;C1306577;C1882327;C3714541;C4082313;C4552775",NULL,NULL,1599
"table_group","C0039224;C0441833;C0687744;C1257890;C1519504;C1705428;C1705429;C1706074",NULL,NULL,1526
"alcohol consumption n","C0001948","C0001948","",875
"isolated systolic hypertension n","C0745133","C0745133","",1051
"hdl c mmol l","C1532563;C3715113","C0023822","",821
"aggressive n $nmbr$","C0001807;C0580822",NULL,NULL,468
"diabetes type ii n","C0011860","","",2081
"ibdq total score mean sd","C0444504;C2347634;C2348143;C2699239;C2964552",NULL,NULL,2313
"intravenous study drug administered no","C0013175;C0348016;C0557651;C0683092;C1521801;C2603343","C0348016","",1189
"no ace i arb","C0021966;C0221138;C1452534;C3888198;C4284014",NULL,NULL,46
"fev $nmbr$ at baseline randomization","C0034656;C0168634;C1442488;C3714541",NULL,NULL,1599
"patient characteristics at randomization","C0034656;C0815172",NULL,NULL,1652
"$nmbr$ day cce","C0332173;C0439228;C0439505",NULL,NULL,1621
"aspartate aminotransferase increased","C0004002;C0205217;C0442805",NULL,NULL,1572
"kccq score","C0449820;C3476798;C4050231",NULL,NULL,748
"p trend","C0369773;C1521798;C2603361;C4554533",NULL,NULL,550
"hyperkalaemia","C0020461;C4552983","C0020461;C4552983",";C0439375;C0700287;C0684224;C0035173",30
"mercaptopurine","C0000618","C0000618","",77
"ldl cholesterol mean sd mg dl","C0023824;C0202117;C0439269;C0444504;C2347634;C2348143;C2699239","C0023824","",1963
"calcium channel blocker ratelowering","C0006684;C3536851;C4521885","C0006684","",1884
"high $nmbr$ $nmbr$","C0205250;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"hospitalized hf","C0018488;C0701159;C1313497;C1538440;C3273279","C0018801",";C0168634;C1524003",12
"total cholesterol mg dl mean sd","C0201950;C0439269;C0444504;C0543421;C2347634;C2348143;C2699239","C0543421","",1504
"central nervous system","C3540014;C3714787",NULL,NULL,927
"baseline fvc l","C0168634;C1442488;C3714541",NULL,NULL,1599
"duration of diabetes yr","C0011847;C0011849;C0439234;C0449238;C2926735","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"laba no ics n","C0815320;C4551720",NULL,NULL,1359
"mssbp sd mmhg","C0439475;C2699239",NULL,NULL,1471
"serum potassium level mean sd meq l","C0302353;C0439375;C0444504;C0543465;C2347634;C2348143;C2699239","C0302353","",1959
"cad history and risk factors n","C0019664;C0019665;C0035648;C0262512;C0262926;C1504769;C1553898;C1705255;C2004062;C2239547;C3813548;C4284121",NULL,NULL,832
"percutaneous coronary intervention or coronary artery bypass graft surgery n","C0010055;C1532338","C2936173;C0010055","",1524
"final mean","C0205088;C0444504;C1546485;C2347634;C2348143;C3853528",NULL,NULL,1680
"total score $nmbr$","C2964552",NULL,NULL,540
"g blockers","C0439267",NULL,NULL,1486
"prior diabetes","C0011847;C0011849;C0332152;C2826257","C0011849","",912
"baseline outcomes","C0168634;C1274040;C1442488",NULL,NULL,1602
"number","C0237753;C0449788",NULL,NULL,1556
"lacosamide","C0893761",NULL,NULL,2049
"chronic obstructive pulmonary","C0024109;C0205191;C0549186;C2707265;C2709248;C4522268",NULL,NULL,982
"alcohol drinker","C0001962;C0001975;C0556338",NULL,NULL,176
"extensive","C0205231","C0205231","",1167
"mtx $nmbr$ and si $nmbr$ mg week","C0024671;C0025677;C0026410;C0332174;C0439230;C0439269;C1417487;C1960952;C2346927;C4321396;C4521761","C0025677","",716
"current smoker n","C3173209;C3241966","C3241966","",1420
"dm aliskiren vs placebo","C0011816;C0032042;C1120110;C1696465;C1706408;C3250443","C0032042","",28
"pioglitazone n $nmbr$ $nmbr$","C0071097",NULL,NULL,1760
"$nmbr$ ci p value","C0008107;C1709380;C3259781",NULL,NULL,519
"albumin creatinine ratio n","C0486293;C1318293","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"mean prebronchodilation l","C0444504;C2347634;C2348143",NULL,NULL,37
"lvef u","C0428772;C0439148;C0488728","C0018801;C0428772","",1273
"bm $nmbr$ kg m $nmbr$ mean s d","C0006416;C0022718;C0369637;C0439209;C0439493;C0441923;C0444504;C1275571;C1513009;C2347634;C2348143;C4054209",NULL,NULL,37
"age of completion of highest education years sd","C0013621;C0013622;C0013658;C0039401;C0205197;C1510829;C1522410;C1554962;C2699239","C0013658","",902
"aspirin $nmbr$ mg n $nmbr$","C0004057;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761","C0004057","",1366
"etr $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ $nmbr$ ci p $nmbr$ $nmbr$","C0008107;C3259781",NULL,NULL,519
"seizure types reported during baseline b n","C0036572;C0168634;C0332307;C0684224;C0700287;C1442488;C1959629;C4319718;C4553401",NULL,NULL,625
"sf $nmbr$ pcs mean sd","C0037712;C0444504;C1864389;C1882368;C2347634;C2348143;C2699239",NULL,NULL,1782
"heart rate mean sd beats min","C0018810;C0444504;C0702093;C1524029;C2347634;C2348143;C2699239;C3813700","C0018810","",1105
"tiotropium $nmbr$ gg qd","C0017454;C0018370;C0213771;C0332173","C0213771","",1372
"egfr mean sd n","C0444504;C1739039;C2347634;C2348143;C2699239;C3811844;C3812682",NULL,NULL,37
"primary end point kaplan meier rate","C0871208;C1521828;C2986535","C2986535","",230
"baseline anti hypertensive usea","C0003364;C0168634;C1442488",";C0003364","",1579
"$nmbr$ to $nmbr$ yr no","C0439234",NULL,NULL,1099
"mean stent diameter per lesion mm sd","C0038257;C0221198;C0552409;C1546698;C2699239;C4330985;C4554674",NULL,NULL,1287
"severity of copda airflow limitation n","C0231999;C0439793;C0443288;C0449295;C0522510",NULL,NULL,561
"time to angiography hr","C0002978;C0040223;C3541383","C3494202","",433
"baseline free pcsk $nmbr$ level by median","C0168634;C0332296;C0441889;C0456079;C0549183;C0876920;C1442488;C1547707;C1880497;C1996904;C2347635;C2348144;C2939193;C2946261",NULL,NULL,635
"fasting insulin pmol l mean sd","C0015663;C0021641;C0439284;C0444504;C1533581;C1579433;C2347634;C2348143;C2699239;C3714501",NULL,NULL,157
"transfusion $nmbr$ units rbcs or whole blood","C0005841;C0014792;C0199960;C0229664;C0370231;C0439148;C1519795;C1546552;C1608383;C1879316;C3853603","C0005841","",1241
"severity of copd combined assessment n","C0024117;C0205195;C0439793;C0522510;C1261322;C1412502;C1516048;C3714496",NULL,NULL,1546
"mean sd post bronchodilator fev $nmbr$ reversibility","C0444504;C0449261;C2347634;C2348143;C2599594;C2699239;C3714541",NULL,NULL,2142
"all cause death n","C0011065;C0015127;C1306577;C1524003;C4082313;C4552775",NULL,NULL,1855
"abnormal angiogram","C0002978;C0205161;C1548816;C2347472;C2699333;C3891555;C4255126",NULL,NULL,686
"region no c","C0017446;C0205147",NULL,NULL,1060
"fh ii","C1854107",NULL,NULL,1598
"history of pvd","C4534349","C0241889","",1493
"incident dm or change in","C0011816;C0392747;C0443172;C1551358;C1705241;C3250443;C4319952",NULL,NULL,767
"msdbp mmhg sd","C0439475;C2699239",NULL,NULL,1471
"low c $nmbr$ $nmbr$ mg dl","C0205251;C0439269;C1550472;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"mean systolic pressure gradient","C0039155;C4687744",NULL,NULL,614
"absent $nmbr$ mg dl","C0332197;C0439269;C4285062",NULL,NULL,485
"fasting tgs median q $nmbr$ q $nmbr$","C0015663;C0549183;C0876920;C1156212;C1537574;C2347635;C2348144;C2939193",NULL,NULL,635
"hba $nmbr$ c $nmbr$","C0019016;C1825777;C3538758","","",820
"administration of study drug","C0001554;C0013175;C0013227;C0150270;C0262754;C0557651;C1254351;C1533734;C2603343;C3161471;C3469597",NULL,NULL,1007
"alcohol consumption at baseline","C0001948;C0168634;C1442488","C0001948","",875
"atorvastatin ls means difference $nmbr$ mg $nmbr$ ci a n $nmbr$","C0008107;C0023668;C0024671;C0026410;C0286651;C0369718;C0439269;C0441922;C1704970;C1705241;C1705242;C1960952;C2346927;C3259781;C4321396;C4521761",NULL,NULL,519
"lisinopril cvd total","C0007222;C0065374;C0439175;C0439810","C0007222","",1790
"infliximab monotherapy","C0666743","C0666743","",154
"overall male female","C0043210;C0086287;C0086582;C0282416;C1561607;C1705497;C1705498;C1706180;C1706428;C1706429","C0086582","",1276
"change mg dl mmol l","C0392747;C0439269;C0443172;C1532563;C1705241;C4319952",NULL,NULL,670
"glucosidase inhibitor","C1512211",NULL,NULL,814
"bivalirudin plus glycoprotein iib iiia inhibitors n $nmbr$","C0016011;C0168273;C0243077",NULL,NULL,776
"time from onset of pain to randomization median iqr h","C0030193;C0033727;C0034656;C0369286;C0441932;C0449244;C0518090;C0549183;C0564385;C0876920;C1962977;C2347635;C2348144;C2939193;C2984058;C4085210;C4085211;C4085212;C4528284;C4553004;C4554132","C0030193;C0449244;C0034656","",2169
"$nmbr$ and $nmbr$ years","C0439234",NULL,NULL,1099
"location of treatment center","C0039798;C0087111;C0205099;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,677
"total n $nmbr$","C0439175;C0439810",NULL,NULL,508
"mucosal healingc n n","C0026724",NULL,NULL,328
"baseline aspirin use","C0004057;C0042153;C0168634;C0457083;C1442488;C1947944",NULL,NULL,118
"mean duration of pd yr","C0439234;C0444504;C0449238;C2347634;C2348143;C2926735;C4553228;C4553229",NULL,NULL,1230
"age mean yr","C0001779;C0439234;C0444504;C2347634;C2348143","C0001779","",480
"indacaterol tiotropium n $nmbr$","C0213771;C1722260","C1722260","",1875
"bivalirudin n $nmbr$","C0168273",NULL,NULL,776
"patients with possible new dm at randomization fpg $nmbr$ $nmbr$","C0011816;C0030705;C0034656;C0205314;C0332149;C1705910;C2362652;C3250443",NULL,NULL,955
"primary efficacy outcome","C0205225;C0439612;C0439631;C1274040;C1280519;C1707887",NULL,NULL,2339
"tg $nmbr$ mg dl n o","C0337445;C0439269","C0041004","",368
"hf hospitalization n","C0018488;C0019993;C1313497;C1538440;C3273279","C0018801",";C0168634;C1524003",12
"previous coronary revascularization","C0205156;C0877341;C1552607","C0877341",";C4049621;C1552607",223
"time from qualifying stroke to randomization","C0034656;C0038454;C0040223;C1514624;C3541383;C4554100",NULL,NULL,1762
"$nmbr$ mm hg heart rate","C0018810;C0439475",NULL,NULL,1888
"no body weight at randomization ixrs","C0005910;C0034656;C0242821;C0460148;C1268086;C1305866;C2985844;C4082212","C0005910","",1250
"alcohol use n","C0001948","C0001948","",875
"left main coronary artery bifurcation","C3898614","C0205042","",228
"paci","C1165245",NULL,NULL,2094
"stiffness subscale","C0427008",NULL,NULL,754
"vi $nmbr$ $nmbr$ ci $nmbr$ $nmbr$","C0008107;C0205999;C3259781",NULL,NULL,515
"secondary outcome","C0027627;C0175668;C0205436;C1274040",NULL,NULL,1484
"$nmbr$ mw distance m","C0012751;C0024548;C0026385;C0369637;C0441923;C0556966",NULL,NULL,923
"medications n of patients","C0013227;C0030705;C0802604;C2598133;C4284232",NULL,NULL,2263
"$nmbr$ lead ecg heart rate beats min","C0018810;C0179504;C0702093;C1524029;C3813700",NULL,NULL,1475
"time since diagnosis of ln years","C0011900;C0040223;C0439234;C0861352;C1428884;C1704338;C1704656;C3541383;C3714709",NULL,NULL,1099
"hypertension requiring treatment","C0578998",NULL,NULL,725
"and or aza at baseline","C0004482;C0168634;C1442488",NULL,NULL,56
"patient s preference not to take","C0040363;C0041260;C0376409;C1515187;C1518422;C1883351",NULL,NULL,431
"$nmbr$ chd risk factors","C0035648;C0280604;C1553898;C3542407",NULL,NULL,175
"patients randomized","C0030705;C0034656;C3815594",NULL,NULL,692
"bp blood pressure ci confidence interval esrd end stage renal disease hr hazard ratio all patients except patients with other race were included with missing covariates imputed event no of patients with esrd rate event rate per $nmbr$ years of follow up pre specified a cox model with treatment group and region as covariates and baseline proteinuria level o or x $nmbr$ g g as strata adjusted a multivariate cox model with treatment group time varying systolic and diastolic bp as covariates pre specified analysis and adjusted for time varying bp","C0002778;C0005823;C0008107;C0009667;C0012634;C0017446;C0022646;C0022661;C0030705;C0033687;C0034510;C0035078;C0037623;C0039155;C0039798;C0040223;C0087111;C0168634;C0205088;C0205147;C0332257;C0332283;C0428883;C0439234;C0441471;C0441833;C0441835;C0441889;C0456079;C0456081;C0679845;C0687744;C0871208;C0936012;C1257890;C1319635;C1415692;C1442488;C1519504;C1521828;C1522326;C1524024;C1533734;C1547707;C1551393;C1565830;C1705169;C1705428;C1705429;C1705492;C1706779;C1708288;C1719822;C1962972;C2316810;C2699638;C2826245;C2946261;C2985465;C3161035;C3259781;C3272743;C3274659;C3538994;C3541383;C3714583;C3853635;C3853906;C3887704;C4019010;C4281991;C4318478;C4522145;C4554346","","",-10
"stroke of atherosclerotic origin","C0038454;C0079946;C0333482;C0439659;C1550512;C4554100","C4554100","",336
"mean baseline ucdai score","C0168634;C0444504;C0449820;C1442488;C2347634;C2348143;C4050231",NULL,NULL,625
"p value by gt","C1435727;C1704693;C1709380;C2697657",NULL,NULL,250
"bmi median iqr kg m $nmbr$","C0549183;C0578022;C0876920;C1532718;C2347635;C2348144;C2939193",";C1305855","",206
"antianginal medications","C0013227;C0802604;C1874267;C2598133;C3537168;C4284232",NULL,NULL,366
"blood eosinophil","C0014467","C0014467","",849
"sex m f","C0009253;C0036864;C0079399;C0804628;C1306057;C1314687;C1522384",NULL,NULL,568
"lv ejection fraction n $nmbr$","C0023128;C0489482;C0731033;C1881413;C2700378",NULL,NULL,2106
"investigator defined drug related aes","C0013227;C0035173;C0439849;C0445223;C1254351;C1412268;C1704788;C2699274;C3539106",NULL,NULL,367
"iwqol lite total score arbitrary units","C0439183;C2964552",NULL,NULL,540
"$nmbr$ $nmbr$ no total no","C0439175;C0439810",NULL,NULL,508
"other climate subset","C0008946;C1515021",NULL,NULL,1657
"grip strength meidan","C0429271;C2598165","C0429271","",578
"p $nmbr$ y $nmbr$ inhibitor","C0369773;C1999216;C2603361",NULL,NULL,812
"uplift population","C0032659;C1257890",NULL,NULL,904
"aml vs chl","C0019829;C0023465;C0023467",NULL,NULL,969
"se","C0036919",NULL,NULL,567
"other atherosclerotic cvdd e","C0333482;C1859330","C0004153","",1698
"medications at time of randomization no","C0013227;C0034656;C0040223;C0802604;C2598133;C3541383;C4284232",NULL,NULL,2263
"sbp $nmbr$ mmhg n $nmbr$","C0085805;C0439475",NULL,NULL,607
"prasugrel","C1620287","C1620287","",4
"korea republic of","C0022773",NULL,NULL,1871
"race no","C0034510;C1706779;C3853635",";C0034510","",1107
"time since start of fit years meanisd","C0036572;C0040223;C0439234;C0439659;C1711239;C2349186;C3541383;C4048158;C4553125",NULL,NULL,1099
"abciximab vs primary","C0205225;C0288672;C0439612;C0439631","C0288672","",374
"for patients using personal cgm","C0030705;C1519021;C1524063",NULL,NULL,1035
"smoking during the previous month","C0332177;C0439231;C2114448",NULL,NULL,1476
"taci n $nmbr$","C0666480;C1425349;C4284230",NULL,NULL,2094
"lipid trial participantss","C0008976;C0023779",NULL,NULL,1020
"high dose statin use n e","C0042153;C0360714;C0444956;C0457083;C1947944","C0444956","",111
"previous clinical stroke or tia","C0007787;C0038454;C0205156;C0205210;C0917805;C1054154;C1552607;C4554100",NULL,NULL,1762
"low dose","C0445550;C1708745","C0445550","",112
"totalhdl cholesterol ratio","C0008377;C0456603;C1547037","C0023822","",821
"laba ics","C0815320;C4551720",NULL,NULL,2193
"moderately high risk without atherosclerotic vascular disease","C0004153;C0205081;C0332167;C1881878;C3272283;C4050568;C4085643;C4319571;C4321491","C4319571","",837
"previous hypertension","C0020538;C0205156;C1552607;C1963138","C0020538","",1364
"previous statin use","C0042153;C0205156;C0360714;C0457083;C1552607;C1947944",NULL,NULL,1044
"intervention","C0184661;C0886296;C1273869",NULL,NULL,290
"n $nmbr$ t","C0369718;C0441922",NULL,NULL,1553
"motor","C1513492;C1705994",NULL,NULL,1473
"patient reported outcome measures","C4277735","C4277735","",1336
"at baseline","C0168634;C1442488",NULL,NULL,625
"ace i n","C0021966;C0221138;C1452534;C4284014",NULL,NULL,46
"number of events patients","C0030705;C0441471;C2360800;C3541888;C4330837",NULL,NULL,1035
"diabetes duration n","C0011847;C0011849;C0449238;C2926735","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"age $nmbr$ $nmbr$ years n $nmbr$","C1510829","C1510829","",481
"bodymass index kg m $nmbr$","C0005893;C0578022;C1305855;C1532718",";C1305855","",206
"intertrochanteric","C0745355",NULL,NULL,538
"vorapaxar group n $nmbr$","C0441848;C2974521","C2974521","",1448
"selexipag vs placebo hazard ratio $nmbr$ cl","C0032042;C0596019;C1696465;C1706408;C2000145;C2985465","C2985465","",975
"range iga modified $nmbr$ score n","C0392747;C0449820;C1514721;C2348147;C2825347;C3542016;C3889737;C4050231",NULL,NULL,1768
"higher dose edoxaban vs warfarin","C0043031;C0444956;C2975435","C0444956","",111
"disease duration y","C0872146","C0449238;C0872146","",903
"lm $nmbr$ $nmbr$","C1261082;C1551056","","",-10
"total hands score","C0018563;C0439175;C0439810;C0449820;C1552914;C4050231",NULL,NULL,1666
"mitral valve disease n $nmbr$ $nmbr$","C0026265;C4553832","C0018824","",103
"established renal disease","C0022658;C0443211;C1272684","C0022658","",320
"history of diabetes","C0011847;C0011849;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"diet diet pravastatin event patients $nmbr$ ooo pt y","C0012155;C0012159;C0030705;C0032743;C0085542;C0441471;C0699718;C1519433;C2983588;C3668949;C4019010",NULL,NULL,1513
"crp median se rng l","C0036919;C0549183;C0876920;C2347635;C2348144;C2939193;C3890735;C4048285","C0006560","",286
"mean change in fn bmd","C0392747;C0443172;C0444504;C1570610;C1705241;C2347634;C2348143;C4319952",NULL,NULL,767
"never smoking","C0037369;C0453996;C1881674;C2003901",NULL,NULL,316
"white race no total no $","C0007457;C0034510;C0043157;C0220938;C0439175;C0439810;C1706779;C3853635","C0043157","",1402
"medication use no","C0013227;C0042153;C0457083;C1947944;C3244316;C4284232",NULL,NULL,441
"number of patients with available data","C0470187;C1511726;C2360800;C3245479;C3714741",NULL,NULL,1427
"age subgroup y","C0001779;C1079230;C1515021","C0001779","",480
"rs $nmbr$","C0035970;C3714753;C3813325","","",-10
"adjusted or $nmbr$ cl","C0456081;C0596019",NULL,NULL,658
"diarrhoea","C0011991;C1963091;C3641756;C4084784;C4084802;C4085317",NULL,NULL,50
"standard deviation triglyceride","C0041004;C0871420","C0041004","",368
"mean sd change from","C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C2699239;C4319952",NULL,NULL,771
"itch nrs $nmbr$ $nmbr$ a $nmbr$","C0033774;C1422257;C2240043;C4050142","C0033774;C4050142","",1362
"tadalafil $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1176316;C1960952;C2346927;C4321396;C4521761","C1176316","",855
"ipss total score","C1019118;C1998280;C2827405;C2964552;C3811063","C1998280",";C1019118;C3811063;C4050465;C4050466;C4049706;C0168634;C1705273;C1880519;C3853603",124
"glucose lowering therapy no","C0017725;C0039798;C0087111;C0441994;C1363945;C2003888","C0020616",";C0013227;C3244316;C4284232;C0450442;C1254351;C1515187;C1521826;C2826257",33
"leading to study drug discontinuation","C0013175;C0040363;C0041260;C0332152;C0457454;C1444662;C1522538;C1883351;C4552847",NULL,NULL,1731
"$nmbr$ years eze simva n $nmbr$","C0439234",NULL,NULL,1099
"primary outcome $nmbr$ point mace","C0205225;C0349381;C0439612;C0439631;C0949745;C1274040;C1445339;C1552961;C2347617;C3714763","C1320716","",414
"alanine aminotransferase or aspartate aminotransferase $nmbr$ x upper limit of normal n $nmbr$","C0001899;C0004002;C0057041;C1415274;C1519815;C3887708",NULL,NULL,1572
"use of methotrexate at randomization","C0025677;C0034656;C1524063","C0025677","",1408
"total study population n $nmbr$ $nmbr$","C0439175;C0439810;C0557651;C2348561;C2603343;C3258257",NULL,NULL,510
"normal or increased baseline gfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$","C0017654;C0168634;C0205217;C0205307;C0231683;C0369637;C0439166;C0439445;C0441923;C0442805;C1424601;C1442488;C2347086;C4553972","C3811844;C0017654","",592
"bivalirudin alone n $nmbr$","C0168273;C0205171;C0439044;C0679994",NULL,NULL,926
"severe to end stage impairment $nmbr$ ml min","C0205082;C0205088;C0221099;C0439445;C0684336;C4050465;C4050466",NULL,NULL,313
"cancer fatal and nonfatal","C0006826;C0998265;C1302234;C1306459;C1705232","C0006826","",1819
"diabetes with no use of diabetes drugs","C0020616;C1524063",NULL,NULL,25
"baseline haq mean s e","C0102923;C0168634;C0444504;C0451208;C1442488;C2347634;C2348143",NULL,NULL,37
"psap b ng ml","C0439275;C1418975;C1420002;C1425004",NULL,NULL,204
"saes","C1519255;C1622657;C4553214","C1519255","",1282
"coronaiy artery disease","C0852949",NULL,NULL,786
"cana","C1418845",NULL,NULL,1302
"swollen joint count $nmbr$ $nmbr$ possible joints","C0332149;C0451521;C1705910;C2362652",";C0451521","",1140
"mean sd fevi ml","C0429706;C0439526;C0444504;C0849974;C1561566;C1705224;C2347634;C2348143;C2699239;C3887665;C4528367",NULL,NULL,1601
"mean pulse pressure mmhg s d","C0232117;C0391850;C0444504;C0445074;C0949236;C1947910;C2347155;C2347634;C2348143","C0949236","",1118
"evolocumab $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C3529352;C4321396;C4521761",NULL,NULL,948
"oral anti dm drug status no","C0011816;C0029167;C0175795;C0304289;C0449438;C3250443",NULL,NULL,955
"one tnfi and","C0205447",NULL,NULL,737
"age years a","C1510829","C1510829","",481
"ed characteristics","C1521970;C3538926",NULL,NULL,411
"non mtx","C0025677;C1417487;C1518422","C0242708",";C0026544",231
"dabigatran $nmbr$ mg twice daily","C0024671;C0026410;C0439269;C0585361;C1960952;C2346927;C2348066;C4321396;C4521761",NULL,NULL,775
"pre bronchodilator fev $nmbr$ fvc","C2599602;C3714541",NULL,NULL,1599
"edoxaban n n rate","C0871208;C1521828;C2975435","C2975435","",1220
"$nmbr$ crcl n","C1846718",NULL,NULL,706
"baseline median","C0168634;C0549183;C0876920;C1442488;C2347635;C2348144;C2939193",NULL,NULL,635
"a aml n $nmbr$","C0023465;C0023467",NULL,NULL,186
"aspirin $nmbr$ clopidogrel","C0004057;C0070166","C0070166",";C0369286;C0033727;C4049621",217
"aza n $nmbr$","C0004482",NULL,NULL,56
"exetimibe simvastatin","C0074554","C0074554","",1840
"stroke or tia no","C0007787;C0038454;C0917805;C1054154;C4554100",NULL,NULL,1762
"cigarette smoking status","C0239059;C0449438;C0677453;C0700219;C1519386;C1704760;C3890423",NULL,NULL,796
"cld $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"systolic mmhg","C0039155;C0439475","C0005823","",1469
"das $nmbr$ range $nmbr$ $nmbr$ mean sd","C0051767;C0057671;C0444504;C1514721;C2347634;C2348143;C2348147;C2699239;C3542016",NULL,NULL,1914
"geometric mean crp concentration mg l","C0086045;C0439268;C1446561;C2986759;C3827302;C3890735;C4048285","C0006560","",286
"adjusted modelc hr $nmbr$ ci p value","C0008107;C0456081;C1709380;C3259781",NULL,NULL,519
"fdc $nmbr$ $nmbr$ pg vs aclidinium $nmbr$ pg","C0030827;C0072225;C0340427;C1266240;C1413520;C2699757;C3539652",NULL,NULL,208
"by gfr stratum tor all participants ml min per $nmbr$ $nmbr$ m","C0017654;C0076836;C0369637;C0439445;C0441923;C0679646;C1199517;C1419603;C1424601;C3539732","C3811844;C0017654","",592
"patients with draining fistulae at baseline n $nmbr$","C0030705;C0168634;C0544791;C1442488",NULL,NULL,1596
"aspirin only","C0004057;C0205171;C1720467","C0004057","",1366
"severe copd","C0024117;C0205082;C1412502;C3714496;C4050465;C4050466",NULL,NULL,313
"qualifying cv event n","C0441471;C1514624;C3538987;C4019010;C4048877;C4318503",NULL,NULL,1777
"history of hyperlipidemia","C4695788",NULL,NULL,1498
"fasting tgs","C0015663;C1156212;C1537574",NULL,NULL,128
"prior heart failure no","C0018801;C0018802;C0332152;C2826257;C4554158","C0018801",";C0168634;C1524003",12
"before bronchodilation","C1371299;C3537072",NULL,NULL,681
"age years median iqr","C0549183;C0876920;C1510829;C2347635;C2348144;C2939193",NULL,NULL,1890
"crp $nmbr$ $nmbr$ mg dl n","C0439269;C3890735;C4048285","C0006560","",286
"black non hispanic n","C0005680;C0027567;C0085756;C0439541;C1518422;C1518424;C1533017;C1533018","C0005680",";C1706779",188
"central and eastern europe","C0015177;C0205099;C1879652","C0239309","",601
"section $nmbr$ c","C0152060;C0700320;C1522472;C1552923;C1705191;C3714523","C2700378","",887
"tjc mean sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,1589
"unadjusted p value","C1439367;C1709380",NULL,NULL,1581
"native hawaiian or","C0337920","C0337920;C0242191","",1331
"median of jsw","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"asa","C0004057;C3853627",NULL,NULL,60
"chinese","C0008120;C0152035",NULL,NULL,770
"$nmbr$ $nmbr$ io i","C0021966;C0221138;C1046794;C3146236",NULL,NULL,444
"lm $nmbr$ bid n $nmbr$","C1261082;C1551056","","",-10
"female sex no total","C0086287;C0439175;C0439810","C0086287","",1277
"administration of study drug bolus no total no","C0001554;C0013175;C0013227;C0150270;C0262754;C0439175;C0439810;C0557651;C1186706;C1254351;C1511237;C1533734;C1705509;C2603343;C3161471;C3469597;C3812160",NULL,NULL,508
"cornell voltage duration product mmxmsec","C0449238;C0598352;C1514468;C1704444;C2926735",NULL,NULL,901
"participation in phase a","C0205390;C0679823;C1710475",NULL,NULL,1523
"interval from symptom onset to qualifying ecg obtained in the er hr","C1272706;C1301820;C1514624;C1552654;C1552713;C1623258;C3810541;C3811131;C4086878","C1272706","",1097
"pulmonary embolisma n n","C0024109;C2707265;C2709248;C4522268",NULL,NULL,572
"lvh by ecgt blood pressure mm hg","C0005823;C0149721;C0439475;C1271104;C1272641","C0005823","",15
"body mass index median iqr b","C0005893;C0549183;C0578022;C0876920;C1305855;C2347635;C2348144;C2939193","C1305855","",1891
"proximal gastrointestinal tract","C0017189;C0205107;C0521362;C4489236","C0205107;C0521362","",2242
"family history of cancerf","C0241889","C0241889","",1493
"at $nmbr$ years","C0439234",NULL,NULL,1099
"history of stroke n","C0019664;C0019665;C0038454;C0262512;C0262926;C1705255;C2004062;C4554100",NULL,NULL,832
"treatment difference $nmbr$ ci","C0008107;C0039798;C0087111;C1522326;C1533734;C1705169;C1705241;C1705242;C3259781;C3538994;C3887704",NULL,NULL,519
"bii score","C0449820;C1413059;C4050231",NULL,NULL,748
"li $nmbr$ $nmbr$ $nmbr$","C0023617;C3495095",NULL,NULL,526
"cerebral hemorrhage","C2937358",NULL,NULL,929
"ra symptom duration $nmbr$ months number","C0237753;C0439231;C0449238;C0449788;C1457887;C2926735;C3538806;C3854129;C4048756",NULL,NULL,901
"rectum and sigmoid colon only","C0034896;C0205171;C0227391;C1720467","C0034896;C0227391","",1441
"basdai $nmbr$ n","C1998004","C1998004","",1354
"fpg mg dl","C0439269",NULL,NULL,192
"antihypertensive antianginal and other cardiovascular medications","C0003364;C0007220;C1874267;C3537168","C0007220","",897
"ff vi $nmbr$ $nmbr$","C0205999;C4554348",NULL,NULL,515
"insulin at baseline","C0021641;C0168634;C1442488;C1533581;C1579433;C3714501",NULL,NULL,157
"pathological q waves","C0429090",NULL,NULL,1606
"duration of asthma yr","C0004096;C0439234;C0449238;C2926735;C2984299",NULL,NULL,694
"baseline cdai score mean s d","C0168634;C0444504;C0449820;C0683448;C1413248;C1442488;C2347634;C2348143;C3273706;C4050231",NULL,NULL,697
"non hdl c mean sd rng dl","C0444504;C1518422;C2347634;C2348143;C2699239;C3642216;C3715113","C0023822","",821
"baseline tg $nmbr$ $nmbr$ mmol l","C0168634;C0337445;C1442488;C1532563","C0041004","",209
"angina pectorisf","C0002962","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"history of atrial fibrillation type no","C0332307;C0729790;C1547052",";C0004238","",1009
"united states","C0041703",NULL,NULL,1550
"number of arterial beds involved","C0003842;C0004916;C0221464;C0237753;C0449788;C1314939",NULL,NULL,1878
"sex n b","C0009253;C0036864;C0079399;C0804628;C1314687;C1522384",NULL,NULL,568
"saba use occasions weekt","C0042153;C0457083;C1947944",NULL,NULL,2185
"non hispanic","C1518424","C0086409","",865
"estimated glomerular filtration rate $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ no total no","C0369637;C0439175;C0439445;C0439810;C0441923;C3811844",NULL,NULL,923
"method of assessing ejection fraction","C0025663;C0302131;C0336969;C0449851;C0812388;C0871511;C1264633;C1516048","C2700378","",887
"mmp $nmbr$ ng ml","C0439275;C0623362;C0919336",NULL,NULL,204
"sbp dbp $ $nmbr$ $ $nmbr$ mmhg","C0085805;C0439475;C0536221;C3813197;C4281799",NULL,NULL,607
"rarely never","C4035880",NULL,NULL,315
"ejection fraction nyha class n","C0489482;C1882083;C2700378","C2700378","",887
"exposed n $nmbr$","C0332157","C0332157",";C0274281;C0231491;C1420817;C4521367;C4521846;C1552607",27
"add on to met su $nmbr$","C0038642;C0428210;C1550543;C1705534;C1883712;C4317104",NULL,NULL,39
"hypertension yes","C0020538;C1549445;C1705108;C1710701;C1963138","C0020538","",1364
"mean sd body mass index kg m $nmbr$","C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143;C2699239","C1305855","",1734
"$nmbr$ mg dabigatran","C0024671;C0026410;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761",NULL,NULL,775
"vte at day $nmbr$","C0332173;C0439228;C0439505;C0630906",NULL,NULL,1621
"post procedure","C3272301","C3272301","",1445
"overall n $nmbr$","C0282416;C1561607",NULL,NULL,1743
"region north america","C0017446;C0028405;C0205147","C0028405","",1463
"ipss categories","C0683312;C1019118;C1998280;C2827405;C3811063","C1998280",";C1019118;C3811063;C4050465;C4050466;C4049706;C0168634;C1705273;C1880519;C3853603",124
"mean systolic blood pressure mm hg","C0039155;C0428886;C0439475;C0444504;C0488053;C0488055;C0871470;C1306620;C2347634;C2348143","C0005823","",1469
"current or former smoker","C0337671;C0521116;C1705970","C0037369","",420
"lipid lowering therapy","C0585943","C0585943;C0086440","",1774
"lowest normal n $nmbr$","C0205307;C0231683;C0439166;C1708760;C2347086;C4553972",NULL,NULL,687
"hbalc mean s d","C0444504;C2347634;C2348143","","",820
"cardiovascular risk factors n","C0850624",NULL,NULL,651
"need for $nmbr$ ng edoxaban dose at","C0017887;C0027552;C0028074;C0178602;C0686904;C0869039;C1114758;C2975435",NULL,NULL,110
"high cardiovascular risk n","C0007226;C0332167;C3272283;C3887460;C4050568;C4319571","C4319571","",837
"body mass indexf","C0518010","C1305855","",1734
"sf $nmbr$ v $nmbr$ pcs mean sd","C0037712;C0444504;C1864389;C1882368;C2347634;C2348143;C2699239",NULL,NULL,1782
"mean s d weight kg","C0005910;C0022718;C0043100;C0439209;C0444504;C1305866;C1705104;C2347634;C2348143;C4054209",NULL,NULL,37
"$nmbr$ n $nmbr$ $nmbr$","C0369718;C0441922",NULL,NULL,1553
"standard care n $nmbr$ py","C0030428;C1442989;C1947933;C2828392;C3538810",NULL,NULL,1517
"dilatative n","C0002940;C0012359;C0700124;C1322279",NULL,NULL,1170
"median body mass index kg m $nmbr$ range","C0005893;C0549183;C0578022;C0876920;C1305855;C1514721;C1532718;C2347635;C2348144;C2348147;C2939193;C3542016","C1305855","",1734
"composite","C0205199;C1547335","C0205199","",1631
"$nmbr$ to $nmbr$ egfr ml min $nmbr$ $nmbr$ m $nmbr$ a","C0040363;C0041260;C0369637;C0439445;C0441923;C1739039;C1883351;C3811844;C3812682","C3811844;C0017654","",307
"umec vi $nmbr$ $nmbr$ $nmbr$","C0205999",NULL,NULL,515
"number of patients randomized","C0034656;C2360800;C3815594",NULL,NULL,692
"d mitral stenosis vhd n $nmbr$","C0026269;C0073187;C0264766;C0332173;C4484261","C0026269","",2249
"iii death from cv causes nonfatal mi hospitalization for ua all revascularization $nmbr$ days nonfatal stroke","C0011065;C0015127;C0019993;C0038454;C0041580;C0042014;C0439070;C0439228;C0581603;C1306577;C1314792;C1524003;C1705160;C3538987;C3810814;C4048877;C4082313;C4318503;C4552775;C4554100",NULL,NULL,1762
"haemoglobin g l","C0019046;C0439267;C0439294;C0456615;C0635222","C0019046","",1177
"total deaths","C0011065;C0439175;C0439810;C1306577",NULL,NULL,508
"renal insufficiency or failure","C0035078;C0231174;C0680095;C1565489","C1565489","",937
"eda","C0162359;C1539327;C3539920;C3887494",NULL,NULL,411
"irbesartan n $nmbr$","C0288171","C0288171","",1209
"$nmbr$ days stroke ischemic","C0038454;C0439228;C0475224;C4554100",NULL,NULL,1762
"st segment deviation timi risk score","C0012727;C0035647;C0036056;C0205419;C0429029;C0429066;C0441635;C0449820;C1114722;C1116089;C1705236;C3272372;C4050231;C4552904",NULL,NULL,748
"diclofenac","C0012091","C0012091","",1324
"$nmbr$ mercaptopurine azathioprine","C0000618;C0004482","C0000618","",77
"clinical history n","C0019664;C0019665;C0205210;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"rec ischemia due to ecg changes","C0022116;C0392747;C0443172;C0678226;C1424025;C1623258;C1705241;C2606415;C4319952;C4321499",NULL,NULL,767
"cancer","C0006826;C0998265;C1306459","C0006826","",1819
"cyclo","C1172566",NULL,NULL,706
"lu kg","C0022718;C0024171;C0024176;C0439209;C2697939;C4054209",NULL,NULL,205
"tobacco use n","C0040335;C0543414;C0841002;C3853727",NULL,NULL,23
"all participants n $nmbr$","C0679646",NULL,NULL,1033
"ace inhibitor","C0003015;C4541021","C0003015","",811
"concomitant medication n","C0013227;C0521115;C3244316;C4284232","C0013227;C0521115","",1916
"$nmbr$ $nmbr$ cl","C0596019",NULL,NULL,658
"egfr ml min $nmbr$ $nmbr$ m $nmbr$ mdrdequation","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"gmr","C1522544;C1704695","C3811844;C0017654","",592
"aspirin use before screening no","C0004057;C0042153;C0220908;C0220909;C0457083;C1698960;C1710031;C1710032;C1710477;C1947944;C2348164",NULL,NULL,798
"frequent exacerbator","C0332183",NULL,NULL,404
"ldl c $nmbr$ mg dl $nmbr$ $nmbr$ mmol l","C0439269;C1532563","C0023824","",1068
"black african","C0337824",NULL,NULL,966
"screening hba $nmbr$ c","C0019016;C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C1825777;C2348164;C3538758","","",820
"era and pde $nmbr$ inhibitors","C0031638;C1521863;C3495919",NULL,NULL,814
"laboratory values","C0022877;C0042295;C3244292;C4283904",NULL,NULL,978
"before bronchodilator use","C0006280;C0042153;C0457083;C1947944",NULL,NULL,118
"cardiogenic shock during first $nmbr$ hr after randomization","C0034656;C0036980;C0205435;C1279901",NULL,NULL,653
"exercise","C0015259;C1522704","C0015259","",1380
"time since diagnosis of type $nmbr$ diabetes","C0011847;C0011849;C0011900;C0040223;C1320657;C1550351;C1704338;C1704656;C3541383","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"pci thrombolysis at randomization","C0034656;C0520997;C4049621",NULL,NULL,621
"weight range kg","C0005910;C0022718;C0043100;C0439209;C1305866;C1514721;C1705104;C2348147;C3542016;C4054209","C0005910","",1250
"baseline creatinine median range mg dl","C0010294;C0168634;C0439269;C0549183;C0876920;C1442488;C1514721;C1561535;C2347635;C2348144;C2348147;C2939193;C3542016",NULL,NULL,625
"ccq total score","C2964552",NULL,NULL,540
"pcs score $nmbr$ $nmbr$ scale","C0175659;C0349674;C0449820;C1864389;C1882368;C1947916;C4050231",NULL,NULL,749
"change mean se","C0036919;C0392747;C0443172;C0444504;C1705241;C2347634;C2348143;C4319952",NULL,NULL,567
"rosuvastain fenofibric acid $nmbr$ $nmbr$","C0060179",NULL,NULL,1696
"$nmbr$ mg dabigatran n $nmbr$","C0024671;C0026410;C0439269;C1960952;C2346927;C2348066;C4321396;C4521761",NULL,NULL,775
"$nmbr$ $nmbr$ $nmbr$ kg m $nmbr$","C1532718",";C1305855","",206
"pre hospital ticagrelor n $nmbr$","C0019994;C0332152;C0740175;C1510665;C1999375;C2257086;C3669034",NULL,NULL,2379
"other $nmbr$ $nmbr$ t","C2603360",NULL,NULL,1616
"sfc","C4521536",NULL,NULL,1283
"psycholeptics","C3653516",NULL,NULL,1671
"clinical and laboratory measurements","C0205210;C0681902",NULL,NULL,979
"ocs maintained increased","C0205217;C0442805;C1314677",NULL,NULL,1421
"uacr mg g median iqr","C0549183;C0876920;C1300563;C2347635;C2348144;C2939193",NULL,NULL,2315
"all randomized patients","C0030705;C0034656;C3815594",NULL,NULL,1035
"lipid lowering medication use","C0023779;C0240320;C0441994;C2003888",NULL,NULL,1022
"timi flow","C3272266",NULL,NULL,531
"ticlopidine n $nmbr$","C0040207",NULL,NULL,1837
"lipids medications","C0013227;C0023779;C0802604;C2598133;C4284232",NULL,NULL,2265
"platelet aggregation inhibitors n","C0032177",NULL,NULL,813
"st depression $nmbr$ mm","C0520887;C4330985;C4554674","C0520887",";C0011570;C0011581;C0344315;C4049644;C0702240;C4085311;C4084909",1856
"patients with $ $nmbr$ bsa at baseline no","C0030705;C0168634;C1442488",NULL,NULL,1308
"patients with change from baseline in total psa modified shs $nmbr$","C0030705;C0168634;C0392747;C0443172;C1442488;C1705241;C2986589;C3889737;C4319952",NULL,NULL,767
"egfr $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$ n $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"clopidogrel n $nmbr$ n n","C0070166","C0070166",";C0369286;C0033727;C4049621",217
"inclusion findings","C0007637;C1512693;C2607943;C2926606;C3539655",NULL,NULL,1141
"mean sd ptga vas","C0042815;C0444504;C2347634;C2348143;C2699239;C3536884;C3827561",NULL,NULL,1766
"alpha glucosidase inhibitors","C1299007;C2756986;C3539108","C1299007","",398
"hba $nmbr$ c $nmbr$ $nmbr$ bp $nmbr$ $nmbr$ mm hg ldl c $nmbr$ mg dl","C0019016;C0037623;C0439269;C0439475;C1415692;C1708288;C1825777;C3538758;C4318478",NULL,NULL,608
"$nmbr$ l $nmbr$ l $nmbr$","C3539687","","",-10
"time since pah diagnosisc years","C0030123;C0040223;C0439234;C3203102;C3541383;C4284467",NULL,NULL,1099
"estimated glomerular filtration","C0232809;C0750572",NULL,NULL,536
"blood pressure eontrolt","C0005823;C1271104;C1272641","C0005823","",15
"history of pvd no","C4534349","C0241889","",1493
"transaminases increased","C0002594;C0205217;C0442805;C0919834","C0002594;C0205217","",2227
"mean sd fevi fvc","C0444504;C0802741;C2347634;C2348143;C2699239;C3815113",NULL,NULL,1600
"statin potency medium n $nmbr$","C0009458;C0360714;C0439536;C1705217;C3244283;C3245505;C4085196;C4522282;C4522283","C0360714","",2205
"severe lite threatening","C0205082;C4050465;C4050466",NULL,NULL,313
"no unknown","C0439673;C3541433;C4050014",NULL,NULL,93
"systemic corticosteroids n a","C4053960",NULL,NULL,1649
"femoral neckc","C0015811",NULL,NULL,512
"serum triglycerides pmol liter","C0439192;C0475211;C0542495","C0041004","",368
"saxagliptin","C1611934","C1611934","",2069
"mixed chronic bronchitis and emphysema","C0008677;C0013990;C0034067;C0205430;C3160715",NULL,NULL,1672
"college graduate or more","C0205172;C0682187",NULL,NULL,1539
"median time from index acute coronary syndrome to randomization iqr mo","C0026544;C0034656;C0040223;C0332177;C0549183;C0600653;C0876920;C0918012;C0948089;C1552854;C1637833;C2347635;C2348144;C2939193;C2986546;C3541383","C0948089",";C0026544",225
"adherence $nmbr$","C1510802","C2364172","",1465
"tgt","C1421391;C1428265;C4321338",NULL,NULL,251
"igt ifg","C1334085;C1708411",NULL,NULL,1259
"$nmbr$ hba $nmbr$ c $nmbr$","C0019016;C1825777;C3538758","","",820
"glycohemoglobin","C0202054;C0696092","","",1176
"prior migraine","C0149931;C0332152;C2826257",NULL,NULL,684
"placebo eze tes fc j $nmbr$ rr $nmbr$ definition","C0032042;C0076172;C1422793;C1550452;C1696465;C1704788;C1706408;C2983605;C3539107;C3888054;C4554402","C0032042","",28
"normal coronary angiography","C0853522",NULL,NULL,1724
"ended $nmbr$ days before trial entry","C0008976;C0439228;C1272693;C1705654;C2746065",NULL,NULL,1621
"coronarv arterv disease","C0012634",NULL,NULL,2117
"post bronchodilation fev $nmbr$","C0439576;C3714541",NULL,NULL,1599
"versus tiotropium $nmbr$ pg tiotropium olodaterol $nmbr$ $nmbr$ $nmbr$ pg","C0030827;C0072225;C1266240;C4032878",NULL,NULL,1510
"versus tiotropium olodaterol $nmbr$ $nmbr$ $nmbr$ pg","C0030827;C0072225;C1266240;C4032878",NULL,NULL,1510
"pooled itt","C1709595;C2349200;C4522255","C1709595;C1524024","",211
"baseline medications n","C0013227;C0168634;C0802604;C1442488;C2598133;C4284232",NULL,NULL,625
"data reported as n or median quartiles $nmbr$ $nmbr$","C0549183;C0684224;C0700287;C0876920;C1511726;C2347635;C2348144;C2828255;C2939193;C3245479;C3714741;C4319718",NULL,NULL,635
"egfr ml min per $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"r","C0205090;C0684010;C2603358","","",-10
"anakinra","C0245109","","",-10
"tngtycerides median","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"fpg month $nmbr$ mg dl","C0332177;C0439231;C0439269",NULL,NULL,192
"procedures for index event","C0025664;C0184661;C0441471;C0600653;C0918012;C1552854;C1637833;C2700391;C2986546;C3538935;C4019010",NULL,NULL,412
"prior stroke","C0038454;C0332152;C2826257;C4554100","C0038454;C0332152","",2380
"aspirin i clopidogrel n $nmbr$ $nmbr$","C0004057;C0021966;C0070166;C0221138","C0070166",";C0369286;C0033727;C4049621",217
"fasting lipids mmol $nmbr$","C0015663;C0023779;C0439190","C0023779;C0015663","",1847
"meddra smq","C1140263",NULL,NULL,587
"sbp $nmbr$ mmhg and dbp $nmbr$ mmhg","C0085805;C0439475;C0536221;C3813197;C4281799",NULL,NULL,607
"egfr mdrd ml min $nmbr$ $nmbr$ m","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682;C3839656","C3811844;C0017654","",592
"fev $nmbr$ at screening","C0220908;C0220909;C1698960;C1710031;C1710032;C1710477;C2348164;C3714541",NULL,NULL,798
"time between index acs and randomization days","C0034656;C0040223;C0439228;C0600653;C0742343;C0918012;C1552854;C1637833;C2986546;C3541383;C4318612",NULL,NULL,2148
"second primary estimated change in total updrs score from baseline to wk $nmbr$","C0168634;C0205225;C0205436;C0332174;C0392747;C0439175;C0439230;C0439612;C0439631;C0439810;C0443172;C0449820;C0457385;C0565930;C0750572;C1442488;C1561503;C1705190;C1705241;C3639721;C4050231;C4319952",NULL,NULL,767
"laci n $nmbr$","C1420705;C3273314;C4281721",NULL,NULL,2152
"history coronary","C0018787;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062",NULL,NULL,832
"methylxanthines","C0066447","C0043318","",359
"se t","C0036919",NULL,NULL,567
"previous vte","C0205156;C0630906;C1552607","C1861172","",2399
"baseline cv treatment","C0039798;C0087111;C0168634;C1442488;C1522326;C1533734;C1705169;C3538987;C3538994;C3887704;C4048877;C4318503",NULL,NULL,625
"median iqr","C0549183;C0876920;C2347635;C2348144;C2939193",NULL,NULL,635
"abbreviations egfr estimated glomerular filtration rate imt intimal medial thickness lv left ventricular two sample comparison t tests were calculated based on log transformed variables geometric mean with $nmbr$ confidence interval in parenthesis","C0000723;C0009667;C0023128;C0162864;C0205098;C0205448;C0225897;C0334121;C0370003;C0439828;C0444686;C0731033;C0871472;C1256463;C1280412;C1441506;C1510411;C1527178;C1704614;C1705938;C1707455;C1708728;C1739039;C1881413;C2347026;C2986759;C2986775;C3811844;C3812682;C4318736",NULL,NULL,1468
"previous heart failure no","C0018801;C0018802;C0205156;C1552607;C4554158","C0018801",";C0168634;C1524003",12
"no epa group n $nmbr$","C0441848",NULL,NULL,1638
"fev $nmbr$ predicted normal","C0205307;C0231683;C0439166;C0681842;C1882327;C2347086;C3714541;C4553972","C0024119","",288
"normal bnp $nmbr$ pg ml n $nmbr$ $nmbr$","C0054015;C0205307;C0231683;C0439166;C0439297;C1095989;C1417808;C2347086;C2982014;C4553972",NULL,NULL,1635
"functional assessment of chronic illness","C0008679;C0278372",NULL,NULL,1702
"prior coronary revascularization n","C0332152;C0877341;C2826257","C0877341",";C4049621;C1552607",223
"ncep risk category at study entry n","C0035647;C1705654;C2983287;C2983669;C4552904","C0035647","",173
"time since diagnosis of psa years mean sd","C0011900;C0040223;C0439234;C0444504;C1704338;C1704656;C2347634;C2348143;C2699239;C3541383;C3810537;C3813209",NULL,NULL,1099
"previous cancer n","C0006826;C0205156;C0998265;C1306459;C1552607","C0006826","",1819
"ace inhibitors arbs n","C0003015;C3888198",NULL,NULL,44
"fasting plasma glucose categories n","C0015663;C0202042;C0455280;C0683312","C0455280;C0015663",";C0168634",21
"metformin hdm","C0025598","C0025598","",1345
"systemic corticosteroid use","C0042153;C0205373;C0239126;C0457083;C1947944;C4053960","C0239126",";C0168634;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1425988;C1947944",120
"psoriasis body surface area $nmbr$","C0005902;C0033860","C0005902;C0033860","",2177
"laba plus ics tiotropium n $nmbr$ placebo n $nmbr$","C0032042;C0213771;C0332287;C0815320;C1696465;C1706408;C4551720",NULL,NULL,2193
"normal acr $nmbr$ mg mg at baseline to albuminuria acr $nmbr$ mg g","C0001925;C0168634;C0205307;C0231683;C0439166;C1300563;C1319635;C1412134;C1442488;C1515941;C2347086;C4553972",NULL,NULL,2315
"history of cv disease","C0683519;C0730226;C0850708;C0944983;C3538987;C4048877;C4318503",NULL,NULL,105
"oral hypoglycemics","C0359086","C0359086","",1744
"effect of ranolazine compared with placebo on angina and recurrent ischemia","C0002962;C0022116;C0032042;C0073633;C1280500;C1455761;C1518681;C1696465;C1706408;C1707455;C2348382;C2945760;C4321499",NULL,NULL,1668
"west europe","C0015176;C1705493",NULL,NULL,600
"fsg mg dl","C0439269",NULL,NULL,192
"fp versus no ics","C0016704;C0815320;C1419068;C1419906;C3541238;C3541412;C4551720",NULL,NULL,1820
"no mvd n $nmbr$ $nmbr$","C1417507;C3272839",NULL,NULL,1775
"no of patients indacaterol placebo","C0030705;C0032042;C1696465;C1706408;C1722260","C0032042","",28
"smoking history r","C0205090;C0684010;C1519384;C2603358","C1519384","",1147
"planned treatment strategy","C0599880;C0679199",NULL,NULL,981
"none at baseline","C0168634;C1442488",NULL,NULL,625
"mnapsi mean sd","C0444504;C2347634;C2348143;C2699239",NULL,NULL,1029
"total randomized","C0034656;C0439175;C0439810;C3815594",NULL,NULL,508
"canakinumab dose per mo","C0026544;C0178602;C0332177;C0869039;C1114758;C2718773",NULL,NULL,110
"right ventricular dysfunction n n j","C0242707;C1556315","C0242707","",1882
"weight $nmbr$ kg","C0005910;C0022718;C0043100;C0439209;C1305866;C1705104;C4054209","C0005910","",1250
"index acute coronary syndrome no","C0600653;C0918012;C0948089;C1552854;C1637833;C2986546",NULL,NULL,734
"oral agents","C0442027;C0450442;C1254351;C1521826;C4521986",NULL,NULL,484
"febuxostat $nmbr$ mg daily n $nmbr$","C0024671;C0026410;C0249529;C0332173;C0439269;C1960952;C2346927;C4321396;C4521761",NULL,NULL,2282
"p vaiue","C0369773;C2603361",NULL,NULL,1872
"nail involvement","C0027342;C1314939;C1432728;C3538766",NULL,NULL,312
"n_","C0369718;C0441922",NULL,NULL,1553
"anti anaemics","C0857322","","",-10
"l $nmbr$ hrs min n $nmbr$","C0439393;C1568891","C3811844;C0017654","",307
"laba ics","C0815320;C4551720",NULL,NULL,1305
"patients with end point","C0030705;C2349179;C2826544","C2349179","",1136
"egfr $nmbr$","C1739039;C3811844;C3812682","C3811844;C0017654","",592
"other atherosclerotic event","C0333482;C0441471;C4019010","C0004153","",1698
"alc $nmbr$ $nmbr$ $nmbr$ $nmbr$","C1424945;C3811058",NULL,NULL,395
"gliclazide modified release no","C0017631;C1709058;C4544813","C0017631","",1788
"no history of af","C0019664;C0019665;C0262512;C0262926;C0344434;C1705255;C2004062;C4049859",NULL,NULL,832
"d $nmbr$ ci","C0008107;C0073187;C0332173;C3259781;C4484261",NULL,NULL,519
"partner n yes","C0682323;C1549445;C1705108;C1710701;C3887537",NULL,NULL,147
"egfr by cystatin c ml min per $nmbr$ $nmbr$ m $nmbr$ geometric mean se","C0036919;C0071744;C0369637;C0439445;C0441923;C1413772;C1739039;C2986759;C3811844;C3812682","C3811844;C0017654","",592
"hdl cholesterol mean","C0023822;C0392885;C0444504;C2347634;C2348143",NULL,NULL,37
"$nmbr$ years $nmbr$ $nmbr$ $nmbr$ $nmbr$","C0439234",NULL,NULL,1099
"units per week mean sd","C0444504;C0560588;C2347634;C2348143;C2699239",NULL,NULL,37
"infliximab n $nmbr$","C0666743","C0666743","",154
"$nmbr$ kg m $nmbr$","C1532718",";C1305855","",206
"nadroparin","C0206232","C0206232","",860
"study $nmbr$ $nmbr$","C0557651;C2603343",NULL,NULL,1730
"tnf antagonist naive","C0231491;C1448177",NULL,NULL,362
"change","C0392747;C0443172;C1705241;C4319952",NULL,NULL,767
"morning","C0332170",NULL,NULL,2043
"$nmbr$ months in $nmbr$ kill","C0162388;C0439231;C0681205;C1550555",NULL,NULL,1530
"atrial fibrillation pattern","C0004238;C0344434;C0449774;C1963067",";C0004238","",1009
"hdl c mmol l mean sd","C0444504;C1532563;C2347634;C2348143;C2699239;C3715113","C0023822","",821
"weight in kg baseline mean sd n wk $nmbr$ and change mean se n","C0022718;C0036919;C0332174;C0392747;C0439209;C0439230;C0443172;C0444504;C1303013;C1705241;C2347634;C2348143;C2699239;C4054209;C4319952","C0043100","",1915
"urine p cr","C0042036;C0042037;C0201975;C2963137;C3539604;C3711669;C4084730;C4553336;C4553337",NULL,NULL,700
"acs presentation","C0449450;C0742343;C4318612",NULL,NULL,2147
"r $nmbr$ n $nmbr$","C0687673",NULL,NULL,1834
"major adverse cardiovascular events","C0007226;C0205082;C0205164;C0877248;C1705413;C3887460;C4318856;C4521762",NULL,NULL,1472
"dead n $nmbr$","C0011065",NULL,NULL,1855
"cigarette smoking status no","C0239059;C0449438;C0677453;C0700219;C1519386;C1704760;C3890423",NULL,NULL,796
"bpearson s chi square test","C0008041",NULL,NULL,773
"ff mdi","C0993596;C1839839;C4049613;C4554348",NULL,NULL,518
"pioglitazone dose mean sd mg","C0024671;C0026410;C0071097;C0178602;C0439269;C0444504;C0869039;C1114758;C1960952;C2346927;C2347634;C2348143;C2699239;C4321396;C4521761",NULL,NULL,1760
"apoe $nmbr$ carrier","C0003595;C0007294;C0523511;C0560175;C1325398;C1412481;C1706209;C3273162",NULL,NULL,784
"ratio mepo pbo $nmbr$ ci","C0008107;C0031962;C0456603;C1547037;C3259781",NULL,NULL,519
"salmeterol $nmbr$ gg bid","C0017454;C0018370;C0073992","C0060657;C0073992","",1508
"health assessment questionnaire score","C2960025","C2960025","",326
"morning peak expiratory flow liters min","C0332170;C0475211;C0702093;C1518922;C1524029;C3813700",NULL,NULL,2042
"cadillac score","C0449820;C4050231",NULL,NULL,748
"risk ratio $nmbr$ cl","C0028873;C0242492;C0596019",NULL,NULL,658
"concomitant anticoagulant antithrombotic or nsaid n","C0003211;C0003280;C0521115;C0848112;C3536711;C3536840","C0003280","",450
"mean s d fpg","C0444504;C2347634;C2348143",NULL,NULL,37
"$nmbr$ mg dl ldl cholesterol","C0023824;C0202117;C0439269",NULL,NULL,192
"hdl c $nmbr$ mg dl","C0439269;C3715113","C0023822","",1962
"$nmbr$ aminosalicylates i i","C0021966;C0221138;C0368663","C0368663","",1691
"cardiothoracic ratio","C0456603;C1547037;C4055270",NULL,NULL,973
"pre randomization pci","C0034656;C0332152;C0740175;C2257086;C3669034;C4049621",NULL,NULL,1736
"duration of total exposure to study treatment weeks","C0039798;C0040363;C0041260;C0087111;C0439175;C0439230;C0439810;C0557651;C1522326;C1533734;C1705169;C1883351;C2603343;C2826870;C3538994;C3887704",NULL,NULL,431
"admission for hf in previous year","C0018488;C0184666;C0205156;C0439234;C0439508;C0809949;C1313497;C1538440;C1552607;C3273279","C0018801",";C0168634;C1524003",12
"bacterial pneumonia","C0004626","C0032285","",589
"idiopathic","C0332240","C0332240","",843
"history of macrovascular disease at baseline n","C0168634;C0683519;C0730226;C0850708;C0944983;C1442488","C0004153","",1698
"np tercile $nmbr$ bnp $nmbr$ pg ml nt probnp $nmbr$ pg ml n $nmbr$","C0054015;C0065827;C0439297;C1095989;C1317554;C1417808;C1706141;C2825907;C2982014;C3887659;C4284038",NULL,NULL,1635
"pe associated with dvt at diagnosis","C0011900;C0070939;C0149871;C0332281;C1704338;C1704656;C1880476;C2926618;C3899446;C4284304",NULL,NULL,1516
"previous coronary artery bypass surgery no","C2144990","C2144990","",227
"diabetes mellitus yes n hypertension","C0011849;C0020538;C1549445;C1705108;C1710701;C1963138",NULL,NULL,147
"age ya","C0001779","C0001779","",480
"combo facilitated pci","C4049621",NULL,NULL,1736
"olodaterol $nmbr$ gg n $nmbr$","C0017454;C0018370;C2934193",NULL,NULL,1510
"mild decrease in gfr $nmbr$ $nmbr$ ml mln per $nmbr$ $nmbr$ m","C0017654;C0369637;C0392756;C0439526;C0441923;C0547047;C1417190;C1424601;C1705224;C2945599;C3815103;C3887665",NULL,NULL,300
"american indian or alaskan native","C0002460;C0238611;C0302891",NULL,NULL,763
"known duration of type $nmbr$ diabetes","C0205309;C0449238;C1320657;C2926735","C0011849;C1320657","",907
"$nmbr$ $nmbr$ to $nmbr$ $nmbr$ years","C0439234",NULL,NULL,1099
"steroids n $nmbr$ vs $nmbr$","C0038317",NULL,NULL,1648
"estimated glomerular filtration rate mdrd ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923;C3811844;C3839656",NULL,NULL,923
"verapamil sr strategy n $nmbr$ $nmbr$","C0679199;C1527129","C0042523","",1450
"mtx non mtx","C0025677;C1417487;C1518422","C0025677","",1408
"mental","C0229992",NULL,NULL,350
"undergoing major vascular surgery","C0005847;C0042381;C0205082;C0205164;C0679637;C1558950;C1801960;C3714645;C4318856;C4521762",NULL,NULL,2338
"diastolic blood pressure $nmbr$ mm hg","C0428883;C0439475;C1305849","C0005823","",1469
"digitalis glycoside","C0012253","C0012265","",989
"group dif $nmbr$","C0441833;C0687744;C0812246;C1257890;C1519504;C1705428;C1705429;C1710304",NULL,NULL,1526
"active smokers","C0205177;C0337664;C3853793;C3888249","C0037369","",420
"total resolution of nail psoriasisd","C0027342;C0439175;C0439810;C1432728;C1514893;C1706463;C2699488;C3538766",NULL,NULL,508
"other candesartan","C0717550","","",1208
"randomized treatments n","C0034656;C0087111;C3815594",NULL,NULL,692
"smoking history pack yr","C0439234;C1519384;C1968515;C2825051;C2828395",NULL,NULL,1099
"lifestyle modifications","C0870811;C2960841",NULL,NULL,1490
"not collected","C1516695;C1516698;C1518422",NULL,NULL,85
"no ace inhibitor arb","C0003015;C3888198;C4541021",NULL,NULL,44
"height cm","C0489786","C0489786","",1249
"systolic total","C0039155;C0439175;C0439810","C0039155","",1917
"baseline hbalc $nmbr$","C0168634;C1442488",NULL,NULL,2188
"b benralizumab $nmbr$ mg q $nmbr$ w","C0024671;C0026410;C0439269;C1960952;C2346927;C2982078;C4321396;C4521761",NULL,NULL,947
"vorapaxar event rate n $nmbr$","C0441471;C0871208;C1521828;C2974521;C4019010","C2974521","",1448
"all participants n $nmbr$ $nmbr$","C0679646",NULL,NULL,1033
"moderate teaes","C0205081;C1881878;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"mean iief ef score mean iief domain score by bmi $nmbr$ $nmbr$ to $nmbr$ $nmbr$ kg m $nmbr$","C0578022;C1532718;C1880389;C1883221;C3533236;C3541951;C3641331",";C1305855","",206
"carotid artery no","C0007272;C0162859","C0007272","",1547
"all cause mortalitv","C0015127;C1524003",NULL,NULL,924
"patients without dm n $nmbr$ $nmbr$","C0011816;C0030705;C3250443",NULL,NULL,955
"voided volume ml","C0042034;C0439526;C0449468;C1552835;C1690016;C1705102;C1705224;C2700258;C3887665",NULL,NULL,1119
"type of tnf antagonist failure n","C0231174;C0231491;C0332307;C0680095;C1448177;C1547052",NULL,NULL,11
"sjc $nmbr$ joints","C0022417;C0392905",";C0451521","",1140
"treatment after randomization in the single dummy phase days","C0034656;C0037179;C0039798;C0087111;C0087136;C0205171;C0205390;C0439228;C1522326;C1533734;C1705169;C1710475;C3538994;C3887704",NULL,NULL,926
"das $nmbr$ score","C0051767;C0057671;C0449820;C4050231",NULL,NULL,143
"currently smokes","C0037366;C0037369;C0439994;C0521116;C1881674","C0037369","",420
"no of risk factors for venous thromboembolism no","C0035648;C1553898;C1861172",NULL,NULL,175
"age cohort no","C2348001",NULL,NULL,45
"tertiary","C0205372",NULL,NULL,1645
"cdai $nmbr$ n","C0683448;C1413248;C3273706",NULL,NULL,697
"psoriasis $nmbr$ of bsa","C0033860","C0033860","",1358
"of target","C1521840;C2986546",NULL,NULL,735
"hemoglobin g $nmbr$","C1319312","C0019046","",1177
"prespecified analysis","C0002778;C0936012;C1524024",NULL,NULL,183
"baseline bmi $nmbr$ to $nmbr$ kg m $nmbr$ n $nmbr$ change from baseline to $nmbr$ weeks","C0168634;C0392747;C0439230;C0443172;C0578022;C1442488;C1532718;C1705241;C4319952",";C1305855","",206
"pad at baseline","C0168634;C0182158;C0332568;C1442488;C3540603;C3669270;C3814046;C4319657",NULL,NULL,1752
"urine albumin to ereatinine ratio","C0001924;C0042038;C0456603;C0587185;C1273442;C1547037;C2362049","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"any clinical ae","C0205210;C3887670","C0877248","",47
"statin users","C0360714;C1706077","C0360714","",872
"i moderate $nmbr$ mg of pravastatin n $nmbr$","C0021966;C0024671;C0026410;C0085542;C0205081;C0221138;C0439269;C1881878;C1960952;C2346927;C4049705;C4049706;C4085643;C4321335;C4321396;C4521761",NULL,NULL,882
"established atherosclerotic disease","C0012634;C0333482;C0443211;C1272684",NULL,NULL,2113
"symptom onset to enrollment","C1516879;C1696073;C3888021;C4086878",NULL,NULL,339
"placebo n i $nmbr$","C0021966;C0032042;C0221138;C0369718;C0441922;C1696465;C1706408","C0032042","",28
"indacaterol glycopyrronium group n $nmbr$","C0441848;C1722260;C3814772","C3814772;C1722260","",1509
"inadequate response $nmbr$ months mmf ggs","C0083765;C0205412;C0209368;C0439231;C0439856;C0871261;C1704632;C1706817;C2911692;C3848524","C0205412","",403
"corticosteroids and immunosuppressants only","C0001617;C0021081;C0205171;C1720467;C3539185;C3540725;C3540726;C3540727","C0021081","",1424
"median ml min","C0439445;C0549183;C0876920;C2347635;C2348144;C2939193","C3811844;C0017654","",307
"patients without psoriasis n $nmbr$","C0030705;C0033860","C0033860","",1358
"death q wave mi idr","C0011065;C0861151;C1306577;C4082313;C4552775","C1305738","",385
"cerebrovascular accident","C0038454",NULL,NULL,1762
"concomitant lipid lowering therapy n","C0521115;C0585943","C0585943;C0086440","",1774
"hemoglobin g $nmbr$ $nmbr$","C1319312","C0019046","",1177
"n $nmbr$ fatty acids","C0015684;C0369718;C0441922",NULL,NULL,1553
"serum mg $nmbr$ $nmbr$ mmol l hypomagnesemia","C0024671;C0026410;C0151723;C0229671;C0439190;C0439268;C0439269;C1532563;C1546774;C1550100;C1960952;C2346927;C4321396;C4521761;C4552839",NULL,NULL,670
"coronary procedure of group","C0018787;C0018821;C0441833;C0687744;C1257890;C1279986;C1519504;C1705428;C1705429;C2986530",NULL,NULL,1526
"previous use of systemic steroids n","C0205156;C0205373;C0281991;C1552607",NULL,NULL,2396
"pre svc","C0231957;C0332152;C0740175;C2257086;C3669034",NULL,NULL,294
"vessel size mean sd mm","C0005847;C0444504;C0456389;C2347634;C2348143;C2699239;C4330985;C4554674",NULL,NULL,1287
"golimumab $nmbr$ $nmbr$ mg","C0024671;C0026410;C0439269;C1960952;C2346927;C2353893;C4321396;C4521761",NULL,NULL,941
"$nmbr$ ml min","C0439445","C3811844;C0017654","",307
"baseline basdai","C0168634;C1442488;C1998004","C1998004","",1354
"height mean sd cm","C0444504;C0489786;C2347634;C2348143;C2699239","C0489786","",1249
"prior coronary revascularization","C0332152;C0877341;C2826257","C0877341",";C4049621;C1552607",223
"timi risk scoret","C0035647;C4552904",NULL,NULL,1954
"vein bypass stented","C0038257;C0042449;C0741847",NULL,NULL,569
"ssz mtx n $nmbr$","C0025677;C1417487","C0025677","",1408
"concern","C2699424","","",-10
"median q $nmbr$ q $nmbr$ tg rich lipoprotein cholesterol","C0065055;C0337445;C0549183;C0699759;C0876920;C2347635;C2348144;C2939193","C0041004","",209
"ischemia","C0022116;C4321499",NULL,NULL,1668
"oral hypoglycemic agent","C0359086","C0359086","",1744
"two or more at baseline","C0168634;C0205172;C0205448;C1442488",NULL,NULL,429
"bivalirudin heparin plus gpi","C0019134;C0168273;C0770546;C1415351","C0019134","",863
"am pef sd l min","C0030771;C0702093;C1518922;C1524029;C1542834;C2699239;C3813700",NULL,NULL,566
"class $nmbr$","C0456387;C1518526;C1705943",NULL,NULL,452
"rosuvastatin fenofibric acid","C0060179;C0965129","C0965129","",886
"at least two cardiovascular risk factors","C0205448;C0850624",NULL,NULL,651
"use at baseline n","C0042153;C0168634;C0457083;C1442488;C1947944",NULL,NULL,625
"percentage with disease duration $nmbr$ years","C0439165;C0439234;C0872146;C1549488;C1561533",NULL,NULL,1099
"baseline lipid and apolipoprotein levels","C0003591;C0023779;C0168634;C0441889;C1442488",NULL,NULL,2190
"$nmbr$ or more","C0205172",NULL,NULL,1539
"$nmbr$ $nmbr$ $nmbr$ $nmbr$ r mmse mini mental","C0205090;C0229992;C0445542;C0451306;C0684010;C2603358","C0451306","",305
"ho active cancer","C0006826;C0019905;C0205177;C0998265;C1306459;C1832110;C3853793;C3888249;C3889614",NULL,NULL,443
"mortality","C0026565;C0026566","C0026565","",1312
"copd rosuvastatin n $nmbr$","C0024117;C0965129;C1412502;C3714496","C0965129","",886
"any sae","C1519255;C1622657;C4553214","C1519255","",1282
"hbalc $nmbr$ mmol mol $nmbr$ $nmbr$ at week $nmbr$","C0332174;C0439230;C3829066","","",820
"europe ii","C0015176;C1710602;C4082587",NULL,NULL,521
"all others n","C1955473;C3539125",NULL,NULL,741
"prior infarction","C0021308;C0332152;C2826257","C0021308","",1288
"time from hospitalization to randomization hr","C0019993;C0034656;C0040223;C3541383",NULL,NULL,692
"uric acid mg dl creatinine clearance ml min per $nmbr$ $nmbr$ m $nmbr$","C0024671;C0026410;C0041980;C0151280;C0369637;C0439269;C0441923;C1960952;C2346927;C3642208;C4321396;C4521761",NULL,NULL,2310
"cardiac failure","C0018801;C0018802","C0018801",";C0168634;C1524003",12
"non epa number of","C0237753;C0449788;C1518422",NULL,NULL,85
"unstable angina no","C0002965","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"apolipoprotein b $nmbr$ mg dl","C0003593;C0439269","C0003591","",1028
"moderate gold $nmbr$","C0018026;C0205081;C1304897;C1881878;C4049705;C4049706;C4085643;C4321335","C0024117;C0521117","",213
"estimated glomerular filtration rate ml min $nmbr$ $nmbr$ m","C0369637;C0439445;C0441923;C3811844","C3811844;C0017654","",592
"sustain $nmbr$ semaglutide add on to insulin vs placebo","C0021641;C0032042;C0443318;C1533581;C1579433;C1696465;C1706408;C1883712;C2732140;C3714501;C3885068",NULL,NULL,157
"baseline crohn s disease medications","C0010346;C0013227;C0168634;C0802604;C1442488;C2598133;C4284232",NULL,NULL,625
"last infusion in the horizon pft","C0024119;C0053122;C0279232;C0574032;C1517741;C1827465",NULL,NULL,457
"time between cessation of full dose warfarin therapy and enrollment mo","C0026544;C0039798;C0087111;C0178602;C0332177;C0366686;C0682295;C0869039;C1114758;C1363945;C1516879;C1696073;C1880019;C3888021;C4303340",NULL,NULL,236
"egfr $nmbr$ to $nmbr$ ml min $nmbr$ $nmbr$ m","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"history of stroke or tia","C0007787;C0019664;C0019665;C0038454;C0262512;C0262926;C0917805;C1054154;C1705255;C2004062;C4554100",NULL,NULL,832
"moderate $nmbr$ fev $nmbr$ predicted","C0205081;C0681842;C1881878;C1882327;C3714541;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"baseline rst segment","C0168634;C0441635;C1425219;C1442488",NULL,NULL,625
"lei $nmbr$ n $nmbr$","C0023401;C0428209",NULL,NULL,526
"mets pbo n $nmbr$ vs evomab n $nmbr$","C0031962;C0812270;C1705694;C2939420",NULL,NULL,435
"tophi present n","C0150312;C0221248;C0369718;C0441922;C0449450",NULL,NULL,1553
"native hawaiian pacific islander","C0242191;C0337920","C0337920;C0242191","",1331
"spinal fractures","C0080179;C0518450","C0080179","",1038
"difference a vs placebo $nmbr$ cl","C0032042;C0596019;C1696465;C1705241;C1705242;C1706408","C0032042","",28
"baseline vertebral fracture","C0080179;C0168634;C1442488",NULL,NULL,625
"any peripheral arterial disease","C0085096;C1704436","C0085096","",933
"in ambulance","C0002422;C3846685","C0002422",";C4049621",191
"implanted pacemaker","C0848753",NULL,NULL,1629
"patients with dactylitis at baseline no","C0030705;C0168634;C0239161;C1442488","C0239161","",492
"minor ischaemic stroke","C0026193;C0205165;C0948008",NULL,NULL,1669
"non st segment elevation acs","C0520886;C0742343;C1518422;C4318612","C3810814","",894
"ff $nmbr$ $nmbr$ $nmbr$","C4554348",NULL,NULL,1597
"non detectable unknown","C0439673;C1518422;C3541433;C3830527;C4050014",NULL,NULL,93
"potassium mean sd meq l","C0032821;C0202194;C0304475;C0439375;C0444504;C0597277;C2347634;C2348143;C2699239;C3714637","C0032821","",1371
"stroke of undetermined cause","C0015127;C0038454;C1524003",NULL,NULL,1762
"drugs and toxins","C0013227;C0040549;C3687832",NULL,NULL,367
"cgfr ml min $nmbr$ $nmbr$ m $nmbr$","C0369637;C0439445;C0441923","C3811844;C0017654","",307
"time from symptom onset to start of fibrinolytic therapy hr","C0040044;C0040223;C0040363;C0041260;C0439659;C0449244;C1457887;C1883351;C3541383;C3854129;C4086878",NULL,NULL,1703
"fc ldl c mg dl","C0439269;C2983605","C0023824","",1963
"other europe n $nmbr$ australia n $nmbr$ and india n $nmbr$ the data from these regions were collapsed due to the small numbers","C0004340;C0015176;C0017446;C0021201;C0205147;C0237753;C0344329;C0392748;C0449788;C0678226;C0700321;C1511726;C2700456;C3245479;C3714741",NULL,NULL,168
"$nmbr$ $nmbr$ i $nmbr$ $nmbr$ n $nmbr$ a","C0021966;C0221138",NULL,NULL,1021
"time since diagnosis years","C0011900;C0040223;C0439234;C1704338;C1704656;C3541383",NULL,NULL,1099
"$nmbr$ episodes of atrial fibrillation in previous $nmbr$ mo","C0004238;C0026544;C0205156;C0332177;C0332189;C0344434;C1552607;C1963067",";C0004238","",1009
"duration of diabetes $nmbr$ yrs","C0011847;C0011849;C0449238;C2926735","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"mean sd unless otherwise indicated","C0444504;C1444656;C2347634;C2348143;C2699239",NULL,NULL,37
"etn no","C0014758;C0717758",NULL,NULL,1587
"empagliflozin n $nmbr$","C3490348","C3490348","",1182
"$nmbr$ ci c","C0008107;C3259781",NULL,NULL,519
"test for trend","C0022885;C0039593;C0392366;C0456984;C1515976;C1521798;C3831328;C4318744;C4554533",NULL,NULL,242
"cv death ml ischemic stroke hospitalization for unstable angina revascularization or heart failure","C0002965;C0011065;C0018801;C0018802;C0019993;C0439526;C0581603;C0948008;C1306577;C1705224;C3538987;C3887665;C4048877;C4082313;C4318503;C4552775;C4554158",NULL,NULL,323
"all baricitinib ra n $nmbr$","C3538806;C4044947;C4048756","C4044947","",1956
"previous segmental resection no","C0205156;C1552607;C2987624",NULL,NULL,1044
"egfr ml min $nmbr$ $nmbr$ mz","C0026655;C0439445;C1705291;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"no metformin","C0025598","C0025598","",1345
"randomly assigned to diuretic","C0012798;C1516050;C1552601",NULL,NULL,992
"type $nmbr$ diabetes","C1320657","C0011849;C1320657","",907
"baseline history of vascular disease","C0005847;C0168634;C0683519;C0730226;C0850708;C0944983;C1442488;C1558950;C1801960",NULL,NULL,105
"month $nmbr$ subgroup x treatment interaction p value","C0039798;C0087111;C0332177;C0439231;C1079230;C1515021;C1522326;C1533734;C1704675;C1705169;C1709380;C3538994;C3887704",NULL,NULL,236
"history of chd at baseline d g","C0019664;C0019665;C0168634;C0262512;C0262926;C0280604;C0439267;C1442488;C1705255;C2004062;C3542407",NULL,NULL,970
"lv mass index g m $nmbr$ $nmbr$","C0455825;C0456715;C0600653;C0918012;C1552854;C1637833;C2986546",NULL,NULL,734
"rash","C0015230","","",170
"empagliflozin pooled n $nmbr$","C1709595;C2349200;C3490348;C4522255",NULL,NULL,2332
"no of days to homa ir testing median iqr","C0022065;C0022071;C0039593;C0392366;C0439228;C0549183;C0876920;C1448132;C2347635;C2348144;C2939193",NULL,NULL,634
"$nmbr$ bmi kg m","C0578022;C1532718",";C1305855","",206
"native coronary","C0018787;C0302891",NULL,NULL,1481
"diastolic blood pressure and lp a","C0065058;C0428883;C1305849;C1439335;C4553379","C0428883","",842
"no prior heart failure n $nmbr$ $nmbr$","C0018801;C0018802;C0332152;C2826257;C4554158","C0018801",";C0168634;C1524003",12
"week $nmbr$ n","C0332174;C0439230",NULL,NULL,1012
"bl updrs high","C0005918;C0006413;C0205250;C1299351;C1552663;C2700149;C2827109;C3639721;C3887512;C3889660;C4321237;C4522209",NULL,NULL,834
"cardiovascular therapies no","C0587038",NULL,NULL,648
"use of systemic glucocorticoid at random","C0017710;C0034656;C0205373;C0439605;C1524063","C0017710","",1348
"age $nmbr$ years and bmi $nmbr$ kg m $nmbr$","C0578022;C1510829;C1532718","C1510829","",481
"prior exposure to topiramate","C0076829;C0274281;C0332152;C0332157;C2826257",NULL,NULL,294
"complex lesions","C0221198;C0439855;C1704241",NULL,NULL,472
"hypertension and left ventricular hypertrophy","C0020538;C0149721;C1963138;C3484363","C0149721","",1496
"any mi n $nmbr$ $nmbr$","C3810814",NULL,NULL,516
"unfractionated heparin before randomisation","C0019134;C0034656;C2825026","C0019134","",864
"total body","C0229960",NULL,NULL,1685
"bl mean mmhg","C0005918;C0006413;C0439475;C0444504;C1552663;C2347634;C2348143;C2827109","C0005823","",1469
"mean number of exacerbations in previous y sd","C0205156;C0237753;C0444504;C0449788;C1552607;C2347634;C2348143;C2699239;C4086268",NULL,NULL,37
"community hospital n","C0020003",NULL,NULL,2361
"$nmbr$ to $nmbr$ cells","C0007584;C0007634","","",-10
"central and south america","C0037713;C0205099;C1879652","C0037713","",580
"mean body mass index kg m $nmbr$","C0005893;C0444504;C0578022;C1305855;C1532718;C2347634;C2348143","C1305855","",1734
"time since asthma","C0004096;C0040223;C2984299;C3541383",NULL,NULL,757
"diagnostic catheterization","C0596429","C0018795",";C4049621",267
"chl","C0019829",NULL,NULL,969
"new use of gpa","C0205314;C1524063;C3495801;C4553145",NULL,NULL,25
"weekly number of hives score $nmbr$","C0042109;C0237753;C0332174;C0449788;C0449820;C4050231",NULL,NULL,2058
"index events pe dvt n","C0070939;C0149871;C0441471;C0600653;C0918012;C1552854;C1637833;C1880476;C2926618;C2986546;C3541888;C3899446;C4284304",NULL,NULL,1516
"mtss cfb","C0009002;C1824728",NULL,NULL,145
"moderate $nmbr$ to $nmbr$","C0040363;C0041260;C0205081;C1881878;C1883351;C4049705;C4049706;C4085643;C4321335",NULL,NULL,321
"ras aldosterone inhibitor","C0002006;C0002007;C0034678;C0525678;C1514727","C0002007",";C0034678;C0525678;C1514727",1758
"oat","C0028753;C0331496;C0939905;C3539067;C3897364",NULL,NULL,254
"aspirin or thienopyridines","C0004057;C1120149;C2936588","C0004057","",1366
"education level","C0013621;C0013658","C0013658","",902
"$nmbr$ antihypertensive medication no","C0003364",";C0003364","",1579
"age range y","C0001779;C1514721;C2348147;C3542016","C0001779","",480
"$nmbr$ $nmbr$ mg liter","C0024671;C0026410;C0439269;C0475211;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"baseline vitamin d","C0014695;C0042866;C0168634;C1442488;C2936842;C3537249;C3714503","C0042866","",866
"formoterol tiotropium n $nmbr$ non tiotropium n $nmbr$","C0060657;C0213771;C1518422","C0213771","",1372
"secondary end points $nmbr$","C0027627;C0175668;C0205436;C2349179",NULL,NULL,1484
"orthostatic test","C0022885;C0039593;C0231472;C0392366;C0456984;C1515976;C3831328;C4318744",NULL,NULL,242
"uncontrolled","C0205318","C0205318","",332
"index event no","C0441471;C0600653;C0918012;C1552854;C1637833;C2986546;C4019010",NULL,NULL,412
"low dose aspirin use strata n","C0042153;C0457083;C1947944;C2608320",NULL,NULL,2183
"$nmbr$ $nmbr$ moderate risk","C0035647;C0205081;C1881878;C4049705;C4049706;C4085643;C4321335;C4552904",NULL,NULL,321
"hdl c mg dl","C0439269;C3715113","C0023822","",1962
"faster aspart basal","C0015663;C0123677;C0205112;C0456962;C2985769","C0650607","",354
"low molecular weight heparin no","C0019139;C3536766","C3536766","",1343
"intracranial bleeding","C0151699","C0151699","",384
"lung neoplasm malignant","C0024121;C0205282",NULL,NULL,476
"teriparatide n $nmbr$","C0070093",NULL,NULL,1015
"in stent restenosis of des","C0011702;C3272317;C4551552","C3272317","",2035
"post bronchodilator fevi $nmbr$ predicted","C0681842;C0849974;C1561566;C1882327;C2599594;C4528367",NULL,NULL,1601
"bii mean sd","C0444504;C1413059;C2347634;C2348143;C2699239",NULL,NULL,1287
"chads $nmbr$ score $nmbr$","C0007928;C0449820;C1413373;C4050231","","",2128
"$nmbr$ chlorthalidone n $nmbr$","C0008294","C0008294","",70
"aerobic exercise","C0001701",NULL,NULL,1694
"cough","C0010200;C1961131;C3274924;C4084725;C4084726;C4084727","C0010200","",1388
"moderate cord qva $nmbr$ sfc","C0205081;C1550235;C1706500;C1881878;C3489532;C4049705;C4049706;C4085643;C4321335;C4521536",NULL,NULL,1283
"simplified disease activity index score $nmbr$ $nmbr$","C0449820;C3869582;C4050231","C1292728",";C4050231;C1299351;C2700149;C3887512;C3889660;C4321237;C4522209",101
"continuous variables mean sd","C0439828;C0444504;C0549178;C2347634;C2348143;C2699239",NULL,NULL,1018
"median serum periostin ng mla","C0017887;C0028074;C0219433;C0229671;C0549183;C0599973;C0876920;C1424662;C1546774;C1550100;C2347635;C2348144;C2939193;C3812270",NULL,NULL,203
"over past $nmbr$ years n","C4086728",NULL,NULL,233
"serum calcium mmol l","C0036785;C0728876;C1532563",NULL,NULL,670
"post bronchodilator fev $nmbr$ reversibility","C0449261;C2599594;C3714541","C0449261;C0231999","",1315
"oral or other systemic corticosteroid","C0442027;C4053960;C4521986",NULL,NULL,1649
"lavolta ii","C1710602;C4082587",NULL,NULL,1303
"sex women n","C0009253;C0036864;C0043210;C0079399;C0804628;C1314687;C1522384",NULL,NULL,568
"ics users n","C0815320;C1706077;C4551720","C3540778","",2182
"death","C0011065;C1306577;C4082313;C4552775",NULL,NULL,1855
"serum ctx ng ml","C0010377;C0229671;C0439275;C0631180;C1546774;C1550100;C3539598",NULL,NULL,951
"calculated annual decline mean se","C0036919;C0332181;C0444504;C0444686;C1441506;C2347634;C2348143",NULL,NULL,37
"adjusted hr enl vs lcz $nmbr$ cl","C0456081;C0596019",NULL,NULL,658
"associated with transient or reversible risk factor","C0035648;C0040704;C0205343;C0205374;C0332281",NULL,NULL,733
"heparin at randomization","C0019134;C0034656;C0770546",NULL,NULL,692
"test for interaction between treatment and race","C0022885;C0034510;C0039593;C0039798;C0087111;C0392366;C0456984;C1515976;C1522326;C1533734;C1704675;C1705169;C1706779;C3538994;C3831328;C3853635;C3887704;C4318744",NULL,NULL,242
"$nmbr$ ml min $nmbr$ $nmbr$ m","C0369637;C0439445;C0441923","C3811844;C0017654","",307
"eosinophils $nmbr$ $nmbr$ x $nmbr$ $nmbr$ n $nmbr$","C0014467;C0200638","C0014467","",849
"menopausal status and use of hrt y","C0282402;C1513126;C1524063",NULL,NULL,25
"dd","C3538867;C3814791","","",-10
"intent of early invasive strategy","C0162425;C0205281;C0679199;C1279919;C1283828;C1334278;C1550453",NULL,NULL,762
"vascular access site","C0005847;C0205145;C0589360;C0750138;C1515974;C1558950;C1801960;C2825164",NULL,NULL,743
"baseline bmi $nmbr$ kg m $nmbr$ n $nmbr$ change from baseline to $nmbr$ weeks","C0168634;C0392747;C0439230;C0443172;C0578022;C1442488;C1532718;C1705241;C4319952",NULL,NULL,1735
"pain $nmbr$ mm vas","C0042815;C4330985;C4554674",NULL,NULL,297
"$nmbr$ years simva","C0439234",NULL,NULL,1099
"egfr ml min $nmbr$ $nmbr$ m","C0369637;C0439445;C0441923;C1739039;C3811844;C3812682","C3811844;C0017654","",592
"baseline mayo score","C0168634;C0449820;C0454788;C1077578;C1442488;C4050231",NULL,NULL,425
"hypertension no hypercholesterolemia no","C0020443;C0020538;C1522133;C1963138","","",1390
"pulmonary disease no","C0024115",NULL,NULL,106
"baseline adjusted hr","C0168634;C0456081;C1442488",NULL,NULL,625
"prior stroke tia","C0007787;C0038454;C0332152;C0917805;C1054154;C2826257;C4554100","C0038454;C0332152","",2380
"duration of pd y","C0449238;C2926735;C4553228;C4553229",NULL,NULL,1230
"aclidinium $nmbr$ pg vs placebo","C0030827;C0032042;C0072225;C1266240;C1696465;C1706408;C2699757",NULL,NULL,2329
"native coronary artery lesions","C0205042;C0221198;C0302891","C0205042","",228
"use of clopidogrel","C0070166;C1524063","C0070166",";C0369286;C0033727;C4049621",217
"everolimus eluting","C0541315",NULL,NULL,633
"non cvd deaths","C0007222;C0011065;C1306577;C1518422",NULL,NULL,323
"nnt","C1417750",NULL,NULL,92
"ez simva $nmbr$ $nmbr$ mg","C0024671;C0026410;C0206578;C0439269;C1960952;C2346927;C4321396;C4521761","C0360714;C1142985","",1862
"week $nmbr$ responders n $nmbr$","C0332174;C0439230",NULL,NULL,1012
"htn hx","C0020538;C0262926;C3814444",NULL,NULL,832
"cad and abi $nmbr$ $nmbr$","C1328319;C1504769;C2239547;C3813548;C3888326;C4284121","C1328319","",1233
"absolute risk reduction $nmbr$ cl","C0596019;C3179139",NULL,NULL,171
"age category years n","C0683312;C1510829;C3889287",NULL,NULL,562
"russia ukraine belarus","C0006539;C0035970;C0041580",NULL,NULL,2348
"timi flow grade $nmbr$ of mi culprit vessel post pci","C0005847;C0441800;C0856742;C0919553;C3244287;C3272266;C4049621",NULL,NULL,2355
"total daily insulin dose lu kg","C0021641;C0022718;C0024171;C0024176;C0439209;C1533581;C1579433;C2348070;C2697939;C3714501;C4054209",NULL,NULL,205
"no of prior aedsd","C0332152;C2826257",NULL,NULL,2374
"hub","C0063034;C1414372;C1708389","","",-10
"history of pci with stenting","C0019664;C0019665;C0038257;C0262512;C0262926;C1705255;C2004062;C2348535;C4049621","C1532338","",1661
"using alendronate at baseline","C0102118;C0168634;C1442488;C1524063",NULL,NULL,625
"white race no","C0007457;C0034510;C0043157;C0220938;C1706779;C3853635","C0043157","",1402
"no of drugs","C0013227;C3687832",NULL,NULL,367
"concomitant csdmards other than methotrexate n","C0025677;C0521115","C0242708",";C0026544",231
"incidence rate difference linagliptin placebo $nmbr$ cl","C0032042;C0596019;C1696465;C1705241;C1705242;C1706408;C1708485;C2746078","C2746078","",1185
"$nmbr$ to $nmbr$ uln","C0040363;C0041260;C1519815;C1883351",NULL,NULL,431
"cholesterol mmol liter","C0008377;C0439190;C0475211","C0008377","",1501
"mean disease duration years","C0439234;C0444504;C0872146;C2347634;C2348143","C0449238;C0872146","",903
"puerto rican","C0034043","","",-10
"efficacy measures","C0079809;C0242485;C1280519;C1707887;C1879489",NULL,NULL,2
"apolipoprotein b g l","C0003593;C0439294;C0456615",NULL,NULL,1706
"myocardiai infarction","C0021308",NULL,NULL,2144
"history of heart failure at baseline","C0168634;C0455531;C1442488","C0018801",";C0168634;C1524003",12
"due to ae","C3887670","C0877248","",47
"current cigarette smoking","C0239059;C0521116;C0700219;C1705970",NULL,NULL,797
"patients with dactylitis no","C0030705;C0239161","C0239161","",492
"nyha class iii or iv n $nmbr$","C0022326;C1882086;C4265176","C0018802;C1882083","",453
"post salbutamol fev $nmbr$ fvcb mean sd","C0001927;C0444504;C0687676;C1704687;C2347634;C2348143;C2699239;C3469826;C3714541",NULL,NULL,584
"baseline uacr $nmbr$ mg g","C0168634;C1300563;C1442488",NULL,NULL,2315
"no glucose lowering drugs","C0013227;C0017725;C0441994;C2003888;C3687832",NULL,NULL,441
"urine albumin creatinine ratio mg g","C0455271;C1300563;C1318330","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"$nmbr$ to $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$ n","C0369637;C0439445;C0441923","C3811844;C0017654","",307
"non hispanic black","C0005680;C0027567;C0085756;C0439541;C1518424","C0005680",";C1706779",188
"basdai mean change from baseline","C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C1998004;C2347634;C2348143;C4319952",NULL,NULL,767
"one or more copd exacerbations n n","C0205172;C0205447;C0740304","C0740304","",891
"moderate risk $nmbr$ $nmbr$","C0035647;C0205081;C1881878;C4049705;C4049706;C4085643;C4321335;C4552904",NULL,NULL,321
"igl n $nmbr$","C0021037;C0314619;C2247518",NULL,NULL,1260
"stroke non fatal","C0038454;C1302234;C1518422;C1705232;C4554100",NULL,NULL,507
"age sd y","C0001779;C2699239","C0001779","",480
"predicted","C0681842;C1882327","C0024119","",288
"fvc l","C3714541",NULL,NULL,1599
"$nmbr$ $nmbr$ pmol liter hscrp level","C0439192;C0441889;C0456079;C0475211;C1547707;C2946261",NULL,NULL,987
"patient global assessment of disease activity $nmbr$ $nmbr$ cm vas","C0042815;C3536884;C3827561;C4054228",NULL,NULL,1751
"score on modified rankin scale no","C0449820;C2984908;C3854213;C4050231",NULL,NULL,2053
"change from baseline to eos uu ml","C0168634;C0392747;C0439342;C0443172;C1442488;C1623465;C1705241;C1861303;C4319952",NULL,NULL,625
"diet group n $nmbr$","C0012155;C0012159;C0441848;C1519433;C2983588;C3668949","C0012155","",1199
"ldi mean sd a","C0444504;C2347634;C2348143;C2699239",NULL,NULL,1030
"combination n $nmbr$","C0205195;C1947911;C3811910",NULL,NULL,997
"number of symptom days per week","C0237753;C0332174;C0439228;C0439230;C0449788;C1457887;C3854129",NULL,NULL,613
"febuxostat","C0249529",NULL,NULL,26
"rivaroxaban plus aspirin n $nmbr$","C0004057;C0332287;C1739768","C1739768","",1225
"no fracture history","C0016658;C0019664;C0019665;C0262512;C0262926;C1705255;C2004062",NULL,NULL,2026
"rate in all participants y","C0679646;C0871208;C1521828",NULL,NULL,2009
"rolofylline","C0166128","C0166128",";C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1114758;C1425688;C1521941;C2709207",67
"$nmbr$ degree of ica stenosis","C0201519;C4034225",NULL,NULL,1123
"risk stratum","C0035647;C4552904","C0035647","",173
"duration $nmbr$ to $nmbr$ years n","C0439234;C0449238;C2926735","C0449238","",1989
"acute coronary syndrome","C0948089","C0948089",";C0026544",225
"laba lama","C0999593;C1416775",NULL,NULL,1300
"n $nmbr$ yr km event rate","C0369718;C0439234;C0441471;C0441922;C0871208;C1521828;C3887676;C4019010",NULL,NULL,2008
"modified acc aha lesion class b $nmbr$ c","C0050451;C0101856;C0221198;C0392747;C0456387;C0772110;C1518526;C1546698;C1705943;C3889737",NULL,NULL,452
"chronic stable angina","C0340288",NULL,NULL,1003
"high dose statin pretreatment n $nmbr$","C0360714;C0444956;C1550147;C2709094;C3539075;C3539076","C0360714","",872
"elevated blood pressure","C0020538;C0497247","C0020538","",1365
"low dose edoxaban vs warfarin","C0043031;C0445550;C1708745;C2975435","C0043031","",858
"individuals with pre diabetes n","C0027361;C0237401;C0362046",NULL,NULL,588
"ind $nmbr$ mg q d n $nmbr$","C0439422;C4049864","","",198
"experience n","C0237607;C0596545",NULL,NULL,1460
"sd standard","C1442989;C2699239;C2828392",NULL,NULL,1482
"$nmbr$ l min","C0439393","C3811844;C0017654","",307
"due worsening angina","C0002965;C0678226;C3146286","C0002962",";C1552607;C0428953;C2926063;C3810814;C1424025;C2606415;C1883468",65
"smoking laboratory parameters","C0022877;C0037369;C0449381;C0453996;C1881674;C3244292;C4283904","C0037369","",420
"placebo $nmbr$ $nmbr$","C0032042;C1696465;C1706408","C0032042","",28
"efficacy endpoints","C1280519;C1707887;C2349179","C1707887;C2349179","",1122
"loop at enrollment","C0445022;C1516879;C1696073;C3888021","C0354100","",991
"urinary protein to creatinine ratio","C1096054","C0455271",";C2348885;C1412134;C1515941;C0168634;C1705943;C4019422;C0549183;C0876920;C2362049",80
"creatinine clearance by c g ml min","C0151280;C0439267",NULL,NULL,1486
"repaired congenital shunt","C0009678;C0205340;C0232180;C0542331;C1442858;C1744681",NULL,NULL,478
"$nmbr$ tcz mtx mtx","C0025677;C1417487",NULL,NULL,84
"death or disabling stroke","C0011065;C0038454;C1306577;C4082313;C4552775;C4554100",NULL,NULL,1762
"$nmbr$ kg m $nmbr$ or more","C0205172;C1532718",";C1305855","",206
"serum ctx i ng ml","C0229671;C0439275;C0631180;C1546774;C1550100",NULL,NULL,951
"stratified by","C0205363",NULL,NULL,713
"every day","C0332173;C0439228;C0439505",NULL,NULL,1621
"mri substudy n $nmbr$","C0024485;C1824234;C3890166",NULL,NULL,517
"levodopa dose mean sd mg day","C0023570;C0178602;C0439422;C0444504;C0869039;C1114758;C2347634;C2348143;C2699239",NULL,NULL,2320
"stage $nmbr$ a $nmbr$ $nmbr$ ml min $nmbr$ $nmbr$ m $nmbr$","C0205390;C0369637;C0439445;C0441923;C1300072;C1306673",NULL,NULL,541
"intensive control","C0162425;C0243148;C0522510;C1283828;C1550141;C1550453;C1882979;C2587213;C3274648;C4553389",NULL,NULL,561
"known duration of type $nmbr$ diabetes years","C0205309;C0439234;C0449238;C1320657;C2926735","C0011849;C1320657","",907
"patients with dactylitis","C0030705;C0239161","C0239161","",492
"chads score","C0007928;C0449820;C1413373;C4050231","","",2128
"aspirin $nmbr$ $nmbr$","C0004057","C0004057","",1366
"saudi arabia","C0036243","C0036243","",1381
"cryptogenic localization related","C0332240;C0439849;C0445223;C0475264;C1744691",NULL,NULL,1604
"difference ff vi versus uc","C0205999;C1705241;C1705242;C4554348",NULL,NULL,1597
"haplotype","C0018591",NULL,NULL,602
"insulin use at baseline","C0168634;C0240016;C1442488",NULL,NULL,122
"phosphorus mmol $nmbr$ $nmbr$","C0031705;C0080014;C0439190;C3714498",NULL,NULL,671
"baseline nihss","C0168634;C1442488;C1697238",NULL,NULL,625
"type of mi","C0332307;C1547052;C3810814",NULL,NULL,516
"loading dose of clopidogrel or ticlopidine","C0040207;C0070166;C3714444","C0070166","",216
"insulin","C0021641;C1533581;C1579433;C3714501",NULL,NULL,157
"sulfonylurea use at baseline","C0038766;C0042153;C0168634;C0457083;C1442488;C1947944;C3536898","C0038766","",752
"stroke embolism","C0013922;C0038454;C1704212;C4554100",NULL,NULL,1762
"ics","C0815320;C4551720","C3540778","",2182
"non q wave","C0429089;C1305738;C1518422","C1305738","",385
"bl bml $nmbr$ kg m","C0005918;C0006413;C1532718;C1552663;C2827109",NULL,NULL,655
"hospitalized without airway compromise","C0701159;C4055482",NULL,NULL,1630
"before bronchodilation liters","C0475211;C1371299;C3537072",NULL,NULL,681
"rate estimate $nmbr$ ci","C0008107;C0750572;C0871208;C1521828;C3259781",NULL,NULL,519
"analysis compared with the pretreatment condition baseline n ldl low density lipoprotein csf cerebrospinal fluid","C0002778;C0007806;C0012634;C0023823;C0168634;C0348080;C0936012;C1442488;C1524024;C1550147;C1705253;C1707455;C2709094;C3539075;C3539076;C3864998",NULL,NULL,852
"baseline tg","C0168634;C0337445;C1442488","C0041004","",209
"anti tnf naive n","C0432633;C1448177",NULL,NULL,362
"preoperative blood pressure mm hg patients fulfilling eligibility criteria","C0005823;C0030705;C0439475;C0445204;C1271104;C1272641;C1512693;C1550543","C0005823","",15
"necrotic core mm","C0027540;C0444669;C1167518;C1706352;C1882467;C3274653;C4330985;C4554674",NULL,NULL,1548
"s blocker","C0565930;C2603362",NULL,NULL,1784
"incidence rate per $nmbr$ person years","C0027361;C0439234;C1708485;C2347489","C0021149","",1998
"creatinine mmol","C0010294;C0439190;C1561535","C0600061;C0010294","",952
"grade of hypertension","C0020538;C0441800;C0919553;C1963138;C3244287","C0020538","",1364
"diabetes with target organ disease","C0011847;C0011849;C0012634;C0178784;C1521840;C2986546","C0011849",";C1704656;C3687832;C1705970;C4285062;C1079230;C0449450;C3250443;C0021966;C0221138;C0369718;C0441922;C0684224",909
"$nmbr$ to $nmbr$ $nmbr$ to $nmbr$ mmol mol","C0040363;C0041260;C1883351;C3829066",NULL,NULL,431
"vildagliptin $nmbr$ mg bid n $nmbr$","C0024671;C0026410;C0439269;C1570906;C1960952;C2346927;C4321396;C4521761","C1570906","",2068
"disabling stroke","C0038454;C4554100",NULL,NULL,1762
"dlqi","C3899393",NULL,NULL,527
"change from baseline in hba $nmbr$ c","C0019016;C0168634;C0392747;C0443172;C1442488;C1705241;C1825777;C3538758;C4319952","","",820
"stage i gfr $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$ and stage v gfr $nmbr$ ml min per $nmbr$ $nmbr$ m $nmbr$ were not considered because they included only $nmbr$ and $nmbr$ patient respectively chf congestive","C0007591;C0017654;C0018802;C0021966;C0023806;C0030705;C0205171;C0221138;C0332257;C0369637;C0439445;C0441766;C0441777;C0441923;C0456533;C0702093;C0742742;C0750591;C1424601;C1518422;C1524029;C1720467;C3813700","C3811844;C0017654","",592
"no regular ppi use","C0042153;C0205272;C0358591;C0457083;C0871125;C1947944;C3811894",NULL,NULL,1738
"early start group n $nmbr$","C0439659;C0441848;C1279919",NULL,NULL,1487
"electrocardiographic findings no","C0438154","C1623258","",1129
"baseline chads $nmbr$ a c","C0007928;C0168634;C1413373;C1442488","","",2128
"hbalc $nmbr$ $nmbr$ mmol mol n","C3829066","","",1176
"c $nmbr$ e $nmbr$ fab bolus n $nmbr$","C1186706;C1511237;C1705509;C3812160",NULL,NULL,632
"biometric parameters","C0005544;C0449381;C2718322",NULL,NULL,1187
"cv death ml or ischemic stroke","C0011065;C0439526;C0948008;C1306577;C1705224;C3538987;C3887665;C4048877;C4082313;C4318503;C4552775",NULL,NULL,323
"thiazolidinediones","C1257987;C3541957","C1257987",";C0289779;C1527178;C1705938;C1552866;C2700399;C0168634",72
"treatment with candesartan","C0039798;C0087111;C0717550;C1522326;C1533734;C1705169;C3538994;C3887704",NULL,NULL,236
"dbp mm hg office measurement mean sd","C0242485;C0439475;C0442603;C0444504;C0536221;C2347634;C2348143;C2699239;C3813197;C4281799",NULL,NULL,605
"pinteraction for treatment and history of heart failure","C0039798;C0087111;C0455531;C1522326;C1533734;C1705169;C3538994;C3887704","C0018801",";C0168634;C1524003",12
"class l ll heart failure","C0018801;C0018802;C0456387;C1518526;C1705943;C4554158","C0018802;C1882083","",453
"furosemide equivalent mg kg","C0016860;C0205163;C0439185;C0439272","C0016860","",1162
"change in nt probnp at $nmbr$","C0392747;C0443172;C0669479;C0754710;C1705241;C4319952",NULL,NULL,767
"western europe plus other","C0043129;C0332287","","",599
"computed tomographic angiography","C1536105","","",-10
"graft n","C0181074;C0332835;C1961139",NULL,NULL,462
"$nmbr$ mg $nmbr$ mgc","C0024671;C0026410;C0439269;C1960952;C2346927;C3888239;C4321396;C4521761",NULL,NULL,192
"asqol ls mean change from baseline se","C0023668;C0036919;C0168634;C0392747;C0443172;C0444504;C1442488;C1705241;C2347634;C2348143;C4319952",NULL,NULL,567
"$nmbr$ oh vitamin d ng ml","C0014695;C0042866;C0220853;C0439275;C2936842;C3537249;C3714503","C0042866","",866
"hbalc $nmbr$ $nmbr$ mmol mol","C3829066","","",1176
"first medical contact","C0199168;C0205435;C0205476;C0332158;C0337611;C1279901;C1705415;C3812666",NULL,NULL,639
"b digit symbol substitution omega $nmbr$ fatty acids vs placebo","C0015684;C0032042;C0582802;C0679214;C1555721;C1696465;C1698987;C1706204;C1706408;C1719844;C3241971","C0032042","",28
"ed duration visit $nmbr$","C0449238;C0545082;C1512346;C2826704;C2926735;C3538926",NULL,NULL,276
"hba $nmbr$ c distribution at baseline n","C0019016;C0168634;C0520511;C1442488;C1704711;C1825777;C3538758","","",820
"egfr ml mn $nmbr$ $nmbr$ m $nmbr$","C0026327;C0026405;C0369637;C0439526;C0441923;C1705224;C1739039;C3811844;C3812682;C3887665;C4285072","C3811844;C0017654","",592
"cangrelor n $nmbr$","C1121991","C1121991","",1247
"beta blockers through hospital discharge or day $nmbr$","C0001645;C0332173;C0439228;C0439505;C0586003","C0001645","",959
"body mass index subgroups","C0005893;C0578022;C1079230;C1305855","C1305855","",1734
"low $nmbr$ $nmbr$ and $nmbr$","C0205251;C1550472;C3890211;C4048187;C4321351;C4522223",NULL,NULL,851
"a v n $nmbr$ v n $nmbr$","C0560268;C1272460;C3887614",NULL,NULL,419
"fev $nmbr$ l prebronchodilator fev $nmbr$ predicted","C0681842;C1882327;C2599602;C3714541",NULL,NULL,1599
"post bronchodilator fev $nmbr$ fvc","C2599594;C3714541",NULL,NULL,680
"serious aes","C0205404;C1412268;C2699274",NULL,NULL,916
"cardiovasculardeath myocardial infarction stroke","C0027051;C0038454;C0428953;C2926063;C3810814;C4552959;C4554100",NULL,NULL,646
"bmi o $nmbr$ kg m $nmbr$ n","C0578022;C1532718",NULL,NULL,1735
"any relevant infarct","C0021308;C2347946","C0021308","",1288
"change in das $nmbr$ $nmbr$ $nmbr$","C0051767;C0057671;C0392747;C0443172;C1705241;C4319952",NULL,NULL,767
"body mass index kg m $nmbr$ median q $nmbr$ q $nmbr$","C0005893;C0549183;C0578022;C0876920;C1305855;C1532718;C2347635;C2348144;C2939193","C1305855","",1734
"corticosteroid use n","C0239126","C0239126",";C0168634;C0024671;C0026410;C0439269;C1960952;C2346927;C4321396;C4521761;C1425988;C1947944",120
"large vessel","C0225990",NULL,NULL,747
"moderate or severe decrease in gfr $nmbr$ ml mln per $nmbr$ $nmbr$ m","C0017654;C0205081;C0205082;C0369637;C0392756;C0439526;C0441923;C0547047;C1417190;C1424601;C1705224;C1881878;C3815103;C3887665;C4049705;C4049706;C4050465;C4050466;C4085643;C4321335",NULL,NULL,313
"serum albumin g $nmbr$ $nmbr$","C0036773;C0439267;C0728877",NULL,NULL,953
"renal function at randomization","C0034656;C0232804",NULL,NULL,692
"established cardiovascular disease","C0007222;C0443211;C1272684","C0007222","",1790
"history of hypertension a c","C0455527",NULL,NULL,1498
"silodosin $nmbr$ mg n $nmbr$","C0024671;C0026410;C0439269;C1870115;C1960952;C2346927;C4321396;C4521761",NULL,NULL,192
"$nmbr$ $nmbr$ week n $nmbr$ $nmbr$ $nmbr$ week n $nmbr$","C0332174;C0439230",NULL,NULL,1012
"history of hf hospitalization","C0018488;C0551577;C1313497;C1538440;C3273279","C0018801",";C0168634;C1524003",12
